PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, SY; Giladi, M; Bohbot, H; Hiller, R; Chung, KY; Khananshvili, D				Lee, Su Youn; Giladi, Moshe; Bohbot, Hilla; Hiller, Reuben; Chung, Ka Young; Khananshvili, Daniel			Structure-dynamic basis of splicing-dependent regulation in tissue-specific variants of the sodium-calcium exchanger	FASEB JOURNAL			English	Article						alternative splicing; HDX-MS; intrinsically disordered proteins; conformational dynamics	CA2+ BINDING DOMAINS; NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER; DISORDERED REGIONS; CRYSTAL-STRUCTURE; NCX; DETERMINANTS; FEATURES; ENERGY; SENSOR	Tissue-specific splice variants of Na+/Ca2+ exchangers contain 2 Ca2+-binding regulatory domains (CBDs), CBD1 and CBD2. Ca2+ interaction with CBD1 activates sodium-calcium exchangers (NCXs), and Ca2+ binding to CBD2 alleviates Na+-dependent inactivation. A combination of mutually exclusive (A, B) and cassette (C-F) exons in CBD2 raises functionally diverse splice variants through unknown mechanisms. Here, the effect of exons on CBDs backbone dynamics were investigated in the 2-domain tandem (CBD12) of the brain, kidney, and cardiac splice variants by using hydrogen-deuterium exchange mass spectrometry and stopped-flow techniques. Mutually exclusive exons stabilize interdomain interactions in the apoprotein, which primarily predefines the extent of responses to Ca2+ binding. Deuterium uptake levels were up to 20% lower in the cardiac vs. the brain CBD12, reveling that elongation of the CBD2 FG loop by cassette exons rigidifies the interdomain Ca2+ salt bridge at the 2-domain interface, which secondarily modulates the Ca2+-bound states. In matching splice variants, the extent of Ca2+-induced rigidification correlates with decreased (up to 10-fold) Ca2+ off rates, where the cardiac CBD12 exhibits the slowest Ca2+ off rates. Collectively, structurally disordered/dynamic segments at mutually exclusive and cassette exons have local and distant effects on the folded structures nearby the Ca2+ binding sites, which may serve as a structure-dynamic basis for splicing-dependent regulation of NCX.	[Lee, Su Youn; Chung, Ka Young] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Giladi, Moshe; Bohbot, Hilla; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Sungkyunkwan University (SKKU); Tel Aviv University	Chung, KY (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea.; Khananshvili, D (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	kychung2@skku.edu; dhanan@post.tau.ac.il	Chung, Ka Young/AAO-7984-2020	Khananshvili, Daniel/0000-0002-4202-9966; Chung, Ka Young/0000-0001-9038-9571; Giladi, Moshe/0000-0002-8589-6920	USA-Israel Binational Foundation Research Grant [2009-334]; Israel Science Foundation [825/14]; National Research Foundation of Korea [NRF-2012R1A1A1039220, NRF-2012R1A5A2A28671860, NRF-2015R1A1A1A05027473]; Fields Estate foundation	USA-Israel Binational Foundation Research Grant(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); National Research Foundation of Korea(National Research Foundation of Korea); Fields Estate foundation	This work was supported by USA-Israel Binational Foundation Research Grant 2009-334; Israel Science Foundation Grant 825/14 (to D.K.); and National Research Foundation of Korea Grants NRF-2012R1A1A1039220, NRF-2012R1A5A2A28671860, and NRF-2015R1A1A1A05027473 (to K-Y.C.). The support from the Fields Estate foundation to D.K. is highly appreciated. The authors declare no conflicts of interest.	Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Beckett D, 2012, METHODS MOL BIOL, V796, P261, DOI 10.1007/978-1-61779-334-9_14; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Buljan M, 2013, CURR OPIN STRUC BIOL, V23, P443, DOI 10.1016/j.sbi.2013.03.006; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Dixit M, 2013, J BIOL CHEM, V288, P4194, DOI 10.1074/jbc.M112.423293; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2014, CURR OPIN CHEM BIOL, V21, P34, DOI 10.1016/j.cbpa.2014.03.011; Giladi M, 2015, BIOCHEM J, V465, P489, DOI 10.1042/BJ20141036; Giladi M, 2013, J BIOL CHEM, V288, P23141, DOI 10.1074/jbc.M113.471698; Giladi M, 2012, BIOCHEMISTRY-US, V51, P7313, DOI 10.1021/bi300739z; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Giladi M, 2012, CELL CALCIUM, V51, P478, DOI 10.1016/j.ceca.2012.04.007; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Hatje K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3460; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; Hryshko L, 2008, AM J PHYSIOL-CELL PH, V295, pC869, DOI 10.1152/ajpcell.00420.2008; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Latysheva NS, 2015, PROTEIN SCI, V24, P909, DOI 10.1002/pro.2674; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Mo JJ, 2012, DRUG DISCOV TODAY, V17, P1323, DOI 10.1016/j.drudis.2012.07.006; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Omelchenko A, 1998, J GEN PHYSIOL, V111, P691, DOI 10.1085/jgp.111.5.691; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reilly L., 2015, FASEB J; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	43	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1356	1366		10.1096/fj.15-282251	http://dx.doi.org/10.1096/fj.15-282251			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644350				2022-12-26	WOS:000370387800030
J	Horton, JR; Engstrom, A; Zoeller, EL; Liu, X; Shanks, JR; Zhang, X; Johns, MA; Vertino, PM; Fu, HA; Cheng, XD				Horton, John R.; Engstrom, Amanda; Zoeller, Elizabeth L.; Liu, Xu; Shanks, John R.; Zhang, Xing; Johns, Margaret A.; Vertino, Paula M.; Fu, Haian; Cheng, Xiaodong			Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE INHIBITOR; CELL-PROLIFERATION; ANTITUMOR-ACTIVITY; CANCER; BINDING; POTENT; RBP2; EZH2; METHYLATION; RECOGNITION	The KDM5/JARID1 family of Fe(II)- and alpha-ketoglutarate-dependent demethylases remove methyl groups from tri- and dimethylated lysine 4 of histone H3. Accumulating evidence from primary tumors and model systems supports a role for KDM5A (JARID1A/RBP2) and KDM5B (JARID1B/PLU1) as oncogenic drivers. The KDM5 family is unique among the Jumonji domain-containing histone demethylases in that there is an atypical insertion of a DNA-binding ARID domain and a histone-binding PHD domain into the Jumonji domain, which separates the catalytic domain into two fragments (JmjN and JmjC). Here we demonstrate that internal deletion of the ARID and PHD1 domains has a negligible effect on in vitro enzymatic kinetics of the KDM5 family of enzymes. We present a crystal structure of the linked JmjN-JmjC domain from KDM5A, which reveals that the linked domain fully reconstitutes the cofactor (metal ion and alpha-ketoglutarate) binding characteristics of other structurally characterized Jumonji domain demethylases. Docking studies with GSK-J1, a selective inhibitor of the KDM6/ KDM5 subfamilies, identify critical residues for binding of the inhibitor to the reconstituted KDM5 Jumonji domain. Further, we found that GSK-J1 inhibited the demethylase activity of KDM5C with 8.5-fold increased potency compared with that of KDM5B at 1 mM alpha-ketoglutarate. In contrast, JIB-04 (a paninhibitor of the Jumonji demethylase superfamily) had the opposite effect and was similar to 8-fold more potent against KDM5B than against KDM5C. Interestingly, the relative selectivity of JIB-04 toward KDM5B over KDM5C in vitro translates to a similar to 10-50-fold greater growth-inhibitory activity against breast cancer cell lines. These data define the minimal requirements for enzymatic activity of the KDM5 family to be the linked JmjN-JmjC domain coupled with the immediate C-terminal helical zinc-binding domain and provide structural characterization of the linked JmjN-JmjC domain for the KDM5 family, which should prove useful in the design of KDM5 demethylase inhibitors with improved potency and selectivity.	[Horton, John R.; Liu, Xu; Shanks, John R.; Zhang, Xing; Cheng, Xiaodong] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Johns, Margaret A.; Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Vertino, Paula M.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Engstrom, Amanda] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA; [Zoeller, Elizabeth L.] Emory Univ, Grad Program Canc Biol, Atlanta, GA 30322 USA; [Johns, Margaret A.; Fu, Haian] Emory Univ, Emory Chem Biol Discovery Ctr, Atlanta, GA 30322 USA; [Vertino, Paula M.; Fu, Haian; Cheng, Xiaodong] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University	Cheng, XD (corresponding author), Emory Univ, Dept Biochem, Atlanta, GA 30322 USA.; Cheng, XD (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	xcheng@emory.edu	Horton, John R/ABB-4770-2020; Liu, Xu/AAB-9392-2021	Liu, Xu/0000-0003-2252-7148; Horton, John/0000-0001-9749-8068; Engstrom, Amanda/0000-0002-6796-2752	NCI, National Institutes of Health (NIH), under NCI Chemical Biology Consortium Contract [HHSN261200800001E]; NIH [GM114306-01, CA077337, F31 CA186511]; Winship Cancer Institute of Emory University Cancer Center Support Grant [P30-CA138292]; Arthur and Sarah Merrill Foundation; NIGMS, NIH [T32 GM008367-26]; NATIONAL CANCER INSTITUTE [F31CA186511, P30CA138292, R01CA077337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114306] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH), under NCI Chemical Biology Consortium Contract; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winship Cancer Institute of Emory University Cancer Center Support Grant; Arthur and Sarah Merrill Foundation; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part with Federal funds from NCI, National Institutes of Health (NIH), under NCI Chemical Biology Consortium Contract HHSN261200800001E (to H. F.), NIH Grants GM114306-01 (to X. C.) and CA077337 (to P. M. V.), developmental funds from the Winship Cancer Institute of Emory University Cancer Center Support Grant P30-CA138292 (to P. M. V. and X. C.) and funds from the Arthur and Sarah Merrill Foundation (to X. C.). The Department of Biochemistry of Emory University School of Medicine supported the use of the Southeast Regional Collaborative Access Team synchrotron beamlines at the Advanced Photon Source of Argonne National Laboratory. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, NIH, Training Grant T32 GM008367-26.; Supported by NIH Predoctoral Fellowship F31 CA186511.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bertino EM, 2011, EXPERT OPIN INV DRUG, V20, P1151, DOI 10.1517/13543784.2011.594437; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bradshaw JM, 2015, NAT CHEM BIOL, V11, P525, DOI [10.1038/NCHEMBIO.1817, 10.1038/nchembio.1817]; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; Cao J, 2014, CELL REP, V6, P868, DOI 10.1016/j.celrep.2014.02.004; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Chen Q, 2013, 2013 SEVENTH INTERNATIONAL CONFERENCE ON INTERNET COMPUTING FOR ENGINEERING AND SCIENCE (ICICSE 2013), P9, DOI 10.1109/ICICSE.2013.10; Cheng XD, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P210; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Koehler C, 2008, BIOMOL NMR ASSIGM, V2, P9, DOI 10.1007/s12104-007-9071-7; Kristensen LH, 2012, FEBS J, V279, P1905, DOI 10.1111/j.1742-4658.2012.08567.x; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Maes T, 2015, EPIGENOMICS-UK, V7, P609, DOI [10.2217/EPI.15.9, 10.2217/epi.15.9]; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martinez S, 2015, J BIOL CHEM, V290, P20702, DOI 10.1074/jbc.R115.648691; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Pilke ES, 2015, DRUG DISCOV TODAY, V20, P743, DOI 10.1016/j.drudis.2014.12.013; Rasmussen PB, 2014, EPIGENOMICS-UK, V6, P277, DOI [10.2217/epi.14.14, 10.2217/EPI.14.14]; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Roy TW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm1031; Ryan RJH, 2012, SCIENCE, V336, P1513, DOI 10.1126/science.1223730; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Torres IO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7204; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Upadhyay AK, 2012, J MOL BIOL, V416, P319, DOI 10.1016/j.jmb.2011.12.036; Van Rechem C, 2015, CANCER DISCOV, V5, P255, DOI 10.1158/2159-8290.CD-14-1326; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Waters NJ, 2015, J CONTROL RELEASE, V220, P758, DOI 10.1016/j.jconrel.2015.09.023; Wong SHK, 2015, CANCER CELL, V28, P198, DOI 10.1016/j.ccell.2015.06.003; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251	74	74	80	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2631	2646		10.1074/jbc.M115.698449	http://dx.doi.org/10.1074/jbc.M115.698449			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26645689	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000369626900009
J	Zou, XT; Meng, J; Li, L; Han, WH; Li, CY; Zhong, R; Miao, XX; Cai, J; Zhang, Y; Zhu, DH				Zou, Xiaoting; Meng, Jiao; Li, Li; Han, Wanhong; Li, Changyin; Zhong, Ran; Miao, Xuexia; Cai, Jun; Zhang, Yong; Zhu, Dahai			Acetoacetate Accelerates Muscle Regeneration and Ameliorates Muscular Dystrophy in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ATP CITRATE LYASE; KETONE-BODIES; CELL-PROLIFERATION; STEM-CELLS; IN-VITRO; SUCCINATE-DEHYDROGENASE; FUMARATE-HYDRATASE; GLUCOSE-METABOLISM; SATELLITE CELLS	Acetoacetate (AA) is a ketone body and acts as a fuel to supply energy for cellular activity of various tissues. Here, we uncovered a novel function of AA in promoting muscle cell proliferation. Notably, the functional role of AA in regulating muscle cell function is further evidenced by its capability to accelerate muscle regeneration in normal mice, and it ameliorates muscular dystrophy in mdx mice. Mechanistically, our data from multiparameter analyses consistently support the notion that AA plays a non-metabolic role in regulating muscle cell function. Finally, we show that AA exerts its function through activation of the MEK1-ERK1/2-cyclin D1 pathway, revealing a novel mechanism in which AA serves as a signaling metabolite in mediating muscle cell function. Our findings highlight the profound functions of a small metabolite as signaling molecule in mammalian cells.	[Zou, Xiaoting; Meng, Jiao; Li, Li; Han, Wanhong; Li, Changyin; Zhong, Ran; Zhang, Yong; Zhu, Dahai] Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Zou, Xiaoting; Meng, Jiao; Li, Li; Han, Wanhong; Li, Changyin; Zhong, Ran; Zhang, Yong; Zhu, Dahai] Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Miao, Xuexia; Cai, Jun] Chinese Acad Sci, Key Lab Genom & Precis Med, China Gastrointestinal Canc Res Ctr, Beijing Inst Genom, Beijing 100101, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhang, Y; Zhu, DH (corresponding author), Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.; Zhang, Y; Zhu, DH (corresponding author), Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	dr_zhangyong@126.com; dhzhu@pumc.edu.cn	Zhu, Dahai/ABA-5315-2021; Zhang, Yong/AAH-6147-2021	Meng, Jiao/0000-0001-9645-758X	National Basic Research Program of China [2011CBA01104, 2015CB943103, 2014CB964703]; National Natural Science Foundation of China [31471289, 31030041]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China restricted to cancer development and suggesting that metab-Grants 2011CBA01104, 2015CB943103, and 2014CB964703 and National Natural Science Foundation of China Grants 31471289 and 31030041. The authors declare that they have no conflicts of interest with the contents of this article.	Abdelmegeed MA, 2004, J PHARMACOL EXP THER, V310, P728, DOI 10.1124/jpet.104.066522; Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Areta JL, 2014, NUTR RES, V34, P1000, DOI 10.1016/j.nutres.2014.09.011; Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Averous J, 2012, EXP CELL RES, V318, P217, DOI 10.1016/j.yexcr.2011.10.015; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BALASSE EO, 1971, J CLIN INVEST, V50, P801, DOI 10.1172/JCI106551; Bardella C, 2011, J PATHOL, V225, P4, DOI 10.1002/path.2932; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bhagavati S, 2008, CURR STEM CELL RES T, V3, P219, DOI 10.2174/157488808785740343; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Chen YW, 2010, INT J BIOCHEM CELL B, V42, P2072, DOI 10.1016/j.biocel.2010.09.017; CREMER JE, 1971, BIOCHEM J, V122, P135, DOI 10.1042/bj1220135; Creuzet S, 1998, EXP CELL RES, V243, P241, DOI 10.1006/excr.1998.4100; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Endo T, 2007, REGEN MED, V2, P243, DOI 10.2217/17460751.2.3.243; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FENSELAU A, 1974, LIFE SCI, V15, P811, DOI 10.1016/0024-3205(74)90519-0; FENSELAU A, 1974, BIOCHEMISTRY-US, V13, P3884, DOI 10.1021/bi00716a010; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Garedew A, 2012, CELL METAB, V15, P466, DOI 10.1016/j.cmet.2012.03.003; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hoffman WH, 2002, NEUROSCI LETT, V334, P71, DOI 10.1016/S0304-3940(02)00816-9; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jain SK, 1999, DIABETES, V48, P1850, DOI 10.2337/diabetes.48.9.1850; Jain SK, 2003, DIABETES CARE, V26, P2139, DOI 10.2337/diacare.26.7.2139; Jorquera R, 2001, HUM MOL GENET, V10, P1741, DOI 10.1093/hmg/10.17.1741; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Kamrava M, 2005, ONCOGENE, V24, P7084, DOI 10.1038/sj.onc.1208857; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kyriakidis DA, 2009, AMINO ACIDS, V37, P443, DOI 10.1007/s00726-009-0241-z; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Li XY, 2011, BIOESSAYS, V33, P485, DOI 10.1002/bies.201100026; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Mohanty S, 2005, INDIAN J MED RES, V122, P425; Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; Nordli DR, 2001, PEDIATRICS, V108, P129, DOI 10.1542/peds.108.1.129; Oermann EK, 2012, SEMIN CELL DEV BIOL, V23, P370, DOI 10.1016/j.semcdb.2012.01.013; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; PALMER TN, 1993, BIOCHEM MOL BIOL INT, V29, P255; Pan JW, 1999, EPILEPSIA, V40, P703, DOI 10.1111/j.1528-1157.1999.tb00766.x; PAULI G, 1972, EUR J BIOCHEM, V29, P553, DOI 10.1111/j.1432-1033.1972.tb02021.x; Pollard PJ, 2009, SCIENCE, V324, P192, DOI 10.1126/science.1173362; Riuzzi F, 2012, J CELL SCI, V125, P1440, DOI 10.1242/jcs.092163; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROUS S, 1980, INT J BIOCHEM, V11, P337, DOI 10.1016/0020-711X(80)90302-X; ROUS S, 1973, FEBS LETT, V37, P231, DOI 10.1016/0014-5793(73)80466-1; Russell RR, 1997, J CLIN INVEST, V100, P2892, DOI 10.1172/JCI119838; Samartsev VN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P598, DOI 10.1134/S0006297910050093; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Schonfeld P, 2010, BBA-BIOENERGETICS, V1797, P929, DOI 10.1016/j.bbabio.2010.01.010; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Uehara Y, 2002, DIABETES, V51, P2922, DOI 10.2337/diabetes.51.10.2922; Usas A, 2011, MEDICINA-LITHUANIA, V47, P469, DOI 10.3390/medicina47090068; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang M, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00085; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	87	39	39	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2181	2195		10.1074/jbc.M115.676510	http://dx.doi.org/10.1074/jbc.M115.676510			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645687	Green Published, hybrid			2022-12-26	WOS:000369610400012
J	Agnihothram, SS; Basco, MDS; Mullis, L; Foley, SL; Hart, ME; Sung, K; Azevedo, MP				Agnihothram, Sudhakar S.; Basco, Maria D. S.; Mullis, Lisa; Foley, Steven L.; Hart, Mark E.; Sung, Kidon; Azevedo, Marli P.			Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CELL-DEATH; ACTIVATION; BACTERIA; GASTROENTERITIS; PREVALENCE; POLYMERASE; LIFE	Gastroenteritis caused by bacterial and viral pathogens constitutes a major public health threat in the United States accounting for 35% of hospitalizations. In particular, Salmonella enterica and noroviruses cause the majority of gastroenteritis infections, with emergence of sporadic outbreaks and incidence of increased infections. Although mechanisms underlying infections by these pathogens have been individually studied, little is known about the mechanisms regulating co-infection by these pathogens. In this study, we utilized RAW 264.7 murine macrophage cells to investigate the mechanisms governing co-infection with S. enterica serovar Heidelberg and murine norovirus (MNV). We demonstrate that infection of RAW 264.7 cells with S. enterica reduces the replication of MNV, in part by blocking virus entry early in the virus life cycle, and inducing antiviral cytokines later in the infection cycle. In particular, bacterial infection prior to, or during MNV infection affected virus entry, whereas MNV entry remained unaltered when the virus infection preceded bacterial invasion. This block in virus entry resulted in reduced virus replication, with the highest impact on replication observed during conditions of co-infection. In contrast, bacterial replication showed a threefold increase in MNV-infected cells, despite the presence of antibiotic in the medium. Most importantly, we present evidence that the infection of MNV-infected macrophages by S. enterica blocked MNV-induced apoptosis, despite allowing efficient virus replication. This apoptosis blockade was evidenced by reduction in DNA fragmentation and absence of poly-ADP ribose polymerase (PARP), caspase 3 and caspase 9 cleavage events. Our study suggests a novel mechanism of pathogenesis whereby initial co-infection with these pathogens could result in prolonged infection by either of these pathogens or both together.	[Agnihothram, Sudhakar S.; Basco, Maria D. S.; Mullis, Lisa; Foley, Steven L.; Hart, Mark E.; Sung, Kidon; Azevedo, Marli P.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Azevedo, MP (corresponding author), US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	Marli.Azevedo@fda.hhs.gov		Foley, Steven/0000-0003-3146-4548; Azevedo, Marli/0000-0002-8591-7269	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	The Study was supported by Intramural Funding From the Food and Drug Administration.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Aliabadi N, 2015, EXPERT REV VACCINES, V14, P1241, DOI 10.1586/14760584.2015.1073110; Andino A, 2015, ScientificWorldJournal, V2015, P520179, DOI 10.1155/2015/520179; BAGASRA O, 1992, P NATL ACAD SCI USA, V89, P6285, DOI 10.1073/pnas.89.14.6285; BERNSTEIN MS, 1991, J CLIN INVEST, V88, P540, DOI 10.1172/JCI115337; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Debbink K, 2014, CLIN INFECT DIS, V58, P1746, DOI 10.1093/cid/ciu120; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Foley SL, 2013, MICROBIOL MOL BIOL R, V77, P582, DOI 10.1128/MMBR.00015-13; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Gokulan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077866; Gonzalez MD, 2016, J CLIN MICROBIOL, V54, P142, DOI 10.1128/JCM.02361-15; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Gonzalez-Hernandez MB, 2012, JOVE-J VIS EXP, DOI 10.3791/4297; GREEN SM, 1994, J GEN VIROL, V75, P1883, DOI 10.1099/0022-1317-75-8-1883; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Han S, 2002, ARCH PHARM RES, V25, P895, DOI 10.1007/BF02977011; Hewitt J, 2009, J APPL MICROBIOL, V107, P65, DOI 10.1111/j.1365-2672.2009.04179.x; Hwang S., 2014, CURR PROTOC MICROBIO, V33, p15K21, DOI DOI 10.1002/9780471729259.MC15K02S33; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Knodler LA, 2015, CURR OPIN MICROBIOL, V23, P23, DOI 10.1016/j.mib.2014.10.010; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kolawole AO, 2014, J GEN VIROL, V95, P1958, DOI 10.1099/vir.0.066753-0; KRAKAUER T, 1993, J GEN VIROL, V74, P1653, DOI 10.1099/0022-1317-74-8-1653; Lahti E, 2006, PEDIATR INFECT DIS J, V25, P160, DOI 10.1097/01.inf.0000199265.90299.26; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Lemasters JJ, 1998, BIOFACTORS, V8, P283, DOI 10.1002/biof.5520080316; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; LoBue AD, 2006, VACCINE, V24, P5220, DOI 10.1016/j.vaccine.2006.03.080; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Miyairi I, 2006, CURR OPIN MICROBIOL, V9, P102, DOI 10.1016/j.mib.2005.12.004; Newman KA, 2015, CAN J POLIT SCI, V48, P225, DOI 10.1017/S000842391500013X; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Peltola VT, 2006, INFECT IMMUN, V74, P2562, DOI 10.1128/IAI.74.5.2562-2567.2006; Rha B, 2013, EMERG INFECT DIS, V19, P1214, DOI 10.3201/eid1908.130483; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Scallan E, 2015, FOODBORNE PATHOG DIS, V12, P492, DOI 10.1089/fpd.2014.1915; Smith AM, 2014, CURR TOP MICROBIOL, V385, P327, DOI 10.1007/82_2014_394; Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293; Trivedi TK, 2013, AM J INFECT CONTROL, V41, P654, DOI 10.1016/j.ajic.2012.08.002; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zhong YM, 2006, J INFECTION, V53, P408, DOI 10.1016/j.jinf.2005.12.028	56	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144911	10.1371/journal.pone.0144911	http://dx.doi.org/10.1371/journal.pone.0144911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658916	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900146
J	Holehouse, AS; Naegle, KM				Holehouse, Alex S.; Naegle, Kristen M.			Reproducible Analysis of Post-Translational Modifications in Proteomes-Application to Human Mutations	PLOS ONE			English	Article							NOONAN SYNDROME; PHOSPHORYLATION; CANCER; RESOURCE; PHOSPHOSITE; MECHANISM; EVOLUTION; DATABASE; RAF1	Background Protein post-translational modifications (PTMs) are an important aspect of protein regulation. The number of PTMs discovered within the human proteome, and other proteomes, has been rapidly expanding in recent years. As a consequence of the rate in which new PTMs are identified, analysis done in one year may result in different conclusions when repeated in subsequent years. Among the various functional questions pertaining to PTMs, one important relationship to address is the interplay between modifications and mutations. Specifically, because the linear sequence surrounding a modification site often determines molecular recognition, it is hypothesized that mutations near sites of PTMs may be more likely to result in a detrimental effect on protein function, resulting in the development of disease. Methods and Results We wrote an application programming interface (API) to make analysis of ProteomeScout, a comprehensive database of PTMs and protein information, easy and reproducible. We used this API to analyze the relationship between PTMs and human mutations associated with disease (based on the 'Clinical Significance' annotation from dbSNP). Proteins containing pathogenic mutations demonstrated a significant study bias which was controlled for by analyzing only well-studied proteins, based on their having at least one pathogenic mutation. We found that pathogenic mutations are significantly more likely to lie within eight amino acids of a phosphoserine, phosphotyrosine or ubiquitination site when compared to mutations in general, based on a Fisher's Exact test. Despite the skew of pathogenic mutations occurring on positively charged arginines, we could not account for this relationship based only on residue type. Finally, we hypothesize a potential mechanism for a pathogenic mutation on RAF1, based on its proximity to a phosphorylation site, which represents a subtle regulation difference that may explain why its biochemical effect has failed to be uncovered previously. The combination of the API and a dynamically expanding PTM database will make the reanalysis of this question and other systems-level questions easier in the future.	[Holehouse, Alex S.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Holehouse, Alex S.; Naegle, Kristen M.] Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA; [Naegle, Kristen M.] Washington Univ, Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Naegle, KM (corresponding author), Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA.	knaegle@wustl.edu	Holehouse, Alex/ABE-8308-2020	Holehouse, Alex/0000-0002-4155-5729; Naegle, Kristen/0000-0001-7146-9592				Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Freschi L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.43; Gnad F, 2010, MOL CELL PROTEOMICS, V9, P2642, DOI 10.1074/mcp.M110.001594; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huyck L, 2012, FEBS LETT, V586, P296, DOI 10.1016/j.febslet.2012.01.018; Kobayashi T, 2010, HUM MUTAT, V31, P284, DOI 10.1002/humu.21187; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Leprevost FD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00199; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Matlock MK, 2015, NUCLEIC ACIDS RES, V43, pD521, DOI 10.1093/nar/gku1154; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Moritz A, 2014, SCI SIGNAL, V3, P1; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radivojac P, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn267; Reimand J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.68; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tatarova Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036310; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang YT, 2010, J PROTEOME RES, V9, P5582, DOI 10.1021/pr100394u; Wang Z, 2011, MOL BIOL EVOL, V28, P1131, DOI 10.1093/molbev/msq268; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144692	10.1371/journal.pone.0144692	http://dx.doi.org/10.1371/journal.pone.0144692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659599	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900088
J	Palikhe, NS; Nahirney, D; Laratta, C; Gandhi, VD; Vethanayagam, D; Bhutani, M; Mayers, I; Cameron, L; Vliagoftis, H				Palikhe, Nami Shrestha; Nahirney, Drew; Laratta, Cheryl; Gandhi, Vivek Dipak; Vethanayagam, Dilini; Bhutani, Mohit; Mayers, Irvin; Cameron, Lisa; Vliagoftis, Harissios			Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14(++)CD16(+) Peripheral Blood Monocytes of Patients with Severe Asthma	PLOS ONE			English	Article							CD14(+) CD16(+) MONOCYTES; DIFFERENTIAL EXPRESSION; UP-REGULATION; ALPHA; SUBPOPULATIONS; INFLAMMATION; AIRWAYS; RANTES; CELLS; IL-8	Background Protease-Activated Receptor-2 (PAR-2), a G protein coupled receptor activated by serine proteases, is widely expressed in humans and is involved in inflammation. PAR-2 activation in the airways plays an important role in the development of allergic airway inflammation. PAR-2 expression is known to be upregulated in the epithelium of asthmatic subjects, but its expression on immune and inflammatory cells in patients with asthma has not been studied. Methods We recruited 12 severe and 24 mild/moderate asthmatics from the University of Alberta Hospital Asthma Clinics and collected baseline demographic information, medication use and parameters of asthma severity. PAR-2 expression on blood inflammatory cells was analyzed by flow cytometry. Results Subjects with severe asthma had higher PAR-2 expression on CD14(++)CD16(+) monocytes (intermediate monocytes) and also higher percentage of CD14(++)CD16(+)PAR-2(+) monocytes (intermediate monocytes expressing PAR-2) in blood compared to subjects with mild/moderate asthma. Receiver operating characteristics (ROC) curve analysis showed that the percent of CD14(++)CD16(+)PAR-2(+) in peripheral blood was able to discriminate between patients with severe and those with mild/moderate asthma with high sensitivity and specificity. In addition, among the whole populations, subjects with a history of asthma exacerbations over the last year had higher percent of CD14(++)CD16(+)PAR-2(+) cells in peripheral blood compared to subjects without exacerbations. Conclusions PAR-2 expression is increased on CD14(++)CD16(+) monocytes in the peripheral blood of subjects with severe asthma and may be a biomarker of asthma severity. Our data suggest that PAR-2 -mediated activation of CD14(++)CD16(+) monocytes may play a role in the pathogenesis of severe asthma.	[Palikhe, Nami Shrestha; Nahirney, Drew; Laratta, Cheryl; Gandhi, Vivek Dipak; Vethanayagam, Dilini; Bhutani, Mohit; Mayers, Irvin; Cameron, Lisa; Vliagoftis, Harissios] Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada; [Bhutani, Mohit; Vliagoftis, Harissios] Univ Alberta, Alberta Asthma Ctr, Edmonton, AB, Canada; [Cameron, Lisa] Univ Western Ontario, Dept Pathol, Schulich Sch Med & Dent, London, ON, Canada	University of Alberta; University of Alberta; Western University (University of Western Ontario)	Cameron, L (corresponding author), Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada.	lisa.cameron@schulich.uwo.ca; hari@ualberta.ca	Gandhi, Vivek Dipak/N-1030-2017	Gandhi, Vivek/0000-0003-4561-7277; Laratta, Cheryl/0000-0002-7656-0173	National Sanitarium Association (NSA); Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions (AIHS); GSK-CIHR Research Chair at the University of Alberta	National Sanitarium Association (NSA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); GSK-CIHR Research Chair at the University of Alberta	This work was funded by grants from the National Sanitarium Association (NSA), the Canadian Institutes of Health Research (CIHR), Alberta Innovates Health Solutions (AIHS) and by funds from the GSK-CIHR Research Chair at the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Barnes PJ, 2012, J ALLERGY CLIN IMMUN, V129, P48, DOI 10.1016/j.jaci.2011.11.006; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Crilly A, 2012, ANN RHEUM DIS, V71, P1049, DOI 10.1136/annrheumdis-2011-200703; Davidson CE, 2013, CLIN EXP ALLERGY, V43, P1274, DOI 10.1111/cea.12185; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Fajt Merritt L, 2013, Ann Am Thorac Soc, V10 Suppl, pS158, DOI 10.1513/AnnalsATS.201303-064AW; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Feld M, 2008, J IMMUNOL, V180, P6903, DOI 10.4049/jimmunol.180.10.6903; Hijdra D, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-38; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jatakanon A, 1999, THORAX, V54, P234, DOI 10.1136/thx.54.3.234; Jiang B, 2010, CLIN EXP RHEUMATOL, V28, pS56; Johansson U, 2005, J LEUKOCYTE BIOL, V78, P967, DOI 10.1189/jlb.0704422; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Liang ZK, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-72; Liu BY, 2015, J IMMUNOL, V194, P5150, DOI 10.4049/jimmunol.1402409; Lopez ML, 2014, CELL IMMUNOL, V288, P47, DOI 10.1016/j.cellimm.2014.02.004; Lopez-Pedrera C, 2010, ARTHRITIS RHEUM-US, V62, P869, DOI 10.1002/art.27299; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Okamoto H, 2003, J DERMATOL, V30, P503, DOI 10.1111/j.1346-8138.2003.tb00424.x; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Shpacovitch VM, 2011, IMMUNOLOGY, V133, P329, DOI 10.1111/j.1365-2567.2011.03443.x; Terasawa T, 2015, TRANSL RES, V165, P336, DOI 10.1016/j.trsl.2014.07.008; WANG SY, 1992, IMMUNOLOGY, V77, P298; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zietkowski Z, 2008, RESP MED, V102, P1198, DOI 10.1016/j.rmed.2008.03.010	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144500	10.1371/journal.pone.0144500	http://dx.doi.org/10.1371/journal.pone.0144500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658828	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900058
J	Silva, CO; Petersen, SB; Reis, CP; Rijo, P; Molpeceres, J; Vorum, H; Neves-Petersen, MT				Silva, Catarina Oliveira; Petersen, Steffen B.; Reis, Catarina Pinto; Rijo, Patrcia; Molpeceres, Jesus; Vorum, Henrik; Neves-Petersen, Maria Teresa			Lysozyme Photochemistry as a Function of Temperature. The Protective Effect of Nanoparticles on Lysozyme Photostability	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; GOLD NANOPARTICLES; SILVER NANOPARTICLES; METAL NANOPARTICLES; N-FORMYLKYNURENINE; DISULFIDE BONDS; FLUORESCENCE; TRYPTOPHAN; DITYROSINE; PROTEINS	The presence of aromatic residues and their close spatial proximity to disulphide bridges makes hen egg white lysozyme labile to UV excitation. UVB induced photo-oxidation of tryptophan and tyrosine residues leads to photochemical products, such as, kynurenine, N-formylky-nurenine and dityrosine and to the disruption of disulphide bridges in proteins. We here report that lysozyme UV induced photochemistry is modulated by temperature, excitation power, illumination time, excitation wavelength and by the presence of plasmonic quencher surfaces, such as gold, and by the presence of natural fluorescence quenchers, such as hyaluronic acid and oleic acid. We show evidence that the photo-oxidation effects triggered by 295 nm at 20 degrees C are reversible and non-reversible at 10 degrees C, 25 degrees C and 30 degrees C. This paper provides evidence that the 295 nm damage threshold of lysozyme lies between 0.1 mu W and 0.3 mu W. Protein conformational changes induced by temperature and UV light have been detected upon monitoring changes in the fluorescence emission spectra of lysozyme tryptophan residues and SYPRO (R) Orange. Lysozyme has been conjugated onto gold nanoparticles, coated with hyaluronic acid and oleic acid (HAOA). Steady state and time resolved fluorescence studies of free and conjugated lysozyme onto HAOA gold nanoparticles reveals that the presence of the polymer decreased the rate of the observed photochemical reactions and induced a preference for short fluorescence decay lifetimes. Size and surface charge of the HAOA gold nanoparticles have been determined by dynamic light scattering and zeta potential measurements. TEM analysis of the particles confirms the presence of a gold core surrounded by a HAOA matrix. We conclude that HAOA gold nanoparticles may efficiently protect lysozyme from the photochemical effects of UVB light and this nanocarrier could be potentially applied to other proteins with clinical relevance. In addition, this study confirms that the temperature plays a critical role in the photochemical pathways a protein enters upon UV excitation.	[Silva, Catarina Oliveira; Reis, Catarina Pinto; Rijo, Patrcia] Univ Lusofona, Res Ctr Biosci & Hlth Technol, P-1749024 Lisbon, Portugal; [Silva, Catarina Oliveira; Molpeceres, Jesus] Univ Alcala de Henares, Dept Biomed Sci, Fac Pharm, E-28871 Alcala De Henares, Spain; [Petersen, Steffen B.] Aalborg Univ, Med Photon Lab, Dept Hlth Sci & Technol, Fac Med, DK-9220 Aalborg, Denmark; [Reis, Catarina Pinto] Univ Lisbon, IBEB, Biophys & Biomed Engn, Fac Sci, P-1749016 Lisbon, Portugal; [Vorum, Henrik] Aalborg Univ, Dept Ophthalmol, DK-9000 Aalborg, Denmark; [Neves-Petersen, Maria Teresa] Aalborg Univ, Dept Clin Med, DK-9000 Aalborg, Denmark	Lusofona University; Universidad de Alcala; Aalborg University; Universidade de Lisboa; Aalborg University; Aalborg University	Reis, CP (corresponding author), Univ Lusofona, Res Ctr Biosci & Hlth Technol, P-1749024 Lisbon, Portugal.	catarinapintoreis@gmail.com; nevespetersen@gmail.com	Silva, Catarina/AAV-8108-2020; /Y-9512-2019; Reis, Catarina/M-8132-2013; iMed.ULisboa, NanoBB/B-5393-2014; Rijo, Patrícia/O-2657-2015	/0000-0003-4201-0795; Reis, Catarina/0000-0002-1046-4031; Rijo, Patrícia/0000-0001-7992-8343; Oliveira Silva, Catarina/0000-0002-5077-5176; Neves-Petersen, Maria Teresa/0000-0003-3178-3709	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BBB-BMC/0611/2012]; European Commission [H2020-644242-SAPHELY]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors would like to thank Fundacao para a Ciencia e Tecnologia (FCT) for the financial support under the project reference PTDC/BBB-BMC/0611/2012. The authors acknowledge the funding from the European Commission through the project H2020-644242-SAPHELY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Fundacao para a Ciencia e Tecnologia (FCT) for the financial support under the project reference PTDC/BBB-BMC/0611/2012. The authors acknowledge the funding from the European Commission through the project H2020-644242-SAPHELY.	Ali MS, 2015, SPECTROCHIM ACTA A, V135, P147, DOI 10.1016/j.saa.2014.06.124; ANDERSON EA, 1948, J PHYS COLLOID CHEM, V52, P1345, DOI 10.1021/j150464a007; Anpo M, 2010, NANOSTRUCT SCI TECHN, P1, DOI 10.1007/978-0-387-48444-0; Avanti C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086244; BAYSE GS, 1972, BIOCHIM BIOPHYS ACTA, V284, P34; Blumlein A, 2013, BBA-PROTEINS PROTEOM, V1834, P2064, DOI 10.1016/j.bbapap.2013.06.001; CANFIELD RE, 1965, J BIOL CHEM, V240, P1997; Chang JY, 2002, FEBS LETT, V511, P73, DOI 10.1016/S0014-5793(01)03284-7; Chanphai P, 2015, EUR POLYM J, V67, P224, DOI 10.1016/j.eurpolymj.2015.03.069; Cockell CS, 2002, ORIGINS LIFE EVOL B, V32, P255, DOI 10.1023/A:1016507810083; Correia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116737; Correia M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111617; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050733; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; DIAMOND R, 1974, J MOL BIOL, V82, P371, DOI 10.1016/0022-2836(74)90598-1; DOOLEY MM, 1982, ARCH BIOCHEM BIOPHYS, V218, P459, DOI 10.1016/0003-9861(82)90368-X; Dreaden TM, 2011, J BIOL CHEM, V286, P22632, DOI 10.1074/jbc.M110.212928; Du J, 2012, ANAL LETT, V45, P2236, DOI 10.1080/00032719.2012.682237; Duran N, 2011, APPL MICROBIOL BIOT, V90, P1609, DOI 10.1007/s00253-011-3249-8; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Geerlof A, 2006, ACTA CRYSTALLOGR D, V62, P1125, DOI 10.1107/S0907444906030307; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; GROSSWEINER L I, 1976, Current Topics in Radiation Research Quarterly, V11, P141; Han Q, 2012, BIOCHEM J, V446, P253, DOI 10.1042/BJ20120416; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Kraemer KH, 1978, J INVEST DERMATOL, V70; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lakowicz JR., 1999, PRINCIPLES FLUORESCE, P25; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Maroufi B, 2008, BBA-PROTEINS PROTEOM, V1784, P1043, DOI 10.1016/j.bbapap.2008.03.010; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MEHLER AH, 1950, J BIOL CHEM, V187, P431; Mitra RN, 2008, J PHYS CHEM C, V112, P8159, DOI 10.1021/jp712106d; Moghadam TT, 2012, INT J BIOL MACROMOL, V51, P91, DOI 10.1016/j.ijbiomac.2012.04.020; Moghadam TT, 2011, INT J BIOL MACROMOL, V49, P629, DOI 10.1016/j.ijbiomac.2011.06.021; Murphy CJ, 2005, J PHYS CHEM B, V109, P13857, DOI 10.1021/jp0516846; NERLOVE M, 1966, ECONOMETRICA, V34, P235, DOI 10.2307/1909870; Neves-Petersen MT, 2010, J FLUORESC, V20, P483, DOI 10.1007/s10895-009-0570-z; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Neves-Petersen MT, 2012, UV LIGHT EFFECTS PRO; PHILLIPS DC, 1967, P NATL ACAD SCI USA, V57, P484; PIRIE A, 1972, BIOCHEM J, V128, P1365, DOI 10.1042/bj1281365; PRYOR WA, 1993, J BIOL CHEM, V268, P3120; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shareghi B, 2015, J IND ENG CHEM, V21, P862, DOI 10.1016/j.jiec.2014.04.024; Shen LY, 2012, J COLLOID INTERF SCI, V388, P56, DOI 10.1016/j.jcis.2012.06.079; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Si S, 2007, CHEM-EUR J, V13, P3160, DOI 10.1002/chem.200601492; Sun J, 2011, J CHROMATOGR B, V879, P3053, DOI 10.1016/j.jchromb.2011.09.009; Volden S, 2012, RSC ADV, V2, P11704, DOI 10.1039/c2ra21931j; Water JJ, 2014, EUR J PHARM BIOPHARM, V88, P325, DOI 10.1016/j.ejpb.2014.09.001; Wimmer R, 1997, J BIOTECHNOL, V55, P85, DOI 10.1016/S0168-1656(97)00061-8; Wu LZ, 2008, J MOL STRUCT, V882, P101, DOI 10.1016/j.molstruc.2007.09.016; Xie JB, 2011, PROTEINS, V79, P2505, DOI 10.1002/prot.23074; YAMASHITA S, 1995, BIOSCI BIOTECH BIOCH, V59, P1255, DOI 10.1271/bbb.59.1255; Yang F, 2006, BBA-PROTEINS PROTEOM, V1764, P1389, DOI 10.1016/j.bbapap.2006.06.012; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	62	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144454	10.1371/journal.pone.0144454	http://dx.doi.org/10.1371/journal.pone.0144454			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656259	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900051
J	Weidner, LD; Paris, A; Frankle, WG; Narendran, R				Weidner, Lora D.; Paris, Antonio; Frankle, W. Gordon; Narendran, Rajesh			Safety of Oral Amphetamine Administered during Positron Emission Tomography Scans in Medically Screened Humans	PLOS ONE			English	Article							INDUCED DOPAMINE RELEASE; INDUCED DISPLACEMENT; STRIATUM	Changes in endogenous dopamine levels can be detected in humans using positron emission tomography scans by measuring the amount by which a specific D-2/3 radioligand is displaced. In some cases, a challenge drug such as amphetamine is introduced to increase the amount of dopamine released into the synaptic cleft. Although intravenous amphetamine is often utilized, oral amphetamine has been shown to be just as effective in increasing endogenous dopamine levels. Based on our own use of oral amphetamine as a challenge drug, we have retroactively reviewed our study charts to determine the cardiovascular safety of 0.5 mg kg(-1) oral d-amphetamine. Of 172 amphetamine administrations in 144 individuals, only 2.8% of subjects experienced any transient adverse effects. In addition, we found no clinically relevant differences in increases of vital signs between healthy controls and patients. We therefore reaffirm the safety of 0.5 mg kg(-1) oral amphetamine in subjects previously screened for cardiovascular risk factors.	[Weidner, Lora D.; Paris, Antonio; Frankle, W. Gordon; Narendran, Rajesh] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Frankle, W. Gordon; Narendran, Rajesh] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narendran, R (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	narendranr@upmc.edu		Frankle, William/0000-0003-0356-4197	National Institute on Drug Abuse [R01DA026472, R01AA0188330]; National Institute of Mental Health [R01MH086523]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026472] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The projects covered in this analysis were supported by National Institute on Drug Abuse (http://www.drugabuse.gov/funding) Awards R01DA026472 and R01AA0188330, and by National Institute of Mental Health (http://www.nimh.nih.gov/funding/index.shtml) Award R01MH086523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; ANGRIST B, 1987, BIOL PSYCHIAT, V22, P1357, DOI 10.1016/0006-3223(87)90070-9; Cardenas L, 2004, SYNAPSE, V51, P27, DOI 10.1002/syn.10282; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; LARUELLE M, 1995, J NUCL MED, V36, P1182; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Narendran R, 2009, SYNAPSE, V63, P447, DOI 10.1002/syn.20628; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Willeit M, 2008, NEUROPSYCHOPHARMACOL, V33, P279, DOI 10.1038/sj.npp.1301400; Zack M, 2015, J PSYCHOPHARMACOL, V29, P971, DOI 10.1177/0269881115592338	13	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0140647	10.1371/journal.pone.0140647	http://dx.doi.org/10.1371/journal.pone.0140647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656737	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000366715900003
J	Cheng, JW; Xiao, M; Kudinha, T; Xu, ZP; Sun, LY; Hou, X; Zhang, L; Fan, X; Kong, FR; Xu, YC				Cheng, Jing-Wei; Xiao, Meng; Kudinha, Timothy; Xu, Zhi-Peng; Sun, Lin-Ying; Hou, Xin; Zhang, Li; Fan, Xin; Kong, Fanrong; Xu, Ying-Chun			The Role of Glutamate Dehydrogenase (GDH) Testing Assay in the Diagnosis of Clostridium difficile Infections: A High Sensitive Screening Test and an Essential Step in the Proposed Laboratory Diagnosis Workflow for Developing Countries like China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BINARY TOXIN; GUIDELINES; SOCIETY; STRAIN	The incidence and severity of Clostridium difficile infection (CDI) in North America and Europe has increased significantly since the 2000s. However, CDI is not widely recognized in China and other developing countries due to limited laboratory diagnostic capacity and low awareness. Most published studies on laboratory workflows for CDI diagnosis are from developed countries, and thus may not be suitable for most developing countries. Therefore, an alternative strategy for developing countries is needed. In this study, we evaluated the performance of the Glutamate Dehydrogenase (GDH) test and its associated workflow on 416 fecal specimens from suspected CDI cases. The assay exhibited excellent sensitivity (100.0%) and specificity (92.8%), compared to culture based method, and thus could be a good screening marker for C. difficile but not for indication of toxin production. The VIDAS CDAB assay, which can detect toxin A/B directly from fecal specimens, showed good specificity (99.7%) and positive predictive value (97.2%), but low sensitivity (45.0%) and negative predictive value (88.3%), compared with PCR-based toxin gene detection. Therefore, we propose a practical and efficient GDH test based workflow strategy for the laboratory diagnosis of CDI in developing countries like China. By applying this new workflow, the CDI laboratory diagnosis rate was notably improved in our center, yet the increasing cost was kept at a minimum level. Furthermore, to gain some insights into the genetic population structure of C. difficile isolates from our hospital, we performed MLST and PCR toxin gene typing.	[Cheng, Jing-Wei; Xiao, Meng; Xu, Zhi-Peng; Hou, Xin; Zhang, Li; Fan, Xin; Xu, Ying-Chun] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Cheng, Jing-Wei; Hou, Xin; Fan, Xin] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China; [Kudinha, Timothy; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West, Westmead, NSW 2145, Australia; [Kudinha, Timothy] Charles Sturt Univ, Orange, NSW, Australia; [Sun, Lin-Ying] Taishan Med Sch, Teaching & Res Sect, Clin Lab, Sch Publ Hlth, Tai An, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney; Charles Sturt University; Shandong First Medical University & Shandong Academy of Medical Sciences	Xu, YC (corresponding author), Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	National Natural Science Foundation of China [81501807]; National Research Special Fund for Public Welfare Industry of Health of China [201402001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Special Fund for Public Welfare Industry of Health of China	This study was financially supported by a National Natural Science Foundation of China (grant number 81501807) and National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001). Website: http://www.nhfpc.gov.cn/zwgkzt/pkjjy1/201302/9cb220c8a5704c0a9ebf5ef65a337544.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by a National Natural Science Foundation of China (grant number 81501807) and National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001).	Bartlett JG, 2005, NEW ENGL J MED, V353, P2503, DOI 10.1056/NEJMe058221; Bassetti M, 2012, EXPERT REV ANTI-INFE, V10, P1405, DOI [10.1586/ERI.12.135, 10.1586/eri.12.135]; Burnham CAD, 2013, CLIN MICROBIOL REV, V26, P604, DOI 10.1128/CMR.00016-13; Chen X, 2013, GASTROENTEROL REP, V1, P153, DOI 10.1093/gastro/got029; Cheng AC, 2011, MED J AUSTRALIA, V194, P353, DOI 10.5694/j.1326-5377.2011.tb03006.x; Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Culbreath K, 2012, J CLIN MICROBIOL, V50, P3073, DOI 10.1128/JCM.00992-12; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hawkey PM, 2013, J CLIN MICROBIOL, V51, P3308, DOI 10.1128/JCM.00587-13; Jin K, 2010, J BIOMED RES, V24, P411, DOI 10.1016/S1674-8301(10)60055-3; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Kawada M, 2011, J INFECT CHEMOTHER, V17, P807, DOI 10.1007/s10156-011-0267-5; Kim H, 2014, ANN LAB MED, V34, P235, DOI 10.3343/alm.2014.34.3.235; Kuwata Y, 2015, EUR J CLIN MICROBIOL, V34, P763, DOI 10.1007/s10096-014-2290-9; Lalande V, 2011, J CLIN MICROBIOL, V49, P2714, DOI 10.1128/JCM.01835-10; Murabata Mayumi, 2008, Kansenshogaku Zasshi, V82, P419; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sharp SE, 2010, J CLIN MICROBIOL, V48, P2082, DOI 10.1128/JCM.00129-10; Stewart DB, 2013, J GASTROINTEST SURG, V17, P118, DOI 10.1007/s11605-012-2056-6; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Ticehurst JR, 2006, J CLIN MICROBIOL, V44, P1145, DOI 10.1128/JCM.44.3.1145-1149.2006; U.S. Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Weber I, 2013, INT J MED MICROBIOL, V303, P128, DOI 10.1016/j.ijmm.2013.02.016; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453	31	28	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144604	10.1371/journal.pone.0144604	http://dx.doi.org/10.1371/journal.pone.0144604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659011	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600064
J	Nazari, M; Mahmoudi, M; Rahmani, F; Akhlaghi, M; Beigy, M; Azarian, M; Shamsian, E; Akhtari, M; Mansouri, R				Nazari, Masoumeh; Mahmoudi, Mahdi; Rahmani, Farzaneh; Akhlaghi, Masoomeh; Beigy, Maani; Azarian, Maryam; Shamsian, Elmira; Akhtari, Maryam; Mansouri, Reza			Association of Killer Cell Immunoglobulin-Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							KIR GENES; DISEASE; HLA; POLYMORPHISMS; LINKAGE	Objectives Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by persistent synovitis, ultimately leading to cartilage and bone degeneration. Natural Killer cells and CD28 null T-cells are suspected as role players in RA pathogenesis. These cells are similar in feature and function, as they both exert their cytotoxic effect via Killer Cell Immunoglobulin-Like Receptors (KIR) on their surface. KIR genes have either an inhibitory or activating effect depending on their intracytoplasmic structure. Herein we genotyped 16 KIR genes, 3 pseudo genes and 6 HLA class. genes as their corresponding ligands in RA patients and control subjects. Methods In this case-control study, KIR and HLA genes were genotyped in 400 RA patients and 372 matched healthy controls using sequence-specific primers (SSP-PCR). Differences in the frequency of genes and haplotypes were determined by chi(2) test. Results KIR2DL2, 2DL5a, 2DL5b and activating KIR: KIR2DS5 and 3DS1 were all protective against RA. KIR2DL5 removal from a full Inhibitory KIR haplotype converted the mild protection (OR = 0.56) to a powerful predisposition to RA (OR = 16.47). Inhibitory haplotype No. 7 comprising KIR2DL5 in the absence of KIR2DL1 and KIR2DL3 confers a 14-fold protective effect against RA. Conclusion Individuals carrying the inhibitory KIR haplotype No. 6 have a high potential risk for developing RA.	[Nazari, Masoumeh; Mansouri, Reza] Shahid Sadoughi Univ Med Sci, Dept Immunol, Yazd, Iran; [Nazari, Masoumeh; Mahmoudi, Mahdi; Rahmani, Farzaneh; Akhlaghi, Masoomeh; Beigy, Maani; Azarian, Maryam; Shamsian, Elmira; Akhtari, Maryam] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran; [Rahmani, Farzaneh; Beigy, Maani] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Rahmani, Farzaneh; Beigy, Maani] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr, Tehran, Iran; [Mansouri, Reza] Shahid Sadoughi Univ Med Sci, Dept Immunol, Yazd, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Mahmoudi, M (corresponding author), Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran.	mahmoudim@tums.ac.ir; Rmansori@ssu.ac.ir	azarian, maryam/GPP-4153-2022; Mansouri, Reza/AAO-4962-2021; Akhtari, Maryam/AAD-3787-2020; Beigy, Maani/S-4091-2019	Akhtari, Maryam/0000-0002-5342-3440; Beigy, Maani/0000-0003-2963-3533; Rahmani, Farzaneh/0000-0002-0530-2054; Mahmoudi, Mahdi/0000-0002-8164-8831				Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Ayo CM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003753; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrington M, 2003, THE KIR GENE CLUSTER; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Gagne K, 2002, HUM IMMUNOL, V63, P271, DOI 10.1016/S0198-8859(02)00373-7; Gourraud PA, 2010, IMMUNOGENETICS, V62, P729, DOI 10.1007/s00251-010-0478-4; Khan A., 1995, METHODS DNA ISOLAT 3, P2488; Kogure T, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/65179; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Majorczyk E, 2007, GENES IMMUN, V8, P678, DOI 10.1038/sj.gene.6364433; Majorczyk E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-256; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; McGeough CM, 2012, RHEUMATOL INT, V32, P1647, DOI 10.1007/s00296-011-1838-6; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Middleton D, 2007, TISSUE ANTIGENS, V69, P577, DOI 10.1111/j.1399-0039.2007.00828.x; Moritz F, 2006, NAT CLIN PRACT RHEUM, V2, P153, DOI 10.1038/ncprheum0117; Navarro AG, 2014, J IMMUNOL, V193, P6192, DOI 10.4049/jimmunol.1400859; Orozco G, 2013, BJU INT, V111, P1148, DOI 10.1111/j.1464-410X.2012.11492.x; Rajagopalan S, 2005, J EXP MED, V201, P1025, DOI 10.1084/jem.20050499; Ramirez-De los Santos S, 2012, DIS MARKERS, V33, P201, DOI [10.3233/DMA-2012-0927, 10.1155/2012/486320]; Redelinghuys P, 2015, ANN RHEUMATIC DIS, DOI 10.1136/annrheumdis-2014-206644; Roberts CH, 2014, GENOME MED, V6, DOI 10.1186/gm537; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1234, DOI 10.1093/nar/gks1140; Ryan JC, 2001, IMMUNOL REV, V181, P126, DOI 10.1034/j.1600-065X.2001.1810110.x; Shegarfi H, 2012, SCI WORLD J, P1, DOI 10.1100/2012/491974; Tajik N, 2010, INT J IMMUNOGENET, V37, P159, DOI 10.1111/j.1744-313X.2010.00906.x; Tajik N, 2009, TISSUE ANTIGENS, V74, P22, DOI 10.1111/j.1399-0039.2009.01263.x; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Yen JH, 2006, SCAND J RHEUMATOL, V35, P124, DOI 10.1080/03009740500381252; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159	34	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143757	10.1371/journal.pone.0143757	http://dx.doi.org/10.1371/journal.pone.0143757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658904	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600014
J	Atay, C; Conway, ER; Angus, D; Wiles, J; Baker, R; Chenery, HJ				Atay, Christina; Conway, Erin R.; Angus, Daniel; Wiles, Janet; Baker, Rosemary; Chenery, Helen J.			An Automated Approach to Examining Conversational Dynamics between People with Dementia and Their Carers	PLOS ONE			English	Article							OLDER-PEOPLE; COMMUNICATION SUPPORT; ALZHEIMERS-DISEASE; DISCOURSE ANALYSIS; COHERENCE; MEMORY; STRATEGIES; ADULTS	The progressive neuropathology involved in dementia frequently causes a gradual decline in communication skills. Communication partners who are unaware of the specific communication problems faced by people with dementia (PWD) can inadvertently challenge their conversation partner, leading to distress and a reduced flow of information between speakers. Previous research has produced an extensive literature base recommending strategies to facilitate conversational engagement in dementia. However, empirical evidence for the beneficial effects of these strategies on conversational dynamics is sparse. This study uses a time-efficient computational discourse analysis tool called Discursis to examine the link between specific communication behaviours and content-based conversational engagement in 20 conversations between PWD living in residential aged-care facilities and care staff members. Conversations analysed here were baseline conversations recorded before staff members underwent communication training. Care staff members spontaneously exhibited a wide range of facilitative and non-facilitative communication behaviours, which were coded for analysis of conversation dynamics within these baseline conversations. A hybrid approach combining manual coding and automated Discursis metric analysis provides two sets of novel insights. Firstly, this study revealed nine communication behaviours that, if used by the care staff member in a given turn, significantly increased the appearance of subsequent content-based engagement in the conversation by PWD. Secondly, the current findings reveal alignment between human- and computer-generated labelling of communication behaviour for 8 out of the total 22 behaviours under investigation. The approach demonstrated in this study provides an empirical procedure for the detailed evaluation of content-based conversational engagement associated with specific communication behaviours.	[Atay, Christina; Conway, Erin R.; Chenery, Helen J.] Univ Queensland, Fac Med & Biomed Sci, UQ Ctr Clin Res, Asia Pacific Ctr Neuromodulat, Herston, Qld, Australia; [Conway, Erin R.] Australian Catholic Univ, Sch Allied Hlth, Fac Hlth Sci, Banyo, Qld, Australia; [Angus, Daniel] Univ Queensland, Fac Humanities & Social Sci, Sch Commun & Arts, St Lucia, Qld, Australia; [Angus, Daniel; Wiles, Janet] Univ Queensland, Sch Informat Technol & Elect Engn, Fac Engn Architecture & Informat Technol, St Lucia, Qld, Australia; [Baker, Rosemary] Fac Med & Biomed Sci, UQ Ctr Clin Res, Herston, Qld, Australia; [Chenery, Helen J.] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia	University of Queensland; Australian Catholic University; University of Queensland; University of Queensland; University of Queensland; Bond University	Atay, C (corresponding author), Univ Queensland, Fac Med & Biomed Sci, UQ Ctr Clin Res, Asia Pacific Ctr Neuromodulat, Herston, Qld, Australia.	c.knuepffer@uq.edu.au	Conway, Erin R/F-3987-2010; Wiles, Janet/C-1989-2008	Conway, Erin R/0000-0002-1740-2562; Wiles, Janet/0000-0002-4051-4116; Angus, Daniel/0000-0002-1412-5096	National Health and Medical Research Council (NHMRC) [511208]; J.O. and J.R. Wicking Trust; Australian Research Council (ARC) Centre of Excellence for the Dynamics of Language;  [CE140100041]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); J.O. and J.R. Wicking Trust; Australian Research Council (ARC) Centre of Excellence for the Dynamics of Language(Australian Research Council); 	This work was supported by the National Health and Medical Research Council (NHMRC), Grant ID: 511208 and the J.O. and J.R. Wicking Trust, which is administered by ANZ Trustees. Both grants were awarded to author HJC. This work was also supported by the Australian Research Council (ARC) Centre of Excellence for the Dynamics of Language. This Grant was awarded to authors HJC and JW. Grant number CE140100041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm N, 2004, NEUROPSYCHOL REHABIL, V14, P117, DOI 10.1080/09602010343000147; Angus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038014; Angus D, 2012, IEEE T AUDIO SPEECH, V20, P1795, DOI 10.1109/TASL.2012.2189566; Angus D, 2012, IEEE T VIS COMPUT GR, V18, P988, DOI 10.1109/TVCG.2011.100; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Baker R, 2015, AGEING SOC, V35, P270, DOI 10.1017/S0144686X13000640; Bloom RL, 2013, DISCOURSE ANAL APPL; Broughton M, 2011, INT J NURS STUD, V48, P1436, DOI 10.1016/j.ijnurstu.2011.05.007; Caramelli P, 1998, HDB NEUROLINGUISTICS, P463, DOI DOI 10.1016/B978-012666055-5/50036-8; Carpiac-Claver ML, 2007, HEALTH COMMUN, V22, P59, DOI 10.1080/10410230701310307; Chatwin J, 2004, COMPLEMENT THER MED, V12, P131, DOI 10.1016/j.ctim.2004.07.042; Chatwin J, 2014, DEMENTIA-LONDON, V13, P737, DOI 10.1177/1471301213485231; Clare L, 2004, NEUROPSYCHOL REHABIL, V14, P385, DOI 10.1080/09602010443000074; Conway E, SUPPORTING QUALITY C; Dijkstra K, 2004, J NEUROLINGUIST, V17, P263, DOI 10.1016/S0911-6044(03)00048-4; Dijkstra K, 2002, DISCOURSE PROCESS, V33, P53, DOI 10.1207/S15326950DP3301_03; Edberg A K, 1995, J Psychiatr Ment Health Nurs, V2, P159, DOI 10.1111/j.1365-2850.1995.tb00051.x; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; ERBER NP, 1994, EUR J DISORDER COMM, V29, P269; Fairclough N., 2013, CRITICAL DISCOURSE A; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harvey K, 2013, ROUT INTROD APPL LIN, P1; Hendryx-Bedalov PM, 1999, INT J AGING HUM DEV, V49, P127, DOI 10.2190/KQY0-VC2Q-0RG1-B9NL; Hubbard G, 2003, AGING MENT HEALTH, V7, P351, DOI 10.1080/1360786031000150685; Hubbard G, 2003, AGEING SOC, V23, P99, DOI 10.1017/S0144686X02008991; Hubbard G, 2002, J AGING STUD, V16, P155, DOI 10.1016/S0890-4065(02)00041-5; Laine M, 1998, J NEUROLINGUIST, V11, P79, DOI 10.1016/S0911-6044(98)00006-2; Liddle J, 2012, INT PSYCHOGERIATR, V1, P1; Mansah M, 2014, TAILORING DEMENTIA C, V34; McGilton KS, 2009, WORLDV EVID-BASED NU, V6, P149, DOI 10.1111/j.1741-6787.2009.00155.x; MENTIS M, 1995, J SPEECH HEAR RES, V38, P1054, DOI 10.1044/jshr.3805.1054; Miller J., 2010, SYSTEMATIC ANAL LANG; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; MUNGAS D, 1991, GERIATRICS, V46, P54; MURDOCH BE, 1987, BRAIN LANG, V31, P122, DOI 10.1016/0093-934X(87)90064-2; Parker I., 2014, DISCOURSE DYNAMICS C; Pashek GV, 2006, J MED SPEECH-LANG PA, V14, P143; RIPICH DN, 1988, J SPEECH HEAR DISORD, V53, P8, DOI 10.1044/jshd.5301.08; Savundranayagam MY, 2005, J GERONTOL B-PSYCHOL, V60, pS48, DOI 10.1093/geronb/60.1.S48; Schegloff Emanuel A., 1984, STRUCTURE SOCIAL ACT, P266, DOI DOI 10.1017/CBO9780511665868.018; Smith ER, 2011, INT PSYCHOGERIATR, V23, P256, DOI 10.1017/S1041610210001845; SPINNLER H, 1988, COGNITIVE NEUROPSYCH, V5, P193, DOI 10.1080/02643298808252933; Ulatowska H, 1988, NEUROPSYCHOLOGICAL S, P108; UQ Dementia Care, 2012, COMM STRAT DEM CAR S; Vasse E, 2010, INT PSYCHOGERIATR, V22, P189, DOI 10.1017/S1041610209990615; VITALIANO PP, 1993, J GERONTOL, V48, pP202, DOI 10.1093/geronj/48.4.P202; Watson BM, 2015, LANG COMMUN, V41, P57, DOI 10.1016/j.langcom.2014.10.013; Wetherell M., 2001, DISCOURSE DATA GUIDE	50	9	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144327	10.1371/journal.pone.0144327	http://dx.doi.org/10.1371/journal.pone.0144327			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26658135	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500019
J	Lee, HC; Lo, HC; Lo, DM; Su, MY; Hu, JR; Wu, CC; Chang, SN; Dai, MS; Tsai, CT; Tsai, HJ				Lee, Hung-Chieh; Lo, Hao-Chan; Lo, Dao-Ming; Su, Mai-Yan; Hu, Jia-Rung; Wu, Chin-Chieh; Chang, Sheng-Nan; Dai, Ming-Shen; Tsai, Chia-Ti; Tsai, Huai-Jen			Amiodarone Induces Overexpression of Similar to Versican b to Repress the EGFR/Gsk3b/Snail Signaling Axis during Cardiac Valve Formation of Zebrafish Embryos	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; CUSHION FORMATION; G1 DOMAIN; IN-VITRO; TGF-BETA; HEART; GROWTH; EXPRESSION; CELL	Although Amiodarone, a class III antiarrhythmic drug, inhibits zebrafish cardiac valve formation, the detailed molecular pathway is still unclear. Here, we proved that Amiodarone acts as an upstream regulator, stimulating similar to versican b (s-vcanb) overexpression at zebrafish embryonic heart and promoting cdh-5 overexpression by inhibiting snail1b at atrioventricular canal (AVC), thus blocking invagination of endocardial cells and, as a result, preventing the formation of cardiac valves. A closer investigation showed that an intricate set of signaling events ultimately caused the up-regulation of cdh5. In particular, we investigated the role of EGFR signaling and the activity of Gsk3b. It was found that knockdown of EGFR signaling resulted in phenotypes similar to those of Amiodarone-treated embryos. Since the reduced phosphorylation of EGFR was rescued by knockdown of s-vcanb, it was concluded that the inhibition of EGFR activity by Amiodarone is s-vcanb-dependent. Moreover, the activity of Gsk3b, a downstream effector of EGFR, was greatly increased in both Amiodarone-treated embryos and EGFR-inhibited embryos. Therefore, it was concluded that reduced EGFR signaling induced by Amiodarone treatment results in the inhibition of Snail functions through increased Gsk3b activity, which, in turn, reduces snail1b expression, leading to the up-regulation the cdh5 at the AVC, finally resulting in defective formation of valves. This signaling cascade implicates the EGFR/Gsk3b/Snail axis as the molecular basis for the inhibition of cardiac valve formation by Amiodarone.	[Lee, Hung-Chieh; Hu, Jia-Rung; Tsai, Huai-Jen] Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan; [Lo, Hao-Chan; Lo, Dao-Ming; Su, Mai-Yan; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Wu, Chin-Chieh; Dai, Ming-Shen] Natl Def Med Ctr, Triserv Gen Hosp, Div Hematol Oncol, Taipei, Taiwan; [Chang, Sheng-Nan] Natl Taiwan Univ Hosp, Yun Lin Branch, Cardiovasc Ctr, Yunlin, Taiwan; [Tsai, Chia-Ti] Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan	Mackay Medical College; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, CT (corresponding author), Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	cttsai1999@gmail.com; hjtsai@mmc.edu.tw	DAI, M/GPS-8291-2022	TSAI, CHIA-TI/0000-0002-4853-8665; CHANG, SHENG NAN/0000-0002-2663-5042	National Taiwan University Hospital [UN102-052]; Taiwan National Science Council [NSC102-2313-B-715-001-MY3]; Tri-Service General Hospital [TSGH-C103-046]	National Taiwan University Hospital(National Taiwan University); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This work was supported by the National Taiwan University Hospital (UN102-052) of CTT, by the Taiwan National Science Council (NSC102-2313-B-715-001-MY3) of HJT, and by the Tri-Service General Hospital (TSGH-C103-046) of MSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Burns TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089133; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen YH, 2012, REPROD TOXICOL, V33, P233, DOI 10.1016/j.reprotox.2011.12.008; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Du WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026396; Goishi K, 2003, MECH DEVELOP, V120, P811, DOI 10.1016/S0925-4773(03)00068-6; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Kang JS, 2004, MECH DEVELOP, V121, P301, DOI 10.1016/j.mod.2004.01.007; Kruithof BPT, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.003; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Latif N, 2005, J HEART VALVE DIS, V14, P218; Lee HC, 2015, ONCOTARGET IN PRESS, DOI 10.18632/oncotarget.5621; Lencinas A, 2011, BIRTH DEFECTS RES C, V93, P298, DOI 10.1002/bdrc.20222; Liu AC, 2007, HISTOL HISTOPATHOL, V22, P873, DOI 10.14670/HH-22.873; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Marhaba R, 2004, J MOL HISTOL, V35, P211; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanchez-Soria P, 2010, SEMIN CELL DEV BIOL, V21, P929, DOI 10.1016/j.semcdb.2010.09.011; Schmalfeldt M, 2000, J CELL SCI, V113, P807; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Sherman LS, 2000, J CELL BIOL, V150, P1071, DOI 10.1083/jcb.150.5.1071; Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0; Thisse C, 1999, DEVELOPMENT, V126, P229; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yamagishi T, 2009, ANAT SCI INT, V84, P77, DOI 10.1007/s12565-009-0027-0; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Yang BL, 1999, J CELL BIOCHEM, V72, P210, DOI 10.1002/(SICI)1097-4644(19990201)72:2<210::AID-JCB5>3.0.CO;2-E; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Yutzey KE, 2005, PHYSIOLOGY, V20, P390, DOI 10.1152/physiol.00035.2005; Zanin MKB, 1999, ANAT RECORD, V256, P366; Zhang Y, 1999, J CELL BIOCHEM, V73, P445, DOI 10.1002/(SICI)1097-4644(19990615)73:4<445::AID-JCB3>3.0.CO;2-D; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	48	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144751	10.1371/journal.pone.0144751	http://dx.doi.org/10.1371/journal.pone.0144751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650936	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300073
J	Yeji, F; Shibanuma, A; Oduro, A; Debpuur, C; Kikuchi, K; Owusu-Agei, S; Gyapong, M; Okawa, S; Ansah, E; Asare, GQ; Nanishi, K; Williams, J; Addei, S; Tawiah, C; Yasuoka, J; Enuameh, Y; Sakeah, E; Wontuo, P; Jimba, M; Hodgson, A				Yeji, Francis; Shibanuma, Akira; Oduro, Abraham; Debpuur, Cornelius; Kikuchi, Kimiyo; Owusu-Agei, Seth; Gyapong, Margaret; Okawa, Sumiyo; Ansah, Evelyn; Asare, Gloria Quansah; Nanishi, Keiko; Williams, John; Addei, Sheila; Tawiah, Charlotte; Yasuoka, Junko; Enuameh, Yeetey; Sakeah, Evelyn; Wontuo, Peter; Jimba, Masamine; Hodgson, Abraham		Ghana EMBRACE Implementation Res	Continuum of Care in a Maternal, Newborn and Child Health Program in Ghana: Low Completion Rate and Multiple Obstacle Factors	PLOS ONE			English	Article							FACILITY-BASED DELIVERY; SOCIOECONOMIC DETERMINANTS; NEONATAL-MORTALITY; SERVICES; BARRIERS; KENYA; BIRTH; DISTRICT; SURVIVAL; PROVINCE	Background Slow progress has been made in achieving the Millennium Development Goals 4 and 5 in Ghana. Ensuring continuum of care (at least four antenatal visits; skilled birth attendance; postnatal care within 48 hours, at two weeks, and six weeks) for mother and newborn is crucial in helping Ghana achieve these goals and beyond. This study examined the levels and factors associated with continuum of care (CoC) completion among Ghanaian women aged 15-49. Methods A retrospective cross-sectional survey was conducted among women who experienced live births between January 2011 and April 2013 in three regions of Ghana. In a two-stage random sampling method, 1,500 women with infants were selected and interviewed about maternal and newborn service usage in line with CoC. Multiple logistic regression models were used to assess factors associated with CoC completion. Results Only 8.0% had CoC completion; the greatest gap and contributor to the low CoC was detected between delivery and postnatal care within 48 hours postpartum. About 95% of women had a minimum of four antenatal visits and postnatal care at six weeks postpartum. A total of 75% had skilled assisted delivery and 25% received postnatal care within 48 hours. Factors associated with CoC completion at 95% CI were geographical location (OR = 0.35, CI 0.13-0.39), marital status (OR = 0.45; CI 0.22-0.95), education (OR = 2.71; CI 1.11-6.57), transportation (OR = 1.97; CI 1.07-3.62), and beliefs about childhood illnesses (OR = 0.34; CI0.21-0.61). Conclusion The continuum of care completion rate is low in the study site. Efforts should focus on increasing postnatal care within 48 hours and overcoming the known obstacles to increasing the continuum of care completion rate.	[Yeji, Francis; Oduro, Abraham; Debpuur, Cornelius; Williams, John; Sakeah, Evelyn; Wontuo, Peter] Navrongo Hlth Res Ctr, Navrongo, Upper East, Ghana; [Shibanuma, Akira; Kikuchi, Kimiyo; Okawa, Sumiyo; Nanishi, Keiko; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Owusu-Agei, Seth; Tawiah, Charlotte; Enuameh, Yeetey] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo, Ghana; [Gyapong, Margaret; Addei, Sheila] Dodowa Hlth Res Ctr, Dodowa, Greater Accra, Ghana; [Ansah, Evelyn; Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Asare, Gloria Quansah] Ghana Hlth Serv Headquarters, Accra, Ghana	Navrongo Health Research Center; University of Tokyo; Kintampo Health Research Centre; Ghana Health Service	Yeji, F (corresponding author), Navrongo Hlth Res Ctr, POB 114, Navrongo, Upper East, Ghana.	francis.yeji@gmail.com	Enuameh, Yeetey/AAO-7304-2020; Shibanuma, Akira/C-7652-2016; Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022	Enuameh, Yeetey/0000-0003-3772-7425; Shibanuma, Akira/0000-0003-2058-1722; Debpuur, Cornelius/0000-0003-0968-5280; Gyapong, Margaret/0000-0002-4818-3497; ODURO, ABRAHAM/0000-0002-4191-7419; Ansah, Evelyn/0000-0003-0401-8606; Narh, Clement/0000-0002-4025-5433; Nanishi, Keiko/0000-0001-7067-8413	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute; District Health Management Teams of Kassena Nankana East; Kassena Nankana West; Kintampo North; Kintampo South; Shai-Osudoku; Ningo-Prampram; Dr. Joseph Green of the University of Tokyo	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute; District Health Management Teams of Kassena Nankana East; Kassena Nankana West; Kintampo North; Kintampo South; Shai-Osudoku; Ningo-Prampram; Dr. Joseph Green of the University of Tokyo	This paper was funded by the Japan International Cooperation Agency (JICA) Human Development Department, and JICA Research Institute (http://www.jica.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Ministry of Foreign Affairs in Japan, the Ministry of Health in Ghana, and the Ghana Health Service (GHS). We are particularly thankful to the study participants, and the District Health Management Teams of Kassena Nankana East, Kassena Nankana West, Kintampo North, Kintampo South, Shai-Osudoku, and Ningo-Prampram, for their support for this study. We also want to thank Dr. Joseph Green of the University of Tokyo for his support. The Ghana EMBRACE Implementation Research Project is conducted by the Government of Ghana, Japan International Cooperation Agency (JICA) Human Development Department, and JICA Research Institute. The views expressed in this study are solely that of the authors and do not necessarily represent the official views of the JICA Human Development Department, the JICA Research Institute, and the GHS	Abor PA, 2011, INT J SOC ECON, V38, P628, DOI 10.1108/03068291111139258; Adjuik M, 2010, GLOBAL HEALTH ACTION, V3, P15, DOI 10.3402/gha.v3i0.5233; Afulani PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117996; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; [Anonymous], 2015, GHANA MULTIPLE INDIC; [Anonymous], 2015, ASSESSMENT ANTENATAL; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Bashour HN, 2008, PUBLIC HEALTH NURS, V25, P115, DOI 10.1111/j.1525-1446.2008.00688.x; Bazzano AN, 2008, TROP MED INT HEALTH, V13, P123, DOI 10.1111/j.1365-3156.2007.01981.x; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Bhutta ZA, 2012, INT J GYNECOL OBSTET, V119, pS13, DOI 10.1016/j.ijgo.2012.04.001; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Denham AR, 2010, SOC SCI MED, V71, P608, DOI 10.1016/j.socscimed.2010.04.022; Doku D, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-29; Eliason S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-261; Esena RK, 2013, INTERNATINAL J SCI T, V5, P184; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Fotso JC, 2008, J URBAN HEALTH, V85, P428, DOI 10.1007/s11524-008-9263-1; Gao Y, 2010, REPROD HEALTH MATTER, V18, P35, DOI 10.1016/S0968-8080(10)36523-2; Ghana Health Service, 2008, NAT SAF MOTH SERV PR; Ghana Statistical Service, 2012, MULT IND CLUST SURV; Ghana Statistical Service. Ghana Health Service, 2009, GHAN DEM HLTH SURV 2; Gitimu A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0442-2; Gyapong M, 2013, INT J EPIDEMIOL, V42, P1686, DOI 10.1093/ije/dyt197; Johnson Joseph de Graft, OPPORTUNUTUES AFRICA; Karch LB., 2012, THINKING CHILDREN UN; Kayode GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-165; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Khanal V, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-19; Kikuchi K, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0539-3; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lassi ZS, 2013, J MATERN-FETAL NEO M, V26, P3, DOI 10.3109/14767058.2013.784737; Lawn JE, 2009, BJOG-INT J OBSTET GY, V116, P49, DOI 10.1111/j.1471-0528.2009.02328.x; LIEBOWITZ B, 1970, GERONTOLOGIST, V10, P11, DOI 10.1093/geront/10.1_Part_1.11; Lincetto O, 2006, OPPOR AFR NEWBORNS P; Lincetto O, 2006, ANTENATAL CARE; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mills S, 2008, MATERN CHILD HLTH J, V12, P577, DOI 10.1007/s10995-007-0289-x; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Mwangome FK, 2012, RURAL REMOTE HEALTH, V12; Naariyong S, 2012, MATERN CHILD HLTH J, V16, P1709, DOI 10.1007/s10995-011-0880-z; Nair M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004749; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Nettey OEA, 2010, GLOBAL HEALTH ACTION, V3, P8, DOI 10.3402/gha.v3i0.5258; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Okyere E, 2010, ANN TROP PAEDIATR, V30, P321, DOI 10.1179/146532810X12858955921311; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Phillips JF, 2006, B WORLD HEALTH ORGAN, V84, P949, DOI 10.2471/BLT.06.030064; Project Fives Alive, 2010, BREAKTHR RES POSTN C; Rishworth AC., 2014, WOMENS NAVIGATION MA; Sines E., 2007, POSTNATAL CARE CRITI; Speizer IS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0398-7; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; Tabatabaie MG, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-5; Takahashi Kenzo, 2013, Trop Med Health, V41, P135, DOI 10.2149/tmh.2013-14; The Partnership for Maternal Newborn & Child Health, 2011, STRAT FRAM 2012 2015; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; Titaley CR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-232; Towns AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105972; UNICEF, 2015, STAT WORLDS CHILDR R; UNICEF, 2012, COMM CHILD SURV PROG; UNICEF, 2013, UNICEF 2013 IGME CHI; Warren C, 2006, POSTNATAL CARE OPPOR, P79; Welaga P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058924; WHO UNICEF, 2010, COUNTD 2015 DEC REP; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World health organization, 2013, WORLD HLTH STAT 2013	74	58	58	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142849	10.1371/journal.pone.0142849	http://dx.doi.org/10.1371/journal.pone.0142849			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650388	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300008
J	Chao, KC; Chang, CC; Chiou, HY; Chang, JS				Chao, Kuo-Ching; Chang, Chun-Chao; Chiou, Hung-Yi; Chang, Jung-Su			Serum Ferritin Is Inversely Correlated with Testosterone in Boys and Young Male Adolescents: A Cross-Sectional Study in Taiwan	PLOS ONE			English	Article							METABOLIC SYNDROME; IRON-METABOLISM; HEPCIDIN; MEN; ASSOCIATION; ANDROGENS; ERYTHROPOIESIS; HYPOGONADISM; CYTOKINE; OBESITY	Objective The transition from childhood to teenaged years is associated with increased testosterone and a decreased iron status. It is not clear whether higher testosterone levels cause the decreased iron status, and to what extent, obesity-related inflammation influences the iron-testosterone relationship. The aim of the present study was to examine relationships of testosterone, iron status, and anti-/proinflammatory cytokines in relation to nutritional status in boys and young adolescent Taiwanese males. Methods In total, 137 boys aged 7 similar to 13 yr were included. Parameters for obesity, the iron status, testosterone, and inflammatory markers were evaluated. Results Overweight and obese (ow/obese) boys had higher mean serum testosterone, interleukin (IL)-1 beta, and nitric oxide (NO) levels compared to their normal-weight counterparts (all p<0.05). Mean serum ferritin was slightly higher in ow/obese boys compared to normal-weight boys, but this did not reach statistical significance. A multiple linear regression showed that serum ferritin (beta = -0.7470, p = 0.003) was inversely correlated with testosterone, while serum IL-10 (beta = 0.3475, p = 0.009) was positively associated with testosterone after adjusting for covariates. When normal-weight boys were separately assessed from ow/obesity boys, the association between testosterone and serum ferritin became stronger (beta = -0.9628, p<0.0001), but the association between testosterone and IL-10 became nonsignificant (beta = 0.1140, p = 0.4065) after adjusting for covariates. In ow/obese boys, only IL-10 was weakly associated with serum testosterone (beta = 0.6444, p = 0.051) after adjusting for age. Conclusions Testosterone and serum ferritin are intrinsically interrelated but this relationship is weaker in ow/obese boys after adjusting for age.	[Chao, Kuo-Ching; Chang, Chun-Chao] Taipei Med Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan; [Chao, Kuo-Ching; Chang, Chun-Chao] Taipei Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chang, Jung-Su] Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Chang, JS (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan.	susanchang@tmu.edu.tw		Chiou, Hung Yi/0000-0002-4545-9697	Taipei Medical University Hospital [103TMU-TMUH-11, 104TMU-TMUH-18]; Ministry of Science and Technology, Taiwan [MOST 103-2320-B-038-015, MOST 104-2311-B-038-005]	Taipei Medical University Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Dr. Jung-Su Chang was supported by grants from Taipei Medical University Hospital (103TMU-TMUH-11 and 104TMU-TMUH-18) and the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-038-015 and MOST 104-2311-B-038-005).	Ahmed SA, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P19, DOI 10.1007/978-3-642-02155-8_2; Bachman E, 2014, J GERONTOL A-BIOL, V69, P725, DOI 10.1093/gerona/glt154; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; Barbosa Maritza Cavalcante, 2013, Rev. Bras. Hematol. Hemoter., V35, P29, DOI 10.5581/1516-8484.20130011; Beggs LA, 2014, AM J PHYSIOL-ENDOC M, V307, pE456, DOI 10.1152/ajpendo.00184.2014; Chang JS, 2013, PEDIAT NEON IN PRESS, P1; Chang JS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-123; Chang JS, 2013, ASIA PAC J CLIN NUTR, V22, P400, DOI 10.6133/apjcn.2013.22.3.07; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coviello AD, 2008, J CLIN ENDOCR METAB, V93, P914, DOI 10.1210/jc.2007-1692; Ferrucci L, 2006, ARCH INTERN MED, V166, P1380, DOI 10.1001/archinte.166.13.1380; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Gautier A, 2011, EUR J ENDOCRINOL, V165, P339, DOI 10.1530/EJE-11-0215; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Guo W, 2013, AGING CELL, V12, P280, DOI 10.1111/acel.12052; HAWKINS WW, 1954, BLOOD, V9, P999, DOI 10.1182/blood.V9.10.999.999; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Laarakkers CMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075518; Liu ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075908; Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809; Mogri M, 2013, CLIN ENDOCRINOL, V78, P593, DOI 10.1111/cen.12018; Noetzli LJ, 2012, AM J HEMATOL, V87, P167, DOI 10.1002/ajh.22247; Price EA, 2008, BLOOD CELL MOL DIS, V41, P158, DOI 10.1016/j.bcmd.2008.04.005; Reinehr T, 2005, J CLIN ENDOCR METAB, V90, P5588, DOI 10.1210/jc.2005-0438; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Soderberg S, 2001, INT J OBESITY, V25, P98, DOI 10.1038/sj.ijo.0801467; Soliman Ashraf, 2014, Indian J Endocrinol Metab, V18, P310, DOI 10.4103/2230-8210.131158; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; Uljterschout L, 2014, PEDIATR RES, V76, P409, DOI 10.1038/pr.2014.109; Vandewalle S, 2015, CURR OPIN ENDOCRINOL, V22, P230, DOI 10.1097/MED.0000000000000160; Vyoral D, 2005, INT J BIOCHEM CELL B, V37, P1768, DOI 10.1016/j.biocel.2005.02.023; Wabitsch M, 1997, J CLIN INVEST, V100, P808, DOI 10.1172/JCI119595; Wang CM, 2014, ASIAN PAC J CANCER P, V15, P605, DOI 10.7314/APJCP.2014.15.2.605; Wittert GA, 2003, J GERONTOL A-BIOL, V58, P618; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Zhang YZ, 2007, CELL PHYSIOL BIOCHEM, V20, P847, DOI 10.1159/000110444	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144238	10.1371/journal.pone.0144238	http://dx.doi.org/10.1371/journal.pone.0144238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646112	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100015
J	Mooney, S; Tracy, R; Osler, T; Grace, C				Mooney, Sarah; Tracy, Russell; Osler, Turner; Grace, Christopher			Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; MONOCYTE ACTIVATION; AIDS; POPULATION; MARKERS; INDIVIDUALS; INITIATION; MORTALITY	Background Biomarkers of inflammation and altered coagulation are of increasing interest as predictors of chronic disease and mortality in HIV patients, as well as the use of risk stratification scores such as the Framingham index and the Veterans Aging Cohort Study (VACS) score. Methods Demographic and laboratory data for 252 HIV patients were assessed for their relationship with 5 biomarkers: hsCRP, D-dimer, Cystatin C, IL-6 and TNF-alpha. Analysis of variance was used to model the association between the number of elevated biomarkers patients had and their Framingham 10 year cardiovascular risk and VACS scores. Results 87% of patients were male and 75.7% were virally suppressed (HIV RNA < 48 copies/ml). The median and interquartile ranges for each biomarker were: hsCRP 1.65 ug/mL (0.73, 3.89), D-dimer 0.17 ug/mL (0.09, 0.31), Cystatin C 0.87 mg/L (0.78, 1.01), IL-6 2.13 pg/mL (1.3, 3.59), TNF-alpha 4.65 pg/mL (3.5, 5.97). 62.6% of patients had more than one biomarker > 75th percentile, while 18.6% had three or more elevated biomarkers. Increased age, cigarette smoking, CD4 counts of < 200 cells/mm(3), Framingham scores and VACS scores were most strongly associated with elevations in biomarkers. When biomarkers were used to predict the Framingham and VACS scores, those with a higher number of elevated biomarkers had higher mean VACS scores, with a similar but less robust finding for Framingham scores. Conclusions Despite viral suppression and immunological stability, biomarkers of inflammation and coagulation remain elevated in a significant number of patients with HIV and are associated with higher scores on risk stratification indices.	[Mooney, Sarah; Grace, Christopher] Univ Vermont, Coll Med, Dept Med, Infect Dis Unit, Burlington, VT 05405 USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Pathol & Biochem, Burlington, VT USA; [Osler, Turner] Univ Vermont, Coll Med, Dept Surg, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Grace, C (corresponding author), Univ Vermont, Coll Med, Dept Med, Infect Dis Unit, Burlington, VT 05405 USA.	Christopher.grace@uvmhealth.org						Armah KA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-399; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060008; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; D'Agostino RB, 2012, J INFECT DIS, V205, pS362, DOI 10.1093/infdis/jis196; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Eckard AR, 2014, J INFECT DIS, V209, P1156, DOI 10.1093/infdis/jiu012; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Guzman-Fulgencio M, 2011, J INFECTION, V63, P382, DOI 10.1016/j.jinf.2011.08.006; Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Palella FJ, 2010, AIDS, V24, P1657, DOI 10.1097/QAD.0b013e3283389dfa; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Salmon-Ceron D, 2009, J HEPATOL, V50, P736, DOI 10.1016/j.jhep.2008.11.018; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Silver SA, 2011, TRANSPLANTATION, V92, P183, DOI 10.1097/TP.0b013e31821f303f; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828	32	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144312	10.1371/journal.pone.0144312	http://dx.doi.org/10.1371/journal.pone.0144312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641655	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700096
J	Solari, C; Echegaray, CV; Cosentino, MS; Petrone, MV; Waisman, A; Luzzani, C; Francia, M; Villodre, E; Lenz, G; Miriuka, S; Baranao, L; Guberman, A				Solari, Claudia; Vazquez Echegaray, Camila; Soledad Cosentino, Maria; Victoria Petrone, Maria; Waisman, Ariel; Luzzani, Carlos; Francia, Marcos; Villodre, Emilly; Lenz, Guido; Miriuka, Santiago; Baranao, Lino; Guberman, Alejandra			Manganese Superoxide Dismutase Gene Expression Is Induced by Nanog and Oct4, Essential Pluripotent Stem Cells' Transcription Factors	PLOS ONE			English	Article							STRESS DEFENSE-MECHANISMS; EARLY EMBRYONIC LETHALITY; MUTANT MICE; MOUSE; DIFFERENTIATION; GLUTATHIONE; EMBRYOGENESIS; STAT3	Pluripotent stem cells possess complex systems that protect them from oxidative stress and ensure genomic stability, vital for their role in development. Even though it has been reported that antioxidant activity diminishes along stem cell differentiation, little is known about the transcriptional regulation of the involved genes. The reported modulation of some of these genes led us to hypothesize that some of them could be regulated by the transcription factors critical for self-renewal and pluripotency in embryonic stem cells (ESCs) and in induced pluripotent stem cells (iPSCs). In this work, we studied the expression profile of multiple genes involved in antioxidant defense systems in both ESCs and iPSCs. We found that Manganese superoxide dismutase gene (Mn-Sod/Sod2) was repressed during diverse differentiation protocols showing an expression pattern similar to Nanog gene. Moreover, Sod2 promoter activity was induced by Oct4 and Nanog when we performed a transactivation assay using two different reporter constructions. Finally, we studied Sod2 gene regulation by modulating the expression of Oct4 and Nanog in ESCs by shRNAs and found that downregulation of any of them reduced Sod2 expression. Our results indicate that pluripotency transcription factors positively modulate Sod2 gene transcription.	[Solari, Claudia; Vazquez Echegaray, Camila; Soledad Cosentino, Maria; Victoria Petrone, Maria; Waisman, Ariel; Luzzani, Carlos; Francia, Marcos; Baranao, Lino; Guberman, Alejandra] Univ Buenos Aires, Lab Regulac Genica Celulas Madre, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Solari, Claudia; Vazquez Echegaray, Camila; Soledad Cosentino, Maria; Victoria Petrone, Maria; Waisman, Ariel; Luzzani, Carlos; Francia, Marcos; Baranao, Lino; Guberman, Alejandra] UBA CONICET, Inst Quim Biol IQUIBICEN, Buenos Aires, DF, Argentina; [Villodre, Emilly; Lenz, Guido] Univ Fed Rio Grande do Sul, Lab Sinalizacao Celular, Dept Biofis, Porto Alegre, RS, Brazil; [Miriuka, Santiago] FLENI, LIAN, Buenos Aires, DF, Argentina; [Miriuka, Santiago; Baranao, Lino; Guberman, Alejandra] Consejo Nacl Invest Cientif & Tecn CONICET, Buenos Aires, DF, Argentina; [Guberman, Alejandra] Univ Buenos Aires, Dept Fisiol & Biol Mol & Celular, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal do Rio Grande do Sul; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Guberman, A (corresponding author), Univ Buenos Aires, Lab Regulac Genica Celulas Madre, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.	algub@qb.fcen.uba.ar	Miriuka, Santiago/ABE-9614-2020; Miriuka, Santiago/AAM-4051-2020; Lenz, Guido/A-7618-2008; Villodre, Emilly Schlee/AAF-5786-2021	Miriuka, Santiago/0000-0003-2402-3920; Francia, Marcos Gabriel/0000-0002-9719-8249; Vazquez Echegaray, Camila/0000-0001-8849-6853; Waisman, Ariel/0000-0002-6860-9512	National Scientific and Technical Research Council (CONICET) [PIP 112-200801-03003, PIP112-201101-00243]; National Agency for Science and Technology Promotion (ANPCyT) [PICT 2011-2713]	National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Science and Technology Promotion (ANPCyT)(ANPCyT)	This work was supported by grants (to AG) from the National Scientific and Technical Research Council (CONICET, PIP 112-200801-03003 and PIP112-201101-00243), National Agency for Science and Technology Promotion (ANPCyT, PICT 2011-2713). CS, MSC, AW and CL are fellows from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Losino N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080681; Losino N, 2011, STEM CELLS DEV, V20, P1439, DOI 10.1089/scd.2010.0336; Luzzani C, 2011, BIOCHEM BIOPH RES CO, V410, P816, DOI 10.1016/j.bbrc.2011.06.070; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Sheshadri P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09516; Solari C, 2011, BIOCHEM BIOPH RES CO, V410, P252, DOI 10.1016/j.bbrc.2011.05.126; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; St John JC, 2006, METH MOL B, V331, P347; Stambrook PJ, 2007, MECH AGEING DEV, V128, P31, DOI 10.1016/j.mad.2006.11.007; Tablada, 2014, INFOSTAT STAT SOFTWA; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trouillas M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-73; Ufer C, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00012; Winkler A, 2011, BIOCHEM BIOPH RES CO, V412, P121, DOI 10.1016/j.bbrc.2011.07.056; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327	35	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144336	10.1371/journal.pone.0144336	http://dx.doi.org/10.1371/journal.pone.0144336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642061	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700098
J	Popov, VB; Jornayvaz, FR; Akgul, EO; Kanda, S; Jurczak, MJ; Zhang, DY; Abudukadier, A; Majumdar, SK; Guigni, B; Petersen, KF; Manchem, VP; Bhanot, S; Shulman, GI; Samuel, VT				Popov, Violeta B.; Jornayvaz, Francois R.; Akgul, Emin O.; Kanda, Shoichi; Jurczak, Michael J.; Zhang, Dongyan; Abudukadier, Abulizi; Majumdar, Sachin K.; Guigni, Blas; Petersen, Kitt Falk; Manchem, Vara Prasad; Bhanot, Sanjay; Shulman, Gerald I.; Samuel, Varman T.			Second-generation antisense oligonucleotides against beta-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance	FASEB JOURNAL			English	Article						Wnt pathway; lipid-induced insulin resistance; nonalcoholic fatty liver disease	FATTY LIVER-DISEASE; MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE-1; KINASE-C-EPSILON; DIACYLGLYCEROL ACYLTRANSFERASE; GLUCOSE-METABOLISM; SIGNALING PATHWAY; ADIPOSE-TISSUE; OBESITY; MECHANISM; ADIPOGENESIS	Although mutations in the Wnt/beta-catenin signaling pathway are linked with the metabolic syndrome and type 2 diabetes in humans, the mechanism is unclear. High-fat-fed male C57BL/6 mice were treated for 4 wk with a 2'-O-methoxyethyl chimeric antisense oligonucleotide (ASO) to decrease hepatic and adipose expression of beta-catenin. beta-Catenin mRNA decreased by approximate to 80% in the liver and by 70% in white adipose tissue relative to control ASO-treated mice. beta-Catenin ASO improved hepatic insulin sensitivity and increased insulin-stimulated whole body glucose metabolism, as assessed during hyperinsulinemic-euglycemic clamp in awake mice. beta-Catenin ASO altered hepatic lipid composition in high-fat-fed mice. There were reductions in hepatic triglyceride (44%, P < 0.05) and diacylglycerol content (60%, P < 0.01) but a 30% increase in ceramide content (P < 0.001). The altered lipid content was attributed to decreased expression of sn-1,2 diacylglycerol acyltransferase and mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase and an increase in serine palmitoyl transferase. The decrease in cellular diacyglycerol was associated with a 33% decrease in PKC epsilon activation (P < 0.05) and 64% increase in Akt2 phosphorylation (P < 0.05). In summary, Reducing-catenin expression decreases expression of enzymes involved in hepatic fatty acid esterification, ameliorates hepatic steatosis and lipid-induced insulin resistance.	[Popov, Violeta B.; Jornayvaz, Francois R.; Akgul, Emin O.; Kanda, Shoichi; Jurczak, Michael J.; Zhang, Dongyan; Abudukadier, Abulizi; Majumdar, Sachin K.; Guigni, Blas; Petersen, Kitt Falk; Shulman, Gerald I.; Samuel, Varman T.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Shulman, Gerald I.; Samuel, Varman T.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA; [Samuel, Varman T.] W Haven Vet Affairs Med Ctr, West Haven, CT USA; [Manchem, Vara Prasad; Bhanot, Sanjay] ISIS Pharmaceut, 2280 Faraday Ave, Carlsbad, CA 92008 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Isis Pharmaceuticals Inc	Samuel, VT (corresponding author), Yale Univ, Sch Med, POB 208020, New Haven, CT 06520 USA.	varman.samuel@yale.edu	Shulman, Gerald I./P-7176-2019; Jornayvaz, François/AAL-2134-2020	Shulman, Gerald I./0000-0003-1529-5668; Jornayvaz, Francois/0000-0001-9425-3137; Guigni, Blas/0000-0002-9667-8195	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK-40936, P30 DK-45735, U24 DK-059635, P30 DK-034989, T32 DK007356-31]; NIH National Institute on Aging Grant [R01 AG-23686]; Distinguished Clinical Investigator Award from the American Diabetes Association; Veterans Affairs Merit Grant [I01 BX000901]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, U24DK059635, P30DK045735, R01DK040936, T32DK007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000901] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging Grant; Distinguished Clinical Investigator Award from the American Diabetes Association; Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Mario Kahn and Aida Groszmann (Yale University School of Medicine) for their expert technical assistance with the studies. These studies were supported by grants from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases R01 DK-40936, P30 DK-45735, U24 DK-059635 (to G.I.S.), P30 DK-034989 and T32 DK007356-31 (to V.B.P.); NIH National Institute on Aging Grant R01 AG-23686 (to G.I.S.); Distinguished Clinical Investigator Award from the American Diabetes Association (to K.F.P); and a Veterans Affairs Merit Grant I01 BX000901 (to V.T.S).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Baker BF, 2001, METHODS, V23, P191, DOI 10.1006/meth.2000.1120; Behari J, 2014, AM J PATHOL, V184, P3284, DOI 10.1016/j.ajpath.2014.08.022; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Geary R S, 2001, Curr Opin Investig Drugs, V2, P562; Graham MJ, 1998, J PHARMACOL EXP THER, V286, P447; Graham MJ, 2001, BIOCHEM PHARMACOL, V62, P297, DOI 10.1016/S0006-2952(01)00669-4; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Li XF, 2012, P NATL ACAD SCI USA, V109, P11402, DOI 10.1073/pnas.1205015109; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Liu SG, 2012, HEPATOLOGY, V55, P931, DOI 10.1002/hep.24766; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Orsulic S, 1999, J CELL SCI, V112, P1237; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	54	9	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1207	1217		10.1096/fj.15-271999	http://dx.doi.org/10.1096/fj.15-271999			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644352	Green Published			2022-12-26	WOS:000370387800018
J	Rousseau, AS; Sibille, B; Murdaca, J; Mothe-Satney, I; Grimaldi, PA; Neels, JG				Rousseau, Anne-Sophie; Sibille, Brigitte; Murdaca, Joseph; Mothe-Satney, Isabelle; Grimaldi, Paul A.; Neels, Jaap G.			alpha-Lipoic acid up-regulates expression of peroxisome proliferator-activated receptor beta in skeletal muscle: involvement of the JNK signaling pathway	FASEB JOURNAL			English	Article						antioxidant; exercise; stress kinases; C2C12; mice	GAMMA-CYCLODEXTRIN COMPLEX; INDUCED INSULIN-RESISTANCE; OBESE ZUCKER RATS; PPAR-DELTA; PROTEIN EXPRESSION; KINASE ACTIVATION; OXIDATIVE STRESS; ACUTE EXERCISE; MICE; AMPK	We hypothesized that alpha-lipoic acid (alpha-LA) might interact with the transcriptional control of peroxisome proliferator-activated receptor (PPAR)beta in skeletal muscle. Molecular mechanisms were investigated using differentiated C2C12 myotubes treated with alpha-LA and/or PPAR beta agonist GW0742. In vivo studies with 3-mo-old C57Bl6 mice were realized: voluntary wheel running (VWR) training (7 wk), and a 6 wk diet containing (or not) alpha-LA (0.25% wt/wt). This last condition was combined with (or not) 1 bout of treadmill exercise (18 m/min for 1 h). Using a reporter assay, we demonstrate that alpha-LA is not an agonist of PPAR beta but regulates PPAR beta target gene expression through an active PPAR beta pathway. GW0742-induced pyruvate dehydrogenase kinase 4 mRNA is potentiated by alpha-LA. In C2C12, alpha-LA lowers the activation of the JNK signaling pathway and increases PPAR beta mRNA and protein levels (2-fold) to the same extent as with the JNK inhibitor SP600125. Similarly to VWR training effect, PPAR beta expression increases (2-fold) in vastus lateralis of animals fed an alpha-LA-enriched diet. However, alpha-LA treatment does not further stimulate the adaptive up-regulation of PPAR beta observed in response to 1 bout of exercise. We have identified a novel mechanism of regulation of PPAR beta expression/action in skeletal muscle with potential physiologic application through the action of alpha-LA, involving the JNK pathway.	Fac Med Nice, INSERM, U1065, Mediterranean Ctr Mol Med C3M, U210, F-06034 Nice, France; Univ Nice Sophia Antipolis, F-06204 Nice 3, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Rousseau, AS (corresponding author), Univ Nice Sophia Antipolis, INSERM, U1065, Mediterranean Ctr Mol Med C3M,Team Adapt Response, Batiment Univ Archimed,151 Route Ginestiere BP 2, F-06204 Nice 3, France.	anne-sophie.rousseau@unice.fr	Rousseau, Anne-Sophie/R-2494-2016; Sibille, Brigitte/Q-8240-2016; Neels, Jaap G/F-5534-2010; MOTHE-SATNEY, ISABELLE/Q-6377-2016	Rousseau, Anne-Sophie/0000-0003-3477-3872; Sibille, Brigitte/0000-0001-6806-0454; Neels, Jaap G/0000-0002-5900-8395; MOTHE-SATNEY, ISABELLE/0000-0002-2693-8385	INSERM; University of Nice Sophia Antipolis; Agence Francaise de Lutte Contre le Dopage (Appel a projet); Association Nationale pour le Traitement a Domicile des Insuffisants Respiratoires (Appel a Projet)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Nice Sophia Antipolis; Agence Francaise de Lutte Contre le Dopage (Appel a projet); Association Nationale pour le Traitement a Domicile des Insuffisants Respiratoires (Appel a Projet)	The authors thank Veronique Corcelle and the animal facility staff [Unite 1065, C3M, Institut National de la Sante et de la Recherche Medicale (INSERM)] for their excellent care of mice. This work was supported by the INSERM, University of Nice Sophia Antipolis, Agence Francaise de Lutte Contre le Dopage (Appel a projet 2010), and Association Nationale pour le Traitement a Domicile des Insuffisants Respiratoires (Appel a Projet 2014). The authors declare no conflicts of interest.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Chen W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09884; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou TC, 2011, J AGR FOOD CHEM, V59, P3050, DOI 10.1021/jf103940u; de Matos MA, 2014, CELL STRESS CHAPERON, V19, P263, DOI 10.1007/s12192-013-0453-8; Drosatos K, 2011, J BIOL CHEM, V286, P36331, DOI 10.1074/jbc.M111.272146; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Gaudel C, 2008, AM J PHYSIOL-ENDOC M, V295, pE297, DOI 10.1152/ajpendo.00581.2007; Giordano C, 2009, PFLUG ARCH EUR J PHY, V458, P901, DOI 10.1007/s00424-009-0676-9; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Kinnunen S, 2009, FREE RADICAL RES, V43, P697, DOI 10.1080/10715760903037673; Lendoye E, 2011, MOL ENDOCRINOL, V25, P1487, DOI 10.1210/me.2010-0504; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mille-Hamard L, 2015, MOL CELL BIOCHEM, V405, P223, DOI 10.1007/s11010-015-2413-3; Naito Y, 2014, J CLIN BIOCHEM NUTR, V55, P97, DOI 10.3164/jcbn.14-56; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Neels JG, 2014, PHYSIOL REV, V94, P795, DOI 10.1152/physrev.00027.2013; Nikolai S, 2014, NUTRITION, V30, P228, DOI 10.1016/j.nut.2013.08.002; Packer L, 2011, J CLIN BIOCHEM NUTR, V48, P26, DOI 10.3164/jcbn.11-005FR; Pershadsingh H. A., 2005, Journal of Applied Research, V5, P510; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; Rochette L, 2013, MOL NUTR FOOD RES, V57, P114, DOI 10.1002/mnfr.201200608; Ropelle ER, 2006, J PHYSIOL-LONDON, V577, P997, DOI 10.1113/jphysiol.2006.120006; Russell AP, 2005, FASEB J, V19, P986, DOI 10.1096/fj.04-3168fje; Saengsirisuwan V, 2004, AM J PHYSIOL-ENDOC M, V287, pE529, DOI 10.1152/ajpendo.00013.2004; Saengsirisuwan V, 2001, J APPL PHYSIOL, V91, P145, DOI 10.1152/jappl.2001.91.1.145; Santos FR, 2012, ARCH PHYSIOL BIOCHEM, V118, P231, DOI 10.3109/13813455.2012.713366; Schnegg CI, 2012, FREE RADICAL BIO MED, V52, P1734, DOI 10.1016/j.freeradbiomed.2012.02.032; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shearer BG, 2010, J MED CHEM, V53, P1857, DOI 10.1021/jm900464j; Shen QWW, 2007, AM J PHYSIOL-CELL PH, V293, pC1395, DOI 10.1152/ajpcell.00115.2007; Stabler SP, 2009, FREE RADICAL BIO MED, V47, P1147, DOI 10.1016/j.freeradbiomed.2009.07.019; Vijayvargia R, 2010, OBESITY, V18, P1701, DOI 10.1038/oby.2009.501; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; Wang KC, 2013, CLIN SCI, V125, P329, DOI 10.1042/CS20120560; Wang Y, 2010, METABOLISM, V59, P967, DOI 10.1016/j.metabol.2009.10.018; Ying ZK, 2011, INFLAMM RES, V60, P219, DOI 10.1007/s00011-010-0256-7	45	10	11	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1287	1299		10.1096/fj.15-280453	http://dx.doi.org/10.1096/fj.15-280453			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26655383				2022-12-26	WOS:000370387800024
J	Takyar, S; Zhang, Y; Haslip, M; Jin, L; Shan, PY; Zhang, XC; Lee, PJ				Takyar, Seyedtaghi; Zhang, Yi; Haslip, Maria; Jin, Lei; Shan, Peiying; Zhang, Xuchen; Lee, Patty J.			An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury	FASEB JOURNAL			English	Article						TLR4; VEGF; HALI; lung injury	GROWTH FACTOR+936 GENOTYPE; VEGF RECEPTOR TRAFFICKING; TOLL-LIKE RECEPTORS; OXIDATIVE STRESS; CELL APOPTOSIS; TLR4; DEFICIENCY; ACTIVATION; CYTOPROTECTION; IDENTIFICATION	TLR4 deficiency causes hypersusceptibility to oxidant-induced injury. We investigated the role of TLR4 in lung protection, using used bone marrow chimeras; cell-specific transgenic modeling; and lentiviral delivery in vivo to knock down or express TLR4 in various lung compartments; and lung-specific VEGF transgenic mice to investigate the effect of TLR4 on VEGF-mediated protection. C57/BL6 mice were exposed to 100% oxygen in an enclosed chamber and assessed for survival and lung injury. Primary endothelial cells were stimulated with recombinant VEGF and exposed to hyperoxia or hydrogen peroxide. Endothelium-specific expression of human TLR4 (as opposed to its expression in epithelium or immune cells) increased the survival of TLR4-deficent mice in hyperoxia by 24 h and decreased LDH release and lung cell apoptosis after 72 h of exposure by 30%. TLR4 expression was necessary and sufficient for the protective effect of VEGF in the lungs and in primary endothelial cells in culture. TLR4 knockdown inhibited VEGF signaling through VEGF receptor 2 (VEGFR2), Akt, and ERK pathways in lungs and primary endothelial cells and decreased the availability of VEGFR2 at the cell surface. These findings demonstrate a novel mechanism through which TLR4, an innate pattern receptor, interacts with an endothelial survival pathway.	[Takyar, Seyedtaghi; Zhang, Yi; Haslip, Maria; Jin, Lei; Shan, Peiying; Lee, Patty J.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, POB 208057, New Haven, CT 06520 USA; [Zhang, Xuchen] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Zhang, Xuchen] Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Takyar, S; Lee, PJ (corresponding author), Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, POB 208057, New Haven, CT 06520 USA.	seyedtaghi.takyar@yale.edu; patty.lee@yale.edu	zhang, xu/GYE-3558-2022	Zhang, Xuchen/0000-0002-1484-4672	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [5R00HL098695-04]; NIH/NHLBI [HL 071595, HL 090660, FAMRI 82384]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090660, R00HL098695, R01HL071595] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.T. was supported by K99/R00 Grant 5R00HL098695-04 [U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)]. P.J.L. was supported by NIH/NHLBI Grants HL 071595, HL 090660, and FAMRI 82384. The authors declare no conflicts of interest.	Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Ballinger MN, 2012, J IMMUNOL, V189, P356, DOI 10.4049/jimmunol.1103124; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Britt RD, 2014, ANTIOXID REDOX SIGN, V20, P2681, DOI 10.1089/ars.2013.5332; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Corne J, 2000, J CLIN INVEST, V106, P783, DOI 10.1172/JCI9674; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Haslip M, 2015, ARTERIOSCL THROM VAS, V35, P1166, DOI 10.1161/ATVBAHA.114.304865; Hildebrandt MAT, 2012, CLIN CANCER RES, V18, P3705, DOI 10.1158/1078-0432.CCR-11-3271; Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kim JY, 2012, ANN THORAC SURG, V94, P1079, DOI 10.1016/j.athoracsur.2012.05.048; Kleeberger SR, 2001, AM J PHYSIOL-LUNG C, V280, pL326, DOI 10.1152/ajplung.2001.280.2.L326; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kolliputi N, 2009, AM J PHYSIOL-LUNG C, V297, pL6, DOI 10.1152/ajplung.90381.2008; Kumpf O, 2010, CRIT CARE, V14, DOI 10.1186/cc9047; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mantell LL, 1999, ANN NY ACAD SCI, V887, P171, DOI 10.1111/j.1749-6632.1999.tb07931.x; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Medford ARL, 2009, CHEST, V136, P457, DOI 10.1378/chest.09-0383; Medford ARL, 2005, THORAX, V60, P244, DOI 10.1136/thx.2004.034785; Minami T, 2003, ARTERIOSCL THROM VAS, V23, P2041, DOI 10.1161/01.ATV.0000089326.63053.9A; Mollen KP, 2008, J LEUKOCYTE BIOL, V83, P80, DOI 10.1189/jlb.0407201; Nakayama M, 2013, EXP CELL RES, V319, P1340, DOI 10.1016/j.yexcr.2013.03.008; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schnetzke U, 2015, GENES IMMUN, V16, P83, DOI 10.1038/gene.2014.67; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tuder RM, 2008, CURR OPIN PHARMACOL, V8, P255, DOI 10.1016/j.coph.2008.03.003; Wang HS, 2014, PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON INNOVATIVE DESIGN AND MANUFACTURING (ICIDM), P123, DOI 10.1109/IDAM.2014.6912682; Yang SY, 2011, GENET TEST MOL BIOMA, V15, P737, DOI 10.1089/gtmb.2011.0054; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225; Zhang Y, 2013, J IMMUNOL, V191, P1393, DOI 10.4049/jimmunol.1300052; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009	57	14	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1317	1327		10.1096/fj.15-275024	http://dx.doi.org/10.1096/fj.15-275024			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26655705	Green Published			2022-12-26	WOS:000370387800027
J	Abdesselem, H; Madani, A; Hani, A; Al-Noubi, M; Goswami, N; Ben Hamidane, H; Billing, AM; Pasquier, J; Bonkowski, MS; Halabi, N; Dalloul, R; Sheriff, MZ; Mesaeli, N; ElRayess, M; Sinclair, DA; Graumann, J; Mazloum, NA				Abdesselem, Houari; Madani, Aisha; Hani, Ahmad; Al-Noubi, Muna; Goswami, Neha; Ben Hamidane, Hisham; Billing, Anja M.; Pasquier, Jennifer; Bonkowski, Michael S.; Halabi, Najeeb; Dalloul, Rajaa; Sheriff, Mohamed Z.; Mesaeli, Nasrin; ElRayess, Mohamed; Sinclair, David A.; Graumann, Johannes; Mazloum, Nayef A.			SIRT1 Limits Adipocyte Hyperplasia through c-Myc Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; WHITE ADIPOSE-TISSUE; CELL-CULTURE; PPAR-GAMMA; METABOLIC-DISORDERS; INSULIN-RESISTANCE; GENE-EXPRESSION; AMINO-ACIDS; FAT; OBESITY	The expansion of fat mass in the obese state is due to increased adipocyte hypertrophy and hyperplasia. The molecular mechanism that drives adipocyte hyperplasia remains unknown. The NAD(+)-dependent protein deacetylase sirtuin 1 (SIRT1), a key regulator of mammalian metabolism, maintains proper metabolic functions in many tissues, counteracting obesity. Here we report that differentiated adipocytes are hyperplastic when SIRT1 is knocked down stably in mouse 3T3-L1 preadipocytes. This phenotype is associated with dysregulated adipocyte metabolism and enhanced inflammation. We also demonstrate that SIRT1 is a key regulator of proliferation in preadipocytes. Quantitative proteomics reveal that the c-Myc pathway is altered to drive enhanced proliferation in SIRT1-silenced 3T3-L1 cells. Moreover, c-Myc is hyperacetylated, levels of p27 are reduced, and cyclin-dependent kinase 2 (CDK2) is activated upon SIRT1 reduction. Remarkably, differentiating SIRT1-silenced preadipocytes exhibit enhanced mitotic clonal expansion accompanied by reduced levels of p27 as well as elevated levels of CCAAT/enhancer-binding protein beta (C/EBP beta) and c-Myc, which is also hyperacetylated. c-Myc activation and enhanced proliferation phenotype are also found to be SIRT1-dependent in proliferating mouse embryonic fibroblasts and differentiating human SW872 preadipocytes. Reducing both SIRT1 and c-Myc expression in 3T3-L1 cells simultaneously does not induce the adipocyte hyperplasia phenotype, confirming that SIRT1 controls adipocyte hyperplasia through c-Myc regulation. A better understanding of the molecular mechanisms of adipocyte hyperplasia will open new avenues toward understanding obesity.	[Abdesselem, Houari; Madani, Aisha; Hani, Ahmad; Dalloul, Rajaa; Sheriff, Mohamed Z.; Mazloum, Nayef A.] Qatar Fdn, Weill Cornell Med Qatar, Dept Microbiol & Immunol, POB 24144, Doha, Qatar; [Al-Noubi, Muna; Goswami, Neha; Ben Hamidane, Hisham; Billing, Anja M.; Mesaeli, Nasrin; Graumann, Johannes] Qatar Fdn, Weill Cornell Med Qatar, Dept Biochem, POB 24144, Doha, Qatar; [Pasquier, Jennifer; Halabi, Najeeb] Qatar Fdn, Weill Cornell Med Qatar, Dept Med Genet, POB 24144, Doha, Qatar; [Bonkowski, Michael S.; Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [ElRayess, Mohamed] Antidoping Lab Qatar, Life Sci Res Div, POB 27775, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Harvard Medical School; Anti Doping Laboratory (Qatar)	Mazloum, NA (corresponding author), Qatar Fdn, Weill Cornell Med Qatar, Dept Microbiol & Immunol, POB 24144, Doha, Qatar.	nam2016@qatar-med.cornell.edu	Elrayess, Mohamed/AAE-8804-2019; Halabi, Najeeb/AAX-8250-2020; Graumann, Johannes/C-5241-2008	Elrayess, Mohamed/0000-0003-3803-4604; Halabi, Najeeb/0000-0002-9345-6132; Graumann, Johannes/0000-0002-3015-5850; Billing, Anja/0000-0002-5770-5496; Madani, Aisha/0000-0002-3803-8384; Pasquier, Jennifer/0000-0002-2465-7942; Sinclair, David/0000-0002-9936-436X; Ben Hamidane, Hisham/0000-0003-4615-6142; Bonkowski, Michael/0000-0003-3416-4612	Biomedical Research Program funds of Weill Cornell Medicine in Qatar by Qatar Foundation; NATIONAL INSTITUTE ON AGING [R37AG028730] Funding Source: NIH RePORTER	Biomedical Research Program funds of Weill Cornell Medicine in Qatar by Qatar Foundation(Qatar Foundation (QF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by Biomedical Research Program funds of Weill Cornell Medicine in Qatar, a program funded by the Qatar Foundation. D.A.S. is a consultant to and/or inventor on patents licensed to GlaxoSmithKline, OvaScience, Cohbar, Segterra, MetroBiotech, and Liberty Biosecurity. M. B. is a consultant for OvaScience.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Erener S, 2012, MOL ENDOCRINOL, V26, P79, DOI 10.1210/me.2011-1163; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Guennoun A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0480-6; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ibarrola N, 2003, ANAL CHEM, V75, P6043, DOI 10.1021/ac034931f; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Liberski AR, 2013, J PROTEOME RES, V12, P3233, DOI 10.1021/pr400099j; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mesaeli N, 2004, MOL BIOL CELL, V15, P1862, DOI 10.1091/mbc.E03-04-0251; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167	41	27	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2119	2135		10.1074/jbc.M115.675645	http://dx.doi.org/10.1074/jbc.M115.675645			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26655722	hybrid, Green Published			2022-12-26	WOS:000369610400007
J	Chen, JQ; Ren, RX; Tan, SY; Zhang, WY; Zhang, XX; Yu, F; Xun, TR; Jiang, SB; Liu, SW; Li, L				Chen, Jinquan; Ren, Ruxia; Tan, Suiyi; Zhang, Wanyue; Zhang, Xuanxuan; Yu, Fei; Xun, Tianrong; Jiang, Shibo; Liu, Shuwen; Li, Lin			A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection	PLOS ONE			English	Article							RETROVIRAL GENE-TRANSFER; GLYCOPROTEIN GP120; ENVELOPE PROTEIN; T-CELLS; SEMEN; ENTRY; SEVI; RECEPTOR; GP41; TRANSMISSION	Background Semen is a major vehicle for HIV transmission. Prostatic acid phosphatase (PAP) fragments, such as PAP248-286, in human semen can form amyloid fibrils to enhance HIV infection. Other endogenous or exogenous factors present during sexual intercourse have also been reported to promote the formation of seminal amyloid fibrils. Methodology and Principal Findings Here, we demonstrated that a synthetic 15-residue peptide derived from the HIV-1 gp120 coreceptor-binding region, designated enhancing peptide 2 (EP2), can rapidly self-assemble into nanofibers. These EP2-derivated nanofibers promptly accelerated the formation of semen amyloid fibrils by PAP248-286, as shown by Thioflavin T (ThT) and Congo red assays. The amyloid fibrils presented similar morphology, assessed via transmission electron microscopy (TEM), in the presence or absence of EP2. Circular dichroism (CD) spectroscopy revealed that EP2 accelerates PAP248-286 amyloid fibril formation by promoting the structural transition of PAP248-286 from a random coil into a cross-beta-sheet. Newly formed semen amyloid fibrils effectively enhanced HIV-1 infection in TZM-bl cells and U87 cells by promoting the binding of HIV-1 virions to target cells. Conclusions and Significance Nanofibers composed of EP2 promote the formation of PAP248-286 amyloid fibrils and enhance HIV-1 infection.	[Chen, Jinquan; Ren, Ruxia; Tan, Suiyi; Zhang, Wanyue; Zhang, Xuanxuan; Xun, Tianrong; Liu, Shuwen; Li, Lin] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Yu, Fei; Jiang, Shibo] Shanghai Med Coll, Key Lab Med Mol Virol MOE MOH, Shanghai, Peoples R China; [Yu, Fei; Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Southern Medical University - China; Fudan University; New York Blood Center	Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	liusw@smu.edu.cn; li75lin@126.com	Yu, Fei/K-4953-2019; Jiang, Shibo/L-4500-2014; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022	Yu, Fei/0000-0001-6332-4326; Jiang, Shibo/0000-0001-8283-7135; Liu, Shuwen/0000-0001-6346-5006	Natural Science Foundation of China [81273560, 31370781]; National Key Science and Technology Special Project [2013ZX10001006]; Natural Science Foundation of Guangdong Province [S2013010014713, S2011020005207]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Special Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by the Natural Science Foundation of China (81273560 to Lin Li and 31370781 to Shuwen Liu http://www.nsfc.gov.cn/), the National Key Science and Technology Special Project (2013ZX10001006 to Shibo Jiang http://www.most.gov.cn/kjjh/gjkjjh/), and by the Natural Science Foundation of Guangdong Province (S2013010014713 to Lin Li and S2011020005207 to Shuwen Liu http://pro.gdstc.gov.cn/egrantweb/).; We thank Wenjuan Li at the Southern Medical University for technical assistance. This study was supported by the Natural Science Foundation of China (81273560 to LL and 31370781 to SL), the National Key Science and Technology Special Project (2013ZX10001006 to SJ), and the Natural Science Foundation of Guangdong Province (S2013010014713 to LL and S2011020005207 to SL).	Anton P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002329; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x; Elias AK, 2014, BBA-PROTEINS PROTEOM, V1844, P1591, DOI 10.1016/j.bbapap.2014.06.006; Gordon LM, 2008, BBA-BIOMEMBRANES, V1778, P2127, DOI 10.1016/j.bbamem.2008.05.002; Greenwood R, 2003, ADV COLLOID INTERFAC, V106, P55, DOI 10.1016/S0001-8686(03)00105-2; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Hartman K, 2013, PEERJ, V1, DOI 10.7717/peerj.5; Huang JH, 2008, J BIOL CHEM, V283, P14994, DOI 10.1074/jbc.M800525200; Introini A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003148; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Li L, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-37; Li MM, 2013, AIDS RES HUM RETROV, V29, P1455, DOI [10.1089/aid.2013.0043, 10.1089/AID.2013.0043]; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Meier C, 2014, WIRES NANOMED NANOBI, V6, P438, DOI 10.1002/wnan.1275; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Olsen JS, 2012, J BIOL CHEM, V287, P11842, DOI 10.1074/jbc.M111.314336; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Planque S, 2010, AIDS, V24, P875, DOI 10.1097/QAD.0b013e3283376e88; Ponomarenko NA, 2006, BIOCHEMISTRY-US, V45, P324, DOI 10.1021/bi050675k; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Roan NR, 2014, J INFECT DIS, V210, P1062, DOI 10.1093/infdis/jiu220; Roan NR, 2014, J VIROL, V88, P7221, DOI 10.1128/JVI.00269-14; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; ROWELL JF, 1995, J IMMUNOL, V155, P1818; Sabatte J, 2011, MICROBES INFECT, V13, P977, DOI 10.1016/j.micinf.2011.06.005; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Singh AK, 2007, ALCOHOL, V41, P591, DOI 10.1016/j.alcohol.2007.08.003; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Tan SY, 2014, FEBS LETT, V588, P1515, DOI 10.1016/j.febslet.2014.03.016; Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104; UNAIDS, WORLD AIDS DAY 2014; Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; Yolamanova M, 2013, NAT NANOTECHNOL, V8, P130, DOI [10.1038/nnano.2012.248, 10.1038/NNANO.2012.248]; Zhang LS, 2014, J PEPT SCI, V20, P46, DOI 10.1002/psc.2587; Zheng YH, 2001, CURR BIOL, V11, P875, DOI 10.1016/S0960-9822(01)00237-8; Zirafi O, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009634	46	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144522	10.1371/journal.pone.0144522	http://dx.doi.org/10.1371/journal.pone.0144522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656730	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900061
J	Liang, GL; Chen, H				Liang, Guolu; Chen, Hong			Scaling Chromosomes for an Evolutionary Karyotype: A Chromosomal Tradeoff between Size and Number across Woody Species	PLOS ONE			English	Article							MECHANISMS	This study aims to examine the expected scaling relationships between chromosome size and number across woody species and to clarify the importance of the scaling for the maintenance of chromosome diversity by analyzing the scaling at the inter- & intra-chromosomal level. To achieve for the goals, chromosome trait data were extracted for 191 woody species (including 56 evergreen species and 135 deciduous species) from the available literature. Cross-species analyses revealed a tradeoff among chromosomes between chromosome size and number, demonstrating there is selective mechanism crossing chromosomes among woody species. And the explanations for the result were presented from intra-to inter-chromosome contexts that the scaling may be compromises among scale symmetry, mechanical requirements, and resource allocation across chromosomes. Therein, a 3/4 scaling pattern was observed between total chromosomes and m-chromosomes within nucleus which may imply total chromosomes may evolve from more to less. In addition, the primary evolutionary trend of karyotype and the role of m-chromosomes in the process of karyotype evolution were also discussed.	[Liang, Guolu] Southwest Univ, Dept Hort, Coll Hort & Landscape Architecture, Chongqinq, Peoples R China; [Chen, Hong] Southwest Univ, Dept Bot, Coll Hort & Landscape Architecture, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Chen, H (corresponding author), Southwest Univ, Dept Bot, Coll Hort & Landscape Architecture, Chongqing, Peoples R China.	chenh.swu@gmail.com			National Science-Technology Support Plan Projects of China [2013BAD02B02]; Key Scientific and Technological Research Project, Chongqing Science and Technology Commission, China [CSTC2014yykfB50001]	National Science-Technology Support Plan Projects of China; Key Scientific and Technological Research Project, Chongqing Science and Technology Commission, China	This study was financially supported by the National Science-Technology Support Plan Projects of China (2013BAD02B02) and by Key Scientific and Technological Research Project, Chongqing Science and Technology Commission, China (CSTC2014yykfB50001).	Aarssen LW, 2006, J ECOL, V94, P569, DOI 10.1111/j.1365-2745.2006.01128.x; AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; [Anonymous], 2013, PERSP ORG BIOL TIM S, P23; Arano H., 1963, BOTAN MAGAZINE, V76, P32, DOI [10.15281/jplantres1887.76.32, DOI 10.15281/JPLANTRES1887.76.32]; Arano H., 1980, KROMOSOMO, V2, P471; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Chen R.Y, 1993, CHROMOSOME ATLAS CHI, V1; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cronk QC, 2004, PLANT ADAPTATION MOL; Dimitrova D, 2001, PLANT BIOLOGY, V3, P88, DOI 10.1055/s-2001-11753; Falster D. S., 2006, SMATR STANDARDISED M; IMAI HT, 1986, AM NAT, V128, P900, DOI 10.1086/284612; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Jones K., 1978, Advances in Botanical Research, V6, P119, DOI 10.1016/S0065-2296(08)60330-4; Kieserman EK, 2011, CELL CYCLE, V10, P3863, DOI 10.4161/cc.10.22.17975; Landry CR, 2014, ADV EXPT MED BIOL; Leitch IJ., 2013, PLANT GENOME DIVERSI, V2; LEUCHTENBERGER C, 1951, P NATL ACAD SCI USA, V37, P33, DOI 10.1073/pnas.37.1.33; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Levin D. A, 2002, OX ECOL EV; Levitsky GA, 1931, B APPL BOT GEN PL BR, V27, P220; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; Li MX, 1985, WUHAN BOT RES, V3, P297; Longo G, 2013, PERSPECTIVES ORG BIO; Losos JB, 2011, AM NAT, V177, P709, DOI 10.1086/660020; Lukhtanov VA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-109; Muratovic E, 2010, TAXON, V59, P165, DOI 10.1002/tax.591016; Niklas KJ, 2007, P NATL ACAD SCI USA, V104, P8891, DOI 10.1073/pnas.0701135104; Niklas KJ, 2015, BOST STUD PHILOS HIS, V307, P57, DOI 10.1007/978-94-017-9412-1_2; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Paszko B, 2006, PLANT SYST EVOL, V258, P39, DOI 10.1007/s00606-005-0389-2; Peruzzi L, 2013, COMP CYTOGENET, V7, P1, DOI 10.3897/CompCytogen.v7i1.4431; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; POLAK M, 1994, TRENDS ECOL EVOL, V9, P122, DOI 10.1016/0169-5347(94)90175-9; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; SRIVASTAVA S, 1991, GENOME, V34, P763, DOI 10.1139/g91-118; Stebbins GL, 1971, CHROMOSOMAL EVOLUTIO; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weiss-Schneeweiss H, 2013, KARYOTYPE DIVERSITY; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2004, PHYS TODAY, V57, P36, DOI 10.1063/1.1809090; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wilkinson D.M., 2007, FUNDAMENTAL PROCESSE; Wise JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006013	46	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144669	10.1371/journal.pone.0144669	http://dx.doi.org/10.1371/journal.pone.0144669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657837	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900084
J	Niyompanich, S; Srisanga, K; Jaresitthikunchai, J; Roytrakul, S; Tungpradabkul, S				Niyompanich, Suthamat; Srisanga, Kitima; Jaresitthikunchai, Janthima; Roytrakul, Sittiruk; Tungpradabkul, Sumalee			Utilization of Whole-Cell MALDI-TOF Mass Spectrometry to Differentiate Burkholderia pseudomallei Wild-Type and Constructed Mutants	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; ASSISTED-LASER-DESORPTION/IONIZATION; OXIDATIVE STRESS-RESPONSE; QUORUM-SENSING SYSTEM; RAPID IDENTIFICATION; ESCHERICHIA-COLI; CLASSIFICATION; BACTERIA; DISCRIMINATION; BIOMARKERS	Whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (whole-cell MALDI-TOF MS) has been widely adopted as a useful technology in the identification and typing of microorganisms. This study employed the whole-cell MALDI-TOF MS to identify and differentiate wild-type and mutants containing constructed single gene mutations of Burkholderia pseudomallei, a pathogenic bacterium causing melioidosis disease in both humans and animals. Candidate biomarkers for the B. pseudomallei mutants, including rpoS, ppk, and bpsI isolates, were determined. Taxon-specific and clinical isolate-specific biomarkers of B. pseudomallei were consistently found and conserved across all average mass spectra. Cluster analysis of MALDI spectra of all isolates exhibited separate distribution. A total of twelve potential mass peaks discriminating between wild-type and mutant isolates were identified using ClinProTools analysis. Two peaks (m/z 2721 and 2748 Da) were specific for the rpoS isolate, three (m/z 3150, 3378, and 7994 Da) for ppk, and seven (m/z 3420, 3520, 3587, 3688, 4623, 4708, and 5450 Da) for bpsI. Our findings demonstrated that the rapid, accurate, and reproducible mass profiling technology could have new implications in laboratory-based rapid differentiation of extensive libraries of genetically altered bacteria.	[Niyompanich, Suthamat; Srisanga, Kitima; Tungpradabkul, Sumalee] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Jaresitthikunchai, Janthima; Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Tungpradabkul, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	pexcotung@gmail.com		Roytrakul, Sittiruk/0000-0003-3696-8390	Thailand Research Fund [BRG5680010]; Ph.D. scholarship from RGJ (the Royal Golden Jubilee) [PHD/0341/2551]	Thailand Research Fund(Thailand Research Fund (TRF)); Ph.D. scholarship from RGJ (the Royal Golden Jubilee)	Support was provided by the Thailand Research Fund, grant number BRG5680010 to ST and the Ph.D. scholarship from RGJ (the Royal Golden Jubilee) No. PHD/0341/2551 to SN.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Bartpho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037762; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Camara JE, 2007, ANAL BIOANAL CHEM, V389, P1633, DOI 10.1007/s00216-007-1558-7; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Christie-Oleza JA, 2013, ENVIRON MICROBIOL, V15, P133, DOI 10.1111/j.1462-2920.2012.02812.x; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Cox Christopher R, 2014, Bacteriophage, V4, pe29011; Demirev PA, 2005, ANAL CHEM, V77, P7455, DOI 10.1021/ac051419g; Demirev PA, 2008, J MASS SPECTROM, V43, P1441, DOI 10.1002/jms.1474; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Durighello E, 2014, ANAL CHEM, V86, P9394, DOI 10.1021/ac501840g; Fujinami Y, 2011, MICROBIOL RES, V166, P77, DOI 10.1016/j.micres.2010.02.005; Hazen TH, 2009, APPL ENVIRON MICROB, V75, P6745, DOI 10.1128/AEM.01171-09; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Hsieh SY, 2008, MOL CELL PROTEOMICS, V7, P448, DOI 10.1074/mcp.M700339-MCP200; Inglis TJJ, 2012, AM J TROP MED HYG, V86, P1039, DOI 10.4269/ajtmh.2012.11-0454; Jangiam W, 2010, MICROBIOL IMMUNOL, V54, P389, DOI 10.1111/j.1348-0421.2010.00230.x; Karger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-229; Ketterlinus Ralf, 2005, Biotechniques, VSuppl, P37; Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042; Lartigue MF, 2013, INFECT GENET EVOL, V13, P230, DOI 10.1016/j.meegid.2012.10.012; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Lengwehasatit I, 2008, MICROB PATHOGENESIS, V44, P238, DOI 10.1016/j.micpath.2007.08.017; Lumjiaktase P, 2006, MICROBIOL-SGM, V152, P3651, DOI 10.1099/mic.0.29226-0; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Mazzeo MF, 2006, APPL ENVIRON MICROB, V72, P1180, DOI 10.1128/AEM.72.2.1180-1189.2006; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Niyompanich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099160; Nomura F, 2015, BBA-PROTEINS PROTEOM, V1854, P528, DOI 10.1016/j.bbapap.2014.10.022; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Rajakaruna L, 2009, INFECT GENET EVOL, V9, P507, DOI 10.1016/j.meegid.2009.01.012; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Russell SC, 2007, ANAL CHEM, V79, P5399, DOI 10.1021/ac0705061; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sermswan RW, 2001, ACTA TROP, V80, P237, DOI 10.1016/S0001-706X(01)00176-0; Siegrist TJ, 2007, J MICROBIOL METH, V68, P554, DOI 10.1016/j.mimet.2006.10.012; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Suarez S, 2013, J MICROBIOL METH, V94, P390, DOI 10.1016/j.mimet.2013.07.021; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Tanigawa K, 2010, APPL ENVIRON MICROB, V76, P4055, DOI 10.1128/AEM.02698-09; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Tungpradabkul S, 1999, MOL CELL PROBE, V13, P99, DOI 10.1006/mcpr.1999.0221; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Utaisincharoen P, 2003, INFECT IMMUN, V71, P3053, DOI 10.1128/IAI.71.6.3053-3057.2003; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Winstanley C, 1998, J MED MICROBIOL, V47, P689, DOI 10.1099/00222615-47-8-689	56	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144128	10.1371/journal.pone.0144128	http://dx.doi.org/10.1371/journal.pone.0144128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656930	Green Published, gold			2022-12-26	WOS:000366715900027
J	Old, JM				Old, Julie M.			Immunological Insights into the Life and Times of the Extinct Tasmanian Tiger (Thylacinus cynocephalus)	PLOS ONE			English	Article							BLOOD-FORMING TISSUES; MATURE T-CELLS; POSTNATAL-DEVELOPMENT; LYMPHOID-TISSUES; BRUSHTAIL POSSUM; IMMUNE TISSUES; POUCH YOUNG; B-CELLS; LUNG; SYSTEM	The thylacine (Thylacinus cynocephalus) was Australia's largest marsupial carnivore until its extinction within the last century. There remains considerable interest and debate regarding the biology of this species. Studies of thylacine biology are now limited to preserved specimens, and parts thereof, as well as written historical accounts of its biology. This study describes the development of the immune tissues of a pouch young thylacine, one of only eleven in existence, and the only specimen to be histologically sectioned. The appearance of the immune tissue of the developing pouch young thylacine is compared to the immune tissues of extant marsupials, providing insights into the immunity, biology and ecology of the extinct thylacine.	[Old, Julie M.] Univ Western Sydney, Sch Sci & Hlth, Water & Wildlife Ecol, Locked Bag 1797, Penrith, NSW 2751, Australia	Western Sydney University	Old, JM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Water & Wildlife Ecol, Locked Bag 1797, Penrith, NSW 2751, Australia.	j.old@westernsydney.edu.au	Old, Julie/HDO-1989-2022; Old, Julie/AAE-7355-2021	Old, Julie/0000-0002-2754-7757	Western Sydney University through an Academic Development Program grant; Western Sydney University	Western Sydney University through an Academic Development Program grant; Western Sydney University	Western Sydney University funded JO through an Academic Development Program grant.r Thanks to Katie Smith of Museum Victoria for allowing me to view the thylacine slides, Leon Hughes for helpful advice and suggestions, and Western Sydney University for funding (Academic Development Program).	Adamski FM, 2000, DEV COMP IMMUNOL, V24, P491, DOI 10.1016/S0145-305X(00)00012-4; Adamski FM, 1999, J IMMUNOL, V162, P6009; Armstrong K.N., 2008, MAMMALS AUSTR, P470; ASHMAN RB, 1975, ACTA ANAT, V91, P594; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; AZZALI G, 1965, AM J ANAT, V116, P449, DOI 10.1002/aja.1001160302; Baker ML, 1999, ANAT REC, V256, P354; Basden K, 1997, REPROD FERT DEVELOP, V9, P243, DOI 10.1071/R96032; Basden K, 1996, REPROD FERT DEVELOP, V8, P989, DOI 10.1071/RD9960989; Beddard F. E., 1891, Proceedings of the Zoological Society, P138; BIENENSTOCK J, 1973, LAB INVEST, V28, P693; BLOCK M, 1964, Ergeb Anat Entwicklungsgesch, V37, P237; Boardman W., 1945, Proceedings of the Linnean Society of New South Wales, V70, P1; Borthwick CR, 2014, J MORPHOL, V275, P822, DOI 10.1002/jmor.20250; Brown GD, 1974, J AUST MAM SOC, V1, P269; Buddle BM, 2000, DEV COMP IMMUNOL, V24, P517, DOI 10.1016/S0145-305X(00)00014-8; Canfield PC, 1996, J ANAT, V189, P159; Canfield PJ, 2000, DEV COMP IMMUNOL, V24, P455, DOI 10.1016/S0145-305X(00)00009-4; Cisternas PA, 1999, ANAT EMBRYOL, V200, P433, DOI 10.1007/s004290050293; Cooke MM, 2002, J ANAT, V200, P113, DOI 10.1046/j.0021-8782.2001.00019.x; Edwards MJ, 2012, DEV COMP IMMUNOL, V37, P213, DOI 10.1016/j.dci.2012.03.013; EMERY JL, 1973, J CLIN PATHOL, V26, P539, DOI 10.1136/jcp.26.7.539; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; Foster WK, 2006, AUST J ZOOL, V54, P343, DOI 10.1071/ZO06033; GEMMELL RT, 1986, J ANAT, V148, P193; Gemmell RT, 1998, CELL TISSUE RES, V252, P683; Guiler ER, 1985, THYLACINE TRAGEDY TA; haRRiS g.P., 1808, T LINNEAN SOC LONDON, V9, P174, DOI DOI 10.1111/J.1096-3642.1818.TB00336.X; HARTWIG H, 1985, EXPERIENTIA, V41, P159, DOI 10.1007/BF02002608; HAYES TG, 1968, J MORPHOL, V124, P445, DOI 10.1002/jmor.1051240404; Haynes JI, 2001, J ZOOL, V253, P167, DOI 10.1017/S0952836901000152; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; JOHNSTONE J, 1898, J LINN SOC ZOOL, V25, P537, DOI DOI 10.1111/J.1096-3642.1898.TB00410.X; JONES M, 1993, J IMMUNOL, V150, P5429; Joss JL, 2009, DEV COMP IMMUNOL, V33, P152, DOI 10.1016/j.dci.2008.08.002; KRAUSE WJ, 1973, AM J ANAT, V137, P337, DOI 10.1002/aja.1001370306; Le Souef AS, 1926, WILD ANIMALS AUSTRAL; Lyne A. G., 1957, Growth, V21, P167; Makanya AN, 2001, ANAT REC, V262, P253, DOI 10.1002/1097-0185(20010301)262:3<253::AID-AR1025>3.0.CO;2-B; McKnight M., IUCN RED LIST THREAT; Menzies BR, 2012, P MICCAIBRATS, V2012, P1; Mooney N., 2008, MAMMALS AUSTR, P167; Old JM, 2004, J ANAT, V205, P25, DOI 10.1111/j.0021-8782.2004.00310.x; Old JM, 2004, DEV COMP IMMUNOL, V28, P347, DOI 10.1016/j.dci.2003.08.004; Old JM, 2003, CELLS TISSUES ORGANS, V175, P192, DOI 10.1159/000074941; Old JM, 2003, J ANAT, V203, P123, DOI 10.1046/j.1469-7580.2003.00207.x; Old JM, 2000, DEV COMP IMMUNOL, V24, P445, DOI 10.1016/S0145-305X(00)00008-2; PABST R, 1990, AM J RESP CELL MOL, V3, P131, DOI 10.1165/ajrcmb/3.2.131; Paddle R., 2000, LAST TASMANIAN TIGER; Paddle Robert, 2012, Australian Zoologist, V36, P75; Phillips BT, 2003, ZOO BIOL, V22, P497, DOI 10.1002/zoo.10092; POSKITT DC, 1984, J COMP PATHOL, V94, P481, DOI 10.1016/0021-9975(84)90036-7; ROWLANDS DT, 1964, J IMMUNOL, V93, P157; Runciman SIC, 1996, ANAT REC, V244, P193, DOI 10.1002/(SICI)1097-0185(199602)244:2<193::AID-AR7>3.0.CO;2-2; Sleightholme SR, 2015, AUST ZOOL, V37, P238; Sleightholme Stephen R., 2012, Australian Zoologist, V36, P232, DOI 10.7882/AZ.2012.027; Smith ME, 2015, SYNTH LIMNOGEOL, V1, P1, DOI 10.1007/978-94-017-9906-5_1; STANLEY NF, 1972, AUST J EXP BIOL MED, V50, P689, DOI 10.1038/icb.1972.62; Stone William H., 1996, P149; Thompson CK, 2015, AUST MAMMAL, V37, P29, DOI 10.1071/AM14025; TYNDALEBISCOE H, 2005, LIFE MARSUPIALS, pNIL6; Young L, 1997, AUST J ZOOL, V45, P423, DOI 10.1071/ZO96063; Young Lauren J., 2012, Comparative Clinical Pathology, V21, P9; Young LF, 2001, AUST J ZOOL, V49, P195, DOI 10.1071/ZO00062; Young LJ, 2003, J ANAT, V202, P315, DOI 10.1046/j.1469-7580.2003.00165.x	65	4	5	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144091	10.1371/journal.pone.0144091	http://dx.doi.org/10.1371/journal.pone.0144091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26655868	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900026
J	Strojny, B; Kurantowicz, N; Sawosz, E; Grodzik, M; Jaworski, S; Kutwin, M; Wierzbicki, M; Hotowy, A; Lipinska, L; Chwalibog, A				Strojny, Barbara; Kurantowicz, Natalia; Sawosz, Ewa; Grodzik, Marta; Jaworski, Slawomir; Kutwin, Marta; Wierzbicki, Mateusz; Hotowy, Anna; Lipinska, Ludwika; Chwalibog, Andre			Long Term Influence of Carbon Nanoparticles on Health and Liver Status in Rats	PLOS ONE			English	Article							NANOSCALE GRAPHENE OXIDE; C-REACTIVE PROTEIN; GRAPHITE NANOPLATELETS; OXIDATIVE STRESS; VIVO; TOXICITY; NANODIAMONDS; MICE; BIODISTRIBUTION; GLUTATHIONE	Due to their excellent biocompatibility, carbon nanoparticles have been widely investigated for prospective biomedical applications. However, their impact on an organism with prolonged exposure is still not well understood. Here, we performed an experiment investigating diamond, graphene oxide and graphite nanoparticles, which were repeatedly administrated intraperitoneally into Wistar rats for four weeks. Some of the animals was sacrificed after the last injection, whereas the rest were sacrificed twelve weeks after the last exposure. We evaluated blood morphology and biochemistry, as well as the redox and inflammatory state of the liver. The results show the retention of nanoparticles within the peritoneal cavity in the form of prominent aggregates in proximity to the injection site, as well as the presence of some nanoparticles in the mesentery. Small aggregates were also visible in the liver serosa, suggesting possible transportation to the liver. However, none of the tested nanoparticles affected the health of animals. This lack of toxic effect may suggest the potential applicability of nanoparticles as drug carriers for local therapies, ensuring accumulation and slow release of drugs into a targeted tissue without harmful systemic side effects.	[Strojny, Barbara; Kurantowicz, Natalia; Sawosz, Ewa; Grodzik, Marta; Jaworski, Slawomir; Kutwin, Marta; Wierzbicki, Mateusz; Hotowy, Anna] Warsaw Univ Life Sci, Div Nanobiotechnol, Warsaw, Poland; [Lipinska, Ludwika] Inst Elect Mat Technol, Dept Chem Technol, Warsaw, Poland; [Chwalibog, Andre] Univ Copenhagen, Dept Vet Clin & Anim Sci, Copenhagen, Denmark	Warsaw University of Life Sciences; Institute of Electronic Materials Technology; University of Copenhagen	Chwalibog, A (corresponding author), Univ Copenhagen, Dept Vet Clin & Anim Sci, Copenhagen, Denmark.	ach@sund.ku.dk	Jaworski, Sławomir/AAI-2313-2020; Grodzik, Marta/J-9404-2015; Wierzbicki, Mateusz/ABF-5482-2020; Grodzik, Marta/AAO-4319-2021	Jaworski, Sławomir/0000-0002-4619-941X; Grodzik, Marta/0000-0001-5359-1885; Wierzbicki, Mateusz/0000-0003-3623-8929; Grodzik, Marta/0000-0001-5359-1885; Kurantowicz, Natalia/0000-0002-7036-1325; Hotowy, Anna/0000-0002-0596-1201; Kutwin, Marta/0000-0001-7059-7875; Chwalibog, Andre/0000-0001-8150-2392; Sawosz Chwalibog, Ewa/0000-0002-0016-4721; Strojny, Barbara/0000-0002-2642-5491	National Science Centre (Poland) [2011/03/B/NZ9/03387, NN311 540840]; grant NCN from the National Science Centre (Poland) [2011/03/B/NZ9/03387, NN311 540840]	National Science Centre (Poland); grant NCN from the National Science Centre (Poland)	This work was supported by the National Science Centre (Poland) grant: 2011/03/B/NZ9/03387 and NN311 540840. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This report is a part of Barbara Strojny's PhD thesis. This work was supported by grant NCN 2011/03/B/NZ9/03387 and NN311 540840 from the National Science Centre (Poland). The authors thank Dr. Michal Mikula from The Maria Sklodowska-Curie Institute of Oncology for help with the cytokine membranes.	Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bolliger AP., 2010, SCHALMS VET HEMATOLO, V6th; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chen GH, 2004, CARBON, V42, P753, DOI 10.1016/j.carbon.2003.12.074; Chowdhury SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02584; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Deng XY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075101; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Grodzik M, 2011, INT J NANOMED, V6, P3041, DOI 10.2147/IJN.S25528; Hong H, 2012, ACS NANO, V6, P2361, DOI 10.1021/nn204625e; HURLIMANN J, 1966, J EXP MED, V123, P365, DOI 10.1084/jem.123.2.365; Jaworski S, 2013, INT J NANOMED, V8, P413, DOI 10.2147/IJN.S39456; Kanakia S, 2014, BIOMATERIALS, V35, P7022, DOI 10.1016/j.biomaterials.2014.04.066; Kanakia S, 2013, INT J NANOMED, V8, P2821, DOI 10.2147/IJN.S47062; Kovacic Peter, 2006, Birth Defects Research, V78, P333, DOI 10.1002/bdrc.20083; Kulakova II, 2004, PHYS SOLID STATE+, V46, P636, DOI 10.1134/1.1711440; Kurantowicz N, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1107-9; Kurantowicz N, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0749-y; Lalwani G, 2013, BIOMACROMOLECULES, V14, P900, DOI 10.1021/bm301995s; Leung L, 2012, DRUG METAB REV, V44, P18, DOI 10.3109/03602532.2011.605791; Li B, 2014, INT J NANOMED, V9, P4697, DOI 10.2147/IJN.S66591; Li J, 2010, BIOMATERIALS, V31, P8410, DOI 10.1016/j.biomaterials.2010.07.058; Li Z, 2011, J NANOMATER, V2011, DOI 10.1155/2011/842613; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Ma-Hock L, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-23; Niemiec T, 2011, J NANOSCI NANOTECHNO, V11, P9072, DOI 10.1166/jnn.2011.3511; Parameters CS, CLIN LAB PARAMETERS; Patlolla AK, 2011, MOL CELL BIOCHEM, V358, P189, DOI 10.1007/s11010-011-0934-y; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Puzyr AP, 2007, DIAM RELAT MATER, V16, P2124, DOI 10.1016/j.diamond.2007.07.025; Qu GB, 2013, J ENVIRON SCI, V25, P873, DOI 10.1016/S1001-0742(12)60252-6; Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151; Sanchez VC, 2012, CHEM RES TOXICOL, V25, P15, DOI 10.1021/tx200339h; Sawosz E, 2015, INT J MOL SCI, V16, P25214, DOI 10.3390/ijms161025214; Schrand AM, 2009, CRIT REV SOLID STATE, V34, P18, DOI 10.1080/10408430902831987; Talukdar Y, 2014, BIOMATERIALS, V35, P4863, DOI 10.1016/j.biomaterials.2014.02.054; Vaijayanthimala V, 2012, BIOMATERIALS, V33, P7794, DOI 10.1016/j.biomaterials.2012.06.084; Wierzbicki M, 2013, INT J NANOMED, V8, P3427, DOI 10.2147/IJN.S49745; Wierzbicki M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-195; Xiao JS, 2013, BIOMATERIALS, V34, P9648, DOI 10.1016/j.biomaterials.2013.08.056; Yang K, 2013, BIOMATERIALS, V34, P2787, DOI 10.1016/j.biomaterials.2013.01.001; Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c; Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064; Zakrzewska KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122579; Zanni E, 2012, NANO LETT, V12, P2740, DOI 10.1021/nl204388p; Zhang XY, 2010, TOXICOL LETT, V198, P237, DOI 10.1016/j.toxlet.2010.07.001; Zheng ZY, 2013, INT J MED SCI, V10, P653, DOI 10.7150/ijms.6050	49	38	39	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144821	10.1371/journal.pone.0144821	http://dx.doi.org/10.1371/journal.pone.0144821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657282	Green Published, gold			2022-12-26	WOS:000366715900110
J	Vieira, P; Eves-van den Akker, S; Verma, R; Wantoch, S; Eisenback, JD; Kamo, K				Vieira, Paulo; Eves-van den Akker, Sebastian; Verma, Ruchi; Wantoch, Sarah; Eisenback, Jonathan D.; Kamo, Kathryn			The Pratylenchus penetrans Transcriptome as a Source for the Development of Alternative Control Strategies: Mining for Putative Genes Involved in Parasitism and Evaluation of in planta RNAi	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; LESION NEMATODE; GLOBODERA-PALLIDA; RETINOL-BINDING; SEQ DATA; GENOME; PROTEIN; SEQUENCE; REVEALS; EXPRESSION	The root lesion nematode Pratylenchus penetrans is considered one of the most economically important species within the genus. Host range studies have shown that nearly 400 plant species can be parasitized by this species. To obtain insight into the transcriptome of this migratory plant-parasitic nematode, we used Illumina mRNA sequencing analysis of a mixed population, as well as nematode reads detected in infected soybean roots 3 and 7 days after nematode infection. Over 140 million paired end reads were obtained for this species, and de novo assembly resulted in a total of 23,715 transcripts. Homology searches showed significant hit matches to 58% of the total number of transcripts using different protein and EST databases. In general, the transcriptome of P. penetrans follows common features reported for other root lesion nematode species. We also explored the efficacy of RNAi, delivered from the host, as a strategy to control P. penetrans, by targeted knock-down of selected nematode genes. Different comparisons were performed to identify putative nematode genes with a role in parasitism, resulting in the identification of transcripts with similarities to other nematode parasitism genes. Focusing on the predicted nematode secreted proteins found in this transcriptome, we observed specific members to be up-regulated at the early time points of infection. In the present study, we observed an enrichment of predicted secreted proteins along the early time points of parasitism by this species, with a significant number being pioneer candidate genes. A representative set of genes examined using RT-PCR confirms their expression during the host infection. The expression patterns of the different candidate genes raise the possibility that they might be involved in critical steps of P. penetrans parasitism. This analysis sheds light on the transcriptional changes that accompany plant infection by P. penetrans, and will aid in identifying potential gene targets for selection and use to design effective control strategies against root lesion nematodes.	[Vieira, Paulo; Eisenback, Jonathan D.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Vieira, Paulo; Verma, Ruchi; Wantoch, Sarah; Kamo, Kathryn] US Natl Arboretum, Floral & Nursery Plants Res Unit, USDA, Beltsville, MD 20705 USA; [Eves-van den Akker, Sebastian] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA); University of Dundee	Vieira, P (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	pvieira@vt.edu	Vieira, Paulo/I-7173-2019	Vieira, Paulo/0000-0001-5627-2628	National Institute of Food and Agriculture, U.S. Department of Agriculture [11588909]; Fred C. Gloeckner Foundation; California Department of Food and Agriculture Specialty Crops Block Grant; ARS [ARS-0425046] Funding Source: Federal RePORTER	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Fred C. Gloeckner Foundation; California Department of Food and Agriculture Specialty Crops Block Grant; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 11588909. This work was also partially funded by the Fred C. Gloeckner Foundation and the California Department of Food and Agriculture 2012 Specialty Crops Block Grant.; We thank Dr. David Chitwood (Nematology Laboratory, USDA, Beltsville, MD) for providing the Pratylenchus penetrans isolate, Dr. Benjamin Matthews (Soybean Genomics and Improvement Laboratory, USDA, Beltsville, MD) for providing the pRAP17 vector and the Agrobacterium tumefaciens strain K599. We thank Prof. Godelieve Gheysen, Prof. Mike Jones and Dr. John Fosu-Nyarko for providing the transcriptome assembly of P. coffeae and P. zeae, respectively. This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 11588909. This work was also partially funded by the Fred C. Gloeckner Foundation and the California Department of Food and Agriculture 2012 Specialty Crops Block Grant. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abad Pierre, 2009, P363, DOI 10.1079/9781845934927.0363; Armstrong SD, 2014, MOL CELL PROTEOMICS, V13, P2527, DOI 10.1074/mcp.M114.038539; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bauters L, 2014, MOL PLANT PATHOL, V15, P352, DOI 10.1111/mpp.12098; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Burke M, 2015, NEMATOLOGY, V17, P621, DOI 10.1163/15685411-00002901; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Castillo P, 2007, NEMATOL MONOGR PERSP, V6, P1; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Cho HJ, 2000, PLANTA, V210, P195, DOI 10.1007/PL00008126; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Duan Cheng-Guo, 2012, Silence, V3, P5, DOI 10.1186/1758-907X-3-5; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Dutta TK, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00760; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Espada M, 2015, MOL PLANT P IN PRESS; Esteves I, 2015, EUR J PLANT PATHOL, V141, P397, DOI 10.1007/s10658-014-0551-1; Eves-van den Akker S, 2014, GENOME BIOL EVOL, V6, P2181, DOI 10.1093/gbe/evu171; Fairfax KC, 2009, INT J PARASITOL, V39, P1561, DOI 10.1016/j.ijpara.2009.06.005; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Fosu-Nyarko J, 2016, MOL PLANT PATHOL, V17, P532, DOI 10.1111/mpp.12301; Furlanetto C, 2005, NEMATOLOGY, V7, P95, DOI 10.1163/1568541054192180; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Goverse A, 2014, ANNU REV PHYTOPATHOL, V52, P243, DOI 10.1146/annurev-phyto-102313-050118; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haegeman A, 2013, MOL PLANT PATHOL, V14, P379, DOI 10.1111/mpp.12014; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Haegeman A, 2009, MOL PLANT PATHOL, V10, P389, DOI [10.1111/J.1364-3703.2009.00539.X, 10.1111/j.1364-3703.2009.00539.x]; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hobert O, 2005, NEURONAL GENOME CAEN; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Iberkleid I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1426-3; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jaubert S, 2004, INT J PARASITOL, V34, P873, DOI 10.1016/j.ijpara.2004.02.008; Jayatilake DV, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-230; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Jones MGK, 2014, ANN APPL BIOL, V164, P163, DOI 10.1111/aab.12105; Joseph S, 2012, MOL BIOCHEM PARASIT, V186, P51, DOI 10.1016/j.molbiopara.2012.09.009; Kagawa H, 1997, CELL STRUCT FUNCT, V22, P213, DOI 10.1247/csf.22.213; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Kramer James M., 1997, Cold Spring Harbor Monograph Series, V33, P471; Kyndt T, 2013, NEMATOLOGY, V15, P519, DOI 10.1163/15685411-00002698; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozano-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004569; McCarter JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r26; Mei YY, 2015, NEMATOLOGY, V17, P409, DOI 10.1163/15685411-00002875; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mitreva M, 2004, MOL GENET GENOMICS, V272, P138, DOI 10.1007/s00438-004-1054-0; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Pearson MS, 2012, J ALLERGY CLIN IMMUN, V130, P13, DOI 10.1016/j.jaci.2012.05.029; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Nguyen QB, 2011, MOL MICROBIOL, V81, P1008, DOI 10.1111/j.1365-2958.2011.07746.x; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Robertson L, 2000, MOL BIOCHEM PARASIT, V111, P41, DOI 10.1016/S0166-6851(00)00295-4; Rotenberg D, 2004, PLANT PATHOL, V53, P294, DOI 10.1111/j.0032-0862.2004.01005.x; Rybarczyk-Mydlowska K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-221; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schwarz EM, 2015, NAT GENET, V47, P416, DOI 10.1038/ng.3237; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Sharma S, 2011, THEOR APPL GENET, V122, P1321, DOI 10.1007/s00122-011-1533-8; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Tytgat T, 2005, PARASITOL RES, V95, P50, DOI 10.1007/s00436-004-1243-0; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; VRAIN TC, 1987, CAN J PLANT PATHOL, V9, P236, DOI 10.1080/07060668709501880; WHITEHEAD AG, 1965, ANN APPL BIOL, V55, P25, DOI 10.1111/j.1744-7348.1965.tb07864.x	82	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144674	10.1371/journal.pone.0144674	http://dx.doi.org/10.1371/journal.pone.0144674			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658731	Green Published, gold			2022-12-26	WOS:000366715900085
J	Inic-Kanada, A; Stojanovic, M; Schlacher, S; Stein, E; Belij-Rammerstorfer, S; Marinkovic, E; Lukic, I; Montanaro, J; Schuerer, N; Bintner, N; Kovacevic-Jovanovic, V; Krnjaja, O; Mayr, UB; Lubitz, W; Barisani-Asenbauer, T				Inic-Kanada, Aleksandra; Stojanovic, Marijana; Schlacher, Simone; Stein, Elisabeth; Belij-Rammerstorfer, Sandra; Marinkovic, Emilija; Lukic, Ivana; Montanaro, Jacqueline; Schuerer, Nadine; Bintner, Nora; Kovacevic-Jovanovic, Vesna; Krnjaja, Ognjen; Mayr, Ulrike Beate; Lubitz, Werner; Barisani-Asenbauer, Talin			Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers	PLOS ONE			English	Article							GENETICALLY INACTIVATED GHOSTS; HOMOLOGOUS AEROSOL CHALLENGE; FEMALE GUINEA-PIGS; BACTERIAL GHOSTS; GENITAL-INFECTION; OUTER-MEMBRANE; ACTINOBACILLUS-PLEUROPNEUMONIAE; CANDIDATE VACCINES; UNSAFE INJECTIONS; PROTECTIVE IMMUNITY	Trachoma, caused by the intracellular bacterium Chlamydia trachomatis (Ct), remains the world's leading preventable infectious cause of blindness. Recent attempts to develop effective vaccines rely on modified chlamydial antigen delivery platforms. As the mechanisms engaged in the pathology of the disease are not fully understood, designing a subunit vaccine specific to chlamydial antigens could improve safety for human use. We propose the delivery of chlamydia-specific antigens to the ocular mucosa using particulate carriers, bacterial ghosts (BGs). We therefore characterized humoral and cellular immune responses after conjunctival and subcutaneous immunization with a N-terminal portion (amino acid 1-893) of the chlamydial polymorphic membrane protein C (PmpC) of Ct serovar B, expressed in probiotic Escherichia coli Nissle 1917 bacterial ghosts (EcN BGs) in BALB/cmice. Three immunizations were performed at two-week intervals, and the immune responses were evaluated two weeks after the final immunization in mice. In a guinea pig model of ocular infection animals were immunized in the same manner as the mice, and protection against challenge was assessed two weeks after the last immunization. N-PmpC was successfully expressed within BGs and delivery to the ocularmucosa was well tolerated without signs of inflammation. N-PmpC- specific mucosal IgA levels in tears yielded significantly increased levels in the group immunized via the conjunctiva compared with the subcutaneously immunized mice. Immunization with N-PmpC EcN BGs via both immunization routes prompted the establishment of an N-PmpC-specific IFN gamma immune response. Immunization via the conjunctiva resulted in a decrease in intensity of the transitional inflammatory reaction in conjunctiva of challenged guinea pigs compared with subcutaneously and non-immunized animals. The delivery of the chlamydial subunit vaccine to the ocular mucosa using a particulate carrier, such as BGs, induced both humoral and cellular immune responses. Further investigations are needed to improve the immunization scheme and dosage.	[Inic-Kanada, Aleksandra; Schlacher, Simone; Stein, Elisabeth; Belij-Rammerstorfer, Sandra; Montanaro, Jacqueline; Schuerer, Nadine; Bintner, Nora; Barisani-Asenbauer, Talin] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Stojanovic, Marijana; Marinkovic, Emilija; Lukic, Ivana; Kovacevic-Jovanovic, Vesna; Krnjaja, Ognjen; Lubitz, Werner] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia; [Mayr, Ulrike Beate] BIRD C GmbH&CoKG, Vienna, Austria	Medical University of Vienna	Barisani-Asenbauer, T (corresponding author), Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	talin.barisani@meduniwien.ac.at	Belij-Rammerstorfer, Sandra/B-8243-2018	Inic-Kanada, Aleksandra/0000-0001-7854-3812; Barisani-Asenbauer, Talin/0000-0002-8661-9183; Schuerer, Nadine/0000-0002-5894-2784; Belij-Rammerstorfer, Sandra/0000-0002-8637-3785; Stojanovic, Marijana/0000-0002-8204-4183; Lukic, Ivana/0000-0002-6330-471X; Stein, Elisabeth/0000-0002-1240-506X	"Laura Bassi Centers of Expertise" Program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG Project) [822768]; Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049]; BIRD-C	"Laura Bassi Centers of Expertise" Program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG Project); Ministry of Education, Science, and Technological Development of the Republic of Serbia; BIRD-C	This research was funded by the "Laura Bassi Centers of Expertise" Program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG Project Number: 822768) and was partly supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (Grant Number 172049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BIRD-C provided support in the form of salaries for authors BM and WL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barisani-Asenbauer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060682; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Boje S, 2016, IMMUNOL CELL BIOL, V94, P185, DOI 10.1038/icb.2015.79; CAMPOS M, 1995, INVEST OPHTH VIS SCI, V36, P1477; Clements CJ, 2004, VACCINE, V22, P2054, DOI 10.1016/j.vaccine.2004.01.008; Dicko M, 2000, B WORLD HEALTH ORGAN, V78, P163; DWYER RS, 1983, BRIT J OPHTHALMOL, V67, P737, DOI 10.1136/bjo.67.11.737; Eko FO, 2003, VACCINE, V21, P3663, DOI 10.1016/S0264-410X(03)00388-8; Eko FO, 2003, VACCINE, V21, P1694, DOI 10.1016/S0264-410X(02)00677-1; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Gebril A, 2012, EXPERT REV VACCINES, V11, P1139, DOI [10.1586/ERV.12.81, 10.1586/erv.12.81]; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; Gomes JP, 2004, J BACTERIOL, V186, P4295, DOI 10.1128/JB.186.13.4295-4306.2004; GRAYSTON JT, 1962, J EXP MED, V115, P1009, DOI 10.1084/jem.115.5.1009; Hensel A, 1996, J BIOTECHNOL, V44, P171, DOI 10.1016/0168-1656(95)00150-6; Hensel A, 2000, VACCINE, V18, P2945, DOI 10.1016/S0264-410X(00)00107-9; Hutchings AB, 2004, J VIROL, V78, P947, DOI 10.1128/JVI.78.2.947-957.2004; Huter V, 2000, J BIOTECHNOL, V83, P161, DOI 10.1016/S0168-1656(00)00310-2; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jechlinger W, 2005, VACCINE, V23, P3609, DOI 10.1016/j.vaccine.2004.11.078; Katinger A, 1999, J BIOTECHNOL, V73, P251, DOI 10.1016/S0168-1656(99)00143-1; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Kersten G, 2007, EXPERT OPIN DRUG DEL, V4, P459, DOI 10.1517/17425247.4.5.459; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Kudela P, 2011, J BIOTECHNOL, V153, P167, DOI 10.1016/j.jbiotec.2011.03.022; Lacy HM, 2011, INFECT IMMUN, V79, P1889, DOI 10.1128/IAI.01257-10; Langemann Timo, 2010, Bioeng Bugs, V1, P326, DOI 10.4161/bbug.1.5.12540; Levine MM, 2000, J PEDIATR GASTR NUTR, V31, P336, DOI 10.1097/00005176-200010000-00003; Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09; Lu CX, 2012, INVEST OPHTH VIS SCI, V53, P2551, DOI 10.1167/iovs.11-9212; Mader HJ, 1997, VACCINE, V15, P195, DOI 10.1016/S0264-410X(96)00141-7; Marchart J, 2003, VACCINE, V21, P1415, DOI 10.1016/S0264-410X(02)00635-7; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; MONNICKENDAM MA, 1983, BRIT MED BULL, V39, P187, DOI 10.1093/oxfordjournals.bmb.a071814; Montanaro J, 2015, DRUG DESIGN IN PRESS; MORRISON RP, 1989, J EXP MED, V169, P663, DOI 10.1084/jem.169.3.663; Muhammad A, 2012, EXPERT REV VACCINES, V11, P97, DOI [10.1586/ERV.11.149, 10.1586/erv.11.149]; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nunes A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000878; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; RAMSEY KH, 1988, INFECT IMMUN, V56, P1320, DOI 10.1128/IAI.56.5.1320-1325.1988; RANK RG, 1983, INFECT IMMUN, V39, P463, DOI 10.1128/IAI.39.1.463-465.1983; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; RANK RG, 1995, INVEST OPHTH VIS SCI, V36, P1344; RANK RG, 1979, INFECT IMMUN, V26, P573, DOI 10.1128/IAI.26.2.573-579.1979; Rank RG, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P845, DOI 10.1016/B978-0-12-369408-9.00044-5; Reinoso R, 2012, MUCOSAL IMMUNOL, V5, P455, DOI 10.1038/mi.2012.27; SCOTT JG, 1971, BRIT J OPHTHALMOL, V55, P189, DOI 10.1136/bjo.55.3.189; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; SOMPOLINSKY D, 1992, ALLERGY, V47, P234, DOI 10.1111/j.1398-9995.1992.tb00656.x; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; Stein E, 2013, INVEST OPHTH VIS SCI, V54, P6326, DOI 10.1167/iovs.13-12044; Tabrizi CA, 2004, CURR OPIN BIOTECH, V15, P530, DOI 10.1016/j.copbio.2004.10.004; Tifrea DF, 2013, INFECT IMMUN, V81, P1741, DOI 10.1128/IAI.00734-12; TREHARNE J D, 1991, Eye (London), V5, P299; Walcher Petra, 2004, Expert Rev Vaccines, V3, P681, DOI 10.1586/14760584.3.6.681; Walcher P, 2008, VACCINE, V26, P6832, DOI 10.1016/j.vaccine.2008.09.088; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; WILLIAMS DM, 1981, J INFECT DIS, V143, P238, DOI 10.1093/infdis/143.2.238; WILLIAMS DM, 1984, J INFECT DIS, V149, P630, DOI 10.1093/infdis/149.4.630; Wilson DP, 2009, J INFECT DIS, V199, P1780, DOI 10.1086/599093; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	69	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144380	10.1371/journal.pone.0144380	http://dx.doi.org/10.1371/journal.pone.0144380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656797	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600041
J	Piater, B; Doerner, A; Guenther, R; Kolmar, H; Hock, B				Piater, Birgit; Doerner, Achim; Guenther, Ralf; Kolmar, Harald; Hock, Bjoern			Aptamers Binding to c-Met Inhibiting Tumor Cell Migration	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; T7 RNA-POLYMERASE; RECEPTOR TYROSINE KINASE; FACTOR/SCATTER FACTOR; MET/HGF RECEPTOR; IN-VITRO; ANTITUMOR-ACTIVITY; SIGNALING PATHWAY; SCATTER-FACTOR; SEMA DOMAIN	The human receptor tyrosine kinase c-Met plays an important role in the control of critical cellular processes. Since c-Met is frequently over expressed or deregulated in human malignancies, blocking its activation is of special interest for therapy. In normal conditions, the c-Met receptor is activated by its bivalent ligand hepatocyte growth factor (HGF). Also bivalent antibodies can activate the receptor by cross linking, limiting therapeutic applications. We report the generation of the RNA aptamer CLN64 containing 2'-fluoro pyrimidine modifications by systematic evolution of ligands by exponential enrichment (SELEX). CLN64 and a previously described single-stranded DNA (ssDNA) aptamer CLN3 exhibited high specificities and affinities to recombinant and cellular expressed c-Met. Both aptamers effectively inhibited HGF-dependent c-Met activation, signaling and cell migration. We showed that these aptamers did not induce c-Met activation, revealing an advantage over bivalent therapeutic molecules. Both aptamers were shown to bind overlapping epitopes but only CLN3 competed with HGF binding to cMet. In addition to their therapeutic and diagnostic potential, CLN3 and CLN64 aptamers exhibit valuable tools to further understand the structural and functional basis for c-Met activation or inhibition by synthetic ligands and their interplay with HGF binding.	[Piater, Birgit; Doerner, Achim; Guenther, Ralf; Hock, Bjoern] Merck KGaA, Prot Engn & Antibody Technol, Darmstadt, Germany; [Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany	Merck KGaA; Technical University of Darmstadt	Hock, B (corresponding author), Merck KGaA, Prot Engn & Antibody Technol, Darmstadt, Germany.	Bjoern.Hock@merckgroup.com	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993; Doerner, Achim/0000-0002-4741-8039				Basilico C, 2008, J BIOL CHEM, V283, P21267, DOI 10.1074/jbc.M800727200; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boltz A, 2011, J BIOL CHEM; Chao KLL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041912; Chelliserrykattil J, 2004, NAT BIOTECHNOL, V22, P1155, DOI 10.1038/nbt1001; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Christensen JG, 2003, CANCER RES, V63, P7345; Christgen M, 2007, CANCER BIOL THER, V6, P1355; Comoglio PM, 1996, GENES CELLS, V1, P347, DOI 10.1046/j.1365-2443.1996.37037.x; Cunha S, 2014, CELL REP, V6, P141, DOI 10.1016/j.celrep.2013.12.010; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; DIRENZO MF, 1995, CANCER RES, V55, P1129; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan SJ, 2000, ONCOGENE, V19, P2212, DOI 10.1038/sj.onc.1203566; FERRACINI R, 1995, ONCOGENE, V10, P739; Gaudino G, 1994, RON HETERODIMERIC TY; Gentile A, 2008, MET TYROSINE KINASE; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Jin L, 1997, CANCER, V79, P749, DOI 10.1002/(SICI)1097-0142(19970215)79:4<749::AID-CNCR12>3.0.CO;2-#; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Kozlov G, 2004, INSIGHTS FUNCTION PS; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Meyer C, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/904750; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Pacchiana G, 2010, J BIOL CHEM, V285, P36149, DOI 10.1074/jbc.M110.134031; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Pagratis NC, 1997, NAT BIOTECHNOL, V15, P68, DOI 10.1038/nbt0197-68; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; Prat M, 1998, J CELL SCI, V111, P237; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Saito T, 2005, DNA CELL BIOL, V24, P624, DOI 10.1089/dna.2005.24.624; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Takeo S, 2001, CANCER GENET CYTOGEN, V130, P127, DOI 10.1016/S0165-4608(01)00479-4; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Tuck AB, 1996, AM J PATHOL, V148, P225; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ueki R, 2014, CHEM COMMUN, V50, P13131, DOI 10.1039/c4cc06016d; Vinkenborg JL, 2012, ANGEW CHEM INT EDIT, V51, P9176, DOI 10.1002/anie.201204174; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Zhou B, 2006, EXP EYE RES, V83, P615, DOI 10.1016/j.exer.2006.02.010	65	9	10	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142412	10.1371/journal.pone.0142412	http://dx.doi.org/10.1371/journal.pone.0142412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658271	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600004
J	Yang, H; He, NP; He, YT; Li, SG; Shi, PL; Zhang, XZ				Yang, Hao; He, Nianpeng; He, Yongtao; Li, Shenggong; Shi, Peili; Zhang, Xianzhou			Stable Water Use Efficiency of Tibetan Alpine Meadows in Past Half Century: Evidence from Wool delta C-13 Values	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; INNER-MONGOLIA; GLOBAL DISTRIBUTION; ATMOSPHERIC CO2; TYPICAL STEPPE; VEGETATION; GRASSLAND; CLIMATE; C-4; HAIR	Understanding the influences of climatic changes on water use efficiency (WUE) of Tibetan alpine meadows is important for predicting their long-term net primary productivity (NPP) because they are considered very sensitive to climate change. Here, we collected wool materials produced from 1962 to 2010 and investigated the long-term WUE of an alpine meadow in Tibet on basis of the carbon isotope values of vegetation (delta C-13(veg)). The values of delta C-13(veg) decreased by 1.34% during 1962-2010, similar to changes in delta C-13 values of atmospheric CO2. Carbon isotope discrimination was highly variable and no trend was apparent in the past half century. Intrinsic water use efficiency (W-i) increased by 18 mu mol.mol(-1) (approximately 23.5%) during 1962-2010 because the increase in the intercellular CO2 concentration (46 mu mol.mol(-1)) was less than that in the atmospheric CO2 concentration (C-a, 73 mu mol.mol(-1)). In addition, Wi increased significantly with increasing growing season temperature and C-a. However, effective water use efficiency (W-e) remained relatively stable, because of increasing vapor pressure deficit. C-a, precipitation, and growing season temperature collectively explained 45% of the variation of W-e. Our findings indicate that the W-e of alpine meadows in the Tibetan Plateau remained relatively stable by physiological adjustment to elevated C-a and growing season temperature. These findings improve our understanding and the capacity to predict NPP of these ecosystems under global change scenarios.	[Yang, Hao; He, Nianpeng; He, Yongtao; Li, Shenggong; Shi, Peili; Zhang, Xianzhou] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Observat & Modeling, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Yang, H (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Observat & Modeling, Beijing 100101, Peoples R China.	yangh@igsnrr.ac.cn	Peili, SHi/AAT-6450-2021; Li, Sheng-Gong/H-5101-2012; zhang, xian/GYA-0290-2022	Li, Sheng-Gong/0000-0003-4889-9927; he, nianpeng/0000-0002-0458-5953; shi, pei li/0000-0002-1120-0003	Natural Sciences Foundation of China [31470506, 31100336]; Knowledge Innovation Project of the Chinese Academy of Sciences [201003011]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by Natural Sciences Foundation of China (http://www.nsfc.gov.cn/) grants 31470506 (NH) and 31100336 (HY), and Knowledge Innovation Project of the Chinese Academy of Sciences (http://english.igsnrr.cas.cn/) grant 201003011 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Auerswald K, 2009, BIOGEOSCIENCES, V6, P795, DOI 10.5194/bg-6-795-2009; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Barbosa ICR, 2010, GLOBAL CHANGE BIOL, V16, P1171, DOI 10.1111/j.1365-2486.2009.02018.x; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; Chen BX, 2014, AGR FOREST METEOROL, V189, P11, DOI 10.1016/j.agrformet.2014.01.002; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Duquesnay A, 1998, PLANT CELL ENVIRON, V21, P565, DOI 10.1046/j.1365-3040.1998.00304.x; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; JONES RJ, 1981, SEARCH, V12, P85; Li Ming-cai, 2007, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V27, P1216; Liu XH, 2007, PLANT ECOL, V193, P195, DOI 10.1007/s11258-006-9258-5; Liu XH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000610; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Lu HY, 2004, BIOGEOCHEMISTRY, V70, P273; Mannel TT, 2007, GLOBAL ECOL BIOGEOGR, V16, P583, DOI 10.1111/j.1466-8238.2007.00322.x; Piao SL, 2012, GLOBAL PLANET CHANGE, V98-99, P73, DOI 10.1016/j.gloplacha.2012.08.009; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Schnyder H., 2008, Multifunctional grasslands in a changing world, Volume 1: XXI International Grassland Congress and VIII International Rangeland Congress, Hohhot, China, 29 June-5 July 2008, P46; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Tang WJ, 2013, J GEOPHYS RES-ATMOS, V118, P13292, DOI 10.1002/2013JD020527; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Wittmer MHOM, 2008, BIOGEOSCIENCES, V5, P913, DOI 10.5194/bg-5-913-2008; Xie H, 2010, THEOR APPL CLIMATOL, V101, P241, DOI 10.1007/s00704-009-0215-9; [闫巍 Yan Wei], 2006, [自然资源学报, Journal of Natural Resources], V21, P756; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yao S, 2000, CHINESE SCI BULL, V45, P98; Zheng SX, 2011, PLANT SOIL, V340, P141, DOI 10.1007/s11104-010-0369-3; Zhou YC, 2011, ALPINE BOT, V121, P79, DOI 10.1007/s00035-011-0093-5	37	1	2	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144752	10.1371/journal.pone.0144752	http://dx.doi.org/10.1371/journal.pone.0144752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26660306	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600084
J	Lee, HS; Choi, EJ; Choi, H; Lee, KS; Kim, HR; Na, BR; Kwon, MS; Jeong, GS; Choi, HG; Choi, EY; Jun, CD				Lee, Hyun-Su; Choi, Eun-Ju; Choi, Heeri; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jeong, Gil-Saeng; Choi, Hyun Gyu; Choi, Eun Young; Jun, Chang-Duk			Oral Administration of 4-Hydroxy-3-Methoxycinnamaldehyde Attenuates Atopic Dermatitis by Inhibiting T Cell and Keratinocyte Activation	PLOS ONE			English	Article							KINASE-C-THETA; PHENOLIC-COMPOUNDS; IN-VITRO; ACID	Atopic dermatitis (AD) is a skin condition caused by an imbalance of distinct subsets of T helper cells. Previously, we showed that 4-hydroxy-3-methoxycinnamaldehyde (4H3MC) inhibits T cell activation but does not induce apoptosis. Here, we examined the mechanism underlying the inhibitory effect of 4H3MC on AD both in vivo and in vitro. We sought to test the pharmacological effects of 4H3MC using a mouse model of 2, 4-'2,4-dinitrocholorobenzene' (DNCB)-and mite-induced AD. Also, we determined whether 4H3MC affects T cell differentiation and proliferation. Oral administration of 4H3MC attenuated the symptoms of DNCB-and mite-induced AD, including increased ear thickness, serum IgE levels, immune cell infiltration into inflammatory lesions, and pathogenic cytokine expression in ear tissues. In vitro, 4H3MC blocked T cell differentiation into Th1 and Th2 subtypes, as reflected by suppression of T-bet and GATA3, which are key transcription factors involved in T cell differentiation. In addition, 4H3MC downregulated T cell proliferation during Th1 and Th2 differentiation and keratinocyte activation. Collectively, these findings suggest that 4H3MC ameliorates AD symptoms by modulating the functions of effector T cells and keratinocytes.	[Lee, Hyun-Su; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea; [Lee, Hyun-Su; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea; [Choi, Eun-Ju; Choi, Heeri] Konkuk Univ, Coll Nat Sci, Div Sport Sci, Chungju, South Korea; [Jeong, Gil-Saeng] Keimyung Univ, Coll Pharm, Daegu, South Korea; [Choi, Hyun Gyu] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Choi, Eun Young] Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Konkuk University; Keimyung University; Yeungnam University; University of Ulsan	Choi, EY (corresponding author), Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul, South Korea.	choieun@ulsan.ac.kr; cdjun@gist.ac.kr			Cell Dynamics Research Program [2007-0056157]; Basic Science Program [2013R1A6A3A04064259]; National Research Foundation (NRF) grants - Ministry of Science, ICT & Future Planning (MSIP), Korea; Bioimaging Research Center at GIST	Cell Dynamics Research Program; Basic Science Program; National Research Foundation (NRF) grants - Ministry of Science, ICT & Future Planning (MSIP), Korea; Bioimaging Research Center at GIST	This work was supported by the Cell Dynamics Research Program (2007-0056157), Basic Science Program (2013R1A6A3A04064259), and the Creative Research Initiative Program (2015) through the National Research Foundation (NRF) grants funded by the Ministry of Science, ICT & Future Planning (MSIP), Korea, and Bioimaging Research Center at GIST.	Akber U, 2015, INT IMMUNOPHARMACOL, V25, P130, DOI 10.1016/j.intimp.2015.01.020; Brandt E, 2011, J CLIN CELL IMMUNOL, V2, DOI [10.4172/2155-9899.1000110.Th2, DOI 10.4172/2155-9899.1000110.TH2]; Buys LM, 2007, AM FAM PHYSICIAN, V75, P523; Cardador-Martinez A, 2002, FOOD ADDIT CONTAM, V19, P62, DOI 10.1080/02652030110062110; Cho JY, 1998, BIOSCI BIOTECH BIOCH, V62, P2273, DOI 10.1271/bbb.62.2273; Choi EJ, 2011, J ETHNOPHARMACOL, V137, P802, DOI 10.1016/j.jep.2011.06.043; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Grammatikos AP, 2008, ANN MED, V40, P482, DOI 10.1080/07853890802082096; Laske N, 2004, PEDIAT ALLERG IMM-UK, V15, P86, DOI 10.1046/j.0905-6157.2003.00106.x; Lee LS, 2013, MOLECULES, V18, P12548, DOI 10.3390/molecules181012548; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; NICKOLOFF BJ, 1995, J INVEST DERMATOL, V105, pS25, DOI 10.1111/1523-1747.ep12315202; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; Oyoshi MK, 2009, ADV IMMUNOL, V102, P135, DOI 10.1016/S0065-2776(09)01203-6; Pfeifhofer-Obermair C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00220; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038	21	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144521	10.1371/journal.pone.0144521	http://dx.doi.org/10.1371/journal.pone.0144521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656486	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500035
J	Gardas, B; Luczka, J; Ptok, A; Dajka, J				Gardas, B.; Luczka, J.; Ptok, A.; Dajka, J.			Energetics of an rf SQUID Coupled to Two Thermal Reservoirs	PLOS ONE			English	Article							JOSEPHSON-JUNCTIONS; HEAT-FLOW; TRANSPORT	We study energetics of a Josephson tunnel junction connecting a superconducting loop pierced by an external magnetic flux (an rf SQUID) and coupled to two independent thermal reservoirs of different temperature. In the framework of the theory of quantum dissipative systems, we analyze energy currents in stationary states. The stationary energy flow can be periodically modulated by the external magnetic flux exemplifying the rf SQUID as a quantum heat interferometer. We also consider the transient regime and identify three distinct regimes: monotonic decay, damped oscillations and pulse-type behavior of energy currents. The first two regimes can be controlled by the external magnetic flux while the last regime is robust against its variation.	[Gardas, B.; Luczka, J.; Dajka, J.] Univ Silesia, PL-40007 Katowice, Poland; [Gardas, B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Luczka, J.; Dajka, J.] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, PL-41500 Chorzow, Poland; [Ptok, A.] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland	University of Silesia in Katowice; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Silesia in Katowice; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences	Dajka, J (corresponding author), Univ Silesia, PL-40007 Katowice, Poland.	jerzy.dajka@us.edu.pl	Ptok, Andrzej/F-1792-2013	Ptok, Andrzej/0000-0002-5566-2656; Gardas, Bartlomiej/0000-0002-1454-1591; Luczka, Jerzy/0000-0003-2296-4532; Dajka, Jerzy/0000-0003-4912-4859	National Center for Science (NCN, Poland) [UMO-2011/01/N/ST3/02473, N202 052940, DEC-2013/09/B/ST3/01659]; NCN (Poland) [UMO-2011/01/N/ST3/02473, N202 052940, DEC-2013/09/B/ST3/01659, 1060/MOB/2013/0]	National Center for Science (NCN, Poland); NCN (Poland)	This work was supported by the National Center for Science (NCN, Poland) under grants UMO-2011/01/N/ST3/02473 (BG), N202 052940 (JL) and DEC-2013/09/B/ST3/01659 (JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the NCN (Poland) under grants UMO-2011/01/N/ST3/02473 (B.G) and Mobility Plus 1060/MOB/2013/0 (B.G), N202 052940 (J.L.) and DEC-2013/09/B/ST3/01659 (J.D.)	ALICKI R, 1979, J PHYS A-MATH GEN, V12, pL103, DOI 10.1088/0305-4470/12/5/007; Armour AD, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.184508; Barone A., 1982, PHYS APPL JOSEPHSON; Ben-Abdallah P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.044301; Breuer H.-P., 2002, THEORY OPEN QUANTUM; Butcher J.C., 2008, NUMERICAL METHODS OR, DOI DOI 10.1002/9780470753767; CALDEIRA AO, 1983, PHYSICA A, V121, P587, DOI 10.1016/0378-4371(83)90013-4; Chang CW, 2006, SCIENCE, V314, P1121, DOI 10.1126/science.1132898; Dambach S, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.054508; DAVIES EB, 1974, COMMUN MATH PHYS, V39, P91, DOI 10.1007/BF01608389; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Elouard C, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/055018; Everitt MJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.043804; Giazotto F, 2012, NATURE, V492, P401, DOI 10.1038/nature11702; Golubev D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094522; Guttman GD, 1998, PHYS REV B, V57, P2717, DOI 10.1103/PhysRevB.57.2717; Guttman GD, 1997, PHYS REV B, V55, P3849, DOI 10.1103/PhysRevB.55.3849; Guttman GD, 1997, PHYS REV B, V55, P12691, DOI 10.1103/PhysRevB.55.12691; Kafanov S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120801; Lee KH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.123604; Leggio B, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.012117; Li BW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.184301; Li NB, 2012, REV MOD PHYS, V84, P1045, DOI 10.1103/RevModPhys.84.1045; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; MAKI K, 1965, PHYS REV LETT, V15, P921, DOI 10.1103/PhysRevLett.15.921; Park JJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230402; Saira OP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027203; Volz S., 2007, TOPICS APPL PHYS, V107; Wang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.177208; Wang L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267203	30	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143912	10.1371/journal.pone.0143912	http://dx.doi.org/10.1371/journal.pone.0143912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641890	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700034
J	Li, YH; Zhang, M; Xiao, HT; Fu, HB; Ho, A; Lin, CY; Huang, Y; Lin, G; Bian, ZX				Li, Yan-hong; Zhang, Man; Xiao, Hai-tao; Fu, Hai-bo; Ho, Alan; Lin, Cheng-yuan; Huang, Yu; Lin, Ge; Bian, Zhao-xiang			Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; ACETYLTRANSFERASE ACTIVITY; ADJUNCT THERAPY; IN-VITRO; ACTIVATION; INHIBITION; MUCINS; GROWTH	Ulcerative colitis (UC) is a common chronic remitting disease but without satisfactory treatment. Alternative medicine berberine has received massive attention for its potential in UC treatment. Conventional therapies with the addition of berberine are becoming attractive as novel therapies in UC. In the present study, we investigated the preclinical activity of a conventional oral 5-aminosalicylic acid (5-ASA) therapy plus berberine in experimental colitis. A subclinical dose of 5-ASA (200 mg/kg/day) alone or 5-ASA plus berberine (20 mg/kg/day) was orally administered for 30 days to C57BL/6 mice with colitis induced by three cycles of 2% dextran sulfate sodium (DSS). The disease severity, inflammatory responses, drug accumulation and potential toxicity of colitis mice were examined. The results showed that comparing to 5-ASA alone, 5-ASA plus berberine more potently ameliorated DSS-induced disease severity, colon shortening, and colon histological injury. Further, the up-regulation in mRNA level of colonic TNF-alpha as well as NF kappa B and JAK2 phosphorylation caused by DSS were more pronouncedly reversed in animals treated with the combination therapy than those treated with 5-ASA alone. Moreover, the addition of berberine to 5-ASA more significantly inhibited lymphocyte TNF-alpha secretion of DSS mice than 5-ASA alone. In the meanwhile, no extra drug accumulation or potential toxicity to major organs of colitis mice was observed with this combination treatment. In summary, our studies provide preclinical rationale for the addition of berberine to 5-ASA as a promising therapeutic strategy in clinic by reducing dose of standard therapy.	[Li, Yan-hong; Zhang, Man; Xiao, Hai-tao; Fu, Hai-bo; Ho, Alan; Lin, Cheng-yuan; Bian, Zhao-xiang] Hong Kong Baptist Univ, Lab Brain & Gut Res, Hong Kong Chinese Med Res Ctr, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Yu; Lin, Ge] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Chinese University of Hong Kong	Bian, ZX (corresponding author), Hong Kong Baptist Univ, Lab Brain & Gut Res, Hong Kong Chinese Med Res Ctr, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	bzxiang@hkbu.edu.hk	Lin, Ge/R-4200-2018; Huang, Yu/K-2866-2017	Lin, Ge/0000-0002-4586-2603; Huang, Yu/0000-0002-1277-6784; LIN, Chengyuan/0000-0001-7929-0212	Food and Health Bureau of The Government of Hong Kong Special Administration Region [Health and Medical Research Fund] [HMRF10111971]	Food and Health Bureau of The Government of Hong Kong Special Administration Region [Health and Medical Research Fund]	This work was supported by grant from the Food and Health Bureau of The Government of Hong Kong Special Administration Region [Health and Medical Research Fund (HMRF10111971)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Ardite E, 1998, BRIT J PHARMACOL, V124, P431, DOI 10.1038/sj.bjp.0701887; Bantel H, 2000, AM J GASTROENTEROL, V95, P3452; Chen CQ, 2014, AM J CHINESE MED, V42, P1053, DOI 10.1142/S0192415X14500669; Chung JG, 1999, FOOD CHEM TOXICOL, V37, P319, DOI 10.1016/S0278-6915(99)00016-2; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; Cottone M, 2011, CURR DRUG TARGETS, V12, P1396, DOI 10.2174/138945011796818126; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Derosa G, 2014, CURR TOP MED CHEM, V14, P200, DOI 10.2174/1568026613666131213155252; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; Fu KQ, 2015, INT IMMUNOPHARMACOL, V24, P128, DOI 10.1016/j.intimp.2014.11.002; Gao MY, 2014, PHARMACOL REP, V66, P480, DOI 10.1016/j.pharep.2013.12.004; Gu GZ, 2011, J CHROMATOGR B, V879, P449, DOI 10.1016/j.jchromb.2010.12.034; Hong T, 2012, IMMUNOPHARM IMMUNOT, V34, P391, DOI 10.3109/08923973.2011.609887; Kaiser GC, 1999, GASTROENTEROLOGY, V116, P602, DOI 10.1016/S0016-5085(99)70182-4; Katz Seymour, 2010, Gastroenterol Hepatol (N Y), V6, P1; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lan JR, 2015, J ETHNOPHARMACOL, V161, P69, DOI 10.1016/j.jep.2014.09.049; LAURSEN LS, 1990, GUT, V31, P1271, DOI 10.1136/gut.31.11.1271; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087810; Lin JG, 1999, AM J CHINESE MED, V27, P265, DOI 10.1142/S0192415X99000306; Liptay S, 1999, BRIT J PHARMACOL, V128, P1361, DOI 10.1038/sj.bjp.0702937; Liu L, 2013, INT IMMUNOPHARMACOL, V17, P314, DOI 10.1016/j.intimp.2013.06.020; Mbodji K, 2013, J NUTR BIOCHEM, V24, P700, DOI 10.1016/j.jnutbio.2012.03.022; Mehta SJ, 2013, ALIMENT PHARM THER, V38, P77, DOI 10.1111/apt.12345; Panes J, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0239-9; Pastorini E, 2008, J CHROMATOGR B, V872, P99, DOI 10.1016/j.jchromb.2008.07.026; Qin X, 2010, J IMMUNOL, V185, P1855, DOI 10.4049/jimmunol.0903853; Rhodes JM, 1997, QJM-MON J ASSOC PHYS, V90, P79, DOI 10.1093/qjmed/90.2.79; Sandborn WJ, 2004, ALIMENT PHARM THER, V19, P1089, DOI 10.1111/j.1365-2036.2004.01964.x; Sayer B, 2002, BRIT J PHARMACOL, V135, P1794, DOI 10.1038/sj.bjp.0704633; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; SHARON P, 1978, GASTROENTEROLOGY, V75, P638; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; Tao FF, 2013, BIOCHEM PHARMACOL, V85, P798, DOI 10.1016/j.bcp.2012.12.002; Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018; Toumi R, 2014, INT J IMMUNOPATH PH, V27, P615, DOI 10.1177/039463201402700418; Toumi R, 2013, IMMUNOPHARM IMMUNOT, V35, P403, DOI 10.3109/08923973.2013.790413; Tsang CM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-619; Tzivras M, 1997, EUR J GASTROEN HEPAT, V9, P729, DOI 10.1097/00042737-199707000-00016; Viennois Emilie, 2013, BMC Res Notes, V6, P360, DOI 10.1186/1756-0500-6-360; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wang Y, 2013, PHARM BIOL; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan F, 1999, J BIOL CHEM, V274, P36631, DOI 10.1074/jbc.274.51.36631; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Zhang C, 2013, CLIN REV ALLERG IMMU, V44, P274, DOI 10.1007/s12016-012-8328-9; Zhao LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094208; Zhou HY, 2000, J PHARMACOL EXP THER, V294, P822	53	35	37	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144101	10.1371/journal.pone.0144101	http://dx.doi.org/10.1371/journal.pone.0144101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642326	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700055
J	Kim, DH; Hwang, JS; Lee, IH; Nam, ST; Hong, J; Zhang, P; Lu, LF; Lee, J; Seok, H; Pothoulakis, C; Lamont, JT; Kim, H				Kim, Dae Hong; Hwang, Jae Sam; Lee, Ik Hwan; Nam, Seung Taek; Hong, Ji; Zhang, Peng; Lu, Li Fang; Lee, Junguee; Seok, Heon; Pothoulakis, Charalabos; Lamont, John Thomas; Kim, Ho			The Insect Peptide CopA3 Increases Colonic Epithelial Cell Proliferation and Mucosal Barrier Function to Prevent Inflammatory Responses in the Gut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; cell cycle; cell proliferation; epidermal growth factor (EGF); epithelial cell; inflammation; peptides; proteasome; protein degradation; ubiquitylation (ubiquitination)	EPIDERMAL-GROWTH-FACTOR; CLOSTRIDIUM-DIFFICILE TOXIN; ULCERATIVE-COLITIS; UBIQUITIN LIGASE; INTESTINAL INFLAMMATION; INTERACTING PROTEIN; CROHNS-DISEASE; BOWEL-DISEASE; APOPTOSIS; DEGRADATION	The epithelial cells of the gut form a physical barrier against the luminal contents. The collapse of this barrier causes inflammation, and its therapeutic restoration can protect the gut against inflammation. EGF enhances mucosal barrier function and increases colonocyte proliferation, thereby ameliorating inflammatory responses in the gut. Based on our previous finding that the insect peptide CopA3 promotes neuronal growth, we herein tested whether CopA3 could increase the cell proliferation of colonocytes, enhance mucosal barrier function, and ameliorate gut inflammation. Our results revealed that CopA3 significantly increased epithelial cell proliferation in mouse colonic crypts and also enhanced colonic epithelial barrier function. Moreover, CopA3 treatment ameliorated Clostridium difficile toxin As-induced inflammation responses in the mouse small intestine (acute enteritis) and completely blocked inflammatory responses and subsequent lethality in the dextran sulfate sodium-induced mouse model of chronic colitis. The marked CopA3-induced increase of colonocyte proliferation was found to require rapid protein degradation of p21(Cip1/Waf1), and an in vitro ubiquitination assay revealed that CopA3 directly facilitated ubiquitin ligase activity against p21(Cip1/Waf1). Taken together, our findings indicate that the insect peptide CopA3 prevents gut inflammation by increasing epithelial cell proliferation and mucosal barrier function.	[Kim, Dae Hong; Lee, Ik Hwan; Nam, Seung Taek; Hong, Ji; Zhang, Peng; Lu, Li Fang; Kim, Ho] Daejin Univ, Coll Nat Sci, Dept Life Sci, Pochon 487711, Gyeonggido, South Korea; [Hwang, Jae Sam] Natl Acad Agr Sci, Dept Agr Biol, RDA, Wonju 55365, South Korea; [Lee, Junguee] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Pathol, Daeheung Ro 64, Daejeon 301723, South Korea; [Seok, Heon] Jungwon Univ, Dept Biomed Engn, Goesan 367700, Chungcheongbukd, South Korea; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Lamont, John Thomas] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA	Daejin University; Rural Development Administration (RDA), Republic of Korea; Catholic University of Korea; Jungwon University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, H (corresponding author), Daejin Univ, Dept Life Sci & Chem, Coll Nat Sci, Pochon, Gyeonggido, South Korea.	hokim@daejin.ac.kr	Kim, Daehong/AAP-7488-2021	Kim, Daehong/0000-0002-1253-8946	Rural Development Administration, Republic of Korea [PJ011043022015]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Next-Generation BioGreen 21 Program (no, PJ011043022015), Rural Development Administration, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Alscher KT, 2001, AM J PHYSIOL-GASTR L, V281, pG569, DOI 10.1152/ajpgi.2001.281.2.G569; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Drucker DJ, 1999, AM J PHYSIOL-GASTR L, V276, pG79, DOI 10.1152/ajpgi.1999.276.1.G79; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; HARPER JW, 1993, CELL, V75, P805; Iwamoto M, 1996, J PATHOL, V180, P152; Izawa H, 2005, INT J ONCOL, V27, P69; Jeffers M, 2002, GASTROENTEROLOGY, V123, P1151, DOI 10.1053/gast.2002.36041; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kang BR, 2012, BMB REP, V45, P85, DOI 10.5483/BMBRep.2012.45.2.85; Kang JK, 2011, ANTIMICROB AGENTS CH, V55, P4850, DOI 10.1128/AAC.00177-11; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim DH, 2014, BIOCHEM BIOPH RES CO, V448, P292, DOI 10.1016/j.bbrc.2014.04.105; Kim H, 2005, GASTROENTEROLOGY, V129, P1875, DOI 10.1053/j.gastro.2005.09.011; Kim H, 2007, GASTROENTEROLOGY, V133, P875, DOI 10.1053/j.gastro.2007.06.063; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Literakova P, 2010, J CHROMATOGR SCI, V48, P436, DOI 10.1093/chromsci/48.6.436; Nam ST, 2013, BIOCHEM BIOPH RES CO, V437, P35, DOI 10.1016/j.bbrc.2013.06.031; Newman B, 2005, CURR OPIN GASTROEN, V21, P401; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; PLAYFORD RJ, 1995, GUT, V37, P595, DOI 10.1136/gut.37.5.595; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Riegler M, 1997, AM J PHYSIOL-GASTR L, V273, pG1014, DOI 10.1152/ajpgi.1997.273.5.G1014; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; SERAFINI EP, 1981, GUT, V22, P648, DOI 10.1136/gut.22.8.648; Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11; Shin JS, 2008, INT J ONCOL, V32, P435; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tsai CH, 1997, AM J PHYSIOL-ENDOC M, V273, pE77, DOI 10.1152/ajpendo.1997.273.1.E77; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Wong NACS, 2003, HUM PATHOL, V34, P580, DOI 10.1016/S0046-8177(03)00125-4; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	41	18	20	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3209	3223		10.1074/jbc.M115.682856	http://dx.doi.org/10.1074/jbc.M115.682856			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26655716	Green Published, hybrid			2022-12-26	WOS:000370854500009
J	Chen, CC; Chen, CW; Ho, CK; Liu, IC; Lin, BC; Chan, TC				Chen, Chien-Chou; Chen, Chao-Wen; Ho, Chi-Kung; Liu, I-Chuan; Lin, Bo-Cheng; Chan, Ta-Chien			Spatial Variation and Resuscitation Process Affecting Survival after Out-of-Hospital Cardiac Arrests (OHCA)	PLOS ONE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; CARDIOPULMONARY-RESUSCITATION; POPULATION-DENSITY; PREDICTORS; OUTCOMES; REGISTRY; IMPACT; EPIDEMIOLOGY; MANAGEMENT; DEPLOYMENT	Background Ambulance response times and resuscitation efforts are critical predictors of the survival rate after out-of-hospital cardiac arrests (OHCA). On the other hand, rural-urban differences in the OHCA survival rates are an important public health issue. Methods We retrospectively reviewed the January 2011-December 2013 OHCA registry data of Kaohsiung City, Taiwan. With particular focus on geospatial variables, we aimed to unveil risk factors predicting the overall OHCA survival until hospital admission. Spatial analysis, network analysis, and the Kriging method by using geographic information systems were applied to analyze spatial variations and calculate the transport distance. Logistic regression was used to identify the risk factors for OHCA survival. Results Among the 4,957 patients, the overall OHCA survival to hospital admission was 16.5%. In the multivariate analysis, female sex (adjusted odds ratio:, AOR, 1.24 [1.06-1.45]), events in public areas (AOR: 1.30 [1.05-1.61]), exposure to automated external defibrillator (AED) shock (AOR: 1.70 [1.30-2.23]), use of laryngeal mask airway (LMA) (AOR: 1.35 [1.16-1.58]), non-trauma patients (AOR: 1.41 [1.04-1.90]), ambulance bypassed the closest hospital (AOR: 1.28 [1.07-1.53]), and OHCA within the high population density areas (AOR: 1.89 [1.55-2.32]) were positively associated with improved OHCA survival. By contrast, a prolonged total emergency medical services (EMS) time interval was negatively associated with OHCA survival (AOR: 0.98 [0.96-0.99]). Conclusions Resuscitative efforts, such as AED or LMA use, and a short total EMS time interval improved OHCA outcomes in emergency departments. The spatial heterogeneity of emergency medical resources between rural and urban areas might affect survival rate.	[Chen, Chien-Chou; Lin, Bo-Cheng; Chan, Ta-Chien] Acad Sinica, Ctr Geog Informat Sci, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ Hosp, Dept Surg, Div Trauma, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Ho, Chi-Kung] Kaohsiung City Govt, Dept Hlth, Kaohsiung, Taiwan; [Liu, I-Chuan] Kaohsiung City Govt, Fire Bur, Kaohsiung, Taiwan	Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, CW (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Trauma, Kaohsiung, Taiwan.	kmutrauma@gmail.com; dachianpig@gmail.com	Chen, Chien-Chou/AAD-7070-2019	Chen, Chao Wen/0000-0002-8405-342X; Lin, Bo-Cheng/0000-0003-3502-6203	Academia Sinica; Ministry of Science and Technology [MOST-103-2627-M-001-006]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was mainly supported by the internal research project named "Multidisciplinary Health Cloud Research Program: Technology Development and Application of Big Health Data" funded by Academia Sinica and also partially supported by a research grant from the Ministry of Science and Technology (grants no. MOST-103-2627-M-001-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Berdowski J, 2011, CIRCULATION, V124, P2225, DOI 10.1161/CIRCULATIONAHA.110.015545; Bertrand C, 2004, RESUSCITATION, V63, P175, DOI 10.1016/j.resuscitation.2004.05.011; Blom MT, 2013, RESUSCITATION, V84, P569, DOI 10.1016/j.resuscitation.2012.10.009; Boyce LW, 2015, NETH HEART J, V23, P20, DOI 10.1007/s12471-014-0617-x; Chen CY, 2013, PEDIATR SURG INT, V29, P471, DOI 10.1007/s00383-013-3302-z; Cudnik MT, 2010, RESUSCITATION, V81, P518, DOI 10.1016/j.resuscitation.2009.12.030; De Maio VJ, 2012, PREHOSP EMERG CARE, V16, P230, DOI 10.3109/10903127.2011.640419; Dyson K, 2014, RESUSCITATION, V85, P1134, DOI 10.1016/j.resuscitation.2014.05.020; Earnest A, 2012, PREHOSP EMERG CARE, V16, P256, DOI 10.3109/10903127.2011.615974; Fake AL, 2013, NEW ZEAL MED J, V126, P28; Goh ES, 2013, ANN ACAD MED SINGAP, V42, P437; Goldberg SA, 2013, CRIT CARE, V17, DOI 10.1186/cc13128; Guimaraes RJPS, 2009, ACTA TROP, V109, P181, DOI 10.1016/j.actatropica.2008.10.012; Hasegawa K, 2013, RESUSCITATION, V84, P1099, DOI 10.1016/j.resuscitation.2013.03.007; Hiltunen P, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-80; Iqbal MB, 2015, AM J CARDIOL, V115, P730, DOI 10.1016/j.amjcard.2014.12.033; Kitamura T, 2010, EUR HEART J, V31, P1365, DOI 10.1093/eurheartj/ehq059; Ko PCI, 2004, RESUSCITATION, V63, P167, DOI 10.1016/j.resuscitation.2004.04.002; Lee CC, 2011, EMERG MED J, V28, P432, DOI 10.1136/emj.2009.087593; Lin CH, 2013, RESUSCITATION, V84, P586, DOI 10.1016/j.resuscitation.2012.09.028; Lin YR, 2007, RESUSCITATION, V74, P83, DOI 10.1016/j.resuscitation.2006.11.022; Mahapatra S, 2005, RESUSCITATION, V65, P197, DOI 10.1016/j.resuscitation.2004.10.017; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Nielsen AM, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-34; Nordberg P, 2015, RESUSCITATION, V90, P143, DOI 10.1016/j.resuscitation.2015.02.036; Pollice A, 2010, ENVIRON MONIT ASSESS, V162, P177, DOI 10.1007/s10661-009-0786-z; Sasson C, 2011, RESUSCITATION, V82, P674, DOI 10.1016/j.resuscitation.2011.02.002; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sladjana A, 2011, EUR J INTERN MED, V22, P386, DOI 10.1016/j.ejim.2011.04.003; Stromsoe A, 2011, RESUSCITATION, V82, P1307, DOI 10.1016/j.resuscitation.2011.04.025; Ta-Chien Chan, 2013, GEOMASKER 1 0; Tetsushi Tachikawa, 2011, NASA LAND PROCESSES; Tritsch L, 2014, RESUSCITATION, V85, P320, DOI 10.1016/j.resuscitation.2013.11.006; van de Glind EMM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-68; Weisfeldt ML, 2011, NEW ENGL J MED, V364, P313, DOI 10.1056/NEJMoa1010663; Wibrandt I, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0028-3; Wissenberg M, 2014, RESUSCITATION, V85, P1212, DOI 10.1016/j.resuscitation.2014.06.008; Writer H, 2010, BMJ CLIN EVID, V2010, P307; Yeung J, 2014, RESUSCITATION, V85, P898, DOI 10.1016/j.resuscitation.2014.02.018	40	19	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144882	10.1371/journal.pone.0144882	http://dx.doi.org/10.1371/journal.pone.0144882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659851	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900133
J	Inoue, E; Watanabe, Y; Xing, JR; Kushima, I; Egawa, J; Okuda, S; Hoya, S; Okada, T; Uno, Y; Ishizuka, K; Sugimoto, A; Igeta, H; Nunokawa, A; Sugiyama, T; Ozaki, N; Someya, T				Inoue, Emiko; Watanabe, Yuichiro; Xing, Jingrui; Kushima, Itaru; Egawa, Jun; Okuda, Shujiro; Hoya, Satoshi; Okada, Takashi; Uno, Yota; Ishizuka, Kanako; Sugimoto, Atsunori; Igeta, Hirofumi; Nunokawa, Ayako; Sugiyama, Toshiro; Ozaki, Norio; Someya, Toshiyuki			Resequencing and Association Analysis of CLN8 with Autism Spectrum Disorder in a Japanese Population	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; MUTATIONS; GENES	Rare variations contribute substantially to autism spectrum disorder (ASD) liability. We recently performed whole-exome sequencing in two families with affected siblings and then carried out a follow-up study and identified ceroid-lipofuscinosis neuronal 8 (epilepsy, progressive with mental retardation) (CLN8) as a potential genetic risk factor for ASD. To further investigate the role of CLN8 in the genetic etiology of ASD, we performed resequencing and association analysis of CLN8 with ASD in a Japanese population. Resequencing the CLN8 coding region in 256 ASD patients identified five rare missense variations: g.1719291G>A (R24H), rs201670636 (F39L), rs116605307 (R97H), rs143701028 (T108M) and rs138581191 (N152S). These variations were genotyped in 568 patients (including the resequenced 256 patients) and 1017 controls. However, no significant association between these variations and ASD was identified. This study does not support a contribution of rare missense CLN8 variations to ASD susceptibility in the Japanese population.	[Inoue, Emiko; Watanabe, Yuichiro; Egawa, Jun; Hoya, Satoshi; Sugimoto, Atsunori; Igeta, Hirofumi; Nunokawa, Ayako; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Xing, Jingrui; Kushima, Itaru; Okada, Takashi; Uno, Yota; Ishizuka, Kanako; Ozaki, Norio] Niigata Univ, Grad Sch Med, Dept Psychiat, Niigata, Japan; [Okuda, Shujiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Bioinformat, Niigata, Japan; [Nunokawa, Ayako] Oojima Hosp, Sanjo, Niigata, Japan; [Sugiyama, Toshiro] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Hamamatsu, Shizuoka 4313192, Japan	Niigata University; Niigata University; Niigata University; Hamamatsu University School of Medicine	Egawa, J (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.	jeg5414@med.niigata-u.ac.jp	Someya, Toshiyuki/ABD-1878-2021; UNO, Yota/M-8928-2014; Okuda, Shujiro/D-1700-2016; Ozaki, Norio/M-8908-2014; Watanabe, Yuichiro/ABB-7176-2021; SUGIMOTO, Atsunori/ABD-1064-2021; Egawa, Jun/GVS-0721-2022; OKADA, Takashi/M-8902-2014	Okuda, Shujiro/0000-0002-7704-8104; Ozaki, Norio/0000-0002-7360-4898; Watanabe, Yuichiro/0000-0002-5496-5997; SUGIMOTO, Atsunori/0000-0002-6684-0016; OKADA, Takashi/0000-0001-5580-9913; Kushima, Itaru/0000-0002-0018-5178	Niigata Medical Association; Japan Foundation for Neuroscience; "Integrated Research on Neuropsychiatric Disorders" of the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and development, AMED	Niigata Medical Association; Japan Foundation for Neuroscience; "Integrated Research on Neuropsychiatric Disorders" of the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by a grant from the Niigata Medical Association, by a grant from the Japan Foundation for Neuroscience, and by a "Integrated Research on Neuropsychiatric Disorders" of the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and development, AMED. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Chien WH, 2010, CLIN GENET, V78, P449, DOI 10.1111/j.1399-0004.2010.01395.x; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-26; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Egawa J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119413; Galizzi G, 2011, NEUROSCI LETT, V488, P258, DOI 10.1016/j.neulet.2010.11.041; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lonka L, 2000, HUM MOL GENET, V9, P1691, DOI 10.1093/hmg/9.11.1691; Nunokawa A, 2010, SCHIZOPHR RES, V116, P61, DOI 10.1016/j.schres.2009.10.016; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranta S, 2004, HUM MUTAT, V23, P300, DOI 10.1002/humu.20018; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Toma C, 2014, MOL PSYCHIATR, V19, P784, DOI 10.1038/mp.2013.106; Vantaggiato C, 2009, HUM MUTAT, V30, P1104, DOI 10.1002/humu.21012; Watanabe Y, 2006, SCHIZOPHR RES, V84, P29, DOI 10.1016/j.schres.2006.03.011; Wei HG, 2014, INT J DEV NEUROSCI, V36, P13, DOI 10.1016/j.ijdevneu.2014.04.004; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144624	10.1371/journal.pone.0144624	http://dx.doi.org/10.1371/journal.pone.0144624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657971	Green Published, gold			2022-12-26	WOS:000366715900075
J	Pettit, AP; Kipen, H; Laumbach, R; Ohman-Strickland, P; Kelly-McNeill, K; Cepeda, C; Fan, ZH; Amorosa, L; Lubitz, S; Schneider, S; Gow, A				Pettit, Ashley P.; Kipen, Howard; Laumbach, Robert; Ohman-Strickland, Pamela; Kelly-McNeill, Kathleen; Cepeda, Clarimel; Fan, Zhi-Hua; Amorosa, Louis; Lubitz, Sara; Schneider, Stephen; Gow, Andrew			Disrupted Nitric Oxide Metabolism from Type II Diabetes and Acute Exposure to Particulate Air Pollution	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DIESEL EXHAUST; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; VASCULAR FUNCTION; ULTRAFINE PARTICLES; TRAFFIC PARTICLES; REACTIVE OXYGEN; INHALATION; INFLAMMATION	Type II diabetes is an established cause of vascular impairment. Particulate air pollution is known to exacerbate cardiovascular and respiratory conditions, particularly in susceptible populations. This study set out to determine the impact of exposure to traffic pollution, with and without particle filtration, on vascular endothelial function in Type II diabetes. Endothelial production of nitric oxide (NO) has previously been linked to vascular health. Reactive hyperemia induces a significant increase in plasma nitrite, the proximal metabolite of NO, in healthy subjects, while diabetics have a lower and more variable level of response. Twenty type II diabetics and 20 controls (ages 46-70 years) were taken on a 1.5hr roadway traffic air pollution exposure as passengers. We analyzed plasma nitrite, as a measure of vascular function, using forearm ischemia to elicit a reactive hyperemic response before and after exposure to one ride with and one without filtration of the particle components of pollution. Control subjects displayed a significant increase in plasma nitrite levels during reactive hyperemia. This response was no longer present following exposure to traffic air pollution, but did not vary with whether or not the particle phase was filtered out. Diabetics did not display an increase in nitrite levels following reactive hyperemia. This response was not altered following pollution exposure. These data suggest that components of acute traffic pollution exposure diminish vascular reactivity in non-diabetic individuals. It also confirms that type II diabetics have a preexisting diminished ability to appropriately respond to a vascular challenge, and that traffic pollution exposure does not cause a further measureable acute change in plasma nitrite levels in Type II diabetics.	[Pettit, Ashley P.] Rutgers State Univ, Grad Sch Biomed Sci, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Kipen, Howard; Laumbach, Robert; Fan, Zhi-Hua; Amorosa, Louis; Lubitz, Sara; Schneider, Stephen] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Kipen, Howard; Laumbach, Robert; Kelly-McNeill, Kathleen; Cepeda, Clarimel; Fan, Zhi-Hua; Gow, Andrew] Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Ohman-Strickland, Pamela] Rutgers State Univ, Sch Publ Hlth, Piscataway, NJ 08854 USA; [Amorosa, Louis; Lubitz, Sara; Schneider, Stephen] Robert Wood Johnson Univ Hosp, New Brunswick, NJ 08901 USA; [Gow, Andrew] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Gow, A (corresponding author), Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA.	gow@rci.rutgers.edu	Gow, Andrew/AAR-2309-2020; Gow, Andrew/N-8566-2013	Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Lubitz, Sara/0000-0002-9514-6744; Pettit, Ashley P./0000-0001-5536-3245	National Institute of Environmental Health Sciences; NIEHS Center Grant [P30ES005022]; Center for Environmental Exposures and Disease, NIEHS [P30ES005022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148, P30ES005022] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Environmental Exposures and Disease, NIEHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by the National Institute of Environmental Health Sciences sponsored UMDNJ (now Rutgers University) Center for Environmental Exposures and Disease, NIEHS Grant #: P30ES005022. The specific website for this center can be found at http://ceed.rutgers.edu/. AG (principle) and HK were investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by NIEHS Center Grant P30ES005022	Adar SD, 2007, EPIDEMIOLOGY, V18, P95, DOI 10.1097/01.ede.0000249409.81050.46; Allen JD, 2009, NITRIC OXIDE-BIOL CH, V20, P231, DOI 10.1016/j.niox.2009.01.002; Allen JD, 2005, FREE RADICAL BIO MED, V38, P1164, DOI 10.1016/j.freeradbiomed.2004.12.018; Banerjee A, 2009, TOXICOL LETT, V187, P187, DOI 10.1016/j.toxlet.2009.02.022; Barath S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-19; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; BUSSE R, 1993, EUR HEART J, V14, P2; Campen M, 2014, INHAL TOXICOL, V26, P353, DOI 10.3109/08958378.2014.897776; Canani LH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-54; Cines DB, 1998, BLOOD, V91, P3527; Cooper ME, 2001, AM J HYPERTENS, V14, P475, DOI 10.1016/S0895-7061(00)01323-6; Cozzi E, 2006, AM J PHYSIOL-HEART C, V291, pH894, DOI 10.1152/ajpheart.01362.2005; DeMeyer GRY, 1997, PROG CARDIOVASC DIS, V39, P325, DOI 10.1016/S0033-0620(97)80031-X; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Haller H, 1997, DRUGS, V53, P1, DOI 10.2165/00003495-199700531-00003; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Hu SS, 2012, ATMOS ENVIRON, V51, P311, DOI 10.1016/j.atmosenv.2011.12.055; Huang W, 2012, AM J RESP CRIT CARE, V186, P1150, DOI 10.1164/rccm.201205-0850OC; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; IKEDA M, 1995, JPN J PHARMACOL, V68, P183, DOI 10.1254/jjp.68.183; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Kadirvelu A, 2002, MED PROGR, P4; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kipen HM, 2011, ENVIRON HEALTH PERSP, V119, P658, DOI 10.1289/ehp.1002784; Langrish JP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004309; Langrish JP, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-8; Laumbach RJ, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0045-5; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Laumbach RJ, 2010, J OCCUP ENVIRON MED, V52, P324, DOI 10.1097/JOM.0b013e3181d241fa; Lefrandt JD, 2010, CURR DIABETES REV, V6, P348, DOI 10.2174/157339910793499128; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Manzella D, 2005, CLIN SCI, V108, P93, DOI 10.1042/CS20040223; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller MR, 2012, FUTUR CARDIOL, V8, P577, DOI [10.2217/fca.12.43, 10.2217/FCA.12.43]; Miller MR, 2009, ENVIRON HEALTH PERSP, V117, P611, DOI 10.1289/ehp.0800235; Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Mombouli JV, 1997, DRUGS, V54, P12, DOI 10.2165/00003495-199700545-00004; Ness J, 1999, CORONARY ARTERY DIS, V10, P343, DOI 10.1097/00019501-199907000-00012; Nordenhall C, 2000, EUR RESPIR J, V15, P1046, DOI 10.1034/j.1399-3003.2000.01512.x; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Peretz A, 2008, ENVIRON HEALTH PERSP, V116, P937, DOI 10.1289/ehp.11027; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Rassaf T, 2006, FREE RADICAL BIO MED, V41, P295, DOI 10.1016/j.freeradbiomed.2006.04.006; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Salvi SS, 2000, AM J RESP CRIT CARE, V161, P550, DOI 10.1164/ajrccm.161.2.9905052; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Verma S, 2001, Cardiol Rev, V9, P250, DOI 10.1097/00045415-200109000-00003; Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33; Wan JX, 2007, INHAL TOXICOL, V19, P177, DOI 10.1080/08958370701496145; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Ying ZK, 2009, TOXICOL SCI, V111, P80, DOI 10.1093/toxsci/kfp004; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008; Zanobetti A, 2014, ENVIRON HEALTH PERSP, V122, P242, DOI 10.1289/ehp.1206136; Zhao HW, 2009, J TOXICOL ENV HEAL A, V72, P560, DOI 10.1080/15287390802706330; Zhu YF, 2008, J AIR WASTE MANAGE, V58, P424, DOI 10.3155/1047-3289.58.3.424; Zhu YF, 2007, ENVIRON SCI TECHNOL, V41, P2138, DOI 10.1021/es0618797; Zuurbier M, 2010, ENVIRON HEALTH PERSP, V118, P783, DOI 10.1289/ehp.0901622	61	6	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144250	10.1371/journal.pone.0144250	http://dx.doi.org/10.1371/journal.pone.0144250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656561	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900035
J	Ruhl, H; Berens, C; Winterhagen, A; Muller, J; Oldenburg, J; Potzsch, B				Ruehl, Heiko; Berens, Christina; Winterhagen, Anna; Mueller, Jens; Oldenburg, Johannes; Poetzsch, Bernd			Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; ANTITHROMBIN-III COMPLEXES; LINKED-IMMUNOSORBENT-ASSAY; PROTHROMBIN FRAGMENT 1+2; IN-VIVO BEHAVIOR; ACTIVATION MARKERS; HUMAN-FIBRINOGEN; MYOCARDIAL-INFARCTION; ANTI-THROMBIN; PCR ASSAY	The objective of this study was to evaluate the elimination kinetics of hemostasis-related biomarkers including the prothrombin activation fragment F1+2, thrombin-antithrombin complex (TAT), plasmin-alpha(2)-antiplasmin complex (PAP), and D-dimer in humans. Autologous serum was used as a biomarker source and infused into 15 healthy volunteers. Serum was prepared from whole blood in the presence of recombinant tissue-type plasminogen activator (final concentration 20 mu g/mL) to induce plasmin generation required for PAP and D-dimer formation. Serum transfusions (50 mL/30 min) were well tolerated by all subjects. Endogenous thrombin formation was not induced by serum infusions as measured using a highly sensitive oligonucleotide-based enzyme capture assay. Median peak levels (x-fold increase over baseline) of F1+ 2, TAT, PAP, and D-dimer of 3.7 nmol/L (28.9), 393 ng/mL (189.6), 3,829 ng/mL (7.0), and 13.4 mg/L (34.2) were achieved at the end of serum infusions. During a 48 h lasting follow-up period all biomarkers showed elimination kinetics of a two-compartment model. Median (interquartile range) terminal half-lives were 1.9 (1.3-3.6) h for F1+ 2, 0.7 (0.7-2.6) h for TAT, and 10.8 (8.8-11.4) h for PAP. With 15.8 (13.1-23.1) h the D-dimer half-life was about twice as long as previously estimated from radiolabeling studies in animals and small numbers of human subjects. The serum approach presented here allows label-free and simultaneous analysis of the elimination kinetics of various hemostasis-related biomarkers. Based on these data changes in biomarker levels could more precisely used to estimate the activity level of the hemostatic system.	[Ruehl, Heiko; Berens, Christina; Winterhagen, Anna; Mueller, Jens; Oldenburg, Johannes; Poetzsch, Bernd] Univ Hosp Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany	University of Bonn	Ruhl, H (corresponding author), Univ Hosp Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany.	heiko.ruehl@ukb.uni-bonn.de	Rühl, Heiko/AAI-3377-2021; Oldenburg, Johannes/ABB-7817-2020; Müller, Jens/A-8264-2012; Rühl, Heiko/E-3226-2017	Rühl, Heiko/0000-0003-0672-2453; Müller, Jens/0000-0001-7713-9631; Oldenburg, Johannes/0000-0002-1585-4100				Adam SS, 2009, BLOOD, V113, P2878, DOI 10.1182/blood-2008-06-165845; Agarwal S, 2000, AM J GASTROENTEROL, V95, P3218; ARDAILLOU N, 1975, THROMB DIATH HAEMOST, V34, P326; ARDAILLOU N, 1980, THROMB HAEMOSTASIS, V44, P146; ARONSON DL, 1977, J CLIN INVEST, V60, P1410, DOI 10.1172/JCI108902; BAUER KA, 1992, BLOOD, V79, P2039; BAUER KA, 1985, J CLIN INVEST, V76, P826, DOI 10.1172/JCI112040; Bozic M, 2002, THROMB RES, V108, P107, DOI 10.1016/S0049-3848(03)00007-0; CATANZARO A, 1974, J LAB CLIN MED, V83, P458; Chandler WL, 2003, BLOOD, V101, P4355, DOI 10.1182/blood-2002-08-2400; Chandler WL, 2000, HAEMOSTASIS, V30, P204; Christensen U, 1996, FEBS LETT, V387, P58, DOI 10.1016/0014-5793(96)00429-2; COLLEN D, 1979, BLOOD, V53, P313; CONWAY EM, 1987, J CLIN INVEST, V80, P1535, DOI 10.1172/JCI113239; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; ESTIVALS M, 1991, BRIT J HAEMATOL, V78, P421, DOI 10.1111/j.1365-2141.1991.tb04458.x; Franks JJ, 1984, PATHOPHYSIOLOGY PLAS, P265; Gorog DA, 2010, J AM COLL CARDIOL, V55, P2701, DOI 10.1016/j.jacc.2009.11.095; GREENBERG CS, 1987, AM J CLIN PATHOL, V87, P94, DOI 10.1093/ajcp/87.1.94; HAYNE OA, 1973, AM J PATHOL, V71, P219; HOLVOET P, 1985, J BIOL CHEM, V260, P2106; HOLVOET P, 1986, THROMB HAEMOSTASIS, V56, P124; KNOT EAR, 1986, THROMB HAEMOSTASIS, V55, P375; Korte W, 2001, CLIN CHEM LAB MED, V39, P627, DOI 10.1515/CCLM.2001.101; LEONARD B, 1983, THROMB RES, V30, P165, DOI 10.1016/0049-3848(83)90239-6; Manco-Johnson MJ, 2009, J THROMB HAEMOST, V7, P2064, DOI 10.1111/j.1538-7836.2009.03633.x; MCFARLANE AS, 1963, J CLIN INVEST, V42, P346, DOI 10.1172/JCI104721; Mueller J, 2005, CLIN CHEM LAB MED, V43, P827, DOI 10.1515/CCLM.2005.139; Muller J, 2007, J VIROL METHODS, V142, P127, DOI 10.1016/j.jviromet.2007.01.013; Muller J, 2011, ANGEW CHEM INT EDIT, V50, P6075, DOI 10.1002/anie.201007032; Ostermann H, 2007, THROMB HAEMOSTASIS, V98, P790, DOI 10.1160/TH07-05-0367; Ota S, 2008, CLIN APPL THROMB-HEM, V14, P279, DOI 10.1177/1076029607309176; PELZER H, 1988, THROMB HAEMOSTASIS, V59, P101; PIZZO SV, 1982, BIOCHIM BIOPHYS ACTA, V718, P177, DOI 10.1016/0304-4165(82)90217-3; Poon MC, 2006, HAEMOPHILIA, V12, P61, DOI 10.1111/j.1365-2516.2006.01336.x; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Reeve E B, 1981, Ann N Y Acad Sci, V370, P680, DOI 10.1111/j.1749-6632.1981.tb29775.x; Ruhl H, 2012, THROMB HAEMOSTASIS, V107, P848, DOI 10.1160/TH11-10-0719; SHIFMAN MA, 1982, J BIOL CHEM, V257, P3243; Siller-Matula JM, 2011, THROMB HAEMOSTASIS, V106, P1020, DOI 10.1160/TH10-11-0711; Sprenger K B, 1987, J Clin Apher, V3, P185, DOI 10.1002/jca.2920030313; TEITEL JM, 1982, BLOOD, V59, P1086; Tripodi A, 1996, CLIN CHEM, V42, P664; Wells MJ, 1997, J BIOL CHEM, V272, P28574, DOI 10.1074/jbc.272.45.28574; Wells MJ, 1998, J BIOL CHEM, V273, P23440, DOI 10.1074/jbc.273.36.23440; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; WESSLER S, 1955, J CLIN INVEST, V34, P647, DOI 10.1172/JCI103114; Whitton C, 2005, THROMB HAEMOSTASIS, V93, P261, DOI 10.1160/TH04-10-0677; ZELLER FP, 1988, DRUG INTEL CLIN PHAR, V22, P6, DOI 10.1177/106002808802200101; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	51	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145012	10.1371/journal.pone.0145012	http://dx.doi.org/10.1371/journal.pone.0145012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658824	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900167
J	Zhao, YS; Li, MF				Zhao, Yunsong; Li, Mengfei			Iterative Beam Hardening Correction for Multi-Material Objects	PLOS ONE			English	Article							ARTIFACTS; ART	In this paper, we propose an iterative beam hardening correction method that is applicable for the case with multiple materials. By assuming that the materials composing scanned object are known and that they are distinguishable by their linear attenuation coefficients at some given energy, the beam hardening correction problem is converted into a nonlinear system problem, which is then solved iteratively. The reconstructed image is the distribution of linear attenuation coefficient of the scanned object at a given energy. So there are no beam hardening artifacts in the image theoretically. The proposed iterative scheme combines an accurate polychromatic forward projection with a linearized backprojection. Both forward projection and backprojection have high degree of parallelism, and are suitable for acceleration on parallel systems. Numerical experiments with both simulated data and real data verifies the validity of the proposed method. The beam hardening artifacts are alleviated effectively. In addition, the proposed method has a good tolerance on the error of the estimated x-ray spectrum.	[Zhao, Yunsong; Li, Mengfei] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Zhao, Yunsong; Li, Mengfei] Beijing Higher Inst Engn Res Ctr Testing & Imagin, Beijing, Peoples R China; [Zhao, Yunsong] Shenzhen ZhongKe TianYue Technol Co Ltd, Shenzhen, Peoples R China; [Zhao, Yunsong] Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Capital Normal University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zhao, YS (corresponding author), Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China.	zhao_yunsong@cnu.edu.cn			National Natural Science Foundation of China [61127003, 61371195, 61401289]; Shenzhen ZhongKe TianYue Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen ZhongKe TianYue Technology Co., Ltd	This work was supported in part by the National Natural Science Foundation of China under Grant 61127003, Grant 61371195, and Grant 61401289. Shenzhen ZhongKe TianYue Technology Co., Ltd. provided support in the form of a salary for author YSZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Brabant L, 2012, NDT&E INT, V51, P68, DOI 10.1016/j.ndteint.2012.07.002; BROOKS RA, 1976, PHYS MED BIOL, V21, P390, DOI 10.1088/0031-9155/21/3/004; De Man B, 2001, IEEE T MED IMAGING, V20, P999, DOI 10.1109/42.959297; Dennis J.E., 1996, NUMERICAL METHODS UN, V16; Hammersberg P, 1998, J Xray Sci Technol, V8, P75; HERMAN GT, 1979, PHYS MED BIOL, V24, P81, DOI 10.1088/0031-9155/24/1/008; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Hubbell J., 1995, TABLES XRAY MASS ATT, DOI 10.18434/T4D01F; JENNINGS RJ, 1988, MED PHYS, V15, P588, DOI 10.1118/1.596210; Kachelriess M, 2006, MED PHYS, V33, P1269, DOI 10.1118/1.2188076; Kak A C, 1988, PRINCIPLES COMPUTERI, V33; Krumm M, 2008, NDT&E INT, V41, P242, DOI 10.1016/j.ndteint.2007.12.001; Long Y, 2014, IEEE T MED IMAGING, V33, P1614, DOI 10.1109/TMI.2014.2320284; Maass C, 2011, MED PHYS, V38, P691, DOI 10.1118/1.3533686; Mendonca P.R., 2010, SPIE MED IMAGING; Niu TY, 2011, MED PHYS, V38, P6027, DOI 10.1118/1.3651619; Sidky EY, 2005, J APPL PHYS, V97, DOI 10.1063/1.1928312; Van Gompel G, 2011, MED PHYS, V38, pS36, DOI 10.1118/1.3577758; Zhao X. F., 2007, PRATACULTURAL SCI, V3, P7; Zhao YS, 2015, IEEE T MED IMAGING, V34, P761, DOI 10.1109/TMI.2014.2373396	22	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144607	10.1371/journal.pone.0144607	http://dx.doi.org/10.1371/journal.pone.0144607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659554	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500047
J	Kurita, H; Takahashi, S; Asada, A; Matsuo, M; Kishikawa, K; Mizuno, A; Numano, R				Kurita, Hirofumi; Takahashi, Shota; Asada, Atsushi; Matsuo, Minako; Kishikawa, Kenta; Mizuno, Akira; Numano, Rika			Novel Parallelized Electroporation by Electrostatic Manipulation of a Water-in-Oil Droplet as a Microreactor	PLOS ONE			English	Article							AQUEOUS DROPLETS; CELLS; TRANSFECTION; DELIVERY; VOLTAGE	Electroporation is the most widely used transfection method for delivery of cell-impermeable molecules into cells. We developed a novel gene transfection method, water-in-oil (W/O) droplet electroporation, using dielectric oil and an aqueous droplet containing mammalian cells and transgene DNA. When a liquid droplet suspended between a pair of electrodes in dielectric oil is exposed to a DC electric field, the droplet moves between the pair of electrodes periodically and droplet deformation occurs under the intense DC electric field. During electrostatic manipulation of the droplet, the local intense electric field and instantaneous short circuit via the droplet due to droplet deformation facilitate gene transfection. This method has several advantages over conventional transfection techniques, including co-transfection of multiple transgene DNAs into even as few as 103 cells, transfection into differentiated neural cells, and the capable establishment of stable cell lines. In addition, there have been improvements in W/O droplet electroporation electrodes for disposable 96-well plates making them suitable for concurrent performance without thermal loading by a DC electric field. This technique will lead to the development of cell transfection methods for novel regenerative medicine and gene therapy.	[Kurita, Hirofumi; Takahashi, Shota; Asada, Atsushi; Matsuo, Minako; Kishikawa, Kenta; Mizuno, Akira; Numano, Rika] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi, Japan; [Numano, Rika] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi, Japan	Toyohashi University of Technology; Toyohashi University of Technology	Mizuno, A (corresponding author), Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi, Japan.	mizuno@ens.tut.ac.jp; numano@ens.tut.ac.jp	Kurita, Hirofumi/K-6757-2012	Kurita, Hirofumi/0000-0002-2538-6590	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [24590350]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24108005]; Takeda Science Foundation; Tatematsu Foundation; Grants-in-Aid for Scientific Research [26390096] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tatematsu Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)'s Program to Foster Young Researchers Cutting-Edge Interdisciplinary Research and Human Resource Development Program for Science and Technology to R.N., the Japan Science and Technology Agency (JST) (to R.N.), and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (24590350 to R.N.), and by a Grant-in-Aid for Scientific Research in Innovative Areas "Plasma Medical Innovation" (24108005 to A. M.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a Grant-in-Aid for Young Scientists (B) (24760648 to H. K.) and a Grant-in-Aid for Scientific Research (C) (26390096 to H. K) from the Japan Society for the Promotion of Science (JSPS). R.N. was also supported in part by Takeda Science Foundation and The Tatematsu Foundation.	Adamo A, 2013, ANAL CHEM, V85, P1637, DOI 10.1021/ac302887a; Asada A, 2013, IEEE T IND APPL, V49, P311, DOI 10.1109/TIA.2012.2229452; Chang D.C., 1992, GUIDE ELECTROPORATIO; Chen FY, 2011, ANAL CHEM, V83, P8816, DOI 10.1021/ac2022794; Fox MB, 2006, ANAL BIOANAL CHEM, V385, P474, DOI 10.1007/s00216-006-0327-3; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Geng T, 2010, J CONTROL RELEASE, V144, P91, DOI 10.1016/j.jconrel.2010.01.030; Gianulis EC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13818; Hamlin BS, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3674301; Hase M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046301; Im DJ, 2012, LANGMUIR, V28, P11656, DOI 10.1021/la3014392; Im DJ, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3665222; Jung YM, 2008, J COLLOID INTERF SCI, V322, P617, DOI 10.1016/j.jcis.2008.04.019; Kawaguchi S, 2007, BIOCHEM BIOPH RES CO, V355, P555, DOI 10.1016/j.bbrc.2007.02.009; Khorshidi B, 2010, J COLLOID INTERF SCI, V352, P211, DOI 10.1016/j.jcis.2010.08.026; Kim SK, 2007, ANAL CHEM, V79, P7761, DOI 10.1021/ac071197h; Knight JS, 2004, J VIROL, V78, P12857, DOI 10.1128/JVI.78.23.12857-12867.2004; Lee DW, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723633; Lin YC, 2001, J MICROMECH MICROENG, V11, P542, DOI 10.1088/0960-1317/11/5/315; Lu H, 2005, LAB CHIP; Luo CX, 2006, ELECTROPHORESIS, V27, P1977, DOI 10.1002/elps.200500665; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Pakhomov AG, 2015, BBA-BIOMEMBRANES, V1848, P958, DOI 10.1016/j.bbamem.2014.12.026; Pucihar G, 2008, BIOPHYS J, V95, P2837, DOI 10.1529/biophysj.108.135541; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takinoue M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3358385; Wang QM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2178; Wang SN, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774071; Xiao K, 2010, ELECTROPHORESIS, V31, P3175, DOI 10.1002/elps.201000155; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhan YH, 2009, ANAL CHEM, V81, P2027, DOI 10.1021/ac9001172	32	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144254	10.1371/journal.pone.0144254	http://dx.doi.org/10.1371/journal.pone.0144254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649904	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300041
J	Yang, W; Du, WW; Li, X; Yee, AJ; Yang, BB				Yang, W.; Du, W. W.; Li, X.; Yee, A. J.; Yang, B. B.			Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis	ONCOGENE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; MICRORNA SPONGES; CANCER; METASTASIS; SURVIVAL; TUMORIGENESIS; INVASION; DIFFERENTIATION; PROTEINS	It has recently been shown that the upregulation of a pseudogene specific to a protein-coding gene could function as a sponge to bind multiple potential targeting microRNAs (miRNAs), resulting in increased gene expression. Similarly, it was recently demonstrated that circular RNAs can function as sponges for miRNAs, and could upregulate expression of mRNAs containing an identical sequence. Furthermore, some mRNAs are now known to not only translate protein, but also function to sponge miRNA binding, facilitating gene expression. Collectively, these appear to be effective mechanisms to ensure gene expression and protein activity. Here we show that expression of a member of the forkhead family of transcription factors, Foxo3, is regulated by the Foxo3 pseudogene (Foxo3P), and Foxo3 circular RNA, both of which bind to eight miRNAs. We found that the ectopic expression of the Foxo3P, Foxo3 circular RNA and Foxo3 mRNA could all suppress tumor growth and cancer cell proliferation and survival. Our results showed that at least three mechanisms are used to ensure protein translation of Foxo3, which reflects an essential role of Foxo3 and its corresponding non-coding RNAs.	[Yang, W.; Du, W. W.; Li, X.; Yee, A. J.; Yang, B. B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Yang, W.; Du, W. W.; Li, X.; Yang, B. B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Li, X.] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China; [Yang, B. B.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; University of Toronto	Yee, AJ; Yang, BB (corresponding author), Univ Toronto, Sunnybrook Res Inst, S Wing Res Bldg,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	albert.yee@sunnybrook.ca; byang@sri.utoronto.ca		Yang, Burton B/0000-0002-2892-7209	Natural Sciences and Engineering Research Council of Canada (NSERC) [227937-2012]; Heart and Stroke Foundation of Ontario [CI 7418]; Canadian Institutes of Health Research; Breast Cancer Foundation of Ontario	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Breast Cancer Foundation of Ontario	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC; 227937-2012) to BBY, who is the recipient of a Career Investigator Award (CI 7418) from the Heart and Stroke Foundation of Ontario. WY is supported by a Graduate Scholarship from Canadian Institutes of Health Research. WWD is supported by a Postdoctoral Fellowship from the Breast Cancer Foundation of Ontario.	AbouHaidar MG, 2014, P NATL ACAD SCI USA, V111, P14542, DOI 10.1073/pnas.1402814111; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Bella L, 2014, CURR DRUG TARGETS, V15, P1; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Bowman A, 2011, CANCER CELL, V20, P415, DOI 10.1016/j.ccr.2011.10.003; Cao L, 2000, J CELL BIOCHEM, V77, P569, DOI 10.1002/(SICI)1097-4644(20000615)77:4<569::AID-JCB5>3.0.CO;2-K; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cho EC, 2014, ONCOTARGET, V5, P4834, DOI 10.18632/oncotarget.2044; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Du WW, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.305; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Keniry M, 2013, GENE DEV, V27, P916, DOI 10.1101/gad.214049.113; Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Li J, 2015, TUMOR BIOL, V36, P685, DOI 10.1007/s13277-014-2698-y; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Moriishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086629; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; Rutnam ZJ, 2012, J CELL SCI, V125, P2075, DOI 10.1242/jcs100818; Salazar M, 2015, CELL DEATH DIFFER, V22, P131, DOI 10.1038/cdd.2014.133; Bilbao PS, 2013, BBA-GEN SUBJECTS, V1830, P4456, DOI 10.1016/j.bbagen.2013.05.034; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Siragam V, 2012, ONCOTARGET, V3, P1370, DOI 10.18632/oncotarget.717; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680	51	242	256	3	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3919	3931		10.1038/onc.2015.460	http://dx.doi.org/10.1038/onc.2015.460			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26657152				2022-12-26	WOS:000381013100004
J	Greene, AS; Hajduk, SL				Greene, Amy Styer; Hajduk, Stephen L.			Trypanosome Lytic Factor-1 Initiates Oxidation-stimulated Osmotic Lysis of Trypanosoma brucei brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; HAPTOGLOBIN-HEMOGLOBIN RECEPTOR; PROGRAMMED CELL-DEATH; MEMBRANE PERMEABILIZATION; TRYPANOCIDAL ACTIVITY; ANTIOXIDANT CAPACITY; PHOSPHATASE-ACTIVITY; GLUTATHIONE CONTENT; 3 AQUAGLYCEROPORINS; APOLIPOPROTEIN L-1	Human innate immunity against the veterinary pathogen Trypanosoma brucei brucei is conferred by trypanosome lytic factors (TLFs), against which human-infective T. brucei gambiense and T. brucei rhodesiense have evolved resistance. TLF-1 is a subclass of high density lipoprotein particles defined by two primate-specific apolipoproteins: the ion channel-forming toxin ApoL1 (apolipoprotein L1) and the hemoglobin (Hb) scavenger Hpr (haptoglobin-related protein). The role of oxidative stress in the TLF-1 lytic mechanism has been controversial. Here we show that oxidative processes are involved in TLF-1 killing of T. brucei brucei. The lipophilic antioxidant N,N'-di-phenyl-p-phenylenediamine protected TLF-1-treated T. brucei brucei from lysis. Conversely, lysis of TLF-1-treated T. brucei brucei was increased by the addition of peroxides or thiol-conjugating agents. Previously, the Hpr-Hb complex was postulated to be a source of free radicals during TLF-1 lysis. However, we found that the iron-containing heme of the Hpr-Hb complex was not involved in TLF-1 lysis. Furthermore, neither high concentrations of transferrin nor knock-out of cytosolic lipid peroxidases prevented TLF-1 lysis. Instead, purified ApoL1 was sufficient to induce lysis, and ApoL1 lysis was inhibited by the antioxidant DPPD. Swelling of TLF-1-treated T. brucei brucei was reminiscent of swelling under hypotonic stress. Moreover, TLF-1-treated T. brucei brucei became rapidly susceptible to hypotonic lysis. T. brucei brucei cells exposed to peroxides or thiol-binding agents were also sensitized to hypotonic lysis in the absence of TLF-1. We postulate that ApoL1 initiates osmotic stress at the plasma membrane, which sensitizes T. brucei brucei to oxidation-stimulated osmotic lysis.	[Greene, Amy Styer; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hajduk, SL (corresponding author), Dept Biochem & Mol Biol, 120A Life Sci Bldg, Athens, GA 30602 USA.	shajduk@bmb.uga.edu			National Institutes of Health [AI039033]; National Science Foundation Graduate Research Fellowship [2011095799]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039033, R21AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in whole or in part by National Institutes of Health Grant AI039033 (to S. L. H.) and National Science Foundation Graduate Research Fellowship Grant 2011095799 (to A. L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Ascoli F, 1981, Methods Enzymol, V76, P72; Bassarak B, 2011, CELL PHYSIOL BIOCHEM, V27, P411, DOI 10.1159/000327968; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Bishop JR, 2001, MOL BIOCHEM PARASIT, V118, P33, DOI 10.1016/S0166-6851(01)00361-9; Bursell JDH, 1996, J MEMBRANE BIOL, V154, P131, DOI 10.1007/s002329900138; Cosentino-Gomes D, 2009, FREE RADICAL BIO MED, V47, P152, DOI 10.1016/j.freeradbiomed.2009.04.020; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; DefriseQuertain F, 1996, BIOCHEM J, V314, P595, DOI 10.1042/bj3140595; DeJesus E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003317; DHONDT J, 1979, NATURE, V282, P613, DOI 10.1038/282613a0; Diaz-Elizondo J, 2006, BIOCHEM BIOPH RES CO, V350, P1076, DOI 10.1016/j.bbrc.2006.10.004; Diechtierow M, 2011, FREE RADICAL BIO MED, V51, P856, DOI 10.1016/j.freeradbiomed.2011.05.014; Dolai S, 2011, J BIOL CHEM, V286, P13638, DOI 10.1074/jbc.M110.201889; Eintracht J, 1998, BIOCHEM J, V336, P659, DOI 10.1042/bj3360659; FAIRLAMB AH, 1989, P NATL ACAD SCI USA, V86, P2607, DOI 10.1073/pnas.86.8.2607; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; HAJDUK SL, 1992, PARASITOL TODAY, V8, P95, DOI 10.1016/0169-4758(92)90247-Y; Hansen DB, 2012, J MEMBRANE BIOL, V245, P77, DOI 10.1007/s00232-012-9416-8; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Higgins MK, 2013, P NATL ACAD SCI USA, V110, P1905, DOI 10.1073/pnas.1214943110; Hiller C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004075; Irigoin F, 2009, BIOCHEM J, V418, P595, DOI 10.1042/BJ20081981; Jimenez V, 2008, J CELL BIOCHEM, V105, P688, DOI 10.1002/jcb.21864; Keij JF, 1999, CYTOMETRY, V35, P48, DOI 10.1002/(SICI)1097-0320(19990101)35:1<48::AID-CYTO7>3.0.CO;2-5; Lambert IH, 2009, AM J PHYSIOL-CELL PH, V297, pC198, DOI 10.1152/ajpcell.00613.2008; Lambert IH, 2003, J MEMBRANE BIOL, V192, P19, DOI 10.1007/s00232-002-1061-1; LUSTBADER JW, 1983, J BIOL CHEM, V258, P1227; Lutje V, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006201.pub2; MESHNICK SR, 1978, J EXP MED, V148, P569, DOI 10.1084/jem.148.2.569; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Niki E, 2000, IUBMB LIFE, V50, P323, DOI 10.1080/15216540051081119; Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016; PENKETH PG, 1986, MOL BIOCHEM PARASIT, V20, P111, DOI 10.1016/0166-6851(86)90023-X; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Portela MPM, 2000, MOL BIOCHEM PARASIT, V110, P273, DOI 10.1016/S0166-6851(00)00277-2; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Raper J, 2001, CURR OPIN MICROBIOL, V4, P402, DOI 10.1016/S1369-5274(00)00226-5; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Ren Z, 2008, CARDIOVASC RES, V77, P73, DOI 10.1093/cvr/cvm031; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; Roggy JL, 1999, MOL BIOCHEM PARASIT, V98, P1, DOI 10.1016/S0166-6851(98)00114-5; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rojas-Rivera D, 2009, FEBS LETT, V583, P3485, DOI 10.1016/j.febslet.2009.10.003; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Steverding D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-78; Tamma G, 2014, J BIOL CHEM, V289, P27807, DOI 10.1074/jbc.M114.586024; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2007, J EUKARYOT MICROBIOL, V54, P448, DOI 10.1111/j.1550-7408.2007.00285.x; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; WAKS M, 1974, BIOCHEMISTRY-US, V13, P15, DOI 10.1021/bi00698a003; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Wright VP, 2009, J PHYSIOL-LONDON, V587, P5767, DOI 10.1113/jphysiol.2009.178285; Zhu LY, 2013, MOL NEUROBIOL, V48, P205, DOI 10.1007/s12035-013-8431-9	63	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3063	3075		10.1074/jbc.M115.680371	http://dx.doi.org/10.1074/jbc.M115.680371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26645690	hybrid, Green Published			2022-12-26	WOS:000369626900042
J	Draberova, L; Paulenda, T; Halova, I; Potuckova, L; Bugajev, V; Bambouskova, M; Tumova, M; Draber, P				Draberova, Lubica; Paulenda, Tomas; Halova, Ivana; Potuckova, Lucie; Bugajev, Viktor; Bambouskova, Monika; Tumova, Magda; Draber, Petr			Ethanol Inhibits High-Affinity Immunoglobulin E Receptor (Fc epsilon RI) Signaling in Mast Cells by Suppressing the Function of Fc epsilon RI-Cholesterol Signalosome	PLOS ONE			English	Article							KAPPA-B ACTIVATION; LIPID RAFTS; NADPH OXIDASE; ALVEOLAR MACROPHAGES; MEMBRANE CHOLESTEROL; NEGATIVE REGULATION; GENERAL-ANESTHESIA; OXIDATIVE STRESS; PHOSPHOLIPASE-D; CHAIN ALCOHOLS	Ethanol has multiple effects on biochemical events in a variety of cell types, including the high-affinity immunoglobulin E receptor (Fc epsilon RI) signaling in antigen-activated mast cells. However, the underlying molecular mechanism remains unknown. To get better understanding of the effect of ethanol on Fc epsilon RI-mediated signaling we examined the effect of short-term treatment with non-toxic concentrations of ethanol on Fc epsilon RI signaling events in mouse bone marrow-derived mast cells. We found that 15 min exposure to ethanol inhibited antigen-induced degranulation, calcium mobilization, expression of proinflammatory cytokine genes (tumor necrosis factor-alpha, interleukin-6, and interleukin-13), and formation of reactive oxygen species in a dose-dependent manner. Removal of cellular cholesterol with methyl-beta-cyclodextrin had a similar effect and potentiated some of the inhibitory effects of ethanol. In contrast, exposure of the cells to cholesterol-saturated methyl-beta-cyclodextrin abolished in part the inhibitory effect of ethanol on calcium response and production of reactive oxygen species, supporting lipid-centric theories of ethanol action on the earliest stages of mast cell signaling. Further studies showed that exposure to ethanol and/or removal of cholesterol inhibited early Fc epsilon RI activation events, including tyrosine phosphorylation of the Fc epsilon RI beta and gamma subunits, SYK kinases, LAT adaptor protein, phospholipase C gamma, STAT5, and AKT and internalization of aggregated Fc epsilon RI. Interestingly, ethanol alone, and particularly in combination with methyl-beta-cyclodextrin, enhanced phosphorylation of negative regulatory tyrosine 507 of LYN kinase. Finally, we found that ethanol reduced passive cutaneous anaphylactic reaction in mice, suggesting that ethanol also inhibits Fc epsilon RI signaling under in vivo conditions. The combined data indicate that ethanol interferes with early antigen-induced signaling events in mast cells by suppressing the function of Fc epsilon RI-cholesterol signalosomes at the plasma membrane.	[Draberova, Lubica; Paulenda, Tomas; Halova, Ivana; Potuckova, Lucie; Bugajev, Viktor; Bambouskova, Monika; Tumova, Magda; Draber, Petr] Acad Sci Czech Republ, Inst Mol Genet, Lab Signal Transduct, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Draberova, L (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Lab Signal Transduct, Prague, Czech Republic.	draberovalu@img.cas.cz; draberpe@img.cas.cz	Paulenda, Tomas/S-1837-2017; Halova, Ivana/G-3512-2014; Bugajev, Viktor/G-3507-2014; Draber, Petr/E-1119-2018	Paulenda, Tomas/0000-0003-1323-4829; Halova, Ivana/0000-0003-3078-7986; Draber, Petr/0000-0002-3986-2025	Grant Agency of the Czech Republic [P302/12/G101]; COST-CZ-MAST from the Ministry of Education Youth and Sports of the Czech Republic [LD12073]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); COST-CZ-MAST from the Ministry of Education Youth and Sports of the Czech Republic	This work was supported by Project P302/12/G101 from the Grant Agency of the Czech Republic and Project LD12073 COST-CZ-MAST from the Ministry of Education Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGASRA O, 1987, IMMUNOLOGY, V61, P63; Boe DM, 2001, J INFECT DIS, V184, P1134, DOI 10.1086/323661; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; BRAYTON RG, 1970, NEW ENGL J MED, V282, P123, DOI 10.1056/NEJM197001152820303; BRODIE C, 1994, CLIN IMMUNOL IMMUNOP, V70, P129, DOI 10.1006/clin.1994.1020; Bugajev V, 2010, FEBS LETT, V584, P4949, DOI 10.1016/j.febslet.2010.08.045; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen SY, 1996, ALCOHOL, V13, P589; CHIN JH, 1977, MOL PHARMACOL, V13, P435; Christian AE, 1997, J LIPID RES, V38, P2264; Cleyrat C, 2013, J CELL SCI, V126, P4913, DOI 10.1242/jcs.128876; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Dalton SR, 2003, LIVER INT, V23, P484, DOI 10.1111/j.1478-3231.2003.00874.x; Daragan VA, 2000, BIOPHYS J, V79, P406, DOI 10.1016/S0006-3495(00)76302-8; Das J, 2009, BIOCHEM J, V421, P405, DOI 10.1042/BJ20082271; DIVIRGILIO F, 1988, J IMMUNOL, V140, P915; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Draberova L, 1996, IMMUNOLOGY, V87, P141; Draberova L, 2014, MOL CELL BIOL, V34, P4285, DOI 10.1128/MCB.00983-14; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; FRANKS NP, 1986, P NATL ACAD SCI USA, V83, P5116, DOI 10.1073/pnas.83.14.5116; FRANKS NP, 1982, NATURE, V300, P487, DOI 10.1038/300487a0; Furlow M, 2011, BIORHEOLOGY, V48, P49, DOI 10.3233/BIR-2011-0583; Ghare S, 2011, ALCOHOL CLIN EXP RES, V35, P1435, DOI 10.1111/j.1530-0277.2011.01479.x; GLASSMAN AB, 1985, ARCH PATHOL LAB MED, V109, P540; GLUCKMAN SJ, 1977, ARCH INTERN MED, V137, P1539, DOI 10.1001/archinte.137.11.1539; GLUCKMAN SJ, 1978, BLOOD, V52, P551; Gray E, 2013, BIOPHYS J, V105, P2751, DOI 10.1016/j.bpj.2013.11.005; Grutzkau A, 2004, CYTOM PART A, V61A, P62, DOI 10.1002/cyto.a.20068; Happel Kyle I, 2005, Proc Am Thorac Soc, V2, P428, DOI 10.1513/pats.200507-065JS; Heneberg P, 2010, J BIOL CHEM, V285, P12787, DOI 10.1074/jbc.M109.052555; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Karavitis J, 2012, CELL IMMUNOL, V274, P61, DOI 10.1016/j.cellimm.2012.02.002; Kennedy RH, 2012, J TOXICOL ENV HEAL A, V75, P1451, DOI 10.1080/15287394.2012.722184; Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039; Kim MJ, 2013, TOXICOL APPL PHARM, V273, P77, DOI 10.1016/j.taap.2013.08.005; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; LI TK, 1969, ACTA CHEM SCAND, V23, P892, DOI 10.3891/acta.chem.scand.23-0892; Lisboa FA, 2009, J IMMUNOL, V183, P5104, DOI 10.4049/jimmunol.0802728; Loftsson T, 2002, J PHARM SCI, V91, P2307, DOI 10.1002/jps.10226; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1609, DOI 10.1097/01.ALC.0000036926.46632.57; Methner DNR, 2010, J BIOL CHEM, V285, P10310, DOI 10.1074/jbc.M109.029561; Meyer HH., 1899, ARCH EXP PATH PHARMA, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; Meyer KH, 1937, T FARADAY SOC, V33, P1062, DOI 10.1039/tf9373301062; Nishijo J, 2003, CHEM PHARM BULL, V51, P1253, DOI 10.1248/cpb.51.1253; Nourissat P, 2008, HEPATOLOGY, V47, P59, DOI 10.1002/hep.21958; Olsen RW, 2014, ALCOHOL CLIN EXP RES, V38, P595, DOI 10.1111/acer.12283; Pascual-Lucas M, 2014, J NEUROCHEM, V129, P448, DOI 10.1111/jnc.12639; Patel M, 1996, ALCOHOL CLIN EXP RES, V20, P275, DOI 10.1111/j.1530-0277.1996.tb01640.x; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Polley A, 2013, CHEM PHYS LIPIDS, V166, P1, DOI 10.1016/j.chemphyslip.2012.11.005; Pruett SB, 2004, J IMMUNOL, V173, P2715, DOI 10.4049/jimmunol.173.4.2715; Ren H, 2012, J BIOL CHEM, V287, P27302, DOI 10.1074/jbc.M111.338921; RIMLAND D, 1980, J LAB CLIN MED, V95, P918; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; ROWE ES, 1985, BIOCHIM BIOPHYS ACTA, V813, P321, DOI 10.1016/0005-2736(85)90248-2; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Salous AK, 2009, BRIT J PHARMACOL, V158, P1395, DOI 10.1111/j.1476-5381.2009.00397.x; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Setiawan I, 2014, J PHYS CHEM B, V118, P537, DOI 10.1021/jp410305m; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Szabo G, 1999, J CLIN IMMUNOL, V19, P67, DOI 10.1023/A:1020518703050; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tobin SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087225; Toivari M, 2000, LIFE SCI, V67, P2795, DOI 10.1016/S0024-3205(00)00863-8; Tolar P, 2001, FOLIA BIOL-PRAGUE, V47, P215; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Yeligar SM, 2012, J IMMUNOL, V188, P3648, DOI 10.4049/jimmunol.1101278; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391; Zhu MH, 2015, J IMMUNOL, V195, P4492, DOI 10.4049/jimmunol.1500665; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	77	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144596	10.1371/journal.pone.0144596	http://dx.doi.org/10.1371/journal.pone.0144596			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658290	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900069
J	Vir, P; Arrigucci, R; Lakehal, K; Davidow, AL; Pine, R; Tyagi, S; Bushkin, Y; Lardizabal, A; Gennaro, ML				Vir, Pooja; Arrigucci, Riccardo; Lakehal, Karim; Davidow, Amy L.; Pine, Richard; Tyagi, Sanjay; Bushkin, Yuri; Lardizabal, Alfred; Gennaro, Maria Laura			Single-Cell Cytokine Gene Expression in Peripheral Blood Cells Correlates with Latent Tuberculosis Status	PLOS ONE			English	Article							CD4(+) T-CELLS; FLOW-CYTOMETRY; MYCOBACTERIUM-TUBERCULOSIS; CD154 EXPRESSION; MESSENGER-RNA; ACTIVATION; INFECTION; RESPONSES; IMMUNODIAGNOSIS; OPTIMIZATION	RNA flow cytometry (FISH-Flow) achieves high-throughput measurement of single-cell gene expression by combining in-situ nucleic acid hybridization with flow cytometry. We tested whether antigen-specific T-cell responses detected by FISH-Flow correlated with latent tuberculosis infection (LTBI), a condition affecting one-third of the world population. Peripheral-blood mononuclear cells from donors, identified as positive or negative for LTBI by current medical practice, were stimulated ex vivo with mycobacterial antigen. IFNG and IL2 mRNA production was assayed by FISH-Flow. Concurrently, immunophenotypes of the cytokine mRNA-positive cells were characterized by conventional, antibody-based staining of cell-surface markers. An association was found between donor LTBI status and antigen-specific induction of IFNG and IL2 transcripts. Induction of these cytokine genes, which was detected by FISH-Flow in a quarter the time required to see release of the corresponding proteins by ELISA, occurred primarily in activated CD4+ T cells via T-cell receptor engagement. Moreover, NK cells contributed to IFNG gene induction. These results show that antigen-driven induction of T-cell cytokine mRNA is a measurable single-cell parameter of the host responses associated with latent tuberculosis. FISH-Flow read-outs contribute a multiscale dimension to the immunophenotyping afforded by antibody-based flow cytometry. Multi-scale, single-cell analyses may satisfy the need to determine disease stage and therapy response for tuberculosis and other infectious pathologies.	[Vir, Pooja; Arrigucci, Riccardo; Lakehal, Karim; Pine, Richard; Tyagi, Sanjay; Bushkin, Yuri; Gennaro, Maria Laura] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Davidow, Amy L.] Rutgers State Univ, New Jersey Med Sch, Sch Publ Hlth, Dept Biostat, Newark, NJ 07102 USA; [Lardizabal, Alfred] Rutgers State Univ, New Jersey Med Sch, Global TB Inst, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gennaro, ML (corresponding author), Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA.	marila.gennaro@rutgers.edu	Vir, Pooja/ABI-3569-2020	Vir, Pooja/0000-0002-6816-5122; Davidow, Amy/0000-0002-3660-7627; Gennaro, Maria Laura/0000-0003-4801-3567; Tyagi, Sanjay/0000-0001-7303-5827	National Institutes of Health [AI-104615, AI-106036]; Rutgers Office of Research and Economic Development - New Jersey Health Foundation; NIH [AI104615, AI106036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106036, R01AI104615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Office of Research and Economic Development - New Jersey Health Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants [AI-104615 and AI-106036] and by an intramural grant from the Rutgers Office of Research and Economic Development, sponsored by the New Jersey Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Samia Ahmed for recruiting study subjects and maintaining the clinical database; Salvatore Marras for helping with HPLC purification of FISH probes; Sukhwinder Singh and the Rutgers NJMS Flow Cytometry and Immunology Core Laboratory for advice and technical support on flow cytometry; George Yap for discussing mechanistic aspects of the assay; and Janani Ravi for helping with preparation of the figures. We also thank Karl Drlica, Patricia Fitzgerald-Bocarsly, and George Yap for critical comments on the manuscript. This work was funded by NIH grants AI104615 and AI106036.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; Bihl F, 2010, J IMMUNOL, V185, P2174, DOI 10.4049/jimmunol.1001486; Bushkin Y, 2015, J IMMUNOL, V194, P836, DOI 10.4049/jimmunol.1401515; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Davidson B, 2012, DIAGN CYTOPATHOL, V40, P525, DOI 10.1002/dc.22809; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Fuhrmann S, 2008, CYTOM PART A, V73A, P1100, DOI 10.1002/cyto.a.20614; Hanley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057002; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926; Kindt T.J., 2007, KUBY IMMUNOLOGY; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; Maino VC, 2013, EXPERT REV MOL DIAGN, V13, P511, DOI 10.1586/14737159.2013.811904; McCullagh P, 1989, GEN LINEAR MODELS; Nomura L, 2008, CYTOM PART A, V73A, P984, DOI 10.1002/cyto.a.20602; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Porichis F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6641; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rovina N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/464039; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Sewell WA, 2011, PATHOLOGY, V43, P580, DOI 10.1097/PAT.0b013e32834a69ae; Stern JNH, 2009, IMMUNOL RES, V45, P1, DOI 10.1007/s12026-008-8024-2; Virgo PF, 2012, ANN CLIN BIOCHEM, V49, P17, DOI 10.1258/acb.2011.011128; World Health Organization, 2014, GLOB TUB REP; Yang HL, 2012, FEMS IMMUNOL MED MIC, V66, P273, DOI 10.1111/j.1574-695X.2012.01002.x	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144904	10.1371/journal.pone.0144904	http://dx.doi.org/10.1371/journal.pone.0144904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658491	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900143
J	Jagadeeshan, S; Shah, U; Chakrabarti, D; Singh, RS				Jagadeeshan, Santosh; Shah, Ushma; Chakrabarti, Debarti; Singh, Rama S.			Female Choice or Male Sex Drive? The Advantages of Male Body Size during Mating in Drosophila Melanogaster	PLOS ONE			English	Article							MATE CHOICE; FRUIT-FLIES; SUCCESS; COURTSHIP; EVOLUTION; BEHAVIOR; SELECTION; DIPTERA; FIELD; TIME	The mating success of larger male Drosophila melanogaster in the laboratory and the wild has been traditionally been explained by female choice, even though the reasons are generally hard to reconcile. Female choice can explain this success by virtue of females taking less time to mate with preferred males, but so can the more aggressive or persistent courtships efforts of large males. Since mating is a negotiation between the two sexes, the behaviors of both are likely to interact and influence mating outcomes. Using a series of assays, we explored these negotiations by testing for the relative influence of male behaviors and its effect on influencing female courtship arousal threshold, which is the time taken for females to accept copulation. Our results show that large males indeed have higher copulation success compared to smaller males. Competition between two males or an increasing number of males had no influence on female sexual arousal threshold;-females therefore may have a relatively fixed 'arousal threshold' that must be reached before they are ready to mate, and larger males appear to be able to manipulate this threshold sooner. On the other hand, the females' physiological and behavioral state drastically influences mating; once females have crossed the courtship arousal threshold they take less time to mate and mate indiscriminately with large and small males. Mating quicker with larger males may be misconstrued to be due to female choice; our results suggest that the mating advantage of larger males may be more a result of heightened male activity and relatively less of female choice. Body size per se may not be a trait under selection by female choice, but size likely amplifies male activity and signal outputs in courtship, allowing them to influence female arousal threshold faster.	[Jagadeeshan, Santosh; Shah, Ushma; Chakrabarti, Debarti; Singh, Rama S.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	McMaster University	Singh, RS (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	singh@mcmaster.ca	Jagadeeshan, Santosh/AAN-9568-2021	Jagadeeshan, Santosh/0000-0002-4285-9281	National Sciences and Engineering Research Council of Canada [2012R00452]; Natural Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the National Sciences and Engineering Research Council of Canada; grant number 2012R00452, http://www.nserc-crsng.gc.ca/index_eng.asp.; We would like to thank Jacqueline Thompson for help with culture media and fly maintenance and Ruwandi Kariyawasam for help with experiments. We would also like to thank Richard Morton for useful discussions during the course of this work, Reuven Dukas, Therese Markow, and an anonymous reviewer for useful comments on a previous version of this manuscript. This study was supported by a Natural Sciences and Engineering Research Council of Canada grant to R. S. S.	Ahuja A, 2008, GENETICS, V179, P503, DOI 10.1534/genetics.107.086363; Andersson Malte, 1994; Darwin C, 1859, ORIGIN SPECIES MEANS; Darwin C., 1871, PRINCIPLES SEXUAL SE, DOI [10.1037/12293-008, DOI 10.1037/12293-008]; Edward DA, 2013, ANIM BEHAV, V86, P269, DOI 10.1016/j.anbehav.2013.05.014; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Fisher RA, 1930, GENETICAL THEORY NAT; Friberg U, 2003, J EVOLUTION BIOL, V16, P797, DOI 10.1046/j.1420-9101.2003.00597.x; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Markow TA, 1996, EVOL BIOL, V29, P73; MARKOW TA, 1992, HEREDITY, V69, P122, DOI 10.1038/hdy.1992.104; MARKOW TA, 1992, J INSECT BEHAV, V5, P375, DOI 10.1007/BF01049845; MARKOW TA, 1988, J COMP PSYCHOL, V102, P169, DOI 10.1037/0735-7036.102.2.169; MARKOW TA, 1987, EVOL GENET, P89; Markow TA, 1986, GENETIC SENSORY BASI, P89; Parker G.A., 1979, P123; PARTRIDGE L, 1987, ANIM BEHAV, V35, P468, DOI 10.1016/S0003-3472(87)80272-5; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; Paterson H.E.H., 1993, EVOLUTION RECOGNITIO; Pavkovic-Lucic S, 2013, EUR J ENTOMOL, V110, P31, DOI 10.14411/eje.2013.004; PITNICK S, 1991, ANIM BEHAV, V41, P735, DOI 10.1016/S0003-3472(05)80340-9; Pitnick S, 2002, P ROY SOC B-BIOL SCI, V269, P1821, DOI 10.1098/rspb.2002.2090; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; ROBERTSON FW, 1960, GENET RES, V1, P288, DOI 10.1017/S0016672300000264; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Taylor ML, 2009, ANIM BIOL, V59, P391, DOI 10.1163/157075509X12499949744180; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809	32	11	11	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144672	10.1371/journal.pone.0144672	http://dx.doi.org/10.1371/journal.pone.0144672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658421	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600076
J	Qu, C; Fu, FY; Liu, M; Zhao, HY; Liu, C; Li, JN; Tang, ZL; Xu, XF; Qiu, X; Wang, R; Lu, K				Qu, Cunmin; Fu, Fuyou; Liu, Miao; Zhao, Huiyan; Liu, Chuan; Li, Jiana; Tang, Zhanglin; Xu, Xinfu; Qiu, Xiao; Wang, Rui; Lu, Kun			Comparative Transcriptome Analysis of Recessive Male Sterility (RGMS) in Sterile and Fertile Brassica napus Lines	PLOS ONE			English	Article							CARRIER PROTEIN REDUCTASE; POLLEN-WALL BIOSYNTHESIS; ARABIDOPSIS-THALIANA; ANTHER DEVELOPMENT; EXINE FORMATION; SPOROPOLLENIN SYNTHESIS; MICROSPORE DEVELOPMENT; TAPETUM DEVELOPMENT; DIFFERENTIAL GENE; RNA-SEQ	The recessive genetic male sterility (RGMS) system plays a key role in the production of hybrid varieties in self-pollinating B. napus plants, and prevents negative cytoplasmic effects. However, the complete molecular mechanism of the male sterility during male-gametogenesis in RGMS remains to be determined. To identify transcriptomic changes that occur during the transition to male sterility in RGMS, we examined the male sterile line WSLA and male fertile line WSLB, which are near-isogenic lines (NILs) differing only in the fertility trait. We evaluated the phenotypic features and sterility stage using anatomical analysis. Comparative RNA sequencing analysis revealed that 3,199 genes were differentially expressed between WSLA andWSLB. Many of these genes are mainly involved in biological processes related to flowering, including pollen tube development and growth, pollen wall assembly and modification, and pollen exine formation and pollination. The transcript profiles of 93 genes associated with pollen wall and anther development were determined by quantitative RT-PCR in different flower parts, and classified into the following three major clades: 1) up-regulated in WSLA plants; 2) down-regulated in WSLA plants; and 3) down-regulated in buds, but have a higher expression in stigmas of WSLA than in WSLB. A subset of genes associated with sporopollenin accumulation were all up-regulated in WSLA. An excess of sporopollenin results in defective pollen wall formation, which leads to male sterility in WSLA. Some of the genes identified in this study are candidates for future research, as they could provide important insight into the molecular mechanisms underlying RGMS in WSLA.	[Qu, Cunmin; Liu, Miao; Zhao, Huiyan; Liu, Chuan; Li, Jiana; Tang, Zhanglin; Xu, Xinfu; Wang, Rui; Lu, Kun] Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Tiansheng Rd 2, Chongqing 400716, Peoples R China; [Qu, Cunmin; Liu, Miao; Zhao, Huiyan; Liu, Chuan; Li, Jiana; Tang, Zhanglin; Xu, Xinfu; Wang, Rui; Lu, Kun] Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing 400716, Peoples R China; [Qu, Cunmin; Qiu, Xiao] Univ Saskatchewan, Food & Bioprod Sci, Saskatoon, SK S7N 5A8, Canada; [Fu, Fuyou] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK S7N 02X, Canada	Southwest University - China; Southwest University - China; University of Saskatchewan; Agriculture & Agri Food Canada	Wang, R (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Tiansheng Rd 2, Chongqing 400716, Peoples R China.	ruiwang71@163.com; drlunkun@swu.edu.cn	Fu, Fuyou/B-9754-2016; Lu, Kun/C-2597-2008	Fu, Fuyou/0000-0002-5020-4496; Lu, Kun/0000-0003-1370-8633	National Science Foundation of China [U1302266, 31401412, 31571701, 31171619]; 111 Project [B12006]; 863 Project [2013AA102602]; Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008]; China Scholarship Council (CSC); earmarked fund for Modern Agro-industry Technology Research System [CARS-13]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); 863 Project(National High Technology Research and Development Program of China); Chongqing Project of Main Crop Variety Innovation; China Scholarship Council (CSC)(China Scholarship Council); earmarked fund for Modern Agro-industry Technology Research System	This work was supported by grants from the National Science Foundation of China [U1302266, 31401412, 31571701, and 31171619, http://www.nsfc.gov.cn], the 111 Project [B12006, http://www.moe.edu.cn], the 863 Project [2013AA102602, www.most.gov.cn], the Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008, http://www.cstc.gov.cn] and the China Scholarship Council (CSC) [www.csc.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from the National Science Foundation of China (U1302266, 31401412, 31571701, 31171619), the 111 Project (B12006), the 863 Project (2013AA102602), the earmarked fund for Modern Agro-industry Technology Research System (CARS-13), the Chongqing Project of Main Crop Variety Innovation (cstc2012ggB80008), and the China Scholarship Council (CSC).	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; Ariizumi T, 2004, PLANT J, V39, P170, DOI 10.1111/j.1365-313X.2004.02118.x; Ariizumi T, 2003, PLANT MOL BIOL, V53, P107, DOI 10.1023/B:PLAN.0000009269.97773.70; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Auger B, 2009, PLANTA, V230, P1167, DOI 10.1007/s00425-009-1017-0; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen FX, 1993, ACTA AGR U PEKINEN S, V19, P57; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; Dobritsa AA, 2010, PLANT PHYSIOL, V153, P937, DOI 10.1104/pp.110.157446; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Dobritsa AA, 2009, SEX PLANT REPROD, V22, P167, DOI 10.1007/s00497-009-0101-8; Dong FM, 2012, MOL BREEDING, V30, P1193, DOI 10.1007/s11032-012-9708-9; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dun XL, 2011, PLANT J, V68, P532, DOI 10.1111/j.1365-313X.2011.04708.x; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; He JP, 2008, THEOR APPL GENET, V117, P11, DOI 10.1007/s00122-008-0747-x; Higginson T, 2003, PLANT J, V35, P177, DOI 10.1046/j.1365-313X.2003.01791.x; Hou GZ., 1990, OIL CROP CHINA, V2, P7; Hruba P, 2005, PLANTA, V220, P931, DOI 10.1007/s00425-004-1409-0; Huang Z, 2007, THEOR APPL GENET, V115, P113, DOI 10.1007/s00122-007-0547-8; Jiang J, 2013, PLANT BIOLOGY, V15, P249, DOI 10.1111/j.1438-8677.2012.00706.x; Kimber D.S., 1995, BRASSICA OILSEEDS PR, P1; Lei B, 2014, INT J MOL SCI, V15, P6137, DOI 10.3390/ijms15046137; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; Pan T., 1988, OIL CROP CHINA, V3, P5; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Sun C, 2001, CHIN J OIL CROP SCI, V24, P1; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wijeratne AJ, 2007, PLANT J, V52, P14, DOI 10.1111/j.1365-313X.2007.03217.x; Wilson ZA, 2009, J EXP BOT, V60, P1479, DOI 10.1093/jxb/erp095; Wu G, 2010, J AGR FOOD CHEM, V58, P2812, DOI 10.1021/jf904255b; Wu Y, 2015, SCI REPORTS, V5; Xia SQ, 2012, THEOR APPL GENET, V124, P1193, DOI 10.1007/s00122-011-1779-1; Xiao ZD, 2013, CZECH J GENET PLANT, V49, P16, DOI 10.17221/33/2012-CJGPB; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Xu J, 2014, PLANT CELL, V26, P1544, DOI 10.1105/tpc.114.122986; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang C, 2007, PLANT CELL, V19, P3530, DOI 10.1105/tpc.107.054981; Yu C, 2015, EUPHYTICA, P1; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhang ZB, 2007, PLANT J, V52, P528, DOI 10.1111/j.1365-313X.2007.03254.x; Zhou ZF, 2012, J EXP BOT, V63, P2041, DOI 10.1093/jxb/err405	56	27	31	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144118	10.1371/journal.pone.0144118	http://dx.doi.org/10.1371/journal.pone.0144118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656530	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500013
J	Schwickert, A; Weghake, E; Bruggemann, K; Engbers, A; Brinkmann, BF; Kemper, B; Seggewiss, J; Stock, C; Ebnet, K; Kiesel, L; Riethmuller, C; Gotte, M				Schwickert, Alexander; Weghake, Esther; Brueggemann, Kathrin; Engbers, Annika; Brinkmann, Benjamin F.; Kemper, Bjoern; Seggewiss, Jochen; Stock, Christian; Ebnet, Klaus; Kiesel, Ludwig; Riethmueller, Christoph; Goette, Martin			microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; JUNCTIONAL ADHESION MOLECULE; ESTROGEN-RECEPTOR-ALPHA; N-WASP; HEPATOCELLULAR-CARCINOMA; ALPHA-V-BETA-3 INTEGRIN; INVADOPODIUM FORMATION; ACTIN CYTOSKELETON; TUMOR-CELLS; MIGRATION	MicroRNAs (miRNAs, micro ribonucleic acids) are pivotal post-transcriptional regulators of gene expression. These endogenous small non-coding RNAs play significant roles in tumorigenesis and tumor progression. miR-142-3p expression is dysregulated in several breast cancer subtypes. We aimed at investigating the role of miR-142-3p in breast cancer cell invasiveness. Supported by transcriptomic Affymetrix array analysis and confirmatory investigations at the mRNA and protein level, we demonstrate that overexpression of miR-142-3p in MDA-MB-231, MDA-MB-468 and MCF-7 breast cancer cells leads to downregulation of WASL (Wiskott-Aldrich syndrome-like, protein: N-WASP), Integrin-alpha V, RAC1, and CFL2, molecules implicated in cytoskeletal regulation and cell motility. ROCK2, IL6ST, KLF4, PGRMC2 and ADCY9 were identified as additional targets in a subset of cell lines. Decreased Matrigel invasiveness was associated with the miR-142-3p-induced expression changes. Confocal immunofluorescence microscopy, nanoscale atomic force microscopy and digital holographic microscopy revealed a change in cell morphology as well as a reduced cell volume and size. A more cortical actin distribution and a loss of membrane protrusions were observed in cells overexpressing miR-142-3p. Luciferase activation assays confirmed direct miR-142-3p-dependent regulation of the 3'-untranslated region of ITGAV and WASL. siRNA-mediated depletion of ITGAV and WASL resulted in a significant reduction of cellular invasiveness, highlighting the contribution of these factors to the miRNA-dependent invasion phenotype. While knockdown of WASL significantly reduced the number of membrane protrusions compared to controls, knockdown of ITGAV resulted in a decreased cell volume, indicating differential contributions of these factors to the miR-142-3p-induced phenotype. Our data identify WASL, ITGAV and several additional cytoskeleton-associated molecules as novel invasion-promoting targets of miR-142-3p in breast cancer.	[Schwickert, Alexander; Weghake, Esther; Brueggemann, Kathrin; Engbers, Annika; Kiesel, Ludwig; Goette, Martin] Munster Univ Hosp, Dept Gynecol & Obstet, Munster, Germany; [Brinkmann, Benjamin F.; Ebnet, Klaus] Univ Munster, ZMBE, Inst Med Biochem, Inst Associated Res Grp Cell Adhes & Cell Polar, D-48149 Munster, Germany; [Kemper, Bjoern] Univ Munster, Ctr Biomed Opt & Photon, Munster, Germany; [Kemper, Bjoern] Univ Munster, Biomed Technol Ctr, Fac Med, D-48149 Munster, Germany; [Seggewiss, Jochen] Univ Munster, Inst Human Genet, Fac Med, D-48149 Munster, Germany; [Stock, Christian] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Stock, Christian] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Riethmueller, Christoph] Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; Hannover Medical School	Gotte, M (corresponding author), Munster Univ Hosp, Dept Gynecol & Obstet, Munster, Germany.	martingotte@uni-muenster.de	Kiesel, Ludwig/ABC-5333-2020; Ebnet, Klaus T/C-8314-2009; Paping, Alexander/AAA-5625-2020; Götte, Martin/G-2254-2018; Gotte, M/Z-5878-2019	Kiesel, Ludwig/0000-0002-7247-9247; Ebnet, Klaus T/0000-0002-0417-7888; Paping, Alexander/0000-0003-2360-6016; Götte, Martin/0000-0003-2360-2496; Gotte, M/0000-0003-2360-2496; Kemper, Bjorn/0000-0003-3693-9397	Innovative Medizinische Forschung (IMF), Medical Faculty Munster University [I-Go 111110]; IZKF, Medical Faculty Munster University [IZKF Eb2/020/14]; BMBF [FKZ13N10937, 01DJ130022A]; Open Access Publication Fund of University of Muenster; EU H RISE-MSCA [645756]	Innovative Medizinische Forschung (IMF), Medical Faculty Munster University; IZKF, Medical Faculty Munster University; BMBF(Federal Ministry of Education & Research (BMBF)); Open Access Publication Fund of University of Muenster; EU H RISE-MSCA	This study was funded by Innovative Medizinische Forschung (IMF), Medical Faculty Munster University, grant number I-Go 111110, URL: http://campus.uni-muenster.de/imf.html; IZKF, Medical Faculty Munster University, grant numberIZKF Eb2/020/14, URL: http://campus.uni-muenster.de/izkf.html; BMBF grants FKZ13N10937 and 01DJ130022A; URL: http://www.bmbf.de/en/index.php; Open Access Publication Fund of University of Muenster (no grant number); URL: http://www.uni-muenster.de/Publizieren/service/publikationsfonds/; EU H2020 RISE-MSCA Project grant number 645756 (GLYCANC) URL:http://cordis.europa.eu/search/result_en?q=GLYCANC&searchType=simple. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Albrecht C, 2012, STEROIDS, V77, P1543, DOI 10.1016/j.steroids.2012.09.006; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bettenworth D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107317; Bischoff A, 2014, CANCER RES, V74, P5256, DOI 10.1158/0008-5472.CAN-13-3319; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Chen J, 2001, J BIOL CHEM, V276, P47901, DOI 10.1074/jbc.M107574200; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Escudero-Esparza A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-43; Flamant S, 2010, HAEMATOL-HEMATOL J, V95, P1325, DOI 10.3324/haematol.2009.020636; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Giri A, 2013, FASEB J, V27, P4089, DOI 10.1096/fj.12-224352; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Havaki S, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-16; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ibrahim SA, 2014, FEBS J, V281, P5009, DOI 10.1111/febs.13026; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kastingschafer CS, 2015, REPROD BIOMED ONLINE, V30, P553, DOI 10.1016/j.rbmo.2015.01.002; Katoh D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.27; Kemper B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798639; Kemper B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2204609; Kimura F, 2010, CANCER SCI, V101, P1133, DOI 10.1111/j.1349-7006.2010.01527.x; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Kumar AV, 2014, INT J CANCER, V135, P2579, DOI 10.1002/ijc.28921; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Marini F, 2011, J THROID RES, V2011, DOI 10.4061/2011/407123; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Nusblat LM, 2011, EUR J CELL BIOL, V90, P205, DOI 10.1016/j.ejcb.2010.07.012; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Peddibhotla SSD, 2013, MOL BIOL CELL, V24, P933, DOI 10.1091/mbc.E12-06-0481; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Pollari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037361; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Riethmuller C, 2006, PFLUG ARCH EUR J PHY, V453, P157, DOI 10.1007/s00424-006-0121-2; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Santos-Carballal B, 2015, SCI REP-UK, V5, DOI 10.1038/srep13567; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Sturge J, 2002, J CELL SCI, V115, P699; Takahashi K, 2011, J CELL BIOCHEM, V112, P3421, DOI 10.1002/jcb.23276; Tanic M, 2015, INT J CANCER, V136, P593, DOI 10.1002/ijc.29021; Thoelking G, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/26/265102; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Wu YJ, 2012, J NEURO-ONCOL, V110, P27, DOI 10.1007/s11060-012-0942-0; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yu F, 2013, INT J CANCER, V133, P2872, DOI 10.1002/ijc.28302; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	72	75	77	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143993	10.1371/journal.pone.0143993	http://dx.doi.org/10.1371/journal.pone.0143993			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657485	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500010
J	Ariyo, EO; Booy, EP; Patel, TR; Dzananovic, E; McRae, EK; Meier, M; McEleney, K; Stetefeld, J; McKenna, SA				Ariyo, Emmanuel O.; Booy, Evan P.; Patel, Trushar R.; Dzananovic, Edis; McRae, Ewan K.; Meier, Markus; McEleney, Kevin; Stetefeld, Jorg; McKenna, Sean A.			Biophysical Characterization of G-Quadruplex Recognition in the PITX1 mRNA by the Specificity Domain of the Helicase RHAU	PLOS ONE			English	Article							HOMEOBOX GENE-EXPRESSION; CIRCULAR-DICHROISM; DNA; SEQUENCE; UNWINDS; STABILITY; BINDING; TRANSCRIPTION; RESOLUTION; INSIGHTS	Nucleic acids rich in guanine are able to fold into unique structures known as G-quadruplexes. G-quadruplexes consist of four tracts of guanylates arranged in parallel or antiparallel strands that are aligned in stacked G-quartet planes. The structure is further stabilized by Hoogsteen hydrogen bonds and monovalent cations centered between the planes. RHAU (RNA helicase associated with AU-rich element) is a member of the ATP-dependent DExH/D family of RNA helicases and can bind and resolve G-quadruplexes. RHAU contains a core helicase domain with an N-terminal extension that enables recognition and full binding affinity to RNA and DNA G-quadruplexes. PITX1, a member of the bicoid class of homeobox proteins, is a transcriptional activator active during development of vertebrates, chiefly in the anterior pituitary gland and several other organs. We have previously demonstrated that RHAU regulates PITX1 levels through interaction with G-quadruplexes at the 3'-end of the PITX1 mRNA. To understand the structural basis of G-quadruplex recognition by RHAU, we characterize a purified minimal PITX1 G-quadruplex using a variety of biophysical techniques including electrophoretic mobility shift assays, UV-VIS spectroscopy, circular dichroism, dynamic light scattering, small angle X-ray scattering and nuclear magnetic resonance spectroscopy. Our biophysical analysis provides evidence that the RNA G-quadruplex, but not its DNA counterpart, can adopt a parallel orientation, and that only the RNA can interact with N-terminal domain of RHAU via the tetrad face of the G-quadruplex. This work extends our insight into how the N-terminal region of RHAU recognizes parallel G-quadruplexes.	[Ariyo, Emmanuel O.; Booy, Evan P.; Dzananovic, Edis; McRae, Ewan K.; Meier, Markus; McEleney, Kevin; Stetefeld, Jorg; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Patel, Trushar R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [McEleney, Kevin; Stetefeld, Jorg; McKenna, Sean A.] Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB R3T 2N2, Canada; [Stetefeld, Jorg; McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Birmingham; University of Manitoba; University of Manitoba	McKenna, SA (corresponding author), Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	sean.mckenna@umanitoba.ca	Meier, Markus/F-2798-2011; Stetefeld, Joerg/H-7630-2017; Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011	Meier, Markus/0000-0003-1068-746X; Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; McKenna, Sean/0000-0002-9407-7257	Cancer Research Society (Canada) [18206]	Cancer Research Society (Canada)	Funded by the Cancer Research Society (Canada) #18206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy Evan P, 2015, Methods Mol Biol, V1259, P125, DOI 10.1007/978-1-4939-2214-7_9; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Booy Evan P, 2012, Methods Mol Biol, V941, P69, DOI 10.1007/978-1-62703-113-4_6; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Collie GW, 2010, NUCLEIC ACIDS RES, V38, P5569, DOI 10.1093/nar/gkq259; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Egli M, 1996, BIOCHEMISTRY-US, V35, P8489, DOI 10.1021/bi9607214; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frees S, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-8; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Gao X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.571; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; HOOGSTEEN K, 1963, ACTA CRYSTALLOGR, V16, P907, DOI 10.1107/S0365110X63002437; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Klopocki E, 2012, EUR J HUM GENET, V20, P705, DOI 10.1038/ejhg.2011.264; Knosel T, 2012, INT J COLORECTAL DIS, V27, P1391, DOI 10.1007/s00384-012-1460-4; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Randazzo A, 2013, TOP CURR CHEM, V330, P67, DOI 10.1007/128_2012_331; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Shang J, 1997, GENOMICS, V40, P108, DOI 10.1006/geno.1996.4558; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Zhang AYQ, 2011, BIOCHEMISTRY-US, V50, P7251, DOI 10.1021/bi200805j	61	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144510	10.1371/journal.pone.0144510	http://dx.doi.org/10.1371/journal.pone.0144510			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649896	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300053
J	Yao, CX; Behring, JB; Shao, D; Sverdlov, AL; Whelan, SA; Elezaby, A; Yin, XY; Siwik, DA; Seta, F; Costello, CE; Cohen, RA; Matsui, R; Colucci, WS; McComb, ME; Bachschmid, MM				Yao, Chunxiang; Behring, Jessica B.; Shao, Di; Sverdlov, Aaron L.; Whelan, Stephen A.; Elezaby, Aly; Yin, Xiaoyan; Siwik, Deborah A.; Seta, Francesca; Costello, Catherine E.; Cohen, Richard A.; Matsui, Reiko; Colucci, Wilson S.; McComb, Mark E.; Bachschmid, Markus M.			Overexpression of Catalase Diminishes Oxidative Cysteine Modifications of Cardiac Proteins	PLOS ONE			English	Article							HUMAN CARBONYL REDUCTASE; HYDROGEN-PEROXIDE; SERINE/THREONINE PHOSPHATASES; CONTRACTILE DYSFUNCTION; MITOCHONDRIAL-MEMBRANE; TRANSGENIC MICE; CYTOCHROME-C; MOUSE HEART; DNA-DAMAGE; LIM DOMAIN	Reactive protein cysteine thiolates are instrumental in redox regulation. Oxidants, such as hydrogen peroxide (H2O2), react with thiolates to form oxidative post-translational modifications, enabling physiological redox signaling. Cardiac disease and aging are associated with oxidative stress which can impair redox signaling by altering essential cysteine thiolates. We previously found that cardiac-specific overexpression of catalase (Cat), an enzyme that detoxifies excess H2O2, protected from oxidative stress and delayed cardiac aging in mice. Using redox proteomics and systems biology, we sought to identify the cysteines that could play a key role in cardiac disease and aging. With a 'Tandem Mass Tag' (TMT) labeling strategy and mass spectrometry, we investigated differential reversible cysteine oxidation in the cardiac proteome of wild type and Cat transgenic (Tg) mice. Reversible cysteine oxidation was measured as thiol occupancy, the ratio of total available versus reversibly oxidized cysteine thiols. Catalase overexpression globally decreased thiol occupancy by >= 1.3 fold in 82 proteins, including numerous mitochondrial and contractile proteins. Systems biology analysis assigned the majority of proteins with differentially modified thiols in Cat Tg mice to pathways of aging and cardiac disease, including cellular stress response, proteostasis, and apoptosis. In addition, Cat Tg mice exhibited diminished protein glutathione adducts and decreased H2O2 production from mitochondrial complex I and II, suggesting improved function of cardiac mitochondria. In conclusion, our data suggest that catalase may alleviate cardiac disease and aging by moderating global protein cysteine thiol oxidation.	[Yao, Chunxiang; Behring, Jessica B.; Shao, Di; Seta, Francesca; Cohen, Richard A.; Matsui, Reiko; Bachschmid, Markus M.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA; [Sverdlov, Aaron L.; Elezaby, Aly; Siwik, Deborah A.; Colucci, Wilson S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Biol Unit,Dept Med, Boston, MA 02118 USA; [Whelan, Stephen A.; Costello, Catherine E.; McComb, Mark E.] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Cardiovasc Prote Ctr, Boston, MA 02118 USA; [Yin, Xiaoyan] Boston Univ, Framingham, MA USA; [Yin, Xiaoyan] NHLBI, Framingham Heart Study, Framingham, MA USA; [Yin, Xiaoyan] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University	McComb, ME (corresponding author), Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Cardiovasc Prote Ctr, Boston, MA 02118 USA.	mccomb@bu.edu; bach@bu.edu	Shao, Di/F-9758-2016; Seta, Francesca/ABB-1566-2020; Sverdlov, Aaron/G-1384-2010	/0000-0002-7166-327X; Whelan, Stephen A/0000-0002-5439-6501; Seta, Francesca/0000-0001-7985-5615; Elezaby, Aly/0000-0001-8389-3200; Bachschmid, Markus Michael/0000-0002-0748-5528; /0000-0002-1070-6408; /0000-0002-4249-485X; Sverdlov, Aaron/0000-0003-2539-8038; Costello, Catherine/0000-0003-1594-5122	NHLBI, National Institutes of Health, Department of Health and Human Services [HHSN268201000031C]; NIH [P01 HL 068758, R37 HL104017, R01 HL064750, R01 HL031607, P41 GM104603, R01 DK103750, S10 OD010724]; National Health and Medical Research Council of Australia [APP1037603]; Royal Australasian College of Physicians; AHA Postdoctoral Fellowship [14POST20490003, 15POST21790006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064750, R01HL031607, R37HL104017, P01HL068758, T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010724] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health, Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians(General Electric); AHA Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NHLBI, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN268201000031C, and by NIH grants P01 HL 068758, R37 HL104017, R01 HL064750, R01 HL031607, P41 GM104603, R01 DK103750 and S10 OD010724. ALS is funded by a CJ Martin Fellowship from the National Health and Medical Research Council of Australia (APP1037603), the Marjorie Hooper Overseas Fellowship from the Royal Australasian College of Physicians and AHA Postdoctoral Fellowship 14POST20490003. DS is funded from the AHA Postdoctoral Fellowship 15POST21790006. The contents are solely the responsibility of the authors and do not represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Behring JB, 2014, FASEB J, V28, P1975, DOI 10.1096/fj.13-233445; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Breton-Romero R, 2014, REDOX BIOL, V2, P529, DOI 10.1016/j.redox.2014.02.005; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; CHEN Y, 1994, FREE RADICAL BIO MED, V17, P529, DOI 10.1016/0891-5849(94)90092-2; CHO ES, 1984, J NUTR, V114, P1853, DOI 10.1093/jn/114.10.1853; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cui ZY, 2014, J MOL CELL CARDIOL, V71, P32, DOI 10.1016/j.yjmcc.2013.10.008; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Dohoney KM, 2004, ONCOGENE, V23, P49, DOI 10.1038/sj.onc.1207005; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Hartmanova T, 2013, CHEM-BIOL INTERACT, V202, P136, DOI 10.1016/j.cbi.2012.12.011; Hasty P, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.22702; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Ishikawa T, 1986, TARGET ORGAN TOXICIT, V1; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; KashibaIwatsuki M, 1997, J BIOCHEM-TOKYO, V122, P1208; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kontaxis G, 1998, BIOCHEMISTRY-US, V37, P7127, DOI 10.1021/bi973055v; Lemasters JJ, 2007, J GASTROEN HEPATOL, V22, pS31, DOI 10.1111/j.1440-1746.2006.04643.x; Li GQ, 1997, AM J PHYSIOL-HEART C, V273, pH1090, DOI 10.1152/ajpheart.1997.273.3.H1090; Liesa M, 2011, CIRCULATION, V124, P806, DOI 10.1161/CIRCULATIONAHA.110.003418; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Ma JJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-103; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Nguyen-nhu NT, 2003, FEBS LETT, V544, P148, DOI 10.1016/S0014-5793(03)00493-9; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Oklu R, 2000, BIOCHEM J, V352, P601, DOI 10.1042/0264-6021:3520601; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Qin FZ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000184; Qin FZ, 2010, CIRC-HEART FAIL, V3, P306, DOI 10.1161/CIRCHEARTFAILURE.109.864785; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Roret T, 2014, J BIOL CHEM, V289, P24588, DOI 10.1074/jbc.M114.572701; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sandri M, 2014, J MOL CELL CARDIOL, V71, P3, DOI 10.1016/j.yjmcc.2013.12.015; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Spencer Jean L, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi1322s44; Sverdlov AL, 2015, J MOL CELL CARDIOL, V78, P165, DOI 10.1016/j.yjmcc.2014.07.018; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; Tinguely JN, 1999, EUR J BIOCHEM, V260, P9, DOI 10.1046/j.1432-1327.1999.00089.x; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Turdi S, 2012, FREE RADICAL BIO MED, V53, P1327, DOI 10.1016/j.freeradbiomed.2012.07.084; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wakatsuki T, 1998, BIOL PHARM BULL, V21, P905; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang XJ, 2014, J MOL CELL CARDIOL, V71, P16, DOI 10.1016/j.yjmcc.2013.11.006; Wolkart G, 2006, PHARMACOL RES, V54, P50, DOI 10.1016/j.phrs.2006.02.005; Wu S, 2007, CLIN EXP PHARMACOL P, V34, P81, DOI 10.1111/j.1440-1681.2007.04540.x; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31	68	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144025	10.1371/journal.pone.0144025	http://dx.doi.org/10.1371/journal.pone.0144025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642319	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700046
J	Li, L; Fang, R; Liu, B; Shi, H; Wang, Y; Zhang, W; Zhang, X; Ye, L				Li, L.; Fang, R.; Liu, B.; Shi, H.; Wang, Y.; Zhang, W.; Zhang, X.; Ye, L.			Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth	ONCOGENE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; PROGNOSTIC-SIGNIFICANCE; ACETYLATION TARGETS; BINDING-PROTEIN; YAP PATHWAY; CELLS; KINASE; PROLIFERATION; EXPRESSION; RECEPTOR	Reduction or loss of tumor-suppressor mammalian STE20-like kinase 1 (MST1) in Hippo pathway contributes to the tumorigenesis. However, the mechanism leading to reduction of MST1 in cancers remains poorly understood. In this study, we explored the hypothesis that the oncoprotein hepatitis B X-interacting protein (HBXIP) is involved in the reduction of MST1 in breast cancer. Immunohistochemical analysis of tissue microarrays revealed that the expression of HBXIP was negatively associated with that of MST1 in 98 clinical breast tissue samples. Then we found that HBXIP could posttranslationally downregulate MST1 in breast cancer cells. Mechanistically, we identified that MST1 could be acetylated on its lysine 35 residue in the cells. Strikingly, the treatment with trichostatin A, an inhibitor of histone deacetylases (HDACs), markedly increased the levels of MST1 acetylation and protein in the cells. Interestingly, the oncoprotein HBXIP could significantly inhibit acetylation of MST1, resulting in the reduction of MST1 protein. Notably, we revealed that the HDAC6 could reduce the protein levels of MST1 through deacetylation modification of MST1 in the cells. Moreover, our data revealed that HBXIP upregulated HDAC6 at the levels of mRNA and protein by activating transcription factor nuclear factor-kappa B. Deacetylation of MST1 promoted the interaction of MST1 with HSC70 in the cells, resulting in a lysosome-dependent degradation of MST1 via chaperone-mediated autophagy (CMA). Functionally, the reduction of tumor-suppressor MST1 mediated by HBXIP promoted the growth of breast cancer cells in vitro and in vivo. Thus we conclude that the deacetylation of MST1 mediated by HBXIP-enhanced HDAC6 results in MST1 degradation in a CMA manner in promotion of breast cancer growth. Our finding provides new insights into the mechanism of tumor-suppressor MST1 reduction in breast cancer.	[Li, L.; Fang, R.; Liu, B.; Shi, H.; Wang, Y.; Zhang, W.; Ye, L.] Nankai Univ, Coll Life Sci, Dept Biochem, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhang, X.] Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Ye, L (corresponding author), Nankai Univ, Coll Life Sci, Dept Biochem, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Zhang, X (corresponding author), Nankai Univ, Coll Life Sci, Dept Canc Res, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	Fang, Runping/AAF-6835-2020		National Basic Research Program of China (973 Program) [2015CB553905]; National Natural Scientific Foundation of China [81372186, 81272218, 31470756]; Tianjin Natural Scientific Foundation [14JCZDJC32800]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Scientific Foundation	This work was supported by grants from the National Basic Research Program of China (973 Program, No. 2015CB553905), the National Natural Scientific Foundation of China (Nos. 81372186, 81272218, 31470756) and Tianjin Natural Scientific Foundation (No. 14JCZDJC32800).	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cinar B, 2011, CANCER RES, V71, P4303, DOI 10.1158/0008-5472.CAN-10-4532; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding G, 2013, FEBS LETT, V587, P880, DOI 10.1016/j.febslet.2013.02.001; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hsu YL, 2015, ONCOGENE, V34, P4056, DOI 10.1038/onc.2014.333; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Kuser-Abali G, 2014, EPIGENETICS-US, V9, P634, DOI 10.4161/epi.27957; Li H, 2015, J BIOL CHEM, V290, P22649, DOI 10.1074/jbc.M115.658468; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Li SS, 2013, BIOCHEM J, V452, P281, DOI 10.1042/BJ20120680; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Lin XY, 2013, TUMOR BIOL, V34, P3239, DOI 10.1007/s13277-013-0895-8; Liu FB, 2014, CARCINOGENESIS, V35, P1144, DOI 10.1093/carcin/bgu021; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Madonna R, 2014, J BIOL CHEM, V289, P19585, DOI 10.1074/jbc.M113.540559; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Minoo P, 2007, MODERN PATHOL, V20, P331, DOI 10.1038/modpathol.3800740; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park SJ, 2014, CANCER LETT, V354, P97, DOI 10.1016/j.canlet.2014.07.041; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Ren AX, 2008, CANCER RES, V68, P2266, DOI 10.1158/0008-5472.CAN-07-6248; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Seidel C, 2007, MOL CARCINOGEN, V46, P865, DOI 10.1002/mc.20317; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang P, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0435-8; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yue L, 2013, CARCINOGENESIS, V34, P927, DOI 10.1093/carcin/bgs399; Zhang KJ, 2014, PROTEIN CELL, V5, P48, DOI 10.1007/s13238-013-0011-2; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005	52	51	55	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4048	4057		10.1038/onc.2015.476	http://dx.doi.org/10.1038/onc.2015.476			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26657153				2022-12-26	WOS:000381020900003
J	de Meij, TGJ; Budding, AE; de Groot, EFJ; Jansen, FM; Kneepkens, CMF; Benninga, MA; Penders, J; van Bodegraven, AA; Savelkoul, PHM				de Meij, Tim G. J.; Budding, Andries E.; de Groot, Evelien F. J.; Jansen, Fenna M.; Kneepkens, C. M. Frank; Benninga, Marc A.; Penders, John; van Bodegraven, Adriaan A.; Savelkoul, Paul H. M.			Composition and stability of intestinal microbiota of healthy children within a Dutch population	FASEB JOURNAL			English	Article						core; 454-pyrosequencing; IS-pro; diversity; microbiome	16S RIBOSOMAL-RNA; INFLAMMATORY-BOWEL-DISEASE; DISTAL GUT MICROBIOTA; BACTERIAL COMMUNITIES; TEMPORAL STABILITY; CROHNS-DISEASE; DIVERSITY; INFANTS; COLONIZATION; ANTIBIOTICS	Numerous diseases linked to microbial imbalance can be traced back to childhood, illustrating the impact of the juvenile microbiota development from infancy toward adulthood. However, knowledge on this subject is currently very limited. The primary aim of this study was to characterize composition and short-and long-term stability of the intestinal microbiota in healthy children. Between November 2011 and June 2014, 61 children 2 to 18 yr of age from different areas in The Netherlands were included and instructed to collect fecal samples weekly, for 6 wk, and a followup sample after 18 mo. The intergenic spacer profiling technique (IS-pro) was used to analyze all available fecal samples. Microbial diversity was calculated by the Shannon diversity index and individual compositional stability by comparing all collection time points. Microbial stability varied per phylum (P < 0.0005), declined rapidly in a short time period, and subsequently stabilized on the long run with very gradual variation, leading to an overall compositional stability of 70% on average over a period of 18 mo. Higher species diversity was correlated to a higher overall compositional stability (P < 0.001). We observed an age-independent bacterial shared core consisting of a limited number of species. In conclusion, in this study, we showed that microbial composition stability in children varied per phylum, at both short-term and long-term intervals. Healthy children seem to share a microbiome core consisting of a limited number of species.-De Meij, T. G. J., Budding, A. E., de Groot, E. F. J., Jansen, F. M., Kneepkens, C. M. F., Benninga, M. A., Penders, J., van Bodegraven, A. A., Savelkoul, P. H. M. Composition and stability of intestinal microbiota of healthy children within a Dutch population. FASEB J. 30, 1512-1522 (2016). www.fasebj.org	[de Meij, Tim G. J.; de Groot, Evelien F. J.; Jansen, Fenna M.; Kneepkens, C. M. Frank] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Gastroenterol, Amsterdam, Netherlands; [Budding, Andries E.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [van Bodegraven, Adriaan A.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Benninga, Marc A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Gastroenterol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Penders, John; Savelkoul, Paul H. M.] Maastricht Univ, Dept Med Microbiol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [van Bodegraven, Adriaan A.] Zuyderland Med Ctr, Dept Gastroentorol Internal Med Intens Care Med &, Heerlen Sittard Geleen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	de Meij, TGJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	t.demeij@vumc.nl	van Bodegraven, Ad A/L-3180-2013; Penders, John/A-1280-2011; van Bodegraven, Ad/ABG-4367-2020	Penders, John/0000-0001-9146-5919; Budding, Andries/0000-0001-5128-5411				Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Balamurugan R, 2008, AM J CLIN NUTR, V88, P1643, DOI 10.3945/ajcn.2008.26511; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Delgado S, 2006, DIGEST DIS SCI, V51, P737, DOI 10.1007/s10620-006-3200-5; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Durban A, 2012, FEMS MICROBIOL ECOL, V81, P427, DOI 10.1111/j.1574-6941.2012.01368.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069621; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mitsue K., 2007, LECT NOTES COMPUT SC, V4551, P106; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2012, ENVIRON MICROBIOL, DOI [10.1111/1462-2920, DOI 10.1111/1462-2920]; Salminen S, 2004, GUT, V53, P1388, DOI 10.1136/gut.2004.041640; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tapiainen T, 2006, APMIS, V114, P812, DOI 10.1111/j.1600-0463.2006.apm_488.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vangay P, 2015, CELL HOST MICROBE, V17, P553, DOI 10.1016/j.chom.2015.04.006; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	53	34	34	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1512	1522		10.1096/fj.15-278622	http://dx.doi.org/10.1096/fj.15-278622			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26655704	Green Submitted			2022-12-26	WOS:000372629100013
J	da Rosa, CVD; Azevedo, SCSF; Bazotte, RB; Peralta, RM; Buttow, NC; Pedrosa, MMD; de Godoi, VAF; Natali, MRM				da Rosa, Carlos Vinicius D.; Azevedo, Silvia C. S. F.; Bazotte, Roberto B.; Peralta, Rosane M.; Buttow, Nilza C.; Pedrosa, Maria Montserrat D.; de Godoi, Vilma A. F.; Natali, Maria Raquel M.			Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats	PLOS ONE			English	Article							PREVENTS MUCOSAL INJURY; SMALL-INTESTINE; DIETARY GLUTAMINE; OXIDATIVE STRESS; ORAL GLUTAMINE; ALKALINE-PHOSPHATASE; MYENTERIC NEURONS; AMINO-ACIDS; SAFETY; ILEUM	We evaluated the effects of the supplementation with L-glutamine and glutamine dipeptide (GDP) on biochemical and morphophysiological parameters in streptozotocin-diabetic rats. For this purpose, thirty animals were distributed into six groups treated orally (gavage) during thirty days: non diabetic rats (Control) + saline, diabetic + saline; Control + L-glutamine (248 mg/kg), Diabetic + L-glutamine (248 mg/kg), Control + GDP (400 mg/kg), Diabetic + GDP (400 mg/kg). Diabetes was induced by an intravenous injection of streptozotocin (60 mg/kg) and confirmed by fasting glucose >= 200 mg/dL. Physiological parameters, i.e., body mass, food intake, blood glucose, water intake, urine and faeces were evaluated during supplementation. After the period of supplementation, the animals were euthanized. The blood was collected for biochemical assays (fructosamine, transaminases, lipid profile, total protein, urea, ammonia). Moreover, the jejunum was excised and stored for morphophysiological assays (intestinal enzyme activity, intestinal wall morphology, crypt proliferative index, number of serotoninergic cells from the mucosa, and vipergic neurons from the submucosal tunica). The physiological parameters, protein metabolism and intestinal enzyme activity did not change with the supplementation with L-glutamine or GDP. In diabetic animals, transaminases and fructosamine improved with L-glutamine and GDP supplementations, while the lipid profile improved with L-glutamine. Furthermore, both forms of supplementation promoted changes in jejunal tunicas and wall morphometry of control and diabetic groups, but only L-glutamine promoted maintenance of serotoninergic cells and vipergic neurons populations. On the other hand, control animals showed changes that may indicate negative effects of L-glutamine. Thus, the supplementation with L-glutamine was more efficient for maintaining intestinal morphophysiology and the supplementation with GDP was more efficient to the organism as a whole. Thus, we can conclude that local differences in absorption and metabolism could explain the differences between the supplementation with L-glutamine or GDP.	[da Rosa, Carlos Vinicius D.; Buttow, Nilza C.; Natali, Maria Raquel M.] Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil; [Azevedo, Silvia C. S. F.; Pedrosa, Maria Montserrat D.; de Godoi, Vilma A. F.] Univ Estadual Maringa, Dept Physiol Sci, Maringa, Parana, Brazil; [Bazotte, Roberto B.] Univ Estadual Maringa, Dept Pharmacol & Therapeut, Maringa, Parana, Brazil; [Peralta, Rosane M.] Univ Estadual Maringa, Dept Biochem, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Natali, MRM (corresponding author), Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil.	mrmnatali@uem.br	BAZOTTE, ROBERTO/S-5851-2019; Pedrosa, Maria Montserrat Diaz/AAW-6411-2020; PERALTA, ROSANE MARINA/J-3912-2016	PERALTA, ROSANE MARINA/0000-0001-5749-0723; Natali, Maria Raquel Marcal/0000-0002-7486-2581; Rosa, Carlos Vinicius Dalto da/0000-0001-9428-630X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [40004015001M9]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES 40004015001M9 (http://www.capes.gov.br/) to CVDR SCSFA RBB RMP NCB VAFG MRMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2003, ENDOCR J, V50, P271, DOI 10.1507/endocrj.50.271; Adeghate E, 2001, Arch Physiol Biochem, V109, P246, DOI 10.1076/apab.109.3.246.11587; Badole SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072817; Badole SL, 2013, CHEM-BIOL INTERACT, V203, P530, DOI 10.1016/j.cbi.2013.02.006; Alves EPB, 2010, NUTR NEUROSCI, V13, P43, DOI 10.1179/147683010X12611460763841; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P1205; Bowtell JL, 1999, J APPL PHYSIOL, V86, P1770, DOI 10.1152/jappl.1999.86.6.1770; CASPARY WF, 1972, DIABETOLOGIA, V8, P412, DOI 10.1007/BF01212169; Rodrigues MLC, 2012, J PEDIAT-BRAZIL, V88, P17, DOI 10.2223/JPED.2153; Chandrasekharan B, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01611.x; CicinSain L, 1996, BEHAV BRAIN RES, V73, P285; Cruzat VF, 2014, NUTRITION, V30, P602, DOI 10.1016/j.nut.2013.10.019; Pereira RVF, 2011, DIGEST DIS SCI, V56, P3507, DOI 10.1007/s10620-011-1806-8; Furst P, 1997, NUTRITION, V13, P731, DOI 10.1016/S0899-9007(97)83035-3; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Garlick PJ, 2001, J NUTR, V131, p2556S, DOI 10.1093/jn/131.9.2556S; GOLDBERG RB, 1981, DIABETES CARE, V4, P561, DOI 10.2337/diacare.4.5.561; Grider JR, 1998, GASTROENTEROLOGY, V115, P370, DOI 10.1016/S0016-5085(98)70203-3; Gupta N, 2002, ANAL BIOCHEM, V311, P98, DOI 10.1016/S0003-2697(02)00379-2; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Hermes-Uliana C, 2014, DIGEST DIS SCI, V59, P937, DOI 10.1007/s10620-013-2993-2; Izbeki F, 2008, DIABETES RES CLIN PR, V80, P192, DOI 10.1016/j.diabres.2007.12.013; Jiang ZM, 1999, JPEN-PARENTER ENTER, V23, pS62, DOI 10.1177/014860719902300516; Jorgensen CS, 2001, DIGEST DIS SCI, V46, P960, DOI 10.1023/A:1010737323153; Labow BI, 2001, J NUTR, V131, p2467S, DOI 10.1093/jn/131.9.2467S; Labow BI, 2000, WORLD J SURG, V24, P1503, DOI 10.1007/s002680010269; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Liu GF, 2012, WORLD J GASTROENTERO, V18, P4875, DOI 10.3748/wjg.v18.i35.4875; LORENZMEYER H, 1977, RES EXP MED, V170, P89, DOI 10.1007/BF01851379; LOWE DK, 1990, AM J CLIN NUTR, V52, P1101, DOI 10.1093/ajcn/52.6.1101; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; MILLER DL, 1977, GASTROENTEROLOGY, V73, P1326; Minguetti-Camara VC, 2014, NUTRIENTS, V6, P4520, DOI 10.3390/nu6104520; MOREL DW, 1989, J LIPID RES, V30, P1827; NAKABOU Y, 1980, METABOLISM, V29, P181, DOI 10.1016/0026-0495(80)90144-4; Nansseu JRN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007689; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Newsholme P, 2011, FRONT BIOSCI-LANDMRK, V16, P315, DOI 10.2741/3690; Noda T, 2001, METABOLISM, V50, P259, DOI 10.1053/meta.2001.21030; NORDSTROM C, 1967, J HISTOCHEM CYTOCHEM, V15, P713, DOI 10.1177/15.12.713; Oda S, 2008, REGUL TOXICOL PHARM, V50, P226, DOI 10.1016/j.yrtph.2007.10.016; Owari M, 2012, PEDIATR SURG INT, V28, P299, DOI 10.1007/s00383-011-3023-0; Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9; da Silva GGP, 2011, WORLD J GASTROENTERO, V17, P898, DOI 10.3748/wjg.v17.i7.898; PORTELAGOMES GM, 1990, PATHOL RES PRACT, V186, P260, DOI 10.1016/S0344-0338(11)80544-3; Satoh J, 2003, INT J MOL MED, V12, P615; Schmidt RE, 2003, AM J PATHOL, V163, P2077, DOI 10.1016/S0002-9440(10)63565-1; Schwimmer JB, 2002, AM J PHYSIOL-GASTR L, V282, pG317, DOI 10.1152/ajpgi.2002.282.2.G317; SEE NA, 1990, J AUTONOM NERV SYST, V31, P219, DOI 10.1016/0165-1838(90)90188-O; Sengul G, 2011, TURK NEUROSURG, V21, P367, DOI 10.5137/1019-5149.JTN.4313-11.0; Sha H, 2006, WORLD J GASTROENTERO, V12, P7149, DOI 10.3748/wjg.v12.i44.7149; Sukhotnik I, 2007, DIGEST DIS SCI, V52, P1497, DOI 10.1007/s10620-006-9629-8; Swaid F, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-53; Takahara H, 2001, AM J PHYSIOL-GASTR L, V281, pG798, DOI 10.1152/ajpgi.2001.281.3.G798; TOMLINSON KC, 1992, PHARMACOL REV, V44, P103; Tronchini EA, 2013, AN ACAD BRAS CIENC, V85, P1165, DOI 10.1590/S0001-37652013005000052; Tronchini Eleandro Aparecido, 2012, Arq. Gastroenterol., V49, P284, DOI 10.1590/S0004-28032012000400010; Tsai PH, 2011, CLIN NUTR, V30, P124, DOI 10.1016/j.clnu.2010.07.005; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Ward E, 2003, EUR J CLIN NUTR, V57, P31, DOI 10.1038/sj.ejcn.1601517; Zanoni Jacqueline Nelisis, 2011, Arq. Gastroenterol., V48, P66, DOI 10.1590/S0004-28032011000100014; Zanoni JN, 2002, ARQ NEURO-PSIQUIAT, V60, P32, DOI 10.1590/S0004-282X2002000100007; Zarei A, 2015, AVICENNA J PHYTOMEDI, V5, P138; Zhao J, 2003, DIABETOLOGIA, V46, P1688, DOI 10.1007/s00125-003-1233-2; ZOUBI SA, 1995, VIRCHOWS ARCH, V426, P501	67	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143005	10.1371/journal.pone.0143005	http://dx.doi.org/10.1371/journal.pone.0143005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659064	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900006
J	Jumbri, K; Rozy, MFA; Ashari, SE; Mohamad, R; Basri, M; Masoumi, HRF				Jumbri, Khairulazhar; Rozy, Mohd Fahruddin Al-Haniff; Ashari, Siti Efliza; Mohamad, Rosfarizan; Basri, Mahiran; Masoumi, Hamid Reza Fard			Optimisation and Characterisation of Lipase-Catalysed Synthesis of a Kojic Monooleate Ester in a Solvent-Free System by Response Surface Methodology	PLOS ONE			English	Article							ENZYMATIC-SYNTHESIS; ACID; RSM; PARAMETERS; TYROSINASE	Kojic acid is widely used to inhibit the browning effect of tyrosinase in cosmetic and food industries. In this work, synthesis of kojic monooleate ester (KMO) was carried out using lipase-catalysed esterification of kojic acid and oleic acid in a solvent-free system. Response Surface Methodology (RSM) based on central composite rotatable design (CCRD) was used to optimise the main important reaction variables, such as enzyme amount, reaction temperature, substrate molar ratio, and reaction time along with immobilised lipase from Candida Antarctica (Novozym 435) as a biocatalyst. The RSM data indicated that the reaction temperature was less significant in comparison to other factors for the production of a KMO ester. By using this statistical analysis, a quadratic model was developed in order to correlate the preparation variable to the response (reaction yield). The optimum conditions for the enzymatic synthesis of KMO were as follows: an enzyme amount of 2.0 wt%, reaction temperature of 83.69 degrees C, substrate molar ratio of 1: 2.37 (mmole kojic acid: oleic acid) and a reaction time of 300.0 min. Under these conditions, the actual yield percentage obtained was 42.09%, which is comparably well with the maximum predicted value of 44.46%. Under the optimal conditions, Novozym 435 could be reused for 5 cycles for KMO production percentage yield of at least 40%. The results demonstrated that statistical analysis using RSM can be used efficiently to optimise the production of a KMO ester. Moreover, the optimum conditions obtained can be applied to scale-up the process and minimise the cost.	[Jumbri, Khairulazhar; Rozy, Mohd Fahruddin Al-Haniff; Ashari, Siti Efliza; Basri, Mahiran; Masoumi, Hamid Reza Fard] Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia; [Mohamad, Rosfarizan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Technol Bioproc, Upm Serdang, Selangor, Malaysia; [Ashari, Siti Efliza; Basri, Mahiran; Masoumi, Hamid Reza Fard] Univ Putra Malaysia, Enzyme & Microbial Technol Res Ctr, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Ashari, SE (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia.	ctefliza@upm.edu.my	jumbri, khairulazhar/P-2679-2019; jumbri, khairulazhar/H-5737-2016; Ashari, Efliza/U-7371-2019	jumbri, khairulazhar/0000-0003-3345-6453; Mohamad, Rosfarizan/0000-0001-5672-1905	UPM-IPM [9406100]; Ministry of Science Technology and Innovation, Malaysia	UPM-IPM; Ministry of Science Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The work was funded by UPM-IPM (grant number 9406100) and the Ministry of Science Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We acknowledge the financial support from UPM-IPM (grant number 9406100) and the Ministry of Science Technology and Innovation, Malaysia.	Ashari SE, 2009, J OLEO SCI, V58, P503, DOI 10.5650/jos.58.503; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Burdock FA, 2001, REGUL TOXICOL PHARM, V33, P80, DOI 10.1006/rtph.2000.1442; Chaibakhsh N, 2009, J IND MICROBIOL BIOT, V36, P1149, DOI 10.1007/s10295-009-0596-x; Chen CS, 2002, J SCI FOOD AGR, V82, P601, DOI 10.1002/jsfa.1083; Dossat V, 2002, ENZYME MICROB TECH, V30, P90, DOI 10.1016/S0141-0229(01)00453-7; El-Boulifi N, 2014, ENZYME MICROB TECH, V55, P128, DOI 10.1016/j.enzmictec.2013.10.009; Foresti ML, 2005, BIOCHEM ENG J, V25, P69, DOI 10.1016/j.bej.2005.04.002; Gunawan ER, 2005, ENZYME MICROB TECH, V37, P739, DOI 10.1016/j.enzmictec.2005.04.010; Hamzaoui AH, 2008, HYDROMETALLURGY, V90, P1, DOI 10.1016/j.hydromet.2007.09.005; Ismail A, 1999, J BIOTECHNOL, V69, P135, DOI 10.1016/S0168-1656(99)00041-3; Kaatz H, 1999, Z NATURFORSCH C, V54, P70; Khamaruddin NH, 2008, J OIL PALM RES, V20, P461; Kim H, 2004, BIOORG MED CHEM LETT, V14, P2843, DOI 10.1016/j.bmcl.2004.03.046; Krishna SH, 2001, PROCESS BIOCHEM, V37, P9; Lajis AFB, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/952452; Li Y, 2005, J AM SOC BREW CHEM, V63, P171, DOI 10.1094/ASBCJ-63-0171; Liu KJ, 1998, J AM OIL CHEM SOC, V75, P1507, DOI 10.1007/s11746-998-0086-8; Masoumi HRF, 2013, SCI WORLD J, DOI 10.1155/2013/962083; Park JY, 2010, RENEW ENERG, V35, P614, DOI 10.1016/j.renene.2009.08.007; Salina M.R., 2005, J OLEO SCI, V54, P203, DOI [10.5650/jos.54.203, DOI 10.5650/JOS.54.203]; Uher M, 2008, CESKA SLOV FARM, V49, P119; Virto C, 1999, ENZYME MICROB TECH, V24, P651, DOI 10.1016/S0141-0229(98)00153-7; Yingying L, 2009, J BIOBASED MATER BIO, V3, P324	24	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144664	10.1371/journal.pone.0144664	http://dx.doi.org/10.1371/journal.pone.0144664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657030	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900083
J	Kim, DH; Kim, L; Park, W; Chang, WH; Kim, YH; Lee, SW; Kwon, GH				Kim, Da-Hye; Kim, Leahyun; Park, Wanjoo; Chang, Won Hyuk; Kim, Yun-Hee; Lee, Seong-Whan; Kwon, Gyu Hyun			Analysis of Time-Dependent Brain Network on Active and MI Tasks for Chronic Stroke Patients	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; CORTICAL MOTOR AREAS; FINGER MOVEMENTS; MENTAL PRACTICE; EEG SIGNALS; IMAGERY; CORTEX; RECOVERY; REORGANIZATION; ORGANIZATION	Several researchers have analyzed brain activities by investigating brain networks. However, there is a lack of the research on the temporal characteristics of the brain network during a stroke by EEG and the comparative studies between motor execution and imagery, which became known to have similar motor functions and pathways. In this study, we proposed the possibility of temporal characteristics on the brain networks of a stroke. We analyzed the temporal properties of the brain networks for nine chronic stroke patients by the active and motor imagery tasks by EEG. High beta band has a specific role in the brain network during motor tasks. In the high beta band, for the active task, there were significant characteristics of centrality and small-worldness on bilateral primary motor cortices at the initial motor execution. The degree centrality significantly increased on the contralateral primary motor cortex, and local efficiency increased on the ipsilateral primary motor cortex. These results indicate that the ipsilateral primary motor cortex constructed a powerful subnetwork by influencing the linked channels as compensatory effect, although the contralateral primary motor cortex organized an inefficient network by using the connected channels due to lesions. For the MI task, degree centrality and local efficiency significantly decreased on the somatosensory area at the initial motor imagery. Then, there were significant correlations between the properties of brain networks and motor function on the contralateral primary motor cortex and somatosensory area for each motor execution/imagery task. Our results represented that the active and MI tasks have different mechanisms of motor acts. Based on these results, we indicated the possibility of customized rehabilitation according to different motor tasks. We expect these results to help in the construction of the customized rehabilitation system depending on motor tasks by understanding temporal functional characteristics on brain network for a stroke.	[Kim, Da-Hye; Kim, Leahyun; Park, Wanjoo] Korea Inst Sci & Technol, Ctr Bion, Seoul, South Korea; [Kwon, Gyu Hyun] Hanyang Univ, Grad Sch Technol & Innovat Management, Seoul 133791, South Korea; [Kim, Da-Hye; Park, Wanjoo; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Kim, Leahyun] Univ Sci & Technol, Dept HCI & Robot, Seoul, South Korea; [Chang, Won Hyuk; Kim, Yun-Hee] Sungkyunkwan Univ, Dept Phys & Rehabil Med, Ctr Prevent & Rehabil, Heart Vasc & Stroke Inst,Samsung Med Ctr,Sch Med, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Hanyang University; Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kwon, GH (corresponding author), Hanyang Univ, Grad Sch Technol & Innovat Management, Seoul 133791, South Korea.	dahyekim@kist.re.kr; ghkwon@hanyang.ac.kr	Kim, Yun-Hee/GVS-6426-2022; Kim, Yun Hee/F-4600-2014		IT R&D program of MOTIE/MISP/KEIT [10045452]; Development of Multimodal Brain-Machine Interface System Based on User Intent Recognition Project; Development of Robot-Assisted Motor Rehabilitation of the Upper Limb Using Bio-Signal Interfaces Project of the Korea Institute of Science and Technology (KIST), South Korea; ICT & Future Planning and Components & Materials Technology Development Program - Ministry of Trade, Industry Energy [10043826]; SMC-KIST Translational Research Program [SMO1140041]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A1A01005128]	IT R&D program of MOTIE/MISP/KEIT; Development of Multimodal Brain-Machine Interface System Based on User Intent Recognition Project; Development of Robot-Assisted Motor Rehabilitation of the Upper Limb Using Bio-Signal Interfaces Project of the Korea Institute of Science and Technology (KIST), South Korea; ICT & Future Planning and Components & Materials Technology Development Program - Ministry of Trade, Industry Energy; SMC-KIST Translational Research Program; National Research Foundation of Korea (NRF) - Korean government (MSIP)(National Research Foundation of Korea)	This work was partly supported by the IT R&D program of MOTIE/MISP/KEIT (10045452), the Development of Multimodal Brain-Machine Interface System Based on User Intent Recognition Project, the Development of Robot-Assisted Motor Rehabilitation of the Upper Limb Using Bio-Signal Interfaces Project of the Korea Institute of Science and Technology (KIST), South Korea, and the ICT & Future Planning and Components & Materials Technology Development Program (10043826) funded by the Ministry of Trade, Industry & Energy, as well as a grant from the SMC-KIST Translational Research Program (SMO1140041) and the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2014R1A2A1A01005128) (WHC & YHK).	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Bai O, 2005, CLIN NEUROPHYSIOL, V116, P1213, DOI 10.1016/j.clinph.2005.01.006; Barclay-Goddard R, 2011, STROKE, V42, pE574, DOI 10.1161/STROKEAHA.111.627414; Bear M.F., 2007, NEUROSCIENCE; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Braun SM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-34; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fallani FD, 2013, NEUROIMAGE, V83, P438, DOI 10.1016/j.neuroimage.2013.06.039; Fallani FD, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501581; Fallani FD, 2010, INT J BIFURCAT CHAOS, V20, P905, DOI 10.1142/S0218127410026198; Fallani FD, 2009, ANAT REC, V292, P2023, DOI 10.1002/ar.20965; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GEVINS A, 1995, TRENDS NEUROSCI, V18, P429, DOI 10.1016/0166-2236(95)94489-R; Gillen G., 2010, STROKE REHABILITATIO; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P1706, DOI 10.1016/j.apmr.2004.11.043; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lalo E, 2007, EXP BRAIN RES, V177, P137, DOI 10.1007/s00221-006-0655-8; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Liu H, 2014, NEURAL REGEN RES, V9, P1474, DOI 10.4103/1673-5374.139465; Mauguiere F, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P79; Mima T, 2000, NEUROSCI LETT, V287, P93, DOI 10.1016/S0304-3940(00)01165-4; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Naito E, 2002, J NEUROSCI, V22, P3683; Ortigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006962; Park W, 2015, IEEE T NEUR SYS REH, V23, P351, DOI 10.1109/TNSRE.2014.2356472; Porro CA, 1996, J NEUROSCI, V16, P7688; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Reagan D, 1989, HUMAN BRAIN ELECTROP; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Tangwiriyasakul C, 2014, CLIN NEUROPHYSIOL, V125, P1112, DOI 10.1016/j.clinph.2013.10.047; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Wang L, 2012, 34 ANN INT C IEEE EN; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEINRICH M, 1982, J NEUROSCI, V2, P1329; World Health Organization, 2014, TOP 10 CAUS DEATH; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077325; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	57	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0139441	10.1371/journal.pone.0139441	http://dx.doi.org/10.1371/journal.pone.0139441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656269	Green Submitted, gold, Green Published			2022-12-26	WOS:000366715900001
J	Kita, Y; Hollo, G; Kita, R; Horie, D; Inoue, M; Hirakata, A				Kita, Yoshiyuki; Hollo, Gabor; Kita, Ritsuko; Horie, Daisuke; Inoue, Makoto; Hirakata, Akito			Differences of Intrasession Reproducibility of Circumpapillary Total Retinal Thickness and Circumpapillary Retinal Nerve Fiber Layer Thickness Measurements Made with the RS-3000 Optical Coherence Tomograph	PLOS ONE			English	Article							SPECTRAL-DOMAIN; SD-OCT; VARIABILITY; PROGRESSION; PARAMETERS	Purpose To evaluate the intrasession reproducibility of various thickness parameters used to diagnose and follow-up glaucoma, in particular circumpapillary total retinal thickness (cpTR) provided by the RS-3000 optical coherence tomograph (OCT). Methods Fifty-three healthy eyes of 28 subjects underwent three consecutive imaging with the RS-3000 Advance OCT (NIDEK, Aichi, Japan) to evaluate the intrasession reproducibility of circumpapillary total retinal thickness (cpTR), circumpapillary retinal nerve fiber layer thickness (cpRNFL), macular ganglion cell complex thickness (mGCC) and macular total retina thickness (mTR) measurements. Intraclass correlation (ICC), coefficient of variation (CV) and reproducibility coefficient (RC) were calculated for each parameter. Results The ICC and CV values for mean cpTR and cpRNFL were 0.987 and 0.897, and 0.60% and 2.81%, respectively. The RC values for the mean cpTR and cpRNFL were 5.95 mu m and 9.04 mu m, respectively. For all cpTR parameters the ICC values were higher and both the CV and RC values were lower than those for the corresponding cpRNFL parameters. The ICC and CV values for superior mGCC, inferior mGCC, superior mTR and inferior mTR were 0.983, 0.980, 0.983 and 0.988, and 0.84%, 0.98%, 0.48% and 0.43%, respectively. The RC values for superior mGCC, inferior mGCC, superior mTR and inferior mTR were 2.86 mu m, 3.12 mu m, 4.41 mu m and 4.43 mu m, respectively. Conclusions Intrasession reproducibility of cpTR, mGCC and mTR measurements made on healthy eyes was high. Repeatability of cpTR measurements was better than that of the corresponding cpRNFL measurements. These results suggest that future clinical investigations addressing detection of glaucoma and glaucomatous progression with the RS-3000 OCT may benefit from focusing on the cpTR parameters.	[Kita, Yoshiyuki; Kita, Ritsuko; Horie, Daisuke; Inoue, Makoto; Hirakata, Akito] Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary	Kyorin University; Semmelweis University	Kita, Y (corresponding author), Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	kitakita220@gmail.com		Kita, Yoshiyuki/0000-0001-9665-1809				Akashi A, 2013, INVEST OPHTH VIS SCI, V54, P6025, DOI 10.1167/iovs.13-12630; [Anonymous], 2015, NAVIS EX US MAN, P345; Bland JM, 1986, BMJ-BRIT MED J, V313, P744; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Giani A, 2012, INVEST OPHTH VIS SCI, V53, P7637, DOI 10.1167/iovs.12-10047; Golzan SM, 2011, COMPUT METH PROG BIO, V104, P206, DOI 10.1016/j.cmpb.2011.08.005; Hirasawa H, 2013, INVEST OPHTH VIS SCI, V54, P2562, DOI 10.1167/iovs.12-10552; Kim NR, 2011, INVEST OPHTH VIS SCI, V52, P3413, DOI 10.1167/iovs.10-6648; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kita Y, 2013, CLIN EXP OPHTHALMOL, V41, P674, DOI 10.1111/ceo.12089; Kita Y, 2013, J GLAUCOMA, V22, P757, DOI 10.1097/IJG.0b013e31825af58a; Kita Y, 2011, JPN J OPHTHALMOL, V55, P228, DOI 10.1007/s10384-011-0017-3; Lee KS, 2013, INVEST OPHTH VIS SCI, V54, P1941, DOI 10.1167/iovs.12-11160; Leite MT, 2011, OPHTHALMOLOGY, V118, P1334, DOI 10.1016/j.ophtha.2010.11.029; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Mwanza JC, 2010, INVEST OPHTH VIS SCI, V51, P5724, DOI 10.1167/iovs.10-5222; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P3817, DOI 10.1167/iovs.11-9369; Naghizadeh F, 2014, J GLAUCOMA, V23, P269, DOI 10.1097/IJG.0b013e3182741c69; Nakanishi H, 2015, GRAEF ARCH CLIN EXP, V253, P1143, DOI 10.1007/s00417-015-3026-y; Pierro L, 2011, INVEST OPHTH VIS SCI, V53, P5912; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Simavli H, 2015, AM J OPHTHALMOL, V159, P545, DOI 10.1016/j.ajo.2014.12.004; Tenkumo K, 2013, JPN J OPHTHALMOL, V57, P451, DOI 10.1007/s10384-013-0254-8; Vajaranant TS, 2011, EYE, V25, P612, DOI 10.1038/eye.2011.17; Vizzeri G, 2009, BRIT J OPHTHALMOL, V93, P775, DOI 10.1136/bjo.2008.150698; Wadhwani M, 2015, J GLAUCOMA, V24, pe109, DOI 10.1097/IJG.0000000000000203; Weinreb RN, 2011, INVEST OPHTH VIS SCI, V52, P7842, DOI 10.1167/iovs.11-7895; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144721	10.1371/journal.pone.0144721	http://dx.doi.org/10.1371/journal.pone.0144721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657805	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900093
J	Vergara, M; Berrios, J; Martinez, I; Diaz-Barrera, A; Acevedo, C; Reyes, JG; Gonzalez, R; Altamirano, C				Vergara, Mauricio; Berrios, Julio; Martinez, Irene; Diaz-Barrera, Alvaro; Acevedo, Cristian; Reyes, Juan G.; Gonzalez, Ramon; Altamirano, Claudia			Endoplasmic Reticulum-Associated rht-PA Processing in CHO Cells: Influence of Mild Hypothermia and Specific Growth Rates in Batch and Chemostat Cultures	PLOS ONE			English	Article							HAMSTER OVARY CELLS; ER STRESS; TRANSCRIPTION LEVEL; ENDOTHELIAL-CELLS; TEMPERATURE; PRODUCTIVITY; DEGRADATION; EXPRESSION; TUNICAMYCIN; PHOSPHORYLATION	Background Chinese hamster ovary (CHO) cells are the main host for producing recombinant proteins with human therapeutic applications mainly because of their capability to perform proper folding and glycosylation processes. In addition, mild hypothermia is one of the main strategies for maximising the productivity of these systems. However, little information is available on the effect of culture temperature on the folding and degradation processes of recombinant proteins that takes place in the endoplasmic reticulum. Methods In order to evaluate the effect of the mild hypothermia on processing/endoplasmatic reticulum-associated degradation (ERAD) processes, batch cultures of CHO cells producing recombinant human tissue plasminogen activator (rht-PA) were carried out at two temperatures (37 degrees C and 33 degrees C) and treated with specific inhibitors of glycosylation and ERAD I (Ubiquitin/Proteasome system) or ERAD II (Autophagosoma/Lisosomal system) pathways. The effect of mild hypothermia was analysed separately from its indirect effect on specific cell growth rate. To do this, chemostat cultures were carried out at the same incubation conditions as the batch cultures, controlling cell growth at high (0.017 h(-1)) and low (0.012 h(-1)) dilution rates. For a better understanding of the investigated phenomenon, cell behaviour was also analysed using principal component analysis (PCA). Results and Conclusion Results suggest that rht-PA is susceptible to degradation by both ERAD pathways studied, revealing that processing and/or ERAD processes are sensitive to temperature cultivation in batch culture. Moreover, by isolating the effect of culture temperature from the effect of cell growth rate verifyed by using chemostat cultures, we have found that processing and/or ERAD processes are more sensitive to reduction in specific growth rate than low temperature, and that temperature reduction may have a positive effect on protein processing. Interestingly, PCA indicated that the integrated performance displayed by CHO cells is modulated predominantly by specific growth rate, indicating that the culture temperature has a lower weighted effect within the range of conditions evaluated in this work.	[Vergara, Mauricio; Reyes, Juan G.] Pontificia Univ Catolica Valparaiso, Inst Chem, Curauma, Chile; [Vergara, Mauricio; Berrios, Julio; Martinez, Irene; Diaz-Barrera, Alvaro; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Valparaiso 4059, Chile; [Acevedo, Cristian] Univ Tecn Federico Santa Maria, Biotechnol Ctr Dr Daniel Alkalay Lowitt, Valparaiso, Chile; [Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX USA; [Altamirano, Claudia] CREAS CONICYT Reg GORE Valparaiso, Curauma, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Universidad Tecnica Federico Santa Maria; Rice University; Rice University	Altamirano, C (corresponding author), Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Av Brasil 2085, Valparaiso 4059, Chile.	claudia.altamirano@ucv.cl	Martinez, Irene/U-5251-2017; Acevedo, Cristian A./D-5133-2011	Berrios, Julio/0000-0002-6180-0023; Reyes, Juan G./0000-0001-5541-5172; Altamirano, Claudia/0000-0002-6389-086X; Alvaro, Diaz-Barrera/0000-0002-0922-8648	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1120667, 3150373]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the 1120667 Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) to CA, and 3150373 Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano C, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue3-fulltext-2; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Becerra S, 2012, BIOCHEM ENG J, V60, P1, DOI 10.1016/j.bej.2011.10.003; Berrios J, 2011, CHEM ENG SCI, V66, P2431, DOI 10.1016/j.ces.2011.03.011; Berrios J, 2009, BIOTECHNOL LETT, V31, P1493, DOI 10.1007/s10529-009-0050-1; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Chen FY, 2015, J MOL NEUROSCI, V55, P995, DOI 10.1007/s12031-014-0456-7; Donoso G, 2005, BIOCHEM J, V387, P897, DOI 10.1042/BJ20041312; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Frigerio L, 2000, CURR BIOL, V10, pR674, DOI 10.1016/S0960-9822(00)00680-1; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gomez N, 2012, BIOTECHNOL BIOENG, V109, P125, DOI 10.1002/bit.23288; HEMMING FW, 1982, BIOSCIENCE REP, V2, P203, DOI 10.1007/BF01136719; HICKMAN S, 1977, J BIOL CHEM, V252, P4402; HUANG ZY, 1992, J MED CHEM, V35, P2048, DOI 10.1021/jm00089a015; Hussain H, 2014, BIOTECHNOL LETT, V36, P1581, DOI 10.1007/s10529-014-1537-y; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kumar N, 2007, CYTOTECHNOLOGY, V53, P33, DOI 10.1007/s10616-007-9047-6; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; Mead EJ, 2009, BIOTECHNOL BIOENG, V102, P1593, DOI 10.1002/bit.22201; Novoradovskaya N, 1998, J CLIN INVEST, V101, P2693, DOI 10.1172/JCI549; Perez GT, 1998, CAN J PHYSIOL PHARM, V76, P1033, DOI 10.1139/cjpp-76-10-11-1033; PONTREMOLI S, 1986, J BIOL CHEM, V261, P8309; Shenkman M, 2007, CELL STRESS CHAPERON, V12, P373, DOI 10.1379/CSC-281.1; Shibata T, 2002, IMMUNOL CELL BIOL, V80, P226, DOI 10.1046/j.1440-1711.2002.01079.x; SHIELDS PP, 1991, BIOCHEM BIOPH RES CO, V177, P1006, DOI 10.1016/0006-291X(91)90638-N; So JS, 2015, MOL CELL BIOL, V35, P2761, DOI 10.1128/MCB.00215-15; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1033, DOI 10.1002/bit.21013; Vergara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093865; WALES RG, 1990, REPROD FERT DEVELOP, V2, P35, DOI 10.1071/RD9900035; Yoon SK, 2006, J BIOTECHNOL, V122, P463, DOI 10.1016/j.jbiotec.2005.09.010; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Yoon SK, 2003, BIOTECHNOL PROGR, V19, P1383, DOI 10.1021/bp034051m	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144224	10.1371/journal.pone.0144224	http://dx.doi.org/10.1371/journal.pone.0144224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659083	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600028
J	Wei, NL; Jia, YF; Wang, X; Zhang, YNA; Yuan, GQ; Zhao, BT; Wang, Y; Zhang, K; Zhang, XD; Pan, YW; Zhang, JG				Wei, Naili; Jia, Yanfei; Wang, Xiu; Zhang, Yinian; Yuan, Guoqiang; Zhao, Baotian; Wang, Yao; Zhang, Kai; Zhang, Xinding; Pan, Yawen; Zhang, Jianguo			Risk Factors for Postoperative Fibrinogen Deficiency after Surgical Removal of Intracranial Tumors	PLOS ONE			English	Article							COAGULATION; OBESITY; PLASMA; TRANSFUSION; BLOOD; PREGNANCY; INJURY; CELLS	Higher levels of fibrinogen, a critical element in hemostasis, are associated with increased postoperative survival rates, especially for patients with massive operative blood loss. Fibrinogen deficiency after surgical management of intracranial tumors may result in postoperative intracranial bleeding and severely worsen patient outcomes. However, no previous studies have systematically identified factors associated with postoperative fibrinogen deficiency. In this study, we retrospectively analyzed data from patients who underwent surgical removal of intracranial tumors in Beijing Tiantan Hospital date from 1/1/2013to12/31/2013. The present study found that patients with postoperative fibrinogen deficiency experienced more operative blood loss and a higher rate of postoperative intracranial hematoma, and they were given more blood transfusions, more plasma transfusions, and were administered larger doses of hemocoagulase compared with patients without postoperative fibrinogen deficiency. Likewise, patients with postoperative fibrinogen deficiency had poorer extended Glasgow Outcome Scale (GOSe), longer hospital stays, and greater hospital expenses than patients without postoperative fibrinogen deficiency. Further, we assessed a comprehensive set of risk factors associated with postoperative fibrinogen deficiency via multiple linear regression. We found that body mass index (BMI), the occurrence of postoperative intracranial hematoma, and administration of hemocoagulasewere positively associated with preoperative-to-postoperative plasma fibrinogen consumption; presenting with a malignant tumor was negatively associated with fibrinogen consumption. Contrary to what might be expected, intraoperative blood loss, the need for blood transfusion, and the need for plasma transfusion were not associated with plasma fibrinogen consumption. Considering our findings together, we concluded that postoperative fibrinogen deficiency is closely associated with postoperative bleeding and poor outcomes and merits careful attention. Practitioners should monitor plasma fibrinogen levels in patients with risk factors for postoperative fibrinogen deficiency. In addition, postoperative fibrinogen deficiency should be remediated as soon as possible to reduce postoperative bleeding, especially when postoperative bleeding is confirmed.	[Wei, Naili; Jia, Yanfei; Zhang, Yinian; Zhang, Xinding; Pan, Yawen] Lanzhou Univ, Dept Neurosurg, Hosp 2, Lanzhou 730030, Gansu, Peoples R China; [Wang, Xiu; Zhao, Baotian; Wang, Yao; Zhang, Kai; Zhang, Jianguo] Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Yuan, Guoqiang] Lanzhou Univ, Inst Neurol, Hosp 2, Lanzhou 730030, Gansu, Peoples R China	Lanzhou University; Capital Medical University; Lanzhou University	Zhang, K (corresponding author), Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Tiantanxili 6, Beijing 100050, Peoples R China.	zhangkai62035@163.com			Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding [ZYLX201305]	Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding	The present study was funded by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding (no. ZYLX201305).	Adelmann D, 2014, BRIT J ANAESTH, V113, P628, DOI 10.1093/bja/aeu133; Bell WR, 1997, DRUGS, V54, P18, DOI 10.2165/00003495-199700543-00005; Bilge YD, 2012, PEDIATR HEMAT ONCOL, V29, P721, DOI 10.3109/08880018.2012.729649; Erber WN, 2002, TRANSFUS APHER SCI, V27, P83, DOI 10.1016/S1473-0502(02)00029-0; Hellstern P, 2002, THROMB RES, V107, pS53, DOI 10.1016/S0049-3848(02)00153-6; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; HSIEH V, 1986, NEUROCHIRURGIE, V32, P404; Kolodziejczyk J, 2013, WSPOLCZESNA ONKOL, V17, P113, DOI 10.5114/wo.2013.34611; Lang T, 2009, ANESTH ANALG, V108, P751, DOI 10.1213/ane.0b013e3181966675; Levy JH, 2014, TRANSFUSION, V54, P1389, DOI 10.1111/trf.12431; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Lovely R, 2013, J PEDIATR-US, V163, P333, DOI 10.1016/j.jpeds.2013.01.004; Luostarinen T, 2012, J ANESTH, V26, P770, DOI 10.1007/s00540-012-1400-z; Martini WZ, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-2; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Neerman-Arbez M, 2007, HUM MUTAT, V28, P540, DOI 10.1002/humu.20483; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nielsen VG, 2014, ANESTH ANALG, V118, P919, DOI 10.1213/ANE.0000000000000048; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Seifman MA, 2011, NEUROSURG REV, V34, P393, DOI 10.1007/s10143-010-0304-3; Sharma S, 2013, INT J OBSTET ANESTH, V22, P113, DOI 10.1016/j.ijoa.2012.12.004; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Smrtka MP, 2012, THROMB RES, V129, P204, DOI 10.1016/j.thromres.2011.08.023; Sorensen B, 2011, THROMB RES, V128, pS13, DOI 10.1016/S0049-3848(12)70004-X; Vorster HH, 1999, THROMB RES, V95, P137, DOI 10.1016/S0049-3848(99)00033-X; Vu TT, 2013, J BIOL CHEM, V288, P16862, DOI 10.1074/jbc.M113.464750; Wang Zhaoyue, 2014, Zhonghua Xue Ye Xue Za Zhi, V35, P50, DOI 10.3760/cma.j.issn.0253-2727.2014.01.013; Weiss G, 2011, BLOOD COAGUL FIBRIN, V22, P727, DOI 10.1097/MBC.0b013e32834cb343; Yaddanapudi S, 2014, INDIAN J ANAESTH, V58, P538, DOI 10.4103/0019-5049.144648; Zhang L, 2011, CLIN APPL THROMB-HEM, V17, P75, DOI 10.1177/1076029609347903; Zhu JF, 2014, CHIN J CANCER, V33, DOI 10.5732/cjc.012.10307	32	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144551	10.1371/journal.pone.0144551	http://dx.doi.org/10.1371/journal.pone.0144551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658430	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600056
J	Rozov, SV; Porkka-Heiskanen, T; Panula, P				Rozov, Stanislav V.; Porkka-Heiskanen, Tarja; Panula, Pertti			On the Role of Histamine Receptors in the Regulation of Circadian Rhythms	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CLOCK GENE-EXPRESSION; LOCOMOTOR-ACTIVITY; BEHAVIORAL CHARACTERIZATION; HISTIDINE-DECARBOXYLASE; PORTACAVAL ANASTOMOSIS; H-3 RECEPTORS; PHASE-SHIFTS; BRAIN; NEURONS	Several lines of evidence suggest a regulatory role of histamine in circadian rhythms, but little is known about signaling pathways that would be involved in such a putative role. The aim of this study was to examine whether histamine mediates its effects on the circadian system through Hrh1 or Hrh3 receptors. We assessed both diurnal and free-running locomotor activity rhythms of Hrh1(-/-) and Hrh3(-/-) mice. We also determined the expression of Per1, Per2 and Bmal1 genes in the suprachiasmatic nuclei, several areas of the cerebral cortex and striatum under symmetric 24 h light-dark cycle at zeitgeber times 14 and 6 by using radioactive in situ hybridization. We found no differences between Hrh1(-/-) and wild type mice in the length, amplitude and mesor of diurnal and free-running activity rhythms as well as in expression of Per1, Per2 and Bmal1 genes in any of the examined brain structures. The amplitude of free-running activity rhythm of the Hrh3(-/-) mice was significantly flattened, whereas the expression of the clock genes in Hrh3(-/-) mice was similar to the wild type animals in all of the assessed brain structures. Therefore, the knockout of Hrh1 receptor had no effects on the circadian rhythm of spontaneous locomotion, and a knockout of Hrh3 receptor caused a substantial reduction of free-running activity rhythm amplitude, but none of these knockout models affected the expression patterns of the core clock genes in any of the studied brain structures.	[Rozov, Stanislav V.; Panula, Pertti] Univ Helsinki, Fac Med, Neurosci Ctr, Helsinki, Finland; [Rozov, Stanislav V.; Panula, Pertti] Univ Helsinki, Dept Anat, Fac Med, Helsinki, Finland; [Porkka-Heiskanen, Tarja] Univ Helsinki, Dept Physiol, Fac Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Panula, P (corresponding author), Univ Helsinki, Fac Med, Neurosci Ctr, Helsinki, Finland.	pertti.panula@helsinki.fi		Stenberg, Tarja/0000-0003-1843-7625; Rozov, Stanislav/0000-0002-0352-5502; Panula, Pertti/0000-0002-1189-5132	Suomen akatemia [253416]; Sigrid Juseliuksen saatio	Suomen akatemia(Academy of Finland); Sigrid Juseliuksen saatio	This work was funded by Suomen akatemia, 253416 (http://www.aka.fi/), and Sigrid Juseliuksen saatio (http://www.sigridjuselius.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, MOL BRAIN RES, V124, P178, DOI 10.1016/j.molbrainres.2004.02.015; Abe H, 2001, EUR J NEUROSCI, V14, P1121, DOI 10.1046/j.0953-816x.2001.01732.x; Abe H, 1998, NEUROSCI LETT, V258, P93, DOI 10.1016/S0304-3940(98)00877-5; [Anonymous], 2013, NLME LINEAR NONLINEA; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Blandina P, 1996, BRIT J PHARMACOL, V119, P1656, DOI 10.1111/j.1476-5381.1996.tb16086.x; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; EATON SJ, 1995, BRAIN RES, V695, P227, DOI 10.1016/0006-8993(95)00635-4; Eaton SJ, 1996, BRAIN RES BULL, V41, P227, DOI 10.1016/S0361-9230(96)00179-7; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; ITOWI N, 1989, NEUROENDOCRINOLOGY, V50, P187, DOI 10.1159/000125220; Karlstedt K, 2001, NEUROSCIENCE, V102, P201, DOI 10.1016/S0306-4522(00)00464-4; Kim YS, 2015, EUR J NEUROSCI, V42, P2467, DOI 10.1111/ejn.13030; LIOU SY, 1983, NEUROSCI LETT, V41, P109; Lozeva V, 2000, HEPATOLOGY, V31, P336, DOI 10.1002/hep.510310212; Lozeva V, 1998, J NEUROCHEM, V71, P1450; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Michelsen KA, 2005, EUR J NEUROSCI, V22, P1997, DOI 10.1111/j.1460-9568.2005.04387.x; MONTI JM, 1990, BRAIN RES BULL, V25, P229, DOI 10.1016/0361-9230(90)90065-8; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Rath MF, 2012, CHRONOBIOL INT, V29, P1289, DOI 10.3109/07420528.2012.728660; Saligrama N, 2013, J IMMUNOL, V191, P614, DOI 10.4049/jimmunol.1203137; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schlicker E, 1999, FUNDAM CLIN PHARM, V13, P120, DOI 10.1111/j.1472-8206.1999.tb00330.x; Schwartz JRL, 2008, CURR NEUROPHARMACOL, V6, P367, DOI 10.2174/157015908787386050; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STEHLE J, 1991, NEUROSCI LETT, V130, P217, DOI 10.1016/0304-3940(91)90400-N; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahashi K, 2002, J CLIN INVEST, V110, P1791, DOI 10.1172/JCI200215784; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; Wisor JP, 2008, J NEUROSCI, V28, P7193, DOI 10.1523/JNEUROSCI.1150-08.2008; Yamamoto Y, 1997, METHOD FIND EXP CLIN, V19, P289; Yanai K, 1998, NEUROSCIENCE, V87, P479, DOI 10.1016/S0306-4522(98)00167-5	46	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144694	10.1371/journal.pone.0144694	http://dx.doi.org/10.1371/journal.pone.0144694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26660098	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500056
J	Weng, MT; Tsao, PN; Lin, HL; Tung, CC; Change, MC; Chang, YT; Wong, JM; Wei, SC				Weng, M. T.; Tsao, P. N.; Lin, H. L.; Tung, C. C.; Change, M. C.; Chang, Y. T.; Wong, J. M.; Wei, S. C.			Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SELF-RENEWAL; NOTCH; EXPRESSION; STAT3; DIFFERENTIATION; ACTIVATION; GROWTH; PROLIFERATION; FLUOROURACIL	The Notch pathway contributes to self-renewal of tumor-initiating cell and inhibition of normal colonic epithelial cell differentiation. Deregulated expression of Notch1 and Jagged1 is observed in colorectal cancer. Hairy/enhancer of split (HES) family, the most characterized targets of Notch, involved in the development of many cancers. In this study, we explored the role of Hes1 in the tumorigenesis of colorectal cancer. Knocking down Hes1 induced CRC cell senescence and decreased the invasion ability, whereas over-expression of Hes1 increased STAT3 phosphorylation activity and up-regulated MMP14 protein level. We further explored the expression of Hes1 in human colorectal cancer and found high Hes1 mRNA expression is associated with poor prognosis in CRC patients. These findings suggest that Hes1 regulates the invasion ability through the STAT3-MMP14 pathway in CRC cells and high Hes1 expression is a predictor of poor prognosis of CRC.	[Weng, M. T.] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Weng, M. T.] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Taoyuan, Taiwan; [Weng, M. T.; Lin, H. L.; Change, M. C.; Chang, Y. T.; Wong, J. M.; Wei, S. C.] Natl Taiwan Univ Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan; [Tsao, P. N.] Natl Taiwan Univ Hosp & Coll Med, Dept Pediat, Taipei, Taiwan; [Tung, C. C.] Natl Taiwan Univ Hosp & Coll Med, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wei, SC (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan.	shuchenwei@ntu.edu.tw		TSAO, PO-NIEN/0000-0002-6114-1769; CHANG, YU-TING/0000-0002-5912-3406	Liver Disease Prevention & Treatment Research Foundation, Taiwan	Liver Disease Prevention & Treatment Research Foundation, Taiwan	This work was supported by Liver Disease Prevention & Treatment Research Foundation, Taiwan, to MTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JM, 2007, EUR J CANCER, V43, P1764, DOI 10.1016/j.ejca.2007.05.009; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Chu D, 2009, J GASTROINTEST SURG, V13, P253, DOI 10.1007/s11605-008-0689-2; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gao F, 2014, SCI REP-UK, V4, DOI 10.1038/srep03963; Gao J, 2011, PATHOL BIOL, V59, P298, DOI 10.1016/j.patbio.2010.11.001; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Giovannini C, 2012, AM J PATHOL, V181, P413, DOI 10.1016/j.ajpath.2012.04.019; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Katoh M, 2005, INT J MOL MED, V16, P493; Katoh M, 2007, INT J ONCOL, V31, P461; Kazanjian A, 2011, CURR COLORECT CANC R, V7, P121, DOI 10.1007/s11888-011-0090-5; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee JH, 2009, MOL CANCER RES, V7, P1663, DOI 10.1158/1541-7786.MCR-09-0191; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Libutti S, 2008, DEVITA HELLMAN ROSEN, V1, P1232; Liu J, 2010, INT J GYNECOL CANCER, V20, P1109, DOI 10.1111/IGC.0b013e3181ea74ad; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Radtke F, 2006, CURR MOL MED, V6, P275, DOI 10.2174/156652406776894527; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tsareva SA, 2007, NEOPLASIA, V9, P279, DOI 10.1593/neo.06820; Ueo T, 2012, DEVELOPMENT, V139, P1071, DOI 10.1242/dev.069070; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Veenendaal LM, 2008, CELL ONCOL, V30, P1; Wang XY, 2010, J CANCER RES CLIN, V136, P989, DOI 10.1007/s00432-009-0744-8; Wang ZP, 2013, CARCINOGENESIS, V34, P678, DOI 10.1093/carcin/bgs361; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Zhang Y, 2010, CANCER-AM CANCER SOC, V116, P5207, DOI 10.1002/cncr.25449; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611; Zhu L, 2012, MED ONCOL, V29, P1037, DOI 10.1007/s12032-011-9975-z; Zugowski C, 2011, BIOL CHEM, V392, P449, DOI 10.1515/BC.2011.038	50	33	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144322	10.1371/journal.pone.0144322	http://dx.doi.org/10.1371/journal.pone.0144322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650241	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300043
J	Sehrish, T; Symonds, VV; Soltis, DE; Soltis, PS; Tate, JA				Sehrish, Tina; Symonds, V. Vaughan; Soltis, Douglas E.; Soltis, Pamela S.; Tate, Jennifer A.			Cytonuclear Coordination Is Not Immediate upon Allopolyploid Formation in Tragopogon miscellus (Asteraceae) Allopolyploids	PLOS ONE			English	Article							RBCS MULTIGENE FAMILY; EXPRESSION LEVEL DOMINANCE; DUPLICATED GENES; SMALL-SUBUNIT; FUNCTIONAL DIVERGENCE; SYNTHETIC POLYPLOIDS; NATURAL-POPULATIONS; RECURRENT FORMATION; MIRUS ASTERACEAE; GENOME EVOLUTION	Allopolyploids, formed by hybridization and chromosome doubling, face the immediate challenge of having duplicated nuclear genomes that interact with the haploid and maternally inherited cytoplasmic (plastid and mitochondrial) genomes. Most of our knowledge of the genomic consequences of allopolyploidy has focused on the fate of the duplicated nuclear genes without regard to their potential interactions with cytoplasmic genomes. As a step toward understanding the fates of nuclear-encoded subunits that are plastid-targeted, here we examine the retention and expression of the gene encoding the small subunit of Ribulose-1, 5-bisphosphate carboxylase/oxygenase (Rubisco; rbcS) in multiple populations of allotetraploid Tragopogon miscellus (Asteraceae). These polyploids formed recently (similar to 80 years ago) and repeatedly from T. dubius and T. pratensis in the northwestern United States. Examination of 79 T. miscellus individuals from 10 natural populations, as well as 25 synthetic allotetraploids, including reciprocally formed plants, revealed a low percentage of naturally occurring individuals that show a bias in either gene (homeolog) loss (12%) or expression (16%), usually toward maintaining the maternal nuclear copy of rbcS. For individuals showing loss, seven retained the maternally derived rbcS homeolog only, while three had the paternally derived copy. All of the synthetic polyploid individuals examined (S-0 and S-1 generations) retained and expressed both parental homeologs. These results demonstrate that cytonuclear coordination does not happen immediately upon polyploid formation in Tragopogon miscellus.	[Sehrish, Tina; Symonds, V. Vaughan; Tate, Jennifer A.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Genet Inst, Gainesville, FL USA	Massey University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tate, JA (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	j.tate@massey.ac.nz	Soltis, Douglas/L-5957-2015	Sehrish, Tina/0000-0002-1007-4471; Tate, Jennifer A./0000-0001-5138-2115; Symonds, Vaughan/0000-0003-2533-6830	Higher Education Commission of Pakistan; Massey University Research Fund; Higher Education Commission (HEC) of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Massey University Research Fund; Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	A PhD scholarship to TS from the Higher Education Commission of Pakistan funded TS. Massey University Research Fund to JT funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Muhammad Faisal for assistance in predicting promoter and terminator elements, Afsana Islam for her guidance in genome walking experiments, and Prashant Joshi for technical assistance. This work was supported in part by a Massey University Research Fund grant to JT. The Higher Education Commission (HEC) of Pakistan is gratefully acknowledged for a Ph. D. scholarship to TS.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Barr CM, 2010, GENETICS, V184, P455, DOI 10.1534/genetics.109.108175; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Buggs RJA, 2012, AM J BOT, V99, P372, DOI 10.3732/ajb.1100395; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Buggs RJA, 2011, CURR BIOL, V21, P551, DOI 10.1016/j.cub.2011.02.016; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; DEAN C, 1989, ANNU REV PLANT PHYS, V40, P415, DOI 10.1146/annurev.pp.40.060189.002215; DEAN C, 1987, MOL GEN GENET, V206, P465, DOI 10.1007/BF00428887; Doyle J. J., 1987, PHYTOCHEM B, P11; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Feldman M., 2012, POLYPLOIDY GENOME EV, P109, DOI DOI 10.1007/978-3-642-31442-1_7; Fishman L, 2006, EVOLUTION, V60, P1372, DOI 10.1111/j.0014-3820.2006.tb01216.x; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gong L, 2014, MOL BIOL EVOL, V31, P2624, DOI 10.1093/molbev/msu207; Gong L, 2012, MOL BIOL EVOL, V29, P3023, DOI 10.1093/molbev/mss110; Goumenaki E, 2010, ENVIRON EXP BOT, V69, P259, DOI 10.1016/j.envexpbot.2010.04.011; GRANT V, 1956, ADV GENET, V8, P55, DOI 10.1016/S0065-2660(08)60499-X; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Hillis DM., 1996, MOL SYSTEMATICS, V2nd; Izumi M, 2012, J EXP BOT, V63, P2159, DOI 10.1093/jxb/err434; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kapralov MV, 2011, MOL BIOL EVOL, V28, P1491, DOI 10.1093/molbev/msq335; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Koh J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-97; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; Levin DA, 2003, SYST BOT, V28, P5; Li BH, 2004, GENOMICS, V83, P311, DOI 10.1016/j.ygeno.2003.08.005; Lim KY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003353; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Malinska H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-291; Matsushita SC, 2012, GENETICS, V191, P535, DOI 10.1534/genetics.112.139295; MIZIORKO HM, 1983, ANNU REV BIOCHEM, V52, P507, DOI 10.1146/annurev.bi.52.070183.002451; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; OEHLKERS F, 1964, ADV GENET, V12, P329, DOI 10.1016/S0065-2660(08)60418-6; OLMSTEAD RG, 1992, ANN MO BOT GARD, V79, P249, DOI 10.2307/2399768; Outchkourov NS, 2003, PLANTA, V216, P1003, DOI 10.1007/s00425-002-0953-8; OWNBEY M, 1953, AM J BOT, V40, P788, DOI 10.2307/2438276; OWNBEY M, 1950, AM J BOT, V37, P487, DOI 10.2307/2438023; Panero Jose L., 2003, Lundellia, P1; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; ROZEN S, 2002, BIOINFORMATICS METHO, P365; Sasanuma T, 2001, MOL GENET GENOMICS, V265, P161, DOI 10.1007/s004380000404; Sehrish T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-701; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Sloan DB, 2015, NEW PHYTOL, V205, P1040, DOI 10.1111/nph.12835; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P8089, DOI 10.1073/pnas.92.18.8089; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SOLTIS PS, 1991, SYST BOT, V16, P407, DOI 10.2307/2419333; SOLTIS PS, 1995, AM J BOT, V82, P1329, DOI 10.2307/2446255; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; Tate JA, 2009, AM J BOT, V96, P979, DOI 10.3732/ajb.0800299; Tate JA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-80; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; WAKSMAN G, 1987, NUCLEIC ACIDS RES, V15, P7181, DOI 10.1093/nar/15.17.7181; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wendel JF, 2012, POLYPLOIDY GENOME EV; Wolf JB, 2009, EVOLUTION, V63, P1364, DOI 10.1111/j.1558-5646.2009.00632.x; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Yang XH, 2011, PLANT CELL TISS ORG, V104, P387, DOI 10.1007/s11240-010-9826-1; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94	90	19	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144339	10.1371/journal.pone.0144339	http://dx.doi.org/10.1371/journal.pone.0144339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646761	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100020
J	Choi, J; Yoon, HI; Lee, J; Keum, KC; Kim, GE; Kim, YB				Choi, Jinhyun; Yoon, Hong In; Lee, Jeongshim; Keum, Ki Chang; Kim, Gwi Eon; Kim, Yong Bae			Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; FIELD IRRADIATION; STAGE-IB; CARCINOMA; SURVIVAL; CHEMORADIOTHERAPY; RADIOTHERAPY; TOMOGRAPHY	Purpose The purpose of this study was to determine optimal extent of prophylactic irradiation of paraaortic lymph nodes (PALN) in patients with uterine cervical cancer who had metastatic pelvic LNs. Methods and Materials We retrospectively evaluated 103 patients with cervical cancer and pelvic lymph nodemetastasis who were treated with prophylactic semi-extended field radiotherapy (SEFRT) between 1990 and 2012. The semi-extended field included PALN below the second lumbar spine with prescribed doses of 45 to 50 Gy. Survival outcomes were calculated using the Kaplan-Meier method, and acute and late toxicities were scored using the Radiation Therapy Oncology Group and European Organisation for Research and Treatment of Cancer toxicity criteria. Results The median follow-up after SEFRT was 61 (range 5-296) months. Overall, 28 patients (27.2%) experienced treatment failures, which were classified as local in 8 patients (7.8%), regional in 8 patients (7.8%), and distant in 13 patients (12.6%). Of the regional failures, only two involved PALN failure around the renal artery or the renal hilum area at the upper margin of the semi-extended field. At 5 years, the overall survival was 82%. Grade 3 or higher acute gastrointestinal and genitourinary toxicities occurred in one and two patients, respectively. As a late toxicity, one patient developed grade 3 small bowel obstruction. Conclusion Prophylactic SEFRT provided favorable outcomes with little acute or late gastrointestinal toxicity. For prophylaxis of PALN recurrences, upper part of PALN might not need to be included in patients with uterine cervical cancer and metastatic pelvic LNs.	[Choi, Jinhyun; Yoon, Hong In; Lee, Jeongshim; Keum, Ki Chang; Kim, Gwi Eon; Kim, Yong Bae] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Yoon, Hong In] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Dept Pharmacol, Seoul, South Korea; [Kim, Gwi Eon] Jeju Natl Univ, Sch Med, Dept Radiat Oncol, Jeju, South Korea; [Kim, Yong Bae] Yonsei Univ, Coll Med, Yonsei Song Dang Inst Canc Res, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Jeju National University; Yonsei University; Yonsei University Health System	Kim, YB (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea.	ybkim3@yuhs.ac		Keum, Ki Chang/0000-0003-4123-7998; Yoon, Hong In/0000-0002-2106-6856; Kim, Yong Bae/0000-0001-7573-6862				Al Asiri M, 2014, CANCER MANAG RES, V6, P339, DOI 10.2147/CMAR.S68262; Atahan IL, 2007, INT J GYNECOL CANCER, V17, P833, DOI 10.1111/j.1525-1438.2007.00895.x; Beadle BM, 2010, INT J RADIAT ONCOL, V76, P1396, DOI 10.1016/j.ijrobp.2009.04.009; BERMAN ML, 1984, GYNECOL ONCOL, V19, P8, DOI 10.1016/0090-8258(84)90151-3; Choi HJ, 2006, CANCER-AM CANCER SOC, V106, P914, DOI 10.1002/cncr.21641; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; DELGADO G, 1989, GYNECOL ONCOL, V35, P314, DOI 10.1016/0090-8258(89)90070-X; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; EIFEL PJ, 1994, INT J RADIAT ONCOL, V29, P9, DOI 10.1016/0360-3016(94)90220-8; Follen M, 2003, CANCER, V98, P2028, DOI 10.1002/cncr.11679; Goff BA, 1999, GYNECOL ONCOL, V74, P436, DOI 10.1006/gyno.1999.5472; Grigsby PW, 2001, J CLIN ONCOL, V19, P3745, DOI 10.1200/JCO.2001.19.17.3745; Kuku S, 2013, BRIT J CANCER, V109, P1504, DOI 10.1038/bjc.2013.491; Liang JA, 2008, CLIN ONCOL-UK, V20, P683, DOI 10.1016/j.clon.2008.06.007; Liang JA, 2014, INT J GYNECOL CANCER, V24, P901, DOI 10.1097/IGC.0b013e31829f4dc5; Ouldamer L, 2012, ACTA OBSTET GYN SCAN, V91, P893, DOI 10.1111/j.1600-0412.2012.01443.x; Park SG, 2014, CANCER RES TREAT, V46, P374, DOI 10.4143/crt.2013.084; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Pinto PS, 2004, RADIOGRAPHICS, V24, P809, DOI 10.1148/rg.243035086; ROSENBERGER A, 1971, AMER J ROENTGENOL RA, V111, P807, DOI 10.2214/ajr.111.4.807; ROTMAN M, 1995, JAMA-J AM MED ASSOC, V274, P387, DOI 10.1001/jama.274.5.387; SPECTOR JG, 1991, OTOLARYNG HEAD NECK, V104, P58, DOI 10.1177/019459989110400112; STEHMAN FB, 1991, CANCER, V67, P2776, DOI 10.1002/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L; Stryker JA, 2000, GYNECOL ONCOL, V79, P399, DOI 10.1006/gyno.2000.5977; Vale CL, 2010, CLIN ONCOL-UK, V22, P590, DOI 10.1016/j.clon.2010.06.002	25	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145158	10.1371/journal.pone.0145158	http://dx.doi.org/10.1371/journal.pone.0145158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659867	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900188
J	Dong, ZQ; Hu, N; Zhang, J; Chen, TT; Cao, MY; Li, HQ; Lei, XJ; Chen, P; Lu, C; Pan, MH				Dong, Zhan-Qi; Hu, Nan; Zhang, Jun; Chen, Ting-Ting; Cao, Ming-Ya; Li, Hai-Qing; Lei, Xue-Jiao; Chen, Peng; Lu, Cheng; Pan, Min-Hui			Oligomerization of Baculovirus LEF-11 Is Involved in Viral DNA Replication	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; BINDING; EXPRESSION; GENE; IDENTIFICATION; LOCALIZATION; PROMOTER; IE1; ACTIVATION; SILKWORM	We have previously reported that baculovirus Bombyx mori nucleopolyhedrovirus (BmNPV) late expression factor 11 (lef-11) is associated with viral DNA replication and have demonstrated that it potentially interacts with itself; however, whether LEF-11 forms oligomers and the impact of LEF-11 oligomerization on viral function have not been substantiated. In this study, we first demonstrated that LEF-11 is capable of forming oligomers. Additionally, a series of analyses using BmNPV LEF-11 truncation mutants indicated that two distinct domains control LEF-11 oligomerization (aa 42-61 and aa 72-101). LEF-11 truncation constructs were inserted into a lef-11-knockout BmNPV bacmid, which was used to demonstrate that truncated LEF-11 lacking either oligomerization domain abrogates viral DNA replication. Finally, site-directed mutagenesis was used to determine that the conserved hydrophobic residues Y58&I59 (representing Y58 and I59), I85 and L88&L89 (representing L88 and L89) are required for LEF-11 oligomerization and viral DNA replication. Collectively, these data indicate that BmNPV LEF-11 oligomerization influences viral DNA replication.	[Dong, Zhan-Qi; Hu, Nan; Zhang, Jun; Chen, Ting-Ting; Cao, Ming-Ya; Li, Hai-Qing; Lei, Xue-Jiao; Chen, Peng; Lu, Cheng; Pan, Min-Hui] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Lu, Cheng; Pan, Min-Hui] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China; [Zhang, Jun] Chongqing Med Univ, Inst Life Sci, Chongqing 400716, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China; Chongqing Medical University	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	lucheng@swu.edu.cn; pmh0476@hotmail.com	Zhang, Jun/AGZ-7722-2022	Dong, Zhanqi/0000-0002-0607-4241	National High-Tech R&D Program of China [2013AA102507]; National Natural Science Foundation of China [31172269, 31272505, 31472152]; China Agriculture Research System [CARS-22]; Fundamental Research Funds for the Central Universities [XDJK2015D002]	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National High-Tech R&D Program of China (No. 2013AA102507), the National Natural Science Foundation of China (Nos. 31172269, 31272505 and 31472152), the China Agriculture Research System (CARS-22) and Fundamental Research Funds for the Central Universities (XDJK2015D002).	Carstens EB, 2002, VIRUS RES, V83, P13, DOI 10.1016/S0168-1702(01)00401-4; Chen T, 2004, J VIROL, V78, P329, DOI 10.1128/JVI.78.1.329-339.2004; Dong ZQ, 2014, VIRUS RES, V184, P62, DOI 10.1016/j.virusres.2014.02.009; Downie K, 2013, J GEN VIROL, V94, P2530, DOI 10.1099/vir.0.056267-0; Evans JT, 1997, J VIROL, V71, P3114, DOI 10.1128/JVI.71.4.3114-3119.1997; Hashem GM, 1999, NUCLEIC ACIDS RES, V27, P3371, DOI 10.1093/nar/27.16.3371; Hefferon KL, 2003, CAN J MICROBIOL, V49, P157, DOI [10.1139/w03-022, 10.1139/W03-022]; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Kremer A, 1998, VIROLOGY, V249, P336, DOI 10.1006/viro.1998.9288; Lin GY, 2002, J VIROL, V76, P2770, DOI 10.1128/JVI.76.6.2770-2779.2002; Lin GY, 2001, J GEN VIROL, V82, P2289, DOI 10.1099/0022-1317-82-9-2289; Liu G, 1999, VIROLOGY, V253, P125, DOI 10.1006/viro.1998.9485; Mikhailov VS, 2006, VIROLOGY, V346, P469, DOI 10.1016/j.virol.2005.11.027; Mikhailov VS, 2005, J BIOL CHEM, V280, P29444, DOI 10.1074/jbc.M503235200; Mikhailov VS, 2000, VIROLOGY, V270, P180, DOI 10.1006/viro.2000.0270; Mikhailov VS, 2002, J VIROL, V76, P2287, DOI 10.1128/JVI.76.5.2287-2297.2002; Mikhailov VS, 1998, DOKL AKAD NAUK+, V361, P405; Mikhallov VS, 2008, VIROLOGY, V370, P415, DOI 10.1016/j.virol.2007.09.001; MORR J, 1995, FEBS LETT, V368, P495, DOI 10.1016/0014-5793(95)00721-K; Muchova K, 2002, ACTA CRYSTALLOGR D, V58, P1542, DOI 10.1107/S0907444902014336; Okano K, 1999, J VIROL, V73, P110, DOI 10.1128/JVI.73.1.110-119.1999; Olson VA, 2002, J VIROL, V76, P9505, DOI 10.1128/JVI.76.18.9505-9515.2002; Olson VA, 2001, J VIROL, V75, P6042, DOI 10.1128/JVI.75.13.6042-6051.2001; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Pathakamuri JA, 2002, J VIROL, V76, P5598, DOI 10.1128/JVI.76.11.5598-5604.2002; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; Vanarsdall AL, 2005, VIROLOGY, V331, P175, DOI 10.1016/j.virol.2004.10.024; WANG HGH, 1991, J VIROL METHODS, V31, P113, DOI 10.1016/0166-0934(91)90149-T; Wu YT, 1999, J VIROL, V73, P5473, DOI 10.1128/JVI.73.7.5473-5480.1999; Zhang J, 2014, VIRUS RES, V184, P111, DOI 10.1016/j.virusres.2014.02.020; Zhang J, 2014, ANTIVIR RES, V104, P143, DOI 10.1016/j.antiviral.2014.01.017	31	17	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144930	10.1371/journal.pone.0144930	http://dx.doi.org/10.1371/journal.pone.0144930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660313	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900152
J	Hamilton, ML; Warwick, J; Terry, A; Allen, MJ; Napier, JA; Sayanova, O				Hamilton, Mary L.; Warwick, Joanna; Terry, Anya; Allen, Michael J.; Napier, Johnathan A.; Sayanova, Olga			Towards the Industrial Production of Omega-3 Long Chain Polyunsaturated Fatty Acids from a Genetically Modified Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							EICOSAPENTAENOIC ACID; CONTINUOUS-CULTURE; FISH-OIL; MICROALGAE; ACCUMULATION; GROWTH; NITROGEN; BIOMASS; RICH; OMEGA-3-FATTY-ACIDS	The marine diatom Phaeodactylum tricornutum can accumulate up to 30% of the omega-3 long chain polyunsaturated fatty acid (LC-PUFA) eicosapentaenoic acid (EPA) and, as such, is considered a good source for the industrial production of EPA. However, P. tricornutum does not naturally accumulate significant levels of the more valuable omega-3 LC-PUFA docosahexaenoic acid (DHA). Previously, we have engineered P. tricornutum to accumulate elevated levels of DHA and docosapentaenoic acid (DPA) by overexpressing heterologous genes encoding enzyme activities of the LC-PUFA biosynthetic pathway. Here, the transgenic strain Pt_Elo5 has been investigated for the scalable production of EPA and DHA. Studies have been performed at the laboratory scale on the cultures growing in up to 1 L flasks a 3.5 L bubble column, a 550 L closed photobioreactor and a 1250 L raceway pond with artificial illumination. Detailed studies were carried out on the effect of different media, carbon sources and illumination on omega-3 LC-PUFAs production by transgenic strain Pt_Elo5 and wild type P. tricornutum grown in 3.5 L bubble columns. The highest content of DHA (7.5% of total fatty acids, TFA) in transgenic strain was achieved in cultures grown in seawater salts, Instant Ocean (IO), supplemented with F/2 nutrients (F2N) under continuous light. After identifying the optimal conditions for omega-3 LC-PUFA accumulation in the small-scale experiments we compared EPA and DHA levels of the transgenic strain grown in a larger fence-style tubular photobioreactor and a raceway pond. We observed a significant production of DHA over EPA, generating an EPA/DPA/DHA profile of 8.7%/4.5%/12.3% of TFA in cells grown in a photobioreactor, equivalent to 6.4 mu g/mg dry weight DHA in a mid-exponentially growing algal culture. Omega-3 LC-PUFAs production in a raceway pond at ambient temperature but supplemented with artificial illumination (110 mu mol photons m(-2)s(-1)) on a 16:8h light: dark cycle, in natural seawater and F/2 nutrients was 24.8% EPA and 10.3% DHA. Transgenic strain grown in RP produced the highest levels of EPA (12.8%) incorporated in neutral lipids. However, the highest partitioning of DHA in neutral lipids was observed in cultures grown in PBR (7.1%). Our results clearly demonstrate the potential for the development of the transgenic Pt_Elo5 as a platform for the commercial production of EPA and DHA.	[Hamilton, Mary L.; Napier, Johnathan A.; Sayanova, Olga] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England; [Warwick, Joanna; Terry, Anya; Allen, Michael J.] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Plymouth Marine Laboratory	Sayanova, O (corresponding author), Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England.	olga.sayanova@rothamsted.ac.uk	Allen, Michael J/C-1248-2011	Allen, Michael J/0000-0001-8504-7171; Napier, Johnathan/0000-0003-3580-3607	Biotechnology and Biological Sciences Research Council (BBSRC), UK; EC-FP7 KBBE, GIAVAP consortium [266401]; Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01); Natural Environment Research Council (NERC); BBSRC [BBS/E/C/00005207, BB/L002957/1] Funding Source: UKRI; NERC [pml010007] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207, BB/L002957/1] Funding Source: researchfish; Natural Environment Research Council [pml010007] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC-FP7 KBBE, GIAVAP consortium; Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC), UK. Plymouth Marine Laboratory receives grant-aided support from the Natural Environment Research Council (NERC). This project was partially funded by EC-FP7 KBBE, as part of the GIAVAP consortium (project ID 266401) and by Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC), UK. Plymouth Marine Laboratory receives grant-aided support from the Natural Environment Research Council (NERC). This project was partially funded by EC-FP7 KBBE, as part of the GIAVAP consortium (project ID 266401) and by Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01).	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Alonso DL, 1998, PHYTOCHEMISTRY, V47, P1473, DOI 10.1016/S0031-9422(97)01080-7; Alonso DL, 2000, PHYTOCHEMISTRY, V54, P461, DOI 10.1016/S0031-9422(00)00084-4; ARAO T, 1987, PHYTOCHEMISTRY, V26, P2573, DOI 10.1016/S0031-9422(00)83880-7; Armenta RE, 2013, J AM OIL CHEM SOC, V90, P167, DOI 10.1007/s11746-012-2154-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cartens M, 1996, J AM OIL CHEM SOC, V73, P1025, DOI 10.1007/BF02523411; Ceron Garcia MC, 2000, J APPL PHYCOL, V12, P239; Chauton MS, 2015, AQUACULTURE, V436, P95, DOI 10.1016/j.aquaculture.2014.10.038; De Riso V, 2009, NUCLEIC ACIDS RES, V37, P1; Draaisma RB, 2013, CURR OPIN BIOTECH, V24, P169, DOI 10.1016/j.copbio.2012.09.012; Garces M, 1993, ANAL BIOCHEM, V211, P139; Garcia MCC, 2005, PROCESS BIOCHEM, V40, P297, DOI 10.1016/j.procbio.2004.01.016; Gardner RD, 2012, J APPL PHYCOL, V24, P1311, DOI 10.1007/s10811-011-9782-0; Grima EM, 1996, J APPL PHYCOL, V8, P359, DOI 10.1007/BF02178579; GRIMA EM, 1994, BIOTECHNOL APPL BIOC, V20, P279; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Koller M, 2014, ALGAL RES, V6, P52, DOI 10.1016/j.algal.2014.09.002; Liang Y, 2006, J PHOTOCH PHOTOBIO B, V82, P161, DOI 10.1016/j.jphotobiol.2005.11.002; Mus F, 2013, APPL MICROBIOL BIOT, V97, P3625, DOI 10.1007/s00253-013-4747-7; Reis A, 1996, BIORESOURCE TECHNOL, V55, P83, DOI 10.1016/0960-8524(95)00157-3; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Ryckebosch E, 2014, FOOD CHEM, V160, P393, DOI 10.1016/j.foodchem.2014.03.087; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Benavides AMS, 2013, BIOMASS BIOENERG, V54, P115, DOI 10.1016/j.biombioe.2013.03.016; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; Wen ZY, 2003, BIOTECHNOL ADV, V21, P273, DOI 10.1016/S0734-9750(03)00051-X; YONGMANITCHAI W, 1991, APPL ENVIRON MICROB, V57, P419, DOI 10.1128/AEM.57.2.419-425.1991; YONGMANITCHAI W, 1992, J AM OIL CHEM SOC, V69, P584, DOI 10.1007/BF02636113	31	71	72	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144054	10.1371/journal.pone.0144054	http://dx.doi.org/10.1371/journal.pone.0144054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658738	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000366715900024
J	Makadzange, AT; Higgins-Biddle, M; Chimukangara, B; Birri, R; Gordon, M; Mahlanza, T; McHugh, G; van Dijk, JH; Bwakura-Dangarembizi, M; Ndung'u, T; Masimirembwa, C; Phelps, B; Amzel, A; Ojikutu, BO; Walker, BD; Ndhlovu, CE				Makadzange, A. T.; Higgins-Biddle, M.; Chimukangara, B.; Birri, R.; Gordon, M.; Mahlanza, T.; McHugh, G.; van Dijk, J. H.; Bwakura-Dangarembizi, M.; Ndung'u, T.; Masimirembwa, C.; Phelps, B.; Amzel, A.; Ojikutu, B. O.; Walker, B. D.; Ndhlovu, C. E.			Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE-INCOME COUNTRIES; SUB-SAHARAN AFRICA; INFECTED CHILDREN; REVERSE-TRANSCRIPTASE; HIV-1-INFECTED CHILDREN; CD4; CHALLENGES; ADHERENCE; RESPONSES	Objective To determine immunologic, virologic outcomes and drug resistance among children and adolescents receiving care during routine programmatic implementation in a low-income country. Methods A cross-sectional evaluation with collection of clinical and laboratory data for children (0-<10 years) and adolescents (10-19 years) attending a public ART program in Harare providing care for pediatric patients since 2004, was conducted. Longitudinal data for each participant was obtained from the clinic based medical record. Results Data from 599 children and adolescents was evaluated. The participants presented to care with low CD4 cell count and CD4%, median baseline CD4% was lower in adolescents compared with children (11.0% vs. 15.0%, p<0.0001). The median age at ART initiation was 8.0 years (IQR 3.0, 12.0); median time on ART was 2.9 years (IQR 1.7, 4.5). On ART, median CD4% improved for all age groups but remained below 25%. Older age (>= 5 years) at ART initiation was associated with severe stunting (HAZ <-2: 53.3% vs. 28.4%, p<0.0001). Virologic failure rate was 30.6% and associated with age at ART initiation. In children, nevira-pine based ART regimen was associated with a 3-fold increased risk of failure (AOR: 3.5; 95% CI: 1.3, 9.1, p = 0.0180). Children (<10y) on ART for >= 4 years had higher failure rates than those on ART for < 4 years (39.6% vs. 23.9%, p = 0.0239). In those initiating ART as adolescents, each additional year in age above 10 years at the time of ART initiation (AOR 0.4 95% CI: 0.1, 0.9, p = 0.0324), and each additional year on ART ( AOR 0.4, 95% CI 0.2, 0.9, p = 0.0379) were associated with decreased risk of virologic failure. Drug resistance was evident in 67.6% of sequenced virus isolates. Conclusions During routine programmatic implementation of HIV care for children and adolescents, delayed age at ART initiation has long-term implications on immunologic recovery, growth and virologic outcomes.	[Makadzange, A. T.; Walker, B. D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Higgins-Biddle, M.; Ojikutu, B. O.] John Snow Inc, Boston, MA USA; [Makadzange, A. T.; Chimukangara, B.; Birri, R.; Mahlanza, T.; McHugh, G.; van Dijk, J. H.; Ndhlovu, C. E.] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe; [Bwakura-Dangarembizi, M.] Univ Zimbabwe, Dept Pediat, Coll Hlth Sci, Harare, Zimbabwe; [Gordon, M.; Ndung'u, T.] Univ KwaZulu Natal, HIV Pathogenesis Program, Durban, South Africa; [Chimukangara, B.; Masimirembwa, C.] African Inst Biomed Sci, Harare, Zimbabwe; [Phelps, B.; Amzel, A.] US Agcy Int Dev, Washington, DC 20523 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Zimbabwe; University of Zimbabwe; University of Kwazulu Natal; United States Agency for International Development (USAID)	Makadzange, AT (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	amakadzange@mgh.harvard.edu	Chimukangara, Ben/AAD-6669-2019; Ndhlovu, Chiratidzo Ellen/N-8763-2013; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Chimukangara, Ben/0000-0002-8391-4531; Ndhlovu, Chiratidzo Ellen/0000-0001-7863-7974; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177; Masimirembwa, Collen/0000-0002-4053-212X; Ndung'u, Thumbi/0000-0003-2962-3992; Gordon, Michelle/0000-0001-9945-1394; Ojikutu, Bisola/0000-0001-7957-8881; Makadzange, Azure Tariro/0000-0001-5330-1470	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development [GHH-I-00-07-00059-00]; USAID; USAID through JSI; University of Zimbabwe College of Health Sciences	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID(United States Agency for International Development (USAID)); USAID through JSI(United States Agency for International Development (USAID)); University of Zimbabwe College of Health Sciences	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development under the terms of contract no. GHH-I-00-07-00059-00, with the contractor as John Snow Inc. The University of Zimbabwe College of Health Sciences was a sub-grantee with Professor Chiratidzo Ndhlovu as the Principal Investigator. USAID funding supported salaries for research personnel, consultant fees, reagents and supplies for the conduct of the proposed study. John Snow Inc. employees who were involved in the study were Molly Higgins-Biddle and Bisola Ojikutu. Molly Higgins-Biddle provided statistical support for the study during the period of data analysis. Dr. Bisola Ojikutu was the Senior Technical Advisor for JSI. Molly Higgins-Biddle was involved in the data analysis, and both were involved with the review of the manuscript. USAID employees Benjamin Phelps and Anouk Amzel provided technical support to the granting agency but were not involved in the study design, data collection, analysis, decision to publish or preparation of the manuscript. In summary the funder (USAID) provided support in the form of salaries through JSI for some of the authors (MH-B and BO), consultant fees (ATM) and University of Zimbabwe research staff. The funder did not have any additional role in study design, data collection or the decision to publish. The specific roles of the authors are articulated in the 'author contributions' section.	Adetokunboh O, 2015, J INFECT PUBLIC HLTH; Avila C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-673; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Chohan BH, 2015, AIDS RES HUM RETROVI; Davies MA, 2012, TROP MED INT HEALTH, V17, P1386, DOI 10.1111/j.1365-3156.2012.03073.x; Derache A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117430; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Emmett SD, 2010, JAIDS-J ACQ IMM DEF, V54, P368, DOI 10.1097/QAI.0b013e3181cf4882; Fitzgerald F, 2013, J INFECT DIS, V207, pS85, DOI 10.1093/infdis/jit115; Foundation KF, 2012, FIN RESP AIDS LOW MI; Galarraga O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067565; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Hazra R, 2010, ANNU REV MED, V61, P169, DOI 10.1146/annurev.med.050108.151127; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kantor R, 2002, AIDS RES HUM RETROV, V18, P1407, DOI 10.1089/088922202320935483; Kekitiinwa A, 2013, LANCET, V381, P1391, DOI [10.1016/S0140-6736(12)62198-9, DOI 10.1016/S0140-6736(12)62198-9]; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Lapadula G, 2013, AIDS, V27, P769, DOI 10.1097/QAD.0b013e32835cb747; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; Lowe S, 2010, PEDIATR INFECT DIS J, V29, P346, DOI 10.1097/INF.0b013e3181c15da4; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Meyers TM, 2011, PEDIATR INFECT DIS J, V30, P974, DOI 10.1097/INF.0b013e31822539f6; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Mutwa PR, 2014, PEDIATR INFECT DIS J, V33, P63, DOI 10.1097/INF.0b013e31829e6b9f; Palmisano L, 2009, HIV MED, V10, P477, DOI 10.1111/j.1468-1293.2009.00715.x; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Persaud D, 2007, J INFECT DIS, V195, P1402, DOI 10.1086/513871; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Skovdal M, 2011, AIDS CARE, V23, P957, DOI 10.1080/09540121.2010.542298; Soh CH, 2003, LANCET, V362, P2045, DOI 10.1016/S0140-6736(03)15098-2; Sohn AH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18555; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-54; UNAIDS, 2013, UNAIDSJC25021E; UNAIDS, 2014, 90 90 90 AMB TREATM; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; Van Dyke RB, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e61; WHO, 2013, GLOB UPD HIV TREATM; WHO, 2006, CONS GUID US ANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2010, ANT THER HIV INF INF; Zanoni BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049591	45	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144057	10.1371/journal.pone.0144057	http://dx.doi.org/10.1371/journal.pone.0144057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658814	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900025
J	Rashedi, E; Nussbaum, MA				Rashedi, Ehsan; Nussbaum, Maury A.			Mathematical Models of Localized Muscle Fatigue: Sensitivity Analysis and Assessment of Two Occupationally-Relevant Models	PLOS ONE			English	Article							BLOOD-FLOW; VOLUNTARY CONTRACTIONS; RECOVERY; EXERCISE; FAILURE; TIME	Muscle fatigue models (MFM) have broad potential application if they can accurately predict muscle capacity and/or endurance time during the execution of diverse tasks. As an initial step toward facilitating improved MFMs, we assessed the sensitivity of selected existing models to their inherent parameters, specifically that model the fatigue and recovery processes, and the accuracy of model predictions. These evaluations were completed for both prolonged and intermittent isometric contractions, and were based on model predictions of endurance times. Based on a recent review of the literature, four MFMs were initially chosen, from which a preliminary assessment led to two of these being considered for more comprehensive evaluation. Both models had a higher sensitivity to their fatigue parameter. Predictions of both models were also more sensitive to the alteration of their parameters in conditions involving lower to moderate levels of effort, though such conditions may be of most practical, contemporary interest or relevance. Although both models yielded accurate predictions of endurance times during prolonged contractions, their predictive ability was inferior for more complex ( intermittent) conditions. When optimizing model parameters for different loading conditions, the recovery parameter showed considerably larger variability, which might be related to the inability of these MFMs in simulating the recovery process under different loading conditions. It is argued that such models may benefit in future work from improving their representation of recovery process, particularly how this process differs across loading conditions.	[Rashedi, Ehsan; Nussbaum, Maury A.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA; [Nussbaum, Maury A.] Virginia Tech, Dept Biomed Engn & Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nussbaum, MA (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	nussbaum@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431				Bentley TA, 2001, APPL ERGON, V32, P127, DOI 10.1016/S0003-6870(00)00048-X; BiglandRitchie B, 1995, ADV EXP MED BIOL, V384, P361; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Chaffin D., 2006, OCCUPATIONAL BIOMECH, V2nd; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Frey-Law LA, 2012, J BIOMECH, V45, P1803, DOI 10.1016/j.jbiomech.2012.04.018; FUJIMOTO T, 1993, J SPORT MED PHYS FIT, V33, P107; FULCO CS, 1994, J APPL PHYSIOL, V77, P179, DOI 10.1152/jappl.1994.77.1.179; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hsiao H, 2001, ERGONOMICS, V44, P537, DOI 10.1080/00140130110034480; Hunter SK, 2009, MUSCLE NERVE, V39, P42, DOI 10.1002/mus.21203; James A, 2012, J APPL PHYSIOL, V113, P1643, DOI 10.1152/japplphysiol.00800.2012; Law LAF, 2010, ERGONOMICS, V53, P109, DOI 10.1080/00140130903389068; Looft JM, 2014, ADAPTATION AND VALID; Ma LA, 2011, INT J IND ERGONOM, V41, P10, DOI 10.1016/j.ergon.2010.11.005; Ma L, 2009, INT J IND ERGONOM, V39, P211, DOI 10.1016/j.ergon.2008.04.004; Pitcher JB, 1997, CLIN EXP PHARMACOL P, V24, P471, DOI 10.1111/j.1440-1681.1997.tb01229.x; Rashedi E, 2015, INT J HUMAN FACTORS, V5, P61, DOI DOI 10.1504/IJHFMS.2015.068119; Rashedi E, 2014, ERGONOMICS, V57, P1864, DOI 10.1080/00140139.2014.952682; Rempel D, 2010, J OCCUP ENVIRON HYG, V7, P194, DOI 10.1080/15459620903558491; Rowell L, 1993, HUMAN CARDIOVASCULAR; Sih B, 2012, INT J SPORTS MED, V33, P258, DOI 10.1055/s-0031-1297958; Sonne MW, 2016, ERGONOMICS, V59, P85, DOI 10.1080/00140139.2015.1051597; Sparto PJ, 1997, J ORTHOP SPORT PHYS, V25, P3, DOI 10.2519/jospt.1997.25.1.3; Vedsted P, 2006, EUR J APPL PHYSIOL, V96, P165, DOI 10.1007/s00421-004-1216-0; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Xia T, 2014, ADVANCES IN PHYSICAL, V15, P231; Xia T, 2008, J BIOMECH, V41, P3046, DOI 10.1016/j.jbiomech.2008.07.013; Zhang Q, 2004, ACTA PHYSIOL SCAND, V180, P57, DOI 10.1046/j.0001-6772.2003.01215.x	30	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143872	10.1371/journal.pone.0143872	http://dx.doi.org/10.1371/journal.pone.0143872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656741	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900020
J	Sigurdsson, S; Forsberg, L; Aspelund, T; van der Geest, RJ; van Buchem, MA; Launer, LJ; Gudnason, V; van Osch, MJ				Sigurdsson, Sigurdur; Forsberg, Lars; Aspelund, Thor; van der Geest, Rob J.; van Buchem, Mark A.; Launer, Lenore J.; Gudnason, Vilmundur; van Osch, Matthias J.			Feasibility of Using Pseudo-Continuous Arterial Spin Labeling Perfusion in a Geriatric Population at 1.5 Tesla	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ELDERLY SUBJECTS; 3.0 T; REPRODUCIBILITY; MRI; RELIABILITY; BRAIN; AGE; LOCALIZATION; RISK	Objectives To evaluate the feasibility of using pseudo-continuous arterial spin labeling (pCASL) perfusion in a geriatric population at 1.5-Tesla. Materials and Methods In 17 participants (mean age 78.8 +/- 1.63 years) we assessed; 1) inter-session repeatability and reliability of resting state perfusion in 27 brain regions; 2) brain activation using finger-tapping as a means to evaluate the ability to detect flow differences; 3) reliability by comparing cerebral blood flow (CBF) with pCASL to CBF with phase contrast (PC-MR). Results The CBF (mean +/- standard deviation (SD)) for the whole brain grey matter (GM) was 40.6 +/- 8.4 and 41.4 +/- 8.7 ml/100g/min for the first and second scan respectively. The within-subject standard deviation (SDw), the repeatability index (RI) and intra-class correlation coefficient (ICC) across the 27 regions ranged from 1.1 to 7.9, 2.2 to 15.5 and 0.35 to 0.98 respectively. For whole brain GM the SDw, RI and ICC were 1.6, 3.2 and 0.96 respectively. The between-subject standard deviation (SDB) was larger than the SDw for all regions. Comparison of CBF at rest and activation on a voxel level showed significantly higher perfusion during finger tapping in the motor-and somatosensory regions. The mean CBF for whole brain GM was 40.6 +/- 8.4 ml/100g/min at rest and 42.6 +/- 8.6 ml/100g/min during activation. Finally the reliability of pCASL against the reference standard of PC-MR was high (ICC = 0.80). The mean CBF for whole brain measured with PC-MRI was 54.3 +/- 10.1 ml/100g/min and 38.3 +/- 7.8 ml/100g/min with pCASL. Conclusions The results demonstrate moderate to high levels of repeatability and reliability for most brain regions, comparable to what has been reported for younger populations. The performance of pCASL at 1.5-Tesla shows that region-specific perfusion measurements with this technique are feasible in studies of a geriatric population.	[Sigurdsson, Sigurdur; Aspelund, Thor; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Forsberg, Lars; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [van der Geest, Rob J.; van Buchem, Mark A.; van Osch, Matthias J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA	Icelandic Heart Association; University of Iceland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sigurdsson, S (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.	sigurdur@hjarta.is	Van Osch, Matthias/AAV-3876-2021; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/AAE-7126-2019; van der Geest, Rob J/J-8193-2015; van Buchem, Mark/AAC-9843-2022	Van Osch, Matthias/0000-0001-7034-8959; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; van der Geest, Rob J/0000-0002-9084-5597; van Buchem, Mark/0000-0003-1881-1998				Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Asllani I, 2008, NEUROIMAGE, V39, P1246, DOI 10.1016/j.neuroimage.2007.10.015; Asllani I, 2009, HUM BRAIN MAPP, V30, P2927, DOI 10.1002/hbm.20719; BARKHOF E, 1994, ACTA RADIOL, V35, P123, DOI 10.1177/028418519403500204; Barth M, 1997, CELL MOL BIOL, V43, P783; Bastos-Leite AJ, 2008, AM J NEURORADIOL, V29, P1296, DOI 10.3174/ajnr.A1091; Bland JM, 1996, BRIT MED J, V313, P744; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Fernandez-Seara MA, 2005, MAGN RESON MED, V54, P1241, DOI 10.1002/mrm.20674; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hermes M, 2007, MAGN RESON MATER PHY, V20, P103, DOI 10.1007/s10334-007-0073-3; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hodkinson DJ, 2013, NEUROIMAGE-CLIN, V3, P301, DOI 10.1016/j.nicl.2013.09.004; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Jain V, 2012, RADIOLOGY, V263, P527, DOI 10.1148/radiol.12111509; Jiang L, 2010, MAGN RESON IMAGING, V28, P1283, DOI 10.1016/j.mri.2010.05.002; Kilroy E, 2014, J MAGN RESON IMAGING, V39, P931, DOI 10.1002/jmri.24246; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Mutke MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087143; Mutsaerts HJMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Sigurdsson S, 2012, NEUROIMAGE, V59, P3862, DOI 10.1016/j.neuroimage.2011.11.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sonntag WE, 1997, ENDOCRINOLOGY, V138, P3515, DOI 10.1210/en.138.8.3515; Spilt A, 2002, J MAGN RESON IMAGING, V16, P1, DOI 10.1002/jmri.10133; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wolk DA, 2012, CURR OPIN NEUROL, V25, P421, DOI 10.1097/WCO.0b013e328354ff0a; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhang Q, 2012, J ALZHEIMERS DIS, V32, P677, DOI 10.3233/JAD-2012-120964; Zhang X, 2013, MAGN RESON MED, V70, P1082, DOI 10.1002/mrm.24550	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144743	10.1371/journal.pone.0144743	http://dx.doi.org/10.1371/journal.pone.0144743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659363	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900100
J	Danskin, B; Denman, D; Valley, M; Ollerenshaw, D; Williams, D; Groblewski, P; Reid, C; Olsen, S; Waters, J				Danskin, Bethanny; Denman, Daniel; Valley, Matthew; Ollerenshaw, Douglas; Williams, Derric; Groblewski, Peter; Reid, Clay; Olsen, Shawn; Waters, Jack			Optogenetics in Mice Performing a Visual Discrimination Task: Measurement and Suppression of Retinal Activation and the Resulting Behavioral Artifact	PLOS ONE			English	Article							OPTICAL-PROPERTIES; COEXPRESSION; NEURONS; TISSUES; CORTEX	Optogenetic techniques are used widely to perturb and interrogate neural circuits in behaving animals, but illumination can have additional effects, such as the activation of endogenous opsins in the retina. We found that illumination, delivered deep into the brain via an optical fiber, evoked a behavioral artifact in mice performing a visually guided discrimination task. Compared with blue (473 nm) and yellow (589 nm) illumination, red (640 nm) illumination evoked a greater behavioral artifact and more activity in the retina, the latter measured with electrical recordings. In the mouse, the sensitivity of retinal opsins declines steeply with wavelength across the visible spectrum, but propagation of light through brain tissue increases with wavelength. Our results suggest that poor retinal sensitivity to red light was overcome by relatively robust propagation of red light through brain tissue and stronger illumination of the retina by red than by blue or yellow light. Light adaptation of the retina, via an external source of illumination, suppressed retinal activation and the behavioral artifact without otherwise impacting behavioral performance. In summary, long wavelength optogenetic stimuli are particularly prone to evoke behavioral artifacts via activation of retinal opsins in the mouse, but light adaptation of the retina can provide a simple and effective mitigation of the artifact.	[Danskin, Bethanny; Denman, Daniel; Valley, Matthew; Ollerenshaw, Douglas; Williams, Derric; Groblewski, Peter; Reid, Clay; Olsen, Shawn; Waters, Jack] Allen Inst Brain Sci, Seattle, WA 98109 USA	Allen Institute for Brain Science	Waters, J (corresponding author), Allen Inst Brain Sci, 551 N 34th St, Seattle, WA 98109 USA.	jackw@alleninstitute.org		Valley, Matthew/0000-0002-7204-5457; denman, daniel/0000-0003-1075-1265; Danskin, Bethanny/0000-0002-4832-1220	Allen Institute for Brain Science; National Institute of Neurological Disorders and Stroke [NS078067]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078067] Funding Source: NIH RePORTER	Allen Institute for Brain Science; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the Allen Institute for Brain Science and award number NS078067 from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful for the hard work and technical support of the many staff members in the Allen Institute. We also thank A. Nagy (Mount Sinai Hospital in Toronto) for providing the G4 ES cell line, used in the development of the Ai32D and Ai35D mouse lines. Funding was provided by the Allen Institute for Brain Science and award number NS078067 from the National Institute of Neurological Disorders and Stroke. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of health and National Institute of Neurological Disorders and Stroke. We thank the Allen Institute founders, Paul G Allen and Jody Allen, for their vision, encouragement and support.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Daniele LL, 2011, VISION RES, V51, P447, DOI 10.1016/j.visres.2010.12.017; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Kravitz AV, 2013, BRAIN RES, V1511, P21, DOI 10.1016/j.brainres.2012.11.018; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Sidor MM, 2015, JOVE-J VIS EXP, DOI 10.3791/51483; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	24	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144760	10.1371/journal.pone.0144760	http://dx.doi.org/10.1371/journal.pone.0144760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657323	Green Published, gold			2022-12-26	WOS:000366903600088
J	Saeb, S; Kording, K; Mohr, DC				Saeb, Sohrab; Koerding, Konrad; Mohr, David C.			Making Activity Recognition Robust against Deceptive Behavior	PLOS ONE			English	Article							MOTION SENSORS	Healthcare services increasingly use the activity recognition technology to track the daily activities of individuals. In some cases, this is used to provide incentives. For example, some health insurance companies offer discount to customers who are physically active, based on the data collected from their activity tracking devices. Therefore, there is an increasing motivation for individuals to cheat, by making activity trackers detect activities that increase their benefits rather than the ones they actually do. In this study, we used a novel method to make activity recognition robust against deceptive behavior. We asked 14 subjects to attempt to trick our smartphone-based activity classifier by making it detect an activity other than the one they actually performed, for example by shaking the phone while seated to make the classifier detect walking. If they succeeded, we used their motion data to retrain the classifier, and asked them to try to trick it again. The experiment ended when subjects could no longer cheat. We found that some subjects were not able to trick the classifier at all, while others required five rounds of retraining. While classifiers trained on normal activity data predicted true activity with similar to 38% accuracy, training on the data gathered during the deceptive behavior increased their accuracy to similar to 84%. We conclude that learning the deceptive behavior of one individual helps to detect the deceptive behavior of others. Thus, we can make current activity recognition robust to deception by including deceptive activity data from a few individuals.	[Saeb, Sohrab; Mohr, David C.] Northwestern Univ, Dept Prevent Med, Ctr Behav Intervent Technol, Chicago, IL 60611 USA; [Saeb, Sohrab; Koerding, Konrad] Northwestern Univ, Dept Rehabil & Phys Med, Rehabil Inst Chicago, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Shirley Ryan AbilityLab	Saeb, S (corresponding author), Northwestern Univ, Dept Prevent Med, Ctr Behav Intervent Technol, Chicago, IL 60611 USA.	s-saeb@northwestern.edu	; Kording, Konrad/A-1233-2007	Mohr, David/0000-0002-5443-7596; Kording, Konrad/0000-0001-8408-4499	US National Institute of Mental Health [P20MH090318, R01MH100482]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH090318, R01MH100482] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by research grants P20MH090318 and R01MH100482 from the US National Institute of Mental Health: https://www.nimh.nih.gov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MV, 2012, FRONT NEUROL, V3, P158, DOI DOI 10.3389/FNEUR.2012.00158; Alshurafa N, 2014, 2014 11TH INTERNATIONAL CONFERENCE ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS (BSN), P92, DOI 10.1109/BSN.2014.38; Antos SA, 2014, J NEUROSCI METH, V231, P22, DOI 10.1016/j.jneumeth.2013.09.015; AUBERTTULKENS G, 1987, AM REV RESPIR DIS, V136, P851, DOI 10.1164/ajrccm/136.4.851; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Brand M, 1997, LEARNING CONCISE MOD; Breiman L., 2001, MACH LEARN, V45, P5; Criminisi A., 2011, MSRTR2011114, V5, P12; Dobkin BH, 2011, NEUROREHAB NEURAL RE, V25, P788, DOI 10.1177/1545968311425908; Helal Abdelsalam, 2009, J Diabetes Sci Technol, V3, P141; KLESGES RC, 1985, AM J EPIDEMIOL, V122, P400, DOI 10.1093/oxfordjournals.aje.a114121; Matula M, 1988, IEEE ENG MED BIOL SO, P29; Mazilu S., 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare, P123, DOI 10.4108/icst.pervasivehealth.2012.248680; McKenna MJ, 1988, COMPUTER VIDEO ANAL, P274; Mearian L, 2015, INSURANCE CO NOW OFF; Mortazavi B., 2012, Proceedings of the 2012 Ninth International Conference on Wearable and Implantable Body Sensor Networks (BSN 2012), P28, DOI 10.1109/BSN.2012.18; Olson P, 2015, FITBIT DATA NOW BEIN; Reddy VR, 2014, LECT NOTES COMPUT SC, V8511, P305, DOI 10.1007/978-3-319-07230-2_30; REDMOND DP, 1985, BEHAV RES METH INSTR, V17, P659, DOI 10.3758/BF03200979; Shoaib M, 2014, SENSORS-BASEL, V14, P10146, DOI 10.3390/s140610146; Tacconi D, 2008, 2008 2ND INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING TECHNOLOGIES FOR HEALTHCARE, P93; Tomlein Michal, 2012, Proceedings of the International Conference on Health Informatics. HEALTHINF 2012, P401	22	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144795	10.1371/journal.pone.0144795	http://dx.doi.org/10.1371/journal.pone.0144795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659118	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600092
J	Matsumoto, CS; Shinoda, K; Terauchi, G; Matsumoto, H; Mizota, A; Miyake, Y				Matsumoto, Celso Soiti; Shinoda, Kei; Terauchi, Gaku; Matsumoto, Harue; Mizota, Atsushi; Miyake, Yozo			Assessment of Macular Function during Vitrectomy: New Approach Using Intraoperative Focal Macular Electroretinograms	PLOS ONE			English	Article							VISUAL SENSATIONS; EYES; DYSTROPHY; MUTATION; REMOVAL; ERGS	Purpose To describe a new technique to record focal macular electroretinograms (FMERGs) during vitrectomy to assess macular function. Methods Intraoperative FMERGs (iFMERGs) were recorded in ten patients (10 eyes) who undergo vitrectomy. iFMERGs were elicited by focal macular stimulation. The stimulus light was directed to the macular area through a 25 gauge (25G) glass fiber optic bundle. Background light was delivered through a dual chandelier-type light fiber probe. Focal macular responses elicited with combinations of stimulus and background luminances were analyzed. Results A stimulus luminance that was approximately 1.75 log units brighter than the background light was able to elicit focal macular responses that were not contaminated by stray light responses. Thus, a stimulus luminance of 160 cd/m(2) delivered on a background of 3 cd/m(2) elicited iFMEGs from only the stimulated area. This combination of stimulus and background luminances did not elicit a response when the stimulus was projected onto the optic nerve head. The iFMERGs elicited by a 10 degrees stimulus with a duration of 100 ms and an inter-stimulus interval of 150 ms consisted of an a-, b-, and d-waves, the oscillatory potentials, and the photopic negative response (PhNR). Conclusions Focal ERGs with all components can be recorded from the macula and other retinal areas during vitreous surgery. This new technique will allow surgeons to assess the function of focal areas of the retina intraoperatively.	[Matsumoto, Celso Soiti; Shinoda, Kei; Terauchi, Gaku; Mizota, Atsushi] Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, Tokyo 1738605, Japan; [Matsumoto, Celso Soiti; Matsumoto, Harue] Matsumoto Eye Clin, Tokushima, Japan; [Miyake, Yozo] Aichi Med Univ, Nagakute, Aichi 4801195, Japan	Teikyo University; Aichi Medical University	Shinoda, K (corresponding author), Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	shinodak@med.teikyo-u.ac.jp	Shinoda, Kei/ABC-7993-2020	Shinoda, Kei/0000-0002-1543-9345	Ministry of Education, Culture, Sports, Science and Technology, Japan [25462735]; Ministry of Health, Labor, and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Support of this study was provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan (ID 25462735), and by the Ministry of Health, Labor, and Welfare, Japan.	Charles S., 2012, RETINA, P1696; Choshi T, 2003, JPN J OPHTHALMOL, V47, P356, DOI 10.1016/S0021-5155(03)00073-X; Hayashi T, 2012, OPTOMETRY VISION SCI, V89, P684, DOI 10.1097/OPX.0b013e31824eea32; HORIGUCHI M, 1991, ARCH OPHTHALMOL-CHIC, V109, P1127, DOI 10.1001/archopht.1991.01080080087035; Kabuto T, 2012, MOL VIS, V18, P1031; Kawaguchi N, 2006, AM J OPHTHALMOL, V141, P407, DOI 10.1016/j.ajo.2005.09.007; Kitakawa T, 2012, DOC OPHTHALMOL, V124, P249, DOI 10.1007/s10633-012-9318-1; Matsumoto CS, 2012, J VISION, V12, DOI 10.1167/12.3.6; MIYAKE Y, 1990, DOC OPHTHALMOL, V75, P111, DOI 10.1007/BF00146547; Miyake Y, 1998, GRAEF ARCH CLIN EXP, V236, P13, DOI 10.1007/s004170050036; MIYAKE Y, 1981, Nippon Ganka Gakkai Zasshi, V85, P1521; MIYAKE Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1123, DOI 10.1001/archopht.1991.01080080083034; MIYAKE Y, 1990, JPN J OPHTHALMOL, V34, P225; MIYAKE Y, 1988, AM J OPHTHALMOL, V106, P546, DOI 10.1016/0002-9394(88)90583-1; MIYAKE Y, 1993, AM J OPHTHALMOL, V116, P576, DOI 10.1016/S0002-9394(14)73199-X; Miyake Y, 2012, RETINA, P202; Nakamura M, 2002, AM J OPHTHALMOL, V133, P278, DOI 10.1016/S0002-9394(01)01304-6; Nishihara H, 2008, INVEST OPHTH VIS SCI, V49, P3121, DOI 10.1167/iovs.08-1835; Niwa T, 2003, INVEST OPHTH VIS SCI, V44, P1652, DOI 10.1167/iovs.02-0404; Ogino K, 2013, INVEST OPHTH VIS SCI, V54, P3771, DOI 10.1167/iovs.12-11494; SANDBERG MA, 1979, AM J OPHTHALMOL, V88, P702, DOI 10.1016/0002-9394(79)90669-X; Shimada Y, 2003, INVEST OPHTH VIS SCI, V44, P1245, DOI 10.1167/iovs.02-0527; Shinoda K, 2011, ELECTRORETINOGRAMS, P33; SHIROYAMA N, 1990, Nippon Ganka Gakkai Zasshi, V94, P1048; Sugisaka E, 2007, AM J OPHTHALMOL, V144, P245, DOI 10.1016/j.ajo.2007.05.001; Sugisaka E, 2006, OPHTHALMOLOGY, V113, P1886; Tanikawa A, 1999, AM J OPHTHALMOL, V127, P559, DOI 10.1016/S0002-9394(98)00447-4; Terasaki H, 1998, AM J OPHTHALMOL, V125, P204, DOI 10.1016/S0002-9394(99)80093-2; Terasaki H, 2001, INVEST OPHTH VIS SCI, V42, P229; Yamada K, 2006, DOC OPHTHALMOL, V113, P83, DOI 10.1007/s10633-006-9017-x	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144627	10.1371/journal.pone.0144627	http://dx.doi.org/10.1371/journal.pone.0144627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658489	gold, Green Published			2022-12-26	WOS:000366903500049
J	Kitterer, D; Segerer, S; Alscher, MD; Braun, N; Latus, J				Kitterer, Daniel; Segerer, Stephan; Alscher, M. Dominik; Braun, Niko; Latus, Joerg			Puumala Hantavirus-Induced Hemorrhagic Fever with Renal Syndrome Must Be Considered across the Borders of Nephrology to Avoid Unnecessary Diagnostic Procedures	PLOS ONE			English	Article							INDUCED NEPHROPATHIA-EPIDEMICA; INFECTIONS; PREVENTION	Background Nephropathia epidemica (NE), a milder form of hemorrhagic fever with renal syndrome, is caused by Puumala virus and is characterized by acute kidney injury and thrombocytopenia. Methods A cross-sectional prospective survey of 456 adult patients with serologically confirmed NE was performed. Results Of the 456 investigated patients, 335 had received inpatient treatment. At time of admission to hospital, 72% of the patients had still an AKI and thrombocytopenia was present in 64% of the patients. The 335 patients were treated in 29 different hospitals and 6 of which had nephrology departments. 10 out of 335 patients received treatment in university hospitals and 63% of patients admitted themselves to hospital. Initially, the patients were admitted to 12 different clinical departments (29% of the patients were referred to a nephrology department) and during the course of the disease, 8% of the patients were transferred to another department in the same hospital and 3% were transferred to a nephrology department at another hospital. Regarding diagnostic procedures, in 28% of the inpatients computed tomography to exclude pulmonary embolism or due to severe gastrointestinal symptoms, lumbar puncture to exclude meningitis, magnetic resonance tomography of the brain owing to suspected stroke because of visual disorders, gastroscopy, or colonoscopy due to gastrointestinal symptoms was performed at time of admission to hospital. Conclusions NE must be considered by physicians across the borders of nephrology to avoid unnecessary diagnostic procedures especially in areas where NE is endemic.	[Kitterer, Daniel; Alscher, M. Dominik; Latus, Joerg] Robert Bosch Krankenhaus, Div Gen Med & Nephrol, Dept Internal Med, Stuttgart, Germany; [Segerer, Stephan] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Braun, Niko] Nephrol Ctr, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; University of Zurich; University Zurich Hospital	Latus, J (corresponding author), Robert Bosch Krankenhaus, Div Gen Med & Nephrol, Dept Internal Med, Stuttgart, Germany.	joerg.latus@rbk.de		Segerer, Stephan/0000-0002-1936-9719				Braun N, 2010, NEPHROL DIAL TRANSPL, V25, P2997, DOI 10.1093/ndt/gfq118; Goeijenbier M, 2014, EURO SURVEILLANCE B, V19; Krautkramer E, 2013, KIDNEY INT, V83, P23, DOI 10.1038/ki.2012.360; Kruger DH, 2013, DTSCH ARZTEBL INT, V110, P461, DOI 10.3238/arztebl.2013.0461; Kruger DH, 2011, HUM VACCINES, V7, P685, DOI 10.4161/hv.7.6.15197; Kruger DH, 2001, MICROBES INFECT, V3, P1129, DOI 10.1016/S1286-4579(01)01474-5; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Latus J, 2015, KIDNEY BLOOD PRESS R, V40, P22, DOI 10.1159/000368479; Latus J, 2015, NEPHROL DIAL TRANSPL, V30, P245, DOI 10.1093/ndt/gfu319; Latus J, 2015, EMERG INFECT DIS, V21, P76, DOI 10.3201/eid2101.140861; Latus J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098397; Latus J, 2012, J CLIN VIROL, V53, P156, DOI 10.1016/j.jcv.2011.11.003; LEE HW, 1989, PROG MED VIROL, V36, P62; Libraty DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035402; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Osadebe Lynda U., 2012, Morbidity and Mortality Weekly Report, V61, P952; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6	20	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144622	10.1371/journal.pone.0144622	http://dx.doi.org/10.1371/journal.pone.0144622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650941	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000366903300061
J	Lu, HY; Chen, YW; Lan, QF; Liao, HJ; Wu, J; Xiao, HY; Dickerson, CA; Wu, P; Pan, QJ				Lu, Haiyan; Chen, Yanwen; Lan, Qiaofen; Liao, Huanjin; Wu, Jing; Xiao, Haiyan; Dickerson, Carol A.; Wu, Ping; Pan, Qingjun			Factors That Influence a Mother's Willingness to Preserve Umbilical Cord Blood: A Survey of 5120 Chinese Mothers	PLOS ONE			English	Article							STEM-CELLS; REGENERATIVE MEDICINE; TRANSPLANTATION; BANKING; ENGRAFTMENT; DISORDERS; KNOWLEDGE; STORAGE; STATE	Background Umbilical Cord blood (UCB), which contains a substantive number of stem cells, could be widely used in transplants to treat a variety of oncologic, genetic, hematologic, and immunodeficiency disorders. However, only a small portion of mothers preserve or donate their UCB in China. The limited availability of UCB has hampered stem cell research and therapy nowadays. To date, no systemic investigations regarding factors that influence a mother's willingness to preserve UCB have been performed in China. In the current study, we are trying to determine those factors which will provide useful information for national health policy development and will raise awareness of the importance of UCB preservation. Methods During 2011 to 2013, 5120 mothers with the average age of 26.1 +/- 8.4 years were included in this study. Those mothers participated in a standardized survey. The information gathered consisted of delivery time, occupation, level of education, knowledge of preservation of UCB, willingness to store UCB, and related concerns. The results have been analyzed with SPSS 16.0. Results The results showed that first-time mothers showed a greater willingness to preserve their UCB (73.3%) compared to those having their second (48.9%) or third child (40.3%). Mothers who were employed at Government Agencies and Organizations were more willing to preserve their UCB (87.3%) than those employed at factories (62.0%), and those who were unemployed (27.3%). Mothers holding master's or college degrees were more willing to preserve their UCB (72.5% and 71.1%, respectively) than mothers with high school diplomas (48.7%) or those who only went to preliminary school or middle school (40.7%). The two strongest factors that influenced an unwillingness to preserve UCB were the high cost and concerns regarding the safety of the preservation. Conclusions The results showed that mothers with higher education or those having better occupations are more likely to preserve their UCB in China. These mothers have related knowledge and understand the importance of the preservation and they could more readily afford the relatively high cost. The government, clinicians and UCB banks should combine efforts to take measures, such as increasing public knowledge of the importance of UCB preservation and decreasing the high cost for its storage will most likely increase the frequency of UCB preservation which will further benefit stem cell research and therapy.	[Lu, Haiyan; Chen, Yanwen; Lan, Qiaofen; Liao, Huanjin; Wu, Jing; Wu, Ping; Pan, Qingjun] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Guangdong, Peoples R China; [Lu, Haiyan; Chen, Yanwen; Lan, Qiaofen; Liao, Huanjin; Wu, Jing; Wu, Ping; Pan, Qingjun] Guangdong Med Coll, Affiliated Hosp, Inst Nephrol, Zhanjiang, Guangdong, Peoples R China; [Xiao, Haiyan; Dickerson, Carol A.] Georgia Regents Univ, Dept Anesthesiol & Perioperat Med, Augusta, GA USA	Guangdong Medical University; Guangdong Medical University; University System of Georgia; Augusta University	Wu, P (corresponding author), Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Guangdong, Peoples R China.	wping62@126.com; stilwapan@gmail.com						Ali H, 2010, ACTA NEUROBIOL EXP, V70, P316; Ballen KK, 2005, BLOOD, V105, P3786, DOI 10.1182/blood-2004-10-4125; Barker JN, 2003, NAT REV CANCER, V3, P526, DOI 10.1038/nrc1125; Broder SM, 2013, TRANSFUSION, V53, P679, DOI 10.1111/j.1537-2995.2012.03785.x; Broxmeyer HE, 2012, ANN NY ACAD SCI, V1266, P151, DOI 10.1111/j.1749-6632.2012.06509.x; Damaris Christensen, 2005, JNCI-J NATL CANCER I, V97, P253; Delaney C, 2010, EXPERT REV HEMATOL, V3, P273, DOI [10.1586/ehm.10.24, 10.1586/EHM.10.24]; Dinc H, 2009, INT NURS REV, V56, P250, DOI 10.1111/j.1466-7657.2008.00689.x; Elmoazzen H, 2015, METHODS MOL BIOL, V1257, P369, DOI 10.1007/978-1-4939-2193-5_18; Fasouliotis SJ, 2000, EUR J OBSTET GYN R B, V90, P13, DOI 10.1016/S0301-2115(99)00214-6; Guillaume A, 2014, J MATERN-FETAL NEO M, V14, P1; Han MX, 2013, MED J AUSTRALIA, V199, P288, DOI 10.5694/mja12.10835; Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323; Jaing TH, 2014, CELL TRANSPLANT, V23, P493, DOI 10.3727/096368914X678300; Kanno Hiroshi, 2013, World J Stem Cells, V5, P163, DOI 10.4252/wjsc.v5.i4.163; Karagiorgou LZ, 2013, BLOOD TRANSFUS, P1; Kurtzberg J, 2009, CURR OPIN PEDIATR, V21, P22, DOI 10.1097/MOP.0b013e32832130bc; MPhil Jon Smythe, 2007, STEM CELLS, V25, P2087; Oran B, 2012, HEMATOL-AM SOC HEMAT, P215, DOI 10.1182/asheducation-2012.1.215; Pawson Rachel, 2014, Midwives, V17, P50; Perlow JH, 2006, J REPROD MED, V51, P642; Suen SSH, 2011, ACTA OBSTET GYN SCAN, V90, P1005, DOI 10.1111/j.1600-0412.2011.01201.x; Sun J, 2010, TRANSFUSION, V50, P1980, DOI 10.1111/j.1537-2995.2010.02720.x; Volarevic V, 2011, BRIT MED BULL, V99, P155, DOI 10.1093/bmb/ldr027; Zhong XY, 2010, ANN NY ACAD SCI, V1205, P17, DOI 10.1111/j.1749-6632.2010.05659.x	25	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144001	10.1371/journal.pone.0144001	http://dx.doi.org/10.1371/journal.pone.0144001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650509	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903300033
J	Yuan, XM; Zeng, YW; Nie, KY; Luo, DAH; Wang, ZJ				Yuan, Xiumei; Zeng, Yawei; Nie, Kaiying; Luo, Dianhui; Wang, Zhaojing			Extraction Optimization, Characterization and Bioactivities of a Major Polysaccharide from Sargassum thunbergii	PLOS ONE			English	Article							MICROWAVE-ASSISTED EXTRACTION; RESPONSE-SURFACE METHODOLOGY; STRUCTURAL-CHARACTERIZATION; HOLO-TRANSFERRIN; BROWN SEAWEED; IN-VITRO; ANTIOXIDANT; SEPARATION; FUCOIDAN	Sargassum thunbergii is a kind of natural edible algae. STP (S. thunbergii polysaccharides) was considered as the main bioactive compounds in S. thunbergii. To obtain the optimal processing conditions for maximum total sugar yield, single factor investigation and response surface methodology (RSM) were employed. The optimal processing conditions were as follows: liquid to solid ratio 120 mL/g, extraction time 210 min, extraction temperature 97 degrees C. The experimental yield 7.53% under optimized conditions was closely agreed with the predicted yield 7.85% of the model. The major polysaccharide fraction from S. thunbergii (named STP-II) was purified by DEAE-Sepharose CL-6B column chromatography. High-performance size-exclusion chromatography (HPSEC), gas chromatography (GC) and high-performance liquid chromatography (HPLC) were used to identify its characterizations, and in vitro antioxidant assays and cytotoxicity assays were used to research its bioactivities. The purified fraction STP-II (63.75%) was a single peak in HPSEC with Sugar KS-804 column, had a molecular weight of 550KD, and comprised mainly of fucose, xylose, galactose, glucose and glucuronic acid. STP-II had higher scavenging activities on hydroxyl radical (76.72% at 0.7 mg/mL) and superoxide radical (95.17% at 2 mg/mL) than Vitamin C (Vc). STP-II also exhibited the capability of anti-proliferation in Caco-2 cells. STP-II possessed good antioxidant and inhibitory activity against human colon cancer Caco-2 cells in vitro and could be explored as novel natural functional food.	[Yuan, Xiumei; Zeng, Yawei; Nie, Kaiying; Luo, Dianhui; Wang, Zhaojing] Huaqiao Univ, Dept Bioengn & Biotechnol, Xiamen, Fujian, Peoples R China	Huaqiao University	Wang, ZJ (corresponding author), Huaqiao Univ, Dept Bioengn & Biotechnol, Xiamen, Fujian, Peoples R China.	zhaojingwang@hqu.edu.cn			National Nature Science Foundation of China [31201314]; Fundamental Research Funds for the Central Universities [JB-ZR1222]; Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University [ZQN-PY316]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University	This work was supported by the National Nature Science Foundation of China (31201314), Fundamental Research Funds for the Central Universities (JB-ZR1222), and Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (ZQN-PY316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Nature Science Foundation of China (31201314), Fundamental Research Funds for the Central Universities (JB-ZR1222), and Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (ZQN-PY316).	Banerjee A, 2005, FOOD CHEM, V90, P727, DOI 10.1016/j.foodchem.2004.04.033; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen C, 2015, LWT-FOOD SCI TECHNOL, V64, P1263, DOI 10.1016/j.lwt.2015.07.009; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; Govender S, 2005, INT J PHARMACEUT, V306, P24, DOI 10.1016/j.ijpharm.2005.07.026; Han X.D., 2005, SPECIAL EC ANIMALS P, V1, P1; Hou XJ, 2008, CARBOHYD POLYM, V72, P67, DOI 10.1016/j.carbpol.2007.07.034; Huang Zhi-xuan, 2005, Zhongguo Zhongyao Zazhi, V30, P211; Itoh H, 1995, ANTICANCER RES, V15, P1937; Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; Lee WC, 2006, J FOOD ENG, V75, P473, DOI 10.1016/j.jfoodeng.2005.04.062; Liu ZD, 2006, CARBOHYD POLYM, V64, P548, DOI 10.1016/j.carbpol.2005.11.006; Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050; Luo DH, 2008, CARBOHYD POLYM, V72, P376, DOI 10.1016/j.carbpol.2007.09.006; Luo DH, 2012, CARBOHYD POLYM, V90, P284, DOI 10.1016/j.carbpol.2012.05.036; Maran JP, 2015, CARBOHYD POLYM, V123, P67, DOI 10.1016/j.carbpol.2014.11.072; Nguyen NK, 2008, J STAT PLAN INFER, V138, P294, DOI 10.1016/j.jspi.2007.05.002; Samavati V, 2013, CARBOHYD POLYM, V95, P588, DOI 10.1016/j.carbpol.2013.02.041; Sarzehi S, 2010, INT J BIOL MACROMOL, V47, P558, DOI 10.1016/j.ijbiomac.2010.08.002; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Wang GY, 2001, CHEM J CHINESE U, V22, P1688; Wang Y, 2016, FOOD CHEM, V194, P257, DOI 10.1016/j.foodchem.2015.08.016; Wang ZY, 2014, INT J BIOL MACROMOL, V64, P139, DOI 10.1016/j.ijbiomac.2013.11.038; Wang ZJ, 2007, CARBOHYD POLYM, V69, P311, DOI 10.1016/j.carbpol.2006.10.013; [王昭晶 Wang Zhaojing], 2005, [分子科学学报, Journal of molecular science], V21, P28; Wang ZJ, 2004, CARBOHYD POLYM, V57, P241, DOI 10.1016/j.carbpol.2004.04.018; [魏玉西 Wei Yuxi], 2006, [中国海洋药物, Chinese Journal of Marine Drugs], V25, P41; Ye CL, 2011, CARBOHYD POLYM, V84, P495, DOI 10.1016/j.carbpol.2010.12.014; You LJ, 2013, FOOD CHEM, V138, P2242, DOI 10.1016/j.foodchem.2012.11.140; Zhang EX, 1997, CHIN J MAR DRUGS, V3, P1; Zheng Y, 1993, J FUJIAN NORM U, V9, P81; Zhu CP, 2013, CARBOHYD POLYM, V92, P1197, DOI 10.1016/j.carbpol.2012.10.073; ZHUANG C, 1995, BIOSCI BIOTECH BIOCH, V59, P563, DOI 10.1271/bbb.59.563	35	41	46	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144773	10.1371/journal.pone.0144773	http://dx.doi.org/10.1371/journal.pone.0144773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649576	Green Published, gold			2022-12-26	WOS:000366903300075
J	Hanna, EM; Zaki, N; Amin, A				Hanna, Eileen Marie; Zaki, Nazar; Amin, Amr			Detecting Protein Complexes in Protein Interaction Networks Modeled as Gene Expression Biclusters	PLOS ONE			English	Article							MODULES; ALGORITHMS; ONTOLOGY; LOGIC; TOOL	Developing suitable methods for the detection of protein complexes in protein interaction networks continues to be an intriguing area of research. The importance of this objective originates from the fact that protein complexes are key players in most cellular processes. The more complexes we identify, the better we can understand normal as well as abnormal molecular events. Up till now, various computational methods were designed for this purpose. However, despite their notable performance, questions arise regarding potential ways to improve them, in addition to ameliorative guidelines to introduce novel approaches. A close interpretation leads to the assent that the way in which protein interaction networks are initially viewed should be adjusted. These networks are dynamic in reality and it is necessary to consider this fact to enhance the detection of protein complexes. In this paper, we present "DyCluster", a framework to model the dynamic aspect of protein interaction networks by incorporating gene expression data, through biclustering techniques, prior to applying complex-detection algorithms. The experimental results show that DyCluster leads to higher numbers of correctly-detected complexes with better evaluation scores. The high accuracy achieved by DyCluster in detecting protein complexes is a valid argument in favor of the proposed method. DyCluster is also able to detect biologically meaningful protein groups. The code and datasets used in the study are downloadable from https://github.com/emhanna/DyCluster.	[Hanna, Eileen Marie; Zaki, Nazar] UAEU, Coll Info Tech, Intelligent Syst, Al Ain 15551, U Arab Emirates; [Amin, Amr] UAEU, Coll Sci, Dept Biol, Al Ain 15551, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt	United Arab Emirates University; United Arab Emirates University; Egyptian Knowledge Bank (EKB); Cairo University	Hanna, EM (corresponding author), UAEU, Coll Info Tech, Intelligent Syst, Al Ain 15551, U Arab Emirates.	eileen.hanna@uaeu.ac.ae	Zaki, Nazar/ABC-1680-2020; Zaki, Nazar M/F-1972-2013; Amin, Amr/I-2137-2019	Zaki, Nazar M/0000-0002-6259-9843; Amin, Amr/0000-0001-8888-1102; Hanna, Eileen Marie/0000-0002-2093-4586	United Arab Emirates University Program for Advance Research (UPAR) [31T052, 31S118]; Terry Fox Foundation, United Arab Emirates [21S088]	United Arab Emirates University Program for Advance Research (UPAR); Terry Fox Foundation, United Arab Emirates	This work was partially supported by grants ref. no. 31T052 and 31S118 from United Arab Emirates University Program for Advance Research (UPAR) and 21S088-Terry Fox Foundation, United Arab Emirates.; The work is partially supported by grants ref. no. 31T052 and 31S118 from United Arab Emirates University Program for Advance Research (UPAR) and 21S088-Terry Fox Foundation, United Arab Emirates.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Adelmant G, 2009, EXPERT REV PROTEOMIC, V6, P5, DOI 10.1586/14789450.6.1.5; Amin A, 2011, HEPATOLOGY, V54, P857, DOI 10.1002/hep.24433; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asyali MH, 2006, CURR BIOINFORM, V1, P55, DOI 10.2174/157489306775330615; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baldi P, 2002, DNA MICROARRAYS GENE; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Bozdag D, 2010, 1 ACM INT C BIOINFOR, P265, DOI [DOI 10.1145/1854776.1854814, 10.1145/1854776.1854814]; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Collins MO, 2008, CURR OPIN BIOTECH, V19, P324, DOI 10.1016/j.copbio.2008.06.002; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dongen S.v, 2000, GRAPH CLUSTERING FLO; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hanna EM, 2014, BIOINFORMATICS 2014: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOINFORMATICS MODELS, METHODS AND ALGORITHMS, P239; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim Y, 2014, BRIEF BIOINFORM, V15, P212, DOI 10.1093/bib/bbt028; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Lee YH, 2010, PROTEOMICS, V10, P3935, DOI 10.1002/pmic.201000289; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Li M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/375262; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lubovac Z, 2006, PROTEINS, V64, P948, DOI 10.1002/prot.21071; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Mukhopadhyay Anirban, 2009, Journal of Bioinformatics and Computational Biology, V7, P853, DOI 10.1142/S0219720009004370; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Oghabian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090801; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Remondini D, 2005, P NATL ACAD SCI USA, V102, P6902, DOI 10.1073/pnas.0502081102; Song L, 2009, BIOINFORMATICS, V25, pI128, DOI 10.1093/bioinformatics/btp192; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wang JX, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-28; Wang JX, 2011, IEEE INT C BIOINFORM, P37, DOI 10.1109/BIBM.2011.45; Watson James D., 2003, DNA SECRET LIFE; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xu B, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S7; Zaki N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04262; Zaki N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-163; Zaki N, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P209, DOI 10.1145/2330163.2330193; Zaki N, 2012, PROTEINS, V80, P2459, DOI 10.1002/prot.24130	60	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144163	10.1371/journal.pone.0144163	http://dx.doi.org/10.1371/journal.pone.0144163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641660	gold, Green Submitted, Green Published			2022-12-26	WOS:000366902700069
J	Jimenez-Perez, L; Cidad, P; Alvarez-Miguel, I; Santos-Hipolito, A; Torres-Merino, R; Alonso, E; de la Fuente, MA; Lopez-Lopez, JR; Perez-Garcia, MT				Jimenez-Perez, Laura; Cidad, Pilar; Alvarez-Miguel, Ines; Santos-Hipolito, Alba; Torres-Merino, Rebeca; Alonso, Esperanza; Angel de la Fuente, Miguel; Ramon Lopez-Lopez, Jose; Teresa Perez-Garcia, M.			Molecular Determinants of Kv1.3 Potassium Channels-induced Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; electrophysiology; mutagenesis; potassium channel; structure-function; Kv1; 3; membrane potential; tyrosine phosphorylation; voltage-dependent conformation	SMOOTH-MUSCLE-CELLS; K+ CHANNELS; ION CHANNELS; SURFACE EXPRESSION; C-TERMINUS; SUBUNITS; SWITCH; IMMUNOMODULATION; LYMPHOCYTES; TARGETS	Changes in voltage-dependent potassium channels (Kv channels) associate to proliferation in many cell types, including transfected HEK293 cells. In this system Kv1.5 overexpression decreases proliferation, whereas Kv1.3 expression increases it independently of K+ fluxes. To identify Kv1.3 domains involved in a proliferation-associated signaling mechanism(s), we constructed chimeric Kv1.3-Kv1.5 channels and point-mutant Kv1.3 channels, which were expressed as GFP- or cherry-fusion proteins. We studied their trafficking and functional expression, combining immunocytochemical and electrophysiological methods, and their impact on cell proliferation. We found that the C terminus is necessary for Kv1.3-induced proliferation. We distinguished two residues (Tyr-447 and Ser-459) whose mutation to alanine abolished proliferation. The insertion into Kv1.5 of a sequence comprising these two residues increased proliferation rate. Moreover, Kv1.3 voltage-dependent transitions from closed to open conformation induced MEK-ERK1/2-dependent Tyr-447 phosphorylation. We conclude that the mechanisms for Kv1.3-induced proliferation involve the accessibility of key docking sites at the C terminus. For one of these sites (Tyr-447) we demonstrated the contribution of MEK/ERK-dependent phosphorylation, which is regulated by voltage-induced conformational changes.	[Teresa Perez-Garcia, M.] Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Edificio IBGM,C Sanz & Fores S-N, Valladolid 47003, Spain; Univ Valladolid, Inst Biol & Genet Mol, Valladolid 47003, Spain; CSIC, Valladolid 47003, Spain; [Jimenez-Perez, Laura] Spanish Minist Econ & Competitividad, Madrid, Spain; [Alvarez-Miguel, Ines] Junta Castilla & Leon, Leon, Spain; [Torres-Merino, Rebeca] Fdn Ramon Areces, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); Spanish Ministry of Economy & Competitiveness	Perez-Garcia, MT (corresponding author), Univ Valladolid, Dept Bioquim & Biol Mol & Fisiol, Edificio IBGM,C Sanz & Fores S-N, Valladolid 47003, Spain.	tperez@ibgm.uva.es	Perez-Garcia, M. Teresa/F-5173-2015; de la Fuente, Miguel A/C-7478-2013; López, José Ramón López/A-5541-2009; Cidad, Pilar/G-1904-2016	Perez-Garcia, M. Teresa/0000-0001-8540-8117; de la Fuente, Miguel A/0000-0003-4619-8756; López, José Ramón López/0000-0002-3870-421X; Cidad, Pilar/0000-0002-6338-7738; Alvarez Miguel, Ines/0000-0001-5054-2172	Ministerio de Economia y Competitividad (MINECO), Instituto de Salud Carlos III (RIC) [RD12/0042/0006]; Programa Estatal de Investigacion [BFU2013-45867-R]; Fundacion Ramon Areces [CIVP16A1843]; Consejeria de Sanidad de la Junta de Castilla y Leon [BIO/VA21/15]	Ministerio de Economia y Competitividad (MINECO), Instituto de Salud Carlos III (RIC); Programa Estatal de Investigacion; Fundacion Ramon Areces; Consejeria de Sanidad de la Junta de Castilla y Leon	This work was supported by grants from the Ministerio de Economia y Competitividad (MINECO), Instituto de Salud Carlos III (RIC, RD12/0042/0006, Red Heracles), and Programa Estatal de Investigacion (BFU2013-45867-R; to J. R. L.-L. and M. T. P.-G.), Fundacion Ramon Areces (CIVP16A1843; to M. A. d l F.), and Consejeria de Sanidad de la Junta de Castilla y Leon (BIO/VA21/15; to M. A. d l F.). The authors declare that they have no conflicts of interest with the contents of this article.	Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Barros F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00049; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bowlby MR, 1997, J GEN PHYSIOL, V110, P601, DOI 10.1085/jgp.110.5.601; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; Cidad P, 2015, PFLUG ARCH EUR J PHY, V467, P1711, DOI 10.1007/s00424-014-1607-y; Cidad P, 2012, ARTERIOSCL THROM VAS, V32, P1299, DOI 10.1161/ATVBAHA.111.242727; Cidad P, 2010, ARTERIOSCL THROM VAS, V30, P1203, DOI 10.1161/ATVBAHA.110.205187; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Colley BS, 2007, NEUROSCIENCE, V144, P531, DOI 10.1016/j.neuroscience.2006.09.055; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Erdogan A, 2005, J VASC RES, V42, P368, DOI 10.1159/000087159; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Hajdu P, 2015, MOL BIOL CELL, V26, P1640, DOI 10.1091/mbc.E14-07-1195; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hu LN, 2012, J BIOL CHEM, V287, P1261, DOI 10.1074/jbc.M111.296798; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Martinez-Marmol R, 2013, J CELL SCI, V126, P5681, DOI 10.1242/jcs.134825; McCormack T, 1999, J BIOL CHEM, V274, P20123, DOI 10.1074/jbc.274.29.20123; Miguel-Velado E, 2005, CIRC RES, V97, P1280, DOI 10.1161/01.RES.0000194322.91255.13; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Vautier F, 2004, GLIA, V48, P337, DOI 10.1002/glia.20088; Villalonga N, 2010, J GEN PHYSIOL, V135, P135, DOI 10.1085/jgp.200910334; Welschoff J, 2014, FASEB J, V28, P2281, DOI 10.1096/fj.13-246348; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983	36	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3569	3580		10.1074/jbc.M115.678995	http://dx.doi.org/10.1074/jbc.M115.678995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26655221	hybrid, Green Published			2022-12-26	WOS:000370854500036
J	Chang, YH; Deng, CR; Dore, AJ; Zhuang, GS				Chang, Yunhua; Deng, Congrui; Dore, Anthony J.; Zhuang, Guoshun			Human Excreta as a Stable and Important Source of Atmospheric Ammonia in the Megacity of Shanghai	PLOS ONE			English	Article							RIVER DELTA REGION; EMISSION INVENTORY; REACTIVE NITROGEN; POLLUTION; AEROSOLS; POLLUTANTS; SULFATE	Although human excreta as a NH3 source has been recognized globally, this source has never been quantitatively determined in cities, hampering efforts to fully assess the causes of urban air pollution. In the present study, the exhausts of 15 ceiling ducts from collecting septic tanks in 13 buildings with 6 function types were selected to quantify NH3 emission rates in the megacity of Shanghai. As a comparison, the ambient NH3 concentrations across Shanghai were also measured at 13 atmospheric monitoring sites. The concentrations of NH3 in the ceiling ducts (2809(-2661)(+5803) mu g m(-3)) outweigh those of the open air (similar to 10 mu g m(-3)) by 2-3 orders of magnitude, and there is no significant difference between different seasons. delta N-15 values of NH3 emitted from two ceiling ducts are also seasonally consistent, suggesting that human excreta may be a stable source of NH3 in urban areas. The NH3 concentration levels were variable and dependent on the different building types and the level of human activity. NH3 emission rates of the six residential buildings (RBNH3) were in agreement with each other. Taking occupation time into account, we confined the range of the average NH3 emission factor for human excreta to be 2-4 times (with the best estimate of 3 times) of the averaged RBNH3 of 66.0 +/- 58.9 g NH3 capita(-1) yr(-1). With this emission factor, the population of similar to 21 million people living in the urban areas of Shanghai annually emitted approximately 1386 Mg NH3, which corresponds to over 11.4% of the total NH3 emissions in the Shanghai urban areas. The spatial distribution of NH3 emissions from human excreta based on population data was calculated for the city of Shanghai at a high-resolution (100x100 m). Our results demonstrate that human excreta should be included in official ammonia emission inventories.	[Chang, Yunhua; Deng, Congrui; Zhuang, Guoshun] Fudan Univ, Dept Environm Sci & Engn, Ctr Atmospher Chem Study, Shanghai 200433, Peoples R China; [Deng, Congrui] Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai 200433, Peoples R China; [Dore, Anthony J.] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland	Fudan University; Fudan University; UK Centre for Ecology & Hydrology (UKCEH)	Deng, CR (corresponding author), Fudan Univ, Dept Environm Sci & Engn, Ctr Atmospher Chem Study, Shanghai 200433, Peoples R China.	congruideng@fudan.edu.cn; gzhuang@fudan.edu.cn		Chang, Yunhua/0000-0002-1622-5330	National Natural Science Foundation of China [21377029, 21277030, 41405115]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported financially by National Natural Science Foundation of China (Grant Nos. 21377029, 21277030 and 41405115) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada T, 2006, J HEALTH SCI, V52, P585, DOI 10.1248/jhs.52.585; Asman WAH, 1998, NEW PHYTOL, V139, P27, DOI 10.1046/j.1469-8137.1998.00180.x; BUIJSMAN E, 1987, ATMOS ENVIRON, V21, P1009, DOI 10.1016/0004-6981(87)90230-7; Chang Y., 2014, ATMOS CHEM PHYS DISC, V14, P8495, DOI DOI 10.5194/ACPD-14-8495-2014; Chang YH, 2012, ENVIRON SCI TECHNOL, V46, P13035, DOI 10.1021/es304806k; Cui SH, 2013, P NATL ACAD SCI USA, V110, P2052, DOI 10.1073/pnas.1221638110; Driscoll CT, 2003, BIOSCIENCE, V53, P357, DOI 10.1641/0006-3568(2003)053[0357:NPITNU]2.0.CO;2; Felix JD, 2013, RAPID COMMUN MASS SP, V27, P2239, DOI 10.1002/rcm.6679; Fu X, 2013, ATMOS ENVIRON, V70, P39, DOI 10.1016/j.atmosenv.2012.12.034; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gong LW, 2013, ATMOS ENVIRON, V77, P893, DOI 10.1016/j.atmosenv.2013.04.079; HEALY TV, 1970, J GEOPHYS RES, V75, P2317, DOI 10.1029/JC075i012p02317; Huang C, 2011, ATMOS CHEM PHYS, V11, P4105, DOI 10.5194/acp-11-4105-2011; Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774; Huang X, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004161; Iyobe T, 2004, J HEALTH SCI, V50, P148; Kong L, 2014, COMING GRIPS AMMONIA; Li KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067018; Liu DW, 2014, ANAL CHEM, V86, P3787, DOI 10.1021/ac403756u; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Meng ZY, 2011, ATMOS CHEM PHYS, V11, P6139, DOI 10.5194/acp-11-6139-2011; Moller D, 1982, Z Gesamte Hyg, V28, P797; Olivier JGJ, 1998, ENVIRON POLLUT, V102, P135, DOI 10.1016/S0269-7491(98)80026-2; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Reis S, 2009, ATMOS CHEM PHYS, V9, P7657, DOI 10.5194/acp-9-7657-2009; Riddick SN, 2012, ATMOS ENVIRON, V55, P319, DOI 10.1016/j.atmosenv.2012.02.052; Roe SM, 2004, ESTIMATING AMMONIA E; Rumsey IC, 2014, ATMOS CHEM PHYS, V14, P5639, DOI 10.5194/acp-14-5639-2014; Schneider A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024008; Seinfeld J.H., 2012, ATMOSPHERIC CHEM PHY; Smith D, 2008, RAPID COMMUN MASS SP, V22, P783, DOI 10.1002/rcm.3434; Sutton MA, 2000, ATMOS ENVIRON, V34, P855, DOI 10.1016/S1352-2310(99)00362-3; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; Wang SX, 2011, ENVIRON SCI TECHNOL, V45, P9293, DOI 10.1021/es2022347; Wang Y, 2013, ATMOS CHEM PHYS, V13, P2635, DOI 10.5194/acp-13-2635-2013; Williams PT, 2005, WASTE TREATMENT AND DISPOSAL, 2ND EDITION, P1, DOI 10.1002/0470012668; Xu W, 2014, ATMOS POLLUT RES, V5, P455, DOI 10.5094/APR.2014.053; Yao XH, 2013, BIOGEOSCIENCES, V10, P7913, DOI 10.5194/bg-10-7913-2013; Ye XN, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024019; Yi K, 2011, SENSORS, V14, P3207	40	19	21	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144661	10.1371/journal.pone.0144661	http://dx.doi.org/10.1371/journal.pone.0144661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656636	Green Published, gold, Green Accepted			2022-12-26	WOS:000366715900081
J	Zaleska, M; Fogl, C; Kho, AL; Ababou, A; Ehler, E; Pfuhl, M				Zaleska, Mariola; Fogl, Claudia; Kho, Ay Lin; Ababou, Abdessamad; Ehler, Elisabeth; Pfuhl, Mark			The Cardiac Stress Response Factor Ms1 Can Bind to DNA and Has a Function in the Nucleus	PLOS ONE			English	Article							STRIATED-MUSCLE ACTIVATOR; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; FORKHEAD DOMAIN; PROTEIN; PHOSPHORYLATION; STARS; HELIX; GENE; RECOGNITION	Ms1 (also known as STARS and ABRA) has been shown to act as an early stress response gene in processes as different as hypertrophy in skeletal and cardiac muscle and growth of collateral blood vessels. It is important for cardiac development in zebrafish and is upregulated in mouse models for cardiac hypertrophy as well as in human failing hearts. Ms1 possesses actin binding sites at its C-terminus and is usually found in the cell bound to actin filaments in the cytosol or in sarcomeres. We determined the NMR structure of the only folded domain of Ms1 comprising the second actin binding site called actin binding domain 2 (ABD2, residues 294-375), and found that it is similar to the winged helix-turn-helix fold adopted mainly by DNA binding domains of transcriptional factors. In vitro experiments show specific binding of this domain, in combination with a newly discovered AT-hook motif located N-terminally, to the sequence (A/C/G) AAA (C/A). NMR and fluorescence titration experiments confirm that this motif is indeed bound specifically by the recognition helix. In neonatal rat cardiomyocytes endogenous Ms1 is found in the nucleus in a spotted pattern, reminiscent of PML bodies. In adult rat cardiomyocytes Ms1 is exclusively found in the sarcomere. A nuclear localisation site in the N-terminus of the protein is required for nuclear localisation. This suggests that Ms1 has the potential to act directly in the nucleus through specific interaction with DNA in development and potentially as a response to stress in adult tissues.	[Zaleska, Mariola; Kho, Ay Lin; Ehler, Elisabeth; Pfuhl, Mark] Kings Coll London, Cardiovasc & Randall Div, London WC2R 2LS, England; [Fogl, Claudia] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Ababou, Abdessamad] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of London; King's College London; University of Leicester; University of Cambridge	Pfuhl, M (corresponding author), Kings Coll London, Cardiovasc & Randall Div, London WC2R 2LS, England.	mark.pfuhl@kcl.ac.uk	Kho, Ay Lin/M-4214-2013	Kho, Ay Lin/0000-0002-9753-2091; Pfuhl, Mark/0000-0001-9592-6639; Ehler, Elisabeth/0000-0001-5646-5964	Departmental BBSRC studentship; BHF Centre of Excellence at KCL, studentship programme; MRC [MR/J010456/1]; BHF Centre of Research Excellence at King's College London; BBSRC; MRC [G0400153, G0600251] Funding Source: UKRI; British Heart Foundation [PG/11/123/29317] Funding Source: researchfish; Medical Research Council [MR/J010456/1, G0600251, G0400153] Funding Source: researchfish	Departmental BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF Centre of Excellence at KCL, studentship programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF Centre of Research Excellence at King's College London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Departmental BBSRC studentship to Claudia Fogl, administered by the then Department of Biochemistry, University of Leicester, no grant number (http://www.bbsrc.ac.uk). It was also supported by the BHF Centre of Excellence at KCL, studentship programme, PhD studentship to Mariola Zaleska via Mark Pfuhl, no grant number (https://www.bhf.org.uk). AK is paid from MRC grant MR/J010456/1 which was awarded to Prof M Gautel, KCL.; We would like to thank Andrea Koekemoer and Nilesh Samani for the gift of full length mouse Ms1 cloned Into the mammalian expression vector pcDNA 3.1(+); Xiaowen Yang and the protein expression lab (PROTEX) at the University of Leicester for the cloning of bacterial expression constructs; Fred Muskett and Andrew Atkinson for help with NMR spectrometers and structure calculation; Steven Terry for help with HeLa & COS cells; Dr. Shiney Reji, St. Thomas Hospital, London for the preparation of ARCs and Mathias Gautel for help and support. MZ was funded through a PhD studentship awarded through the BHF Centre of Research Excellence at King's College London, CF was funded through a BBSRC studentship to the University of Leicster, AK is funded through the MRC (MR/J010456/1).	ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; BERG OG, 1982, BIOPHYS CHEM, V15, P41, DOI 10.1016/0301-4622(82)87015-4; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Chong NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040966; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fogl C, 2011, PROTEINS; Fonfria-Subiros E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037120; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Koekemoer AL, 2009, FEBS LETT, V583, P2964, DOI 10.1016/j.febslet.2009.08.011; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee TY, 2011, NUCLEIC ACIDS RES, V39, pD777, DOI 10.1093/nar/gkq970; Lin JZ, 2011, PROTEIN SCI, V20, P216, DOI 10.1002/pro.548; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Mahadeva H, 2002, FEBS LETT, V521, P100, DOI 10.1016/S0014-5793(02)02833-8; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Murphy TC, 2004, INVEST OPHTH VIS SCI, V45, P2531, DOI 10.1167/iovs.04-0167; Ounzain S, 2012, MOL CELL BIOL, V32, P1830, DOI 10.1128/MCB.06374-11; Pang TL, 2010, J CELL SCI, V123, P3745, DOI 10.1242/jcs.064709; REEVES R, 1990, J BIOL CHEM, V265, P8573; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Risner LE, 2013, J BIOL CHEM, V288, P29901, DOI 10.1074/jbc.M113.474858; Sarvan S, 2011, NAT STRUCT MOL BIOL, V18, P857, DOI 10.1038/nsmb.2093; Schroder S, 2011, BIOCHEM J, V435, P651, DOI 10.1042/BJ20101810; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Troidl K, 2009, ARTERIOSCL THROM VAS, V29, P2093, DOI 10.1161/ATVBAHA.109.195305; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Vacha P, 2013, BIOPHYS CHEM, V184, P68, DOI 10.1016/j.bpc.2013.09.002; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wallace MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00469; Zhang M, 2006, CIRCULATION, V113, P1235, DOI 10.1161/CIRCULATIONAHA.105.581397; Zhang X, 2012, P NATL ACAD SCI USA, V109, P12485, DOI 10.1073/pnas.1207821109; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144614	10.1371/journal.pone.0144614	http://dx.doi.org/10.1371/journal.pone.0144614			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656831	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900071
J	Bordas, R; Lefevre, C; Veeckmans, B; Pitt-Francis, J; Fetita, C; Brightling, CE; Kay, D; Siddiqui, S; Burrowes, KS				Bordas, Rafel; Lefevre, Christophe; Veeckmans, Bart; Pitt-Francis, Joe; Fetita, Catalin; Brightling, Christopher E.; Kay, David; Siddiqui, Salman; Burrowes, Kelly S.			Development and Analysis of Patient-Based Complete Conducting Airways Models	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; 3-DIMENSIONAL MODEL; BRONCHIAL TREE; VENTILATION DEFECTS; PRESSURE DROP; HUMAN LUNGS; RESISTANCE; ASTHMA; CT; HETEROGENEITY	The analysis of high-resolution computed tomography (CT) images of the lung is dependent on inter-subject differences in airway geometry. The application of computational models in understanding the significance of these differences has previously been shown to be a useful tool in biomedical research. Studies using image-based geometries alone are limited to the analysis of the central airways, down to generation 6-10, as other airways are not visible on high-resolution CT. However, airways distal to this, often termed the small airways, are known to play a crucial role in common airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Other studies have incorporated an algorithmic approach to extrapolate CT segmented airways in order to obtain a complete conducting airway tree down to the level of the acinus. These models have typically been used for mechanistic studies, but also have the potential to be used in a patient-specific setting. In the current study, an image analysis and modelling pipeline was developed and applied to a number of healthy (n = 11) and asthmatic (n = 24) CT patient scans to produce complete patient-based airway models to the acinar level (mean terminal generation 15.8 +/- 0.47). The resulting models are analysed in terms of morphometric properties and seen to be consistent with previous work. A number of global clinical lung function measures are compared to resistance predictions in the models to assess their suitability for use in a patient-specific setting. We show a significant difference (p < 0.01) in airways resistance at all tested flow rates in complete airway trees built using CT data from severe asthmatics (GINA 3-5) versus healthy subjects. Further, model predictions of airways resistance at all flow rates are shown to correlate with patient forced expiratory volume in one second (FEV1) (Spearman rho = -0.65, p < 0.001) and, at low flow rates (0.00017 L/s), FEV1 over forced vital capacity (FEV1/FVC) (rho = -0.58, p < 0.001). We conclude that the pipeline and anatomical models can be used directly in mechanistic modelling studies and can form the basis for future patient-based modelling studies.	[Bordas, Rafel; Pitt-Francis, Joe; Kay, David; Burrowes, Kelly S.] Univ Oxford, Dept Comp Sci, Computat Biol, Oxford, England; [Lefevre, Christophe; Fetita, Catalin] Inst Mines Telecom, Telecom SudParis, CNRS, ARTEMIS Dept,UMR 8145, Paris, France; [Veeckmans, Bart] Materialise NV, Leuven, Belgium; [Brightling, Christopher E.; Siddiqui, Salman] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); IMT - Institut Mines-Telecom; IMT Atlantique; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Cite; University of Leicester	Bordas, R (corresponding author), Univ Oxford, Dept Comp Sci, Computat Biol, Oxford, England.	rafel.bordas@cs.ox.ac.uk		brightling, chris/0000-0002-9345-4903; Burrowes, Kelly/0000-0002-6369-2951; Kay, David/0000-0003-4984-3669; Pitt-Francis, Joe/0000-0002-5094-5403; Siddiqui, Salman/0000-0003-3770-7870; Bordas, Rafel/0000-0002-0856-544X	European Union [270194]	European Union(European Commission)	This work was funded by the European Union Framework 7 AirPROM (Airway Disease Predicting Outcomes through Patient Specific Computational Modelling) project (Grant Agreement No. 270194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrowes KS, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0057; Campana L, 2009, J APPL PHYSIOL, V106, P1293, DOI 10.1152/japplphysiol.91428.2008; Choi JS, 2011, THESIS; De Backer JW, 2008, J BIOMECH, V41, P106, DOI 10.1016/j.jbiomech.2007.07.009; De Backer JW, 2010, RADIOLOGY, V257, P854, DOI 10.1148/radiol.10100322; Fetita C., 2009, P 2 INT WORKSHOP PUL, P215; Fetita C, 2010, PROC SPIE, V7625, DOI 10.1117/12.844445; Fetita CI, 2004, IEEE T MED IMAGING, V23, P1353, DOI 10.1109/TMI.2004.826945; Gillis HL, 1999, ANN BIOMED ENG, V27, P14, DOI 10.1114/1.161; Gonem S, 2014, CLIN EXP ALLERGY, V44, P499, DOI 10.1111/cea.12257; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; Hedges KL, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0090; HORSFIEL.K, 1971, J APPL PHYSIOL, V31, P207, DOI 10.1152/jappl.1971.31.2.207; HORSFIELD K, 1976, RESP PHYSIOL, V26, P351, DOI 10.1016/0034-5687(76)90005-0; Hunter P, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0004; HYATT RE, 1963, J CLIN INVEST, V42, P29, DOI 10.1172/JCI104693; Ismail M, 2013, INT J NUMER METH BIO, V29, P1285, DOI 10.1002/cnm.2577; Kim M, 2015, INT J NUMER IN PRESS; Kindlmann GL, 2009, IEEE T VIS COMPUT GR, V15, P1415, DOI 10.1109/TVCG.2009.177; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Leary D, 2014, J APPL PHYSIOL, V117, P353, DOI 10.1152/japplphysiol.00881.2013; Leary D, 2012, J APPL PHYSIOL, V112, P167, DOI 10.1152/japplphysiol.00633.2011; Lutchen KR, 1997, J APPL PHYSIOL, V83, P1192, DOI 10.1152/jappl.1997.83.4.1192; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; Ma BS, 2006, ANN BIOMED ENG, V34, P1691, DOI 10.1007/s10439-006-9184-7; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P371, DOI 10.1016/0034-5687(70)90093-9; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; Schultz T, 2010, IEEE T VIS COMPUT GR, V16, P109, DOI 10.1109/TVCG.2009.44; Serra J., 1983, IMAGE ANAL MATH MORP; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Swan AJ, 2012, J THEOR BIOL, V300, P222, DOI 10.1016/j.jtbi.2012.01.042; Tawhai MH, 2000, ANN BIOMED ENG, V28, P793, DOI 10.1114/1.1289457; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; Tawhai MH, 2001, RESP PHYSIOL, V127, P249, DOI 10.1016/S0034-5687(01)00239-0; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Tgavalekos NT, 2003, ANN BIOMED ENG, V31, P363, DOI 10.1114/1.1557972; Van Holsbeke CS, 2013, RESP CARE, pe127; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; Wongviriyawong C, 2012, J APPL PHYSIOL, V112, P237, DOI 10.1152/japplphysiol.01400.2010; Yin YB, 2010, J BIOMECH, V43, P2159, DOI 10.1016/j.jbiomech.2010.03.048	43	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144105	10.1371/journal.pone.0144105	http://dx.doi.org/10.1371/journal.pone.0144105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656288	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600023
J	Gonzalez-Alcaide, G; Park, J; Huamani, C; Belinchon, I; Ramos, JM				Gonzalez-Alcaide, Gregorio; Park, Jinseo; Huamani, Charles; Belinchon, Isabel; Ramos, Jose M.			Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942-2013)	PLOS ONE			English	Article							BIBLIOMETRIC ANALYSIS; SCIENTIFIC COLLABORATION; COAUTHORSHIP NETWORKS; MULTI-AUTHORSHIP; PUVA-ETRETINATE; DOUBLE-BLIND; PUBLICATION; PLACEBO; WORLDWIDE; ARTICLES	Background Although researchers have worked in collaboration since the origins of modern science and the publication of the first scientific journals in the eighteenth century, this phenomenon has acquired exceptional importance in the last several decades. Since the mid-twentieth century, new knowledge has been generated from within an ever-growing network of investigators, working cooperatively in research groups across countries and institutions. Cooperation is a crucial determinant of academic success. Objective The aim of the present paper is to analyze the evolution of scientific collaboration at the micro level, with regard to the scientific production generated on psoriasis research. Methods A bibliographic search in the Medline database containing the MeSH terms "psoriasis" or "psoriatic arthritis" was carried out. The search results were limited to articles, reviews and letters. After identifying the co-authorships of documents on psoriasis indexed in the Medline database (1942-2013), various bibliometric indicators were obtained, including the average number of authors per document and degree of multi-authorship over time. In addition, we performed a network analysis to study the evolution of certain features of the co-authorship network as a whole: average degree, size of the largest component, clustering coefficient, density and average distance. We also analyzed the evolution of the giant component to characterize the changing research patterns in the field, and we calculated social network indicators for the nodes, namely betweenness and closeness. Results The main active research clusters in the area were identified, along with their authors of reference. Our analysis of 28,670 documents sheds light on different aspects related to the evolution of scientific collaboration in the field, including the progressive increase in the mean number of co-authors (which stood at 5.17 in the 2004-2013 decade), and the rise in multi-authored papers signed by many different authors (in the same decade, 25.77% of the documents had between 6 and 9 co-authors, and 10.28% had 10 or more). With regard to the network indicators, the average degree gradually increased up to 10.97 in the study period. The percentage of authors pertaining to the largest component also rose to 73.02% of the authors. The clustering coefficient, on the other hand, remained stable throughout the entire 70-year period, with values hovering around 0.9. Finally, the average distance peaked in the decades 1974-1983 (8.29) and 1984-2003 (8.12) then fell over the next two decades, down to 5.25 in 2004-2013. The construction of the co-authorship network (threshold of collaboration >= 10 co-authored works) revealed a giant component of 161 researchers, containing 6 highly cohesive sub-components. Conclusions Our study reveals the existence of a growing research community in which collaboration is increasingly important. We can highlight an essential feature associated with scientific collaboration: multi-authored papers, with growing numbers of collaborators contributing to them, are becoming more and more common, therefore the formation of research groups of increasing depth (specialization) and breadth (multidisciplinarity) is now a cornerstone of research success.	[Gonzalez-Alcaide, Gregorio] Univ Valencia, Dept Hist Sci & Documentat, Valencia, Spain; [Park, Jinseo] Korea Inst Sci & Technol Informat, Deajeon, South Korea; [Huamani, Charles] Inst Nacl Salud, Lima, Peru; [Belinchon, Isabel] Hosp Gen Univ Alicante, Dept Dermatol, Alicante, Spain; [Ramos, Jose M.] Univ Miguel Hernandez Elche, Dept Med, Alicante, Spain; [Ramos, Jose M.] Hosp Gen Univ Alicante, Dept Internal Med, Alicante, Spain	University of Valencia; Korea Institute of Science & Technology Information (KISTI); Instituto Nacional de Salud - Peru; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; General University Hospital of Alicante	Gonzalez-Alcaide, G (corresponding author), Univ Valencia, Dept Hist Sci & Documentat, Valencia, Spain.	gregorio.gonzalez@uv.es	Ramos, Jose M./B-6420-2018; Huamaní, Charles/AAA-6790-2021; Gonzalez-Alcaide, Gregorio/K-7679-2014	Ramos, Jose M./0000-0002-6501-9867; Huamaní, Charles/0000-0003-2090-6531; Park, Jinseo/0000-0003-1899-1861; Gonzalez-Alcaide, Gregorio/0000-0003-3853-5222	Generalitat Valenciana [GV/2015/049]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work has been supported by the Generalitat Valenciana (Project GV/2015/049). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales ME, 2011, AM J PREV MED, V41, P112, DOI 10.1016/j.amepre.2011.03.018; BAYER AE, 1991, J HIGH EDUC, V62, P613, DOI 10.2307/1982193; Bian J, 2014, J BIOMED INFORM, V52, P130, DOI 10.1016/j.jbi.2014.01.015; Bozeman B, 2013, J TECHNOL TRANSFER, V38, P1, DOI 10.1007/s10961-012-9281-8; Braun T, 2001, SCIENTOMETRICS, V51, P499, DOI 10.1023/A:1019643002560; Burt R. S, 1992, STRUCTURAL HOLES; Chandra A, 2015, MOL IMMUNOL, V64, P313, DOI 10.1016/j.molimm.2014.12.014; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Chow DS, 2015, AM J ROENTGENOL, V204, pW52, DOI 10.2214/AJR.14.12852; CRANE D, 1969, AM SOCIOL REV, V34, P335, DOI 10.2307/2092499; de Montjoye YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05277; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Della Mea V, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S26; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Glanzel W, 2002, LIBR TRENDS, V50, P461; Glanzel W., 2005, HDB QUANTITATIVE SCI, P257, DOI [DOI 10.1007/1-4020-2755-9_12, DOI 10.1007/1-4020-2755-9]; Goff KL, 2015, BRIT J DERMATOL, V172, P1665, DOI 10.1111/bjd.13715; Gonzalez Alcaide G, 2014, REV ESP DOC CIENT, V37, pe62, DOI [10.3989/redc.2014.4.1186, DOI 10.3989/REDC.2014.4.1186]; Gonzalez-Alcaide G, 2013, REV SOC BRAS MED TRO, V46, P719, DOI 10.1590/0037-8682-0207-2013; Gonzalez-Alcaide G, 2013, ALCOHOL CLIN EXP RES, V37, pE381, DOI 10.1111/j.1530-0277.2012.01934.x; Gonzalez-Alcaide G, 2012, REV INST MED TROP SP, V54, P219, DOI 10.1590/S0036-46652012000400007; Gonzalez-Teruel A, 2015, SCIENTOMETRICS, V103, P687, DOI 10.1007/s11192-015-1548-z; GORDON MD, 1980, SCIENTOMETRICS, V2, P193, DOI 10.1007/BF02016697; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gutierrez-Vela Maria M, 2012, J Clin Exp Dent, V4, pe112, DOI 10.4317/jced.50646; Huang SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103733; Ioannidis JPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101698; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jamshidi AR, 2013, RHEUMATOL INT, V33, P361, DOI 10.1007/s00296-012-2428-y; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; Kennedy MS, 2014, J NURS SCHOLARSHIP, V46, P416, DOI 10.1111/jnu.12093; Kretschmer H, 2004, SCIENTOMETRICS, V60, P409, DOI 10.1023/B:SCIE.0000034383.86665.22; Kshitij A, 2015, SCIENTOMETRICS, V102, P285, DOI 10.1007/s11192-014-1310-y; Lambiotte R, 2009, J INFORMETR, V3, P180, DOI 10.1016/j.joi.2009.03.007; Laudel G, 2002, RES EVALUAT, V11, P3, DOI 10.3152/147154402781776961; LAWRENCE CM, 1984, BRIT J DERMATOL, V110, P221, DOI 10.1111/j.1365-2133.1984.tb07471.x; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Long JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001434; Mali F, 2012, UNDERST COMPLEX SYST, P195, DOI 10.1007/978-3-642-23068-4_6; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; Nabout JC, 2015, SCIENTOMETRICS, V102, P357, DOI 10.1007/s11192-014-1385-5; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; Newman ME, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, DOI 10.1103/PhysRevE.69.026113]; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; PARKER S, 1984, BRIT J DERMATOL, V110, P215, DOI 10.1111/j.1365-2133.1984.tb07470.x; Pavlovsky L, 2009, CLIN EXP DERMATOL, V34, pE91, DOI 10.1111/j.1365-2230.2008.03199.x; Persson O, 2004, SCIENTOMETRICS, V60, P421, DOI 10.1023/B:SCIE.0000034384.35498.7d; PETERS HPF, 1991, SCIENTOMETRICS, V20, P235, DOI 10.1007/BF02018157; Price D. de S., 1975, CI INFORM RIO DE JAN, V4, P27; Ram S, 2014, DESIDOC J LIB INF TE, V34, P46, DOI 10.14429/djlit.34.5945; Ramos JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-55; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Richard MA, 2013, J EUR ACAD DERMATOL, V27, P2, DOI 10.1111/jdv.12162; Sahu SR, 2014, SCIENTOMETRICS, V98, P2161, DOI 10.1007/s11192-013-1127-0; Schneider J.W, 2009, CELEBRATING SCHOLARL, V5, P9, DOI DOI 1458990/FILE/1458992.PDF#PAGE=11; Schoeffel N, 2010, J EUR ACAD DERMATOL, V24, P85, DOI 10.1111/j.1468-3083.2009.03293.x; SCHUBERT A, 1991, SCIENTOMETRICS, V20, P317, DOI 10.1007/BF02018161; Tsay MY, 2005, J MED LIBR ASSOC, V93, P450; Vanni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093376; Velden T, 2010, SCIENTOMETRICS, V85, P219, DOI 10.1007/s11192-010-0224-6; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitfield J, 2008, NATURE, V455, P720, DOI 10.1038/455720a; WILLKENS RF, 1984, ARTHRITIS RHEUM-US, V27, P376, DOI 10.1002/art.1780270403; Wu B, 2009, SWSM 09, P33; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Yu Q, 2013, INT J CARDIOL, V167, P631, DOI 10.1016/j.ijcard.2012.09.134; Yu Q, 2011, SCIENTOMETRICS, V89, P553, DOI 10.1007/s11192-011-0465-z; Zare-Farashbandi F, 2014, J RES MED SCI, V19, P41; Zhang CC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-52; Zhao ZG, 2011, INT J OPHTHALMOL-CHI, V4, P115, DOI 10.3980/j.issn.2222-3959.2011.02.01	73	20	20	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144837	10.1371/journal.pone.0144837	http://dx.doi.org/10.1371/journal.pone.0144837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658481	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600094
J	Vas, J; Andersen, IL				Vas, Judit; Andersen, Inger Lise			Density-Dependent Spacing Behaviour and Activity Budget in Pregnant, Domestic Goats (Capra hircus)	PLOS ONE			English	Article							GROUP-SIZE; SOCIAL INTERACTIONS; FEEDING-BEHAVIOR; DAIRY GOATS; SHEEP; EWES; AGE; REQUIREMENTS; ASSOCIATIONS; ORGANIZATION	Very little is known about the spacing behaviour in social groups of domestic goats (Capra hircus) in the farm environment. In this experiment, we studied interindividual distances, movement patterns and activity budgets in pregnant goats housed at three different densities. Norwegian dairy goats were kept in stable social groups of six animals throughout pregnancy at 1, 2 or 3 m(2) per individual and their spacing behaviours (i.e. distance travelled, nearest and furthest neighbour distance) and activity budgets (e.g. resting, feeding, social activities) were monitored. Observations were made in the first, second and last thirds of pregnancy in the mornings, at noon and in the afternoons of each of these phases (4.5 hours per observation period). The findings show that goats held at animal densities of 2 and 3 m(2) moved longer distances when they had more space per animal and kept larger nearest and furthest neighbour distances when compared to the 1 m(2) per animal density. Less feeding activity was observed at the high animal density compared to the medium and low density treatments. The phase of gestation also had an impact on almost all behavioural variables. Closer to parturition, animals moved further distances and the increase in nearest and furthest neighbour distance was more pronounced at the lower animal densities. During the last period of gestation, goats spent less time feeding and more on resting, social behaviours and engaging in other various activities. Our data suggest that more space per goat is needed for goats closer to parturition than in the early gestation phase. We concluded that in goats spacing behaviour is density-dependent and changes with stages of pregnancy and activities. Finally, the lower density allowed animals to express individual preferences regarding spacing behaviour which is important in ensuring good welfare in a farming situation.	[Vas, Judit; Andersen, Inger Lise] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Norwegian University of Life Sciences	Vas, J (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	b.vas.judit@gmail.com	Vas, Judit/GRJ-7640-2022		EU	EU(European Commission)	This study was conducted in frame of the Animal Welfare Indicators project (AWIN), which was financed by the EU VII Framework programme (FP7-KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENUGA MK, 1991, SMALL RUMINANT RES, V4, P245, DOI 10.1016/0921-4488(91)90148-J; Andersen IL, 2007, APPL ANIM BEHAV SCI, V108, P89, DOI 10.1016/j.applanim.2006.10.015; ARNOLD GW, 1981, APPL ANIM ETHOL, V7, P239, DOI 10.1016/0304-3762(81)90081-X; ARNOLD GW, 1985, APPL ANIM BEHAV SCI, V14, P173, DOI 10.1016/0168-1591(85)90028-0; ARNOLD GW, 1978, ETHOLOGY FREE RANGIN, P51; Arnould U, 2003, APPL ANIM BEHAV SCI, V84, P281, DOI 10.1016/j.applanim.2003.07.003; Aschwanden J, 2008, APPL ANIM BEHAV SCI, V114, P116, DOI 10.1016/j.applanim.2008.02.002; Aschwanden J, 2008, PHYSIOL BEHAV, V95, P641, DOI 10.1016/j.physbeh.2008.09.016; Aschwanden J, 2009, APPL ANIM BEHAV SCI, V119, P171, DOI 10.1016/j.applanim.2009.04.005; Aschwanden J, 2009, APPL ANIM BEHAV SCI, V119, P180, DOI 10.1016/j.applanim.2009.04.004; Averos X, 2010, ANIMAL, V4, P777, DOI 10.1017/S1751731109991613; Averos X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094767; Averos X, 2014, APPL ANIM BEHAV SCI, V150, P17, DOI 10.1016/j.applanim.2013.11.002; Boe KE, 2006, APPL ANIM BEHAV SCI, V98, P249, DOI 10.1016/j.applanim.2005.10.001; Boe KE, 2013, APPL ANIM BEHAV SCI, V147, P112, DOI 10.1016/j.applanim.2013.04.024; Boe KE, 2010, APPL ANIM BEHAV SCI, V125, P109, DOI 10.1016/j.applanim.2010.04.011; Calhim S, 2006, ANIM BEHAV, V72, P31, DOI 10.1016/j.anbehav.2005.08.013; Chojnacki RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094253; Cvikel N, 2015, CURR BIOL, V25, P206, DOI 10.1016/j.cub.2014.11.010; Dettmer AM, 2014, PSYCHONEUROENDOCRINO, V42, P59, DOI 10.1016/j.psyneuen.2014.01.002; Ehrlenbruch R, 2010, APPL ANIM BEHAV SCI, V126, P105, DOI 10.1016/j.applanim.2010.06.004; Ehrlenbruch R, 2010, APPL ANIM BEHAV SCI, V122, P35, DOI 10.1016/j.applanim.2009.11.004; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; evez I. R. C., 1997, ETOLOGIA, V5, P19; Faerevik G, 2007, APPL ANIM BEHAV SCI, V108, P215, DOI 10.1016/j.applanim.2007.01.010; Fedele V, 2002, LIVEST PROD SCI, V74, P19, DOI 10.1016/S0301-6226(01)00285-8; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Gonyou HW, 2006, J ANIM SCI, V84, P229, DOI 10.2527/2006.841229x; Gorgulu M, 2008, SMALL RUMINANT RES, V78, P41, DOI 10.1016/j.smallrumres.2008.04.004; Haugland I, 2010, EFFEKT AKTIVITET RES; Hediger H., 1955, STUDIES PSYCHOL BEHA; HUTSON GD, 1984, APPL ANIM BEHAV SCI, V12, P111, DOI 10.1016/0168-1591(84)90101-1; Jorgensen GHM, 2011, ETHOLOGY, V117, P597, DOI 10.1111/j.1439-0310.2011.01908.x; Jorgensen GHM, 2007, APPL ANIM BEHAV SCI, V107, P239, DOI 10.1016/j.applanim.2006.10.007; Jorgensen GHM, 2009, SMALL RUMINANT RES, V87, P57, DOI 10.1016/j.smallrumres.2009.10.002; KEELING L, 1995, APPL ANIM BEHAV SCI, V44, P171, DOI 10.1016/0168-1591(95)00612-V; Leone EH, 2008, POULTRY SCI, V87, P3, DOI 10.3382/ps.2007-00026; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; Leone EH, 2007, APPL ANIM BEHAV SCI, V102, P39, DOI 10.1016/j.applanim.2006.03.004; LICKLITER RE, 1987, APPL ANIM BEHAV SCI, V19, P137, DOI 10.1016/0168-1591(87)90210-3; Liste G, 2015, APPL ANIM BEHAV SCI, V163, P144, DOI 10.1016/j.applanim.2014.11.013; Loretz C, 2004, APPL ANIM BEHAV SCI, V87, P275, DOI 10.1016/j.applanim.2004.01.005; Mangalam M, 2013, ANIM BEHAV, V85, P763, DOI 10.1016/j.anbehav.2013.01.019; MANSON FJ, 1990, APPL ANIM BEHAV SCI, V26, P69, DOI 10.1016/0168-1591(90)90088-U; McBride G., 1971, P53; Michelena P, 2009, BEHAV ECOL, V20, P145, DOI 10.1093/beheco/arn126; Michelena P, 2008, APPL ANIM BEHAV SCI, V112, P81, DOI 10.1016/j.applanim.2007.06.020; Miranda-de la Lama GC, 2011, APPL ANIM BEHAV SCI, V134, P48, DOI 10.1016/j.applanim.2011.06.004; NEWBERRY RC, 1990, APPL ANIM BEHAV SCI, V25, P125, DOI 10.1016/0168-1591(90)90075-O; NIELSEN BL, 1995, LIVEST PROD SCI, V44, P73, DOI 10.1016/0301-6226(95)00060-X; OBRIEN PH, 1988, APPL ANIM BEHAV SCI, V21, P209, DOI 10.1016/0168-1591(88)90110-4; Olofsson J, 1999, J DAIRY SCI, V82, P69, DOI 10.3168/jds.S0022-0302(99)75210-0; Hai PV, 2014, APPL ANIM BEHAV SCI, V159, P50, DOI 10.1016/j.applanim.2014.07.004; Robbers Y, 2015, PHYSIOL BEHAV, V139, P351, DOI 10.1016/j.physbeh.2014.11.020; ROSENBLUM LA, 1964, ANIM BEHAV, V12, P338, DOI 10.1016/0003-3472(64)90021-1; Sanches C, 1998, CHICKITIZER SOFTWARE; Serment A, 2012, APPL ANIM BEHAV SCI, V141, P130, DOI 10.1016/j.applanim.2012.08.004; SHANK C C, 1972, Zeitschrift fuer Tierpsychologie, V30, P488; Shi JB, 2006, J ETHOL, V24, P117, DOI 10.1007/s10164-005-0170-6; Sibbald AM, 2000, APPL ANIM BEHAV SCI, V70, P49, DOI 10.1016/S0168-1591(00)00145-3; Simensen E, 2010, ACTA AGR SCAND A-AN, V60, P187, DOI 10.1080/09064702.2010.509809; Skotnicka E, 2003, COMP BIOCHEM PHYS C, V134, P385, DOI 10.1016/S1532-0456(03)00007-3; Vas J, 2013, APPL ANIM BEHAV SCI, V147, P117, DOI 10.1016/j.applanim.2013.04.009	64	10	10	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144583	10.1371/journal.pone.0144583	http://dx.doi.org/10.1371/journal.pone.0144583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657240	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500044
J	Timm-Davis, LL; DeWitt, TJ; Marshall, CD				Timm-Davis, Lori L.; DeWitt, Thomas J.; Marshall, Christopher D.			Divergent Skull Morphology Supports Two Trophic Specializations in Otters (Lutrinae)	PLOS ONE			English	Article							SEA OTTERS; SEXUAL-DIMORPHISM; SARCOMERE-LENGTH; FEEDING ECOLOGY; BITE FORCE; LUTRA-PERSPICILLATA; FORAGING PATTERNS; PREY SELECTION; CLAWLESS OTTER; FIBER LENGTH	Variation in terrestrial mammalian skull morphology is known to constrain feeding performance, which in turn influences dietary habits and ultimately fitness. Among mustelids, otters have evolved two feeding specializations: underwater raptorial capture of prey (mouth-oriented) and capture of prey by hand (hand-oriented), both of which have likely associations with morphology and bite performance. However, feeding biomechanics and performance data for otters are sparse. The first goal of this study was to investigate the relationships between feeding morphology and bite performance among two mouth-oriented piscivores (Pteronura brasiliensis and Lontra canadensis) and two hand-oriented invertebrate specialists (Enhydra lutris and Aonyx cinerea). Since other vertebrate taxa that are mouth-oriented piscivores tend to possess longer skulls and mandibles, with jaws designed for increased velocity at the expense of biting capability, we hypothesized that mouth-oriented otters would also possess long, narrow skulls indicative of high velocity jaws. Conversely, hand-oriented otters were expected to possess short, blunt skulls with adaptations to increase bite force and crushing capability. Concomitant with these skull shapes we hypothesized that sea otters would possess a greater mandibular bluntness index, providing for a greater mechanical advantage compared to other otter species investigated. A second goal was to examine morphological variation at a finer scale by assessing variation in cranial morphology among three sea otter subspecies. Since diet varies among these subspecies, and their populations are isolated, we hypothesized that the magnitude of mandibular bluntness and concomitant mechanical advantage, as well as occlusal surface area would also vary within species according to their primary food source (fish versus hard invertebrates). Functional expectations were met for comparisons among and within species. Among species the phylogeny suggests a deeply rooted transition to alternative foraging types. Yet within foraging types alternative species were also strongly variable, suggesting either selective differences in the extent or nature of realized foraging mode, or an accumulation of non-adaptive changes during the long independent evolutionary history. At the finest scale, variation among subspecies indicates that trophic adaptation occurred rapidly, making it interesting that we happened to find both deeply and shallowly-rooted transformations associated with diet type in otter species and subspecies.	[Timm-Davis, Lori L.; DeWitt, Thomas J.; Marshall, Christopher D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Timm-Davis, Lori L.; Marshall, Christopher D.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Timm-Davis, LL (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lori.timm@sjcd.edu	Marshall, Christopher/AAF-9097-2019	DeWitt, Thomas/0000-0001-7405-3904	W.B. Davis Endowed Scholarship at Texas AM University; Lerner-Gray Fund for Marine Research; Erma Lee and Luke Mooney Graduate Travel Grants; Department of Marine Biology at Texas AM University	W.B. Davis Endowed Scholarship at Texas AM University; Lerner-Gray Fund for Marine Research; Erma Lee and Luke Mooney Graduate Travel Grants; Department of Marine Biology at Texas AM University	This work was supported by: W.B. Davis Endowed Scholarship at Texas A&M University; Lerner-Gray Fund for Marine Research; Erma Lee and Luke Mooney Graduate Travel Grants; Department of Marine Biology at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to extend our gratitude to Dr. Jim Kenagy and Jeff Bradley at the Burk Museum of Natural History (Seattle, Washington), and collection managers at the National Museum of Natural History (Washington, D.C.), and the American Museum of Natural History (New York, New York) for allowing us access to otter specimens. We also want to thank the following for financial support: W.B. Davis Endowed Scholarship at Texas A&M University, Lerner-Gray Fund for Marine Research, Erma Lee and Luke Mooney Graduate Travel Grants, and the Department of Marine Biology at Texas A&M University.	Abramov AV, 2005, ZOOL ANZ, V244, P11, DOI 10.1016/j.jcz.2004.12.002; Aldridge K, 2002, J HUM EVOL, V60, P94; Anton SC, 1999, INT J PRIMATOL, V20, P441, DOI 10.1023/A:1020509006259; BERTA A, 1985, J PALEONTOL, V59, P809; Blundell GM, 2002, BEHAV ECOL, V13, P134, DOI 10.1093/beheco/13.1.134; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L, P59; Carss David N., 1995, Hystrix, V7, P179; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; CROMPTON A W, 1969, Discovery (New Haven), V5, P23; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Enders C. K., 2010, APPL MISSING DATA AN; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Figueirido B, 2009, J ZOOL, V277, P70, DOI 10.1111/j.1469-7998.2008.00511.x; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; GANS C, 1987, J MORPHOL, V192, P63, DOI 10.1002/jmor.1051920106; GARSHELIS DL, 1986, J WILDLIFE MANAGE, V50, P637, DOI 10.2307/3800974; Ginter CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034481; Gittleman JL, 1997, J ZOOL, V242, P97, DOI 10.1111/j.1469-7998.1997.tb02932.x; Goswami A, 2006, EVOLUTION, V60, P169; GREAVES WS, 1985, ZOOL J LINN SOC-LOND, V85, P267, DOI 10.1111/j.1096-3642.1985.tb01506.x; GREAVES WS, 1983, BIOL J LINN SOC, V20, P353, DOI 10.1111/j.1095-8312.1983.tb01596.x; GREEN GA, 1991, MAR MAMMAL SCI, V7, P395, DOI 10.1111/j.1748-7692.1991.tb00114.x; Hattori K, 2003, J VET MED SCI, V65, P439, DOI 10.1292/jvms.65.439; He T, 2002, LAB ANIM-UK, V36, P86, DOI 10.1258/0023677021911795; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel A, 2008, J EXP BIOL, V211, P86, DOI 10.1242/jeb.012211; HERRING SW, 1985, AM ZOOL, V25, P339; HERRING SW, 1979, AM J ANAT, V154, P563, DOI 10.1002/aja.1001540410; HERRING SW, 1984, MUSCLE NERVE, V7, P161, DOI 10.1002/mus.880070213; Herring SW, 2001, COMP BIOCHEM PHYS A, V131, P207, DOI 10.1016/S1095-6433(01)00472-X; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Hussain SA, 1997, BIOL CONSERV, V80, P199, DOI 10.1016/S0006-3207(96)00033-X; Hylander WL, 1972, THESIS; Jacques H, 2009, AFR ZOOL, V44, P159, DOI 10.3377/004.044.0204; Johnson JB, 2008, EVOLUTION, V62, P1243, DOI 10.1111/j.1558-5646.2008.00343.x; Koepfli K-P, 2002, J ZOOL LOND, V246, P401; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; KRUUK H, 1994, BIOL CONSERV, V69, P115, DOI 10.1016/0006-3207(94)90334-4; KVITEK RG, 1993, MAR MAMMAL SCI, V9, P168, DOI 10.1111/j.1748-7692.1993.tb00441.x; Laidre KL, 2006, J MAMMAL, V87, P799, DOI 10.1644/05-MAMM-A-244R2.1; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lee S, 2004, J MORPHOL, V260, P57, DOI 10.1002/jmor.10212; Lewis ME, 2008, CR PALEVOL, V7, P607, DOI 10.1016/j.crpv.2008.09.010; LYNCH JM, 1993, BIOL ENVIRON, V93B, P97; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; Medina-Vogel G, 2004, MAR MAMMAL SCI, V20, P134, DOI 10.1111/j.1748-7692.2004.tb01144.x; Meiri S, 2005, FUNCT ECOL, V19, P337, DOI 10.1111/j.1365-2435.2005.00964.x; MOTTA PJ, 1992, NETH J ZOOL, V42, P400; MUHL ZF, 1978, ARCH ORAL BIOL, V23, P1051, DOI 10.1016/0003-9969(78)90108-5; Nogueira MR, 2009, FUNCT ECOL, V23, P715, DOI 10.1111/j.1365-2435.2009.01549.x; OSTFELD RS, 1982, OECOLOGIA, V53, P170, DOI 10.1007/BF00545660; Pfaller JB, 2011, J EXP BIOL, V214, P1655, DOI 10.1242/jeb.048090; Popowics TE, 2003, J MORPHOL, V256, P322, DOI 10.1002/jmor.10091; Preuschoft Holger, 2002, Senckenbergiana Lethaea, V82, P207; RADINSKY LB, 1968, J COMP NEUROL, V134, P495, DOI 10.1002/cne.901340408; RADINSKY LB, 1981, BIOL J LINN SOC, V16, P337, DOI 10.1111/j.1095-8312.1981.tb01657.x; RADINSKY LB, 1981, BIOL J LINN SOC, V15, P369, DOI 10.1111/j.1095-8312.1981.tb00770.x; RADINSKY LB, 1985, ANNU REV ECOL SYST, V16, P1; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; RALLS K, 1995, CAN J ZOOL, V73, P523, DOI 10.1139/z95-060; RIEDMAN ML, 1988, CAN J ZOOL, V66, P1396, DOI 10.1139/z88-205; RILEY MA, 1985, J MAMMAL, V66, P519, DOI 10.2307/1380927; ROEST AI, 1985, CALIF FISH GAME, V71, P179; Rosas FCW, 1999, BIOTROPICA, V31, P502, DOI 10.1111/j.1744-7429.1999.tb00393.x; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Satoh K, 2006, J MORPHOL, V267, P987, DOI 10.1002/jmor.10443; SIVASOTHI N, 1994, HYDROBIOLOGIA, V285, P151, DOI 10.1007/BF00005663; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Sokal RR, 1995, BIOMETRY; Somers MJ, 1996, AFR J ECOL, V34, P158, DOI 10.1111/j.1365-2028.1996.tb00609.x; Swanson EM, 2010, P R SOC B, V2512, P1471; Tanner JB, 2010, J MORPHOL, V271, P353, DOI 10.1002/jmor.10802; Taylor AB, 2009, AM J PHYS ANTHROPOL, V139, P353, DOI 10.1002/ajpa.20991; Timm LT, 2013, THESIS TEXAS A M U C, P173; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; TOWEILL DE, 1974, J WILDLIFE MANAGE, V38, P107, DOI 10.2307/3800205; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; van Zyll de Jong CG, 1972, SYSTEMATIC REV NEARC; VANEIJDEN TMGJ, 1992, ANAT REC, V232, P78, DOI 10.1002/ar.1092320109; Watt J, 2000, OECOLOGIA, V124, P289, DOI 10.1007/s004420000373; WEIJS WA, 1983, ARCH ORAL BIOL, V28, P307, DOI 10.1016/0003-9969(83)90073-0; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Westneat MW, 2005, P ROY SOC B-BIOL SCI, V272, P993, DOI 10.1098/rspb.2004.3013; WESTNEAT MW, 1994, ZOOMORPHOLOGY, V114, P103, DOI 10.1007/BF00396643; WILLIAMS PE, 1978, J ANAT, V127, P459; WILSON DE, 1991, J MAMMAL, V72, P22, DOI 10.2307/1381977; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	94	30	30	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143236	10.1371/journal.pone.0143236	http://dx.doi.org/10.1371/journal.pone.0143236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649575	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300015
J	Lobo, MR; Kukino, A; Tran, H; Schabel, MC; Springer, CS; Gillespie, GY; Grafe, MR; Woltjer, RL; Pike, MM				Lobo, Merryl R.; Kukino, Ayaka; Tran, Huong; Schabel, Matthias C.; Springer, Charles S., Jr.; Gillespie, G. Yancey; Grafe, Marjorie R.; Woltjer, Randall L.; Pike, Martin M.			Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; CONTRAST-ENHANCED MRI; PROTEASOME INHIBITOR BORTEZOMIB; INPUT FUNCTION ESTIMATION; MONTE-CARLO METHOD; IN-VIVO; KAPPA-B; PROLONGS SURVIVAL; KINASE INHIBITOR; TUMOR-GROWTH	Prognosis remains extremely poor for malignant glioma. Targeted therapeutic approaches, including single agent anti-angiogenic and proteasome inhibition strategies, have not resulted in sustained anti-glioma clinical efficacy. We tested the anti-glioma efficacy of the anti-angiogenic receptor tyrosine kinase inhibitor cediranib and the novel proteasome inhibitor SC68896, in combination and as single agents. To assess anti-angiogenic effects and evaluate efficacy we employed 4C8 intracranial mouse glioma and a dual-bolus perfusion MRI approach to measure K-trans, relative cerebral blood flow and volume (rCBF, rCBV), and relative mean transit time (rMTT) in combination with anatomical MRI measurements of tumor growth. While single agent cediranib or SC68896 treatment did not alter tumor growth or survival, combined cediranib/SC68896 significantly delayed tumor growth and increased median survival by 2-fold, compared to untreated. This was accompanied by substantially increased tumor necrosis in the cediranib/SC68896 group (p<0.01), not observed with single agent treatments. Mean vessel density was significantly lower, and mean vessel lumen area was significantly higher, for the combined cediranib/SC68896 group versus untreated. Consistent with our previous findings, cediranib alone did not significantly alter mean tumor rCBF, rCBV, rMTT, or K-trans. In contrast, SC68896 reduced rCBF in comparison to untreated, but without concomitant reductions in rCBV, rMTT, or K-trans. Importantly, combined cediranib/SC68896 substantially reduced rCBF, rCBV. rMTT, and K-trans. A novel analysis of K-trans/rCBV suggests that changes in K-trans with time and/or treatment are related to altered total vascular surface area. The data suggest that combined cediranib/SC68896 induced potent anti-angiogenic effects, resulting in increased vascular efficiency and reduced extravasation, consistent with a process of vascular normalization. The study represents the first demonstration that the combination of cediranib with a proteasome inhibitor substantially increases the anti-angiogenic efficacy produced from either agent alone, and synergistically slows glioma tumor growth and extends survival, suggesting a promising treatment which warrants further investigation.	[Lobo, Merryl R.; Kukino, Ayaka; Schabel, Matthias C.; Springer, Charles S., Jr.; Pike, Martin M.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Lobo, Merryl R.; Pike, Martin M.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Tran, Huong; Grafe, Marjorie R.; Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham	Pike, MM (corresponding author), Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA.	pikema@ohsu.edu	Schabel, Matthias C./H-4647-2019	Gillespie, George/0000-0001-6436-9542	National Institutes of Health, National Cancer Institute [1R21 CA114279-01A2, 1R21 CA167302-01]; NATIONAL CANCER INSTITUTE [R21CA114279, R21CA167302] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute grants 1R21 CA114279-01A2 (MMP) and 1R21 CA167302-01 (MMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Befani CD, 2012, J MOL MED, V90, P45, DOI 10.1007/s00109-011-0805-8; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Birle DC, 2007, CANCER RES, V67, P1735, DOI 10.1158/0008-5472.CAN-06-2722; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Buac D, 2013, CURR PHARM DESIGN, V19, P4025, DOI 10.2174/1381612811319220012; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Daniel KG, 2005, CURR CANCER DRUG TAR, V5, P529, DOI 10.2174/156800905774574075; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; Drexler HCA, 2000, FASEB J, V14, P65, DOI 10.1096/fasebj.14.1.65; Driscoll JJ, 2012, SEMIN HEMATOL, V49, P277, DOI 10.1053/j.seminhematol.2012.04.002; DYER CA, 1995, J NEUROPATH EXP NEUR, V54, P852, DOI 10.1097/00005072-199511000-00012; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Gotink KJ, 2010, ANGIOGENESIS, V13, P1, DOI 10.1007/s10456-009-9160-6; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Inoue T, 2006, ANTI-CANCER DRUG, V17, P261, DOI 10.1097/00001813-200603000-00004; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055527; Kaluz S, 2008, J CELL BIOCHEM, V104, P536, DOI 10.1002/jcb.21644; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Khan T, 2006, J IMMUNOL, V176, P6302, DOI 10.4049/jimmunol.176.10.6302; Labussiere M, 2008, ONCOL REP, V20, P1283, DOI 10.3892/or_00000142; Leban J, 2008, BIOORGAN MED CHEM, V16, P4579, DOI 10.1016/j.bmc.2008.02.042; LeBlanc R, 2002, CANCER RES, V62, P4996; Li X, 2009, NMR BIOMED, V22, P148, DOI 10.1002/nbm.1293; Lobo MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114110; Lobo MR, 2013, NEURO-ONCOLOGY, V15, P1673, DOI 10.1093/neuonc/not119; Martinho O, 2013, TRANSL ONCOL, V6, P187, DOI 10.1593/tlo.12400; Matsuo Y, 2010, DIGEST DIS SCI, V55, P1167, DOI 10.1007/s10620-009-0814-4; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Milano A, 2009, ONCOTARGETS THER, V2, P171; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Nestler U, 2015, ACTA NEUROCHIR, V157, P179, DOI 10.1007/s00701-014-2271-x; Njus JM, 2008, P INT SOC MAGN RESON, V16; Noguchi M, 2014, BBA-REV CANCER, V1846, P342, DOI 10.1016/j.bbcan.2014.07.013; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Peng L, 2013, ONCOL REP, V29, P571, DOI 10.3892/or.2012.2165; Phillips H, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.2001; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Rahman R, 2010, J ONCOL, V2010, DOI 10.1155/2010/251231; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Roth P, 2009, CLIN CANCER RES, V15, P6609, DOI 10.1158/1078-0432.CCR-09-0548; Schabel MC, 2010, PHYS MED BIOL, V55, P4783, DOI 10.1088/0031-9155/55/16/011; Schabel MC, 2010, PHYS MED BIOL, V55, P4807, DOI 10.1088/0031-9155/55/16/012; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shin DH, 2008, ONCOGENE, V27, P1939, DOI 10.1038/sj.onc.1210826; Shin DH, 2008, BLOOD, V111, P3131, DOI 10.1182/blood-2007-11-120576; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sterz J, 2008, EXPERT OPIN INV DRUG, V17, P879, DOI 10.1517/13543784.17.6.879 ; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Tabatabai G, 2009, CURR OPIN NEUROL, V22, P639, DOI 10.1097/WCO.0b013e328332ba28; Thaker NG, 2009, EXPERT REV NEUROTHER, V9, P1815, DOI 10.1586/ERN.09.116; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Yeramian A, 2012, INT J CANCER, V130, P967, DOI 10.1002/ijc.26096; Yu CR, 2006, MOL CANCER THER, V5, P2378, DOI 10.1158/1535-7163.MCT-06-0235; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	74	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144488	10.1371/journal.pone.0144488	http://dx.doi.org/10.1371/journal.pone.0144488			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645398	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903100026
J	Lindborg, P; Friberg, AK				Lindborg, PerMagnus; Friberg, Anders K.			Colour Association with Music Is Mediated by Emotion: Evidence from an Experiment Using a CIE Lab Interface and Interviews	PLOS ONE			English	Article								Crossmodal associations may arise at neurological, perceptual, cognitive, or emotional levels of brain processing. Higher-level modal correspondences between musical timbre and visual colour have been previously investigated, though with limited sets of colour. We developed a novel response method that employs a tablet interface to navigate the CIE Lab colour space. The method was used in an experiment where 27 film music excerpts were presented to participants (n = 22) who continuously manipulated the colour and size of an on-screen patch to match the music. Analysis of the data replicated and extended earlier research, for example, that happy music was associated with yellow, music expressing anger with large red colour patches, and sad music with smaller patches towards dark blue. Correlation analysis suggested patterns of relationships between audio features and colour patch parameters. Using partial least squares regression, we tested models for predicting colour patch responses from audio features and ratings of perceived emotion in the music. Parsimonious models that included emotion robustly explained between 60% and 75% of the variation in each of the colour patch parameters, as measured by cross-validated R-2. To illuminate the quantitative findings, we performed a content analysis of structured spoken interviews with the participants. This provided further evidence of a significant emotion mediation mechanism, whereby people tended to match colour association with the perceived emotion in the music. The mixed method approach of our study gives strong evidence that emotion can mediate crossmodal association between music and visual colour. The CIE Lab interface promises to be a useful tool in perceptual ratings of music and other sounds.	[Lindborg, PerMagnus] Nanyang Technol Univ, Sch Art Design & Media, Area Interact Media, Singapore 639798, Singapore; [Lindborg, PerMagnus; Friberg, Anders K.] KTH Royal Inst Technol, Dept Speech Mus & Hearing, Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Royal Institute of Technology	Lindborg, P (corresponding author), Nanyang Technol Univ, Sch Art Design & Media, Area Interact Media, Singapore 639798, Singapore.	permagnus@ntu.edu.sg	Friberg, Anders K/A-2490-2012; Lindborg, PerMagnus/E-8520-2018	Lindborg, PerMagnus/0000-0001-8121-9263	Tier 1 grant, Academic Research Fund, Ministry of Education, Singapore [4010958]	Tier 1 grant, Academic Research Fund, Ministry of Education, Singapore	The work was supported by Tier 1 grant #4010958, Academic Research Fund, Ministry of Education, Singapore.	Asutay E, 2012, J AUDIO ENG SOC, V60, P21; Barbiere J.M., 2007, EMPIR STUD ARTS, V25, P193, DOI [10.2190/A704-5647-5245-R47P, DOI 10.2190/A704-5647-5245-R47P]; Bauer M, 2012, QUALITATIVE RES TEXT; Bresin R., 2005, P INT COMPUTER MUSIC, P367; Cabrera D, 2014, PSYSOUND3; Cabrera D, 2008, ACOUSTICS; Chion Michael, 2003, FILM A SOUND ART; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Cycling ` 74 (), 2015, MAX 7 SOFTW; Datteri DL, 2004, P ICMPC8 AD AUSTR; Eerola T, 2011, PSYCHOL MUSIC, V39, P18, DOI 10.1177/0305735610362821; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fastl H., 2007, PSYCHOACOUSTICS FACT, V3rd; Flick U, 2012, QUALITATIVE RES TEXT; Fox J., 2015, COMPANION APPL REGRE; Friberg A., 2011, GEMESSENE INTERPRETA, P237; Friberg A, 2014, ARXIV14037923; Gabrielsson A., 2010, HDB MUSIC EMOTION TH, P547; GAVER WW, 1993, ECOL PSYCHOL, V5, P285, DOI 10.1207/s15326969eco0504_2; Giannakis K, 2001, MUSICAL IMAGERY, P161; Hansen T, 2009, J VISION, V9, DOI 10.1167/9.4.26; Hoffmann G, 2003, CIELAB COLOR SPACE; Holm J, 2009, J NEW MUSIC RES, V38, P87, DOI 10.1080/09298210902940094; Huron D.B., 2006, SWEET ANTICIPATION M; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kabacoff RI., 2011, R ACTION DATA ANAL G, V1; Lartillot O, 2013, MIRTOOLBOX V1 5; Lindborg P, 2015, APPL ACOUST, V92, P47, DOI 10.1016/j.apacoust.2015.01.002; Lindborg PM, 2015, PERSONALITY TR UNPUB; Lipscomb SD, 2008, P ICMPC8 AD AUSTR; Mevik B., 2015, PARTIAL LEAST SQUARE; Nygren P, 2009, THESIS; Palmer SE, 2006, P NATL ACAD SCI; Pierce AH, 1901, STUDIES AUDITORY VIS, P188; Pitteri M, 2015, PSYCHOL RES, P1; Plazak J, 2011, MUSIC SCI, V15, P29, DOI 10.1177/1029864910391455; R Core Team, 2013, R LANG ENV STAT COMP; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Spence C., 2012, FLAVOUR, V1, P1, DOI [10.1186/2044-7248-1-12, DOI 10.1186/2044-7248-1-12]; Spence C, 2001, ATTENTIONAL CAPTURE; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Tuuri K, 2012, J NEW MUSIC RES, V41, P137, DOI 10.1080/09298215.2011.614951; Velasco C, 2015, FOOD QUAL PREFER, V41, P151, DOI 10.1016/j.foodqual.2014.11.010; Vuoskoski JK, 2013, PSYCHOL MUSIC; Whittle P, 2003, COLOUR PERCEPTION MI; Wold H., 1985, PARTIAL LEAST SQUARE, P581; Woods AT, 2015, PEERJ, V3, DOI 10.7717/peerj.1058	49	23	23	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144013	10.1371/journal.pone.0144013	http://dx.doi.org/10.1371/journal.pone.0144013			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642050	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700044
J	Liu, GS; Wang, JH; Lee, JH; Tsai, PJ; Tsai, HE; Sheu, SJ; Lin, HC; Dusting, GJ; Tai, MH; Bee, YS				Liu, Guei-Sheung; Wang, Jiang-Hui; Lee, Jia Hui; Tsai, Pei-Jhen; Tsai, Han-En; Sheu, Shwu-Jiuan; Lin, Hsiu-Chen; Dusting, Gregory J.; Tai, Ming-Hong; Bee, Youn-Shen			Gene Delivery by Subconjunctival Injection of Adenovirus in Rats: A Study of Local Distribution, Transgene Duration and Safety	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; MEDIATED TRANSFER; IMMUNE-RESPONSE; DRUG-DELIVERY; EXPRESSION; MOUSE; THERAPY; VECTORS; CELLS; BIODISTRIBUTION	Subconjunctival injection is a minimally invasive route for gene delivery to ocular tissues, but has traditionally been limited to use in the cornea. The accurate ocular distribution of virus has not, however, been previously investigated. Adenovirus is an attractive gene vector as it can deliver large genes and allow for short-term gene expression, but how safe it is when delivered via subconjunctival injection remains to be established. We have characterized the bio-distribution and safety of subconjunctivally administered adenovirus in Brown Norway rats. The bio-distribution and transgene duration of adenovirus carrying luciferase gene (Ad-Luci) at various time intervals were evaluated via bioluminescence imaging after subconjunctival injection. Adenovirus carrying a reporter gene, beta-galactosidase (Ad-LacZ) or hrGFP (Ad-hrGFP) was administered subconjunctivally and the viral distribution in various ocular tissues was assessed by histological analysis and quantitative PCR (qPCR). Hepatic damage was assessed by biochemical and immunohistological analysis with TUNEL stain. Systemic immunogenicity was assessed by measuring serum level of TNF-alpha via ELISA, 2 hours and 14 days after administration of adenovirus. Retinal function was examined by electroretinography. Subconjunctival injection of Ad-Luci induced luciferase expression in the injected eyes within 24 hours, for at least 64 days. Histological analysis showed adenovirus distributed across anterior and posterior ocular tissues. qPCR demonstrated different amounts of adenovirus in different ocular tissues, with the highest amounts closest to the injection site Unlike the intravenous route, subconjunctivally delivered adenovirus did not elicit any detectable hepatic injury or systemic immunogenicity. Retinal function was unaffected by adenovirus irrespective of administration route. In conclusion, an adeno-viral vector administered subconjunctivally can infiltrate into different ocular tissues and lead to short-term ocular transgene expression, without causing hepatic injury and immune activation. Therefore, subconjunctivally administered adenovirus may be a promising gene delivery approach for managing anterior and posterior segment eye diseases requiring short-term therapy.	[Liu, Guei-Sheung; Wang, Jiang-Hui; Lee, Jia Hui; Dusting, Gregory J.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Liu, Guei-Sheung; Wang, Jiang-Hui; Dusting, Gregory J.] Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia; [Tsai, Pei-Jhen; Sheu, Shwu-Jiuan; Lin, Hsiu-Chen; Bee, Youn-Shen] Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Tsai, Han-En; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Sheu, Shwu-Jiuan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Bee, Youn-Shen] Natl Def Med Ctr, Taipei, Taiwan; [Bee, Youn-Shen] Yuh Ing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; National Yang Ming Chiao Tung University; National Defense Medical Center	Bee, YS (corresponding author), Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.	ysbee@vghks.gov.tw	Wang, Jiang-Hui/AAW-4653-2020; Liu, Guei-Sheung/Q-6472-2018	Wang, Jiang-Hui/0000-0002-1551-9660; Liu, Guei-Sheung/0000-0003-3379-724X; Tsai, Pei- Jhen/0000-0003-0005-1476	National Science Council, Taiwan [NSC100-2314-B-075B-006]; Kaohsiung Veterans General Hospital [VGHKS 96-075, 98-062, 99-062, 101-056]; National Health and Medical Research Council of Australia (NHMRC) [1061912]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from National Science Council, Taiwan (NSC100-2314-B-075B-006), Kaohsiung Veterans General Hospital (VGHKS 96-075, 98-062, 99-062, 101-056) and the National Health and Medical Research Council of Australia (NHMRC #1061912). The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government.	Ali RR, 1998, GENE THER, V5, P1561, DOI 10.1038/sj.gt.3300761; Solinis MA, 2015, EUR J PHARM BIOPHARM, V95, P331, DOI 10.1016/j.ejpb.2014.12.022; Ashtari M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8791; Borras T, 2012, INVEST OPHTH VIS SCI, V53, P2506, DOI 10.1167/iovs.12-9483o; BRODY SL, 1994, HUM GENE THER, V5, P437, DOI 10.1089/hum.1994.5.4-437; Chan HH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-83; Cheng HC, 2007, MOL VIS, V13, P2344; De Kozak Y, 2002, CLIN EXP IMMUNOL, V130, P212, DOI 10.1046/j.1365-2249.2002.01969.x; Fejer G, 2005, J IMMUNOL, V175, P1498, DOI 10.4049/jimmunol.175.3.1498; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; GUZMAN RJ, 1994, P NATL ACAD SCI USA, V91, P10732, DOI 10.1073/pnas.91.22.10732; Hamilton MM, 2006, INVEST OPHTH VIS SCI, V47, P299, DOI 10.1167/iovs.05-0731; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Ildefonso CJ, 2010, MOL THER, V18, P1885, DOI 10.1038/mt.2010.139; Jiang XD, 2015, DRUG DES DEV THER, V9, P3043, DOI 10.2147/DDDT.S85529; Julien S, 2008, MOL VIS, V14, P1358; Koblin BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024517; Kong FS, 2010, EXP EYE RES, V90, P546, DOI 10.1016/j.exer.2010.01.011; Lam S, 2014, GENES DIS, V1, P227, DOI 10.1016/j.gendis.2014.09.002; Liu GS, 2011, HUM GENE THER, V22, P325, DOI 10.1089/hum.2010.090; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohan RR, 2013, OCUL SURF, V11, P150, DOI 10.1016/j.jtos.2012.10.004; Rhee EG, 2011, J VIROL, V85, P315, DOI 10.1128/JVI.01597-10; Salako MA, 2011, MOL THER, V19, P490, DOI 10.1038/mt.2010.247; Stevens Sue, 2009, Community Eye Health, V22, P15; Tai MH, 2003, EXP NEUROL, V183, P508, DOI 10.1016/S0014-4886(03)00130-4; Ueyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108071; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Veneziale RW, 2007, CUTAN OCUL TOXICOL, V26, P83, DOI 10.1080/15569520701212167; Wang HP, 2013, INT J MOL MED, V31, P377, DOI 10.3892/ijmm.2012.1197; Wen SF, 2003, EXP EYE RES, V77, P355, DOI 10.1016/S0014-4835(03)00122-2; Yan H, 2013, OPHTHALMIC RES, V49, P81, DOI 10.1159/000342979; Yanagi Y, 2003, INVEST OPHTH VIS SCI, V44, P751, DOI 10.1167/iovs.02-0222; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3495; Yang JG, 2009, ACTA PHARMACOL SIN, V30, P413, DOI 10.1038/aps.2009.23; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Zhou SY, 2010, MOL VIS, V16, P1389	38	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143956	10.1371/journal.pone.0143956	http://dx.doi.org/10.1371/journal.pone.0143956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642208	gold, Green Published			2022-12-26	WOS:000366902700036
J	Martinou, AF; Stavrinides, MC				Martinou, Angeliki F.; Stavrinides, Menelaos C.			Effects of Sublethal Concentrations of Insecticides on the Functional Response of Two Mirid Generalist Predators	PLOS ONE			English	Article							TETRANYCHUS-URTICAE ACARI; BIOLOGICAL-CONTROL AGENT; TUTA-ABSOLUTA; BENEFICIAL ARTHROPODS; MACROLOPHUS-PYGMAEUS; TOMATO PINWORM; BEMISIA-TABACI; PEST-CONTROL; HOST-PLANT; BEHAVIOR	The use of agrochemicals particularly pesticides, can hamper the effectiveness of natural enemies, causing disruption in the ecosystem service of biological control. In the current study, the effects of the insecticides thiacloprid and chlorantraniliprole on the functional response curves were assessed for two mirid predator nymphs, Macrolophus pygmaeus Rambur and Nesidiocoris tenuis Reuter. In the absence of insecticides, both predators exhibited a type II functional response when feeding on eggs of the moth Ephestia kuehniella. N. tenuis seems to be a more efficient predator than M. pygmaeus, as model estimated handling time was significantly lower for the former than for the latter. Residual exposure of M. pygmaeus to sublethal concentrations of either insecticide was associated with a change in the asymptote but not the type of the functional response curve. Thiacloprid seems to be the least compatible with M. pygmaeus, as it led to both a significant reduction of the attack rate and an increase in handling time. In contrast, chlorantraniliprole exposure significantly increased the handling time, but not the attack rate of the predator. Residual exposure of N. tenuis to sublethal concentrations of either insecticide did not have a significant effect on the type nor the parameters of the functional response model. The results show that pesticide residues that do not have lethal effects on beneficial arthropods can reduce prey consumption depending on predator species and on likely risks associated with toxicity.	[Martinou, Angeliki F.; Stavrinides, Menelaos C.] Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, CY-3036 Limassol, Cyprus	Cyprus University of Technology	Stavrinides, MC (corresponding author), Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Arch Kyprianos 30, CY-3036 Limassol, Cyprus.	m.stavrinides@cut.ac.cy	Martinou, Kelly/AAN-5691-2020	Martinou, Kelly/0000-0003-2892-8583; Stavrinides, Menelaos/0000-0002-6459-1941	Hydroflies project an INTERREG (Interregional Cooperation) Greece-Cyprus program [C(2008)1131/28-03-2008]	Hydroflies project an INTERREG (Interregional Cooperation) Greece-Cyprus program	Part of the study was funded through the Hydroflies project (C(2008)1131/28-03-2008), an INTERREG (Interregional Cooperation) Greece-Cyprus (2007-2013) program (http://www.greececyprus.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljetlawi AA, 2004, J ANIM ECOL, V73, P239, DOI 10.1111/j.0021-8790.2004.00800.x; Ambrose DP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.18701; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Cabello T, 2015, ENVIRON ENTOMOL, V44, P12, DOI 10.1093/ee/nvu017; Candolfi M. P., 2001, EUR STAND CHAR REG T; CHESSON J, 1989, ECOLOGY, V70, P1227, DOI 10.2307/1938180; Chong JH, 2006, BIOL CONTROL, V39, P320, DOI 10.1016/j.biocontrol.2006.08.013; Claver MA, 2003, J APPL ENTOMOL, V127, P18, DOI 10.1046/j.1439-0418.2003.00654.x; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Croft B. A., 1990, ARTHROPOD BIOL CONTR; De Clercq P, 2000, BIOL CONTROL, V18, P65, DOI 10.1006/bcon.1999.0808; Delpuech JM, 2012, ECOTOX ENVIRON SAFE, V84, P32, DOI 10.1016/j.ecoenv.2012.06.007; Deng LL, 2007, ENVIRON TOXICOL CHEM, V26, P478, DOI 10.1897/06-344R.1; Desneux N, 2005, J ECON ENTOMOL, V98, P9, DOI 10.1603/0022-0493-98.1.9; Desneux N, 2004, ENTOMOL EXP APPL, V112, P227, DOI 10.1111/j.0013-8703.2004.00198.x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Fantke P, 2014, ENVIRON SCI TECHNOL, V48, P8588, DOI 10.1021/es500434p; Gardiner MM, 2009, INTEGRATED PEST MANAGEMENT: CONCEPTS, TACTICS, STRATEGIES AND CASE STUDIES, P151; Hassell M.P., 2000, SPATIAL TEMPORAL DYN; HASSELL MP, 1977, J ANIM ECOL, V46, P249, DOI 10.2307/3959; HASSELL MP, 1982, ANN APPL BIOL, V101, P170; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holling C. S., 1965, MEMOIRS ENTOMOLOGICA, V97, P5, DOI DOI 10.4039/ENTM9745FV; Holling C. S., 1966, MEM ENTOMOL SOC CAN, V98, P5, DOI [10.4039/entm9848fv, DOI 10.4039/ENTM9848FV]; JULIANO SA, 1985, EVOLUTION, V39, P212, DOI 10.1111/j.1558-5646.1985.tb04096.x; Juliano SA, 2001, DESIGN ANAL ECOLOGIC, P159; Lampropoulos PD, 2013, BASIC APPL ECOL, V14, P605, DOI 10.1016/j.baae.2013.08.004; Li DX, 2006, J APPL ENTOMOL, V130, P314, DOI 10.1111/j.1439-0418.2006.01056.x; Malaquias JB, 2014, ECOTOXICOLOGY, V23, P192, DOI 10.1007/s10646-013-1162-x; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Martinou AF, 2010, ECOL ENTOMOL, V35, P183, DOI 10.1111/j.1365-2311.2009.01171.x; Maselou DA, 2014, BIOL CONTROL, V79, P92, DOI 10.1016/j.biocontrol.2014.09.002; Messina FJ, 1998, ENVIRON ENTOMOL, V27, P1196, DOI 10.1093/ee/27.5.1196; Mills NJ, 2004, ECOL ENTOMOL, V29, P208, DOI 10.1111/j.0307-6946.2004.00584.x; Milonas PG, 2011, BIOL CONTROL, V59, P141, DOI 10.1016/j.biocontrol.2011.06.016; Molla O, 2014, BIOCONTROL, V59, P175, DOI 10.1007/s10526-013-9553-8; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Murray GPD, 2013, ETHOLOGY, V119, P751, DOI 10.1111/eth.12117; Omirou M, 2009, FOOD CHEM, V116, P499, DOI 10.1016/j.foodchem.2009.03.007; Pekar S, 2012, PEST MANAG SCI, V68, P1438, DOI 10.1002/ps.3397; Perdikis D, 2011, BIOL CONTROL, V59, P13, DOI 10.1016/j.biocontrol.2011.03.014; Poletti M, 2007, BIOL CONTROL, V40, P30, DOI 10.1016/j.biocontrol.2006.09.001; R Core Development Team, 2008, R LANG ENV STAT COMP; Rezac M, 2010, BIOCONTROL, V55, P503, DOI 10.1007/s10526-010-9272-3; Stavrinides MC, 2003, B ENTOMOL RES, V93, P343, DOI 10.1079/BER2003243; TREXLER JC, 1988, OECOLOGIA, V76, P206, DOI 10.1007/BF00379954; Urbaneja A, 2009, J APPL ENTOMOL, V133, P292, DOI 10.1111/j.1439-0418.2008.01319.x; Urbaneja A, 2012, PEST MANAG SCI, V68, P1215, DOI 10.1002/ps.3344; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zhang LP, 2011, PEST MANAG SCI, V67, P226, DOI 10.1002/ps.2056	54	21	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144413	10.1371/journal.pone.0144413	http://dx.doi.org/10.1371/journal.pone.0144413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641652	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700114
J	Shen, XJ; Huang, TC; Wang, GY; Li, GL				Shen, Xiaojuan; Huang, Tongcheng; Wang, Guanyu; Li, Guanglin			How the Sequence of a Gene Specifies Structural Symmetry in Proteins	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; BETA-TREFOIL FAMILY; CODON USAGE; ESCHERICHIA-COLI; DNA-SEQUENCES; IN-VIVO; EVOLUTION; TRANSLATION; REPEATS; DUPLICATION	Internal symmetry is commonly observed in the majority of fundamental protein folds. Meanwhile, sufficient evidence suggests that nascent polypeptide chains of proteins have the potential to start the co-translational folding process and this process allows mRNA to contain additional information on protein structure. In this paper, we study the relationship between gene sequences and protein structures from the viewpoint of symmetry to explore how gene sequences code for structural symmetry in proteins. We found that, for a set of two-fold symmetric proteins from left-handed beta-helix fold, intragenic symmetry always exists in their corresponding gene sequences. Meanwhile, codon usage bias and local mRNA structure might be involved in modulating translation speed for the formation of structural symmetry: a major decrease of local codon usage bias in the middle of the codon sequence can be identified as a common feature; and major or consecutive decreases in local mRNA folding energy near the boundaries of the symmetric substructures can also be observed. The results suggest that gene duplication and fusion may be an evolutionarily conserved process for this protein fold. In addition, the usage of rare codons and the formation of higher order of secondary structure near the boundaries of symmetric substructures might have coevolved as conserved mechanisms to slow down translation elongation and to facilitate effective folding of symmetric substructures. These findings provide valuable insights into our understanding of the mechanisms of translation and its evolution, as well as the design of proteins via symmetric modules.	[Shen, Xiaojuan; Huang, Tongcheng] Shaoyang Univ, Dept Informat Engn, Shaoyang, Hunan, Peoples R China; [Shen, Xiaojuan; Li, Guanglin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Key Lab Human Machine Intelligence Synergy Syst, Shenzhen, Peoples R China; [Shen, Xiaojuan; Wang, Guanyu] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China	Shaoyang University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Southern University of Science & Technology	Wang, GY (corresponding author), South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China.	wanggy@sustc.edu.cn; gl.li@siat.ac.cn		Li, Guanglin/0000-0001-9016-2617	National Natural Science Foundation of China [61135004, 61471186]; Hunan Provincial Natural Science Foundation of China [14JJ7075]; key Scientific Research fund of Hunan Provincial Education Department [13A091]; key Scientific Research fund of Provincial Key Laboratory of Informational Service for Rural Area of Southwestern Hunan; Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); key Scientific Research fund of Hunan Provincial Education Department(Hunan Provincial Education Department); key Scientific Research fund of Provincial Key Laboratory of Informational Service for Rural Area of Southwestern Hunan; Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province	GLL received funding from the National Natural Science Foundation of China (61135004): http://www.nsfc.gov.cn/. He conceived and designed the experiments, and contributed to the writing of the manuscript. GYW received funding from the National Natural Science Foundation of China (61471186): http://www.nsfc.gov.cn/. He conceived and designed the experiments, and contributed to the writing of the manuscript. TCH received funding from the Hunan Provincial Natural Science Foundation of China (14JJ7075): http://www.hnst.gov.cn/zxgz/zkjj/. He contributed to the writing of the manuscript. TCH received funding from the key Scientific Research fund of Hunan Provincial Education Department (13A091): http://gov.hnedu.cn/zwgk.jsp. TCH received funding from the key Scientific Research fund of Provincial Key Laboratory of Informational Service for Rural Area of Southwestern Hunan: http://www.hnst.gov.cn/zxgz/zkjj/. He contributed to the writing of the manuscript. TCH received funding from the Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province: http: http://gov.hnedu.cn/zwgk.jsp. He contributed to the writing of the manuscript.	Abraham AL, 2008, BIOINFORMATICS, V24, P1536, DOI 10.1093/bioinformatics/btn234; Achaz G, 2007, BIOINFORMATICS, V23, P119, DOI 10.1093/bioinformatics/btl519; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blaber M, 2012, CURRENT OPINION STRU; Blaber M, 2012, CELLULAR MOL LIFE SC, P1; Broom A, 2012, STRUCTURE, V20, P161, DOI 10.1016/j.str.2011.10.021; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; CROMBIE T, 1992, J MOL BIOL, V228, P7, DOI 10.1016/0022-2836(92)90486-4; De Winter R, 1995, CELL BIOL, V15, P3023; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Forrest L, 2015, ANN REV BIOPHYSICS, V44; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163; Huang YZ, 2007, PROTEINS, V68, P267, DOI 10.1002/prot.21330; Iengar P, 2006, STRUCTURE, V14, P529, DOI 10.1016/j.str.2005.11.021; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ji HF, 2010, TRENDS BIOCHEM SCI, V35, P129, DOI 10.1016/j.tibs.2009.12.002; Ji XF, 2007, COMPUT BIOL CHEM, V31, P61, DOI 10.1016/j.compbiolchem.2007.01.002; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Li MF, 2005, CHAOS SOLITON FRACT, V25, P491, DOI 10.1016/j.chaos.2004.11.049; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; MCLACHLAN AD, 1977, NATURE, V267, P465, DOI 10.1038/267465a0; MCLACHLAN AD, 1972, J MOL BIOL, V64, P417, DOI 10.1016/0022-2836(72)90508-6; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; MEDIGUE C, 1991, MOL MICROBIOL, V5, P2629, DOI 10.1111/j.1365-2958.1991.tb01972.x; Mount D. W., 2004, BIOINFORMATICS, V2; Parisi G, 2000, MOL PHYLOGENET EVOL, V14, P323, DOI 10.1006/mpev.1999.0734; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Salem GM, 1999, J MOL BIOL, V287, P969, DOI 10.1006/jmbi.1999.2642; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen XJ, 2011, J THEOR BIOL, V285, P77, DOI 10.1016/j.jtbi.2011.06.011; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Taylor WR, 2002, PROTEIN ENG, V15, P79, DOI 10.1093/protein/15.2.79; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tuller T, 2015, NUCLEIC ACIDS RES, V43, P13, DOI 10.1093/nar/gku1313; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Venkatakrishnan AJ, 2010, BIOCHEM SOC T, V38, P879, DOI 10.1042/BST0380879; Vogel C, 2006, BIOESSAYS, V28, P973, DOI 10.1002/bies.20474; Wang XC, 2008, J MOL GRAPH MODEL, V26, P829, DOI 10.1016/j.jmgm.2007.04.014; Wolynes PG, 1996, P NATL ACAD SCI USA, V93, P14249, DOI 10.1073/pnas.93.25.14249; Xu RZ, 2005, COMPUT BIOL CHEM, V29, P79, DOI 10.1016/j.compbiolchem.2004.12.003; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	62	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144473	10.1371/journal.pone.0144473	http://dx.doi.org/10.1371/journal.pone.0144473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641668	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700132
J	Caballero, IC; Sakla, AJ; Detwiler, JT; Le Gall, M; Behmer, ST; Criscione, CD				Caballero, Isabel C.; Sakla, Andrew J.; Detwiler, Jillian T.; Le Gall, Marion; Behmer, Spencer T.; Criscione, Charles D.			Physiological Status Drives Metabolic Rate in Mediterranean Geckos Infected with Pentastomes	PLOS ONE			English	Article							HEMIDACTYLUS-TURCICUS; HYPAXIAL MUSCLES; HOST; PARASITE; LIZARD; IGUANA	Negative effects of parasites on their hosts are well documented, but the proximate mechanisms by which parasites reduce their host's fitness are poorly understood. For example, it has been suggested that parasites might be energetically demanding. However, a recent meta-analysis suggests that they have statistically insignificant effects on host resting metabolic rate (RMR). It is possible, though, that energetic costs associated with parasites are only manifested during and/or following periods of activity. Here, we measured CO2 production (a surrogate for metabolism) in Mediterranean geckos (Hemidactylus turcicus) infected with a lung parasite, the pentastome Raillietiella indica, under two physiological conditions: rested and recently active. In rested geckos, there was a negative, but non-significant association between the number of pentastomes (i.e., infection intensity) and CO2 production. In recently active geckos (chased for 3 minutes), we recorded CO2 production from its maximum value until it declined to a stationary phase. We analyzed this decline as a 3 phase function (initial decline, secondary decline, stationary). Geckos that were recently active showed, in the secondary phase, a significant decrease in CO2 production as pentastome intensity increased. Moreover, duration of the secondary phase showed a significant positive association with the number of pentastomes. These results suggest that the intensity of pentastome load exerts a weak effect on the metabolism of resting geckos, but a strong physiological effect on geckos that have recently been active; we speculate this occurs via mechanical constraints on breathing. Our results provide a potential mechanism by which pentastomes can reduce gecko fitness.	[Caballero, Isabel C.; Sakla, Andrew J.; Criscione, Charles D.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Detwiler, Jillian T.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Le Gall, Marion] Penn State Univ, Dept Entomol, State Coll, PA USA; [Behmer, Spencer T.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Manitoba; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Texas A&M University System; Texas A&M University College Station	Caballero, IC (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	icabal@tamu.edu	Le Gall, Marion/AFK-8033-2022	Le Gall, Marion/0000-0002-8358-0332; Sakla, Andrew/0000-0002-2410-0394	Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries; Office of the Vice President for Research	Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Emily Kasl and Nick Stokes assisted with sampling geckos. CDC's cat Phoenix demonstrated that there are natural events that can stress geckos. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho JM, 1990, HELMINTH COMMUNITIES; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALI JH, 1981, SYST PARASITOL, V3, P193, DOI 10.1007/BF00014851; BENNETT AF, 1973, COMP BIOCHEM PHYSIOL, V46, P653, DOI 10.1016/0300-9629(73)90119-9; CARRIER D, 1990, J EXP BIOL, V152, P453; CARRIER DR, 1989, J EXP BIOL, V143, P435; Chappell MA, 1999, FUNCT ECOL, V13, P163, DOI 10.1046/j.1365-2435.1999.00265.x; Criscione CD, 2001, J PARASITOL, V87, P1273, DOI 10.1645/0022-3395(2001)087[1273:TGPHCO]2.0.CO;2; Criscione CD, 2001, COMP PARASITOL, V68, P149; DALLAL GE, 1986, AM STAT, V40, P294, DOI 10.2307/2684607; Downs CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2636; Goater TM, 2014, PARASITISM: THE DIVERSITY AND ECOLOGY OF ANIMAL PARASITES, 2ND EDITION, P1; Goldberg Stephen R., 2004, Bishop Museum Occasional Papers, V79, P58; Hechinger Ryan F., 2012, P234; Kelehear C, 2013, OIKOS, V122, P1317, DOI 10.1111/j.1600-0706.2013.00292.x; Kelehear C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024936; Klein W, 2010, RESP PHYSIOL NEUROBI, V173, pS26, DOI 10.1016/j.resp.2010.04.019; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; PENCE DB, 1988, COPEIA, P565; Poore GCB, 2012, SYST PARASITOL, V82, P211, DOI 10.1007/s11230-012-9363-x; R Core Team, 2013, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley J, 1999, PARASITOLOGY, V119, pS89, DOI 10.1017/S0031182000084651; Robar N, 2011, CAN J ZOOL, V89, P1146, DOI 10.1139/Z11-084; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; ROSE FL, 1968, AM MIDL NAT, V79, P159, DOI 10.2307/2423161; SCHALL JJ, 1982, SCIENCE, V217, P1057, DOI 10.1126/science.7112113; SCHALL JJ, 1986, J HERPETOL, V20, P318, DOI 10.2307/1564498; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Scholnick DA, 2012, J HERPETOL, V46, P643, DOI 10.1670/11-146; Schwanz LE, 2006, J EXP BIOL, V209, P5029, DOI 10.1242/jeb.02601; Serrano E, 2014, EPIDEMIOL INFECT, V142, P1533, DOI 10.1017/S0950268813002100; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Sorci G, 2013, PARASITE IMMUNOL, V35, P350, DOI 10.1111/pim.12047; VELLEMAN PF, 1981, AM STAT, V35, P234, DOI 10.2307/2683296; Viney ME, 2014, ECOIMMUNOLOGY; Weinstein RB, 1999, PHYSIOL BIOCHEM ZOOL, V72, P732, DOI 10.1086/316710	38	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144477	10.1371/journal.pone.0144477	http://dx.doi.org/10.1371/journal.pone.0144477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657838	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900056
J	Carbajo, D; Magi, S; Itoh, M; Kawaji, H; Lassmann, T; Arner, E; Forrest, ARR; Carninci, P; Hayashizaki, Y; Daub, CO; Okada-Hatakeyama, M; Mar, JC				Carbajo, Daniel; Magi, Shigeyuki; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Arner, Erik; Forrest, Alistair R. R.; Carninci, Piero; Hayashizaki, Yoshihide; Daub, Carsten O.; Okada-Hatakeyama, Mariko; Mar, Jessica C.		FANTOM Consortium	Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage	PLOS ONE			English	Article							PROTEIN-INTERACTION DATABASE; MOLECULAR INTERACTION DATABASE; TRANSCRIPTION FACTORS; CELL-DIFFERENTIATION; NETWORK; UPDATE; IREFINDEX; PRODUCTS; RESOURCE; DURATION	Understanding how cells use complex transcriptional programs to alter their fate in response to specific stimuli is an important question in biology. For the MCF-7 human breast cancer cell line, we applied gene expression trajectory models to identify the genes involved in driving cell fate transitions. We modified trajectory models to account for the scenario where cells were exposed to different stimuli, in this case epidermal growth factor and heregulin, to arrive at different cell fates, i.e. proliferation and differentiation respectively. Using genome-wide CAGE time series data collected from the FANTOM5 consortium, we identified the sets of promoters that were involved in the transition of MCF-7 cells to their specific fates versus those with expression changes that were generic to both stimuli. Of the 1,552 promoters identified, 1,091 had stimulus-specific expression while 461 promoters had generic expression profiles over the time course surveyed. Many of these stimulus-specific promoters mapped to key regulators of the ERK (extracellular signal-regulated kinases) signaling pathway such as FHL2 (four and a half LIM domains 2). We observed that in general, generic promoters peaked in their expression early on in the time course, while stimulus-specific promoters tended to show activation of their expression at a later stage. The genes that mapped to stimulus-specific promoters were enriched for pathways that control focal adhesion, p53 signaling and MAPK signaling while generic promoters were enriched for cell death, transcription and the cell cycle. We identified 162 genes that were controlled by an alternative promoter during the time course where a subset of 37 genes had separate promoters that were classified as stimulus-specific and generic. The results of our study highlighted the degree of complexity involved in regulating a cell fate transition where multiple promoters mapping to the same gene can demonstrate quite divergent expression profiles.	[Carbajo, Daniel; Mar, Jessica C.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Magi, Shigeyuki; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Arner, Erik; Forrest, Alistair R. R.; Carninci, Piero; Daub, Carsten O.] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Arner, Erik; Forrest, Alistair R. R.; Carninci, Piero; Hayashizaki, Yoshihide; Daub, Carsten O.] RIKEN Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Kawaji, Hideya; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Lassmann, Timo] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia; [Arner, Erik] Karolinska Inst, Dept Med, Stockholm, Sweden; [Arner, Erik] Karolinska Univ Hosp, Ctr Metab & Endocrinol, Stockholm, Sweden; [Forrest, Alistair R. R.] Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Forrest, Alistair R. R.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Daub, Carsten O.] Karolinska Inst, Dept Biosci, Stockholm, Sweden; [Daub, Carsten O.] Karolinska Inst, Nutr & Sci Life Lab, Stockholm, Sweden; [Mar, Jessica C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; RIKEN; RIKEN; RIKEN; RIKEN; Telethon Kids Institute; University of Western Australia; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Karolinska Institutet; Karolinska Institutet; Yeshiva University; Albert Einstein College of Medicine	Okada-Hatakeyama, M (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa, Japan.	marikoh@riken.jp; jessica.mar@einstein.yu.edu	Lassmann, Timo/A-8271-2008; Kere, Juha/A-9179-2008; Hide, Winston/R-3815-2019; Hayashizaki, Yoshihide/N-6590-2015; Carninci, Piero/K-1568-2014; Mackay-Sim, Alan/C-3431-2008; Daub, Carsten O/A-7436-2010; Katayama, Shintaro/F-2958-2010; Kawaji, Hideya/N-5116-2015; Wolvetang, Ernst jurgen/D-6644-2017; Lassmann, Timo/HCH-4313-2022; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017; Itoh, Masayoshi/N-5363-2015; Wells, Christine/A-5071-2010; Bodega, Beatrice/I-4644-2018	Lassmann, Timo/0000-0002-0138-2691; Kere, Juha/0000-0003-1974-0271; Hide, Winston/0000-0002-8621-3271; Carninci, Piero/0000-0001-7202-7243; Mackay-Sim, Alan/0000-0003-4446-5371; Daub, Carsten O/0000-0002-3295-8729; Katayama, Shintaro/0000-0001-7581-5157; Kawaji, Hideya/0000-0002-0575-0308; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Lassmann, Timo/0000-0002-0138-2691; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Itoh, Masayoshi/0000-0002-1772-318X; Mar, Jessica/0000-0002-5147-9299; Meehan, Terrence/0000-0003-1980-3228; Ekwall, Karl/0000-0002-3029-4041; Knox, Alan/0000-0002-5906-4143; Wells, Christine/0000-0003-3133-3628; IIDA, Kei/0000-0001-7130-8705; Forrest, Alistair/0000-0003-4543-1675; Huminiecki, Lukasz/0000-0003-1943-4450; Burroughs, A. Max/0000-0002-2229-8771; Bodega, Beatrice/0000-0003-0527-9234; Moro, Kazuyo/0000-0002-7377-1303; Heutink, Peter/0000-0001-5218-1737; Arner, Erik/0000-0003-1225-4908; Alam, Intikhab/0000-0001-5306-847X	Research Grant for RIKEN Omics Science Center from MEXT; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan; Research Grant from MEXT; MEXT; Grants-in-Aid for Scientific Research [26240044] Funding Source: KAKEN	Research Grant for RIKEN Omics Science Center from MEXT; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grant from MEXT; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FANTOM5 was made possible by the following grants: Research Grant for RIKEN Omics Science Center from MEXT to YH; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to YH; Research Grant from MEXT to the RIKEN Center for Life Science Technologies; Research Grant to RIKEN Preventive Medicine and Diagnosis Innovation Program from MEXT to YH.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Califano D, 2000, J BIOL CHEM, V275, P19297, DOI 10.1074/jbc.M905866199; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chawla K, 2013, BIOINFORMATICS, V29, P2519, DOI 10.1093/bioinformatics/btt432; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Dawson JA, 2012, BIOMETRICS, V68, P455, DOI 10.1111/j.1541-0420.2011.01688.x; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Mar JC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000626; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mora A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-455; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nasarre P, 2003, NEOPLASIA, V5, P83, DOI 10.1016/S1476-5586(03)80020-9; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	45	1	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144176	10.1371/journal.pone.0144176	http://dx.doi.org/10.1371/journal.pone.0144176			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658111	Green Published, gold			2022-12-26	WOS:000366715900029
J	Chen, HX; Lu, CP; Jiang, H; Peng, JH				Chen, Haixia; Lu, Changping; Jiang, Hui; Peng, Jinhui			Global Transcriptome Analysis Reveals Distinct Aluminum-Tolerance Pathways in the Al-Accumulating Species Hydrangea macrophylla and Marker Identification	PLOS ONE			English	Article							REGULATES MULTIPLE GENES; PLASMA-MEMBRANE; ACTIVATED CITRATE; ARABIDOPSIS; TRANSPORTER; PLANT; MECHANISMS; TOXICITY; PROTON; DETOXIFICATION	Hydrangea (Hydrangea macrophylla) is a well known Al-accumulating plant, showing a high level of aluminum (Al) tolerance and accumulation. Although the physiological mechanisms for detoxification of Al and the roles of Al in blue hydrangea sepals have been reported, the molecular mechanisms of Al tolerance and accumulation are poorly understood in hydrangea. In this study, we conducted a genome-wide transcriptome analysis of Al-response genes in the roots and leaves of hydrangea by RNA sequencing (RNA-seq). The assembly of hydrangea transcriptome provides a rich source for gene identification and mining molecular markers, including single nucleotide polymorphism (SNP) and simple sequence repeat (SSR). A total of 401,215 transcripts with an average length of 810.77bp were assembled, generating 256,127 unigenes. After annotation, 4,287 genes in the roots and 730 genes in the leaves were up-regulated by Al exposure, while 236 genes in the roots and 719 genes in the leaves were down-regulated, respectively. Many transporters, including MATE and ABC families, were involved in the process of Al-citrate complex transporting from the roots in hydrangea. A plasma membrane Al uptake transporter, Nramp aluminum transporter was up-regulated in roots and leaves under Al stress, indicating it may play an important role in Al tolerance by reducing the level of toxic Al. Although the exact roles of these candidate genes remain to be examined, these results provide a platform for further functional analysis of the process of detoxification of Al in hydrangea.	[Chen, Haixia; Lu, Changping; Jiang, Hui; Peng, Jinhui] Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China	Hunan Agricultural University	Chen, HX (corresponding author), Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China.	chenhaixia1996@126.com			National Natural Science Foundation of China [31201656]; Scientific Research Fund of Hunan Provincial Education Department [14B093]; Hunan co-innovation center for utilization of botanicals functional ingredients	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Hunan co-innovation center for utilization of botanicals functional ingredients	The authors thank the scientific research fund of Hunan co-innovation center for utilization of botanicals functional ingredients. This work was supported by grants from the National Natural Science Foundation of China (31201656) and Scientific Research Fund of Hunan Provincial Education Department (14B093).	Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Chang YC, 1999, PLANT CELL ENVIRON, V22, P1009, DOI 10.1046/j.1365-3040.1999.00467.x; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; COSGROVE D J, 1989, Planta (Heidelberg), V177, P121, DOI 10.1007/BF00392162; Fan W, 2014, PLANT CELL ENVIRON, V37, P1586, DOI 10.1111/pce.12258; Frelet-Barrand A, 2008, PLANT CELL PHYSIOL, V49, P557, DOI 10.1093/pcp/pcn034; Garcia-Oliveira AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-134; Gould B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124424; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanikenne M, 2011, CURR OPIN PLANT BIOL, V14, P252, DOI 10.1016/j.pbi.2011.04.003; Hotta H, 2008, ANAL SCI, V24, P795, DOI 10.2116/analsci.24.795; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Iuchi S, 2007, P NATL ACAD SCI USA, V104, P9900, DOI 10.1073/pnas.0700117104; Janicka-Russak M, 2008, J EXP BOT, V59, P3721, DOI 10.1093/jxb/ern219; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JY, 2014, P NATL ACAD SCI USA, V111, P6503, DOI 10.1073/pnas.1318975111; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2000, PLANT CELL PHYSIOL, V41, P383, DOI 10.1093/pcp/41.4.383; Ma JF, 1997, PLANT PHYSL, V113, P033; Negishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043189; Ohno T, 2003, PLANT CELL PHYSIOL, V44, P156, DOI 10.1093/pcp/pcg025; Ohyama Y, 2013, PLANT PHYSIOL, V162, P1937, DOI 10.1104/pp.113.218958; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Sawaki Y, 2009, PLANT PHYSIOL, V150, P281, DOI 10.1104/pp.108.134700; Schreiber HD, 2011, BIOMETALS, V24, P1005, DOI 10.1007/s10534-011-9458-x; Schumacher K, 2010, CURR OPIN PLANT BIOL, V13, P724, DOI 10.1016/j.pbi.2010.07.003; Tabuchi A, 2001, PHYSIOL PLANTARUM, V112, P353, DOI 10.1034/j.1399-3054.2001.1120308.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yang XY, 2011, PLANT CELL ENVIRON, V34, P2138, DOI 10.1111/j.1365-3040.2011.02410.x; Yokosho K, 2014, PLANT CELL PHYSIOL, V55, P2077, DOI 10.1093/pcp/pcu135; Yokosho K, 2011, PLANT J, V68, P1061, DOI 10.1111/j.1365-313X.2011.04757.x; Yu L, 2010, J EXP BOT, V61, P1625, DOI 10.1093/jxb/erq028; Zhu HF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0395-z	42	20	25	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144927	10.1371/journal.pone.0144927	http://dx.doi.org/10.1371/journal.pone.0144927			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660093	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900151
J	Di, JL; Rutherford, S; Wu, JL; Song, B; Ma, L; Chen, JY; Chu, C				Di, Jiangli; Rutherford, Shannon; Wu, Jiuling; Song, Bo; Ma, Lan; Chen, Jingyi; Chu, Cordia			Knowledge of Cervical Cancer Screening among Women across Different Socio-Economic Regions of China	PLOS ONE			English	Article							ATTITUDES; BARRIERS; BELIEFS; HEALTH; URBAN	Background and Objective China has a high burden of cervical cancer (CC) and wide disparities in CC burden exist among different socio-economic regions. In order to reduce these disparities, China's government launched the National Cervical Cancer Screening Program in Rural Areas (NCCSPRA) in 2009. Understanding the factors associated with underutilization of CC screening among target populations is important to improve the screening participation rate, and a high participation rate is key to achieving the goals of a screening program. However, data on the knowledge of CC among target populations in program areas is lacking in China. This study will investigate the knowledge of CC prevention and control among women in specific project counties to develop a better understanding of factors that might influence CC screening participation in order to improve the implementation of the NCCSPRA. Materials and Methods A cross-sectional survey was conducted and face-to-face interview questionnaires were completed by 308 women who received CC screening services in 6 project counties of NCCSPRA across different socio-economic regions of China. ANOVA and Chi-square tests were used to compare the knowledge rates and scores across the different subgroups. Logistic regression was conducted to examine factors associated with knowledge level. Results The overall CC knowledge rate of the target population was only 19.5%. Regional socioeconomic level, advice from doctors, age, and educational status were strong predictors of knowledge level of CC screening. Significantly lower knowledge rates and scores were identified in older women (55-64 years old), less educated women (with primary school or illiterate), women in less developed regions and women who did not receive any advice about screening results from doctors. Conclusion The knowledge of CC screening among women in the project counties of NCCSPRA was found to be very poor. Given the importance of knowledge in encouraging women to participate in screening is key to reducing CC burden in rural women in China, it is urgent that a targeted health promotion intervention is developed and implemented in project counties, especially targeting older women, women with less education and women in less developed regions, and focus on improving their CC knowledge and encouraging them to communicate with health care providers. The health promotion intervention targeting health care providers is also important to improve their knowledge of CC and provide best advice to women.	[Di, Jiangli; Wu, Jiuling; Song, Bo; Ma, Lan; Chen, Jingyi] China CDC, Natl Ctr Women & Childrens Hlth, Beijing, Peoples R China; [Di, Jiangli; Rutherford, Shannon; Chu, Cordia] Griffith Univ, Brisbane, Qld 4111, Australia	Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention; Griffith University	Di, JL (corresponding author), China CDC, Natl Ctr Women & Childrens Hlth, Beijing, Peoples R China.	dijiangli@chinawch.org.cn; 590@chinawch.org.cn		Chu, Cordia/0000-0002-3683-5638				Al-Naggar RA, 2010, ASIAN PAC J CANCER P, V11, P867; Ali SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011059; [Anonymous], 2009, LANCET, V374, P358; [Anonymous], 2014, LANCET, V384, P2000; [Anonymous], 2009, MAN PLAN RUR AR CERV; Anttila A, 2009, EUR J CANCER, V45, P2649, DOI 10.1016/j.ejca.2009.07.020; Denny-Smith T, 2006, J AM ACAD NURSE PRAC, V18, P62, DOI 10.1111/j.1745-7599.2006.00100.x; Duffett-Leger LA, 2008, JOGNN-J OBST GYN NEO, V37, P572, DOI 10.1111/j.1552-6909.2008.00276.x; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; GLOBOCAN, 2014, GLOBOCAN 2012 EST CA; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Hoque Monjurul, 2008, East Afr J Public Health, V5, P111; Huang Y, 2011, ASIAN PAC J CANCER P, V12, P203; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067005; Jian WY, 2010, HEALTH AFFAIR, V29, P2189, DOI 10.1377/hlthaff.2009.0989; Leite MF, 2014, J HUMAN GROWTH DEV, V24, P208; MOH, 2012, REC PROC MAJ WOM CHI; MOH, 2012, WOM HLTH COMM HLTH; MOH, 2006, RES ASS RES POL WOM; Mutyaba Twaha, 2006, BMC Med Educ, V6, P13, DOI 10.1186/1472-6920-6-13; NBS, 2014, NAT DAT; NCC DPCB NHFPC, 2012, CHIN CANC REG ANN RE; NCC DPCB NHFPC, 2013, CHIN CANC REG ANN RE; NOCPC NCCR DPCB, 2010, CHIN CANC REG ANN RE; Nwankwo KC, 2011, EUR J CANCER CARE, V20, P362, DOI 10.1111/j.1365-2354.2009.01175.x; Powe BD, 2003, CANCER NURS, V26, P454; Shea J, 2013, J CLIN NURS, V22, P3310, DOI 10.1111/jocn.12420; Tebeu PM, 2008, INT J GYNECOL CANCER, V18, P761, DOI 10.1111/j.1525-1438.2007.01066.x; WHO, 2014, COMPR CERV CANC CONT; WHO, 2006, COMPR CERV CANC CONT; Wong LP, 2010, EUR J OBSTET GYN R B, V148, P90, DOI 10.1016/j.ejogrb.2009.10.002; Yanikkerem E, 2013, J CANCER EDUC, V28, P375, DOI 10.1007/s13187-012-0409-1	34	11	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144819	10.1371/journal.pone.0144819	http://dx.doi.org/10.1371/journal.pone.0144819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657110	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900109
J	Hadlari, T; Swindles, GT; Galloway, JM; Bell, KM; Sulphur, KC; Heaman, LM; Beranek, LP; Fallas, KM				Hadlari, Thomas; Swindles, Graeme T.; Galloway, Jennifer M.; Bell, Kimberley M.; Sulphur, Kyle C.; Heaman, Larry M.; Beranek, Luke P.; Fallas, Karen M.			1.8 Billion Years of Detrital Zircon Recycling Calibrates a Refractory Part of Earth's Sedimentary Cycle	PLOS ONE			English	Article							NORTHWESTERN CANADA; CORDILLERAN MIOGEOCLINE; U-PB; PROVENANCE; GEOCHRONOLOGY; STRATA; YUKON; LAURENTIA; EVOLUTION; TERRANE	Detrital zircon studies are providing new insights on the evolution of sedimentary basins but the role of sedimentary recycling remains largely undefined. In a broad region of northwestern North America, this contribution traces the pathway of detrital zircon sand grains from Proterozoic sandstones through Phanerozoic strata and argues for multi-stage sedimentary recycling over more than a billion years. As a test of our hypothesis, integrated palynology and detrital zircon provenance provides clear evidence for erosion of Carboniferous strata in the northern Cordillera as a sediment source for Upper Cretaceous strata. Our results help to calibrate Earth's sedimentary cycle by showing that recycling dominates sedimentary provenance for the refractory mineral zircon.	[Hadlari, Thomas; Galloway, Jennifer M.; Fallas, Karen M.] Geol Survey Canada, Calgary, AB T2L 2A7, Canada; [Swindles, Graeme T.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Bell, Kimberley M.; Sulphur, Kyle C.] Univ Calgary, Dept Geosci, Calgary, AB, Canada; [Heaman, Larry M.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Beranek, Luke P.] Mem Univ Newfoundland, Dept Earth Sci, St John, NF, Canada	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Leeds; University of Calgary; University of Alberta; Memorial University Newfoundland	Hadlari, T (corresponding author), Geol Survey Canada, 3303 33Rd St Nw, Calgary, AB T2L 2A7, Canada.	thomas.hadlari@canada.ca	Swindles, Graeme/AAU-4321-2020	Swindles, Graeme/0000-0001-8039-1790; galloway, jennifer/0000-0002-4548-6396; Hadlari, Thomas/0000-0002-1264-0051; Fallas, Karen/0000-0002-5645-9561	Geological Survey of Canada	Geological Survey of Canada(Natural Resources Canada)	This work was supported by internal project funding to TH, JG, and KF which was provided by the Geological Survey of Canada through the GEM program.; We acknowledge full support of the Geological Survey of Canada and this is a CALE contribution. Special thanks to Drs. RH Rainbird, WG Davis, and AR Sweet.	Beranek LP, 2011, TECTONICS, V30, DOI 10.1029/2010TC002849; Beranek LP, 2010, GEOL SOC AM BULL, V122, P1899, DOI 10.1130/B30120.1; Beranek LP, 2010, CAN J EARTH SCI, V47, P53, DOI 10.1139/E09-065; Colpron M., 2006, PALEOZOIC EVOLUTION, V45, P131; Condie KC, 2009, GONDWANA RES, V15, P228, DOI 10.1016/j.gr.2008.06.001; Cook FA, 2004, TECTONICS, V23, DOI 10.1029/2002TC001412; Dickinson WR, 2009, GEOLOGY, V37, P503, DOI 10.1130/G25646A.1; Furlanetto F, 2009, YUKON EXPLORATION GE, P125; Furlanetto F, 2013, PRECAMBRIAN RES, V224, P512, DOI 10.1016/j.precamres.2012.10.010; Hadlari T, 2012, GEOL SOC AM BULL, V124, P1155, DOI 10.1130/B30530.1; Hadlari T, 2014, MAR PETROL GEOL, V57, P173, DOI 10.1016/j.marpetgeo.2014.05.019; Lane LS, 2014, GEOL SOC AM BULL, V126, P398, DOI 10.1130/B30848.1; Lemieux Y, 2011, CAN J EARTH SCI, V48, P515, DOI 10.1139/E10-056; Piercey SJ, 2009, GEOSPHERE, V5, P439, DOI 10.1130/GES00505.1; Rainbird RH, 1997, J GEOL, V105, P1, DOI 10.1086/606144; Rohr TS, 2008, J GEOL SOC LONDON, V165, P755, DOI 10.1144/0016-76492007-102; Snyder DB, 2009, GEOL SOC SPEC PUBL, V318, P257, DOI 10.1144/SP318.9; Thorkelson DJ, 2005, CAN J EARTH SCI, V42, P1045, DOI 10.1139/e04-075	18	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144727	10.1371/journal.pone.0144727	http://dx.doi.org/10.1371/journal.pone.0144727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658165	Green Published, gold			2022-12-26	WOS:000366715900095
J	Rawson, R; Anilkumar, A; Newbury, RO; Bafna, V; Aquino, M; Palmquist, J; Hoffman, HM; Mueller, JL; Dohil, R; Broide, DH; Aceves, SS				Rawson, Renee; Anilkumar, Arjun; Newbury, Robert O.; Bafna, Vineet; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Dohil, Ranjan; Broide, David H.; Aceves, Seema S.			The TGF beta 1 Promoter SNP C-509T and Food Sensitization Promote Esophageal Remodeling in Pediatric Eosinophilic Esophagitis	PLOS ONE			English	Article							DISEASE SEVERITY; DIETARY THERAPY; CHILDREN; ASSOCIATION; EXPRESSION; VARIANTS; ALLERGY; RISK; GENE; IDENTIFICATION	Background Eosinophilic esophagitis (EoE) is a chronic antigen mediated disease associated with substantial esophageal remodeling and fibrosis. The functional TGF beta 1 promoter SNP C-509 associates with renal fibrosis and asthma. The effect of TGF beta 1 genotype and EoE severity or potential gene-environment interactions have not been previously reported in EoE. Methods Genotype at TGF beta 1 C-509T and remodeling was analyzed in 144 subjects with EoE. The severity of remodeling and inflammation was analyzed in the context of IgE sensitization to food antigens and C-509T genotype. Results The TGF beta 1 promoter C-509 genotypes CC, CT, and TT were 35%, 52%, and 13%, respectively. Sixty-six percent of subjects were sensitized to foods by positive skin prick test (SPT) or serum specific IgE. TT genotype subjects had significantly more TGF beta 1 (CC subjects = 1300 per mm(2); TT = 2250 per mm(2)) (p<0.05) and tryptase (CC subjects = 145 per mm(2): TT = 307 per mm(2)) (p<0.05) positive cells and higher epithelial remodeling scores (2.4 vs 3.7, p<0.001) than CC subjects. The differences in TGF beta 1 and tryptase positive cells as well as fibrosis were significantly increased when there was concurrent food sensitization. Food sensitization alone did not associate with any parameters of inflammation or remodeling. Conclusions Our data support a gene-environment interaction between food and genotype at C-509 that modulates disease severity in EoE. Since EoE subjects often continue to consume foods to which they are sensitized, these findings may have clinical relevance for disease management.	[Rawson, Renee; Anilkumar, Arjun; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Broide, David H.; Aceves, Seema S.] Univ Calif San Diego, Div Allergy, Immunol, La Jolla, CA 92093 USA; [Rawson, Renee; Anilkumar, Arjun; Hoffman, Hal M.; Mueller, James L.; Aceves, Seema S.] Univ Calif San Diego, Ctr Infect Immun & Inflammat, La Jolla, CA 92093 USA; [Dohil, Ranjan] Univ Calif San Diego, Div Pediat Gastroenterol & Nutr, La Jolla, CA 92093 USA; [Rawson, Renee; Newbury, Robert O.; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Dohil, Ranjan; Aceves, Seema S.] Rady Childrens Hosp, San Diego, CA USA; [Rawson, Renee; Newbury, Robert O.; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Dohil, Ranjan; Aceves, Seema S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Anilkumar, Arjun; Hoffman, Hal M.; Broide, David H.; Aceves, Seema S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Newbury, Robert O.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Aceves, SS (corresponding author), Univ Calif San Diego, Div Allergy, Immunol, La Jolla, CA 92093 USA.	saceves@ucsd.edu	Bafna, Vineet/AAY-8111-2020	Bafna, Vineet/0000-0002-5810-6241; Broide, David/0000-0001-8405-9090	DOD [FA100044]; NIH/NIAID [AI 092135, AI 107779, AI 70535, AI 72115]; ART/APFED HOPE Award; Hearst Foundation; CEGIR part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS [U54 AI117804]; NIAID; NIDDK; NIH of CTSA [UL1TR000100, UL1TR001442]; NCATS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100, UL1TR001442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092135, U54AI117804, U19AI070535, R01AI107779, R01AI072115] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ART/APFED HOPE Award; Hearst Foundation; CEGIR part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH of CTSA; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by DOD FA100044 (D.H.B, S.A.), NIH/NIAID AI 092135 (S.A), ART/APFED HOPE Award (S.A.), NIH/NIAID AI 107779 (D.H.B.), AI 70535 (D.H.B.), AI 72115 (D.H.B.), Hearst Foundation (R.D.), Dr. Aceves also has funding from CEGIR (U54 AI117804) part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS, and is funded through collaboration between NIAID, NIDDK, and NCATS. The UCSD/RCHSD database is supported by the NIH grant UL1TR000100 of CTSA funding prior to August 13, 2015 and grant UL1TR001442 of CTSA funding beginning August 13, 2015 and beyond. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2013, J ALLERGY CLIN IMMUN, V132, P378, DOI 10.1016/j.jaci.2013.02.030; Aceves SS, 2010, ALLERGY, V65, P109, DOI 10.1111/j.1398-9995.2009.02142.x; Aceves SS, 2014, CLIN GASTROENTEROL H, V12, P1216, DOI 10.1016/j.cgh.2013.09.007; Aceves SS, 2009, ANN ALLERG ASTHMA IM, V103, P401, DOI 10.1016/S1081-1206(10)60359-6; Aceves SS, 2007, J ALLERGY CLIN IMMUN, V119, P206, DOI 10.1016/j.jaci.2006.10.016; Beppu L, 2014, J PEDIAT GASTROENTER; Beppu LY, 2014, J ALLERGY C IN PRESS; Caldwell JM, 2010, J ALLERGY CLIN IMMUN, V125, P879, DOI 10.1016/j.jaci.2010.01.038; Che Z, 2014, HUM IMMUNOL, V75, P141, DOI 10.1016/j.humimm.2013.11.008; Cho JY, 2014, J PEDIATR GASTR NUTR, V59, P10, DOI 10.1097/MPG.0000000000000343; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Dohil R, 2010, GASTROENTEROLOGY, V139, P418, DOI 10.1053/j.gastro.2010.05.001; Frischmeyer-Guerrerio PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006448; Greenhawt Matthew, 2013, Gastroenterology, V144, P1560, DOI 10.1053/j.gastro.2013.04.034; Henderson CJ, 2012, J ALLERGY CLIN IMMUN, V129, P1570, DOI 10.1016/j.jaci.2012.03.023; Hill DJ, 2000, J PEDIATR-US, V137, P475, DOI 10.1067/mpd.2000.108207; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Khalil MS, 2005, NEPHRON EXP NEPHROL, V101, pE31, DOI 10.1159/000086227; Korsapati H, 2009, GUT, V58, P1056, DOI 10.1136/gut.2008.168146; Kuchen T, 2014, ALLERGY, V69, P1248, DOI 10.1111/all.12455; Lexmond WS, 2014, AM J GASTROENTEROL, V109, P646, DOI 10.1038/ajg.2014.12; Liacouras Chris A, 2011, Gastroenterol Hepatol (N Y), V7, P264; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lieberman JA, 2012, ALLERGY, V67, P1299, DOI 10.1111/j.1398-9995.2012.02881.x; Lin ZY, 2013, THER ADV GASTROENTER, V6, P97, DOI 10.1177/1756283X12470017; Lucendo AJ, 2011, J ALLERGY CLIN IMMUN, V128, P1037, DOI 10.1016/j.jaci.2011.08.007; Maloney JM, 2011, J ALLERGY CLIN IMMUN, V128, P214, DOI 10.1016/j.jaci.2011.04.024; Nicodeme F, 2013, CLIN GASTROENTEROL H, V11, P1101, DOI 10.1016/j.cgh.2013.03.020; Panek M, 2014, INT J MOL MED, V34, P975, DOI 10.3892/ijmm.2014.1894; Persad R, 2012, J PEDIATR GASTR NUTR, V55, P251, DOI 10.1097/MPG.0b013e31824b6391; Rodriguez-Sanchez J, 2014, ALLERGY, V69, P936, DOI 10.1111/all.12420; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Salam MT, 2007, AM J RESP CRIT CARE, V176, P1192, DOI 10.1164/rccm.200704-561OC; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Sharma S, 2009, AM J RESP CRIT CARE, V179, P356, DOI 10.1164/rccm.200808-1268OC; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V130, P461, DOI 10.1016/j.jaci.2012.05.021; Straumann A, 2011, CLIN GASTROENTEROL H, V9, P400, DOI 10.1016/j.cgh.2011.01.017; Tampe B, 2014, NEPHROL DIAL TRANSPL, V29, P72, DOI 10.1093/ndt/gft025; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; Wen T, 2014, J ALLERGY C IN PRESS; Yen EH, 2010, J PEDIATR GASTR NUTR, V51, P584, DOI 10.1097/MPG.0b013e3181de7685	43	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144651	10.1371/journal.pone.0144651	http://dx.doi.org/10.1371/journal.pone.0144651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656423	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900080
J	Taus, NS; Cunha, CW; Marquard, J; O'Toole, D; Li, H				Taus, Naomi S.; Cunha, Cristina W.; Marquard, Jana; O'Toole, Donal; Li, Hong			Cross-Reactivity of Neutralizing Antibodies among Malignant Catarrhal Fever Viruses	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; SHEEP NASAL SECRETIONS; OVINE HERPESVIRUS 2; ALCELAPHINE HERPESVIRUS-1; EXPERIMENTAL-INFECTION; EAST-AFRICA; RUMINANTS	Some members of the gamma herpesvirus genus Macavirus are maintained in nature as subclinical infections in well-adapted ungulate hosts. Transmission of these viruses to poorly adapted hosts, such as American bison and cattle, can result in the frequently fatal disease malignant catarrhal fever (MCF). Based on phylogenetic analysis, the MCF viruses (MCFV) cluster into two subgroups corresponding to the reservoir hosts' subfamilies: Alcelaphinae/Hippotraginae and Caprinae. Antibody cross-reactivity among MCFVs has been demonstrated using techniques such as enzyme linked immunosorbent and immunofluorescence assays. However, minimal information is available as to whether virus neutralizing antibodies generated against one MCFV cross react with other members of the genus. This study tested the neutralizing activity of serum and plasma from select MCFV-infected reservoir hosts against alcelaphine herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 (OvHV-2). Neutralizing antibody activity against AlHV-1 was detected in samples from infected hosts in the Alcelaphinae and Hippotraginae subfamilies, but not from hosts in the Caprinae subfamily. OvHV-2 neutralizing activity was demonstrated in samples from goats (Caprinae) but not from wildebeest (Alcelaphinae). These results show that neutralizing antibody cross reactivity is present to MCFVs within a virus subgroup but not between subgroups. This information is important for diagnosing infection with MCFVs and in the development of vaccines against MCF.	[Taus, Naomi S.; Li, Hong] ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA; [Taus, Naomi S.; Cunha, Cristina W.; Marquard, Jana; Li, Hong] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [O'Toole, Donal] Univ Wyoming, Wyoming State Vet Lab, Laramie, WY 82071 USA	United States Department of Agriculture (USDA); Washington State University; University of Wyoming	Taus, NS (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA.	tausns@vetmed.wsu.edu	Cunha, Cristina/AAC-6120-2021; Cunha, Cristina/V-7622-2019	Cunha, Cristina/0000-0002-8168-5448; 	United States Department of Agriculture, Agricultural Research Service [CWU 5348-32000-032-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the United States Department of Agriculture, Agricultural Research Service (CWU 5348-32000-032-00D). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cunha CW, 2015, VET MICROBIOL, V2, P209; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Gailbreath KL, 2008, VET MICROBIOL, V132, P65, DOI 10.1016/j.vetmic.2008.04.035; Giangaspero M, 2013, J VET MED SCI, V75, P815, DOI 10.1292/jvms.12-0424; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Heuschele W. P., 1984, Proceedings of the United States Animal Health Association, V88, P640; Li H, 2006, J VET DIAGN INVEST, V18, P119, DOI 10.1177/104063870601800120; Li H, 2005, J GEN VIROL, V86, P3021, DOI 10.1099/vir.0.81238-0; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; LI H, 1995, J GEN VIROL, V76, P123, DOI 10.1099/0022-1317-76-1-123; LI H, 1994, J CLIN MICROBIOL, V32, P1674, DOI 10.1128/JCM.32.7.1674-1679.1994; Li H, 2001, J VET DIAGN INVEST, V13, P361, DOI 10.1177/104063870101300417; Li H, 2014, ANNU REV ANIM BIOSCI, V2, P209, DOI 10.1146/annurev-animal-022513-114156; Li H, 2013, J VIROL METHODS, V188, P104, DOI 10.1016/j.jviromet.2012.12.008; PLOWRIGHT W, 1967, RES VET SCI, V8, P129; REID HW, 1975, RES VET SCI, V18, P269, DOI 10.1016/S0034-5288(18)33577-X; ROSSITER PB, 1981, J COMP PATHOL, V91, P303, DOI 10.1016/0021-9975(81)90036-0; Russell GC, 2013, J GEN VIROL, V94, P2515, DOI 10.1099/vir.0.055673-0; Schultheiss PC, 2000, J VET DIAGN INVEST, V12, P497, DOI 10.1177/104063870001200602; SEAL BS, 1989, AM J VET RES, V50, P1447; Taus NS, 2005, J GEN VIROL, V86, P575, DOI 10.1099/vir.0.80707-0	21	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145073	10.1371/journal.pone.0145073	http://dx.doi.org/10.1371/journal.pone.0145073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658281	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900181
J	Narayan, O; Leung, MCH; Wong, DTL; Meredith, IT; Cameron, JD				Narayan, Om; Leung, Michael C. H.; Wong, Dennis T. L.; Meredith, Ian T.; Cameron, James D.			Percutaneous Coronary Intervention Enhances Accelerative Wave Intensity in Coronary Arteries	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; LEFT-VENTRICULAR HYPERTROPHY; PRESSURE MEASUREMENT; PHYSIOLOGICAL-BASIS; HUMANS; STENOSIS; HYPEREMIA; ADENOSINE; DISEASE; INTRACORONARY	Background The systolic forward travelling compression wave (sFCW) and diastolic backward travelling decompression waves (dBEW) predominantly accelerate coronary blood flow. The effect of a coronary stenosis on the intensity of these waves in the distal vessel is unknown. We investigated the relationship between established physiological indices of hyperemic coronary flow and the intensity of the two major accelerative coronary waves identified by Coronary Wave Intensity analysis (CWIA). Methodology/Principal Findings Simultaneous intracoronary pressure and velocity measurement was performed during adenosine induced hyperemia in 17 patients with pressure/Doppler flow wires positioned distal to the target lesion. CWI profiles were generated from this data. Fractional Flow Reserve (FFR) and Coronary Flow Velocity Reserve (CFVR) were calculated concurrently. The intensity of the dBEW was significantly correlated with FFR (R = -0.70, P = 0.003) and CFVR (R = -0.73, P = 0.001). The intensity of the sFCW was also significantly correlated with baseline FFR (R = 0.71, p = 0.002) and CFVR (R = 0.59, P = 0.01). Stenting of the target lesion resulted in a median 178% (interquartile range 55-280%) (P<0.0001) increase in sFCW intensity and a median 117% (interquartile range 27-509%) (P = 0.001) increase in dBEW intensity. The increase in accelerative wave intensity following PCI was proportionate to the baseline FFR and CFVR, such that stenting of lesions associated with the greatest flow limitation (lowest FFR and CFVR) resulted in the largest increases in wave intensity. Conclusions Increasing ischemia severity is associated with proportionate reductions in cumulative intensity of both major accelerative coronary waves. Impaired diastolic microvascular decompression may represent a novel, important pathophysiologic mechanism driving the reduction in coronary blood flow in the setting of an epicardial stenosis.	[Narayan, Om] Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Melbourne, Vic 3004, Australia; Monash Univ, Sch Clin Sci Monash Hlth, Melbourne, Vic 3004, Australia	Monash University; Monash University	Narayan, O (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Melbourne, Vic 3004, Australia.	om_narayan@hotmail.com	Cameron, james/GQP-4595-2022	Cameron, james/0000-0003-0589-0367	National Health and Medical Research Council Postgraduate Scholarship [1039186]; Monash Medical Centre Clinical Academic Fellowship (Australia)	National Health and Medical Research Council Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Monash Medical Centre Clinical Academic Fellowship (Australia)	ON is the recipient of a National Health and Medical Research Council Postgraduate Scholarship (Grant number 1039186, http://www.nhmrc.gov.au/) and a Monash Medical Centre Clinical Academic Fellowship (Australia). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bishop AH, 2004, AM HEART J, V147, P792, DOI 10.1016/j.ahj.2003.12.009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Davies JE, 2006, CIRCULATION, V113, P1768, DOI 10.1161/CIRCULATIONAHA.105.603050; Davies JE, 2006, AM J PHYSIOL-HEART C, V290, pH878, DOI 10.1152/ajpheart.00751.2005; Davies JE, 2011, CIRCULATION, V124, P1565, DOI 10.1161/CIRCULATIONAHA.110.011916; De Bruyne B, 2003, CIRCULATION, V107, P1877, DOI 10.1161/01.CIR.0000061950.24940.88; GOULD KL, 1990, CARDIOVASC INTER RAD, V13, P5, DOI 10.1007/BF02576930; GOULD KL, 1978, CIRC RES, V43, P242, DOI 10.1161/01.RES.43.2.242; GOULD KL, 1978, AM J CARDIOL, V41, P267, DOI 10.1016/0002-9149(78)90165-0; GOULD KL, 1974, AM J CARDIOL, V33, P87, DOI 10.1016/0002-9149(74)90743-7; HOUGHTON JL, 1990, J AM COLL CARDIOL, V15, P43, DOI 10.1016/0735-1097(90)90173-M; Johnson NP, 2012, JACC-CARDIOVASC IMAG, V5, P193, DOI 10.1016/j.jcmg.2011.09.020; KERN MJ, 1989, J AM COLL CARDIOL, V13, P1042, DOI 10.1016/0735-1097(89)90259-3; Kolyva C, 2008, AM J PHYSIOL-HEART C, V295, pH482, DOI 10.1152/ajpheart.00223.2008; Lim CCS, 2011, J AM COLL CARDIOL, V57, P653, DOI 10.1016/j.jacc.2010.07.058; Lopez-Palop R, 2004, HEART, V90, P95, DOI 10.1136/heart.90.1.95; Park DW, 2013, EUR HEART J, V34, P1662, DOI 10.1093/eurheartj/eht048; Parker KH, 2009, MED BIOL ENG COMPUT, V47, P175, DOI 10.1007/s11517-009-0439-y; Pijls NHJ, 2000, CIRCULATION, V102, P2371, DOI 10.1161/01.CIR.102.19.2371; PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183; Pijls NHJ, 2000, CATHETER CARDIO INTE, V49, P1; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Rolandi MC, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0405-1; Siebes M, 2009, MED BIOL ENG COMPUT, V47, P233, DOI 10.1007/s11517-009-0448-x; Sun YH, 2000, J APPL PHYSIOL, V89, P1636, DOI 10.1152/jappl.2000.89.4.1636; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Tyberg JV, 2009, MED BIOL ENG COMPUT, V47, P221, DOI 10.1007/s11517-008-0430-z; van de Hoef TP, 2013, NAT REV CARDIOL, V10, P439, DOI 10.1038/nrcardio.2013.86; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142998	10.1371/journal.pone.0142998	http://dx.doi.org/10.1371/journal.pone.0142998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658896	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600008
J	Osorio-Zambrano, WF; Davey, S				Osorio-Zambrano, William F.; Davey, Scott			Chk1 Activation Protects Rad9A from Degradation as Part of a Positive Feedback Loop during Checkpoint Signalling	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; SCF-BETA-TRCP; NUCLEAR-LOCALIZATION; IONIZING-RADIATION; MAMMALIAN-CELLS; SOMATIC WEE1; FACTOR-C; PHOSPHORYLATION; KINASE; CLASPIN	Phosphorylation of Rad9A at S387 is critical for establishing a physical interaction with TopBP1, and to downstream activation of Chk1 for checkpoint activation. We have previously demonstrated a phosphorylation of Rad9A that occurs at late time points in cells exposed to genotoxic agents, which is eliminated by either Rad9A overexpression, or conversion of S387 to a non-phosphorylatable analogue. Based on this, we hypothesized that this late Rad9A phosphorylation is part of a feedback loop regulating the checkpoint. Here, we show that Rad9A is hyperphosphorylated and accumulates in cells exposed to bleomycin. Following the removal of bleomycin, Rad9A is polyubiquitinated, and Rad9A protein levels drop, indicating an active degradation process for Rad9A. Chk1 inhibition by UCN-01 or siRNA reduces Rad9A levels in cells synchronized in S-phase or exposed to DNA damage, indicating that Chk1 activation is required for Rad9A stabilization in S-phase and during checkpoint activation. Together, these results demonstrate a positive feedback loop involving Rad9A-dependend activation of Chk1, coupled with Chk1-dependent stabilization of Rad9A that is critical for checkpoint regulation.	[Osorio-Zambrano, William F.; Davey, Scott] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada; [Osorio-Zambrano, William F.; Davey, Scott] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Davey, Scott] Queens Univ, Dept Oncol, Kingston, ON K7L 3N6, Canada; [Davey, Scott] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Davey, S (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada.	scott.davey@queensu.ca		Osorio Zambrano, William Frend/0000-0001-7901-7654	Canadian Breast Cancer Foundation-Ontario Chapter	Canadian Breast Cancer Foundation-Ontario Chapter	This work was supported by operating funds from the Canadian Breast Cancer Foundation-Ontario Chapter (SD), and by infrastructure support through the Canada Foundation for Innovation Leaders Opportunity Fund, and the Ontario Research Fund (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldin V, 2002, J BIOL CHEM, V277, P35176, DOI 10.1074/jbc.M204430200; Bassermann F, 2013, BIOCH BIOPHYS ACTA; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Broustas CG, 2012, J CELL BIOCHEM, V113, P742, DOI 10.1002/jcb.23424; Card DAG, 2010, J BIOL CHEM, V285, P15653, DOI 10.1074/jbc.M109.096156; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; Cheng CK, 2005, CANCER RES, V65, P8646, DOI 10.1158/0008-5472.CAN-04-4243; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dang TY, 2005, GENES CELLS, V10, P287, DOI 10.1111/j.1365-2443.2005.00840.x; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Greer DA, 2003, CANCER RES, V63, P4829; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; Kelly R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085859; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kubota S, 2014, J BIOL CHEM, V289, P5730, DOI 10.1074/jbc.M113.546655; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Loegering D, 2004, J BIOL CHEM, V279, P18641, DOI 10.1074/jbc.M313536200; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nakanishi M, 2010, CHROMOSOME RES, V18, P103, DOI 10.1007/s10577-009-9086-2; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Parker AE, 1998, J BIOL CHEM, V273, P18340, DOI 10.1074/jbc.273.29.18340; Poon RYC, 1997, CANCER RES, V57, P5168; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Sierant ML, 2010, CELL CYCLE, V9, P548, DOI 10.4161/cc.9.3.10553; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Sorensen CS, 2004, CELL CYCLE, V3, P941; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; St Onge RP, 2001, J BIOL CHEM, V276, P41898, DOI 10.1074/jbc.M105152200; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou Zhanru, 2013, ScientificWorldJournal, V2013, P458797, DOI 10.1155/2013/458797; Zhu A, 2008, CANCER RES, V68, P1267, DOI 10.1158/0008-5472.CAN-07-2304	75	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144434	10.1371/journal.pone.0144434	http://dx.doi.org/10.1371/journal.pone.0144434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658951	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600045
J	Kuster, K; Cousin, ME; Jemmi, T; Schupbach-Regula, G; Magouras, I				Kuster, Karin; Cousin, Marie-Eve; Jemmi, Thomas; Schuepbach-Regula, Gertraud; Magouras, Ioannis			Expert Opinion on the Perceived Effectiveness and Importance of On-Farm Biosecurity Measures for Cattle and Swine Farms in Switzerland	PLOS ONE			English	Article							EQUINE INFLUENZA OUTBREAK; WILD BOAR; PIG HERDS; INFECTIOUS-DISEASES; RISK-FACTORS; PERCEPTIONS; AUSTRALIA; SPREAD; BIOCONTAINMENT; VETERINARIANS	Biosecurity is crucial for safeguarding livestock from infectious diseases. Despite the plethora of biosecurity recommendations, published scientific evidence on the effectiveness of individual biosecurity measures is limited. The objective of this study was to assess the perception of Swiss experts about the effectiveness and importance of individual on-farm biosecurity measures for cattle and swine farms (31 and 30 measures, respectively). Using a modified Delphi method, 16 Swiss livestock disease specialists (8 for each species) were interviewed. The experts were asked to rank biosecurity measures that were written on cards, by allocating a score from 0 (lowest) to 5 (highest). Experts ranked biosecurity measures based on their importance related to Swiss legislation, feasibility, as well as the effort required for implementation and the benefit of each biosecurity measure. The experts also ranked biosecurity measures based on their effectiveness in preventing an infectious agent from entering and spreading on a farm, solely based on transmission characteristics of specific pathogens. The pathogens considered by cattle experts were those causing Bluetongue (BT), Bovine Viral Diarrhea (BVD), Foot and Mouth Disease (FMD) and Infectious Bovine Rhinotracheitis (IBR). Swine experts expressed their opinion on the pathogens causing African Swine Fever (ASF), Enzootic Pneumonia (EP), Porcine Reproductive and Respiratory Syndrome (PRRS), as well as FMD. For cattle farms, biosecurity measures that improve disease awareness of farmers were ranked as both most important and most effective. For swine farms, the most important and effective measures identified were those related to animal movements. Among all single measures evaluated, education of farmers was perceived by the experts to be the most important and effective for protecting both Swiss cattle and swine farms from disease. The findings of this study provide an important basis for recommendation to farmers and policy makers.	[Kuster, Karin; Schuepbach-Regula, Gertraud; Magouras, Ioannis] Univ Bern, Vet Publ Hlth Inst, Vetsuisse Fac, CH-3097 Liebefeld, Switzerland; [Cousin, Marie-Eve] Swiss Fed Inst Technol, Consumer Behav, Inst Environm Decis IED, CH-8092 Zurich, Switzerland; [Jemmi, Thomas] Fed Food Safety & Vet Off FSVO, CH-3003 Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Magouras, I (corresponding author), Univ Bern, Vet Publ Hlth Inst, Vetsuisse Fac, Schwarzenburgstr 155, CH-3097 Liebefeld, Switzerland.	ioannis.magouras@vetsuisse.unibe.ch	Schüpbach-Regula, Gertraud/S-1971-2017	Schüpbach-Regula, Gertraud/0000-0002-2310-7105; Magouras, Ioannis/0000-0002-9282-8512	Federal Food Safety and Veterinary Office (FSVO) [1.11.19]; Veterinary Public Health Institute, University of Bern	Federal Food Safety and Veterinary Office (FSVO); Veterinary Public Health Institute, University of Bern	The project was funded by the Federal Food Safety and Veterinary Office (FSVO), grant No 1.11.19 (http://www.blv.admin.ch/index.html?lang=en). The funding was received by Prof. Gertraud Schupbach, director of the Veterinary Public Health Institute, University of Bern. The co-author T. Jemmi who is employed by the FSVO assisted in the planning and design of the study but had no infuence in any step of data collection, analysis and interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the Federal Food Safety and Veterinary Office (FSVO). We would like to thank each of the participating experts for their contribution to this project.	Braun U, 2013, SCHWEIZ ARCH TIERH, V155, P123, DOI 10.1024/0036-7281/a000428; Brennan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028139; Bundesamt fur Statistik, 2012, SCHW LANDW TASCH; Burgman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022998; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; Cross P, 2009, VET REC, V165, P397, DOI 10.1136/vr.165.14.397; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; European Commission, 2007, NEW AN HLTH STRAT EU; Fasina FO, 2012, PREV VET MED, V103, P178, DOI 10.1016/j.prevetmed.2011.09.016; Fellstrom C., 2012, INFECT ECOL EPIDEMIO, V2, P17093, DOI [DOI 10.3402/IEE.V2I0.17093, 10.3402/iee.v2i0.17093]; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Firestone SM, 2013, PREV VET MED, V110, P28, DOI 10.1016/j.prevetmed.2013.02.003; Firestone SM, 2011, PREV VET MED, V100, P53, DOI 10.1016/j.prevetmed.2011.03.002; Gelaude P, 2014, POULTRY SCI, V93, P2740, DOI 10.3382/ps.2014-04002; Graham JP, 2008, PUBLIC HEALTH REP, V123, P282, DOI 10.1177/003335490812300309; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; Gustafson LL, 2013, PREV VET MED, V109, P1, DOI 10.1016/j.prevetmed.2012.11.019; Hintze J, 2012, NCSS 8; Hoe FGH, 2006, J DAIRY SCI, V89, P2297, DOI 10.3168/jds.S0022-0302(06)72301-3; Horst HS, 1996, PREV VET MED, V27, P183, DOI 10.1016/0167-5877(95)01003-3; Hsu CC, 2007, PARE, V12, P1; Kuhnert P, 2014, VET MICROBIOL, V174, P261, DOI 10.1016/j.vetmic.2014.08.022; Laanen M, 2013, VET J, V198, P508, DOI 10.1016/j.tvjl.2013.08.029; Lindberg A, 2005, PREV VET MED, V72, P55, DOI 10.1016/j.prevetmed.2005.07.018; Linstone H. A., 1975, DELPHI METHOD TECHNI; Mangen MJJ, 2002, PREV VET MED, V56, P141, DOI 10.1016/S0167-5877(02)00155-1; Maunsell F, 2008, VET CLIN N AM-FOOD A, V24, P155, DOI 10.1016/j.cvfa.2007.10.007; Moore DA, 2008, JAVMA-J AM VET MED A, V233, P249, DOI 10.2460/javma.233.2.249; Morgan M. G., 2001, RISK COMMUNICATION M; Mur L, 2012, TRANSBOUND EMERG DIS, V59, P526, DOI 10.1111/j.1865-1682.2012.01308.x; Nampanya S, 2012, TRANSBOUND EMERG DIS, V59, P117, DOI 10.1111/j.1865-1682.2011.01247.x; Nathues C, 2016, TRANSBOUND EMERG DIS, V63, pE251, DOI 10.1111/tbed.12262; Noremark M, 2010, TRANSBOUND EMERG DIS, V57, P225, DOI 10.1111/j.1865-1682.2010.01140.x; Noremark M, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-28; Noremark M, 2009, PREV VET MED, V90, P1, DOI 10.1016/j.prevetmed.2009.03.008; Oidtmann BC, 2011, PREV VET MED, V102, P329, DOI 10.1016/j.prevetmed.2011.07.016; Pinto CJ, 2003, PREV VET MED, V59, P139, DOI 10.1016/S0167-5877(03)00074-6; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Presi P, 2011, PREV VET MED, V99, P112, DOI 10.1016/j.prevetmed.2011.01.012; Pritchard G, 2005, IN PRACTICE, V27, P230; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Sarrazin S, 2014, PREV VET MED, V117, P129, DOI 10.1016/j.prevetmed.2014.07.014; Sawford K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-182; Sayers RG, 2013, VET J, V197, P259, DOI 10.1016/j.tvjl.2012.11.017; Schemann K, 2012, PREV VET MED, V106, P97, DOI 10.1016/j.prevetmed.2012.01.013; Schemann K, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-152; Schembri N, 2015, PREV VET MED, V118, P104, DOI 10.1016/j.prevetmed.2014.11.008; Schley D, 2009, J R SOC INTERFACE, V6, P455, DOI 10.1098/rsif.2008.0306; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siegwart N, 2006, VET J, V172, P386, DOI 10.1016/j.tvjl.2005.07.018; Simon-Grife M, 2013, PREV VET MED, V110, P223, DOI 10.1016/j.prevetmed.2012.11.028; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Toma L, 2013, PREV VET MED, V108, P321, DOI 10.1016/j.prevetmed.2012.11.009; Van Steenwinkel S, 2011, PREV VET MED, V98, P259, DOI 10.1016/j.prevetmed.2010.12.004; Villarroel A, 2007, JAVMA-J AM VET MED A, V230, P808, DOI 10.2460/javma.230.6.808; WAHID (World Animal Health Information Database), 2015, WORLD AN HLTH INF DA; Wells SJ, 2000, J DAIRY SCI, V83, P2380, DOI 10.3168/jds.S0022-0302(00)75127-7; Willgert KJE, 2011, GEOSPATIAL HEALTH, V5, P227, DOI 10.4081/gh.2011.175; Wu N, 2011, J WILDLIFE DIS, V47, P868, DOI 10.7589/0090-3558-47.4.868	59	33	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144533	10.1371/journal.pone.0144533	http://dx.doi.org/10.1371/journal.pone.0144533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656893	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500036
J	Provazzi, PJS; Mukherjee, S; Hanson, AM; Nogueira, ML; Carneiro, BM; Frick, DN; Rahal, P				Provazzi, Paola J. S.; Mukherjee, Sourav; Hanson, Alicia M.; Nogueira, Mauricio L.; Carneiro, Bruno M.; Frick, David N.; Rahal, Paula			Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 5A; RNA HELICASE; IN-VIVO; MUTATIONAL ANALYSIS; SERINE PROTEINASE; CRYSTAL-STRUCTURE; CDNA-CLONE; SUBGENOMIC REPLICON; MOLECULAR-CLONING	The hepatitis C virus (HCV) is a species of diverse genotypes that infect over 170 million people worldwide, causing chronic inflammation, cirrhosis and hepatocellular carcinoma. HCV genotype 3a is common in Brazil, and it is associated with a relatively poor response to current direct-acting antiviral therapies. The HCV NS3 protein cleaves part of the HCV polyprotein, and cellular antiviral proteins. It is therefore the target of several HCV drugs. In addition to its protease activity, NS3 is also an RNA helicase. Previously, HCV present in a relapse patient was found to harbor a mutation known to be lethal to HCV genotype 1b. The point mutation encodes the amino acid substitution W501R in the helicase RNA binding site. To examine how the W501R substitution affects NS3 helicase activity in a genotype 3a background, wild type and W501R genotype 3a NS3 alleles were sub-cloned, expressed in E. coli, and the recombinant proteins were purified and characterized. The impact of the W501R allele on genotype 2a and 3a subgenomic replicons was also analyzed. Assays monitoring helicase-catalyzed DNA and RNA unwinding revealed that the catalytic efficiency of wild type genotype 3a NS3 helicase was more than 600 times greater than the W501R protein. Other assays revealed that the W501R protein bound DNA less than 2 times weaker than wild type, and both proteins hydrolyzed ATP at similar rates. In Huh7.5 cells, both genotype 2a and 3a subgenomic HCV replicons harboring the W501R allele showed a severe defect in replication. Since the W501R allele is carried as a minor variant, its replication would therefore need to be attributed to the trans-complementation by other wild type quasispecies.	[Provazzi, Paola J. S.; Carneiro, Bruno M.; Rahal, Paula] Sao Paulo State Univ UNESP, Dept Biol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil; [Mukherjee, Sourav; Hanson, Alicia M.; Frick, David N.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53217 USA; [Nogueira, Mauricio L.] Sao Jose do Rio Preto Med Sch, Virol Lab, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil	Universidade Estadual Paulista; University of Wisconsin System; University of Wisconsin Milwaukee	Provazzi, PJS (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.	paolaprovazzi@gmail.com	Carneiro, Bruno/J-5870-2013; Nogueira, Mauricio L/B-7599-2012; Provazzi, Paola Jocelan Scarin/A-1864-2016; Carneiro, Bruno/P-2415-2019; Rahal, Paula/D-3871-2012	Nogueira, Mauricio L/0000-0003-1102-2419; Rahal, Paula/0000-0001-5693-6148; Frick, David/0000-0002-2434-7223; Carneiro, Bruno/0000-0002-2355-7907	State of Sao Paulo [FAPESP - 2009/02887-7, 2009/14256-1]; National Council for Scientific and Technological Development [CNPq - 151316/2013-9]; National Institutes of Health Grants [R01 AI088001]; UWM Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088001] Funding Source: NIH RePORTER	State of Sao Paulo; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWM Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Foundation for Research Support of the State of Sao Paulo (FAPESP - 2009/02887-7; 2009/14256-1), The National Council for Scientific and Technological Development (CNPq - 151316/2013-9), National Institutes of Health Grants R01 AI088001 and a Research Growth Initiative Award from the UWM Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; [Anonymous], 2013, SOV PACK INS; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Barritt AS, 2012, GASTROENTEROLOGY, V142, P1314, DOI 10.1053/j.gastro.2012.02.013; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Belon CA, 2008, BIOTECHNIQUES, V45, P433, DOI 10.2144/000112834; Bittar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062393; Bittar C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-36; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cha Agnes, 2014, P T, V39, P345; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Cho YG, 1998, J VIROL METHODS, V72, P109, DOI 10.1016/S0166-0934(98)00010-X; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Domingo E., 1996, VIRAL HEPAT REV, V2, P15; Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; Forns X, 1997, P NATL ACAD SCI USA, V94, P13909, DOI 10.1073/pnas.94.25.13909; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Jardim ACG, 2009, INFECT GENET EVOL, V9, P689, DOI 10.1016/j.meegid.2008.11.001; Gomez J, 1999, J VIRAL HEPATITIS, V6, P3, DOI 10.1046/j.1365-2893.1999.t01-1-6120131.x; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hanson AM, 2012, METHOD ENZYMOL, V511, P463, DOI 10.1016/B978-0-12-396546-2.00021-8; Herod MR, 2014, J VIROL, V88, P2748, DOI 10.1128/JVI.03588-13; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Jardim ACG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-61; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kazakov T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004817; Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kim JW, 2003, J VIROL, V77, P571, DOI 10.1128/JVI.77.1.571-582.2003; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LaPlante SR, 2014, J MED CHEM, V57, P2074, DOI 10.1021/jm401432c; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Li KL, 2012, J MED CHEM, V55, P3319, DOI 10.1021/jm300021v; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; LIN C, 1995, P NATL ACAD SCI USA, V92, P7622, DOI 10.1073/pnas.92.17.7622; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Moerke Nathan J, 2009, Curr Protoc Chem Biol, V1, P1, DOI 10.1002/9780470559277.ch090102; Mukherjee S, 2012, NUCLEIC ACIDS RES, V40, P8607, DOI 10.1093/nar/gks623; Ndjomou J, 2012, ANTIVIR RES, V96, P245, DOI 10.1016/j.antiviral.2012.08.006; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; OKAMOTO H, 1992, VIROLOGY, V190, P894, DOI 10.1016/0042-6822(92)90933-G; Paolini C, 2000, J GEN VIROL, V81, P1649, DOI 10.1099/0022-1317-81-7-1649; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Provazzi Paola Js, 2010, BMC Res Notes, V3, P196, DOI 10.1186/1756-0500-3-196; Saeed M, 2012, EFFICIENT REPLICATIO; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; TAKAMIZAWA A, 1991, J VIROL, V65, P1105, DOI 10.1128/JVI.65.3.1105-1113.1991; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tomei L, 1996, J GEN VIROL, V77, P1065, DOI 10.1099/0022-1317-77-5-1065; Trepo C, 1999, CURR OPIN INFECT DIS, V12, P481, DOI 10.1097/00001432-199910000-00011; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Yokoyama K, 2011, ARCH VIROL, V156, P1591, DOI 10.1007/s00705-011-1038-4	78	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144638	10.1371/journal.pone.0144638	http://dx.doi.org/10.1371/journal.pone.0144638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658750	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500050
J	Liu, CH; Guan, H; Wang, YD; Chen, M; Xu, B; Zhang, L; Lu, K; Tao, T; Zhang, XW; Huang, YQ				Liu, Chunhui; Guan, Han; Wang, Yiduo; Chen, Ming; Xu, Bin; Zhang, Lei; Lu, Kai; Tao, Tao; Zhang, Xiaowen; Huang, Yeqing			miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; TUMOR-GROWTH; NSCLC CELLS; MICRORNA-195; METASTASIS; SUPPRESSES; INVASION; EXPRESSION	Prostate cancer (PCa) is one of the leading causes of deaths in America. The major cause of mortality can be attributed to metastasis. Cancer metastasis involves sequential and interrelated events. miRNAs and epithelial-mesenchymal transition (EMT) are implicated in this process. miR-195 is downregulated in many human cancers. However, the roles of miR-195 in PCa metastasis and EMT remain unclear. In this study, data from Memorial Sloan Kettering Cancer Center (MSKCC) prostate cancer database were re-analysed to detect miR-195 expression and its roles in PCa. miR-195 was then overexpressed in castration-resistant PCa cell lines, DU-145 and PC-3. The role of miR-195 in migration and invasion in vitro was also investigated, and common markers in EMT were evaluated through Western blot analysis. A luciferase reporter assay was conducted to confirm the target gene of miR-195; were validated in PCa cells. In MSKCC data re-analyses, miR-195 was poorly expressed in metastatic PCa; miR-195 could be used to diagnose metastatic PCa by measuring the corresponding expression. Area under the receiver operating characteristic curve (AUC-ROC) was 0.705 (P = 0.017). Low miR-195 expression was characterised with a shorter relapse-free survival (RFS) time. miR-195 overexpression suppressed cell migration, invasion and EMT. Fibroblast growth factor 2 (FGF2) was confirmed as a direct target of miR-195. FGF2 knockdown also suppressed migration, invasion and EMT; by contrast, increased FGF2 partially reversed the suppressive effect of miR-195. And data from ONCOMINE prostate cancer database showed that PCa patients with high FGF2 expression showed shorter RFS time (P = 0.046). Overall, this study demonstrated that miR-195 suppressed PCa cell metastasis by downregulating FGF2. miR-195 restoration may be considered as a new therapeutic method to treat metastatic PCa.	[Liu, Chunhui; Guan, Han; Wang, Yiduo; Chen, Ming; Xu, Bin; Zhang, Lei; Lu, Kai; Tao, Tao; Zhang, Xiaowen; Huang, Yeqing] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Chunhui; Guan, Han; Wang, Yiduo; Chen, Ming; Xu, Bin; Zhang, Lei; Lu, Kai; Tao, Tao; Zhang, Xiaowen; Huang, Yeqing] Southeast Univ, Sch Med, Surg Res Ctr, Inst Urol, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Chen, M (corresponding author), Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, 87 Dingjia Bridge Hunan Rd, Nanjing 210009, Jiangsu, Peoples R China.	mingchenseu@126.com		Xu, Bin/0000-0002-5099-6673	National Natural Science Foundation of China [81370849, 81300472, 81202034]; Natural Science Foundation of Jiangsu Province [BL2013032, BK2012336]; Nanjing City [201201053]; Southeast University [3290002402]; Science Foundation of Ministry of Education of China [20120092120071]; Fundamental Research Funds for the Central Universities; Scientific Research Innovation Project of University in Jiangsu Province [KYLX_0203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Nanjing City; Southeast University; Science Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Innovation Project of University in Jiangsu Province	This study was supported by National Natural Science Foundation of China (81370849, 81300472, and 81202034), Natural Science Foundation of Jiangsu Province (BL2013032 and BK2012336) and Nanjing City (201201053) and Southeast University (3290002402), Science Foundation of Ministry of Education of China (20120092120071), Fundamental Research Funds for the Central Universities and Scientific Research Innovation Project of University in Jiangsu Province (KYLX_0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (81370849, 81300472, and 81202034), Natural Science Foundation of Jiangsu Province (BL2013032 and BK2012336) and Nanjing City (201201053) and Southeast University (3290002402), Science Foundation of Ministry of Education of China (20120092120071), Fundamental Research Funds for the Central Universities and Scientific Research Innovation Project of University in Jiangsu Province (KYLX_0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer M, 2014, TUMOR BIOL, V35, P11301, DOI 10.1007/s13277-014-2445-4; [Anonymous], [No title captured]; Chen J, 2014, J CELL PHYSIOL, V229, P1647, DOI 10.1002/jcp.24610; Cheng ZS, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.51; Cronauer MV, 2003, EUR UROL, V43, P309, DOI 10.1016/S0302-2838(03)00005-8; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deng HX, 2013, GENE, V518, P351, DOI 10.1016/j.gene.2012.12.103; Diaz-Lopez A, 2014, CANCER MANAG RES, V6, P205, DOI 10.2147/CMAR.S38156; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Giri D, 1999, CLIN CANCER RES, V5, P1063; GOSPODAROWICZ D, 1974, P NATL ACAD SCI USA, V71, P2295, DOI 10.1073/pnas.71.6.2295; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HZ, 2014, TUMOR BIOL, V35, P8861, DOI 10.1007/s13277-014-2153-0; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Liu ZC, 2014, BBA-GEN SUBJECTS, V1840, P3096, DOI 10.1016/j.bbagen.2014.07.018; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Nomura S, 2008, BRIT J CANCER, V99, P305, DOI 10.1038/sj.bjc.6604473; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Semenas J, 2012, CURR DRUG TARGETS, V13, P1308, DOI 10.2174/138945012802429615; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun XH, 2015, TUMOR BIOL, V36, P2127, DOI 10.1007/s13277-014-2822-z; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Wang L, 2014, MOL MED REP, V10, P473, DOI 10.3892/mmr.2014.2178; Wang XL, 2014, TUMOR BIOL, V35, P8765, DOI 10.1007/s13277-014-2140-5; Wang XQ, 2012, MED ONCOL, V29, P919, DOI 10.1007/s12032-011-9880-5; Wen X, 2014, AM J CLIN EXP UROL, V2, P219; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Yang Y, 2014, MOL MED REP, V10, P2643, DOI 10.3892/mmr.2014.2526; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhao FL, 2014, MOL BIOL REP, V41, P5913, DOI 10.1007/s11033-014-3466-1; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	42	53	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144073	10.1371/journal.pone.0144073	http://dx.doi.org/10.1371/journal.pone.0144073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650737	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300035
J	Stefan, LM; Gomez-Diaz, E; Elguero, E; Proctor, HC; McCoy, KD; Gonzalez-Solis, J				Stefan, Laura M.; Gomez-Diaz, Elena; Elguero, Eric; Proctor, Heather C.; McCoy, Karen D.; Gonzalez-Solis, Jacob			Niche Partitioning of Feather Mites within a Seabird Host, Calonectris borealis	PLOS ONE			English	Article							ACARI AVENZOARIIDAE; STABLE-ISOTOPES; MODELS; SHEARWATERS; COMPETITION; BEHAVIOR; BIRDS; DIET; TRANSMISSION; PREFERENCES	According to classic niche theory, species can coexist in heterogeneous environments by reducing interspecific competition via niche partitioning, e.g. trophic or spatial partitioning. However, support for the role of competition on niche partitioning remains controversial. Here, we tested for spatial and trophic partitioning in feather mites, a diverse and abundant group of arthropods. We focused on the two dominant mite species, Microspalax brevipes and Zachvatkinia ovata, inhabiting flight feathers of the Cory's shearwater, Calonectris borealis. We performed mite counts across and within primary and tail feathers on free-living shearwaters breeding on an oceanic island (Gran Canaria, Canary Islands). We then investigated trophic relationships between the two mite species and the host using stable isotope analyses of carbon and nitrogen on mite tissues and potential host food sources. The distribution of the two mite species showed clear spatial segregation among feathers; M. brevipes showed high preference for the central wing primary feathers, whereas Z. ovata was restricted to the two outermost primaries. Morphological differences between M. brevipes and Z. ovata support an adaptive basis for the spatial segregation of the two mite species. However, the two mites overlap in some central primaries and statistical modeling showed that Z. ovata tends to outcompete M. brevipes. Isotopic analyses indicated similar isotopic values for the two mite species and a strong correlation in carbon signatures between mites inhabiting the same individual host suggesting that diet is mainly based on shared host-associated resources. Among the four candidate tissues examined (blood, feather remains, skin remains and preen gland oil), we conclude that the diet is most likely dominated by preen gland oil, while the contribution of exogenous material to mite diets is less marked. Our results indicate that ongoing competition for space and resources plays a central role in structuring feather mite communities. They also illustrate that symbiotic infracommunities are excellent model systems to study trophic ecology, and can improve our understanding of mechanisms of niche differentiation and species coexistence.	[Stefan, Laura M.; Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Stefan, Laura M.; Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Gomez-Diaz, Elena] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Stefan, Laura M.; Elguero, Eric; McCoy, Karen D.] UM, CNRS, IRD, Ctr IRD,MIVEGEC Res Unit,UMR 5290, Montpellier, France; [Proctor, Heather C.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Alberta	Stefan, LM (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain.	laura.stefan@ub.edu	Gonzalez-Solis, Jacob/AAZ-5338-2021; Gómez-Díaz, Elena/AAA-9141-2019; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/C-3942-2008; Proctor, Heather C./A-2677-2014; Gómez-Díaz, Elena/G-2503-2011; McCoy, Karen D/F-7061-2012	Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gómez-Díaz, Elena/0000-0002-4146-9003; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Proctor, Heather C./0000-0002-4920-9556; Gómez-Díaz, Elena/0000-0002-4146-9003; McCoy, Karen D/0000-0002-8972-3808	University of Barcelona; Ministerio de Ciencia e Innovacion, Spain; Ministerio de Ciencia e Innovacion (Spain) [CGL2006-01315/BOS, CGL2009-11278/BOS]; CNRS (France); IRD (France); Fondos FEDER; Marie Curie Reintegration Grant [ERG-2010276838]	University of Barcelona; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); IRD (France); Fondos FEDER(European Commission); Marie Curie Reintegration Grant(European Commission)	The present investigation was performed during the postgraduate project of LS supported by a PhD grant from the University of Barcelona. EG-D was supported by a JdC contract from the Ministerio de Ciencia e Innovacion, Spain. Financial support was provided by CGL2006-01315/BOS and CGL2009-11278/BOS from Ministerio de Ciencia e Innovacion (Spain), the CNRS and IRD (France) and Fondos FEDER for JGS, KM and LS, and by a Marie Curie Reintegration Grant to EG-D (ERG-2010276838).	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; ATYEO WT, 1991, FOLIA PARASIT, V38, P327; Blanco G, 2001, J AVIAN BIOL, V32, P271, DOI 10.1111/j.0908-8857.2001.320310.x; Bolker BM, 2013, METHODS ECOL EVOL, V4, P501, DOI 10.1111/2041-210X.12044; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bridge ES, 2003, INT J ACAROL, V29, P389, DOI 10.1080/01647950308684356; Brown CR, 2006, CAN J ZOOL, V84, P1307, DOI 10.1139/Z06-110; CHOE JC, 1989, OECOLOGIA, V79, P10, DOI 10.1007/BF00378233; Clayton Dale H., 2010, Open Ornithology Journal, V3, P41, DOI 10.2174/1874453201003010041; CLAYTON DH, 1994, ANIM BEHAV, V47, P195, DOI 10.1006/anbe.1994.1022; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Dabert J, 1999, EXP APPL ACAROL, V23, P437, DOI 10.1023/A:1006180705101; Dabert Jacek, 1992, Genus (Wroclaw), V3, P1; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deudero S, 2002, DIS AQUAT ORGAN, V52, P77, DOI 10.3354/dao052077; Dubinin V. B., 1951, Fauna USSR Moscow, V6, P1; Fernandez-Gonzalez S, 2015, INT J PARASITOL, V45, P655, DOI 10.1016/j.ijpara.2015.04.003; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; Friggens MM, 2005, OIKOS, V108, P76, DOI 10.1111/j.0030-1299.2005.13275.x; Galvan I, 2008, J EVOLUTION BIOL, V21, P133, DOI 10.1111/j.1420-9101.2007.01459.x; Galvan I, 2012, J AVIAN BIOL, V43, P273, DOI 10.1111/j.1600-048X.2012.05686.x; Gomez-Diaz E, 2008, ECOGRAPHY, V31, P477, DOI 10.1111/j.0906-7590.2008.05330.x; Gomez-Diaz E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010454; Harbison CW, 2009, INT J PARASITOL, V39, P569, DOI 10.1016/j.ijpara.2008.09.014; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jovani R, 2006, CAN J ZOOL, V84, P729, DOI 10.1139/Z06-042; Jovani R, 2004, J AVIAN BIOL, V35, P16, DOI 10.1111/j.0908-8857.2004.03213.x; Jovani R, 2001, J PARASITOL, V87, P1187, DOI 10.1645/0022-3395(2001)087[1187:AHFAMM]2.0.CO;2; Krantz G., 2009, MANUAL ACAROLOGY; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; LEVIN DA, 1970, AM NAT, V104, P455, DOI 10.1086/282680; LEVINS RICHARD, 1968; Mestre A, 2011, J PARASITOL, V97, P237, DOI 10.1645/GE-2585.1; Mironov S.V., 1989, Parazitologicheskii Sbornik, V36, P91; Mironov SV, 2008, J PARASITOL, V94, P1243, DOI 10.1645/GE-1579.1; Mironov SV, 2015, SYST PARASITOL, V90, P91, DOI 10.1007/s11230-014-9532-1; Morin P., 1999, COMMUNITY ECOL; Mouillot D, 2003, J ANIM ECOL, V72, P757, DOI 10.1046/j.1365-2656.2003.00749.x; PATRICK MJ, 1991, ECOLOGY, V72, P755, DOI 10.2307/2937218; Perez-Tris J, 2002, BIOL J LINN SOC, V76, P481, DOI 10.1046/j.1095-8312.2002.00083.x; Persson ME, 2007, J FISH BIOL, V71, P441, DOI 10.1111/j.1095-8649.2007.01500.x; Pilosof S, 2012, PARASITOLOGY, V139, P1739, DOI 10.1017/S0031182012001205; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Proctor HC, 2004, J PARASITOL, V90, P60, DOI 10.1645/GE-57R; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Reed DL, 2000, J PARASITOL, V86, P951, DOI 10.1645/0022-3395(2000)086[0951:SPOHHB]2.0.CO;2; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Stefan LM, 2014, FOLIA PARASIT, V61, P90, DOI 10.14411/fp.2014.009; Stefan LM, 2013, ZOOTAXA, V3682, P105, DOI 10.11646/zootaxa.3682.1.4; Voigt CC, 2006, CAN J ZOOL, V84, P397, DOI 10.1139/z06-007; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Wiles PR, 2000, CAN J ZOOL, V78, P1397, DOI 10.1139/cjz-78-8-1397	58	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144728	10.1371/journal.pone.0144728	http://dx.doi.org/10.1371/journal.pone.0144728			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650672	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300070
J	Jenny, L; Dobo, J; Gal, P; Schroeder, V				Jenny, Lorenz; Dobo, Jozsef; Gal, Peter; Schroeder, Verena			MASP-1 Induced Clotting - The First Model of Prothrombin Activation by MASP-1	PLOS ONE			English	Article							COMPLEMENT LECTIN PATHWAY; THROMBIN; MEIZOTHROMBIN; COAGULATION; BINDING; FIBRINOGEN; INTERFACE; PROCEEDS; SYSTEM	Mannan-binding lectin-associated serine protease-1 (MASP-1), a protein of the complement lectin pathway, resembles thrombin in terms of structural features and substrate specificity. Due to its interplay with several coagulation factors, it has the ability to induce fibrin clot formation independent of the usual coagulation activation pathways. We have recently shown that MASP-1 activates prothrombin and identified arginine (R) 155, R271, and R393 as potential cleavage sites. FXa cleaves R320 instead of R393, and thrombin cleaves R155 and R284 in prothrombin. Here we have used three arginine-to-glutamine mutants of prothrombin, R271Q, R320Q, R393Q and the serine-to-alanine active site mutant S525A to investigate in detail the mechanism of MASP-1 mediated prothrombin activation. Prothrombin wildtype and mutants were digested with MASP-1 and the cleavage products were analysed by SDS-PAGE and N-terminal sequencing. A functional clotting assay was performed by thrombelastography. We have found that MASP-1 activates prothrombin via two simultaneous pathways, either cleaving at R271 or R393 first. Both pathways result in the formation of several active alternative thrombin species. Functional studies confirmed that both R393 and R320 are required for prothrombin activation by MASP-1, whereas R155 is not considered to be an important cleavage site in this process. In conclusion, we have described for the first time a detailed model of prothrombin activation by MASP-1.	[Jenny, Lorenz; Schroeder, Verena] Univ Hosp Bern, Haemostasis Res Lab, Univ Clin Haematol, CH-3010 Bern, Switzerland; [Jenny, Lorenz; Schroeder, Verena] Univ Bern, Dept Clin Res, Bern, Switzerland; [Dobo, Jozsef; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	University of Bern; University Hospital of Bern; University of Bern; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Schroeder, V (corresponding author), Univ Hosp Bern, Haemostasis Res Lab, Univ Clin Haematol, CH-3010 Bern, Switzerland.	verena.schroeder@dkf.unibe.ch	Gal, Peter/B-5886-2011	Dobo, Jozsef/0000-0001-9187-8502; Schroeder, Verena/0000-0001-6508-3271	Swiss National Science Foundation [310030_140925]; OPO Foundation (Zurich, Switzerland); Hungarian Scientific Research Fund (OTKA) [NK100834]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OPO Foundation (Zurich, Switzerland); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grants from the Swiss National Science Foundation (grant 310030_140925) to VS, OPO Foundation (Zurich, Switzerland) to VS, Hungarian Scientific Research Fund (OTKA grant NK100834) to JD and PG, and the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences to JD and PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; BOVILL EG, 1995, ARTERIOSCL THROM VAS, V15, P754, DOI 10.1161/01.ATV.15.6.754; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Dobo J, 2014, MOL IMMUNOL, V61, P69, DOI 10.1016/j.molimm.2014.05.013; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Hess K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035690; HIGGINS DL, 1983, J BIOL CHEM, V258, P9276; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Jenny L, 2015, CLIN EXP IMMUNOL, V180, P227, DOI 10.1111/cei.12574; Jenny L, 2015, MOL IMMUNOL, V65, P398, DOI 10.1016/j.molimm.2015.02.014; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; MANN KG, 1990, BLOOD, V76, P1; Megyeri M, 2013, J BIOL CHEM, V288, P8922, DOI 10.1074/jbc.M112.446500; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Parej K, 2013, MOL IMMUNOL, V54, P415, DOI 10.1016/j.molimm.2013.01.009; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROSING J, 1980, J BIOL CHEM, V255, P274; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Tang YQ, 2012, BBA-PROTEINS PROTEOM, V1824, P253, DOI 10.1016/j.bbapap.2011.05.021	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144633	10.1371/journal.pone.0144633	http://dx.doi.org/10.1371/journal.pone.0144633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645987	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100030
J	Castelnuovo, B; Kiragga, A; Musaazi, J; Sempa, J; Mubiru, F; Wanyama, J; Wandera, B; Kamya, MR; Kambugu, A				Castelnuovo, Barbara; Kiragga, Agnes; Musaazi, Joseph; Sempa, Joseph; Mubiru, Frank; Wanyama, Jane; Wandera, Bonnie; Kamya, Moses Robert; Kambugu, Andrew			Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TREATMENT PROGRAMS; ADULT PATIENTS; THERAPY; TOXICITY; FAILURE; CARE; 1ST	Background Short-medium term studies from sub-Saharan Africa show that, despite high early mortality, substantial loss to program, and high rates toxicity, patients on antiretroviral treatment have achieved outcomes comparable to those in developed settings. However, these studies were unable to account for long term outcomes of patients as they stayed longer on treatment. Objectives We aim to describe ten years outcomes of one of the first cohort of HIV positive patients started on antiretroviral treatment (ART) in Sub-Saharan Africa. Methods We report 10-years outcomes including mortality, retention, CD4-count response, virological outcomes, ART regimens change from a prospective cohort of 559 patients initiating ART and followed up for 10 years Uganda. Results Of 559 patients, 69.1% were female, median age (IQR) was 38 (33-44) years, median CD4-count (IQR) 98 (21-163) cell/mu L; 74% were started on stavudine, lamivudine and nevi-rapine, 26% on zidovudine, lamivudine and efavirenz. After 10 years 361 (65%) patients were still in the study; 127 (22.7%) had died; 30 (5%) were lost to follow-up; 27 (5%) transferred; 18 (3%) withdrew consent. The probability of death was high in the first year (0.15, 95%, CI 0.12-0.18). The median CD4 count increased from 98 to 589 cell/mu L (IQR: 450739 cell/mu L) with a median increase of 357 cells/mu L (IQR: 128-600 cells/mu L); 7.4% never attained initial viral suppression and of those who did 31.7% experienced viral failure. Three hundred and two patients had at least one drug substitution while on first line after a median of 40 months; 66 (11.9%) of the patients were switched to a second line PI-based regimen due to confirmed treatment failure. Conclusions Despite the high rate of early mortality due to advanced disease at presentation the outcomes from this cohort are encouraging, particularly the remarkable and incremental immune-recovery and a satisfactory rate of virologic suppression.	[Castelnuovo, Barbara; Kiragga, Agnes; Musaazi, Joseph; Sempa, Joseph; Mubiru, Frank; Wanyama, Jane; Wandera, Bonnie; Kambugu, Andrew] Makerere Univ, Mulago Hosp, Infect Dis Inst, Kampala, Uganda; [Kamya, Moses Robert] Makerere Univ, Mulago Hosp, Sch Med, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital	Castelnuovo, B (corresponding author), Makerere Univ, Mulago Hosp, Infect Dis Inst, Kampala, Uganda.	bcastelnuovo@idi.co.ug	Wanyama, Jane Namukasa/J-5481-2019	Bukulu Sempa, Joseph/0000-0003-1062-0417				Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Boulle A, 2007, ANTIVIR THER, V12, P753; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Castelnuovo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051631; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Center for Disease Control and Prevention, GLOC HIV AIDS UG; De Beaudrap P, 2013, JAIDS-J ACQ IMM DEF, V62, P381, DOI 10.1097/QAI.0b013e31827a2a7a; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kiragga AN, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-3; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Makerere University John Hopkins (MUJHU) Laboratory, 2009, UG REF RANG FLOW CYT; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nwaka S, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-11; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Uganda Ministry of Health, 2013, NAT ANT TREATM CAR G; UNAIDS Access to antoretrovira treatment in Africa, 2013, UNAIDS ACCESS ANTORE; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization HIV/AIDS, ANT THER COV SUBS AF	23	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142722	10.1371/journal.pone.0142722	http://dx.doi.org/10.1371/journal.pone.0142722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642214	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700009
J	Gaytan, F; Morales, C; Leon, S; Garcia-Galiano, D; Roa, J; Tena-Sempere, M				Gaytan, Francisco; Morales, Concepcion; Leon, Silvia; Garcia-Galiano, David; Roa, Juan; Tena-Sempere, Manuel			Crowding and Follicular Fate: Spatial Determinants of Follicular Reserve and Activation of Follicular Growth in the Mammalian Ovary	PLOS ONE			English	Article							PRIMORDIAL FOLLICLES; GROWING FOLLICLES; HYPOGONADAL HPG; OOCYTE GROWTH; SHORT-TERM; HORMONE; DYNAMICS; KISSPEPTIN; RECEPTOR; NUMBER	Initiation of growth of resting ovarian follicles is a key phenomenon for providing an adequate number of mature oocytes in each ovulation, while preventing premature exhaustion of primordial follicle reserve during the reproductive lifespan. Resting follicle dynamics strongly suggest that primordial follicles are under constant inhibitory influences, by mechanisms and factors whose nature remains ill defined. In this work, we aimed to assess the influence of spatial determinants, with special attention to clustering patterns and crowding, on the fate of early follicles in the adult mouse and human ovary. To this end, detailed histological and morphometric analyses, targeting resting and early growing follicles, were conducted in ovaries from mice, either wild type (WT) or genetically modified to lack kisspeptin receptor expression (Kiss1r KO), and healthy adult women. Kiss1r KO mice were studied as model of persistent hypogonadotropism and anovulation. Different qualitative and quantitative indices of the patterns of spatial distribution of resting and early growing follicles in the mouse and human ovary, including the Morisita's index of clustering, were obtained. Our results show that resting primordial follicles display a clear-cut clustered pattern of spatial distribution in adult mouse and human ovaries, and that resting follicle aggrupation is inversely correlated with the proportion of follicles initiating growth and entering into the growing pool. As a whole, our data suggest that resting follicle crowding, defined by changes in density and clustered pattern of distribution, is a major determinant of follicular activation and the fate of ovarian reserve. Uneven follicle crowding would constitute the structural counterpart of the major humoral regulators of early follicular growth, with potential implications in ovarian ageing and pathophysiology.	[Gaytan, Francisco; Leon, Silvia; Garcia-Galiano, David; Roa, Juan; Tena-Sempere, Manuel] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba 14004, Spain; [Gaytan, Francisco; Roa, Juan; Tena-Sempere, Manuel] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Cordoba 14004, Spain; [Gaytan, Francisco; Leon, Silvia; Roa, Juan; Tena-Sempere, Manuel] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed IMIBIC, Cordoba 14004, Spain; [Morales, Concepcion] Univ Cordoba, Dept Pathol, Cordoba 14004, Spain; [Tena-Sempere, Manuel] Univ Turku, FiDiPro Program, Dept Physiol, FIN-20520 Turku, Finland	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Cordoba; University of Turku	Gaytan, F (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba 14004, Spain.	bc1galuf@uco.es; fi1tesem@uco.es	Tena-Sempere, Manuel/AAX-3602-2021; Rivas, Juan Roa/L-3689-2014; Garcia Galiano, David/GSE-3416-2022; Garcia-Galiano, David/Q-8089-2019	Tena-Sempere, Manuel/0000-0002-4741-5567; Rivas, Juan Roa/0000-0002-8970-421X; Garcia-Galiano, David/0000-0001-9506-8785	Ministerio de Economia y Competitividad, Spain [BFU2011-025021, BFU2014-57581]; EU funds from FEDER Program; Junta de Andalucia, Spain [P12-FQM-01943]	Ministerio de Economia y Competitividad, Spain; EU funds from FEDER Program; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was supported by grants BFU2011-025021 and BFU2014-57581 (Ministerio de Economia y Competitividad, Spain; co-funded with EU funds from FEDER Program), and project P12-FQM-01943 (Junta de Andalucia, Spain) (to MT-S). CIBER Fisiopatologia de la Obesidad y Nutricion is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Allan CM, 2006, J ENDOCRINOL, V188, P549, DOI 10.1677/joe.1.06614; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; Armstrong RA, 2006, J MICROSC-OXFORD, V221, P153, DOI 10.1111/j.1365-2818.2006.01559.x; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Byskov AG, 1997, MOL HUM REPROD, V3, P795, DOI 10.1093/molehr/3.9.795; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Charleston JS, 2007, HUM REPROD, V22, P2103, DOI 10.1093/humrep/dem137; Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Dorfman MD, 2014, ENDOCRINOLOGY, V155, P3098, DOI 10.1210/en.2014-1111; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Faire M, 2015, DEV BIOL, V403, P69, DOI 10.1016/j.ydbio.2015.04.006; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Gaytan F, 2003, J CLIN ENDOCR METAB, V88, P879, DOI 10.1210/jc.2002-021196; Gaytan F, 2009, AM J PHYSIOL-ENDOC M, V296, pE520, DOI 10.1152/ajpendo.90895.2008; Gaytan F, 2014, ENDOCRINOLOGY, V155, P3088, DOI 10.1210/en.2014-1110; Gomez R, 2011, J CLIN ENDOCR METAB, V96, P2484, DOI 10.1210/jc.2011-0075; GOUGEON A, 1994, BIOL REPROD, V50, P653, DOI 10.1095/biolreprod50.3.653; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Gougeon A., 2004, OVARY, V2nd ed., P25, DOI [DOI 10.1016/B978-012444562-8/50003-3, 10.1016/B978-012444562-8/50003-3]; HALPIN DMG, 1986, J REPROD FERTIL, V77, P287, DOI 10.1530/jrf.0.0770287; HALPIN DMG, 1988, J REPROD FERTIL, V82, P393, DOI 10.1530/jrf.0.0820393; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; HIRSHFIELD AN, 1995, BIOL REPROD, V53, P1208, DOI 10.1095/biolreprod53.5.1208; HIRSHFIELD AN, 1992, BIOL REPROD, V47, P466, DOI 10.1095/biolreprod47.3.466; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; Hutcheson K, 1989, ESTIMATION ANAL INSE, P335; Jonard S, 2005, HUM REPROD, V20, P2893, DOI 10.1093/humrep/dei159; KRARUP T, 1969, NATURE, V224, P187, DOI 10.1038/224187a0; Laoharatchatathanin T, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.127902; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; MEIJSROELOFS HMA, 1990, J ENDOCRINOL, V124, P247, DOI 10.1677/joe.0.1240247; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; MEREDITH S, 1986, BIOL REPROD, V35, P68, DOI 10.1095/biolreprod35.1.68; Monget P, 2012, MOL CELL ENDOCRINOL, V356, P2, DOI 10.1016/j.mce.2011.07.046; Monniaux D, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117077; Morisita M., 1962, RES POPUL ECOL, V4, P1, DOI [10.1007/BF02533903, DOI 10.1007/BF02533903]; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; PETERS H, 1978, CLIN ENDOCRINOL META, V7, P469, DOI 10.1016/S0300-595X(78)80005-X; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Ren Y, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0151-3; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Tingen CM, 2009, BIOL REPROD, V81, P16, DOI 10.1095/biolreprod.108.074898; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; vanWezel IL, 1996, BIOL REPROD, V55, P1003, DOI 10.1095/biolreprod55.5.1003; Wang XX, 2014, J CELL BIOL, V206, P923, DOI 10.1083/jcb.201403084; Wang Y, 2005, BIOL REPROD, V73, P610, DOI 10.1095/biolreprod.105.039602; Zhang H, 2014, CURR BIOL, V24, P2501, DOI 10.1016/j.cub.2014.09.023; Zheng WJ, 2014, MOL HUM REPROD, V20, P286, DOI 10.1093/molehr/gau007; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	56	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144099	10.1371/journal.pone.0144099	http://dx.doi.org/10.1371/journal.pone.0144099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642206	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700054
J	Vargas-Angel, B; Richards, CL; Vroom, PS; Price, NN; Schils, T; Young, CW; Smith, J; Johnson, MD; Brainard, RE				Vargas-Angel, Bernardo; Richards, Cristi L.; Vroom, Peter S.; Price, Nichole N.; Schils, Tom; Young, Charles W.; Smith, Jennifer; Johnson, Maggie D.; Brainard, Russell E.			Baseline Assessment of Net Calcium Carbonate Accretion Rates on US Pacific Reefs	PLOS ONE			English	Article							CRUSTOSE CORALLINE ALGAE; OCEAN ACIDIFICATION; CLIMATE-CHANGE; COMMUNITY; ECOSYSTEM; SURVIVAL; DIOXIDE; CONSEQUENCES; PRODUCTIVITY; METABOLISM	This paper presents a comprehensive quantitative baseline assessment of in situ net calcium carbonate accretion rates (g CaCO3 cm(-2) yr(-1)) of early successional recruitment communities on Calcification Accretion Unit (CAU) plates deployed on coral reefs at 78 discrete sites, across 11 islands in the central and south Pacific Oceans. Accretion rates varied substantially within and between islands, reef zones, levels of wave exposure, and island geomorphology. For forereef sites, mean accretion rates were the highest at Rose Atoll, Jarvis, and Swains Islands, and the lowest at Johnston Atoll and Tutuila. A comparison between reef zones showed higher accretion rates on forereefs compared to lagoon sites; mean accretion rates were also higher on windward than leeward sites but only for a subset of islands. High levels of spatial variability in net carbonate accretion rates reported herein draw attention to the heterogeneity of the community assemblages. Percent cover of key early successional taxa on CAU plates did not reflect that of the mature communities present on surrounding benthos, possibly due to the short deployment period (2 years) of the experimental units. Yet, net CaCO3 accretion rates were positively correlated with crustose coralline algae (CCA) percent cover on the surrounding benthos and on the CAU plates, which on average represented >70% of the accreted material. For foreeefs and lagoon sites combined CaCO3 accretion rates were statistically correlated with total alkalinity and Chlorophyll-a; a GAM analysis indicated that SiOH and Halimeda were the best predictor variables of accretion rates on lagoon sites, and total alkalinity and Chlorophyll-a for forereef sites, demonstrating the utility of CAUs as a tool to monitor changes in reef accretion rates as they relate to ocean acidification. This study underscores the pivotal role CCA play as a key benthic component and supporting actively calcifying reefs; high Mg-calcite exoskeletons makes CCA extremely susceptible changes in ocean water pH, emphasizing the far-reaching threat that ocean acidification poses to the ecological function and persistence of coral reefs worldwide.	[Vargas-Angel, Bernardo; Young, Charles W.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96818 USA; [Vroom, Peter S.] Ocean Associates, Honolulu, HI 96818 USA; [Price, Nichole N.] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Schils, Tom] Univ Guam, Marine Lab, Mangilao, GU 96913 USA; [Smith, Jennifer; Johnson, Maggie D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Brainard, Russell E.] NOAA, Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI 96818 USA	University of Hawaii System; Bigelow Laboratory for Ocean Sciences; University of Guam; University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA	Vargas-Angel, B (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96818 USA.	Bernado.VargasAngel@noaa.gov	Johnson, Maggie D/C-6469-2013; Schils, Tom/A-7087-2008	Johnson, Maggie D/0000-0002-1319-2545; Schils, Tom/0000-0002-1516-9082; Price, Nichole/0000-0001-6773-3215	NOAA Coral Reef Conservation Program; NOAA NMFS Office of Science and Technology; NOAA Ocean Acidification Program; NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED); Scripps Institution of Oceanography; American Samoa Department of Marine and Wildlife Resources; National Park of American Samoa; National Marine Sanctuary of American Samoa; U.S. Fish and Wildlife Service; NOAA Ship Hi'ialakai	NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA NMFS Office of Science and Technology; NOAA Ocean Acidification Program; NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED); Scripps Institution of Oceanography(University of California System); American Samoa Department of Marine and Wildlife Resources; National Park of American Samoa; National Marine Sanctuary of American Samoa; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); NOAA Ship Hi'ialakai	This work was supported by the NOAA Coral Reef Conservation Program, the NOAA NMFS Office of Science and Technology, and NOAA Ocean Acidification Program. Institutional, logistic, and financial support was also provided by NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED) and Scripps Institution of Oceanography. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ocean Associates provided support in the form of a salary for author PSV, but did not have any additional role in the study.; This work was supported by the NOAA Ocean Acidification Program and the NOAA NMFS Office of Science and Technology. Institutional, logistic, and financial support was also provided by NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED) and Scripps Institution of Oceanography. Permission to work in American Samoa and the Pacific Island National Marine Monument was granted by the American Samoa Department of Marine and Wildlife Resources, the National Park of American Samoa, the National Marine Sanctuary of American Samoa, and by the U.S. Fish and Wildlife Service. Thanks are due to the officers and crew of the NOAA Ship Hi'ialakai for support with dive and small boat operations. A number of CRED staff assisted with construction, deployment, and recovery of the CAU assemblies. E Penland, E Looney, P Misa-Lozada, B Richards, and H, Bailey assisted with CAU lab processing; staff from J Smith Lab at Scripps helped with the CAU plate image analysis, and T Acoba, J Ehses, and A Dillon assisted with figure preparation and formatting. The authors also want to thank B Schumacher, J Samson, P Misa-Lozada, and T Oliver, as well as to anonymous reviewers, whose comments greatly improved this manuscript. The manuscript contents are solely the opinion of the authors and do not constitute a statement of policy, decision, or position on behalf of NOAA or the U.S. Government.	Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2007, SYSTAT SYSTAT 12 STA; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; Barnes D.J., 1990, P109; Borowitza M.A., 1982, Progress phycol. Res., V1, P137; BOSENCE DWJ, 1983, J GEOL SOC LONDON, V140, P365, DOI 10.1144/gsjgs.140.3.0365; Brinkman TJ, 2015, MAR FRESHWATER RES, V66, P360, DOI 10.1071/MF14077; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Cooley SR, 2009, OCEANOGRAPHY, V22, P172, DOI 10.5670/oceanog.2009.106; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Craig P, 2005, 11 NOS NCCOS NOAA CT, P312; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Diaz-Pulido G., 2007, CLIMATE CHANGE GREAT, P151; Diaz-Pulido G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4310; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Dufault AM, 2012, P ROY SOC B-BIOL SCI, V279, P2951, DOI 10.1098/rspb.2011.2545; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Fabricius K, 2013, P R SOC B, V282; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Goldberg W, 2013, BIOL REEF ORGANISMS; Goodenough AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034338; Gorley C.K., 2006, GETTING STARTED PRIM; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Hallock P, 1997, NATL GEOGR RES EXPLO, V9, P358; Hamylton SM, 2013, CORAL REEFS, V32, P1025, DOI 10.1007/s00338-013-1074-5; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel PL, 2011, B MAR SCI, V87, P639, DOI 10.5343/bms.2010.1107; Kamenos NA, 2013, GLOBAL CHANGE BIOL, V19, P3621, DOI 10.1111/gcb.12351; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KLUMPP DW, 1992, MAR ECOL PROG SER, V86, P77, DOI 10.3354/meps086077; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kurihara H, 2008, J EXP MAR BIOL ECOL, V367, P41, DOI 10.1016/j.jembe.2008.08.016; Lee D, 2001, CHEM GEOL, V172, P307, DOI 10.1016/S0009-2541(00)00258-8; Littler MM, 1984, PHYCOLOG RES, V3, P324; Maragos James, 2008, V1, P595, DOI 10.1007/978-1-4020-6847-8_15; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miller J, 2008, 73 NOS NCCOS NOAA CT, P353; Morse JW, 2006, GEOCHIM COSMOCHIM AC, V70, P5814, DOI 10.1016/j.gca.2006.08.017; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Noisette F, 2013, J PHYCOL, V49, P746, DOI 10.1111/jpy.12085; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Portner HO, 2005, J GEOPHYS RES, V110; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Price NN, 2011, MAR ECOL PROG SER, V440, P67, DOI 10.3354/meps09309; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Semesi IS, 2009, ESTUAR COAST SHELF S, V84, P337, DOI 10.1016/j.ecss.2009.03.038; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Smith AM, 2012, PHYTOCHEMISTRY, V81, P97, DOI 10.1016/j.phytochem.2012.06.003; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; SMITH SV, 1975, LIMNOL OCEANOGR, V20, P493, DOI 10.4319/lo.1975.20.3.0493; Solomon S., 2007, PHYS SCI BASIS WORKI; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Tanhua T, 2013, INT GEOPHYS SERIES, V103, P787, DOI DOI 10.1016/B978-0-12-391851-2.00030-1; Tucker M., 1990, CARBONATE SEDIMENTOL; Ulfsbo A, 2014, THESIS; US. Census Bureau, 2010, AM SAM DEM PROF DAT; Vecsei A, 2004, GLOBAL PLANET CHANGE, V43, P1, DOI 10.1016/j.gloplacha.2003.12.002; Vroom P. S., 2003, BIOLOGIST, V50, P222; Vroom PS, 2010, BIODIVERS CONSERV, V19, P797, DOI 10.1007/s10531-009-9735-y; Vroom PS, 2001, AM SCI, V89, P524, DOI 10.1511/2001.40.748	78	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142196	10.1371/journal.pone.0142196	http://dx.doi.org/10.1371/journal.pone.0142196			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641885	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700007
J	Lucero, LM; Weltzin, MM; Eaton, JB; Cooper, JF; Lindstrom, JM; Lukas, RJ; Whiteaker, P				Lucero, Linda M.; Weltzin, Maegan M.; Eaton, J. Brek; Cooper, John F.; Lindstrom, Jon M.; Lukas, Ronald J.; Whiteaker, Paul			Differential alpha 4(+)/(-)beta 2 Agonist-binding Site Contributions to alpha 4 beta 2 Nicotinic Acetylcholine Receptor Function within and between Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; CENTRAL-NERVOUS-SYSTEM; BETA-3 SUBUNITS; ALTERNATE STOICHIOMETRIES; ALPHA-4-ALPHA-4 INTERFACE; COGNITIVE FUNCTION; SMOKING-CESSATION; SAZETIDINE-A; EXPRESSION; BRAIN	Two alpha 4 beta 2 nicotinic acetylcholine receptor (alpha 4 beta 2-nAChR) isoforms exist with (alpha 4)(2)(beta 2)(3) and (alpha 4)(3)(beta 2)(2) subunit stoichiometries and high versus low agonist sensitivities (HS and LS), respectively. Both isoforms contain a pair of alpha 4(+)/(-)beta 2 agonist-binding sites. The LS isoform also contains a unique alpha 4(+)/(-)alpha 4 site with lower agonist affinity than the alpha 4(+)/(-)beta 2 sites. However, the relative roles of the conserved alpha 4(+)/(-)beta 2 agonist-binding sites in and between the isoforms have not been studied. We used a fully linked subunit concatemeric nAChR approach to express pure populations of HS or LS isoform alpha 4 beta 2*-nAChR. This approach also allowed us to mutate individual subunit interfaces, or combinations thereof, on each isoform background. We used this approach to systematically mutate a triplet of beta 2 subunit (-)-face E-loop residues to their non-conserved alpha 4 subunit counterparts or vice versa (beta 2HQT and alpha 4VFL, respectively). Mutant-nAChR constructs (and unmodified controls) were expressed in Xenopus oocytes. Acetylcholine concentration-response curves and maximum function were measured using two-electrode voltage clamp electrophysiology. Surface expression was measured with I-125-mAb 295 binding and was used to define function/nAChR. If the alpha 4(+)/(-)beta 2 sites contribute equally to function, making identical beta 2HQT substitutions at either site should produce similar functional outcomes. Instead, highly differential outcomes within the HS isoform, and between the two isoforms, were observed. In contrast, alpha 4VFL mutation effects were very similar in all positions of both isoforms. Our results indicate that the identity of subunits neighboring the otherwise equivalent alpha 4(+)/(-)beta 2 agonist sites modifies their contributions to nAChR activation and that E-loop residues are an important contributor to this neighbor effect.	[Lucero, Linda M.; Weltzin, Maegan M.; Eaton, J. Brek; Lukas, Ronald J.; Whiteaker, Paul] Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Cooper, John F.; Lindstrom, Jon M.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	Barrow Neurological Institute; University of Pennsylvania	Whiteaker, P (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	paul.whiteaker@dignityhealth.org			National Institutes of Health [DA026627, DA012242, DA030929]; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012242, R21DA026627, R01DA030929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA026627 and DA012242 (to P. W.) and DA030929 (to J. M. L.) and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P. W. and R. J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreo MA, 1996, J MED CHEM, V39, P817, DOI 10.1021/jm9506884; Ahring PK, 2015, NEUROPHARMACOLOGY, V92, P135, DOI 10.1016/j.neuropharm.2014.12.035; ANAND R, 1991, J BIOL CHEM, V266, P11192; Brejc K, 2002, NOVART FDN SYMP, V245, P22; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dash B, 2014, J BIOL CHEM, V289, P28338, DOI 10.1074/jbc.M114.566018; Dash B, 2012, J BIOL CHEM, V287, P14259, DOI 10.1074/jbc.M111.322610; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grupe M, 2015, BASIC CLIN PHARMACOL, V116, P187, DOI 10.1111/bcpt.12361; Grupe M, 2013, BIOCHEM PHARMACOL, V86, P1487, DOI 10.1016/j.bcp.2013.09.005; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hsiao B, 2008, J NEUROPHYSIOL, V99, P999, DOI 10.1152/jn.01040.2007; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; Marks MJ, 2010, J MOL NEUROSCI, V40, P96, DOI 10.1007/s12031-009-9264-x; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Rollema H, 2007, TRENDS PHARMACOL SCI, V28, P316, DOI 10.1016/j.tips.2007.05.003; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Son CD, 2009, MOL PHARMACOL, V75, P1137, DOI 10.1124/mol.108.054494; Steinlein OK, 2001, AM J MED GENET, V106, P139, DOI 10.1002/ajmg.1571; Stitzel JA, 2008, FRONT BIOSCI-LANDMRK, V13, P477, DOI 10.2741/2694; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Voineskos S, 2007, J PSYCHIATR NEUROSCI, V32, P412; Weltzin MM, 2016, NEUROPHARMACOLOGY, V102, P158, DOI 10.1016/j.neuropharm.2015.11.004; Whiteaker P, 2006, J COMP NEUROL, V499, P1016, DOI 10.1002/cne.21181; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	54	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2444	2459		10.1074/jbc.M115.684373	http://dx.doi.org/10.1074/jbc.M115.684373			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644472	Green Published, hybrid			2022-12-26	WOS:000369610400033
J	Jomura, M; Akashi, Y; Itoh, H; Yuki, R; Sakai, Y; Maruyama, Y				Jomura, Mayuko; Akashi, Yuhei; Itoh, Hiromu; Yuki, Risa; Sakai, Yoshimi; Maruyama, Yutaka			Biotic and Abiotic Factors Controlling Respiration Rates of Above- and Belowground Woody Debris of Fagus crenata and Quercus crispula in Japan	PLOS ONE			English	Article							PINUS-RADIATA; CARBON CONCENTRATION; CONIFEROUS FOREST; TEMPERATE FOREST; DOWNED LOGS; NEW-ZEALAND; DECOMPOSITION; MOISTURE; ROOTS; DECAY	As a large, long-term pool and source of carbon and nutrients, woody litter is an important component of forest ecosystems. The objective of this study was to estimate the effect of the factors that regulate the rate of decomposition of coarse and fine woody debris (CFWD) of dominant tree species in a cool-temperate forest in Japan. Respiration rates of dead stems, branches, and coarse and fine roots of Fagus crenata and Quercus crispula felled 4 years prior obtained in situ ranged from 20.9 to 500.1 mg CO2 [kg dry wood](-1) h(-1) in a one-time measurement in summer. Respiration rate had a significant negative relationship with diameter; in particular, that of a sample of Q. crispula with a diameter of >15 cm and substantial heartwood was low. It also had a significant positive relationship with moisture content. The explanatory variables diameter, [N], wood density, and moisture content were interrelated. The most parsimonious path model showed 14 significant correlations among 8 factors and respiration. Diameter and [C] had large negative direct effects on CFWD respiration rate, and moisture content and species had medium positive direct effects. [N] and temperature did not have direct or indirect effects, and position and wood density had indirect effects. The model revealed some interrelationships between controlling factors. We discussed the influence of the direct effects of explanatory variables and the influence especially of species and position. We speculate that the small R-2 value of the most parsimonious model was probably due to the omission of microbial biomass and activity. These direct and indirect effects and interrelationships between explanatory variables could be used to develop a process-based CFWD decomposition model.	[Jomura, Mayuko; Akashi, Yuhei; Itoh, Hiromu; Yuki, Risa; Maruyama, Yutaka] Nihon Univ, Coll Bioresource Sci, Dept Forest Sci & Resources, Fujisawa, Kanagawa, Japan; [Sakai, Yoshimi] Forestry & Forest Prod Res Inst, Kyusyu Res Ctr, Kumamoto, Kumamoto, Japan	Nihon University; Forestry & Forest Products Research Institute - Japan	Jomura, M (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Forest Sci & Resources, Fujisawa, Kanagawa, Japan.	joumura.mayuko@nihon-u.ac.jp		Jomura, Mayuko/0000-0002-9858-3771	Nihon University College of Bioresource Sciences Research Grant; Grants-in-Aid for Scientific Research [25450227] Funding Source: KAKEN	Nihon University College of Bioresource Sciences Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Nihon University College of Bioresource Sciences Research Grant (2012).; This work was funded by a Nihon University College of Bioresource Sciences Research Grant (2012). We thank Hideki Tarumi, of Nihon University, for helping to collect samples.	Augusto L, 2014, GCB BIOENERG, DOI [10.1111/gcbb.121271-13, DOI 10.1111/GCBB.121271-13]; Augusto L, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008059; Baker JS, 2008, FOR ECOL MANAG, V255, P598; Berg B., 2003, DECOMPOSITION PROCES; Bert D, 2006, FOREST ECOL MANAG, V222, P279, DOI 10.1016/j.foreco.2005.10.030; Bond-Lamberty B, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000839; Chambers JQ, 2001, BIOGEOCHEMISTRY, V52, P115, DOI 10.1023/A:1006473530673; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen H, 2000, FOREST ECOL MANAG, V138, P51, DOI 10.1016/S0378-1127(00)00411-4; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Elias M, 2003, CAN J FOREST RES, V33, P1039, DOI [10.1139/x03-018, 10.1139/X03-018]; FFPRI, 2003, FFPRI WOOD IND HDB; Forrester JA, 2012, FOREST ECOL MANAG, V265, P124, DOI 10.1016/j.foreco.2011.10.038; Fox J, 2015, CRAN R PROJECT STAT; Fukasawa Y, 2009, J FOREST RES-JPN, V14, P20, DOI 10.1007/s10310-008-0098-0; Fukasawa Y, 2009, CAN J FOREST RES, V39, P1606, DOI 10.1139/X09-080; Garrett LG, 2008, FOREST ECOL MANAG, V255, P3839, DOI 10.1016/j.foreco.2008.03.031; Garrett LG, 2012, FOREST ECOL MANAG, V269, P116, DOI 10.1016/j.foreco.2011.12.030; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Gough CM, 2007, FOREST ECOL MANAG, V244, P60, DOI 10.1016/j.foreco.2007.03.039; Grace JB., 2015, STRUCTURAL EQUATION; Guo JF, 2014, PLANT SOIL, V385, P149, DOI 10.1007/s11104-014-2205-7; Hagemann U, 2010, FOREST ECOL MANAG, V260, P1762, DOI 10.1016/j.foreco.2010.08.018; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1995, BIOTROPICA, V27, P305, DOI 10.2307/2388916; Herrmann S, 2013, SCAND J FOREST RES, V28, P346, DOI 10.1080/02827581.2012.747622; Hiscox J, 2015, FUNGAL ECOL, V14, P24, DOI 10.1016/j.funeco.2014.11.001; Hood I. A., 2011, New Zealand Plant Protection, V64, P188; Janisch JE, 2005, ECOSCIENCE, V12, P151, DOI 10.2980/i1195-6860-12-2-151.1; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; Jomura M, 2008, FOREST ECOL MANAG, V255, P149, DOI 10.1016/j.foreco.2007.09.002; Kuyah S, 2012, AGR ECOSYST ENVIRON, V158, P225, DOI 10.1016/j.agee.2012.05.010; Liu WJ, 2013, FOREST ECOL MANAG, V310, P623, DOI 10.1016/j.foreco.2013.09.013; Mackensen J, 2003, SOIL BIOL BIOCHEM, V35, P177, DOI 10.1016/S0038-0717(02)00255-9; MARRA JL, 1994, CAN J FOREST RES, V24, P1811, DOI 10.1139/x94-234; Matsuoka S., 1970, B GOVT FOREST EXPT S, V232, P109; Naesset E, 1999, CAN J FOREST RES, V29, P372, DOI 10.1139/cjfr-29-3-372; Namm BH, 2011, PSWGTR19X HUMB STAT; Ohtsuka T, 2014, ECOL RES, V29, P91, DOI 10.1007/s11284-013-1102-5; Olajuyigbe S, 2012, FORESTRY, V85, P485, DOI 10.1093/forestry/cps045; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Progar RA, 2000, OECOLOGIA, V124, P426, DOI 10.1007/PL00008868; Rajala T, 2010, CAN J FOREST RES, V40, P2384, DOI 10.1139/X10-176; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Renninger HJ, 2014, J GEOPHYS RES-BIOGEO, V119, P630, DOI 10.1002/2013JG002542; Rinkes ZL, 2014, FRONT MICROBIOL, V4, P21; Rowland L, 2013, ECOSYSTEMS, V16, P1294, DOI 10.1007/s10021-013-9684-x; Schowalter TD, 2002, WOOD FIBER SCI, V34, P158; Takenami K., 1964, Journal of the Japan Wood Research Society, V10, P22; Vanderhoof M, 2013, BIOGEOCHEMISTRY, V114, P299, DOI 10.1007/s10533-012-9810-4; Wang CK, 2002, OECOLOGIA, V132, P374, DOI 10.1007/s00442-002-0987-4; Wu JB, 2010, SCAND J FOREST RES, V25, P500, DOI 10.1080/02827581.2010.524166; Yoneda T., 1978, JIBP [Japanese Committee for the International Biological Program] Synthesis, V18, P258; YONEDA T, 1975, Japanese Journal of Ecology, V25, P40; YONEDA T, 1975, Japanese Journal of Ecology, V25, P132; Yoon TK, 2014, J FOREST RES-JPN, V19, P249, DOI 10.1007/s10310-013-0412-3; [No title captured]	60	6	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145113	10.1371/journal.pone.0145113	http://dx.doi.org/10.1371/journal.pone.0145113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658727	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900184
J	Maeda, J; Yurkon, CR; Fujii, Y; Fujisawa, H; Kato, S; Brents, CA; Uesaka, M; Fujimori, A; Kitamura, H; Kato, TA				Maeda, Junko; Yurkon, Charles R.; Fujii, Yoshihiro; Fujisawa, Hiroshi; Kato, Sayaka; Brents, Colleen A.; Uesaka, Mitsuru; Fujimori, Akira; Kitamura, Hisashi; Kato, Takamitsu A.			Solution Radioactivated by Hadron Radiation Can Increase Sister Chromatid Exchanges	PLOS ONE			English	Article							IN-BEAM PET; INTERCELLULAR COMMUNICATION; FRAGMENT REACTION; LOW FLUENCES; ION BEAMS; CELLS; IRRADIATION; INITIATION; PARTICLES; INDUCTION	When energetic particles irradiate matter, it becomes activated by nuclear reactions. Radioactivation induced cellular effects are not clearly understood, but it could be a part of bystander effects. This investigation is aimed at understanding the biological effects from radioactivation in solution induced by hadron radiation. Water or phosphate buffered saline was activated by being exposed to hadron radiation including protons, carbon- and iron-ions. 1 mL of radioactivated solution was transferred to flasks with Chinese hamster ovary (CHO) cells cultured in 5 mL of complete media. The induction of sister chromatid exchanges (SCE) was used to observe any increase in DNA damage responses. The energy spectrum and the half-lives of the radioactivation were analyzed by NaI scintillation detector in order to identify generated radionuclides. In the radioactivated solution, 511 keV gamma-rays were observed, and their half-lives were approximately 2 min, 10 min, and 20 min. They respectively correspond to the beta+ decay of O-15, N-13, and C-11. The SCE frequencies in CHO cells increased depending on the amount of radioactivation in the solution. These were suppressed with a 2-hour delayed solution transfer or pretreatment with dimethyl sulfoxide (DMSO). Our results suggest that the SCE induction by radioactivated solution was mediated by free radicals produced by the annihilated gamma-rays. Since the SCE induction and DMSO modulation are also reported in radiation-induced bystander effects, our results imply that radioactivation of the solution may have some contribution to the bystander effects from hadron radiation. Further investigations are required to assess if radioactivation effects would attribute an additional level of cancer risk of the hadron radiation therapy itself.	[Maeda, Junko; Yurkon, Charles R.; Kato, Sayaka; Brents, Colleen A.; Kato, Takamitsu A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Fujii, Yoshihiro] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Inashiki, Ibaraki, Japan; [Fujisawa, Hiroshi; Uesaka, Mitsuru] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Fujimori, Akira] Natl Inst Radiol Sci, Int Open Lab, Res Ctr Charged Particle Therapy, Chiba 260, Japan; [Kitamura, Hisashi] Natl Inst Radiol Sci, Res Dev & Support Ctr, Chiba 260, Japan	Colorado State University; University of Tokyo; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology	Kato, TA (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	Takamitsu.Kato@Colostate.edu	Kato, Takamitsu A/D-7969-2015; Kitamura, Hisashi/AAH-5031-2020	Kitamura, Hisashi/0000-0002-3449-7364; Kato, Takamitsu/0000-0002-6263-600X	Dr. Akiko Ueno Radiobiology Fund; National Institute of Radiological Sciences President Special Grant	Dr. Akiko Ueno Radiobiology Fund; National Institute of Radiological Sciences President Special Grant	This research is partially funded by Dr. Akiko Ueno Radiobiology Fund (TAK) and National Institute of Radiological Sciences President Special Grant (HF, TAK).	Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Bedford JS, 2002, RADIAT RES, V158, P251, DOI 10.1667/0033-7587(2002)158[0251:HACHIR]2.0.CO;2; Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; Fujibuchi T, 2012, RADIAT PROT DOSIM, V148, P168, DOI 10.1093/rpd/ncr005; Fujibuchi T, 2009, RADIOL PHYS TECHNOL, V2, P159, DOI 10.1007/s12194-009-0060-7; Fujisawa H, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-91; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kozlovsky B, 2002, ASTROPHYS J SUPPL S, V141, P523, DOI 10.1086/340545; LATT SA, 1980, AM J HUM GENET, V32, P297; Lyng FM, 2000, BRIT J CANCER, V83, P1223, DOI 10.1054/bjoc.2000.1433; Matsufuji N, 2003, PHYS MED BIOL, V48, P1605, DOI 10.1088/0031-9155/48/11/309; Matsumoto K, 2009, MAGN RESON MED, V61, P1033, DOI 10.1002/mrm.21958; Miyatake A, 2013, MED PHYS, V40, DOI 10.1118/1.4818057; Miyatake A, 2010, MED PHYS, V37, P4445, DOI 10.1118/1.3462559; Muller H, 2006, PHYS MED BIOL, V51, P1779, DOI 10.1088/0031-9155/51/7/010; MUNRO TR, 1970, RADIAT RES, V42, P451, DOI 10.2307/3572962; Nagasawa H, 2002, MUTAT RES-FUND MOL M, V508, P121, DOI 10.1016/S0027-5107(02)00193-8; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAGASAWA H, 1990, MUTAT RES, V244, P233, DOI 10.1016/0165-7992(90)90134-6; Nishio T, 2005, MED PHYS, V32, P1070, DOI 10.1118/1.1879692; Pawelke J, 1996, PHYS MED BIOL, V41, P279, DOI 10.1088/0031-9155/41/2/006; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; PERRY P, 1975, NATURE, V258, P121, DOI 10.1038/258121a0; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ra SJ, 2011, J KOREAN PHYS SOC, V59, P703, DOI 10.3938/jkps.59.703; Schall I, 1996, NUCL INSTRUM METH B, V117, P221, DOI 10.1016/0168-583X(96)00325-4; SCHARDT D, 1995, ADV SPACE RES, V17, P87; Schettino G, 2003, RADIAT RES, V160, P505, DOI 10.1667/RR3060; Siva S, 2015, CANCER LETT, V356, P82, DOI 10.1016/j.canlet.2013.09.018; TOBEY RA, 1970, J CELL BIOL, V46, P151, DOI 10.1083/jcb.46.1.151; Vincke H, 2011, RADIAT PROT DOSIM, V146, P434, DOI 10.1093/rpd/ncr245; Vinnikov V, 2012, MUTAT RES-FUND MOL M, V731, P107, DOI 10.1016/j.mrfmmm.2011.12.006; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; WOLFF S, 1975, EXP CELL RES, V93, P23, DOI 10.1016/0014-4827(75)90418-8; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797	37	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144619	10.1371/journal.pone.0144619	http://dx.doi.org/10.1371/journal.pone.0144619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657140	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900072
J	Sun, JW; Kranzler, HR; Bi, JB				Sun, Jiangwen; Kranzler, Henry R.; Bi, Jinbo			An Effective Method to Identify Heritable Components from Multivariate Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRINCIPAL-COMPONENTS; OPIOID USE; DEPENDENCE; REGRESSION; COCAINE; SUBTYPES; TRAIT	Multivariate phenotypes may be characterized collectively by a variety of low level traits, such as in the diagnosis of a disease that relies on multiple disease indicators. Such multivariate phenotypes are often used in genetic association studies. If highly heritable components of a multivariate phenotype can be identified, it can maximize the likelihood of finding genetic associations. Existing methods for phenotype refinement perform unsupervised cluster analysis on low-level traits and hence do not assess heritability. Existing heritable component analytics either cannot utilize general pedigrees or have to estimate the entire covariance matrix of low-level traits from limited samples, which leads to inaccurate estimates and is often computationally prohibitive. It is also difficult for these methods to exclude fixed effects from other covariates such as age, sex and race, in order to identify truly heritable components. We propose to search for a combination of low-level traits and directly maximize the heritability of this combined trait. A quadratic optimization problem is thus derived where the objective function is formulated by decomposing the traditional maximum likelihood method for estimating the heritability of a quantitative trait. The proposed approach can generate linearly-combined traits of high heritability that has been corrected for the fixed effects of covariates. The effectiveness of the proposed approach is demonstrated in simulations and by a case study of cocaine dependence. Our approach was computationally efficient and derived traits of higher heritability than those by other methods. Additional association analysis with the derived cocaine-use trait identified genetic markers that were replicated in an independent sample, further confirming the utility and advantage of the proposed approach.	[Sun, Jiangwen; Bi, Jinbo] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Kranzler, Henry R.] Univ Penn, Treatment Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Philadelphia VAMC, Philadelphia, PA USA	University of Connecticut; University of Pennsylvania; Pennsylvania Medicine	Bi, JB (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	jinbo@engr.uconn.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450	NIH; Study of Addiction: Genetics and Environment (SAGE) through the NIH Genes, Environment and Health Initiative [GEI] [U01 HG004422]; Gene Environment Association Studies (GENEVA) under GEI; NIH [R01DA037349]; NSF [DBI-1356655]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037349] Funding Source: NIH RePORTER; Direct For Biological Sciences [1356655] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Study of Addiction: Genetics and Environment (SAGE) through the NIH Genes, Environment and Health Initiative [GEI]; Gene Environment Association Studies (GENEVA) under GEI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Joel Gelernter, M.D., from Yale University who was instrumental in recruiting, characterizing, and genotyping the subjects in the SSADDA dataset used here. Kathleen Brady, M. D., Ph.D., of the Medical University of South Carolina, Roger Weiss, M.D., of McLean Hospital and Harvard Medical School, and David Oslin, M.D., of the University of Pennsylvania Perelman School of Medicine oversaw study recruitment at their respective sites. Funding support for that work was provided by NIH.; Funding support for the Study of Addiction: Genetics and Environment (SAGE) was provided through the NIH Genes, Environment and Health Initiative [GEI] (U01 HG004422). SAGE is one of the genome-wide association studies funded as part of the Gene Environment Association Studies (GENEVA) under GEI. The dataset used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000092.v1.p1 through dbGaP accession number phs000092.v1.p.; This work was supported by NIH grant R01DA037349 and NSF grant DBI-1356655.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Balding DJ, 2008, HDB STAT GENETICS; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Bi JB, 2014, AM J MED GENET B, V165, P148, DOI 10.1002/ajmg.b.32216; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Boligon AA, 2009, S AFR J ANIM SCI, V39, P145; Chan G, 2011, ADDICTION, V106, P1146, DOI 10.1111/j.1360-0443.2011.03390.x; Connor EE, 2012, FEED EFFICIENCY BEEF; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Gelernter J, 2014, MOL PSYCHIATR, V19, P717, DOI 10.1038/mp.2013.99; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Gelernter J, 2014, BIOL PSYCHIAT, V76, P66, DOI 10.1016/j.biopsych.2013.08.034; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Karp R. M., 2002, NOT AM MATH SOC, V49, P544; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Kranzler HR, 2008, ADDICT BEHAV, V33, P41, DOI 10.1016/j.addbeh.2007.05.011; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; Lange K, 2013, BIOINFORMATICS, V29, P1568, DOI 10.1093/bioinformatics/btt187; Lehrmann E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000114; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; National Institutes of Health, 2009, STUD ADD GEN ENV SAG; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Ott J, 1999, HUM HERED, V49, P106, DOI 10.1159/000022854; Oualkacha K, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1711; Pierucci-Lagha A, 2007, DRUG ALCOHOL DEPEN, V91, P85, DOI 10.1016/j.drugalcdep.2007.04.014; Soriano FX, 2009, EPIGENETICS-US, V4, P152, DOI 10.4161/epi.4.3.8753; Sun JW, 2012, ADDICT BEHAV, V37, P1138, DOI 10.1016/j.addbeh.2012.05.010; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik V., 1998, STAT LEARNING THEORY; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang JC, 2012, ANNU REV GENOM HUM G, V13, P241, DOI 10.1146/annurev-genom-090711-163844; Wang YJ, 2007, HUM HERED, V64, P182, DOI 10.1159/000102991; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144418	10.1371/journal.pone.0144418	http://dx.doi.org/10.1371/journal.pone.0144418			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658140	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900046
J	Wang, LJ; Wang, JG; Zhang, XY; Li, J; Wei, XY; Cheng, J; Ling, Q; Xie, HY; Zhou, L; Xu, X; Zheng, SS				Wang, Lijun; Wang, Jianguo; Zhang, Xuanyu; Li, Jie; Wei, Xuyong; Cheng, Jun; Ling, Qi; Xie, Haiyang; Zhou, Lin; Xu, Xiao; Zheng, Shusen			Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; MICROVASCULAR INVASION; NATIONWIDE SURVEY; RESECTION; IMPACT; COMPLICATIONS; METASTASIS; RECURRENCE; EXPRESSION; SELECTION	Background Needle core biopsy (NCB) is one of the most widely used and accepted methods for the diagnosis of focal hepatic lesions. Although many studies have assessed the diagnostic accuracy of NCB in predicting the tumor grade, it is still under debate. Objective To identify the influence of number of biopsies on NCB diagnostic accuracy. Methods 153 patients with HCC were selected from patients who received preoperative NCB under the guidance of ultrasonography in our hospital. The diagnostic reference standard was the surgical pathologic diagnosis. Results Using a 3-tier grading scheme (well, moderate and poor), the accuracy of NCB has no significant differences among different number of passes in HCC <= 5cm. For HCC > 5 <= 8cm, the increasing number of passes could increase the diagnostic accuracy (63.3%, 81.8%, and 84.8% for passes one, two, and three, respectively). While in HCC>8cm, the diagnostic accuracy of passes one, two, and three were 62.1%, 69%, and 75.8%, respectively. Conclusions The accuracy of NCB in assessing tumor grading associated with tumor size and number of passes. Meanwhile, a minimum of two passes should be performed to get better accuracy in patients with HCC > 5cm.	[Wang, Lijun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Jun; Ling, Qi; Xu, Xiao; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jianguo; Zhang, Xuanyu; Li, Jie; Wei, Xuyong; Ling, Qi; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China; [Xie, Haiyang; Zhou, Lin; Xu, Xiao; Zheng, Shusen] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Xu, X (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	zdyyxx@163.com; zyzss@zju.edu.cn			National High-tech R&D Program of China (863 Program) [2012AA020204]; National science and technology major projects [2012ZX10002010-001-005]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Chang Jiang Scholars Program; Program for New Century Excellent Talents in University" of the Ministry of Education of China	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National science and technology major projects; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents in University" of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National High-tech R&D Program of China (863 Program) (No. 2012AA020204), National science and technology major projects (No. 2012ZX10002010-001-005), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Chang Jiang Scholars Program and "Program for New Century Excellent Talents in University" of the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki AK, 2008, NATURE, V456, P443, DOI 10.1038/456443c; Barreto SG, 2013, ANZ J SURG, V83, P331, DOI 10.1111/j.1445-2197.2012.06196.x; Braune C, 2001, Z GASTROENTEROL, V39, P789, DOI 10.1055/s-2001-17188; Cheah YL, 2012, LIVER CANCER, V1, P183, DOI 10.1159/000343832; Cillo U, 2004, ANN SURG, V239, P150, DOI 10.1097/01.sla.0000109146.72827.76; Colecchia A, 2011, J HEPATOL, V54, P300, DOI 10.1016/j.jhep.2010.06.037; Davison JM, 2014, MODERN PATHOL, V27, P1521, DOI 10.1038/modpathol.2014.37; Diamond DL, 2006, HEPATOLOGY, V44, P299, DOI 10.1002/hep.21318; Durand F, 2001, J HEPATOL, V35, P254, DOI 10.1016/S0168-8278(01)00108-8; Esnaola NF, 2002, J GASTROINTEST SURG, V6, P224, DOI 10.1016/S1091-255X(01)00015-4; Frilling A, 2002, ANN SURG, V235, P604, DOI 10.1097/00000658-200204000-00023; FROEHLICH F, 1993, DIGEST DIS SCI, V38, P1480, DOI 10.1007/BF01308607; Han DH, 2013, J GASTROEN HEPATOL, V28, P1384, DOI 10.1111/jgh.12200; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Ikai I, 2004, CANCER-AM CANCER SOC, V101, P796, DOI 10.1002/cncr.20426; Iwatsuki S, 2000, J AM COLL SURGEONS, V191, P389, DOI 10.1016/S1072-7515(00)00688-8; Kaido T, 2013, SURGERY, V154, P1053, DOI 10.1016/j.surg.2013.04.056; KENMOCHI K, 1987, LIVER, V7, P18; Llovet JM, 1998, HEPATOLOGY, V27, P1572, DOI 10.1002/hep.510270616; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Ng KKC, 2004, ARCH SURG-CHICAGO, V139, P193, DOI 10.1001/archsurg.139.2.193; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Pawlik TM, 2007, ANN SURG, V245, P435, DOI 10.1097/01.sla.0000250420.73854.ad; PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103; Roayaie S, 2002, ANN SURG, V235, P533, DOI 10.1097/00000658-200204000-00012; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; Shin E, 2014, PATHOL ONCOL RES, V20, P667, DOI 10.1007/s12253-014-9747-0; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Sutcliffe R, 2006, BRIT J SURG, V93, P11, DOI 10.1002/bjs.5198; Tamura S, 2001, ARCH SURG-CHICAGO, V136, P25, DOI 10.1001/archsurg.136.1.25; Thorgeirsson SS, 2006, J HEPATOL, V44, P798, DOI 10.1016/j.jhep.2006.01.008; Uenishi T, 2001, DIGEST SURG, V18, P225, DOI 10.1159/000050137; Wang JB, 2013, DISASTER ADV, V6, P93; Wu LM, 2013, HEPATOB PANCREAT DIS, V12, P54, DOI 10.1016/S1499-3872(13)60006-5; Xu X, 2016, GUT, V65, P1035, DOI 10.1136/gutjnl-2014-308513; Yao FY, 2007, AM J TRANSPLANT, V7, P2587, DOI 10.1111/j.1600-6143.2007.01965.x; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4; Zhou Zhanru, 2013, ScientificWorldJournal, V2013, P458797, DOI 10.1155/2013/458797	39	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144216	10.1371/journal.pone.0144216	http://dx.doi.org/10.1371/journal.pone.0144216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658912	gold, Green Published			2022-12-26	WOS:000366715900032
J	Wang, XC; Xue, QH; Yan, FX; Liu, JP; Li, SJ; Hu, SS				Wang, Xiaocou; Xue, Qinghua; Yan, Fuxia; Liu, Jinping; Li, Shoujun; Hu, Shengshou			Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass	PLOS ONE			English	Article							N-ACETYLCYSTEINE; RENAL INJURY; INFLAMMATION; INHIBITOR; DURATION	Objective Infants are more vulnerable to kidney injuries induced by inflammatory response syndrome and ischemia-reperfusion injury following cardiopulmonary bypass especially with prolonged hypothermic low-flow (HLF). This study aims to evaluate the protective role of ulinastatin, an anti-inflammatory agent, against acute kidney injuries in infant piglets model undergoing surgery on HLF cardiopulmonary bypass. Methods Eighteen general-type infant piglets were randomly separated into the ulinastatin group (Group U, n = 6), the control group (Group C, n = 6), and the sham operation group (Group S, n = 6), and anaesthetized. The groups U and C received following experimental procedure: median thoracotomy, routine CPB and HLF, and finally weaned from CPB. The group S only underwent sham median thoracotomy. Ulinastatin at a dose of 5,000 units/kg body weight and a certain volume of saline were administrated to animals of the groups U and C at the beginning of CPB and at aortic declamping, respectively. Venous blood samples were collected at 3 different time points: after anesthesia induction in all experimental groups, 5 minutes, and 120 minutes after CPB in the Groups U and C. Markers for inflammation and acute kidney injury were tested in the collected plasma. N-acetyl-beta-D-glucosaminidase (NAG) from urine, markers of oxidative stress injury and TUNEL-positive cells in kidney tissues were also detected. Results The expressions of plasma inflammatory markers and acute kidney injury markers increased both in Group U and Group C at 5 min and 120 min after CPB. Also, numbers of TUNEL-positive cells and oxidative stress markers in kidney rose in both groups. At the time point of 120-min after CPB, compared with the Group C, some plasma inflammatory and acute kidney injury markers as well as TUNEL-positive cells and oxidative stress markers in kidney were significantly reduced in the Group U. Histologic analyses showed that HLF promoted acute tubular necrosis and dilatation. Conclusions HLF cardiopulmonary bypass surgery could intensify systemic inflammatory responses and oxidative stress on infant piglets, thus causing acute kidney injury. Ulinastatin might reduce such inflammatory response and oxidative stress and the extent of kidney injury.	[Wang, Xiaocou] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol Crit Care & Pain Med, Wenzhou, Zhejiang, Peoples R China; [Wang, Xiaocou; Xue, Qinghua; Yan, Fuxia] Chinese Acad Med Sci, Dept Anesthesiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Wang, Xiaocou; Xue, Qinghua; Yan, Fuxia; Liu, Jinping; Li, Shoujun; Hu, Shengshou] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Jinping] Chinese Acad Med Sci, Dept Cardiopulm Bypass, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Shoujun; Hu, Shengshou] Chinese Acad Med Sci, Dept Surg, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China	Wenzhou Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Yan, FX (corresponding author), Chinese Acad Med Sci, Dept Anesthesiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	yanfuxia@sina.com			National Key Basic Research Development Program (973 Program); Ministry of Science and Technology of People's Republic of China [2010CB529507]	National Key Basic Research Development Program (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China)	This research was supported by a grant funded from the National Key Basic Research Development Program (973 Program) and by a project funded by the Ministry of Science and Technology of People's Republic of China (Project name: Basic research of congenital heart disease formation, development and intervention; Grant Recipient: Shengshou Hu; Grant Number: 2010CB529507; [http://www.most.gov.cn/]).	Nguyen B, 2014, J THORAC CARDIOV SUR, V148, P690, DOI 10.1016/j.jtcvs.2013.12.048; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Day J R S, 2005, Int J Surg, V3, P129, DOI 10.1016/j.ijsu.2005.04.002; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goebel U, 2010, ANESTH ANALG, V111, P29, DOI 10.1213/ANE.0b013e3181e0cca4; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Jiang C, 2013, EXP THER MED, V5, P197, DOI 10.3892/etm.2012.737; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Li XY, 2015, EXP THER MED, V9, P411, DOI 10.3892/etm.2014.2088; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; Moussavian MR, 2007, TRANSPL INT, V20, P884, DOI 10.1111/j.1432-2277.2007.00538.x; Nakanishi K, 2006, CRIT CARE MED, V34, P1351, DOI 10.1097/01.CCM.0000215110.55899.AE; Nishiyama T, 2001, CRIT CARE MED, V29, P1979, DOI 10.1097/00003246-200110000-00021; Park KH, 2010, J KOREAN MED SCI, V25, P128, DOI 10.3346/jkms.2010.25.1.128; Pastuszko P, 2012, J THORAC CARDIOV SUR, V143, P1436, DOI 10.1016/j.jtcvs.2012.01.018; Qu XF, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-107; Seitz S, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13744; Sleeman P, 2013, CRIT CARE, V17, DOI 10.1186/cc13092; Sugita T, 2002, J CARDIOVASC SURG, V43, P437; [王晓凑 Wang Xiaocou], 2012, [实用儿科临床杂志, Journal of Applied Clinical Pediatrics], V27, P50; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113973; Zhu JQ, 2007, J THORAC CARDIOV SUR, V133, P696, DOI 10.1016/j.jtcvs.2006.09.046	24	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144516	10.1371/journal.pone.0144516	http://dx.doi.org/10.1371/journal.pone.0144516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656098	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900060
J	Xu, CY; Shi, XM; Ji, A; Shi, LN; Zhou, C; Cui, YQ				Xu, Changyan; Shi, Xiaomei; Ji, An; Shi, Lina; Zhou, Chen; Cui, Yunqi			Fabrication and Characteristics of Reduced Graphene Oxide Produced with Different Green Reductants	PLOS ONE			English	Article							GRAPHITE OXIDE; AQUEOUS DISPERSIONS; CHEMICAL-REDUCTION; RAMAN-SPECTROSCOPY; FACILE SYNTHESIS; VITAMIN-C; NANOSHEETS; FILMS; CONDUCTIVITY; HYDRAZINE	There has been an upsurge of green reductants for the preparation of graphene materials taking consideration of human health and the environment in recent years. In this paper, reduced graphene oxides (RGOs) were prepared by chemical reduction of graphene oxide (GO) with three green reductants, L-ascorbic acid (L-AA), D-glucose (D-GLC) and tea poly-phenol (TP), and comparatively characterized by X-ray photoelectron spectroscopy (XPS), Fourier transform infrared (FTIR) spectra, Raman spectra and electrical conductivity analysis. Results showed that all these three reductants were effective to remove oxygen-containing functional groups in GO and restore the electrical conductivity of the obtained RGO. The RGO sample with L-ascorbic acid as a reductant and reduced with the existence of ammonia had the highest electrical conductivity (9.8 S.cm(-1)) among all the obtained RGO samples. The mechanisms regarding to the reduction of GO and the dispersion of RGO in water were also proposed. It is the good dispersibility of reduced graphene oxide in water that will facilitate its further use in composite materials and conductive ink.	[Xu, Changyan; Shi, Xiaomei; Ji, An; Shi, Lina; Zhou, Chen; Cui, Yunqi] Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Xu, CY (corresponding author), Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China.	changyanxu1999@163.com	Cui, Yunqi/GXH-1829-2022	Xu, Changyan/0000-0003-4370-9784	Education Department of Jiangsu Province; Science and Technology Department of Jiangsu Province; Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Research and popularization of key techniques of functional electromagnetic shielding composites [BC2013432]; Research and innovation project of the academic degree graduate students in Jiangsu Province [KYLX15_0935]	Education Department of Jiangsu Province; Science and Technology Department of Jiangsu Province; Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Research and popularization of key techniques of functional electromagnetic shielding composites; Research and innovation project of the academic degree graduate students in Jiangsu Province	The first Project name is "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)." It can be accessed at http://jsycw.ec.js.edu.cn/. The funding institution is The Education Department of Jiangsu Province. The second Project name is "Research and popularization of key techniques of functional electromagnetic shielding composites (Grant No. BC2013432)." It can be accessed at http://210.73.128.105/cpsb/CPSB/login.jsp?typ = nolog. The funding institution is Science and Technology Department of Jiangsu Province. CYX received these two fundings. The third Project name is "Research and innovation project of the academic degree graduate students in Jiangsu Province (KYLX15_0935)." It can be accessed at http://gsnfu.njfu.edu.cn/html/69/13965.html. The funding institution is Nanjing Forestry University. XMS received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)", "Research and popularization of key techniques of functional electromagnetic shielding composites (Grant No. BC2013432)" and "Research and innovation project of the academic degree graduate students in Jiangsu Province (KYLX15_0935)."	Amini S, 2011, J MATER SCI, V46, P6255, DOI 10.1007/s10853-011-5432-9; Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g; Chua CK, 2013, J MATER CHEM A, V1, P1892, DOI 10.1039/c2ta00665k; Dua V, 2010, ANGEW CHEM INT EDIT, V49, P2154, DOI 10.1002/anie.200905089; Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306; Feng YY, 2012, CARBOHYD POLYM, V87, P644, DOI 10.1016/j.carbpol.2011.08.039; Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Finn DJ, 2014, J MATER CHEM C, V2, P925, DOI 10.1039/c3tc31993h; Gao J, 2010, CHEM MATER, V22, P2213, DOI 10.1021/cm902635j; Gao YH, 2014, IND ENG CHEM RES, V53, P16777, DOI 10.1021/ie502675z; He DF, 2014, AICHE J, V60, P2757, DOI 10.1002/aic.14499; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Ismach A, 2010, NANO LETT, V10, P1542, DOI 10.1021/nl9037714; Kang D, 2015, MATER CHEM PHYS, V149, P129, DOI 10.1016/j.matchemphys.2014.09.055; Kim K, 2014, CARBON, V66, P172, DOI 10.1016/j.carbon.2013.08.055; Kong D, 2012, LANGMUIR, V28, P13467, DOI 10.1021/la301775d; Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y; Lee D, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FD21; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Liao RJ, 2011, J PHYS CHEM C, V115, P20740, DOI 10.1021/jp2068683; Liu PB, 2013, MATER LETT, V91, P125, DOI 10.1016/j.matlet.2012.09.085; Loryuenyong V, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/923403; Luo DC, 2011, J PHYS CHEM C, V115, P11327, DOI 10.1021/jp110001y; Mao F, 2015, J MATER SCI, V50, P6518, DOI 10.1007/s10853-015-9212-9; Marks J, 1985, VITAMINS THEIR ROLE; Moon IK, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1067; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Obata S, 2013, CARBON, V55, P126, DOI 10.1016/j.carbon.2012.12.018; Pantea D, 2003, APPL SURF SCI, V217, P181, DOI 10.1016/S0169-4332(03)00550-6; Park S, 2011, CARBON, V49, P3019, DOI 10.1016/j.carbon.2011.02.071; Pasrija D, 2015, LWT-FOOD SCI TECHNOL, V64, P289, DOI 10.1016/j.lwt.2015.05.054; Pei SF, 2010, CARBON, V48, P4466, DOI 10.1016/j.carbon.2010.08.006; Shao YL, 2015, CHEM SOC REV, V44, P3639, DOI 10.1039/c4cs00316k; Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167; Song P, 2012, RSC ADV, V2, P1168, DOI 10.1039/c1ra00934f; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Staudenmaier L., 1898, EUR J INORG CHEM, V31, P1481, DOI 10.1002/cber.18980310237; Su XQ, 2013, ADV POWDER TECHNOL, V24, P317, DOI 10.1016/j.apt.2012.08.003; Sutter P, 2009, NAT MATER, V8, P171, DOI 10.1038/nmat2392; Pham TA, 2011, COLLOID SURFACE A, V384, P543, DOI 10.1016/j.colsurfa.2011.05.019; Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI 10.1038/NNANO.2008.329; Venkanna M, 2014, AIP CONF PROC, V1591, P574, DOI 10.1063/1.4872679; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; Wang Y, 2011, ACS APPL MATER INTER, V3, P1127, DOI 10.1021/am1012613; Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y; Yang XM, 2010, POLYMER, V51, P3431, DOI 10.1016/j.polymer.2010.05.034; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhao N, 2014, J PHYS CHEM SOLIDS, V75, P1141, DOI 10.1016/j.jpcs.2014.05.008; Zhao WF, 2010, J MATER CHEM, V20, P5817, DOI 10.1039/c0jm01354d; Zhou TN, 2011, COMPOS SCI TECHNOL, V71, P1266, DOI 10.1016/j.compscitech.2011.04.016; Zhou XZ, 2010, CHEM COMMUN, V46, P6974, DOI 10.1039/c0cc01681k; Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387	56	78	80	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144842	10.1371/journal.pone.0144842	http://dx.doi.org/10.1371/journal.pone.0144842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658644	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900116
J	Zhou, HX; Jiang, Y; Nie, LW; Yin, HZ; Li, HF; Dong, XM; Zhao, FF; Zhang, HH; Pu, YG; Huang, ZF; Song, JL; Sun, ET				Zhou, Huaxing; Jiang, Yuan; Nie, Liuwang; Yin, Huazong; Li, Haifeng; Dong, Xianmei; Zhao, Feifei; Zhang, Huanhuan; Pu, Youguang; Huang, Zhenfeng; Song, Jiaolian; Sun, Entao			The Historical Speciation of Mauremys Sensu Lato: Ancestral Area Reconstruction and Interspecific Gene Flow Level Assessment Provide New Insights	PLOS ONE			English	Article							FRESH-WATER TURTLE; TESTUDINES; PHYLOGEOGRAPHY; PHYLOGENY; SELECTION; JAPONICA; ORIGIN; MA	Mauremys sensu lato was divided into Mauremys, Chinemys, Ocadia, and Annamemys based on earlier research on morphology. Phylogenetic research on this group has been controversial because of disagreements regarding taxonomy, and the historical speciation is still poorly understood. In this study, 32 individuals of eight species that are widely distributed in Eurasia were collected. The complete mitochondrial (mt) sequences of 14 individuals of eight species were sequenced. Phylogenetic relationships, interspecific divergence times, and ancestral area reconstructions were explored using mt genome data (10,854 bp). Subsequent interspecific gene flow level assessment was performed using five unlinked polymorphic microsatellite loci. The Bayesian and maximum likelihood analyses revealed a paraphyletic relationship among four old genera (Mauremys, Annamemys, Chinemys, and Ocadia) and suggested the four old genera should be merged into the genus (Mauremys). Ancestral area reconstruction and divergence time estimation suggested Southeast Asia may be the area of origin for the common ancestral species of this genus and genetic drift may have played a decisive role in species divergence due to the isolated event of a glacial age. However, M. japonica may have been speciated due to the creation of the island of Japan. The detection of extensive gene flow suggested no vicariance occurred between Asia and Southeast Asia. Inconsistent results between gene flow assessment and phylogenetic analysis revealed the hybrid origin of M. mutica (Southeast Asian). Here ancestral area reconstruction and interspecific gene flow level assessment were first used to explore species origins and evolution of Mauremys sensu lato, which provided new insights on this genus.	[Zhou, Huaxing; Nie, Liuwang; Yin, Huazong; Li, Haifeng; Dong, Xianmei; Zhao, Feifei; Zhang, Huanhuan; Pu, Youguang; Huang, Zhenfeng; Song, Jiaolian] Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China; [Zhou, Huaxing; Nie, Liuwang; Yin, Huazong; Li, Haifeng; Zhang, Huanhuan] Anhui Normal Univ, Life Sci Coll, Wuhu, Peoples R China; [Jiang, Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Sun, Entao] Wannan Med Coll, Dept Med Parasitol, Wuhu, Peoples R China	Anhui Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Wannan Medical College	Nie, LW (corresponding author), Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China.	lwnie@mail.ahnu.edu.cn	jiang, anyi/GPT-0379-2022	Nie, Liu-Wang/0000-0003-2660-5799; Zhou, Huaxing/0000-0002-5569-0083	National Natural Science Foundation of China (NSFC) [31372198, 30970351]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC, No. 31372198 and 30970351)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Barth D, 2004, ZOOL SCR, V33, P213, DOI 10.1111/j.0300-3256.2004.00150.x; Barth Dana, 2003, Salamandra, V38, P233; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Feldman Chris R., 2004, Asiatic Herpetological Research, V10, P28; Fritz U, 2006, ZOOL SCR, V35, P97, DOI 10.1111/j.1463-6409.2005.00218.x; Green M.R., 2012, MOL CLONING LAB MANU; Hartl Daniel L., 1997; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hirayama R., 1984, Studia Geologica Salmanticensia Volumen Especial, V1, P141; Honda M, 2002, J ZOOL SYST EVOL RES, V40, P195, DOI 10.1046/j.1439-0469.2002.00176.x; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lourenco JM, 2012, MOL PHYLOGENET EVOL, V62, P496, DOI 10.1016/j.ympev.2011.10.022; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; Le M, 2014, ORG DIVERS EVOL, V14, P279, DOI 10.1007/s13127-014-0169-3; Parham JF, 2001, ASIAN HERPETOL RES, V9, P71; Qi Y, 2014, MOL ECOL, V23, P5575, DOI 10.1111/mec.12960; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Spinks PQ, 2004, MOL PHYLOGENET EVOL, V32, P164, DOI 10.1016/j.ympev.2003.12.015; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stuart BL, 2007, CONSERV GENET, V8, P169, DOI 10.1007/s10592-006-9159-0; Suzuki D, 2011, J ZOOL SYST EVOL RES, V49, P141, DOI 10.1111/j.1439-0469.2010.00577.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vamberger M, 2014, ZOOL SCR, V43, P313, DOI 10.1111/zsc.12055; Vamberger M, 2013, ORG DIVERS EVOL, V13, P77, DOI 10.1007/s13127-012-0102-6; van Dijk PP, 2012, CHELON RES MONOGR, V5, DOI [DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014, 10.3854/crm.5.000]; Wink Michael, 2001, Zoologische Abhandlungen (Dresden), V51, P41; Yeh F.C., 1997, MOL BIOL BIOTECHNOL, V10, P295; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang LQ, 2012, MOL BIOL REP, V39, P8315, DOI 10.1007/s11033-012-1681-1; Zhou T, 2004, ATLAS IDENTIFICATION	37	10	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144711	10.1371/journal.pone.0144711	http://dx.doi.org/10.1371/journal.pone.0144711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657158	Green Published, gold			2022-12-26	WOS:000366715900091
J	Dixit, M; Raghuvanshi, A; Gupta, CP; Kureel, J; Mansoori, MN; Shukla, P; John, AA; Singh, K; Purohit, D; Awasthi, P; Singh, D; Goel, A				Dixit, Manisha; Raghuvanshi, Ashutosh; Gupta, Chandra Prakash; Kureel, Jyoti; Mansoori, Mohd Nizam; Shukla, Priyanka; John, Aijaz A.; Singh, Kavita; Purohit, Dipak; Awasthi, Pallavi; Singh, Divya; Goel, Atul			Medicarpin, a Natural Pterocarpan, Heals Cortical Bone Defect by Activation of Notch and Wnt Canonical Signaling Pathways	PLOS ONE			English	Article							OSTEOGENIC ACTIVITY; REGENERATION; INJURY; INFLAMMATION; DEFICIENCY; COMPONENTS; CATENIN	We evaluated the bone regeneration and healing effect of Medicarpin (med) in cortical bone defect model that heals by intramembranous ossification. For the study, female Sprague-Dawley rats were ovariectomized and rendered osteopenic. A drill hole injury was generated in mid femoral bones of all the animals. Med treatment was commenced the day after and continued for 15 days. PTH was taken as a reference standard. Fifteen days post-treatment, animals were sacrificed. Bones were collected for histomorphometry studies at the injury site by micro-computed tomography (mu CT) and confocal microscopy. RNA and protein was harvested from newly generated bone. For immunohistochemistry, 5 mu m sections of decalcified femur bone adjoining the drill hole site were cut. By mu CT analysis and calcein labeling of newly generated bone it was found that med promotes bone healing and new bone formation at the injury site and was comparable to PTH in many aspects. Med treatment led to increase in the Runx-2 and osteocalcin signals indicating expansion of osteo-progenitors at the injury site as evaluated by qPCR and immunohistochemical localization. It was observed that med promoted bone regeneration by activating canonical Wnt and notch signaling pathway. This was evident by increased transcript and protein levels of Wnt and notch signaling components in the defect region. Finally, we confirmed that med treatment leads to elevated bone healing in pre-osteoblasts by co localization of beta catenin with osteoblast marker alkaline phosphatase. In conclusion, med treatment promotes new bone regeneration and healing at the injury site by activating Wnt/canonical and notch signaling pathways. This study also forms a strong case for evaluation of med in delayed union and non-union fracture cases.	[Dixit, Manisha; Kureel, Jyoti; Mansoori, Mohd Nizam; Shukla, Priyanka; John, Aijaz A.; Singh, Divya] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Dixit, Manisha; Kureel, Jyoti; Mansoori, Mohd Nizam; Shukla, Priyanka; John, Aijaz A.; Singh, Divya] CSIR Cent Drug Res Inst, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Lucknow, Uttar Pradesh, India; [Raghuvanshi, Ashutosh; Gupta, Chandra Prakash; Purohit, Dipak; Awasthi, Pallavi; Goel, Atul] CSIR Cent Drug Res Inst, Div Med & Proc Chem, Lucknow, Uttar Pradesh, India; [Singh, Kavita] CSIR Cent Drug Res Inst, Sophisticated Anal & Instrumentat Facil, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, D (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, BS 10-1,Sect 10, Lucknow, Uttar Pradesh, India.	divya_singh@cdri.res.in; atul_goel@cdri.res.in			Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI); Department of Biotechnology; Council of Scientific and Industrial Research; University Grants Commission, Government of India	Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI); Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India)	Study supported by Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), Fellowship grants from the Department of Biotechnology (MD), Council of Scientific and Industrial Research (AR, CPG, JK, MNM, KS, AAJ), University Grants Commission (PS), Government of India.; Fellowship grants from the Department of Biotechnology (MD), Council of Scientific and Industrial Research (AR, CPG, JK, MNM, KS, AAJ), University Grants Commission (PS), Government of India. Authors are thankful to SAIF division for use of confocal microscopy facility and Mr. G.K Nagar for histology related experiments.	Barnes GL, 2008, J BONE JOINT SURG AM, V90A, P120, DOI 10.2106/JBJS.G.01443; Bhargavan B, 2012, J NUTR BIOCHEM, V23, P27, DOI 10.1016/j.jnutbio.2010.11.002; Brandi ML, 2012, EXPERT OPIN INV DRUG, V21, P1169, DOI 10.1517/13543784.2012.696610; Campbell TM, 2003, CALCIFIED TISSUE INT, V73, P49, DOI 10.1007/s00223-002-2120-4; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dishowitz MI, 2012, J ORTHOP RES, V30, P296, DOI 10.1002/jor.21518; Durao SFO, 2012, INT J ORAL MAX IMPL, V27, P1400; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Gittens SA, 2004, J PHARM PHARM SCI, V7, P27; Goel AK., 2014, U.S. Patent, Patent No. [8,686,028, 8686028]; Goel A, 2013, CHEM REV, V113, P1614, DOI 10.1021/cr300219y; Goel A, 2012, ORG BIOMOL CHEM, V10, P9583, DOI 10.1039/c2ob25722j; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Lenton K, 2011, GENESIS, V49, P784, DOI 10.1002/dvg.20768; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Matsushita Y, 2013, J BIOL CHEM, V288, P19973, DOI 10.1074/jbc.M113.454652; Maurya R, 2009, BIOORG MED CHEM LETT, V19, P610, DOI 10.1016/j.bmcl.2008.12.064; McBride-Gagyi SH, 2015, BONE, V81, P533, DOI 10.1016/j.bone.2015.09.003; McGee-Lawrence ME, 2013, BIOCHEM BIOPH RES CO, V441, P886, DOI 10.1016/j.bbrc.2013.10.155; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Monfoulet L, 2010, BONE, V46, P447, DOI 10.1016/j.bone.2009.09.007; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pandey R, 2010, MENOPAUSE, V17, P602, DOI 10.1097/gme.0b013e3181d0f7f0; Pietrogrande L, 2009, INT J WOMENS HEALTH, V1, P193; Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434; Shen J, 2013, TISSUE ENG PT A, V19, P2390, DOI [10.1089/ten.tea.2012.0519, 10.1089/ten.TEA.2012.0519]; Sikon A, 2010, INT J WOMENS HEALTH, V2, P37; Tanaka K, 2010, BONE, V47, P1006, DOI 10.1016/j.bone.2010.08.016; Tyagi AM, 2010, MOL CELL ENDOCRINOL, V325, P101, DOI 10.1016/j.mce.2010.05.016; Warden SJ, 2009, BONE, V44, P485, DOI 10.1016/j.bone.2008.11.007; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]	36	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144541	10.1371/journal.pone.0144541	http://dx.doi.org/10.1371/journal.pone.0144541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657206	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600053
J	Hasegawa, K; Tanaka, S; Fujiki, F; Morimoto, S; Nakajima, H; Tatsumi, N; Nakata, J; Takashima, S; Nishida, S; Tsuboi, A; Oka, Y; Oji, Y; Kumanogoh, A; Sugiyama, H; Hosen, N				Hasegawa, Kana; Tanaka, Satomi; Fujiki, Fumihiro; Morimoto, Soyoko; Nakajima, Hiroko; Tatsumi, Naoya; Nakata, Jun; Takashima, Satoshi; Nishida, Sumiyuki; Tsuboi, Akihiro; Oka, Yoshihiro; Oji, Yusuke; Kumanogoh, Atsushi; Sugiyama, Haruo; Hosen, Naoki			An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells	PLOS ONE			English	Article							WT1 PEPTIDE VACCINATION; TUMOR; LYMPHOCYTES; RECEPTOR; TRANSFORMATION; TRANSPLANTATION; IDENTIFICATION; MAINTENANCE; PROGENITOR; REMISSION	Leukemia differs substantially with respect to stromal milieu from tumors that progress locally as solid masses, and the physiological importance of immunosurveillance in leukemia remains unclear. However, currently available mouse leukemia models have critical limitations in the context of analyzing immunological regulation of leukemia development. In this study, we transferred mouse MLL/AF9 leukemia-initiating cells into immunocompetent recipient mice without any pre-conditioning such as irradiation, and then analyzed the spontaneous T cell response to an immunogenic antigen expressed in leukemia cells. When the minimum numbers of leukemia-initiating cells for engraftment were transferred, leukemia cells were eradicated by the adaptive immune response in most, if not all, wild-type mice, but not in Rag2(-/-) recipient mice, which lack adaptive immunity. By contrast, mice transplanted with larger numbers of leukemia cells always developed leukemia. In mice with advanced leukemia, antigen-specific CTLs were also expanded, but were unresponsive to antigen stimulation and expressed high levels of PD-1 and LAG-3. These results provide the first clear demonstration that the spontaneous CTL response to a tumor-cell antigen has the potential to eradicate leukemia, whereas antigen-specific CTLs are exhausted in animals with advanced leukemia. This immunocompetent mouse leukemia model provides a useful platform for developing effective immunotherapies against leukemia.	[Hasegawa, Kana; Fujiki, Fumihiro; Nakajima, Hiroko; Oka, Yoshihiro] Osaka Univ, Dept Canc Immunol, Grad Sch Med, Suita, Osaka, Japan; [Hasegawa, Kana; Tanaka, Satomi; Morimoto, Soyoko; Tatsumi, Naoya; Sugiyama, Haruo] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka, Japan; [Nakata, Jun; Tsuboi, Akihiro] Osaka Univ, Dept Canc Immunotherapy, Grad Sch Med, Suita, Osaka, Japan; [Takashima, Satoshi; Nishida, Sumiyuki; Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, Dept Resp Med Allergy & Rheumat Dis, Grad Sch Med, Suita, Osaka, Japan; [Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, Dept Immunopathol, Immunol Frontier Res Ctr WP1, Suita, Osaka, Japan; [Oji, Yusuke; Hosen, Naoki] Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Hosen, N (corresponding author), Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka, Japan.	hnaoki@imed3.med.osaka-u.ac.jp		Nakata, Jun/0000-0002-7494-1204	Ministry of Education, Culture, Sports, Science and Technology of Japan [23130509]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (Grant 23130509) (to N.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bai AL, 2008, P NATL ACAD SCI USA, V105, P13003, DOI 10.1073/pnas.0805599105; Bocchia M, 1996, BLOOD, V87, P3587, DOI 10.1182/blood.V87.9.3587.bloodjournal8793587; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Chiba Y, 2010, JPN J CLIN ONCOL, V40, P395, DOI 10.1093/jjco/hyp196; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gao LQ, 2000, BLOOD, V95, P2198, DOI 10.1182/blood.V95.7.2198.007k38_2198_2203; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Greiner J, 2005, BLOOD, V106, P938, DOI 10.1182/blood-2004-12-4787; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hashii Y, 2012, LEUKEMIA, V26, P530, DOI 10.1038/leu.2011.226; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Keilholz U, 2009, BLOOD, V113, P6541, DOI 10.1182/blood-2009-02-202598; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Liu XV, 2012, J IMMUNOL, V189, P1826, DOI 10.4049/jimmunol.1200965; Lyman MA, 2004, J IMMUNOL, V172, P6558, DOI 10.4049/jimmunol.172.11.6558; Maeda T, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.29; Masaki A, 2013, J IMMUNOL, V191, P135, DOI 10.4049/jimmunol.1202692; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Molldrem JJ, 1997, BLOOD, V90, P2529, DOI 10.1182/blood.V90.7.2529.2529_2529_2534; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muller-Schmah C, 2012, ANN HEMATOL, V91, P27, DOI 10.1007/s00277-011-1332-y; Mumprecht S, 2009, BLOOD, V114, P1528, DOI 10.1182/blood-2008-09-179697; Nakata J, 2014, LEUKEMIA, V28, P1316, DOI 10.1038/leu.2013.374; Ohminami H, 2000, BLOOD, V95, P286; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rusakiewicz S, 2009, CANCER IMMUNOL IMMUN, V58, P1449, DOI 10.1007/s00262-009-0703-x; Sachs Z, 2014, BLOOD, V124, P3274, DOI 10.1182/blood-2013-08-521708; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Slany RK, 1998, MOL CELL BIOL, V18, P122, DOI 10.1128/MCB.18.1.122; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zhang L, 2013, J CLIN INVEST, V123, P1999, DOI 10.1172/JCI63980; Zhang L, 2009, BLOOD, V114, P1545, DOI 10.1182/blood-2009-03-206672	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144594	10.1371/journal.pone.0144594	http://dx.doi.org/10.1371/journal.pone.0144594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658107	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600061
J	Muelken, P; Schmidt, CE; Shelley, D; Tally, L; Harris, AC				Muelken, Peter; Schmidt, Clare E.; Shelley, David; Tally, Laura; Harris, Andrew C.			A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation	PLOS ONE			English	Article							BRAIN REWARD FUNCTION; REINFORCEMENT THRESHOLD; TOBACCO; SENSITIZATION; DEPENDENCE; RECEPTORS; EXPOSURE; NEUROBIOLOGY; TOLERANCE; ADDICTION	Avoidance of the negative affective (emotional) symptoms of nicotine withdrawal (e.g., anhedonia, anxiety) contributes to tobacco addiction. Establishing the minimal nicotine exposure conditions required to demonstrate negative affective withdrawal signs in animals, as well as understanding moderators of these conditions, could inform tobacco addiction-related research, treatment, and policy. The goal of this study was to determine the minimal duration of continuous nicotine infusion required to demonstrate nicotine withdrawal in rats as measured by elevations in intracranial self-stimulation (ICSS) thresholds (anhedonia-like behavior). Administration of the nicotinic acetylcholine receptor antagonist mecamylamine (3.0 mg/kg, s.c.) on alternate test days throughout the course of a 2-week continuous nicotine infusion (3.2 mg/kg/day via osmotic minipump) elicited elevations in ICSS thresholds beginning on the second day of infusion. Magnitude of antagonist-precipitated withdrawal did not change with further nicotine exposure and mecamylamine injections, and was similar to that observed in a positive control group receiving mecamylamine following a 14-day nicotine infusion. Expression of a significant withdrawal effect was delayed in nicotine-infused rats receiving mecamylamine on all test days rather than on alternate test days. In a separate study, rats exhibited a transient increase in ICSS thresholds following cessation of a 2-day continuous nicotine infusion (3.2 mg/kg/day). Magnitude of this spontaneous withdrawal effect was similar to that observed in rats receiving a 9-day nicotine infusion. Our findings demonstrate that rats exhibit antagonist-precipitated and spontaneous nicotine withdrawal following a 2-day continuous nicotine infusion, at least under the experimental conditions studied here. Magnitude of these effects were similar to those observed in traditional models involving more prolonged nicotine exposure. Further development of these models, including evaluation of more clinically relevant nicotine dosing regimens and other measures of nicotine withdrawal (e.g., anxiety-like behavior, somatic signs), may be useful for understanding the development of the nicotine withdrawal syndrome.	[Muelken, Peter; Schmidt, Clare E.; Shelley, David; Tally, Laura; Harris, Andrew C.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA; [Muelken, Peter] Univ Minnesota, Dept Ecol Evolut & Behav, Minneapolis, MN 55455 USA; [Schmidt, Clare E.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Harris, Andrew C.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Harris, Andrew C.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, AC (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA.	harr0547@umn.edu			Minneapolis Medical Research Foundation (MMRF) Translational Addiction Research Program [07639]	Minneapolis Medical Research Foundation (MMRF) Translational Addiction Research Program	This work was funded by Minneapolis Medical Research Foundation (MMRF) Translational Addiction Research Program, award #07639, awarded to A.C.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Balfour DJK, 2015, CURR TOP BEHAV NEURO, V24, P99, DOI 10.1007/978-3-319-13482-6_4; Benowitz NL, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.01.015; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; BLASIG J, 1973, PSYCHOPHARMACOLOGIA, V33, P19; Bruijnzeel AW, 2007, NEUROPSYCHOPHARMACOL, V32, P955, DOI 10.1038/sj.npp.1301192; Bruijnzeel AW, 2010, PSYCHOPHARMACOLOGY, V212, P485, DOI 10.1007/s00213-010-1970-0; Bruijnzeel AW, 2009, BIOL PSYCHIAT, V66, P110, DOI 10.1016/j.biopsych.2009.01.010; Carlezon WA, 2007, NAT PROTOC, V2, P2987, DOI 10.1038/nprot.2007.441; CARNEY RM, 1984, NEW ENGL J MED, V310, P614, DOI 10.1056/NEJM198403083101002; Cohen Ami, 2013, Front Psychiatry, V4, P41, DOI 10.3389/fpsyt.2013.00041; Craig EL, 2014, DRUG METAB DISPOS, V42, P1447, DOI 10.1124/dmd.114.058719; Cryan JF, 2003, PSYCHOPHARMACOLOGY, V168, P347, DOI 10.1007/s00213-003-1445-7; Damaj MI, 2003, J PHARMACOL EXP THER, V307, P526, DOI 10.1124/jpet.103.054908; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012138; Debruyne D, 2003, J PHARM SCI-US, V92, P1051, DOI 10.1002/jps.10302; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; DiFranza JR, 2007, NICOTINE TOB RES, V9, P9, DOI 10.1080/14622200601078277; DiFranza JR, 2012, BRAIN SCI, V2, P523, DOI 10.3390/brainsci2040523; DiFranza JR, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-26; DiFranza JR, 2005, NICOTINE TOB RES, V7, P9, DOI 10.1080/14622200412331328538; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Donny EC, 2012, NICOTINE TOB RES, V14, P1319, DOI 10.1093/ntr/nts162; Doubeni CA, 2010, PEDIATRICS, V125, P1127, DOI 10.1542/peds.2009-0238; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Etter JF, 2006, ADDICTION, V101, P362, DOI 10.1111/j.1360-0443.2005.01289.x; Fenster CP, 1999, J NEUROSCI, V19, P4804; Gould TJ, 2014, BRAIN RES, V1559, P1, DOI 10.1016/j.brainres.2014.02.038; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grebenstein P, 2013, PHARMACOL BIOCHEM BE, V114, P70, DOI 10.1016/j.pbb.2013.10.020; Grebenstein PE, 2015, DRUG ALCOHOL DEPEN, V151, P181, DOI 10.1016/j.drugalcdep.2015.03.030; Harris AC, 2005, PSYCHOPHARMACOLOGY, V178, P353, DOI 10.1007/s00213-005-2155-0; Harris AC, 2013, PSYCHOPHARMACOLOGY, V225, P291, DOI 10.1007/s00213-012-2814-x; Harris AC, 2011, PSYCHOPHARMACOLOGY, V217, P153, DOI 10.1007/s00213-011-2273-9; Harris AC, 2010, PHARMACOL BIOCHEM BE, V96, P217, DOI 10.1016/j.pbb.2010.05.008; Harrison AA, 2001, NEUROPSYCHOPHARMACOL, V25, P55, DOI 10.1016/S0893-133X(00)00237-2; Harrison AA, 2001, J PHARMACOL EXP THER, V297, P316; Hatsukami DK, 2013, NICOTINE TOB RES, V15, P1003, DOI 10.1093/ntr/nts214; Hatsukami DK, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.035584; Hilario MRF, 2012, NEUROPSYCHOPHARMACOL, V37, P2661, DOI 10.1038/npp.2012.130; Hughes JR, 2007, NICOTINE TOB RES, V9, P329, DOI 10.1080/14622200701188927; HUGHES JR, 1990, RES ADV ALCOHOL DRUG, V10, P317; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; HUSTONLYONS D, 1992, PHARMACOL BIOCHEM BE, V41, P755, DOI 10.1016/0091-3057(92)90223-3; Igari M, 2014, NEUROPSYCHOPHARMACOL, V39, P445, DOI 10.1038/npp.2013.216; Jackson KJ, 2015, NEUROPHARMACOLOGY, V96, P223, DOI 10.1016/j.neuropharm.2014.11.009; Johnson PM, 2008, PHARMACOL BIOCHEM BE, V90, P409, DOI 10.1016/j.pbb.2008.03.024; Kenny PJ, 2005, J NEUROSCI, V25, P6208, DOI 10.1523/JNEUROSCI.4785-04.2005; Kenny PJ, 2003, J PHARMACOL EXP THER, V306, P1068, DOI 10.1124/jpet.103.052027; Kenny PJ, 2001, PHARMACOL BIOCHEM BE, V70, P531, DOI 10.1016/S0091-3057(01)00651-7; Killen JD, 2003, ADDICT BEHAV, V28, P461, DOI 10.1016/S0306-4603(01)00266-0; Kirshenbaum A, 2015, PSYCHOPHARMACOLOGY, V232, P1583, DOI 10.1007/s00213-014-3792-y; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; LeSage MG, 2002, PHARMACOL BIOCHEM BE, V72, P279, DOI 10.1016/S0091-3057(01)00775-4; Littleton J, 2001, ADDICTION, V96, P87, DOI 10.1046/j.1360-0443.2001.961877.x; Liu JA, 2004, PHARMACOL BIOCHEM BE, V79, P101, DOI 10.1016/j.pbb.2004.06.006; Malin David H, 2009, Handb Exp Pharmacol, P401, DOI 10.1007/978-3-540-69248-5_14; Manbeck KE, 2014, PHARMACOL BIOCHEM BE, V116, P84, DOI 10.1016/j.pbb.2013.11.002; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; Markou A, 2008, PHILOS T R SOC B, V363, P3159, DOI 10.1098/rstb.2008.0095; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Marshall DL, 1997, J NEUROCHEM, V68, P1511; MORRISON CF, 1974, PSYCHOPHARMACOLOGIA, V38, P25, DOI 10.1007/BF00421284; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; Nguyen HN, 2004, J NEUROCHEM, V90, P40, DOI 10.1111/j.1471-4159.2004.02482.x; O'Dell LE, 2007, NEUROTOXICOL TERATOL, V29, P17, DOI 10.1016/j.ntt.2006.11.003; O'Dell LE, 2006, PSYCHOPHARMACOLOGY, V186, P612, DOI 10.1007/s00213-006-0383-6; O'Loughlin J, 2003, AM J PREV MED, V25, P219, DOI 10.1016/S0749-3797(03)00198-3; OCHOA ELM, 1990, MOL NEUROBIOL, V4, P251, DOI 10.1007/BF02780343; Overstreet DH, 2002, ALCOHOL CLIN EXP RES, V26, P1259, DOI 10.1097/01.ALC.0000023983.10615.D7; Paolini M, 2011, BIOCHEM PHARMACOL, V82, P996, DOI 10.1016/j.bcp.2011.07.075; Piasecki TM, 2003, J ABNORM PSYCHOL, V112, P14, DOI 10.1037/0021-843X.112.1.14; Roiko SA, 2009, PHARMACOL BIOCHEM BE, V93, P105, DOI 10.1016/j.pbb.2009.04.011; Samaha AN, 2005, BIOL PSYCHIAT, V57, P351, DOI 10.1016/j.biopsych.2004.11.040; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; Skjei KL, 2003, PSYCHOPHARMACOLOGY, V168, P280, DOI 10.1007/s00213-003-1414-1; Sofuoglu M, 2012, DRUG ALCOHOL DEPEN, V125, P1, DOI 10.1016/j.drugalcdep.2012.04.023; Sorge RE, 2009, J PHARMACOL EXP THER, V330, P633, DOI 10.1124/jpet.109.154641; Swan GE, 1996, ADDICT BEHAV, V21, P481, DOI 10.1016/0306-4603(95)00070-4; Vann RE, 2006, PSYCHOPHARMACOLOGY, V184, P482, DOI 10.1007/s00213-005-0037-0; Vieira-Brock PL, 2013, NICOTINE TOB RES, V15, P1839, DOI 10.1093/ntr/ntt067; Wang H, 2005, BRAIN RES REV, V48, P420, DOI 10.1016/j.brainresrev.2004.09.003; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Watkins SS, 2000, J PHARMACOL EXP THER, V292, P1053; Wileyto P, 2009, TOB CONTROL, V18, P387, DOI 10.1136/tc.2009.030189; Zeller M, 2009, TOB CONTROL, V18, P324, DOI 10.1136/tc.2008.027318	88	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144553	10.1371/journal.pone.0144553	http://dx.doi.org/10.1371/journal.pone.0144553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658557	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600057
J	Sater, MRA; Lamelas, A; Wang, GL; Clark, TA; Roltgen, K; Mane, S; Korlach, J; Pluschke, G; Schmid, CD				Sater, Mohamad R. Abdul; Lamelas, Araceli; Wang, Guilin; Clark, Tyson A.; Roeltgen, Katharina; Mane, Shrikant; Korlach, Jonas; Pluschke, Gerd; Schmid, Christoph D.			DNA Methylation Assessed by SMRT Sequencing Is Linked to Mutations in Neisseria meningitidis Isolates	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; SINGLE-MOLECULE; CYTOSINE METHYLATION; ESCHERICHIA-COLI; MISMATCH REPAIR; GENOME; EVOLUTION; GONORRHOEAE; MECHANISMS; RESOLUTION	The Gram-negative bacterium Neisseria meningitidis features extensive genetic variability. To present, proposed virulence genotypes are also detected in isolates from asymptomatic carriers, indicating more complex mechanisms underlying variable colonization modes of N. meningitidis. We applied the Single Molecule, Real-Time (SMRT) sequencing method from Pacific Biosciences to assess the genome-wide DNA modification profiles of two genetically related N. meningitidis strains, both of serogroup A. The resulting DNA methylomes revealed clear divergences, represented by the detection of shared and of strain-specific DNA methylation target motifs. The positional distribution of these methylated target sites within the genomic sequences displayed clear biases, which suggest a functional role of DNA methylation related to the regulation of genes. DNA methylation in N. meningitidis has a likely underestimated potential for variability, as evidenced by a careful analysis of the ORF status of a panel of confirmed and predicted DNA methyltransferase genes in an extended collection of N. meningitidis strains of serogroup A. Based on high coverage short sequence reads, we find phase variability as a major contributor to the variability in DNA methylation. Taking into account the phase variable loci, the inferred functional status of DNA methyltransferase genes matched the observed methylation profiles. Towards an elucidation of presently incompletely characterized functional consequences of DNA methylation in N. meningitidis, we reveal a prominent colocalization of methylated bases with Single Nucleotide Polymorphisms (SNPs) detected within our genomic sequence collection. As a novel observation we report increased mutability also at 6mA methylated nucleotides, complementing mutational hotspots previously described at 5mC methylated nucleotides. These findings suggest a more diverse role of DNA methylation and Restriction-Modification (RM) systems in the evolution of prokaryotic genomes.	[Sater, Mohamad R. Abdul; Lamelas, Araceli; Roeltgen, Katharina; Pluschke, Gerd; Schmid, Christoph D.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Sater, Mohamad R. Abdul; Lamelas, Araceli; Roeltgen, Katharina; Pluschke, Gerd; Schmid, Christoph D.] Univ Basel, Basel, Switzerland; [Wang, Guilin; Mane, Shrikant] Yale Univ, Yale Ctr Genom Anal, New Haven, CT USA; [Clark, Tyson A.; Korlach, Jonas] Pacif Biosci, Menlo Pk, CA USA; [Sater, Mohamad R. Abdul; Schmid, Christoph D.] SIB, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Yale University; Swiss Institute of Bioinformatics	Schmid, CD (corresponding author), Swiss Trop & Publ Hlth Inst, Socinstr 57, Basel, Switzerland.	Christoph.Schmid@unibas.ch	Cabello, Araceli Lamelas/Q-6726-2018; Cabello, Araceli Lamelas/AAC-6066-2019	Cabello, Araceli Lamelas/0000-0002-1939-5642; Cabello, Araceli Lamelas/0000-0002-1939-5642; Clark, Tyson/0000-0002-7779-3227; Sater, Mohamad/0000-0003-1912-0590	Forschungsfonds of the University of Basel [DZX2056]; Pacific Biosciences	Forschungsfonds of the University of Basel; Pacific Biosciences	This work was supported by the Forschungsfonds of the University of Basel (grant "DZX2056" to CS). Additional support in the form of salaries for authors (TC and JK are employees of Pacific Biosciences), and contributions of reagents and materials (GW and MS from the Yale Center for Genomic Analysis). The funders did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambur OH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039742; Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Bart A, 2001, INFECT IMMUN, V69, P1816, DOI 10.1128/IAI.69.3.1816-1820.2001; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Clark TA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-4; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Claus H, 2000, J BACTERIOL, V182, P1296, DOI 10.1128/JB.182.5.1296-1303.2000; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Feng ZX, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002935; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Furuta Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004272; Gawthorne JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032337; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Ishikawa K, 2010, DNA RES, V17, P325, DOI 10.1093/dnares/dsq027; Jen FEC, 2014, ANTIMICROB AGENTS CH, V58, P4219, DOI 10.1128/AAC.00004-14; Jolley KA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-34; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; Kozdon JB, 2013, P NATL ACAD SCI USA, V110, pE4658, DOI 10.1073/pnas.1319315110; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kwiatek A, 2010, J BACTERIOL, V192, P3951, DOI 10.1128/JB.00098-10; Lamelas A, 2014, MBIO, V5, DOI 10.1128/mBio.01974-14; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Maiden MCJ, 2013, CLIN INFECT DIS, V56, P364, DOI 10.1093/cid/cis896; Maiden MCJ, 2008, CURR OPIN MICROBIOL, V11, P467, DOI 10.1016/j.mib.2008.09.002; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Molina N, 2008, GENOME RES, V18, P148, DOI 10.1101/gr.6759507; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Powers JG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-675; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; RITCHOT N, 1990, GENE, V86, P103, DOI 10.1016/0378-1119(90)90120-G; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Schadt EE, 2013, GENOME RES, V23, P129, DOI 10.1101/gr.136739.111; Schoen C, 2011, J BACTERIOL, V193, P2064, DOI 10.1128/JB.00084-11; Seib KL, 2015, NUCLEIC ACIDS RES, V43, P4150, DOI 10.1093/nar/gkv219; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Trivedi K, 2011, TRENDS MICROBIOL, V19, P456, DOI 10.1016/j.tim.2011.06.006; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283	62	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144612	10.1371/journal.pone.0144612	http://dx.doi.org/10.1371/journal.pone.0144612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656597	gold, Green Accepted, Green Published			2022-12-26	WOS:000366903600068
J	Trevisanuto, D; Bertuola, F; Lanzoni, P; Cavallin, F; Matediana, E; Manzungu, OW; Gomez, E; Da Dalt, L; Putoto, G				Trevisanuto, Daniele; Bertuola, Federica; Lanzoni, Paolo; Cavallin, Francesco; Matediana, Eduardo; Manzungu, Olivier Wingi; Gomez, Ermelinda; Da Dalt, Liviana; Putoto, Giovanni			Effect of a Neonatal Resuscitation Course on Healthcare Providers' Performances Assessed by Video Recording in a Low-Resource Setting	PLOS ONE			English	Article							MORTALITY; BIRTH	Background We assessed the effect of an adapted neonatal resuscitation program (NRP) course on healthcare providers' performances in a low-resource setting through the use of video recording. Methods A video recorder, mounted to the radiant warmers in the delivery rooms at Beira Central Hospital, Mozambique, was used to record all resuscitations. One-hundred resuscitations (50 before and 50 after participation in an adapted NRP course) were collected and assessed based on a previously published score. Results All 100 neonates received initial steps; from these, 77 and 32 needed bag-mask ventilation (BMV) and chest compressions (CC), respectively. There was a significant improvement in resuscitation scores in all levels of resuscitation from before to after the course: for "initial steps", the score increased from 33% (IQR 28-39) to 44% (IQR 39-56), p<0.0001; for BMV, from 20% (20-40) to 40% (40-60), p = 0.001; and for CC, from 0% (0-10) to 20% (0-50), p = 0.01. Times of resuscitative interventions after the course were improved in comparison to those obtained before the course, but remained non-compliant with the recommended algorithm. Conclusions Although resuscitations remained below the recommended standards in terms of quality and time of execution, clinical practice of healthcare providers improved after participation in an adapted NRP course. Video recording was well-accepted by the staff, useful for objective assessment of performance during resuscitation, and can be used as an educational tool in a low-resource setting.	[Trevisanuto, Daniele; Bertuola, Federica; Da Dalt, Liviana] Univ Padua, Sch Med, Dept Women & Children Hlth, Azienda Osped Padova, Padua, Italy; [Lanzoni, Paolo; Putoto, Giovanni] Doctors Africa CUAMM, Padua, Italy; [Matediana, Eduardo] Beira Cent Hosp, Dept Obstet & Gynecol, Beira, Mozambique; [Manzungu, Olivier Wingi; Gomez, Ermelinda] Beira Cent Hosp, Dept Pediat, Beira, Mozambique	University of Padua; Azienda Ospedaliera - Universita di Padova	Trevisanuto, D (corresponding author), Univ Padua, Sch Med, Dept Women & Children Hlth, Azienda Osped Padova, Padua, Italy.	trevo@pediatria.unipd.it	Putoto, Giovanni/ABG-2069-2020; van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881	Associazione Pulcino, Italy	Associazione Pulcino, Italy	Associazione Pulcino, Italy supported the study providing funds for video cameras. The funders had no role in the study design or conduct; the management, analysis, or interpretation of the data; the preparation, review, or approval of the report; or the decision to submit the manuscript for publication.	American Heart Association American Academy of Pediatrics, 2011, NEON RES TXB; Brugada M, 2011, NEONATOLOGY, V100, P99, DOI 10.1159/000322009; Carbine DN, 2000, PEDIATRICS, V106, P654, DOI 10.1542/peds.106.4.654; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Ersdal HL, 2012, PEDIATRICS, V129, pE1238, DOI 10.1542/peds.2011-3134; Jabbour M, 1996, ANN EMERG MED, V28, P690, DOI 10.1016/S0196-0644(96)70095-1; Kattwinkel J, 2010, PEDIATRICS, V126, pE1400, DOI 10.1542/peds.2010-2972E; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McCarthy LK, 2013, J PEDIATR-US, V163, P1553, DOI 10.1016/j.jpeds.2013.06.007; O'Donnell CPF, 2008, ARCH DIS CHILD-FETAL, V93, pF82, DOI 10.1136/adc.2007.118505; Opiyo N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001599; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Singhal N, 2012, RESUSCITATION, V83, P90, DOI 10.1016/j.resuscitation.2011.07.010; Trevisanuto D, 2007, PEDIATR ANESTH, V17, P28, DOI 10.1111/j.1460-9592.2006.02001.x; UNICEF, 2017, LEVELS TRENDS CHILD; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; WHO, 2014, HLTH REL MILL DEV GO; World Health Organization,, 2012, GUID BAS NEWB RES; Xu T, 2014, RESUSCITATION, V85, P253, DOI 10.1016/j.resuscitation.2013.10.020	24	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144443	10.1371/journal.pone.0144443	http://dx.doi.org/10.1371/journal.pone.0144443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659661	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600047
J	Uys, P; Brand, H; Warren, R; van der Spuy, G; Hoal, EG; van Helden, PD				Uys, Pieter; Brand, Hilmarie; Warren, Robin; van der Spuy, Gian; Hoal, Eileen G.; van Helden, Paul D.			The Risk of Tuberculosis Reinfection Soon after Cure of a First Disease Episode Is Extremely High in a Hyperendemic Community	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SUSCEPTIBILITY; TRANSMISSION; INFECTION	Elevated rates of reinfection tuberculosis in various hyperendemic regions have been reported and, in particular, it has been shown that in a high-incidence setting near Cape Town, South Africa, the rate of reinfection tuberculosis (TB) disease after cure of a previous TB disease episode is about four times greater than the rate of first-time TB disease. It is not known whether this elevated rate is caused by a high reinfection rate due, for instance, to living circumstances, or a high rate of progress to disease specific to the patients, or both. In order to address that question we analysed an extensive data set from clinics attended by TB patients in the high-incidence setting near Cape Town, South Africa and found that, in fact, the (average) rate of reinfection (as opposed to the rate of reinfection disease) after cure of a previous TB disease episode is initially about 0.85 per annum. This rate diminishes rapidly over time and after about ten years this rate is similar to the rate of infection in the general population. Also, the rate of progress to disease after reinfection is initially high but declines in subsequent years down to the figure typical for the general population. These findings suggest that the first few months after cure of a TB disease episode form a critical period for controlling reinfection disease in a hyperendemic setting and that monitoring such cured patients could pre-empt a reinfection progressing to active disease.	[Uys, Pieter; Brand, Hilmarie] Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, SACEMA, ZA-7600 Stellenbosch, Western Cape, South Africa; [Uys, Pieter; Warren, Robin; van der Spuy, Gian; Hoal, Eileen G.; van Helden, Paul D.] Univ Stellenbosch, Fac Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, ZA-7600 Stellenbosch, Western Cape, South Africa	National Research Foundation - South Africa; Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University	Uys, P (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, SACEMA, ZA-7600 Stellenbosch, Western Cape, South Africa.	pieter@edserve.co.za	van der Spuy, Gian/AAY-7701-2020	van der Spuy, Gian/0000-0002-9067-5903; Warren, Robin/0000-0001-5741-7358				Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cobat A, 2015, J INFECT DIS, V211, P317, DOI 10.1093/infdis/jiu446; Cobat A, 2010, J INFECT DIS, V201, P15, DOI 10.1086/648611; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Daya M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1021; Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012; Gomes MGM, 2012, P ROY SOC B-BIOL SCI, V279, P2473, DOI 10.1098/rspb.2011.2712; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI, DOI [10.1002/9781118032985, DOI 10.1002/9781118032985]; Klein JP, 2003, SURVIVAL ANAL; Kumar D, 2011, MICROBES INFECT, V13, P121, DOI 10.1016/j.micinf.2010.10.009; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Rodrigues P, 2009, J THEOR BIOL, V259, P280, DOI 10.1016/j.jtbi.2009.03.013; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Salie M, 2015, TUBERCULOSIS, V95, P817, DOI 10.1016/j.tube.2015.09.003; Salie M, 2014, J INFECT DIS, V209, P216, DOI 10.1093/infdis/jit443; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Shen G, 2006, EMERG INFECT DIS; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; Uys P, 2011, CLIN INFECT DIS, V52, P1399, DOI 10.1093/cid/cir229; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144487	10.1371/journal.pone.0144487	http://dx.doi.org/10.1371/journal.pone.0144487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649422	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300050
J	Yadesa, TM; Gudina, EK; Angamo, MT				Yadesa, Tadele Mekuriya; Gudina, Esayas Kebede; Angamo, Mulugeta Tarekegn			Antimicrobial Use-Related Problems and Predictors among Hospitalized Medical In-Patients in Southwest Ethiopia: Prospective Observational Study	PLOS ONE			English	Article							ICU	Background The spread of antimicrobial resistance in developing countries is associated with complex and interconnected factors, such as excessive and unnecessary prescribing of antimicrobials, increased self-prescribing by the people and poor quality of available antimicrobials. Moreover, the failure to implement infection control practices and the dearth of routine susceptibility testing and surveillance magnify the problems. This may spread the inappropriateness of prescribing, ending up with the spread of antimicrobial resistance. Objective The aim of this study was to assess antimicrobial use related problems and associated factors among patients admitted at Jimma University specialized hospital. Methods A hospital based prospective observational study design was employed at medical wards of Jimma University specialized hospital, Ethiopia. Data collected from patient medication charts and from the patients was analyzed using SPSS, version 16.0. Logistic regression was used to determine the associations between variables. Statistical significance was considered at p-value <0.05. Results Out of 152 study participants, at least one antimicrobial use problem was identified among 115(75.7%). Accordingly, additional antimicrobials were needed by 45(29.6%) of the patients, whereas they were unnecessary among 44(28.9%). Similarly, 17% of the patients were noncompliant to at least one antimicrobial therapy, while 8.6% experienced at least one type of adverse drug reaction. On the other hand, the coverage of the infectious medical condition in the national guidelines (AOR = 4.888) and the duration of hospital stay (AOR = 3.086) were the determinants of the antimicrobial use problems. Conclusion Most of the antimicrobial use problems identified were related to delay of initiation of effective antimicrobials and excessive use; use without indication or using duplicates of broad spectrum antimicrobials or use for longer duration than recommended. The coverage of the infectious medical condition in the national treatment guidelines and the duration of hospital stay were the determinants of the antimicrobial use problems.	[Yadesa, Tadele Mekuriya; Angamo, Mulugeta Tarekegn] Jimma Univ, Dept Pharm, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Gudina, Esayas Kebede] Jimma Univ, Dept Internal Med, Coll Publ Hlth & Med Sci, Jimma, Ethiopia	Jimma University; Jimma University	Yadesa, TM (corresponding author), Jimma Univ, Dept Pharm, Coll Publ Hlth & Med Sci, Jimma, Ethiopia.	maatiikoo4@gmail.com	Mekuriya Yadesa, Tadele/GWQ-3954-2022; Gudina, Esayas Kebede/U-9370-2019; Angamo, Mulugeta/O-9568-2014; Gudina, Esayas Kebede/AAX-2374-2020	Gudina, Esayas Kebede/0000-0002-6264-9695; Angamo, Mulugeta/0000-0002-8604-6258; Gudina, Esayas Kebede/0000-0002-6264-9695; YADESA, TADELE/0000-0001-5151-2610	Jimma University	Jimma University	Jimma University funded the research as staff research.	Agalu A, 2011, J MULTIDISCIP HEALTH, V4, P377, DOI 10.2147/JMDH.S24671; Aryanti R, 2002, CHILD HLTH RES PROJE, V4, P5; Azza MH, 2011, INT J INFECT CONTROL, V7; Baktygul K, 2011, NAGOYA J MED SCI, V73, P157; Banja WD, 2007, ANTIBIOTIC USE 2 HOS, P33; Bergmans DCJJ, 1997, J ANTIMICROB CHEMOTH, V39, P527, DOI 10.1093/jac/39.4.527; Canton R, 2013, ENFERM INFEC MICR CL, V31, P1, DOI [10.1016/j.eimc.2012.08.007, 10.1016/S0213-005X(13)70126-5]; Ceyhan M, 2010, INT J INFECT DIS, V14, pE55, DOI 10.1016/j.ijid.2009.03.013; Cipolle RJ, 2007, PHARM CARE PRACTICES; Dagnew Mulat, 2013, BMC Res Notes, V6, P283, DOI 10.1186/1756-0500-6-283; Estela L, 2007, REV SAUDE PUBLICA, V41; Haq E, 2010, JUMDC, V1, P1; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Imai-Kamata S, 2011, INT J QUAL HEALTH C, V23, P167, DOI 10.1093/intqhc/mzq080; John PB, 2001, CLIN INFECT DIS   S2, V33, pS78; Martin C, 2011, IMPLEMENTING ANTIMIC, P2; Singh N, 2000, CHEST, V117, P1496, DOI 10.1378/chest.117.5.1496; Suttajit Siritree, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P489; Toubes E, 2003, CLIN INFECT DIS, V36, P724, DOI 10.1086/368081; van der Velden LBJ, 2012, EUR J CLIN MICROBIOL, V31, P1561, DOI 10.1007/s10096-011-1478-5; Vlahovic-Palcevski V, 2007, CLIN MICROBIOL INFEC, V13, P277, DOI 10.1111/j.1469-0691.2006.01613.x; Werner NL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-187	22	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0138385	10.1371/journal.pone.0138385	http://dx.doi.org/10.1371/journal.pone.0138385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649431	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300002
J	Kuo, YT; Shih, PH; Kao, SH; Yeh, GC; Lee, HM				Kuo, Yung-Ting; Shih, Ping-Hsiao; Kao, Shu-Huei; Yeh, Geng-Chang; Lee, Horng-Mo			Pyrroloquinoline Quinone Resists Denervation-Induced Skeletal Muscle Atrophy by Activating PGC-1 alpha and Integrating Mitochondrial Electron Transport Chain Complexes	PLOS ONE			English	Article							TIME-COURSE; FIBER TYPES; APOPTOSIS; RECEPTOR; METABOLISM; MECHANISMS; EXPRESSION; SOLEUS; DISUSE	Denervation-mediated skeletal muscle atrophy results from the loss of electric stimulation and leads to protein degradation, which is critically regulated by the well-confirmed transcriptional co-activator peroxisome proliferator co-activator 1 alpha (PGC-1 alpha). No adequate treatments of muscle wasting are available. Pyrroloquinoline quinone (PQQ), a naturally occurring antioxidant component with multiple functions including mitochondrial modulation, demonstrates the ability to protect against muscle dysfunction. However, it remains unclear whether PQQ enhances PGC-1 alpha activation and resists skeletal muscle atrophy in mice subjected to a denervation operation. This work investigates the expression of PGC-1 alpha and mitochondrial function in the skeletal muscle of denervated mice administered PQQ. The C57BL6/J mouse was subjected to a hindlimb sciatic axotomy. A PQQ-containing ALZET (R) osmotic pump (equivalent to 4.5 mg/day/kg b.w.) was implanted subcutaneously into the right lower abdomen of the mouse. In the time course study, the mouse was sacrificed and the gastrocnemius muscle was prepared for further myopathological staining, energy metabolism analysis, western blotting, and real-time quantitative PCR studies. We observed that PQQ administration abolished the denervation-induced decrease in muscle mass and reduced mitochondrial activities, as evidenced by the reduced fiber size and the decreased expression of cytochrome c oxidase and NADH-tetrazolium reductase. Bioenergetic analysis demonstrated that PQQ reprogrammed the denervation-induced increase in the mitochondrial oxygen consumption rate (OCR) and led to an increase in the extracellular acidification rate (ECAR), a measurement of the glycolytic metabolism. The protein levels of PGC-1 alpha and the electron transport chain (ETC) complexes were also increased by treatment with PQQ. Furthermore, PQQ administration highly enhanced the expression of oxidative fibers and maintained the type II glycolytic fibers. This pre-clinical in vivo study suggests that PQQ may provide a potent therapeutic benefit for the treatment of denervation-induced atrophy by activating PGC-1 alpha and maintaining the mitochondrial ETC complex in skeletal muscles.	[Kuo, Yung-Ting; Yeh, Geng-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Kuo, Yung-Ting; Shih, Ping-Hsiao; Yeh, Geng-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Kuo, Yung-Ting] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Taipei, Taiwan; [Kao, Shu-Huei; Lee, Horng-Mo] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Lee, HM (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.	leehorng@tmu.edu.tw	Shih, Ping-Hsiao/GPG-2472-2022	Shih, Ping-Hsiao/0000-0002-8387-105X; KUO, Yung-Ting/0000-0002-4579-9421; Kao, Shu-Huei/0000-0003-4618-0898	Taipei Medical University [TMU101-AE3-Y08]	Taipei Medical University	The authors received funding from Taipei Medical University (TMU101-AE3-Y08).	ADAMS L, 1995, J CELL BIOL, V131, P1341, DOI 10.1083/jcb.131.5.1341; Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Ashley Z, 2007, AM J PHYSIOL-CELL PH, V292, pC440, DOI 10.1152/ajpcell.00085.2006; Bauerly K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021779; Borisov AB, 2000, ANAT RECORD, V258, P305; Borisov AB, 2000, ANAT REC, V258, P292; Callahan ZJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12359; Carraro U, 2015, EUR J TRANSL MYOL, V25, P77, DOI 10.4081/ejtm.2015.4832; Chen CN, 2015, AM J PHYSIOL-ENDOC M, V308, pE942, DOI 10.1152/ajpendo.00508.2014; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; dAlbis A, 1995, BIOL CELL, V85, P9, DOI 10.1016/0248-4900(96)89123-4; Danon MJ, 2007, CLIN BIOCHEM, V40, P46, DOI 10.1016/j.clinbiochem.2006.09.002; Degens H, 2008, APPL PHYSIOL NUTR ME, V33, P299, DOI 10.1139/H07-189; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Dubowitz V, 2006, NEUROMUSCULAR DISORD, V16, P865, DOI 10.1016/j.nmd.2006.09.003; Dutt V, 2015, PHARMACOL RES, V99, P86, DOI 10.1016/j.phrs.2015.05.010; Gong DZ, 2012, EUR J PHARMACOL, V697, P53, DOI 10.1016/j.ejphar.2012.09.052; Guerfali I, 2007, PFLUG ARCH EUR J PHY, V454, P297, DOI 10.1007/s00424-007-0206-6; Gullapalli R, 2012, DRUG DELIV, V19, P239, DOI 10.3109/10717544.2012.691121; Hara H, 2007, NEUROCHEM RES, V32, P489, DOI 10.1007/s11064-006-9257-x; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Hawkins JL, 2015, NEUROSCIENCE, V290, P115, DOI 10.1016/j.neuroscience.2015.01.034; Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Midrio M, 2006, EUR J APPL PHYSIOL, V98, P1, DOI 10.1007/s00421-006-0256-z; Min ZH, 2014, J CANCER, V5, P609, DOI 10.7150/jca.9002; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Singh K, 2011, AM J PHYSIOL-CELL PH, V300, pC138, DOI 10.1152/ajpcell.00181.2010; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Vainshtein A, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0033-y; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Yang LJ, 2015, EUR SPINE J, V24, P1702, DOI 10.1007/s00586-014-3630-2	39	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143600	10.1371/journal.pone.0143600	http://dx.doi.org/10.1371/journal.pone.0143600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646764	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903100004
J	Li, L; Li, CY; Pan, P; Chen, XL; Wu, XK; Ng, EHY; Yang, DZ				Li, Lin; Li, Chengyan; Pan, Ping; Chen, Xiaoli; Wu, Xiaoke; Ng, Ernest Hung Yu; Yang, Dongzi			A Single Arm Pilot Study of Effects of Berberine on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese Women with Polycystic Ovary Syndrome	PLOS ONE			English	Article							GLUCOSE-METABOLISM; METFORMIN; CLOMIPHENE; INDUCTION; TRIAL	Objective To evaluate the effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome. Methods Berberine 0.4 g three times per day was given for four months to 102 anovulatory Chinese women with polycystic ovary syndrome. The menstrual pattern, ovulation rate, hormonal and metabolic profiles were compared before and after the berberine treatment. Ovulation was confirmed by serum progesterone level >= 10ng/ml. Results A total of 98 of 102 subjects (96.1%) completed the four month treatment, including 69 (70.4%, 69/98) normal weight and 29 (29.6%, 29/98) overweight/obese. Fourteen women (14.3%, 14/98) had regained regular menses after berberine treatment and there was no significant difference between normal weight and overweight/obese groups. The ovulation rate was 25.0% over four months in the whole group, 22.5% in the normal weight group and 31.0% in the overweight/obese group. Sex hormone binding globulin, insulin resistance, total cholesterol, total triglyceride and low-density lipoprotein cholesterol decreased after berberine treatment in the normal weight group only. Conclusions Our study found that administration of berberine alone may improve the menstrual pattern and ovulation rate in anovulatory Chinese women with polycystic ovary syndrome. Berberine can also decrease sex hormone binding globulin, insulin resistance, total cholesterol, triglycerides and low-density lipoprotein cholesterol in normal weight polycystic ovary syndrome women.	[Li, Lin; Li, Chengyan; Pan, Ping; Chen, Xiaoli; Yang, Dongzi] Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Li, Chengyan] Guangdong Med Coll, Dept Obstetr & Gynecol, Affiliated Hosp, Zhanjiang, Peoples R China; [Wu, Xiaoke] Heilongjiang Univ Chinese Med, Dept Obstet & Gynecol, Affiliated Hosp 1, Harbin, Peoples R China; [Ng, Ernest Hung Yu] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Heilongjiang University of Chinese Medicine; University of Hong Kong	Yang, DZ (corresponding author), Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	yangdz@mail.sysu.edu.cn	Li, Chengyan/AAS-4540-2021	Ng, Ernest/0000-0002-7688-4557	Natural Science Foundation of Research Project of Guangdong Province [2014A030313011]; National Natural Science Foundation of China [81370680]; specialized National Natural Science Foundation of China (popular science) [81320004]; specialized research fund for the doctoral program of Chinese Ministry of Education [20130171130009]; Natural Science Foundation of Key Research Project of Guangdong Province [2013020012660]	Natural Science Foundation of Research Project of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); specialized National Natural Science Foundation of China (popular science)(National Natural Science Foundation of China (NSFC)); specialized research fund for the doctoral program of Chinese Ministry of Education; Natural Science Foundation of Key Research Project of Guangdong Province	This study was supported by the Natural Science Foundation of Research Project of Guangdong Province, No. 2014A030313011. The grant receipt is Lin Li. This study was also supported by Grant No. 81370680 from the National Natural Science Foundation of China, Grant No. 81320004 from the specialized National Natural Science Foundation of China (popular science), Grant No. 20130171130009 from the specialized research fund for the doctoral program of Chinese Ministry of Education, Grant No. 2013020012660 from the Natural Science Foundation of Key Research Project of Guangdong Province. All fundings are contributed to Dongzi Yang.	An Y, 2014, CLIN ENDOCRINOL, V80, P425, DOI 10.1111/cen.12294; Angioni S, 2008, OBSTET GYNECOL SURV, V63, P796, DOI 10.1097/OGX.0b013e3181895a06; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Bridger T, 2006, ARCH PEDIAT ADOL MED, V160, P241, DOI 10.1001/archpedi.160.3.241; Chen XL, 2006, HUM REPROD, V21, P2027, DOI 10.1093/humrep/del142; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gu Y, 2010, TALANTA, V81, P766, DOI 10.1016/j.talanta.2010.01.015; Ko BS, 2005, BIOL PHARM BULL, V28, P1431, DOI 10.1248/bpb.28.1431; Ladson G, 2011, FERTIL STERIL, V95, P1059, DOI 10.1016/j.fertnstert.2010.12.002; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Li Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003934; MATHUR RS, 1981, FERTIL STERIL, V35, P29; Mohiyiddeen L, 2013, J OBSTET GYNAECOL, V33, P165, DOI 10.3109/01443615.2012.745839; Ni YX, 1998, ZHONG XI YI JIE HE Z, V8, P711; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P4068, DOI 10.1210/jc.2005-0110; Pan GY, 2003, PLANTA MED, V69, P632, DOI 10.1055/s-2003-41121; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Wei W, 2012, EUR J ENDOCRINOL, V166, P99, DOI 10.1530/EJE-11-0616; World Health Organization, 2000, RIGH HLTH IND AIR ST, P15; Xie P., 2005, CHINESE J CLIN HEALT, V8, P402; Yin J, 2002, METABOLISM, V51, P1439, DOI 10.1053/meta.2002.34715; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Zain MM, 2009, FERTIL STERIL, V91, P514, DOI 10.1016/j.fertnstert.2007.12.002; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhao XM, 2011, FERTIL STERIL, V96, P792, DOI 10.1016/j.fertnstert.2011.06.040; Zhou LB, 2007, METABOLISM, V56, P405, DOI 10.1016/j.metabol.2006.10.025	26	16	20	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144072	10.1371/journal.pone.0144072	http://dx.doi.org/10.1371/journal.pone.0144072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645811	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903100013
J	Shang, XS; Ding, YH; Wang, YH; Yang, LF				Shang, Xiaosen; Ding, Yunhong; Wang, Yonghui; Yang, Lifeng			Rheological and Performance Research on a Regenerable Polyvinyl Alcohol Fracturing Fluid	PLOS ONE			English	Article							GUM	A regenerable polyvinyl alcohol/organic boron fracturing fluid system with 1.6 wt% polyvinyl alcohol (PVOH) and 1.2 wt% organic boron (OBT) was studied, and its main regeneration mechanism is the reversible cross-linking reaction between B(OH)(4)(-) and hydroxyl groups of PVOH as the change of pH. Results of rheology evaluations show that both the apparent viscosity and the thermal stability of the fracturing fluid decreased with the regeneration number of times increasing. In addition, the apparent viscosity of the fluid which was without regeneration was more sensitive to the shear action compared with that of the fluid with regeneration once or twice. When the fracturing fluid was without regeneration, the elasticity was dominating due to the three-dimensional network structure of the formed gel; the viscosity gradually occupied the advantage when the fracturing fluid was regenerated once or twice. The settling velocity of proppant was accelerated by both the regeneration process and the increasing temperature, but it was decelerated when the proppant ratio increased. Results of core damage tests indicate that less permeability damage was caused by the PVOH/OBT fracturing fluid compared with that caused by the guar gum fracturing fluid after gel breaking.	[Shang, Xiaosen; Ding, Yunhong; Wang, Yonghui; Yang, Lifeng] PetroChina Res Inst Petr Explorat & Dev Langfang, Langfang 065007, Hebei, Peoples R China; [Shang, Xiaosen] PetroChina Res Inst Petr Explorat & Dev, Beijing 100083, Peoples R China	China National Petroleum Corporation; China National Petroleum Corporation	Shang, XS (corresponding author), PetroChina Res Inst Petr Explorat & Dev Langfang, Langfang 065007, Hebei, Peoples R China.	shangxs2015@163.com			National Science and Technology Major Project of China [2011ZX05013-003]; Key Laboratory of Reservoir Simulation of China National Petroleum Corporation (CNPC)	National Science and Technology Major Project of China; Key Laboratory of Reservoir Simulation of China National Petroleum Corporation (CNPC)	This work was supported by the National Science and Technology Major Project of China (Grant No. 2011ZX05013-003) and The Key Laboratory of Reservoir Simulation of China National Petroleum Corporation (CNPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brannon HD, 1996, P SPE ANN TECHN C EX; Carlos B, 2010, FOOD HYDROCOLLOID, V24, P783; Chindam C, 2014, MATER LETT, V116, P296, DOI 10.1016/j.matlet.2013.11.054; Dantas TNC, 2005, J DISPER SCI TECHNOL, V26, P1, DOI 10.1081/DIS-200040161; Ganguly S, 2002, SPE J, V7, P309, DOI 10.2118/79402-PA; [郭建春 Guo Jianchun], 2012, [石油学报, Acta Petrolei Sinica], V33, P1018; Hou XQ, 2013, PETROL EXPLOR DEV+, V40, P646, DOI 10.1016/S1876-3804(13)60085-3; Johannes K, 2012, PETROLEUM ENG GUIDE; Khair EMM, 2011, J PETROL SCI ENG, V78, P131, DOI 10.1016/j.petrol.2011.05.011; Li A, 2014, P SPE LAT AM CAR PET; Li L, 2015, CHINA ADHESIVE, V24, P19; Li ZM, 2005, POLYMER, V46, P5358, DOI 10.1016/j.polymer.2005.04.016; [刘平礼 Liu Pingli], 2014, [油田化学, Oilfield Chemistry], V31, P334; Lu H, 2014, PETROL SCI TECHNOL, V32, P1233, DOI 10.1080/10916466.2011.649098; Lu Y, 1999, P SPE INT S OILF CHE; Lukocs B., 2007, US Patent Application, Patent No. 20070173413; Luo XR, 2014, J PETROL SCI ENG, V120, P154, DOI 10.1016/j.petrol.2014.06.009; Luyster MR, 2000, P SPE INT S FORM DAM; Maitland GC, 2000, CURR OPIN COLLOID IN, V5, P301, DOI 10.1016/S1359-0294(00)00069-8; Maleki MR, 2012, J PETROL SCI ENG, V92-93, P158, DOI 10.1016/j.petrol.2012.06.011; Medina-Torres L, 2000, FOOD HYDROCOLLOID, V14, P417, DOI 10.1016/S0268-005X(00)00015-1; Peressini D, 2015, FOOD HYDROCOLLOID, V43, P73, DOI 10.1016/j.foodhyd.2014.04.036; Samuel M., 2000, P SPE ROCK MOUNT REG; Sun H., 2011, P SPE INT S OILF CHE; Tang HB, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40489; Vargas-Vasquez SM, 2009, PETROL SCI TECHNOL, V27, P1727, DOI 10.1080/10916460802611564; Wang L, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0088-6; Williams NJ, 2012, P INT PETR TECHN C F; [薛小佳 Xue XiaoJia], 2012, [油田化学, Oilfield Chemistry], V29, P415; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082651	30	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144449	10.1371/journal.pone.0144449	http://dx.doi.org/10.1371/journal.pone.0144449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641857	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700124
J	Adhikary, S; Sanyal, S; Basu, M; Sengupta, I; Sen, S; Srivastava, DK; Roy, S; Das, C				Adhikary, Santanu; Sanyal, Sulagna; Basu, Moitri; Sengupta, Isha; Sen, Sabyasachi; Srivastava, Dushyant Kumar; Roy, Siddhartha; Das, Chandrima			Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; HISTONE MODIFICATIONS; METHYLATION STATES; H4K16 ACETYLATION; LYSINE 36; PROTEIN; DEACETYLASE; EXPRESSION; NURD; DIFFERENTIATION	ZMYND8 (zinc finger MYND (Myeloid, Nervy and DEAF-1)-type containing 8), a newly identified component of the transcriptional coregulator network, was found to interact with the Nucleosome Remodeling and Deacetylase (NuRD) complex. Previous reports have shown that ZMYND8 is instrumental in recruiting the NuRD complex to damaged chromatin for repressing transcription and promoting double strand break repair by homologous recombination. However, the mode of transcription regulation by ZMYND8 has remained elusive. Here, we report that through its specific key residues present in its conserved chromatin-binding modules, ZMYND8 interacts with the selective epigenetic marks H3.1K36Me2/H4K16Ac. Furthermore, ZMYND8 shows a clear preference for canonical histone H3.1 over variant H3.3. Interestingly, ZMYND8 was found to be recruited to several developmental genes, including the all-trans-retinoic acid (ATRA)responsive ones, through its modified histone-binding ability. Being itself inducible by ATRA, this zinc finger transcription factor is involved in modulating other ATRA-inducible genes. We found that ZMYND8 interacts with transcription initiation-competent RNA polymerase II phosphorylated at Ser-5 in a DNA template-dependent manner and can alter the global gene transcription. Overall, our study identifies that ZMYND8 has CHD4-independent functions in regulating gene expression through its modified histone-binding ability.	[Adhikary, Santanu; Sanyal, Sulagna; Basu, Moitri; Sengupta, Isha; Sen, Sabyasachi; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India; [Adhikary, Santanu; Srivastava, Dushyant Kumar; Roy, Siddhartha] Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Saha Institute of Nuclear Physics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.; Roy, S (corresponding author), Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	roysiddhartha@iicb.res.in; chandrima.das@saha.ac.in	Das, Chandrima/AAI-7398-2021		Biomolecular Assembly, Recognition and Dynamics Project from the Department of Atomic Energy [12-RD-SIN-5.04-0103]; Ramalingaswami Fellowship, Department of Biotechnology, Government of India; Department of Biotechnology; Indian Council of Scientific and Medical Research, Government of India; Department of Science and Technology	Biomolecular Assembly, Recognition and Dynamics Project from the Department of Atomic Energy; Ramalingaswami Fellowship, Department of Biotechnology, Government of India; Department of Biotechnology; Indian Council of Scientific and Medical Research, Government of India; Department of Science and Technology(Department of Science & Technology (India))	This work was supported in part by research grants from Biomolecular Assembly, Recognition and Dynamics Project, Grant 12-R&D-SIN-5.04-0103 from the Department of Atomic Energy, and a Ramalingaswami Fellowship, Department of Biotechnology, Government of India to C. D. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of fellowships from Department of Biotechnology and Indian Council of Scientific and Medical Research, Government of India.; Recipient of Indian Council of Scientific and Industrial Research Network Project (UNSEEN) and Ramanujan Fellowship from Department of Science and Technology. To whom correspondence may be addressed: Tel.: 91-33-2499-5733; Fax: 91-33-2473-5197; E-mail: roysiddhartha@iicb.res.in.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bierkens M, 2013, GENE CHROMOSOME CANC, V52, P56, DOI 10.1002/gcc.22006; Chakrabarti S, 2001, BIOPOLYMERS, V56, P85, DOI 10.1002/1097-0282(2000)56:2<85::AID-BIP1054>3.0.CO;2-7; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091793; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; Das C, 2014, P NATL ACAD SCI USA, V111, pE1072, DOI 10.1073/pnas.1319122111; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; Fang HB, 2010, NEUROREPORT, V21, P19, DOI 10.1097/WNR.0b013e3283315aec; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gersten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103292; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; Horikoshi Nobuo, 2013, Genome Integr, V4, P3, DOI 10.1186/2041-9414-4-3; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; Kawamura K, 2007, BIOL REPROD, V76, P611, DOI 10.1095/biolreprod.106.058008; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; Larive RM, 2012, MOL BIOL CELL, V23, P2373, DOI 10.1091/mbc.E12-01-0060; Li J, 2005, J BIOL CHEM, V280, P37948, DOI 10.1074/jbc.M509299200; Li YQ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.582; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nishibuchi G, 2014, J BIOL CHEM, V289, P28956, DOI 10.1074/jbc.M114.573725; O'Shaughnessy A, 2013, BIOCHEM SOC T, V41, P777, DOI 10.1042/BST20130027; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Poloni A, 2015, J MOL NEUROSCI, V55, P91, DOI 10.1007/s12031-014-0345-0; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Singh A, 2011, CANCER-AM CANCER SOC, V117, P5189, DOI 10.1002/cncr.26145; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Wernicke C, 2010, PHARMACOL REP, V62, P649, DOI 10.1016/S1734-1140(10)70322-4; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	60	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2664	2681		10.1074/jbc.M115.679985	http://dx.doi.org/10.1074/jbc.M115.679985			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26655721	hybrid, Green Published			2022-12-26	WOS:000369626900011
J	Maklashina, E; Rajagukguk, S; Starbird, CA; McDonald, WH; Koganitsky, A; Eisenbach, M; Iverson, TM; Cecchini, G				Maklashina, Elena; Rajagukguk, Sany; Starbird, Chrystal A.; McDonald, W. Hayes; Koganitsky, Anna; Eisenbach, Michael; Iverson, Tina M.; Cecchini, Gary			Binding of the Covalent Flavin Assembly Factor to the Flavoprotein Subunit of Complex II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOL-FUMARATE REDUCTASE; L-ASPARTATE OXIDASE; SUCCINATE-DEHYDROGENASE; ESCHERICHIA-COLI; WOLINELLA-SUCCINOGENES; CRYSTAL-STRUCTURE; ACTIVE-SITE; PROTEIN; FLAVINYLATION; ATTACHMENT	Escherichia coli harbors two highly conserved homologs of the essential mitochondrial respiratory complex II (succinate: ubiquinone oxidoreductase). Aerobically the bacterium synthesizes succinate: quinone reductase as part of its respiratory chain, whereas under microaerophilic conditions, the quinol: fumarate reductase can be utilized. All complex II enzymes harbor a covalently bound FAD co-factor that is essential for their ability to oxidize succinate. In eukaryotes and many bacteria, assembly of the covalent flavin linkage is facilitated by a small protein assembly factor, termed SdhE in E. coli. How SdhE assists with formation of the covalent flavin bond and how it binds the flavoprotein subunit of complex II remain unknown. Using photo-cross-linking, we report the interaction site between the flavoprotein of complex II and the SdhE assembly factor. These data indicate that SdhE binds to the flavoprotein between two independently folded domains and that this binding mode likely influences the interdomain orientation. In so doing, SdhE likely orients amino acid residues near the dicarboxylate and FAD binding site, which facilitates formation of the covalent flavin linkage. These studies identify how the conserved SdhE assembly factor and its homologs participate in complex II maturation.	[Maklashina, Elena; Rajagukguk, Sany; Cecchini, Gary] Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Starbird, Chrystal A.] Vanderbilt Univ, Grad Program Chem & Phys Biol, 221 Kirkland Hall, Nashville, TN 37232 USA; [McDonald, W. Hayes; Iverson, Tina M.] Vanderbilt Univ, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA; [McDonald, W. Hayes; Iverson, Tina M.] Vanderbilt Univ, Mass Spectrometry Res Ctr, 221 Kirkland Hall, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Dept Pharmacol, 221 Kirkland Hall, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, 221 Kirkland Hall, Nashville, TN 37232 USA; [Koganitsky, Anna; Eisenbach, Michael] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Weizmann Institute of Science	Cecchini, G (corresponding author), VA Med Ctr, Mol Biol 151 S, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu	; McDonald, W. Hayes/B-4109-2016	Eisenbach, Michael/0000-0001-9048-4720; McDonald, W. Hayes/0000-0002-3510-426X	National Institutes of Health [GM61606, 5T32GM008320]; Department of Veterans Affairs Merit Award [BX001077]; Vanderbilt Core Grant in Vision Research [P30EY008126]; U.S.-Israel Binational Science Foundation [BSF 2009161]; National Science Foundation [DGE: 0909667]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, R01GM061606, T32GM008320] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); Vanderbilt Core Grant in Vision Research; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant GM61606, Department of Veterans Affairs Merit Award BX001077, Vanderbilt Core Grant in Vision Research P30EY008126, and U.S.-Israel Binational Science Foundation grant BSF 2009161. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Graduate Fellowship DGE: 0909667 and National Institutes of Health Training Grant 5T32GM008320.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLAUT M, 1989, J BIOL CHEM, V264, P13599; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P3018, DOI 10.1021/bi015939r; BRANDSCH R, 1991, J BIOL CHEM, V266, P19056; BRANDSCH R, 1989, EUR J BIOCHEM, V182, P125, DOI 10.1111/j.1432-1033.1989.tb14808.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2013, HANDBOOK OF FLAVOPROTEINS: COMPLEX FLAVOPROTEINS, DEHYDROGENASES AND PHYSICAL METHODS, VOL 2, P141; Cohen-Ben-Lulu GN, 2008, EMBO J, V27, P1134, DOI 10.1038/emboj.2008.48; Cunane LM, 2005, BIOCHEMISTRY-US, V44, P2963, DOI 10.1021/bi048020r; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 2012, J BIOL CHEM, V287, P35430, DOI 10.1074/jbc.R112.408419; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Iverson TM, 2000, CURR OPIN STRUC BIOL, V10, P448, DOI 10.1016/S0959-440X(00)00113-5; KEARNEY EB, 1960, J BIOL CHEM, V235, P865; Kim J, 1995, J BIOL CHEM, V270, P31202, DOI 10.1074/jbc.270.52.31202; Klanner C, 2000, FEBS LETT, V470, P365, DOI 10.1016/S0014-5793(00)01322-3; Kounosu A, 2014, FEBS LETT, V588, P1058, DOI 10.1016/j.febslet.2014.02.022; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Lancaster CRD, 2001, EUR J BIOCHEM, V268, P1820, DOI 10.1046/j.1432-1327.2001.02053.x; Lancia JK, 2014, BIOPOLYMERS, V101, P391, DOI 10.1002/bip.22395; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P1877, DOI 10.1016/j.bbabio.2010.02.015; Masuda H, 2012, FEMS MICROBIOL LETT, V328, P174, DOI 10.1111/j.1574-6968.2012.02496.x; Mattevi A, 1999, STRUCTURE, V7, P745, DOI 10.1016/S0969-2126(99)80099-9; McNeil MB, 2014, FEBS LETT, V588, P414, DOI 10.1016/j.febslet.2013.12.019; McNeil MB, 2013, BIOCHEMISTRY-US, V52, P7628, DOI 10.1021/bi401006a; McNeil MB, 2013, BBA-BIOENERGETICS, V1827, P637, DOI 10.1016/j.bbabio.2012.09.003; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Melin F, 2014, CHEMPHYSCHEM, V15, P3572, DOI 10.1002/cphc.201402354; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Na U, 2014, CELL METAB, V20, P253, DOI 10.1016/j.cmet.2014.05.014; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Robinson KM, 1996, J BIOL CHEM, V271, P4061; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; WALSH C, 1980, ACCOUNTS CHEM RES, V13, P148, DOI 10.1021/ar50149a004; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; WOOD D, 1984, BIOCHEM J, V222, P519, DOI 10.1042/bj2220519; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	59	13	15	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2904	2916		10.1074/jbc.M115.690396	http://dx.doi.org/10.1074/jbc.M115.690396			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644464	hybrid, Green Published			2022-12-26	WOS:000369626900028
J	Garcia-Ramirez, RA; Ramirez-Venegas, A; Quintana-Carrillo, R; Camarena, AE; Falfan-Valencia, R; Meja-Arangure, JM				Alejandro Garcia-Ramirez, Roman; Ramirez-Venegas, Alejandra; Quintana-Carrillo, Roger; Eduardo Camarena, Angel; Falfan-Valencia, Ramces; Manuel Meja-Arangure, Juan			TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population	PLOS ONE			English	Article							CYTOKINE GENE POLYMORPHISMS; NECROSIS-FACTOR PRODUCTION; INFLAMMATORY CYTOKINES; SEVERE PNEUMONIA; INTERLEUKIN-1-BETA; ALPHA; RISK; LTA	Background Hypercytokinemia is the main immunopathological mechanism contributing to a more severe clinical course in influenza A (H1N1) virus infections. Most patients infected with the influenza A (H1N1) pdm09 virus had increased systemic levels of pro-inflammatory cytokines; including interleukin IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha). We propose that single-nucleotide polymorphisms (SNPs) in the promoter regions of pro-inflammatory genes are associated with the severity of influenza A (H1N1) pdm09 virus infection. Methods 145 patients with influenza A (H1N1) (pA/H1N1), 133 patients with influenza-like illness (ILI), and 360 asymptomatic healthy contacts (AHCs) were included. Eleven SNPs were genotyped in six genes (TNF, LT, IL1B, IL6, CCL1, and IL8) using real-time PCR; the ancestral genotype was used for comparison. Genotypes were correlated with 27 clinical severity variables. Ten cytokines (GM-CSF, TNF-alpha, IL-2, IL-1 beta, IL-6, IL-8, IFN-gamma, IL-10, IL-5, and IL-4) were measured on a Luminex 100. Results The IL6 rs1818879 (GA) heterozygous genotype was associated with severe influenza A (H1N1) virus infection (odds ratio [OR] = 5.94, 95% confidence interval [CI] 3.05-11.56), and two IL1B SNPs, rs16944 AG and rs3136558 TC, were associated with a decreased risk of infection (OR = 0.52 and OR = 0.51, respectively). Genetic susceptibility was determined (pA/H1N1 vs. AHC): the LTA rs909253 TC heterozygous genotype conferred greater risk (OR = 1.9), and a similar association was observed with the IL1B rs3136558 CC genotype (OR = 1.89). Additionally, severely ill patients were compared with moderately ill patients. The TNF- 238 GA genotype was associated with an increased risk of disease severity (OR = 16.06, p = 0.007). Compared with ILIs, patients with severe pA/H1N1 infections exhibited increased serum IL- 5 (p<0.001) and IL- 6 (p = 0.007) levels. Conclusions The TNF gene was associated with disease severity, whereas IL1B and IL6 SNPs were associated with influenza A (H1N1) virus infection.	[Alejandro Garcia-Ramirez, Roman; Manuel Meja-Arangure, Juan] IMSS, Coordinat Hlth Res, Mexico City 06720, DF, Mexico; [Alejandro Garcia-Ramirez, Roman] Univ Nacl Autonoma Mexico, Grad Program Biol Sci, Mexico City 04360, DF, Mexico; [Alejandro Garcia-Ramirez, Roman; Eduardo Camarena, Angel; Falfan-Valencia, Ramces] Natl Inst Resp Dis, HLA Lab, Mexico City 14080, DF, Mexico; [Ramirez-Venegas, Alejandra; Quintana-Carrillo, Roger] Natl Inst Resp Dis, Res Dept Smoking & COPD, Mexico City 14080, DF, Mexico	Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico	Falfan-Valencia, R (corresponding author), Natl Inst Resp Dis, HLA Lab, Mexico City 14080, DF, Mexico.	rfalfanv@iner.gob.mx; juan.mejiaa@imss.gob.mx	Mejia-Arangure, Juan Manuel/T-6743-2019; Falfán-Valencia, Ramcés/M-7331-2018	Mejia-Arangure, Juan Manuel/0000-0001-8027-6231; Falfán-Valencia, Ramcés/0000-0001-6877-8124	Mexican Institute of Social Security [FIS/IMSS/PROT/G13/1212, CONACyT-FOSIS SALUD2009-C02-126699]; Coordinacion de Investigacion en Salud of the IMSS	Mexican Institute of Social Security; Coordinacion de Investigacion en Salud of the IMSS	This paper constitutes a partial fulfillment of the Graduate Program in Biological Sciences of the National Autonomous University of Mexico (UNAM) for RAGR. RA Garcia-Ramirez acknowledges the academic support provided by the National Council of Science and Technology (CONACyT) and Posgrado en Ciencias Biologicas, UNAM. The authors thank the Coordinacion de Investigacion en Salud of the IMSS for covering the translation and publishing costs. This study was funded by the Mexican Institute of Social Security, Grants FIS/IMSS/PROT/G13/1212 and CONACyT-FOSIS SALUD2009-C02-126699.; This paper constitutes a partial fulfillment of the Graduate Program in Biological Sciences of the National Autonomous University of Mexico (UNAM) for RAGR. RA Garcia-Ramirez acknowledges the academic support provided by the National Council of Science and Technology (CONACyT) and Posgrado en Ciencias Biologicas, UNAM. The authors thank the Coordinacion de Investigacion en Salud of the IMSS for covering the translation and publishing costs. This study was funded by the Mexican Institute of Social Security, Grants FIS/IMSS/PROT/G13/1212 and CONACyT-FOSIS SALUD2009-C02-126699.	Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012; Atan D, 2013, MOL VIS, V19, P184; Belfer I, 2004, GENES IMMUN, V5, P505, DOI 10.1038/sj.gene.6364118; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Borja-Aburto VH, 2012, ARCH MED RES, V43, P563, DOI 10.1016/j.arcmed.2012.09.005; Broekhuizen R, 2005, AM J CLIN NUTR, V82, P1059, DOI 10.1093/ajcn/82.5.1059; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2013, INT J INFECT DIS, V17, pE1186, DOI 10.1016/j.ijid.2013.07.006; Chiaretti A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/495848; Chowell Gerardo, 2012, PLoS Curr, V4, pRRN1306, DOI 10.1371/currents.RRN1306; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Davila J., 2014, PLOS CURR-TREE LIFE, V6, DOI [10.1371/currents.outbreaks.a855a92f19db1d90ca955f5e908d6631, DOI 10.1371/CURRENTS.OUTBREAKS.A855A92F19DB1D90CA955F5E908D6631, DOI 10.1371/CURRENTS.0UTBREAKS.A855A92F19DB1D90CA955F5E908D6631]; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Estella A, 2011, J INFECT DEV COUNTR, V5, P540, DOI 10.3855/jidc.1618; Jimenez-Corona ME, 2012, SALUD PUBLICA MEXICO, V54, P607, DOI 10.1590/S0036-36342012000600009; Gomez-Gomez A, 2010, EMERG INFECT DIS, V16, P27, DOI 10.3201/eid1601.090941; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; JULKUNEN I, 1985, J VIROL METHODS, V10, P75, DOI 10.1016/0166-0934(85)90091-6; Kerr JR, 2003, J CLIN PATHOL, V56, P725, DOI 10.1136/jcp.56.10.725; Knight JC, 1999, P ASSOC AM PHYSICIAN, V111, P290, DOI 10.1046/j.1525-1381.1999.99237.x; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liu YX, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-37; Martinez-Ocana J, 2013, J CLIN VIROL, V58, P108, DOI 10.1016/j.jcv.2013.05.013; Matsushita K, 2006, ARTERIOSCL THROM VAS, V26, P871, DOI 10.1161/01.ATV.0000208363.85388.8f; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Morales-Garcia G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-299; Nishida M, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-27; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Romanova EN, 2013, TERAPEVT ARKH, V85, P58; Seki M, 2004, EUR RESPIR J, V24, P143, DOI 10.1183/09031936.04.00126103; Sinha S, MALAR J, V20, P13; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wu CL, 2003, CRIT CARE MED, V31, P812, DOI 10.1097/01.CCM.0000054865.47068.58; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028680; Zuniga J, 2011, AUTOIMMUNITY, V44, P562, DOI 10.3109/08916934.2011.592885	41	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144832	10.1371/journal.pone.0144832	http://dx.doi.org/10.1371/journal.pone.0144832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657940	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900113
J	Ho, BL; Cheng, SC; Shi, L; Wang, TY; Ho, KI; Chou, CY				Ho, Bo-Lin; Cheng, Shu-Chun; Shi, Lin; Wang, Ting-Yun; Ho, Kuan-I; Chou, Chi-Yuan			Critical Assessment of the Important Residues Involved in the Dimerization and Catalysis of MERS Coronavirus Main Protease	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-CORONAVIRUS; PAPAIN-LIKE PROTEASE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; THIOPURINE ANALOGS; CRYSTAL-STRUCTURES; 3C-LIKE PROTEASE; SARS; MECHANISM; BAT	Background A highly pathogenic human coronavirus (CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), has emerged in Jeddah and other places in Saudi Arabia, and has quickly spread to European and Asian countries since September 2012. Up to the 1st October 2015 it has infected at least 1593 people with a global fatality rate of about 35%. Studies to understand the virus are necessary and urgent. In the present study, MERS-CoV main protease (M-pro) is expressed; the dimerization of the protein and its relationship to catalysis are investigated. Methods and Results The crystal structure of MERS-CoV M-pro indicates that it shares a similar scaffold to that of other coronaviral M-pro and consists of chymotrypsin-like domains I and II and a helical domain III of five helices. Analytical ultracentrifugation analysis demonstrated that MERS-CoV M-pro undergoes a monomer to dimer conversion in the presence of a peptide substrate. Glu169 is a key residue and plays a dual role in both dimerization and catalysis. The mutagenesis of other residues found on the dimerization interface indicate that dimerization of MERS-CoV M-pro is required for its catalytic activity. One mutation, M298R, resulted in a stable dimer with a higher level of proteolytic activity than the wild-type enzyme. Conclusions MERS-CoV M-pro shows substrate-induced dimerization and potent proteolytic activity. A critical assessment of the residues important to these processes provides insights into the correlation between dimerization and catalysis within the coronaviral M-pro family.	[Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chou, CY (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	cychou@ym.edu.tw		Chou, Chi-Yuan/0000-0002-3400-171X	Ministry of Science and Technology, Taiwan [103-2320-B-010-025, 104-2320-B-010-034]; National Yang-Ming University (Aim for Top University Plan from Ministry of Education); Ministry of Science and Technology of Taiwan, ROC; National Core Facility Program for Biotechnology; NYMU	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Yang-Ming University (Aim for Top University Plan from Ministry of Education); Ministry of Science and Technology of Taiwan, ROC; National Core Facility Program for Biotechnology; NYMU	This research was supported by grants from Ministry of Science and Technology, Taiwan (103-2320-B-010-025 and 104-2320-B-010-034) to CYC. We also thank National Yang-Ming University for its financial support (Aim for Top University Plan from Ministry of Education). Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the Ministry of Science and Technology of Taiwan, ROC. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology.; This research was supported by grants from Ministry of Science and Technology, Taiwan (103-2320-B-010-025 and 104-2320-B-010-034) to CYC. We also thank NYMU for its financial support (Aim for Top University Plan from Ministry of Education). Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the Ministry of Science and Technology of Taiwan, ROC. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anderson LJ, 2012, NEW ENGL J MED, V367, P1850, DOI 10.1056/NEJMe1212300; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Cheng KW, 2015, ANTIVIR RES, V115, P9, DOI 10.1016/j.antiviral.2014.12.011; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Chou CY, 2008, BIOCHEM PHARMACOL, V75, P1601, DOI 10.1016/j.bcp.2008.01.005; Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040; Chou CY, 2011, METHODS, V54, P76, DOI 10.1016/j.ymeth.2010.11.002; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Chou YW, 2012, ARCH BIOCHEM BIOPHYS, V520, P74, DOI 10.1016/j.abb.2012.02.015; Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013; Eckerle I, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-359; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hsieh YH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-4; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Kilianski A, 2013, J VIROL, V87, P11955, DOI 10.1128/JVI.02105-13; Lin MH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-54; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Needle D, 2015, ACTA CRYSTALLOGR D, V71, P1102, DOI 10.1107/S1399004715003521; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463; Wu AD, 2015, VIRUS RES, V208, P56, DOI 10.1016/j.virusres.2015.05.018; Wu CG, 2013, ACTA CRYSTALLOGR D, V69, P747, DOI 10.1107/S0907444913001315; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang SN, 2010, PROTEIN CELL, V1, P371, DOI 10.1007/s13238-010-0044-8	36	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144865	10.1371/journal.pone.0144865	http://dx.doi.org/10.1371/journal.pone.0144865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658006	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900124
J	Kemp, DW; Rivers, AR; Kemp, KM; Lipp, EK; Porter, JW; Wares, JP				Kemp, Dustin W.; Rivers, Adam R.; Kemp, Keri M.; Lipp, Erin K.; Porter, James W.; Wares, John P.			Spatial Homogeneity of Bacterial Communities Associated with the Surface Mucus Layer of the Reef-Building Coral Acropora palmata	PLOS ONE			English	Article							DIVERSITY; DISEASE; RNA; SEQUENCES; COMPLEX; UNIFRAC; SEARCH	Coral surface mucus layer (SML) microbiota are critical components of the coral holobiont and play important roles in nutrient cycling and defense against pathogens. We sequenced 16S rRNA amplicons to examine the structure of the SML microbiome within and between colonies of the threatened Caribbean reef-building coral Acropora palmata in the Florida Keys. Samples were taken from three spatially distinct colony regions-uppermost (high irradiance), underside (low irradiance), and the colony base-representing microhabitats that vary in irradiance and water flow. Phylogenetic diversity (PD) values of coral SML bacteria communities were greater than surrounding seawater and lower than adjacent sediment. Bacterial diversity and community composition was consistent among the three microhabitats. Cyanobacteria, Bacteroidetes, Alphaproteobacteria, and Proteobacteria, respectively were the most abundant phyla represented in the samples. This is the first time spatial variability of the surface mucus layer of A. palmata has been studied. Homogeneity in the microbiome of A. palmata contrasts with SML heterogeneity found in other Caribbean corals. These findings suggest that, during non-stressful conditions, host regulation of SML microbiota may override diverse physiochemical influences induced by the topographical complexity of A. palmata. Documenting the spatial distribution of SML microbes is essential to understanding the functional roles these microorganisms play in coral health and adaptability to environmental perturbations.	[Kemp, Dustin W.; Kemp, Keri M.; Porter, James W.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Rivers, Adam R.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Lipp, Erin K.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Wares, John P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kemp, DW (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	DKemp1@uga.edu		Kemp, Dustin/0000-0002-9396-1518; Wares, John/0000-0003-1827-0669; Rivers, Adam/0000-0002-3703-834X; Kemp, Keri/0000-0003-3538-852X; Lipp, Erin/0000-0002-8066-0636	National Science Foundation Ecology of Infectious Diseases [1015342]; Directorate For Geosciences [1015342] Funding Source: National Science Foundation	National Science Foundation Ecology of Infectious Diseases(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research project was supported by the National Science Foundation Ecology of Infectious Diseases grant #1015342 awarded to JWP, EKL, and JPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank MOTE Tropical Research Laboratory and Erich Bartels for laboratory and boat support. Meredith Meyers provided dive and sample collection assistance and Ron Eytan was very helpful with sample analysis and software support. All samples were collected under the permit FKNMS-2010-131-A1. This research project was supported by the National Science Foundation Ecology of Infectious Diseases grant #1015342 awarded to JWP, EKL, and JPW	Acinas SG, 2006, FEMS MICROBIOLOGY EC, V24, P27; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bak RPM, 1974, PROCEEDINGS 2ND INTE; Baums IB, 2014, MOL ECOLOGY; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bourne DG, 2013, ISME J, V7, P1452, DOI 10.1038/ismej.2012.172; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Closek CJ, 2014, ISME J, V8, P2411, DOI 10.1038/ismej.2014.85; Daniels CA, 2011, MAR ECOL PROG SER, V426, P29, DOI 10.3354/meps09024; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FUHRMAN JA, 1993, APPL ENVIRON MICROB, V59, P1294, DOI 10.1128/AEM.59.5.1294-1302.1993; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamada M, 2013, MOL BIOL EVOL, V30, P167, DOI 10.1093/molbev/mss213; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Kaandorp JA, 2001, THE ALGORITHMIC BEAU; Kaiser E, 1997, APPL ENVIRON MICROB, V63, P4026, DOI 10.1128/AEM.63.10.4026-4031.1997; Kemp DW, 2008, CORAL REEFS, V27, P289, DOI 10.1007/s00338-007-0333-8; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; McKew BA, 2012, APPL ENVIRON MICROB, V78, P5229, DOI 10.1128/AEM.07764-11; Meyer JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100316; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Oksanen J., 2007, COMMUN ECOL PACK, P631; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Pantos O, 2015, ISME J, V9, P1916, DOI 10.1038/ismej.2015.3; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MARINE ECOLOGY PROGR, V243; Roos PJ, 1967, GROWTH AND OCCURRENC; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Sebens KP, 1998, MAR BIOL, V131, P347, DOI 10.1007/s002270050328; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Team RC, 2014, R A LANGUAGE AND ENV; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang QT, 2002, BIOTECHNIQUES, V33, P788, DOI 10.2144/02334st02; Whitehead LF, 2003, J EXP BIOL, V206, P3149, DOI 10.1242/jeb.00539; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	52	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143790	10.1371/journal.pone.0143790	http://dx.doi.org/10.1371/journal.pone.0143790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659364	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900018
J	Farr, A; Kiss, H; Hagmann, M; Machal, S; Holzer, I; Kueronya, V; Husslein, PW; Petricevic, L				Farr, Alex; Kiss, Herbert; Hagmann, Michael; Machal, Susanne; Holzer, Iris; Kueronya, Verena; Husslein, Peter Wolf; Petricevic, Ljubomir			Role of Lactobacillus Species in the Intermediate Vaginal Flora in Early Pregnancy: A Retrospective Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BACTERIAL VAGINOSIS; PRETERM DELIVERY; LATE MISCARRIAGE; GRAM STAIN; BIRTH; METAANALYSIS; WOMEN; CLINDAMYCIN; PREVENTION	Background Poor obstetrical outcomes are associated with imbalances in the vaginal flora. The present study evaluated the role of vaginal Lactobacillus species in women with intermediate vaginal flora with regard to obstetrical outcomes. Methods We retrospectively analysed data from all women with singleton pregnancies who had undergone routine screening for asymptomatic vaginal infections at our tertiary referral centre between 2005 and 2014. Vaginal smears were Gram-stained and classified according to the Nugent scoring system as normal flora (score 0-3), intermediate vaginal flora (4-6), or bacterial vaginosis (7-10). Only women with intermediate vaginal flora were investigated. Women with a Nugent score of 4 were categorised into those with and without Lactobacilli. Follow-up smears were obtained 4-6 weeks after the initial smears. Descriptive data analysis, the Welch's t-test, the Fisher's exact test, and multiple regression analysis with adjustment for confounders were performed. Gestational age at delivery and birth weight were the outcome measures. Results At antenatal screening, 529/8421 women presented with intermediate vaginal flora. Amongst these, 349/529 (66%) had a Nugent score of 4, 94/529 (17.8%) a Nugent score of 5, and 86/529 (16.2%) a Nugent score of 6. Amongst those with a Nugent score of 4, 232/349 (66.5%) women were in the Lactobacilli group and 117/349 (33.5%) in the Non-Lactobacilli group. The preterm delivery rate was significantly lower in the Lactobacilli than in the Non-Lactobacilli group (OR 0.34, CI 0.21-0.55; p<0.001). Mean birth weight was 2979 +/- 842 g and 2388 +/- 1155 g in the study groups, respectively (MD 564.12, CI 346.23-781.92; p<0.001). On follow-up smears, bacterial vaginosis rates were 9% in the Lactobacilli and 7.8% in the Non-Lactobacilli group. Conclusions The absence of vaginal Lactobacillus species and any bacterial colonisation increases the risks of preterm delivery and low birth weight in women with intermediate vaginal flora in early pregnancy.	[Farr, Alex; Kiss, Herbert; Machal, Susanne; Holzer, Iris; Kueronya, Verena; Husslein, Peter Wolf; Petricevic, Ljubomir] Med Univ Vienna, Div Obstet & Fetomaternal Med, Dept Obstet & Gynaecol, Vienna, Austria; [Hagmann, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Petricevic, L (corresponding author), Med Univ Vienna, Div Obstet & Fetomaternal Med, Dept Obstet & Gynaecol, Vienna, Austria.	ljubomir.petricevic@meduniwien.ac.at						Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Brown HK, 2014, INT J EPIDEMIOL, V43, P802, DOI 10.1093/ije/dyt251; Donati L, 2010, ARCH GYNECOL OBSTET, V281, P589, DOI 10.1007/s00404-009-1318-3; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Donders GGG, 2007, BEST PRACT RES CL OB, V21, P355, DOI 10.1016/j.bpobgyn.2007.01.002; Farr A, 2015, BIRTH-ISS PERINAT C, V42, P173, DOI 10.1111/birt.12154; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Guerra B, 2006, EUR J OBSTET GYN R B, V128, P40, DOI 10.1016/j.ejogrb.2005.12.024; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Honda H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04799; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; Kiss H, 2004, BMJ-BRIT MED J, V329, P371, DOI 10.1136/bmj.38169.519653.EB; Lamont RF, 2011, AM J OBSTET GYNECOL, V205, P177, DOI 10.1016/j.ajog.2011.03.047; Leitich H, 2003, AM J OBSTET GYNECOL, V188, P752, DOI 10.1067/mob.2003.167; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Parma M, 2014, ALTERN THER HEALTH M, V20, P52; Petricevic L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05136; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; SPERNOL R, 1985, WIEN MED WOCHENSCHR, V135, P65; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; Ugwumadu A, 2003, LANCET, V361, P983, DOI 10.1016/S0140-6736(03)12823-1	25	14	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144181	10.1371/journal.pone.0144181	http://dx.doi.org/10.1371/journal.pone.0144181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658473	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600027
J	Longley, RJ; Halbroth, BR; Ewer, KJ; Hill, AVS; Spencer, AJ				Longley, Rhea J.; Halbroth, Benedict R.; Ewer, Katie J.; Hill, Adrian V. S.; Spencer, Alexandra J.			Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice	PLOS ONE			English	Article							LIVER-STAGE ANTIGEN-1; T-CELL IMMUNOGENICITY; SPOROZOITE INOCULATION; MALARIA SPOROZOITES; PROTECTIVE EFFICACY; VACCINE; IMMUNIZATION; IMMUNITY; PROTEIN; EPITOPE	Malaria, caused by the Plasmodium parasite, remains a serious global public health concern. A vaccine could have a substantial impact on eliminating this disease, alongside other preventative measures. We recently described the development of three novel, viral vectored vaccines expressing either of the antigens PfUIS3, PfLSA1 and PfLSAP2. Each vaccination regimen provided high levels of protection against chimeric parasite challenge in a mouse model, largely dependent on CD8(+) T cells. In this study we aimed to further characterize the induced cellular immune response to these vaccines. We utilized both the IFN gamma enzyme-linked immunosorbent spot assay and intracellular cytokine staining to achieve this aim. We identified immunodominant peptide responses for CD4(+) and CD8(+) T cells for each of the antigens in BALB/c, C57BL/6 and HLA-A2 transgenic mice, creating a useful tool for researchers for subsequent study of these antigens. We also compared these immunodominant peptides with those generated from epitope prediction software, and found that only a small proportion of the large number of epitopes predicted by the software were identifiable experimentally. Furthermore, we characterized the polyfunctionality of the induced CD8(+) T cell responses. These findings contribute to our understanding of the immunological mechanisms underlying these protective vaccines, and provide a useful basis for the assessment of these and related vaccines as clinical constructs.	[Longley, Rhea J.; Halbroth, Benedict R.; Ewer, Katie J.; Hill, Adrian V. S.; Spencer, Alexandra J.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Longley, RJ (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	Longley.r@wehi.edu.au	Spencer, Alexandra/AAE-6494-2019; Ewer, Katie J/B-4328-2011; Longley, Rhea J/C-9573-2018	Spencer, Alexandra/0000-0001-7958-6961; Ewer, Katie J/0000-0001-9827-9836; Longley, Rhea J/0000-0002-4510-5602; Halbroth, Benedict/0000-0002-1253-2843; Hill, Adrian/0000-0003-0900-9629	Wellcome Trust [095540/Z/11/Z]; Rhodes Trust; Nuffield Department of Medicine Studentship; European Union [316655]	Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust; Nuffield Department of Medicine Studentship; European Union(European Commission)	This work has been funded by a grant from the Wellcome Trust (095540/Z/11/Z) with additional funding by the Rhodes Trust and a Nuffield Department of Medicine Studentship to support RJL. BRH receives funding from the European Union Seventh Framework Programme FP7/2012-2016 under grant agreement number 316655 (VACTRAIN). AVSH is a Jenner Institute Investigator; AJS is a James Martin Fellow. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Brando C, 2007, INFECT IMMUN, V75, P838, DOI 10.1128/IAI.01075-06; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Prieur E, 2004, P NATL ACAD SCI USA, V101, P290, DOI 10.1073/pnas.0307158101; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reyes-Sandoval A, 2012, MOL THER, V20, P1633, DOI 10.1038/mt.2012.25; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; ROCK KL, 1992, P NATL ACAD SCI USA, V89, P8918, DOI 10.1073/pnas.89.19.8918; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Sidney J, 1996, IMMUNOL TODAY, V17, P261, DOI 10.1016/0167-5699(96)80542-1; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; The RTS, 2015, LANCET, V386, P31, DOI DOI 10.1016/S0140-6736(15)60721-8; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602	40	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144515	10.1371/journal.pone.0144515	http://dx.doi.org/10.1371/journal.pone.0144515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659715	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600050
J	Tiwary, E; Hegde, S; Purushotham, S; Deivanayagam, C; Srivastava, O				Tiwary, Ekta; Hegde, Shylaja; Purushotham, Sangeetha; Deivanayagam, Champion; Srivastava, Om			Interaction of beta A3-Crystallin with Deamidated Mutants of alpha A- and alpha B-Crystallins	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CHAPERONE-LIKE ACTIVITY; HUMAN SENILE CATARACTOGENESIS; SURFACE-PLASMON RESONANCE; AGE-DEPENDENT DEAMIDATION; GAMMA-D-CRYSTALLIN; HUMAN LENS; BOVINE LENS; FUNCTIONAL-PROPERTIES; BACKBONE CLEAVAGE	Interaction among crystallins is required for the maintenance of lens transparency. Deamidation is one of the most common post-translational modifications in crystallins, which results in incorrect interaction and leads to aggregate formation. Various studies have established interaction among the alpha- and beta-crystallins. Here, we investigated the effects of the deamidation of alpha A- and alpha B-crystallins on their interaction with beta A3-crystallin using surface plasmon resonance (SPR) and fluorescence lifetime imaging microscopy-fluorescence resonance energy transfer (FLIM-FRET) methods. SPR analysis confirmed adherence of WT alpha A- and WT alpha B-crystallins and their deamidated mutants with beta A3-crystallin. The deamidated mutants of alpha A-crystallin (alpha A N101D and alpha A N123D) displayed lower adherence propensity for beta A3-crystallin relative to the binding affinity shown by WT alpha A-crystallin. Among alpha B-crystallin mutants, alpha B N78D displayed higher adherence propensity whereas alpha B N146D mutant showed slightly lower binding affinity for beta A3-crystallin relative to that shown by WT alpha B-crystallin. Under the in vivo condition (FLIM-FRET), both alpha A-deamidated mutants (alpha A N101D and alpha A N123D) exhibited strong interaction with beta A3-crystallin (32 +/- 4% and 36 +/- 4% FRET efficiencies, respectively) compared to WT alpha A-crystallin (18 +/- 4%). Similarly, the alpha B N78D and alpha B N146D mutants showed strong interaction (36 +/- 4% and 22 +/- 4% FRET efficiencies, respectively) with beta A3-crystallin compared to 18 +/- 4% FRET efficiency of WT alpha B-crystallin. Further, FLIM-FRET analysis of the C-terminal domain (CTE), N-terminal domain (NTD), and core domain (CD) of alpha A- and alpha B-crystallins with beta A3-crystallin suggested that interaction sites most likely reside in the alpha A CTE and alpha B NTD regions, respectively, as these domains showed the highest FRET efficiencies. Overall, results suggest that similar to WT alpha A- and WT alpha B-crystallins, the deamidated mutants showed strong interaction for beta A3-crystallin. Variable in vitro and in vivo interactions are most likely due to the mutant's large size oligomers, reduced hydrophobicity, and altered structures. Together, the results suggest that deamidation of alpha-crystallin may facilitate greater interaction and the formation of large oligomers with other crystallins, and this may contribute to the cataractogenic mechanism.	[Tiwary, Ekta; Hegde, Shylaja; Srivastava, Om] Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA; [Purushotham, Sangeetha; Deivanayagam, Champion] Univ Alabama Birmingham, Dept Vis Sci, Struct Biol Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Srivastava, O (corresponding author), Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA.	srivasta@uab.edu		Deivanayagam, Champion/0000-0003-2972-1824	National Eye Institution [EY06400]; NATIONAL EYE INSTITUTE [R01EY006400] Funding Source: NIH RePORTER	National Eye Institution; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funded by National Eye Institution, EY06400 (https://nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Asomugha CO, 2011, MOL VIS, V17, P2356; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Feil IK, 2001, J BIOL CHEM, V276, P12024, DOI 10.1074/jbc.M010856200; Ferrini W, 2004, INVEST OPHTH VIS SCI, V45, P1436, DOI 10.1167/iovs.03-0760; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Graw J, 1999, PROG RETIN EYE RES, V18, P235, DOI 10.1016/S1350-9462(98)00018-4; GROENEN PJTA, 1993, FEBS LETT, V322, P69, DOI 10.1016/0014-5793(93)81113-E; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Gupta R, 2009, J BIOL CHEM, V284, P18481, DOI 10.1074/jbc.M109.013789; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harrington V, 2004, MOL VIS, V10, P476; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Kamei A, 2002, BIOL PHARM BULL, V25, P611, DOI 10.1248/bpb.25.611; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Liu BF, 2005, MOL VIS, V11, P321; Lu SS, 2007, MOL VIS, V13, P1154; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MERCK KB, 1993, MOL BIOL REP, V18, P209, DOI 10.1007/BF01674432; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; ORTWERTH BJ, 1992, EXP EYE RES, V54, P103, DOI 10.1016/0014-4835(92)90074-3; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Ponce A, 2005, MOL VIS, V11, P752; Rajan S, 2006, MOL CELL BIOCHEM, V288, P125, DOI 10.1007/s11010-006-9128-4; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Srivastava OP, 2008, MOL VIS, V14, P1872; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; SRIVASTAVA OP, 1983, EXP EYE RES, V36, P363, DOI 10.1016/0014-4835(83)90118-5; SRIVASTAVA OP, 1983, EXP EYE RES, V36, P695, DOI 10.1016/0014-4835(83)90107-0; Srivastava OP, 2003, MOL VIS, V9, P110; Takata T, 2007, BIOCHEMISTRY-US, V46, P8861, DOI 10.1021/bi700487q; Takemoto L, 2000, MOL VIS, V6, P164; Takemoto L, 2001, EXP EYE RES, V72, P559, DOI 10.1006/exer.2001.0983; Takemoto L, 2001, CURR EYE RES, V22, P148, DOI 10.1076/ceyr.22.2.148.5524; Takemoto L, 1999, MOL VIS, V5, pU1; Takemoto L, 2008, EXP EYE RES, V87, P496, DOI 10.1016/j.exer.2008.08.018; Wang SSS, 2010, MOL VIS, V16, P2777; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	56	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144621	10.1371/journal.pone.0144621	http://dx.doi.org/10.1371/journal.pone.0144621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657544	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600070
J	Yoo, TK; Min, JW; Kim, MK; Lee, E; Kim, J; Lee, HB; Kang, YJ; Kim, YG; Moon, HG; Moon, K; Cho, N; Noh, DY; Han, W				Yoo, Tae-Kyung; Min, Jun Won; Kim, Min Kyoon; Lee, Eunshin; Kim, Jongjin; Lee, Han-Byoel; Kang, Young Joon; Kim, Yun-Gyoung; Moon, Hyeong-Gon; Moon, Kyung; Cho, Nariya; Noh, Dong-Young; Han, Wonshik			In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients	PLOS ONE			English	Article							DOUBLING TIME; PROGNOSIS; MAMMOGRAPHY; ASSOCIATION; ULTRASOUND; CARCINOMA; DENSITY; SIZE; KI67	Objective The aim of our study was to evaluate the effect of tumor growth rate, calculated from tumor size measurements by US, on breast cancer patients' outcome. Patients and Methods Breast cancer patients who received at least two serial breast ultrasonographies (US) in our institution during preoperative period and were surgically treated between 2002 and 2010 were reviewed. Tumor growth rate was determined by specific growth rate (SGR) using the two time point tumor sizes by US. Results A total of 957 patients were analyzed. The median duration between initial and second US was 28 days (range, 8-140). The median initial tumor size was 1.7cm (range, 0.4-7.0) and median second size was 1.9cm (range, 0.3-7.2). 523(54.6%) cases had increase in size. The median SGR(x10(-2)) was 0.59 (range, -11.90 similar to 31.49) and mean tumor doubling time was 14.51 days. Tumor growth rate was higher when initial tumor size was smaller. Lymphovascular invasion, axillary lymph node metastasis, and higher histologic grade were significantly associated with higher SGR. SGR was significantly associated with disease-free survival (DFS) in a univariate analysis (p = 0.04), but not in a multivariate Cox analysis (p > 0.05). High SGR was significantly associated with worse DFS in a subgroup of initial tumor size > 2cm (p = 0.018), but not in those with tumor size < 2cm (p > 0.05). Conclusion Our results showed that tumor growth rate measured by US in a relatively short time interval was associated with other worse prognostic factors and DFS, but it was not an independent prognostic factor in breast cancer patients.	[Yoo, Tae-Kyung; Kim, Min Kyoon; Lee, Eunshin; Kim, Jongjin; Lee, Han-Byoel; Kang, Young Joon; Kim, Yun-Gyoung; Moon, Hyeong-Gon; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Min, Jun Won] Dankook Univ, Coll Med, Dept Surg, Cheonan, South Korea; [Moon, Kyung; Cho, Nariya] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Moon, Hyeong-Gon; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Breast Canc Biol, Seoul, South Korea	Seoul National University (SNU); Dankook University; Seoul National University (SNU); Seoul National University (SNU)	Han, W (corresponding author), Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea.	hanw@snu.ac.kr	Han, Wonshik/B-3699-2008	Han, Wonshik/0000-0001-7310-0764; Moon, Hyeong-Gon/0000-0002-9981-0286	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1A2A2A01008264]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	Supported in part by a National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIP) (grant number: 2015R1A2A2A01008264) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported in part by a National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIP) (grant number: 2015R1A2A2A01008264) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277)	Boisserie-Lacroix M, 2013, ONCOLOGIST, V18, P802, DOI 10.1634/theoncologist.2013-0380; Bosch AM, 2003, EUR J RADIOL, V48, P285, DOI 10.1016/S0720-048X(03)00081-0; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; Costantini M, 2012, CLIN BREAST CANCER, V12, P331, DOI 10.1016/j.clbc.2012.07.002; El-Bastawissi AY, 2001, ANN EPIDEMIOL, V11, P257, DOI 10.1016/S1047-2797(00)00225-8; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; GALANTE E, 1986, BRIT J CANCER, V54, P833, DOI 10.1038/bjc.1986.247; Ganz Patricia A., 2000, Breast J, V6, P324, DOI 10.1046/j.1524-4741.2000.20042.x; Hart D, 1998, BRIT J CANCER, V78, P382, DOI 10.1038/bjc.1998.503; HEUSER L, 1979, CANCER, V43, P1888, DOI 10.1002/1097-0142(197905)43:5<1888::AID-CNCR2820430545>3.0.CO;2-M; HEUSER LS, 1984, CANCER, V53, P96, DOI 10.1002/1097-0142(19840101)53:1<96::AID-CNCR2820530117>3.0.CO;2-A; Jacquemier J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2249; Kontzoglou K, 2013, ONCOLOGY-BASEL, V84, P219, DOI 10.1159/000346475; KUROISHI T, 1990, JPN J CANCER RES, V81, P454, DOI 10.1111/j.1349-7006.1990.tb02591.x; KUSAMA S, 1972, CANCER-AM CANCER SOC, V30, P594, DOI 10.1002/1097-0142(197208)30:2<594::AID-CNCR2820300241>3.0.CO;2-2; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Mehrara E, 2009, ACTA ONCOL, V48, P591, DOI 10.1080/02841860802616736; Moon HG, 2010, J CLIN ONCOL, V28, P1692, DOI 10.1200/JCO.2009.25.9226; PEARLMAN AW, 1976, CANCER, V38, P1826, DOI 10.1002/1097-0142(197610)38:4<1826::AID-CNCR2820380460>3.0.CO;2-L; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Ryu EB, 2014, EUR RADIOL, V24, P2227, DOI 10.1007/s00330-014-3256-0; SPRATT JS, 1986, CANCER RES, V46, P970; TABBANE F, 1989, CANCER, V64, P2081, DOI 10.1002/1097-0142(19891115)64:10<2081::AID-CNCR2820641019>3.0.CO;2-7; VONFOURNIER D, 1980, CANCER-AM CANCER SOC, V45, P2198; Wagner JL, 2011, ANN SURG, V254, P119, DOI 10.1097/SLA.0b013e318217e97f; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092	26	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144144	10.1371/journal.pone.0144144	http://dx.doi.org/10.1371/journal.pone.0144144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657267	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903500014
J	Bu, RY; Lu, JW; Ren, T; Liu, B; Li, XK; Cong, RH				Bu, Rongyan; Lu, Jianwei; Ren, Tao; Liu, Bo; Li, Xiaokun; Cong, Rihuan			Particulate Organic Matter Affects Soil Nitrogen Mineralization under Two Crop Rotation Systems	PLOS ONE			English	Article							N-MINERALIZATION; LAND-USE; CARBON SEQUESTRATION; MICROBIAL BIOMASS; HUMIC FRACTIONS; PADDY; DECOMPOSITION; AVAILABILITY; PRODUCTIVITY; MANAGEMENT	Changes in the quantity and/or quality of soil labile organic matter between and after different types of cultivation system could play a dominant role in soil nitrogen (N) mineralization. The quantity and quality of particulate organic matter (POM) and potentially mineralizable-N (PMN) contents were measured in soils from 16 paired rice-rapeseed (RR)/cotton-rapeseed (CR) rotations sites in Hubei province, central China. Then four paired soils encompassing low (10th percentile), intermediate (25th and 75th percentiles), and high (90th percentile) levels of soil PMN were selected to further study the effects of POM on soil N mineralization by quantifying the net N mineralization in original soils and soils from which POM was removed. Both soil POM carbon (POM-C) and N (POM-N) contents were 45.8% and 55.8% higher under the RR rotation compared to the CR rotation, respectively. The PMN contents were highly correlated with the POM contents. The PMN and microbial biomass N (MBN) contents concurrently and significantly decreased when POM was removed. The reduction rate of PMN was positively correlated with changes in MBN after the removal of POM. The reduction rates of PMN and MBN after POM removal are lower under RR rotations (38.0% and 16.3%, respectively) than CR rotations (45.6% and 19.5%, respectively). Furthermore, infrared spectroscopy indicated that compounds with low-bioavailability accumulated (e.g., aromatic recalcitrant materials) in the soil POM fraction under the RR rotation but not under the CR rotation. The results of the present study demonstrated that POM plays a vital role in soil N mineralization under different rotation systems. The discrepancy between POM content and composition resulting from different crop rotation systems caused differences in N mineralization in soils.	[Bu, Rongyan; Lu, Jianwei; Ren, Tao; Liu, Bo; Li, Xiaokun; Cong, Rihuan] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Bu, Rongyan; Lu, Jianwei; Ren, Tao; Liu, Bo; Li, Xiaokun; Cong, Rihuan] Minist Agr, Key Lab Arable Land Conservat,Middle & Lower Reac, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Ren, T (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China.	rentao@mail.hzau.edu.cn		Ren, Tao/0000-0002-7147-3775	National Natural Science Foundation of China [41401324]; Specialize Research Fund for the Doctoral Program of Higher Education [20120146120021]; earmarked fund for China Agriculture Research System [CARS-13]; Fundamental Research Funds for the Central Universities [2013QC045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialize Research Fund for the Doctoral Program of Higher Education; earmarked fund for China Agriculture Research System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (41401324), the Specialize Research Fund for the Doctoral Program of Higher Education (20120146120021), the earmarked fund for China Agriculture Research System (CARS-13), and the Fundamental Research Funds for the Central Universities (2013QC045).	Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8; Besnard E, 1996, EUR J SOIL SCI, V47, P495, DOI 10.1111/j.1365-2389.1996.tb01849.x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Carpenter-Boggs L, 2000, SOIL SCI SOC AM J, V64, P2038, DOI 10.2136/sssaj2000.6462038x; Chang RY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085426; Chen XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103720; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Cookson WR, 2004, SOIL BIOL BIOCHEM, V36, P2097, DOI 10.1016/j.soilbio.2004.05.013; [戴传云 Dai Chuanyun], 2003, [重庆大学学报. 自然科学版, Journal of Chongqing University(Natural Science Edition)], V26, P15; Doane TA, 2003, GEODERMA, V114, P319, DOI 10.1016/S0016-7061(03)00047-8; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Gosling P, 2013, BIOL FERT SOILS, V49, P1001, DOI 10.1007/s00374-013-0791-9; Han ChengWei, 2007, Scientia Agricultura Sinica, V40, P107; Huang Shan, 2009, Huanjing Kexue, V30, P1146; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Lehmann J, 2001, GEODERMA, V99, P147, DOI 10.1016/S0016-7061(00)00070-7; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Liu XL, 2010, PEDOSPHERE, V20, P666, DOI 10.1016/S1002-0160(10)60056-2; Marriott EE, 2006, SOIL BIOL BIOCHEM, V38, P1527, DOI 10.1016/j.soilbio.2005.11.009; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; MEELU OP, 1979, PLANT SOIL, V51, P51, DOI 10.1007/BF02205926; Mendham DS, 2004, SOIL BIOL BIOCHEM, V36, P1067, DOI 10.1016/j.soilbio.2004.02.018; Olk DC, 2007, EUR J SOIL SCI, V58, P270, DOI 10.1111/j.1365-2389.2006.00836.x; Olk DC, 1996, EUR J SOIL SCI, V47, P293, DOI 10.1111/j.1365-2389.1996.tb01403.x; Preger AC, 2010, EUR J SOIL SCI, V61, P551, DOI 10.1111/j.1365-2389.2010.01248.x; Rahn CR, 2003, SOIL USE MANAGE, V19, P193, DOI [10.1079/SUM2003188, 10.1111/j.1475-2743.2003.tb00304.x]; Rahn CR, 2002, J SCI FOOD AGR, V82, P19, DOI 10.1002/jsfa.1003; Ros GH, 2012, SOIL BIOL BIOCHEM, V45, P132, DOI 10.1016/j.soilbio.2011.10.015; Ros GH, 2011, SOIL BIOL BIOCHEM, V43, P1714, DOI 10.1016/j.soilbio.2011.04.017; Roth PJ, 2011, GLOBAL CHANGE BIOL, V17, P3405, DOI 10.1111/j.1365-2486.2011.02500.x; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Sano S, 2006, SOIL SCI PLANT NUTR, V52, P49, DOI 10.1111/j.1747-0765.2006.00003.x; Sequeira CH, 2011, SOIL BIOL BIOCHEM, V43, P438, DOI 10.1016/j.soilbio.2010.11.014; [申小冉 SHEN Xiaoran], 2011, [干旱地区农业研究, Agricultural Research in the Arid Areas], V29, P121; SKJEMSTAD JO, 1990, AUST J SOIL RES, V28, P267, DOI 10.1071/SR9900267; Sparks D.L., 1996, SOIL SCI SOC AM BOOK; SPARLING G, 1993, SOIL BIOL BIOCHEM, V25, P1793, DOI 10.1016/0038-0717(93)90185-E; Stelzer RS, 2014, BIOGEOCHEMISTRY, V119, P387, DOI 10.1007/s10533-014-9975-0; Wang WN, 2012, FIELD CROP RES, V137, P37, DOI 10.1016/j.fcr.2012.08.010; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Whalen JK, 2000, SOIL BIOL BIOCHEM, V32, P1345, DOI 10.1016/S0038-0717(00)00040-7; Witt C, 2000, PLANT SOIL, V225, P263, DOI 10.1023/A:1026594118145; Xiang SR, 2008, SOIL BIOL BIOCHEM, V40, P2281, DOI 10.1016/j.soilbio.2008.05.004; Xiao KC, 2013, SOIL BIOL BIOCHEM, V67, P70, DOI 10.1016/j.soilbio.2013.08.012; Yamada T, 2010, JARQ-JPN AGR RES Q, V44, P269, DOI 10.6090/jarq.44.269; Yin F, 2007, J SOIL SEDIMENT, V7, P136, DOI 10.1065/jss2007.04.218; Zeller B, 2011, SOIL BIOL BIOCHEM, V43, P542, DOI 10.1016/j.soilbio.2010.11.019	48	22	24	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143835	10.1371/journal.pone.0143835	http://dx.doi.org/10.1371/journal.pone.0143835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26647157	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903100007
J	Moon, CM; Jung, SA; Kim, SE; Song, HJ; Jung, Y; Ye, BD; Cheon, JH; Kim, YS; Kim, YH; Kim, JS; Han, DS				Moon, Chang Mo; Jung, Sung-Ae; Kim, Seong-Eun; Song, Hyun Joo; Jung, Yunho; Ye, Byong Duk; Cheon, Jae Hee; Kim, You Sun; Kim, Young-Ho; Kim, Joo Sung; Han, Dong Soo		CONNECT Study Grp	Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HELICOBACTER-PYLORI; ULCERATIVE-COLITIS; RISK-FACTORS; FEATURES; CLASSIFICATION; EPIDEMIOLOGY; PREDICTORS; REMISSION; SURGERY	Diagnostic delay frequently occurs in Crohn's disease (CD) patients because of diagnostic limitations. However, diagnostic delay and its related factors remain poorly defined. Therefore, we aimed to identify the predictors associated with diagnostic delay and to evaluate the impact of diagnostic delay on clinical course in a Korean CD patient cohort. We performed a multicenter retrospective analysis of 1,047 CD patients registered in the Crohn's Disease Clinical Network and Cohort study in Korea. The mean interval of diagnostic delay was 16.0 +/- 33.1 months. Multivariate analysis showed that older age at diagnosis (>= 40 years) (p = 0.014), concomitant upper gastrointestinal (UGI) disease (p = 0.012) and penetrating disease behavior at diagnosis (p = 0.001) were positively associated with long diagnostic delay (>= 18 months). During the longitudinal follow-up, long diagnostic delay was independently predictive of further development of intestinal stenosis (hazard ratio [HR], 1.43; 95% confidence interval [CI], 1.07-1.93; p = 0.017), internal fistulas (HR, 1.62; 95% CI, 1.12-2.33; p = 0.011), and perianal fistulas (HR, 1.38; 95% CI, 1.06-1.80; p = 0.016). However, as for the risk of abscess formation, bowel perforation, and CD-related abdominal surgery, no significant association with diagnostic delay was observed. Older age at diagnosis, UGI involvement, and penetrating behavior are associated with long diagnostic delay in Korean CD patients. Moreover, diagnostic delay is associated with an increased risk of CD-related complications such as intestinal stenosis, internal fistulas, and perianal fistulas.	[Moon, Chang Mo; Jung, Sung-Ae; Kim, Seong-Eun] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Song, Hyun Joo] Jeju Natl Univ, Sch Med, Dept Internal Med, Jeju, South Korea; [Jung, Yunho] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Ye, Byong Duk] Univ Ulsan, Coll Med, Dept Internal Med, Seoul, South Korea; [Cheon, Jae Hee] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, You Sun] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Young-Ho] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Han, Dong Soo] Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med, Guri, South Korea	Ewha Womans University; Jeju National University; Soonchunhyang University; University of Ulsan; Yonsei University; Yonsei University Health System; Inje University; Sungkyunkwan University (SKKU); Seoul National University (SNU); Hanyang University	Jung, SA (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.	jassa@ewha.ac.kr	Han, Dong Soo/P-1753-2015; Ye, Byong Duk/AAF-4955-2020; Han, Dong Soo/AHD-6285-2022; Song, hyunjoo/GWC-1292-2022; Kim, You Sun/AFR-0428-2022; Cheon, Jae Hee/B-4523-2015	Ye, Byong Duk/0000-0001-6647-6325; Han, Dong Soo/0000-0001-7103-3318; Kim, You Sun/0000-0002-5156-3458; Cheon, Jae Hee/0000-0002-2282-8904; Jung, Seok Won/0000-0001-7001-0341; /0000-0002-7760-0050	Korea Centers for Disease Control and Prevention [2013-E63004-01]	Korea Centers for Disease Control and Prevention	This work was supported by the Research Program, funded by the Korea Centers for Disease Control and Prevention (2013-E63004-01).	Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; BROE PJ, 1982, SURGERY, V91, P249; Cheon JH, 2013, J GASTROEN HEPATOL, V28, P220, DOI 10.1111/jgh.12053; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Hall B, 2015, DIGEST DIS, V33, P42, DOI 10.1159/000366047; Kane SV, 2005, J CLIN GASTROENTEROL, V39, P32; Kim ES, 2010, GUT LIVER, V4, P1, DOI 10.5009/gnl.2010.4.1.1; Lakatos PL, 2007, WORLD J GASTROENTERO, V13, P6134, DOI 10.3748/wjg.13.6134; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Li Y, 2015, DIGEST LIVER DIS, V47, P544, DOI 10.1016/j.dld.2015.03.004; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; MARSHALL BJ, 1984, LANCET, V1, P1311; Moayyedi P, 2003, AM J GASTROENTEROL, V98, P2621, DOI [10.1016/j.amjgastroenterol.2003.07.003, 10.1111/j.1572-0241.2003.08724.x]; Moon CM, 2014, J GASTROEN HEPATOL, V29, P74, DOI 10.1111/jgh.12369; Nahon S, 2014, J CROHNS COLITIS, V8, P964, DOI 10.1016/j.crohns.2014.01.023; Ng SC, 2014, BEST PRACT RES CL GA, V28, P363, DOI 10.1016/j.bpg.2014.04.003; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; Oberhuber G, 2000, VIRCHOWS ARCH, V437, P293, DOI 10.1007/s004280000226; Park SH, 2007, INFLAMM BOWEL DIS, V13, P278, DOI 10.1002/ibd.20015; Perminow G, 2009, SCAND J GASTROENTERO, V44, P446, DOI 10.1080/00365520802647434; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1770, DOI 10.1038/ajg.2012.117; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3458; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Rutgeerts P, 2006, GASTROINTEST ENDOSC, V63, P433, DOI 10.1016/j.gie.2005.08.011; Ryan WR, 2004, AM J SURG, V187, P219, DOI 10.1016/j.amjsurg.2003.11.007; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schoepfer AM, 2013, AM J GASTROENTEROL, V108, P1744, DOI 10.1038/ajg.2013.248; Schoepfer AM, 2012, DIGESTION, V86, P23, DOI 10.1159/000341961; Schreiber S, 2010, AM J GASTROENTEROL, V105, P1574, DOI 10.1038/ajg.2010.78; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simren M, 2002, AM J GASTROENTEROL, V97, P389; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Song XM, 2011, DIS COLON RECTUM, V54, P1147, DOI 10.1097/DCR.0b013e318222ddc3; Thienpont C, 2014, DIGEST DIS, V32, P35, DOI 10.1159/000367824; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310; Ye BD, 2014, INTEST RES, V12, P263, DOI 10.5217/ir.2014.12.4.263; Ye Byong Duk, 2009, Korean J Gastroenterol, V53, P161; Ye BD, 2010, SCAND J GASTROENTERO, V45, P1178, DOI 10.3109/00365521.2010.497936; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x; Yoon JY, 2014, INTEST RES, V12, P80, DOI [10.5217/ir.2014.12.1.80, 10.5217/ir.2014.12.3.173]	43	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144390	10.1371/journal.pone.0144390	http://dx.doi.org/10.1371/journal.pone.0144390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26647084	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100023
J	Ali, TB; Schleret, TR; Reilly, BM; Chen, WY; Abagyan, R				Ali, Thibault B.; Schleret, Thomas R.; Reilly, Brian M.; Chen, Winston Yuchen; Abagyan, Ruben			Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RIVASTIGMINE; EFFICACY; SAFETY; PATCH	This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia. We conducted a statistical analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) and the Canada Vigilance Adverse Reaction Database (CVARD) concerning the side effects of cholinesterase inhibitors. The statistics calculated for each adverse event were the frequency and the reporting odds ratios (ROR). A total of 9877 and 2247 reports were extracted from the FAERS and CVARD databases, respectively. A disproportionately higher frequency of reports of death as an adverse event for rivastigmine, compared to the other acetylcholinesterase inhibiting drugs, was observed in both the FAERS (ROR = 3.42; CI95% = 2.94-3.98; P<0.0001) and CVARD (ROR = 3.67; CI95% = 1.92-7.00; P = 0.001) databases. While cholinesterase inhibitors remain to be an important therapeutic tool against Alzheimer's disease, the disproportionate prevalence of fatal outcomes with rivastigmine compared with alternatives should be taken into consideration.	[Ali, Thibault B.; Schleret, Thomas R.; Reilly, Brian M.; Chen, Winston Yuchen; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Abagyan, R (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	ruben@ucsd.edu		reilly, brian/0000-0001-7418-1359	NIGMS NIH HHS [R01 GM071872] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aly HAA, 2015, WHO TECH REP SER, V994, P1; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; Chen M, 2013, OVERVIEW POSTMARKETI; Chen Y., 2008, PHARM MED, V22, P359, DOI 10.1007/bf03256733; Emre M, 2010, CNS NEUROSCI THER, V16, P246, DOI 10.1111/j.1755-5949.2010.00141.x; Gruber T, 2007, NOVARTIS PHARM IMPOR; Guerchet M., 2013, POLICY BRIEF HEADS G; Han HJ, 2011, J CLIN NEUROL, V7, P137, DOI 10.3988/jcn.2011.7.3.137; Health Canada, 2013, INSTR CAN VIG ADV RE; Health Canada, 2014, CAN VIG ADV REACT ON; Health Canada, 2014, SEARCH CAN VIG ADV R; HOFFMAN KB, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0042866; Huang FL, 2010, CURR CLIN PHARMACOL, V5, P115, DOI 10.2174/157488410791110805; Jann MW, 2000, PHARMACOTHERAPY, V20, P1, DOI 10.1592/phco.20.1.1.34664; Lovborg H, 2012, CURR DRUG SAF, V7, P30, DOI 10.2174/157488612800492717; Pirker C, 2002, CONTACT DERMATITIS, V47, P135, DOI 10.1034/j.1600-0536.2002.470302.x; Prince M, 2013, WORLD ALZHEIMER REP; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Sahin OZ, 2014, CASE REPORT RARE CAS, V2014, P14; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; US Food and Drug Administration, 2014, FDA ADV EV REP SYST; Wilkinson D G, 1999, Expert Opin Pharmacother, V1, P121, DOI 10.1517/14656566.1.1.121; Wilkinson DG, 2004, DRUG AGING, V21, P453, DOI 10.2165/00002512-200421070-00004; Winblad B, 2007, NEUROLOGY, V69, pS14, DOI 10.1212/01.wnl.0000281847.17519.e0; Winston C, 2014, EARLY DRUG ALERT	29	85	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144337	10.1371/journal.pone.0144337	http://dx.doi.org/10.1371/journal.pone.0144337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642212	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700099
J	Sotiriadis, G; Dodagatta-Marri, E; Kouser, L; Alhamlan, FS; Kishore, U; Karteris, E				Sotiriadis, Georgios; Dodagatta-Marri, Eswari; Kouser, Lubna; Alhamlan, Fatimah S.; Kishore, Uday; Karteris, Emmanouil			Surfactant Proteins SP-A and SP-D Modulate Uterine Contractile Events in ULTR Myometrial Cell Line	PLOS ONE			English	Article							POOLED AMNIOTIC-FLUID; TRANSCRIPTION FACTOR; FETAL MEMBRANES; PRETERM BIRTH; EXPRESSION; PREGNANCY; PURIFICATION; CHEMOKINES; RECEPTORS; SUPPRESS	Pulmonary surfactant proteins SP-A and SP-D are pattern recognition innate immune molecules. However, there is extrapulmonary existence, especially in the amniotic fluid and at the feto-maternal interface. There is sufficient evidence to suggest that SP-A and SP-D are involved in the initiation of labour. This is of great importance given that preterm birth is associated with increased mortality and morbidity. In this study, we investigated the effects of recombinant forms of SP-A and SP-D (rhSP-A and rhSP-D, the comprising of trimeric lectin domain) on contractile events in vitro, using a human myometrial cell line (ULTR) as an experimental model. Treatment with rhSP-A or rhSP-D increased the cell velocity, distance travelled and displacement by ULTR cells. rhSP-A and rhSP-D also affected the contractile response of ULTRs when grown on collagen matrices showing reduced surface area. We investigated this effect further by measuring contractility-associated protein (CAP) genes. Treatment with rhSP-A and rhSP-D induced expression of oxytocin receptor (OXTR) and connexin 43 (CX43). In addition, rhSP-A and rhSP-D were able to induce secretion of GROa and IL-8. rhSP-D also induced the expression of IL-6 and IL-6 Ra. We provide evidence that SP-A and SP-D play a key role in modulating events prior to labour by reconditioning the human myometrium and in inducing CAP genes and pro-inflammatory cytokines thus shifting the uterus from a quiescent state to a contractile one.	[Sotiriadis, Georgios; Dodagatta-Marri, Eswari; Kouser, Lubna; Kishore, Uday; Karteris, Emmanouil] Brunel Univ London, Coll Hlth & Life Sci, Ctr Infect Immun & Dis Mech, Uxbridge UB8 3PH, Middx, England; [Alhamlan, Fatimah S.] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Karteris, Emmanouil] Brunel Univ London, Inst Environm Heath & Soc, Uxbridge UB8 3PH, Middx, England	Brunel University; King Faisal Specialist Hospital & Research Center; Brunel University	Karteris, E (corresponding author), Brunel Univ London, Coll Hlth & Life Sci, Ctr Infect Immun & Dis Mech, Uxbridge UB8 3PH, Middx, England.	Emmanouil.karteris@brunel.ac.uk	Karteris, Emmanouil/AAC-6821-2022; Kishore, Uday/Y-7976-2018	Kishore, Uday/0000-0002-6033-6759				Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; Borron PJ, 2002, J IMMUNOL, V169, P5844, DOI 10.4049/jimmunol.169.10.5844; Breuiller-Fouche M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1188, DOI 10.1152/ajpendo.00746.2009; Clemens SL, J APPL THEORY, p[1, 3]; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Devost D, 2007, AM J PHYSIOL-ENDOC M, V292, pE1, DOI 10.1152/ajpendo.00529.2005; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dodagatta-Marri E, 2014, METHODS MOL BIOL, V1100, P273, DOI 10.1007/978-1-62703-724-2_22; Foster HA, 2014, J STEROID BIOCHEM, V139, P166, DOI 10.1016/j.jsbmb.2013.02.017; Garcia-Verdugo I, 2008, BIOL REPROD, V79, P348, DOI 10.1095/biolreprod.108.068338; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HAAGSMAN HP, 1991, ANNU REV PHYSIOL, V53, P441, DOI 10.1146/annurev.physiol.53.1.441; Jaffer S, 2009, ENDOCRINOLOGY, V150, P4672, DOI 10.1210/en.2009-0419; Karbani N, 2014, METHODS MOL BIOL, V1100, P257, DOI 10.1007/978-1-62703-724-2_21; Karteris E, 2001, MOL GENET METAB, V72, P287, DOI 10.1006/mgme.2001.3159; Karteris E, 2001, J CLIN ENDOCR METAB, V86, P4512, DOI 10.1210/jc.86.9.4512; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Krolak-Olejnik B, 2006, PEDIATR INT, V48, P586, DOI 10.1111/j.1442-200X.2006.02289.x; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madhukaran SP, 2015, MOL IMMUNOL, V66, P197, DOI 10.1016/j.molimm.2015.03.001; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; MIYAMURA K, 1994, BBA-LIPID LIPID MET, V1210, P303, DOI 10.1016/0005-2760(94)90233-X; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Mosher AA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S7; Nadesalingam J, 2003, J BIOL CHEM, V278, P25678, DOI 10.1074/jbc.M210186200; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Oberley RE, 2004, MOL HUM REPROD, V10, P861, DOI 10.1093/molehr/gah117; OHMERSCHROCK D, 1995, J CELL SCI, V108, P3695; PEREZREYES N, 1992, P NATL ACAD SCI USA, V89, P1224, DOI 10.1073/pnas.89.4.1224; Rajagopal SP, 2015, MOL HUM REPROD; Reynolds LP, 1998, J ANIM SCI, V76, P1671; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Schaub B, 2004, CLIN EXP ALLERGY, V34, P1819, DOI 10.1111/j.1365-2222.2004.02068.x; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Sykes L, 2014, REPRODUCTION, V148, pR29, DOI 10.1530/REP-13-0587; Vassiliadis S, 2005, Clin Dev Immunol, V12, P125, DOI 10.1080/17402520500125484; Yadav AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108815; Zaragoza DB, 2006, BIOL REPROD, V75, P697, DOI 10.1095/biolreprod.106.053439	41	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143379	10.1371/journal.pone.0143379	http://dx.doi.org/10.1371/journal.pone.0143379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641881	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700016
J	Nelson, SM; Shay, AE; James, JL; Carlson, BA; Urban, JF; Prabhu, KS				Nelson, Shakira M.; Shay, Ashley E.; James, Jannaal L.; Carlson, Bradley A.; Urban, Joseph F., Jr.; Prabhu, K. Sandeep			Selenoprotein Expression in Macrophages Is Critical for Optimal Clearance of Parasitic Helminth Nippostrongylus brasiliensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; NEMATODE-INDUCED ALTERATIONS; GENE-EXPRESSION; SELENIUM DEFICIENCY; IMMUNE-RESPONSE; UP-REGULATION; IN-VIVO; CELLS; RECEPTOR; STAT6	The plasticity of macrophages is evident in helminthic parasite infections, providing protection from inflammation. Previously we demonstrated that the micronutrient selenium induces a phenotypic switch in macrophage activation from a classically activated (pro-inflammatory; M1/CAM) toward an alternatively activated (anti-inflammatory; M2/AAM) phenotype, where cyclooxygenase (COX)-dependent cyclopentenone prostaglandin J(2) (15d-PGJ(2)) plays a key role. Here, we hypothesize that dietary selenium modulates macrophage polarization toward an AAM phenotype to assist in the increasing clearance of adult Nippostrongylus brasiliensis, a gastrointestinal nematode parasite. Mice on a selenium-adequate (0.08 ppm) diet significantly augmented intestinal AAM presence while decreasing adult worms and fecal egg production when compared with infection of mice on selenium-deficient (<0.01 ppm) diet. Further increase in dietary selenium to supraphysiological levels (0.4 ppm) had very little or no impact on worm expulsion. Normal adult worm clearance and enhanced AAM marker expression were observed in the selenium-supplemented Trsp(fl/fl)Cre(WT) mice that express selenoproteins driven by tRNA(Sec) (Trsp), whereas N. brasiliensis-infected Trsp(fl/fl)Cre(LysM) selenium-supplemented mice showed a decreased clearance, with lowered intestinal expression of several AAM markers. Inhibition of the COX pathway with indomethacin resulted in delayed worm expulsion in selenium-adequate mice. This was rescued with 15d-PGJ(2), which partially recapitulated the effect of selenium supplementation on fecal egg output in addition to increasing markers of AAMs in the small intestine. Antagonism of PPAR gamma blocked the effect of selenium. These results suggest that optimal expression of selenoproteins and selenium-dependent production of COX-derived endogenous prostanoids, such as Delta(12)-PGJ(2) and 15d-PGJ(2), may regulate AAM activation to enhance anti-helminthic parasite responses.	[Nelson, Shakira M.; Shay, Ashley E.; James, Jannaal L.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Nelson, Shakira M.; Shay, Ashley E.; James, Jannaal L.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Nelson, Shakira M.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Carlson, Bradley A.] NCI, Mol Biol Selenium Sect, Mouse Canc Genet Program, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Agriculture (USDA)	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 115 Henning Bldg, University Pk, PA 16802 USA.	ksprabhu@psu.edu		Urban, Joseph/0000-0002-1590-8869	National Institutes of Health Public Health Service Grant [DK077152]; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project [4475]; National Institutes of Health Predoctoral Training Grant [T32 AI074551]; Agricultural Research Service of the United States Department of Agriculture [1235-5100-058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Grant; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project; National Institutes of Health Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agricultural Research Service of the United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant DK077152 and United States Department of Agriculture National Institute of Food and Agriculture Hatch Project 4475 (to K. S. P.), National Institutes of Health Predoctoral Training Grant T32 AI074551 (to A. E. S.), and the Agricultural Research Service of the United States Department of Agriculture (1235-5100-058) (to J. F. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony BJ, 2012, PPAR RES, V2012, DOI 10.1155/2012/128068; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Coste A, 2003, IMMUNITY, V19, P329, DOI 10.1016/S1074-7613(03)00229-2; de Souza AP, 2010, PARASITOL RES, V106, P1293, DOI 10.1007/s00436-010-1794-1; DUNN A, 1986, J HELMINTHOL, V60, P260, DOI 10.1017/S0022149X00008464; Fredericks GJ, 2015, ANTIOXID REDOX SIGN, V23, P854, DOI 10.1089/ars.2015.6375; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Horsnell WGC, 2010, IMMUNOBIOLOGY, V215, P704, DOI 10.1016/j.imbio.2010.05.011; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Panzer M, 2012, J IMMUNOL, V188, P615, DOI 10.4049/jimmunol.1101164; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Schmid-Grendelmeier P, 2002, J IMMUNOL, V169, P1021, DOI 10.4049/jimmunol.169.2.1021; Smith AD, 2013, INFECT IMMUN, V81, P2546, DOI 10.1128/IAI.01047-12; Sotillo J, 2014, MOL CELL PROTEOMICS, V13, P2736, DOI 10.1074/mcp.M114.038950; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Turanov AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140353; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Urban JF, 2001, J IMMUNOL, V167, P6078, DOI 10.4049/jimmunol.167.11.6078; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Yeung KJA, 2005, EXP PARASITOL, V109, P201, DOI 10.1016/j.exppara.2004.12.015; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	49	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2787	2798		10.1074/jbc.M115.684738	http://dx.doi.org/10.1074/jbc.M115.684738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644468	hybrid, Green Published			2022-12-26	WOS:000369626900019
J	Eidizadeh, A; Khajehalichalehshtari, M; Freyer, D; Trendelenburg, G				Eidizadeh, Abass; Khajehalichalehshtari, Manuel; Freyer, Dorette; Trendelenburg, George			Assessment of the Therapeutic Potential of Metallothionein-II Application in Focal Cerebral Ischemia In Vitro and In Vivo	PLOS ONE			English	Article							MEDIATED NEUROPROTECTION; NEURONAL INJURY; NITRIC-OXIDE; ROLES; MICE; REGENERATION; PROTEINS; PROTECTS; SURVIVAL; STROKE	Metallothionein-II (MT-II) is an ubiquitously expressed small-molecular-weight protein and highly induced in various species and tissues upon stress, inflammation, and ischemia. MT-deficiency exacerbates ischemic injury in rodent stroke models in vitro and in vivo. However, there is conflicting data on the potential neuroprotective effect of exogenously applied metallothionein. Thus, we applied MT-II in an in vitro stroke model and intraperitoneally (i.p.) in two in vivo standard models of transient middle cerebral artery occlusion (MCAO) (a 'stringent' one [ 60min MCAO/48h reperfusion] and a 'mild' one [30min MCAO/72h reperfusion]), as well as i.v. together with recombinant tissue plasminogen activator (rtPA) to evaluate if exogenous MT-II-application protects against ischemic stroke. Whereas MT-II did not protect against 60min MCAO, there was a significant reduction of direct and indirect infarct volumes and neurological deficit in the MT-II (i.p.) treated animals in the 'mild' model at 3d after MCAO. Furthermore, MT-II also improved survival of the mice after MCAO, suppressed TNF-alpha mRNA induction in ischemic brain tissue, and protected primary neuronal cells against oxygen-glucose-deprivation in vitro. Thus, exogenous application of MT-II protects against ischemic injury in vitro and in vivo. However, long-term studies with different species and larger sampling sizes are required before a clinical use can be envisaged.	[Eidizadeh, Abass; Khajehalichalehshtari, Manuel; Trendelenburg, George] Univ Med Ctr Gottingen, Dept Neurol, D-37075 Gottingen, Germany; [Freyer, Dorette] Charite Univ Med Ctr, Dept Neurol, D-10117 Berlin, Germany	University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Trendelenburg, G (corresponding author), Univ Med Ctr Gottingen, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.	george.trendelenburg@med.uni-goettingen.de		Eidizadeh, Abass/0000-0001-8910-3150	Ministry of Science and Culture of Lower Saxony (Niedersachsenstipendium); Georg-August-University Gottingen Foundation	Ministry of Science and Culture of Lower Saxony (Niedersachsenstipendium); Georg-August-University Gottingen Foundation	This work was supported by the Ministry of Science and Culture of Lower Saxony (Niedersachsenstipendium) to AE and Georg-August-University Gottingen Foundation to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Borghesi LA, 1996, CELL STRESS CHAPERON, V1, P99, DOI 10.1379/1466-1268(1996)001<0099:SPAAOI>2.3.CO;2; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Chung RS, 2008, J NEUROCHEM, V104, P14, DOI 10.1111/j.1171-4159.2007.05026.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Diaz-Ruiz A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/436429; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Ebadi M, 2005, MOL BRAIN RES, V134, P67, DOI 10.1016/j.molbrainres.2004.09.011; Edmands SD, 2009, ANESTHESIOLOGY, V110, P538, DOI 10.1097/ALN.0b013e3181974bba; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harhausen D, 2010, J IMMUNOL, V184, P6407, DOI 10.4049/jimmunol.0902342; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Howells C, 2010, FEBS J, V277, P2931, DOI 10.1111/j.1742-4658.2010.07718.x; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ito Y, 2013, CURR PHARM BIOTECHNO, V14, P400, DOI 10.2174/1389201011314040003; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Koumura A, 2009, BRAIN RES, V1292, P148, DOI 10.1016/j.brainres.2009.07.050; Kumari MVR, 1998, FREE RADICAL RES, V29, P93, DOI 10.1080/10715769800300111; Lautenschlager M, 2000, NEUROSCIENCE, V97, P383, DOI 10.1016/S0306-4522(99)00599-0; Leung JYK, 2012, CELL MOL LIFE SCI, V69, P809, DOI 10.1007/s00018-011-0790-7; Levene HB, 2007, J NEUROSCI METH, V164, P304, DOI 10.1016/j.jneumeth.2007.05.007; Lewis KE, 2012, HISTOL HISTOPATHOL, V27, P1459, DOI 10.14670/HH-27.1459; Lynes MA, 2006, EXP BIOL MED, V231, P1548, DOI 10.1177/153537020623100915; Malavolta M, 2012, REJUV RES, V15, P140, DOI 10.1089/rej.2011.1261; Neal JW, 1996, NEUROPATH APPL NEURO, V22, P243; Penkowa M, 1999, J NEUROSCI, V19, P2535; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARZ MA, 1995, P NATL ACAD SCI USA, V92, P4452, DOI 10.1073/pnas.92.10.4452; SEARLE PF, 1984, MOL CELL BIOL, V4, P1221, DOI 10.1128/MCB.4.7.1221; Sohn EJ, 2012, BBA-GEN SUBJECTS, V1820, P1647, DOI 10.1016/j.bbagen.2012.06.012; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; UITENBROEK D. G, 1997, SISA BINOMIAL; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; West AK, 2011, J BIOL INORG CHEM, V16, P1115, DOI 10.1007/s00775-011-0817-4; Ziegler G, 2011, J CEREBR BLOOD F MET, V31, P757, DOI 10.1038/jcbfm.2010.161	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144035	10.1371/journal.pone.0144035	http://dx.doi.org/10.1371/journal.pone.0144035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658636	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900023
J	Han, Y; Zhang, B; Qin, XT; Li, MY; Guo, YL				Han, Yao; Zhang, Bin; Qin, Xiaoting; Li, Mingyang; Guo, Yulong			Investigation of a miRNA-Induced Gene Silencing Technique in Petunia Reveals Alterations in miR173 Precursor Processing and the Accumulation of Secondary siRNAs from Endogenous Genes	PLOS ONE			English	Article							HAIRPIN RNA CONSTRUCTS; TRANS-ACTING SIRNAS; ARTIFICIAL MICRORNAS; FUNCTIONAL GENOMICS; ANTISENSE RNA; ONE-STEP; PLANTS; ARABIDOPSIS; BIOGENESIS; CLONING	MIGS (miRNA-induced gene silencing) is a straightforward and efficient gene silencing technique in Arabidopsis. It works by exploiting miR173 to trigger the production of phasiRNAs (phased small interfering RNAs). MIGS can be used in plant species other than Arabidopsis by co-expression of miR173 and target gene fragments fused to an upstream miR173 target site. However, the efficiency and technical mechanisms have not been thoroughly investigated in other plants. In this work, two vectors, pMIGS-chs and pMIGS-pds, were constructed and transformed into petunia plants. The transgenic plants showed CHS (chalcone synthase) and PDS (phytoene desaturase) gene-silencing phenotypes respectively, indicating that MIGS functions in petunia. MIGS-chs plants were used to investigate the mechanisms of this technique in petunia. Results of 50-RACE showed that the miR173 target site was cleaved at the expected position and that endogenous CHS genes were cut at multiple positions. Small RNA deep sequencing analysis showed that the processing of Arabidopsis miR173 precursors in MIGS-chs transgenic petunia plants did not occur in exactly the same way as in Arabidopsis, suggesting differences in the machinery of miRNA processing between plant species. Small RNAs in-phase with the miR173 cleavage register were produced immediately downstream from the cleavage site and out-of-phase small RNAs were accumulated at relatively high levels from processing cycle 5 onwards. Secondary siRNAs were generated from multiple sites of endogenous CHS-A and CHS-J genes, indicating that miR173 cleavage induced siRNAs have the same ability to initiate siRNA transitivity as the siRNAs functioning in co-suppression and hpRNA silencing. On account of the simplicity of vector construction and the transitive amplification of signals from endogenous transcripts, MIGS is a good alternative gene silencing method for plants, especially for silencing a cluster of homologous genes with redundant functions.	[Han, Yao; Zhang, Bin; Qin, Xiaoting; Li, Mingyang; Guo, Yulong] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing Engn Res Ctr Floriculture, Key Lab Hort Sci Southern Mt Reg,Minist Educ, Chongqing, Peoples R China	Southwest University - China	Guo, YL (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Chongqing Engn Res Ctr Floriculture, Key Lab Hort Sci Southern Mt Reg,Minist Educ, Chongqing, Peoples R China.	yulong@swu.edu.cn			National Natural Science Foundation of China [31272199]; '111' Project [B12006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '111' Project(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China (31272199, http://www.nsfc.gov.cn/) and the '111' Project (B12006, http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Cho YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076954; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Conner Anthony J., 2009, P395, DOI 10.1007/978-0-387-84796-2_19; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Gilchrist E, 2010, BRIEF FUNCT GENOMICS, V9, P103, DOI 10.1093/bfgp/elp059; Guo YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098783; Gutierrez-Nava MD, 2008, PLANT PHYSIOL, V147, P543, DOI 10.1104/pp.108.118307; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jiang YX, 2013, PLANTA, V238, P325, DOI 10.1007/s00425-013-1896-y; Kasai M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-63; KOES RE, 1989, GENE, V81, P245, DOI 10.1016/0378-1119(89)90185-6; Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; McHale M, 2013, PLANT J, V76, P519, DOI 10.1111/tpj.12306; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Purkayastha A, 2009, PLANT PHYSIOL BIOCH, V47, P967, DOI 10.1016/j.plaphy.2009.09.001; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Velten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030141; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038186; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zhang ZYJ, 2014, PLANTA, V239, P1139, DOI 10.1007/s00425-014-2054-x	52	8	9	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144909	10.1371/journal.pone.0144909	http://dx.doi.org/10.1371/journal.pone.0144909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658695	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900144
J	Hermes, C; Mettler, R; Santiago-Alarcon, D; Segelbacher, G; Schaefer, HM				Hermes, Claudia; Mettler, Raeann; Santiago-Alarcon, Diego; Segelbacher, Gernot; Schaefer, H. Martin			Spatial Isolation and Temporal Variation in Fitness and Condition Facilitate Divergence in a Migratory Divide	PLOS ONE			English	Article							DISRUPTIVE SELECTION; SYMPATRIC SPECIATION; SEDENTARY BLACKCAPS; SYLVIA-ATRICAPILLA; HABITAT PREFERENCE; BREEDING GROUNDS; EVOLUTION; HETEROZYGOSITY; MICROEVOLUTION; DIVERSITY	A novel migratory polymorphism evolved within the last 60 years in blackcaps (Sylvia atricapilla) breeding sympatrically in southwestern Germany. While most individuals winter in the traditional areas in the Mediterranean, a growing number of blackcaps started migrating to Britain instead. The rapid microevolution of this new strategy has been attributed to assortative mating and better physical condition of birds wintering in Britain. However, the isolating barriers as well as the physical condition of birds are not well known. In our study, we examined whether spatial isolation occurred among individuals with distinct migratory behaviour and birds with different arrival dates also differed in physical and genetic condition. We caught blackcaps in six consecutive years upon arrival on the breeding grounds and assigned them via stable isotope analysis to their wintering areas. Analysis of the vegetation structure within blackcap territories revealed different microhabitat preferences of birds migrating to distinct wintering areas. Blackcaps arriving early on the breeding grounds had higher survival rates, better body condition and higher multilocus heterozygosities than later arriving birds. We did however not find an effect of parasite infection status on arrival time. Our results suggest that early arriving birds have disproportionate effects on population dynamics. Allochrony and habitat isolation may thus act together to facilitate ongoing divergence in hybrid zones, and migratory divides in particular.	[Hermes, Claudia; Mettler, Raeann; Santiago-Alarcon, Diego; Schaefer, H. Martin] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, Freiburg, Germany; [Santiago-Alarcon, Diego] Inst Ecol AC, Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico; [Segelbacher, Gernot] Univ Freiburg, Fac Environm & Nat Resources, Dept Wildlife Ecol & Management, Freiburg, Germany	University of Freiburg; Instituto de Ecologia - Mexico; University of Freiburg	Hermes, C (corresponding author), Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, Freiburg, Germany.	claudia.hermes@wildlife.uni-freiburg.de	Santiago-Alarcon, Diego/G-2485-2018; Santiago-Alarcon, Diego/AAF-3641-2020; Segelbacher, Gernot/F-3633-2011	Santiago-Alarcon, Diego/0000-0002-4914-5580; Santiago-Alarcon, Diego/0000-0002-4914-5580; Segelbacher, Gernot/0000-0002-8024-7008	Deutsche Forschungsgmeinschaft [1008/6-1]; Alexander von Humboldt-Stiftung; Wissenschaftliche Gesellschaft Freiburg; German Research Foundation (DFG); Albert Ludwigs University Freiburg; DFG [1008/6-1]	Deutsche Forschungsgmeinschaft; Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation); Wissenschaftliche Gesellschaft Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgmeinschaft (www.dfg.de, grant number 1008/6-1 to HMS), the Alexander von Humboldt-Stiftung (www.humboldt-foundation.de, postdoctoral grant to DS-A) and Wissenschaftliche Gesellschaft Freiburg (www.wissges.uni-freiburg.de, grant to HMS and GS). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gregor Rolshausen, Marius Adrion and Nicola Moratscheck for their help with collecting field data. Isotope analyses were performed by Keith A. Hobson and Len I. Wassenaar (Environment Canada, Saskatoon, Canada). This research was funded by DFG grant 1008/6-1. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Aksoy S, 2013, MOL ECOL RESOUR, V13, P341, DOI 10.1111/1755-0998.12061; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; BAIRLEIN F, 1978, Journal fuer Ornithologie, V119, P14, DOI 10.1007/BF01642970; BAIRLEIN F, 1980, Journal fuer Ornithologie, V121, P325, DOI 10.1007/BF01643331; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Beltman JB, 2005, THEOR POPUL BIOL, V67, P189, DOI 10.1016/j.tpb.2005.01.001; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; BERTHOLD P, 1995, BIRD STUDY, V42, P89, DOI 10.1080/00063659509477155; Berthold P, 1990, MONCHSGRASMUCKE SYLV; Bibby C.J., 1995, METHODEN FELDORNITHO; Brelsford A, 2009, EVOLUTION, V63, P3050, DOI 10.1111/j.1558-5646.2009.00777.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; de la Hera I, 2012, J AVIAN BIOL, V43, P333, DOI 10.1111/j.1600-048X.2012.05804.x; DeGroote LW, 2010, J AVIAN BIOL, V41, P147, DOI 10.1111/j.1600-048X.2009.04782.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Fraser KC, 2008, AVIAN CONSERV ECOL, V3; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Glutz von Blotzheim U.N., 1991, HDB VOGEL MITTELEURO; Gwinner E, 1990, BIRD MIGRATION PHYSL; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; HELBIG AJ, 1994, NATURWISSENSCHAFTEN, V81, P184, DOI 10.1007/BF01134540; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; HOILEITNER M, 1995, BEHAV ECOL SOCIOBIOL, V37, P399, DOI 10.1007/BF00170587; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; Mettler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081365; Moller AP, 2011, J EVOLUTION BIOL, V24, P676, DOI 10.1111/j.1420-9101.2010.02202.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Olano-Marin J, 2011, EVOLUTION, V65, P3175, DOI 10.1111/j.1558-5646.2011.01369.x; Olano-Marin J, 2011, MOL ECOL, V20, P4028, DOI 10.1111/j.1365-294X.2011.05177.x; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Perez-Tris J, 2002, J ANIM ECOL, V71, P211, DOI 10.1046/j.1365-2656.2002.00590.x; Phillimore AB, 2008, AM NAT, V171, P646, DOI 10.1086/587074; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICE WR, 1988, AM NAT, V131, P911, DOI 10.1086/284831; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rolshausen G, 2010, OECOLOGIA, V162, P175, DOI 10.1007/s00442-009-1445-3; Ruegg K, 2012, J EVOLUTION BIOL, V25, P1741, DOI 10.1111/j.1420-9101.2012.02554.x; Sandberg R, 1996, OIKOS, V77, P577, DOI 10.2307/3545949; Santiago-Alarcon D, 2011, PARASITOLOGY, V138, P824, DOI 10.1017/S0031182011000515; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; Segelbacher G, 2008, MOL ECOL RESOUR, V8, P1108, DOI 10.1111/j.1755-0998.2008.02171.x; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Vallin N, 2011, INT J ECOL, V2011, P1; Wassenaar LI, 2007, ISOT ENVIRON HEALT S, V39, P211	54	0	1	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144264	10.1371/journal.pone.0144264	http://dx.doi.org/10.1371/journal.pone.0144264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656955	Green Published, gold			2022-12-26	WOS:000366715900036
J	Khan, SU; Ali, N; Abbas, Z				Khan, Sami Ullah; Ali, Nasir; Abbas, Zaheer			Hydromagnetic Flow and Heat Transfer over a Porous Oscillating Stretching Surface in a Viscoelastic Fluid with Porous Medium	PLOS ONE			English	Article							STAGNATION POINT FLOW; MICROPOLAR FLUID; MHD FLOW; SHEET; 2ND-GRADE; SUCTION; MASS	An analysis is carried out to study the heat transfer in unsteady two-dimensional boundary layer flow of a magnetohydrodynamics (MHD) second grade fluid over a porous oscillating stretching surface embedded in porous medium. The flow is induced due to infinite elastic sheet which is stretched periodically. With the help of dimensionless variables, the governing flow equations are reduced to a system of non-linear partial differential equations. This system has been solved numerically using the finite difference scheme, in which a coordinate transformation is used to transform the semi-infinite physical space to a bounded computational domain. The influence of the involved parameters on the flow, the temperature distribution, the skin-friction coefficient and the local Nusselt number is shown and discussed in detail. The study reveals that an oscillatory sheet embedded in a fluid-saturated porous medium generates oscillatory motion in the fluid. The amplitude and phase of oscillations depends on the rheology of the fluid as well as on the other parameters coming through imposed boundary conditions, inclusion of body force term and permeability of the porous medium. It is found that amplitude of flow velocity increases with increasing visco-elastic and mass suction/injection parameters. However, it decreases with increasing the strength of the applied magnetic field. Moreover, the temperature of fluid is a decreasing function of viscoelastic parameter, mass suction/injection parameter and Prandtl number.	[Khan, Sami Ullah; Ali, Nasir] Int Islamic Univ, Dept Math & Stat, Islamabad 44000, Pakistan; [Abbas, Zaheer] Islamia Univ Bahawalpur, Dept Math, Bahawalpur 63100, Pakistan	International Islamic University, Pakistan; Islamia University of Bahawalpur	Khan, SU (corresponding author), Int Islamic Univ, Dept Math & Stat, Islamabad 44000, Pakistan.	sk_iiu@yahoo.com	Abbas, Zaheer/ABD-6378-2021; Ali, Nasir/ABB-1446-2021; Sami, Khan Ullah/AAZ-6520-2021; Abbas, Zaheer/AAZ-4317-2021; Abbas, Zaheer/AAZ-4295-2021	Abbas, Zaheer/0000-0002-1300-7098; Abbas, Zaheer/0000-0002-1300-7098				Abbas Z, 2008, INT J NONLIN MECH, V43, P783, DOI 10.1016/j.ijnonlinmec.2008.04.009; Abbas Z, 2009, INT J NUMER METH FL, V59, P443, DOI 10.1002/fld.1825; Ali Nasir, 2015, Nonlinear Engineering. Modeling and Application, V4, P223, DOI 10.1515/nleng-2015-0019; Ali N, 2015, COMPUTER ME IN PRESS, DOI [10.1080/10255842.2015, DOI 10.1080/10255842.2015]; Ali N, 2015, Z NATURFORSCH A, V70, P567, DOI 10.1515/zna-2014-0273; Baag S, 2014, J KING SAUD IN PRESS; Cortell R, 2006, INT J HEAT MASS TRAN, V49, P1851, DOI 10.1016/j.ijheatmasstransfer.2005.11.013; Cortell R, 2006, INT J NONLIN MECH, V41, P78, DOI 10.1016/j.ijnonlinmec.2005.04.008; DANDAPAT BS, 1989, INT J NONLINEAR MECH, V24, P215, DOI 10.1016/0020-7462(89)90040-1; Davidson P.A., 2001, INTRO MAGNETOHYDRODY, P431, DOI [DOI 10.1017/CB09780511626333, 10.1017/CBO9780511626333, DOI 10.1017/CBO9780511626333]; Gul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126698; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; Hayat T, 2008, INT J HEAT MASS TRAN, V51, P4528, DOI 10.1016/j.ijheatmasstransfer.2007.12.022; Ishak A, 2008, MECCANICA, V43, P411, DOI 10.1007/s11012-007-9103-5; Javed T, 2015, CAN J PHYS, V93, P1138, DOI 10.1139/cjp-2014-0270; Khan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095423; MCLEOD JB, 1987, ARCH RATION MECH AN, V98, P385, DOI 10.1007/BF00276915; Mishra SR, 2015, ALEX ENG J, V54, P681, DOI 10.1016/j.aej.2015.04.010; Mishra SR, 2013, INT J HEAT MASS TRAN, V57, P433, DOI 10.1016/j.ijheatmasstransfer.2012.10.053; Mishra S. R., 2013, WORLD APPL SCI J, V28, P1275; Mohanty B, 2015, ALEX ENG J, V54, P223, DOI 10.1016/j.aej.2015.03.010; Nazar R, 2004, INT J NONLIN MECH, V39, P1227, DOI [10.1016/j.ijnonlinmec.2003.08.007, 10.1016/j.ijnonlinemec.2003.08.007]; RAJAGOPAL KR, 1984, RHEOL ACTA, V23, P213, DOI 10.1007/BF01332078; ROLLINS D, 1991, ACTA MECH, V89, P167, DOI 10.1007/BF01171253; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Sheikh M, 2015, J MAG MAGNE IN PRESS, P3043; Tripathy RS, 2015, ALEX ENG J, V54, P673, DOI 10.1016/j.aej.2015.04.012; WANG CY, 1988, ACTA MECH, V72, P261, DOI 10.1007/BF01178312; Wang YQ, 2008, NONLINEAR ANAL-REAL, V9, P1269, DOI 10.1016/j.nonrwa.2007.02.016; Wang YQ, 2007, INT J NONLINEAR MECH, V42, P432, DOI 10.1016/j.ijnonlinmec.2007.01.003; Zheng LC, 2013, ACTA MECH SINICA-PRC, V29, P667, DOI 10.1007/s10409-013-0066-6	31	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144299	10.1371/journal.pone.0144299	http://dx.doi.org/10.1371/journal.pone.0144299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657931	Green Submitted, gold, Green Published			2022-12-26	WOS:000366715900037
J	Scott, N; McBryde, E; Kirwan, A; Stoove, M				Scott, Nick; McBryde, Emma; Kirwan, Amy; Stoove, Mark			Modelling the Impact of Condom Distribution on the Incidence and Prevalence of Sexually Transmitted Infections in an Adult Male Prison System	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; SOUTH-WALES PRISONS; HIV TRANSMISSION; AUSTRALIA; SEX; OUTBREAK; SYPHILIS	Aims To determine the effects of 1) a condom distribution program and 2) a condom distribution program combined with opt-out sexually transmitted infection (STI) screening on the transmission and prevalence of STIs in a prison system. Methods Using data from an implementation evaluation of a state-wide prison condom program and parameter estimates from available literature, a deterministic model was developed to quantify the incidence and prevalence of sexually transmitted HIV, hepatitis B, chlamydia, syphilis and gonorrhoea across 14 Victorian prisons. The model included individual prison populations (by longer (>2 years) or shorter sentence lengths) and monthly prisoner transfers. For each STI, simulations were compared: without any intervention; with a condom distribution program; and with a combined condom and opt-out STI screening at prison reception intervention program. Results Condoms reduced the annual incidence of syphilis by 99% (N = 66 averted cases); gonorrhoea by 98% (N = 113 cases); hepatitis B by 71% (N = 5 cases); chlamydia by 27% (N = 196 cases); and HIV by 50% (N = 2 cases every 10 years). Condom availability changed the in-prison epidemiology of gonorrhoea and syphilis from self-sustaining to levels unlikely to result in infection outbreaks; however, condoms did not reduce chlamydia prevalence below a self-sustaining level due to its high infectiousness, high prevalence and low detection rate. When combined with a screening intervention program, condoms reduced chlamydia prevalence further, but not below a self-sustaining level. The low prevalence of HIV and hepatitis B in Australian prisons meant the effects of condoms were predicted to be small. Conclusion Condoms are predicted to effectively reduce the incidence of STIs in prison and are predicted to control syphilis and gonorrhoea transmission, however even combined with a screening on arrival program may be insufficient to reduce chlamydia prevalence below self-sustaining levels. To control chlamydia transmission additional screening of the existing prison population would be required.	[Scott, Nick; McBryde, Emma; Kirwan, Amy; Stoove, Mark] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia; [Scott, Nick; Stoove, Mark] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3008, Australia; [McBryde, Emma] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia; [McBryde, Emma] Univ Melbourne, Dept Med, Parkville, Vic 3050, Australia	Burnet Institute; Monash University; James Cook University; University of Melbourne	Scott, N (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia.	Nick.Scott@Burnet.edu.au	; McBryde, Emma/D-2220-2018	Stoove, Mark/0000-0003-2887-1409; McBryde, Emma/0000-0002-9570-9172	Justice Health, Victorian Department of Justice	Justice Health, Victorian Department of Justice	The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program. The authors wish to thank Justice Health, Victorian Department of Justice, for funding this modelling component as part of a broader evaluation of their condom implementation program. The authors also wish to thank Justice Health and Corrections Victoria for the provision of some of the operations data utilised in the modelling.; Justice Health, Victorian Department of Justice funded this modelling study as part of a broader evaluation of their condom implementation program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2011, THE HEALTH OF AUSTRA; ALCABES P, 1988, NEW YORK STATE J MED, V88, P495; Anglemyer A, 2013, JAMA-J AM MED ASSOC, V310, P1619, DOI [10.1001/jama.2013.278328, 10.1002/14651858.CD009153.pub3]; Australian Government Department of Health, 2014, THIRD NATIONAL SEXUA; Baggaley RF, 2010, INTERNATIONAL JOURNA; Braithwaite J, 2002, BRIT J CRIMINOL, V42, P563, DOI 10.1093/bjc/42.3.563; Butler T, 2003, THE 2001 NEW SOUTH W; Butler T, 2011, NATIONAL PRISON ENTR; Butler T, 2010, SEXUAL HEALTH AND BE; Butler T, 2008, AUST NZ J PUBL HEAL, V32, P73, DOI 10.1111/j.1753-6405.2008.00169.x; Butler T, 2002, AUST NZ J PUBL HEAL, V26, P390, DOI 10.1111/j.1467-842X.2002.tb00193.x; Butler T, 2011, DRUG ALCOHOL REV, V30, P188, DOI 10.1111/j.1465-3362.2010.00216.x; Calzavara L, 1998, RESEAU JURIDIQUE CAN, V5, P9; Chen JL, 2002, AM J PUBLIC HEALTH, V92, P1473, DOI 10.2105/AJPH.92.9.1473; CROFTS N, 1995, BRIT MED J, V310, P285, DOI 10.1136/bmj.310.6975.285; Dolan K, 2004, J LAW MED ETHICS, V32, P124, DOI 10.1111/j.1748-720X.2004.tb00457.x; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Forrest G, 2009, INT J PRISON HEALTH, V5, P233, DOI 10.1080/17449200903343274; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P234, DOI 10.1111/j.1467-842X.2003.tb00814.x; Guy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071436; Heale P, 2003, SURVEY OF HARMS IN V; Hellard M E, 2004, Sex Health, V1, P107, DOI 10.1071/SH03018; HEYMANN DL, 2008, CONTROL OF COMMUNICA; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Hunt DR, 2009, AM J GASTROENTEROL, V104, P1024, DOI 10.1038/ajg.2008.143; Iversen J, 2012, AUSTRALIAN NEEDLE AN; Jurgens R, 1996, HIV AIDS IN PRISONS; Krebs CP, 2002, AIDS EDUC PREV, V14, P53, DOI 10.1521/aeap.14.7.53.23865; Lewis D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-113; Melbourne Sexual Health Centre, 2012, CHLAMYDIA GONORRHOEA; Richters J, 2008, SEXUAL HEALTH AND BE; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Sylla M, 2010, AM J PUBLIC HEALTH, V100, P982, DOI 10.2105/AJPH.2009.172452; The Kirby Institute, 2014, HIV VIRAL HEPATITIS; Tucker JD, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-296; Vynnycky E, 2010, AN INTRODUCTION TO I; Werb D, 2008, J PUBLIC HEALTH-UK, V30, P126, DOI 10.1093/pubmed/fdn021; Wilson DP, 2010, SEX TRANSM INFECT, V86, P117, DOI 10.1136/sti.2009.036673; Winter R, 2009, FINAL REPORT TO THE; Wolfe MI, 2001, AM J PUBLIC HEALTH, V91, P1220, DOI 10.2105/AJPH.91.8.1220; World Health Organisation (WHO), 2005, PREVALENCE AND INCID; World Health Organisation (WHO), 2015, CONSOLIDATED GUIDELI; Yap L, 2007, SEX TRANSM INFECT, V83, P219, DOI 10.1136/sti.2006.022996	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144869	10.1371/journal.pone.0144869	http://dx.doi.org/10.1371/journal.pone.0144869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658518	gold, Green Accepted, Green Published			2022-12-26	WOS:000366715900127
J	Asaridou, SS; Hagoort, P; McQueen, JM				Asaridou, Salomi S.; Hagoort, Peter; McQueen, James M.			Effects of Early Bilingual Experience with a Tone and a Non-Tone Language on Speech-Music Integration	PLOS ONE			English	Article							PITCH; PERCEPTION	We investigated music and language processing in a group of early bilinguals who spoke a tone language and a non-tone language (Cantonese and Dutch). We assessed online speech-music processing interactions, that is, interactions that occur when speech and music are processed simultaneously in songs, with a speeded classification task. In this task, participants judged sung pseudowords either musically (based on the direction of the musical interval) or phonologically (based on the identity of the sung vowel). We also assessed longer-term effects of linguistic experience on musical ability, that is, the influence of extensive prior experience with language when processing music. These effects were assessed with a task in which participants had to learn to identify musical intervals and with four pitch-perception tasks. Our hypothesis was that due to their experience in two different languages using lexical versus intonational tone, the early Cantonese-Dutch bilinguals would outperform the Dutch control participants. In online processing, the Cantonese-Dutch bilinguals processed speech and music more holistically than controls. This effect seems to be driven by experience with a tone language, in which integration of segmental and pitch information is fundamental. Regarding longer-term effects of linguistic experience, we found no evidence for a bilingual advantage in either the music-interval learning task or the pitch-perception tasks. Together, these results suggest that being a Cantonese-Dutch bilingual does not have any measurable longer-term effects on pitch and music processing, but does have consequences for how speech and music are processed jointly.	[Asaridou, Salomi S.; Hagoort, Peter; McQueen, James M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Asaridou, Salomi S.; Hagoort, Peter; McQueen, James M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [McQueen, James M.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen	Asaridou, SS (corresponding author), Univ Calif Irvine, Sch Med, Dept Neurol, Irvine, CA 92717 USA.	sasarido@uci.edu	Hagoort, Peter/B-7417-2012; McQueen, James M./B-2212-2010	McQueen, James M./0000-0003-3734-6286	International Max Planck Research School	International Max Planck Research School	This work was supported by an International Max Planck Research School doctoral fellowship awarded to SSA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Asaridou SS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00321; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bauer RS., 1997, GRUYTER, DOI [10.1515/9783110823707, DOI 10.1515/9783110823707]; Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Bialystok E, 2015, PSYCHOL SCI, V26, P944, DOI 10.1177/0956797615573759; Bialystok Ellen, 2001, ANNU REV APPL LINGUI, V21, P169, DOI [DOI 10.1017/S0267190501000101, 10.1017/S0267190501000101]; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Boersma P, 2021, PRAAT DOING PHONETIC; Bradley E. D., 2013, REV RES HUMAN LEARNI, V1; CAMPBELL R, 1995, BRIT J DEV PSYCHOL, V13, P61, DOI 10.1111/j.2044-835X.1995.tb00664.x; Chandrasekaran B, 2007, BRAIN RES, V1128, P148, DOI 10.1016/j.brainres.2006.10.064; Cooper A, 2012, J ACOUST SOC AM, V131, P4756, DOI 10.1121/1.4714355; de Bruin A, 2015, PSYCHOL SCI, V26, P99, DOI 10.1177/0956797614557866; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Garner W. R., 1983, PERCEPTION COGNITION, P1, DOI DOI 10.1016/S0896-6273(02)00897-8; GARNER WR, 1970, COGNITIVE PSYCHOL, V1, P225, DOI 10.1016/0010-0285(70)90016-2; Giuliano RJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00146; Gordon RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009889; Hart J., 1998, INTONATION SYSTEMS S, P96; Hove MJ, 2010, PSYCHON B REV, V17, P310, DOI 10.3758/PBR.17.3.310; Iverson P, 2003, COGNITION, V87, pB47, DOI 10.1016/S0010-0277(02)00198-1; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Khouw E, 2007, J PHONETICS, V35, P104, DOI 10.1016/j.wocn.2005.10.003; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; LEE L, 1993, PERCEPT PSYCHOPHYS, V53, P157, DOI 10.3758/BF03211726; Li P, 2006, BEHAV RES METHODS, V38, P202, DOI 10.3758/BF03192770; Macmillan NA, 2005, DETECTION THEORY USE; Marie C, 2012, CORTEX, V48, P447, DOI 10.1016/j.cortex.2010.11.006; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Peretz I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00145; Pfordresher PQ, 2009, ATTEN PERCEPT PSYCHO, V71, P1385, DOI 10.3758/APP.71.6.1385; REPP BH, 1990, J PHONETICS, V18, P481, DOI 10.1016/S0095-4470(19)30410-3; Ressel V, 2012, J NEUROSCI, V32, P16597, DOI 10.1523/JNEUROSCI.1996-12.2012; Rodriguez-Fornells A, 2006, LANG LEARN, V56, P133, DOI 10.1111/j.1467-9922.2006.00359.x; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Singh L, 2012, COGNITION, V124, P128, DOI 10.1016/j.cognition.2012.05.008; Stevens CJ, 2013, PSYCHOL MUSIC, V41, P59, DOI 10.1177/0305735611415749; Wong PCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033424	46	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144225	10.1371/journal.pone.0144225	http://dx.doi.org/10.1371/journal.pone.0144225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1ZA	26659377	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600029
J	Kanemaru, K; Noguchi, E; Tokunaga, T; Nagai, K; Hiroyama, T; Nakamura, Y; Tahara-Hanaoka, S; Shibuya, A				Kanemaru, Kazumasa; Noguchi, Emiko; Tokunaga, Takahiro; Nagai, Kei; Hiroyama, Takashi; Nakamura, Yukio; Tahara-Hanaoka, Satoko; Shibuya, Akira			Tie2 Signaling Enhances Mast Cell Progenitor Adhesion to Vascular Cell Adhesion Molecule1 (VCAM-1) through alpha 4 beta 1 Integrin	PLOS ONE			English	Article							BONE-MARROW; IMMUNOGLOBULIN-E; IN-VIVO; INFLAMMATORY RESPONSES; EXPRESSION CLONING; PERIPHERAL-BLOOD; RECEPTOR; ACTIVATION; LIGAND; ANGIOPOIETIN-2	Mast cell (MC) activation contributes considerably to immune responses, such as host protection and allergy. Cell surface immunoreceptors expressed on MCs play an important role in MC activation. Although various immunoreceptors on MCs have been identified, the regulatory mechanism of MC activation is not fully understood. To understand the regulatory mechanisms of MC activation, we used gene expression analyses of human and mouse MCs to identify a novel immunoreceptor expressed on MCs. We found that Tek, which encodes Tie2, was preferentially expressed in the MCs of both humans and mice. However, Tie2 was not detected on the cell surface of the mouse MCs of the peritoneal cavity, ear skin, or colon lamina propria. In contrast, it was expressed on mouse bone marrow-derived MCs and bone marrow MC progenitors (BM-MCps). Stimulation of Tie2 by its ligand angiopoietin- 1 induced tyrosine phosphorylation of Tie2 in MEDMC-BRC6, a mouse embryonic stem cell-derived mast cell line, and enhanced MEDMC-BRC6 and mouse BM-MCp adhesion to vascular cell adhesion molecule-1 (VCAM-1) through alpha 4 beta 1 integrin. These results suggest that Tie2 signaling induces alpha 4 beta 1 integrin activation on BM-MCps for adhesion to VCAM-1.	[Kanemaru, Kazumasa; Nagai, Kei; Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko; Tokunaga, Takahiro] Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan; [Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko; Tahara-Hanaoka, Satoko; Shibuya, Akira] Core Res Evolut Sci & Technol AMED CREST, Tokyo, Japan; [Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Tokunaga, Takahiro] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; RIKEN; University of Fukui	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp	Nakamura, Yukio/A-5263-2016	Nakamura, Yukio/0000-0001-8056-4946; Nagai, Kei/0000-0001-5050-5291	Ministry of Education, Culture, Sports, Science and Technology of Japan;  [13J00798]; Grants-in-Aid for Scientific Research [15K15659] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by grants to AS, EN and ST-H, provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported in part by grants to KK, provided by Grant- in-Aid for Japan Society for the Promotion of Science Fellows (grant number 13J00798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2006, BLOOD, V108, P1588, DOI 10.1182/blood-2005-12-012781; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Boyce JA, 2002, BLOOD, V99, P2890, DOI 10.1182/blood.V99.8.2890; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; Collmann E, 2013, J ALLERGY CLIN IMMUN, V132, P959, DOI 10.1016/j.jaci.2013.03.008; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; Dahlin JS, 2012, J IMMUNOL, V189, P3869, DOI 10.4049/jimmunol.1201200; Dahlin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020261; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Hurst SD, 1999, J IMMUNOL, V163, P5937; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koh GY, 2013, TRENDS MOL MED, V19, P31, DOI 10.1016/j.molmed.2012.10.010; Koksal BT, 2014, ALLERGY ASTHMA PROC, V35, P482, DOI 10.2500/aap.2014.35.3793; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lee OH, 2006, MOL CANCER RES, V4, P915, DOI 10.1158/1541-7786.MCR-06-0184; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Makinde TO, 2011, AM J RESP CELL MOL, V44, P384, DOI 10.1165/rcmb.2009-0330OC; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Migalovich-Sheikhet H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00238; Moon KY, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-143; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076160; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Pennock JL, 2004, BLOOD, V103, P2655, DOI 10.1182/blood-2003-09-3146; Pepinsky RB, 2002, BIOCHEMISTRY-US, V41, P7125, DOI 10.1021/bi020024d; Ratajczak MZ, 2015, LEUKEMIA, V29, P1452, DOI 10.1038/leu.2015.66; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Shik D, 2010, CLIN EXP ALLERGY, V40, P700, DOI 10.1111/j.1365-2222.2010.03501.x; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Yamakawa D, 2013, J BIOL CHEM, V288, P12469, DOI 10.1074/jbc.M112.433979; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zhou BO, 2015, ELIFE, V4, DOI 10.7554/eLife.05521	56	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144436	10.1371/journal.pone.0144436	http://dx.doi.org/10.1371/journal.pone.0144436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659448	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600046
J	Lu, WY; Chen, JY; Chang, CF; Weng, WC; Lee, WT; Shieh, JS				Lu, Wen-Yu; Chen, Jyun-Yu; Chang, Chi-Feng; Weng, Wen-Chin; Lee, Wang-Tso; Shieh, Jiann-Shing			Multiscale Entropy of Electroencephalogram as a Potential Predictor for the Prognosis of Neonatal Seizures	PLOS ONE			English	Article							IMMATURE BRAIN; TIME-SERIES; EEG; COMPLEXITY; MECHANISMS; MANAGEMENT; EPILEPSY; STATE	Objective Increasing animal studies supported the harmful effects of prolonged or frequent neonatal seizures in developing brain, including increased risk of later epilepsy. Various nonlinear analytic measures had been applied to investigate the change of brain complexity with age. This study focuses on clarifying the relationship between later epilepsy and the changes of electroencephalogram (EEG) complexity in neonatal seizures. Methods EEG signals from 19 channels of the whole brain from 32 neonates below 2 months old were acquired. The neonates were classified into 3 groups: 9 were normal controls, 9 were neonatal seizures without later epilepsy, and 14 were neonatal seizures with later epilepsy. Sample entropy (SamEn), multiscale entropy (MSE) and complexity index (CI) were analyzed. Results Although there was no significant change in SamEn, the CI values showed significantly decreased over Channels C3, C4, and Cz in patients with neonatal seizures and later epilepsy compared with control group. More multifocal epileptiform discharges in EEG, more abnormal neuroimaging findings, and higher incidence of future developmental delay were noted in the group with later epilepsy. Conclusions Decreased MSE and CI values in patients with neonatal seizures and later epilepsy may reflect the mixed effects of acute insults, underlying brain immaturity, and prolonged seizures-related injuries. The analysis of MSE and CI can therefore provide a quantifiable and accurate way to decrypt the mystery of neonatal seizures, and could be a promising predictor.	[Lu, Wen-Yu] New Taipei City Hosp, Dept Pediat, Taipei, Taiwan; [Lu, Wen-Yu; Weng, Wen-Chin; Lee, Wang-Tso] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Jyun-Yu; Chang, Chi-Feng; Shieh, Jiann-Shing] Yuan Ze Univ, Dept Mech Engn, Taoyuan, Taiwan; [Weng, Wen-Chin; Lee, Wang-Tso] Natl Taiwan Univ Hosp, Clin Ctr Neurosci & Behav, Taipei, Taiwan; [Lee, Wang-Tso] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Shieh, Jiann-Shing] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan	New Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; Yuan Ze University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Yuan Ze University	Lee, WT (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	leeped@hotmail.com		Lee, Wang-Tso/0000-0003-3231-9764; weng, wen-chin/0000-0002-6923-9138	Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan - Ministry of Science and Technology [NSC 102-2911-I-008-001]	Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan - Ministry of Science and Technology	This research was financially supported by Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan, which is sponsored by the Ministry of Science and Technology (Grant Number: NSC 102-2911-I-008-001).	AHMED MU, 2011, C P IEEE ENG MED BIO, P810, DOI DOI 10.1109/IEMBS.2011.6090185; Catarino A, 2011, CLIN NEUROPHYSIOL, V122, P2375, DOI 10.1016/j.clinph.2011.05.004; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa MD, 2008, CARDIOVASC ENG, V8, P88, DOI 10.1007/s10558-007-9049-1; Dubois J, 2008, CEREB CORTEX, V18, P1444, DOI 10.1093/cercor/bhm180; Friedman L, 2014, LIFE SCI, V94, P92, DOI 10.1016/j.lfs.2013.11.003; Glass HC, 2009, J CHILD NEUROL, V24, P591, DOI 10.1177/0883073808327832; Glowinski D., 2010, MM 10PROCEEDINGS ACM, P1035; Hecox K, 2003, NEUROCOMPUTING, V52-4, P779, DOI 10.1016/S0925-2312(02)00774-9; Janjarasjitt S, 2008, CLIN NEUROPHYSIOL, V119, P1812, DOI 10.1016/j.clinph.2008.03.024; Kight KE, 2014, NEUROBIOL DIS, V72, P136, DOI 10.1016/j.nbd.2014.05.027; Lai YH, 2013, PEDIATR NEONATOL, V54, P166, DOI 10.1016/j.pedneo.2013.01.001; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Mizrahi EM, 2001, PEDIATRIC EPILEPSY: DIAGNOSIS AND THERAPY, SECOND EDITION, P145; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Nardou R, 2013, SEMIN FETAL NEONAT M, V18, P175, DOI 10.1016/j.siny.2013.02.003; Ni L, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/618743; Ouyang GX, 2013, EPILEPSY RES, V104, P246, DOI 10.1016/j.eplepsyres.2012.11.003; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pitkanen A, 2014, NEUROBIOL DIS, V72, P224, DOI 10.1016/j.nbd.2014.05.037; Pressler RM, 2013, SEMIN FETAL NEONAT M, V18, P216, DOI 10.1016/j.siny.2013.04.005; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Ramantani G, 2013, EPILEPTIC DISORD, V15, P365, DOI 10.1684/epd.2013.0619; Sanchez RM, 2001, EPILEPSIA, V42, P577, DOI 10.1046/j.1528-1157.2001.12000.x; Scher MS, 2005, J CLIN NEUROPHYSIOL, V22, P159; SCHOUTEN JC, 1994, PHYS REV E, V49, P126, DOI 10.1103/PhysRevE.49.126; Stafstrom CE, 2006, EPILEPSIA, V47, P1407, DOI 10.1111/j.1528-1167.2006.00674_1.x; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Thibeault-Eybalin MP, 2009, PEDIATR NEUROL, V40, P175, DOI 10.1016/j.pediatrneurol.2008.10.026; Torisu H, 2014, BRAIN DEV-JPN, V36, P342, DOI [10.1016/j.braindev.2013.05.009, 10.1016/j.braindev.2014.01.016]; Vakorin VA, 2011, J NEUROSCI, V31, P6405, DOI 10.1523/JNEUROSCI.3153-10.2011; van Rooij LGM, 2013, SEMIN FETAL NEONAT M, V18, P209, DOI 10.1016/j.siny.2013.01.001; van Rooij LGM, 2013, PEDIATR DRUGS, V15, P9, DOI 10.1007/s40272-012-0005-1; Weng WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134083; Zhang X, 2013, IEEE J BIOMED HEALTH, V17, P470, DOI 10.1109/JBHI.2013.2241071	36	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144732	10.1371/journal.pone.0144732	http://dx.doi.org/10.1371/journal.pone.0144732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658680	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600081
J	Sharma, R; Sastry, GN				Sharma, Reetu; Sastry, G. Narahari			Deciphering the Dynamics of Non-Covalent Interactions Affecting Thermal Stability of a Protein: Molecular Dynamics Study on Point Mutant of Thermus thermophilus Isopropylmalate Dehydrogenase	PLOS ONE			English	Article							3-ISOPROPYLMALATE DEHYDROGENASE; CRYSTAL-STRUCTURES; GLOBULAR-PROTEINS; ENZYMES; THERMOSTABILITY; STABILIZATION; MECHANISM; DESIGN	Thermus thermophilius isopropylmalate dehydrogenase catalyzes oxidative decarboxylation and dehydrogenation of isopropylmalate. Substitution of leucine to alanine at position 172 enhances the thermal stability among the known point mutants. Exploring the dynamic properties of non-covalent interactions such as saltbridges, hydrogen bonds and hydrophobic interactions to explain thermal stability of a protein is interesting in its own right. In this study dynamic changes in the non-covalent interactions are studied to decipher the deterministic features of thermal stability of a protein considering a case study of a point mutant in Thermus thermophilus isopropylmalate dehydrogenase. A total of four molecular dynamic simulations of 0.2 mu s were carried out on wild type and mutant's functional dimers at 300 K and 337 K. Higher thermal stability of the mutant as compared to wild type is revealed by root mean square deviation, root mean square fluctuations and C alpha-C alpha distance with an increase in temperature from 300 K to 337 K. Most of the regions of wild type fluctuate higher than the corresponding regions of mutant with an increase in temperature. C alpha-C alpha distance analysis suggests that long distance networks are significantly affected in wild type as compared to the mutant. Short lived contacts are higher in wild type, while long lived contacts are lost at 337 K. The mutant forms less hydrogen bonds with water as compared to wild type at 337 K. In contrast to wild type, the mutant shows significant increase in unique saltbridges, hydrogen bonds and hydrophobic contacts at 337 K. The current study indicates that there is a strong inter-dependence of thermal stability on the way in which non-covalent interactions reorganize, and it is rewarding to explore this connection in single mutant studies.	[Sharma, Reetu; Sastry, G. Narahari] CSIR Indian Inst Chem Technol, Ctr Mol Modeling, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Sastry, GN (corresponding author), CSIR Indian Inst Chem Technol, Ctr Mol Modeling, Hyderabad 500007, Andhra Pradesh, India.	nsastry@gmail.com		Sharma, Reetu/0000-0002-3300-9832	Genomics and Informatics Solutions for Integrating Biology [GENESIS BSC0121]; Department of Science and Technology (DST)	Genomics and Informatics Solutions for Integrating Biology; Department of Science and Technology (DST)(Department of Science & Technology (India))	The authors thank Genomics and Informatics Solutions for Integrating Biology (GENESIS BSC0121) and Department of Science and Technology (DST) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Genomics and Informatics Solutions for Integrating Biology (GENESIS BSC0121) and Department of Science and Technology (DST) for financial support.	Akanuma S, 1997, FEBS LETT, V410, P141, DOI 10.1016/S0014-5793(97)00540-1; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Chourasia M, 2011, INT J BIOL MACROMOL, V48, P540, DOI 10.1016/j.ijbiomac.2011.01.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Guang-Hong Z, 2007, CHINESE PHYS LETT, V24; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKEDA K, 1967, PROG THEOR PHYS, V38, P584, DOI 10.1143/PTP.38.584; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; IPPOLITO JA, 1990, J MOL BIOL, V215, P457, DOI 10.1016/S0022-2836(05)80364-X; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kotsuka T, 1996, J BACTERIOL, V178, P723, DOI 10.1128/jb.178.3.723-727.1996; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Manjunath K, 2013, J CHEM INF MODEL, V53, P2448, DOI 10.1021/ci400306m; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MORIYAMA H, 1995, J BIOCHEM-TOKYO, V117, P408, DOI 10.1093/jb/117.2.408; Nagata C, 1996, ACTA CRYSTALLOGR D, V52, P623, DOI 10.1107/S0907444995016623; Nurachman Z, 2000, PROTEIN ENG, V13, P253, DOI 10.1093/protein/13.4.253; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PERUTZ MF, 1975, NATURE, V255, P256, DOI 10.1038/255256a0; Qu CX, 1997, PROTEIN ENG, V10, P45, DOI 10.1093/protein/10.1.45; Qu CX, 2001, ACTA CRYSTALLOGR D, V57, P225, DOI 10.1107/S0907444900017388; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Saha S, 2015, J PHYS CHEM B, V119, P11121, DOI 10.1021/acs.jpcb.5b03005; Sakurai M, 1996, ACTA CRYSTALLOGR D, V52, P124, DOI 10.1107/S0907444995007190; Schrodinger L., 2020, PYMOL; Srivani P, 2008, CURR PHARM DESIGN, V14, P3854, DOI 10.2174/138161208786898653; Srivastava HK, 2011, J CHEM INF MODEL, V51, P558, DOI 10.1021/ci100474n; Sterpone F, 2009, J PHYS CHEM B, V113, P131, DOI 10.1021/jp805199c; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Stojanovic S. D., 2009, OPEN STRUCT BIOL J, V3, P34, DOI DOI 10.2174/1874199100903010034; Suzuki T, 2002, PROTEIN ENG, V15, P471, DOI 10.1093/protein/15.6.471; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; VANDENBURG B, 1994, EUR J BIOCHEM, V220, P981; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vieille C, 1996, Biotechnol Annu Rev, V2, P1, DOI 10.1016/S1387-2656(08)70006-1; Vijay D, 2010, CHEM PHYS LETT, V485, P235, DOI 10.1016/j.cplett.2009.12.012; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144294	10.1371/journal.pone.0144294	http://dx.doi.org/10.1371/journal.pone.0144294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657745	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600035
J	Sui, YJ; Wu, F; Lv, JF; Li, HX; Li, X; Du, ZW; Sun, MY; Zheng, YH; Yang, LF; Zhong, LL; Zhang, XY; Zhang, GZ				Sui, Yujie; Wu, Fei; Lv, Junfeng; Li, Hongxia; Li, Xin; Du, Zhenwu; Sun, Meiyan; Zheng, Yuhao; Yang, Longfei; Zhong, Lili; Zhang, Xingyi; Zhang, Guizhen			Identification of the Novel TMEM16A Inhibitor Dehydroandrographolide and Its Anticancer Activity on SW620 Cells	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNEL; TUMOR-GROWTH; ANO1; EXPRESSION; CARCINOMA; HEAD	TMEM16A, a calcium-activated chloride channel (CaCC), is highly amplified and expressed in human cancers and is involved in the growth and metastasis of some malignancies. Inhibition of TMEM16A represents a novel pharmaceutical approach for the treatment of cancers and metastases. The purpose of this study is to identify a new TMEM16A inhibitor, investigate the effects of this inhibitor on the proliferation and metastasis of TMEM16A-amplified SW620 cells, and to elucidate the underlying molecular mechanism in vitro. We identified a novel small-molecule TMEM16A inhibitor dehydroandrographolide (DP). By using patch clamp electrophysiology, we showed that DP inhibited TMEM16A chloride currents in Fisher rat thyroid (FRT) cells that were transfected stably with human TMEM16A and in TMEM16A-overexpressed SW620 cells but did not alter cystic fibrosis transmembrane conductance regulator (CFTR) chloride currents. Further functional studies showed that DP suppressed the proliferation of SW620 cells in a dose-and time-dependent manner using MTT assays. Moreover, DP significantly inhibited migration and invasion of SW620 cells as detected by wound-healing and transwell assays. Further mechanistic study demonstrated that knockdown of human TMEM16A decreased the inhibitory effect of DP on the proliferation of SW620 cells and that TMEM16A-dependent cells (SW620 and HCT116) were more sensitive to DP than TMEM16A-independent cells (SW480 and HCT8). In addition, we found that treatment of SW620 cells with DP led to a decrease in TMEM16A protein levels but had no effect on TMEM16A mRNA levels. The current work reveals that DP, a novel TMEM16A inhibitor, exerts its anticancer activity on SW620 cells partly through a TMEM16A-dependent mechanism, which may introduce a new targeting approach for an antitumour therapy in TMEM16A-amplified cancers.	[Sui, Yujie; Li, Xin; Du, Zhenwu; Sun, Meiyan; Zheng, Yuhao; Yang, Longfei; Zhong, Lili; Zhang, Guizhen] Jilin Univ, Key Lab Mol & Chem Genet Crit Human Dis Jilin Pro, Bethune Hosp 2, Changchun 130023, Peoples R China; [Wu, Fei] Jilin Univ, Dept Gynecol & Obstet, Bethune Hosp 2, Changchun 130023, Peoples R China; [Lv, Junfeng] Jilin Univ, Dept Radiol, Bethune Hosp 2, Changchun 130023, Peoples R China; [Li, Hongxia] Jilin Univ, Dept Dermatol, Bethune Hosp 1, Changchun 130023, Peoples R China; [Zhang, Xingyi] Jilin Univ, Dept Thorac Surg, Bethune Hosp 2, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; Jilin University	Zhang, XY (corresponding author), Jilin Univ, Dept Thorac Surg, Bethune Hosp 2, Changchun 130023, Peoples R China.	xingyizhang@live.com; Zhang4083@163.com	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670	China Postdoctoral Science Foundation [2014M551198]; Jilin Province health and Family Planning Commission Project [2014Q024]; Jilin University experimental technology project [409020720137]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jilin Province health and Family Planning Commission Project; Jilin University experimental technology project	This study was supported by China Postdoctoral Science Foundation (No. 2014M551198), Jilin Province health and Family Planning Commission Project (No. 2014Q024) and Jilin University experimental technology project in 2015 (409020720137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Chen H, 2014, BIOORG MED CHEM LETT, V24, P2353, DOI 10.1016/j.bmcl.2014.03.060; Cheung HY, 2005, PLANTA MED, V71, P1106, DOI 10.1055/s-2005-873128; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Guang RJ, 2000, CANCER RES, V60, P749; Jacobsen KS, 2013, PFLUG ARCH EUR J PHY, V465, P1753, DOI 10.1007/s00424-013-1315-z; Liu SH, 2014, BIOCHEM PHARMACOL, V87, P229, DOI 10.1016/j.bcp.2013.10.014; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Matsuba S, 2014, J PHARMACOL EXP THER, V351, P510, DOI 10.1124/jpet.114.217315; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sauter DRP, 2015, PFLUG ARCH EUR J PHY, V467, P1495, DOI 10.1007/s00424-014-1598-8; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shen KK, 2014, CHEM-BIOL INTERACT, V218, P99, DOI 10.1016/j.cbi.2014.04.020; Shiwarski DJ, 2014, CLIN CANCER RES, V20, P4673, DOI 10.1158/1078-0432.CCR-14-0363; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tung YT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/305898; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Wanitchakool P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0096; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yao Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038030	30	21	22	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144715	10.1371/journal.pone.0144715	http://dx.doi.org/10.1371/journal.pone.0144715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657333	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903600080
J	Biller, OM; Adler, LS; Irwin, RE; McAllister, C; Palmer-Young, EC				Biller, Olivia Masi; Adler, Lynn S.; Irwin, Rebecca E.; McAllister, Caitlin; Palmer-Young, Evan C.			Possible Synergistic Effects of Thymol and Nicotine against Crithidia bombi Parasitism in Bumble Bees	PLOS ONE			English	Article							SELF-MEDICATION; ESSENTIAL OILS; TRYPANOSOME PARASITE; ANTIMICROBIAL ACTIVITY; PATHOGENIC BACTERIA; NECTAR-NICOTINE; GUT MICROBIOTA; DOSE-RESPONSE; HOST; INFECTION	Floral nectar contains secondary compounds with antimicrobial properties that can affect not only plant-pollinator interactions, but also interactions between pollinators and their parasites. Although recent work has shown that consumption of plant secondary compounds can reduce pollinator parasite loads, little is known about the effects of dosage or compound combinations. We used the generalist pollinator Bombus impatiens and its obligate gut parasite Crithidia bombi to study the effects of nectar chemistry on host-parasite interactions. In two experiments we tested (1) whether the secondary compounds thymol and nicotine act synergistically to reduce parasitism, and (2) whether dietary thymol concentration affects parasite resistance. In both experiments, uninfected Bombus impatiens were inoculated with Crithidia and then fed particular diet treatments for 7 days, after which infection levels were assessed. In the synergism experiment, thymol and nicotine alone and in combination did not significantly affect parasite load or host mortality. However, the thymol-nicotine combination treatment reduced log-transformed parasite counts by 30% relative to the control group (P = 0.08). For the experiment in which we manipulated thymol concentration, we found no significant effect of any thymol concentration on Crithidia load, but moderate (2 ppm) thymol concentrations incurred a near-significant increase in mortality (P = 0.054). Our results tentatively suggest the value of a mixed diet for host immunity, yet contrast with research on the antimicrobial activity of dietary thymol and nicotine in vertebrate and other invertebrate systems. We suggest that future research evaluate genetic variation in Crithidia virulence, multi-strain competition, and Crithidia interactions with the gut microbe community that may mediate antimicrobial activities of secondary compounds.	[Biller, Olivia Masi; Adler, Lynn S.; McAllister, Caitlin; Palmer-Young, Evan C.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Irwin, Rebecca E.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	University of Massachusetts System; University of Massachusetts Amherst; Dartmouth College	Palmer-Young, EC (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	epalmery@cns.umass.edu	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073; Biller, Olivia/0000-0001-9832-1838	National Science Foundation (NSF) [NSFDEB-1258096]; NSF GRFP [DGE-0907995]; NSF DDIG [NSFDEB-1501907]; National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES) [USDA-AFRI 2013-02536]; Garden Club of America Centennial Pollinator Fellowship; Direct For Biological Sciences [1501907] Funding Source: National Science Foundation; Division Of Environmental Biology [1638866] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF DDIG(National Science Foundation (NSF)); National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES); Garden Club of America Centennial Pollinator Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation (NSF; www.nsf.gov) under NSFDEB-1258096 (to LSA and REI), NSF GRFP (Grant DGE-0907995 to ECP-Y), and NSF DDIG (Grant NSFDEB-1501907 to ECP-Y and LSA); by the National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA; www.usda.gov) Cooperative State Research, Education, and Extension Service (CSREES) Grant USDA-AFRI 2013-02536 (to LSA and REI); and by the Garden Club of America (www.gcamerica.org) Centennial Pollinator Fellowship (to ECP-Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J, 2014, ECOL ENTOMOL, V39, P273, DOI 10.1111/een.12110; Adler LS, 2005, ECOLOGY, V86, P2968, DOI 10.1890/05-0118; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; [Anonymous], 2014, LANG ENV STAT COMP; Baer B, 2003, OIKOS, V101, P563, DOI 10.1034/j.1600-0706.2003.12395.x; BAKER HG, 1977, BOT GAZ, V138, P183, DOI 10.1086/336914; BAKER HG, 1977, APIDOLOGIE, V8, P349, DOI 10.1051/apido:19770405; Baracchi D, 2015, F1000 RES, P4; BARBOSA P, 1991, ECOLOGY, V72, P1567, DOI 10.2307/1940956; Barribeau SM, 2014, P NATL ACAD SCI USA, V111, P3496, DOI 10.1073/pnas.1318628111; BELL RR, 1983, J NUTR, V113, P2479, DOI 10.1093/jn/113.12.2479; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Charpentier G, 2014, PEST MANAG SCI, V70, P140, DOI 10.1002/ps.3539; Cisarovsky G, 2012, J EVOLUTION BIOL, V25, P1053, DOI 10.1111/j.1420-9101.2012.02507.x; Cisarovsky G, 2014, ENTOMOL EXP APPL, V152, P209, DOI 10.1111/eea.12218; Colla S, 2011, GUIDE BUMBLE BEES E; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Cordes N, 2012, J INVERTEBR PATHOL, V109, P209, DOI 10.1016/j.jip.2011.11.005; Costa C, 2010, APIDOLOGIE, V41, P141, DOI 10.1051/apido/2009070; Daferera DJ, 2000, J AGR FOOD CHEM, V48, P2576, DOI 10.1021/jf990835x; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Drescher N, 2014, OECOLOGIA, V176, P943, DOI 10.1007/s00442-014-3070-z; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Erler S, 2014, ECOL EVOL, V4, P3960, DOI 10.1002/ece3.1252; Floris I, 2004, J ECON ENTOMOL, V97, P187, DOI 10.1603/0022-0493-97.2.187; Fox J., 2019, R COMPANION APPL REG, V.; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Gherman BI, 2014, BEHAV ECOL SOCIOBIOL, V68, P1777, DOI 10.1007/s00265-014-1786-8; Gillespie S, 2010, ECOL ENTOMOL, V35, P737, DOI 10.1111/j.1365-2311.2010.01234.x; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Guyot C, 1998, J AGR FOOD CHEM, V46, P625, DOI 10.1021/jf970510l; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; HIEBERT SM, 1983, ECOLOGY, V64, P399, DOI 10.2307/1937086; Hodgson DJ, 2004, J EVOLUTION BIOL, V17, P1018, DOI 10.1111/j.1420-9101.2004.00750.x; Kearns CA, 1997, BIOSCIENCE, V47, P297, DOI 10.2307/1313191; Koch H, 2012, ECOL LETT, V15, P1095, DOI 10.1111/j.1461-0248.2012.01831.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; Kordali S, 2008, BIORESOURCE TECHNOL, V99, P8788, DOI 10.1016/j.biortech.2008.04.048; Korner P, 2005, ENTOMOL SCI, V8, P151, DOI 10.1111/j.1479-8298.2005.00113.x; Lefevre T, 2012, J ANIM ECOL, V81, P70, DOI 10.1111/j.1365-2656.2011.01901.x; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Logan A, 2005, PARASITOLOGY, V130, P637, DOI 10.1017/S0031182005007304; Macheboeuf D, 2008, ANIM FEED SCI TECH, V145, P335, DOI 10.1016/j.anifeedsci.2007.05.044; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; MARTINI M, 1990, BOT ACTA, V103, P343, DOI 10.1111/j.1438-8677.1990.tb00172.x; Mason PA, 2014, OECOLOGIA, V176, P477, DOI 10.1007/s00442-014-3029-0; McArt SH, 2014, ECOL LETT, V17, P624, DOI 10.1111/ele.12257; Michiels J, 2007, LIVEST SCI, V109, P157, DOI 10.1016/j.livsci.2007.01.132; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Nicolson SW, 1998, AM ZOOL, V38, P418; Nicolson SW, 2008, PHYSIOL ENTOMOL, V15, P433, DOI [10.1111/j.1365-3032.1990.tb00532, DOI 10.1111/J.1365-3032.1990.TB00532]; Noakes TD, 2006, BRIT J SPORT MED, V40, P567, DOI 10.1136/bjsm.2005.020354; Otterstatter MC, 2006, PARASITOLOGY, V133, P749, DOI 10.1017/S003118200600120X; Otterstatter MC, 2005, BEHAV ECOL SOCIOBIOL, V58, P383, DOI 10.1007/s00265-005-0945-3; Oussalah M, 2007, FOOD CONTROL, V18, P414, DOI 10.1016/j.foodcont.2005.11.009; Pavia CS, 2000, J MED MICROBIOL, V49, P675, DOI 10.1099/0022-1317-49-7-675; Pina-Vaz C, 2004, J EUR ACAD DERMATOL, V18, P73, DOI 10.1111/j.1468-3083.2004.00886.x; Pinheiro J, R PACKAGE VERSION; Plepys D, 2002, OIKOS, V99, P69, DOI 10.1034/j.1600-0706.2002.990107.x; Popp M, 2012, MICROBIOLOGYOPEN, V1, P362, DOI 10.1002/mbo3.35; Raguso RA, 2015, ECOLOGY, V96, P617, DOI 10.1890/14-1474.1; Richards LA, 2012, J CHEM ECOL, V38, P1276, DOI 10.1007/s10886-012-0190-y; Richardson LL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2471; Sadd BM, 2013, PARASITE IMMUNOL, V35, P339, DOI 10.1111/pim.12043; Salathe RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022054; Santoro GF, 2007, PARASITOL RES, V100, P783, DOI 10.1007/s00436-006-0326-5; Schiestl FP, 1999, P ENTOMOL SOC WASH, V101, P880; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel R, 2014, J ANIM ECOL, V83, P823, DOI 10.1111/1365-2656.12185; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Silva EM, 2000, J ECON ENTOMOL, V93, P1216, DOI 10.1603/0022-0493-93.4.1216; Singaravelan N, 2006, J CHEM ECOL, V32, P49, DOI 10.1007/s10886-006-9350-2; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Stephenson AG, 2012, NEW PHYTOL, V193, P827, DOI 10.1111/j.1469-8137.2011.04035.x; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Thomson JD, 2015, ARTHROPOD-PLANT INTE, V9, P1, DOI 10.1007/s11829-014-9350-z; THORPE KW, 1986, J CHEM ECOL, V12, P1329, DOI 10.1007/BF01012352; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; Ulrich Y, 2011, J EVOLUTION BIOL, V24, P354, DOI 10.1111/j.1420-9101.2010.02172.x; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Zaidi MI, 2012, AFR J MICROBIOL RES, V6, P5134, DOI 10.5897/AJMR11.1209	100	36	36	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144668	10.1371/journal.pone.0144668	http://dx.doi.org/10.1371/journal.pone.0144668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657643	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500054
J	King, AD; Chow, SKK; Yu, KH; Mo, FKF; Yeung, DKW; Yuan, J; Law, BKH; Bhatia, KS; Vlantis, AC; Ahuja, AT				King, Ann D.; Chow, Steven Kwok Keung; Yu, Kwok-Hung; Mo, Frankie Kwok Fai; Yeung, David K. W.; Yuan, Jing; Law, Benjamin King Hong; Bhatia, Kunwar S.; Vlantis, Alexander C.; Ahuja, Anil T.			DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck	PLOS ONE			English	Article							CONTRAST-ENHANCED-MRI; NEOADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; TUMOR RESPONSE; BREAST-CANCER; RADIOTHERAPY; REGRESSION; OUTCOMES	Background and Purpose It is important to identify patients with head and neck squamous cell carcinoma (SCC) who fail to respond to chemoradiotherapy so that they can undergo post-treatment salvage surgery while the disease is still operable. This study aimed to determine the diagnostic performance of dynamic contrast enhanced (DCE)-MRI using a pharmacokinetic model for pre-treatment predictive imaging, as well as post-treatment diagnosis, of residual SCC at primary and nodal sites in the head and neck. Material and Methods Forty-nine patients with 83 SCC sites (primary and/or nodal) underwent pre-treatment DCE-MRI, and 43 patients underwent post-treatment DCE-MRI, of which 33 SCC sites had a residual mass amenable to analysis. Pre-treatment, post-treatment and % change in the mean K-trans, k(ep), v(e) and AUGC were obtained from SCC sites. Logistic regression was used to correlate DCE parameters at each SCC site with treatment response at the same site, based on clinical outcome at that site at a minimum of two years. Results None of the pre-treatment DCE-MRI parameters showed significant correlations with SCC site failure (SF) (29/83 sites) or site control (SC) (54/83 sites). Post-treatment residual masses with SF (14/33) had significantly higher k(ep) (p = 0.05), higher AUGC (p = 0.02), and lower % reduction in AUGC (p = 0.02), than residual masses with SC (19/33), with the% change in AUGC remaining significant on multivariate analysis. Conclusion Pre-treatment DCE-MRI did not predict which SCC sites would fail treatment, but post-treatment DCE-MRI showed potential for identifying residual masses that had failed treatment.	[King, Ann D.; Law, Benjamin King Hong; Bhatia, Kunwar S.; Ahuja, Anil T.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Chow, Steven Kwok Keung] Univ Wollongong, Fac Engn & Informat Sci, Sch Phys, Wollongong, NSW 2522, Australia; [Yu, Kwok-Hung] Alpha Oncol Ctr, Hong Kong, Hong Kong, Peoples R China; [Mo, Frankie Kwok Fai; Yeung, David K. W.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Yuan, Jing] Hong Kong Sanat & Hosp, Med Phys & Res Dept, Hong Kong, Hong Kong, Peoples R China; [Vlantis, Alexander C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; University of Wollongong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	King, AD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China.	king2015@cuhk.edu.hk	Mo, Frankie/AAC-9230-2022; Law, Benjamin King Hong/J-2179-2016; Ahuja, Anil T/H-4031-2017; King, Ann D/C-9845-2011; Yuan, Jing/E-4236-2013; Chow, Steven Kwok Keung/GNH-4779-2022; Mo, Frankie/AAG-8079-2021; Vlantis, Alexander/J-9785-2017	Mo, Frankie/0000-0002-0566-3212; Law, Benjamin King Hong/0000-0003-3836-8196; Ahuja, Anil T/0000-0002-0726-5402; King, Ann D/0000-0002-5280-8349; Yuan, Jing/0000-0001-8112-3608; Chow, Kwok Keung/0000-0002-7201-4888; Vlantis, Alexander/0000-0003-3109-5236	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK4660/08, SEG_CUHK02]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was fully supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK4660/08 and SEG_CUHK02).	Agrawal S, 2012, CLIN RADIOL, V67, pE1, DOI 10.1016/j.crad.2012.03.005; Ah-See MLW, 2008, CLIN CANCER RES, V14, P6580, DOI 10.1158/1078-0432.CCR-07-4310; Baba Y, 1997, INT J RADIAT ONCOL, V37, P783, DOI 10.1016/S0360-3016(96)00595-0; Cao Y, 2011, SEMIN RADIAT ONCOL, V21, P147, DOI 10.1016/j.semradonc.2010.11.001; Chawla S, 2011, AM J NEURORADIOL, V32, P778, DOI 10.3174/ajnr.A2376; Chawla S, 2013, AM J ROENTGENOL, V200, P35, DOI 10.2214/AJR.12.9432; Chikui T, 2012, J MAGN RESON IMAGING, V36, P589, DOI 10.1002/jmri.23704; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Gollub MJ, 2012, EUR RADIOL, V22, P821, DOI 10.1007/s00330-011-2321-1; Hoskin PJ, 1999, BRIT J RADIOL, V72, P1093, DOI 10.1259/bjr.72.863.10700827; Huang SH, 2013, INT J RADIAT ONCOL, V87, P1078, DOI 10.1016/j.ijrobp.2013.08.049; Isles MG, 2008, CLIN OTOLARYNGOL, V33, P210, DOI 10.1111/j.1749-4486.2008.01688.x; Khalifa F, 2014, MED PHYS, V41, DOI 10.1118/1.4898202; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Li SP, 2012, J MAGN RESON IMAGING, V35, P745, DOI 10.1002/jmri.22838; Ng SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115933; Ng SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072230; O'Sullivan B, 2012, RADIOTHER ONCOL, V103, P49, DOI 10.1016/j.radonc.2012.02.009; Pickles MD, 2005, BREAST CANCER RES TR, V91, P1, DOI 10.1007/s10549-004-5819-2; Shukla-Dave A, 2012, INT J RADIAT ONCOL, V82, P1837, DOI 10.1016/j.ijrobp.2011.03.006; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tomura N, 2005, AM J OTOLARYNG, V26, P163, DOI 10.1016/j.amjoto.2004.11.011; Wang P, 2012, MED PHYS, V39, P5277, DOI 10.1118/1.4737022; Wasser K, 2003, EUR RADIOL, V13, P1213, DOI 10.1007/s00330-002-1730-6; Yoo DS, 2012, CLIN CANCER RES, V18, P1404, DOI 10.1158/1078-0432.CCR-11-1982; Yuan J, 2012, QUANT IMAGING MED SU, V2, P21, DOI [10.3978/j.issn.2223-4292.2012.01.06, 10.3978/j.issn.2223-4292.2012.11.04]; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9	28	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144770	10.1371/journal.pone.0144770	http://dx.doi.org/10.1371/journal.pone.0144770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657972	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500059
J	Rice, S; Koziel, JA				Rice, Somchai; Koziel, Jacek A.			Characterizing the Smell of Marijuana by Odor Impact of Volatile Compounds: An Application of Simultaneous Chemical and Sensory Analysis	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; MASS SPECTROMETRY-OLFACTOMETRY; ION MOBILITY SPECTROMETRY; GAS-CHROMATOGRAPHY; HEADSPACE VOLATILES; CANNABIS-SATIVA; EXPLOSIVES; EFFICACY; DRUGS; AROMA	Recent US legislation permitting recreational use of marijuana in certain states brings the use of marijuana odor as probable cause for search and seizure to the forefront of forensic science, once again. This study showed the use of solid-phase microextraction with multi-dimensional gas chromatography-mass spectrometry and simultaneous human olfaction to characterize the total aroma of marijuana. The application of odor activity analysis offers an explanation as to why high volatile chemical concentration does not equate to most potent odor impact of a certain compound. This suggests that more attention should be focused on highly odorous compounds typically present in low concentrations, such as nonanal, decanol, o-cymene, benzaldehyde, which have more potent odor impact than previously reported marijuana headspace volatiles.	[Rice, Somchai; Koziel, Jacek A.] Iowa State Univ, Interdept Toxicol Grad Program, Ames, IA 50011 USA; [Rice, Somchai; Koziel, Jacek A.] Iowa State Univ, Agr & Biosyst Engn, Ames, IA USA	Iowa State University; Iowa State University	Koziel, JA (corresponding author), Iowa State Univ, Interdept Toxicol Grad Program, Ames, IA 50011 USA.	koziel@iastate.edu	Rice, Somchai/O-1426-2015; Koziel, Jacek A./B-5483-2014; Rice, Somchai/AAG-8148-2019	Rice, Somchai/0000-0001-8868-3202; Koziel, Jacek A./0000-0002-2387-0354; Rice, Somchai/0000-0001-8868-3202				Acree T., 2004, FLAVORNET HUMAN ODOR; *AIHA, 1989, OD THRESH CHEM EST O; [Anonymous], 1994, GOOD SCENTS CO INFOR; Bertoli A, 2010, IND CROP PROD, V32, P329, DOI 10.1016/j.indcrop.2010.05.012; Cai LS, 2007, J CHROMATOGR A, V1147, P66, DOI 10.1016/j.chroma.2007.02.044; Devos M., 1990, STANDARDIZED HUMAN O; Doty RL, 2004, LAW HUMAN BEHAV, V28, P223, DOI 10.1023/B:LAHU.0000022324.13389.ea; Ferreira V, 2002, J AGR FOOD CHEM, V50, P4048, DOI 10.1021/jf0115645; Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4; Furton KG, 2000, J CHROMATOGR SCI, V38, P297, DOI 10.1093/chromsci/38.7.297; Furton KG, 1998, M INV FOR SCI TECHN, V3576, P41; Grosch Werner, 1994, Flavour and Fragrance Journal, V9, P147, DOI 10.1002/ffj.2730090403; Guth H, 1997, J AGR FOOD CHEM, V45, P3027, DOI 10.1021/jf970280a; HOOD LVS, 1973, NATURE, V242, P402, DOI 10.1038/242402a0; HOOD LVS, 1978, J CHROMATOGR, V166, P499, DOI 10.1016/S0021-9673(00)95633-4; Jezierski T, 2014, FORENSIC SCI INT, V237, P112, DOI 10.1016/j.forsciint.2014.01.013; Kabir A, 2013, TRAC-TREND ANAL CHEM, V45, P264, DOI 10.1016/j.trac.2012.11.013; Kongshaug KE, 1999, CHROMATOGRAPHIA, V50, P247, DOI 10.1007/BF02490660; Lai H, 2008, ANAL BIOANAL CHEM, V392, P105, DOI 10.1007/s00216-008-2229-z; Lai H, 2008, J SEP SCI, V31, P402, DOI 10.1002/jssc.200700292; Lit L, 2011, ANIM COGN, V14, P387, DOI 10.1007/s10071-010-0373-2; Lo YCM, 2008, J ENVIRON QUAL, V37, P521, DOI 10.2134/jeq2006.0382; Lorenzo N, 2003, ANAL BIOANAL CHEM, V376, P1212, DOI 10.1007/s00216-003-2018-7; Macias Michael S., 2008, American Biotechnology Laboratory, V26, P26; MARIN AB, 1992, J AGR FOOD CHEM, V40, P650, DOI 10.1021/jf00016a026; OSMAN A, 1985, J FORENSIC SCI SOC, V25, P377, DOI 10.1016/S0015-7368(85)72417-6; Parker DB, 2012, T ASABE, V55, P2357; PATTON S., 1957, FOOD RES, V22, P316; Porto C. da, 2014, International Journal of Applied Research in Natural Products, V7, P8; Rather M. A., 2011, Journal of Pharmacy Research, V4, P2651; Rice S.K., 2015, THESIS; Rice S, 2015, FORENSIC SCI INT, V257, P257, DOI 10.1016/j.forsciint.2015.08.027; Ross SA, 1996, J NAT PROD, V59, P49, DOI 10.1021/np960004a; Rothschild M, 2005, BOT J LINN SOC, V147, P387, DOI 10.1111/j.1095-8339.2005.00417.x; Vance E, 2008, NATURE, V455, P726, DOI 10.1038/455726a	35	38	39	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144160	10.1371/journal.pone.0144160	http://dx.doi.org/10.1371/journal.pone.0144160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657499	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500015
J	Schulz, J; Dumke, J; Hinse, D; Dreier, J; Habig, C; Kemper, N				Schulz, Jochen; Dumke, Jessika; Hinse, Dennis; Dreier, Jens; Habig, Christin; Kemper, Nicole			Organic Turkey Flocks: A Reservoir of Streptococcus gallolyticus subspecies gallolyticus	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MRSA CC398; BOVIS; STRAINS; ENDOCARDITIS; ASSOCIATION; ENTEROCOCCI; INFECTION; HUMANS; COLI	Streptococcus gallolyticus subspecies gallolyticus (S. gallolyticus) can colonise the gastro-intestinal tract of humans and animals and is known to cause similar infections in both humans and animals. Data about the spread or prevalence in farm animals are missing. In this study, Trypton Soya Agar was modified to a selective medium enabling the isolation and quantification of S. gallolyticus from faecal samples. The bacterium was observed in 82 out of 91 faecal samples obtained from 18 different organic turkey flocks. The prevalence of shedding birds was estimated by the number of positive fresh droppings and reached up to 100% on most farms. Furthermore, for the first time S. gallolyticus was quantified in faeces from poultry flocks. The median of colony forming units (CFU) per gramme faeces was 3.6 x 105CFU/g. Typing of one isolate from each positive faecal sample by multilocus sequence typing delivered 24 sequence types (STs). Most of the isolates belonged to the clonal complex CC58. The same STs of this complex were detected in up to six different flocks. Partly, these flocks were located in various regions and stocked with varying breeding lines. Regarding the biochemical profiles of the same STs from different farms, the results did not contradict a spread of specific STs in the organic turkey production. Moreover, checking the pubMLST database revealed that STs found in this study were also found in other animal species and in humans. The high detection rate and the number of S. gallolyticus in turkey faeces indicate that this bacterium probably belongs to the common microbiota of the gastrointestinal tract of turkeys from organic flocks. Furthermore, the findings of this study support the suggestion of a possible interspecies transmission.	[Dumke, Jessika; Hinse, Dennis; Dreier, Jens] Ruhr Univ Bochum, Inst Lab & Transfus Med, Bad Oeynhausen, Germany	Ruhr University Bochum	Schulz, J (corresponding author), Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany.	jochen.schulz@tiho-hannover.de	Schulz, Jochen/AAA-7340-2021; Dreier, Jens/F-1134-2013	Schulz, Jochen/0000-0002-9747-6763; Dreier, Jens/0000-0002-1337-7750; Kemper, Nicole/0000-0003-0092-4302				Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Adejumo, 2014, ADV MICROBIOLOGY, V4, P774, DOI [10.4236/aim.2014.412085, DOI 10.4236/AIM.2014.412085]; Baele M, 2000, VET MICROBIOL, V71, P103, DOI 10.1016/S0378-1135(99)00169-8; Beck M, 2008, J CLIN MICROBIOL, V46, P2966, DOI 10.1128/JCM.00078-08; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Chadfield MS, 2007, J CLIN MICROBIOL, V45, P822, DOI 10.1128/JCM.00922-06; Christensen N., 2009, Surveillance (Wellington), V36, P13; Cools D, 2001, APPL SOIL ECOL, V17, P53, DOI 10.1016/S0929-1393(00)00133-5; Corredoira J, 2008, CLIN MICROBIOL INFEC, V14, P190, DOI 10.1111/j.1469-0691.2007.01913.x; Cuny C, 2009, INT J MED MICROBIOL, V299, P100; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Devriese LA, 1999, VET MICROBIOL, V70, P87, DOI 10.1016/S0378-1135(99)00124-8; Devriese LA, 1998, J CLIN MICROBIOL, V36, P3520, DOI 10.1128/JCM.36.12.3520-3523.1998; Droual R, 1997, AVIAN PATHOL, V26, P433, DOI 10.1080/03079459708419225; Dumke J, 2014, J CLIN MICROBIOL, V52, P2472, DOI 10.1128/JCM.03329-13; Dumke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126507; Ellmerich S, 2000, CARCINOGENESIS, V21, P753, DOI 10.1093/carcin/21.4.753; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Giannitsioti E, 2007, CLIN MICROBIOL INFEC, V13, P770, DOI 10.1111/j.1469-0691.2007.01753.x; Habig C, 2013, DGS MAGAZIN, V36, P35; Hinse D, 2011, SYST APPL MICROBIOL, V34, P52, DOI 10.1016/j.syapm.2010.11.010; Hogg R, 2009, VET REC, V165, P297, DOI 10.1136/vetrec.165.10.297-a; Jans C, 2015, INFECT GENET EVOL, V33, P419, DOI 10.1016/j.meegid.2014.09.017; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kimpe A, 2003, AVIAN DIS, V47, P559, DOI 10.1637/6081; Kimpe A, 2002, AVIAN PATHOL, V31, P393, DOI 10.1080/03079450220141679; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Lin IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020519; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marcinakova M, 2005, CZECH J ANIM SCI, V50, P341, DOI 10.17221/4175-CJAS; Martin S.W., 1987, VET EPIDEMIOLOGY PRI; OSAWA R, 1990, APPL ENVIRON MICROB, V56, P3609, DOI 10.1128/AEM.56.11.3609-3611.1990; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; Sasaki E, 2004, J VET MED SCI, V66, P1467, DOI 10.1292/jvms.66.1467; Schulz J, 2011, AVIAN PATHOL, V40, P243, DOI 10.1080/03079457.2010.544290; Sekizaki T, 2008, AVIAN DIS, V52, P183, DOI 10.1637/8048-070307-Case; Sillanpaa J, 2008, FEMS MICROBIOL LETT, V289, P104, DOI 10.1111/j.1574-6968.2008.01378.x; Snyder ML, 1940, J INFECT DIS, V67, P113, DOI 10.1093/infdis/67.2.113; van den Bogaard AE, 2002, J ANTIMICROB CHEMOTH, V49, P497, DOI 10.1093/jac/49.3.497; Van Hoorebeke S, 2010, PREV VET MED, V94, P94, DOI 10.1016/j.prevetmed.2009.11.022; Welton LA, 1998, ANTIMICROB AGENTS CH, V42, P705, DOI 10.1128/AAC.42.3.705; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144412	10.1371/journal.pone.0144412	http://dx.doi.org/10.1371/journal.pone.0144412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657757	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500027
J	Williams, PH; Byvaltsev, AM; Cederberg, B; Berezin, MV; Odegaard, F; Rasmussen, C; Richardson, LL; Huang, JX; Sheffield, CS; Williams, ST				Williams, Paul H.; Byvaltsev, Alexandr M.; Cederberg, Bjorn; Berezin, Mikhail V.; Odegaard, Frode; Rasmussen, Claus; Richardson, Leif L.; Huang, Jiaxing; Sheffield, Cory S.; Williams, Suzanne T.			Genes Suggest Ancestral Colour Polymorphisms Are Shared across Morphologically Cryptic Species in Arctic Bumblebees	PLOS ONE			English	Article							HYMENOPTERA APIDAE; MITOCHONDRIAL-DNA; MOLECULAR SYSTEMATICS; BARCODES HYMENOPTERA; INTEGRATIVE TAXONOMY; BEES BOMBUS; DELIMITATION; PATTERNS; PHYLOGENY; WORLDWIDE	Our grasp of biodiversity is fine-tuned through the process of revisionary taxonomy. If species do exist in nature and can be discovered with available techniques, then we expect these revisions to converge on broadly shared interpretations of species. But for the primarily arctic bumblebees of the subgenus Alpinobombus of the genus Bombus, revisions by some of the most experienced specialists are unusual for bumblebees in that they have all reached different conclusions on the number of species present. Recent revisions based on skeletal morphology have concluded that there are from four to six species, while variation in colour pattern of the hair raised questions as to whether at least seven species might be present. Even more species are supported if we accept the recent move away from viewing species as morphotypes to viewing them instead as evolutionarily independent lineages (EILs) using data from genes. EILs are recognised here in practice from the gene coalescents that provide direct evidence for their evolutionary independence. We show from fitting both general mixed Yule/coalescent (GMYC) models and Poisson-tree-process (PTP) models to data for the mitochondrial COI gene that there is support for nine species in the subgenus Alpinobombus. Examination of the more slowly evolving nuclear PEPCK gene shows further support for a previously unrecognised taxon as a new species in northwestern North America. The three pairs of the most morphologically similar sister species are separated allopatrically and prevented from interbreeding by oceans. We also find that most of the species show multiple shared colour patterns, giving the appearance of mimicry among parts of the different species. However, reconstructing ancestral colour-pattern states shows that speciation is likely to have cut across widespread ancestral polymorphisms, without or largely without convergence. In the particular case of Alpinobombus, morphological, colour-pattern, and genetic groups show little agreement, which may help to explain the lack of agreement among previous taxonomic revisions.	[Williams, Paul H.; Williams, Suzanne T.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Byvaltsev, Alexandr M.] Novosibirsk State Univ, Dept Gen Biol & Ecol, Novosibirsk 630090, Russia; [Cederberg, Bjorn] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden; [Berezin, Mikhail V.] Moscow Zoo, Entomol Dept Insectarium, Moscow, Russia; [Odegaard, Frode] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Rasmussen, Claus] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Richardson, Leif L.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT USA; [Huang, Jiaxing] Chinese Acad Agr Sci, Minist Agr, Inst Apicultural Res, Key Lab Insect Pollinator Biol, Beijing 100193, Peoples R China; [Sheffield, Cory S.] Royal Saskatchewan Museum, Regina, SK, Canada	Natural History Museum London; Novosibirsk State University; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research; Aarhus University; University of Vermont; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs	Williams, PH (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	paw@nhm.ac.uk	Rasmussen, Claus/J-6714-2012; Rasmussen, Claus/X-4760-2019; Sheffield, Cory/I-4812-2019; Byvaltsev, Alexandr M/B-9961-2017; Williams, Suzanne T/A-9604-2008; Byvaltsev, Alexandr/Q-4549-2019	Rasmussen, Claus/0000-0003-1529-6548; Sheffield, Cory/0000-0003-0603-7333; Williams, Suzanne T/0000-0003-2995-5823; Byvaltsev, Alexandr/0000-0001-6555-5646	Grant of the President of the Russian Federation [MK-6176.2015.4]; Saskatchewan Ministry of Agriculture; Canada-Saskatchewan Growing Forward 2 bi-lateral agreement [20130112]; Carlsberg Foundation [2009-01-0534, 2011-01-0463]; Research Council of Norway [266134/F50]; Norwegian Biodiversity Information Centre [70184209]; Taxonomy Initiative of the Norwegian Biodiversity Information Centre [70184228]; Agricultural Science and Technology Innovation Program, China [CAAS-ASTIP-2015-IAR]; National Science Foundation [NSF-DBI 0956388, NSF-DBI 0956340]; Direct For Biological Sciences [0956340] Funding Source: National Science Foundation	Grant of the President of the Russian Federation; Saskatchewan Ministry of Agriculture; Canada-Saskatchewan Growing Forward 2 bi-lateral agreement; Carlsberg Foundation(Carlsberg Foundation); Research Council of Norway(Research Council of Norway); Norwegian Biodiversity Information Centre; Taxonomy Initiative of the Norwegian Biodiversity Information Centre; Agricultural Science and Technology Innovation Program, China; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The database of species' distributions in Russia was created with the financial support from a Grant of the President of the Russian Federation for young Russian scientists (grant MK-6176.2015.4) (to AB). DNA barcodes for some of the material were funded by the Saskatchewan Ministry of Agriculture and the Canada-Saskatchewan Growing Forward 2 bi-lateral agreement (grant 20130112) (to CS). Work in Greenland was supported by the Carlsberg Foundation (grants 2009-01-0534 and 2011-01-0463) (to CR). DNA barcodes for some of the Norwegian material were funded by the Research Council of Norway (grant 266134/F50) and the Norwegian Biodiversity Information Centre (grant 70184209). The Norwegian part of the project was funded by the Taxonomy Initiative of the Norwegian Biodiversity Information Centre (grant 70184228) (to FO). DNA sequencing for some of the material was funded by the Agricultural Science and Technology Innovation Program, China (grant CAAS-ASTIP-2015-IAR) (to JH). Part of the database of species' distributions in North America was created with financial support from grants from the National Science Foundation to John Ascher, Douglas Yanega, and Jerome Rozen (grants NSF-DBI 0956388 and NSF-DBI 0956340) (to LR). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Ackery PR, 1984, MILKWEED BUTTERFLIES; Barrio IC, 2013, ARCTIC, V66, P429; BARROWCLOUGH GF, 1982, AUK, V99, P601; Baum D, 2012, TREE THINKING INTRO; Bertsch A, 2005, INSECT SOC, V52, P45, DOI 10.1007/s00040-004-0761-1; Bertsch Andreas, 2004, Beitraege zur Entomologie, V54, P365; Bolton Barry, 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P52; Brigham-Grette J, 2001, QUATERNARY SCI REV, V20, P15, DOI 10.1016/S0277-3791(00)00134-7; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cardoso A, 2009, MOL ECOL, V18, P648, DOI 10.1111/j.1365-294X.2008.04048.x; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Cristiano MP, 2012, APIDOLOGIE, V43, P527, DOI 10.1007/s13592-012-0122-4; De Meulemeester T, 2012, APPROCHE INTEGRATIVE; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duennes MA, 2012, MOL PHYLOGENET EVOL, V64, P219, DOI 10.1016/j.ympev.2012.03.018; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Elias SA, 2013, ENCY QUATERNARY SCI, P191, DOI DOI 10.1016/B978-0-444-53643-3.00116-3; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; Friese H., 1910, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V29; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gjershaug JO, 2013, ZOOTAXA, V3716, P431, DOI 10.11646/zootaxa.3716.3.6; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hines HM, 2012, ZOOL J LINN SOC-LOND, V166, P805, DOI 10.1111/j.1096-3642.2012.00861.x; Huang JX, 2015, APIDOLOGIE, V46, P250, DOI 10.1007/s13592-014-0319-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurd P. D. Jr., 1979, Catalog of Hymenoptera in America north of Mexico. Volume 2. Apocrita (Aculeata)., P1741; International Commission on Zoological Nomenclature (ICZN), 1999, INT CODE ZOOLOGICAL; Kronforst MR, 2012, PIGM CELL MELANOMA R, V25, P411, DOI 10.1111/j.1755-148X.2012.01014.x; Kruger E., 1951, Teil Tijdschr Ent Amsterdam, V93, P141; Lecocq T, 2015, APIDOLOGIE; Lecocq T, 2014, ANIMAL CONSERVATION; Lecocq T, 2015, ZOOL SCR, V44, P281, DOI 10.1111/zsc.12107; Lecocq T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-263; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; LOKEN A, 1973, Norsk Entomologisk Tidsskrift, V20, P1; Maddison, 2018, MESQUITE MODULAR SYS; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Mallet J., 1997, TRENDS ECOL EVOL, V12, P453, DOI DOI 10.1016/S0169-5347(97)85758-8; Mayr E., 1963, ANIMAL SPECIES EVOLU; Michener C. D., 2007, BEES WORLD; MILLIRON HE, 1973, MEM ENTOMOL SOC CAN, P81, DOI 10.4039/entm10589fv; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Neumeyer R, 2014, ZOOKEYS, P67, DOI 10.3897/zookeys.400.6611; Pamilo P, 1997, ENTOMOL FENNICA, V7, P187, DOI 10.33338/ef.83908; PANFILOV D. V., 1960, BIULL MOSKOV OBSHCHESTVA ISPYTATELEI PRIRODY OTDEL BIOL, V65, P53; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Paterson H.E.H., 1985, Transvaal Museum Monograph, P21; PEKKARINEN A, 1979, Acta Zoologica Fennica, P1; Pittioni B, 1939, KONOWIA, V17, P244; PLOWRIGHT RC, 1980, EVOLUTION, V34, P622, DOI 10.2307/2408017; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pringle H, 2014, SCIENCE, V343, P961, DOI 10.1126/science.343.6174.961; Radoszkowski O., 1884, B MOSKOVSKOGO OBSHCH, V59, P51; Rapti Z, 2014, BIOL J LINN SOC, V113, P384, DOI 10.1111/bij.12356; RASMONT P, 1984, Spixiana, V7, P135; Rasmont P., 1983, NOTES FAUNIQUES GEMB, V7, P1; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; REINIG W F, 1981, Spixiana, V4, P159; Reinig WF, 1935, J GENET, V30, P321, DOI 10.1007/BF02982243; Reinig WF, 1939, VERHANDLUNGEN DTSCH, V12, P170; RICHARDS K W, 1973, Quaestiones Entomologicae, V9, P115; Richards O. W., 1931, TROMSO MUSEUMS ARSHE, V50, P1; Richards OW, 1929, P ROYAL ENTOMOLOGICA, V3, P75; Rougerie R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101108; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Skorikov A. S., 1937, Entomologiske Meddelelser, V20, P37; Skorikov A. S., 1931, ABHANDLUNGEN PAMIR E, P175; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Strange JP, 2009, APIDOLOGIE, V40, P134, DOI 10.1051/apido/2008070; SVENSSON BG, 1979, ENTOMOL SCAND, V10, P275; SVENSSON BG, 1977, ZOON, V5, P63; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terzo M, 2005, APIDOLOGIE, V36, P85, DOI 10.1051/apido:2004072; Tkalcu B., 1968, Annotationes Zoologicae et Botanicae Bratislava, VNo. 52, P1; TKALCU B, 1989, ACTA ENTOMOL BOHEMOS, V86, P39; Vogt O., 1909, SITZUNGSBERICHTE GES, V1909, P28; Vogt Oskar, 1911, Sitzungsberichte der Gesellschaft Naturforschender Freunde zu Berlin, V1911; von Dalla Torre KW, 1880, NATURHISTORIKER, V2, P40; Williams P.H., 1991, Bulletin of the British Museum (Natural History) Entomology, V60, P1; Williams P, 2007, BIOL J LINN SOC, V92, P97, DOI 10.1111/j.1095-8312.2007.00878.x; Williams PH, 2013, APIDOLOGIE, V44, P121, DOI 10.1007/s13592-012-0161-x; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PH, 2011, ZOOL J LINN SOC-LOND, V163, P813, DOI 10.1111/j.1096-3642.2011.00729.x; Williams Paul H., 2010, Insecta Matsumurana, V66, P115; Williams PH, 2008, APIDOLOGIE, V39, P637, DOI 10.1051/apido:2008048; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; Williams PH, 1997, P ROY SOC B-BIOL SCI, V264, P141, DOI 10.1098/rspb.1997.0021; Williams PH, 2014, BUMBLE BEES N AM IDE; Williams ST, 2006, MOL PHYLOGENET EVOL, V39, P33, DOI 10.1016/j.ympev.2005.12.017; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	105	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144544	10.1371/journal.pone.0144544	http://dx.doi.org/10.1371/journal.pone.0144544			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657658	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000366903500037
J	Senger, S; Sapone, A; Fiorentino, MR; Mazzarella, G; Lauwers, GY; Fasano, A				Senger, Stefania; Sapone, Anna; Fiorentino, Maria Rosaria; Mazzarella, Giuseppe; Lauwers, Gregory Y.; Fasano, Alessio			Celiac Disease Histopathology Recapitulates Hedgehog Downregulation, Consistent with Wound Healing Processes Activation	PLOS ONE			English	Article							RESTRICTED T-CELLS; STEM-CELLS; SMALL-INTESTINE; SMOOTH-MUSCLE; INTERFERON-GAMMA; GENE-EXPRESSION; MOUSE INTESTINE; SONIC HEDGEHOG; IN-VITRO; CRYPT	Background In celiac disease (CD), intestinal epithelium damage occurs secondary to an immune insult and is characterized by blunting of the villi and crypt hyperplasia. Similarities between Hedgehog (Hh)/BMP4 downregulation, as reported in a mouse model, and CD histopathology, suggest mechanistic involvement of Hh/BMP4/WNT pathways in proliferation and differentiation of immature epithelial cells in the context of human intestinal homeostasis and regeneration after damage. Herein we examined the nature of intestinal crypt hyperplasia and involvement of Hh/BMP4 in CD histopathology. Methods and Findings Immunohistochemistry, qPCR and in situ hybridization were used to study a cohort of 24 healthy controls (HC) and 24 patients with diagnosed acute celiac disease (A-CD) intestinal biopsies. In A-CD we observed an increase in cells positive for Leucin-rich repeat-containing G protein-coupled receptor 5 (LGR5), an epithelial stem cell specific marker and expansion of WNT responding compartment. Further, we observed alteration in number and distribution of mesenchymal cells, predicted to be part of the intestinal stem cells niche. At the molecular level we found downregulation of indian hedgehog (IHH) and other components of the Hh pathway, but we did not observe a concurrent downregulation of BMP4. However, we observed upregulation of BMPs antagonists, gremlin 1 and gremlin 2. Conclusions Our data suggest that acute CD histopathology partially recapitulates the phenotype reported in Hh knockdown models. Specifically, Hh/BMP4 paradigm appears to be decoupled in CD, as the expansion of the immature cell population does not occur consequent to downregulation of BMP4. Instead, we provide evidence that upregulation of BMP antagonists play a key role in intestinal crypt hyperplasia. This study sheds light on the molecular mechanisms underlying CD histopathology and the limitations in the use of mouse models for celiac disease.	[Senger, Stefania; Sapone, Anna; Fiorentino, Maria Rosaria; Fasano, Alessio] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mucosal Immunol & Biol Res,Children & Celiac, Charlestown, MA 02129 USA; [Sapone, Anna] Beth Israel Deaconess Med Ctr, Celiac Ctr, Div Gastroenterol, Dept Med, Boston, MA 02215 USA; [Sapone, Anna] Harvard Univ, Sch Med, Boston, MA USA; [Mazzarella, Giuseppe] CNR, Inst Food Sci, I-83100 Avellino, Italy; [Lauwers, Gregory Y.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Harvard University; Massachusetts General Hospital	Fasano, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mucosal Immunol & Biol Res,Children & Celiac, Charlestown, MA 02129 USA.	afasano@mgh.harvard.edu	Fasano, Alessio/K-5486-2016; Fiorentino, Maria/AAV-9514-2020; Mazzarella, Giuseppe/GSO-3318-2022	Fasano, Alessio/0000-0002-2134-0261; Fiorentino, Maria R/0000-0001-5318-7313; Mazzarella, Giuseppe/0000-0002-7294-8277	NIH grant [R01DK048373]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048373] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors declare that the study entitled: "Celiac Disease Histopathology Recapitulates Hedgehog Downregulation, Consistent with Wound Healing Processes Activation" was funded exclusively by NIH grant, R01DK048373 to AF and there was no additional external funding received for this study.	Bajaj-Elliott M, 1998, J CLIN INVEST, V102, P1473, DOI 10.1172/JCI2792; Bardella MT, 2007, HISTOPATHOLOGY, V50, P465, DOI 10.1111/j.1365-2559.2007.02621.x; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Capuano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029094; Ciccocioppo R, 2005, LAB INVEST, V85, P397, DOI 10.1038/labinvest.3700225; Gentile Nicole M, 2012, Curr Gastroenterol Rep, V14, P380, DOI 10.1007/s11894-012-0276-2; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Liang R, 2013, CANADIAN J GASTROENT, V27, pe5; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Malamut G, 2015, BEST PRACT RES CL GA, V29, P451, DOI 10.1016/j.bpg.2015.05.005; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Savidge TC, 1996, GUT, V39, P185, DOI 10.1136/gut.39.2.185; SAVIDGE TC, 1995, GUT, V36, P321, DOI 10.1136/gut.36.3.321; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELBY WS, 1983, CLIN EXP IMMUNOL, V52, P219; Shi ZD, 2010, J BIOL CHEM, V285, P32415, DOI 10.1074/jbc.M110.164863; Simmons JG, 2002, AM J PHYSIOL-GASTR L, V283, pG809, DOI 10.1152/ajpgi.00057.2002; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; Vanuytsel T, 2013, BBA-GEN SUBJECTS, V1830, P2410, DOI 10.1016/j.bbagen.2012.08.006; Verbeke S, 2002, J CLIN PATHOL, V55, P440, DOI 10.1136/jcp.55.6.440; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zuniga A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-23	42	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144634	10.1371/journal.pone.0144634	http://dx.doi.org/10.1371/journal.pone.0144634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649570	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300063
J	Wang, JW; Lin, GT; Alwaal, A; Zhang, XY; Wang, GF; Jia, XY; Banie, L; Villalta, J; Lin, CS; Lue, TF				Wang, Jianwen; Lin, Guiting; Alwaal, Amjad; Zhang, Xiaoyu; Wang, Guifang; Jia, Xingyuan; Banie, Lia; Villalta, Jacqueline; Lin, Ching-Shwun; Lue, Tom F.			Kinetics of Label Retaining Cells in the Developing Rat Kidneys	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; FILAMENT PROTEIN NESTIN; STEM-CELLS; STEM/PROGENITOR CELLS; ADULT KIDNEY; PROGENITOR CELLS; PROXIMAL TUBULE; LINEAGE; MARKER; DIFFERENTIATION	Background The kidney is a specialized low-regenerative organ with several different types of cellular lineages. The BrdU label-retaining cell (LRCs) approach has been used as part of a strategy to identify tissue-specific stem cells in the kidney; however, because the complementary base pairing in double-stranded DNA blocks the access of the anti-BrdU antibody to BrdU subunits, the stem cell marker expression in BrdU-labeled cells are often difficult to detect. In this study, we introduced a new cell labeling and detection method in which BrdU was replaced with 5-ethynyl-2-deoxyuridine (EdU) and examined the time-dependent dynamic changes of EdU-labeled cells and potential stem/progenitor markers in the development of kidney. Methods Newborn rats were intraperitoneally injected with EdU, and their kidneys were harvested respectively at different time points at 1 day, 3 days, 1 week, 2 weeks, and 6 weeks post-injection. The kidney tissues were processed for EdU and cellular markers by immunofluorescence staining. Results At the early stage, LRCs labeled by EdU were 2176.0 +/- 355.6 cells at day one in each renal tissue section, but dropped to 168 +/- 48.4 cells by week 6. As time increased, the numbers of LRCs were differentially expressed in the renal cortex and papilla. At the postnatal day one, nearly twice as many cells in the cortex were EdU-labeled as compared to the papilla (28.6 +/- 3.6% vs. 15.6 +/- 3.4%, P<0.05), while there were more LRCs within the renal papilla since the postnatal week one, and at the postnatal week 6, one third as many cells in the cortex were EdU-labeled as compared to the papilla (2.5 +/- 0.1% vs. 7.7 +/- 2.7%, P<0.05). The long-term LRCs at 6-week time point were associated exclusively with the glomeruli in the cortex and the renal tubules in the papilla. At 6 weeks, the EdU-labeled LRCs combined with expression of CD34, RECA-1, Nestin, and Synaptopodin were discretely but widely distributed within the glomeruli; Stro-1 around the glomeruli; and alpha-smooth muscle actin (SMA) in arteries. Conversely, co-expression of CD34, RECA-1, and Nestin with the long term EdU-labeled LRCs was significantly lower in renal tubules (P<0.01), while Stro-1 and Synaptopodin were not detected. Conclusion Our data found that at 6-week time point, EdU-labeled LRCs existing in the glomeruli expressed undifferentiated podocyte and endothelial markers at high rates, while those in the renal tubules expressed Nestin and vascular markers at low rates. To understand the characterization and localization of these EdU-LRCs, further studies will be needed to test cell lineage tracing, clonogenicity and differentiation potency, and the contributions to the regeneration of the kidney in response to renal injury/repair.	[Wang, Jianwen; Jia, Xingyuan] Capital Med Univ, Beijing ChaoYang Hosp, Dept Urol, Beijing 100020, Peoples R China; [Wang, Jianwen; Lin, Guiting; Alwaal, Amjad; Zhang, Xiaoyu; Wang, Guifang; Banie, Lia; Villalta, Jacqueline; Lin, Ching-Shwun; Lue, Tom F.] Univ Calif San Francisco, Sch Med, Dept Urol, Knuppe Mol Urol Lab, San Francisco, CA 94143 USA	Capital Medical University; University of California System; University of California San Francisco	Wang, JW (corresponding author), Capital Med Univ, Beijing ChaoYang Hosp, Dept Urol, 8 Gongtinanlu, Beijing 100020, Peoples R China.	wjianw99@sina.cn	Zhang, xiaoyu/GXA-3206-2022					Aggarwal S, 2013, STEM CELL TRANSL MED, V2, P1011, DOI 10.5966/sctm.2013-0097; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bertram JF, 2000, ANAT REC, V258, P128; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Chen J, 2006, J AM SOC NEPHROL, V17, P1283, DOI 10.1681/ASN.2005101032; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Gangenahalli GU, 2006, STEM CELLS DEV, V15, P305, DOI 10.1089/scd.2006.15.305; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Kim K, 2008, INT J CLIN EXP PATHO, V1, P232; Kitamura S, 2015, STEM CELLS, V33, P774, DOI 10.1002/stem.1891; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Langworthy M, 2009, J AM SOC NEPHROL, V20, P311, DOI 10.1681/ASN.2008010094; Lasagni L, 2010, J AM SOC NEPHROL, V21, P1612, DOI 10.1681/ASN.2010010048; Lin CS, 2012, CYTOTHERAPY, V14, P1159, DOI 10.3109/14653249.2012.729817; Lin GT, 2015, STEM CELLS DEV, V24, P264, DOI 10.1089/scd.2014.0360; Lin GT, 2012, CYTOTHERAPY, V14, P240, DOI 10.3109/14653249.2011.627918; Lin GT, 2011, STEM CELLS DEV, V20, P1747, DOI 10.1089/scd.2010.0564; Lin GT, 2009, CYTOTHERAPY, V11, P864, DOI 10.3109/14653240903180084; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Lopez MLSS, 2004, DEV CELL, V6, P719; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; Maeshima Akito, 2007, Clin Exp Nephrol, V11, P269, DOI 10.1007/s10157-007-0500-9; Maeshima A, 2006, J AM SOC NEPHROL, V17, P188, DOI 10.1681/ASN.2005040370; McCampbell KK, 2012, BIOCHEM J, V444, P153, DOI 10.1042/BJ20120176; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; NARBAITZ R, 1991, ANAT EMBRYOL, V183, P353; Ning HX, 2011, BIOCHEM BIOPH RES CO, V413, P353, DOI 10.1016/j.bbrc.2011.08.104; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Oliver JA, 2009, J AM SOC NEPHROL, V20, P2315, DOI 10.1681/ASN.2008111203; Patschan D, 2007, KIDNEY INT, V71, P744, DOI 10.1038/sj.ki.5002102; Pippin JW, 2013, AM J PATHOL, V183, P542, DOI 10.1016/j.ajpath.2013.04.024; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Romagnani P, 2015, NAT REV NEPHROL, V11, P420, DOI 10.1038/nrneph.2015.67; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Stern CD, 2001, NAT CELL BIOL, V3, pE216, DOI 10.1038/ncb0901-e216; Tsuji K, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/537204; Vogetseder A, 2005, HISTOCHEM CELL BIOL, V124, P97, DOI 10.1007/s00418-005-0023-y; Wagner N, 2006, AM J PHYSIOL-REG I, V291, pR779, DOI 10.1152/ajpregu.00219.2006; Ward HH, 2011, BBA-MOL BASIS DIS, V1812, P1344, DOI 10.1016/j.bbadis.2011.01.010; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Zhang H, 2012, UROLOGY, V79, DOI [10.1016/j.urology.2011.10.051, DOI 10.1016/J.UROL0GY.2011.10.051]; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	52	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144734	10.1371/journal.pone.0144734	http://dx.doi.org/10.1371/journal.pone.0144734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650841	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300072
J	Zheng, YL; Sun, YP; Zhang, H; Liu, WJ; Jiang, R; Li, WY; Zheng, YH; Zhang, ZG				Zheng, Yu-Liang; Sun, Yang-Peng; Zhang, Hong; Liu, Wen-Jing; Jiang, Rui; Li, Wen-Yu; Zheng, You-Hua; Zhang, Zhi-Guang			Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential	PLOS ONE			English	Article							STROMAL CELLS; BONE-MARROW; DERIVATION; PRECURSORS; INDUCTION; CULTURES; TISSUES	Induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs) serve as a promising source for cell-based therapies in regenerative medicine. However, optimal methods for transforming iPSCs into MSCs and the characteristics of iPSC-MSCs obtained from different methods remain poorly understood. In this study, we developed a one-step method for obtaining iPSC-MSCs (CD146+STRO-1+MSCs) from human synovial fluid MSC-derived induced iPSCs (SFMSC-iPSCs). CD146-STRO-1-SFMSCs were reprogrammed into iPSCs by transduction with lentivirus-mediated Sox2, Oct-3/4, klf4, and c-Myc. SFMSC-iPSCs were maintained with mTeSR1 medium in Matrigel-coated culture plates. Single dissociated cells were obtained by digesting the SFMSC-iPSCs with trypsin. The dissociated cells were then plated into Matrigel-coated culture plate with alpha minimum essential medium supplemented with 10% fetal bovine serum, 1x Glutamax, and the ROCK inhibitor Y-27632. Cells were then passaged in standard cell culture plates with alpha minimum essential medium supplemented with 10% fetal bovine serum and 1x Glutamax. After passaging in vitro, the cells showed a homogenous spindle-shape similar to their ancestor cells (SFMSCs), but with more robust proliferative activity. Flow cytometric analysis revealed typical MSC surface markers, including expression of CD73, CD90, CD105, and CD44 and lack of CD45, CD34, CD11b, CD19, and HLA-DR. However, these cells were positive for CD146 and stro-1, which the ancestor cells were not. Moreover, the cells could also be induced to differentiate in osteogenic, chondrogenic, and adipogenic lineages in vitro. The differentiation potential was improved compared with the ancestor cells in vitro. The cells were not found to exhibit oncogenicity in vivo. Therefore, the method presented herein facilitated the generation of STRO-1+CD146+MSCs from SFMSC-iPSCs exhibiting enhanced proliferation and differentiation potential.	[Zheng, Yu-Liang; Sun, Yang-Peng; Zhang, Hong; Liu, Wen-Jing; Zheng, You-Hua; Zhang, Zhi-Guang] Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Rui; Li, Wen-Yu] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Wen-Jing] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yu-Liang] Guangdong Second Tradit Chinese Med Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Sun, YP (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	sunyp@mail2.sysu.edu.cn; kouqiangzzg@hotmail.com			National Science Foundation of China [81271115]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Science Foundation of China (81271115), http://isisn.nsfc.gov.cn/egrantweb/.	Bakopoulou A, 2013, ARCH ORAL BIOL, V58, P1556, DOI 10.1016/j.archoralbio.2013.06.018; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Bensidhoum M, 2004, BLOOD, V103, P3313, DOI 10.1182/blood-2003-04-1121; Brown SE, 2009, CELLS TISSUES ORGANS, V189, P256, DOI 10.1159/000151746; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Choo A, 2011, METHODS MOL BIOL, V690, P175, DOI 10.1007/978-1-60761-962-8_12; de Bruin T, 2005, AM J VET RES, V66, P1903, DOI 10.2460/ajvr.2005.66.1903; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gadkari R, 2014, REGEN MED, V9, P453, DOI [10.2217/RME.14.13, 10.2217/rme.14.13]; Harvanova D, 2011, FOLIA BIOL-PRAGUE, V57, P119; Hynes K, 2016, METHODS MOL BIOL, V1357, P353, DOI 10.1007/7651_2014_142; Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042; Kim YK, 2012, J CRANIO MAXILL SURG, V40, pE337, DOI 10.1016/j.jcms.2012.02.002; Koyama N, 2011, LIFE SCI, V89, P741, DOI 10.1016/j.lfs.2011.09.005; Lee EJ, 2010, TISSUE ENG PT A, V16, P705, DOI 10.1089/ten.tea.2008.0596; Lei M, 2014, BIOMATERIALS, V35, P6332, DOI 10.1016/j.biomaterials.2014.04.071; Li Y, 2014, CELL TRANSPLANT, V23, P776; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225; Mahmood A, 2012, STEM CELLS DEV, V21, P3114, DOI 10.1089/scd.2012.0035; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Nasef A, 2009, INT J LAB HEMATOL, V31, P9, DOI 10.1111/j.1751-553X.2007.00997.x; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Papadopoulou A, 2012, ANN RHEUM DIS, V71, P1733, DOI 10.1136/annrheumdis-2011-200985; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Russell KC, 2013, TISSUE ENG PT A, V19, P2253, DOI [10.1089/ten.tea.2012.0649, 10.1089/ten.TEA.2012.0649]; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SIMMONS PJ, 1991, BLOOD, V78, P55; Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345; Sun Y, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/214841; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei HM, 2012, STEM CELL RES, V9, P87, DOI 10.1016/j.scr.2012.04.003; Wu RR, 2013, HUM CELL, V26, P19, DOI 10.1007/s13577-011-0022-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	45	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144226	10.1371/journal.pone.0144226	http://dx.doi.org/10.1371/journal.pone.0144226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649753	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903300040
J	Berrou, E; Kauskot, A; Adam, F; Harel, A; Legendre, P; Bombled, CL; Rothschild, C; Prevost, N; Christophe, OD; Lenting, PJ; Denis, CV; Rosa, JP; Bryckaert, M				Berrou, Eliane; Kauskot, Alexandre; Adam, Frederic; Harel, Amelie; Legendre, Paulette; Bombled, Cecile Lavenu; Rothschild, Chantal; Prevost, Nicolas; Christophe, Olivier D.; Lenting, Peter J.; Denis, Cecile V.; Rosa, Jean-Philippe; Bryckaert, Marijke			Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M	PLOS ONE			English	Article							VONWILLEBRAND DISEASE; THROMBOCYTOPENIA	Thrombocytopenia and increased platelet clearance observed in von Willebrand diseasetype 2B (VWD-2B) may be explained by platelet apoptosis triggered by the constitutive binding of VWF to its receptor, glycoprotein Ib (GPIb). Apoptosis was assessed in platelets from two patients with a severe VWD-2B mutation VWF/p.V1316M and from mice transiently expressing VWF/p.V1316M. We now report that the VWD-2B mutation VWF/p. V1316M which binds spontaneously to its receptor GPIba does not induce apoptosis. In 2 unrelated patients (P1 and P2) exhibiting different VWF plasma levels (70% and 36%, respectively, compared with normal pooled human plasma given as 100%), inner transmembrane depolarization of mitochondria, characteristic of apoptotic events was undetectable in platelets, whether washed or in whole blood. No or a moderate phosphatidyl serine (PS) exposure as measured by annexin-V staining was observed for P1 and P2, respectively. Expression of pro-apoptotic proteins Bak and Bax, and caspase-3 activity were similar to control platelets. In the VWD-2B mouse model expressing high levels of mVWF/p.V1316M (423%), similar to what is found in inflammatory pathologies, no significant difference was observed between mice expressing mVWF/WT and mVWF/p.V1316M. These results strongly argue against apoptosis as a mechanism for the thrombocytopenia of severe VWD-2B exhibiting the VWF/p.V1316M mutation.	[Berrou, Eliane; Kauskot, Alexandre; Adam, Frederic; Harel, Amelie; Legendre, Paulette; Bombled, Cecile Lavenu; Christophe, Olivier D.; Lenting, Peter J.; Denis, Cecile V.; Rosa, Jean-Philippe; Bryckaert, Marijke] Univ Paris Saclay, Univ Paris 11, INSERM, UMR S 1176, F-94276 Le Kremlin Bicetre, France; [Bombled, Cecile Lavenu] AP HP, Serv Hematol Biol, Le Kremlin Bicetre, France; [Rothschild, Chantal] Hop Necker Enfants Malad, Ctr Hemophilie, Paris, France; [Prevost, Nicolas] Kyoto Gakuen Univ, Kameoka, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bryckaert, M (corresponding author), Univ Paris Saclay, Univ Paris 11, INSERM, UMR S 1176, F-94276 Le Kremlin Bicetre, France.	marijke.bryckaert@inserm.fr	christophe, olivier/W-4268-2017; ROSA, JEAN-PHILIPPE/B-6245-2018; Denis, Cecile/A-7649-2011; Lenting, Peter/AAH-5663-2019; Kauskot, Alexandre/J-6794-2015; Lenting, Peter/F-8269-2013	christophe, olivier/0000-0002-9080-6336; ROSA, JEAN-PHILIPPE/0000-0001-7342-0389; Denis, Cecile/0000-0001-5152-9156; Lenting, Peter/0000-0002-7937-3429; Kauskot, Alexandre/0000-0002-4064-8114; Lenting, Peter/0000-0002-7937-3429; ADAM, Frederic/0000-0001-6603-2687; Bryckaert, Marijke/0000-0003-3398-0976	INSERM; Agence Nationale de la Recherche [ANR 11 BSV101001]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was financially supported by grants from INSERM and Agence Nationale de la Recherche (ANR 11 BSV101001 to C.V Denis).	Baumgartner R, 2013, J PROTEOMICS, V94, P540, DOI 10.1016/j.jprot.2013.10.015; Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8; Casari C, 2013, J CLIN INVEST, V123, P5071, DOI 10.1172/JCI69458; Casari C, 2013, BLOOD, V122, P2893, DOI 10.1182/blood-2013-03-493312; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; GINSBURG D, 1992, BLOOD, V79, P2507; Li S, 2010, THROMB HAEMOSTASIS, V8, P341, DOI [10.1111/j.1538-7836.2009.03653.x, DOI 10.1111/J.1538-7836.2009.03653.X]; Nurden P, 2000, BRIT J HAEMATOL, V110, P704, DOI 10.1046/j.1365-2141.2000.02246.x; Nurden P, 2010, BLOOD, V115, P2649, DOI 10.1182/blood-2009-07-231886; OKITA JR, 1989, BLOOD, V74, P715; Rand ML, 2010, AM J HEMATOL, V85, P584, DOI 10.1002/ajh.21768; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; Ruggeri ZM, 2007, THROMB HAEMOSTASIS, V98, P55, DOI 10.1160/TH07-04-0279; van der Wal DE, 2010, J THROMB HAEMOST, V8, P2554, DOI 10.1111/j.1538-7836.2010.04043.x	14	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143896	10.1371/journal.pone.0143896	http://dx.doi.org/10.1371/journal.pone.0143896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645283	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903100009
J	Yuan, HJ; Houck, KL; Tian, Y; Bharadwaj, U; Hull, K; Zhou, Z; Zhou, MZ; Wu, XP; Tweardy, DJ; Romo, D; Fu, XY; Zhang, YJ; Zhang, JN; Dong, JF				Yuan, Hengjie; Houck, Katie L.; Tian, Ye; Bharadwaj, Uddalak; Hull, Ken; Zhou, Zhou; Zhou, Mingzhao; Wu, Xiaoping; Tweardy, David J.; Romo, Daniel; Fu, Xiaoyun; Zhang, Yanjun; Zhang, Jianning; Dong, Jing-fei			Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species	PLOS ONE			English	Article							SIGNAL TRANSDUCER; TRANSCRIPTION; ACTIVATION; STAT3; INTERLEUKIN-6; CONSTITUENTS; AGGREGATION; TYROSINE; FRUIT	Background Piperlongumine (PL) is a compound isolated from the piper longum plant. It possesses anti-cancer activities through blocking the transcription factor STAT3 and by inducing reactive oxygen species (ROS) in cancer, but not normal cells. It also inhibits platelet aggregation induced by collagen, but the underlying mechanism is not known. Objective We conducted in vitro experiments to test the hypothesis that PL regulates a non-transcriptional activity of STAT3 to specifically reduce the reactivity of human platelets to collagen. Results PL dose-dependently blocked collagen-induced platelet aggregation, calcium influx, CD62p expression and thrombus formation on collagen with a maximal inhibition at 100 mu M. It reduced platelet microvesiculation induced by collagen. PL blocked the activation of JAK2 and STAT3 in collagen-stimulated platelets. This inhibitory effect was significantly reduced in platelets pretreated with a STAT3 inhibitor. Although PL induced ROS production in platelets; quenching ROS using excessive reducing agents: 20 mu M GSH and 0.5 mM L-Cysteine, did not block the inhibitory effects. The NADPH oxidase inhibitor Apocynin also had no effect. Conclusions PL inhibited collagen-induced platelet reactivity by targeting the JAK2-STAT3 pathway. We also provide experimental evidence that PL and collagen induce different oxidants that have differential effects on platelets. Studying these differential effects may uncover new mechanisms of regulating platelet functions by oxidants in redox signals.	[Yuan, Hengjie; Houck, Katie L.; Tian, Ye; Zhou, Zhou; Wu, Xiaoping; Fu, Xiaoyun; Dong, Jing-fei] Bloodworks Northwest Res Inst, Seattle, WA USA; [Yuan, Hengjie; Tian, Ye; Zhang, Jianning] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Tianjin, Peoples R China; [Bharadwaj, Uddalak; Tweardy, David J.] Baylor Coll Med, Div Infect Dis, Dept Med, Houston, TX 77030 USA; [Hull, Ken; Zhou, Mingzhao; Romo, Daniel] Texas A&M Univ, Nat Prod LINCHPIN Lab, College Stn, TX USA; [Hull, Ken; Zhou, Mingzhao; Romo, Daniel] Texas A&M Univ, Dept Chem, College Stn, TX USA; [Zhang, Yanjun] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Fu, Xiaoyun; Dong, Jing-fei] Univ Washington, Sch Med, Div Hematol, Dept Med, Seattle, WA 98195 USA	Tianjin Medical University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Imperial College London; University of Washington; University of Washington Seattle	Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Tianjin, Peoples R China.	jfdong@BloodworksNW.org; jianningzhang@hotmail.com	Tweardy, David/L-3929-2019; zhang, yanjun/S-5114-2019	Zhang, Yanjun/0000-0002-3123-1405; Romo, Daniel/0000-0003-3805-092X; Yuan, Hengjie/0000-0001-7132-5572	National Heart, Lung, and Blood Institute [HL71895, HL085769]; National Cancer Institute [CA149783]; Cancer Prevention and Research Institute of Texas [RP100421]; Tianjin Science and Technology Support Program of China [14ZCZDSY00020]; Natural Science Foundation of China [13JCYBJC21900, 12JCYBJC31500]; John S. Dunn Gulf Coast Consortium for Chemical Genomics Discovery Project; Tianjin Natural Science Foundation of China [13JCYBJC21900]; Tianjin Municipal Science and Technology Project [14ZCZDSY00020]; Vice President for Research, College of Science, and Department of Chemistry at Texas AM University; NATIONAL CANCER INSTITUTE [R21CA149783] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085769, R01HL071895] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas; Tianjin Science and Technology Support Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); John S. Dunn Gulf Coast Consortium for Chemical Genomics Discovery Project; Tianjin Natural Science Foundation of China; Tianjin Municipal Science and Technology Project; Vice President for Research, College of Science, and Department of Chemistry at Texas AM University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by 1) grants HL71895 and HL085769 from the National Heart, Lung, and Blood Institute and CA149783 from the National Cancer Institute; 2) the Cancer Prevention and Research Institute of Texas (RP100421); 3) the Tianjin Science and Technology Support Program of China (No. 14ZCZDSY00020); 4) the Natural Science Foundation of China (No. 13JCYBJC21900 and 12JCYBJC31500); 5) the John S. Dunn Gulf Coast Consortium for Chemical Genomics Discovery Project; and 6) Tianjin Natural Science Foundation of China (No. 13JCYBJC21900) and Tianjin Municipal Science and Technology Project (No. 14ZCZDSY00020).; We thank the Vice President for Research, College of Science, and Department of Chemistry at Texas A&M University for seed funding to the Natural Products LINCHPIN Laboratory.	Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Arthur JF, 2012, J THROMB HAEMOST, V10, P1133, DOI 10.1111/j.1538-7836.2012.04734.x; Arthur JF, 2008, PLATELETS, V19, P1, DOI 10.1080/09537100701817224; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bezerra DP, 2013, EUR J PHARM SCI, V48, P453, DOI 10.1016/j.ejps.2012.12.003; Bharadwaj U, 2014, ONCOGENE IN PRESS; BOSIN TR, 1991, BIOCHEM PHARMACOL, V41, P967, DOI 10.1016/0006-2952(91)90203-H; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Hu H, 2005, THROMB RES, V116, P241, DOI 10.1016/j.thromres.2004.12.015; Iwashita M, 2007, EUR J PHARMACOL, V570, P38, DOI 10.1016/j.ejphar.2007.05.073; Jarvius M, 2013, BIOCHEM BIOPH RES CO, V431, P117, DOI 10.1016/j.bbrc.2013.01.017; Jin Z, 2009, PHYTOTHER RES, V23, P1194, DOI 10.1002/ptr.2630; Kim KS, 2006, PIGM CELL RES, V19, P90, DOI 10.1111/j.1600-0749.2005.00281.x; Kumar S, 2011, J ACUPUNCT MERIDIAN, V4, P134, DOI 10.1016/S2005-2901(11)60020-4; Lee SE, 2007, FOOD ADDIT CONTAM A, V24, P391, DOI 10.1080/02652030601053147; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; MILSOM JP, 1979, METABOLISM, V28, P313, DOI 10.1016/0026-0495(79)90101-X; Morikawa T, 2004, PLANTA MED, V70, P152, DOI 10.1055/s-2004-815493; Park BS, 2007, PHYTOMEDICINE, V14, P853, DOI 10.1016/j.phymed.2007.06.011; Park BS, 2008, PHYTOTHER RES, V22, P1195, DOI 10.1002/ptr.2432; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Silva DR, 2009, MOLECULES, V14, P1171, DOI 10.3390/molecules14031171; Son DJ, 2012, BIOCHEM BIOPH RES CO, V427, P349, DOI 10.1016/j.bbrc.2012.09.061; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Zhang HL, 2008, BIOORG MED CHEM LETT, V18, P3272, DOI 10.1016/j.bmcl.2008.04.052; Zhang YJ, 2013, THROMB HAEMOSTASIS, V110, P331, DOI 10.1160/TH12-11-0853; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou Z, 2013, CIRCULATION, V127, P476, DOI 10.1161/CIRCULATIONAHA.112.132126	32	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143964	10.1371/journal.pone.0143964	http://dx.doi.org/10.1371/journal.pone.0143964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645674	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903100012
J	Kotapalli, SS; Nallam, SSA; Nadella, L; Banerjee, T; Rode, HB; Mainkar, PS; Ummanni, R				Kotapalli, Sudha Sravanti; Nallam, Sri Satya Anila; Nadella, Lavanya; Banerjee, Tanmay; Rode, Haridas B.; Mainkar, Prathama S.; Ummanni, Ramesh			Identification of New Molecular Entities (NMEs) as Potential Leads against Tuberculosis from Open Source Compound Repository	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG DISCOVERY; BACTERICIDAL ACTIVITIES; MEDICINAL CHEMISTRY; INHIBITORS; COMBINATORIAL; SMEGMATIS; EXPOSURE; GENOMICS; LIBRARY	The purpose of this study was to provide a number of diverse and promising early-lead compounds that will feed into the drug discovery pipeline for developing new antitubercular agents. The results from the phenotypic screening of the open-source compound library against Mycobacterium smegmatis and Mycobacterium bovis (BCG) with hit validation against M. tuberculosis (H37Rv) have identified novel potent hit compounds. To determine their druglikeness, a systematic analysis of physicochemical properties of the hit compounds has been performed using cheminformatics tools. The hit molecules were analysed by clustering based on their chemical finger prints and structural similarity determining their chemical diversity. The hit compound library is also filtered for druglikeness based on the physicochemical descriptors following Lipinski filters. The robust filtration of hits followed by secondary screening against BCG, H37Rv and cytotoxicity evaluation has identified 12 compounds with potential against H37Rv (MIC range 0.4 to 12.5 mu M). Furthermore in cytotoxicity assays, 12 compounds displayed low cytotoxicity against liver and lung cells providing high therapeutic index > 50. To avoid any variations in activity due to the route of chemical synthesis, the hit compounds were re synthesized independently and confirmed for their potential against H37Rv. Taken together, the hits reported here provides copious potential starting points for generation of new leads eventually adds to drug discovery pipeline against tuberculosis.	[Kotapalli, Sudha Sravanti; Nallam, Sri Satya Anila; Ummanni, Ramesh] CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, Andhra Pradesh, India; [Nadella, Lavanya; Rode, Haridas B.; Mainkar, Prathama S.] CSIR Indian Inst Chem Technol, Div Nat Prod Chem, Hyderabad 500007, Andhra Pradesh, India; [Banerjee, Tanmay] Syngene Int Ltd, Bangalore 560099, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Syngene International Limited	Mainkar, PS (corresponding author), CSIR Indian Inst Chem Technol, Div Nat Prod Chem, Hyderabad 500007, Andhra Pradesh, India.	prathama@iict.res.in; ummanni@iict.res.in			Open Source Drug Discovery (OSDD)-Council for Scientific and Industrial Research (CSIR), India [HCP-0001]; Syngene International Ltd.	Open Source Drug Discovery (OSDD)-Council for Scientific and Industrial Research (CSIR), India; Syngene International Ltd.	The authors thank Open Source Drug Discovery (OSDD)-Council for Scientific and Industrial Research (CSIR), India for financial support under project code HCP-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Syngene International Ltd. provided support in the form of salaries for authors [TB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2008, TB SCI FACTS DRUG RE; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Bakker-Woudenberg IAJM, 2005, ANTIMICROB AGENTS CH, V49, P2387, DOI 10.1128/AAC.49.6.2387-2398.2005; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Barile FA, 2010, CLINICAL TOXICOLOGY: PRINCIPLES AND MECHANISMS, 2ND EDITION, P1, DOI 10.3109/9781420092264; Barry CE, 2000, BIOCHEM PHARMACOL, V59, P221, DOI 10.1016/S0006-2952(99)00253-1; Berry M, 2009, EUR RESPIR REV, V18, P195, DOI 10.1183/09059180.00005209; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381; Castro A, 2006, BIOORGAN MED CHEM, V14, P1644, DOI 10.1016/j.bmc.2005.10.012; Cordone A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-231; Forbes L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129234; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Grant SS, 2013, ACS CHEM BIOL, V8, P2224, DOI 10.1021/cb4004817; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; Haggarty SJ, 2005, CURR OPIN CHEM BIOL, V9, P296, DOI 10.1016/j.cbpa.2005.04.006; Hitchcock SA, 2006, J MED CHEM, V49, P7559, DOI 10.1021/jm060642i; Jao CW, 2008, J NAT PROD, V71, P1275, DOI 10.1021/np800064w; Khan A, 2008, J MICROBIOL METH, V73, P62, DOI 10.1016/j.mimet.2008.01.015; King GM, 2003, APPL ENVIRON MICROB, V69, P7266, DOI 10.1128/AEM.69.12.7266-7272.2003; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Liofilchem, 2015, LIST BACT BACT ANT A; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lu T, 2003, J ANTIMICROB CHEMOTH, V52, P61, DOI 10.1093/jac/dkg268; Monge A, 2006, MOL DIVERS, V10, P389, DOI 10.1007/s11030-006-9033-5; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; MURDOCK KC, 1978, J MED CHEM, V21, P403, DOI 10.1021/jm00202a020; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Savjani KT, 2012, ISRN PHARM, V2012, DOI DOI 10.5402/2012/195727; Shahbazi Y, 2015, J PATHOG, V2015, DOI DOI 10.1155/2015/916305; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sood R., 2006, Infectious Disorders - Drug Targets, V6, P343, DOI 10.2174/187152606779025860; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Strausberg RL, 2003, SCIENCE, V300, P294, DOI 10.1126/science.1083395; VANHOOF R, 1980, ANTIMICROB AGENTS CH, V18, P118, DOI 10.1128/AAC.18.1.118; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization website, 2014, FACTSH; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; YAMORI S, 1992, MICROBIOL IMMUNOL, V36, P361, DOI 10.1111/j.1348-0421.1992.tb02035.x; Zuo X, 2010, J AGR FOOD CHEM, V58, P2755, DOI 10.1021/jf902863z	49	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144018	10.1371/journal.pone.0144018	http://dx.doi.org/10.1371/journal.pone.0144018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642200	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700045
J	Ceccon, M; Merlo, MEB; Mologni, L; Poggio, T; Varesio, LM; Menotti, M; Bombelli, S; Rigolio, R; Manazza, AD; Di Giacomo, F; Ambrogio, C; Giudici, G; Casati, C; Mastini, C; Compagno, M; Turner, SD; Gambacorti-Passerini, C; Chiarle, R; Voena, C				Ceccon, M.; Merlo, M. E. Boggio; Mologni, L.; Poggio, T.; Varesio, L. M.; Menotti, M.; Bombelli, S.; Rigolio, R.; Manazza, A. D.; Di Giacomo, F.; Ambrogio, C.; Giudici, G.; Casati, C.; Mastini, C.; Compagno, M.; Turner, S. D.; Gambacorti-Passerini, C.; Chiarle, R.; Voena, C.			Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency	ONCOGENE			English	Article							ANAPLASTIC LYMPHOMA KINASE; LUNG-CANCER; ACQUIRED-RESISTANCE; CONFER RESISTANCE; DNA-REPLICATION; NUCLEAR EXPORT; INHIBITORS; MUTATIONS; SENSITIVITY; CRIZOTINIB	Most of the anaplastic large-cell lymphoma (ALCL) cases carry the t(2; 5; p23;q35) that produces the fusion protein NPM-ALK (nucleophosmin-anaplastic lymphoma kinase). NPM-ALK-deregulated kinase activity drives several pathways that support malignant transformation of lymphoma cells. We found that in ALK-rearranged ALCL cell lines, NPM-ALK was distributed in equal amounts between the cytoplasm and the nucleus. Only the cytoplasmic portion was catalytically active in both cell lines and primary ALCL, whereas the nuclear portion was inactive because of heterodimerization with NPM1. Thus, about 50% of the NPM-ALK is not active and sequestered as NPM-ALK/NPM1 heterodimers in the nucleus. Overexpression or relocalization of NPM-ALK to the cytoplasm by NPM genetic knockout or knockdown caused ERK1/2 (extracellular signal-regulated protein kinases 1 and 2) increased phosphorylation and cell death through the engagement of an ATM/Chk2- and gamma H2AX (phosphorylated H2A histone family member X)-mediated DNA-damage response. Remarkably, human NPM-ALK-amplified cell lines resistant to ALK tyrosine kinase inhibitors (TKIs) underwent apoptosis upon drug withdrawal as a consequence of ERK1/2 hyperactivation. Altogether, these findings indicate that an excess of NPM-ALK activation and signaling induces apoptosis via oncogenic stress responses. A 'drug holiday' where the ALK TKI treatment is suspended could represent a therapeutic option in cells that become resistant by NPM-ALK amplification.	[Ceccon, M.; Mologni, L.; Bombelli, S.; Gambacorti-Passerini, C.] Univ Milano Bicocca, Dept Hlth Sci, Via Cadore 48, I-20900 Monza, Italy; [Merlo, M. E. Boggio; Poggio, T.; Varesio, L. M.; Menotti, M.; Manazza, A. D.; Di Giacomo, F.; Mastini, C.; Compagno, M.; Chiarle, R.; Voena, C.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Merlo, M. E. Boggio; Poggio, T.; Varesio, L. M.; Menotti, M.; Manazza, A. D.; Di Giacomo, F.; Mastini, C.; Compagno, M.; Chiarle, R.; Voena, C.] Citta Salute & Sci, CERMS, Turin, Italy; [Rigolio, R.] Univ Milano Bicocca, Surg & Translat Med Dept, Monza, Italy; [Ambrogio, C.] Ctr Nacl Invest Oncol, Mol Oncol Program, Madrid, Spain; [Giudici, G.] Univ Milano Bicocca, Pediat Clin, Tettamanti Res Ctr, Monza, Italy; [Casati, C.] MetaSystems Slr, Milan, Italy; [Compagno, M.; Chiarle, R.] Childrens Hosp, Dept Pathol, Boston, MA USA; [Compagno, M.; Chiarle, R.] Harvard Med Sch, Enders 1116-1,320 Longwood Ave, Boston, MA 02115 USA; [Turner, S. D.] Addenbrookes Hosp, Div Mol Histopathol, Cambridge, England; [Gambacorti-Passerini, C.] San Gerardo Hosp, Sect Haematol, Monza, Italy	University of Milano-Bicocca; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Milano-Bicocca; University of Milano-Bicocca; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; San Gerardo Hospital	Gambacorti-Passerini, C (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Via Cadore 48, I-20900 Monza, Italy.; Chiarle, R (corresponding author), Harvard Med Sch, Enders 1116-1,320 Longwood Ave, Boston, MA 02115 USA.; Chiarle, R (corresponding author), Childrens Hosp Boston, Dept Pathol, Enders 1116-1,320 Longwood Ave, Boston, MA 02115 USA.	carlo.gambacorti@unimib.it; roberto.chiarle@childrens.harvard.edu	Menotti, Matteo/AAA-9312-2022; VOENA, Claudia/ADJ-6244-2022; Turner, Suzanne Dawn/K-4405-2013; Mologni, Luca/AAC-1065-2022	Turner, Suzanne Dawn/0000-0002-8439-4507; Mologni, Luca/0000-0002-6365-5149; Boggio Merlo, Maria Elena/0000-0002-1967-7308; Menotti, Matteo/0000-0002-1260-2389; Voena, Claudia/0000-0002-1324-1431; Ambrogio, Chiara/0000-0003-4122-701X; Varesio, Lydia/0000-0001-6394-1607; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Poggio, Teresa/0000-0003-2560-8488	Regione Lombardia [ID14546A]; Fondazione Berlucchi Onlus Grant; FP7 ERC-StG [242965]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-12023]; Koch Institute/DFCC Bridge Project Fund; Ellison Foundation Boston; Worldwide Cancer Research Association [12-0216]; Grant for Oncology Innovation by Merck-Serono;  [R01 CA196703-01]; NATIONAL CANCER INSTITUTE [R01CA196703] Funding Source: NIH RePORTER	Regione Lombardia(Regione Lombardia); Fondazione Berlucchi Onlus Grant; FP7 ERC-StG; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Koch Institute/DFCC Bridge Project Fund; Ellison Foundation Boston(Lawrence Ellison Foundation); Worldwide Cancer Research Association; Grant for Oncology Innovation by Merck-Serono; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Maria Stella Scalzo for technical support, Dr Emanuela Colombo for kindly providing MEFs that lack NPM1 (MEF NPM<SUP>-/-</SUP>p53<SUP>-/-</SUP>) and control fibroblasts (MEF p53<SUP>-/-</SUP>), Dr Guido Serini for the use of his confocal microscopy unit at the Candiolo Cancer Institute-IRCCS, Torino, Italy. We also thank Ariad Pharmaceutical, Pfizer, Astellas and Novartis that kindly provided all drugs used in this study. This work was supported by the Regione Lombardia (ID14546A) and Fondazione Berlucchi Onlus Grant 2014 (to CGP), and by grants FP7 ERC-2009-StG (Proposal No. 242965-'Lunely'); Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant IG-12023; Koch Institute/DFCC Bridge Project Fund; Ellison Foundation Boston; Worldwide Cancer Research Association (former AICR) grant 12-0216; the Grant for Oncology Innovation by Merck-Serono and R01 CA196703-01 (to RC).	Amin AD, 2015, CANCER RES, V75, P2916, DOI 10.1158/0008-5472.CAN-14-3437; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Ceccon M, 2015, MOL CANCER RES, V13, P775, DOI 10.1158/1541-7786.MCR-14-0157; Ceccon M, 2013, MOL CANCER RES, V11, P122, DOI 10.1158/1541-7786.MCR-12-0569; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Cui YX, 2009, BLOOD, V113, P5217, DOI 10.1182/blood-2008-06-160168; Das A, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0002-5; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Dengler MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025139; Desplat V, 2005, CANCER-AM CANCER SOC, V103, P102, DOI 10.1002/cncr.20758; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Funakoshi Y, 2013, INVEST NEW DRUG, V31, P1158, DOI 10.1007/s10637-013-9959-2; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hapgood G, 2015, BLOOD, V126, P17, DOI 10.1182/blood-2014-10-567461; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Ignatius Ou SH, 2014, J THORAC ONCOL, V9, P549, DOI DOI 10.1097/JTO.0000000000000094; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Katayama R, 2015, CLIN CANCER RES, V21, P2227, DOI 10.1158/1078-0432.CCR-14-2791; Katayama R, 2014, CLIN CANCER RES, V20, P5686, DOI 10.1158/1078-0432.CCR-14-1511; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Koop A, 2014, BRIT J DERMATOL, V170, P220, DOI 10.1111/bjd.12615; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Martinengo C, 2014, CANCER RES, V74, P6094, DOI 10.1158/0008-5472.CAN-14-0268; Maya-Mendoza A, 2015, MOL ONCOL, V9, P601, DOI 10.1016/j.molonc.2014.11.001; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Mologni L, 2015, ONCOTARGET, V6, P5720, DOI 10.18632/oncotarget.3122; Mologni L, 2015, TRANSL LUNG CANCER R, V4, P5, DOI 10.3978/j.issn.2218-6751.2014.07.02; Mologni L, 2012, EXPERT OPIN INV DRUG, V21, P985, DOI 10.1517/13543784.2012.690031; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Pall G, 2015, CURR OPIN ONCOL, V27, P118, DOI 10.1097/CCO.0000000000000165; Passerini CG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt378; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Rassidakis GZ, 2005, LEUKEMIA, V19, P1663, DOI 10.1038/sj.leu.2403840; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Suda K, 2012, LUNG CANCER, V76, P292, DOI 10.1016/j.lungcan.2011.11.007; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tipping AJ, 2001, BLOOD, V98, P3864, DOI 10.1182/blood.V98.13.3864; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Voena C, 2012, EXPERT OPIN INV DRUG, V21, P1751, DOI 10.1517/13543784.2012.717930; Walker CJ, 2013, BLOOD, V122, P3034, DOI 10.1182/blood-2013-04-495374; Wei F, 2011, CURR MED CHEM, V18, P5476, DOI 10.2174/092986711798194388; Zdzalik D, 2014, J CANCER RES CLIN, V140, P589, DOI 10.1007/s00432-014-1589-3	54	28	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3854	3865		10.1038/onc.2015.456	http://dx.doi.org/10.1038/onc.2015.456			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26657151	Green Accepted			2022-12-26	WOS:000380753200010
J	Akpa, MM; Iglesias, D; Chu, L; Thiebaut, A; Jentoft, I; Hammond, L; Torban, E; Goodyer, PR				Akpa, Murielle M.; Iglesias, Diana; Chu, LeeLee; Thiebaut, Antonin; Jentoft, Ida; Hammond, Leah; Torban, Elena; Goodyer, Paul R.			Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; dicer; mesenchymal stem cells (MSCs); microRNA (miRNA); polycomb; Enhancer of Zeste 2; kidney development; Wilms tumor 1	GENE; RNA; MUTATIONS; BINDING; LOCALIZATION; BIOGENESIS; PATHWAYS; ROLES	Hereditary forms of Wilms arise from developmentally arrested clones of renal progenitor cells with biallelic mutations of WT1; recently, it has been found that Wilms tumors may also be associated with biallelic mutations in DICER1 or DROSHA, crucial for miRNA biogenesis. We have previously shown that a critical role for WT1 during normal nephrogenesis is to suppress transcription of the Polycomb group protein, EZH2, thereby de-repressing genes in the differentiation cascade. Here we show that WT1 also suppresses translation of EZH2. All major WT1 isoforms induce an array of miRNAs, which target the 3 UTR of EZH2 and other Polycomb-associated transcripts. We show that the WT1(+KTS) isoform binds to the 5 UTR of EZH2 and interacts directly with the miRNA-containing RISC to enhance post-transcriptional inhibition. These observations suggest a novel mechanism through which WT1 regulates the transition from resting stem cell to activated progenitor cell during nephrogenesis. Our findings also offer a plausible explanation for the fact that Wilms tumors can arise either from loss of WT1 or loss of miRNA processing enzymes.	[Akpa, Murielle M.; Goodyer, Paul R.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Torban, Elena; Goodyer, Paul R.] McGill Univ, Dept Expt Med, Montreal, PQ H3A 1A3, Canada; [Iglesias, Diana; Chu, LeeLee; Thiebaut, Antonin; Jentoft, Ida; Hammond, Leah; Goodyer, Paul R.] McGill Univ, Ctr Hlth, Res Inst, Dept Pediat, Montreal, PQ H4A 3J1, Canada	McGill University; McGill University; McGill University	Goodyer, PR (corresponding author), Montreal Childrens Hosp, Dept Human Genet, Res Inst, 1001 Decarie Blvd,Bloc E,Lab E012371, Montreal, PQ H4A 3J1, Canada.; Goodyer, PR (corresponding author), Montreal Childrens Hosp, Dept Pediat, Res Inst, 1001 Decarie Blvd,Bloc E,Lab E012371, Montreal, PQ H4A 3J1, Canada.	paul.goodyer@mcgill.ca	Thiébaut, Antonin/AAR-7016-2020	Thiébaut, Antonin/0000-0002-7587-5587; Jentoft, Ida/0000-0001-7726-1717	Canadian Institutes of Health Research (CIHR) [MOP-119571]; Fonds de la Recherche en Sante du Quebec (FRSQ); James McGill Research Chair	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); James McGill Research Chair	This work was supported in part by Operating Grant MOP-119571 from the Canadian Institutes of Health Research (CIHR) and an infrastructure support grant to the McGill University Health Center Research Institute from the Fonds de la Recherche en Sante du Quebec (FRSQ). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a James McGill Research Chair. To whom correspondence should be addressed: Depts. of Human Genetics and Pediatrics, Montreal Children's Hospital Research Institute, 1001 Decarie Blvd., Bloc E, Lab E012371, Montreal, QC H4A 3J1, Canada. Tel.: 514-412-4400 (ext. 22584); Fax: 514-412-4478; E-mail: paul.goodyer@mcgill.ca.	Aiden AP, 2010, CELL STEM CELL, V6, P591, DOI 10.1016/j.stem.2010.03.016; Akpa MM, 2015, J BIOL CHEM, V290, P2279, DOI 10.1074/jbc.M114.573576; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; Charlieu JP, 1995, J CELL SCI, P95; Cone T E Jr, 1970, Pediatrics, V46, P587; Davies R, 1999, CANCER RES, V59, p1747S; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Friedman JM, 2009, CELL CYCLE, V8, P2313, DOI 10.4161/cc.8.15.9168; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Fukuzawa R, 2007, J CLIN PATHOL, V60, P1013, DOI 10.1136/jcp.2006.043083; Gagnon KT, 2012, NUCLEIC ACID THER, V22, P3, DOI 10.1089/nat.2011.0330; HUFF V, 1991, AM J HUM GENET, V48, P997; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2004, IUBMB LIFE, V56, P95, DOI 10.1080/15216540410001670142; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Morrison AA, 2008, BBA-REV CANCER, V1785, P55, DOI 10.1016/j.bbcan.2007.10.002; Morrison AA, 2008, AM J PHYSIOL-RENAL, V295, pF12, DOI 10.1152/ajprenal.00597.2007; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; O'Rourke Jason R., 2006, Birth Defects Research, V78, P172, DOI 10.1002/bdrc.20071; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Torrezan GT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5039; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Wu MK, 2013, J PATHOL, V230, P154, DOI 10.1002/path.4196; Zhai G, 2001, BIOCHEMISTRY-US, V40, P2032, DOI 10.1021/bi001941r; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	35	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3785	3795		10.1074/jbc.M115.678029	http://dx.doi.org/10.1074/jbc.M115.678029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26655220	Green Published, hybrid			2022-12-26	WOS:000371338400010
J	Blevins, TP; Mitchell, MC; Korom, M; Wang, H; Yu, YY; Morrison, LA; Belshe, RB				Blevins, Tamara P.; Mitchell, Michelle C.; Korom, Maria; Wang, Hong; Yu, Yinyi; Morrison, Lynda A.; Belshe, Robert B.			Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses	PLOS ONE			English	Article							GLYCOPROTEIN-C; INFECTED-CELLS; COMPLEMENT; PROTECTION; VACCINE; INFECTIVITY; TYPE-1; HSV-2; IMMUNIZATION; COMPONENT	We report a rapid, higher throughput method for measuring neutralizing antibody to herpes simplex virus (HSV) in human sera. Clinical isolates and sera from the Herpevac Trial for Women were used in a colorimetric assay in which infection of tissue culture (lack of neutralization) was indicated by substrate metabolism by beta-galactosidase induced in the ELVIS cell line. The neutralization assay was optimized by addition of guinea pig complement, which particularly enhanced neutralizing antibody titers to HSV-2. Higher neutralizing antibody titers were also achieved using virus particles isolated from the supernatant of infected cells rather than lysate of infected cells as the source of virus. The effect of assay incubation time and incubation time with substrate were also optimized. We found that incubating with substrate until a standard optical density of 1.0 was reached permitted a better comparison among virus isolates, and achieved reliable measurement of neutralizing antibody activity. Interestingly, in contrast to results in the absence of complement, addition of complement allowed sera from HSV-2 gD-vaccinated subjects to neutralize HSV-1 and HSV-2 clinical and laboratory isolates with equal potency.	[Blevins, Tamara P.; Mitchell, Michelle C.; Yu, Yinyi; Belshe, Robert B.] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO USA; [Korom, Maria; Wang, Hong; Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University	Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	morrisla@slu.edu		Blevins, Tamara/0000-0003-1955-2641	National Institutes of Health [10E-12-0106]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health contract 10E-12-0106 to Robert Belshe. The funders had no role in study design, data collection and analysis or preparation of the manuscript, but authorization to publish was given.	ACKERMANN M, 1984, J VIROL, V52, P108, DOI 10.1128/JVI.52.1.108-118.1984; Ashley RL, 1997, VIRAL IMMUNOL, V10, P213, DOI 10.1089/vim.1997.10.213; Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177; Awasthi S, 2011, J VIROL, V85, P10472, DOI 10.1128/JVI.00849-11; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005; Campadelli-Fiume G, 2012, CURR OPIN VIROL, V2, P28, DOI 10.1016/j.coviro.2011.12.001; Cooper D, 2004, VACCINE, V23, P236, DOI 10.1016/j.vaccine.2004.05.011; DOUTLIK S, 1989, ACTA VIROL, V33, P435; Dudek TE, 2011, J INFECT DIS, V203, P1434, DOI 10.1093/infdis/jir047; DUFF R, 1971, J VIROL, V8, P469, DOI 10.1128/JVI.8.4.469-477.1971; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; GARLAND SM, 1995, J VIROL METHODS, V55, P285, DOI 10.1016/0166-0934(95)00061-9; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; HEINEMAN HS, 1967, J IMMUNOL, V99, P214; HUEMER HP, 1993, ARCH VIROL, V130, P353, DOI 10.1007/BF01309666; KAHLON J, 1986, J CLIN MICROBIOL, V23, P725, DOI 10.1128/JCM.23.4.725-730.1986; KNIPE DM, 1982, J VIROL, V43, P314, DOI 10.1128/JVI.43.1.314-324.1982; LANGENBERG AGM, 1995, ANN INTERN MED, V122, P889, DOI 10.7326/0003-4819-122-12-199506150-00001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCNEARNEY TA, 1987, J EXP MED, V166, P1525, DOI 10.1084/jem.166.5.1525; Morrison LA, 1996, VIROLOGY, V220, P402, DOI 10.1006/viro.1996.0328; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RATNER JJ, 1980, INFECT IMMUN, V27, P113, DOI 10.1128/IAI.27.1.113-117.1980; SCHMIDT NJ, 1975, INFECT IMMUN, V12, P728, DOI 10.1128/IAI.12.4.728-732.1975; SHIMIZU F, 1977, INFECT IMMUN, V16, P531, DOI 10.1128/IAI.16.2.531-536.1977; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; STABELL EC, 1992, J VIROL METHODS, V38, P195, DOI 10.1016/0166-0934(92)90110-Y; SZE P, 1992, VIRUS RES, V26, P141, DOI 10.1016/0168-1702(92)90153-Z; YOSHINO K, 1966, J IMMUNOL, V96, P196	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144738	10.1371/journal.pone.0144738	http://dx.doi.org/10.1371/journal.pone.0144738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658766	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900098
J	Bodewes, R; Garcia, AR; Brasseur, SM; Conteras, GJS; van de Bildt, MWG; Koopmans, MPG; Osterhaus, ADME; Kuiken, T				Bodewes, Rogier; Garcia, Ana Rubio; Brasseur, Sophie M.; Conteras, Guillermo J. Sanchez; van de Bildt, Marco W. G.; Koopmans, Marion P. G.; Osterhaus, Albert D. M. E.; Kuiken, Thijs			Seroprevalence of Antibodies against Seal Influenza A(H10N7) Virus in Harbor Seals and Gray Seals from the Netherlands	PLOS ONE			English	Article							B VIRUS	In the spring and summer 2014, an outbreak of seal influenza A(H10N7) virus infection occurred among harbor seals (Phoca vitulina) off the coasts of Sweden and Denmark. This virus subsequently spread to harbor seals off the coasts of Germany and the Netherlands. While thousands of seals were reported dead in Sweden, Denmark and Germany, only a limited number of seals were found dead in the Netherlands. To determine the extent of exposure of seals in the Netherlands to influenza A/H10N7 virus, we measured specific antibody titers in serum samples from live-captured seals and seals admitted for rehabilitation in the Netherlands by use of a hemagglutination inhibition assay and an ELISA. In harbor seals in 2015, antibodies against seal influenza A(H10N7) virus were detected in 41% (32 out of 78) pups, 10% (5 out of 52) weaners, and 58% (7 out of 12) subadults or adults. In gray seals (Halichoerus grypus) in 2015, specific antibodies were not found in the pups (n = 26), but in 26% (5 out of 19) of the older animals. These findings indicate that, despite apparent low mortality, infection with seal influenza A(H10N7) virus was geographically widespread and also occurred in grey seals.	[Bodewes, Rogier; van de Bildt, Marco W. G.; Koopmans, Marion P. G.; Osterhaus, Albert D. M. E.; Kuiken, Thijs] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Garcia, Ana Rubio; Conteras, Guillermo J. Sanchez] Seal Rehabil & Res Ctr, Pieterburen, Netherlands; [Brasseur, Sophie M.] Wageningen Univ, IMARES Inst Marine Resources & Ecosyst Studies, Texel, Netherlands; [Koopmans, Marion P. G.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Osterhaus, Albert D. M. E.] Artemis One Hlth, Utrecht, Netherlands; [Osterhaus, Albert D. M. E.] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; University of Veterinary Medicine Hannover, Foundation	Bodewes, R (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecth, Netherlands.	rogier.bodewes@gmail.com	Koopmans, Marion/Y-9170-2019	Koopmans, Marion/0000-0002-5204-2312; Bodewes, Rogier/0000-0002-0689-7889; Sanchez Contreras, Guillermo J./0000-0002-7664-2531; Kuiken, Thijs/0000-0001-5501-9049	European Commission [643476]; ZonMW grant [91213058]	European Commission(European CommissionEuropean Commission Joint Research Centre); ZonMW grant	This study was financially supported by the European Commission H2020 programme under contract number 643476 (www.compare_europe.eu) and ZonMW grant 91213058 (www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Bodewes R, 2015, EMERG INFECT DIS, V21, P720, DOI 10.3201/eid2104.141675; Bodewes R, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.2; Bodewes R, 2013, EMERG INFECT DIS, V19, P511, DOI 10.3201/eid1903.120965; CALLAN RJ, 1995, J GEN VIROL, V76, P199, DOI 10.1099/0022-1317-76-1-199; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Fereidouni S, 2014, ECOHEALTH; GERACI JR, 1984, CAN J FISH AQUAT SCI, V41, P151, DOI 10.1139/f84-015; Goldstein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062259; Koninklijk Nederlands Meteorologisch Instituut (KNMI), DAGG WEER NED; Krog JS, 2015, EMERG INFECT DIS, V21, P684, DOI 10.3201/eid2104.141484; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Palmer DF, 1975, ADV LAB TECHNIQUES I, P25; Rijks JM, 2005, EMERG INFECT DIS, V11, P1945, DOI 10.3201/eid1112.050596; ROSS PS, 1994, VET IMMUNOL IMMUNOP, V42, P331, DOI 10.1016/0165-2427(94)90077-9; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; Zohari S, 2014, EUROSURVEILLANCE, V19	17	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144899	10.1371/journal.pone.0144899	http://dx.doi.org/10.1371/journal.pone.0144899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658347	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900142
J	Chang, MC; Lin, LD; Wu, MT; Chan, CP; Chang, HH; Lee, MS; Sun, TY; Jeng, PY; Yeung, SY; Lin, HJ; Jeng, JH				Chang, Mei-Chi; Lin, Li-Deh; Wu, Min-Tsz; Chan, Chiu-Po; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Po-Yuan; Yeung, Sin-Yuet; Lin, Hsueh-Jen; Jeng, Jiiang-Huei			Effects of Camphorquinone on Cytotoxicity, Cell Cycle Regulation and Prostaglandin E-2 Production of Dental Pulp Cells: Role of ROS, ATM/Chk2, MEK/ERK and Hemeoxygenase-1	PLOS ONE			English	Article							CARBOXYLESTERASE EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; RESIN; APOPTOSIS; TEGDMA; INITIATORS; ACTIVATION; PATHWAYS; SURVIVAL; KINASES	Camphorquinone (CQ) is a popularly-used photosensitizer in composite resin restoration. In this study, the effects of CQ on cytotoxicity and inflammation-related genes and proteins expression of pulp cells were investigated. The role of reactive oxygen species (ROS), ATM/Chk2/p53 and hemeoxygenase-1 (HO-1) and MEK/ERK signaling was also evaluated. We found that ROS and free radicals may play important role in CQ toxicity. CQ (1 and 2 mM) decreased the viability of pulp cells to about 70% and 50% of control, respectively. CQ also induced G(2)/M cell cycle arrest and apoptosis of pulp cells. The expression of type I collagen, cdc2, cyclin B, and cdc25C was inhibited, while p21, HO-1 and cyclooxygenase-2 (COX-2) were stimulated by CQ. CQ also activated ATM, Chk2, and p53 phosphorylation and GADD45 alpha expression. Besides, exposure to CQ increased cellular ROS level and 8-isoprostane production. CQ also stimulated COX-2 expression and PGE(2) production of pulp cells. The reduction of cell viability caused by CQ can be attenuated by N-acetyl-L-cysteine (NAC), catalase and superoxide dismutase (SOD), but can be promoted by Zinc protoporphyin (ZnPP). CQ stimulated ERK1/2 phosphorylation, and U0126 prevented the CQ-induced COX-2 expression and prostaglandin E-2 (PGE(2)) production. These results indicate that CQ may cause cytotoxicity, cell cycle arrest, apoptosis, and PGE(2) production of pulp cells. These events could be due to stimulation of ROS and 8-isoprostane production, ATM/Chk2/p53 signaling, HO-1, COX-2 and p21 expression, as well as the inhibition of cdc2, cdc25C and cyclin B1. These results are important for understanding the role of ROS in pathogenesis of pulp necrosis and pulpal inflammation after clinical composite resin filling.	[Chang, Mei-Chi] Chang Gung Univ Sci & Technol, Biomed Sci Team, Taoyuan, Taiwan; [Lin, Li-Deh; Wu, Min-Tsz; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Jiiang-Huei] Grad Inst Clin Dent, Lab Dent Pharmacol Toxicol & Mat Biocompatibil, Taipei, Taiwan; [Lin, Li-Deh; Wu, Min-Tsz; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Jiiang-Huei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Li-Deh; Wu, Min-Tsz; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet] Chang Gung Mem Hosp, Dept Dent, Taipei 10591, Taiwan; [Jeng, Po-Yuan] Univ Cardenal Herrera, CEU, Sch Dent, Valencia, Spain; [Lin, Hsueh-Jen] Show Chwan Mem Hosp, Dept Dent, Changhua, Taiwan	Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Universidad CEU Cardenal Herrera; Show Chwan Memorial Hospital	Jeng, JH (corresponding author), Grad Inst Clin Dent, Lab Dent Pharmacol Toxicol & Mat Biocompatibil, Taipei, Taiwan.	jhjeng@ntu.edu.tw		LIN, LI-DEH/0000-0002-6050-7394	Ministry of Science and Technology [NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002, NSC102-2314-B002-051-MY2]; National Taiwan University Hospital (NTUH); Chang Gung Memorial Hospital [CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Hospital (NTUH); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study is supported by grants from Ministry of Science and Technology (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002, and NSC102-2314-B002-051-MY2), National Taiwan University Hospital (NTUH) and Chang Gung Memorial Hospital (CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061), and National Taiwan University Hospital (NTUH).; This study is supported by grants from Chang Gung Memorial Hospital (CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061) and Ministry of Science and Technology (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002, and NSC102-2314-B002-051-MY2), National Taiwan University Hospital (NTUH) and National Taiwan University Hospital (NTUH).	Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Chang HH, 2014, ACTA BIOMATER, V10, P722, DOI 10.1016/j.actbio.2013.10.006; Chang MC, 2006, INT ENDOD J, V39, P819, DOI 10.1111/j.1365-2591.2006.01156.x; Chang MC, 2012, ACTA BIOMATER, V8, P1380, DOI 10.1016/j.actbio.2011.09.011; Chang MC, 2010, INT ENDOD J, V43, P461, DOI 10.1111/j.1365-2591.2010.01699.x; Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Chang MC, 2009, BIOMATERIALS, V30, P4070, DOI 10.1016/j.biomaterials.2009.04.034; Chang MC, 2009, J ENDODONT, V35, P508, DOI 10.1016/j.joen.2008.12.023; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Eckhardt A, 2009, BIOMATERIALS, V30, P2006, DOI 10.1016/j.biomaterials.2008.12.045; Engelmann J, 2005, J BIOMED MATER RES B, V75B, P272, DOI 10.1002/jbm.b.30360; Ferenbach DA, 2010, NEPHRON EXP NEPHROL, V115, pE33, DOI 10.1159/000313828; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; Geurtsen W, 1998, J BIOMED MATER RES, V41, P474, DOI 10.1002/(SICI)1097-4636(19980905)41:3<474::AID-JBM18>3.0.CO;2-I; Geurtsen W, 1999, J BIOMED MATER RES, V48, P772, DOI 10.1002/(SICI)1097-4636(1999)48:6<772::AID-JBM2>3.0.CO;2-X; Guven G, 2007, J ENDODONT, V33, P18, DOI 10.1016/j.joen.2006.07.014; Hebling J, 1999, J ENDODONT, V25, P676, DOI 10.1016/S0099-2399(99)80354-9; Huang FM, 2003, BIOMATERIALS, V24, P1869, DOI 10.1016/S0142-9612(02)00584-7; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Masuki K, 2007, DENT MATER J, V26, P861, DOI 10.4012/dmj.26.861; McClay DR, 1999, EXP CELL RES, V253, P296, DOI 10.1006/excr.1999.4723; McGarvey TW, 2000, UROL ONCOL, V5, P71, DOI 10.1016/S1078-1439(99)00003-4; Michelsen VB, 2007, J CHROMATOGR B, V850, P83, DOI 10.1016/j.jchromb.2006.11.003; Miyauchi M, 1996, J ENDODONT, V22, P600, DOI 10.1016/S0099-2399(96)80029-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Samuelsen JT, 2007, DENT MATER, V23, P34, DOI 10.1016/j.dental.2005.11.037; Silva GAB, 2006, OPER DENT, V31, P297, DOI 10.2341/05-65; Spagnuolo G, 2004, J DENT RES, V83, P703, DOI 10.1177/154405910408300909; Spagnuolo G, 2008, J ENDODONT, V34, P684, DOI 10.1016/j.joen.2008.02.040; Spahl W, 1998, J DENT, V26, P137, DOI 10.1016/S0300-5712(96)00086-3; Stansbury J W, 2000, J Esthet Dent, V12, P300, DOI 10.1111/j.1708-8240.2000.tb00239.x; TAIRA M, 1988, J DENT RES, V67, P24, DOI 10.1177/00220345880670010401; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Volk J, 2009, DENT MATER, V25, P1556, DOI 10.1016/j.dental.2009.07.009	40	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143663	10.1371/journal.pone.0143663	http://dx.doi.org/10.1371/journal.pone.0143663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658076	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900015
J	Day, PE; Ntani, G; Crozier, SR; Mahon, PA; Inskip, HM; Cooper, C; Harvey, NC; Godfrey, KM; Hanson, MA; Lewis, RM; Cleal, JK				Day, Pricilla E.; Ntani, Georgia; Crozier, Sarah R.; Mahon, Pam A.; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.; Hanson, Mark A.; Lewis, Rohan M.; Cleal, Jane K.			Maternal Factors Are Associated with the Expression of Placental Genes Involved in Amino Acid Metabolism and Transport	PLOS ONE			English	Article							BIRTH-WEIGHT; IN-UTERO; SIZE; PREGNANCY; SMOKING; SYSTEM; GROWTH; SEX; RESTRICTION; EXPOSURE	Introduction Maternal environment and lifestyle factors may modify placental function to match the mother's capacity to support the demands of fetal growth. Much remains to be understood about maternal influences on placental metabolic and amino acid transporter gene expression. We investigated the influences of maternal lifestyle and body composition (e.g. fat and muscle content) on a selection of metabolic and amino acid transporter genes and their associations with fetal growth. Methods RNA was extracted from 102 term Southampton Women's Survey placental samples. Expression of nine metabolic, seven exchange, eight accumulative and three facilitated transporter genes was analyzed using quantitative real-time PCR. Results Increased placental LAT2 (p = 0.01), y(+)LAT2 (p = 0.03), aspartate aminotransferase 2 (p = 0.02) and decreased aspartate aminotransferase 1 (p = 0.04) mRNA expression associated with pre-pregnancy maternal smoking. Placental mRNA expression of TAT1 (p = 0.01), ASCT1 (p = 0.03), mitochondrial branched chain aminotransferase (p = 0.02) and glutamine synthetase (p = 0.05) was positively associated with maternal strenuous exercise. Increased glutamine synthetase mRNA expression (r = 0.20, p = 0.05) associated with higher maternal diet quality (prudent dietary pattern) pre-pregnancy. Lower LAT4 (r = -0.25, p = 0.05) and aspartate aminotransferase 2 mRNA expression (r = -0.28, p = 0.01) associated with higher early pregnancy diet quality. Lower placental ASCT1 mRNA expression associated with measures of increased maternal fat mass, including pre-pregnancy BMI (r = -0.26, p = 0.01). Lower placental mRNA expression of alanine aminotransferase 2 associated with greater neonatal adiposity, for example neonatal subscapular skinfold thickness (r = -0.33, p = 0.001). Conclusion A number of maternal influences have been linked with outcomes in childhood, independently of neonatal size; our finding of associations between placental expression of transporter and metabolic genes and maternal smoking, physical activity and diet raises the possibility that their effects are mediated in part through alterations in placental function. The observed changes in placental gene expression in relation to modifiable maternal factors are important as they could form part of interventions aimed at maintaining a healthy lifestyle for the mother and for optimal fetal development.	[Day, Pricilla E.; Godfrey, Keith M.; Hanson, Mark A.; Lewis, Rohan M.; Cleal, Jane K.] Univ Southampton, Inst Dev Sci, Southampton SO16 6YD, Hants, England; [Ntani, Georgia; Crozier, Sarah R.; Mahon, Pam A.; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England; [Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.; Hanson, Mark A.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton SO16 6YD, Hants, England; [Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.; Hanson, Mark A.] Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England; [Cooper, Cyrus] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Nuffield Orthoped Ctr, Oxford OX3 7HE, England; [Lewis, Rohan M.; Cleal, Jane K.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Nuffield Orthopaedic Centre; University of Oxford; University of Southampton	Cleal, JK (corresponding author), Univ Southampton, Inst Dev Sci, Tremona Rd, Southampton SO16 6YD, Hants, England.	j.k.cleal@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Lewis, Rohan/C-9350-2011; Cleal, Jane/AAC-9070-2019; Cleal, Jane/AAC-5062-2019; Inskip, Hazel/L-5467-2018	Hanson, Mark/0000-0002-6907-613X; Lewis, Rohan/0000-0003-4044-9104; Cleal, Jane/0000-0001-7978-4327; Cooper, Cyrus/0000-0003-3510-0709; Godfrey, Keith/0000-0002-4643-0618; Harvey, Nicholas/0000-0002-8194-2512; Inskip, Hazel/0000-0001-8897-1749; Crozier, Sarah/0000-0002-9524-1127	Medical Research Council [MC_US_A620_0033]; Wessex Medical Research; Arthritis Research UK; National Osteoporosis Society; International Osteoporosis Foundation; Cohen Trust; NIHR Southampton Biomedical Research Centre; University of Southampton; University Hospital Southampton NHS Foundation Trust; NIHR Musculoskeletal Biomedical Research Unit; University of Oxford; Dunhill Medical Trust; Gerald Kerkut Charitable Trust; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union [289346]; MRC [MC_U147585819, MC_UP_A620_1017, G0400491, MC_U147585827, MC_UU_12011/4] Funding Source: UKRI; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Medical Research Council [MC_U147585827, MC_UP_A620_1014, MC_UU_12011/4, MC_UU_12011/1, MC_UP_A620_1017, MC_U147585819, U1475000001, G0400491, MC_U147585824] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10085, NF-SI-0508-10082] Funding Source: researchfish; Versus Arthritis [17702] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wessex Medical Research; Arthritis Research UK(Versus Arthritis); National Osteoporosis Society; International Osteoporosis Foundation; Cohen Trust; NIHR Southampton Biomedical Research Centre; University of Southampton; University Hospital Southampton NHS Foundation Trust; NIHR Musculoskeletal Biomedical Research Unit; University of Oxford; Dunhill Medical Trust(Dunhill Medical Trust); Gerald Kerkut Charitable Trust; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	This work was supported by grants from the Medical Research Council (MC_US_A620_0033), Wessex Medical Research, Arthritis Research UK, National Osteoporosis Society, International Osteoporosis Foundation, Cohen Trust, NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, and NIHR Musculoskeletal Biomedical Research Unit, University of Oxford. Participants were drawn from a cohort study funded by the Medical Research Council and the Dunhill Medical Trust. PED was supported by the Gerald Kerkut Charitable Trust. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and by the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no 289346.	Alwasel SH, 2014, PLACENTA, V35, P365, DOI 10.1016/j.placenta.2014.03.003; Alwasel SH, 2010, PLACENTA, V31, P607, DOI 10.1016/j.placenta.2010.04.010; Armitage P., 2002, STAT METHODS MED RES; Bhardwaj A, 2014, POSTGRAD MED J, V90, P450, DOI 10.1136/postgradmedj-2013-132377; Chitty L. S., 2008, CHARTS RECOMMENDED C; Cleal JK, 2011, J PHYSIOL-LONDON, V589, P987, DOI 10.1113/jphysiol.2010.198549; Cleal JK, 2010, PLACENTA, V31, P556, DOI 10.1016/j.placenta.2010.03.006; Cleal JK, 2009, PLACENTA, V30, P1002, DOI 10.1016/j.placenta.2009.09.002; Crozier SR, 2006, EUR J CLIN NUTR, V60, P1391, DOI 10.1038/sj.ejcn.1602469; Day PEL, 2013, PLACENTA, V34, P1223, DOI 10.1016/j.placenta.2013.10.003; Diaz P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121798; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Ericsson A, 2005, AM J PHYSIOL-REG I, V288, pR656, DOI 10.1152/ajpregu.00407.2004; FRISANCHO AR, 1974, AM J CLIN NUTR, V27, P1052, DOI 10.1093/ajcn/27.8.1052; Fukuhara D, 2007, AM J PATHOL, V170, P888, DOI 10.2353/ajpath.2007.060428; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Harris ST, 2015, MATERN CHILD HLTH J, V19, P528, DOI 10.1007/s10995-014-1534-8; Harrison GG, 1988, ANTHROPOMETRIC STAND, P55; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Howard A, 2004, J NUTR, V134, P2957, DOI 10.1093/jn/134.11.2957; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Jansson N, 2003, PLACENTA, V24, P191; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Lewis RM, 2013, PLACENTA, V34, pS46, DOI 10.1016/j.placenta.2012.10.010; Lewis RM, 2010, PLACENTA, V31, P418, DOI 10.1016/j.placenta.2010.02.001; Mahon P. A., 2009, Norsk Epidemiologi, V19, P45; Malek A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-61; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; Mund M, 2013, INT J ENV RES PUB HE, V10, P6485, DOI 10.3390/ijerph10126485; NAEYE RL, 1987, HUM PATHOL, V18, P387, DOI 10.1016/S0046-8177(87)80170-3; Pike KC, 2010, THORAX, V65, P1099, DOI 10.1136/thx.2010.134742; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; POZEFSKY T, 1976, J CLIN INVEST, V57, P444, DOI 10.1172/JCI108295; Ravaglia G, 2002, BRIT J NUTR, V88, P563, DOI 10.1079/BJN2002700; Robinson SM, 2004, EUR J CLIN NUTR, V58, P1174, DOI 10.1038/sj.ejcn.1601946; Roos S, 2009, AM J PHYSIOL-CELL PH, V296, pC142, DOI 10.1152/ajpcell.00330.2008; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; ROYSTON P, 1995, STAT MED, V14, P1417, DOI 10.1002/sim.4780141303; Saif Z, 2014, PLACENTA, V35, P260, DOI 10.1016/j.placenta.2014.01.012; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Sengers BG, 2010, EXP PHYSIOL, V95, P829, DOI 10.1113/expphysiol.2010.052902; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Shibata E, 2008, PLACENTA, V29, P879, DOI 10.1016/j.placenta.2008.07.001; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; van Abeelen AFM, 2011, PLACENTA, V32, P694, DOI 10.1016/j.placenta.2011.06.012; Wang N, 2014, PLACENTA, V35, P437, DOI 10.1016/j.placenta.2014.04.006; Weissgerber TL, 2010, J APPL PHYSIOL, V108, P1217, DOI 10.1152/japplphysiol.00008.2010; Winder NR, 2011, PLACENTA, V32, P806, DOI 10.1016/j.placenta.2011.09.001; Xie XL, 2013, FOOD CHEM TOXICOL, V59, P137, DOI 10.1016/j.fct.2013.05.044; Yamagata K, 2006, NEUROSCIENCE, V143, P729, DOI 10.1016/j.neuroscience.2006.08.050	54	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143653	10.1371/journal.pone.0143653	http://dx.doi.org/10.1371/journal.pone.0143653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657885	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000366715900014
J	Faupel-Badger, JM; Nelson, DE; Izmirlian, G; Ross, KH; Raue, K; Tsakraklides, S; Miyaoka, A; Spiegelman, M				Faupel-Badger, Jessica M.; Nelson, David E.; Izmirlian, Grant; Ross, Katherine H.; Raue, Kimberley; Tsakraklides, Sophia; Miyaoka, Atsushi; Spiegelman, Maura			Independent Association of Postdoctoral Training with Subsequent Careers in Cancer Prevention	PLOS ONE			English	Article							PROGRAM; WEB	The purpose of this study was to examine the career paths of alumni from the National Cancer Institute (NCI) Cancer Prevention Fellowship Program (CPFP), a structured in-house postdoctoral training program of 3-4 years duration, and specifically what proportion of the alumni were currently performing cancer prevention-related activities. The analyses here included 119 CPFP alumni and 85 unsuccessful CPFP applicants, all of whom completed postdoctoral training between 1987-2011 and are currently employed. Postdoctoral training experiences and current career outcomes data were collected via online surveys. Differences between groups were assessed using chi-square and Fisher's exact test p-values and subsequent regression analyses adjusted for differences between the groups. Compared to 15.3% of unsuccessful CPFP applicants, 52.1% of CPFP alumni (odds ratio [OR] = 4.99, 95% confidence interval [95% CI): 1.91-13.0) were currently spending the majority of their time working in cancer prevention. Among those doing any cancer prevention-focused work, 54.3% of CPFP alumni spent the majority of their time performing cancer prevention research activities when compared to 25.5% of unsuccessful applicants (OR = 4.26, 95% CI: 1.38-13.2). In addition to the independent effect of the NCI CPFP, scientific discipline, and employment sector were also associated with currently working in cancer prevention and involvement in cancer prevention research-related activities. These results from a structured postdoctoral training program are relevant not only to the cancer prevention community but also to those interested in evaluating alignment of postdoctoral training programs with available and desired career paths more broadly.	[Faupel-Badger, Jessica M.] NIGMS, Bethesda, MD 20892 USA; [Nelson, David E.; Ross, Katherine H.] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Bethesda, MD 20892 USA; [Izmirlian, Grant] NCI, Biometry Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA; [Raue, Kimberley; Tsakraklides, Sophia; Miyaoka, Atsushi; Spiegelman, Maura] Westat Corp, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat	Faupel-Badger, JM (corresponding author), NIGMS, Bethesda, MD 20892 USA.	badgerje@mail.nih.gov		Faupel-Badger, Jessica/0000-0001-9729-3660	National Institutes of Health Evaluation Set-Aside Program	National Institutes of Health Evaluation Set-Aside Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health Evaluation Set-Aside Program. NIH Staff provided input on the survey questions but did not participate in the collection of data. Westat staff analyzed the data and provided an anonymized dataset to NIH staff for regression analysis.	Advisory Committee to the NIH Director, 2012, BIOM RES WORKF WORK; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Chang S, 2005, ACAD MED, V80, P261, DOI 10.1097/00001888-200503000-00011; Chang S, 2013, J CANC ED S2, V27, pS118; Chang SN, 2014, CANCER EPIDEM BIOMAR, V23, P1133, DOI 10.1158/1055-9965.EPI-14-0194; Chang S, 2009, CANCER EPIDEM BIOMAR, V18, P2348, DOI 10.1158/1055-9965.EPI-09-0664; Colditz GA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003218; Committee on Science Engineering and Public Policy (COSEPUP), 2014, POSTD EXP REV; Committee on Science Engineering and Public Policy (COSEPUP), 2000, ENH POSTD EXP SCI EN; Community Preventive Services Task Force, GUID COMM PREV SERV; Faupel-Badger J, 2013, J CANCER EDUC, V28, P18, DOI 10.1007/s13187-012-0437-x; Faupel-Badger JM, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-06-0102; Husten C G, 1993, J Cancer Educ, V8, P281; Kochanek KD, 2013, NCHS DATA BRIEF, V2014, P1; Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107; Millar MM, 2011, PUBLIC OPIN QUART, V75, P249, DOI 10.1093/poq/nfr003; Pion GM, 2008, EVAL HEALTH PROF, V31, P335, DOI 10.1177/0163278708324434; Polka JK, 2015, MOL BIOL CELL, V26, P1413, DOI 10.1091/mbc.E14-10-1432; R Core Team, 2021, R LANGUAGE ENV STAT; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; U.S. Department of Health and Human Services, OFF DIS PREV HLTH PR; U.S. Preventive Services Task Force, REC PRIM CAR PRACT	22	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144880	10.1371/journal.pone.0144880	http://dx.doi.org/10.1371/journal.pone.0144880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659381	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900131
J	Gackowski, D; Zarakowska, E; Starczak, M; Modrzejewska, M; Olinski, R				Gackowski, Daniel; Zarakowska, Ewelina; Starczak, Marta; Modrzejewska, Martyna; Olinski, Ryszard			Tissue-Specific Differences in DNA Modifications (5-Hydroxymethylcytosine, 5-Formylcytosine, 5-Carboxylcytosine and 5-Hydroxymethyluracil) and Their Interrelationships	PLOS ONE			English	Article							STEM-CELL DNA; METHYLATION; DERIVATIVES; OXIDATION; 5-METHYLCYTOSINE; THYMINE; BRAIN	Background Replication-independent active/enzymatic demethylation may be an important process in the functioning of somatic cells. The most plausible mechanisms of active 5-methylcytosine demethylation, leading to activation of previously silenced genes, involve ten-eleven translocation (TET) proteins that participate in oxidation of 5-methylcytosine to 5-hydroxymethylcytosine which can be further oxidized to 5-formylcytosine and 5-carboxylcytosine. Recently, 5-hydroxymethylcytosine was demonstrated to be a relatively stable modification, and the previously observed substantial differences in the level of this modification in various murine tissues were shown to depend mostly on cell proliferation rate. Some experimental evidence supports the hypothesis that 5-hydroxymethyluracil may be also generated by TET enzymes and has epigenetic functions. Results Using an isotope-dilution automated online two-dimensional ultra-performance liquid chromatography with tandem mass spectrometry, we have analyzed, for the first time, all the products of active DNA demethylation pathway: 5-methyl-2'-deoxycytidine, 5-hydroxymethyl-2'-deoxycytidine, 5-formyl-2'-deoxycytidine and 5-carboxyl-2'-deoxycytidine, as well as 5-hydroxymethyl-2'-deoxyuridine, in DNA isolated from various rat and porcine tissues. A strong significant inverse linear correlation was found between the proliferation rate of cells and the global level of 5-hydroxymethyl-2'-deoxycytidine in both porcine (R-2 = 0.88) and rat tissues (R-2 = 0.83); no such relationship was observed for 5-formyl-2'-deoxycytidine and 5-carboxyl-2'-deoxycytidine. Moreover, a substrate-product correlation was demonstrated for the two consecutive steps of iterative oxidation pathway: between 5-hydroxymethyl-2'-deoxycytidine and its product 5-formyl-2'-deoxycytidine, as well as between 5-formyl-2'-deoxycytidine and 5-carboxyl-2'-deoxycytidine (R-2 = 0.60 and R-2 = 0.71, respectively). Conclusions Good correlations within the substrate-product sets of iterative oxidation pathway may suggest that a part of 5-formyl-2'-deoxycytidine and/or 5-carboxyl-2'-deoxycytidine can be directly linked to a small portion of 5-hydroxymethyl-2'-deoxycytidine which defines the active demethylation process.	[Gackowski, Daniel; Zarakowska, Ewelina; Starczak, Marta; Modrzejewska, Martyna; Olinski, Ryszard] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Clin Biochem, Bydgoszcz, Poland	Nicolaus Copernicus University	Olinski, R (corresponding author), Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Clin Biochem, Bydgoszcz, Poland.	ryszardo@cm.umk.pl	Zarakowska, Ewelina/G-7912-2014; Starczak, Marta/P-4773-2019; Gackowski, Daniel/G-5693-2012; Modrzejewska, Martyna/GZK-3475-2022; Modrzejewska, Martyna/P-8977-2019; Olinski, Ryszard/E-9607-2014	Zarakowska, Ewelina/0000-0003-0508-7777; Starczak, Marta/0000-0003-4098-7412; Gackowski, Daniel/0000-0002-7259-1511; Modrzejewska, Martyna/0000-0002-9464-8419; Olinski, Ryszard/0000-0001-9927-8755	National Science Centre [DEC-2012/07/B/NZ1/00008]; National Science Center	National Science Centre(National Science Centre, Poland); National Science Center(National Science Centre, Poland)	This work was supported by the National Science Centre (RO) DEC-2012/07/B/NZ1/00008, https://www.ncn.gov.pl/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Martin Bachman for providing his raw data on the cell proliferation rate, and Prof. Tomasz Drewa and his coworkers for supplying Wistar rats used in this study. The study was funded in part by a grant from the National Science Center (decision no. DEC-2012/07/B/NZ1/00008).	Bachman M, 2015, NAT CHEM BIOL, V11, P555, DOI 10.1038/nchembio.1848; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cao HC, 2006, J AM SOC MASS SPECTR, V17, P1335, DOI 10.1016/j.jasms.2006.05.019; DIVAKAR KJ, 1982, J CHEM SOC PERK T 1, P1171, DOI 10.1039/p19820001171; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guz J, 2008, MUTAT RES-FUND MOL M, V640, P170, DOI 10.1016/j.mrfmmm.2007.12.013; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rahman AAHA, 2001, TETRAHEDRON LETT, V42, P1061; Schiesser S, 2012, ANGEW CHEM INT EDIT, V51, P6516, DOI 10.1002/anie.201202583; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Shibutani T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05220; Song CX, 2013, TRENDS BIOCHEM SCI, V38, P480, DOI 10.1016/j.tibs.2013.07.003; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tang Y, 2015, ANAL CHEM, V87, P3445, DOI 10.1021/ac504786r; Wagner M, 2015, ANGEW CHEM INT EDIT, V54, P12511, DOI 10.1002/anie.201502722; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019	27	28	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144859	10.1371/journal.pone.0144859	http://dx.doi.org/10.1371/journal.pone.0144859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660343	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900121
J	Huang, Y; Xie, J; Wang, T				Huang, Yu; Xie, Jun; Wang, Tao			A Fluorescence-Based Genetic Screen to Study Retinal Degeneration in Drosophila	PLOS ONE			English	Article							NERVOUS-SYSTEM; HUMAN SCO1; PROTEIN; TRANSPORT; RAB6; EYE; MUTANTS; ENCODES; CHANNEL; MODEL	The Drosophila visual system has been proved to be a powerful genetic model to study eye disease such as retinal degeneration. Here, we describe a genetic method termed "Rh1::GFP ey-flp/hid" that is based on the fluorescence of GFP-tagged major rhodopsin Rh1 in the eyes of living flies and can be used to monitor the integrity of photoreceptor cells. Through combination of this method and ERG recording, we examined a collection of 667 mutants and identified 18 genes that are required for photoreceptor cell maintenance, photoresponse, and rhodopsin synthesis. Our findings demonstrate that this "Rh1::GFP eyflp/hid" method enables high-throughput F1 genetic screens to rapidly and precisely identify mutations of retinal degeneration.	[Huang, Yu; Xie, Jun; Wang, Tao] Natl Inst Biol Sci, Beijing, Peoples R China; [Xie, Jun] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University	Wang, T (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	wangtao1006@nibs.ac.cn		Wang, Tao/0000-0002-2395-3483	'973' grant from the Chinese Ministry of Science [2014CB849700]	'973' grant from the Chinese Ministry of Science	This work was supported by a '973' grant (2014CB849700) to T.W. from the Chinese Ministry of Science. T.W. contributed to the study design, analysis, dicision to publish and preparation of the manuscript.; We thank Dr. Craig Montell, Dr. Nansi Colley, Dr. William Pak, the Bloomington Stock Center, and the Kyoto Drosophila Genetic Resource Center for fly stocks and reagents. We thank Xianglei Yu and Futing An for assistance with the genetic screen and thank Ying Wang for preparing sections for EM. We thank David O'Keefe for critical reading of the manuscript. This work was supported by a '973' grant (2014CB849700) to T.W. from the Chinese Ministry of Science.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Charng WL, 2014, CURR OPIN NEUROBIOL, V27, P158, DOI 10.1016/j.conb.2014.03.001; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Dourlen P, 2015, METHODS MOL BIOL, V1254, P351, DOI 10.1007/978-1-4939-2152-2_25; Dourlen P, 2013, JOVE-J VIS EXP, DOI 10.3791/50610; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gambis A, 2011, DEV BIOL, V351, P128, DOI 10.1016/j.ydbio.2010.12.040; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kuo Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.351; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Lee S, 2007, DEV NEUROBIOL, V67, P1533, DOI 10.1002/dneu.20526; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Mayer T, 1996, J BIOL CHEM, V271, P16097, DOI 10.1074/jbc.271.27.16097; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013151; Pichaud F, 2001, DEVELOPMENT, V128, P815; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Porcelli D, 2010, MITOCHONDRION, V10, P433, DOI 10.1016/j.mito.2010.04.002; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Satoh T, 2013, DEVELOPMENT, V140, P385, DOI 10.1242/dev.083683; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shetty KM, 1998, J BIOL CHEM, V273, P20425, DOI 10.1074/jbc.273.32.20425; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Stowers RS, 1999, GENETICS, V152, P1631; Tong C, 2011, NEURON, V71, P447, DOI 10.1016/j.neuron.2011.06.040; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wang T, 2008, NEURON, V57, P56, DOI 10.1016/j.neuron.2007.11.020; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2006, J NEUROSCI, V26, P12816, DOI 10.1523/JNEUROSCI.3673-06.2006; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Xiong B, 2013, TRENDS NEUROSCI, V36, P652, DOI 10.1016/j.tins.2013.08.003; XU T, 1993, DEVELOPMENT, V117, P1223; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	62	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144925	10.1371/journal.pone.0144925	http://dx.doi.org/10.1371/journal.pone.0144925			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659849	gold, Green Published			2022-12-26	WOS:000366715900150
J	Kronen, M; Berg, IA				Kronen, Miriam; Berg, Ivan A.			Mesaconase/Fumarase FumD in Escherichia coli O157:H7 and Promiscuity of Escherichia coli Class I Fumarases FumA and FumB	PLOS ONE			English	Article							3-METHYLASPARTATE AMMONIA-LYASE; BACTERIUM RHODOSPIRILLUM-RUBRUM; L-CITRAMALATE HYDROLYASE; ISOLEUCINE BIOSYNTHESIS; CLOSTRIDIUM-TETANOMORPHUM; METHYLOBACTERIUM-EXTORQUENS; CITRATE LYASE; PATHWAY; CYCLE; PURIFICATION	Mesaconase catalyzes the hydration of mesaconate (methylfumarate) to (S)-citramalate. The enzyme participates in the methylaspartate pathway of glutamate fermentation as well as in the metabolism of various C-5-dicarboxylic acids such as mesaconate or L-threo-beta-methylmalate. We have recently shown that Burkholderia xenovorans uses a promiscuous class I fumarase to catalyze this reaction in the course of mesaconate utilization. Here we show that classical Escherichia coli class I fumarases A and B (FumA and FumB) are capable of hydrating mesaconate with 4% (FumA) and 19% (FumB) of the catalytic efficiency k(cat)/K-m, compared to the physiological substrate fumarate. Furthermore, the genomes of 14.8% of sequenced Enterobacteriaceae (26.5% of E. coli, 90.6% of E. coli O157:H7 strains) possess an additional class I fumarase homologue which we designated as fumarase D (FumD). All these organisms are (opportunistic) pathogens. fumD is clustered with the key genes for two enzymes of the methylaspartate pathway of glutamate fermentation, glutamate mutase and methylaspartate ammonia lyase, converting glutamate to mesaconate. Heterologously produced FumD was a promiscuous mesaconase/fumarase with a 2- to 3-fold preference for mesaconate over fumarate. Therefore, these bacteria have the genetic potential to convert glutamate to (S)-citramalate, but the further fate of citramalate is still unclear. Our bioinformatic analysis identified several other putative mesaconase genes and revealed that mesaconases probably evolved several times from various class I fumarases independently. Most, if not all iron-dependent fumarases, are capable to catalyze mesaconate hydration.	[Kronen, Miriam; Berg, Ivan A.] Univ Freiburg, Fak Biol, Mikrobiol, D-79106 Freiburg, Germany	University of Freiburg	Berg, IA (corresponding author), Univ Freiburg, Fak Biol, Mikrobiol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ivan.berg@biologie.uni-freiburg.de	Berg, Ivan/AAZ-3917-2020	Kronen, Miriam/0000-0001-8486-7872; Berg, Ivan/0000-0002-1864-4969	Deutsche Forschungsgemeinschaft [BE 4822/2-2, BE 4822/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (BE 4822/2-2 and Heisenberg Fellowship BE 4822/1-2 to I.A.B.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIBI SA, 1973, J CLIN INVEST, V52, P1586, DOI 10.1172/JCI107335; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASANO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P223, DOI 10.1271/bbb.58.223; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Berg IA, 2009, MICROBIOLOGY+, V78, P16, DOI 10.1134/S0026261709010032; BERGMEYER HU, 1975, Z KLIN CHEM KLIN BIO, V13, P507; BLAIR AH, 1966, J BIOL CHEM, V241, P400; Boiangiu CD, 2005, J MOL MICROB BIOTECH, V10, P105, DOI 10.1159/000091558; Borjian F, 2016, ISME J, V10, P546, DOI 10.1038/ismej.2015.132; BOTT M, 1994, MOL MICROBIOL, V14, P347, DOI 10.1111/j.1365-2958.1994.tb01295.x; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown G, 2008, BIOCHEMISTRY-US, V47, P5724, DOI 10.1021/bi800097h; BUCKEL W, 1976, EUR J BIOCHEM, V64, P255, DOI 10.1111/j.1432-1033.1976.tb10295.x; CHARON NW, 1974, J BACTERIOL, V117, P203, DOI 10.1128/JB.117.1.203-211.1974; Degu A, 2011, PLANTA, V234, P501, DOI 10.1007/s00425-011-1411-2; EIKMANNS B, 1983, ARCH MICROBIOL, V136, P111, DOI 10.1007/BF00404783; Feliciano PR, 2012, INT J BIOL MACROMOL, V51, P25, DOI 10.1016/j.ijbiomac.2012.04.025; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1994, ARCH BIOCHEM BIOPHYS, V311, P509, DOI 10.1006/abbi.1994.1269; Fuchs G, 2014, J BIOTECHNOL, V192, P314, DOI 10.1016/j.jbiotec.2014.02.015; Gerike U, 1998, MICROBIOL-UK, V144, P929, DOI 10.1099/00221287-144-4-929; Herter S, 2001, J BACTERIOL, V183, P4305, DOI 10.1128/JB.183.14.4305-4316.2001; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Ivanovsky RN, 1997, FEMS MICROBIOL LETT, V153, P399, DOI 10.1016/S0378-1097(97)00280-2; KATO Y, 1995, APPL MICROBIOL BIOT, V43, P901; Kato Y, 1997, ARCH MICROBIOL, V168, P457, DOI 10.1007/s002030050522; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; Kim OB, 2007, ARCH MICROBIOL, V188, P583, DOI 10.1007/s00203-007-0279-9; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kronen M, 2015, APPL ENVIRON MICROB, V81, P5632, DOI 10.1128/AEM.00822-15; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leroy B, 2015, MICROBIOL-SGM, V161, P1061, DOI 10.1099/mic.0.000067; Lu PL, 2013, CELL RES, V23, P635, DOI 10.1038/cr.2013.13; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; Otten A, 2015, METAB ENG, V30, P156, DOI 10.1016/j.ymben.2015.06.003; Peltz ED, 2015, J TRAUMA ACUTE CARE, V78, P742, DOI 10.1097/TA.0000000000000589; REANEY SK, 1993, J GEN MICROBIOL, V139, P403, DOI 10.1099/00221287-139-3-403; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Risso C, 2008, J BACTERIOL, V190, P2266, DOI 10.1128/JB.01841-07; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sasikaran J, 2014, NAT CHEM BIOL, V10, P371, DOI 10.1038/nchembio.1482; Schneider K, 2000, BIOCHEMISTRY-US, V39, P9438, DOI 10.1021/bi000401r; SHIBATA H, 1985, J BACTERIOL, V164, P762, DOI 10.1128/JB.164.2.762-768.1985; Shimoyama T, 2007, FEMS MICROBIOL LETT, V270, P207, DOI 10.1111/j.1574-6968.2007.00665.x; Sonntag F, 2015, APPL MICROBIOL BIOT, V99, P3407, DOI 10.1007/s00253-015-6418-3; Sonntag F, 2014, APPL MICROBIOL BIOT, V98, P4533, DOI 10.1007/s00253-013-5456-y; Steinmetz PA, 2014, MOL MICROBIOL, V94, P218, DOI 10.1111/mmi.12759; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUZUKI S, 1977, J BIOCHEM-TOKYO, V81, P1917, DOI 10.1093/oxfordjournals.jbchem.a131654; SUZUKI S, 1976, J BIOCHEM-TOKYO, V80, P867, DOI 10.1093/oxfordjournals.jbchem.a131349; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng CP, 2001, J BACTERIOL, V183, P461, DOI 10.1128/JB.183.2.461-467.2001; van Vugt-Lussenburg BMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055549; van Vugt-Lussenburg BMA, 2009, MICROBIOL-SGM, V155, P3015, DOI 10.1099/mic.0.030320-0; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VanKuijk BLM, 1996, ARCH MICROBIOL, V165, P126; Veetil VP, 2012, BIOCHEMISTRY-US, V51, P4237, DOI 10.1021/bi300430j; WANG CC, 1969, J BIOL CHEM, V244, P2516; WANG CC, 1969, J BIOL CHEM, V244, P2527; Wang JY, 2015, METAB ENG, V30, P190, DOI 10.1016/j.ymben.2015.06.001; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; YUMOTO N, 1988, BIOCHEM BIOPH RES CO, V153, P1236, DOI 10.1016/S0006-291X(88)81360-3; ZEHR BD, 1989, ANAL BIOCHEM, V182, P157, DOI 10.1016/0003-2697(89)90734-3	68	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145098	10.1371/journal.pone.0145098	http://dx.doi.org/10.1371/journal.pone.0145098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658641	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900183
J	Li, XM; Su, XO				Li, Xiaomin; Su, Xiaoou			Assessment of the Polychlorinated Biphenyl (PCB) Occurrence in Copper Sulfates and the Influential Role of PCB Levels on Grapes	PLOS ONE			English	Article							DIBENZO-P-DIOXINS; POLYBROMINATED DIPHENYL ETHERS; DIETARY EXPOSURE; AREA; CHINA; PCDD/FS; SAMPLES; SOIL; TEMPERATURE; PCDD/PCDF	Copper sulfates (CuSO4) are widely used as the primary component of fungicides in the grape industry. The agricultural-grade CuSO4 that we collected from Chinese nationwide markets were found to be contaminated by polychlorinated dibenzo-p-dioxins and dibenzofurans and high levels of polychlorinated biphenyls (Sigma(19)PCBs: 0.32 similar to 9.51 ng/g). In the following research, we studied the impact of CuSO4 application on PCB levels in grape products through a field experiment, and conducted a national survey to speculate the role that CuSO4 played on the occurrence of PCB in grapes. In the field experiment, an obvious increase of PCBs in grape leaves (from 174 to 250 pg/g fw) was observed after Bordeaux mixture (the main component of which is CuSO4) application. As to the main PCB congener in CuSO4, the most toxic CB 126 (toxic equivalency factor = 0.1) also increased in grape peels (from 1.66 to 2.93 pg/g fw) after pesticide spray. Both the correlation study and the principal component analysis indicated that environmental factors were dominant PCB contributors to grapes, and grapes from e-waste dismantling area containing the highest PCBs also proved the notion. It is worth noting that this report describes the first research examining PCBs in CuSO4 and its influence on agricultural products to date.	[Li, Xiaomin; Su, Xiaoou] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Li, XM (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China.	lixiaomin@caas.cn; suxiaoou@caas.cn	Li, Xiaomin/ABI-2638-2020	Li, Xiaomin/0000-0002-9037-211X	special Fund for Agro-scientific Research in the Public Interest [201203088]; National Natural Science Foundation of China [21307157]; State Key Laboratory of Environmental Chemistry and Ecotoxicology [KF2012-08]	special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Environmental Chemistry and Ecotoxicology	The special Fund for Agro-scientific Research in the Public Interest (201203088) sponsored the rent of the experimental site and article publishment. (SXO) NRLs: www.moa.gov.cn/. The National Natural Science Foundation of China (NO. 21307157) sponsored the standard purchase and reagent and material purchase. (LXM) NRLs: www.nsfc.gov.cn/. The State Key Laboratory of Environmental Chemistry and Ecotoxicology (KF2012-08) sponsored sample collection, reagent and material purchase and analysis cost. (LXM) NRLs: et.rcees.ac.cn/.	Altarawneh M, 2009, PROG ENERG COMBUST, V35, P245, DOI 10.1016/j.pecs.2008.12.001; Aries E, 2006, CHEMOSPHERE, V65, P1470, DOI 10.1016/j.chemosphere.2006.04.020; Aslan S, 2010, CHEMOSPHERE, V80, P1213, DOI 10.1016/j.chemosphere.2010.06.008; Bocio A, 2005, ENVIRON RES, V97, P1, DOI 10.1016/j.envres.2004.01.012; Brun LA, 2001, ENVIRON POLLUT, V111, P293, DOI 10.1016/S0269-7491(00)00067-1; Chaignon V, 2003, ENVIRON POLLUT, V123, P229, DOI 10.1016/S0269-7491(02)00374-3; Chen JW, 2006, ENVIRON POLLUT, V144, P510, DOI 10.1016/j.envpol.2006.01.039; Fu JJ, 2012, CHEMOSPHERE, V88, P330, DOI 10.1016/j.chemosphere.2012.03.006; Grassi P, 2010, CHEMOSPHERE, V79, P292, DOI 10.1016/j.chemosphere.2010.01.028; Haws LC, 2006, TOXICOL SCI, V89, P4, DOI 10.1093/toxsci/kfi294; HERMANSON MH, 2015, US ENV SCI TECHNOL, V49, P855; HULSTER A, 1994, ENVIRON SCI TECHNOL, V28, P1110, DOI 10.1021/es00055a021; Komp P, 1997, ENVIRON SCI TECHNOL, V31, P886, DOI 10.1021/es960590u; Li YM, 2009, ENVIRON SCI TECHNOL, V43, P1030, DOI 10.1021/es802138w; Liu HX, 2006, ANAL CHIM ACTA, V557, P314, DOI 10.1016/j.aca.2005.10.001; Liu PY, 2015, CHEMOSPHERE, V118, P253, DOI 10.1016/j.chemosphere.2014.09.037; Lu DS, 2015, CHEMOSPHERE, V137, P14, DOI 10.1016/j.chemosphere.2015.04.043; Mihats D, 2015, CHEMOSPHERE, V126, P53, DOI 10.1016/j.chemosphere.2015.02.006; Moolenaar SW, 1998, J ENVIRON QUAL, V27, P828, DOI 10.2134/jeq1998.00472425002700040017x; MULLER JF, 1993, CHEMOSPHERE, V27, P195, DOI 10.1016/0045-6535(93)90293-E; Ogura I, 2004, ENVIRON SCI TECHNOL, V38, P3279, DOI 10.1021/es0354622; Okay OS, 2009, CHEMOSPHERE, V76, P159, DOI 10.1016/j.chemosphere.2009.03.051; Pan Y, 2013, CHEMOSPHERE, V92, P765, DOI 10.1016/j.chemosphere.2013.04.003; Papadopoulos A, 2004, CHEMOSPHERE, V57, P413, DOI 10.1016/j.chemosphere.2004.07.006; Pozo K, 2006, ENVIRON SCI TECHNOL, V40, P4867, DOI 10.1021/es060447t; Schmid P, 2005, CHEMOSPHERE, V58, P227, DOI 10.1016/j.chemosphere.2004.08.045; United Nation Environment Program (UNEP), STOCKH CONV PERS ORG; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Wagrowski DM, 1998, ENVIRON SCI TECHNOL, V32, P2389, DOI 10.1021/es9706920; Wang P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05975; Wen S, 2009, CHEMOSPHERE, V74, P981, DOI 10.1016/j.chemosphere.2008.10.002; WHO (World Health Organization), 1998, ASS HLTH RISK DIOX R; Xing GH, 2010, CHEMOSPHERE, V81, P1239, DOI 10.1016/j.chemosphere.2010.09.032; Xing Y, 2005, CHEMOSPHERE, V60, P731, DOI 10.1016/j.chemosphere.2005.05.001; Yeo HG, 2004, SCI TOTAL ENVIRON, V324, P261, DOI 10.1016/j.scitotenv.2003.10.031; Zhang Z, 2008, ENVIRON SCI TECHNOL, V42, P6514, DOI 10.1021/es8004078; Zheng MH, 1996, CHEMOSPHERE, V32, P595	37	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144896	10.1371/journal.pone.0144896	http://dx.doi.org/10.1371/journal.pone.0144896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658158	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900141
J	Rivera-Perez, JI; Cano, RJ; Narganes-Storde, Y; Chanlatte-Baik, L; Toranzos, GA				Rivera-Perez, Jessica I.; Cano, Raul J.; Narganes-Storde, Yvonne; Chanlatte-Baik, Luis; Toranzos, Gary A.			Retroviral DNA Sequences as a Means for Determining Ancient Diets	PLOS ONE			English	Article							MOLECULAR ANALYSIS; DIVERSITY	For ages, specialists from varying fields have studied the diets of the primeval inhabitants of our planet, detecting diet remains in archaeological specimens using a range of morphological and biochemical methods. As of recent, metagenomic ancient DNA studies have allowed for the comparison of the fecal and gut microbiomes associated to archaeological specimens from various regions of the world; however the complex dynamics represented in those microbial communities still remain unclear. Theoretically, similar to eukaryote DNA the presence of genes from key microbes or enzymes, as well as the presence of DNA from viruses specific to key organisms, may suggest the ingestion of specific diet components. In this study we demonstrate that ancient virus DNA obtained from coprolites also provides information reconstructing the host's diet, as inferred from sequences obtained from pre-Columbian coprolites. This depicts a novel and reliable approach to determine new components as well as validate the previously suggested diets of extinct cultures and animals. Furthermore, to our knowledge this represents the first description of the eukaryotic viral diversity found in paleofaeces belonging to pre-Columbian cultures.	[Rivera-Perez, Jessica I.; Toranzos, Gary A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Cano, Raul J.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA; [Narganes-Storde, Yvonne; Chanlatte-Baik, Luis] Univ Puerto Rico, Ctr Archaeol Res, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; California State University System; California Polytechnic State University San Luis Obispo; University of Puerto Rico	Rivera-Perez, JI (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.	jessica.i.rivera88@gmail.com			Research Initiative for Scientific Enhancement Program of the University of Puerto Rico (UPR), NIH Grant [5R25GM061151-13]; Department of Defense (DOD Grant) [W911NF-11-1-0218]; Steve Massey (Laboratory of Bioinformatics, UPR); Department of Biology of the UPR; Dean's office	Research Initiative for Scientific Enhancement Program of the University of Puerto Rico (UPR), NIH Grant; Department of Defense (DOD Grant); Steve Massey (Laboratory of Bioinformatics, UPR); Department of Biology of the UPR; Dean's office	This study was partially funded by the Research Initiative for Scientific Enhancement Program of the University of Puerto Rico (UPR), NIH Grant No. 5R25GM061151-13. Funds for sequencing came from a Department of Defense grant to the University of Puerto Rico (DOD Grant No. W911NF-11-1-0218) and from Steve Massey (Laboratory of Bioinformatics, UPR). Additional funds came from the Department of Biology of the UPR and the Dean's office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Alcover JA, 1999, BIOL J LINN SOC, V66, P57, DOI 10.1006/bijl.1998.0260; Alvarez AJ, 1996, ENVIRON TOXIC WATER, V11, P129, DOI 10.1002/(SICI)1098-2256(1996)11:2<129::AID-TOX8>3.0.CO;2-B; [Anonymous], 1996, J ARCHAEOL METHOD TH, DOI [10.1007/BF02229401, DOI 10.1007/BF02229401]; Appelt S, 2014, APPL ENVIRON MICROB, V80, P2648, DOI 10.1128/AEM.03242-13; Appelt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088376; Boeke J, 1997, RETROVIRUSES, P1; Bolte AL, 1999, AVIAN PATHOL, V28, P415, DOI 10.1080/03079459994434; Brace S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2371; Cano RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106833; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Canter Ronald. Yucatan Channel and Trade, 2006, FAMSI J ANC AM; Chanlatte Baik L, 2005, CULTURA LA HUECA; Chanlatte-Baik L, 1983, VIEQUES PUERTO RICO; Cotton B, 2013, LAS VEGAS WORLDCOMP, V2013, P1; Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3; de Araujo A.J.G., 1985, Memorias do Instituto Oswaldo Cruz, V80, P141, DOI 10.1590/S0074-02761985000200003; de las Casas FB, 1967, APOLOGETICA HIST SUM, VII; Drancourt Michel, 2008, P55; Fulton T, 2014, ANCIENT DNA METHODS; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Hollocher TC, 2014, SOC SEDIMENT GEOL, V16, P547; HORNE PD, 1985, J ARCHAEOL SCI, V12, P299, DOI 10.1016/0305-4403(85)90035-4; Laffoon JE, 2014, J ANTHROPOL ARCHAEOL, V35, P220, DOI 10.1016/j.jaa.2014.06.004; Leach JD, 2010, BRIT J NUTR, V103, P1558, DOI 10.1017/S0007114510000966; Lee A, 2013, PHIL T R SOC B, V368, P1; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Narganes-Sorde Y, 2002, CULTURA SALADOIDE PU; Nelson PN, 2004, CLIN EXP IMMUNOL, V138, P1, DOI 10.1111/j.1365-2249.2004.02592.x; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Ng TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/pnas.1410429111; Oviedo F de, HIST GEN NATURAL IND; Pagan-Jimenez J, 2007, ARCHAEOPRESS PUBLISH; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Ramos Reniel Rodriguez, 2013, Life-The Excitement of Biology, V1, P83, DOI 10.9784/LEB1(1)Rodriguez.09; REINHARD KJ, 1988, HOMO, V37, P217; Santiago-Rodriguez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065191; Sistiaga A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101045; Song WJ, 2004, J VIROL, V78, P12576, DOI 10.1128/JVI.78.22.12576-12590.2004; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Turvey ST, 2007, BIOL LETTERS, V3, P193, DOI 10.1098/rsbl.2006.0585; Weiss RA, 2013, PHIL T R SOC B, V368, P1; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	46	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144951	10.1371/journal.pone.0144951	http://dx.doi.org/10.1371/journal.pone.0144951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660678	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900154
J	Xie, F; Varghese, F; Pakhomov, AG; Semenov, I; Xiao, S; Philpott, J; Zemlin, C				Xie, Fei; Varghese, Frency; Pakhomov, Andrei G.; Semenov, Iurii; Xiao, Shu; Philpott, Jonathan; Zemlin, Christian			Ablation of Myocardial Tissue With Nanosecond Pulsed Electric Fields	PLOS ONE			English	Article							PULMONARY VEIN STENOSIS; RADIOFREQUENCY CATHETER ABLATION; ATRIAL-FIBRILLATION ABLATION; PARKINSON-WHITE-SYNDROME; OF-THE-ART; IRREVERSIBLE ELECTROPORATION; SUPRA-ELECTROPORATION; LESION DEPTH; THERAPY; SAFETY	Background Ablation of cardiac tissue is an essential tool for the treatment of arrhythmias, particularly of atrial fibrillation, atrial flutter, and ventricular tachycardia. Current ablation technologies suffer from substantial recurrence rates, thermal side effects, and long procedure times. We demonstrate that ablation with nanosecond pulsed electric fields (nsPEFs) can potentially overcome these limitations. Methods We used optical mapping to monitor electrical activity in Langendorff-perfused New Zealand rabbit hearts (n = 12). We repeatedly inserted two shock electrodes, spaced 2-4 mm apart, into the ventricles (through the entire wall) and applied nanosecond pulsed electric fields (nsPEF) (5-20 kV/cm, 350 ns duration, at varying pulse numbers and frequencies) to create linear lesions of 12-18 mm length. Hearts were stained either with tetrazolium chloride (TTC) or propidium iodide (PI) to determine the extent of ablation. Some stained lesions were sectioned to obtain the three-dimensional geometry of the ablated volume. Results In all animals (12/12), we were able to create nonconducting lesions with less than 2 seconds of nsPEF application per site and minimal heating (<0.2 degrees C) of the tissue. The geometry of the ablated volume was smoother and more uniform throughout the wall than typical for RF ablation. The width of the lesions could be controlled up to 6 mm via the electrode spacing and the shock parameters. Conclusions Ablation with nsPEFs is a promising alternative to radiofrequency (RF) ablation of AF. It may dramatically reduce procedure times and produce more consistent lesion thickness than RF ablation.	[Xie, Fei; Varghese, Frency; Zemlin, Christian] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA; [Xie, Fei; Varghese, Frency; Pakhomov, Andrei G.; Semenov, Iurii; Xiao, Shu; Zemlin, Christian] Old Dominion Univ, Ctr Bioelect, Norfolk, VA USA; [Philpott, Jonathan] Eastern Virginia Med Sch, Dept Surg, Norfolk, VA 23501 USA	Old Dominion University; Old Dominion University; Eastern Virginia Medical School	Zemlin, C (corresponding author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA.	czemlin@odu.edu		Semenov, Iurii/0000-0002-0302-1355				Ang R, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0631-7; Arena CB, 2012, BIOPHYS J, V103, P2033, DOI 10.1016/j.bpj.2012.09.017; Bertaglia E, 2007, HEART RHYTHM, V4, P1265, DOI 10.1016/j.hrthm.2007.06.016; Chen R, 2014, EUR J CANCER, V50, P2705, DOI 10.1016/j.ejca.2014.07.006; Cummings JE, 2006, ANN INTERN MED, V144, P572, DOI 10.7326/0003-4819-144-8-200604180-00007; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Gal P, 2014, INT J CARDIOL, V176, P891, DOI 10.1016/j.ijcard.2014.08.034; Gerstenfeld ER, 2003, J CARDIOVASC ELECTR, V14, P685, DOI 10.1046/j.1540-8167.2003.03013.x; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V341, P1266, DOI 10.1016/j.bbrc.2006.01.094; Gowrishankar TR, 2003, P NATL ACAD SCI USA, V100, P3203, DOI 10.1073/pnas.0636434100; Hargrave B, 2013, GENE THER, V20, P151, DOI 10.1038/gt.2012.15; Holmes DR, 2009, JACC-CARDIOVASC INTE, V2, P267, DOI 10.1016/j.jcin.2008.12.014; JACKMAN WM, 1991, NEW ENGL J MED, V324, P1605, DOI 10.1056/NEJM199106063242301; Joshi R. P., 2010, Critical Reviews in Biomedical Engineering, V38, P255, DOI 10.1615/CritRevBiomedEng.v38.i3.20; Jourda F, 2015, EUROPACE, V17, P225, DOI 10.1093/europace/euu215; Kearney K, 2014, ANN CARDIOTHORAC SUR, V3, P15, DOI 10.3978/j.issn.2225-319X.2014.01.03; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Khan AR, 2014, CIRC-ARRHYTHMIA ELEC, V7, P853, DOI 10.1161/CIRCEP.114.001853; Kotnik T, 2000, IEEE T BIO-MED ENG, V47, P1074, DOI 10.1109/10.855935; Kuwahara T, 2014, EUROPACE, V16, P834, DOI 10.1093/europace/eut368; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Mankowski J, 2000, IEEE T PLASMA SCI, V28, P102, DOI 10.1109/27.842875; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; Natale A, 2013, NAT REV CARDIOL, V10, P63, DOI 10.1038/nrcardio.2012.198; Neven K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P913, DOI 10.1161/CIRCEP.114.001607; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Pappone C, 2004, CIRCULATION, V109, P2724, DOI 10.1161/01.CIR.0000131866.44650.46; Philpott JM, 2015, ANN THORAC SURG, V100, P1541, DOI 10.1016/j.athoracsur.2015.07.006; Piccini JP, 2011, J INTERV CARD ELECTR, V32, P233, DOI 10.1007/s10840-011-9603-z; Rostamian A, 2014, J INTERV CARD ELECTR, V40, P63, DOI 10.1007/s10840-014-9885-z; Santangeli P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P739, DOI 10.1161/CIRCEP.113.000629; Saviz M, 2014, J ELECT BIOIMPEDANCE, V69, P9; Scheinman MM, 2005, PACE, V28, P152, DOI 10.1111/j.1540-8159.2005.09461.x; Schleifer JW, 2013, CARDIOL CLIN, V31, P595, DOI 10.1016/j.ccl.2013.07.007; Semenov I, 2015, BBA-BIOMEMBRANES, V1848, P2118, DOI 10.1016/j.bbamem.2015.06.018; Son RS, 2014, J MEMBRANE BIOL, V247, P1209, DOI 10.1007/s00232-014-9699-z; Spragg DD, 2008, J CARDIOVASC ELECTR, V19, P627, DOI 10.1111/j.1540-8167.2008.01181.x; Wang YT, 2012, AM J PHYSIOL-HEART C, V303, pH439, DOI 10.1152/ajpheart.01121.2011; Wikswo JP, 1995, BIOPHYS J, V69, P2195, DOI 10.1016/S0006-3495(95)80115-3; Winkle RA, 2014, HEART RHYTHM, V11, P963, DOI 10.1016/j.hrthm.2014.03.013; Wittkampf FHM, 2012, CIRC-ARRHYTHMIA ELEC, V5, P581, DOI 10.1161/CIRCEP.111.970079; Woods CE, 2014, CIRC RES, V114, P1532, DOI 10.1161/CIRCRESAHA.114.302362; Wu SH, 2013, INT J CARDIOL, V169, P35, DOI 10.1016/j.ijcard.2013.08.083; Xiao DY, 2013, BIOELECTROMAGNETICS, V34, P512, DOI 10.1002/bem.21796; Yang HM, 2007, CARDIOVASC PATHOL, V16, P51, DOI 10.1016/j.carpath.2006.07.007; Yokoyama K, 2006, CIRCULATION, V113, P11, DOI 10.1161/CIRCULATIONAHA.105.540062; Zhao JC, 2015, INT J MOL SCI, V16, P10834, DOI 10.3390/ijms160510834	49	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144833	10.1371/journal.pone.0144833	http://dx.doi.org/10.1371/journal.pone.0144833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658139	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900114
J	Lundgren, BR; Connolly, MP; Choudhary, P; Brookins-Little, TS; Chatterjee, S; Raina, R; Nomura, CT				Lundgren, Benjamin R.; Connolly, Morgan P.; Choudhary, Pratibha; Brookins-Little, Tiffany S.; Chatterjee, Snigdha; Raina, Ramesh; Nomura, Christopher T.			Defining the Metabolic Functions and Roles in Virulence of the rpoN1 and rpoN2 Genes in Ralstonia solanacearum GMI1000	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SIGMA-FACTOR; ESCHERICHIA-COLI; SEQUENCES; ASSIMILATION; CLONING; OPERON; IDENTIFICATION; RECOGNITION; CATABOLISM	The alternative sigma factor RpoN is a unique regulator found among bacteria. It controls numerous processes that range from basic metabolism to more complex functions such as motility and nitrogen fixation. Our current understanding of RpoN function is largely derived from studies on prototypical bacteria such as Escherichia coli. Bacillus subtilis and Pseudomonas putida. Although the extent and necessity of RpoN-dependent functions differ radically between these model organisms, each bacterium depends on a single chromosomal rpoN gene to meet the cellular demands of RpoN regulation. The bacterium Ralstonia solanacearum is often recognized for being the causative agent of wilt disease in crops, including banana, peanut and potato. However, this plant pathogen is also one of the few bacterial species whose genome possesses dual rpoN genes. To determine if the rpoN genes in this bacterium are genetically redundant and interchangeable, we constructed and characterized Delta rpoN1, Delta rpoN2 and Delta rpoN1 Delta rpoN2 mutants of R. solanacearum GMI1000. It was found that growth on a small range of metabolites, including dicarboxylates, ethanol, nitrate, ornithine, proline and xanthine, were dependent on only the rpoN1 gene. Furthermore, the rpoN1 gene was required for wilt disease on tomato whereas rpoN2 had no observable role in virulence or metabolism in R. solanacearum GMI1000. Interestingly, plasmid-based expression of rpoN2 did not fully rescue the metabolic deficiencies of the Delta rpoN1 mutants; full recovery was specific to rpoN1. In comparison, only rpoN2 was able to genetically complement a Delta rpoN E. coli mutant. These results demonstrate that the RpoN1 and RpoN2 proteins are not functionally equivalent or interchangeable in R. solanacearum GMI1000.	[Lundgren, Benjamin R.; Connolly, Morgan P.; Brookins-Little, Tiffany S.; Nomura, Christopher T.] SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA; [Choudhary, Pratibha; Chatterjee, Snigdha; Raina, Ramesh] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Nomura, Christopher T.] SUNY Coll Environm Sci & Forestry, Ctr Appl Microbiol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Syracuse University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nomura, CT (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA.	ctnomura@esf.edu		Chatterjee, Snigdha/0000-0003-0506-7426	National Institutes of Health [R15 GM104880-01A1]; National Science Foundation [CBET 1263905]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104880] Funding Source: NIH RePORTER; Directorate For Engineering [1263905] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Institutes of Health (www.nih.gov) Grant R15 GM104880-01A1 awarded to CTN and National Science Foundation (www.nsf.gov) Grant CBET 1263905 awarded to CTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NO, 2001, J BACTERIOL, V183, P2497; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Conway K, 2012, SIGMA 54 PROMOTER DA; Dalsing BL, 2014, J BACTERIOL, V196, P949, DOI 10.1128/JB.01378-13; Doucleff M, 2007, J MOL BIOL, V369, P1070, DOI 10.1016/j.jmb.2007.04.019; FRUND C, 1989, J BACTERIOL, V171, P6539; Gallegos MT, 1999, J MOL BIOL, V288, P539, DOI 10.1006/jmbi.1999.2704; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Hayward AC, 2001, LAB GUIDE IDENTIFICA, P151; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jacobs JM, 2012, MBIO, V3, DOI 10.1128/mBio.00114-12; JENKINS LS, 1987, J BACTERIOL, V169, P2096, DOI 10.1128/jb.169.5.2096-2102.1987; Kang YW, 2002, MOL MICROBIOL, V46, P427, DOI 10.1046/j.1365-2958.2002.03187.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; Lundgren BR, 2014, J BACTERIOL, V196, P2543, DOI 10.1128/JB.01615-14; MACALUSO A, 1990, J BACTERIOL, V172, P7249, DOI 10.1128/jb.172.12.7249-7255.1990; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Muse WB, 1998, J BACTERIOL, V180, P1166, DOI 10.1128/JB.180.5.1166-1173.1998; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; Palacios S, 2004, MICROBIOL-SGM, V150, P3877, DOI 10.1099/mic.0.27299-0; Poggio S, 2002, MOL MICROBIOL, V46, P75, DOI 10.1046/j.1365-2958.2002.03158.x; Poggio S, 2006, J BIOL CHEM, V281, P27205, DOI 10.1074/jbc.M601735200; Ray SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00229; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; Schobert M, 1999, MICROBIOL-SGM, V145, P471, DOI 10.1099/13500872-145-2-471; Southern E, 2000, NUCLEIC ACIDS RES, V28, P2563, DOI 10.1093/nar/28.13.2563; Studholme DJ, 2000, FEMS MICROBIOL LETT, V186, P1; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Suvorova IA, 2012, J BACTERIOL, V194, P3234, DOI 10.1128/JB.00163-12; Syed A, 1998, J BACTERIOL, V180, P5619, DOI 10.1128/JB.180.21.5619-5625.1998; Taniyama K, 2012, J BACTERIOL, V194, P1447, DOI 10.1128/JB.06590-11; Taylor M, 1996, MOL MICROBIOL, V22, P1045, DOI 10.1046/j.1365-2958.1996.01547.x; Tralau T, 2007, J BACTERIOL, V189, P6743, DOI 10.1128/JB.00889-07; Valentini M, 2011, J BACTERIOL, V193, P4307, DOI 10.1128/JB.05074-11; WONG CN, 1994, J MOL BIOL, V236, P81, DOI 10.1006/jmbi.1994.1120; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	44	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144852	10.1371/journal.pone.0144852	http://dx.doi.org/10.1371/journal.pone.0144852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659655	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600097
J	Tsai, JR; Liu, PL; Chen, YH; Chou, SH; Cheng, YJ; Hwang, JJ; Chong, IW				Tsai, Jong-Rung; Liu, Po-Len; Chen, Yung-Hsiang; Chou, Shah-Hwa; Cheng, Yu-Jen; Hwang, Jhi-Jhu; Chong, Inn-Wen			Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-kappa b/MMPs Signaling Pathway	PLOS ONE			English	Article							INDUCED APOPTOSIS; PROSTATE-CANCER; DOWN-REGULATION; NUDE-MICE; B PATHWAY; EXPRESSION; ADENOCARCINOMA; INVASION; RESISTIN; LEPTIN	Adipose tissue is now considered as an endocrine organ involved in metabolic and inflammatory reactions. Adiponectin, a 244-amino acid peptide hormone, is associated with insulin resistance and carcinogenesis. Curcumin (diferuloylmethane) is the principal curcuminoid of the popular Indian spice, turmeric. Curcumin possesses antitumor effects, including the inhibition of neovascularization and regulation of cell cycle and apoptosis. However, the effects of adiponectin and curcumin on non-small cell lung cancer (NSCLC) remain unclear. In this study, we evaluated the expression of adiponectin in paired tumors and normal lung tissues from 77 patients with NSCLC using real-time polymerase chain reaction, western blotting, and immunohistochemistry. Kaplan-Meier survival analysis showed that patients with low adiponectin expression ratio (<1) had significantly longer survival time than those with high expression ratio (>1) (p = 0.015). Curcumin inhibited the migratory and invasive ability of A549 cells via the inhibition of adiponectin expression by blocking the adiponectin receptor 1. Curcumin treatment also inhibited the in vivo tumor growth of A549 cells and adiponectin expression. These results suggest that adiponectin can be a prognostic indicator of NSCLC. The effect of curcumin in decreasing the migratory and invasive ability of A549 cells by inhibiting adiponectin expression is probably mediated through NF-kappa B/MMP pathways. Curcumin could be an important potential adjuvant therapeutic agent for lung cancer in the future.	[Tsai, Jong-Rung; Liu, Po-Len; Chou, Shah-Hwa; Hwang, Jhi-Jhu; Chong, Inn-Wen] Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan; [Tsai, Jong-Rung; Hwang, Jhi-Jhu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chou, Shah-Hwa] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Chest Surg, Kaohsiung, Taiwan; [Cheng, Yu-Jen] I Shou Univ, Dept Hlth Management, Div Thorac Surg, Dept Surg,E Da Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; E-Da Hospital; I Shou University	Chong, IW (corresponding author), Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan.	chong@kmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Tsai, Jong rung/0000-0002-3222-0409	National Science Council of R.O.C, Taiwan [NSC 100 - 2320 - B - 037 - 012 - MY2, NSC 100-2320-B-037-012-MY2]	National Science Council of R.O.C, Taiwan	This study was supported by the grants NSC 100 - 2320 - B - 037 - 012 - MY2 from the National Science Council of R.O.C, Taiwan to Jong-Rung Tsai. The National Science Council of R.O.C, Taiwan is a government organization which is external to the authors' university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the grants NSC 100-2320-B-037-012-MY2 from the National Science Council of R.O.C, Taiwan to Jong-Rung Tsai. The National Science Council of R.O.C, Taiwan is a government organization which is external to our university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghafar J, 2013, TOHOKU J EXP MED, V229, P153, DOI 10.1620/tjem.229.153; Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Barb D, 2006, EXPERT OPIN INV DRUG, V15, P917, DOI 10.1517/13543784.15.8.917; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chen QY, 2010, ONCOL REP, V23, P1285, DOI 10.3892/or_00000762; Chiu YC, 2009, CARCINOGENESIS, V30, P1651, DOI 10.1093/carcin/bgp156; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Gottschling S, 2012, CANCER GENOM PROTEOM, V9, P275; Hong JH, 2006, PROSTATE CANCER P D, V9, P147, DOI 10.1038/sj.pcan.4500856; Housa D, 2008, PHYSIOL RES, V57, P451, DOI 10.33549/physiolres.931156; Ishikawa M, 2007, CANCER SCI, V98, P1120, DOI 10.1111/j.1349-7006.2007.00486.x; Karapanagiotou EM, 2008, LUNG CANCER, V61, P391, DOI 10.1016/j.lungcan.2008.01.018; Kerenidi T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0507-x; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lee YK, 2009, ANN NY ACAD SCI, V1171, P489, DOI 10.1111/j.1749-6632.2009.04699.x; Li YG, 2012, FEBS J, V279, P2247, DOI 10.1111/j.1742-4658.2012.08607.x; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; MacDougald OA, 2007, CELL METAB, V6, P159, DOI 10.1016/j.cmet.2007.08.010; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; Mareel M, 2006, ACTA CHIR BELG, V106, P635; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; MENON LG, 1995, CANCER LETT, V95, P221, DOI 10.1016/0304-3835(95)03887-3; Menon LG, 1999, CANCER LETT, V141, P159, DOI 10.1016/S0304-3835(99)00098-1; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Petridou ET, 2007, ONCOLOGY-BASEL, V73, P261, DOI 10.1159/000127424; Petridou ET, 2011, METABOLISM, V60, P1100, DOI 10.1016/j.metabol.2010.12.002; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; SATOSKAR RR, 1986, INT J CLIN PHARM TH, V24, P651; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Tsai JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091331; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Wu SH, 2010, ANTICANCER RES, V30, P2125; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	44	62	64	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144462	10.1371/journal.pone.0144462	http://dx.doi.org/10.1371/journal.pone.0144462			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656720	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500028
J	Chang, LL; Liu, XW; Wang, DD; Ma, J; Zhou, TY; Chen, Y; Sheng, R; Hu, YZ; Du, Y; He, QJ; Yang, B; Zhu, H				Chang, Linlin; Liu, Xiaowen; Wang, Dandan; Ma, Jian; Zhou, Tianyi; Chen, Ying; Sheng, Rong; Hu, Yongzhou; Du, Ying; He, Qiaojun; Yang, Bo; Zhu, Hong			Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia	PLOS ONE			English	Article							DNA TOPOISOMERASE; CANCER-THERAPY; HEPATOCELLULAR-CARCINOMA; ANTITUMOR AGENTS; SOLID TUMORS; IN-VITRO; INHIBITION; CELLS; KINASE; ATM	In spite of the tremendous efforts dedicated to developing hypoxia-activated prodrugs, no agents yet have been approved for clinical therapy. In the present study, the hypoxic selective anti-cancer activity as well as the cellular target of a novel tirapazamine (TPZ) analogue, 7-methyl-3-(3-chlorophenyl)-quinoxaline-2-carbonitrile 1,4-dioxide (Q6) were investigated. Q6 implemented anti-cancer effects via poisoning topoisomerase II (topo II) under hypoxia. Modified trapped in agarose DNA immunostaining (TARDIS) assay showed more topo II-DNA cleavage complexes trapped by Q6 than TPZ at even lower concentration. In addition, by introducing ataxia-telangiectasia-mutated (ATM) kinase inhibitors caffeine and KU-60019, we displayed that Q6-triggered apoptosis was attributed, at least partially, to DNA double-strand breaks generated by the topo II-targeting effect. Collectively, Q6 stood out for its better hypoxia-selectivity and topo II-poisoning than the parental compound TPZ. All these data shed light on the research of Q6 as a promising hypoxia-activated prodrug candidate for human hepatocellular carcinoma therapy.	[Chang, Linlin; Liu, Xiaowen; Wang, Dandan; Ma, Jian; Zhou, Tianyi; Chen, Ying; He, Qiaojun; Yang, Bo; Zhu, Hong] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310003, Zhejiang, Peoples R China; [Sheng, Rong; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, ZJU ENS Joint Lab Med Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Du, Ying] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, H (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310003, Zhejiang, Peoples R China.	hongzhu@zju.edu.cn		Zhu, Hong/0000-0002-2575-4031	National Natural Science Foundation of China [81473228, 81473226]; Zhejiang Provincial Program for The Cultivation of HighLevel Innovative Health Talents, Zhejiang Science and Technology Department [2013C33158]; Zhejiang Provincial Nature Science Foundation of China [LQ12H16010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for The Cultivation of HighLevel Innovative Health Talents, Zhejiang Science and Technology Department; Zhejiang Provincial Nature Science Foundation of China	The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (81473228, 81473226, http://www.nsfc.gov.cn/), Zhejiang Provincial Program for The Cultivation of HighLevel Innovative Health Talents, Zhejiang Science and Technology Department (2013C33158, http://www.zjkjt.gov.cn/), and Zhejiang Provincial Nature Science Foundation of China (LQ12H16010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbattista MR, 2015, CANCER BIOL THER, V16, P610, DOI 10.1080/15384047.2015.1017171; Ahn GO, 2007, FRONT BIOSCI-LANDMRK, V12, P3483, DOI 10.2741/2329; Biddlestone-Thorpe L, 2013, CLIN CANCER RES, V19, P3189, DOI 10.1158/1078-0432.CCR-12-3408; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; Dai M, 2010, J CELL MOL MED, V14, P2281, DOI 10.1111/j.1582-4934.2009.00822.x; Gammon L, 2015, J ORAL PATHOL MED; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hicks KO, 2010, CLIN CANCER RES, V16, P4946, DOI 10.1158/1078-0432.CCR-10-1439; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Hsieh T, 1994, Adv Pharmacol, V29A, P191; Hu YZ, 2012, MOLECULES, V17, P9683, DOI 10.3390/molecules17089683; Kawatani M, 2011, CHEM BIOL, V18, P743, DOI 10.1016/j.chembiol.2011.03.012; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Liu XW, 2014, AUTOPHAGY, V10, P111, DOI 10.4161/auto.26838; Magdolenova Z, 2015, NANOTOXICOLOGY, V9, P44, DOI 10.3109/17435390.2013.847505; Marcu L, 2006, CURR CLIN PHARMACOL, V1, P71, DOI 10.2174/157488406775268192; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Papadopoulou MV, 2003, CLIN CANCER RES, V9, P5714; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; Patterson LH, 2000, BRIT J CANCER, V83, P1589, DOI 10.1054/bjoc.2000.1564; Peters KB, 2002, CANCER RES, V62, P5248; Raleigh SM, 1998, INT J RADIAT ONCOL, V42, P763, DOI 10.1016/S0360-3016(98)00308-3; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saggar JK, 2014, INT J CANCER, V134, P2726, DOI 10.1002/ijc.28595; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smart DJ, 2008, MUTAT RES-FUND MOL M, V641, P43, DOI 10.1016/j.mrfmmm.2008.03.005; Sudan S, 2014, NUTR CANCER, V66, P1237, DOI 10.1080/01635581.2014.951733; Sun JD, 2015, CANCER BIOL THER, V16, P438, DOI 10.1080/15384047.2014.1003005; TANABE K, 1991, CANCER RES, V51, P4903; Tang YZ, 2014, MOL CANCER THER, V13, P1526, DOI 10.1158/1535-7163.MCT-13-0981; Toh YM, 2011, CLIN CANCER RES, V17, P5026, DOI 10.1158/1078-0432.CCR-11-0235; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Zheng L, 2014, INT J CANCER, V135, P1721, DOI 10.1002/ijc.28810; Zheng L, 2011, CANCER LETT, V309, P27, DOI 10.1016/j.canlet.2011.05.011; Zhu H, 2007, MOL CANCER THER, V6, P484, DOI 10.1158/1535-7163.MCT-06-0584; Zirkin S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.458851	45	9	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144506	10.1371/journal.pone.0144506	http://dx.doi.org/10.1371/journal.pone.0144506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649750	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300052
J	Ferreira, RB; Faivovich, J; Beard, KH; Pombal, JP				Ferreira, Rodrigo B.; Faivovich, Julian; Beard, Karen H.; Pombal, Jose P., Jr.			The First Bromeligenous Species of Dendropsophus (Anura: Hylidae) from Brazil's Atlantic Forest	PLOS ONE			English	Article							ESPIRITO-SANTO; AMAZON BASIN; PHYLOGENETIC-RELATIONSHIPS; RAIN-FOREST; SOUTHEASTERN; HYLA; AMPHIBIA; TREEFROG; FROG; BROMELIADS	We describe a new treefrog species of Dendropsophus collected on rocky outcrops in the Brazilian Atlantic Forest. Ecologically, the new species can be distinguished from all known congeners by having a larval phase associated with rainwater accumulated in bromeliad phytotelms instead of temporary or lentic water bodies. Phylogenetic analysis based on molecular data confirms that the new species is a member of Dendropsophus; our analysis does not assign it to any recognized species group in the genus. Morphologically, based on comparison with the 96 known congeners, the new species is diagnosed by its small size, framed dorsal color pattern, and short webbing between toes IV-V. The advertisement call is composed of a moderate-pitched two-note call (similar to 5 kHz). The territorial call contains more notes and pulses than the advertisement call. Field observations suggest that this new bromeligenous species uses a variety of bromeliad species to breed in, and may be both territorial and exhibit male parental care.	[Ferreira, Rodrigo B.; Beard, Karen H.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Ferreira, Rodrigo B.; Beard, Karen H.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Ferreira, Rodrigo B.] Univ Vila Velha, Lab Ecol Populacoes & Conservacao, Vila Velha, ES, Brazil; [Faivovich, Julian] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Herpetol, Buenos Aires, DF, Argentina; [Faivovich, Julian] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Pombal, Jose P., Jr.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, RJ, Brazil	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Centro Universitario Vila Velha; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Buenos Aires; Universidade Federal do Rio de Janeiro	Ferreira, RB (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	rodrigoecologia@yahoo.com.br	Faivovich, Julián/A-9887-2008; Pombal, Jose P/C-6365-2015; Beard, Karen/B-7177-2011	Pombal, Jose P/0000-0003-4900-630X; Beard, Karen/0000-0003-4997-2495; Faivovich, Julian/0000-0001-7157-8131; Ferreira, Rodrigo/0000-0001-6099-5116	Herpetologists' League, Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICTs 2011-1895, 2013-404]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 1112008010 2422]; Sao Paulo Research Foundation (FAPESP) [2012/10000-5, 2013/50741-7]; CNPq; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Utah Agricultural Experiment Station, Utah State University; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [231020/2013-9]	Herpetologists' League, Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Utah Agricultural Experiment Station, Utah State University; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RBF received funding from The Herpetologists' League, Ecology Center at Utah State University, Dr. Dinesh and Kalpana Patel Fellowship, IdeaWild, Jack Berryman Institute, the Rufford Foundation and Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 231020/2013-9). JF thanks Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICTs 2011-1895, 2013-404), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP 1112008010 2422), and Sao Paulo Research Foundation (FAPESP; 2012/10000-5 and 2013/50741-7). JPP received financial support from CNPq and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). This research was supported by the Utah Agricultural Experiment Station, Utah State University, and approved as journal paper number 8807. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHL ERNST, 1933, ZOOL ANZ, V104, P25; Almeida Antonio de Padua, 2011, Check List, V7, P542; American and Veterinary Medical Association, 2013, GUID EUTH AN, P102; [Anonymous], 2014, R LANG ENV STAT COMP; Audacity Team, 2014, AUDACITY R FREE AUDI; Bokermann W., 1964, NEOTROPICA, V10, P2; Bokermann W. C. A., 1962, Neotropica, V8, P81; BOKERMANN W C A, 1968, Journal of Herpetology, V1, P25, DOI 10.2307/1563259; BOKERMANN WERNER C. A., 1962, ATAS SOC BIOL RIO DE JANEIRO, V6, P52; Canedo Clarissa, 2010, South American Journal of Herpetology, V5, P199, DOI 10.2994/057.005.0305; CARAMASCHI U, 1983, Revista Brasileira de Biologia, V43, P195; Carvalho-e-Silva Sergio Potsch, 2003, Rev. Bras. Zool., V20, P553, DOI 10.1590/S0101-81752003000300029; CEBEA/CFMV-Comissao de Etica Bioetica e Bem-Estar Animal, 2013, GUIA BRAS BOAS PRAT, P22; Cochran D.M., 1970, B US NATL MUSEUM, V288, P1, DOI DOI 10.5962/BHL.PART.6346; Cruz C.A.G., 2000, B MUSEU NACL, V434, P1; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Duellman W.E., 1983, P33; DUELLMAN W E, 1973, Herpetologica, V29, P219; DUELLMAN W E, 1982, Amphibia-Reptilia, V3, P153, DOI 10.1163/156853882X00383; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; DUELLMAN W E, 1969, Herpetologica, V25, P241; Duellman W.E., 1974, Occasional Papers Mus Nat Hist Univ Kans, VNo. 23, P1; Duellman W. E., 1986, BIOL AMPHIBIANS; Duellman WE, 2001, HYLID FROGS MIDDLE A; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2014, S AM J HERPETOL, V9, P207, DOI 10.2994/SAJH-D-14-00032.1; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Ferreira RB, 2012, J HERPETOL, V46, P19, DOI 10.1670/09-040; Ferreira RB, 2012, IHERINGIA SER ZOOL, V102, P163, DOI 10.1590/S0073-47212012000200008; Fouquet A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.3035.1.3; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Goin CJ, 1966, Q J FLORIDA ACAD SCI, V29, P29; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Gomes M, 1966, IHERINGIA SER ZOOL, V80, P33; Guarnizo CE, 2012, HERPETOLOGICA, V68, P523, DOI 10.1655/HERPETOLOGICA-D-10-00038; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Haddad CFB, 2013, ANFIBIOS MATA ATLANT; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HEYER W R, 1977, Papeis Avulsos de Zoologia (Sao Paulo), V31, P141; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jungfer KH, 2010, SALAMANDRA, V46, P204; Jungfer KH, 1999, AMPHIBIA-REPTILIA, V20, P235, DOI 10.1163/156853899507040; KAPLAN M, 1991, J HERPETOL, V25, P313, DOI 10.2307/1564589; KAPLAN M, 1994, J HERPETOL, V28, P79, DOI 10.2307/1564684; Kaplan M, 1977, J HERPETOL, V31, P230; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kohler J, 2005, J HERPETOL, V39, P43, DOI 10.1670/0022-1511(2005)039[0043:ANSOSH]2.0.CO;2; Kohler J, 2001, STUD NEOTROP FAUNA E, V36, P105, DOI 10.1076/snfe.36.2.105.2135; Kollman L. J. C., 2007, ESPECIES FLORA AMEAC, P144; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lescure J., 2000, COLLECTION PATRIMOIN, V45; Lourenco-De-Moraes R, 2014, ZOOTAXA, V3846, P348, DOI 10.11646/zootaxa.3846.3.2; Lourenco-De-Moraes R, 2013, J HERPETOL, V47, P575, DOI 10.1670/11-326; Lutz B., 1973, BRAZILIAN SPECIES HY; Mageski Marcio, 2014, Boletim do Museu de Biologia Mello Leitao Nova Serie, V34, P97; Mageski Marcio, 2014, Herpetology Notes, V7, P363; Ortega-Andrade HM, 2013, ZOOTAXA, V3652, P163, DOI 10.11646/zootaxa.3652.1.6; Melin D., 1941, Goteborgs Vetenskaps Samhalles Handlingar (6), V1B, P1; Mendes Sergio L., 2000, Boletim do Museu de Biologia Mello Leitao, V11-12, P7; Mijares-Urrutia A, 2000, J HERPETOL, V34, P80, DOI 10.2307/1565242; Mijares-Urrutia Abraham, 1998, Revista Brasileira de Biologia, V58, P659, DOI 10.1590/S0034-71081998000400013; Miller M.A., 2010, P GAT COMP ENV WORKS; Moravec J, 2006, ZOOTAXA, P23; Motta AP, 2012, ZOOTAXA, P18, DOI 10.11646/zootaxa.3249.1.2; Napoli M., 1998, B MUS NAC NOVA SER Z, V391, P1; Napoli Marcelo Felgueiras, 2000, Alytes (Paris), V17, P165; Napoli Marcelo Felgueiras, 1999, Alytes (Paris), V16, P165; Orrico VGD, 2014, ZOOTAXA, V3881, P341, DOI 10.11646/zootaxa.3881.4.3; Passamani M, 2011, MAMMALIA, V75, P83, DOI 10.1515/MAMM.2010.064; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peixoto Oswaldo Luiz, 1995, Revista Universidade Rural Serie Ciencias da Vida, V17, P75; Pertel W, 2010, CALDASIA, V32, P149; Pimenta Bruno V. S., 2014, Arquivos de Zoologia (Sao Paulo), V45, P1; Pombal JP, 2003, J HERPETOL, V37, P453, DOI 10.1670/220-01A; Pombal Jr J.P., 1998, B MUSEU NACL ZOOLOGI, V390, P1; Porembski Stefan, 1998, Diversity and Distributions, V4, P107, DOI 10.1046/j.1365-2699.1998.00013.x; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Rivera-Correa M, 2012, ZOOTAXA, P50; RIVERO J A, 1971, Caribbean Journal of Science, V11, P1; RIVERO JUAN A., 1961, BULL MUS COMP ZOOL HARVARD UNIV, V126, P1; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Roedder Dennis, 2007, Salamandra, V43, P91; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Silva-Soares T, 2010, ZOOTAXA, P63; Suarez P, 2013, CYTOGENET GENOME RES, V141, P295, DOI 10.1159/000354997; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Thomaz L. D., 1997, B MUSEU BIOL MELLO L, V7, P3; Toledo LF, 2014, ACTA ETHOLOGICA; Touchon JC, 2008, P NATL ACAD SCI USA, V105, P7495, DOI 10.1073/pnas.0711579105; Venables WN., 2002, MODERN APPL STAT S 4; VIGLE GO, 1990, HERPETOLOGICA, V46, P467; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wendt Tania, 2010, Boletim do Museu de Biologia Mello Leitao Nova Serie, V27, P21; WEYGOLDT P, 1987, STUD NEOTROP FAUNA E, V22, P237, DOI 10.1080/01650528709360736; WEYGOLDT P, 1981, Salamandra, V17, P1	97	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142893	10.1371/journal.pone.0142893	http://dx.doi.org/10.1371/journal.pone.0142893			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650515	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300009
J	Chen, F; Long, ZH; Yin, JB; Zuo, ZY; Li, H				Chen, Feng; Long, Zonghong; Yin, Jinbo; Zuo, Zhiyi; Li, Hong			Isoflurane Post-Treatment Improves Outcome after an Embolic Stroke in Rabbits	PLOS ONE			English	Article							ISCHEMIA; INJURY; RATS; NEUROPROTECTION; EPIDEMIOLOGY; PREVALENCE; MICE	Application of commonly used volatile anesthetics after brain ischemia onset (post-treatment) provides neuroprotection in rodents. To further test its translational potential, this study was designed to determine whether isoflurane post-treatment induced neuroprotection in rabbits after embolic stroke. White male New Zealand rabbits received intra-carotid injection of clots when they were awake. Some rabbits were exposed to 2.5% isoflurane for 1 h at 5 min after the injection. Isoflurane post-treatment increased the tolerance of rabbits to the amount of clots. Isoflurane post-treatment also reduced brain infarct volumes and plasma S100B 3 days after the injection of 5 mg clots and improved neurological deficit scores after the stroke. Isoflurane post-treatment improves neurological outcome in rabbits after embolic stroke.	[Chen, Feng; Long, Zonghong; Zuo, Zhiyi; Li, Hong] Third Mil Med Univ, Dept Anesthesiol, Xinqiao Hosp, Chongqing, Peoples R China; [Yin, Jinbo] Third Mil Med Univ, Dept Neurosurg, Xinqiao Hosp, Chongqing, Peoples R China; [Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA	Army Medical University; Army Medical University; University of Virginia	Zuo, ZY (corresponding author), Third Mil Med Univ, Dept Anesthesiol, Xinqiao Hosp, Chongqing, Peoples R China.	zz3c@virginia.edu; Lh78553@126.com	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	Natural Science Foundation Project of CQ CSTC of China [CSTC2013C292]; National Natural Science Foundation of China, Beijing, China [81070094, 81471192]; Robert M. Epstein Professorship, University of Virginia, Charlottesville, VA, USA	Natural Science Foundation Project of CQ CSTC of China(Natural Science Foundation Project of CQ CSTC); National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Robert M. Epstein Professorship, University of Virginia, Charlottesville, VA, USA	This study was supported by grants from Natural Science Foundation Project of CQ CSTC (CSTC2013C292) of China, the National Natural Science Foundation of China (grant numbers: 81070094 and 81471192), Beijing, China, and Robert M. Epstein Professorship, University of Virginia, Charlottesville, VA, USA.	Altay O, 2012, STROKE, V43, P2513, DOI 10.1161/STROKEAHA.112.661728; An SA, 2013, CLIN BIOCHEM, V46, P710, DOI 10.1016/j.clinbiochem.2013.02.005; DRUMMOND JC, 1985, ANESTHESIOLOGY, V62, P336, DOI 10.1097/00000542-198503000-00020; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; GARCIA JH, 1993, AM J PATHOL, V142, P623; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Lapchak PA, 2010, BRAIN RES, V1309, P136, DOI 10.1016/j.brainres.2009.10.067; Lapchak PA, 2009, BRAIN RES, V1294, P211, DOI 10.1016/j.brainres.2009.07.058; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li H, 2013, NEUROBIOL DIS, V54, P216, DOI 10.1016/j.nbd.2012.12.014; Ren XY, 2014, NEUROL SCI, V35, P1401, DOI 10.1007/s10072-014-1726-4; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	16	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143931	10.1371/journal.pone.0143931	http://dx.doi.org/10.1371/journal.pone.0143931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645542	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903100011
J	Chang, YL; Sheng, JY; Ohashi, K; Beguer-Pon, M; Miyazawa, Y				Chang, Yu-Lin; Sheng, Jinyu; Ohashi, Kyoko; Beguer-Pon, Melanie; Miyazawa, Yasumasa			Impacts of Interannual Ocean Circulation Variability on Japanese Eel Larval Migration in the Western North Pacific Ocean	PLOS ONE			English	Article							EQUATORIAL CURRENT; EUROPEAN EEL; GLASS EELS; EL-NINO; ANGUILLA; TRANSPORT; WATER; LEPTOCEPHALI; RECRUITMENT; MORTALITY	The Japanese eel larvae hatch near the West Mariana Ridge seamount chain and travel through the North Equatorial Current (NEC), the Kuroshio, and the Subtropical Countercurrent (STCC) region during their shoreward migration toward East Asia. The interannual variability of circulation over the subtropical and tropical regions of the western North Pacific Ocean is affected by the Philippines-Taiwan Oscillation (PTO). This study examines the effect of the PTO on the Japanese eel larval migration routes using a three-dimensional (3D) particle tracking method, including vertical and horizontal swimming behavior. The 3D circulation and hydrography used for particle tracking are from the ocean circulation reanalysis produced by the Japan Coastal Ocean Predictability Experiment 2 (JCOPE2). Our results demonstrate that bifurcation of the NEC and the strength and spatial variation of the Kuroshio affect the distribution and migration of eel larvae. During the positive phase of PTO, more virtual eels ("v-eels") can enter the Kuroshio to reach the south coast of Japan and more v-eels reach the South China Sea through the Luzon Strait; the stronger and more offshore swing of the Kuroshio in the East China Sea leads to fewer eels entering the East China Sea and the onshore movement of the Kuroshio to the south of Japan brings the eels closer to the Japanese coast. Significant differences in eel migration routes and distributions regulated by ocean circulation in different PTO phases can also affect the otolith increment. The estimated otolith increment suggests that eel age tends to be underestimated after six months of simulation due to the cooler lower layer temperature. Underestimation is more significant in the positive PTO years due to the wide distribution in higher latitudes than in the negative PTO years.	[Chang, Yu-Lin] Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan; [Chang, Yu-Lin; Sheng, Jinyu; Ohashi, Kyoko; Beguer-Pon, Melanie] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Miyazawa, Yasumasa] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan	National Taiwan Normal University; Dalhousie University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Chang, YL (corresponding author), Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan.	ychang@ntnu.edu.tw	Miyazawa, Yasumasa/J-3196-2014	Miyazawa, Yasumasa/0000-0002-0107-6272	Ministry of Science and Technology of Taiwan [102-2611-M-003-003-MY3]; research abroad grant [104-2918-I-003-001]; Lloyd's Register Foundation; JSPS KAKENHI [26287116]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); research abroad grant; Lloyd's Register Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YLC is supported by the Ministry of Science and Technology of Taiwan under grant 102-2611- M-003-003-MY3, and the research abroad grant (104-2918-I-003-001). JS is supported by Lloyd's Register Foundation. YM is supported by JSPS KAKENHI (26287116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The observed drifter data are obtained from the Global Drifter Program. YLC is supported by the Ministry of Science and Technology of Taiwan under grant 102-2611-M-003-003-MY3, and the research abroad grant (104-2918-I-003-001). JS is supported by Lloyd's Register Foundation, which helps to protect life and property by supporting engineering-related education, public engagement, and the application of research. YM is supported by JSPS KAKENHI (26287116).	Aida K., 2003, EEL BIOL; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Baltazar-Soares M, 2014, CURRENT BIOL; Blanke B, 2012, DYNAM ATMOS OCEANS, V55-56, P22, DOI 10.1016/j.dynatmoce.2012.04.003; Bonhommeau S, 2009, J FISH BIOL, V74, P1891, DOI 10.1111/j.1095-8649.2009.02298.x; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Chang YL, 2012, J CLIMATE, V25, P1597, DOI 10.1175/JCLI-D-11-00158.1; Chang YL, 2015, PROG OCEANOGR, V135, P64, DOI 10.1016/j.pocean.2015.04.006; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Fukuda N, 2009, J FISH BIOL, V74, P1915, DOI 10.1111/j.1095-8649.2009.02287.x; Gentleman W, 2002, HYDROBIOLOGIA, V480, P69, DOI 10.1023/A:1021289119442; Han YS, 2009, ZOOL STUD, V48, P632; ICES (2006) (International Council for the Exploration of the Sea), 2006, REP EIF ICES WORK GR; Jacoby D, 2014, ANGUILLA JAPONICA IU; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kuroki Mari, 2010, Coastal Marine Science, V34, P31; Mellor G, 2002, OCEAN FORECASTING CO, P55, DOI DOI 10.1007/978-3-662-22648-3_4; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Ohashi K, 2015, ATMOSPHERE OCEAN; Press W., 1992, NUMERICAL RECIPES FO; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Qiu B, 2010, J PHYS OCEANOGR, V40, P213, DOI 10.1175/2009JPO4285.1; Rypina II, 2014, LIMNOL OCEANOGR, V59, P1704, DOI 10.4319/lo.2014.59.5.1704; Shan SL, 2014, OCEAN DYNAM, V64, P117, DOI 10.1007/s10236-013-0672-7; Sheng JY, 2009, J MARINE SYST, V77, P350, DOI 10.1016/j.jmarsys.2008.01.013; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; Tesch F.-W., 2003, THE EEL; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; Wang J, 2014, GEOPHYS RES LETT, V41, P8538, DOI 10.1002/2014GL062118; Wuenschel MJ, 2008, MAR BIOL, V154, P775, DOI 10.1007/s00227-008-0970-7; Yamada Y, 2009, MAR ECOL PROG SER, V379, P241, DOI 10.3354/meps07912; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x; Zenimoto K, 2011, MAR ECOL PROG SER, V438, P219, DOI 10.3354/meps09255	44	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144423	10.1371/journal.pone.0144423	http://dx.doi.org/10.1371/journal.pone.0144423			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642318	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700118
J	Dovana, F; Mucciarelli, M; Mascarello, M; Fusconi, A				Dovana, Francesco; Mucciarelli, Marco; Mascarello, Maurizio; Fusconi, Anna			In Vitro Morphogenesis of Arabidopsis to Search for Novel Endophytic Fungi Modulating Plant Growth	PLOS ONE			English	Article							MODEL SYSTEM; THALIANA; DIVERSITY; BACTERIA; IDENTIFICATION; ARCHITECTURE; MYCORRHIZAE; PATHOGENS; PHOSPHATE; RESPONSES	Fungal endophytes have shown to affect plant growth and to confer stress tolerance to the host; however, effects of endophytes isolated from water plants have been poorly investigated. In this study, fungi isolated from stems (stem-E) and roots (root-E) of Mentha aquatica L. (water mint) were identified, and their morphogenetic properties analysed on in vitro cultured Arabidopsis (L.) Heynh., 14 and 21 days after inoculation (DAI). Nineteen fungi were analysed and, based on ITS analysis, 17 isolates showed to be genetically distinct. The overall effect of water mint endophytes on Arabidopsis fresh (FW) and dry weight (DW) was neutral and positive, respectively, and the increased DW, mainly occurring 14 DAI, was possibly related to plant defence mechanism. Only three fungi increased both FW and DW of Arabidopsis at 14 and 21 DAI, thus behaving as plant growth promoting (PGP) fungi. E-treatment caused a reduction of root depth and primary root length in most cases and inhibition-to-promotion of root area and lateral root length, from 14 DAI. Only Phoma macrostoma, among the water mint PGP fungi, increased both root area and depth, 21 DAI. Root depth and area 14 DAI were shown to influence DWs, indicating that the extension of the root system, and thus nutrient uptake, was an important determinant of plant dry biomass. Reduction of Arabidopsis root depth occurred to a great extent when plants where treated with stem-E while root area decreased or increased under the effects of stem-E and root-E, respectively, pointing to an influence of the endophyte origin on root extension. M. aquatica and many other perennial hydrophytes have growing worldwide application in water pollution remediation. The present study provided a model for directed screening of endophytes able to modulate plant growth in the perspective of future field applications of these fungi.	[Dovana, Francesco] Univ Piemonte Orientale, Dept Sci & Innovat Technol, Alessandria, Italy; [Mucciarelli, Marco; Mascarello, Maurizio; Fusconi, Anna] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Turin	Mucciarelli, M (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	marco.mucciarelli@unito.it	Mucciarelli, Marco/D-6054-2011; dovana, francesco/AAA-4431-2020	dovana, francesco/0000-0002-8556-7692	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	A. Fusconi and M. Mucciarelli were supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contreras-Cornejo HA, 2015, J PLANT GROWTH REGUL, V34, P425, DOI 10.1007/s00344-014-9471-8; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Avelar FF, 2014, ENVIRON TECHNOL, V35, P2095, DOI 10.1080/09593330.2014.893025; Bailey KL, 2011, BIOL CONTROL, V59, P268, DOI 10.1016/j.biocontrol.2011.06.019; Botella L, 2011, FUNGAL DIVERS, V47, P9, DOI 10.1007/s13225-010-0061-1; Brankovic S, 2015, BIOTECHNOL BIOTECHNO, V26, P2731; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Dolatabadi HK, 2011, SYMBIOSIS, V53, P29, DOI 10.1007/s13199-010-0104-0; Fouda A. H., 2015, Annals of Agricultural Science (Cairo), V60, P95; Fusconi A, 2014, ANN BOT-LONDON, V113, P19, DOI 10.1093/aob/mct258; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goh CH, 2013, J CHEM ECOL, V39, P826, DOI 10.1007/s10886-013-0326-8; Gramaje D, 2011, PLANT DIS, V95, P1040, DOI 10.1094/PDIS-01-11-0025; Gravel V, 2007, SOIL BIOL BIOCHEM, V39, P1968, DOI 10.1016/j.soilbio.2007.02.015; Haichar FE, 2014, SOIL BIOL BIOCHEM, V77, P69, DOI 10.1016/j.soilbio.2014.06.017; Hamann E, 2013, ANN BOT-LONDON, V112, P1869, DOI 10.1093/aob/mct221; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005; Jaber LR, 2010, ECOL ENTOMOL, V35, P25, DOI 10.1111/j.1365-2311.2009.01152.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Khan AL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-51; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Ludwig-Muller J, 2015, J PLANT PHYSIOL, V172, P4, DOI 10.1016/j.jplph.2014.01.002; Mandyam KG, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00776; Mandyam KG, 2013, FUNGAL BIOL-UK, V117, P250, DOI 10.1016/j.funbio.2013.02.001; Martinuz A, 2015, PLANTA, V241, P1015, DOI 10.1007/s00425-014-2237-5; Mayerhofer MS, 2013, MYCORRHIZA, V23, P119, DOI 10.1007/s00572-012-0456-9; Mucciarelli M, 2003, NEW PHYTOL, V158, P579, DOI 10.1046/j.1469-8137.2003.00762.x; Mucciarelli M, 2002, MYCOLOGIA, V94, P28, DOI 10.2307/3761843; Mucciarelli M, 2007, MICROB ECOL, V54, P685, DOI 10.1007/s00248-007-9227-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murphy BR, 2015, SYMBIOSIS, V65, P1, DOI 10.1007/s13199-015-0314-6; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Okane I, 2015, CURR SC, V108, P1; Okubara PA, 2005, PLANT SOIL, V274, P215, DOI 10.1007/s11104-004-7328-9; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; PITT JI, 1991, PHYTOPATHOLOGY, V81, P1108, DOI 10.1094/Phyto-81-1108; Rai M, 2014, SYMBIOSIS, V62, P63, DOI 10.1007/s13199-014-0273-3; Remans T, 2012, ANN BOT-LONDON, V110, P239, DOI 10.1093/aob/mcs105; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rosa LH, 2010, FEMS MICROBIOL ECOL, V73, P178, DOI 10.1111/j.1574-6941.2010.00872.x; Salas-Marina MA, 2011, J MICROBIOL BIOTECHN, V21, P686, DOI 10.4014/jmb.1101.01012; Sandberg DC, 2014, MICROB ECOL, V67, P735, DOI 10.1007/s00248-013-0324-y; Sati SC, 2010, SYMBIOSIS, V50, P143, DOI 10.1007/s13199-010-0054-6; Sherameti I, 2008, MOL PLANT MICROBE IN, V21, P799, DOI 10.1094/MPMI-21-6-0799; Skouboe P, INTEGRATION MODERN T, P179; Su H, 2014, CHIANG MAI J SCI, V41, P1; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Vadassery J, 2008, MOL PLANT MICROBE IN, V21, P1371, DOI 10.1094/MPMI-21-10-1371; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Vaz ABM, 2012, APPL SOIL ECOL, V61, P288, DOI 10.1016/j.apsoil.2011.10.017; Wachowska U, 2014, BIOCONTROL, V59, P635, DOI 10.1007/s10526-014-9596-5; Wang XM, 2015, J BASIC MICROB, V55, P659, DOI 10.1002/jobm.201300601; Wani ZA, 2015, APPL MICROBIOL BIOT, V99, P2955, DOI 10.1007/s00253-015-6487-3; Waqas M, 2015, MOLECULES, V9, P10754; Waqas M, 2014, J PLANT INTERACT, V9, P478, DOI 10.1080/17429145.2013.860562; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06; Zurayk R, 2002, WATER AIR SOIL POLL, V139, P355, DOI 10.1023/A:1015840601761	61	12	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143353	10.1371/journal.pone.0143353	http://dx.doi.org/10.1371/journal.pone.0143353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641657	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700015
J	Garbarino, S; Magnavita, N				Garbarino, Sergio; Magnavita, Nicola			Work Stress and Metabolic Syndrome in Police Officers. A Prospective Study	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; CORONARY-HEART-DISEASE; JOB DEMAND-CONTROL; CARDIOVASCULAR-DISEASE; PSYCHOMETRIC PROPERTIES; OCCUPATIONAL STRESS; DECISION LATITUDE; PERCEIVED STRESS; OXIDATIVE STRESS; LIFE-STYLE	Objective The aim of this longitudinal study was to evaluate the association between occupational stress and metabolic syndrome (MetS) in a rapid response police unit. Method Work-related stress was continuously monitored during the 5-year period with both the Demand-Control-Support (DCS) and the Effort-Reward Imbalance (ERI) models. Blood pressure, body mass index (BMI), waist circumference, triglycerides, HDL-cholesterol, and fasting blood glucose were measured at baseline in January 2009, and in January 2014. 234 out of 290 police officers (81%) completed the follow-up. Results The majority of police officers had high stress levels. At follow-up, police officers in the highest quartile of stress had significantly higher mean levels of triglycerides, and lower levels of HDL-cholesterol than their colleagues in the lowest quartile. Police officers with high stress had an increased adjusted risk of developing MetS (aOR = 2.68; CI95%= 1.08-6.70), and hypertriglyceridemia (aOR = 7.86; CI95 = 1.29-48.04). Demand and Effort were significant predictors of MetS. Conclusion Our study supports the hypothesis that work-related stress induces MetS, particularly through its effects on blood lipids. Future longitudinal studies with continuous monitoring of stress levels will definitively confirm this hypothesis.	[Garbarino, Sergio] Minist Interior, State Police Hlth Serv Dept, Genoa, Italy; [Garbarino, Sergio] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Garbarino, Sergio] Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Dept Publ Hlth, Rome, Italy	University of Genoa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Dept Publ Hlth, Rome, Italy.	nicolamagnavita@gmail.com	Magnavita, Nicola/J-6074-2014; Garbarino, Sergio/AAV-4629-2021; Garbarino, Sergio/X-5368-2018	Magnavita, Nicola/0000-0002-0988-7344; Garbarino, Sergio/0000-0002-8508-552X; Garbarino, Sergio/0000-0002-8508-552X				Allard KO, 2011, J OCCUP ENVIRON MED, V53, P1364, DOI 10.1097/JOM.0b013e3182363bda; Almadi T, 2013, PSYCHOPHYSIOLOGY, V50, P821, DOI 10.1111/psyp.12069; Aschbacher K, 2014, PSYCHONEUROENDOCRINO, V46, P14, DOI 10.1016/j.psyneuen.2014.04.003; Bartoli F, 2013, METAB SYNDR RELAT D, V11, P301, DOI 10.1089/met.2013.0010; Baughman P, 2016, AM J HUM BIOL, V28, P138, DOI 10.1002/ajhb.22748; Beck-Nielsen H., 2013, METABOLIC SYNDROME, DOI [10.1007/978-3-7091-1331-8_2, DOI 10.1007/978-3-7091-1331-8_]; Bergmann N, 2014, ENDOCR CONNECT, V3, pR55, DOI 10.1530/EC-14-0031; Berset M, 2011, SCAND J WORK ENV HEA, V37, P45, DOI 10.5271/sjweh.3089; Bhandari R, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/189384; Bo S, 2007, DIABETES RES CLIN PR, V75, P362, DOI 10.1016/j.diabres.2006.06.031; Braga RT, 2014, AM J MENS HEALTH, V8, P503, DOI 10.1177/1557988314526750; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chen X, 2015, J OCCUP ENVIRON MED, V57, P400, DOI 10.1097/JOM.0000000000000372; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Copertaro A, 2009, EPIDEMIOL PREV, V33, P227; Dashti HS, 2015, AM J HYPERTENS; Djindjic N, 2012, ANN OCCUP HYG, V56, P1051, DOI 10.1093/annhyg/mes059; Edwards EM, 2012, J OCCUP ENVIRON MED, V54, P1447, DOI 10.1097/JOM.0b013e3182783f27; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Falkner B, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0449-5; Federation ID, 2006, IDF CONS WORLDW DEF; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fujishiro K, 2011, J IMMIGR MINOR HEALT, V13, P533, DOI 10.1007/s10903-010-9364-2; Garbarino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097188; Garbarino S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002791; Gimeno D, 2010, OCCUP ENVIRON MED, V67, P256, DOI 10.1136/oem.2009.047324; Griep RH, 2009, INT ARCH OCC ENV HEA, V82, P1163, DOI 10.1007/s00420-009-0460-3; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P243; Hartley TA, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/861219; Hermida RC, 2007, CHRONOBIOL INT, V24, P749, DOI 10.1080/07420520701535837; Hermida RC, 2010, CHRONOBIOL INT, V27, P1629, DOI 10.3109/07420528.2010.510230; Janczura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133750; Joseph PN, 2009, J OCCUP ENVIRON MED, V51, P700, DOI 10.1097/JOM.0b013e3181a02252; Kang MG, 2004, YONSEI MED J, V45, P838, DOI 10.3349/ymj.2004.45.5.838; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kawada T, 2013, INT ARCH OCC ENV HEA, V86, P725, DOI 10.1007/s00420-013-0870-0; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kumar Pranav, 2013, Indian J Public Health, V57, P24, DOI 10.4103/0019-557X.111364; Maggi S, 2006, J GERONTOL A-BIOL, V61, P505, DOI 10.1093/gerona/61.5.505; Magnavita N, 2008, RADIOL MED, V113, P329, DOI 10.1007/s11547-008-0259-4; Magnavita N, 2007, G Ital Med Lav Ergon, V29, P667; Magnavita Nicola, 2013, Psychiatry J, V2013, P701872, DOI 10.1155/2013/701872; Magnavita N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130944; Magnavita N, 2014, J NURS SCHOLARSHIP, V46, P366, DOI 10.1111/jnu.12088; Magnavita N, 2014, RADIOL MED, V119, P142, DOI 10.1007/s11547-013-0329-0; Magnavita N, 2013, AM J IND MED, V56, P765, DOI 10.1002/ajim.22155; Magnavital Nicola, 2014, G Ital Med Lav Ergon, V36, P400; Maia DB, 2008, J AFFECT DISORDERS, V107, P259, DOI 10.1016/j.jad.2007.08.013; da Silva MEM, 2012, J MED ETHICS, V38, P639, DOI 10.1136/medethics-2011-100208; McCanlies EC, 2012, WORK, V43, P133, DOI 10.3233/WOR-2012-1399; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Niedhammer I, 2002, INT ARCH OCC ENV HEA, V75, P129, DOI 10.1007/s004200100270; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nomura K, 2010, AM J IND MED, V53, P1128, DOI 10.1002/ajim.20859; Novelletto BF, 2012, METAB SYNDR RELAT D, V10, P56, DOI 10.1089/met.2011.0065; Pelfrene E, 2001, WORK STRESS, V15, P297, DOI 10.1080/02678370110086399; Pickering T G, 2001, Curr Hypertens Rep, V3, P249, DOI 10.1007/s11906-001-0047-1; Puustinen PJ, 2011, PSYCHOSOM MED, V73, P158, DOI 10.1097/PSY.0b013e3182037315; Rosenbaum S, 2015, METABOLISM, V64, P926, DOI [10.1016/j.metabol.2015.04.009, 10.1016/j.metabol.2015.01.016]; Sale JEM, 2002, INT ARCH OCC ENV HEA, V75, P145, DOI 10.1007/s004200100289; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Scheen A J, 2003, Rev Med Liege, V58, P479; Schmidt B, 2015, INT J CARDIOL, V178, P24, DOI 10.1016/j.ijcard.2014.10.115; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siervo M, 2014, J ALZHEIMERS DIS, V41, P151, DOI 10.3233/JAD-132279; Soderberg M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1102; Song Fu-jun, 2013, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V31, P834; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Thayyil J, 2012, N AM J MED SCI, V4, P630, DOI 10.4103/1947-2714.104313; Tsimakouridze Elena V, 2015, Front Pharmacol, V6, P77, DOI 10.3389/fphar.2015.00077; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Vidigal FD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1198; Violanti JM, 2009, ARCH ENVIRON OCCUP H, V64, P194, DOI 10.1080/19338240903241259; Walvekar SS, 2015, J CLIN DIAGN RES, V9, pBC10, DOI 10.7860/JCDR/2015/12015.5576; Wilson MG, 2012, J SCI MED SPORT, V15, P266, DOI 10.1016/j.jsams.2011.10.007; Wirth MD, 2014, J OCCUP ENVIRON MED, V56, P986, DOI 10.1097/JOM.0000000000000213; Yamamoto K, 2011, J PHYSIOL ANTHROPOL, V30, P15, DOI 10.2114/jpa2.30.15; Yoo HL, 2009, J OCCUP ENVIRON MED, V51, P46, DOI 10.1097/JOM.0b013e31817f9e43; Yoo H, 2013, J OCCUP ENVIRON MED, V55, P111, DOI 10.1097/JOM.0b013e31826e294c; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027481	83	86	89	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144318	10.1371/journal.pone.0144318	http://dx.doi.org/10.1371/journal.pone.0144318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641879	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700097
J	Jiang, SW; Fei, AH; Peng, Y; Zhang, J; Lu, YR; Wang, HR; Chen, M; Pan, SM				Jiang, Shaowei; Fei, Aihua; Peng, Ya; Zhang, Jun; Lu, You-ran; Wang, Hai-rong; Chen, Miao; Pan, Shuming			Predictors of Outcome and Hemorrhage in Patients Undergoing Endovascular Therapy with Solitaire Stent for Acute Ischemic Stroke	PLOS ONE			English	Article							ANTERIOR CIRCULATION STROKE; IMPAIRED GLUCOSE-TOLERANCE; MECHANICAL THROMBECTOMY; PROGNOSTIC-FACTORS; INTRAVENOUS THROMBOLYSIS; DIABETES-MELLITUS; HYPERGLYCEMIA; REVASCULARIZATION; PREVALENCE; MANAGEMENT	Background Endovascular mechanical thrombectomy is emerging as a promising therapeutic approach for acute ischemic stroke and show some advantages. However, the data of predicting clinical outcome after thrombectomy with Solitaire retriever were limited. We attempt to identify prognostic factors of clinical outcome in patients with acute ischemic stroke undergoing thrombectomy with Solitaire retriever. Methods We conducted a retrospective analysis of consecutive acute ischemic strokes cases treated between December 2010 and December2013 where the Solitaire stent retriever was used for acute ischemic stroke. We assessed the effect of selected demographic characteristics, clinical factors on poor outcome at 3 months (modified Rankin score 3-6), mortality at 3 months, and hemorrhage within 24 h (symptomatic and asymptomatic). Clinical, imaging and logistic variables were analyzed. A multivariate logistic regression analysis was used to identify variables influencing clinical outcome, based on discharge NIHSS score change and mRS at 3 months. Results Eighty nine consecutive patients with acute ischemic stroke underwent mechanical thrombectomy. Multivariate analysis revealed that admission NIHSS score, Serum glucose and endovascular procedure duration were independently associated with clinical outcome. Sex, NIHSS score at admission, diabetes and time of operation were associated with sICH in 1 day. NIHSS score >= 20 (OR 9.38; 95% CI 2.41-36.50), onset to reperfusion >5 hours (OR 5.23; 95% CI1.34,20.41) and symptomatic intracranial hemorrhage (OR 10.19; 95% CI1.80,57.83) were potential predictive factors of mortality at 3 months. Conclusion Multiple pre- and intra-procedural factors can be used to predict clinical outcome, symptomatic intracranial hemorrhage and mortality in acute ischemic stroke patients undergoing endovascular therapy. This knowledge is helpful for patients selection for endovascular mechanical thrombectomy.	[Jiang, Shaowei; Fei, Aihua; Wang, Hai-rong; Chen, Miao; Pan, Shuming] Shanghai Jiao Tong Univ, Sch Med, Emergency Dept, Xinhua Hosp, Shanghai 200092, Peoples R China; [Peng, Ya] Soochow Univ, Cerebral Vasc Dis Ctr, Peoples Hosp Changzhou 1, Changzhou 213003, Peoples R China; [Zhang, Jun; Lu, You-ran] Soochow Univ, Dept Med Imaging, Peoples Hosp Changzhou 1, Changzhou 213003, Peoples R China	Shanghai Jiao Tong University; Soochow University - China; Soochow University - China	Pan, SM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Emergency Dept, Xinhua Hosp, Shanghai 200092, Peoples R China.	shumingpan@163.com	Wang, Hairong/HGF-1825-2022		Science and Technology Commission of Shanghai Municipality grants [13ZR1426500]	Science and Technology Commission of Shanghai Municipality grants	This study is supported by 2013-2014 National clinical key specialty construction project and Science and Technology Commission of Shanghai Municipality grants 13ZR1426500.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Chindaprasirt Jarin, 2013, ISRN Neurol, V2013, P710681, DOI 10.1155/2013/710681; Christensen H, 2002, EUR J NEUROL, V9, P297, DOI 10.1046/j.1468-1331.2002.00409.x; Costalat V, 2012, EUR J RADIOL, V81, P4075, DOI 10.1016/j.ejrad.2012.07.012; Covel CL, 2014, THROMB HAEMOSTASIS, V111, P385, DOI 10.1160/TH13-04-0347; Davalos A, 2012, STROKE, V43, P2699, DOI 10.1161/STROKEAHA.112.663328; Desilles JP, 2013, STROKE, V44, P1915, DOI 10.1161/STROKEAHA.111.000813; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Gratz PP, 2014, STROKE, V45, P152, DOI 10.1161/STROKEAHA.113.002591; Gray CS, 2004, AGE AGEING, V33, P71, DOI 10.1093/ageing/afh026; Grunwald IQ, 2011, AM J NEURORADIOL, V32, P238, DOI 10.3174/ajnr.A2346; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hametner C, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0262-z; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hill Michael D, 2014, Handb Clin Neurol, V126, P167, DOI 10.1016/B978-0-444-53480-4.00012-6; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Koh Jun Seok, 2012, Neurointervention, V7, P1, DOI 10.5469/neuroint.2012.7.1.1; Kruyt ND, 2010, NAT REV NEUROL, V6, P145, DOI 10.1038/nrneurol.2009.231; Lefevre PH, 2014, J NEURORADIOLOGY, V41, P80, DOI 10.1016/j.neurad.2013.10.002; Leigh R, 2004, STROKE, V35, P1903, DOI 10.1161/01.STR.0000132571.77987.4c; Lewandowski CA, 1999, STROKE, V30, P2598, DOI 10.1161/01.STR.30.12.2598; Lorenzano S, 2013, STROKE, V44, P3401, DOI 10.1161/STROKEAHA.113.002908; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Mishra SM, 2014, AM J NEURORADIOL, V35, P2265, DOI 10.3174/ajnr.A4048; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Pereira VM, 2013, STROKE, V44, P2802, DOI 10.1161/STROKEAHA.113.001232; PESSIN MS, 1991, AM J NEURORADIOL, V12, P1123; Powers WJ, 2015, STROKE, DOI DOI 10.1161/STR.0000000000000074; Raoult H, 2013, J NEURORADIOLOGY, V40, P252, DOI 10.1016/j.neurad.2013.04.001; Roth DL, 2011, STROKE, V42, P626, DOI 10.1161/STROKEAHA.110.595322; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Shi ZS, 2014, STROKE, V45, P1977, DOI 10.1161/STROKEAHA.114.005603; Skagen K, 2015, J STROKE CEREBROVASC; Smit EJ, 2013, STROKE, V44, P2194, DOI 10.1161/STROKEAHA.111.000675; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Soize S, 2013, NEURORADIOLOGY, V55, P977, DOI 10.1007/s00234-013-1191-4; Strbian D, 2011, NEUROLOGY, V77, P341, DOI 10.1212/WNL.0b013e3182267b8c; Yang Y, 2015, INT J SURG, V16, P36, DOI 10.1016/j.ijsu.2015.02.013	46	51	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144452	10.1371/journal.pone.0144452	http://dx.doi.org/10.1371/journal.pone.0144452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642052	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700125
J	Rebollo-Lopez, MJ; Lelievre, J; Alvarez-Gomez, D; Castro-Pichel, J; Martinez-Jimenez, F; Papadatos, G; Kumar, V; Colmenarejo, G; Mugumbate, G; Hurle, M; Barroso, V; Young, RJ; Martinez-Hoyos, M; del Rio, RG; Bates, RH; Lopez-Roman, EM; Mendoza-Losana, A; Brown, JR; Alvarez-Ruiz, E; Marti-Renom, MA; Overington, JP; Cammack, N; Ballell, L; Barros-Aguire, D				Jose Rebollo-Lopez, Maria; Lelievre, Joel; Alvarez-Gomez, Daniel; Castro-Pichel, Julia; Martinez-Jimenez, Francisco; Papadatos, George; Kumar, Vinod; Colmenarejo, Gonzalo; Mugumbate, Grace; Hurle, Mark; Barroso, Vanessa; Young, Rob J.; Martinez-Hoyos, Maria; Gonzalez del Rio, Ruben; Bates, Robert H.; Maria Lopez-Roman, Eva; Mendoza-Losana, Alfonso; Brown, James R.; Alvarez-Ruiz, Emilio; Marti-Renom, Marc A.; Overington, John P.; Cammack, Nicholas; Ballell, Lluis; Barros-Aguire, David			Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery	PLOS ONE			English	Article							PROTEIN; DATABASE	As a follow up to the antimycobacterial screening exercise and the release of GSK's first Tres Cantos Antimycobacterial Set (TCAMS-TB), this paper presents the results of a second antitubercular screening effort of two hundred and fifty thousand compounds recently added to the GSK collection. The compounds were further prioritized based on not only antitubercular potency but also on physicochemical characteristics. The 50 most attractive compounds were then progressed for evaluation in three different predictive computational biology algorithms based on structural similarity or GSK historical biological assay data in order to determine their possible mechanisms of action. This effort has resulted in the identification of novel compounds and their hypothesized targets that will hopefully fuel future TB drug discovery and target validation programs alike.	[Jose Rebollo-Lopez, Maria; Lelievre, Joel; Alvarez-Gomez, Daniel; Castro-Pichel, Julia; Martinez-Hoyos, Maria; Gonzalez del Rio, Ruben; Bates, Robert H.; Maria Lopez-Roman, Eva; Mendoza-Losana, Alfonso; Cammack, Nicholas; Ballell, Lluis; Barros-Aguire, David] GlaxoSmithKline, Dis Developing World, Madrid, Spain; [Martinez-Jimenez, Francisco; Marti-Renom, Marc A.] CNAG, Genome Biol Grp, Barcelona, Spain; [Martinez-Jimenez, Francisco; Marti-Renom, Marc A.] CRG, Gene Regulat Stem Cells & Canc Program, Barcelona, Spain; [Papadatos, George; Mugumbate, Grace; Overington, John P.] EMBL EBI, Cambridge, England; [Kumar, Vinod; Hurle, Mark; Brown, James R.] GlaxoSmithKline, Computat Biol, Quantitat Sci, Collegeville, PA USA; [Colmenarejo, Gonzalo] GlaxoSmithKline, Ctr Invest Basica, CSci Computat Chem, Madrid, Spain; [Young, Rob J.] GlaxoSmithKline, Med Res Ctr, CSC Med Chem, Stevenage, Herts, England; [Marti-Renom, Marc A.] ICREA, Barcelona, Spain; [Barroso, Vanessa; Alvarez-Ruiz, Emilio] GlaxoSmithKline, Ctr Invest Basica Platform Technol & Sci, Madrid, Spain	GlaxoSmithKline; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; ICREA; GlaxoSmithKline	Lelievre, J (corresponding author), GlaxoSmithKline, Dis Developing World, Madrid, Spain.	joel.l.lelievre@gsk.com; mmarti@pcb.ub.cat	Marti-Renom, Marc A./Y-8803-2019; Young, Robert/AAM-7439-2020; Colmenarejo, Gonzalo/Q-6535-2018; Mendoza-Losana, Alfonso/AAF-4383-2021; Overington, John/G-8607-2015	Marti-Renom, Marc A./0000-0002-0151-4279; Young, Robert/0000-0002-7763-0575; Colmenarejo, Gonzalo/0000-0002-8249-4547; Mendoza-Losana, Alfonso/0000-0003-2493-4118; Martinez-Jimenez, Francisco/0000-0001-7804-1134; Papadatos, George/0000-0002-8314-7061; Overington, John/0000-0002-5859-1064; Mugumbate, Grace/0000-0002-2829-9425; Brown, James/0000-0002-9368-627X; Ballell, Lluis/0000-0002-3029-1860	TB Alliance; European Union [261378]; ERA-NET Pathogenomics Project GeMoA [PIM2010EPA-00719]; GlaxoSmithKline; ICREA Funding Source: Custom	TB Alliance; European Union(European Commission); ERA-NET Pathogenomics Project GeMoA; GlaxoSmithKline(GlaxoSmithKline); ICREA(ICREA)	The research behind these results received funding from the TB Alliance, the European Union's 7th framework programme (FP7-2007-2013) under grant agreement ORCHID no. 261378 and the ERA-NET Pathogenomics Project GeMoA (PIM2010EPA-00719). Those funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder GlaxoSmithKline provided support in the form of salaries for authors [MJR, JL, DAG, JCP, GC, VB, RJY, MMH, RGR, RHB, EMLR, AML, JRB, EAR, NC. LB and DBA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The research behind these results received funding from the TB Alliance, the European Union's 7th framework programme (FP7-2007-2013) under grant agreement ORCHID no. 261378 and the ERA-NET Pathogenomics Project GeMoA (PIM2010EPA-00719). Marc A. MartiRenom (mmarti@pcb.ub.cat) is the Corresponding Author for computational analysis.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Analytical Methods Committee, 1989, ANALYST, V114, P1693, DOI 10.1039/AN9891401693; Andries K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102135; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Coma I, 2009, METHODS MOL BIOL, V565, P69, DOI 10.1007/978-1-60327-258-2_4; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hill AP, 2010, DRUG DISCOV TODAY, V15, P648, DOI 10.1016/j.drudis.2010.05.016; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Kalinina OV, 2012, NUCLEIC ACIDS RES, V40, pD549, DOI 10.1093/nar/gkr1049; Kalinina OV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002043; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; KANEHISA M., 2002, NOVART FDN SYMP, V247, P3; Konc J, 2010, NUCLEIC ACIDS RES, V38, pW436, DOI 10.1093/nar/gkq479; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Marti-Renom MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S4; Martinez-Jimenez F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004157; Martinez-Jimenez F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003253; Nathan C, 2015, IMMUNOL REV, V264, P308, DOI 10.1111/imr.12275; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Remuinan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060933; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Trefzer C, 2012, J AM CHEM SOC, V134, P912, DOI 10.1021/ja211042r; Valko K, 1997, ANAL CHEM, V69, P2022, DOI 10.1021/ac961242d; Warrier T, 2015, IDENTIFICATION NOVEL; WHO, 2014, GLOB TUB REP 2014; Young RJ, 2011, DRUG DISCOV TODAY, V16, P822, DOI 10.1016/j.drudis.2011.06.001	33	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142293	10.1371/journal.pone.0142293	http://dx.doi.org/10.1371/journal.pone.0142293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642067	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700008
J	Ohmayer, U; Gil-Hernandez, A; Sauert, M; Martin-Marcos, P; Tamame, M; Tschochner, H; Griesenbeck, J; Milkereit, P				Ohmayer, Uli; Gil-Hernandez, Alvaro; Sauert, Martina; Martin-Marcos, Pilar; Tamame, Mercedes; Tschochner, Herbert; Griesenbeck, Joachim; Milkereit, Philipp			Studies on the Coordination of Ribosomal Protein Assembly Events Involved in Processing and Stabilization of Yeast Early Large Ribosomal Subunit Precursors	PLOS ONE			English	Article							PUTATIVE RNA HELICASE; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC RIBOSOME; ANGSTROM RESOLUTION; IN-VIVO; NUCLEAR EXPORT; PRE-RIBOSOME; BIOGENESIS; MATURATION; DYNAMICS	Cellular production of ribosomes involves the formation of highly defined interactions between ribosomal proteins (r-proteins) and ribosomal RNAs (rRNAs). Moreover in eukaryotic cells, efficient ribosome maturation requires the transient association of a large number of ribosome biogenesis factors (RBFs) with newly forming ribosomal subunits. Here, we investigated how r-protein assembly events in the large ribosomal subunit (LSU) rRNA domain II are coordinated with each other and with the association of RBFs in early LSU precursors of the yeast Saccharomyces cerevisiae. Specific effects on the pre-ribosomal association of RBFs could be observed in yeast mutants blocked in LSU rRNA domain II assembly. Moreover, formation of a cluster of r-proteins was identified as a downstream event in LSU rRNA domain II assembly. We analyzed in more detail the functional relevance of eukaryote specific bridges established by this r-protein cluster between LSU rRNA domain II and VI and discuss how they can support the stabilization and efficient processing of yeast early LSU precursor RNAs.	[Ohmayer, Uli; Sauert, Martina; Tschochner, Herbert; Griesenbeck, Joachim; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany; [Gil-Hernandez, Alvaro; Martin-Marcos, Pilar; Tamame, Mercedes] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	University of Regensburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Tamame, M (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain.	tamame@usal.es; Herbert.Tschochner@vkl.uni-regensburg.de; Joachim.Griesenbeck@vkl.uni-regensburg.de; Philipp.Milkereit@vkl.uni-regensburg.de		Tamame, Mercedes/0000-0002-6484-0346; Sauert, Martina/0000-0002-2179-9515; Griesenbeck, Joachim/0000-0002-7817-6095	collaborative research center from "Deutsche Forschungsgemeinschaft" [SFB 960]; CSIC JAE Predoc Fellowship from Spanish Research Council CSIC; EMBO Short Term Fellowship [ASTF 266-2013]; Spanish Ministry of Economy and Competitiveness (MINECO) [IPT-2012-1321-06000]	collaborative research center from "Deutsche Forschungsgemeinschaft"(German Research Foundation (DFG)); CSIC JAE Predoc Fellowship from Spanish Research Council CSIC; EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Spanish Ministry of Economy and Competitiveness (MINECO)	This work was supported by a grant which was given in the collaborative research center SFB 960, from the "Deutsche Forschungsgemeinschaft" (www.dfg.de) to JG, HT and PM. AGH acknowledges support through a CSIC JAE Predoc Fellowship from the Spanish Research Council CSIC and an EMBO Short Term Fellowship (ASTF 266-2013). PMM and MT were supported in part by project IPT-2012-1321-06000, granted by the Spanish Ministry of Economy and Competitiveness (MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2013, NUCLEIC ACIDS RES, V41, P1284, DOI 10.1093/nar/gks1259; Babiano R, 2013, NUCLEIC ACIDS RES, V41, P9461, DOI 10.1093/nar/gkt726; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2014, J CELL BIOL, V207, P481, DOI 10.1083/jcb.201408111; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; de la Cruz J, 1998, RNA, V4, P1268, DOI 10.1017/S1355838298981158; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Dembowski JA, 2013, RNA, V19, P1639, DOI 10.1261/rna.041194.113; Dembowski JA, 2013, NUCLEIC ACIDS RES, V41, P7889, DOI 10.1093/nar/gkt545; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez-Pevida A, 2015, WIRES RNA, V6, P191, DOI 10.1002/wrna.1267; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gamalinda M, 2014, RNA, V20, P1725, DOI 10.1261/rna.046649.114; Gamalinda M, 2014, GENE DEV, V28, P198, DOI 10.1101/gad.228825.113; Gamalinda M, 2013, NUCLEIC ACIDS RES, V41, P1965, DOI 10.1093/nar/gks1272; Gerhardy S, 2014, CHROMOSOMA, V123, P327, DOI 10.1007/s00412-014-0463-z; Graifer D, 2015, BIOCHIMIE, V109, P1, DOI 10.1016/j.biochi.2014.11.016; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Hector RD, 2014, NUCLEIC ACIDS RES, V42, P12138, DOI 10.1093/nar/gku815; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hierlmeier T, 2013, NUCLEIC ACIDS RES, V41, P1191, DOI 10.1093/nar/gks1056; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Jakob S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032552; Jakovljevic J, 2012, RNA, V18, P1805, DOI 10.1261/rna.032540.112; Jeeninga RE, 1997, RNA, V3, P476; Johnson AW, 2001, METHOD ENZYMOL, V342, P260, DOI 10.1016/S0076-6879(01)42550-X; Garcia-Gomez JJ, 2011, MOL CELL BIOL, V31, P4156, DOI 10.1128/MCB.05436-11; Kaser A, 2001, BIOL CHEM, V382, P1637, DOI 10.1515/BC.2001.199; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; Lapeyre B, 2004, MOL CELL, V16, P663, DOI 10.1016/j.molcel.2004.10.022; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Lebreton A, 2006, J BIOL CHEM, V281, P27099, DOI 10.1074/jbc.M602199200; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; McCann KL, 2015, GENE DEV, V29, P862, DOI 10.1101/gad.256370.114; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Ohmayer U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068412; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Pillet B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005565; Pintard L, 2000, MOL CELL BIOL, V20, P1370, DOI 10.1128/MCB.20.4.1370-1381.2000; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Polikanov YS, 2014, NAT STRUCT MOL BIOL, V21, P787, DOI 10.1038/nsmb.2871; Pratte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082741; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sentenac A, 2013, BBA-GENE REGUL MECH, V1829, P251, DOI 10.1016/j.bbagrm.2012.10.012; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Talkish J, 2014, MOL CELL BIOL, V34, P1863, DOI 10.1128/MCB.01322-13; VANNUES RW, 1995, J MOL BIOL, V250, P24, DOI 10.1006/jmbi.1995.0355; Venema J, 1998, METH MOL B, V77, P257; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wan K, 2015, CURR GENET, V61, P31, DOI 10.1007/s00294-014-0442-1; Wang MS, 2015, RNA, V21, P1240, DOI 10.1261/rna.051169.115; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445	67	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143768	10.1371/journal.pone.0143768	http://dx.doi.org/10.1371/journal.pone.0143768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642313	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700028
J	Pietralik, Z; Kolodziejska, Z; Weiss, M; Kozak, M				Pietralik, Zuzanna; Kolodziejska, Zaneta; Weiss, Marek; Kozak, Maciej			Gemini Surfactants Based on Bis-Imidazolium Alkoxy Derivatives as Effective Agents for Delivery of Nucleic Acids: A Structural and Spectroscopic Study	PLOS ONE			English	Article							GENE-THERAPY; BROMIDE) SURFACTANTS; AQUEOUS-SOLUTION; CATIONIC LIPIDS; PLASMID DNA; SPACER; LIPOPLEXES; COMPLEXES; BEHAVIOR; CONDENSATION	The success rate of gene therapy depends on the efficient transfection of genetic material into cells. The golden mean between harmlessness and high effectiveness can be provided by synthetic lipid-like molecules that are similar to the components of biological membranes. Cationic gemini surfactants are one such moiety and because of their favourable physicochemical properties (double positive electric charge, reduced toxicity, low values of critical micelle concentration), they show great potential as delivery system components for genetic material in gene therapy. The aim of this study was to investigate the process of the complexation of cationic gemini surfactants with nucleic acids: double-stranded DNA of different sizes (21 bp, similar to 185 bp, similar to 20 kbp) and siRNA (21 bp). The tested series of dicationic surfactants consists of bis-imidazolium quaternary salts with varying lengths of hydrophobic side chains (m = 5, 6, 7, 8, 9, 11, 12, 14, 16). On the basis of the data obtained by circular dichroism spectroscopy and electrophoresis, we concluded that the studied gemini surfactants with long side chains effectively bind nucleic acids at low concentrations, which leads to the formation of stable lipoplexes. Images obtained by atomic force microscopy also confirmed the formation of vesicular structures, i.e., complexes between DNA and surfactants. The cytotoxicity of selected surfactants was also tested on HeLa cells. The surfactant toxicity significantly depends on surfactant geometry (the length of hydrophobic chain).	[Pietralik, Zuzanna; Kolodziejska, Zaneta; Kozak, Maciej] Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, PL-61614 Poznan, Poland; [Weiss, Marek] Poznan Univ Tech, Inst Phys, PL-60965 Poznan, Poland; [Kozak, Maciej] Adam Mickiewicz Univ, Fac Phys, Joint Lab SAXS Studies, PL-61614 Poznan, Poland	Adam Mickiewicz University; Poznan University of Technology; Adam Mickiewicz University	Kozak, M (corresponding author), Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, Umultowska 85, PL-61614 Poznan, Poland.	mkozak@amu.edu.pl	Pietralik-Molińska, Zuzanna/AAE-8265-2021; Weiss, Marek/M-8296-2014	Weiss, Marek/0000-0001-9539-138X; Kozak, Maciej/0000-0003-3312-6518	National Science Centre (Poland) [DEC-2011/01/B/ST5/00846]; Ministry of Science and Higher Education in Poland [06/62/DSPB/0215]	National Science Centre (Poland); Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland)	This research has been financed by the National Science Centre (Poland) with funds granted pursuant to decision no. DEC-2011/01/B/ST5/00846. M.W. thanks the Ministry of Science and Higher Education in Poland for financial support within Project No. 06/62/DSPB/0215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcik J, 2006, FEBS LETT, V580, P5671, DOI 10.1016/j.febslet.2006.09.017; [Anonymous], OPT PROT HELA CELLS; Badea I, 2005, J GENE MED, V7, P1200, DOI 10.1002/jgm.763; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Barran-Berdon AL, 2014, J MATER CHEM B, V2, P4640, DOI 10.1039/c4tb00389f; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Belletti D, 2013, COLLOID SURFACE A, V436, P459, DOI 10.1016/j.colsurfa.2013.07.021; Bello-Roufai M, 2007, NUCLEIC ACIDS RES, V35, P728, DOI 10.1093/nar/gkl860; Bombelli C, 2005, LANGMUIR, V21, P10271, DOI 10.1021/la051324+; Braun CS, 2001, ULTRAVIOLET ABSORPTI, P253; Chen GX, 2014, ONCOTARGETS THER, V7, P1901, DOI 10.2147/OTT.S50483; Dan N, 2014, ADV COLLOID INTERFAC, V205, P230, DOI 10.1016/j.cis.2014.01.013; Donkuru M, 2010, NANOMEDICINE-UK, V5, P1103, DOI [10.2217/nnm.10.80, 10.2217/NNM.10.80]; Emery DE, 2004, CLIN APPL IMMUNOL RE, V4, P411; Falsini S, 2014, SOFT MATTER, V10, P2226, DOI 10.1039/c3sm52429a; Gandhi NS, 2014, J CONTROL RELEASE, V194, P238, DOI 10.1016/j.jconrel.2014.09.001; Giacca M, 2012, J CONTROL RELEASE, V161, P377, DOI 10.1016/j.jconrel.2012.04.008; Ibraheem D, 2014, INT J PHARMACEUT, V459, P70, DOI 10.1016/j.ijpharm.2013.11.041; Ilies MA, 2006, J MED CHEM, V49, P3872, DOI 10.1021/jm0601755; In M, 2007, J DISPER SCI TECHNOL, V28, P143, DOI 10.1080/01932690600991888; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kamboj R, 2012, LANGMUIR, V28, P11969, DOI 10.1021/la300920p; Karlsson L, 2002, J COLLOID INTERF SCI, V252, P290, DOI 10.1006/jcis.2002.8477; Khatri N, 2012, J PHARM BIOALLIED SC, V4, pS1, DOI 10.4103/0975-7406.94115; Kirby AJ, 2003, ANGEW CHEM INT EDIT, V42, P1448, DOI 10.1002/anie.200201597; Kumar K, 2015, J MATER CHEM B, V3, P1495, DOI 10.1039/c4tb01948b; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110; Luciani P, 2007, BIOMACROMOLECULES, V8, P1999, DOI 10.1021/bm070202o; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munoz-Ubeda M, 2012, BIOMACROMOLECULES; Munoz-Ubeda M, 2012, BIOMACROMOLECULES, V13, P3926, DOI 10.1021/bm301066w; Munoz-Ubeda M, 2011, J AM CHEM SOC, V133, P18014, DOI 10.1021/ja204693f; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; O'Mahony AM, 2014, J PHARM SCI-US, V103, P1346, DOI 10.1002/jps.23922; Pietralik Z, 2010, ACTA PHYS POL A, V117, P311, DOI 10.12693/APhysPolA.117.311; Pietralik Z, 2015, COLLOID SURFACE B, V131, P83, DOI 10.1016/j.colsurfb.2015.04.042; Pietralik Z, 2013, INT J MOL SCI, V14, P7642, DOI 10.3390/ijms14047642; Ristori S, 2012, SOFT MATTER, V8, P749, DOI 10.1039/c1sm06470c; Rosenzweig HS, 2001, BIOCONJUGATE CHEM, V12, P258, DOI 10.1021/bc000099z; Sharma VD, 2014, MED RES REV, V34, P1, DOI 10.1002/med.21272; Verma M, 2012, J PERS MED, V2, P1, DOI 10.3390/jpm2010001; Wang CZ, 2007, PHYS CHEM CHEM PHYS, V9, P1616, DOI 10.1039/b618579g; Wettig SD, 2007, J GENE MED, V9, P649, DOI 10.1002/jgm.1060; Zana R, 2002, ADV COLLOID INTERFAC, V97, P205, DOI 10.1016/S0001-8686(01)00069-0; Zana R, 2002, J COLLOID INTERF SCI, V246, P182, DOI 10.1006/jcis.2001.7921; ZANA R, 1991, LANGMUIR, V7, P1072, DOI 10.1021/la00054a008; Zhao XF, 2008, CHINESE J CHEM ENG, V16, P923, DOI 10.1016/S1004-9541(09)60017-3; Zhou T, 2012, COLLOID SURFACE A, V414, P33, DOI 10.1016/j.colsurfa.2012.08.060	51	16	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144373	10.1371/journal.pone.0144373	http://dx.doi.org/10.1371/journal.pone.0144373			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641889	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700106
J	Bajaj, H; Scorciapino, MA; Moynie, L; Page, MGP; Naismith, JH; Ceccarelli, M; Winterhalter, M				Bajaj, Harsha; Scorciapino, Mariano A.; Moynie, Lucile; Page, Malcolm G. P.; Naismith, James H.; Ceccarelli, Matteo; Winterhalter, Mathias			Molecular Basis of Filtering Carbapenems by Porins from beta-Lactam-resistant Clinical Strains of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; ANTIBACTERIAL RESISTANCE; ANTIBIOTICS; MECHANISM; DYNAMICS; CHANNEL; PROTEIN; OMPF; RECONSTRUCTION; TRANSLOCATION	Integral membrane proteins known as porins are the major pathway by which hydrophilic antibiotics cross the outer membrane of Gram-negative bacteria. Single point mutations in porins can decrease the permeability of an antibiotic, either by reduction of channel size or modification of electrostatics in the channel, and thereby confer clinical resistance. Here, we investigate four mutant OmpC proteins from four different clinical isolates of Escherichia coli obtained sequentially from a single patient during a course of antimicrobial chemotherapy. OmpC porin from the first isolate (OmpC20) undergoes three consecutive and additive substitutions giving rise to OmpC26, OmpC28, and finally OmpC33. The permeability of two zwitterionic carbapenems, imipenem and meropenem, measured using liposome permeation assays and single channel electrophysiology differs significantly between OmpC20 and OmpC33. Molecular dynamic simulations show that the antibiotics must pass through the constriction zone of porins with a specific orientation, where the antibiotic dipole is aligned along the electric field inside the porin. We identify that changes in the vector of the electric field in the mutated porin, OmpC33, create an additional barrier by "trapping" the antibiotic in an unfavorable orientation in the constriction zone that suffers steric hindrance for the reorientation needed for its onward translocation. Identification and understanding the underlying molecular details of such a barrier to translocation will aid in the design of new antibiotics with improved permeation properties in Gram-negative bacteria.	[Bajaj, Harsha; Winterhalter, Mathias] Jacobs Univ Bremen, Sch Sci & Engn, Campus Ring 1, D-28759 Bremen, Germany; [Scorciapino, Mariano A.; Ceccarelli, Matteo] Univ Cagliari, Dept Phys, SP Monserrato Sestu Km 0-700, I-09042 Monserrato, CA, Italy; [Moynie, Lucile; Naismith, James H.] Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Page, Malcolm G. P.] Basilea Pharmaceut Int Ltd, Grenzacherstr 487, CH-4058 Basel, Switzerland	Jacobs University; University of Cagliari; University of St Andrews; Basilea Pharmaceutica Ltd.	Winterhalter, M (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Campus Ring 1, D-28759 Bremen, Germany.; Ceccarelli, M (corresponding author), Univ Cagliari, Dept Phys, SP Monserrato Sestu Km 0-700, I-09042 Monserrato, CA, Italy.	matteo.ceccarelli@dsf.unica.it; m.winterhalter@jacobs-university.de	Naismith, James Henderson/H-3408-2012; Scorciapino, Mariano Andrea/AAD-1256-2020; Ceccarelli, Matteo/C-8557-2018; Naismith, James Henderson/AAB-8614-2020; Bajaj, Harsha/AAA-1483-2020	Naismith, James Henderson/0000-0001-6744-5061; Ceccarelli, Matteo/0000-0003-4272-902X; Naismith, James Henderson/0000-0001-6744-5061; Bajaj, Harsha/0000-0001-5422-5182; SCORCIAPINO, MARIANO ANDREA/0000-0001-7502-7265; Moynie, Lucile/0000-0002-4097-4331; Winterhalter, Mathias/0000-0002-1604-3318	Innovative Medicines Initiatives Joint Undertaking Grant [15525]; European Union's seventh framework program; EFPIA	Innovative Medicines Initiatives Joint Undertaking Grant; European Union's seventh framework program; EFPIA	The work was conducted as part of the "Translocation" consortium and supported by Innovative Medicines Initiatives Joint Undertaking Grant 15525, resources which are composed of financial contribution from the European Union's seventh framework program (FP7/2007-2013) and EFPIA. The authors declare that they have no conflicts of interest with the contents of this article.	Acosta-Gutierrez S, 2015, J PHYS CHEM LETT, V6, P1807, DOI 10.1021/acs.jpclett.5b00612; [Anonymous], BIOCHEMISTRY, V49, P6928; Bajaj H, 2012, BIOCHEMISTRY-US, V51, P10244, DOI 10.1021/bi301398j; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; Benz R., 2004, BACTERIAL EUKARYOTIC, DOI [10.1002/3527603875, DOI 10.1002/3527603875]; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Case D. A., 2006, AMBER 9; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001; Frisch M.J., 2016, GAUSSIAN16 REV B01; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Isabella VM, 2015, CHEM BIOL, V22, P535, DOI 10.1016/j.chembiol.2015.03.018; JEANTEUR D, 1994, P NATL ACAD SCI USA, V91, P10675, DOI 10.1073/pnas.91.22.10675; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kumar A, 2010, J PHYS CHEM B, V114, P9608, DOI 10.1021/jp9110579; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lou H., 2011, J BIOL CHEM, V6; Low AS, 2001, MOL MICROBIOL, V42, P619, DOI 10.1046/j.1365-2958.2001.02647.x; Mahendran KR, 2010, J PHYS CHEM B, V114, P5170, DOI 10.1021/jp911485k; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; NAKAE T, 1976, J BIOL CHEM, V251, P2176; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Tran QT, 2013, PROTEINS, V81, P291, DOI 10.1002/prot.24185; Raiteri P, 2006, J PHYS CHEM B, V110, P3533, DOI 10.1021/jp054359r; Singh PR, 2012, J PHYS CHEM B, V116, P4433, DOI 10.1021/jp2123136; Stavenger RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008605; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Tran QT, 2014, PROTEINS, V82, P2998, DOI 10.1002/prot.24659; TRIAS J, 1989, ANTIMICROB AGENTS CH, V33, P1201, DOI 10.1128/AAC.33.8.1202; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84	43	50	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2837	2847		10.1074/jbc.M115.690156	http://dx.doi.org/10.1074/jbc.M115.690156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26645688	hybrid, Green Published			2022-12-26	WOS:000369626900023
J	ter Horst, AC; Koppen, M; Selen, LPJ; Medendorp, WP				ter Horst, Arjan C.; Koppen, Mathieu; Selen, Luc P. J.; Medendorp, W. Pieter			Reliability-Based Weighting of Visual and Vestibular Cues in Displacement Estimation	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; LINEAR DISPLACEMENT; HEADING PERCEPTION; MULTISENSORY INTEGRATION; SPATIAL MEMORY; OPTIC FLOW; DISTANCE; MSTD; DISCRIMINATION; ACCELERATION	When navigating through the environment, our brain needs to infer how far we move and in which direction we are heading. In this estimation process, the brain may rely on multiple sensory modalities, including the visual and vestibular systems. Previous research has mainly focused on heading estimation, showing that sensory cues are combined by weighting them in proportion to their reliability, consistent with statistically optimal integration. But while heading estimation could improve with the ongoing motion, due to the constant flow of information, the estimate of how far we move requires the integration of sensory information across the whole displacement. In this study, we investigate whether the brain optimally combines visual and vestibular information during a displacement estimation task, even if their reliability varies from trial to trial. Participants were seated on a linear sled, immersed in a stereoscopic virtual reality environment. They were subjected to a passive linear motion involving visual and vestibular cues with different levels of visual coherence to change relative cue reliability and with cue discrepancies to test relative cue weighting. Participants performed a two-interval two-alternative forced-choice task, indicating which of two sequentially perceived displacements was larger. Our results show that humans adapt their weighting of visual and vestibular information from trial to trial in proportion to their reliability. These results provide evidence that humans optimally integrate visual and vestibular information in order to estimate their body displacement.	[ter Horst, Arjan C.; Koppen, Mathieu; Selen, Luc P. J.; Medendorp, W. Pieter] Radboud Univ Nijmegen, Donders Insitute Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	ter Horst, AC (corresponding author), Radboud Univ Nijmegen, Donders Insitute Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.terhorst@donders.ru.nl	Medendorp, W. Pieter/A-7369-2010; Selen, Luc/A-6066-2009	Medendorp, W. Pieter/0000-0001-9615-4220; Selen, Luc/0000-0001-5774-5415	European Research Council [EU-ERC 283567]; Netherlands Organisation for Scientific Research [NWO-VICI: 453-11-001, NWOVENI: 451-10-017]	European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work is supported by grants from the European Research Council (EU-ERC 283567) and the Netherlands Organisation for Scientific Research (NWO-VICI: 453-11-001; NWOVENI: 451-10-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Angelaki DE, 2011, J PHYSIOL-LONDON, V589, P825, DOI 10.1113/jphysiol.2010.194720; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; BERTHOZ A, 1995, SCIENCE, V269, P95, DOI 10.1126/science.7604286; Bremmer F, 1999, EXP BRAIN RES, V127, P33, DOI 10.1007/s002210050771; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Campos JL, 2012, EXP BRAIN RES, V218, P551, DOI 10.1007/s00221-012-3048-1; Campos JL, 2012, FRONTIERS NEUROSCIEN; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; Drugowitsch J, 2014, ELIFE, V3, DOI 10.7554/eLife.03005; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fetsch CR, 2011, SENSORY CUE INTEGRAT; Frenz H, 2005, VISION RES, V45, P1679, DOI 10.1016/j.visres.2004.12.019; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; ISRAEL I, 1993, J NEUROPHYSIOL, V70, P1270, DOI 10.1152/jn.1993.70.3.1270; ISRAEL I, 1989, J NEUROPHYSIOL, V62, P247, DOI 10.1152/jn.1989.62.1.247; Israel I, 1997, J NEUROPHYSIOL, V77, P3180, DOI 10.1152/jn.1997.77.6.3180; Kingma H, 2005, BMC EAR NOSE THROAT, V5, DOI 10.1186/1472-6815-5-5; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; Redlick FP, 2001, VISION RES, V41, P213, DOI 10.1016/S0042-6989(00)00243-1; Sun HJ, 2004, EXP BRAIN RES, V154, P246, DOI 10.1007/s00221-003-1652-9; Wright WG, 2005, J VESTIBUL RES-EQUIL, V15, P185	32	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145015	10.1371/journal.pone.0145015	http://dx.doi.org/10.1371/journal.pone.0145015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658990	Green Published, gold			2022-12-26	WOS:000366715900168
J	Weis, C; Hess, A; Budinsky, L; Fabry, B				Weis, Christian; Hess, Andreas; Budinsky, Lubos; Fabry, Ben			In-Vivo Imaging of Cell Migration Using Contrast Enhanced MRI and SVM Based Post-Processing	PLOS ONE			English	Article							LYMPH-NODES; TRACKING; NANOPARTICLES; CANCER	The migration of cells within a living organism can be observed with magnetic resonance imaging (MRI) in combination with iron oxide nanoparticles as an intracellular contrast agent. This method, however, suffers from low sensitivity and specificty. Here, we developed a quantitative non-invasive in-vivo cell localization method using contrast enhanced multiparametric MRI and support vector machines (SVM) based post-processing. Imaging phantoms consisting of agarose with compartments containing different concentrations of cancer cells labeled with iron oxide nanoparticles were used to train and evaluate the SVM for cell localization. From the magnitude and phase data acquired with a series of T-2(+)-weighted gradient-echo scans at different echo-times, we extracted features that are characteristic for the presence of superparamagnetic nanoparticles, in particular hyper-and hypointensities, relaxation rates, short-range phase perturbations, and perturbation dynamics. High detection quality was achieved by SVM analysis of the multiparametric featurespace. The in-vivo applicability was validated in animal studies. The SVM detected the presence of iron oxide nanoparticles in the imaging phantoms with high specificity and sensitivity with a detection limit of 30 labeled cells per mm(3), corresponding to 19 mu M of iron oxide. As proof-of-concept, we applied the method to follow the migration of labeled cancer cells injected in rats. The combination of iron oxide labeled cells, multiparametric MRI and a SVM based post processing provides high spatial resolution, specificity, and sensitivity, and is therefore suitable for non-invasive in-vivo cell detection and cell migration studies over prolonged time periods.	[Weis, Christian; Fabry, Ben] Univ Erlangen Nurnberg, Biophys Grp, D-91054 Erlangen, Germany; [Weis, Christian] Univ Heidelberg Hosp, Clin Diagnost & Intervent Radiol, Heidelberg, Germany; [Hess, Andreas; Budinsky, Lubos] Univ Erlangen Nurnberg, Pharmacol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Weis, C (corresponding author), Univ Erlangen Nurnberg, Biophys Grp, D-91054 Erlangen, Germany.	christian.weis@med.uni-heidelberg.de	Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Budinsky, Lubos/0000-0003-2171-0098				Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Foster P, 2008, NEOPLASIA, V10, P207, DOI 10.1593/neo.07937; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hahn DA, 2010, IEEE T MED IMAGING, V29, P1140, DOI 10.1109/TMI.2010.2041358; Hong H, 2010, CURR TOP MED CHEM, V10, P1237, DOI 10.2174/156802610791384234; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Kovesi P, 2000, PSYCHOL RES-PSYCH FO, V64, P136, DOI 10.1007/s004260000024; Li BN, 2011, COMPUT BIOL MED, V41, P1, DOI 10.1016/j.compbiomed.2010.10.007; Liu TA, 2010, MAGN RESON IMAGING, V28, P1383, DOI 10.1016/j.mri.2010.06.011; Long CM, 2009, EXPERT OPIN BIOL TH, V9, P293, DOI 10.1517/14712590802715723 ; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Wang Paul C, 2012, J Basic Clin Med, V1, P1; Weis C, 2014, MAGN RESON MED, V71, P1896, DOI 10.1002/mrm.24832	22	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0140548	10.1371/journal.pone.0140548	http://dx.doi.org/10.1371/journal.pone.0140548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656497	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900002
J	Kang, JI; Hong, JY; Lee, HJ; Bae, SY; Jung, C; Park, HJ; Lee, SK				Kang, Ji In; Hong, Ji-Young; Lee, Hye-Jung; Bae, Song Yi; Jung, Cholomi; Park, Hyen Joo; Lee, Sang Kook			Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL-MESENCHYMAL TRANSITIONS; POTENT INHIBITORY-ACTIVITY; DAPHNANE DITERPENE ESTERS; COA-CARBOXYLASE-ALPHA; DNA TOPOISOMERASE-I; MTOR COMPLEX; GROWTH; DISEASE; GENKWA	Yuanhuacine (YC), a daphnane diterpenoid from the flowers of Daphne genkwa, exhibited a potential growth inhibitory activity against human non-small cell lung cancer (NSCLC) cells. YC also suppressed the invasion and migration of lung cancer cells. However, the precise molecular mechanisms remain to be elucidated. In the present study, we report that YC significantly activated AMP-activated protein kinase (AMPK) signaling pathway and suppressed mTORC2-mediated downstream signaling pathway in H1993 human NSCLC cells. AMPK plays an important role in energy metabolism and cancer biology. Therefore, activators of AMPK signaling pathways can be applicable to the treatment of cancer. YC enhanced the expression of p-AMPK alpha. The co-treatment of YC and compound C (an AMPK inhibitor) or metformin (an AMPK activator) also confirmed that YC increases p-AMPK alpha. YC also suppressed the activation of the mammalian target of rapamycin (mTOR) expression, a downstream target of AMPK. Further study revealed that YC modulatesm TORC2-associated downstream signaling pathways with a decreased expressions of p-Akt, p-protein kinase C alpha (PKC alpha), p-ras-related C3 botulinum toxin substrate 1 (Rac1) and filamentous actin (F-actin) that are known to activate cell growth and organize actin cytoskeleton. In addition, YC inhibited the tumor growth in H1993 cell-implanted xenograft nude mouse model. These data suggest the YC could be a potential candidate for cancer chemotherapeutic agents derived from natural products by regulating AMPK/mTORC2 signaling pathway and actin cytoskeleton organization.	[Kang, Ji In; Hong, Ji-Young; Lee, Hye-Jung; Bae, Song Yi; Jung, Cholomi; Park, Hyen Joo; Lee, Sang Kook] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea	Seoul National University (SNU)	Lee, SK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea.	sklee61@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2012389, 20100024361]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2013R1A1A2012389 and No. 20100024361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; HALL IH, 1982, J PHARM SCI, V71, P1263, DOI 10.1002/jps.2600711120; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; He WD, 2002, MINI-REV MED CHEM, V2, P185, DOI 10.2174/1389557024605492; Hong JY, 2010, CHEM PHARM BULL, V58, P234, DOI 10.1248/cpb.58.234; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Hwang HJ, 2006, J NUTR BIOCHEM, V17, P356, DOI 10.1016/j.jnutbio.2005.08.009; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim GD, 2013, MAR DRUGS, V11, P1087, DOI 10.3390/md11041087; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li JN, 2001, CANCER RES, V61, P1493; Lin YC, 2010, J AGR FOOD CHEM, V58, P9511, DOI 10.1021/jf1019533; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Mooney MH, 2008, BRIT J PHARMACOL, V153, P1669, DOI 10.1038/bjp.2008.37; Park BY, 2007, J ETHNOPHARMACOL, V111, P496, DOI 10.1016/j.jep.2006.12.023; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shane ER, 2013, J CHIROPR MED, V12, P252, DOI 10.1016/j.jcm.2013.08.001; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Spiro SG, 2010, RESPIROLOGY, V15, P44, DOI 10.1111/j.1440-1843.2009.01674.x; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Suzuki A, 2005, J BIOL CHEM, V280, P31557, DOI 10.1074/jbc.M503714200; Tang W, 1992, CHINESE DRUGS PLANT, P429, DOI DOI 10.1007/978-3-642-73739-8_54; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhan ZJ, 2005, BIOORGAN MED CHEM, V13, P645, DOI 10.1016/j.bmc.2004.10.054; Zhang RW, 2014, J BIOL CHEM, V289, P6394, DOI 10.1074/jbc.M113.513960; Zhang SX, 2006, BIOORGAN MED CHEM, V14, P3888, DOI 10.1016/j.bmc.2006.01.055; Zhang SX, 2009, J DRUG TARGET, V17, P286, DOI 10.1080/10611860902737912	50	20	22	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144368	10.1371/journal.pone.0144368	http://dx.doi.org/10.1371/journal.pone.0144368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656173	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600039
J	Omer, T; Intes, X; Hahn, J				Omer, Travis; Intes, Xavier; Hahn, Juergen			Temporal Data Set Reduction Based on D-Optimality for Quantitative FLIM-FRET Imaging	PLOS ONE			English	Article							WIDE-FIELD ILLUMINATION; PHASOR APPROACH; PROTEIN INTERACTIONS; TIME-DOMAIN; FLUORESCENCE; TOMOGRAPHY; MICROSCOPY; ACTIVATION; DESIGN; PAIR	Fluorescence lifetime imaging (FLIM) when paired with Forster resonance energy transfer (FLIM-FRET) enables the monitoring of nanoscale interactions in living biological samples. FLIM-FRET model-based estimation methods allow the quantitative retrieval of parameters such as the quenched (interacting) and unquenched (non-interacting) fractional populations of the donor fluorophore and/or the distance of the interactions. The quantitative accuracy of such model-based approaches is dependent on multiple factors such as signal-to-noise ratio and number of temporal points acquired when sampling the fluorescence decays. For high-throughput or in vivo applications of FLIM-FRET, it is desirable to acquire a limited number of temporal points for fast acquisition times. Yet, it is critical to acquire temporal data sets with sufficient information content to allow for accurate FLIM-FRET parameter estimation. Herein, an optimal experimental design approach based upon sensitivity analysis is presented in order to identify the time points that provide the best quantitative estimates of the parameters for a determined number of temporal sampling points. More specifically, the D-optimality criterion is employed to identify, within a sparse temporal data set, the set of time points leading to optimal estimations of the quenched fractional population of the donor fluorophore. Overall, a reduced set of 10 time points (compared to a typical complete set of 90 time points) was identified to have minimal impact on parameter estimation accuracy (approximate to 5%), with in silico and in vivo experiment validations. This reduction of the number of needed time points by almost an order of magnitude allows the use of FLIM-FRET for certain high-throughput applications which would be infeasible if the entire number of time sampling points were used.	[Omer, Travis; Intes, Xavier; Hahn, Juergen] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Hahn, Juergen] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Hahn, J (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.	hahnj@rpi.edu	Hahn, Juergen/H-8025-2019	Hahn, Juergen/0000-0002-1078-4203	National Science Foundation [CBET 0941313, CBET 1149407]; National Institute of Health [R01 AI110642, R01 EB19443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB019443] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1149407] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (http://www.nsf.gov/) under awards CBET 0941313 (TO, JH) and CBET 1149407 (XI) and National Institute of Health (http://www.nih.gov/) Grants R01 AI110642 (JH) and R01 EB19443 (XI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080269; Atkinson AC., 2007, OPTIMUM EXPT DESIGNS; Barroso MM, 2011, J HISTOCHEM CYTOCHEM, V59, P237, DOI 10.1369/0022155411398487; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bonami P, 2008, DISCRETE OPTIM, V5, P186, DOI 10.1016/j.disopt.2006.10.011; Chang CW, 2007, METHOD CELL BIOL, V81, P495, DOI 10.1016/S0091-679X(06)81024-1; Chen J, 2011, MED PHYS, V38, P5788, DOI 10.1118/1.3641827; Chen J, 2011, BIOMED OPT EXPRESS, V2, P871, DOI 10.1364/BOE.2.000871; Chen Y, 2003, REV SCI INSTRUM, V74, P3466, DOI 10.1063/1.1583864; Cubeddu R, 2002, J PHYS D APPL PHYS, V35, pR61, DOI 10.1088/0022-3727/35/9/201; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dette H, 1997, J ROY STAT SOC B MET, V59, P97, DOI 10.1111/1467-9868.00056; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Ducros N, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020503; Elangovan M, 2002, J MICROSC-OXFORD, V205, P3, DOI 10.1046/j.0022-2720.2001.00984.x; Fereidouni F, 2013, OPT EXPRESS, V21, P11769, DOI 10.1364/OE.21.011769; Franceschini G, 2008, CHEM ENG SCI, V63, P4846, DOI 10.1016/j.ces.2007.11.034; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Hinde E, 2013, P NATL ACAD SCI USA, V110, P135, DOI 10.1073/pnas.1211882110; Keller SB, 2008, ANAL CHEM, V80, P7876, DOI 10.1021/ac801252q; Khinkis Leonid A, 2003, Nonlinearity Biol Toxicol Med, V1, P363, DOI 10.1080/15401420390249925; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Kumar S, 2011, CHEMPHYSCHEM, V12, P609, DOI 10.1002/cphc.201000874; Lakowicz J.R., 2006, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LAKOWICZ JR, 1994, CELL CALCIUM, V15, P7, DOI 10.1016/0143-4160(94)90100-7; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Leray A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069335; Lewis GA, 1998, PHARM EXPT DESIGN; Luo KQ, 2001, BIOCHEM BIOPH RES CO, V283, P1054, DOI 10.1006/bbrc.2001.4896; Masters BR, 2010, ENCY LIFE SCI ELS, DOI DOI 10.1002/9780470015902.A0022093; McGinty J, 2011, BIOMED OPT EXPRESS, V2, P1907, DOI 10.1364/BOE.2.001907; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Muller HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097540; Niedre MJ, 2008, P NATL ACAD SCI USA, V105, P19126, DOI 10.1073/pnas.0804798105; Nobis M, 2013, CANCER RES, V73, P4674, DOI 10.1158/0008-5472.CAN-12-4545; Omer T, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086023; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pian Q, 2015, OPT LETT, V40, P431, DOI 10.1364/OL.40.000431; Rajoria Shilpi, 2014, Curr Mol Imaging, V3, P144; Rowley MI, 2011, PROC SPIE, V7903, DOI 10.1117/12.873890; Ruck A, 2009, SLIM MULTISPECTRAL F, V7183, DOI DOI 10.1117/12.809101; Ruck A, 2007, MICROSC RES TECHNIQ, V70, P485, DOI 10.1002/jemt.20433; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Sinsuebphon N, 2014, PROC SPIE, V8937, DOI 10.1117/12.2040097; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Talati R, 2014, METHODS, V66, P139, DOI 10.1016/j.ymeth.2013.08.017; Tichauer KM, 2011, BIOMED OPT EXPRESS, V2, P3021, DOI 10.1364/BOE.2.003021; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; TURANYI T, 1990, J MATH CHEM, V5, P203, DOI 10.1007/BF01166355; Ucinski D., 2004, OPTIMAL MEASUREMENT; Vandenberghe L, 1998, SIAM J MATRIX ANAL A, V19, P499, DOI 10.1137/S0895479896303430; Venugopal Vivek, 2012, Biomed Opt Express, V3, P3161, DOI 10.1364/BOE.3.003161; Venugopal V, 2010, OPT LETT, V35, P3189, DOI 10.1364/OL.35.003189; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Wallrabe H, 2007, MOL BIOL CELL, V18, P2226, DOI 10.1091/mbc.E06-08-0700; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; WALTER E, 1990, AUTOMATICA, V26, P195, DOI 10.1016/0005-1098(90)90116-Y; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zhao LL, 2014, OPT LETT, V39, P4156, DOI 10.1364/OL.39.004156; Zhao LL, 2014, BIOMED OPT EXPRESS, V5, P944, DOI 10.1364/BOE.5.000944; Zhao LL, 2013, OPT LETT, V38, P3976, DOI 10.1364/OL.38.003976; Zheng G, 2004, J PORPHYR PHTHALOCYA, V8, P1106, DOI 10.1142/S1088424604000477	68	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144421	10.1371/journal.pone.0144421	http://dx.doi.org/10.1371/journal.pone.0144421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658308	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600042
J	Kachele, M; Hennige, AM; Machann, J; Hieronimus, A; Lamprinou, A; Machicao, F; Schick, F; Fritsche, A; Stefan, N; Nurnberg, B; Haring, HU; Staiger, H				Kaechele, Martin; Hennige, Anita M.; Machann, Juergen; Hieronimus, Anja; Lamprinou, Apostolia; Machicao, Fausto; Schick, Fritz; Fritsche, Andreas; Stefan, Norbert; Nuernberg, Bernd; Haering, Hans-Ulrich; Staiger, Harald			Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers	PLOS ONE			English	Article							G-BETA-GAMMA; INSULIN SENSITIVITY; CARDIOVASCULAR RISK; ACTIVATION; OBESITY; NIACIN; INHIBITION; PI3K-GAMMA; RESISTANCE; GLUCOSE	Objective Phosphoinositide 3-kinase gamma (PI3K gamma) is a G-protein-coupled receptor-activated lipid kinase mainly expressed in leukocytes and cells of the cardiovascular system. PI3K gamma plays an important signaling role in inflammatory processes. Since subclinical inflammation is a hallmark of atherosclerosis, obesity-related insulin resistance, and pancreatic beta-cell failure, we asked whether common genetic variation in the PI3K gamma gene (PIK3CG) contributes to body fat content/distribution, serum adipokine/cytokine concentrations, alterations in plasma lipid profiles, insulin sensitivity, insulin release, and glucose homeostasis. Study Design Using a tagging single nucleotide polymorphism (SNP) approach, we analyzed genotype-phenotype associations in 2,068 German subjects genotyped for 10 PIK3CG SNPs and characterized by oral glucose tolerance tests. In subgroups, data from hyperinsulinaemic-euglycaemic clamps, magnetic resonance spectroscopy of the liver, whole-body magnetic resonance imaging, and intravenous glucose tolerance tests were available, and peripheral blood mononuclear cells (PBMCs) were used for gene expression analysis. Results After appropriate adjustment, none of the PIK3CG tagging SNPs was significantly associated with body fat content/distribution, adipokine/cytokine concentrations, insulin sensitivity, insulin secretion, or blood glucose concentrations (p>0.0127, all; Bonferroni-corrected alpha-level: 0.0051). However, six non-linked SNPs displayed at least nominal associations with plasma HDL-cholesterol concentrations, two of them (rs4288294 and rs116697954) reaching the level of study-wide significance (p = 0.0003 and p = 0.0004, respectively). More precisely, rs4288294 and rs116697954 influenced HDL2-, but not HDL3-, cholesterol. With respect to the SNPs' in vivo functionality, rs4288294 was significantly associated with PIK3CG mRNA expression in PBMCs. Conclusions We could demonstrate that common genetic variation in the PIK3CG locus, possibly via altered PIK3CG gene expression, determines plasma HDL-cholesterol concentrations. Since HDL2-, but not HDL3-, cholesterol is influenced by PIK3CG variants, PI3K gamma may play a role in HDL clearance rather than in HDL biogenesis. Even though the molecular pathways connecting PI3K gamma and HDL metabolism remain to be further elucidated, this finding could add a novel aspect to the pathophysiological role of PI3K gamma in atherogenesis.	[Kaechele, Martin; Hieronimus, Anja; Lamprinou, Apostolia; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Hennige, Anita M.; Machann, Juergen; Hieronimus, Anja; Lamprinou, Apostolia; Machicao, Fausto; Schick, Fritz; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Hennige, Anita M.; Machann, Juergen; Hieronimus, Anja; Lamprinou, Apostolia; Machicao, Fausto; Schick, Fritz; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Tubingen, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen Hosp, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Nutr & Prevent Med, Tubingen, Germany; [Nuernberg, Bernd] Univ Tubingen Hosp, Dept Expt & Clin Pharmacol & Toxicol, Div Pharmacol & Expt Therapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Staiger, H (corresponding author), Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de		Nurnberg, Bernd/0000-0002-5995-6555; Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595; Schick, Fritz/0000-0002-4231-3406	German Federal Ministry of Education and Research (BMBF) [01GI0925]; Deutsche Forschungsgemeinschaft [STE 1096/3-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). Norbert Stefan is supported by a Heisenberg professorship from the Deutsche Forschungsgemeinschaft (STE 1096/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzinger JJ, 2012, J LIPID RES, V53, P34, DOI 10.1194/jlr.M018887; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fougerat A, 2008, CIRCULATION, V117, P1310, DOI 10.1161/CIRCULATIONAHA.107.720466; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Kantartzis K, 2008, DIABETES CARE, V31, P366, DOI 10.2337/dc07-1558; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Keene D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4379; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Machann J, 2006, MAGN RESON MED, V55, P913, DOI 10.1002/mrm.20825; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; PATSCH W, 1989, CLIN CHEM, V35, P265; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rubenfire M, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0349-3; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Welty FK, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0400-4; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams PT, 2011, ATHEROSCLEROSIS, V214, P196, DOI 10.1016/j.atherosclerosis.2010.10.024; Wymann MP, 2013, ANN NY ACAD SCI, V1280, P44, DOI 10.1111/nyas.12037	39	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144494	10.1371/journal.pone.0144494	http://dx.doi.org/10.1371/journal.pone.0144494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658747	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500033
J	Castellano, CA; Baillargeon, JP; Nugent, S; Tremblay, S; Fortier, M; Imbeault, H; Duval, J; Cunnane, SC				Castellano, Christian-Alexandre; Baillargeon, Jean-Patrice; Nugent, Scott; Tremblay, Sebastien; Fortier, Melanie; Imbeault, Helene; Duval, Julie; Cunnane, Stephen C.			Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance	PLOS ONE			English	Article							COGNITIVE FUNCTION; METABOLISM; DISEASE; AGE; ASSOCIATION; SENSITIVITY; ADULTS	Objective To investigate whether cerebral metabolic rate of glucose (CMRglu) is altered in normal weight young women with polycystic ovary syndrome (PCOS) who exhibit mild insulin resistance. Materials and methods Seven women with PCOS were compared to eleven healthy female controls of similar age, education and body mass index. Regional brain glucose uptake was quantified using FDG with dynamic positron emission tomography and magnetic resonance imaging, and its potential relationship with insulin resistance assessed using the updated homeostasis model assessment (HOMA2-IR). A battery of cognitive tests was administered to evaluate working memory, attention and executive function. Results The PCOS group had 10% higher fasting glucose and 40% higher HOMA2-IR (p <= 0.035) compared to the Controls. The PCOS group had 9-14% lower CMRglu in specific regions of the frontal, parietal and temporal cortices (p <= 0.018). A significant negative relation was found between the CMRglu and HOMA2-IR mainly in the frontal, parietal and temporal cortices as well as in the hippocampus and the amygdala (p <= 0.05). Globally, cognitive performance was normal in both groups but scores on the PASAT test of working memory tended to be low in the PCOS group. Conclusions The PCOS group exhibited a pattern of low regional CMRglu that correlated inversely with HOMA2-IR in several brain regions and which resembled the pattern seen in aging and early Alzheimer's disease. These results suggest that a direct association between mild insulin resistance and brain glucose hypometabolism independent of overweight or obesity can exist in young adults in their 20s. Further investigation of the influence of insulin resistance on brain glucose metabolism and cognition in younger and middle-aged adults is warranted.	[Castellano, Christian-Alexandre; Nugent, Scott; Fortier, Melanie; Cunnane, Stephen C.] Univ Sherbrooke, Geriatr Inst, Res Ctr Aging, Sherbrooke, PQ J1K 2R1, Canada; [Imbeault, Helene; Duval, Julie] Univ Sherbrooke, Geriatr Inst, Hlth & Social Sci Ctr, Sherbrooke, PQ J1K 2R1, Canada; [Castellano, Christian-Alexandre; Nugent, Scott; Cunnane, Stephen C.] Univ Sherbrooke, Dept Physiol & Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [Baillargeon, Jean-Patrice; Cunnane, Stephen C.] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Baillargeon, Jean-Patrice] Ctr Hosp Univ Sherbrooke, Res Ctr, Sherbrooke, PQ, Canada; [Tremblay, Sebastien] Univ Sherbrooke, Sherbrooke Mol Imaging Ctr, Sherbrooke, PQ J1K 2R1, Canada; [Tremblay, Sebastien] Univ Sherbrooke, Dept Nucl Med & Radiobiol, Sherbrooke, PQ J1K 2R1, Canada; [Duval, Julie] Ctr Hosp Univ Sherbrooke, Dept Neurol, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Castellano, CA (corresponding author), Univ Sherbrooke, Geriatr Inst, Res Ctr Aging, Sherbrooke, PQ J1K 2R1, Canada.	Alexandre.Castellano@USherbrooke.ca		Baillargeon, Jean-Patrice/0000-0002-1336-081X; Castellano, Christian-Alexandre/0000-0002-3425-4522	Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-Sante (FRQS); Universite de Sherbrooke	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); Universite de Sherbrooke	This work was supported by Canadian Institutes of Health Research (CIHR), Fonds de Recherche du Quebec-Sante (FRQS), and Universite de Sherbrooke. SCC is a Universite de Sherbrooke Research Chair in Brain Metabolism and Cognition during Aging. SN is supported by PhD training award from the FRQS.	Abete I, 2008, J HUM NUTR DIET, V21, P591, DOI 10.1111/j.1365-277X.2008.00902.x; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Barnard L, 2007, PSYCHONEUROENDOCRINO, V32, P906, DOI 10.1016/j.psyneuen.2007.06.010; Barry JA, 2013, HUM REPROD, V28, P2832, DOI 10.1093/humrep/det335; Bendlin B, 2013, ALZHEIMERS DEMENT, V9, P411; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Bove RM, 2013, OBESITY, V21, P1343, DOI 10.1002/oby.20212; Buvat I., 2007, MED NUCL, V31, P165, DOI [10.1016/j.mednuc.2007.03.003, DOI 10.1016/J.MEDNUC.2007.03.003]; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Castellano CA, 2015, J ALZHEIMERS DIS, V43, P1343, DOI 10.3233/JAD-141074; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Corbould A, 2008, DIABETES-METAB RES, V24, P520, DOI 10.1002/dmrr.872; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Delis DC, 2001, DELIS KAPLAN EXECUTI; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; DUARA R, 1984, ANN NEUROL, V16, P702, DOI 10.1002/ana.410160613; Dukart J, 2013, NEUROIMAGE-CLIN, V3, P84, DOI 10.1016/j.nicl.2013.07.005; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fulghesu AM, 2006, FERTIL STERIL, V86, P398, DOI 10.1016/j.fertnstert.2006.01.024; Garcia-Casares N, 2014, J ALZHEIMERS DIS, V40, P375, DOI 10.3233/JAD-131736; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hirvonen J, 2011, DIABETES, V60, P443, DOI 10.2337/db10-0940; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Marano CM, 2014, PSYCHIAT RES-NEUROIM, V222, P84, DOI 10.1016/j.pscychresns.2014.01.009; Miller KK, 2004, PSYCHIAT RES-NEUROIM, V132, P197, DOI 10.1016/j.pscychresns.2004.09.003; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Nugent S, 2015, BIOGERONTOL IN PRESS; Nugent S, 2014, AM J PHYSIOL-ENDOC M, V306, pE1315, DOI 10.1152/ajpendo.00067.2014; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Poitrenaud J., 1995, NEUROPSYCHOLOGIE CLI; Rabasa-Lhoret R, 2003, J CLIN ENDOCR METAB, V88, P4917, DOI 10.1210/jc.2002-030316; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; Schattmann L, 2007, HORM BEHAV, V51, P587, DOI 10.1016/j.yhbeh.2007.02.007; Schuur M, 2010, EUR J EPIDEMIOL, V25, P561, DOI 10.1007/s10654-010-9476-y; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Willette AA, 2015, JAMA NEUROL, V72, P1013, DOI 10.1001/jamaneurol.2015.0613; Willette AA, 2015, DIABETES, V64, P1933, DOI 10.2337/db14-1507; Zheng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063332	48	18	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144116	10.1371/journal.pone.0144116	http://dx.doi.org/10.1371/journal.pone.0144116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650926	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300037
J	Hillier, NK; Kavanagh, RMB				Hillier, N. Kirk; Kavanagh, Rhys M. B.			Differential Octopaminergic Modulation of Olfactory Receptor Neuron Responses to Sex Pheromones in Heliothis virescens	PLOS ONE			English	Article							SPODOPTERA-LITTORALIS LEPIDOPTERA; ANTENNAL LOBE; MACROGLOMERULAR COMPLEX; PHOTOPERIOD CUES; PLANT VOLATILES; MOTH; FEMALE; ODOR; EXPRESSION; HAWKMOTH	Octopamine is an important neuromodulator of neural function in invertebrates. Octopamine increases male moth sensitivity to female sex pheromones, however, relatively little is known as to the role of octopamine in the female olfactory system, nor its possible effects on the reception of non-pheromone odorants. The purpose of this study was to determine relative effects of octopamine on the sensitivity of the peripheral olfactory system in male and female Heliothis virescens. Single sensillum recording was conducted in both sexes following injection with octopamine or Ringer solution, and during odorant stimulation with conspecific female sex pheromone or host plant volatiles. Results indicate that octopamine plays a significant modulatory role in female sex pheromone detection in female moths; and that male and female pheromone detection neurons share distinct pharmacological and physiological similarities in H. virescens despite sexual dimorphism at the antennal level.	[Hillier, N. Kirk; Kavanagh, Rhys M. B.] Acadia Univ, Dept Biol, Wolfville, NS B4P 2R6, Canada	Acadia University	Hillier, NK (corresponding author), Acadia Univ, Dept Biol, 33 Westwood Ave, Wolfville, NS B4P 2R6, Canada.	khillier@acadiau.ca	Hillier, Neil/AAM-7270-2020		NSERC Discovery grant [356109-2008 RGPIN]; Canada Foundation for Innovation [22087]; Atlantic Canada Opportunities Agency - Atlantic Innovation Fund [197853]; Nova Scotia Research Innovation Trust; Acadia University funds	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Atlantic Canada Opportunities Agency - Atlantic Innovation Fund; Nova Scotia Research Innovation Trust; Acadia University funds	Funded by an NSERC Discovery grant (356109-2008 RGPIN) to NKH, Canada Foundation for Innovation (22087) to NKH, Atlantic Canada Opportunities Agency - Atlantic Innovation Fund (197853) to NKH, the Nova Scotia Research Innovation Trust, Acadia University funds to NKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Christopher Ogbuah for assistance with rearing moths. Funding for this project was provided by an NSERC Discovery Grant to N.K.H. Infrastructure support was also provided by the Canadian Foundation for Innovation, Atlantic Canada Opportunities Agency-Atlantic Innovation Fund, the Nova Scotia Research Innovation Trust, and Acadia University.	ALMAAS TJ, 1991, J CHEM ECOL, V17, P953, DOI 10.1007/BF01395602; ANTON S, 1994, J COMP NEUROL, V350, P199, DOI 10.1002/cne.903500205; Baker TC, 2004, J COMP PHYSIOL A, V190, P155, DOI 10.1007/s00359-003-0483-2; Barrozo RB, 2010, J EXP BIOL, V213, P1100, DOI 10.1242/jeb.040139; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Berg BG, 1998, J COMP PHYSIOL A, V183, P669, DOI 10.1007/s003590050290; Brigaud I, 2009, CELL TISSUE RES, V335, P455, DOI 10.1007/s00441-008-0722-5; Callahan FE, 2000, INSECT BIOCHEM MOLEC, V30, P507, DOI 10.1016/S0965-1748(00)00027-8; Cunningham JP, 2004, J EXP BIOL, V207, P87, DOI 10.1242/jeb.00733; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; EVANS PD, 1982, J PHYSIOL-LONDON, V324, P93, DOI 10.1113/jphysiol.1982.sp014102; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; GODDE J, 1989, J NEUROSCI METH, V29, P77, DOI 10.1016/0165-0270(89)90111-8; Grosmaitre X, 2001, CHEM SENSES, V26, P653, DOI 10.1093/chemse/26.6.653; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Hansson BS, 2002, TRENDS NEUROSCI, V25, P270, DOI 10.1016/S0166-2236(02)02140-9; HANSSON BS, 1989, PHYSIOL ENTOMOL, V14, P147, DOI 10.1111/j.1365-3032.1989.tb00946.x; Harrewijn Paul, 1995, Chemoecology, V5-6, P55, DOI 10.1007/BF01259434; Hillier NK, 2007, J COMP PHYSIOL A, V193, P649, DOI 10.1007/s00359-007-0220-3; Hillier NK, 2006, J COMP PHYSIOL A, V192, P199, DOI 10.1007/s00359-005-0061-x; Homberg U, 1994, PROG ZOOL, V40; Homberg U, 1999, INSECT OLFACTION; Kaissling K.-E, 1995, EXPT CELL BIOL TASTE, P361; Keil TA., 1999, INSECT OLFACTION; KENNEDY JS, 1974, SCIENCE, V184, P999, DOI 10.1126/science.184.4140.999; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Lam F, 2013, PEPTIDES, V41, P66, DOI 10.1016/j.peptides.2012.03.034; Lelito JP, 2008, J CHEM ECOL, V34, P725, DOI 10.1007/s10886-008-9475-6; Lim H, 2008, ANIM BEHAV, V75, P673, DOI 10.1016/j.anbehav.2007.07.021; Lim H, 2007, J CHEM ECOL, V33, P1257, DOI 10.1007/s10886-007-9291-4; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P265, DOI 10.1002/arch.940200404; LINN CE, 1986, ARCH INSECT BIOCHEM, V3, P161, DOI 10.1002/arch.940030206; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P285, DOI 10.1002/arch.940200405; LINN CE, 1984, ARCH INSECT BIOCHEM, V1, P331, DOI 10.1002/arch.940010405; Lott JK, 2007, THESIS; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; OCHIENG SA, 1995, TISSUE CELL, V27, P221, DOI 10.1016/S0040-8166(95)80024-7; ORCHARD I, 1985, J NEUROBIOL, V16, P171, DOI 10.1002/neu.480160303; ORCHARD I, 1984, J INSECT PHYSIOL, V30, P901, DOI 10.1016/0022-1910(84)90066-0; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Roelofs W.L., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V49, P67; SAS Institute Inc, 2012, NEW FEAT JMP 10; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; SEABROOK WD, 1987, J CHEM ECOL, V13, P1443, DOI 10.1007/BF01012290; Skiri HT, 2004, CHEM SENSES, V29, P253, DOI 10.1093/chemse/bjh026; Sokal RR, 1995, BIOMETRY; Stelinski LL, 2003, J INSECT PHYSIOL, V49, P845, DOI 10.1016/S0022-1910(03)00136-7; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vickers NJ, 2003, CHEM SENSES, V28, P325, DOI 10.1093/chemse/28.4.325; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Zhukovskaya MI, 2012, CHEM SENSES, V37, P421, DOI 10.1093/chemse/bjr121	61	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143179	10.1371/journal.pone.0143179	http://dx.doi.org/10.1371/journal.pone.0143179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650832	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300012
J	Scanu, B; Linaldeddu, BT; Deidda, A; Jung, T				Scanu, Bruno; Linaldeddu, Benedetto T.; Deidda, Antonio; Jung, Thomas			Diversity of Phytophthora Species from Declining Mediterranean Maquis Vegetation, including Two New Species, Phytophthora crassamura and P. ornamentata sp nov.	PLOS ONE			English	Article							EUCALYPTUS-MARGINATA; NATURAL ECOSYSTEMS; OAK FORESTS; CINNAMOMI; PATHOGEN; MULTIPLE; CONSERVATION; BIODIVERSITY; PHOSPHITE; BANKSIA	The Mediterranean basin is recognized as a global biodiversity hotspot accounting for more than 25,000 plant species that represent almost 10% of the world's vascular flora. In particular, the maquis vegetation on Mediterranean islands and archipelagos constitutes an important resource of the Mediterranean plant diversity due to its high rate of endemism. Since 2009, a severe and widespread dieback and mortality of Quercus ilex trees and several other plant species of the Mediterranean maquis has been observed in the National Park of La Maddalena archipelago (northeast Sardinia, Italy). Infected plants showed severe decline symptoms and a significant reduction of natural regeneration. First studies revealed the involvement of the highly invasive wide-host range pathogen Phytophthora cinnamomi and several fungal pathogens. Subsequent detailed research led to a better understanding of these epidemics showing that multiple Phytophthora spp. were involved, some of them unknown to science. In total, nine Phytophthora species were isolated from rhizosphere soil samples collected from around symptomatic trees and shrubs including Asparagus albus, Cistus sp., Juniperus phoenicea, J. oxycedrus, Pistacia lentiscus and Rhamnus alaternus. Based on morphological characters, growth-temperature relations and sequence analysis of the ITS and cox1 gene regions, the isolates were identified as Phytophthora asparagi, P. bilorbang, P. cinnamomi, P. cryptogea, P. gonapodyides, P. melonis, P. syringae and two new Clade 6 taxa which are here described as P. crassamura sp. nov. and P. ornamentata sp. nov. Pathogenicity tests supported their possible involvement in the severe decline that is currently threatening the Mediterranean maquis vegetation in the La Maddalena archipelago.	[Scanu, Bruno; Linaldeddu, Benedetto T.; Deidda, Antonio] Univ Sassari, Sez Patol Vegetale Entomol SPaVE, Dipartimento Agr, I-07100 Sassari, Italy; [Jung, Thomas] Phytophthora Res & Consultancy, D-83131 Nussdorf, Germany; [Jung, Thomas] Univ Algarve, Lab Mol Biotechnol & Phytopathol, Ctr Mediterranean Bioresources & Food MeditBio, P-8005139 Faro, Portugal	University of Sassari; Universidade do Algarve	Scanu, B (corresponding author), Univ Sassari, Sez Patol Vegetale Entomol SPaVE, Dipartimento Agr, Viale Italia 39, I-07100 Sassari, Italy.	bscanu@uniss.it	Linaldeddu, Benedetto/V-1349-2019; Jung, Thomas/F-1665-2013; Linaldeddu, Benedetto/J-4646-2015; Deidda, Antonio/AAA-6343-2022; Scanu, Bruno/AAQ-1671-2020	Linaldeddu, Benedetto/0000-0003-2428-9905; Jung, Thomas/0000-0003-2034-0718; Linaldeddu, Benedetto/0000-0003-2428-9905; Deidda, Antonio/0000-0003-1672-2721; Scanu, Bruno/0000-0002-0690-580X	National Park of the La Maddalena archipelago; Sardinian Regional Government; Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy	National Park of the La Maddalena archipelago; Sardinian Regional Government(Regione Sardegna); Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy	This research was supported by grants from the National Park of the La Maddalena archipelago and from the Sardinian Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013 - Axis IV Human Resources, Objective l.3, Line of Activity l.3.1.). TJ acknowledges support by the Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy.; The authors would like to thank Paola Brundu who provided help and support with logistic and field work in the National Park of La Maddalena archipelago, and Emma Dempsey for English language editing. TJ acknowledges support by the Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy.	Aghighi S, 2012, EUR J PLANT PATHOL, V133, P841, DOI 10.1007/s10658-012-0006-5; Biondi E., 2005, FITOSOCIOLOGIA S1, V42, P1; Bocchieri E., 1992, FLORA MEDITERRANEA, V2, P33; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; BRASIER CM, 1993, PLANT PATHOL, V42, P140, DOI 10.1111/j.1365-3059.1993.tb01482.x; Brasier CM, 2003, MYCOL RES, V107, P277, DOI 10.1017/S095375620300738X; Brasier CM, 1967, THESIS; Burgess TI, 2009, PLANT DIS, V93, P215, DOI 10.1094/PDIS-93-3-0215; Cacciola SO, 1996, INFORM FITOPATOLOGIC, V7-8, P33; Cacciola SO, 2006, J PLANT PATHOL, V88, pS34; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Cunnington JH, 2005, AUSTRALAS PLANT PATH, V34, P413, DOI 10.1071/AP05034; Dick M.W, 1990, KEYS TO PYTHIUM; ELLIOTT CG, 1966, J GEN MICROBIOL, V42, P425, DOI 10.1099/00221287-42-3-425; Erwin C. D., 1996, PHYTOPHTHORA DIS WOR; Franceschini A., 2012, IOBC/WPRS Bulletin, V76, P101; Granke LL, 2012, PERSOONIA, V28, P146; Guharoy S, 2006, J PHYTOPATHOL, V154, P612, DOI 10.1111/j.1439-0434.2006.01155.x; Hall T., 2001, BIOEDIT VERSION 5 0; Hansen E, 1999, ANN FOR SCI, V56, P539, DOI 10.1051/forest:19990702; Hansen E, 2015, P 7 M IUFRO WORK PAR; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Hardy GES, 2001, AUSTRALAS PLANT PATH, V30, P133, DOI 10.1071/AP01012; Henricot B, 2014, PLANT PATHOL, V63, P1095, DOI 10.1111/ppa.12194; Ho HH, 2007, MYCOTAXON, V102, P339; Huberli D, 2013, AUSTRALAS PLANT PATH, V42, P251, DOI 10.1007/s13313-012-0195-6; Jung T, 2016, FOREST PATHOL, V46, P134, DOI 10.1111/efp.12239; Jung T, 2013, FOREST PATHOL, V43, P266, DOI 10.1111/efp.12025; Jung T, 1996, EUR J FOREST PATHOL, V26, P253; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Jung T, 2013, CABI PLANT PROT SER, P146, DOI 10.1079/9781780640938.0146; Linaldeddu BT, 2014, FOREST PATHOL, V44, P191, DOI 10.1111/efp.12081; Linaldeddu BT, 2013, MYCOLOGIA, V105, P1266, DOI 10.3852/12-370; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Mirabolfathy M, 2001, MYCOL RES, V105, P1166, DOI 10.1016/S0953-7562(08)61987-5; Mohaghegh P, 2011, PLANT DIS, V95, P455, DOI 10.1094/PDIS-05-10-0379; Moralejo E, 2009, PLANT PATHOL, V58, P100, DOI 10.1111/j.1365-3059.2008.01930.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Perez-Sierra A, 2013, FOREST PATHOL, V43, P331, DOI 10.1111/efp.12037; Rea AJ, 2010, AUSTRALAS PLANT PATH, V39, P477, DOI 10.1071/AP10014; Reeser PW, 2011, MYCOLOGIA, V103, P22, DOI 10.3852/10-013; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saude C, 2008, PHYTOPATHOLOGY, V98, P1075, DOI 10.1094/PHYTO-98-10-1075; Scanu B, 2014, FOREST PATHOL, V44, P1, DOI 10.1111/efp.12064; Scanu B, 2013, FOREST PATHOL, V43, P340, DOI 10.1111/efp.12039; Scanu B, 2015, P 7 M IUFRO WORK PAR; Scanu B, 2014, PHYTOPATHOL MEDITERR, V53, P480; Scott PM, 2009, PERSOONIA, V22, P1, DOI 10.3767/003158509X415450; Shearer BL, 2007, AUSTRALAS PLANT PATH, V36, P78, DOI 10.1071/AP06085; Shearer BL, 1989, JARRAH DIEBACK DYNAM; Smith RS, 2003, PHYTOPHTHORA FORESTS, P194; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Thompson JD, 2005, TAXON, V54, P967, DOI 10.2307/25065481; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vettraino AM, 2002, FOREST PATHOL, V32, P19, DOI 10.1046/j.1439-0329.2002.00264.x; Yang X., 2013, J PLANT PATHOL, V4, P5, DOI [10.4172/2157-7471.1000180, DOI 10.4172/2157-7471.1000180]	57	42	42	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143234	10.1371/journal.pone.0143234	http://dx.doi.org/10.1371/journal.pone.0143234			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649428	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903300014
J	Ali, SA; Chew, YW; Omar, TC; Azman, N				Ali, Syed A.; Chew, Yik Wei; Omar, Tasyriq Che; Azman, Nizuwan			Use of FabV-Triclosan Plasmid Selection System for Efficient Expression and Production of Recombinant Proteins in Escherichia coli	PLOS ONE			English	Article							ANTIBIOTIC-FREE SELECTION; ESSENTIAL GENE MARKER; PERSPECTIVES; MAINTENANCE; AUXOTROPHY; MECHANISMS; ACID	Maintenance of recombinant plasmid vectors in host bacteria relies on the presence of selection antibiotics in the growth media to suppress plasmid -free segregants. However, presence of antibiotic resistance genes and antibiotics themselves is not acceptable in several applications of biotechnology. Previously, we have shown that FabV-Triclosan selection system can be used to select high and medium copy number plasmid vectors in E. coli. Here, we have extended our previous work and demonstrated that expression vectors containing FabV can be used efficiently to express heterologous recombinant proteins in similar or better amounts in E. coli host when compared with expression vectors containing beta-lactamase. Use of small amount of non-antibiotic Triclosan as selection agent in growth medium, enhanced plasmid stability, applicability in various culture media, and compatibility with other selection systems for multiple plasmid maintenance are noteworthy features of FabV-Triclosan selection system.	[Ali, Syed A.; Chew, Yik Wei; Omar, Tasyriq Che] Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, Kepala Batas 13200, Pulau Pinang, Malaysia; [Azman, Nizuwan] Univ Sains Malaysia, Adv Med & Dent Inst, Div Res Publicat & Innovat, Kepala Batas 13200, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Ali, SA (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, Kepala Batas 13200, Pulau Pinang, Malaysia.	alilabwork@gmail.com	Omar, Mohammad Tasyriq Che/L-3839-2017; Azman, Nizuwan/Y-5331-2019; Chew, Yik Wei/M-9669-2017; Omar, Mohammad Tasyriq Che/AFP-0240-2022	Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Chew, Yik Wei/0000-0003-4772-0702; Omar, Mohammad Tasyriq Che/0000-0002-1294-7520	ERGS grant from the Ministry of Higher Education (MOHE), Government of Malaysia [203/CIPPT/6730104]; Ministry of Higher Education (MOHE), Government of Malaysia [KPM (B) 860208015480]	ERGS grant from the Ministry of Higher Education (MOHE), Government of Malaysia; Ministry of Higher Education (MOHE), Government of Malaysia	This work was supported by the ERGS grant (203/CIPPT/6730104) from the Ministry of Higher Education (MOHE), Government of Malaysia, to SAA. YWC is a recipient of MyMaster scholarship (KPM (B) 860208015480) under MyBrain15 program of Ministry of Higher Education (MOHE), Government of Malaysia.	Ali SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129547; Carnes AE, 2009, BIOTECHNOL BIOENG, V104, P505, DOI 10.1002/bit.22415; Cranenburgh RM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e26; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; Dong WR, 2010, APPL ENVIRON MICROB, V76, P2295, DOI 10.1128/AEM.02462-09; Dryselius R, 2003, BIOTECHNIQUES, V35, P1060; El-Attar LMR, 2012, VACCINE, V30, P1702, DOI 10.1016/j.vaccine.2011.12.078; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Goh S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-61; Hagg P, 2004, J BIOTECHNOL, V111, P17, DOI 10.1016/j.jbiotec.2004.03.010; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Jang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057075; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; Mualif SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130446; Oliveira PH, 2013, TRENDS BIOTECHNOL, V31, P539, DOI 10.1016/j.tibtech.2013.06.001; Peubez I, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-65; Rodricks JV, 2010, CRIT REV TOXICOL, V40, P422, DOI 10.3109/10408441003667514; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selvamani RSV, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-58; Teow SY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-107; Vandermeulen G, 2011, MOL THER, V19, P1942, DOI 10.1038/mt.2011.182; Vidal L, 2008, J BIOTECHNOL, V134, P127, DOI 10.1016/j.jbiotec.2008.01.011	24	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144189	10.1371/journal.pone.0144189	http://dx.doi.org/10.1371/journal.pone.0144189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642325	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700073
J	Oh, YS; Bae, SS; Park, JB; Ha, SH; Ryu, SH; Suh, PG				Oh, Yong-Seok; Bae, Sun Sik; Park, Jong Bae; Ha, Sang Hoon; Ryu, Sung Ho; Suh, Pann-Ghill			Mouse Sphingosine Kinase 1a Is Negatively Regulated through Conventional PKC-Dependent Phosphorylation at S373 Residue	PLOS ONE			English	Article							FACTOR-INDUCED ACTIVATION; CALCIUM MOBILIZATION; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; CELLULAR-REGULATION; DISTINCT ROLES; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; RECEPTOR; PATHWAY	Sphingosine kinase is a lipid kinase that converts sphingosine into sphingosine-1-phosphate, an important signaling molecule with intracellular and extracellular functions. Although diverse extracellular stimuli influence cellular sphingosine kinase activity, the molecular mechanisms underlying its regulation remain to be clarified. In this study, we investigated the phosphorylation-dependent regulation of mouse sphingosine kinase (mSK) isoforms 1 and 2. mSK1a was robustly phosphorylated in response to extracellular stimuli such as phorbol ester, whereas mSK2 exhibited a high basal level of phosphorylation in quiescent cells regardless of agonist stimulation. Interestingly, phorbol ester-induced phosphorylation of mSK1a correlated with suppression of its activity. Chemical inhibition of conventional PKCs (cPKCs) abolished mSK1a phosphorylation, while overexpression of PKC alpha, a cPKC isoform, potentiated the phosphorylation, in response to phorbol ester. Furthermore, an in vitro kinase assay showed that PKC alpha directly phosphorylated mSK1a. In addition, phosphopeptide mapping analysis determined that the S373 residue of mSK1a was the only site phosphorylated by cPKC. Interestingly, alanine substitution of S373 made mSK1a refractory to the inhibitory effect of phorbol esters, whereas glutamate substitution of the same residue resulted in a significant reduction in mSK1a activity, suggesting the significant role of this phosphorylation event. Taken together, we propose that mSK1a is negatively regulated through cPKC-dependent phosphorylation at S373 residue.	[Oh, Yong-Seok] DGIST, Dept Brain Cognit Sci, Taegu, South Korea; [Park, Jong Bae; Ha, Sang Hoon; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang, South Korea; [Bae, Sun Sik; Suh, Pann-Ghill] UNIST, Dept Biol Sci, Ulsan, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST)	Oh, YS (corresponding author), DGIST, Dept Brain Cognit Sci, Taegu, South Korea.	ysoh2040@dgist.ac.kr; pgsuh@unist.ac.kr	Suh, Pann-Ghill/F-3610-2010	Oh, Yong-Seok/0000-0002-9039-2014; Ryu, Sung Ho/0000-0003-0913-3048	Daegu Gyeongbuk Institute of Science & Technology (DGIST) MIREBraiN program [14-01-HRLA-01]; Daegu Gyeongbuk Institute of Science & Technology (DGIST) RD program [15-BD-0402]; Basic Science Research Program through the ministry of science, ICT & future planning of Korea [2015010015, 2014R1A1A1003159]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2010-0028684]	Daegu Gyeongbuk Institute of Science & Technology (DGIST) MIREBraiN program; Daegu Gyeongbuk Institute of Science & Technology (DGIST) RD program; Basic Science Research Program through the ministry of science, ICT & future planning of Korea; National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by Daegu Gyeongbuk Institute of Science & Technology (DGIST) MIREBraiN program (14-01-HRLA-01), R&D program (15-BD-0402) to YSO, Basic Science Research Program through the ministry of science, ICT & future planning of Korea (2015010015, 2014R1A1A1003159) to YSO. In addition, the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2010-0028684) to PGS has supported this work.	Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Alemany R, 1999, J BIOL CHEM, V274, P3994, DOI 10.1074/jbc.274.7.3994; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buehrer BM, 1996, BBA-LIPID LIPID MET, V1303, P233, DOI 10.1016/0005-2760(96)00092-6; Choi OH, 1996, NATURE, V380, P634; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heringdorf DMZ, 1998, EMBO J, V17, P2830, DOI 10.1093/emboj/17.10.2830; Jensen ON, 1996, ELECTROPHORESIS, V17, P938, DOI 10.1002/elps.1150170516; Jo SK, 2009, KIDNEY INT, V75, P167, DOI 10.1038/ki.2008.400; Karliner JS, 2013, BBA-MOL CELL BIOL L, V1831, P203, DOI 10.1016/j.bbalip.2012.06.006; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lai WQ, 2009, J IMMUNOL, V183, P2097, DOI 10.4049/jimmunol.0804376; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Machwate M, 1998, MOL PHARMACOL, V54, P70, DOI 10.1124/mol.54.1.70; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NIXON JS, 1991, DRUG EXP CLIN RES, V17, P389; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1994, J BIOL CHEM, V269, P17924; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne Nigel J, 2012, Adv Biol Regul, V52, P31; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 1996, EUR J BIOCHEM, V237, P819, DOI 10.1111/j.1432-1033.1996.0819p.x; Rigogliuso S, 2010, J ONCOL, V2010, DOI 10.1155/2010/509329; Rius RA, 1997, FEBS LETT, V417, P173, DOI 10.1016/S0014-5793(97)01277-5; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143695	10.1371/journal.pone.0143695	http://dx.doi.org/10.1371/journal.pone.0143695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642194	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700027
J	Sokol, S; Portais, JC				Sokol, Serguei; Portais, Jean-Charles			Theoretical Basis for Dynamic Label Propagation in Stationary Metabolic Networks under Step and Periodic Inputs	PLOS ONE			English	Article							BIDIRECTIONAL REACTION STEPS; FLUX ANALYSIS; FRAMEWORK; PATHWAY	The dynamics of label propagation in a stationary metabolic network during an isotope labeling experiment can provide highly valuable information on the network topology, metabolic fluxes, and on the size of metabolite pools. However, major issues, both in the experimental set-up and in the accompanying numerical methods currently limit the application of this approach. Here, we propose a method to apply novel types of label inputs, sinusoidal or more generally periodic label inputs, to address both the practical and numerical challenges of dynamic labeling experiments. By considering a simple metabolic system, i.e. a linear, non-reversible pathway of arbitrary length, we develop mathematical descriptions of label propagation for both classical and novel label inputs. Theoretical developments and computer simulations show that the application of rectangular periodic pulses has both numerical and practical advantages over other approaches. We applied the strategy to estimate fluxes in a simulated experiment performed on a complex metabolic network ( the central carbon metabolism of Escherichia coli), to further demonstrate its value in conditions which are close to those in real experiments. This study provides a theoretical basis for the rational interpretation of label propagation curves in real experiments, and will help identify the strengths, pitfalls and limitations of such experiments. The cases described here can also be used as test cases for more general numerical methods aimed at identifying network topology, analyzing metabolic fluxes or measuring concentrations of metabolites.	[Sokol, Serguei; Portais, Jean-Charles] Univ Toulouse, LISBP, INSA, UPS,INP, Toulouse, France; [Sokol, Serguei; Portais, Jean-Charles] INRA, Lab Ingn Syst Biol & Proc, UMR792, F-31931 Toulouse, France; [Sokol, Serguei; Portais, Jean-Charles] CNRS, UMR5504, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Sokol, S (corresponding author), Univ Toulouse, LISBP, INSA, UPS,INP, Toulouse, France.	sokol@insa-toulouse.fr	Sokol, Serguei/Z-3029-2019	Sokol, Serguei/0000-0002-5674-3327; Portais, Jean-Charles/0000-0002-3480-0933	Agence Nationale de la Recherche ('METABOHUB' ANR-11-INBS-0010-01) Region Midi-Pyrenees; European Regional Development Fund; French Ministry for Higher Education and Research; SICOVAL; Institut National de la Recherche Agronomique; IBiSa	Agence Nationale de la Recherche ('METABOHUB' ANR-11-INBS-0010-01) Region Midi-Pyrenees(French National Research Agency (ANR)); European Regional Development Fund(European Commission); French Ministry for Higher Education and Research; SICOVAL; Institut National de la Recherche Agronomique; IBiSa	This work was supported by Agence Nationale de la Recherche ('METABOHUB' ANR-11-INBS-0010-01) Region Midi-Pyrenees, the European Regional Development Fund, the French Ministry for Higher Education and Research, the SICOVAL, the Institut National de la Recherche Agronomique, and IBiSa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Kajihata S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/627014; MARKUS M, 1985, ARCH BIOL MED EXP, V18, P261; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Mollney M, 1999, BIOTECHNOL BIOENG, V66, P86, DOI 10.1002/(SICI)1097-0290(1999)66:2<86::AID-BIT2>3.0.CO;2-A; Noack S, 2011, J BIOTECHNOL, V154, P179, DOI 10.1016/j.jbiotec.2010.07.008; Noh K, 2007, J BIOTECHNOL, V129, P249, DOI 10.1016/j.jbiotec.2006.11.015; Noh K, 2011, APPL MICROBIOL BIOT, V91, P1247, DOI 10.1007/s00253-011-3390-4; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Schaub J, 2008, BIOTECHNOL BIOENG, V99, P1170, DOI 10.1002/bit.21675; Sokol S, 2012, BIOINFORMATICS, V28, P687, DOI 10.1093/bioinformatics/btr716; SUNDSTROM DW, 1976, BIOTECHNOL BIOENG, V18, P1, DOI 10.1002/bit.260180102; Tang YJ, 2009, MASS SPECTROM REV, V28, P362, DOI 10.1002/mas.20191; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 2005, ADV BIOCHEM ENG BIOT, V92, P145, DOI 10.1007/b98921; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wiechert W, 2001, MATH BIOSCI, V169, P173, DOI 10.1016/S0025-5564(00)00059-6; Wittmann C., 2013, METABOLOMICS PRACTIC, P285; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhao Z, 2008, METAB ENG, V10, P178, DOI 10.1016/j.ymben.2008.04.003	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144652	10.1371/journal.pone.0144652	http://dx.doi.org/10.1371/journal.pone.0144652			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641860	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700151
J	Zhao, Y; Masiello, D; McMillian, M; Nguyen, C; Wu, Y; Melendez, E; Smbatyan, G; Kida, A; He, Y; Teo, JL; Kahn, M				Zhao, Y.; Masiello, D.; McMillian, M.; Nguyen, C.; Wu, Y.; Melendez, E.; Smbatyan, G.; Kida, A.; He, Y.; Teo, J-L; Kahn, M.			CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells	ONCOGENE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; BETA-CATENIN; GENE-EXPRESSION; CANCER-CELLS; DIFFERENTIAL ROLES; KINASE INHIBITION; BINDING PROTEIN	CREB-binding protein (CBP) and p300 are highly homologous transcriptional coactivators with unique, non-redundant roles that bind a wide array of proteins, including catenins-beta and gamma. ICG-001 is a small-molecule inhibitor that specifically inhibits the CBP/catenin interaction. Importantly, ICG-001 does not inhibit the p300/catenin interaction. We demonstrate that specifically inhibiting the interaction between CBP and catenin with ICG-001 results in the differentiation of quiescent drug-resistant chronic myelogenous leukemia-initiating cells (CML LICs), thereby sensitizing them to BCR-ABL tyrosine kinase inhibitors, for example, Imatinib. Using ICG-001 in a NOD/SCID/IL2R gamma(-/-) mouse model of engrafted human chronic myelogenous leukemia, we now demonstrate the complete elimination of engrafted leukemia after only one course of combined chemotherapy. Combination-treated animals live as long as their non-engrafted littermates. Results from these studies demonstrate that specifically antagonizing the CBP/catenin interaction with ICG-001 can eliminate drug-resistant CML LICs without deleterious effects to the normal endogenous hematopoietic stem cell population.	[Zhao, Y.] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA USA; [Zhao, Y.; McMillian, M.; Nguyen, C.; Melendez, E.; Smbatyan, G.; Teo, J-L; Kahn, M.] Univ Southern Calif, Norris Comprehens Canc Ctr, 1450 Biggy St,NRT 4501, Los Angeles, CA 90033 USA; [Zhao, Y.; Masiello, D.; McMillian, M.; Nguyen, C.; Wu, Y.; Melendez, E.; Smbatyan, G.; Kida, A.; He, Y.; Teo, J-L; Kahn, M.] Univ Southern Calif, Keck Sch Med, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA USA; [Kahn, M.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Kahn, M.] Univ Southern Calif, Keck Sch Med, Dept Mol Pharmacol & Toxicol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Kahn, M (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, 1450 Biggy St,NRT 4501, Los Angeles, CA 90033 USA.	kahnm@usc.edu			USC Norris Comprehensive Cancer Center Support Grant [P30 CA014089]; NIH [1R01CA166161-01A1, 1R01 HL112638-01]; NATIONAL CANCER INSTITUTE [R01CA166161, P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112638] Funding Source: NIH RePORTER	USC Norris Comprehensive Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support from USC Norris Comprehensive Cancer Center Support Grant P30 CA014089, NIH 1R01CA166161-01A1 and NIH 1R01 HL112638-01 is gratefully acknowledged.	Banerjee ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033165; Bolton-Gillespie E, 2013, BLOOD, V121, P4175, DOI 10.1182/blood-2012-11-466938; Chan WI, 2011, MOL CELL BIOL, V31, P5046, DOI 10.1128/MCB.05830-11; el-Khoueiry A., 2013, J CLIN ONC ABSTR, V31, P2501, DOI DOI 10.1200/jco.2013.31.15_suppl.2501; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gang EJ, 2014, ONCOGENE, V33, P2169, DOI 10.1038/onc.2013.169; Giles FJ, 2008, SEMIN ONCOL, V35, pS1, DOI 10.1053/j.seminoncol.2007.12.002; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hasegawa K, 2012, STEM CELL TRANSL MED, V1, P18, DOI 10.5966/sctm.2011-0033; He KJ, 2014, INT J CANCER, V134, P43, DOI 10.1002/ijc.28341; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jabbour EJ, 2013, CL LYMPH MYELOM LEUK, V13, P515, DOI 10.1016/j.clml.2013.03.018; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kim YM, 2011, CURR CANCER DRUG TAR, V11, P213, DOI 10.2174/156800911794328420; Konig H, 2008, LEUKEMIA, V22, P748, DOI 10.1038/sj.leu.2405086; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Lenz HJ, 2014, CANCER SCI, V105, P1087, DOI 10.1111/cas.12471; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Nicholson E, 2009, CLIN LYMPHOMA MYELOM, V9, pS376, DOI 10.3816/CLM.2009.s.037; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Park E, 2011, BLOOD, V118, P2191, DOI 10.1182/blood-2011-04-351239; Pehlivan M, 2009, LEUKEMIA RES, V33, P1062, DOI 10.1016/j.leukres.2008.11.013; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rice KN, 2010, INT J HEMATOL, V91, P748, DOI 10.1007/s12185-010-0615-8; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127; Xia BF, 2012, BIOPHARM DRUG DISPOS, V33, P536, DOI 10.1002/bdd.1821; Yamada T, 2003, CANCER RES, V63, P895; Yeung J, 2010, CANCER CELL, V18, P606, DOI 10.1016/j.ccr.2010.10.032; Zemans RL, 2011, P NATL ACAD SCI USA, V108, P15990, DOI 10.1073/pnas.1110144108; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	49	36	36	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3705	3717		10.1038/onc.2015.438	http://dx.doi.org/10.1038/onc.2015.438			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26657156	Green Accepted			2022-12-26	WOS:000379622800009
J	Panfoli, I; Ravera, S; Podesta, M; Cossu, C; Santucci, L; Bartolucci, M; Bruschi, M; Calzia, D; Sabatini, F; Bruschettini, M; Ramenghi, LA; Romantsik, O; Marimpietri, D; Pistoia, V; Ghiggeri, G; Frassoni, F; Candiano, G				Panfoli, Isabella; Ravera, Silvia; Podesta, Marina; Cossu, Claudia; Santucci, Laura; Bartolucci, Martina; Bruschi, Maurizio; Calzia, Daniela; Sabatini, Federica; Bruschettini, Matteo; Ramenghi, Luca Antonio; Romantsik, Olga; Marimpietri, Danilo; Pistoia, Vito; Ghiggeri, Gianmarco; Frassoni, Francesco; Candiano, Giovanni			Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants	FASEB JOURNAL			English	Article						ATP synthesis; oxidative phosphorylation; umbilical cord; electron transport chain; energy metabolism	STROMAL CELLS; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIA; MYELIN; STRESS	Exosomes are secreted nanovesicles that are able to transfer RNA and proteins to target cells. The emerging role ofmesenchymal stemcell (MSC) exosomes as promoters of aerobic ATP synthesis restoration in damaged cells, prompted us to assess whether they contain an extramitochondrial aerobic respiration capacity. Exosomes were isolated from culture medium of human MSCs from umbilical cord of >= 37-wk-old newborns or between 28- to 30-wk-old newborns (i.e., term or preterm infants). Characterization of samples was conducted by cytofluorometry. Oxidative phosphorylation capacity was assessed by Western blot analysis, oximetry, and luminometric and fluorometric analyses. MSC exosomes express functional respiratory complexes I, IV, and V, consuming oxygen. ATP synthesis was only detectable in exosomes from term newborns, suggestive of a specific mechanism that is not completed at an early gestational age. Activities are outward facing and comparable to those detected in mitochondria isolated from term MSCs. MSC exosomes display an unsuspected aerobic respiratory ability independent of whole mitochondria. This may be relevant for their ability to rescue cell bioenergetics. The differential oxidative metabolism of pretermvs. term exosomes sheds new light on the preterm newborn's clinical vulnerability. A reduced ability to repair damaged tissue and an increased capability to cope with anoxic environment for preterm infants can be envisaged.-Panfoli, I., Ravera, S., Podesta, M., Cossu, C., Santucci, L., Bartolucci, M., Bruschi, M., Calzia, D., Sabatini, F., Bruschettini, M., Ramenghi, L. A., Romantsik, O., Marimpietri, D., Pistoia, V., Ghiggeri, G., Frassoni, F., Candiano, G. Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants. FASEB J. 30, 1416-1424 (2016). www.fasebj.org	[Panfoli, Isabella; Bartolucci, Martina; Calzia, Daniela] Univ Genoa, Dipartimento Farm, Lab Biochim, Genoa, Italy; [Ravera, Silvia; Podesta, Marina; Cossu, Claudia; Sabatini, Federica; Frassoni, Francesco] Ist Giannina Gaslini, Lab Cellule Staminali Postnatali & Terapie Cellul, I-16148 Genoa, Italy; [Santucci, Laura; Bruschi, Maurizio; Ghiggeri, Gianmarco; Candiano, Giovanni] Ist Giannina Gaslini, Lab Pathophysiol Uremia, I-16148 Genoa, Italy; [Bruschettini, Matteo; Ramenghi, Luca Antonio; Romantsik, Olga] Ist Giannina Gaslini, Neonatal Intens Care Unit, I-16148 Genoa, Italy; [Marimpietri, Danilo; Pistoia, Vito] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy; [Bruschettini, Matteo; Romantsik, Olga] Lund Univ, Inst Clin Sci, Lund, Sweden	University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Lund University	Ravera, S (corresponding author), Ist Giannina Gaslini, UOC Lab Cellule Staminali Postnatali & Terapie Ce, Via Gerolamo Gaslini 5, I-16147 Genoa, Italy.	silvia.ravera@gmail.com	Ghiggeri, Gian Marco/N-4712-2015; Candiano, Giovanni/J-9357-2018; matteo, bruschettini/J-6030-2019; Frassoni, Francesco/K-3971-2018; Ravera, Silvia/AAA-7982-2019; Bartolucci, Martina/AAA-6582-2019; Marimpietri, Danilo/AAA-7283-2020; Podestà, Marina/K-3875-2016; Sabatini, Federica/J-5984-2016; Bruschi, Maurizio/E-7090-2016; Ramenghi, Luca/AAB-4067-2020; Panfoli, Isabella/X-1247-2019; Marimpietri, Danilo/J-5975-2016	Ghiggeri, Gian Marco/0000-0003-3659-9062; Candiano, Giovanni/0000-0002-7385-2787; matteo, bruschettini/0000-0002-4775-872X; Frassoni, Francesco/0000-0003-1262-0648; Ravera, Silvia/0000-0002-0803-1042; Bartolucci, Martina/0000-0001-5289-4219; Marimpietri, Danilo/0000-0001-6360-1661; Podestà, Marina/0000-0002-6755-613X; Sabatini, Federica/0000-0003-2271-2597; Bruschi, Maurizio/0000-0001-6036-1500; Ramenghi, Luca/0000-0003-0065-762X; Panfoli, Isabella/0000-0002-6261-1128; santucci, laura/0000-0003-2516-7889; Romantsik, Olga/0000-0003-1414-9386	Cinque per mille e Ricerca Corrente, Ministero della Salute, to Istituto Giannina Gaslini; Compagnia di San Paolo [2014AAI637.U/812/AR pv 2013.0958]; Associazione Italiana per la Ricerca sul Cancro [IG 13013]; Renal Child Foundation	Cinque per mille e Ricerca Corrente, Ministero della Salute, to Istituto Giannina Gaslini; Compagnia di San Paolo(Compagnia di San Paolo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Renal Child Foundation	This work was supported by funds from Cinque per mille e Ricerca Corrente, Ministero della Salute, to Istituto Giannina Gaslini; a Compagnia di San Paolo grant (2014AAI637.U/812/AR pv 2013.0958 to F.F); an Associazione Italiana per la Ricerca sul Cancro grant (IG 13013 to V.P); and funds from the Renal Child Foundation.	Almgren M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.014; Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bruschi M, 2003, PROTEOMICS, V3, P821, DOI 10.1002/pmic.200300361; Bruschi M, 2015, EXPERT REV PROTEOMIC, V12, P425, DOI 10.1586/14789450.2015.1055324; Burnstock G, 2015, PURINERG SIGNAL, V11, P277, DOI 10.1007/s11302-015-9452-9; Capelli C, 2011, CYTOTHERAPY, V13, P786, DOI 10.3109/14653249.2011.563294; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lai RC, 2015, SEMIN CELL DEV BIOL, V40, P82, DOI 10.1016/j.semcdb.2015.03.001; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Panfoli I, 2011, EXPERT REV PROTEOMIC, V8, P231, DOI [10.1586/EPR.11.1, 10.1586/epr.11.1]; Panfoli I, 2009, INT J BIOCHEM CELL B, V41, P2555, DOI 10.1016/j.biocel.2009.08.013; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Ravera S, 2013, BIOCHIMIE, V95, P1991, DOI 10.1016/j.biochi.2013.07.003; Ravera S, 2013, J NEUROCHEM, V126, P82, DOI 10.1111/jnc.12253; Ravera S, 2011, CELL MOL NEUROBIOL, V31, P313, DOI 10.1007/s10571-010-9624-7; Ravera S, 2009, INT J BIOCHEM CELL B, V41, P1581, DOI 10.1016/j.biocel.2009.01.009; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142	43	55	57	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1416	1424		10.1096/fj.15-279679	http://dx.doi.org/10.1096/fj.15-279679			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26655706				2022-12-26	WOS:000372629100005
J	Deusch, O; O'Flynn, C; Colyer, A; Swanson, KS; Allaway, D; Morris, P				Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Swanson, Kelly S.; Allaway, David; Morris, Penelope			A Longitudinal Study of the Feline Faecal Microbiome Identifies Changes into Early Adulthood Irrespective of Sexual Development	PLOS ONE			English	Article							COLI NISSLE 1917; GUT MICROBIOME; MEGASPHAERA-ELSDENII; FOOD-INTAKE; PROTEIN; RUMEN; CATS; OVARIOHYSTERECTOMY; HOUSEHOLDS; INDUCTION	Companion animals provide an excellent model for studies of the gut microbiome because potential confounders such as diet and environment can be more readily controlled for than in humans. Additionally, domestic cats and dogs are typically neutered early in life, enabling an investigation into the potential effect of sex hormones on the microbiome. In a longitudinal study to investigate the potential effects of neutering, neutering age and gender on the gut microbiome during growth, the faeces of kittens (16 male, 14 female) were sampled at 18, 30 and 42 weeks of age. DNA was shotgun sequenced on the Illumina platform and sequence reads were annotated for taxonomy and function by comparison to a database of protein coding genes. In a statistical analysis of diversity, taxonomy and functional potential of the microbiomes, age was identified as the only factor with significant associations. No significant effects were detected for gender, neutering, or age when neutered (19 or 31 weeks). At 18 weeks of age the microbiome was dominated by the genera Lactobacillus and Bifidobacterium (35% and 20% average abundance). Structural and functional diversity was significantly increased by week 30 but there was no further significant increase. At 42 weeks of age the most abundant genera were Bacteroides (16%), Prevotella (14%) and Megasphaera (8%). Significant differences in functional potential included an enrichment for genes in energy metabolism (carbon metabolism and oxidative phosphorylation) and depletion in cell motility (flagella and chemotaxis). We conclude that the feline faecal microbiome is predominantly determined by age when diet and environment are controlled for. We suggest this finding may also be informative for studies of the human microbiome, where control over such factors is usually limited.	[Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Allaway, David; Morris, Penelope] WALTHAM Ctr Pet Nutr, Freeby Lane, Melton Mowbray, Leics, England; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	Mars; WALTHAM Petcare Science Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Deusch, O (corresponding author), WALTHAM Ctr Pet Nutr, Freeby Lane, Melton Mowbray, Leics, England.	deuscoli@effem.com		Allaway, David/0000-0003-4602-8933; Swanson, Kelly/0000-0001-5518-3076; Deusch, Oliver/0000-0003-3378-6129	Mars Petcare UK	Mars Petcare UK	This work was funded by Mars Petcare UK. The WALTHAM Centre of Pet Nutrition is the fundamental research centre for Mars Petcare.	Allaway D., 2013, The WALTHAM International Sciences Symposium 2013: from pet food to pet care - bridging the gap, Portland, Oregon, USA, 1-4 October, 2013. Abstracts, P59; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barry KA, 2010, J ANIM SCI, V88, P2978, DOI 10.2527/jas.2009-2464; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Belsito KR, 2009, J ANIM SCI, V87, P594, DOI 10.2527/jas.2008-0887; Biagi G, 2013, AM J VET RES, V74, P90, DOI 10.2460/ajvr.74.1.90; Cave NJ, 2007, NEW ZEAL VET J, V55, P113, DOI 10.1080/00480169.2007.36752; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; COUNOTTE GHM, 1981, APPL ENVIRON MICROB, V42, P649, DOI 10.1128/AEM.42.4.649-655.1981; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Deusch O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101021; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Faya M, 2013, THERIOGENOLOGY, V80, P584, DOI 10.1016/j.theriogenology.2013.05.026; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Flynn MF, 1996, J AM VET MED ASSOC, V209, P1572; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; Hoenig M, 2002, AM J VET RES, V63, P634, DOI 10.2460/ajvr.2002.63.634; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Kanakupt K, 2011, J ANIM SCI, V89, P1376, DOI 10.2527/jas.2010-3201; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07417; Li J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0316-1; Liu JM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks828; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Marx H, 2011, J BACTERIOL, V193, P5578, DOI 10.1128/JB.05861-11; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; Murray JK, 2008, VET REC, V163, P381, DOI 10.1136/vr.163.13.381; Murray JK, 2009, VET REC, V164, P137, DOI 10.1136/vr.164.5.137; O'Sullivan O, 2013, J ANTIMICROB CHEMOTH, V68, P214, DOI 10.1093/jac/dks348; Rajilic-Stojanovic M, 2013, ENVIRON MICROBIOL, V15, P1146, DOI 10.1111/1462-2920.12023; Rodrigues Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083197; Root MV, 1997, VET RADIOL ULTRASOUN, V38, P42, DOI 10.1111/j.1740-8261.1997.tb01601.x; Ross EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073056; RUSSELL JB, 1978, APPL ENVIRON MICROB, V36, P319, DOI 10.1128/AEM.36.2.319-329.1978; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Steinle N, 2013, FASEB J, V27; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Troge A, 2012, INT J MED MICROBIOL, V302, P304, DOI 10.1016/j.ijmm.2012.09.004; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yoshida Y, 2009, ANIM SCI J, V80, P709, DOI 10.1111/j.1740-0929.2009.00692.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	69	36	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144881	10.1371/journal.pone.0144881	http://dx.doi.org/10.1371/journal.pone.0144881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659594	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900132
J	Leipoldt, F; Zeyhle, P; Kulik, A; Kalinowski, J; Heide, L; Kaysser, L				Leipoldt, Franziska; Zeyhle, Philipp; Kulik, Andreas; Kalinowski, Joern; Heide, Lutz; Kaysser, Leonard			Diversity of ABBA Prenyltransferases in Marine Streptomyces sp CNQ-509: Promiscuous Enzymes for the Biosynthesis of Mixed Terpenoid Compounds	PLOS ONE			English	Article							MEVALONATE PATHWAY; GENE-CLUSTER; AROMATIC PRENYLTRANSFERASES; HETEROLOGOUS EXPRESSION; NATURAL-PRODUCT; PRENYLATION; BACTERIUM; IDENTIFICATION; PHENAZINES; MECHANISM	Terpenoids are arguably the largest and most diverse family of natural products, featuring prominently in e.g. signalling, self-defence, UV-protection and electron transfer. Prenyl-transferases are essential players in terpenoid and hybrid isoprenoid biosynthesis that install isoprene units on target molecules and thereby often modulate their bioactivity. In our search for new prenyltransferase biocatalysts we focused on the marine-derived Streptomyces sp. CNQ-509, a particularly rich source of meroterpenoid chemistry. Sequencing and analysis of the genome of Streptomyces sp. CNQ-509 revealed seven putative phenol/phenazine-specific ABBA prenyltransferases, and one putative indole-specific ABBA prenyltransferase. To elucidate the substrate specificity of the ABBA prenyltransferases and to learn about their role in secondary metabolism, CnqP1-CnqP8 were produced in Escherichia coli and incubated with various aromatic and isoprenoid substrates. Five of the eight prenyltransferases displayed enzymatic activity. The efficient conversion of dihydroxynaphthalene derivatives by CnqP3 (encoded by AA958_24325) and the co-location of AA958_24325 with genes characteristic for the biosynthesis of THN (tetrahydroxynaphthalene)-derived natural products indicates that the enzyme is involved in the formation of debromomarinone or other naphthoquinone-derived meroterpenoids. Moreover, CnqP3 showed high flexibility towards a range of aromatic and isoprenoid substrates and thus represents an interesting new tool for biocatalytic applications.	[Leipoldt, Franziska; Zeyhle, Philipp; Heide, Lutz; Kaysser, Leonard] Univ Tubingen, Inst Pharmaceut, Pharmaceut Biol, Tubingen, Germany; [Leipoldt, Franziska; Heide, Lutz; Kaysser, Leonard] Partner Site Tubingen, German Ctr Infect Res DZIF, Tubingen, Germany; [Kulik, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbial Biotechnol, Tubingen, Germany; [Kalinowski, Joern] Univ Bielefeld, Microbial Genom & Biotechnol, Ctr Biotechnol, D-33615 Bielefeld, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research; Eberhard Karls University of Tubingen; University of Bielefeld	Kaysser, L (corresponding author), Univ Tubingen, Inst Pharmaceut, Pharmaceut Biol, Tubingen, Germany.	leonard.kaysser@pharm.uni-tuebingen.de	Kaysser, Leonard/Q-2091-2019	Kaysser, Leonard/0000-0002-3943-993X; Kulik, Andreas/0000-0002-6914-7313; Heide, Lutz/0000-0001-7809-7453	GenBioCom German Federal Ministry of Education and Research; German Centre for Infection Research (DZIF) - German Federal Ministry of Education and Research; DFG [SFB 766]; German Centre for Infection Research; German Federal Ministry of Education and Research (GenBioCom)	GenBioCom German Federal Ministry of Education and Research; German Centre for Infection Research (DZIF) - German Federal Ministry of Education and Research; DFG(German Research Foundation (DFG)); German Centre for Infection Research; German Federal Ministry of Education and Research (GenBioCom)	This work was supported by GenBioCom German Federal Ministry of Education and Research to JK and LH, and German Centre for Infection Research (DZIF) - German Federal Ministry of Education and Research to LK. AK was supported by grants from the DFG (SFB 766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank William Fenical and Paul R. Jensen ( University of California, San Diego, USA) for providing Streptomyces sp. CNQ-509. We are grateful to T. Bonitz, E. Haug-Schifferdecker, U. Metzger and K. Seeger for synthesis of DMAPP, GPP and FPP. Thanks to K. Seeger and Y. Haagen for generation of the nphB and fnq26 expression plasmids. The work was funded by the German Centre for Infection Research and the German Federal Ministry of Education and Research (GenBioCom). A. K. was supported by grants from the DFG (SFB 766).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bonitz T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085707; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; Brandt W, 2009, PHYTOCHEMISTRY, V70, P1758, DOI 10.1016/j.phytochem.2009.09.001; Cho JY, 2006, ORG LETT, V8, P2471, DOI 10.1021/ol060630r; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Espindola APDdM, 2008, THESIS; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Gallagher KA, 2010, CURR OPIN BIOTECH, V21, P794, DOI 10.1016/j.copbio.2010.09.010; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Haug-Schifferdecker E, 2010, J BIOL CHEM, V285, P16487, DOI 10.1074/jbc.M110.113720; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Izumikawa M, 2010, J NAT PROD, V73, P208, DOI 10.1021/np900747t; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kalaitzis JA, 2003, ORG LETT, V5, P4449, DOI 10.1021/ol035748b; Kawasaki T, 2003, J ANTIBIOT, V56, P957, DOI 10.7164/antibiotics.56.957; Kaysser L, 2012, J AM CHEM SOC, V134, P11988, DOI 10.1021/ja305665f; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kumano T, 2010, J BIOL CHEM, V285, P39663, DOI 10.1074/jbc.M110.153957; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Kuzuyama T, 2002, J ANTIBIOT, V55, P919, DOI 10.7164/antibiotics.55.919; Kwon HC, 2010, J NAT PROD, V73, P2047, DOI 10.1021/np1006229; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Park J, STRAIN CNQ 509 2010; PATHIRANA C, 1992, TETRAHEDRON LETT, V33, P7663, DOI 10.1016/0040-4039(93)88010-G; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Prieto-Davo A, 2008, AQUAT MICROB ECOL, V52, P1, DOI 10.3354/ame01211; Riclea R, 2011, CHEM-EUR J, V17, P11930, DOI 10.1002/chem.201101139; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruckert C, 2015, J BIOTECHNOL, V216, P140, DOI 10.1016/j.jbiotec.2015.08.009; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saleh O, 2012, MEDCHEMCOMM, V3, P1009, DOI 10.1039/c2md20045g; Saleh O, 2009, PHYTOCHEMISTRY, V70, P1728, DOI 10.1016/j.phytochem.2009.05.009; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt J, 2012, ORG LETT, V14, P4042, DOI 10.1021/ol300954s; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Seeger K, 2011, MICROB BIOTECHNOL, V4, P252, DOI 10.1111/j.1751-7915.2010.00234.x; Shindo K, 2011, BIOSCI BIOTECH BIOCH, V75, P505, DOI 10.1271/bbb.100731; SHINYA K, 1990, J ANTIBIOT, V43, P444, DOI 10.7164/antibiotics.43.444; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Teufel R, 2014, ANGEW CHEM INT EDIT, V53, P11019, DOI 10.1002/anie.201405694; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Zeyhle P, 2014, CHEMBIOCHEM, V15, P2385, DOI 10.1002/cbic.201402394	52	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143237	10.1371/journal.pone.0143237	http://dx.doi.org/10.1371/journal.pone.0143237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659564	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900007
J	Lukowski, A; Maderek, E; Giertych, MJ; Karolewski, P				Lukowski, Adrian; Maderek, Ewa; Giertych, Marian J.; Karolewski, Piotr			Sex Ratio and Body Mass of Adult Herbivorous Beetles Depend on Time of Occurrence and Light Conditions	PLOS ONE			English	Article							HOST-PLANT QUALITY; PRUNUS-SEROTINA; LEAF BEETLE; BIRD CHERRY; GONIOCTENA-QUINQUEPUNCTATA; INSECT HERBIVORE; FOOD QUALITY; TRADE-OFF; GROWTH; PERFORMANCE	Body mass and sex ratio (F/M) of folivorous insects are easily measured parameters that are commonly used to assess the effect of food quality, living conditions, and preferences on the selection of favourable sites for offspring. A study was conducted on the polyphagous beetle, Gonioctena quinquepunctata (a pest of the native Prunus padus and alien P. serotina) and on the monophagous beetle, Altica brevicollis coryletorum (a pest of Corylus avellana). Both species have a similar life cycle with emergence of current-year adults in summer, and reproduction of 1-year-old insects in spring. A. brevicollis coryletorum feeds primarily on sunlit shrubs, while G. quinquepunctata prefers shaded leaves. The present study assessed the effect of time of occurrence (insect age) on body mass in both sexes and on the sex ratio F/M, taking into account the influence of light conditions associated with their favoured food source (sunlit vs. shaded leaves). We hypothesized that a change in body mass in current-year insects would be determined by the amount of consumed food, while the sex ratio would be stable, when in 1-year-old insects females would die shortly after oviposition, while males would be active for a prolonged time. Results confirmed the hypothesis that changes in mass of current-year beetles was determined by the amount of food intake. We also found that in spring, unfertilized females coexist with fertilized ones and that the latter females live for some time after oviposition; resulting in fluctuations of the mean mass for females. In both species, 1-year-old beetles were heavier than current-year. The preference of A. brevicollis coryletorum for sunlit leaves results in a higher body weight than in G. quinquepunctata in both seasons. The data are consistent and indicate seasonal fluctuations in body mass and changes in the sex ratio in 1-year-old beetles, due to the entrance into their reproductive period.	[Lukowski, Adrian; Maderek, Ewa; Giertych, Marian J.; Karolewski, Piotr] Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; [Lukowski, Adrian] Poznan Univ Life Sci, Fac Forestry, Dept Forest Protect, Poznan, Poland; [Giertych, Marian J.] Univ ZielonaGora, Fac Biol Sci, Zielonagora, Poland	Polish Academy of Sciences; Poznan University of Life Sciences	Lukowski, A (corresponding author), Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland.	adrian.lukowski@gmail.com	Łukowski, Adrian/K-2923-2019; Giertych, Marian J/A-1618-2008	Łukowski, Adrian/0000-0002-4860-4984; Maderek, Ewa/0000-0003-3933-000X; Giertych, Marian/0000-0001-5578-9545; Karolewski, Piotr/0000-0003-3064-1274	National Science Centre, Poland [N N304 037640]; statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik	National Science Centre, Poland(National Science Centre, Poland); statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik	The research was financially supported by the National Science Centre, Poland (grant no. N N304 037640 for PK), the statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik, and grant for young scientists (for AL; Poznan University of Life Sciences, Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1992, TREE PHYSIOL, V10, P343, DOI 10.1093/treephys/10.4.343; Alonso C, 2000, ACTA OECOL, V21, P257, DOI 10.1016/S1146-609X(00)01082-1; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BARTKOWSKA J, 1975, Polskie Pismo Entomologiczne, V45, P633; Bjorkman C, 1997, OIKOS, V79, P45, DOI 10.2307/3546088; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Closset-Kopp D, 2007, FOREST ECOL MANAG, V247, P120, DOI 10.1016/j.foreco.2007.04.023; Crawley MJ, 1997, PLANT ECOL; Crone EE, 1999, J CHEM ECOL, V25, P635, DOI 10.1023/A:1020966206840; DEACON J, 1974, NEW PHYTOL, V73, P1055, DOI 10.1111/j.1469-8137.1974.tb01331.x; Decocq G, 2004, J APPL ECOL, V41, P1065, DOI 10.1111/j.0021-8901.2004.00960.x; DIXON AFG, 1971, ANN APPL BIOL, V68, P135, DOI 10.1111/j.1744-7348.1971.tb06450.x; Dominy NJ, 2008, ANN BOT-LONDON, V101, P1363, DOI 10.1093/aob/mcn046; Gantner M., 2002, Acta Scientiarum Polonorum - Hortorum Cultus, V1, P55; Giertych MJ, 2005, ENTOMOL EXP APPL, V117, P59, DOI 10.1111/j.1570-7458.2005.00332.x; Gokirmak T, 2009, GENET RESOUR CROP EV, V56, P147, DOI 10.1007/s10722-008-9352-8; Gruev Blagoy, 1997, Scopolia, V37, P1; Halarewicz A., 2011, Lene Pr Badaw, V72, P267; Halarewicz A, 2011, POL J ECOL, V59, P589; Hardin JW, 1997, J TORREY BOT SOC, V124, P124, DOI 10.2307/2996580; Harvey JA, 2012, ENTOMOL EXP APPL, V144, P14, DOI 10.1111/j.1570-7458.2012.01252.x; Heleno RH, 2009, CONSERV BIOL, V23, P410, DOI 10.1111/j.1523-1739.2008.01129.x; Hemming JDC, 1999, J CHEM ECOL, V25, P1687, DOI 10.1023/A:1020805420160; Henriksson J, 2003, OIKOS, V103, P3, DOI 10.1034/j.1600-0706.2003.12306.x; Jansen MPT, 1997, ENTOMOL EXP APPL, V82, P319, DOI 10.1023/A:1002916325052; Jaworski Tomasz, 2013, Lesne Prace Badawcze, V74, P345; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Kaplan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093714; Karolewski P, 2014, EUR J ENTOMOL, V111, P227, DOI 10.14411/eje.2014.026; Karolewski P, 2013, ACTA OECOL, V53, P19, DOI 10.1016/j.actao.2013.08.004; Karolewski P, 2010, TREE PHYSIOL, V30, P969, DOI 10.1093/treephys/tpq060; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Kral J., 1964, Entomologische Blaetter Krefeld, V60, P126; Kudo S, 1995, ECOL ENTOMOL, V20, P367, DOI 10.1111/j.1365-2311.1995.tb00469.x; LEATHER S R, 1986, Entomologist's Gazette, V37, P209; Leather SR, 1996, J ECOL, V84, P125, DOI 10.2307/2261707; Leather SR, 1995, EUR J ENTOMOL, V92, P623; Lee KP, 2010, ENTOMOL EXP APPL, V136, P151, DOI 10.1111/j.1570-7458.2010.01018.x; Lee M.R., 2004, BRUSH MANAGEMENT PRE; Levesque KR, 2002, B ENTOMOL RES, V92, P127, DOI 10.1079/BER2002153; Lukowski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126072; Lukowski A, 2014, SYLWAN, V158, P595; Maderek E, 2015, ENTOMOL EXP APPL, V155, P193, DOI 10.1111/eea.12298; Mardulyn P, 1997, SYST BIOL, V46, P722, DOI 10.2307/2413502; Mathur V, 2011, ENTOMOL EXP APPL, V139, P215, DOI 10.1111/j.1570-7458.2011.01122.x; Molina-Montenegro MA, 2006, ACTA OECOL, V30, P147, DOI 10.1016/j.actao.2006.02.008; Mooney EH, 2012, ECOLOGY, V93, P2683, DOI 10.1890/11-1620.1; Moreau G, 2003, OECOLOGIA, V135, P391, DOI 10.1007/s00442-003-1213-8; Nowakowska K, 2006, ELECT J POLISH AGR, V9, P05; Osier TL, 2007, ENTOMOL EXP APPL, V123, P159, DOI 10.1111/j.1570-7458.2007.00534.x; Paquette A, 2007, FOREST ECOL MANAG, V241, P278, DOI 10.1016/j.foreco.2007.01.004; Perez-Contreras T, 2014, ACTA OECOL, V55, P15, DOI 10.1016/j.actao.2013.10.006; Rehounek Jiri, 2002, Acta Universitatis Palackianae Olomucensis Facultas Rerum Naturalium Biologica, V39-40, P123; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Tong Y. F., 2006, Wetlands Ecology and Management, V14, P39, DOI 10.1007/s11273-005-2565-0; Tremmel M, 2013, BEHAV ECOL, V24, P386, DOI 10.1093/beheco/ars175; Urban J., 1998, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V46, P7; Uusitalo M, 2004, AGRIFOODRESEARCG REP; Vanhellemont M, 2009, THESIS; Wennstrom A, 2010, CHEMOECOLOGY, V20, P35, DOI 10.1007/s00049-010-0040-8	63	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144718	10.1371/journal.pone.0144718	http://dx.doi.org/10.1371/journal.pone.0144718			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657564	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900092
J	Rytioja, J; Hilden, K; Makinen, S; Vehmaanpera, J; Hatakka, A; Makela, MR				Rytioja, Johanna; Hilden, Kristiina; Makinen, Susanna; Vehmaanpera, Jari; Hatakka, Annele; Makela, Miia R.			Saccharification of Lignocelluloses by Carbohydrate Active Enzymes of the White Rot Fungus Dichomitus squalens	PLOS ONE			English	Article							CELLOBIOSE DEHYDROGENASE; TRICHODERMA-REESEI; PHANEROCHAETE-CHRYSOSPORIUM; SPRUCE WOOD; MANGANESE PEROXIDASES; DEGRADING ENZYMES; LIGNIN; PURIFICATION; XYLANASE; LACCASE	White rot fungus Dichomitus squalens is an efficient lignocellulose degrading basidiomycete and a promising source for new plant cell wall polysaccharides depolymerizing enzymes. In this work, we focused on cellobiohydrolases (CBHs) of D. squalens. The native CBHI fraction of the fungus, consisting three isoenzymes, was purified and it maintained the activity for 60 min at 50 degrees C, and was stable in acidic pH. Due to the lack of enzyme activity assay for detecting only CBHII activity, CBHII of D. squalens was produced recombinantly in an industrially important ascomycete host, Trichoderma reesei. CBH enzymes of D. squalens showed potential in hydrolysis of complex lignocellulose substrates sugar beet pulp and wheat bran, and microcrystalline cellulose, Avicel. Recombinant CBHII (rCel6A) of D. squalens hydrolysed all the studied plant biomasses. Compared to individual activities, synergistic effect between rCel6A and native CBHI fraction of D. squalens was significant in the hydrolysis of Avicel. Furthermore, the addition of laccase to the mixture of CBHI fraction and rCel6A significantly enhanced the amount of released reducing sugars from sugar beet pulp. Especially, synergy between individual enzymes is a crucial factor in the tailor-made enzyme mixtures needed for hydrolysis of different plant biomass feedstocks. Our data supports the importance of oxidoreductases in improved enzyme cocktails for lignocellulose saccharification.	[Rytioja, Johanna; Hilden, Kristiina; Hatakka, Annele; Makela, Miia R.] Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Helsinki, Finland; [Makinen, Susanna; Vehmaanpera, Jari] Roal Oy, Rajamaki, Finland	University of Helsinki	Makela, MR (corresponding author), Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Helsinki, Finland.	miia.r.makela@helsinki.fi	Mäkelä, Miia R./F-2181-2011; Hildén, Kristiina/B-7766-2009	Mäkelä, Miia R./0000-0003-0771-2329; Hildén, Kristiina/0000-0002-0126-8186; Hatakka, Annele/0000-0001-7056-3931; Karppi, Johanna/0000-0002-8393-6546	European Community's Seventh Framework Programme (FP7) under the project NEMO [222699]	European Community's Seventh Framework Programme (FP7) under the project NEMO	Funding for the research was received from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project NEMO (grant agreement no. 222699). The Doctoral Programme of Biomass Biorefining (BIOREGS), the Doctoral Programme of Microbiology and Biotechnology (MBDP) and the Finnish Cultural Foundation are acknowledged for the personal grants to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY MJ, 1981, ENZYME MICROB TECH, V3, P153, DOI 10.1016/0141-0229(81)90076-4; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Baminger U, 2001, APPL ENVIRON MICROB, V67, P1766, DOI 10.1128/AEM.67.4.1766-1774.2001; Baminger U, 1999, J MICROBIOL METH, V35, P253, DOI 10.1016/S0167-7012(99)00022-6; Bergmans MEF, 1996, J CEREAL SCI, V23, P235, DOI 10.1006/jcrs.1996.0024; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Boer H, 2000, BIOTECHNOL BIOENG, V69, P486, DOI 10.1002/1097-0290(20000905)69:5<486::AID-BIT3>3.0.CO;2-N; BRILLOUET JM, 1985, CARBOHYD RES, V144, P113, DOI 10.1016/0008-6215(85)85012-6; Budak SO, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-523; Energy research Centre of the Netherlands, 2012, PHYLLIS2 DAT BIOM WA; Fackler K, 2006, ENZYME MICROB TECH, V39, P1476, DOI 10.1016/j.enzmictec.2006.03.043; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Hakala TK, 2005, ENZYME MICROB TECH, V36, P461, DOI 10.1016/j.enzmictec.2004.10.004; Hakala TK, 2004, ENZYME MICROB TECH, V34, P255, DOI 10.1016/j.enzmictec.2003.10.014; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Igarashi K, 1998, EUR J BIOCHEM, V253, P101, DOI 10.1046/j.1432-1327.1998.2530101.x; JOUTSJOKI VV, 1993, CURR GENET, V24, P223, DOI 10.1007/BF00351796; Jurado M, 2009, BIORESOURCE TECHNOL, V100, P6378, DOI 10.1016/j.biortech.2009.07.049; Kamal-Eldin Afaf, 2009, Food Nutr Res, V53, DOI 10.3402/fnr.v53i0.1912; KARHUNEN T, 1993, MOL GEN GENET, V241, P515, DOI 10.1007/BF00279893; Kudanga T, 2014, APPL MICROBIOL BIOT, V98, P6525, DOI 10.1007/s00253-014-5810-8; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Li DM, 1999, BBA-PROTEIN STRUCT M, V1434, P356, DOI 10.1016/S0167-4838(99)00191-0; Liu Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1432, DOI 10.1271/bbb.80888; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lucatero S, 2004, BIOTECHNOL LETT, V26, P41, DOI 10.1023/B:BILE.0000009458.58602.d9; Micard V, 1996, ENZYME MICROB TECH, V19, P162, DOI 10.1016/0141-0229(95)00224-3; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moilanen U, 2011, ENZYME MICROB TECH, V49, P492, DOI 10.1016/j.enzmictec.2011.09.012; Mukelu MR., 2014, FUNGAL GENOMICS, P175, DOI DOI 10.1007/978-3-642-45218-5_8; Paloheimo M, 2003, APPL ENVIRON MICROB, V69, P7073, DOI 10.1128/AEM.69.12.7073-7082.2003; Palonen H, 2004, BIOTECHNOL BIOENG, V86, P550, DOI 10.1002/bit.20135; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Perie FH, 1996, BBA-PROTEIN STRUCT M, V1297, P139, DOI 10.1016/S0167-4838(96)00096-9; Perie FH, 1998, ARCH BIOCHEM BIOPHYS, V353, P349, DOI 10.1006/abbi.1998.0625; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V146, P118, DOI 10.1016/j.biortech.2013.07.069; REESE ET, 1969, APPL MICROBIOL, V17, P242, DOI 10.1128/AEM.17.2.242-245.1969; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; ROUAU X, 1986, CARBOHYD RES, V145, P279, DOI 10.1016/S0008-6215(00)90435-X; Rytioja J, 2014, MICROBIOL MOL BIOL R, V78, P614, DOI 10.1128/MMBR.00035-14; Rytioja J, 2014, FUNGAL GENET BIOL, V72, P91, DOI 10.1016/j.fgb.2013.12.008; Susla M, 2007, BIORESOURCE TECHNOL, V98, P2109, DOI 10.1016/j.biortech.2006.08.007; Temp U, 1999, APPL ENVIRON MICROB, V65, P389; Toda H, 2008, BIOSCI BIOTECH BIOCH, V72, P3142, DOI 10.1271/bbb.80316; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; VANTILBEURGH H, 1982, FEBS LETT, V149, P152, DOI 10.1016/0014-5793(82)81092-2; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Varnai A, 2011, BIORESOURCE TECHNOL, V102, P9096, DOI 10.1016/j.biortech.2011.06.059; Varnai A, 2011, BIORESOURCE TECHNOL, V102, P1220, DOI 10.1016/j.biortech.2010.07.120; VENKATADRI R, 1990, APPL ENVIRON MICROB, V56, P2684, DOI 10.1128/AEM.56.9.2684-2691.1990; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Yoshida M, 2009, BIOSCI BIOTECH BIOCH, V73, P67, DOI 10.1271/bbb.80477	55	12	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145166	10.1371/journal.pone.0145166	http://dx.doi.org/10.1371/journal.pone.0145166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660105	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900189
J	Saleem, S; Azam, A; Maqsood, SI; Muslim, I; Bashir, S; Fazal, N; Riaz, M; Ali, SHB; Niazi, MK; Ishaq, M; Waheed, NK; Qamar, R; Azam, M				Saleem, Saba; Azam, Aisha; Maqsood, Sundus Ijaz; Muslim, Irfan; Bashir, Shaheena; Fazal, Nosheen; Riaz, Moeen; Ali, Syeda Hafiza Benish; Niazi, Muhammad Khizar; Ishaq, Mazhar; Waheed, Nadia Khalida; Qamar, Raheel; Azam, Maleeha			Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; ANGIOTENSIN-CONVERTING ENZYME; ENDOTHELIAL GROWTH-FACTOR; INSERTION/DELETION POLYMORPHISM; DELETION POLYMORPHISM; 4G/5G POLYMORPHISM; GENETIC-VARIATION; I/D POLYMORPHISM; PROMOTER 4G/5G; ASSOCIATION	In the present study we determined the association of angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms with diabetic retinopathy (DR) and its sub-clinical classes in Pakistani type 2 diabetic patients. A total of 353 diabetic subjects including 160 DR and 193 diabetic non retinopathy (DNR) as well as 198 healthy controls were genotyped by allele specific polymerase chain reaction (PCR) for ACE Insertion/Deletion (ID) polymorphism, rs4646994 in intron 16 and PAI-1 4G/5G (deletion/insertion) polymorphism, rs1799768 in promoter region of the gene. To statistically assess the genotype-phenotype association, multivariate logistic regression analysis was applied to the genotype data of DR, DNR and control individuals as well as the subtypes of DR. The ACE genotype ID was found to be significantly associated with DR (p = 0.009, odds ratio (OR) 1.870 [95% confidence interval (CI) = 1.04-3.36]) and its sub-clinical class non-proliferative DR (NPDR) (p = 0.006, OR 2.250 [95% CI = 1.098-4.620]), while PAI polymorphism did not show any association with DR in the current cohort. In conclusion in Pakistani population the ACE ID polymorphism was observed to be significantly associated with DR and NPDR, but not with the severe form of the disease i.e. proliferative DR (PDR).	[Saleem, Saba; Bashir, Shaheena; Fazal, Nosheen; Riaz, Moeen; Ali, Syeda Hafiza Benish; Qamar, Raheel; Azam, Maleeha] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Azam, Aisha; Muslim, Irfan] Mayo Hosp, Inst Ophthalmol, Lahore, Pakistan; [Maqsood, Sundus Ijaz] Royal Coll Ophthalmologists, Mersey Deanery, England; [Niazi, Muhammad Khizar; Ishaq, Mazhar] Armed Forces Inst Ophthalmol, Rawalpindi, Pakistan; [Niazi, Muhammad Khizar; Ishaq, Mazhar] Army Med Coll, Rawalpindi, Pakistan; [Waheed, Nadia Khalida] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan; [Qamar, Raheel] Pakistan Acad Sci, Islamabad, Pakistan	COMSATS University Islamabad (CUI); National University of Sciences & Technology - Pakistan; Tufts University	Qamar, R (corresponding author), COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan.	raheelqamar@hotmail.com; malihazam@gmail.com	Niazi, Muhammad Khizar/AAM-5459-2020; Azam, Maleeha/AAD-9924-2022; Azam, Maleeha/L-1721-2017	Niazi, Muhammad Khizar/0000-0003-3870-3599; Azam, Maleeha/0000-0003-0170-3325	Higher Education Commission (HEC) Pakistan [3738]; COMSATS Institute of Information Technology, Islamabad, Pakistan	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan); COMSATS Institute of Information Technology, Islamabad, Pakistan	This work was funded by a grant from Higher Education Commission (HEC) Pakistan (3738) to MA and RQ and by a core grant to RQ from the COMSATS Institute of Information Technology, Islamabad, Pakistan.	Ahmed W, 2011, MOL BIOL REP, V38, P2541, DOI 10.1007/s11033-010-0392-8; Anderson JL, 1999, J AM COLL CARDIOL, V34, P1778, DOI 10.1016/S0735-1097(99)00424-6; Broch M, 1998, DIABETES CARE, V21, P463, DOI 10.2337/diacare.21.3.463a; Dobrovolsky AB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P99, DOI 10.1023/A:1013960416302; Downie LE, 2009, NEUROSCIENCE, V161, P195, DOI 10.1016/j.neuroscience.2009.02.084; Ezzidi I, 2009, DIABETES METAB, V35, P214, DOI 10.1016/j.diabet.2008.12.002; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Globocnik-Petrovic M, 2003, OPHTHALMOLOGICA, V217, P219, DOI 10.1159/000068975; Gutierrez C, 1997, METABOLISM, V46, P976, DOI 10.1016/S0026-0495(97)90090-1; Ishizaki E, 2006, AM J OPHTHALMOL, V141, P129, DOI 10.1016/j.ajo.2005.08.066; Kathiresan S, 2005, CIRCULATION, V112, P1728, DOI 10.1161/CIRCULATIONAHA.105.547836; Kimura H, 1998, KIDNEY INT, V54, P1659, DOI 10.1046/j.1523-1755.1998.00139.x; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Lu Y, 2012, J RENIN-ANGIO-ALDO S, V13, P289, DOI 10.1177/1470320311432187; MANSFIELD MW, 1994, THROMB HAEMOSTASIS, V71, P731; Garcia PJM, 2014, WORLD J CARDIOL, V6, P968, DOI 10.4330/wjc.v6.i9.968; Matsumoto A, 2000, DIABETES RES CLIN PR, V50, P195, DOI 10.1016/S0168-8227(00)00194-7; Matsushita K, 2010, INVEST OPHTH VIS SCI, V51, P5979, DOI 10.1167/iovs.10-5377; Mazaheri H, 2015, IRAN J PUBLIC HEALTH, V44, P369; Meigs JB, 2006, OBESITY, V14, P753, DOI 10.1038/oby.2006.85; MIGDALIS IN, 1990, SOUTHERN MED J, V83, P425; Nagi DK, 1996, DIABETIC MED, V13, P59, DOI 10.1002/(SICI)1096-9136(199601)13:1<59::AID-DIA2>3.0.CO;2-Z; Nagi DK, 1997, DIABETES CARE, V20, P1304, DOI 10.2337/diacare.20.8.1304; NAGI DK, 1995, DIABETIC MED, V12, P997, DOI 10.1111/j.1464-5491.1995.tb00412.x; NAKAI K, 1994, CIRCULATION, V90, P2199, DOI 10.1161/01.CIR.90.5.2199; Ng DPK, 2008, DIABETES, V57, P2541, DOI 10.2337/db08-0581; Nikzamir A, 2010, OPHTHALMIC GENET, V31, P108, DOI 10.3109/13816810.2010.482554; Olszowski T, 2015, CARIES RES, V49, P390, DOI 10.1159/000381962; Otani A, 1998, CIRC RES, V82, P619, DOI 10.1161/01.RES.82.5.619; Puavilai G, 1999, DIABETES RES CLIN PR, V44, P21, DOI 10.1016/S0168-8227(99)00008-X; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Santos KG, 2003, DIABETES RES CLIN PR, V61, P133, DOI 10.1016/S0168-8227(03)00112-8; Tariq K, 2013, MOL VIS, V19, P710; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wang J, 2010, HUM HERED, V69, P212, DOI 10.1159/000289597; Wong TYH, 2000, KIDNEY INT, V57, P632; Zhang Wenbo, 2011, J Cardiovasc Dis Res, V2, P96, DOI 10.4103/0975-3583.83035	37	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144557	10.1371/journal.pone.0144557	http://dx.doi.org/10.1371/journal.pone.0144557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658948	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900063
J	Salem, TZ; Seaborn, CP; Turney, CM; Xue, JL; Shang, H; Cheng, XW				Salem, Tamer Z.; Seaborn, Craig P.; Turney, Colin M.; Xue, Jianli; Shang, Hui; Cheng, Xiao-Wen			The Influence of SV40 polyA on Gene Expression of Baculovirus Expression Vector Systems	PLOS ONE			English	Article							MESSENGER-RNA; POLYADENYLATION; TRANSLATION; SEQUENCE; TRANSCRIPTION; RECOGNITION; POLYMERASE; CLEAVAGE; SUBUNIT; VACCINE	The simian virus 40 polyadenylation signal (SV40 polyA) has been routinely inserted downstream of the polyhedrin promoter in many baculovirus expression vector systems (BEVS). In the baculovirus prototype Autographa californica multiple nucleopolyhedrovirus (AcMNPV), the polyhedrin promoter (very late promoter) transcribes its gene by a viral RNA polymerase therefore there is no supporting evidence that SV40 polyA is required for the proper gene expression under the polyhedrin promoter. Moreover, the effect of the SV40 polyA sequence on the polyhedrin promoter activity has not been tested either at its natural polyhedrin locus or in other loci in the viral genome. In order to test the significance of adding the SV40 polyA sequence on gene expression, the expression of the enhanced green fluorescent protein (egfp) was evaluated with and without the presence of SV40 polyA under the control of the polyhedrin promoter at different genomic loci (polyherin, ecdysteroid UDP-glucosyltransferase (egt), and gp37). In this study, spectrofluorometry and western blot showed reduction of EGFP protein for all recombinant viruses with SV40 polyA, whereas qPCR showed an increase in the egfp mRNA levels. Therefore, we conclude that SV40 polyA increases mRNA levels but decreases protein production in the BEVS when the polyhedrin promoter is used at different loci. This work suggests that SV40 polyA in BEVSs should be replaced by an AcMNPV late gene polyA for optimal protein production or left untouched for optimal RNA production (RNA interference applications).	[Salem, Tamer Z.; Seaborn, Craig P.; Turney, Colin M.; Xue, Jianli; Shang, Hui; Cheng, Xiao-Wen] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Salem, Tamer Z.] Univ Sci & Technol Zewail City, Biomed Sci, Giza, Egypt; [Salem, Tamer Z.] ARC, AGERI, Dept Microbial Mol Biol, Giza, Egypt	University System of Ohio; Miami University; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Salem, TZ (corresponding author), Miami Univ, Dept Microbiol, 32 Pearson Hall, Oxford, OH 45056 USA.	tsalem@zewailcity.edu.eg; Chengx@MiamiOH.edu	CHENG, Xiao-Wen/AAA-6949-2020; Salem, Tamer/I-5778-2019	Salem, Tamer/0000-0002-6264-5037	US Department of Agriculture (US-Egypt Science and Technology Joint Fund) [58-3148-7-164]; National Natural Science Foundation of China [31228020]	US Department of Agriculture (US-Egypt Science and Technology Joint Fund); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the US Department of Agriculture (US-Egypt Science and Technology Joint Fund project no. 58-3148-7-164) and National Natural Science Foundation of China (contract no. 31228020); We thank Mike Hughes for help in statistical analyses and Dr. Fareed Aboul-Ela for proofreading of the manuscript. This research is partially supported by the US Department of Agriculture (US-Egypt Science and Technology Joint Fund project no. 58-3148-7-164) and the National Natural Science Foundation of China (31228020) to XWC.	Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; BLISSARD GW, 1990, ANNU REV ENTOMOL, V35, P127, DOI 10.1146/annurev.en.35.010190.001015; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Cheng XW, 2001, J GEN VIROL, V82, P299, DOI 10.1099/0022-1317-82-2-299; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Deschuyteneer M, 2010, HUM VACCINES, V6, P407, DOI 10.4161/hv.6.5.11023; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Herniou E. A., 2012, VIRUS TAXONOMY, P163; Jarvis DL, 2009, METHOD ENZYMOL, V463, P191, DOI 10.1016/S0076-6879(09)63014-7; Jin JP, 2000, J VIROL, V74, P8930, DOI 10.1128/JVI.74.19.8930-8937.2000; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; KUZIO J, 1984, VIROLOGY, V139, P414, DOI 10.1016/0042-6822(84)90388-X; Luckow V. A, 1991, Recombinant DNA technology and applications., P97; MAEDA S, 1989, BIOCHEM BIOPH RES CO, V165, P1177, DOI 10.1016/0006-291X(89)92726-5; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Passarelli A. Lorena, 2007, Virologica Sinica, V22, P94; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Tani H, 2008, FUTURE VIROL, V3, P35, DOI 10.2217/17460794.3.1.35; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Oers MM, 1999, J GEN VIROL, V80, P2253, DOI 10.1099/0022-1317-80-8-2253; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; WESTWOOD JA, 1993, VIROLOGY, V195, P90, DOI 10.1006/viro.1993.1349; WU JG, 1989, J GEN VIROL, V70, P2449, DOI 10.1099/0022-1317-70-9-2449; Xue J-L, 2011, CURRENT PROTOCOLS MI; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019	30	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145019	10.1371/journal.pone.0145019	http://dx.doi.org/10.1371/journal.pone.0145019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659470	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900170
J	Xu, JH; Peng, ZC				Xu, Jianhua; Peng, Zongchao			People at Risk of Influenza Pandemics: The Evolution of Perception and Behavior	PLOS ONE			English	Article							H1N1 INFLUENZA; INFECTION; CAMPAIGNS; MORTALITY; IMPACT	Influenza pandemics can severely impact human health and society. Understanding public perception and behavior toward influenza pandemics is important for minimizing the effects of such events. Public perception and behavior are expected to change over the course of an influenza pandemic, but this idea has received little attention in previous studies. Our study aimed to understand the dynamics of public perception and behavior over the course of the 2009 H1N1 influenza pandemic. Three consecutive cross-sectional surveys were administered among Beijing residents with random-digit dialing techniques in March 2008 and August and November 2009. Effective samples of 507, 508 and 1006 respondents were interviewed in each of the three surveys, respectively. The mean scores of risk perception were low to moderate across the three surveys. The perceived risk of infection of self was significantly lower than that of the community, revealing an optimistic bias. Longitudinally, the perceived risk of contracting H1N1 increased, whereas the perceived risk of being unable to obtain medicine and medical care once influenza permeated the community first increased and then decreased. Responsive actions toward influenza varied. Most respondents took actions that required little extra effort, such as ventilating rooms; these actions did not change over time. Comparatively, a smaller number of respondents took actions for coping with influenza, such as vaccination; however, these actions were taken by an increasing number of respondents over time. The association between risk perception and behavior was unstable. Positive, insignificant, and negative associations were obtained in the three surveys. In conclusion, the evolving patterns of risk perception and responsive behavior over the course of an influenza pandemic are sensitive to how risk and behavior are defined and scoped.	[Xu, Jianhua] Peking Univ, Coll Environm Sci & Engn, Beijing 100871, Peoples R China; [Xu, Jianhua; Peng, Zongchao] Tsinghua Univ, Sch Publ Policy & Management, Ctr Crisis Management Res, Beijing 100084, Peoples R China	Peking University; Tsinghua University	Peng, ZC (corresponding author), Tsinghua Univ, Sch Publ Policy & Management, Ctr Crisis Management Res, Beijing 100084, Peoples R China.	pengzch@mail.tsinghua.edu.cn			National Natural Science Foundation of China [91024031, 91124003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China under grant nos. 91024031 and 91124003, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Natural Science Foundation of China under Grant No. 91024031 and 91124003. We are very grateful to Tian Tang and Beibei Zou, who were graduate students at Tsinghua University, for their contributions in data collection.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2010, LONGMAN DICTIONARY O, P1980; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Cao B, 2009, EMERG INFECT DIS, V15, P1418, DOI 10.3201/eid1509.090794; Collignon PJ, 2006, MED J AUSTRALIA, V185, pS54; Congressional Budget Office, 2005, POT INFL PAND POSS M; Eastwood K, 2010, EMERG INFECT DIS, V16, P1211, DOI 10.3201/eid1608.100132; Edwards W, 1954, PSYCHOL BULL, V51, P27; Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2; Gostin LO, 2004, J LAW MED ETHICS, V32, P565, DOI 10.1111/j.1748-720X.2004.tb01962.x; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Juckett G, 2006, AM FAM PHYSICIAN, V74, P783; Karademas EC, 2013, J HEALTH PSYCHOL, V18, P419, DOI 10.1177/1359105312436765; Karlsson M, 2014, J HEALTH ECON, V36, P1, DOI 10.1016/j.jhealeco.2014.03.005; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Liang HG, 2004, INT J MED INFORM, V73, P675, DOI 10.1016/j.ijmedinf.2004.05.010; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Ministry of Health, 2005, PREPAREDNESS AND CON; Ofri D, 2009, NEW ENGL J MED, V361, P2594, DOI 10.1056/NEJMp0911047; Oshitani Hitoshi, 2006, Journal of Infection and Chemotherapy, V12, P167, DOI 10.1007/s10156-006-0453-z; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016460; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Slater MD, 1999, HEALTH COMMUN, V11, P335, DOI 10.1207/S15327027HC1104_2; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SteelFisher GK, 2012, LANCET INFECT DIS, V12, P845, DOI 10.1016/S1473-3099(12)70206-2; SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102; Tooher R, 2013, INFLUENZA OTHER RESP, V7, P1316, DOI 10.1111/irv.12103; van der Pligt J, 1996, EUR PSYCHOL, V1, P34, DOI 10.1027/1016-9040.1.1.34; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; WEISS JA, 1994, J POLICY ANAL MANAG, V13, P82, DOI 10.2307/3325092; WHO, 2008, WHO OUTBREAK COMMUNI; WHO, 2009, SWINE INFLUENZA; WHO, 2008, WHO GUIDELINES FOR E; Wong LP, 2011, J BEHAV MED, V34, P23, DOI 10.1007/s10865-010-9283-7; World Health Organization, 2005, WHO GLOBAL INFLUENZA; Xue L, 2014, CHINAS CRISIS MANAGE, P57; Yang P, 2010, J INFECTION, V61, P277, DOI 10.1016/j.jinf.2010.07.010; Yates F.J., 1992, RISK TAKING BEHAV, P1	44	23	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144868	10.1371/journal.pone.0144868	http://dx.doi.org/10.1371/journal.pone.0144868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658371	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900126
J	Zhang, N; Wen, J; Zimmer, EA				Zhang, Ning; Wen, Jun; Zimmer, Elizabeth A.			Congruent Deep Relationships in the Grape Family (Vitaceae) Based on Sequences of Chloroplast Genomes and Mitochondrial Genes via Genome Skimming	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; BIOGEOGRAPHIC DIVERSIFICATION; INTERCONTINENTAL DISJUNCTIONS; AUSTRALIAN VITACEAE; MOLECULAR PHYLOGENY; SPECIES TREES; NORTH-AMERICA; MIXED MODELS; NUCLEAR; DNA	Vitaceae is well-known for having one of the most economically important fruits, i.e., the grape (Vitis vinifera). The deep phylogeny of the grape family was not resolved until a recent phylogenomic analysis of 417 nuclear genes from transcriptome data. However, it has been reported extensively that topologies based on nuclear and organellar genes may be incongruent due to differences in their evolutionary histories. Therefore, it is important to reconstruct a backbone phylogeny of the grape family using plastomes and mitochondrial genes. In this study, next-generation sequencing data sets of 27 species were obtained using genome skimming with total DNAs from silica-gel preserved tissue samples on an Illumina HiSeq 2500 instrument. Plastomes were assembled using the combination of de novo and reference genome (of V. vinifera) methods. Sixteen mitochondrial genes were also obtained via genome skimming using the reference genome of V. vinifera. Extensive phylogenetic analyses were performed using maximum likelihood and Bayesian methods. The topology based on either plastome data or mitochondrial genes is congruent with the one using hundreds of nuclear genes, indicating that the grape family did not exhibit significant reticulation at the deep level. The results showcase the power of genome skimming in capturing extensive phylogenetic data: especially from chloroplast and mitochondrial DNAs.	[Zhang, Ning; Wen, Jun; Zimmer, Elizabeth A.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC 166, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC 166, Washington, DC 20013 USA.	wenj@si.edu; zimmerl@si.edu			National Museum of Natural History; Laboratories of Analytical Biology of the Smithsonian National Museum of Natural History (NMNH); National Science Foundation [DEB 0743474]; Smithsonian Institution	National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); Laboratories of Analytical Biology of the Smithsonian National Museum of Natural History (NMNH); National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution)	This study was supported by a Peter Buck Postdoctoral Fellowship from the National Museum of Natural History, Smithsonian Institution, awarded to Ning Zhang, the Laboratories of Analytical Biology of the Smithsonian National Museum of Natural History (NMNH), a grant from the National Science Foundation (DEB 0743474 to S.R. Manchester and J. Wen), a Smithsonian Endowment Grant, and the Small Grants Program of the National Museum of Natural History.	Barrett CF, 2015, NEW PHYTOL; Blischak PD, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400044; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Govindarajulu R, 2015, AM J BOT, V102, P544, DOI 10.3732/ajb.1500026; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; Ingrouille MJ, 2002, BOT J LINN SOC, V138, P421, DOI 10.1046/j.1095-8339.2002.00028.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu XQ, 2013, MOL PHYLOGENET EVOL, V66, P43, DOI 10.1016/j.ympev.2012.09.003; Lu LM, 2013, MOL PHYLOGENET EVOL, V68, P502, DOI 10.1016/j.ympev.2013.04.023; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; Mandel JR, 2015, J SYST EVOL, V53, P391, DOI 10.1111/jse.12167; Mandel JR, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300085; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Nie ZL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-17; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Richardson AO, 2007, J EXP BOT, V58, P1, DOI 10.1093/jxb/erl148; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rossetto M, 2002, SYST BOT, V27, P522; Rossetto M, 2001, GENET RESOUR CROP EV, V48, P307, DOI 10.1023/A:1011225319360; Rossetto M, 2007, CAN J BOT, V85, P722, DOI 10.1139/B07-022; Rothfels CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076957; Soejima A, 2006, AM J BOT, V93, P278, DOI 10.3732/ajb.93.2.278; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; WEN J, 2013, PHILIPP J SCI, V142, P223; Wen J, 2015, BOTANY, V2015; Wen J., 2007, FAMILIES GENERA VASC, P466, DOI [10.1007/978-3-540-32219-1_54, DOI 10.1007/978-3-540-32219-1_54]; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Wen J, 2014, PHYTOKEYS, V42, P11, DOI 10.3897/phytokeys.42.7704; Wen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074394; Wolf PG, 2015, GENOME BIOL EVOL; Yi TS, 2015, MOL PHYLOGENET EVOL, V85, P10, DOI 10.1016/j.ympev.2014.09.028; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zimmer EA, 2015, J SYST EVOL, V53, P371, DOI 10.1111/jse.12174; Zimmer EA, 2013, MOL PHYLOGENET EVOL, V66, P539, DOI 10.1016/j.ympev.2013.01.005	52	66	67	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144701	10.1371/journal.pone.0144701	http://dx.doi.org/10.1371/journal.pone.0144701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656830	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900090
J	Cetkovska, K; Sustova, H; Kosztyu, P; Uldrijan, S				Cetkovska, Katerina; Sustova, Hana; Kosztyu, Pavlna; Uldrijan, Stjepan			A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; WILLIAMS-BEUREN-SYNDROME; P53 TUMOR-SUPPRESSOR; LONG TERMINAL REPEAT; HISTONE DEACETYLASE-3; HUMAN CYTOMEGALOVIRUS; P53-INDEPENDENT ROLE; HIV-1 TRANSCRIPTION; ACIDIC DOMAIN; CELL-CYCLE	Williams-Beuren syndrome-associated transcription factor TFII-I plays a critical regulatory role in bone and neural tissue development and in immunity, in part by regulating cell proliferation in response to mitogens. Mdm2, a cellular oncogene responsible for the loss of p53 tumor suppressor activity in a significant proportion of human cancers, was identified in this study as a new binding partner for TFII-I and a negative regulator of TFII-I-mediated transcription. These findings suggest a new p53-independent mechanism by which increased Mdm2 levels found in human tumors could influence cancer cells. In addition to that, we present data indicating that TFII-I is an important cellular regulator of transcription from the immediate-early promoter of human cytomegalovirus, a promoter sequence frequently used in mammalian expression vectors, including vectors for gene therapy. Our observation that Mdm2 over-expression can decrease the ability of TFII-I to activate the CMV promoter might have implications for the efficiency of experimental gene therapy based on CMV promoter-derived vectors in cancers with Mdm2 gene amplification.	[Cetkovska, Katerina; Uldrijan, Stjepan] St Annes Univ Hosp, Int Clin Res Ctr, Ctr Biomol & Cellular Engn, Brno, Czech Republic; [Cetkovska, Katerina; Sustova, Hana; Kosztyu, Pavlna; Uldrijan, Stjepan] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno	Uldrijan, S (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Ctr Biomol & Cellular Engn, Brno, Czech Republic.	uldrijan@med.muni.cz	Uldrijan, Stjepan/N-1664-2016	Uldrijan, Stjepan/0000-0001-8316-2539	European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Czech Science Foundation [301/09/1324]; Ministry of Education, Youth and Sports of the Czech Republic (Specific University Research Grant) [MUNI/A/1123/2014]	European Regional Development Fund - Project FNUSA-ICRC; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic (Specific University Research Grant)	This work was supported by the European Regional Development Fund - Project FNUSA-ICRC (CZ.1.05/1.1.00/02.0123), the Czech Science Foundation (Project 301/09/1324), and by the Ministry of Education, Youth and Sports of the Czech Republic (Specific University Research Grant MUNI/A/1123/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2008, MOL CELL BIOCHEM, V316, P99, DOI 10.1007/s11010-008-9816-3; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Barami K, 2010, J CLIN NEUROSCI, V17, P819, DOI 10.1016/j.jocn.2009.10.040; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Cheriyath V, 2002, J BIOL CHEM, V277, P22798, DOI 10.1074/jbc.M202956200; Cheriyath V, 1998, MOL CELL BIOL, V18, P4444, DOI 10.1128/MCB.18.8.4444; Cross B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228981; Crusselle-Davis VJ, 2007, FEBS J, V274, P6065, DOI 10.1111/j.1742-4658.2007.06128.x; Dahabieh MS, 2011, VIROLOGY, V418, P57, DOI 10.1016/j.virol.2011.07.002; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Dimitriadi M, 2008, BRIT J CANCER, V99, P1144, DOI 10.1038/sj.bjc.6604643; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hakre S, 2006, MOL CELL, V24, P301, DOI 10.1016/j.molcel.2006.09.005; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Isomura H, 2005, J VIROL, V79, P9597, DOI 10.1128/JVI.79.15.9597-9607.2005; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Johnson-Pais T, 2001, P NATL ACAD SCI USA, V98, P2211, DOI 10.1073/pnas.051415898; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lazebnik MB, 2009, J BIOL CHEM, V284, P36234, DOI 10.1074/jbc.C109.063115; Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012; Liu CYY, 2009, J VIROL, V83, P3604, DOI 10.1128/JVI.01778-08; Macias MP, 1996, J VIROL, V70, P3628, DOI 10.1128/JVI.70.6.3628-3635.1996; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; MAIO JJ, 1988, J VIROL, V62, P1398, DOI 10.1128/JVI.62.4.1398-1407.1988; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Matlaf LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068176; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Mobley CM, 2000, J VIROL, V74, P6511, DOI 10.1128/JVI.74.14.6511-6519.2000; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Montano MA, 1996, P NATL ACAD SCI USA, V93, P12376, DOI 10.1073/pnas.93.22.12376; Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; REIFENBERGER G, 1993, CANCER RES, V53, P2736; Rodova M, 2013, PLASMID, V69, P223, DOI 10.1016/j.plasmid.2013.01.004; Roy AL, 2007, BBA-GENE STRUCT EXPR, V1769, P613, DOI 10.1016/j.bbaexp.2007.10.002; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Sacrist n C, 2004, J BIOL CHEM, V279, P7147, DOI 10.1074/jbc.M303724200; Sadowski I, 2005, EUR J CANCER, V41, P2528, DOI 10.1016/j.ejca.2005.08.011; Shen X, 2009, GENES CELLS, V14, P1133, DOI 10.1111/j.1365-2443.2009.01340.x; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Taylor HE, 2011, J VIROL, V85, P7699, DOI 10.1128/JVI.00337-11; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wen YD, 2003, J BIOL CHEM, V278, P1841, DOI 10.1074/jbc.M206528200; Wright J, 2015, J VIROL, V89, P7053, DOI 10.1128/JVI.00683-15; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	60	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144753	10.1371/journal.pone.0144753	http://dx.doi.org/10.1371/journal.pone.0144753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656605	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600085
J	Chan, RW; Ho, LC; Zhou, IY; Gao, PP; Chan, KC; Wu, EX				Chan, Russell W.; Ho, Leon C.; Zhou, Iris Y.; Gao, Patrick P.; Chan, Kevin C.; Wu, Ed X.			Structural and Functional Brain Remodeling during Pregnancy with Diffusion Tensor MRI and Resting-State Functional MRI	PLOS ONE			English	Article							MANGANESE-ENHANCED MRI; DENTATE GYRUS; RAT-BRAIN; MATERNAL-BEHAVIOR; HIPPOCAMPAL CONNECTIVITY; ESTROUS-CYCLE; FEMALE RAT; ADULT-RAT; PLASTICITY; NETWORKS	Although pregnancy-induced hormonal changes have been shown to alter the brain at the neuronal level, the exact effects of pregnancy on brain at the tissue level remain unclear. In this study, diffusion tensor imaging (DTI) and resting-state functional MRI (rsfMRI) were employed to investigate and document the effects of pregnancy on the structure and function of the brain tissues. Fifteen Sprague-Dawley female rats were longitudinally studied at three days before mating (baseline) and seventeen days after mating (G17). G17 is equivalent to the early stage of the third trimester in humans. Seven age-matched nulliparous female rats served as non-pregnant controls and were scanned at the same time-points. For DTI, diffusivity was found to generally increase in the whole brain during pregnancy, indicating structural changes at microscopic levels that facilitated water molecular movement. Regionally, mean diffusivity increased more pronouncedly in the dorsal hippocampus while fractional anisotropy in the dorsal dentate gyrus increased significantly during pregnancy. For rsfMRI, bilateral functional connectivity in the hippocampus increased significantly during pregnancy. Moreover, fractional anisotropy increase in the dentate gyrus appeared to correlate with the bilateral functional connectivity increase in the hippocampus. These findings revealed tissue structural modifications in the whole brain during pregnancy, and that the hippocampus was structurally and functionally remodeled in a more marked manner.	[Chan, Russell W.; Ho, Leon C.; Zhou, Iris Y.; Gao, Patrick P.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Pokfulam, Hong Kong, Peoples R China; [Chan, Russell W.; Ho, Leon C.; Zhou, Iris Y.; Gao, Patrick P.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Pokfulam, Hong Kong, Peoples R China; [Chan, Kevin C.] Univ Pittsburgh, Dept Ophthalmol, UPMC Eye Ctr, Ophthalmol & Visual Sci Res Ctr, Pittsburgh, PA 15260 USA	University of Hong Kong; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, EX (corresponding author), Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Pokfulam, Hong Kong, Peoples R China.	ewu@eee.hku.hk	Zhou, Iris Yuwen/A-2089-2017; Chan, Kevin C/AAK-7665-2020; Wu, Ed Xuekui/C-1579-2009	Zhou, Iris Yuwen/0000-0002-4351-7398; Chan, Kevin C/0000-0003-4012-7084; Wu, Ed Xuekui/0000-0001-5581-1546; Chan, Russell/0000-0002-7680-9231	Hong Kong Research Grants Council [RGC GRF HKU7837/11M]; Croucher Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Croucher Foundation	This work was supported in part by the Hong Kong Research Grants Council (RGC GRF HKU7837/11M) and Croucher Foundation. EXW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Shujuan Fan and Dr. Adrian Tsang for their comments on the manuscript. This work was supported in part by the Hong Kong Research Grants Council (RGC GRF HKU7837/11M) and Croucher Foundation.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BAER SM, 1991, J NEUROPHYSIOL, V65, P874, DOI 10.1152/jn.1991.65.4.874; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bathellier B, 2013, P NATL ACAD SCI USA, V110, P19950, DOI 10.1073/pnas.1312125110; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Brunton PJ, 2003, J NEUROENDOCRINOL, V15, P633, DOI 10.1046/j.1365-2826.2003.01045.x; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chan KC, 2014, NEUROIMAGE, V90, P235, DOI 10.1016/j.neuroimage.2013.12.056; Chan KC, 2012, NEUROIMAGE, V59, P2274, DOI 10.1016/j.neuroimage.2011.09.055; CHESLEY LC, 1985, OBSTET GYNECOL, V65, P423; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Ding AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051704; Ding AY, 2012, MAGN RESON IMAGING, V30, P993, DOI 10.1016/j.mri.2012.02.012; Dukart J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114227; Fan SJ, 2013, NMR BIOMED, V26, P1089, DOI 10.1002/nbm.2922; FLEMING AS, 1974, J COMP PHYSIOL PSYCH, V86, P957, DOI 10.1037/h0036414; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Galea LAM, 2000, HORM BEHAV, V37, P86, DOI 10.1006/hbeh.1999.1560; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Gregg C, 2009, J NEUROL SCI, V285, P22, DOI 10.1016/j.jns.2009.06.040; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kim S., 2012, FUNCT NEURORADIOL, P293; Kinsley CH, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0106-72; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; LAW RO, 1994, J EXP ZOOL, V268, P90, DOI 10.1002/jez.1402680204; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Liang ZF, 2013, NEUROIMAGE, V83, P237, DOI 10.1016/j.neuroimage.2013.06.029; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lorberbaum JP, 1999, DEPRESS ANXIETY, V10, P99, DOI 10.1002/(SICI)1520-6394(1999)10:3<99::AID-DA2>3.0.CO;2-#; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Moya J, 2014, J EXPO SCI ENV EPID, V24, P449, DOI 10.1038/jes.2013.92; MUHLETHALER M, 1984, BRAIN RES, V308, P97, DOI 10.1016/0006-8993(84)90921-1; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Oatridge A, 2002, AM J NEURORADIOL, V23, P19; Oja SS, 1996, METAB BRAIN DIS, V11, P153, DOI 10.1007/BF02069502; Ottowitz WE, 2008, PSYCHONEUROENDOCRINO, V33, P1419, DOI 10.1016/j.psyneuen.2008.09.013; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; Parekh MB, 2010, EXP NEUROL, V224, P258, DOI 10.1016/j.expneurol.2010.03.031; Paris JJ, 2008, REPRODUCTION, V136, P105, DOI 10.1530/REP-07-0512; PasantesMorales H, 1997, AMINO ACIDS, V12, P281, DOI 10.1007/BF01373008; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; ROSENBLATT JS, 1967, SCIENCE, V156, P1512, DOI 10.1126/science.156.3781.1512; ROSENBLATT JS, 1988, PSYCHONEUROENDOCRINO, V13, P29, DOI 10.1016/0306-4530(88)90005-4; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Shah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084241; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Stack EC, 2002, BEHAV BRAIN RES, V131, P17, DOI 10.1016/S0166-4328(01)00370-9; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; TURNER O, 1994, EXP PHYSIOL, V79, P681, DOI 10.1113/expphysiol.1994.sp003800; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, HIPPOCAMPUS, V20, P345, DOI 10.1002/hipo.20771; Wartella J, 2003, PHYSIOL BEHAV, V79, P373, DOI 10.1016/S0031-9384(03)00150-1; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Woolley CS, 1998, HORM BEHAV, V34, P140, DOI 10.1006/hbeh.1998.1466; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhou IY, 2014, NEUROIMAGE, V84, P1, DOI 10.1016/j.neuroimage.2013.08.037; Zhou IY, 2013, NEUROSCI LETT, V553, P170, DOI 10.1016/j.neulet.2013.08.041	85	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144328	10.1371/journal.pone.0144328	http://dx.doi.org/10.1371/journal.pone.0144328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658306	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500020
J	Cramer, MD; Hoffman, MT				Cramer, Michael D.; Hoffman, M. Timm			The Consequences of Precipitation Seasonality for Mediterranean-Ecosystem Vegetation of South Africa	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; PHOSPHORUS LIMITATION; NUTRIENT DYNAMICS; CANOPY STRUCTURE; CLIMATE; DIVERSITY; WATER; RAINFALL; GROWTH; FOREST	Globally, mediterranean-climate ecosystem vegetation has converged on an evergreen, sclerophyllous and shrubby growth form. The particular aspects of mediterranean-climate regions that contribute to this convergence include summer droughts and relatively nutrient-poor soils. We hypothesised that winter-precipitation implies stressful summer droughts and leaches soils due to greater water availability (i.e. balance between precipitation and potential evapotranspiration; P-PET) during cold periods. We conducted a comparative analysis of normalised difference vegetation indices (NDVI) and edaphic and climate properties across the biomes of South Africa. NDVI was strongly correlated with both precipitation and P-PET (r(2) = 0.8). There was no evidence, however, that winter-precipitation reduces NDVI in comparison to similar amounts of summer-precipitation. Base saturation (BS), a measure of soil leaching was, however, negatively related to P-PET (r(2) = 0.64). This led to an interaction between P-PET and BS in determining NDVI, indicating the existence of a trade-off between water availability and soil nutrients that enables NDVI to increase with precipitation, despite negative consequences for soil nutrient availability. The mechanism of this trade-off is suggested to be that water increases nutrient accessibility. This implies that along with nutrient-depauperate geologies and long periods of time since glaciation, the winter-precipitation may have contributed to the highly leached status of the soils. Since many of the ecophysiological characteristics of mediterranean-ecosystem flora are associated with low nutrient availabilities (e.g. evergreen foliage, sclerophylly, cluster roots), we conclude that mediterranean-climates promote convergence of growth-forms in these regions through high leaching capacity.	[Cramer, Michael D.; Hoffman, M. Timm] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa	University of Cape Town	Cramer, MD (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa.	Michael.cramer@uct.ac.za	Hoffman, Timm/K-4937-2016; Cramer, Michael D/A-3213-2013	Hoffman, Timm/0000-0002-5843-2397; Cramer, Michael D/0000-0003-0989-3266				ALBRECHT WA, 1957, GEOGR REV, V47, P86, DOI 10.2307/212191; [Anonymous], 2014, QGIS GEOGR INF SYST; Archibald S, 2010, INT J WILDLAND FIRE, V19, P774, DOI [10.1071/WF08207, 10.1071/WF10008]; Batjes N. H., 2012, Report - ISRIC World Soil Information; BEERY M, 1971, Ohio Journal of Science, V71, P43; Belda M, 2014, CLIM RES, V59, P1, DOI 10.3354/cr01204; Bergh NG, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P1; Born J, 2007, J BIOGEOGR, V34, P147, DOI 10.1111/j.1365-2699.2006.01595.x; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2005, GLOBAL ECOL BIOGEOGR, V14, P509, DOI 10.1111/j.1466-822x.2005.00166.x; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; Cramer MD, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P248; Cramer MD, 2012, OECOLOGIA, V169, P61, DOI 10.1007/s00442-011-2177-8; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1993, OIKOS, V67, P56, DOI 10.2307/3545095; Daget P, 1988, MEDITERRANEAN TYPE E, P139; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; HARGREAVES GL, 1985, J IRRIG DRAIN ENG, V111, P265, DOI 10.1061/(ASCE)0733-9437(1985)111:3(265); Hawkins HJ, 2009, FUNCT PLANT BIOL, V36, P752, DOI 10.1071/FP09046; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2014, PACKAGE DISMO; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Huston MA, 2012, ECOL MONOGR, V82, P277, DOI 10.1890/11-1927.1; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Koenker R., 2013, QUANTREG QUANTILE RE; Lamont B. B, 1995, ECOLOGY BIOGEOGRAPHY, P211, DOI DOI 10.1007/978-1-4612-2490-7_9; Lamont BB, 2002, FUNCT ECOL, V16, P403, DOI 10.1046/j.1365-2435.2002.00631.x; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; MILLER PC, 1983, ECOL STUD, V43, P133; Montenegro G., 1995, ECOLOGY BIOGEOGRAPHY, P160; MUCINA L., 2006, VEGETATION S AFRICA, V19; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; ORSHAN G, 1983, ECOL STUD, V43, P86; Pate JS, 2001, AUST J BOT, V49, P529, DOI 10.1071/BT00086; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; R Development Core Team, 2014, R LANG ENV STAT COMP; Richard Y, 1998, INT J REMOTE SENS, V19, P2907, DOI 10.1080/014311698214343; Richards MB, 1997, PLANT ECOL, V130, P143, DOI 10.1023/A:1009742225383; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Ripley BS, 2013, J EXP BOT, V64, P5485, DOI 10.1093/jxb/ert314; Rosseel Y, 2014, PACKAGE LAVAAN LATEN; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; SCHULTZ PA, 1993, ADV SPACE RES-SERIES, V13, P277, DOI 10.1016/0273-1177(93)90559-T; Schulze R.E., 1997, S AFRICAN ATLAS AGRO; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Soderberg K, 2007, ECOSYSTEMS, V10, P550, DOI 10.1007/s10021-007-9032-0; SPECHT RL, 1983, ECOL STUD, V43, P120; Specht RL, 1988, MEDITERRANEAN TYPE E, P149; STOCK WD, 1986, J ECOL, V74, P317, DOI 10.2307/2260257; Stock WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P1147, DOI 10.1111/j.1466-8238.2011.00752.x; SWAIN P.H., 1973, P AM SOC PHOT REM SE, P536; Trabucco A., 2009, GLOBAL ARIDITY INDEX; Turner BL, 2013, PLANT SOIL, V367, P225, DOI 10.1007/s11104-012-1493-z; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wessels K, 2011, APPL VEG SCI, V14, P49, DOI 10.1111/j.1654-109X.2010.01100.x; West AG, 2012, NEW PHYTOL, V195, P396, DOI 10.1111/j.1469-8137.2012.04170.x; WITKOWSKI ETF, 1990, ACTA OECOL, V11, P311; Xu C, 2012, ENVIRON MONIT ASSESS, V184, P1275, DOI 10.1007/s10661-011-2039-1; Yates MJ, 2010, FUNCT ECOL, V24, P485, DOI 10.1111/j.1365-2435.2009.01678.x	74	15	15	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144512	10.1371/journal.pone.0144512	http://dx.doi.org/10.1371/journal.pone.0144512			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650081	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300054
J	Hunter, DJ; Torkelson, JL; Bodnar, J; Mortazavi, B; Laurent, T; Deason, J; Thephavongsa, K; Zhong, JM				Hunter, Daniel J.; Torkelson, Jessica L.; Bodnar, James; Mortazavi, Bobak; Laurent, Timothy; Deason, Jeff; Thephavongsa, Khanhkeo; Zhong, Jianmin			The Rickettsia Endosymbiont of Ixodes pacificus Contains All the Genes of De Novo Folate Biosynthesis	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR BACTERIA; BLACK-LEGGED TICK; GENOME SEQUENCE; 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE; GTP CYCLOHYDROLASE; ESCHERICHIA-COLI; PROVIDES INSIGHT; SYMBIONTS; WOLBACHIA; MANIPULATORS	Ticks and other arthropods often are hosts to nutrient providing bacterial endosymbionts, which contribute to their host's fitness by supplying nutrients such as vitamins and amino acids. It has been detected, in our lab, that Ixodes pacificus is host to Rickettsia species phylotype G021. This endosymbiont is predominantly present, and 100% maternally transmitted in I. pacificus. To study roles of phylotype G021 in I. pacificus, bioinformatic and molecular approaches were carried out. MUMmer genome alignments of whole genome sequence of I. scapularis, a close relative to I. pacificus, against completely sequenced genomes of R. bellii OSU85-389, R. conorii, and R. felis, identified 8,190 unique sequences that are homologous to Rickettsia sequences in the NCBI Trace Archive. MetaCyc metabolic reconstructions revealed that all folate gene orthologues (folA, folC, folE, folKP, ptpS) required for de novo folate biosynthesis are present in the genome of Rickettsia buchneri in I. scapularis. To examine the metabolic capability of phylotype G021 in I. pacificus, genes of the folate biosynthesis pathway of the bacterium were PCR amplified using degenerate primers. BLAST searches identified that nucleotide sequences of the folA, folC, folE, folKP, and ptpS genes possess 98.6%, 98.8%, 98.9%, 98.5% and 99.0% identity respectively to the corresponding genes of Rickettsia buchneri. Phylogenetic tree constructions show that the folate genes of phylotype G021 and homologous genes from various Rickettsia species are monophyletic. This study has shown that all folate genes exist in the genome of Rickettsia species phylotype G021 and that this bacterium has the genetic capability for de novo folate synthesis.	[Hunter, Daniel J.; Torkelson, Jessica L.; Bodnar, James; Laurent, Timothy; Deason, Jeff; Thephavongsa, Khanhkeo; Zhong, Jianmin] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Mortazavi, Bobak] Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA	California State University System; California State Polytechnic University, Humboldt; Yale University	Zhong, JM (corresponding author), Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA.	jz15@humboldt.edu	Zhong, Jianmin/AAO-9401-2020	Zhong, Jianmin/0000-0002-4746-8458	National Institute of Health AREA [1 R15 AI099902-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI099902] Funding Source: NIH RePORTER	National Institute of Health AREA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health AREA grant 1 R15 AI099902-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NE, 2014, MBIO, V5, DOI 10.1128/mBio.01378-14; Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Akman L, 2001, P NATL ACAD SCI USA, V98, P7546, DOI 10.1073/pnas.131057498; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Blatch SA, 2010, FLY, V4, P312, DOI 10.4161/fly.4.4.13258; Breeuwer JAJ, 1996, EXP APPL ACAROL, V20, P421, DOI 10.1007/BF00053306; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Cheng D, 2013, TICKS TICK-BORNE DIS, V4, P421, DOI 10.1016/j.ttbdis.2013.04.006; Cheng D, 2013, TICKS TICK-BORNE DIS, V4, P280, DOI 10.1016/j.ttbdis.2012.12.005; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Darnton-Hill I, 2015, NUTRIENTS, V7, P1744, DOI 10.3390/nu7031744; Defossez E, 2011, P ROY SOC B-BIOL SCI, V278, P1419, DOI 10.1098/rspb.2010.1884; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dittrich S, 2008, MOL MICROBIOL, V67, P609, DOI 10.1111/j.1365-2958.2007.06073.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; El Yacoubi B, 2006, J BIOL CHEM, V281, P37586, DOI 10.1074/jbc.M607114200; FAN HZ, 1992, J CLIN INVEST, V90, P1803, DOI 10.1172/JCI116055; Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003; Fermer C, 1997, J BACTERIOL, V179, P831, DOI 10.1128/jb.179.3.831-837.1997; Furman DP, 1984, TICKS CALIFORNIA ACA, pviii; Gengenbacher M, 2008, FEMS MICROBIOL LETT, V287, P128, DOI 10.1111/j.1574-6968.2008.01302.x; Gerdes S, 2012, J EXP BOT, V63, P5379, DOI 10.1093/jxb/ers208; Gillespie JJ, 2015, GENOME BIOL EVOL, V7, P35, DOI 10.1093/gbe/evu262; Gillespie JJ, 2012, J BACTERIOL, V194, P376, DOI 10.1128/JB.06244-11; Ginkel SZ, 1997, FEMS MICROBIOL LETT, V156, P69, DOI 10.1016/S0378-1097(97)00402-3; Grochowski LL, 2007, BIOCHEMISTRY-US, V46, P6658, DOI 10.1021/bi700052a; Gross R, 2009, MOL MICROBIOL, V73, P751, DOI 10.1111/j.1365-2958.2009.06820.x; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hossain T, 2004, P NATL ACAD SCI USA, V101, P5158, DOI 10.1073/pnas.0401342101; Kambhampati S, 2013, GENOMICS, V102, P479, DOI 10.1016/j.ygeno.2013.09.003; Kurlovs AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104815; Kurtti TJ, 2015, INT J SYST EVOL MICR, V65, P965, DOI 10.1099/ijs.0.000047; MARTIN MM, 1970, SCIENCE, V169, P16, DOI 10.1126/science.169.3940.16; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Merhej V, 2014, INFECT GENET EVOL, V25, P122, DOI 10.1016/j.meegid.2014.03.014; Moran-Cadenas F, 2007, VECTOR-BORNE ZOONOT, V7, P555, DOI 10.1089/vbz.2006.0596; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Neef A, 2011, GENOME BIOL EVOL, V3, P1437, DOI 10.1093/gbe/evr118; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Phan JN, 2011, VECTOR-BORNE ZOONOT, V11, P957, DOI 10.1089/vbz.2010.0077; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Pribat A, 2009, J BACTERIOL, V191, P4158, DOI 10.1128/JB.00416-09; PYNE C, 1992, J BACTERIOL, V174, P1750, DOI 10.1128/jb.174.6.1750-1759.1992; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Sentausa E, 2012, J BACTERIOL, V194, P5130, DOI 10.1128/JB.01118-12; Sifakis S, 2000, ANN NY ACAD SCI, V900, P125, DOI 10.1111/j.1749-6632.2000.tb06223.x; Sybesma W, 2004, METAB ENG, V6, P109, DOI 10.1016/j.ymben.2003.11.002; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P3069, DOI 10.1128/AEM.69.6.3069-3076.2003; Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011; Vigneron A, 2014, CURR BIOL, V24, P2267, DOI 10.1016/j.cub.2014.07.065; Wang P, 2010, MOL BIOCHEM PARASIT, V172, P41, DOI 10.1016/j.molbiopara.2010.03.012; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WESTROM DR, 1985, J MED ENTOMOL, V22, P507, DOI 10.1093/jmedent/22.5.507; WHEELER PR, 1992, INT J LEPROSY, V60, P445; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	64	68	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144552	10.1371/journal.pone.0144552	http://dx.doi.org/10.1371/journal.pone.0144552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650541	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300057
J	Raiho, AM; Hooten, MB; Bates, S; Hobbs, NT				Raiho, Ann M.; Hooten, Mevin B.; Bates, Scott; Hobbs, N. Thompson			Forecasting the Effects of Fertility Control on Overabundant Ungulates: White-Tailed Deer in the National Capital Region	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SURVIVAL RATES; IMMUNOCONTRACEPTION; POPULATIONS; EFFICACY; PATTERNS	Overabundant populations of ungulates have caused environmental degradation and loss of biological diversity in ecosystems throughout the world. Culling or regulated harvest is often used to control overabundant species. These methods are difficult to implement in national parks, other types of conservation reserves, or in residential areas where public hunting may be forbidden by policy. As a result, fertility control has been recommended as a non-lethal alternative for regulating ungulate populations. We evaluate this alternative using white-tailed deer in national parks in the vicinity of Washington, D.C., USA as a model system. Managers seek to reduce densities of white-tailed deer from the current average (50 deer per km(2)) to decrease harm to native plant communities caused by deer. We present a Bayesian hierarchical model using 13 years of population estimates from 8 national parks in the National Capital Region Network. We offer a novel way to evaluate management actions relative to goals using short term forecasts. Our approach confirms past analyses that fertility control is incapable of rapidly reducing deer abundance. Fertility control can be combined with culling to maintain a population below carrying capacity with a high probability of success. This gives managers confronted with problematic overabundance a framework for implementing management actions with a realistic assessment of uncertainty.	[Raiho, Ann M.; Hobbs, N. Thompson] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Raiho, Ann M.; Hobbs, N. Thompson] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Colorado Cooperat Fish & Wildlife Res Unit, US Geol Survey, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Bates, Scott] Natl Pk Serv, Urban Ecol Ctr, Natl Capital Reg, Washington, DC 20240 USA	Colorado State University; Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University; United States Department of the Interior	Raiho, AM (corresponding author), St Marys Coll, Dept Biol, Notre Dame, IN 46556 USA.	araiho@nd.edu	Hobbs, Tom/C-5263-2016		Rocky Mountains Cooperative Ecosystem Studies Unit (RM-CESU), RM-CESU [H2370094000, J2340110031]; NTH; National Parks Service, Biological Resources Management Division	Rocky Mountains Cooperative Ecosystem Studies Unit (RM-CESU), RM-CESU; NTH; National Parks Service, Biological Resources Management Division	This work was supported by Rocky Mountains Cooperative Ecosystem Studies Unit (RM-CESU), RM-CESU Cooperative Agreement Number: H2370094000 (WASO), J2340110031. The PI for this grant is NTH. The task agreement follows: A primary mission of the Natural Resource Ecology Laboratory at Colorado State University is to understand and quantify ecosystems, and effectively communicate this information to decision-makers, managers, students, and the public. This project will meet these mission goals by 1) summarizing the issues, data protocols, approaches, and future needs for ungulate management throughout the NPS; and 2) quantifying population sizes, trajectories, and effects of different management strategies. Products will be summarized in a report to NPS managers and leadership. In addition, results will be presented to a wide variety of audiences, including: academics and managers via peer-reviewed publications and at science conferences; students and faculty of Colorado State University during lectures and seminars (Dr. Hobbs teaches a modeling course "Systems Ecology", which incorporates real-world results and models); and the general public through NPS press releases, newspaper articles, and the NPS website. This agreement will provide employment and education opportunities for a research assistant and graduate student at Colorado State University. The research assistant will gain hands on experience and direct knowledge about ungulate management science and real world management implementation in the NPS. Additionally, the research assistant will learn how to create searchable databases, facilitate a science/management workshop, gain a variety of perspectives from parks and managers during interviews for data and the workshop, and develop their writing abilities. These collective experiences will increase the capability of the research assistant to find future work in a state or federal wildlife agency or private sector (e.g., one of the many private consultants that works on ungulate management plans). The graduate student will learn state-of-the-art modeling procedures, greatly increase their quantitative, writing, and presentation capabilities, and develop materials that will be presented at university classes and seminars and national science conferences. The knowledge gained during the process will also facilitate interactions within the academic and agency setting and give the student a set of quantitative skills that are very marketable (e.g., developing hierarchical models in a Bayesian framework). The review (task 1) developed in this agreement will benefit the scientific community at large by informing them of current trends in NPS management and the scientific basis for those decisions. The models (task 2) will further the wildlife scientific and management communities on the limitations and requirements of using fertility control technology and culling to control ungulate populations. It will also increase the ability of the NPS to obtain correct targets during reduction operations, which will facilitate cooperative management efforts with state agencies outside of NPS units. The funders provided the data and helped the PI determine which model experiments to conduct.; This study was funded by the National Parks Service, Biological Resources Management Division. Comments and suggestions from Barry Noon, Ryan Monello, and Jenny Powers improved the manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. government.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Barlow ND, 1997, WILDLIFE RES, V24, P129, DOI 10.1071/WR95027; Bates S., 2006, WHITE TAILED DEER DE; Berliner LM, 1996, FUND THEOR, V79, P15; Bowman Jacob L., 2007, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V61, P76; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckland S.T., 2005, ENCY BIOSTATISTICS V, VWiley and Sons.; Campbell TA, 2005, WILDLIFE SOC B, V33, P212, DOI 10.2193/0091-7648(2005)33[212:PCOACA]2.0.CO;2; Caswell H., 2006, MATRIX POPULATION MO; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DePerno CS, 2000, WILDLIFE SOC B, V28, P1030; DIAMOND J, 1992, NAT HIST, P2; DUSEK GL, 1992, J WILDLIFE MANAGE, V56, P645, DOI 10.2307/3809455; FULLER TK, 1990, WILDLIFE MONOGR, P1; GARROTT RA, 1993, CONSERV BIOL, V7, P946, DOI 10.1046/j.1523-1739.1993.740946.x; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Grovenburg TW, 2011, AM MIDL NAT, V165, P426, DOI 10.1674/0003-0031-165.2.426; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Hobbs NT, 2000, J WILDLIFE MANAGE, V64, P473, DOI 10.2307/3803245; Hobbs NT, 2015, ECOLOGICAL IN PRESS; HONE J, 1992, J APPL ECOL, V29, P695, DOI 10.2307/2404478; Jewell PA, 1981, PROBLEMS MANAGEMENT; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kilpatrick HJ, 2001, CAN J ZOOL, V79, P949, DOI 10.1139/cjz-79-6-949; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; Knight TM, 2009, FOREST ECOL MANAG, V257, P1095, DOI 10.1016/j.foreco.2008.11.018; Knowlton FF, 1972, J WILDLIFE MANAGEMEN, V36; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; Malcolm KD, 2010, ANIM REPROD SCI, V117, P261, DOI 10.1016/j.anireprosci.2009.05.003; McCabe Thomas R., 1997, P11; McCullough D.R., 1979, GEORGE RESERVE DEER; McShea WJ, 1997, J WILDLIFE MANAGE, V61, P560, DOI 10.2307/3802615; Noon BR, 2001, WILDLIFE 2001 POPULA, P441; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Plummer M, 2012, JAGS VERSION 3 3 0 U; Plummer M, 2013, R PACKAGE VERSION 3; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Burroughs JP, 2006, J WILDLIFE MANAGE, V70, P743, DOI 10.2193/0022-541X(2006)70[743:CMASOW]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Ransom JI, 2014, J APPL ECOL, V51, P259, DOI 10.1111/1365-2664.12166; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Todd CR, 2008, J APPL ECOL, V45, P568, DOI 10.1111/j.1365-2664.2007.01434.x; Van Der Peet S, 2007, AUSTRAL ECOLOGY, V32, P720, DOI [10.1111/j.1442-9993.2007.01786.x, DOI 10.1111/J.1442-9993.2007.01786.X]; VanDeelen TR, 1997, J WILDLIFE MANAGE, V61, P903, DOI 10.2307/3802199; VerCauteren K.C., 2003, USDA STAFF PUBLICATI, V281; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; WESTERN D, 1979, AFR J ECOL, V17, P185, DOI 10.1111/j.1365-2028.1979.tb00256.x; Whitlaw HA, 1998, J WILDLIFE MANAGE, V62, P1335, DOI 10.2307/3801999; Wickham Brian M., 1993, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V47, P222; Wright R, 1993, RENEWABLE RESOURCES, V11, P18	57	19	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143122	10.1371/journal.pone.0143122	http://dx.doi.org/10.1371/journal.pone.0143122			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650739	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903300011
J	Czaplicki, A; Jarocka, M; Walawski, J				Czaplicki, Adam; Jarocka, Marta; Walawski, Jacek			Isokinetic Identification of Knee Joint Torques before and after Anterior Cruciate Ligament Reconstruction	PLOS ONE			English	Article							PATELLAR TENDON; ACCELERATED REHABILITATION; QUADRICEPS STRENGTH; HAMSTRING TENDON; MUSCLE STRENGTH; SEMITENDINOSUS; RETURN; STABILITY; AUTOGRAFT; FIXATION	The aim of this study was to evaluate the serial change of isokinetic muscle strength of the knees before and after anterior cruciate ligament reconstruction (ACLR) in physically active males and to estimate the time of return to full physical fitness. Extension and flexion torques were measured for the injured and healthy limbs at two angular velocities approximately 1.5 months before the surgery and 3, 6, and 12 months after ACLR. Significant differences (p <= 0.05) in peak knee extension and flexion torques, hamstring/quadriceps (H/Q) strength ratios, uninvolved/involved limb peak torque ratios, and the normalized work of these muscles between the four stages of rehabilitation were identified. Significant differences between extension peak torques for the injured and healthy limbs were also detected at all stages. The obtained results showed that 12 months of rehabilitation were insufficient for the involved knee joint to recover its strength to the level of strength of the uninvolved knee joint. The results helped to evaluate the progress of the rehabilitation and to implement necessary modifications optimizing the rehabilitation training program. The results of the study may also be used as referential data for physically active males of similar age.	[Czaplicki, Adam] Josef Pilsudski Univ Phys Educ, Fac Phys Educ & Sport, Dept Biomech & Comp Sci, Biala Podlaska, Poland; [Jarocka, Marta] Josef Pilsudski Univ Phys Educ, Fac Tourism & Hlth, Dept Physiotherapy, Biala Podlaska, Poland; [Walawski, Jacek] Josef Pilsudski Univ Phys Educ, Fac Tourism & Hlth, Dept Rehabil Med, Biala Podlaska, Poland; [Walawski, Jacek] MSW Hosp, Orthopaed Surg Unit, Dept Gen Surg, Lublin, Poland	Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw	Czaplicki, A (corresponding author), Josef Pilsudski Univ Phys Educ, Fac Phys Educ & Sport, Dept Biomech & Comp Sci, Biala Podlaska, Poland.	adam.czaplicki@awf-bp.edu.pl	Czaplicki, Adam/E-2719-2019	Czaplicki, Adam/0000-0003-2816-099X				Alkjaer T, 2011, KNEE SURG SPORT TR A, V19, P615, DOI 10.1007/s00167-010-1302-2; [Anonymous], 1999, BIOD SYST 3 ADV SOFT; Arampatzis A, 2004, CLIN BIOMECH, V19, P277, DOI 10.1016/j.clinbiomech.2003.11.011; Ardern CL, 2011, AM J SPORT MED, V39, P538, DOI 10.1177/0363546510384798; Aune AK, 2001, AM J SPORT MED, V29, P722, DOI 10.1177/03635465010290060901; Cascio BM, 2004, CLIN SPORT MED, V23, P395, DOI 10.1016/j.csm.2004.03.004; Coombs Rosalind, 2002, J Sports Sci Med, V1, P56; DANIEL DM, 1985, J BONE JOINT SURG AM, V67A, P720, DOI 10.2106/00004623-198567050-00006; Deneweth JM, 2010, AM J SPORT MED, V38, P1820, DOI 10.1177/0363546510365531; Ejerhed L, 2003, AM J SPORT MED, V31, P19, DOI 10.1177/03635465030310011401; FEIRING D C, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P298; Hartigan EH, 2012, J APPL BIOMECH, V28, P366, DOI 10.1123/jab.28.4.366; Herzog W, 1988, J BIOMECH, V21, P124; Hislop H J, 1967, Phys Ther, V47, P114; Jarocka M, 2013, POL J SPORT TOURISM, V20, P13; KANNUS P, 1988, PHYS THER, V68, P961, DOI 10.1093/ptj/68.6.961; Karanikas K, 2009, EUR J PHYS REHAB MED, V45, P37; KAUFMAN KR, 1995, J BIOMECH, V28, P1243, DOI 10.1016/0021-9290(94)00176-5; Keays SL, 2003, J ORTHOPAED RES, V21, P231, DOI 10.1016/S0736-0266(02)00160-2; Keays SL, 2001, KNEE, V8, P229, DOI 10.1016/S0968-0160(01)00099-0; Kellis E, 1996, MED SCI SPORT EXER, V28, P900, DOI 10.1097/00005768-199607000-00018; Konishi Y, 2012, SCAND J MED SCI SPOR, V22, P791, DOI 10.1111/j.1600-0838.2011.01332.x; Kvist J, 2004, SPORTS MED, V34, P269, DOI 10.2165/00007256-200434040-00006; Lewek M, 2002, CLIN BIOMECH, V17, P56, DOI 10.1016/S0268-0033(01)00097-3; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; MACDONALD PB, 1995, AM J SPORT MED, V23, P588, DOI 10.1177/036354659502300512; Oberlander KD, 2013, MED SCI SPORT EXER, V45, P506, DOI 10.1249/MSS.0b013e3182752ae3; Roewer BD, 2011, J BIOMECH, V44, P1948, DOI 10.1016/j.jbiomech.2011.04.037; Rudolph KS, 2001, KNEE SURG SPORT TR A, V9, P62, DOI 10.1007/s001670000166; SACHS RA, 1989, AM J SPORT MED, V17, P760, DOI 10.1177/036354658901700606; SAPEGA AA, 1990, J BONE JOINT SURG AM, V72A, P1562, DOI 10.2106/00004623-199072100-00023; Scanlan SF, 2013, J BIOMECH, V46, P849, DOI 10.1016/j.jbiomech.2012.12.026; Scanlan SF, 2010, J BIOMECH, V43, P1817, DOI 10.1016/j.jbiomech.2010.02.010; Scranton PE, 1998, ARTHROSCOPY, V14, P702, DOI 10.1016/S0749-8063(98)70097-0; SHELBOURNE KD, 1990, AM J SPORT MED, V18, P292, DOI 10.1177/036354659001800313; SnyderMackler L, 1997, AM J SPORT MED, V25, P191, DOI 10.1177/036354659702500209; STROYAN M, 1993, J ORTHOP SPORT PHYS, V17, P279, DOI 10.2519/jospt.1993.17.6.279; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Torry MR, 2011, CLIN BIOMECH, V26, P1019, DOI 10.1016/j.clinbiomech.2011.06.010; Urabe Y, 2002, J SPORT REHABIL, V11, P252, DOI 10.1123/jsr.11.4.252; van Grinsven S, 2010, KNEE SURG SPORT TR A, V18, P1128, DOI 10.1007/s00167-009-1027-2; Wagner M, 2005, AM J SPORT MED, V33, P1327, DOI 10.1177/0363546504273488; Witvrouw E, 2001, INT ORTHOP, V25, P308, DOI 10.1007/s002640100268; YASUDA K, 1995, AM J SPORT MED, V23, P706, DOI 10.1177/036354659502300613; Zabala ME, 2013, J BIOMECH, V46, P515, DOI 10.1016/j.jbiomech.2012.10.010; Zysk SP, 2000, ACTA ORTHOP SCAND, V71, P381, DOI 10.1080/000164700317393385	46	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144283	10.1371/journal.pone.0144283	http://dx.doi.org/10.1371/journal.pone.0144283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646385	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903100017
J	Jalal, B; Krishnakumar, D; Ramachandran, VS				Jalal, Baland; Krishnakumar, Divya; Ramachandran, Vilayanur S.			"I Feel Contaminated in My Fake Hand": Obsessive-Compulsive-Disorder like Disgust Sensations Arise from Dummy during Rubber Hand Illusion	PLOS ONE			English	Article							BODILY SELF; PAIN; SENSITIVITY; OWNERSHIP	Despite its theoretical and clinical interest, there are no experimental studies exploring obsessive-compulsive disorder (OCD)-like disgust sensations through using somatosensory illusions. Such illusions provide important clues to the nature and limits of multisensory integration and how the brain constructs body image; and may potentially inform novel therapies. One such effect is the rubber hand illusion (RHI) in which tactile sensations are referred to a rubber hand; if the experimenter simultaneously strokes a subject's occluded hand together with a visible fake hand, the subject starts experiencing the touch sensations as arising from the dummy. In this study, we explore whether OCD-like disgust may result from contamination of a dummy hand during the RHI; suggesting a possible integration of somatosensory and limbic inputs in the construction of body image. We predicted that participants would experience sensations of disgust, when placing a disgust stimulus (fake feces, vomit or blood) on the dummy hand after establishing the RHI. We found that 9 out of 11 participants experienced greater disgust during the synchronous condition (real hidden hand and fake hand are stroked in synchrony) compared to the asynchronous control condition (real hidden hand and fake hand are stroked in asynchrony); and on average such disgust was significantly greater during the synchronous condition compared to the asynchronous control condition, Z = 2.7, p = .008. These results argue against a strictly hierarchical modular approach to brain function and suggest that a four-way multisensory interaction occurs between vision, touch, proprioception on the one hand and primal emotions like disgust on the other. These findings may inform novel clinical approaches for OCD; that is, contaminating a dummy during the RHI could possibly be used as part of an in-vivo exposure-intervention for OCD.	[Jalal, Baland; Krishnakumar, Divya; Ramachandran, Vilayanur S.] Univ Calif San Diego, Ctr Brain & Cognit, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Jalal, B (corresponding author), Univ Calif San Diego, Ctr Brain & Cognit, La Jolla, CA 92093 USA.	bjalal@ucsd.edu						Abramowitz JS, 1996, BEHAV THER, V27, P583, DOI 10.1016/S0005-7894(96)80045-1; Altman SE, 2009, CLIN PSYCHOL REV, V29, P638, DOI 10.1016/j.cpr.2009.08.001; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Avery JA, 2015, HUM BRAIN MAPP, V36, P2996, DOI 10.1002/hbm.22823; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Breiter HC, 1996, NEUROIMAGE, V4, pS127, DOI 10.1006/nimg.1996.0063; Capelari EDP, 2009, PERCEPTION, V38, P92, DOI 10.1068/p5892; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; HAMILTON JG, 1995, J FAM PRACTICE, V41, P169; Jalal B, 2013, SOC NEUROSCIENCE, V732, pEE6; Jalal B, FRONT PSYCH IN PRESS; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Limanowski J, 2014, NEUROIMAGE, V86, P514, DOI 10.1016/j.neuroimage.2013.10.035; Martini M, 2014, EUR J PAIN, V18, P1040, DOI 10.1002/j.1532-2149.2014.00451.x; Martini M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00438; Mohan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052400; Phillips ML, 2000, PSYCHOL MED, V30, P1037, DOI 10.1017/S0033291799002652; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramachandran VS, 2011, PERCEPTION, V40, P367, DOI 10.1068/p6754; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Samad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117178; Shapira NA, 2003, BIOL PSYCHIAT, V54, P751, DOI 10.1016/S0006-3223(03)00003-9; Thakkar KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027089; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547	33	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0139159	10.1371/journal.pone.0139159	http://dx.doi.org/10.1371/journal.pone.0139159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26642323	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700001
J	Martinez-Zamora, A; Meseguer, S; Esteve, JM; Villarroya, M; Aguado, C; Enriquez, JA; Knecht, E; Armengod, ME				Martinez-Zamora, Ana; Meseguer, Salvador; Esteve, Juan M.; Villarroya, Magda; Aguado, Carmen; Enriquez, J. Antonio; Knecht, Erwin; Armengod, M. -Eugenia			Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier	PLOS ONE			English	Article							FATTY-ACID OXIDATION; RESPIRATORY-CHAIN DEFICIENCY; HYPERTROPHIC CARDIOMYOPATHY; LACTIC-ACIDOSIS; ROS PRODUCTION; CELL-SURVIVAL; WOBBLE BASE; STRESS; TRANSLATION; KINASE	GTPBP3 is an evolutionary conserved protein presumably involved in mitochondrial tRNA (mt-tRNA) modification. In humans, GTPBP3 mutations cause hypertrophic cardiomyopathy with lactic acidosis, and have been associated with a defect in mitochondrial translation, yet the pathomechanism remains unclear. Here we use a GTPBP3 stable-silencing model (shGTPBP3 cells) for a further characterization of the phenotype conferred by the GTPBP3 defect. We experimentally show for the first time that GTPBP3 depletion is associated with an mt-tRNA hypomodification status, as mt-tRNAs from shGTPBP3 cells were more sensitive to digestion by angiogenin than tRNAs from control cells. Despite the effect of stable silencing of GTPBP3 on global mitochondrial translation being rather mild, the steady-state levels and activity of Complex I, and cellular ATP levels were 50% of those found in the controls. Notably, the ATPase activity of Complex V increased by about 40% in GTPBP3 depleted cells suggesting that mitochondria consume ATP to maintain the membrane potential. Moreover, shGTPBP3 cells exhibited enhanced antioxidant capacity and a nearly 2-fold increase in the uncoupling protein UCP2 levels. Our data indicate that stable silencing of GTPBP3 triggers an AMPK-dependent retrograde signaling pathway that down-regulates the expression of the NDUFAF3 and NDUFAF4 Complex I assembly factors and the mitochondrial pyruvate carrier (MPC), while up-regulating the expression of UCP2. We also found that genes involved in glycolysis and oxidation of fatty acids are up-regulated. These data are compatible with a model in which high UCP2 levels, together with a reduction in pyruvate transport due to the down-regulation of MPC, promote a shift from pyruvate to fatty acid oxidation, and to an uncoupling of glycolysis and oxidative phosphorylation. These metabolic alterations, and the low ATP levels, may negatively affect heart function.	[Martinez-Zamora, Ana; Meseguer, Salvador; Villarroya, Magda; Armengod, M. -Eugenia] Ctr Invest Principe Felipe, Lab RNA Modificat & Mitochondrial Dis, Valencia, Spain; [Esteve, Juan M.; Aguado, Carmen; Knecht, Erwin] Ctr Invest Principe Felipe, Lab Intracellular Prot Degradat & Rare Dis, Valencia, Spain; [Aguado, Carmen; Knecht, Erwin; Armengod, M. -Eugenia] CIBERER, Node U721, Valencia, Spain; [Enriquez, J. Antonio] Ctr Nacl Invest Cardiovasc Carl III, Dept Desarrollo & Reparac Cardiovasc, Madrid, Spain; [Enriquez, J. Antonio] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain	Prince Felipe Research Center; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza	Armengod, ME (corresponding author), Ctr Invest Principe Felipe, Lab RNA Modificat & Mitochondrial Dis, Valencia, Spain.	marmengod@cipf.es	Enríquez, J.A./M-8468-2016; Knecht, Erwin/K-2432-2014; Villarroya, M Magdalena/K-7621-2014; Knecht, Erwin/A-9366-2014; Aguado, Carmen/K-4354-2014; Meseguer, Salvador/K-7137-2014	Enríquez, J.A./0000-0002-3671-2961; Knecht, Erwin/0000-0002-7208-3832; Villarroya, M Magdalena/0000-0003-4542-7430; Aguado, Carmen/0000-0002-3113-4269; Meseguer, Salvador/0000-0002-2718-4351	Spanish Ministry of Economy and Competitiveness [BFU2010-19737, BFU2014-58673-P, BFU2011-22630, SAF2014-54604-C3-2-R]; Generalitat Valenciana [ACOMP/2012/065, PROMETEO/2012/061]; Instituto de Salud Carlos III	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by grants from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/) (grant numbers BFU2010-19737 and BFU2014-58673-P to M.-E. A., BFU2011-22630 and SAF2014-54604-C3-2-R to E.K.) and the Generalitat Valenciana (http://www.gva.es/va/inicio/presentacion) (grant numbers ACOMP/2012/065 to M.-E. A., and PROMETEO/2012/061 to M.-E. A. and E.K.), and a PhD fellowship from the Instituto de Salud Carlos III (http://www.isciii.es/) to A.M.-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Aebi H, 1984, Methods Enzymol, V105, P121; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Barnes K, 2002, J CELL SCI, V115, P2433; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Calegari VC, 2011, J ENDOCRINOL, V208, P257, DOI 10.1530/JOE-10-0450; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Capella MAM, 2007, CELL BIOL TOXICOL, V23, P413, DOI 10.1007/s10565-007-9003-4; Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cotan D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; del Hoyo P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-95; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Dominy JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015008; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364; Armengod ME, 2014, RNA BIOL, V11, P1495, DOI 10.4161/15476286.2014.992269; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Jager G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060246; Jaswal JS, 2011, BBA-MOL CELL RES, V1813, P1333, DOI 10.1016/j.bbamcr.2011.01.015; Jezek P, 2014, PHYSIOL RES, V63, pS73, DOI 10.33549/physiolres.932633; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; KNECHT E, 1984, HISTOCHEMISTRY, V80, P359, DOI 10.1007/BF00495417; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Kukat A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004385; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li N, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/740849; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Lowes DA, 2011, BIOCHEM J, V436, P123, DOI 10.1042/BJ20102135; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Martinez-Vicente M, 2005, J BIOL CHEM, V280, P30660, DOI 10.1074/jbc.M503223200; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Moran M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001; Moreno-Loshuertos R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001379; Moukadiri I, 2014, NUCLEIC ACIDS RES, V42, P2602, DOI 10.1093/nar/gkt1228; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Rendon OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z; Schonfeld P, 2010, BBA-BIOENERGETICS, V1797, P929, DOI 10.1016/j.bbabio.2010.01.010; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Sissler M, 2008, METHODS, V44, P176, DOI 10.1016/j.ymeth.2007.11.002; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Soper J W, 1979, Methods Enzymol, V55, P328; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Villarroya M, 2008, MOL CELL BIOL, V28, P7514, DOI 10.1128/MCB.00946-08; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Westhof Eric, 2014, F1000Prime Rep, V6, P19, DOI 10.12703/P6-19; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Wu SB, 2014, BBA-GEN SUBJECTS, V1840, P1331, DOI 10.1016/j.bbagen.2013.10.034; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675	117	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144273	10.1371/journal.pone.0144273	http://dx.doi.org/10.1371/journal.pone.0144273			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642043	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700089
J	Raghunayakula, S; Subramonian, D; Dasso, M; Kumar, R; Zhang, XD				Raghunayakula, Sarita; Subramonian, Divya; Dasso, Mary; Kumar, Rita; Zhang, Xiang-Dong			Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells	PLOS ONE			English	Article							ACTIVATING PROTEIN RANGAP1; XENOPUS EGG EXTRACT; ARGININE DEPRIVATION; E3 LIGASE; KB CELLS; IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; SUMO-1 MODIFICATION; GTP HYDROLYSIS; RAN	Annulate lamellae are cytoplasmic organelles containing stacked sheets of membranes embedded with pore complexes. These cytoplasmic pore complexes at annulate lamellae are morphologically similar to nuclear pore complexes at the nuclear envelope. Although annulate lamellae has been observed in nearly all types of cells, their biological functions are still largely unknown. Here we show that SUMO1-modification of the Ran GTPase-activating protein RanGAP1 not only target RanGAP1 to its known sites at nuclear pore complexes but also to annulate lamellae pore complexes through interactions with the Ran-binding protein RanBP2 and the SUMO-conjugating enzyme Ubc9 in mammalian cells. Furthermore, upregulation of annulate lamellae, which decreases the number of nuclear pore complexes and concurrently increases that of annulate lamellae pore complexes, causes a redistribution of nuclear transport receptors including importin alpha/beta and the exportin CRM1 from nuclear pore complexes to annulate lamellae pore complexes and also reduces the rates of nuclear import and export. Moreover, our results reveal that importin alpha/beta-mediated import complexes initially accumulate at annulate lamellae pore complexes upon the activation of nuclear import and subsequently disassociate for nuclear import through nuclear pore complexes in cells with upregulation of annulate lamellae. Lastly, CRM1-mediated export complexes are concentrated at both nuclear pore complexes and annulate lamellae pore complexes when the disassembly of these export complexes is inhibited by transient expression of a Ran GTPase mutant arrested in its GTP-bound form, suggesting that RanGAP1/RanBP2-activated RanGTP hydrolysis at these pore complexes is required for the dissociation of the export complexes. Hence, our findings provide a foundation for further investigation of how upregulation of annulate lamellae decreases the rates of nuclear transport and also for elucidation of the biological significance of the interaction between annulate lamellae pore complexes and nuclear transport complexes in mammalian cells.	[Raghunayakula, Sarita; Subramonian, Divya; Zhang, Xiang-Dong] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Dasso, Mary] NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Kumar, Rita] Wayne State Univ, Dept Emergency Med, Detroit, MI USA; [Kumar, Rita] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA	Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University	Zhang, XD (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	xzhang@wayne.edu	Subramonian, Divya/AGF-1165-2022	Subramonian, Divya/0000-0002-9849-6512; Kumar, Rita/0000-0002-9573-7667; Zhang, Xiang-Dong/0000-0001-5097-3191; Dasso, Mary/0000-0002-5410-1371	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008954] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; CHAMBERS VC, 1964, J CELL BIOL, V21, P133, DOI 10.1083/jcb.21.1.133; CHEN TY, 1988, J CELL BIOL, V107, P1299, DOI 10.1083/jcb.107.4.1299; Clever M, 2013, NUCLEUS-PHILA, V4, P105, DOI 10.4161/nucl.23796; Cordes VC, 1997, EXP CELL RES, V237, P419, DOI 10.1006/excr.1997.3806; Cordes VC, 1996, CELL TISSUE RES, V284, P177, DOI 10.1007/s004410050578; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Cronshaw JM, 2003, P NATL ACAD SCI USA, V100, P5823, DOI 10.1073/pnas.1031047100; Dabauvalle MC, 1999, EUR J CELL BIOL, V78, P749, DOI 10.1016/S0171-9335(99)80043-0; DABAUVALLE MC, 1991, BIOL CELL, V72, P25, DOI 10.1016/0248-4900(91)90074-W; DABAUVALLE MC, 1991, J CELL BIOL, V112, P1073, DOI 10.1083/jcb.112.6.1073; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DEBRABANDER M, 1975, J CELL SCI, V19, P331; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; EPSTEIN MA, 1961, J BIOPHYS BIOCHEM CY, V10, P153, DOI 10.1083/jcb.10.2.153; Ewald A, 1996, J CELL SCI, V109, P1813; Ewald A, 2001, EUR J CELL BIOL, V80, P678, DOI 10.1078/0171-9335-00207; Ewald A, 1997, EUR J CELL BIOL, V73, P259; Flotho A, 2012, NUCLEUS-AUSTIN, V3, P429, DOI 10.4161/nucl.21980; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fung HYJ, 2014, SEMIN CANCER BIOL, V27, P52, DOI 10.1016/j.semcancer.2014.03.002; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; KESSEL RG, 1984, J MORPHOL, V179, P291, DOI 10.1002/jmor.1051790307; KESSEL RG, 1989, ELECTRON MICROSC REV, V2, P257, DOI 10.1016/0892-0354(89)90003-8; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; LANE NJ, 1965, J CELL BIOL, V27, P603, DOI 10.1083/jcb.27.3.603; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Maul GG, 1977, INT REV CYTOL S, P75; MCCULLOCH D, 1952, J EXP ZOOL, V119, P47, DOI 10.1002/jez.1401190105; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; MERISKO EM, 1989, TISSUE CELL, V21, P343, DOI 10.1016/0040-8166(89)90049-9; Miller BR, 2000, TRAFFIC, V1, P941, DOI 10.1034/j.1600-0854.2000.011204.x; Murawala P, 2009, J CELL SCI, V122, P3113, DOI 10.1242/jcs.037523; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x; PALADE GE, 1955, J BIOPHYS BIOCHEM CY, V1, P567, DOI 10.1083/jcb.1.6.567; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perez-Terzic C, 2003, CIRC RES, V92, P444, DOI 10.1161/01.RES.0000059415.25070.54; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; SCHEER U, 1969, J CELL BIOL, V42, P519, DOI 10.1083/jcb.42.2.519; SCHULZ HERIBERT, 1957, ONCOLOGIA, V10, P307; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; SWIFT HEWSON, 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P415, DOI 10.1083/jcb.2.4.415; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WEISSFELD AS, 1977, J CELL BIOL, V75, P889, DOI 10.1083/jcb.75.3.889; WEISSFELD AS, 1977, J CELL BIOL, V75, P881, DOI 10.1083/jcb.75.3.881; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	82	9	9	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144508	10.1371/journal.pone.0144508	http://dx.doi.org/10.1371/journal.pone.0144508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642330	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700136
J	Steinach, M; Kohlberg, E; Maggioni, MA; Mendt, S; Opatz, O; Stahn, A; Tiedemann, J; Gunga, HC				Steinach, Mathias; Kohlberg, Eberhard; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Tiedemann, Josefine; Gunga, Hanns-Christian			Changes of 25-OH-Vitamin D during Overwintering at the German Antarctic Stations Neumayer II and III	PLOS ONE			English	Article							VITAMIN-D STATUS; 25-HYDROXYVITAMIN D; DIETARY-INTAKE; D DEFICIENCY; BODY-COMPOSITION; SEASONAL-CHANGES; SERUM-LEVELS; FOOD; WOMEN; SUNLIGHT	Purpose Humans in Antarctica face different environmental challenges, such as low ultra-violet radiation, which is crucial for vitamin D production in humans. Therefore we assessed changes in 25-OH-vitamin D serum concentration during 13 months of overwintering at the German Stations Neumayer II and III (2007-2012). We hypothesized that (i) 25-OH-vitamin D serum concentration would significantly decrease, (ii) changes would be affected by age, gender, baseline (i.e. pre-overwintering) fat mass, baseline 25-OH-vitamin D serum concentration, and station residence, and (iii) our results would not differ from similar previous studies in comparable high latitudes. Materials & Methods 25-OH-vitamin D serum concentrations were determined before, after, and monthly during the campaigns from venous blood samples of n = 43 participants (28 men, 15 women). Baseline fat mass was determined via bio impedance analysis and body plethysmography. Data were analyzed for change over time, dependency on independent parameters, and after categorization for sufficiency (> 50nmol/l), insufficiency (25-50nmol/l), and deficiency (<25nmol/l). Results were compared with data from similar previous studies. Results We found a significant decrease of 25-OH-vitamin D with dependency on month. Age, gender, fat mass, and station residence had no influence. Only baseline 25-OH-vitamin D serum concentrations significantly affected subsequent 25-OH-vitamin D values. Conclusions Overwinterings at the Antarctic German research stations Neumayer II and III are associated with a decrease in 25-OH-vitamin D serum concentrations, unaffected by age, gender, baseline fat mass, and station residence. Higher baseline vitamin D serum concentrations might protect from subsequent deficiencies. Residence at the Neumayer Stations may lead to lower vitamin D serum concentrations than found in other comparable high latitudes.	[Steinach, Mathias; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Tiedemann, Josefine; Gunga, Hanns-Christian] Charite, Ctr Space Med & Extreme Environments Berlin, Inst Physiol, D-13353 Berlin, Germany; [Kohlberg, Eberhard] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Maggioni, Martina Anna] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Milan	Steinach, M (corresponding author), Charite, Ctr Space Med & Extreme Environments Berlin, Inst Physiol, D-13353 Berlin, Germany.	mathias.steinach@charite.de	Maggioni, Martina Anna A/M-2931-2016; Maggioni, Martina Anna/P-1351-2019	Maggioni, Martina Anna A/0000-0002-6319-8566; Maggioni, Martina Anna/0000-0002-6319-8566; Mendt, Stefan/0000-0001-8227-9655	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne); Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724 [AZ50WB0724]; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030 [AZ50WB1030]; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330 [AZ50WB1330]	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin)(Federal Ministry for Economic Affairs and Energy (BMWi)); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne); Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330	All grants were received by the Federal Ministry for Economic Affairs and Energy (BMWi, Berlin, website:http://www.bmwi.de/en), the German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel, website:http://www.dlr.de/rd/en), and the German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne, website:http://www.dlr.de/dlr/en). Grant numbers: "Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724" (AZ50WB0724), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030" (AZ50WB1030), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330" (AZ50WB1330). Initials of author who received funding: HCG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud M, 2014, J STEROID BIOCHEM, V144, P232, DOI 10.1016/j.jsbmb.2013.10.020; Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Andersen R, 2013, EUR J CLIN NUTR, V67, P270, DOI 10.1038/ejcn.2013.3; Andersen S, 2013, BRIT J NUTR, V110, P50, DOI 10.1017/S0007114512004709; Anderson LN, 2010, CAN J PUBLIC HEALTH, V101, P318, DOI 10.1007/BF03405294; Arabi A, 2010, BONE, V47, P408, DOI 10.1016/j.bone.2010.05.002; AWI, 2012, A WEG I POL MAR RES; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bersamin A, 2008, J AM DIET ASSOC, V108, P266, DOI 10.1016/j.jada.2007.10.046; Bhattacharyya M, 2008, INT J BIOMETEOROL, V52, P869, DOI 10.1007/s00484-008-0183-2; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Brustad M, 2007, PHOTOCH PHOTOBIO SCI, V6, P903, DOI 10.1039/b702947k; Brustad Magritt, 2003, Int J Circumpolar Health, V62, P40; Cattermole TJ, 1999, AVIAT SPACE ENVIR MD, V70, P135; Clark MK, 2011, OBES RES CLIN PRACT, V5, pE85, DOI 10.1016/j.orcp.2010.09.180; Custaud MA, 2004, EUR J APPL PHYSIOL, V91, P508, DOI 10.1007/s00421-003-1027-8; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P827, DOI 10.1111/j.1365-2826.2008.01721.x; EDHOLM OG, 1966, P NUTR SOC, V25, P113, DOI 10.1079/PNS19660025; FAIRNEY A, 1979, POSTGRAD MED J, V55, P248, DOI 10.1136/pgmj.55.642.248; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Ganji Vijay, 2010, Int Arch Med, V3, P29, DOI 10.1186/1755-7682-3-29; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Grant WB, 2011, EUR J CLIN NUTR, V65, P1016, DOI 10.1038/ejcn.2011.68; GUENTER CA, 1970, ARCH INTERN MED, V125, P630, DOI 10.1001/archinte.125.4.630; Gulseth HL, 2013, CURR VASC PHARMACOL, V11, P968, DOI 10.2174/15701611113119990169; HARFORD RR, 1993, METABOLISM, V42, P1159, DOI 10.1016/0026-0495(93)90274-R; Heaney RP, 2011, J BONE MINER RES, V26, P455, DOI 10.1002/jbmr.328; HOLICK MF, 1989, LANCET, V2, P1104; Holick MF, 1999, BIOLOGIC EFFECTS OF LIGHT 1998, P11; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Huotari A, 2008, INT J CIRCUMPOL HEAL, V67, P164, DOI 10.3402/ijch.v67i2-3.18258; KENNAWAY DJ, 1991, AM J PHYSIOL, V260, pR1137, DOI 10.1152/ajpregu.1991.260.6.R1137; Kim SH, 2014, PUBLIC HEALTH NUTR, V17, P122, DOI 10.1017/S1368980012004703; Kulie T, 2009, J AM BOARD FAM MED, V22, P698, DOI 10.3122/jabfm.2009.06.090037; Kull M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-22; Laaksi IT, 2006, EUR J CLIN NUTR, V60, P1035, DOI 10.1038/sj.ejcn.1602414; Lehmann B, 2012, VITAMIN D UPDATE 201, P1; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Luick B, 2014, INT J CIRCUMPOL HEAL, V73, DOI 10.3402/ijch.v73.22732; LUND B, 1979, SCAND J CLIN LAB INV, V39, P23, DOI 10.3109/00365517909104935; Maalouf NM, 2008, CURR OPIN NEPHROL HY, V17, P408, DOI 10.1097/MNH.0b013e3283040c99; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Maillet A, 1995, J GRAVIT PHYSL, V2, P25; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Mattila PH, 2011, J AGR FOOD CHEM, V59, P8298, DOI 10.1021/jf2012634; MCLAUGHLIN M, 1974, LANCET, V1, P536; OLIVERI MB, 1994, EUR J CLIN NUTR, V48, P397; Ovesen L, 2003, ANN NUTR METAB, V47, P107, DOI 10.1159/000070031; Palinkas LA, 2000, AVIAT SPACE ENVIR MD, V71, P619; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; PARKER RH, 1985, EUR J APPL PHYSIOL, V54, P363, DOI 10.1007/BF02337179; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Persson K, 2013, ACTA PAEDIATR, V102, P644, DOI 10.1111/apa.12172; Piirainen T, 2007, EUR J CLIN NUTR, V61, P123, DOI 10.1038/sj.ejcn.1602506; Premkumar M, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0129-0; REED HL, 1990, J CLIN ENDOCR METAB, V70, P965, DOI 10.1210/jcem-70-4-965; Rejnmark L, 2004, CALCIFIED TISSUE INT, V74, P255, DOI 10.1007/s00223-003-0110-9; Rodriguez-Rodriguez E, 2009, OBESITY, V17, P778, DOI 10.1038/oby.2008.649; ROTHBLUM ED, 1990, J PSYCHOL, V124, P253, DOI 10.1080/00223980.1990.10543221; Sharma S, 2011, NUTR REV, V69, P468, DOI 10.1111/j.1753-4887.2011.00406.x; Shearer WT, 2002, J ALLERGY CLIN IMMUN, V109, P854, DOI 10.1067/mai.2002.123873; Smith SM, 2009, AM J CLIN NUTR, V89, P1092, DOI 10.3945/ajcn.2008.27189; Sohl E, 2013, OSTEOPOROSIS INT, V24, P187, DOI 10.1007/s00198-012-2124-5; Soni M, 2012, SCAND J CLIN LAB INV, V72, P79, DOI 10.3109/00365513.2012.681969; Stahn A, 2014, HUMAN PHYSL EXTREME; Stahn A, 2013, HDB ANTHROPOMETRY PH; Strassl H, 1951, POLARFORSCHUNG, V21, P40; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Taylor CL, 2014, J NUTR, V144, P654, DOI 10.3945/jn.113.189811; Valtuena J, 2013, QJM-INT J MED, V106, P809, DOI 10.1093/qjmed/hct089; Vats P, 2005, NUTR NEUROSCI, V8, P233, DOI 10.1080/10284150500193726; Vieth R, 2005, ANN MED, V37, P278, DOI 10.1080/07853890510007313; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Whiting SJ, 2005, J NUTR, V135, P304, DOI 10.1093/jn/135.2.304; Wolff AE, 2008, NAT CLIN PRACT RHEUM, V4, P580, DOI 10.1038/ncprheum0921; Zerath E, 1999, EUR J APPL PHYSIOL, V79, P141, DOI 10.1007/s004210050487	89	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144130	10.1371/journal.pone.0144130	http://dx.doi.org/10.1371/journal.pone.0144130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641669	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700060
J	Naini, SM; Choukroun, GJ; Ryan, JR; Hentschel, DM; Shah, JV; Bonventre, JV				Naini, Said Movahedi; Choukroun, Gabriel J.; Ryan, James R.; Hentschel, Dirk M.; Shah, Jagesh V.; Bonventre, Joseph V.			Cytosolic phospholipase A(2)alpha regulates G(1) progression through modulating FOXO1 activity	FASEB JOURNAL			English	Article						zebrafish; cell cycle; p27(Kip1); cyclin D1; PGE(2)	DEPENDENT KINASE INHIBITOR; FORKHEAD TRANSCRIPTION FACTORS; MESANGIAL CELL-PROLIFERATION; ARACHIDONIC-ACID METABOLISM; CYCLIN D1; CANCER CELLS; PROTEIN-KINASES; MAP KINASE; P27(KIP1); A(2)	Group IVA phospholipase A(2)alpha [cytosolic phospholipase A(2)alpha (cPLA(2))] is a key mediator of inflammation and tumorigenesis. In this study, by using a combination of chemical inhibition and genetic approaches in zebrafish and murine cells, we identify a mechanism by which cPLA(2) promotes cell proliferation. We identified 2 cpla(2)alpha genes in zebrafish, cpla(2)alpha a and cpla(2)alpha b, with conserved phospholipase activity. In zebrafish, loss of cpla(2)alpha expression or inhibition of cpla(2)alpha activity diminished G(1) progression through the cell cycle. This phenotype was also seen in both mouse embryonic fibroblasts and mesangial cells. G(1) progression was rescued by the addition of arachidonic acid or prostaglandin E-2 (PGE(2)), indicating a phospholipase-dependent mechanism. We further show that PGE(2), through PI3K/AKT activation, promoted Forkhead box protein O1 (FOXO1) phosphorylation and FOXO1 nuclear export. This led to up-regulation of cyclin D1 and down-regulation of p27(Kip1), thus promoting G(1) progression. Finally, using pharmacologic inhibitors, we show that cPLA(2)alpha, rapidly accelerated fibrosarcoma (RAF)/MEK/ERK, and PI3K/AKT signaling pathways cooperatively regulate G(1) progression in response to platelet-derived growth factor stimulation. In summary, these data indicate that cPLA(2)alpha, through its phospholipase activity, is a critical effector of G(1) phase progression through the cell cycle and suggest that pharmacological targeting of this enzyme may have important therapeutic benefits in disease mechanisms that involve excessive cell proliferation, in particular, cancer and proliferative glomerulopathies.	[Naini, Said Movahedi; Ryan, James R.; Hentschel, Dirk M.; Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Med, Renal Div,Brigham & Womens Hosp, Boston, MA 02115 USA; [Shah, Jagesh V.; Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Choukroun, Gabriel J.] Amiens Southern Hosp, Div Renal, Amiens, France; [Bonventre, Joseph V.] Harvard Stem Cell Inst, Cambridge, MA USA; [Shah, Jagesh V.; Bonventre, Joseph V.] Harvard MIT, Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Harvard University; Harvard University	Bonventre, JV (corresponding author), Harvard Univ, Inst Med, Div Renal, 4 Blackfan Circle, Boston, MA 02115 USA.	joseph_bonventre@hms.harvard.edu	Gabriel, Choukroun/AAL-4969-2021		U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK054741, DKD072381, DK039773]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054741, R01DK054741, R37DK039773, R01DK039773, R01DK072381] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Chuan Wu (Center for Neurological Diseases, Brigham and Women's Hospital) for FOXO1-Luc and Martin McMahon (University of California, San Francisco, Comprehensive Cancer Center, San Francisco, CA, USA) for EGFP Delta Raf-1:AR plasmid. This work was supported by U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054741, DKD072381, and DK039773 (to J.V.B.). All authors have read and approved the manuscript. This manuscript has not been published or submitted in any format in part or in its entirety elsewhere. S.M.N., G.J.C., J.R.R., J.V.S., and J.V.B. designed the experiments. S.M.N. and G.J.C. performed experiments and collected and analyzed data. S.M.N. and J.V.B. wrote the manuscript. All the authors discussed the results and commented on the manuscript. The authors declare no conflicts of interest.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Antoniotti S, 2003, J CELL PHYSIOL, V197, P370, DOI 10.1002/jcp.10359; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BONVENTRE JV, 1991, KIDNEY INT, V39, P438, DOI 10.1038/ki.1991.55; BONVENTRE JV, 1992, J AM SOC NEPHROL, V3, P128; BONVENTRE JV, 1988, AM J PHYSIOL, V254, pF87, DOI 10.1152/ajprenal.1988.254.1.F87; Bunt G, 1997, J CELL SCI, V110, P2449; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Choukroun GJ, 2000, J CLIN INVEST, V106, P983, DOI 10.1172/JCI8914; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dubey RK, 1997, CURR OPIN NEPHROL HY, V6, P88, DOI 10.1097/00041552-199701000-00016; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; George RJ, 2007, PROSTAG OTH LIPID M, V83, P112, DOI 10.1016/j.prostaglandins.2006.10.005; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Inoue CN, 1997, P SOC EXP BIOL MED, V216, P370; Iwanaga R, 2006, ONCOGENE, V25, P1786, DOI 10.1038/sj.onc.1209210; Kang SS, 2000, INVEST OPHTH VIS SCI, V41, P2164; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; MENE P, 1990, KIDNEY INT, V37, P1256, DOI 10.1038/ki.1990.109; MENE P, 1990, KIDNEY INT, V38, P232, DOI 10.1038/ki.1990.191; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; MONTROSE DC, 2015, PROSTAG OTH LIPID M, V117, P26; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; Ono T, 2002, BIOCHEM J, V363, P727, DOI 10.1042/0264-6021:3630727; Postlethwait J, 2004, METHOD CELL BIOL, V77, P255; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang Y, 2011, INVEST OPHTH VIS SCI, V52, P8231, DOI 10.1167/iovs.11-7542; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yarden A, 1995, BBA-GENE STRUCT EXPR, V1264, P257, DOI 10.1016/0167-4781(95)00175-1; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zharkikh A, 1995, MOL PHYLOGENET EVOL, V4, P44, DOI 10.1006/mpev.1995.1005	53	17	18	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1155	1170		10.1096/fj.15-278416	http://dx.doi.org/10.1096/fj.15-278416			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644349	Green Published			2022-12-26	WOS:000370387800014
J	Wang, HJ; Song, CH; Ding, YL; Pan, XK; Ge, Z; Tan, BH; Gowda, C; Sachdev, M; Muthusami, S; Ouyang, HS; Lai, LX; Francis, OL; Morris, CL; Abdel-Azim, H; Dorsam, G; Xiang, MX; Payne, KJ; Dovat, S				Wang, Haijun; Song, Chunhua; Ding, Yali; Pan, Xiaokang; Ge, Zheng; Tan, Bi-Hua; Gowda, Chandrika; Sachdev, Mansi; Muthusami, Sunil; Ouyang, Hongsheng; Lai, Liangxue; Francis, Olivia L.; Morris, Christopher L.; Abdel-Azim, Hisham; Dorsam, Glenn; Xiang, Meixian; Payne, Kimberly J.; Dovat, Sinisa			Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hematopoiesis; lymphocyte; signal transduction; transcription regulation; transcription repressor; tumor suppressor gene; ck2; ikzf1	ACUTE MYELOID-LEUKEMIA; DNA-BINDING PROTEINS; GENOME-WIDE ANALYSIS; MYELOPROLIFERATIVE NEOPLASMS; CENTROMERIC HETEROCHROMATIN; NUCLEAR-PROTEIN; BREAST-CANCER; ACTIVE GENES; EXPRESSION; INHIBITORS	Impaired function of the Ikaros (IKZF1) protein is associated with the development of high-risk B-cell precursor acute lymphoblastic leukemia (B-ALL). The mechanisms of Ikaros tumor suppressor activity in leukemia are unknown. Ikaros binds to the upstream regulatory elements of its target genes and regulates their transcription via chromatin remodeling. Here, we report that Ikaros represses transcription of the histone H3K4 demethylase, JARID1B (KDM5B). Transcriptional repression of JARID1B is associated with increased global levels of H3K4 trimethylation. Ikaros-mediated repression of JARID1B is dependent on the activity of the histone deacetylase, HDAC1, which binds to the upstream regulatory element of JARID1B in complex with Ikaros. In leukemia, JARID1B is overexpressed, and its inhibition results in cellular growth arrest. Ikaros-mediated repression of JARID1B in leukemia is impaired by pro-oncogenic casein kinase 2 (CK2). Inhibition of CK2 results in increased binding of the Ikaros-HDAC1 complex to the promoter of JARID1B, with increased formation of trimethylated histone H3 lysine 27 and decreased histone H3 Lys-9 acetylation. In cases of high-risk B-ALL that carry deletion of one Ikaros (IKZF1) allele, targeted inhibition of CK2 restores Ikaros binding to the JARID1B promoter and repression of JARID1B. In summary, the presented data suggest a mechanism through which Ikaros and HDAC1 regulate the epigenetic signature in leukemia: via regulation of JARID1B transcription. The presented data identify JARID1B as a novel therapeutic target in B-ALL and provide a rationale for the use of CK2 inhibitors in the treatment of high-risk B-ALL.	[Wang, Haijun; Ouyang, Hongsheng; Lai, Liangxue] Xinxiang Med Univ, Dept Pathol, Xinxiang 453003, Henan, Peoples R China; [Wang, Haijun; Song, Chunhua; Ding, Yali; Pan, Xiaokang; Ge, Zheng; Tan, Bi-Hua; Gowda, Chandrika; Sachdev, Mansi; Muthusami, Sunil; Dovat, Sinisa] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Francis, Olivia L.; Morris, Christopher L.; Payne, Kimberly J.] Loma Linda Univ, Loma Linda, CA 92350 USA; [Abdel-Azim, Hisham] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA; [Dorsam, Glenn] N Dakota State Univ, Fargo, ND 58108 USA; [Xiang, Meixian] South Cent Univ Nationalities, Coll Pharm, Wuhan 430074, Peoples R China	Xinxiang Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Loma Linda University; Children's Hospital Los Angeles; University of Southern California; North Dakota State University Fargo; South Central Minzu University	Dovat, S (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Div Pediat Hematol Oncol, Hershey, PA 17033 USA.	sdovat@hmc.psu.edu	Payne, Kimberly/AAS-6814-2020; Ding, Yali/AAD-1895-2019; song, chunhua/K-7882-2016; Dorsam, Glenn/GYD-8815-2022; song, chunhua/K-7882-2016	Payne, Kimberly/0000-0002-7025-5821; song, chunhua/0000-0001-7563-0339; Muthusami, Sunil/0000-0003-0497-6142; song, chunhua/0000-0002-4081-2543; Dovat, Sinisa/0000-0003-3906-6165	National Institutes of Health (NIH) [R01 HL095120]; St. Baldrick's Foundation; Hyundai Hope on Wheels Scholar Grant Award; Four Diamonds Fund of the Pennsylvania State University College of Medicine; John Wawrynovic Leukemia Research Scholar Endowment; NIH [R21CA162259, 1R15AI101968-01A1]; Hyundai Hope on Wheels Grant; Department of Pathology and Human Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine (NIH) at Loma Linda University School of Medicine [P20MD006988]; Natural Science Foundation of China [31200264]; Natural Science Foundation of Hubei Province [2015BCA268]; Natural Science Foundation of Wuhan City [2015070404010201, 2014070404010210]; NATIONAL CANCER INSTITUTE [R21CA162259] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101968] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; Hyundai Hope on Wheels Scholar Grant Award; Four Diamonds Fund of the Pennsylvania State University College of Medicine; John Wawrynovic Leukemia Research Scholar Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels Grant; Department of Pathology and Human Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine (NIH) at Loma Linda University School of Medicine; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Natural Science Foundation of Wuhan City; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health (NIH) Grant R01 HL095120, a St. Baldrick's Foundation Career Development Award, a Hyundai Hope on Wheels Scholar Grant Award, the Four Diamonds Fund of the Pennsylvania State University College of Medicine, and the John Wawrynovic Leukemia Research Scholar Endowment (to S. D.). This work was also supported by NIH grant R21CA162259, a St. Baldrick's Foundation Research Grant, a Hyundai Hope on Wheels Grant (to K. J. P.), the Department of Pathology and Human Anatomy, the Department of Basic Sciences (Grant to Promote Collaborative and Translational Research to K. J. P. and C. L. M.), and the Center for Health Disparities and Molecular Medicine (NIH Grant P20MD006988) at Loma Linda University School of Medicine. This work was supported in part by NIH Grant 1R15AI101968-01A1 (to G. P. D.) and by Natural Science Foundation of China Grant 31200264, Natural Science Foundation of Hubei Province Grant 2015BCA268, and "Chenguang Planning" from Natural Science Foundation of Wuhan City Grants 2015070404010201 and 2014070404010210 (to M. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Battistutta R, 2011, BIOCHEMISTRY-US, V50, P8478, DOI 10.1021/bi2008382; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Blair Lauren P, 2011, Cancers (Basel), V3, P1383, DOI 10.3390/cancers3011383; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cellot S, 2013, BLOOD, V122, P1545, DOI 10.1182/blood-2013-04-496281; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; ERNST P, 1993, MOL CELL BIOL, V13, P2982, DOI 10.1128/MCB.13.5.2982; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Jager R, 2010, LEUKEMIA, V24, P1290, DOI 10.1038/leu.2010.99; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koipally J, 2002, J BIOL CHEM, V277, P23143, DOI 10.1074/jbc.M202079200; Li ZJ, 2012, PEDIATR BLOOD CANCER, V59, P69, DOI 10.1002/pbc.23406; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Madsen B, 2002, MECH DEVELOP, V119, pS239, DOI 10.1016/S0925-4773(03)00123-0; Mai A, 2008, BIOORG MED CHEM LETT, V18, P2530, DOI 10.1016/j.bmcl.2008.03.055; Gomes AM, 2014, HAEMATOLOGICA, V99, P1062, DOI 10.3324/haematol.2013.096438; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Rudant J, 2013, LEUKEMIA, V27, P746, DOI 10.1038/leu.2012.244; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Song CH, 2015, BLOOD, V126, P1813, DOI 10.1182/blood-2015-06-651505; Stewart MH, 2015, BLOOD, V125, P2075, DOI 10.1182/blood-2014-08-596734; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Theocharides APA, 2015, LEUKEMIA, V29, P177, DOI 10.1038/leu.2014.150; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yagi T, 2002, BLOOD, V99, P1350, DOI 10.1182/blood.V99.4.1350; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	61	39	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4004	4018		10.1074/jbc.M115.679332	http://dx.doi.org/10.1074/jbc.M115.679332			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26655717	hybrid, Green Published			2022-12-26	WOS:000371338400027
J	Garner, KL; Perrett, RM; Voliotis, M; Bowsher, C; Pope, GR; Pham, T; Caunt, CJ; Tsaneva-Atanasova, K; McArdle, CA				Garner, Kathryn L.; Perrett, Rebecca M.; Voliotis, Margaritis; Bowsher, Clive; Pope, George R.; Thanh Pham; Caunt, Christopher J.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Information Transfer in Gonadotropin-releasing Hormone (GnRH) Signaling EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK)-MEDIATED FEEDBACK LOOPS CONTROL HORMONE SENSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASES; PROTEIN-COUPLED RECEPTOR; SPATIOTEMPORAL REGULATION; PULSE-FREQUENCY; ERK; DESENSITIZATION; INTERNALIZATION; PITUITARY; GROWTH; CANCER	Cell signaling pathways are noisy communication channels, and statistical measures derived from information theory can be used to quantify the information they transfer. Here we use single cell signaling measures to calculate mutual information as a measure of information transfer via gonadotropin-releasing hormone (GnRH) receptors (GnRHR) to extracellular signal-regulated kinase (ERK) or nuclear factor of activated T-cells (NFAT). This revealed mutual information values <1 bit, implying that individual GnRH-responsive cells cannot unambiguously differentiate even two equally probable input concentrations. Addressing possible mechanisms for mitigation of information loss, we focused on the ERK pathway and developed a stochastic activation model incorporating negative feedback and constitutive activity. Model simulations revealed interplay between fast (min) and slow (min-h) negative feedback loops with maximal information transfer at intermediate feedback levels. Consistent with this, experiments revealed that reducing negative feedback (by expressing catalytically inactive ERK2) and increasing negative feedback (by Egr1-driven expression of dual-specificity phosphatase 5 (DUSP5)) both reduced information transfer from GnRHR to ERK. It was also reduced by blocking protein synthesis (to prevent GnRH from increasing DUSP expression) but did not differ for different GnRHRs that do or do not undergo rapid homologous desensitization. Thus, the first statistical measures of information transfer via these receptors reveals that individual cells are unreliable sensors of GnRH concentration and that this reliability is maximal at intermediate levels of ERK-mediated negative feedback but is not influenced by receptor desensitization.	[Garner, Kathryn L.; Perrett, Rebecca M.; Pope, George R.; McArdle, Craig A.] Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Voliotis, Margaritis; Bowsher, Clive] Univ Bristol, Sch Math, Univ Walk, Bristol BS8 1TW, Avon, England; [Thanh Pham] Texas A&M Univ Corpus Christi, Corpus Christi, TX 78412 USA; [Caunt, Christopher J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Tsaneva-Atanasova, Krasimira] Univ Exeter, Coll Engn Math & Phys Sci, Dept Math, Exeter EX4 4QF, Devon, England	University of Bristol; University of Bristol; Texas A&M University System; Texas A&M University Corpus Christi; University of Bath; University of Exeter	McArdle, CA (corresponding author), Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	McArdle, Craig/AAQ-5660-2021; Garner, Kathryn/AAQ-2052-2020; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019	McArdle, Craig/0000-0003-4836-5351; Garner, Kathryn/0000-0001-8539-8959; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Voliotis, Margaritis/0000-0001-6488-7198	Biochemical and Biophysical Science Research Council (BBSRC) [BB/J014699/1]; MRC Biomedical Informatics Fellowship [MR/K021826/1]; BBSRC [BB/J014699/1] Funding Source: UKRI; EPSRC [EP/L000296/1, EP/N014391/1] Funding Source: UKRI; MRC [MR/K021826/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014699/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L000296/1, EP/N014391/1] Funding Source: researchfish; Medical Research Council [MR/K021826/1] Funding Source: researchfish	Biochemical and Biophysical Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Biomedical Informatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Biochemical and Biophysical Science Research Council award (BBSRC BB/J014699/1; to C. A. M. and K. T.-A.). The authors declare that they have no conflicts of interest with the contents of this article.r Holds a MRC Biomedical Informatics Fellowship (MR/K021826/1).	Armstrong SP, 2010, J BIOL CHEM, V285, P24360, DOI 10.1074/jbc.M110.115964; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Bowsher CG, 2014, CURR OPIN BIOTECH, V28, P149, DOI 10.1016/j.copbio.2014.04.010; Bowsher CG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002965; Brennan MD, 2012, SCIENCE, V338, P334, DOI 10.1126/science.1227946; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P276, DOI 10.1016/j.tem.2006.07.008; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Caunt CJ, 2010, J CELL SCI, V123, P4310, DOI 10.1242/jcs.076349; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; DAVIDSON JS, 1994, BIOCHEM J, V300, P299, DOI 10.1042/bj3000299; Heding A, 1998, J BIOL CHEM, V273, P11472, DOI 10.1074/jbc.273.19.11472; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; LOUMAYE E, 1983, J BIOL CHEM, V258, P2002; Luttrell LM, 2002, J CELL SCI, V115, P455; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; McArdle C. A., 2014, KNOBIL NEILLS PHYSL, V1, P399; MCARDLE CA, 1992, MOL CELL ENDOCRINOL, V87, P95, DOI 10.1016/0303-7207(92)90237-Z; McArdle CA, 1999, MOL CELL ENDOCRINOL, V151, P129, DOI 10.1016/S0303-7207(99)00024-6; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Pawson AJ, 2008, ENDOCRINOLOGY, V149, P1415, DOI 10.1210/en.2007-1159; Perrett RM, 2014, J BIOL CHEM, V289, P7873, DOI 10.1074/jbc.M113.532473; Perrett RM, 2013, J BIOL CHEM, V288, P21001, DOI 10.1074/jbc.M113.455345; Rushworth LK, 2014, P NATL ACAD SCI USA, V111, P18267, DOI 10.1073/pnas.1420159112; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shankaran H, 2010, CURR OPIN GENET DEV, V20, P650, DOI 10.1016/j.gde.2010.08.002; Uda S, 2013, SCIENCE, V341, P558, DOI 10.1126/science.1234511; Voliotis M, 2014, P NATL ACAD SCI USA, V111, pE326, DOI 10.1073/pnas.1314446111; Voliotis M, 2012, NUCLEIC ACIDS RES, V40, P7084, DOI 10.1093/nar/gks385	37	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2246	2259		10.1074/jbc.M115.686964	http://dx.doi.org/10.1074/jbc.M115.686964			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644469	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000369610400016
J	Marland, JRK; Hasel, P; Bonnycastle, K; Cousin, MA				Marland, Jamie Roslin Keynes; Hasel, Philip; Bonnycastle, Katherine; Cousin, Michael Alan			Mitochondrial Calcium Uptake Modulates Synaptic Vesicle Endocytosis in Central Nerve Terminals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+; KINETICS; RELEASE; INFLUX; MCU; EXOCYTOSIS; RETRIEVAL; MEMBRANE; PROTEIN; ATP	Presynaptic calcium influx triggers synaptic vesicle (SV) exocytosis and modulates subsequent SV endocytosis. A number of calcium clearance mechanisms are present in central nerve terminals that regulate intracellular free calcium levels both during and after stimulation. During action potential stimulation, mitochondria rapidly accumulate presynaptic calcium via the mitochondrial calcium uniporter (MCU). The role of mitochondrial calcium uptake in modulating SV recycling has been debated extensively, but a definitive conclusion has not been achieved. To directly address this question, we manipulated the expression of the MCU channel subunit in primary cultures of neurons expressing a genetically encoded reporter of SV turnover. Knockdown of MCU resulted in ablation of activity-dependent mitochondrial calcium uptake but had no effect on the rate or extent of SV exocytosis. In contrast, the rate of SV endocytosis was increased in the absence of mitochondrial calcium uptake and slowed when MCU was overexpressed. MCU knockdown did not perturb activity-dependent increases in presynaptic free calcium, suggesting that SV endocytosis may be controlled by calcium accumulation and efflux from mitochondria in their immediate vicinity.	[Marland, Jamie Roslin Keynes; Hasel, Philip; Bonnycastle, Katherine; Cousin, Michael Alan] Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	M.Cousin@ed.ac.uk		Marland, Jamie/0000-0001-6442-082X; Hasel, Philip/0000-0003-4378-3685; Cousin, Michael/0000-0002-1762-160X	Medical Research Council [G1002117]; MRC [G1002117] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G1002117 to (M. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Billups B, 2002, J NEUROSCI, V22, P5840; Caldwell L, 2013, SYNAPSE, V67, P729, DOI 10.1002/syn.21678; Chen M, 2011, ACTA BIOCH BIOPH SIN, V43, P822, DOI 10.1093/abbs/gmr075; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chouhan AK, 2012, J NEUROSCI, V32, P1233, DOI 10.1523/JNEUROSCI.1301-11.2012; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Egashira Y, 2015, J NEUROSCI, V35, P3701, DOI 10.1523/JNEUROSCI.4160-14.2015; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Leitz J, 2011, J NEUROSCI, V31, P16318, DOI 10.1523/JNEUROSCI.3358-11.2011; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Patron M, 2013, J BIOL CHEM, V288, P10750, DOI 10.1074/jbc.R112.420752; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Rossano AJ, 2013, J PHYSIOL-LONDON, V591, P1691, DOI 10.1113/jphysiol.2012.248377; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Scott R, 2007, J ANAT, V210, P642, DOI 10.1111/j.1469-7580.2007.00728.x; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Waters J, 2003, PFLUG ARCH EUR J PHY, V447, P363, DOI 10.1007/s00424-003-1182-0; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Wu XS, 2014, J NEUROSCI, V34, P2652, DOI 10.1523/JNEUROSCI.3582-13.2014; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015	44	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2080	2086		10.1074/jbc.M115.686956	http://dx.doi.org/10.1074/jbc.M115.686956			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644474	Green Published, hybrid			2022-12-26	WOS:000369610400004
J	Bernasconi, L; Ramenzoni, LL; Al-Majid, A; Tini, GM; Graber, SM; Schmidlin, PR; Irani, S				Bernasconi, Luca; Ramenzoni, Liza L.; Al-Majid, Ahmed; Tini, Gabrielo M.; Graber, Sereina M.; Schmidlin, Patrick R.; Irani, Sarosh			Elevated Matrix Metalloproteinase Levels in Bronchi Infected with Periodontopathogenic Bacteria	PLOS ONE			English	Article							TREPONEMA-DENTICOLA; LUNG; MICROBIOME; MMP-8; MATRIX-METALLOPROTEINASE-9; TISSUE; TNF	Objectives To determine whether bronchial colonisations/infections with periodontopathogenic bacteria are associated with elevated inflammatory markers such as MMPs, interleukins and Tumor necrosis factor alpha in the bronchial fluid. Methods Periodontal status was assessed in consecutive outpatients planned for elective bronchoscopies, and PCR for periodontopathogenic bacteria was performed from a protected specimen brush sample taken from the bronchial mucosa. Additionally, MMPs, interleukins and Tumor necrosis factor alpha were measured in the bronchial fluid. Results Out of the four species assessed, one species was found in 13 of 91 (14%) patients, and two in 12 (13%), three in 13 (14%) and all four in 1 (1%) patient, respectively. In multiple linear regression models the presence of Treponema denticola showed a consistent pattern of positive effects in bronchial fluid (Bonferroni adjusted p-values) on the levels of MMP9 (p adj.: 0.028) and MMP12 (p adj.: 0.029). Active smoking was independently associated with increased levels of aMMP8 (p adj.: 0.005) and MMP9 (p adj.: 0.009). Levels of IL-1 beta, IL-8 and Tumor necrosis factor alpha measured in the bronchial fluid were not affected by the presence of periodontopathogenic bacteria. Conclusions Bronchial colonisation/infection with Treponema denticola and smoking are independently associated with elevated MMPs (MMP9/MMP12 and MMP8/MMP9, respectively) in the bronchial fluid.	[Bernasconi, Luca] Cantonal Hosp Aarau, Ctr Lab Med, CH-5001 Aarau, Switzerland; [Ramenzoni, Liza L.; Al-Majid, Ahmed; Schmidlin, Patrick R.] Univ Zurich, Ctr Dent Med, Clin Prevent Dent Periodontol & Cariol, CH-8032 Zurich, Switzerland; [Tini, Gabrielo M.; Irani, Sarosh] Cantonal Hosp Aarau, Clin Pulm & Sleep Med, CH-5001 Aarau, Switzerland; [Graber, Sereina M.] Univ Zurich Irchel, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland	Kantonsspital Aarau AG (KSA); University of Zurich; Kantonsspital Aarau AG (KSA); University of Zurich	Irani, S (corresponding author), Cantonal Hosp Aarau, Clin Pulm & Sleep Med, CH-5001 Aarau, Switzerland.	siran@gmx.ch	Irani, Sarosh/AAO-6911-2020	Irani, Sarosh/0000-0002-7667-9748; Ramenzoni, Liza L./0000-0002-7732-2118	Research Council of the Cantonal Hospital Aarau, Switzerland; Cantonal Hospital Aarau Endoscopy Team	Research Council of the Cantonal Hospital Aarau, Switzerland; Cantonal Hospital Aarau Endoscopy Team	This work was supported by the Research Fund from the Research Council of the Cantonal Hospital Aarau, Switzerland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Research Fund from the Research Council of the Cantonal Hospital Aarau, Switzerland. We also thank Constanze Spelters for her precise work as study nurse and the the Cantonal Hospital Aarau Endoscopy Team for its support.	Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Craig VJ, 2013, J IMMUNOL, V190, P4283, DOI 10.4049/jimmunol.1201043; Cutress T W, 1987, Int Dent J, V37, P222; CUTRESS TW, 1978, COMMUNITY DENT ORAL, V6, P245, DOI 10.1111/j.1600-0528.1978.tb01159.x; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Eick S, 2011, DIAGN MICR INFEC DIS, V69, P12, DOI 10.1016/j.diagmicrobio.2010.08.017; El-Solh AA, 2009, J INFECTION, V59, P49, DOI 10.1016/j.jinf.2009.05.004; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fenno JC, 2012, J ORAL MICROBIOL, V4; Grenier D, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.21517; Haq I, 2011, THORAX, V66, P970, DOI 10.1136/thx.2011.159087; Hellyer TP, 2015, THORAX, V70, P41, DOI 10.1136/thoraxjnl-2014-205766; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; Irani Sarosh, 2011, Schweiz Monatsschr Zahnmed, V121, P1144; Kraft-Neumarker M, 2012, J PERIODONTAL RES, V47, P121, DOI 10.1111/j.1600-0765.2011.01416.x; Mocchegiani E, 2011, CURR OPIN PULM MED, V17, pS11, DOI 10.1097/01.mcp.0000410743.98087.12; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Noh MK, 2013, EXP THER MED, V6, P847, DOI 10.3892/etm.2013.1222; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; Ramseier CA, 2009, J PERIODONTOL, V80, P436, DOI [10.1902/jop.2009.080480, 10.1902/jop.2009.080480 ]; Schmidlin PR, 2015, J INFECTION, V70, P255, DOI 10.1016/j.jinf.2014.10.005; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sorsa T, 1999, ANN NY ACAD SCI, V878, P130, DOI 10.1111/j.1749-6632.1999.tb07679.x; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Victor Dayanand John, 2014, J Int Oral Health, V6, P67; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Villalta PC, 2014, AM J PHYSIOL-LUNG C, V307, pL652, DOI 10.1152/ajplung.00113.2014; Wilkinson TS, 2012, CHEST, V142, P1425, DOI 10.1378/chest.11-3273; Xie SS, 2014, J INT MED RES, V42, P1272, DOI 10.1177/0300060514548290; Yakob M, 2013, ORAL DIS, V19, P694, DOI 10.1111/odi.12057; Yakob M, 2012, J CLIN PERIODONTOL, V39, P256, DOI 10.1111/j.1600-051X.2011.01813.x; Zehnder M, 2011, J ENDODONT, V37, P17, DOI 10.1016/j.joen.2010.10.003	35	4	5	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144461	10.1371/journal.pone.0144461	http://dx.doi.org/10.1371/journal.pone.0144461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656474	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000366715900052
J	Butler, NM; Atkins, PA; Voytas, DF; Douches, DS				Butler, Nathaniel M.; Atkins, Paul A.; Voytas, Daniel F.; Douches, David S.			Generation and Inheritance of Targeted Mutations in Potato (Solanum tuberosum L.) Using the CRISPR/Cas System	PLOS ONE			English	Article							HOMING ENDONUCLEASES; GENOME; MUTAGENESIS; GENES; TOMATO; CROPS; MODEL	Genome editing using sequence-specific nucleases (SSNs) offers an alternative approach to conventional genetic engineering and an opportunity to extend the benefits of genetic engineering in agriculture. Currently available SSN platforms, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas (clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated systems (Cas)) have been used in a range of plant species for targeted mutagenesis via nonhomologous end joining (NHEJ) are just beginning to be explored in crops such as potato (Solanum tuberosum Group Tuberosum L.). In this study, CRISPR/Cas reagents expressing one of two single-guide RNA (sgRNA) targeting the potato ACETOLACTATE SYNTHASE1 (StALS1) gene were tested for inducing targeted mutations in callus and stable events of diploid and tetraploid potato using Agrobacterium-mediated transformation with either a conventional T-DNA or a modified geminivirus T-DNA. The percentage of primary events with targeted mutations ranged from 3-60% per transformation and from 0-29% above an expected threshold based on the number of ALS alleles. Primary events with targeted mutation frequencies above the expected threshold were used for mutation cloning and inheritance studies using clonal propagation and crosses or selfing. Four of the nine primary events used for mutation cloning had more than one mutation type, and eight primary events contained targeted mutations that were maintained across clonal generations. Somatic mutations were most evident in the diploid background with three of the four primary events having more than two mutation types at a single ALS locus. Conversely, in the tetraploid background, four of the five candidates carried only one mutation type. Single targeted mutations were inherited through the germline of both diploid and tetraploid primary events with transmission percentages ranging from 87-100%. This demonstration of CRISPR/Cas in potato extends the range of plant species modified using CRISPR/Cas and provides a framework for future studies.	[Butler, Nathaniel M.; Douches, David S.] Michigan State Univ, Dept Plant Soils & Microbial Sci, E Lansing, MI 48824 USA; [Atkins, Paul A.; Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Michigan State University; University of Minnesota System; University of Minnesota Twin Cities	Douches, DS (corresponding author), Michigan State Univ, Dept Plant Soils & Microbial Sci, E Lansing, MI 48824 USA.	douchesd@msu.edu		Butler, Nathaniel/0000-0002-9235-7626; Voytas, Daniel/0000-0002-4944-1224; Atkins, Paul/0000-0002-4840-7825	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture [2013-33522-21090]; Agricultural Research Service; Direct For Biological Sciences [1339209] Funding Source: National Science Foundation	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture; Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Biotechnology Risk Assessment Grant Program competitive grant no. 2013-33522-21090 from the USDA National Institute of Food and Agriculture and the Agricultural Research Service (http://nifa.usda.gov/) to DFV and DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2012, PLANT GENOME-US, V5, P42, DOI 10.3835/plantgenome2012.06.0008; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Endo M, 2013, J PESTIC SCI, V38, P49, DOI 10.1584/jpestics.D12-073; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hunter P, 2014, EMBO REP, V15, P1; Jansky SH, 2014, J PLANT REGIST, V8, P195, DOI 10.3198/jpr2013.05.0024crg; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lor VS, 2014, PLANT PHYSIOL, V166, P1288, DOI 10.1104/pp.114.247593; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Palmgren MG, 2014, TRENDS PLANT SCI, P1; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; SMITH JK, 1989, P NATL ACAD SCI USA, V86, P4179, DOI 10.1073/pnas.86.11.4179; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Verhoeven HA, 1988, PLANT CELL REP, V7, P47, DOI [10.1007/BF00272976, DOI 10.1007/BF00272976]; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Wu JC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093806, 10.1371/journal.pone.0090528]; Xu H, 2015, GENOME RES; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	33	130	143	1	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144591	10.1371/journal.pone.0144591	http://dx.doi.org/10.1371/journal.pone.0144591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657719	Green Published, gold			2022-12-26	WOS:000366715900067
J	Thompson, DR; Momplaisir, FM; Adams, JW; Yehia, BR; Anderson, EA; Alleyne, G; Brady, KA				Thompson, Dana R.; Momplaisir, Florence M.; Adams, Joella W.; Yehia, Baligh R.; Anderson, Emily A.; Alleyne, Gregg; Brady, Kathleen A.			Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD-TRANSMISSION; CESAREAN-SECTION; ANTIRETROVIRAL THERAPY; PRETERM DELIVERY; VAGINAL DELIVERY; PREVENTION; METAANALYSIS; COHORT; RISK	Objective Current guidelines call for HIV-infected women to deliver via scheduled Caesarean when the maternal HIV viral load (VL) is > 1,000 copies/ml. We describe the mode of delivery among HIV-infected women and evaluate adherence to relevant recommendations. Study Design We performed a population-based surveillance analysis of HIV-infected pregnant women in Philadelphia from 2005 to 2013, comparing mode of delivery (vaginal, scheduled Caesarean, or emergent Caesarean) by VL during pregnancy, closest to the time of delivery (<= 1,000 copies/ml versus an unknown VL or VL > 1,000 copies/ml) and associated factors in multivariable analysis. Results Our cohort included 824 deliveries from 648 HIV-infected women, of whom 69.4% had a VL <= 1,000 copies/ml and 30.6% lacked a VL or had a VL > 1,000 copies/ml during pregnancy, closest to the time of delivery. Mode of delivery varied by VL: 56.6% of births were vaginal, 30.1% scheduled Caesarean, and 13.3% emergent Caesarean when the VL was <= 1,000 copies/ml; when the VL was unknown or > 1,000 copies/ml, 32.9% of births were vaginal, 49.9% scheduled Caesarean and 17.5% emergent Caesarean. In multivariable analyses, Hispanic women (adjusted odds ratio (AOR) 0.17, 95% Confidence Interval (CI) 0.04-0.76) and non-Hispanic black women (AOR 0.27, 95% CI 0.10-0.77) were less to likely to deliver via scheduled Caesarean compared to non-Hispanic white women. Women who delivered prior to 38 weeks' gestation (AOR 0.37, 95% CI 0.18-0.76) were also less likely to deliver via scheduled Caesarean compared to women who delivered after 38 weeks' gestation. An interaction term for race and gestational age at delivery was significant in multivariable analysis. Non-Hispanic black (AOR 0.06, 95% CI 0.01-0.36) and Hispanic women (AOR 0.03, 95% CI 0.00-0.59) were more likely to deliver prematurely and less likely to deliver via scheduled C-section compared to non-Hispanic white women. Having a previous Caesarean (AOR 27.77, 95% CI 8.94-86.18) increased the odds of scheduled Caesarean delivery. Conclusions Only half of deliveries for women with an unknown VL or VL > 1,000 copies/ml occurred via scheduled Caesarean. Delivery prior to 38 weeks, particularly among minority women, resulted in a missed opportunity to receive a scheduled Caesarean. However, even when delivering at or after 38 weeks' gestation, a significant proportion of women did not get a scheduled Caesarean when indicated, suggesting a need for focused public health interventions to increase the proportion of women achieving viral suppression during pregnancy and delivering via scheduled Caesarean when indicated.	[Thompson, Dana R.] Christiana Care Hlth Syst, Ctr Womens & Childrens Hlth Res, Newark, DE 19718 USA; [Momplaisir, Florence M.] Drexel Univ, Div Infect Dis & HIV Med, Coll Med, Philadelphia, PA 19104 USA; [Adams, Joella W.; Anderson, Emily A.; Brady, Kathleen A.] Philadelphia Dept Publ Hlth, AIDS Act & Coordinating Off, Philadelphia, PA USA; [Yehia, Baligh R.; Brady, Kathleen A.] Hosp Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [Yehia, Baligh R.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Drexel Univ, Dept Obstet & Gynecol, Coll Med, Philadelphia, PA 19104 USA	Christiana Care Health System; Drexel University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Drexel University	Thompson, DR (corresponding author), Christiana Care Hlth Syst, Ctr Womens & Childrens Hlth Res, Newark, DE 19718 USA.	dana.thompson@christianacare.org		Adams, Joella/0000-0002-7703-5944				Aebi-Popp K, 2013, JAIDS-J ACQ IMM DEF, V64, P58, DOI 10.1097/QAI.0b013e3182a334e3; Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; [Anonymous], 2008, MMWR; [Anonymous], HIV SURV REP; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; BURNS LR, 1995, MED CARE, V33, P365, DOI 10.1097/00005650-199504000-00004; Centers for Disease Control and Prevention, 2005, ENH PER SURV 15 AR; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Curtin S.C., 2013, NATL VITAL STAT REPO, V62; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Goler NC, 2008, J PERINATOL, V28, P597, DOI 10.1038/jp.2008.70; KEELER EB, 1993, MILBANK Q, V71, P365, DOI 10.2307/3350407; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Kozhimannil KB, 2014, MED CARE, V52, P649, DOI 10.1097/MLR.0000000000000153; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mitler LK, 2000, J CLIN EPIDEMIOL, V53, P1030, DOI 10.1016/S0895-4356(00)00221-3; Momplaisir FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132262; Myer L, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-94; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2015, REC US ANT DRUGS PRE; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Practice CoO, 2001, INT J GYNECOL OBSTET, V73, P279; Short CES, 2014, HIV MED, V15, P233, DOI 10.1111/hiv.12083; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; STAFFORD RS, 1991, JAMA-J AM MED ASSOC, V265, P59, DOI 10.1001/jama.265.1.59; Suy A, 2008, EUR J OBSTET GYN R B, V139, P127, DOI 10.1016/j.ejogrb.2007.12.007; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; TUSSING AD, 1993, SOC SCI MED, V37, P1251; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144592	10.1371/journal.pone.0144592	http://dx.doi.org/10.1371/journal.pone.0144592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657902	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900068
J	Fujita, K; Kuge, K; Ozawa, N; Sahara, S; Zaiki, K; Nakaoji, K; Hamada, K; Takenaka, Y; Tanahashi, T; Tamai, K; Kaneda, Y; Maeda, A				Fujita, Kosuke; Kuge, Katsunori; Ozawa, Noriyasu; Sahara, Shunya; Zaiki, Kaori; Nakaoji, Koichi; Hamada, Kazuhiko; Takenaka, Yukiko; Tanahashi, Takao; Tamai, Katsuto; Kaneda, Yasufumi; Maeda, Akito			Cinnamtannin B-1 Promotes Migration of Mesenchymal Stem Cells and Accelerates Wound Healing in Mice	PLOS ONE			English	Article							BONE-MARROW; STROMAL CELLS; IN-VITRO; REPAIR; SKIN; TRANSDIFFERENTIATION; ANTIOXIDANT; MOUSE	Substances that enhance the migration of mesenchymal stem cells to damaged sites have the potential to improve the effectiveness of tissue repair. We previously found that ethanol extracts of Mallotus philippinensis bark promoted migration of mesenchymal stem cells and improved wound healing in a mouse model. We also demonstrated that bark extracts contain cinnamtannin B-1, a flavonoid with in vitro migratory activity against mesenchymal stem cells. However, the in vivo effects of cinnamtannin B-1 on the migration of mesenchymal stem cells and underlying mechanism of this action remain unknown. Therefore, we examined the effects of cinnamtannin B-1 on in vivo migration of mesenchymal stem cells and wound healing in mice. In addition, we characterized cinnamtannin B-1-induced migration of mesenchymal stem cells pharmacologically and structurally. The mobilization of endogenous mesenchymal stem cells into the blood circulation was enhanced in cinnamtannin B-1-treated mice as shown by flow cytometric analysis of peripheral blood cells. Whole animal imaging analysis using luciferase-expressing mesenchymal stem cells as a tracer revealed that cinnamtannin B-1 increased the homing of mesenchymal stem cells to wounds and accelerated healing in a diabetic mouse model. Additionally, the cinnamtannin B-1-induced migration of mesenchymal stem cells was pharmacologically susceptible to inhibitors of phosphatidylinositol 3-kinase, phospholipase C, lipoxygenase, and purines. Furthermore, biflavonoids with similar structural features to cinnamtannin B-1 also augmented the migration of mesenchymal stem cells by similar pharmacological mechanisms. These results demonstrate that cinnamtannin B-1 promoted mesenchymal stem cell migration in vivo and improved wound healing in mice. Furthermore, the results reveal that cinnamtannin B-1-induced migration of mesenchymal stem cells may be mediated by specific signaling pathways, and the flavonoid skeleton may be relevant to its effects on mesenchymal stem cell migration.	[Fujita, Kosuke; Kuge, Katsunori; Ozawa, Noriyasu; Sahara, Shunya; Zaiki, Kaori; Nakaoji, Koichi; Maeda, Akito] Osaka Univ, UIC, PIAS Collaborat Res, Skin Regenerat, Suita, Osaka 5650871, Japan; [Ozawa, Noriyasu; Sahara, Shunya; Zaiki, Kaori; Nakaoji, Koichi; Hamada, Kazuhiko] PIAS Corp, Div Res & Dev, Kobe, Hyogo 6512241, Japan; [Takenaka, Yukiko; Tanahashi, Takao] Kobe Pharmaceut Univ, Dept Organ Chem, Kobe, Hyogo 6588558, Japan; [Tamai, Katsuto] Osaka Univ, Grad Sch Med, Div Stem Cell Therapy Sci, Suita, Osaka 5650871, Japan; [Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Suita, Osaka 5650871, Japan	Osaka University; Kobe Pharmaceutical University; Osaka University; Osaka University	Maeda, A (corresponding author), Osaka Univ, UIC, PIAS Collaborat Res, Skin Regenerat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	amaeda@uic.osaka-u.ac.jp	Maeda, Akito/AAX-6252-2020	Maeda, Akito/0000-0001-8776-9135	Ministry of Education, Culture, Sports, Science and Technology [23618007]; Osaka University [J119801020]; PIAS Corporation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University; PIAS Corporation	This work was supported in part by Grants-in-Aid for Scientific Research (C,23618007) from the Ministry of Education, Culture, Sports, Science and Technology, and by Budget for Joint Research at the Osaka University (J119801020). The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. PIAS Corporation provided support in the form of salaries for authors NO, SS, KZ, KN, and KH, but did not have any additional role in the study design, data collection, and analysis, decision to publish, preparation of the manuscript. The specific roles of these authors are described in the author contributions section.	Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Bicker J, 2009, FITOTERAPIA, V80, P483, DOI 10.1016/j.fitote.2009.08.015; Bouaziz A, 2007, ARCH BIOCHEM BIOPHYS, V457, P235, DOI 10.1016/j.abb.2006.10.020; Cho M, 2014, PHYTOMEDICINE, V21, P560, DOI 10.1016/j.phymed.2013.10.006; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2010, CELL TRANSPLANT, V19, P1369, DOI 10.3727/096368910X514288; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Fujita R, 2015, STEM CELLS, V33, P962, DOI 10.1002/stem.1900; Furumoto T, 2014, PHYTOMEDICINE, V21, P247, DOI 10.1016/j.phymed.2013.09.003; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hong S, 2014, BRIT J DERMATOL, V171, P30, DOI 10.1111/bjd.12899; Houghton PJ, 2005, J ETHNOPHARMACOL, V100, P100, DOI 10.1016/j.jep.2005.07.001; Idowu TO, 2010, PHYTOCHEMISTRY, V71, P2092, DOI 10.1016/j.phytochem.2010.08.018; Iinuma S, 2015, J IMMUNOL, V194, P1996, DOI 10.4049/jimmunol.1400914; Introna Martino, 2015, Curr Opin Organ Transplant, V20, P72, DOI 10.1097/MOT.0000000000000158; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; KARANJGAOKAR CG, 1967, TETRAHEDRON LETT, P3195, DOI 10.1016/S0040-4039(01)89897-X; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kim YW, 2012, J GASTROEN HEPATOL, V27, P397, DOI 10.1111/j.1440-1746.2011.06873.x; Li XC, 2002, TETRAHEDRON, V58, P8709, DOI 10.1016/S0040-4020(02)01096-7; Lin MN, 2013, BRAIN RES, V1513, P1, DOI 10.1016/j.brainres.2013.03.035; Lopez JJ, 2008, LIFE SCI, V82, P977, DOI 10.1016/j.lfs.2008.03.009; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; MURTI VVS, 1967, TETRAHEDRON, V23, P397, DOI 10.1016/S0040-4020(01)83325-1; Bui NT, 2014, PHYTOMEDICINE, V21, P570, DOI 10.1016/j.phymed.2013.10.010; Nishikawa T, 2009, J CELL MOL MED, V13, P535, DOI 10.1111/j.1582-4934.2008.00341.x; Park JS, 2015, METHODS, V84, P3, DOI 10.1016/j.ymeth.2015.03.002; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schneider N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120538; Sharma J, 2011, ARG PHRMACOLOGYONLIN, V3, P1256; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Tang JM, 2012, J CELL BIOCHEM, V113, P2704, DOI 10.1002/jcb.24148; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125; Wang H, 2008, EUR J PHARMACOL, V599, P24, DOI 10.1016/j.ejphar.2008.09.030; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420	39	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144166	10.1371/journal.pone.0144166	http://dx.doi.org/10.1371/journal.pone.0144166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657737	gold, Green Published			2022-12-26	WOS:000366903600025
J	Hu, BR; Yue, YQ; Zhu, Y; Wen, W; Zhang, FM; Hardie, JW				Hu, Boran; Yue, Yaqing; Zhu, Yong; Wen, Wen; Zhang, Fengmin; Hardie, Jim W.			Proton Nuclear Magnetic Resonance-Spectroscopic Discrimination of Wines Reflects Genetic Homology of Several Different Grape (V. vinifera L.) Cultivars	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; RED WINES; H-1-NMR; NMR; VARIETIES; PARENTAGE; MERLOT; REGION	Background and Aims Proton nuclear magnetic resonance spectroscopy coupled multivariate analysis (H-1 NMR-PCA/ PLS-DA) is an important tool for the discrimination of wine products. Although H-1 NMR has been shown to discriminate wines of different cultivars, a grape genetic component of the discrimination has been inferred only from discrimination of cultivars of undefined genetic homology and in the presence of many confounding environmental factors. We aimed to confirm the influence of grape genotypes in the absence of those factors. Methods and Results We applied H-1 NMR-PCA/PLS-DA and hierarchical cluster analysis (HCA) to wines from five, variously genetically-related grapevine (V. vinifera) cultivars; all grown similarly on the same site and vinified similarly. We also compared the semi-quantitative profiles of the discriminant metabolites of each cultivar with previously reported chemical analyses. The cultivars were clearly distinguishable and there was a general correlation between their grouping and their genetic homology as revealed by recent genomic studies. Between cultivars, the relative amounts of several of the cultivar-related discriminant metabolites conformed closely with reported chemical analyses. Conclusions Differences in grape-derived metabolites associated with genetic differences alone are a major source of H-1 NMR-based discrimination of wines and H-1 NMR has the capacity to discriminate between very closely related cultivars. Significance of the Study The study confirms that genetic variation among grape cultivars alone can account for the discrimination of wine by H-1 NMR-PCA/PLS and indicates that H-1 NMR spectra of wine of single grape cultivars may in future be used in tandem with hierarchical cluster analysis to elucidate genetic lineages and metabolomic relations of grapevine cultivars. In the absence of genetic information, for example, where predecessor varieties are no longer extant, this may be a particularly useful approach.	[Hu, Boran; Yue, Yaqing] Yangzhou Univ, Coll Food Sci & Engn, Yangzhou 225009, Jiangsu, Peoples R China; [Zhu, Yong; Wen, Wen] Yangzhou Univ, Coll Tourism & Gastron, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Fengmin] Yangzhou Univ, Testing Ctr, Yangzhou 225009, Jiangsu, Peoples R China; [Hardie, Jim W.] Northern Melbourne Inst TAFE, Epping, Vic, Australia	Yangzhou University; Yangzhou University; Yangzhou University	Hu, BR (corresponding author), Yangzhou Univ, Coll Food Sci & Engn, Yangzhou 225009, Jiangsu, Peoples R China.	huboran@yzu.edu.cn	Hardie, William J/J-5599-2017	Hardie, William J/0000-0001-9489-9157	National Natural Science Foundation of China 465 [31271857]; Ch teau Sun God, 466 Great Wall Wines, COFCO Group, P.R. China; National Natural Science Foundation of China; National Natural Science Foundation of China [31271857]; Chateau Sun God, Great Wall Wines, COFCO Group, P.R.China	National Natural Science Foundation of China 465; Ch teau Sun God, 466 Great Wall Wines, COFCO Group, P.R. China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chateau Sun God, Great Wall Wines, COFCO Group, P.R.China	The research was supported by the National Natural Science Foundation of China 465 (Project No. 31271857. The authors gratefully acknowledge the support of Ch teau Sun God, 466 Great Wall Wines, COFCO Group, P.R. China. The founding is supported by National Natural Science Foundation of China. Boran Hu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by the National Natural Science Foundation of China (Project No.31271857). We gratefully acknowledge the support of Chateau Sun God, Great Wall Wines, COFCO Group, P.R.China, all the wine samples are provided by it. We also thank the comments and suggestions by our anonymous journal reviewers.	Ali K, 2011, J BIOMOL NMR, V49, P255, DOI 10.1007/s10858-011-9487-3; AMERINE M. A., 1958, Vitis, V1, P224; Anastasiadi M, 2009, J AGR FOOD CHEM, V57, P11067, DOI 10.1021/jf902137e; Arozarena I, 2000, J SCI FOOD AGR, V80, P1909, DOI 10.1002/1097-0010(200010)80:13<1909::AID-JSFA728>3.0.CO;2-U; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; Bourzeix M., 1983, Progres Agricole et Viticole, V100, P421; Bowers J. E., 2000, Acta Horticulturae, P129; Bowers JE, 1997, NAT GENET, V16, P84, DOI 10.1038/ng0597-84; Brescia MA, 2002, ANAL CHIM ACTA, V458, P177, DOI 10.1016/S0003-2670(01)01532-X; Cliff MA, 2007, FOOD RES INT, V40, P92, DOI 10.1016/j.foodres.2006.08.002; Coulter AD, 2004, AUSTR NZ WINE IND J, V19, P16; Du YY, 2007, CHINESE J CHEM, V25, P930, DOI 10.1002/cjoc.200790181; FRANKEL EN, 1995, J AGR FOOD CHEM, V43, P890, DOI 10.1021/jf00052a008; Hong YS, 2011, MAGN RESON CHEM, V49, pS13, DOI 10.1002/mrc.2832; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Imparato G, 2011, J AGR FOOD CHEM, V59, P4429, DOI 10.1021/jf200587n; Jackson R.S., 2000, WINE SCI; Jiang B, 2012, MOLECULES, V17, P8804, DOI 10.3390/molecules17088804; KLIEWER W. M., 1967, AMER J ENOL VITICULT, V18, P42; Kosir IJ, 2002, ANAL CHIM ACTA, V458, P77, DOI 10.1016/S0003-2670(01)01549-5; Lafon-Lafourcade S., 1959, VITIS, V2, P45; Landrault N, 2001, J AGR FOOD CHEM, V49, P3341, DOI 10.1021/jf010128f; Larsen FH, 2006, J CHEMOMETR, V20, P198, DOI 10.1002/cem.991; Lee JE, 2009, J AGR FOOD CHEM, V57, P4810, DOI 10.1021/jf900502a; Olmo H. P., 1948, CALIFORNIA AGRIC EXPT STA BULL, V704, P1; OUGH C S, 1968, Vitis, V7, P321; Papotti G, 2013, J AGR FOOD CHEM, V61, P1741, DOI 10.1021/jf302728b; Pereira GE, 2005, J AGR FOOD CHEM, V53, P6382, DOI 10.1021/jf058058q; Pereira GE, 2007, J INT SCI VIGNE VIN, V41, P103; Robinson J., 2012, WINE GRAPES COMPLETE, P426; Rochfort S, 2010, FOOD CHEM, V121, P1296, DOI 10.1016/j.foodchem.2010.01.067; Son HS, 2008, J AGR FOOD CHEM, V56, P8007, DOI 10.1021/jf801424u; Son HS, 2009, FOOD RES INT, V42, P1483, DOI 10.1016/j.foodres.2009.08.006; Son HS, 2009, J AGR FOOD CHEM, V57, P1481, DOI 10.1021/jf803388w; Viggiani L, 2008, J AGR FOOD CHEM, V56, P8273, DOI 10.1021/jf801513u; Woraratphoka J, 2007, FOOD CHEM, V104, P1485, DOI 10.1016/j.foodchem.2007.02.020	36	14	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142840	10.1371/journal.pone.0142840	http://dx.doi.org/10.1371/journal.pone.0142840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658757	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600007
J	Dahlui, M; Azahar, N; Bulgiba, A; Zaki, R; Oche, OM; Adekunjo, FO; Chinna, K				Dahlui, Maznah; Azahar, Nazar; Bulgiba, Awang; Zaki, Rafdzah; Oche, Oche Mansur; Adekunjo, Felix Oluyemi; Chinna, Karuthan			HIV/AIDS Related Stigma and Discrimination against PLWHA in Nigerian Population	PLOS ONE			English	Article							HIV-INFECTION; WOMEN; CARE; TRANSMISSION; EXPERIENCES; DISCLOSURE; PEOPLE	Background HIV/AIDS remain a major public health concern in Nigeria. People living with HIV/AIDS (PLWHA) face not only personal medical problems but also social problems associated with the disease such as stigma and discriminatory attitudes. This study provides an insight into HIV/AIDS related stigma and discrimination against PLWHA in Nigeria. Methods The data for this study was extracted from the 2013 Nigeria Demographic and Health Survey conducted by the National Population Commission. All men and women aged 15-49 years, permanent residents and visitors of the households were eligible for the interview. Several questionnaires were used in the survey, some covering questions on HIV/AIDS. Results A total of 56 307 men and women aged 15-49 years participated in this national survey. About half of the population in Nigeria have HIV stigma. Younger persons, men, those without formal education and those within poor wealth index are more likely to have stigma towards PLWHA. In addition, married people are more likely to have stigma on PLWHA and are more likely to blame PLWHA for bringing the disease to the community. Also about half of the population discriminates against PLWHA. However, those with higher levels of education and those from higher wealth index seem to be more compassionate towards PLWHA. About 70% in the population are willing to care for relative with AIDS, even more so among those with higher level of education. Conclusion There is a high level of HIV stigma and discrimination against PLWHA in the Nigerian population. Education seems to play a major role in the society with respect to HIV stigma and discrimination against PLWHA. Educating the population with factual information on HIV/AIDS is needed to reduce stigma and discrimination towards PLWHA in the community.	[Dahlui, Maznah] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Azahar, Nazar] Univ Teknol MARA, Fac Hlth Sci, Dept Med Lab Technol, George Town, Malaysia; [Bulgiba, Awang; Zaki, Rafdzah; Chinna, Karuthan] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Oche, Oche Mansur] Usmanu Danfodiyo Univ, Dept Community Hlth, Sokoto, Nigeria; [Adekunjo, Felix Oluyemi] Univ Malaya, Fac Econ & Adm, Dept Dev Studies, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Universiti Malaya; Universiti Malaya	Dahlui, M (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	maznahd@ummc.edu.my	ZAKI, RAFDZAH AHMAD/B-9520-2010; DAHLUI, MAZNAH/B-8976-2010; Dahlui, Maznah/F-9665-2010; chinna, karuthan/E-4495-2014; Bulgiba, Awang/B-8271-2010; Azahar, Nazar/N-7476-2015; Oche, Oche Mansur/AAU-4935-2021	ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; DAHLUI, MAZNAH/0000-0003-4923-9410; chinna, karuthan/0000-0002-5449-2341; Bulgiba, Awang/0000-0002-5313-0445; Azahar, Nazar/0000-0002-0412-4268; 	University of Malaya Research Grant UMRG Africa-Asia Development University Network [RP026-2012C]; University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]	University of Malaya Research Grant UMRG Africa-Asia Development University Network; University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant	The authors value the collaboration with Usmanu Danfodiyo University, Sokoto, Nigeria in coming up with this manuscript. Obtaining the data and development of this manuscript were supported by the University of Malaya Research Grant UMRG Africa-Asia Development University Network (RP026-2012C) and University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (E000010-20001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alubo O, 2002, AIDS CARE, V14, P117, DOI 10.1080/09540120220097991; Babalola S, 2007, AIDS BEHAV, V11, P759, DOI 10.1007/s10461-006-9189-0; Bharat S, 2011, SAHARA J-J SOC ASP H, V8, P138, DOI 10.1080/17290376.2011.9724996; Blackstock O, 2005, NEW ENGL J MED, V353, P752, DOI 10.1056/NEJMp058198; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Campbell C, 2007, J HEALTH PSYCHOL, V12, P403, DOI 10.1177/1359105307076229; Cock D, 2014, DAILY HIV AIDS REPOR; Ehiri John E, 2005, AIDS Public Policy J, V20, P25; Ekanem E E, 2004, Afr J Reprod Health, V8, P91, DOI 10.2307/3583183; Etiebet MA, 2004, AIDS CARE, V16, P37, DOI 10.1080/09540120310001633958; Greeff M, 2008, QUAL HEALTH RES, V18, P311, DOI 10.1177/1049732307311118; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; Iwelunmor J, 2006, Int Q Community Health Educ, V27, P321, DOI 10.2190/IQ.27.4.d; Kalichman S., 2005, POSITIVE PREVENTION, P1; Lal Panna, 1998, Journal of Communicable Diseases, V30, P38; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Makoae LN, 2008, J ASSOC NURSE AIDS C, V19, P137, DOI 10.1016/j.jana.2007.11.004; Mbonu NC, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/145891; Miller AN, 2007, QUAL HEALTH RES, V17, P586, DOI 10.1177/1049732307301498; Monjok Emmanuel, 2009, Afr J Reprod Health, V13, P21; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Nyblade L, 2006, CAN WE MEASURE HIV A; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Okoror TA, 2008, INT Q COMMUNITY HEAL, V28, P201, DOI 10.2190/IQ.28.3.c; Oyediran K, 2005, 25 INT POP C INT UN; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parker R, 2007, AIDS RELATED STIGMA; Rankin WW, 2005, PLOS MED, V2, P702, DOI 10.1371/journal.pmed.0020247; Santos ML, 2014, BMC PUBLIC HLTH, V14; Shisana O, 2007, TECHNICAL REPORT; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stewart R, 2002, ADDRESSING HIV AIDS; Thorne C, 2003, CURR HIV RES, V1, P447, DOI 10.2174/1570162033485140; UNAIDS, 2014, FAST TRACT END AIDS; UNAIDS, 2000, HIV AIDS REL STIGM D; Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341; Wailoo K, 2006, LANCET, V367, P531, DOI 10.1016/S0140-6736(06)68186-5; Zierler S, 2000, AM J PUBLIC HEALTH, V90, P208, DOI 10.2105/AJPH.90.2.208	39	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143749	10.1371/journal.pone.0143749	http://dx.doi.org/10.1371/journal.pone.0143749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26658767	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500004
J	Haider, S; Rahman, R; Ghosh, S; Pal, R				Haider, Saad; Rahman, Raziur; Ghosh, Souparno; Pal, Ranadip			A Copula Based Approach for Design of Multivariate Random Forests for Drug Sensitivity Prediction	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; CELL LUNG-CANCER; CHEMOSENSITIVITY	Modeling sensitivity to drugs based on genetic characterizations is a significant challenge in the area of systems medicine. Ensemble based approaches such as Random Forests have been shown to perform well in both individual sensitivity prediction studies and team science based prediction challenges. However, Random Forests generate a deterministic predictive model for each drug based on the genetic characterization of the cell lines and ignores the relationship between different drug sensitivities during model generation. This application motivates the need for generation of multivariate ensemble learning techniques that can increase prediction accuracy and improve variable importance ranking by incorporating the relationships between different output responses. In this article, we propose a novel cost criterion that captures the dissimilarity in the output response structure between the training data and node samples as the difference in the two empirical copulas. We illustrate that copulas are suitable for capturing the multivariate structure of output responses independent of the marginal distributions and the copula based multivariate random forest framework can provide higher accuracy prediction and improved variable selection. The proposed framework has been validated on genomics of drug sensitivity for cancer and cancer cell line encyclopedia database.	[Haider, Saad; Rahman, Raziur; Pal, Ranadip] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA; [Ghosh, Souparno] Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Pal, R (corresponding author), Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA.	ranadip.pal@ttu.edu	Pal, Ranadip/F-3905-2012	Pal, Ranadip/0000-0002-9311-5901	National Science Foundation [CCF 0953366]; Direct For Computer & Info Scie & Enginr [0953366] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation Grant CCF 0953366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biau G, 2012, J MACH LEARN RES, V13, P1063; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broad-Novartis Cancer Cell Line Encyclopedia, GEN PHARM CHAR LARG; Ciuffreda L, 2009, NEOPLASIA, V11, P720, DOI 10.1593/neo.09398; CLAYTON DG, 1978, BIOMETRIKA, V65, P141, DOI 10.2307/2335289; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Demarta S, 2005, INT STAT REV, V73, P111, DOI 10.1111/j.1751-5823.2005.tb00254.x; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Frank M.J., 1979, AEQUATIONES MATH, V19, P194, DOI DOI 10.1007/BF02189866; Gonen M, 2014, BIOINFORMATICS, V30, pI556, DOI 10.1093/bioinformatics/btu464; Gumbel EJ, 1960, PUBL I STAT U PARIS, V9, P171; Johnston SRD, 2006, DRUG TODAY, V42, P441, DOI 10.1358/dot.2006.42.7.985637; Kouros Owzar PKS, 2003, METRON, VLXI, P323; Larsen AB, 2010, CELL SIGNAL, V22, P636, DOI 10.1016/j.cellsig.2009.11.018; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; LEE LF, 1983, ECONOMETRICA, V51, P507, DOI 10.2307/1912003; Ling YH, 2007, MOL PHARMACOL, V72, P248, DOI 10.1124/mol.107.034827; Ma PC, 2005, CLIN CANCER RES, V11, P2312, DOI 10.1158/1078-0432.CCR-04-1708; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Morabito A, 2009, ONCOLOGIST, V14, P378, DOI 10.1634/theoncologist.2008-0261; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Segal M, 2011, WIRES DATA MIN KNOWL, V1, P80, DOI 10.1002/widm.12; Sim K. C., 2004, PRECISION MATRIX MOD; Sklar A., 1959, PUBL I STAT U PARIS, V8, P229, DOI DOI 10.1007/978-3-642-33590-7; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Tanizaki J, 2011, J THORAC ONCOL, V6, P1624, DOI 10.1097/JTO.0b013e31822591e9; Walther Z, 2011, CANCER J, V17, P71, DOI 10.1097/PPO.0b013e318212dd6d; Wan Q, 2013, IEEE INT WORK GENOM, P53, DOI 10.1109/GENSIPS.2013.6735929; Wan Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101183; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	38	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144490	10.1371/journal.pone.0144490	http://dx.doi.org/10.1371/journal.pone.0144490			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658256	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500031
J	Mayati, A; Bruyere, A; Moreau, A; Jouan, E; Denizot, C; Parmentier, Y; Fardel, O				Mayati, Abdullah; Bruyere, Arnaud; Moreau, Amelie; Jouan, Elodie; Denizot, Claire; Parmentier, Yannick; Fardel, Olivier			Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220	PLOS ONE			English	Article							N-TERMINAL KINASE; GF 109203X; MULTIDRUG-RESISTANCE; SELECTIVE INHIBITORS; POTENT INHIBITORS; GLYCOGEN-SYNTHASE; DRUG-INTERACTIONS; RAT ADIPOCYTES; S6 KINASE; CELL-LINE	Ro 31-8220 is a potent protein kinase C (PKC) inhibitor belonging to the chemical class of bisindolylmaleimides (BIMs). Various PKC-independent effects of Ro 31-8220 have however been demonstrated, including inhibition of the ATP-binding cassette drug transporter breast cancer resistance protein. In the present study, we reported that the BIM also blocks activity of the solute carrier organic cation transporter (OCT) 1, involved in uptake of marketed drugs in the liver, in a PKC-independent manner. Ro 31-8220, in contrast to other pan-PKC inhibitors such as staurosporine and chelerythrine, was thus shown to cis-inhibit uptake of the reference OCT1 substrate tetraethylammonium in OCT1-transfected HEK293 cells in a concentration-dependent manner (IC50 = 0.18 mu M) and without altering membrane expression of OCT1. This blockage of OCT1 was also observed in human hepatic HepaRG cells that constitutionally express OCT1. It likely occurred through a mixed mechanism of inhibition. Ro 31-8220 additionally trans-inhibited TEA uptake in OCT1-transfected HEK293 cells, which likely discards a transport of Ro 31-8220 by OCT1. Besides Ro 318220, 7 additional BIMs, including the PKC inhibitor LY 333531, inhibited OCT1 activity, whereas 4 other BIMs were without effect. In silico analysis of structure-activity relationships next revealed that various molecular descriptors, especially 3D-WHIM descriptors related to total size, correspond to key physico-chemical parameters for inhibition of OCT1 activity by BIMs. In addition to activity of OCT1, Ro 31-8220 inhibited those of other organic cation transporters such as multidrug and toxin extrusion protein (MATE) 1 and MATE2-K, whereas, by contrast, it stimulated that of OCT2. Taken together, these data extend the nature of cellular off-targets of the BIM Ro 31-8220 to OCT1 and other organic cation transporters, which has likely to be kept in mind when using Ro 31-8220 and other BIMs as PKC inhibitors in experimental or clinical studies.	[Mayati, Abdullah; Bruyere, Arnaud; Jouan, Elodie; Fardel, Olivier] IRSET, UMR INSERM U1085, Fac Pharm, F-35043 Rennes, France; [Moreau, Amelie; Denizot, Claire; Parmentier, Yannick] Technol Servier, Ctr Pharmacocinet, F-45000 Orleans, France; [Fardel, Olivier] Ctr Hosp Univ, Pole Biol, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Servier; CHU Rennes	Fardel, O (corresponding author), IRSET, UMR INSERM U1085, Fac Pharm, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	olivier.fardel@univ-rennes1.fr	Bruyere, Arnaud/J-8577-2015; Fardel, Olivier/J-8560-2015; Sharma, Ashwani/AAK-3879-2020	Bruyere, Arnaud/0000-0003-1158-1413; Sharma, Ashwani/0000-0001-9835-1973; Moreau, Amelie/0000-0002-7485-2332				Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bansal D, 2013, DIABETES METAB J, V37, P375, DOI 10.4093/dmj.2013.37.5.375; Bayer M, 2009, NUCL MED BIOL, V36, P287, DOI 10.1016/j.nucmedbio.2008.12.010; Begemann M, 1998, ANTICANCER RES, V18, P3139; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Bosco R, 2011, MINI-REV MED CHEM, V11, P185, DOI 10.2174/138955711795049899; Bucher S, 2014, J BIOCHEM MOL TOXIC, V28, P119, DOI 10.1002/jbt.21543; Camenisch G, 1998, EUR J PHARM SCI, V6, P313, DOI 10.1016/S0928-0987(97)10019-7; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Ciarimboli G, 2004, J CELL PHYSIOL, V201, P420, DOI 10.1002/jcp.20081; Cuenda A, 2000, METH MOL B, V99, P161; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Ezeamuzie CI, 2004, BRIT J PHARMACOL, V143, P725, DOI 10.1038/sj.bjp.0706028; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V206, P119, DOI 10.1006/bbrc.1995.1017; Gekeler V, 1996, BRIT J CANCER, V74, P897, DOI 10.1038/bjc.1996.454; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hers I, 1999, FEBS LETT, V460, P433, DOI 10.1016/S0014-5793(99)01389-7; Jouan E, 2014, FUND CLIN PHARMACOL, V28, P65, DOI 10.1111/j.1472-8206.2012.01071.x; Karlgren M, 2012, J MED CHEM, V55, P4740, DOI 10.1021/jm300212s; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Le Vee M, 2006, EUR J PHARM SCI, V28, P109, DOI 10.1016/j.ejps.2006.01.004; Le Vee M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121232; Lecureur V, 2005, FEBS LETT, V579, P1904, DOI 10.1016/j.febslet.2005.01.081; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Lingameneni R, 2000, FEBS LETT, V473, P265, DOI 10.1016/S0014-5793(00)01532-5; Galvez MIL, 2009, CURR DIABETES REV, V5, P14, DOI 10.2174/157339909787314167; Loweth JA, 2009, NEUROSCI LETT, V455, P88, DOI 10.1016/j.neulet.2009.03.012; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mwanjewe J, 2001, BIOCHEM J, V359, P211, DOI 10.1042/0264-6021:3590211; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Pedersen JM, 2008, J MED CHEM, V51, P3275, DOI 10.1021/jm7015683; Pietig G, 2001, J BIOL CHEM, V276, P33741, DOI 10.1074/jbc.M104617200; Roberts NA, 2005, BRIT J PHARMACOL, V145, P477, DOI 10.1038/sj.bjp.0706210; Robey RW, 2007, MOL CANCER THER, V6, P1877, DOI 10.1158/1535-7163.MCT-06-0811; Roth M, 2011, J PHARMACOL EXP THER, V339, P624, DOI 10.1124/jpet.111.184564; Schonhoff CM, 2013, HEPATOLOGY, V58, P284, DOI 10.1002/hep.26333; Standaert ML, 1999, ENDOCRINOLOGY, V140, P2145, DOI 10.1210/en.140.5.2145; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stross C, 2010, AM J PHYSIOL-GASTR L, V299, pG320, DOI 10.1152/ajpgi.00180.2010; Todeschini R, 1997, SAR QSAR Environ Res, V7, P173, DOI 10.1080/10629369708039130; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; Wang QD, 2006, INT J CANCER, V118, P326, DOI 10.1002/ijc.21373; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wittwer MB, 2013, J MED CHEM, V56, P781, DOI 10.1021/jm301302s; Yasujima T, 2011, J PHARM SCI-US, V100, P4006, DOI 10.1002/jps.22548; Yeo EJ, 1997, BBA-MOL CELL RES, V1356, P308, DOI 10.1016/S0167-4889(97)00006-2; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Zelcer N, 2003, J BIOL CHEM, V278, P23538, DOI 10.1074/jbc.M303504200; Zhang L, 1999, J PHARMACOL EXP THER, V288, P1192	57	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144667	10.1371/journal.pone.0144667	http://dx.doi.org/10.1371/journal.pone.0144667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657401	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500053
J	Han, FL; Forster, CA; Clark, JM; Xu, X				Han, Fenglu; Forster, Catherine A.; Clark, James M.; Xu, Xing			A New Taxon of Basal Ceratopsian from China and the Early Evolution of Ceratopsia	PLOS ONE			English	Article							DINOSAUR CHANGCHUNSAURUS-PARVUS; NEOCERATOPSIAN DINOSAUR; TUCHENGZI FORMATION; JILIN PROVINCE	Ceratopsia is one of the best studied herbivorous ornithischian clades, but the early evolution of Ceratopsia, including the placement of Psittacosaurus, is still controversial and unclear. Here, we report a second basal ceratopsian, Hualianceratops wucaiwanensis gen. et sp. nov., from the Upper Jurassic (Oxfordian) Shishugou Formation of the Junggar Basin, northwestern China. This new taxon is characterized by a prominent caudodorsal process on the subtemporal ramus of the jugal, a robust quadrate with an expansive quadratojugal facet, a prominent notch near the ventral region of the quadrate, a deep and short dentary, and strongly rugose texturing on the lateral surface of the dentary. Hualianceratops shares several derived characters with both Psittacosaurus and the basal ceratopsians Yinlong, Chaoyangsaurus, and Xuanhuaceratops. A new comprehensive phylogeny of ceratopsians weakly supports both Yinlong and Hualianceratops as chaoyangsaurids (along with Chaoyangsaurus and Xuanhuaceratops), as well as the monophyly of Chaoyangosauridae + Psittacosaurus. This analysis also weakly supports the novel hypothesis that Chaoyangsauridae + Psittacosaurus is the sister group to the rest of Neoceratopsia, suggesting a basal split between these clades before the Late Jurassic. This phylogeny and the earliest Late Jurassic age of Yinlong and Hualianceratops imply that at least five ceratopsian lineages (Yinlong, Hualianceratops, Chaoyangsaurus + Xuanhuaceratops, Psittacosaurus, Neoceratopsia) were present at the beginning of the Late Jurassic.	[Han, Fenglu] China Univ Geosci, Sch Earth Sci, Wuhan 430074, Peoples R China; [Han, Fenglu; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Forster, Catherine A.; Clark, James M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	China University of Geosciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; George Washington University	Han, FL (corresponding author), China Univ Geosci, Sch Earth Sci, Wuhan 430074, Peoples R China.	hfl0501@163.com		, Fenglu/0000-0003-3399-4008	National Natural Science Foundation of China [41120124002]; National Geographic Society; U.S. National Science Foundation [EAR 0310217, EAR 0228559]; CAF; Fundamental Research Funds for the Central Universities [CUGL140806]; China postdoctoral Science Foundation [2014M552108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Geographic Society(National Geographic Society); U.S. National Science Foundation(National Science Foundation (NSF)); CAF; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Collection of the fossils and subsequent research were funded by the National Natural Science Foundation of China (41120124002; http://www.nsfc.gov.cn) to XX, the National Geographic Society to JMC, the U.S. National Science Foundation (EAR 0310217 and EAR 0228559; http://www.nsf.gov) to JMC and CAF, and the Fundamental Research Funds for the Central Universities (CUGL140806; http://www.moe.gov.cn/) and China postdoctoral Science Foundation (2014M552108; http://www.chinapostdoctor.org.cn) to FLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov AO, 2006, J SYST PALAEONTOL, V4, P359, DOI 10.1017/S1477201906001933; BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Eberth DA, 2010, PALAIOS, V25, P112, DOI 10.2110/palo.2009.p09-028r; Farke AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112055; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Han F-L, J VERTEBR P IN PRESS; Han FX., 2009, THESIS; He HY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025274; Jin LY, 2010, J VERTEBR PALEONTOL, V30, P196, DOI 10.1080/02724630903412372; Lee YN, 2011, NATURWISSENSCHAFTEN, V98, P39, DOI 10.1007/s00114-010-0739-y; Lucas SG, 2006, CRETACEOUS RES, V27, P189, DOI 10.1016/j.cretres.2005.11.011; Makovicky PJ, 2011, J VERTEBR PALEONTOL, V31, P626, DOI 10.1080/02724634.2011.557114; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Marsh O.C., 1889, AM J SCI, V38, P173, DOI [10.2475/ajs.s3-38.224.173, DOI 10.2475/AJS.S3-38.224.173]; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; Maryanska T, 2004, DINOSAURIA, 2ND EDITION, P464; Morschhauser EM, 2012, AAI3509219; Osborn H. F., 1923, American Museum Novitates, V95, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 1990, P579; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno Paul C., 2010, P21; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Xu Huan, 2012, Palaeoworld, V21, P222, DOI 10.1016/j.palwor.2012.10.003; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; You Hai-Lu, 2010, P59; You Hailu, 2004, P478; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P593; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P168; You HL, 2003, ACTA PALAEONTOL POL, V48, P261; Zhao XJ, 2006, ACTA GEOL SIN-ENGL, V80, P467; Zhao XJ, 1999, J VERTEBR PALEONTOL, V19, P681; Zhou Chang-Fu, 2006, Palaeoworld, V15, P100, DOI 10.1016/j.palwor.2005.11.001	42	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143369	10.1371/journal.pone.0143369	http://dx.doi.org/10.1371/journal.pone.0143369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649770	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300016
J	Makino, TT; Yokoyama, J				Makino, Takashi T.; Yokoyama, Jun			Nonrandom Composition of Flower Colors in a Plant Community: Mutually Different Co-Flowering Natives and Disturbance by Aliens	PLOS ONE			English	Article							POLLINATION SYSTEMS; BOMBUS-TERRESTRIS; FLORAL COLOR; CHARACTER DISPLACEMENT; INSECT POLLINATORS; VISION; DISCRIMINATION; COMPETITION; HUMMINGBIRD; MIMICRY	When pollinators use flower color to locate food sources, a distinct color can serve as a reproductive barrier against co-flowering species. This anti-interference function of flower color may result in a community assembly of plant species displaying mutually different flower colors. However, such color dispersion is not ubiquitous, suggesting a variable selection across communities and existence of some opposing factors. We conducted a 30-week study in a plant community and measured the floral reflectances of 244 species. The reflectances were evaluated in insect color spaces (bees, swallowtails, and flies), and the dispersion was compared with random expectations. We found that co-existing colors were overdispersed for each analyzed pollinator type, and this overdispersion was statistically significant for bees. Furthermore, we showed that exclusion of 32 aliens from the analysis significantly increased the color dispersion of native flowers in every color space. This result indicated that aliens disturbed a native plant-pollinator network via similarly colored flowers. Our results demonstrate the masking effects of aliens in the detection of color dispersion of native flowers and that variations in pollinator vision yield different outcomes. Our results also support the hypothesis that co-flowering species are one of the drivers of color diversification and affect the community assembly.	[Makino, Takashi T.; Yokoyama, Jun] Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan; [Yokoyama, Jun] Yamagata Univ, Inst Reg Innovat, Yamagata 990, Japan	Yamagata University; Yamagata University	Makino, TT (corresponding author), Yamagata Univ, Fac Sci, Dept Biol, 1-4-12 Kojirakawa, Yamagata 990, Japan.	mkntkst@gmail.com			Sasakawa Scientific Research [25-503]; JSPS KAKENHI Grant [26840139, 26291076]	Sasakawa Scientific Research; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Sasakawa Scientific Research (No. 25-503) to TTM, http://www.jss.or.jp/ikusei/sasakawa/; a JSPS KAKENHI Grant (No. 26840139) to TTM, http://www.jsps.go.jp/english/index.html; and a JSPS KAKENHI Grant (No. 26291076) to JY, http://www.jsps.go.jp/english/index.html.	ARMBRUSTER WS, 1994, ECOLOGY, V75, P315, DOI 10.2307/1939537; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; Benitez-Vieyra S, 2007, P ROY SOC B-BIOL SCI, V274, P2239, DOI 10.1098/rspb.2007.0588; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackiston D, 2011, J EXP BIOL, V214, P509, DOI 10.1242/jeb.048728; Brown BJ, 2002, ECOLOGY, V83, P2328, DOI 10.1890/0012-9658(2002)083[2328:CFPBAI]2.0.CO;2; Campbell DR, 2010, ECOLOGY, V91, P2638, DOI 10.1890/09-0941.1; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P115, DOI 10.1080/07929978.1997.10676678; Chittka L., 2001, COGNITIVE ECOLOGY PO, DOI 10.1017/CBO9780511542268; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; de Jager ML, 2011, OECOLOGIA, V166, P543, DOI 10.1007/s00442-010-1879-7; Dyer AG, 2006, ENTOMOL GEN, V28, P257; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Eaton DAR, 2012, ECOLOGY, V93, pS182, DOI 10.1890/11-0501.1; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; FUKUSHI T, 1989, J COMP PHYSIOL A, V166, P57, DOI 10.1007/BF00190210; Glover B.J., 2007, UNDERSTANDING FLOWER; GOLDSMITH TH, 1979, J COMP PHYSIOL, V130, P209, DOI 10.1007/BF00614607; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Harder LD, 2006, ECOLOGY EVOLUTION FL; Jersakova J, 2007, FUNCT ECOL, V21, P496, DOI 10.1111/j.1365-2435.2007.01256.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kalisz S, 2008, HEREDITY, V100, P171, DOI 10.1038/sj.hdy.6800939; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; King VM, 2012, BIOL INVASIONS, V14, P1809, DOI 10.1007/s10530-012-0191-3; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; LUNAU K, 1994, J COMP PHYSIOL A, V174, P575, DOI 10.1007/BF00217378; McEwen JR, 2010, P ROY SOC B-BIOL SCI, V277, P2957, DOI 10.1098/rspb.2010.0501; MENZEL R, 1993, BIOL REV, V68, P81, DOI 10.1111/j.1469-185X.1993.tb00732.x; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1403, DOI 10.1093/aob/mcp062; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Muchhala N, 2007, P ROY SOC B-BIOL SCI, V274, P2731, DOI 10.1098/rspb.2007.0670; Muchhala N, 2014, EVOLUTION, V68, P2275, DOI 10.1111/evo.12441; Muchhala N, 2012, FUNCT ECOL, V26, P476, DOI 10.1111/j.1365-2435.2011.01950.x; Myczko L, 2014, APIDOLOGIE; Newman E, 2012, P ROY SOC B-BIOL SCI, V279, P2309, DOI 10.1098/rspb.2011.2375; Ohashi K, 2015, FUNCT ECOL; Ollerton J, 2009, NATURWISSENSCHAFTEN, V96, P221, DOI 10.1007/s00114-008-0467-8; Papadopulos AST, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0960; Pellissier Loic, 2012, Systematics Association Special Volume Series, V81, P392; Roy BA, 1999, TRENDS PLANT SCI, V4, P325, DOI 10.1016/S1360-1385(99)01445-4; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Smith SD, 2008, EVOLUTION, V62, P793, DOI 10.1111/j.1558-5646.2008.00327.x; Suzuki MF, 2014, FUNCT ECOL, V28, P549, DOI 10.1111/1365-2435.12209; TROJE N, 1993, Z NATURFORSCH C, V48, P96; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357; Whitfield M, 2014, BEHAV ECOL, V25, P328, DOI 10.1093/beheco/art115; Willmer P., 2011, POLLINATION FLORAL E	58	15	15	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143443	10.1371/journal.pone.0143443	http://dx.doi.org/10.1371/journal.pone.0143443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650121	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903300018
J	Moser, DA; Paoloni-Giacobino, A; Stenz, L; Adouan, W; Manini, A; Suardi, F; Cordero, MI; Vital, M; Rossignol, AS; Rusconi-Serpa, S; Ansermet, F; Dayer, AG; Schechter, DS				Moser, Dominik A.; Paoloni-Giacobino, Ariane; Stenz, Ludwig; Adouan, Wafae; Manini, Aurelia; Suardi, Francesca; Cordero, Maria I.; Vital, Marylene; Rossignol, Ana Sancho; Rusconi-Serpa, Sandra; Ansermet, Francois; Dayer, Alexandre G.; Schechter, Daniel S.			BDNF Methylation and Maternal Brain Activity in a Violence-Related Sample	PLOS ONE			English	Article							PROMOTER METHYLATION; POSTTRAUMATIC-STRESS; NEUROTROPHIC FACTOR; SUICIDAL IDEATION; MOTHERS; FEAR; EXPRESSION; CHILD; PTSD; IV	It is known that increased circulating glucocorticoids in the wake of excessive, chronic, repetitive stress increases anxiety and impairs Brain-Derived Neurotrophic Factor (BDNF) signaling. Recent studies of BDNF gene methylation in relation to maternal care have linked high BDNF methylation levels in the blood of adults to lower quality of received maternal care measured via self-report. Yet the specific mechanisms by which these phenomena occur remain to be established. The present study examines the link between methylation of the BDNF gene promoter region and patterns of neural activity that are associated with maternal response to stressful versus non-stressful child stimuli within a sample that includes mothers with interpersonal violence-related PTSD (IPV-PTSD). 46 mothers underwent fMRI. The contrast of neural activity when watching children-including their ownwas then correlated to BDNF methylation. Consistent with the existing literature, the present study found that maternal BDNF methylation was associated with higher levels of maternal anxiety and greater childhood exposure to domestic violence. fMRI results showed a positive correlation of BDNF methylation with maternal brain activity in the anterior cingulate (ACC), and ventromedial prefrontal cortex (vmPFC), regions generally credited with a regulatory function toward brain areas that are generating emotions. Furthermore we found a negative correlation of BDNF methylation with the activity of the right hippocampus. Since our stimuli focus on stressful parenting conditions, these data suggest that the correlation between vmPFC/ACC activity and BDNF methylation may be linked to mothers who are at a disadvantage with respect to emotion regulation when facing stressful parenting situations. Overall, this study provides evidence that epigenetic signatures of stress-related genes can be linked to functional brain regions regulating parenting stress, thus advancing our understanding of mothers at risk for stress-related psychopathology.	[Moser, Dominik A.; Manini, Aurelia; Suardi, Francesca; Vital, Marylene; Rossignol, Ana Sancho; Rusconi-Serpa, Sandra; Ansermet, Francois; Schechter, Daniel S.] Univ Hosp Geneva, Dept Child & Adolescent Psychiat, Geneva, Switzerland; [Moser, Dominik A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Paoloni-Giacobino, Ariane; Stenz, Ludwig; Adouan, Wafae] Univ Hosp Geneva, Dept Genet Med & Dev, Fac Med, Geneva, Switzerland; [Cordero, Maria I.; Dayer, Alexandre G.] Manchester Metropolitan Univ, Fac Hlth Psychol & Social Care, Manchester M15 6BH, Lancs, England	University of Geneva; Icahn School of Medicine at Mount Sinai; University of Geneva; Manchester Metropolitan University	Moser, DA (corresponding author), Univ Hosp Geneva, Dept Child & Adolescent Psychiat, Geneva, Switzerland.	domamoser@gmail.com	Cordero, Maria Isabel/A-2532-2013; Giacobino, Ariane/AHC-7144-2022; Cordero, Maria Isabel/AAF-2935-2019; Stenz, L/N-7605-2017; SCHECHTER, Daniel S/ABF-5565-2020; Moser, Dominik Andreas/H-9359-2019	Cordero, Maria Isabel/0000-0003-0692-8064; Cordero, Maria Isabel/0000-0003-0692-8064; Stenz, L/0000-0002-2339-9451; SCHECHTER, Daniel S/0000-0003-1663-6305; Moser, Dominik Andreas/0000-0001-7119-1033; Giacobino, Ariane/0000-0001-9432-1785; Dayer, Alexandre/0000-0002-4490-9780	National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" - Swiss National Science Foundation [51AU40_125759]; Gertrude von Meissner Foundation; Oak Foundation; la Fondation Prim'Enfance; Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; Geneva-Lausanne University Hospitals	National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" - Swiss National Science Foundation; Gertrude von Meissner Foundation; Oak Foundation; la Fondation Prim'Enfance; Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; Geneva-Lausanne University Hospitals	This research was supported by the National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" (nccr-synapsy.ch) financed by the Swiss National Science Foundation (no 51AU40_125759), the Gertrude von Meissner Foundation, the Oak Foundation (http://www.oakfnd.org) and la Fondation Prim'Enfance (http://www.primenfance.ch). This work was further supported in part by the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities, the EPFL and the Geneva-Lausanne University Hospitals (http://www.cibm.ch). The authors report no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" (nccr-synapsy.ch) financed by the Swiss National Science Foundation (no 51AU40_125759), the Gertrude von Meissner Foundation, the Oak Foundation (http://www.oakfnd.org) and la Fondation Prim'Enfance (http://www.primenfance.ch). This work was further supported in part by the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities, the EPFL and the Geneva-Lausanne University Hospitals (http://www.cibm.ch).	Association WM., 1999, B MED ETHICS NO, V147, P18; Baker-Andresen D, 2013, LEARN MEMORY, V20, P237, DOI 10.1101/lm.029520.112; Beck AT., 1996, MANUAL BECK DEPRESSI; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boersma GJ, 2014, EPIGENETICS-US, V9, P437, DOI 10.4161/epi.27558; Borelli JL, 2012, INFANT MENT HEALTH J, V33, P506, DOI 10.1002/imhj.21340; Braithwaite EC, 2015, EPIGENETICS-US, V10, P408, DOI 10.1080/15592294.2015.1039221; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Cannon EA, 2009, ARCH PEDIAT ADOL MED, V163, P706, DOI 10.1001/archpediatrics.2009.91; Carlberg L, 2014, J AFFECT DISORDERS, V168, P399, DOI 10.1016/j.jad.2014.07.022; Chatterjee D, 2007, BRAIN RES, V1158, P11, DOI 10.1016/j.brainres.2007.04.069; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Derogatis LR., 1994, SCL 90 R SYMPTOM CHE; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Doherty TS, 2016, BEHAV BRAIN RES, V298, P55, DOI 10.1016/j.bbr.2015.05.028; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Ho SS, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00152; Jeanneteau FD, 2012, P NATL ACAD SCI USA, V109, P1305, DOI 10.1073/pnas.1114122109; Kang HJ, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.035; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Kim JM, 2015, INT J PSYCHIAT MED, V49, P75, DOI 10.1177/0091217415574439; Kim JM, 2014, AM J GERIAT PSYCHIAT, V22, P989, DOI 10.1016/j.jagp.2014.02.011; Kleimann A, 2015, J NEURAL TRANSM, V122, P925, DOI 10.1007/s00702-014-1336-6; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Laurent HK, 2012, INFANT BEHAV DEV, V35, P761, DOI 10.1016/j.infbeh.2012.07.007; Lenzi D, 2009, CEREB CORTEX, V19, P1124, DOI 10.1093/cercor/bhn153; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Marshall RD, 1998, J CLIN PSYCHOPHARM, V18, P10, DOI 10.1097/00004714-199802000-00003; Martin SL, 2002, INT J EPIDEMIOL, V31, P560, DOI 10.1093/ije/31.3.560; McAdams TA, 2015, PSYCHOL MED, V45, P2583, DOI 10.1017/S0033291715000501; Moser DA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01575; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; Pat-Horenczyk R, 2015, INFANT MENT HEALTH J, V36, P337, DOI 10.1002/imhj.21515; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Schechter DS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00690; Schechter DS, 2012, SOC COGN AFFECT NEUR, V7, P969, DOI 10.1093/scan/nsr069; Schechter DS, 2005, ATTACH HUM DEV, V7, P313, DOI 10.1080/14616730500246011; Schulz-Klaus B, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00205; St-Cyr S, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00145; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Strathearn L, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00176; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Straus Murray A, 2004, Violence Vict, V19, P507; Swain JE, 2008, J CHILD PSYCHOL PSYC, V49, P1042, DOI 10.1111/j.1469-7610.2008.01963.x; Thaler L, 2014, PROG NEURO-PSYCHOPH, V54, P43, DOI 10.1016/j.pnpbp.2014.04.010; Unternaehrer E, 2015, STRESS, V18, P451, DOI 10.3109/10253890.2015.1038992; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weder N, 2014, J AM ACAD CHILD PSY, V53, P417, DOI 10.1016/j.jaac.2013.12.025; Zeanah C.H., 2000, HDB INFANT MENTAL HL, P222; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	53	32	32	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143427	10.1371/journal.pone.0143427	http://dx.doi.org/10.1371/journal.pone.0143427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649946	Green Published, gold			2022-12-26	WOS:000366903300017
J	Batchelder, CA; Martinez, ML; Tarantal, AF				Batchelder, Cynthia A.; Martinez, Michele L.; Tarantal, Alice F.			Natural Scaffolds for Renal Differentiation of Human Embryonic Stem Cells for Kidney Tissue Engineering	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX SCAFFOLDS; PORCINE KIDNEYS; TRANSPLANTATION; DECELLULARIZATION; REGENERATION; ONTOGENY; PROGENITORS; GENERATION; STRATEGIES; ORGANOIDS	Despite the enthusiasm for bioengineering of functional renal tissues for transplantation, many obstacles remain before the potential of this technology can be realized in a clinical setting. Viable tissue engineering strategies for the kidney require identification of the necessary cell populations, efficient scaffolds, and the 3D culture conditions to develop and support the unique architecture and physiological function of this vital organ. Our studies have previously demonstrated that decellularized sections of rhesus monkey kidneys of all age groups provide a natural extracellular matrix (ECM) with sufficient structural properties with spatial and organizational influences on human embryonic stem cell (hESC) migration and differentiation. To further explore the use of decellularized natural kidney scaffolds for renal tissue engineering, pluripotent hESC were seeded in whole-or on sections of kidney ECM and cell migration and phenotype compared with the established differentiation assays for hESC. Results of qPCR and immunohistochemical analyses demonstrated upregulation of renal lineage markers when hESC were cultured in decellularized scaffolds without cytokine or growth factor stimulation, suggesting a role for the ECM in directing renal lineage differentiation. hESC were also differentiated with growth factors and compared when seeded on renal ECM or a new biologically inert polysaccharide scaffold for further maturation. Renal lineage markers were progressively upregulated over time on both scaffolds and hESC were shown to express signature genes of renal progenitor, proximal tubule, endothelial, and collecting duct populations. These findings suggest that natural scaffolds enhance expression of renal lineage markers particularly when compared to embryoid body culture. The results of these studies show the capabilities of a novel polysaccharide scaffold to aid in defining a protocol for renal progenitor differentiation from hESC, and advance the promise of tissue engineering as a source of functional kidney tissue.	[Batchelder, Cynthia A.; Martinez, Michele L.; Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tarantal, AF (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	aftarantal@ucdavis.edu			UC Davis Translational Human Embryonic Stem Cell Shared Research Facility [CL1-00504]; base operating grant for the California National Primate Research Center [P51-OD011107]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	UC Davis Translational Human Embryonic Stem Cell Shared Research Facility; base operating grant for the California National Primate Research Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the UC Davis Translational Human Embryonic Stem Cell Shared Research Facility (# CL1-00504) and the base operating grant for the California National Primate Research Center (# P51-OD011107). These entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Batchelder CA, 2014, ANAT REC, V297, P1392, DOI 10.1002/ar.22943; Batchelder CA, 2013, ANAT REC, V296, P1747, DOI 10.1002/ar.22756; Batchelder CA, 2010, ANAT REC, V293, P1971, DOI 10.1002/ar.21242; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Bonandrini B, 2014, TISSUE ENG PT A, V20, P1486, DOI [10.1089/ten.tea.2013.0269, 10.1089/ten.TEA.2013.0269]; Bontrop RE, 2001, IMMUNOL REV, V183, P5, DOI 10.1034/j.1600-065x.2001.1830101.x; Caralt M, 2015, AM J TRANSPLANT, V15, P64, DOI 10.1111/ajt.12999; Challen GA, 2006, J AM SOC NEPHROL, V17, P1896, DOI 10.1681/ASN.2005111228; Crowley C, 2015, J TISSUE ENG REGEN M, V9, P357, DOI 10.1002/term.1847; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; Gupta S, 2006, J AM SOC NEPHROL, V17, P3028, DOI 10.1681/ASN.2006030275; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Hiatt MJ, 2010, AM J PATHOL, V176, P630, DOI 10.2353/ajpath.2010.090389; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Katari R, 2014, NEPHRON EXP NEPHROL, V126, P119, DOI 10.1159/000360684; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Ko IK, 2014, TECHNOLOGY, V2, P243, DOI 10.1142/S2339547814500228; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nakayama KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064134; Nakayama KH, 2011, TISSUE ENG PT A, V17, P2891, DOI [10.1089/ten.TEA.2010.0714, 10.1089/ten.tea.2010.0714]; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Orlando G, 2013, BIOMATERIALS, V34, P5915, DOI 10.1016/j.biomaterials.2013.04.033; Orlando G, 2012, ANN SURG, V256, P363, DOI 10.1097/SLA.0b013e31825a02ab; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Park KM, 2012, TRANSPL P, V44, P1146, DOI 10.1016/j.transproceed.2012.03.043; Peloso A, 2015, TRANSPLANTATION, V99, P1807, DOI 10.1097/TP.0000000000000811; Petrosyan A, 2015, CELLR4, V3, pe1401; Rogers SA, 1998, KIDNEY INT, V54, P27, DOI 10.1046/j.1523-1755.1998.00971.x; Ross EA, 2012, ORGANOGENESIS, V8, P49, DOI 10.4161/org.20209; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Tarantal AF, 2001, KIDNEY INT, V59, P446, DOI 10.1046/j.1523-1755.2001.059002446.x; Tarantal AF, 2011, STEM CELLS BIOL REG, P393, DOI 10.1007/978-1-61779-322-6_21; Trobridge GD, 2010, GENE THER, V17, P939, DOI 10.1038/gt.2010.47; Uzarski JS, 2014, CURR OPIN NEPHROL HY, V23, P399, DOI 10.1097/01.mnh.0000447019.66970.ea; Wang YJ, 2015, XENOTRANSPLANTATION, V22, P48, DOI 10.1111/xen.12141; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Xia Y, 2014, NAT PROTOC, V9, P2693, DOI 10.1038/nprot.2014.182; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yu YL, 2014, BIOMATERIALS, V35, P6822, DOI 10.1016/j.biomaterials.2014.04.074	51	41	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143849	10.1371/journal.pone.0143849	http://dx.doi.org/10.1371/journal.pone.0143849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645109	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903100008
J	Guo, CH; Wei, MZ; Liu, H				Guo, Chaohua; Wei, Mingzhen; Liu, Hong			Modeling of Gas Production from Shale Reservoirs Considering Multiple Transport Mechanisms	PLOS ONE			English	Article							TANGENTIAL MOMENTUM ACCOMMODATION; NATURALLY FRACTURED RESERVOIRS; POROUS-MEDIA; FLOW; PERMEABILITY; SIMULATION; PRESSURES; CHANNELS; PIPES	Gas transport in unconventional shale strata is a multi-mechanism-coupling process that is different from the process observed in conventional reservoirs. In micro fractures which are inborn or induced by hydraulic stimulation, viscous flow dominates. And gas surface diffusion and gas desorption should be further considered in organic nano pores. Also, the Klin-kenberg effect should be considered when dealing with the gas transport problem. In addition, following two factors can play significant roles under certain circumstances but have not received enough attention in previous models. During pressure depletion, gas viscosity will change with Knudsen number; and pore radius will increase when the adsorption gas desorbs from the pore wall. In this paper, a comprehensive mathematical model that incorporates all known mechanisms for simulating gas flow in shale strata is presented. The objective of this study was to provide a more accurate reservoir model for simulation based on the flow mechanisms in the pore scale and formation geometry. Complex mechanisms, including viscous flow, Knudsen diffusion, slip flow, and desorption, are optionally integrated into different continua in the model. Sensitivity analysis was conducted to evaluate the effect of different mechanisms on the gas production. The results showed that adsorption and gas viscosity change will have a great impact on gas production. Ignoring one of following scenarios, such as adsorption, gas permeability change, gas viscosity change, or pore radius change, will underestimate gas production.	[Guo, Chaohua; Wei, Mingzhen] Missouri Univ Sci & Technol, Dept Petr Engn, Rolla, MO 65401 USA; [Liu, Hong] Chongqing Univ Sci & Technol, Dept Petr Engn, Chongqing 401331, Peoples R China	University of Missouri System; Missouri University of Science & Technology; Chongqing University of Science & Technology	Guo, CH (corresponding author), Missouri Univ Sci & Technol, Dept Petr Engn, Rolla, MO 65401 USA.	chaohua.guo@mst.edu			RPSEA through the "Ultra-Deepwater and Unconventional Natural Gas and Other Petroleum Resources"; Baker Hughes and Hess Company	RPSEA through the "Ultra-Deepwater and Unconventional Natural Gas and Other Petroleum Resources"; Baker Hughes and Hess Company	Funding for this project is provided by RPSEA through the "Ultra-Deepwater and Unconventional Natural Gas and Other Petroleum Resources". The authors also wish to acknowledge for the consultant support from Baker Hughes and Hess Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1941, DRILLING PRODUCTION; [Anonymous], 1954, J PET TECHNOL, DOI DOI 10.2118/271-G; Arkilic EB, 2001, J FLUID MECH, V437, P29, DOI 10.1017/S0022112001004128; Beskok A, 1999, MICROSCALE THERM ENG, V3, P43; BROWN GP, 1946, J APPL PHYS, V17, P802, DOI 10.1063/1.1707647; Bustin A., 2008, UNC RES C COL US 10; Cao BY, 2006, INT J ENG SCI, V44, P927, DOI 10.1016/j.ijengsci.2006.06.005; Cao BY, 2009, INT J MOL SCI, V10, P4638, DOI 10.3390/ijms10114638; Cao BY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1871363; Civan F, 2011, TRANSPORT POROUS MED, V86, P925, DOI 10.1007/s11242-010-9665-x; Cui X, 2009, GEOFLUIDS, V9, P208, DOI 10.1111/j.1468-8123.2009.00244.x; Freeman C., 2012, LAT AM CAR PETR ENG; Guo C., 2015, SPE 176714; Guo CH, 2015, FUEL, V143, P107, DOI 10.1016/j.fuel.2014.11.032; Guo C, 2017, J INTELL MANUF, V28, P657, DOI 10.1007/s10845-014-1002-8; Hill D.G., 2000, GAS TIPS, V6, P4, DOI DOI 10.1016/J.FUEL.2005.05.002; Javadpour F, 2009, J CAN PETROL TECHNOL, V48, P16, DOI 10.2118/09-08-16-DA; Javadpour F., 2007, J CANADIAN PETROLEUM, V46; Kast W, 2000, INT J HEAT MASS TRAN, V43, P807, DOI 10.1016/S0017-9310(99)00158-1; KAZEMI H, 1976, SOC PETROL ENG J, V16, P317, DOI 10.2118/5719-PA; Michalis VK, 2010, MICROFLUID NANOFLUID, V9, P847, DOI 10.1007/s10404-010-0606-3; Moridis G., 2010, LAT AM CAR PETR ENG; Ozkan E., 2010, ANN TECHN C EXH LIM; PEACEMAN DW, 1983, SOC PETROL ENG J, V23, P531, DOI 10.2118/10528-PA; Pruess K., 1999, TOUGH2 USERS GUIDE V; Sakhaee-Pour A, 2012, SPE RESERV EVAL ENG, V15, P401, DOI 10.2118/146944-PA; Shabro V., 2011, N AM UNC GAS C EXH T; Shabro V, 2012, ANN TECHN C EXH TEX; Wang Z., 2013, RETROSPECTIVE REV SH; WARREN JE, 1963, SOC PETROL ENG J, V3, P245, DOI 10.2118/426-PA; Wu Y.S., 2011, EUROPEC EAGE ANN C E; Wu YS, 1998, TRANSPORT POROUS MED, V32, P117, DOI 10.1023/A:1006535211684; Xiong X., 2012, ANN TECHN C EXH TEX; Ziarani AS, 2012, TRANSPORT POROUS MED, V91, P239, DOI 10.1007/s11242-011-9842-6	34	16	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143649	10.1371/journal.pone.0143649	http://dx.doi.org/10.1371/journal.pone.0143649			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657698	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900013
J	Shen, ZF; Yu, XJ; Sheng, YW; Li, JL; Luo, JC				Shen, Zhanfeng; Yu, Xinju; Sheng, Yongwei; Li, Junli; Luo, Jiancheng			A Fast Algorithm to Estimate the Deepest Points of Lakes for Regional Lake Registration	PLOS ONE			English	Article							DIGITAL ELEVATION MODELS; MEDIAL AXIS; SKELETONIZATION; EXTRACTION; SURFACE; IMAGE	When conducting image registration in the U.S. state of Alaska, it is very difficult to locate satisfactory ground control points because ice, snow, and lakes cover much of the ground. However, GCPs can be located by seeking stable points from the extracted lake data. This paper defines a process to estimate the deepest points of lakes as the most stable ground control points for registration. We estimate the deepest point of a lake by computing the center point of the largest inner circle (LIC) of the polygon representing the lake. An LIC-seeking method based on Voronoi diagrams is proposed, and an algorithm based on medial axis simplification (MAS) is introduced. The proposed design also incorporates parallel data computing. A key issue of selecting a policy for partitioning vector data is carefully studied, the selected policy that equalize the algorithm complexity is proved the most optimized policy for vector parallel processing. Using several experimental applications, we conclude that the presented approach accurately estimates the deepest points in Alaskan lakes; furthermore, we gain perfect efficiency using MAS and a policy of algorithm complexity equalization.	[Shen, Zhanfeng; Yu, Xinju; Luo, Jiancheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing 100101, Peoples R China; [Sheng, Yongwei] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; [Li, Junli] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi 830020, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Yu, XJ (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing 100101, Peoples R China.	yuxj@radi.ac.cn	Li, Junli/C-8904-2014; Luo, jian/HGE-7331-2022		Chinese 863 project [2013AA12A401]; National Natural Science Foundation project of China [41101398, 41301438]; National Aeronautics and Space Administration through the Terrestrial Hydrology Program [NNX08AE51G]	Chinese 863 project(National High Technology Research and Development Program of China); National Natural Science Foundation project of China(National Natural Science Foundation of China (NSFC)); National Aeronautics and Space Administration through the Terrestrial Hydrology Program	This work was supported by the Chinese 863 project (No. 2013AA12A401), National Natural Science Foundation project of China (No. 41101398), the National Aeronautics and Space Administration through the Terrestrial Hydrology Program (No. NNX08AE51G).; This work was supported in part by the Chinese 863 project (No. 2013AA12A401), National Natural Science Foundation project of China (No. 41301438), and in part by the National Aeronautics and Space Administration through the Terrestrial Hydrology Program (No. NNX08AE51G).	Attali D, 2001, COMP GEOM-THEOR APPL, V19, P175, DOI 10.1016/S0925-7721(01)00019-0; Beristain A, 2012, J MATH IMAGING VIS, V42, P225, DOI 10.1007/s10851-011-0291-1; Blum H., 1967, MODELS PERCEPTION SP, P362, DOI DOI 10.1142/S0218654308001154; Borgefors G., 1991, P 7 SCAND C IM AN, V2, P974; Chaussard J, 2011, PATTERN RECOGN LETT, V32, P1384, DOI 10.1016/j.patrec.2010.09.002; Cheong O, 2011, COMP GEOM-THEOR APPL, V44, P234, DOI 10.1016/j.comgeo.2010.11.004; DAVIES ER, 1981, PATTERN RECOGN, V14, P53, DOI 10.1016/0031-3203(81)90045-5; Dey TK, 2004, COMPUT AIDED DESIGN, V36, P195, DOI 10.1016/S0010-4485(03)00061-7; Dorado R, 2009, COMPUT AIDED DESIGN, V41, P1050, DOI 10.1016/j.cad.2009.08.005; Drysdale R. L.  III, 1978, Proceedings of the Sixteenth Annual Allerton Conference on Communication, Control and Computing, P833; Hesselink WH, 2008, IEEE T PATTERN ANAL, V30, P2204, DOI 10.1109/TPAMI.2008.21; Hulin J, 2009, THESIS; KIMMEL R, 1995, COMPUT VIS IMAGE UND, V62, P382, DOI 10.1006/cviu.1995.1062; Kirkpatrick D. G., 1979, 20th Annual Symposium of Foundations of Computer Science, P18, DOI 10.1109/SFCS.1979.15; LEE DT, 1981, SIAM J COMPUT, V10, P73, DOI 10.1137/0210006; LEE DT, 1982, IEEE T PATTERN ANAL, V4, P363, DOI 10.1109/TPAMI.1982.4767267; Leymarie FF, 2007, IEEE T PATTERN ANAL, V29, P313, DOI 10.1109/TPAMI.2007.44; O'-Rourke, 2008, COMPUTATIONAL GEOMET; OGNIEWICZ RL, 1995, PATTERN RECOGN, V28, P343, DOI 10.1016/0031-3203(94)00105-U; OISHI Y, 1995, GRAPH MODEL IM PROC, V57, P303, DOI 10.1006/gmip.1995.1027; Preparata F. P., 1977, MATH FDN COMPUTER SC, P443; Quesada A., 2008, POLAR LAKES RIVERS L, P583; Ramamurthy R, 1999, J COMPUT APPL MATH, V102, P119, DOI 10.1016/S0377-0427(98)00211-8; Serra J, 1983, IMAGE ANAL MATH MORP; Shah CA, 2008, IEEE T GEOSCI REMOTE, V46, P3908, DOI 10.1109/TGRS.2008.2000636; Shen DY, 2012, IEEE GEOSCI REMOTE S, V9, P194, DOI 10.1109/LGRS.2011.2163812; Shen Zhan-feng, 2006, Journal of the Harbin Institute of Technology, V38, P1968; Shen ZF, 2012, J INDIAN SOC REMOTE, V40, P357, DOI 10.1007/s12524-011-0166-3; Siddiqi K., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P828, DOI 10.1109/ICCV.1999.790307; TALBOT H, 1992, P SOC PHOTO-OPT INS, V1818, P862, DOI 10.1117/12.131499; Wang JD, 2012, REMOTE SENS ENVIRON, V119, P325, DOI 10.1016/j.rse.2011.10.027; Zhu HS, 2015, ADV ENG SOFTW, V85, P96, DOI 10.1016/j.advengsoft.2015.03.004	32	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144700	10.1371/journal.pone.0144700	http://dx.doi.org/10.1371/journal.pone.0144700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656598	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900089
J	Miglietta, MP; Odegard, D; Faure, B; Faucci, A				Miglietta, Maria Pia; Odegard, Dean; Faure, Baptiste; Faucci, Anuschka			Barcoding Techniques Help Tracking the Evolutionary History of the Introduced Species Pennaria disticha (Hydrozoa, Cnidaria)	PLOS ONE			English	Article							BLACKFORDIA-VIRGINICA; MAEOTIAS-MARGINATA; GENETIC-ANALYSIS; MARINE HABITATS; SEA; HYDROMEDUSAE; HYDRACTINIIDAE	The Christmas tree hydroid Pennaria disticha is listed as one of the most common introduced species in Hawaii. Firstly reported in Kaneohe Bay (Oahu) in 1928, it is now established throughout the entire archipelago, including the Northwestern Hawaiian Islands, a U.S. National Monument and World Heritage site. The Hawaiian population of P. disticha has also been reported as being the source of further introductions to Palmyra Atoll in the U.S. Line Islands. Using a phylogenetic hypothesis based on a 611 base pair fragment of the mitochondrial 16S barcoding gene, we demonstrate that P. disticha is a complex of cryptic species, rather than one species with cosmopolitan distribution. We also show that in Hawaii there are three species of Pennaria, rather than one introduced species. Two of these species share haplotypes with specimens from distant locations such as Florida and Panama and may have been introduced, possibly from the Atlantic Ocean. A third species could either represent a lineage with nearly cosmopolitan distribution, or another introduced species. Our dataset refutes the widely accepted idea that only one lineage of P. disticha is present in Hawaii. On the contrary, P. disticha in Hawaii may be the outcome of multiple independent introductions of several morphologically undistinguishable cryptic lineages. Our results uncover an unsuspected complexity within the very common hydroid P. disticha, and highlight the need for routine use of molecular tools, such as DNA barcoding, to improve the identification and recognition of non-indigenous species.	[Miglietta, Maria Pia] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Odegard, Dean] Univ Notre Dame, Notre Dame, IN 46556 USA; [Faure, Baptiste] Univ La Reunion, Lab Ecol Marine, St Denis, Reunion, France; [Faucci, Anuschka] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	Texas A&M University System; University of Notre Dame; University of La Reunion; University of Hawaii System; University of Hawaii Manoa	Miglietta, MP (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	miglietm@tamug.edu		Odegard, Dean/0000-0002-7093-6889	University of Notre Dame; Texas AAMP;M University at Galveston; University of Notre Dame; Texas AAMP;M University at Galveston	University of Notre Dame; Texas AAMP;M University at Galveston; University of Notre Dame; Texas AAMP;M University at Galveston	Funding was provided by the University of Notre Dame and Texas A&M University at Galveston (start-up funds to MPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Calder Dale R., 2010, Zootaxa, V2590, P1; Carlton J., 2009, MARINE BIOINVASIONS; Carlton James T., 1999, Population and Community Biology Series, V24, P195; Coles SL, 2006, PAC SCI, V60, P483, DOI 10.1353/psc.2006.0026; Concepcion GT, 2010, MAR ECOL PROG SER, V401, P113, DOI 10.3354/meps08364; Costello JH, 2002, LIMNOL OCEANOGR, V47, P934, DOI 10.4319/lo.2002.47.4.0934; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2009, MOL ECOL, V18, P4827, DOI 10.1111/j.1365-294X.2009.04405.x; Edmondson CH, 1933, REEF SHORE FAUNA HAW; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Godwin S, 2006, REDUCING POTENTIAL I; Haddad MA, 2014, ZOOTAXA, V3796, P494, DOI 10.11646/zootaxa.3796.3.5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knapp I.S., 2011, Marine Biodiversity Records, V4; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; Megina C, 2013, MAR BIOL, V160, P371, DOI 10.1007/s00227-012-2094-3; Miglietta MP, 2011, INTEGR COMP BIOL, V51, P449, DOI 10.1093/icb/icr024; Miglietta MP, 2008, J PLANKTON RES, V30, P783, DOI 10.1093/plankt/fbn038; Miglietta MP, 2009, ZOOL SCR, V38, P403, DOI 10.1111/j.1463-6409.2008.00376.x; Miglietta MP, 2009, BIOL INVASIONS, V11, P825, DOI 10.1007/s10530-008-9296-0; MILLS CE, 1995, MAR BIOL, V122, P279; Mills CE, 2000, SCI MAR, V64, P151, DOI 10.3989/scimar.2000.64s1151; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Moura CJ, 2011, ZOOL SCR, V40, P520, DOI 10.1111/j.1463-6409.2011.00489.x; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; Phair N, 2015, CONSERV GENET, V16, P801, DOI 10.1007/s10592-015-0701-9; Rambaut A, 2014, FIGTREE 1 4; Ray GL, 2005, ANSRP056 ERDCTN; Rossi S, 2012, MAR ECOL PROG SER, V467, P97, DOI 10.3354/meps09848; Santini F, 2012, EVOL BIOL, V39, P141, DOI 10.1007/s11692-012-9177-4; Schuchert P, 2014, MOL PHYLOGENET EVOL, V76, P1, DOI 10.1016/j.ympev.2014.02.020; See K, 2009, MARINE BIOGEOGRAPHIC, P275; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tezcan OD, 2013, TOXICON, V61, P125, DOI 10.1016/j.toxicon.2012.10.019; Vainola R, 2001, SARSIA, V86, P401	43	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144762	10.1371/journal.pone.0144762	http://dx.doi.org/10.1371/journal.pone.0144762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657561	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600089
J	Thaler, C; Faizy, T; Sedlacik, J; Holst, B; Stellmann, JP; Young, KL; Heesen, C; Fiehler, J; Siemonsen, S				Thaler, Christian; Faizy, Tobias; Sedlacik, Jan; Holst, Brigitte; Stellmann, Jan-Patrick; Young, Kim Lea; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			T1-Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients	PLOS ONE			English	Article							SPIN-ECHO MRI; HYPOINTENSE LESIONS; WHITE-MATTER; MAGNETIZATION-TRANSFER; COGNITIVE IMPAIRMENT; FUNCTIONAL COMPOSITE; POSTMORTEM MRI; T1-WEIGHTED MR; BRAIN; T1	Background Magnetic Resonance Imaging (MRI) is an established tool in diagnosing and evaluating disease activity in Multiple Sclerosis (MS). While clinical-radiological correlations are limited in general, hypointense T1 lesions (also known as Black Holes (BH)) have shown some promising results. The definition of BHs is very heterogeneous and depends on subjective visual evaluation. Objective We aimed to improve clinical-radiological correlations by defining BHs using T1 relaxation time (T1-RT) thresholds to achieve best possible correlation between BH lesion volume and clinical disability. Method 40 patients with mainly relapsing-remitting MS underwent MRI including 3-dimensional fluid attenuated inversion recovery (FLAIR), magnetization-prepared rapid gradient echo (MPRAGE) before and after Gadolinium (GD) injection and double inversion-contrast magnetization-prepared rapid gradient echo (MP2RAGE) sequences. BHs (BHvis) were marked by two raters on native T1-weighted (T1w)-MPRAGE, contrast-enhancing lesions (CE lesions) on T1w-MPRAGE after GD and FLAIR lesions (total-FLAIR lesions) were detected separately. BHvis and total-FLAIR lesion maps were registered to MP2RAGE images, and the mean T1-RT were calculated for all lesion ROIs. Mean T1 values of the cortex (CTX) were calculated for each patient. Subsequently, Spearman rank correlations between clinical scores (Expanded Disability Status Scale and Multiple Sclerosis Functional Composite) and lesion volume were determined for different T1-RT thresholds. Results Significant differences in T1-RT were obtained between all different lesion types with highest T1 values in visually marked BHs (BHvis: 1453.3 +/- 213.4 ms, total-FLAIR lesions: 1394.33 +/- 187.38 ms, CTX: 1305.6 +/- 35.8 ms; p<0.05). Significant correlations between BHvis/total-FLAIR lesion volume and clinical disability were obtained for a wide range of T1-RT thresholds. The highest correlation for BHvis and total-FLAIR lesion masks were found at T1-RT>1500 ms (Expanded Disability Status Scale vs. lesion volume: r(BHvis) = 0.442 and r(total-FLAIR) = 0.497, p<0.05; Multiple Sclerosis Functional Composite vs. lesion volume: r(BHvis) = -0.53 and r(total-FLAIR) = -0.627, p<0.05). Conclusion Clinical-radiological correlations in MS patients are increased by application of T1-RT thresholds. With the short acquisition time of the MP2RAGE sequences, quantitative T1 maps could be easily established in clinical studies.	[Thaler, Christian; Faizy, Tobias; Sedlacik, Jan; Holst, Brigitte; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Stellmann, Jan-Patrick; Young, Kim Lea; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Stellmann, Jan-Patrick; Young, Kim Lea; Heesen, Christoph; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Thaler, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	c.thaler@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Gellissen, Susanne/0000-0002-7444-7265	Biogen; Merck-Serono; Teva; Sanofi Aventis; Genzyme	Biogen(Biogen); Merck-Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Sanofi Aventis(Sanofi-Aventis); Genzyme(Sanofi-AventisGenzyme Corporation)	C. Heesen has received lecture honoraria and grants from Biogen, Merck-Serono, Teva, Sanofi Aventis, and Genzyme. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; Caligiuri ME, 2015, NEUROINFORMATICS, V13, P261, DOI 10.1007/s12021-015-9260-y; Castriota-Scanderbeg A, 2004, MULT SCLER J, V10, P556, DOI 10.1191/1352458504ms1073oa; De Groot CJA, 2001, BRAIN, V124, P1635, DOI 10.1093/brain/124.8.1635; Enzinger C, 2004, ANN NEUROL, V55, P563, DOI 10.1002/ana.20027; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Giugni E, 1997, MULT SCLER, V3, P221, DOI 10.1177/135245859700300401; Griffin CM, 2002, MULT SCLER J, V8, P211, DOI 10.1191/1352458502ms807oa; Jain S, 2015, NEUROIMAGE-CLIN, V8, P367, DOI 10.1016/j.nicl.2015.05.003; Jonkman LE, 2015, J NEUROL, V262, P1074, DOI 10.1007/s00415-015-7689-4; Kappos L, 2002, NEUROSTATUS NEUROSTA; Kober T, 2012, INVEST RADIOL, V47, P346, DOI 10.1097/RLI.0b013e31824600e9; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; LOEVNER LA, 1995, AM J NEURORADIOL, V16, P1473; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; Manfredonia F, 2007, ARCH NEUROL-CHICAGO, V64, P411, DOI 10.1001/archneur.64.3.411; Miller DM, 2000, ARCH NEUROL-CHICAGO, V57, P1319, DOI 10.1001/archneur.57.9.1319; Mitjana R, 2014, MULT SCLER J, V20, P1471, DOI 10.1177/1352458514526083; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; O'Riordan JI, 1998, MULT SCLER J, V4, P408, DOI 10.1191/135245898678919483; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; Pichler A, 2013, MULT SCLER J, V19, P167, DOI 10.1177/1352458512448107; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Riva M, 2009, AM J NEURORADIOL, V30, P1394, DOI 10.3174/ajnr.A1573; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Sahraian MA, 2010, ACTA NEUROL SCAND, V122, P1, DOI 10.1111/j.1600-0404.2009.01221.x; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Simioni S, 2014, J NEUROL, V261, P1606, DOI 10.1007/s00415-014-7398-4; Simon JH, 2000, NEUROLOGY, V55, P185, DOI 10.1212/WNL.55.2.185; Tam RC, 2011, MULT SCLER J, V17, P949, DOI 10.1177/1352458511402113; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Venkatesan R, 1998, MAGNET RESON MED, V40, P592, DOI 10.1002/mrm.1910400412	38	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144693	10.1371/journal.pone.0144693	http://dx.doi.org/10.1371/journal.pone.0144693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659852	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903600079
J	Maier, LJ; Liakoni, E; Schildmann, J; Schaub, MP; Liechti, ME				Maier, Larissa J.; Liakoni, Evangelia; Schildmann, Jan; Schaub, Michael P.; Liechti, Matthias E.			Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement	PLOS ONE			English	Article							NEUROENHANCEMENT; METHYLPHENIDATE	Pharmacological cognitive enhancement (PCE) refers to the nonmedical use of prescription or recreational drugs to enhance cognitive performance. Several concerns about PCE have been raised in the public. The aim of the present study was to investigate students' attitudes toward PCE. Students at three Swiss universities were invited by e-mail to participate in a web-based survey. Of the 29,282 students who were contacted, 3,056 participated. Of these students, 22% indicated that they had used prescription drugs (12%) or recreational substances including alcohol (14%) at least once for PCE. The use of prescription drugs or recreational substances including alcohol prior to the last exam was reported by 16%. Users of pharmacological cognitive enhancers were more likely to consider PCE fair (24%) compared with nonusers (11%). Only a minority of the participants agreed with the nonmedical use of prescription drugs by fellow students when assuming weak (7%) or hypothetically strong efficacy and availability to everyone (14%). Two-thirds (68%) considered performance that is obtained with PCE less worthy of recognition. Additionally, 80% disagreed that PCE is acceptable in a competitive environment. More than half (64%) agreed that PCE in academia is similar to doping in sports. Nearly half (48%) claimed that unregulated access to pharmacological cognitive enhancers increases the pressure to engage in PCE and educational inequality (55%). In conclusion, Swiss students' main concerns regarding PCE were related to coercion and fairness. As expected, these concerns were more prevalent among nonusers than among users of pharmacological cognitive enhancers. More balanced information on PCE should be shared with students, and future monitoring of PCE is recommended.	[Maier, Larissa J.; Schaub, Michael P.] Univ Zurich, Associated Inst, Swiss Res Inst Publ Hlth & Addict ISGF, Zurich, Switzerland; [Maier, Larissa J.; Schaub, Michael P.] WHO Collaborating Ctr, Zurich, Switzerland; [Liakoni, Evangelia; Liechti, Matthias E.] Univ Basel Hosp, Dept Clin Res, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland; [Schildmann, Jan] Ruhr Univ Bochum, Inst Med Eth & Geschichte Med, Bochum, Germany	University of Zurich; World Health Organization; University of Basel; Ruhr University Bochum	Liechti, ME (corresponding author), Univ Basel Hosp, Dept Clin Res, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland.	matthias.liechti@usb.ch	Schaub, Michael P./ABF-9468-2021; Maier, Larissa/P-8669-2014; Maier, Larissa J/C-2922-2017	Schaub, Michael P./0000-0002-8375-4005; Maier, Larissa/0000-0002-4302-0488; Maier, Larissa J/0000-0002-4302-0488; Schildmann, Jan/0000-0002-5755-7630	Division of Clinical Pharmacology & Toxicology, University Hospital Basel; Swiss Centre of Applied Human Toxicology (SCAHT); Swiss Research Institute for Public Health and Addiction (ISGF), Zurich	Division of Clinical Pharmacology & Toxicology, University Hospital Basel; Swiss Centre of Applied Human Toxicology (SCAHT); Swiss Research Institute for Public Health and Addiction (ISGF), Zurich	This study was supported by internal funds from the Division of Clinical Pharmacology & Toxicology, University Hospital Basel (ML), Swiss Centre of Applied Human Toxicology (SCAHT) (ML), and Swiss Research Institute for Public Health and Addiction (ISGF), Zurich (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagot KS, 2014, ADDICTION, V109, P547, DOI 10.1111/add.12460; Bell S, 2013, NEUROETHICS-NETH, V6, P197, DOI 10.1007/s12152-012-9153-9; de Jongh R, 2008, NEUROSCI BIOBEHAV R, V32, P760, DOI 10.1016/j.neubiorev.2007.12.001; Dodge T, 2012, PSYCHOL ADDICT BEHAV, V26, P678, DOI 10.1037/a0027872; Faulmuller N, 2013, AM J BIOETHICS, V13, P45, DOI 10.1080/15265161.2013.794880; Forlini C, 2014, NEUROETHICS; Forlini C, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-9; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Franke AndreasG., 2012, AJOB PRIMARY RES, V3, P48, DOI [DOI 10.1080/21507716.2011.608411, 10.1080/21507716.2011.608411]; Goold I, 2015, MED LAW REV, V23, P427, DOI 10.1093/medlaw/fwu028; Hall W., 2012, AJOB PRIMARY RES, V3, P81, DOI [DOI 10.1080/21507716.2012.720639, 10.1080/21507716.2012.720639]; Maier LJ, 2015, EUR PSYCHOL, V20, P155, DOI 10.1027/1016-9040/a000228; Maier LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077967; Maslen H, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00107; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Partridge B., 2014, PERMANCE ENHANCEM, V3, P20, DOI [https://doi.org/10.1016/j.peh.2014.03.001, DOI 10.1016/J.PEH.2014.03.001]; Partridge B, 2013, DRUG ALCOHOL REV, V32, P295, DOI 10.1111/dar.12005; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Sattler S, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-8; Sattler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068821; Schelle KJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00010; Schelle KJ, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00053; Shook JR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00228	23	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144402	10.1371/journal.pone.0144402	http://dx.doi.org/10.1371/journal.pone.0144402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26657300	Green Accepted, Green Published, gold			2022-12-26	WOS:000366903500026
J	Haley, BM; Paunesku, T; Grdina, DJ; Woloschak, GE				Haley, Benjamin M.; Paunesku, Tatjana; Grdina, David J.; Woloschak, Gayle E.			The Increase in Animal Mortality Risk following Exposure to Sparsely Ionizing Radiation Is Not Linear Quadratic with Dose	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; CANCER-RISKS; PROTECTION; UNCERTAINTY; HUMANS; ISSUES; MODELS; CT	Introduction The US government regulates allowable radiation exposures relying, in large part, on the seventh report from the committee to estimate the Biological Effect of Ionizing Radiation (BEIR VII), which estimated that most contemporary exposures- protracted or low-dose, carry 1.5 fold less risk of carcinogenesis and mortality per Gy than acute exposures of atomic bomb survivors. This correction is known as the dose and dose rate effectiveness factor for the life span study of atomic bomb survivors (DDREFLSS). It was calculated by applying a linear-quadratic dose response model to data from Japanese atomic bomb survivors and a limited number of animal studies. Methods and Results We argue that the linear-quadratic model does not provide appropriate support to estimate the risk of contemporary exposures. In this work, we re-estimated DDREFLSS using 15 animal studies that were not included in BEIR VII's original analysis. Acute exposure data led to a DDREFLSS estimate from 0.9 to 3.0. By contrast, data that included both acute and protracted exposures led to a DDREFLSS estimate from 4.8 to infinity. These two estimates are significantly different, violating the assumptions of the linear-quadratic model, which predicts that DDREFLSS values calculated in either way should be the same. Conclusions Therefore, we propose that future estimates of the risk of protracted exposures should be based on direct comparisons of data from acute and protracted exposures, rather than from extrapolations from a linear-quadratic model. The risk of low dose exposures may be extrapolated from these protracted estimates, though we encourage ongoing debate as to whether this is the most valid approach. We also encourage efforts to enlarge the datasets used to estimate the risk of protracted exposures by including both human and animal data, carcinogenesis outcomes, a wider range of exposures, and by making more radiobiology data publicly accessible. We believe that these steps will contribute to better estimates of the risks of contemporary radiation exposures.	[Haley, Benjamin M.; Paunesku, Tatjana; Woloschak, Gayle E.] Northwestern Univ, Dept Radiat Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grdina, David J.] Univ Chicago, Radiat Dept, Chicago, IL 60637 USA; [Grdina, David J.] Univ Chicago, Dept Cellular Oncol, Chicago, IL 60637 USA; [Woloschak, Gayle E.] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Woloschak, Gayle E.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Woloschak, GE (corresponding author), Northwestern Univ, Dept Radiat Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.	g-woloschak@northwestern.edu	Paunesku, Tatjana/A-3488-2017; Paunesku, Tatjana/AAF-8529-2021; Woloschak, Gayle E/A-3799-2017	Paunesku, Tatjana/0000-0001-8698-2938; Paunesku, Tatjana/0000-0001-8698-2938; Woloschak, Gayle E/0000-0001-9209-8954	U.S. Department of Energy Office of Science, Low Dose Radiation Research Program [DE-SC0001271, DEFG02-07ER64342]; European Commission [028275 (FI6R)]	U.S. Department of Energy Office of Science, Low Dose Radiation Research Program(United States Department of Energy (DOE)); European Commission(European CommissionEuropean Commission Joint Research Centre)	Time to conduct the analysis in this paper and Janus Data was supported by Gayle E Woloschak, U.S. Department of Energy Office of Science, Low Dose Radiation Research Program, http://lowdose.energy.gov/, DE-SC0001271, DEFG02-07ER64342. Data was also obtained from the European Radiobiology Archive supported by European Commission, http://ec.europa.eu/index_en.htm, 028275 (FI6R).	[Anonymous], 2014, R LANG ENV STAT COMP; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Bates D., 2014, LINEAR MIXED EFFECTS; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; BREIMER LH, 1988, BRIT J CANCER, V57, P6, DOI 10.1038/bjc.1988.2; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; COX DR, 1972, J R STAT SOC B, V34, P187; Dahl DB, 2014, XTABLE EXPORT TABLES; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P293, DOI 10.2307/2288631; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448; Gerber G, 1996, INT RADIOBIOLOGY ARC; German Comission on Radiological Protection-SSK, 2006, COMM 2006 DRAFT ICRP; German Commission on Radiological Protection (SSK), 2014, DOS DOS RAT EFF FACT; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Goodman DM, 2013, JAMA-J AM MED ASSOC, V309, P647, DOI 10.1001/jama.2013.83; Haley B, 2011, HEALTH PHYS, V100, P613, DOI 10.1097/HP.0b013e3181febad3; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoel DG, 2015, HEALTH PHYS, V108, P351, DOI 10.1097/HP.0000000000000189; International Commission on Radiological Protection, 2005, ANN ICRP, V99; Jacob P, 2009, OCCUP ENVIRON MED, V66, P789, DOI 10.1136/oem.2008.043265; Land CE, 2009, HEALTH PHYS, V97, P407, DOI 10.1097/HP.0b013e3181b1871b; Little MP, 2008, RADIAT RES, V169, P660, DOI 10.1667/RR1091.1; Marples B, 2008, INT J RADIAT ONCOL, V70, P1310, DOI 10.1016/j.ijrobp.2007.11.071; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1; Mothersill C, 2013, RADIAT ENVIRON BIOPH, V52, P293, DOI 10.1007/s00411-013-0472-y; National Council on Radiation Protection and Measurements, 2009, 160 NAT COUNC RAD PR; National Council on Radiation Protection and Measurements, 1980, INFL DOS ITS DISTR T; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pierce DA, 1996, RADIAT RES, V146, P1, DOI 10.2307/3579391; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; R Core Team, 2014, PANDER R PANDOC WRIT; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Tapio S, 2008, INT J RADIAT BIOL, V84, P930, DOI 10.1080/09553000802460214; Therneau T, 2012, COXME MIXED EFFECTS; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Therneau TM., 2014, RADIOACTIVITY HLTH H, DOI DOI 10.2172/6608787; United Nations Scientific Committee on the Effects of Atomic Radiation, 2012, UNC RISK EST RAD IND; United Nations Scientific Committee on the Effects of Atomic Radiation, 2006, EFF ION RAD ANN A EP; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Viechtbauer W., 2010, J STAT SOFTW, P36; Wang QO, 2010, RADIAT ENVIRON BIOPH, V49, P317, DOI 10.1007/s00411-010-0270-8; Wickham H, 2014, DPLYR GRAMMAR DATA M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1	52	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0140989	10.1371/journal.pone.0140989	http://dx.doi.org/10.1371/journal.pone.0140989			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649569	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300003
J	Lee, JH; Kim, T; Lee, JJ; Lee, KJ; Kim, HK; Yun, B; Jeon, J; Kim, SK; Ma, JY				Lee, Ji-Hye; Kim, Taesoo; Lee, Jung-Jin; Lee, Kwang Jin; Kim, Hyun-Kyu; Yun, Bora; Jeon, Jongwook; Kim, Sang Kyum; Ma, Jin Yeul			The Herbal Medicine KBH-1 Inhibits Fat Accumulation in 3T3-L1 Adipocytes and Reduces High Fat Diet-Induced Obesity through Regulation of the AMPK Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PPAR-GAMMA; DIFFERENTIATION; EXPRESSION; ADIPOGENESIS; METABOLISM; RECEPTOR; ENERGY; LIPOLYSIS; EXTRACT	The aim of this study was to investigate whether a novel formulation of an herbal extract, KBH-1, has an inhibitory effect on obesity. To determine its anti-obesity effects and its underlying mechanism, we performed anti-obesity-related experiments in vitro and in vivo. 3T3-L1 preadipocytes were analyzed for lipid accumulation as well as the protein and gene expression of molecular targets involved in fatty acid synthesis. To determine whether KBH-1 oral administration results in a reduction in high-fat diet (HFD)-induced obesity, we examined five groups (n = 9) of C57BL/6 mice as follows: 10% kcal fat diet-fed mice (ND), 60% kcal fat diet-fed mice (HFD), HFD-fed mice treated with orlistat (tetrahydrolipstatin, marketed under the trade name Xenical), HFD-fed mice treated with 150 mg/kg KBH-1 (KBH-1 150) and HFD-fed mice treated with 300 mg/kg KBH-1 (KBH- 1 300). During adipogenesis of 3T3-L1 cells in vitro, KBH- 1 significantly reduced lipid accumulation and downregulated the expression of master adipogenic transcription factors, including CCAAT/ enhancer binding protein (C/EBP) beta, C/EBP a and peroxisome proliferation-activity receptor (PPAR)., which led to the suppression of the expression of several adipocyte-specific genes and proteins. KBH- 1 also markedly phosphorylated the adenosine monophosphate-activated protein kinase ( AMPK) and acetyl-CoA carboxylase (ACC). In addition, KBH-1-induced the inhibition effect on lipid accumulation and AMPK-mediated signal activation were decreased by blocking AMPK phosphorylation using AMPK siRNA. Furthermore, daily oral administration of KBH- 1 resulted in dose-dependent decreases in body weight, fat pad mass and fat tissue size without systemic toxicity. These results suggest that KBH- 1 inhibits lipid accumulation by down-regulating the major transcription factors of the adipogenesis pathway by regulating the AMPK pathway in 3T3-L1 adipocytes and in mice with HFD-induced obesity. These results implicate KBH-1, a safe herbal extract, as a potential anti-obesity therapeutic agent.	[Lee, Ji-Hye; Kim, Taesoo; Lee, Jung-Jin; Lee, Kwang Jin; Jeon, Jongwook; Ma, Jin Yeul] Korea Inst Oriental Med, KM Applicat Ctr, Daejeon 305811, South Korea; [Lee, Ji-Hye; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea; [Kim, Hyun-Kyu; Yun, Bora] Kolmar BNH, Nutraceut Food R&D Ctr, Sejong 339851, South Korea	Korea Institute of Oriental Medicine (KIOM); Chungnam National University	Kim, SK (corresponding author), Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea.	sangkim@cnu.ac.kr; jyma@kiom.re.kr		Kim, Sang Kyum/0000-0001-5769-0792	Korea Institute Oriental Medicine (KIOM) [K15280]; Innopolis Foundation [1711008676 (A2013DD103)]	Korea Institute Oriental Medicine (KIOM); Innopolis Foundation	This research was in part supported by the grant K15280 awarded to J.Y. Ma of Korea Institute Oriental Medicine (KIOM) and Innopolis Foundation (Project No. 1711008676 (A2013DD103)) awarded to H.K. Kim of Kolmar BNH from the Ministry of Science, ICT and Future Planning (MISP), Korea. Authors have an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arun N, 2002, PLANT FOOD HUM NUTR, V57, P41, DOI 10.1023/A:1013106527829; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Cho SY, 2007, AM J PHYSIOL-ENDOC M, V292, pE1166, DOI 10.1152/ajpendo.00436.2006; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Choi KM, 2013, J NUTR BIOCHEM, V24, P335, DOI 10.1016/j.jnutbio.2012.06.018; Chung BS, 1990, DICT KOREAN FOLK MED; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, BIOCHEM SOC T, V25, P1229, DOI 10.1042/bst0251229; He YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076495; Jeong Mi-Young, 2013, Evid Based Complement Alternat Med, V2013, P475386, DOI 10.1155/2013/475386; Jiang Y, 2005, J NAT PROD, V68, P875, DOI 10.1021/np050026+; Jou PC, 2010, J AGR FOOD CHEM, V58, P12703, DOI 10.1021/jf103121c; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karamadoukis L, 2009, CLIN NEPHROL, V71, P430; Kim A, 2014, ONCOL REP, V31, P287, DOI 10.3892/or.2013.2822; Kiyohara H, 2004, EVID-BASED COMPL ALT, V1, P83, DOI 10.1093/ecam/neh004; Kwak DH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/413906; Kwak DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049530; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Li CJ, 2008, PLANTA MED, V74, P133, DOI 10.1055/s-2008-1034296; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Pari Leelavinothan, 2008, Archives of Physiology and Biochemistry, V114, P127, DOI [10.1080/13813450802033958, 10.1080/13813450802033958 ]; Park JP, 2011, BIOTECHNOL BIOPROC E, V16, P1065, DOI 10.1007/s12257-011-0215-3; Ramadan G, 2011, INFLAMMATION, V34, P291, DOI 10.1007/s10753-010-9278-0; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sham TT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925302; Shim Ki-Shuk, 2012, Evid Based Complement Alternat Med, V2012, P325791, DOI 10.1155/2012/325791; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Thi KVL, 2012, BIOL PHARM BULL, V35, P1379, DOI 10.1248/bpb.b12-00426; Thompson GM, 2004, ANAL BIOCHEM, V330, P21, DOI 10.1016/j.ab.2004.03.061; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Xing YF, 2010, BIOCHEM BIOPH RES CO, V396, P691, DOI 10.1016/j.bbrc.2010.04.163; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yiu WF, 2011, J FOOD SCI, V76, pH80, DOI 10.1111/j.1750-3841.2011.02042.x; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011	45	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142041	10.1371/journal.pone.0142041	http://dx.doi.org/10.1371/journal.pone.0142041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649747	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300004
J	Parent, M; Boudier, A; Perrin, J; Vigneron, C; Maincent, P; Violle, N; Bisson, JF; Lartaud, I; Dupuis, F				Parent, Marianne; Boudier, Ariane; Perrin, Julien; Vigneron, Claude; Maincent, Philippe; Violle, Nicolas; Bisson, Jean-Francois; Lartaud, Isabelle; Dupuis, Francois			In Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke	PLOS ONE			English	Article							NITRIC-OXIDE; BLOOD-PRESSURE; ISCHEMIC-STROKE; RAT MODEL; NITROSOTHIOLS; IMPLANTS; WISTAR; VITRO; EFFICACY; DELIVERY	Treatment of stroke, especially during the first hours or days, is still lacking. S-nitrosoglutathione (GSNO), a cerebroprotective agent with short life time, may help if administered early with a sustain delivery while avoiding intensive reduction in blood pressure. We developed in situ forming implants (biocompatible biodegradable copolymer) and microparticles (same polymer and solvent emulsified with an external oily phase) of GSNO to lengthen its effects and allow cerebroprotection after a single subcutaneous administration to Wistar rats. Arterial pressure was recorded for 3 days (telemetry, n = 14), whole-blood platelet aggregation up to 13 days (aggregometry, n = 58), and neurological score, cerebral infarct size and edema volume for 2 days after obstruction of the middle cerebral artery by autologous blood clots (n = 30). GSNO-loaded formulations (30 mg/kg) induced a slighter and longer hypotension (-10 vs. -56 +/- 6 mmHg mean arterial pressure, 18 h vs. 40 min) than free GSNO at the same dose. The change in pulse pressure (-50%) lasted even up to 42 h for microparticles. GSNO-loaded formulations (30 mg/kg) prevented the transient 24 h hyperaggregability observed with free GSNO and 7.5 mg/kg-loaded formulations. When injected 2 h after stroke, GSNO-loaded microparticles (30 mg/kg) reduced neurological score at 24 (-62%) and 48 h (-75%) vs. empty microparticles and free GSNO 7.5 mg/kg and, compared to free GSNO, divided infarct size by 10 and edema volume by 8 at 48 h. Corresponding implants reduced infarct size and edema volume by 2.5 to 3 times. The longer (at least 2 days) but slight effects on arterial pressures show sustained delivery of GSNO-loaded formulations (30 mg/kg), which prevent transient platelet hyper-responsiveness and afford cerebroprotection against the consequences of stroke. In conclusion, in situ GSNO-loaded formulations are promising candidates for the treatment of stroke.	[Parent, Marianne; Boudier, Ariane; Vigneron, Claude; Maincent, Philippe; Lartaud, Isabelle; Dupuis, Francois] Univ Lorraine, CITHEFOR EA 3452, Fac Pharm, Nancy, France; [Perrin, Julien] Univ Lorraine, INSERM U1116, Fac Med, Vandoeuvre Les Nancy, France; [Violle, Nicolas; Bisson, Jean-Francois] ETAP Ethol Appl, Res Ctr Pharmacol Nutr & Toxicol, Vandoeuvre Les Nancy, France	Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Dupuis, F (corresponding author), Univ Lorraine, CITHEFOR EA 3452, Fac Pharm, Nancy, France.	Francois.Dupuis@univ-lorraine.fr		DUPUIS, Francois/0000-0003-1947-3839; Parent, Marianne/0000-0002-7447-9806; Lartaud, Isabelle/0000-0001-9257-6311	Agence Nationale de la Recherche [ANR NanoSNO project] [EA3452]; French Ministry of Research and Education (Paris, France)	Agence Nationale de la Recherche [ANR NanoSNO project](French National Research Agency (ANR)); French Ministry of Research and Education (Paris, France)	This work was supported by the Agence Nationale de la Recherche [ANR NanoSNO project 2010-2014, managed by P. LEROY, Universite de Lorraine, EA3452 CITHEFOR]; and the French Ministry of Research and Education (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no commercial affiliation between ETAP-Lab and the other laboratory implicated in this work. ETAP-Lab did not provide any financial support to the present project. ETAP-Lab provided salaries only for authors that are members of its staff: Nicolas Violle and Jean-Francois Bisson. ETAP-Lab realized the stroke study in its own facilities on the demand of EA3542. For this study, EA3542 provided GSNO, formulations and consumable materials (Animals, syringe,...). ETAP-Lab provided surgeons, experimenters and laboratory technician, as well as facilities and equipment. ETAP-Lab participated to the study design, data collection and analysis, decision to publish, and preparation of the manuscript relatives to the stroke study.	Ahmed TA, 2014, AAPS PHARMSCITECH, V15, P772, DOI 10.1208/s12249-014-0101-3; Al-Sa'doni H, 2000, CLIN SCI, V98, P507, DOI 10.1042/CS19990267; Ankolekar S, 2013, STROKE, V44, P3120, DOI 10.1161/STROKEAHA.113.001301; Bath PMW, 2015, LANCET, V385, P617, DOI 10.1016/S0140-6736(14)61121-1; Bath PMW, 2014, INT J STROKE, V9, P372, DOI 10.1111/ijs.12235; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bramanti E, 2010, TALANTA, V81, P1295, DOI 10.1016/j.talanta.2010.02.024; Defontis M, 2013, EXP TOXICOL PATHOL, V65, P637, DOI 10.1016/j.etp.2012.07.003; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gaucher C, 2013, CURR PHARM DESIGN, V19, P458, DOI 10.2174/138161213804143635; Geeganage C, 2011, STROKE, V42, P491, DOI 10.1161/STROKEAHA.110.596163; Giustarini D, 2007, J CHROMATOGR B, V851, P124, DOI 10.1016/j.jchromb.2006.09.031; Gordge MP, 2010, BRIT J PHARMACOL, V159, P1572, DOI 10.1111/j.1476-5381.2010.00670.x; He J, 2014, JAMA-J AM MED ASSOC, V311, P479, DOI 10.1001/jama.2013.282543; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kaposzta Z, 2002, CIRCULATION, V106, P3057, DOI 10.1161/01.CIR.0000041251.07332.28; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Kim CW, 2011, THROMB RES, V127, P565, DOI 10.1016/j.thromres.2011.02.004; Kozak W, 2008, J PHARMACOL EXP THER, V326, P773, DOI 10.1124/jpet.108.139618; Kranz H, 2008, EUR J PHARM SCI, V34, P164, DOI 10.1016/j.ejps.2008.03.004; Kranz H, 2001, INT J PHARM, V212, P11, DOI 10.1016/S0378-5173(00)00568-8; LARTAUD I, 1993, AM J PHYSIOL, V264, pH851, DOI 10.1152/ajpheart.1993.264.3.H851; Lee M, 2015, STROKE, V46, P1883, DOI 10.1161/STROKEAHA.115.009552; Li JZ, 2008, CHEM PHARM BULL, V56, P796, DOI 10.1248/cpb.56.796; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; Munzel T, 2011, CIRCULATION, V123, P2132, DOI 10.1161/CIRCULATIONAHA.110.981407; Nedelmann M, 2007, BRAIN RES, V1130, P188, DOI 10.1016/j.brainres.2006.10.087; Niederhoffer N, 1997, HYPERTENSION, V30, P1169, DOI 10.1161/01.HYP.30.5.1169; Niessen F, 2003, STROKE, V34, P2019, DOI 10.1161/01.STR.0000080941.73934.30; Parent M, 2013, EUR J PHARM BIOPHARM, V85, P640, DOI 10.1016/j.ejpb.2013.08.005; Parent M, 2013, J CONTROL RELEASE, V172, P292, DOI 10.1016/j.jconrel.2013.08.024; Parent M, 2013, CURR PHARM ANAL, V9, P31; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Rassaf T, 2002, CIRC RES, V91, P470, DOI 10.1161/01.RES.0000035038.41739.CB; Rassaf T, 2006, EUR HEART J, V27, P1699, DOI 10.1093/eurheartj/ehl096; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Sehba FA, 1999, STROKE, V30, P1955, DOI 10.1161/01.STR.30.9.1955; Shatoor AS, 2012, THROMB RES, V130, P75, DOI 10.1016/j.thromres.2012.01.001; Sogo N, 2000, BRIT J PHARMACOL, V131, P1236, DOI 10.1038/sj.bjp.0703700; Solorio L, 2010, J CONTROL RELEASE, V143, P183, DOI 10.1016/j.jconrel.2010.01.001; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tsikas D, 2001, BBA-PROTEIN STRUCT M, V1546, P422, DOI 10.1016/S0167-4838(01)00166-2; Yoo JW, 2009, BIOMATERIALS, V30, P3978, DOI 10.1016/j.biomaterials.2009.04.004; Zanini GM, 2012, J NEUROIMMUNE PHARM, V7, P477, DOI 10.1007/s11481-012-9343-6; Zhang GY, 2011, BLOOD, V118, P3670, DOI 10.1182/blood-2011-03-341107	48	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144659	10.1371/journal.pone.0144659	http://dx.doi.org/10.1371/journal.pone.0144659			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646285	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903100032
J	Takakura, K; Shibazaki, Y; Yoneyama, H; Fujii, M; Hashiguchi, T; Ito, Z; Kajihara, M; Misawa, T; Homma, S; Ohkusa, T; Koido, S				Takakura, Kazuki; Shibazaki, Yuichiro; Yoneyama, Hiroyuki; Fujii, Masato; Hashiguchi, Taishi; Ito, Zensho; Kajihara, Mikio; Misawa, Takeyuki; Homma, Sadamu; Ohkusa, Toshifumi; Koido, Shigeo			Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model	PLOS ONE			English	Article							CHONDROITIN-SULFATE-E; CARCINOMA; BINDING; GLYCOSAMINOGLYCANS; PROTEOGLYCAN; INVOLVEMENT; METASTASIS; MOTILITY; PATHWAY; BIOLOGY	Chondroitin sulfate E (CS-E), a highly sulfated glycosaminoglycan, is known to promote tumor invasion and metastasis. Because the presence of CS-E is detected in both tumor and stromal cells in pancreatic ductal adenocarcinoma (PDAC), multistage involvement of CS-E in the development of PDAC has been considered. However, its involvement in the early stage of PDAC progression is still not fully understood. In this study, to clarify the direct role of CS-E in tumor, but not stromal, cells of PDAC, we focused on carbohydrate sulfotransferase 15 (CHST15), a specific enzyme that biosynthesizes CS-E, and investigated the effects of the CHST15 siRNA on tumor cell proliferation in vitro and growth in vivo. CHST15 mRNA is highly expressed in the human pancreatic cancer cell lines PANC-1, MIA PaCa-2, Capan-1 and Capan-2. CHST15 siRNA significantly inhibited the expression of CHST15 mRNA in these four cells in vitro. Silencing of the CHST15 gene in the cells was associated with significant reduction of proliferation and up-regulation of the cell cycle inhibitor-related gene p21(CIP1/WAF1). In a subcutaneous xenograft tumor model of PANC-1 in nude mice, a single intratumoral injection of CHST15 siRNA almost completely suppressed tumor growth. Reduced CHST15 protein signals associated with tumor necrosis were observed with the treatment with CHST15 siRNA. These results provide evidence of the direct action of CHST15 on the proliferation of pancreatic tumor cells partly through the p21(CIP1/WAF1) pathway. Thus, CHST15-CS-E axis-mediated tumor cell proliferation could be a novel therapeutic target in the early stage of PDAC progression.	[Takakura, Kazuki; Ito, Zensho; Kajihara, Mikio; Ohkusa, Toshifumi; Koido, Shigeo] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Shibazaki, Yuichiro; Yoneyama, Hiroyuki; Fujii, Masato; Hashiguchi, Taishi] Stel Inst & Co Inc, Tokyo, Japan; [Misawa, Takeyuki] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan; [Homma, Sadamu] Jikei Univ, Sch Med, Dept Oncol, Inst DNA Med, Tokyo, Japan; [Koido, Shigeo] Jikei Univ, Sch Med, Inst Clin Med & Res, Kashiwa, Chiba, Japan	Jikei University; Jikei University; Jikei University; Jikei University	Takakura, K (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	ktakakura@jikei.ac.jp	大草, 敏史/HGD-2376-2022		Mitsui Life Social Welfare Foundation; medical office (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine); Stelic Institute Co., Inc.	Mitsui Life Social Welfare Foundation; medical office (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine); Stelic Institute Co., Inc.	This work was supported, in part, by the Mitsui Life Social Welfare Foundation, grant number N/A, SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Besides this, the necessary expenses were paid from the financial resources of our medical office (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine). Stelic Institute & Co., Inc. provided support in the form of salaries for authors (YS, HY, MF, TH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Brune K, 2008, CANCER EPIDEM BIOMAR, V17, P3536, DOI 10.1158/1055-9965.EPI-08-0630; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dhir V, 2014, EXPERT REV GASTROENT, V8, P775, DOI 10.1586/17474124.2014.917953; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fuccio Lorenzo, 2014, Curr Treat Options Gastroenterol, V12, P183, DOI 10.1007/s11938-014-0015-x; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Mizumoto S, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/56319, 10.1155/2013/656319]; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Nakai Yousuke, 2012, Gastrointest Endosc Clin N Am, V22, P315, DOI 10.1016/j.giec.2012.04.014; Ohta M, 2005, CANCER RES, V65, P10822, DOI 10.1158/0008-5472.CAN-05-0777; Shirley LA, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/207129; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Takakura K, 2014, ANTICANCER RES, V34, P4849; Tan EH, 2014, ONCOGENE, V33, P3325, DOI 10.1038/onc.2013.287; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Vallen MJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111806; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Wegrowski Y, 2004, CRIT REV ONCOL HEMAT, V49, P259, DOI 10.1016/j.critrevonc.2003.10.005; Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	29	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142981	10.1371/journal.pone.0142981	http://dx.doi.org/10.1371/journal.pone.0142981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642349	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700010
J	Mendoza-Olazaran, S; Morfin-Otero, R; Villarreal-Trevino, L; Rodriguez-Noriega, E; Llaca-Diaz, J; Camacho-Ortiz, A; Gonzalez, GM; Casillas-Vega, N; Garza-Gonzalez, E				Mendoza-Olazaran, Soraya; Morfin-Otero, Rayo; Villarreal-Trevino, Licet; Rodriguez-Noriega, Eduardo; Llaca-Diaz, Jorge; Camacho-Ortiz, Adrian; Gonzalez, Gloria M.; Casillas-Vega, Nestor; Garza-Gonzalez, Elvira			Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; FIELD GEL-ELECTROPHORESIS; 23S RIBOSOMAL-RNA; NOSOCOMIAL SPREAD; RESISTANCE; STRAINS; EPIDERMIDIS; AUREUS; IDENTIFICATION	Objectives We aimed to characterise the staphylococcal cassette chromosome mec (SCCmec) type, genetic relatedness, biofilm formation and composition, icaADBC genes detection, icaD expression, and antibiotic susceptibility of planktonic and biofilm cells of Staphylococcus hominis isolates from blood. Methods The study included 67 S. hominis blood isolates. Methicillin resistance was evaluated with the cefoxitin disk test. mecA gene and SCCmec were detected by multiplex PCR. Genetic relatedness was determined by pulsed-field gel electrophoresis. Biofilm formation and composition were evaluated by staining with crystal violet and by detachment assay, respectively; and the biofilm index (BI) was determined. Detection and expression of icaADBC genes were performed by multiplex PCR and real-time PCR, respectively. Antibiotic susceptibilities of planktonic cells (minimum inhibitory concentration, MIC) and biofilm cells (minimum biofilm eradication concentration, MBEC) were determined by the broth dilution method. Results Eighty-five percent (57/67) of isolates were methicillin resistant and mecA positive. Of the mecA-positive isolates, 66.7%(38/57) carried a new putative SCCmec type. Four clones were detected, with two to five isolates each. Among all isolates, 91% (61/67) were categorised as strong biofilm producers. Biofilm biomass composition was heterogeneous ( polysaccharides, proteins and DNA). All isolates presented the icaD gene, and 6.66%(1/15) isolates expressed icaD. This isolate presented the five genes of ica operon. Higher BI and MBEC values than the MIC values were observed for amikacin, vancomycin, linezolid, oxacillin, ciprofloxacin, and chloramphenicol. Conclusions S. hominis isolates were highly resistant to methicillin and other antimicrobials. Most of the detected SCCmec types were different than those described for S. aureus. Isolates indicated low clonality. The results indicate that S. hominis is a strong biofilm producer with an extracellular matrix with similar composition of proteins, DNA and N-acetylglucosamine; and presents high frequency and low expression of icaD gene. Biofilm production is associated with increased antibiotic resistance.	[Mendoza-Olazaran, Soraya; Casillas-Vega, Nestor; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo] Univ Guadalajara, Inst Patol Infecciosa & Expt, Ctr Univ Ciencias Salud, Guadalajara 44430, Jalisco, Mexico; [Villarreal-Trevino, Licet] Univ Autonoma Nuevo Leon, Dept Microbiol & Inmunol, Fac Ciencias Biol, Monterrey, Nuevo Leon, Mexico; [Llaca-Diaz, Jorge; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Dept Patol Clin, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Serv Infectol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Gonzalez, Gloria M.] Univ Autonoma Nuevo Leon, Fac Med, Dept Microbiol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad de Guadalajara; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Morfín-Otero, Rayo/AAR-8027-2021; Casillas-Vega, Nestor/A-8210-2019	Morfín-Otero, Rayo/0000-0001-9576-1950; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Villarreal, Licet/0000-0002-4721-6162; Mendoza-Olazaran, Soraya/0000-0001-5649-4810; Llaca Diaz, Jorge Martin/0000-0001-6875-2530; Casillas-Vega, Nestor/0000-0003-2242-9126	CONACyT (Mexican Council for Science and Technology) [CB-2011-01-167802]	CONACyT (Mexican Council for Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grant CB-2011-01-167802 from CONACyT (Mexican Council for Science and Technology).	Arciola CR, 2005, J BIOMED MATER RES A, V75A, P408, DOI 10.1002/jbm.a.30445; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X; Chamon RC, 2014, DIAGN MICR INFEC DIS, V80, P307, DOI 10.1016/j.diagmicrobio.2014.09.011; Chaves F, 2005, J CLIN MICROBIOL, V43, P4877, DOI 10.1128/JCM.43.9.4877-4879.2005; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CLSI, 2017, M100 CLSI, DOI DOI 10.1039/C4DT01694G; Cui BT, 2015, J MED MICROBIOL, V64, P591, DOI 10.1099/jmm.0.000059; Cunha BA, 2007, HEART LUNG, V36, P380, DOI 10.1016/j.hrtlng.2006.11.002; d'Azevedo PA, 2008, J MED MICROBIOL, V57, P256, DOI 10.1099/jmm.0.47345-0; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de Almeida LM, 2013, ANTIMICROB AGENTS CH, V57, P4082, DOI 10.1128/AAC.00437-13; DEIGHTON M, 1993, INFECT IMMUN, V61, P4473, DOI 10.1128/IAI.61.10.4473-4479.1993; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07; Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Garza-Gonzalez E, 2011, SCAND J INFECT DIS, V43, P930, DOI 10.3109/00365548.2011.598873; de Allori MCG, 2006, BIOL PHARM BULL, V29, P1592, DOI 10.1248/bpb.29.1592; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Klingenberg C, 2005, PEDIATR INFECT DIS J, V24, P817, DOI 10.1097/01.inf.0000176735.20008.cd; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; Mendoza-Olazaran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061161; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0; Qu Y, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-16; de Gopegui ER, 2011, ENFERM INFEC MICR CL, V29, P339, DOI 10.1016/j.eimc.2011.02.001; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; Sunbul M, 2006, PACE, V29, P543, DOI 10.1111/j.1540-8159.2006.00391.x; Sychev YV, 2014, EYE, V28, P1517, DOI 10.1038/eye.2014.201; Szczuka E, 2015, FOLIA MICROBIOL, V60, P1, DOI 10.1007/s12223-014-0332-4; Szczuka E, 2014, POL J MICROBIOL, V63, P349; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Palazzo ICV, 2008, J ANTIMICROB CHEMOTH, V62, P1222, DOI 10.1093/jac/dkn375; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wohoush A, 2011, CLIN MICROBIOL INFEC, V17, P569, DOI 10.1111/j.1469-0691.2010.03372.x; Won JY, 2013, CLIN OPHTHALMOL, V7, P1193, DOI 10.2147/OPTH.S46792; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]	44	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144684	10.1371/journal.pone.0144684	http://dx.doi.org/10.1371/journal.pone.0144684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659110	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900086
J	Pinar, IP; Arthur, JF; Andrews, RK; Gardiner, EE; Ryan, K; Carberry, J				Pinar, Isaac P.; Arthur, Jane F.; Andrews, Robert K.; Gardiner, Elizabeth E.; Ryan, Kris; Carberry, Josie			Methods to Determine the Lagrangian Shear Experienced by Platelets during Thrombus Growth	PLOS ONE			English	Article							AGGREGATION; MECHANISM; FLOW	Platelets can become activated in response to changes in flow-induced shear; however, the underlying molecular mechanisms are not clearly understood. Here we present new techniques for experimentally measuring the flow-induced shear rate experienced by platelets prior to adhering to a thrombus. We examined the dynamics of blood flow around experimentally grown thrombus geometries using a novel combination of experimental (ex vivo) and numerical (in silico) methodologies. Using a microcapillary system, platelet aggregate formation was analysed at elevated shear rates in the presence of coagulation inhibitors, where thrombus formation is predominantly platelet-dependent. These approaches permit the resolution and quantification of thrombus parameters at the scale of individual platelets (2 mu m) in order to quantify real time thrombus development. Using our new techniques we can correlate the shear rate experienced by platelets with the extent of platelet adhesion and aggregation. The techniques presented offer the unique capacity to determine the flow properties for a temporally evolving thrombus field in real time.	[Pinar, Isaac P.; Ryan, Kris; Carberry, Josie] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Pinar, Isaac P.; Carberry, Josie] Monash Univ, Fac Engn, Div Biol Engn, Melbourne, Vic 3004, Australia; [Arthur, Jane F.; Andrews, Robert K.; Gardiner, Elizabeth E.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Carberry, J (corresponding author), Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia.	Josie.Carberry@monash.edu	Gardiner, Elizabeth/P-8716-2019; ARTHUR, JANE/AAW-9983-2020	Gardiner, Elizabeth/0000-0001-9453-9688; Andrews, Robert Keith/0000-0001-9577-8082	National Health and Medical Research Council of Australia; National Heart Foundation of Australia; Victorian Life Sciences Computation Initiative (VLSCI) [VR0023]; Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE) [MONASH024]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Victorian Life Sciences Computation Initiative (VLSCI); Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE)	This research was supported by the National Health and Medical Research Council of Australia, the National Heart Foundation of Australia, the Victorian Life Sciences Computation Initiative (VLSCI) (grant VR0023 using the Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia) and by the Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE) (www.massive.org.au) (grant MONASH024).	Al-Tamimi M, 2012, BLOOD, V119, P4311, DOI 10.1182/blood-2011-10-386607; Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; Branchford BR, 2015, THROMB RES, V136, P13, DOI 10.1016/j.thromres.2015.05.012; Casa LDC, 2015, J VASC SURG, V61, P1068, DOI 10.1016/j.jvs.2014.12.050; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Colace TV, 2013, ANNU REV BIOMED ENG, V15, P283, DOI 10.1146/annurev-bioeng-071812-152406; Cosemans JMEM, 2013, CARDIOVASC RES, V99, P342, DOI 10.1093/cvr/cvt110; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082493; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; OPENCFD, 2014, OPENFOAM OP SOURC CF; Pitts KL, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/10/105302; Pitts KL, 2014, PLOS ONE, V9; Press WH, 2007, NUMERICAL RECIPES AR, V3, P907; Tolouei E, 2011, ANN BIOMED ENG, V39, P1403, DOI 10.1007/s10439-010-0239-4; Visualization Sciences Group (VSG), 2014, AV STAND 3D AN SOFTW; Westein E, 2013, P NATL ACAD SCI USA, V110, P1357, DOI 10.1073/pnas.1209905110; Yuan YP, 1997, J BIOL CHEM, V272, P21847, DOI 10.1074/jbc.272.35.21847	18	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144860	10.1371/journal.pone.0144860	http://dx.doi.org/10.1371/journal.pone.0144860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660525	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900122
J	Aboulnasr, F; Hazari, S; Nayak, S; Chandra, PK; Panigrahi, R; Ferraris, P; Chava, S; Kurt, R; Song, K; Dash, A; Balart, LA; Garry, RF; Wu, T; Dash, S				Aboulnasr, Fatma; Hazari, Sidhartha; Nayak, Satyam; Chandra, Partha K.; Panigrahi, Rajesh; Ferraris, Pauline; Chava, Srinivas; Kurt, Ramazan; Song, Kyongsub; Dash, Asha; Balart, Luis A.; Garry, Robert F.; Wu, Tong; Dash, Srikanta			IFN-lambda Inhibits MiR-122 Transcription through a Stat3-HNF4 alpha Inflammatory Feedback Loop in an IFN-alpha Resistant HCV Cell Culture System	PLOS ONE			English	Article							HEPATITIS-C VIRUS; JAK-STAT PATHWAY; GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; HEPATOCELLULAR-CARCINOMA; ANTIVIRAL ACTIVITY; INTERFERON-LAMBDA; VIRAL CLEARANCE; IL28B; INFECTION	Background HCV replication in persistently infected cell culture remains resistant to IFN-alpha/RBV combination treatment, whereas IFN-lambda 1 induces viral clearance. The antiviral mechanisms by which IFN-lambda 1 induces sustained HCV clearance have not been determined. Aim To investigate the mechanisms by which IFN-lambda clears HCV replication in an HCV cell culture model. Methods IFN-alpha sensitive (S3-GFP) and resistant (R4-GFP) cells were treated with equivalent concentrations of either IFN-alpha or IFN-lambda. The relative antiviral effects of IFN-alpha and IFN-lambda 1 were compared by measuring the HCV replication, quantification of HCV-GFP expression by flow cytometry, and viral RNA levels by real time RT-PCR. Activation of Jak-Stat signaling, interferon stimulated gene (ISG) expression, and miRNA-122 transcription in S3-GFP and R4GFP cells were examined. Results We have shown that IFN-lambda 1 induces HCV clearance in IFN-alpha resistant and sensitive replicon cell lines in a dose dependent manner through Jak-Stat signaling, and induces STAT 1 and STAT 2 activation, ISRE-luciferase promoter activation and ISG expression. Stat 3 activation is also involved in IFN-lambda 1 induced antiviral activity in HCV cell culture. IFN-lambda 1 induced Stat 3 phosphorylation reduces the expression of hepatocyte nuclear factor 4 alpha (HNF4 alpha) through miR-24 in R4-GFP cells. Reduced expression of HNF4 alpha is associated with decreased expression of miR-122 resulting in an anti-HCV effect. Northern blot analysis confirms that IFN-lambda 1 reduces miR-122 levels in R4-GFP cells. Our results indicate that IFN-lambda 1 activates the Stat 3-HNF4 alpha feedback inflammatory loop to inhibit miR-122 transcription in HCV cell culture. Conclusions In addition to the classical Jak-Stat antiviral signaling pathway, IFN-lambda 1 inhibits HCV replication through the suppression of miRNA-122 transcription via an inflammatory Stat 3-HNF4 alpha feedback loop. Inflammatory feedback circuits activated by IFNs during chronic inflammation expose non-responders to the risk of hepatocellular carcinoma.	[Aboulnasr, Fatma; Hazari, Sidhartha; Nayak, Satyam; Chandra, Partha K.; Panigrahi, Rajesh; Ferraris, Pauline; Chava, Srinivas; Song, Kyongsub; Dash, Asha; Wu, Tong; Dash, Srikanta] Tulane Univ, Sch Med, Pathol & Lab Med, New Orleans, LA 70112 USA; [Kurt, Ramazan; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, New Orleans, LA 70112 USA; [Garry, Robert F.] Tulane Univ, Sch Med, Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Dash, S (corresponding author), Tulane Univ, Sch Med, Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	sdash@tulane.edu	Ferraris, Pauline/F-9077-2017	Ferraris, Pauline/0000-0002-8796-3074; Panigrahi, Rajesh/0000-0002-6704-0029; Garry, Robert/0000-0002-5683-3250	National Institutes of Health [CA127481, CA089121, AI103106]; NATIONAL CANCER INSTITUTE [R01CA127481, R01CA089121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported but National Institutes of Health grants CA127481, CA089121, AI103106.	Asselah T, 2013, LIVER INT, V33, P93, DOI 10.1111/liv.12076; Chandra PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108616; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Datta S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-351; Dolganiuc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044915; Donnelly RP, 2011, TRENDS IMMUNOL, V32, P443, DOI 10.1016/j.it.2011.07.002; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hazari S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-36; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lee HC, 2014, J BIOL CHEM, V289, P5310, DOI 10.1074/jbc.M113.536102; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Matsuura K, 2014, J GASTROEN HEPATOL, V29, P241, DOI 10.1111/jgh.12475; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827; Morgan TR, 2011, CLIN GASTROENTEROL H, V9, P293, DOI 10.1016/j.cgh.2010.12.014; Panigrahi R, 2015, J VIROL, V89, P626, DOI 10.1128/JVI.02492-14; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Wang H, 2014, HEPATOLOGY, V60, P1466, DOI 10.1002/hep.27287; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0141655	10.1371/journal.pone.0141655	http://dx.doi.org/10.1371/journal.pone.0141655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657215	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600002
J	Peyro, M; Soheilypour, M; Ghavami, A; Mofrad, MRK				Peyro, Mohaddeseh; Soheilypour, Mohammad; Ghavami, Ali; Mofrad, Mohammad R. K.			Nucleoporin's Like Charge Regions Are Major Regulators of FG Coverage and Dynamics Inside the Nuclear Pore Complex	PLOS ONE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; MOLECULAR-DYNAMICS; TRANSLOCATION; PROTEINS; INSIGHTS; DISEASE; PERMEABILITY; ARCHITECTURE; SIMULATIONS; SNAPSHOTS	Nucleocytoplasmic transport has been the subject of a large body of research in the past few decades. Recently, the focus of investigations in this field has shifted from studies of the overall function of the nuclear pore complex (NPC) to the examination of the role of different domains of phenylalanine-glycine nucleoporin (FG Nup) sequences on the NPC function. In our recent bioinformatics study, we showed that FG Nups have some evolutionarily conserved sequence-based features that might govern their physical behavior inside the NPC. We proposed the 'like charge regions' (LCRs), sequences of charged residues with only one type of charge, as one of the features that play a significant role in the formation of FG network inside the central channel. In this study, we further explore the role of LCRs in the distribution of FG Nups, using a recently developed coarse-grained molecular dynamics model. Our results demonstrate how LCRs affect the formation of two transport pathways. While some FG Nups locate their FG network at the center of the NPC forming a homogeneous meshwork of FG repeats, other FG Nups cover the space adjacent to the NPC wall. LCRs in the former group, i.e. FG Nups that form an FG domain at the center, tend to regulate the size of the highly dense, doughnut-shaped FG meshwork and leave a small low FG density area at the center of the pore for passive diffusion. On the other hand, LCRs in the latter group of FG Nups enable them to maximize their interactions and cover a larger space inside the NPC to increase its capability to transport numerous cargos at the same time. Finally, a new viewpoint is proposed that reconciles different models for the nuclear pore selective barrier function.	[Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859; Ghavami, Ali/0000-0002-8523-1515				Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Ando D, 2014, BIOPHYS J, V106, P1997, DOI 10.1016/j.bpj.2014.03.021; Ando D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073831; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Cronshaw JM, 2004, TRENDS ENDOCRIN MET, V15, P34, DOI 10.1016/j.tem.2003.11.005; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Duarte-Rey C, 2012, AUTOIMMUN REV, V11, P898, DOI 10.1016/j.autrev.2012.03.005; Fiserova J, 2010, BIOCHEM SOC T, V38, P273, DOI 10.1042/BST0380273; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; Ghavami A, 2014, BIOPHYS J, V107, P1393, DOI [10.1016/j.bpj.2014.07.060, 10.1016/j.bpj.20014.07.060]; Ghavami A, 2013, J CHEM THEORY COMPUT, V9, P432, DOI 10.1021/ct300684j; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Kapon R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036001; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107; Mincer JS, 2011, P NATL ACAD SCI USA, V108, pE351, DOI 10.1073/pnas.1104521108; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Peyro M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15795; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Sheffield LG, 2006, J NEUROPATH EXP NEUR, V65, P45, DOI 10.1097/01.jnen.0000195939.40410.08; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wolf C, 2008, BIOPHYS J, V95, P2073, DOI 10.1529/biophysj.108.130336; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143745	10.1371/journal.pone.0143745	http://dx.doi.org/10.1371/journal.pone.0143745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658558	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600013
J	Bae, JS; Kim, SH; Shin, CI; Joo, I; Yoon, JH; Lee, HJ; Yang, HK; Baek, JH; Kim, TH; Han, JK; Choi, BI				Bae, Jae Seok; Kim, Se Hyung; Shin, Cheong-Il; Joo, Ijin; Yoon, Jeong Hee; Lee, Hyuk-Joon; Yang, Han-Kwang; Baek, Jee Hyun; Kim, Tae Han; Han, Joon Koo; Choi, Byung Ihn			Efficacy of Gastric Balloon Dilatation and/or Retrievable Stent Insertion for Pyloric Spasms after Pylorus-Preserving Gastrectomy: Retrospective Analysis	PLOS ONE			English	Article							CONVENTIONAL DISTAL GASTRECTOMY; BENIGN ESOPHAGEAL STRICTURES; POSTOPERATIVE EVALUATION; METAL STENT; CANCER; DILATION; PALLIATION; EXPERIENCE; PLACEMENT; CARCINOMA	Purpose We retrospectively investigated the feasibility and clinical efficacy of balloon dilatation and subsequent retrievable stent insertion, when necessitated, for pyloric spasms after pylorus-preserving gastrectomy (PPG). Materials and Methods Forty-five patients experiencing pyloric spasms after PPG underwent fluoroscopic balloon dilations to alleviate obstructive symptoms due to delayed gastric emptying. Patients showing poor response to balloon dilation underwent subsequent retrievable stent insertion. Safety of the procedures was analyzed, and subjective symptoms and objective signs of pyloric spasms were analyzed and compared before and after treatment. Results Thirty-three patients (73.3%, 33/45) showed good response to balloon dilatation requiring no further treatment (balloon group). Conversely, 12 patients (26.7%, 12/45) showed poor or no response after balloon dilation requiring subsequent stent insertion (stent group). Balloon dilations and/or stent insertions were safely performed in all patients except one patient who suffered a transmural tear after balloon dilatation. In both groups, mean subjective symptom score was significantly improved and mean pyloric canal-to-height of the adjacent vertebral body ratio was significantly increased after the procedures (P < .05). Conclusion Balloon dilation is a safe and effective treatment for patients with pyloric spasms after PPG. In patients refractory to balloon dilations, retrievable stent placement can be a safe alternative tool.	[Bae, Jae Seok; Kim, Se Hyung; Shin, Cheong-Il; Joo, Ijin; Yoon, Jeong Hee; Han, Joon Koo; Choi, Byung Ihn] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Shin, Cheong-Il; Han, Joon Koo; Choi, Byung Ihn] Seoul Natl Univ Hosp, Inst Radiat Med, Seoul 110744, South Korea; [Lee, Hyuk-Joon; Yang, Han-Kwang; Kim, Tae Han] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Baek, Jee Hyun] New Korea Hosp, Dept Radiol, Gimpo, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.	shkim7071@gmail.com	Bae, Jaeseok/T-9071-2019; Yoon, Jeong Hee/ABA-5127-2021	Bae, Jaeseok/0000-0003-2768-7917; Yoon, Jeong Hee/0000-0002-9925-9973	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A3005937]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study by J.S.B. et al. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A3005937) (http://www.nrf.re.kr/nrf_eng_cms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron TH, 2006, GASTROINTEST ENDOSC, V64, P263, DOI 10.1016/j.gie.2006.03.936; Cheng YS, 2003, WORLD J GASTROENTERO, V9, P2359; De Luca L, 2004, DIGEST LIVER DIS, V36, P806, DOI 10.1016/j.dld.2004.07.010; DENYS A, 1994, J VASC INTERV RADIOL, V5, P781, DOI 10.1016/S1051-0443(94)71602-X; Hagiwara A, 2001, GASTROINTEST ENDOSC, V53, P504, DOI 10.1067/mge.2001.113281; Hotta T, 2001, SURG TODAY, V31, P774, DOI 10.1007/s005950170046; Ikeguchi M, 2010, INDIAN J SURG, V72, P453, DOI 10.1007/s12262-010-0167-4; Ikeguchi M, 2010, SURG TODAY, V40, P228, DOI 10.1007/s00595-009-4043-4; Imada T, 1998, SURG TODAY, V28, P135, DOI 10.1007/s005950050094; Isozaki H, 1996, BRIT J SURG, V83, P266, DOI 10.1046/j.1365-2168.1996.02093.x; Jeong JY, 2004, SURGERY, V135, P171, DOI 10.1016/S0039-6060(03)00346-5; Jiang XH, 2011, ANN SURG, V253, P928, DOI 10.1097/SLA.0b013e3182117b24; Kim HH, 2014, J CLIN ONCOL, V32, P627, DOI 10.1200/JCO.2013.48.8551; Kim JH, 2008, KOREAN J RADIOL, V9, P364, DOI 10.3348/kjr.2008.9.4.364; Kim JH, 2008, J VASC INTERV RADIOL, V19, P565, DOI 10.1016/j.jvir.2007.11.015; Kim JH, 2010, KOREAN J RADIOL, V11, P497, DOI 10.3348/kjr.2010.11.5.497; Ko HK, 2007, J VASC INTERV RADIOL, V18, P725, DOI 10.1016/j.jvir.2007.02.030; KODAMA M, 1995, WORLD J SURG, V19, P456, DOI 10.1007/BF00299190; MAKI T, 1967, SURGERY, V61, P838; Morita S, 2008, BRIT J SURG, V95, P1131, DOI 10.1002/bjs.6295; Nagano Hideki, 2004, Gastric Cancer, V7, P54, DOI 10.1007/s10120-004-0269-4; Nunobe S, 2007, GASTRIC CANCER, V10, P167, DOI 10.1007/s10120-007-0434-7; Nunobe S, 2007, WORLD J SURG, V31, P2335, DOI 10.1007/s00268-007-9262-5; Park DJ, 2008, WORLD J SURG, V32, P1029, DOI 10.1007/s00268-007-9441-4; Repici A, 2004, GASTROINTEST ENDOSC, V60, P513, DOI 10.1016/S0016-5107(04)01882-6; Song H, 2000, RADIOLOGY, V217, P551; Suh YS, 2014, ANN SURG, V259, P485, DOI 10.1097/SLA.0b013e318294d142; Tanaka N, 2011, SURG ENDOSC, V25, P114, DOI 10.1007/s00464-010-1142-7; Tomita R, 2003, WORLD J SURG, V27, P725, DOI 10.1007/s00268-003-6906-y; Zhang J, 2013, J PEDIATR SURG, V48, P2235, DOI 10.1016/j.jpedsurg.2013.06.005; Zhu YQ, 2010, NEUROGASTROENT MOTIL, V22, P1240, DOI 10.1111/j.1365-2982.2010.01573.x	31	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144470	10.1371/journal.pone.0144470	http://dx.doi.org/10.1371/journal.pone.0144470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657405	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500029
J	Brauman, A; Majeed, MZ; Buatois, B; Robert, A; Pablo, AL; Miambi, E				Brauman, Alain; Majeed, Muhammad Zeeshan; Buatois, Bruno; Robert, Alain; Pablo, Anne-Laure; Miambi, Edouard			Nitrous Oxide (N2O) Emissions by Termites: Does the Feeding Guild Matter?	PLOS ONE			English	Article							HUMIC MODEL COMPOUNDS; FIXATION GENES; PHYLOGENETIC DIVERSITY; XYLOPHAGOUS TERMITES; GUT; MINERALIZATION; DENITRIFICATION; CUBITERMES; COMMUNITY; TRANSFORMATION	In the tropics, termites are major players in the mineralization of organic matter leading to the production of greenhouse gases including nitrous oxide (N2O). Termites have a wide trophic diversity and their N-metabolism depends on the feeding guild. This study assessed the extent to which N2O emission levels were determined by termite feeding guild and tested the hypothesis that termite species feeding on a diet rich in N emit higher levels of N2O than those feeding on a diet low in N. An in-vitro incubation approach was used to determine the levels of N2O production in 14 termite species belonging to different feeding guilds, collected from a wide range of biomes. Fungus-growing and soil-feeding termites emit N2O. The N2O production levels varied considerably, ranging from 13.14 to 117.62 ng N2O-N d(-1) (g dry wt.)(-1) for soil-feeding species, with Cubitermes spp. having the highest production levels, and from 39.61 to 65.61 ng N2O-N d(-1) (g dry wt.)(-1) for fungus-growing species. Wood-feeding termites were net N2O consumers rather than N2O producers with a consumption ranging from 16.09 to 45.22 ng N2O-N d(-1) (g dry wt.)(-1). Incubating live termites together with their mound increased the levels of N2O production by between 6 and 13 fold for soil-feeders, with the highest increase in Capritermes capricornis, and between 14 and 34 fold for fungus-growers, with the highest increase in Macrotermes muelleri. Ammoniaoxidizing (amoA-AOB and amoA-AOA) and denitrifying (nirK, nirS, nosZ) gene markers were detected in the guts of all termite species studied. No correlation was found between the abundance of these marker genes and the levels of N2O production from different feeding guilds. Overall, these results support the hypothesis that N2O production rates were higher in termites feeding on substrates with higher N content, such as soil and fungi, compared to those feeding on N-poor wood.	[Brauman, Alain; Majeed, Muhammad Zeeshan; Pablo, Anne-Laure] IRD, UMR ECO&SOLS, Campus Supagro, Montpellier, France; [Brauman, Alain] IRD, UMR Eco&Sols, LMI LUSES, Land Dev Dept, Bangkok, Thailand; [Buatois, Bruno] CNRS, UMR CEFE 5175, Montpellier, France; [Robert, Alain] IRD, iEES, Bondy, France; [Miambi, Edouard] Univ Paris Est Creteil, iEES, Creteil, France	Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Majeed, MZ (corresponding author), Univ Sargodha, Univ Coll Agr, Dept Entomol, Sargodha, Punjab, Pakistan.	zeeshan.majeed@uos.edu.pk	Majeed, Muhammad Z/A-9791-2019; brauman, alain/X-8747-2019; brauman, alain/C-8400-2009	Majeed, Muhammad Z/0000-0002-3786-8589; brauman, alain/0000-0002-4865-2919	project BAMBI (ANR-Metagenome; France)	project BAMBI (ANR-Metagenome; France)(French National Research Agency (ANR))	This study was funded by the project BAMBI (ANR-Metagenome; France).	Attard E, 2011, GLOBAL CHANGE BIOL, V17, P1975, DOI 10.1111/j.1365-2486.2010.02340.x; Bignell DE, 2006, SOIL BIOL, P183; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Brummer C, 2009, GEOPHYS RES LETT, P36; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Chapuis-Lardy L, 2010, APPL SOIL ECOL, V45, P201, DOI 10.1016/j.apsoil.2010.04.006; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Desai MS, 2012, ISME J, V6, P1302, DOI 10.1038/ismej.2011.194; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; IPCC, 2007, IPPC 4 ASS REP CLIM; Ji R, 2000, SOIL BIOL BIOCHEM, V32, P1281, DOI 10.1016/S0038-0717(00)00046-8; Ji R, 2001, BIOL FERT SOILS, V33, P166, DOI 10.1007/s003740000310; Ji R, 2006, BIOGEOCHEMISTRY, V78, P267, DOI 10.1007/s10533-005-4279-z; Jouquet P, 2011, EUR J SOIL BIOL, V47, P215, DOI 10.1016/j.ejsobi.2011.05.005; Kappler A, 2000, SOIL BIOL BIOCHEM, V32, P1271, DOI 10.1016/S0038-0717(00)00047-X; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Levy-Booth DJ, 2014, SOIL BIOL BIOCHEM, V75, P11, DOI 10.1016/j.soilbio.2014.03.021; Majeed MZ, 2013, PEDOBIOLOGIA, V56, P49, DOI 10.1016/j.pedobi.2012.10.003; Majeed MZ, 2012, EUR J SOIL BIOL, V53, P121, DOI 10.1016/j.ejsobi.2012.10.002; Morales SE, 2010, ISME J, V4, P799, DOI 10.1038/ismej.2010.8; Ndiaye D, 2004, PLANT SOIL, V259, P277, DOI 10.1023/B:PLSO.0000020980.50095.e1; Ngugi DK, 2012, ENVIRON MICROBIOL, V14, P860, DOI 10.1111/j.1462-2920.2011.02648.x; Ngugi DK, 2011, BIOGEOCHEMISTRY, V103, P355, DOI 10.1007/s10533-010-9478-6; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P2747, DOI 10.1128/AEM.62.8.2747-2752.1996; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rouland-Lefevre C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P289; Sanderson MG, 1996, GLOBAL BIOGEOCHEM CY, V10, P543, DOI 10.1029/96GB01893; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Wood T.G., 1978, International Biological Programme, P245; Wuebbles DJ, 2009, SCIENCE, V326, P56, DOI 10.1126/science.1179571; Yamada A, 2007, MOL ECOL, V16, P3768, DOI 10.1111/j.1365-294X.2007.03326.x	34	17	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144340	10.1371/journal.pone.0144340	http://dx.doi.org/10.1371/journal.pone.0144340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658648	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500021
J	Krishnan, S; Collett, M; Robinson, PJ				Krishnan, Sai; Collett, Michael; Robinson, Phillip J.			SH3 Domains Differentially Stimulate Distinct Dynamin I Assembly Modes and G Domain Activity	PLOS ONE			English	Article							GTPASE ACTIVITY; PHOSPHORYLATION; ACTIVATION; OLIGOMERIZATION; REQUIREMENT; MECHANISM; PROTEINS; BINDING	Dynamin I is a highly regulated GTPase enzyme enriched in nerve terminals which mediates vesicle fission during synaptic vesicle endocytosis. One regulatory mechanism involves its interactions with proteins containing Src homology 3 (SH3) domains. At least 30 SH3 domain-containing proteins bind dynamin at its proline-rich domain (PRD). Those that stimulate dynamin activity act by promoting its oligomerisation. We undertook a systematic parallel screening of 13 glutathione-S-transferase (GST)-tagged endocytosis-related SH3 domains on dynamin binding, GTPase activity and oligomerisation. No correlation was found between dynamin binding and their potency to stimulate GTPase activity. There was limited correlation between the extent of their ability to stimulate dynamin activity and the level of oligomerisation, indicating an as yet uncharacterised allosteric coupling of the PRD and G domain. We examined the two variants, dynamin Iab and Ibb, which differ in the alternately splice middle domain alpha 2 helix. They responded differently to the panel of SH3s, with the extent of stimulation between the splice variants varying greatly between the SH3s. This study reveals that SH3 binding can act as a heterotropic allosteric regulator of the G domain via the middle domain alpha 2 helix, suggesting an involvement of this helix in communicating the PRD-mediated allostery. This indicates that SH3 binding both stabilises multiple conformations of the tetrameric building block of dynamin, and promotes assembly of dynamin-SH3 complexes with distinct rates of GTP hydrolysis.	[Krishnan, Sai; Collett, Michael; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney	Robinson, PJ (corresponding author), Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia.	probinson@cmri.org.au	Robinson, Phillip J/G-4008-2011	Robinson, Phillip J/0000-0002-7878-0313	National Health & Medical Research Council Australia [GNT1069493, GNT1052494, GNT1047070]; Children's Medical Research Institute (CMRI); CMRI	National Health & Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Children's Medical Research Institute (CMRI); CMRI	The authors are grateful for financial support from the National Health & Medical Research Council Australia (GNT1069493, GNT1052494, and GNT1047070) and the Children's Medical Research Institute (CMRI), and for equipment from the Australian Cancer Research Foundation, the Ramaciotti Foundation and the Cancer Institute NSW. SK and MC gratefully acknowledge scholarship support from CMRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for financial support from the National Health & Medical Research Council Australia (GNT1047070 and GNT1069493) and the Children's Medical Research Institute (CMRI), and for equipment from the Australian Cancer Research Foundation, the Ramaciotti Foundation and the Cancer Institute NSW. SK and MC gratefully acknowledge scholarship support from CMRI. This research has been facilitated by access to Australian Proteome Analysis Facility and to the CSIRO Recombinant Protein Production Facility, which are funded by an initiative of the Australian Government as part of the National Collaborative Research Infrastructure Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Brymora A, 2001, ANAL BIOCHEM, V295, P119, DOI 10.1006/abio.2001.5215; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chan LS, 2010, J PROTEOME RES, V9, P4028, DOI 10.1021/pr100223n; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; Daniel JA, 2015, TRAFFIC, V16, P635, DOI 10.1111/tra.12272; Faelber K, 2013, PROG MOL BIOL TRANSL, V117, P411, DOI 10.1016/B978-0-12-386931-9.00015-5; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Kay BK, 2012, FEBS LETT, V586, P2606, DOI 10.1016/j.febslet.2012.05.025; Knezevic I, 2011, J CELL MOL MED, V15, P2364, DOI 10.1111/j.1582-4934.2010.01226.x; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Liu GY, 2013, NEUROMOL MED, V15, P384, DOI 10.1007/s12017-013-8225-2; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Mattila JP, 2015, NATURE; McPherson PS, 1999, CELL SIGNAL, V11, P229, DOI 10.1016/S0898-6568(98)00059-X; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; Pawlowski N, 2010, BIOESSAYS, V32, P1033, DOI 10.1002/bies.201000086; POWELL KA, 1995, NEUROSCIENCE, V64, P821, DOI 10.1016/0306-4522(94)00337-5; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; ROBINSON PJ, 1983, J NEUROCHEM, V41, P909, DOI 10.1111/j.1471-4159.1983.tb09034.x; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Ross JA, 2011, BIOPHYS J, V100, P729, DOI 10.1016/j.bpj.2010.12.3717; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TUMA PL, 1994, J BIOL CHEM, V269, P30842; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144609	10.1371/journal.pone.0144609	http://dx.doi.org/10.1371/journal.pone.0144609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659814	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500048
J	Matsumoto, K				Matsumoto, Ken'ichi			Energy Structure and Energy Security under Climate Mitigation Scenarios in China	PLOS ONE			English	Article							CARBON; STABILIZATION; REDUCTION; SOCIETY; PATHWAY	This study investigates how energy structure and energy security in China will change in the future under climate mitigation policy scenarios using Representative Concentration Pathways in a computable general equilibrium model. The findings suggest that to reduce greenhouse gas emissions, China needs to shift its energy structure from fossil fuel dominance to renewables and nuclear. The lower the allowable emissions, the larger the shifts required. Among fossil fuels, coal use particularly must significantly decrease. Such structural shifts will improve energy self-sufficiency, thus enhancing energy security. Under the policy scenarios, energy-source diversity as measured by the Herfindahl Index improves until 2050, after which diversity declines because of high dependence on a specific energy source (nuclear and biomass). Overall, however, it is revealed that energy security improves along with progress in climate mitigation. These improvements will also contribute to the economy by reducing energy procurement risks.	[Matsumoto, Ken'ichi] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan	University Shiga Prefecture	Matsumoto, K (corresponding author), Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan.	matsumoto.k@ses.usp.ac.jp		Matsumoto, Ken'ichi/0000-0002-9349-9765	Japan Society for the Promotion of Science (KAKENHI) [24710046, 25241030, 15K00669, 15K16161]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Risk Information on Climate Change (Theme B); Grants-in-Aid for Scientific Research [25241030] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Risk Information on Climate Change (Theme B); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (KAKENHI 24710046, 25241030, 15K00669 and 15K16161; http://www.jsps.go.jp/english/index.html) to KM, Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Risk Information on Climate Change (Theme B); http://www.mext.go.jp/english/ to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A?el J.A., 2015, CONTEMP PHYS, V56, P2, DOI [10.1080/00107514.2015.1006251, DOI 10.1080/00107514.2015.1006251]; Ahn Hwi-joon, 2000, HANGUK HOEHWASA YONG; Ang BW, 2015, RENEW SUST ENERG REV, V42, P1077, DOI 10.1016/j.rser.2014.10.064; ARMINGTON PS, 1969, INT MONET FUND S PAP, V16, P159; Audient P., 2014, WEATHER MATTERS ENER, P17; British Petroleum (BP), 2014, STAT REV WORLD EN JU; Coppin P, 2014, WEATHER MATTERS ENER, P399; Dai HC, 2011, ENERG POLICY, V39, P2875, DOI 10.1016/j.enpol.2011.02.062; Dimaranan B.V., 2006, GLOBAL TRADE ASSISTA; European Commission Joint Research Centre Netherlands Environmental Assessment Agency, 2010, EM DAT GLOB ATM RES; Federation of Electric Power Companies of Japan, 2004, HARM NUCL EN DER; Frondel M., 2008, RUHR EC PAPER, P52, DOI [https://dx.doi.org/10.2139/ssrn.1161141, DOI 10.2139/SSRN.1161141]; Gunasekera D., 2014, WEATHER MATTERS ENER, P497; Hubler M, 2014, ENERG POLICY, V75, P57, DOI 10.1016/j.enpol.2014.02.019; Hubler M, 2012, ENERG POLICY, V50, P315, DOI 10.1016/j.enpol.2012.07.025; Hubler M, 2011, ENERG ECON, V33, P131, DOI 10.1016/j.eneco.2010.09.002; International Energy Agency, 2012, EN BAL OECD COUNTR 2; International Energy Agency, 2012, EN BAL NONOECD COUNT; International Energy Agency, 2008, WORLD EN OUTL 2008; International Energy Agency, 2013, WORLD EN OUTL 2013; IPCC, P AR6 SCOP M ADD AB; Lehl U, 2009, MORE BASKETS RENEWAB; Masui T., 2010, ANAL 4 5 W M2 STABIL; Masui T, 2011, CLIMATIC CHANGE, V109, P59, DOI 10.1007/s10584-011-0150-5; Matsumoto K, 2009, ENV SCI, V22, P391; Matsumoto K, 2014, USAEE IAEE WORKING P, P14; Matsumoto K., 2013, GLOBAL ENERGY POLICY, P45; Matsumoto K, 2011, MANAG ENVIRON QUAL, V22, P33, DOI 10.1108/14777831111098462; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nautilus Institute, 2013, AS EN SEC; Neff T.L., 1997, PAC AS REG EN SEC PA; Okagawa A, 2012, ENERG ECON, V34, pS391, DOI 10.1016/j.eneco.2012.07.011; Paltsev S, 2005, 125 MIT; Paltsev S, 2012, ENERG ECON, V34, pS444, DOI 10.1016/j.eneco.2012.04.007; Peace J, 2008, INSIGHTS NOT NUMBERS; Renne D.S., 2014, WEATHER MATTERS ENER, P257; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rogner HH, 1997, ANNU REV ENERG ENV, V22, P217, DOI 10.1146/annurev.energy.22.1.217; Ronalds B.F., 2014, WEATHER MATTERS ENER, P3; Saveyn B, 2012, ENERG ECON, V34, pS451, DOI 10.1016/j.eneco.2012.04.010; Saveyn B, 2011, ENERG ECON, V33, pS34, DOI 10.1016/j.eneco.2011.07.024; Shukla PR, 2008, CLIM POLICY, V8, pS156, DOI 10.3763/cpol.2007.0498; Sims R.E, 2014, WEATHER MATTERS ENER, P91; Stanislaw JA., 2007, CLIMATE CHANGE ENERG; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; U. S. Department of Justice and Federal Trade Commision, 2010, HORIZONTAL MERGER GU; *UN DEP EC SOC AFF, 2004, WORLD POP 2300; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; United Nations Environment Programme, 2007, GLOB ENV OUTL; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; van Vuuren DP, 2014, CLIMATIC CHANGE, V122, P373, DOI 10.1007/s10584-013-0906-1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; von Hippel D, 2011, ENERG POLICY, V39, P6719, DOI 10.1016/j.enpol.2009.07.001; von Hippel D, 2011, ENERG POLICY, V39, P6712, DOI 10.1016/j.enpol.2008.01.010; Wang K, 2009, ENERG POLICY, V37, P2930, DOI 10.1016/j.enpol.2009.03.023; Wang YJ, 2011, ENERG POLICY, V39, P6745, DOI 10.1016/j.enpol.2010.07.002; Zhang ZX, 1998, J POLICY MODEL, V20, P213, DOI 10.1016/S0161-8938(97)00005-7; Zillman J.W., 2014, WEATHER MATTERS ENER, P201, DOI DOI 10.1007/978-1-4614-9221-4_9	59	11	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144884	10.1371/journal.pone.0144884	http://dx.doi.org/10.1371/journal.pone.0144884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26660094	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500064
J	Kvistad, L; Ingwersen, D; Pavlova, A; Bull, JK; Sunnucks, P				Kvistad, Lynna; Ingwersen, Dean; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul			Very Low Population Structure in a Highly Mobile and Wide-Ranging Endangered Bird Species	PLOS ONE			English	Article							HONEYEATER XANTHOMYZA-PHRYGIA; MICROSATELLITE NULL ALLELES; REGENT-HONEYEATER; COMPUTER-PROGRAM; CLIMATE-CHANGE; FRAGMENTED LANDSCAPES; HABITAT FRAGMENTATION; ANTHOCHAERA-PHRYGIA; TELL US; CONSERVATION	The loss of biodiversity following fragmentation and degradation of habitat is a major issue in conservation biology. As competition for resources increases following habitat loss and fragmentation, severe population declines may occur even in common, highly mobile species; such demographic decline may cause changes within the population structure of the species. The regent honeyeater, Anthochaera phrygia, is a highly nomadic woodland bird once common in its native southeast Australia. It has experienced a sharp decline in abundance since the late 1970s, following clearing of large areas of its preferred habitat, boxironbark woodland, within the last 200 years. A captive breeding program has been established as part of efforts to restore this species. This study used genetic data to examine the range-wide population structure of regent honeyeaters, including spatial structure, its change through time, sex differences in philopatry and mobility, and genetic differences between the captive and wild populations. There was low genetic differentiation between birds captured in different geographic areas. Despite the recent demographic decline, low spatial structure appears to have some temporal consistency. Both sexes appear to be highly mobile, and there does not seem to be significant genetic differentiation between the captive and wild populations. We conclude that management efforts for survival of this species, including habitat protection, restoration, and release of captive-bred birds into the wild, can treat the species as effectively a single genetic population.	[Kvistad, Lynna; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia; [Ingwersen, Dean] BirdLife Australia, Melbourne, Vic, Australia	Monash University	Kvistad, L (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.	lynna.kvistad@monash.edu	Pavlova, Alexandra/H-4749-2014	Pavlova, Alexandra/0000-0001-9455-4124; Bull, James/0000-0002-0274-4359; Sunnucks, Paul/0000-0002-8139-7059	BirdLife Australia's Woodland Birds program; Australian Research Council Linkage Grant [LP0776322]; Victorian Department of Environment and Primary Industries; Museum of Victoria; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority	BirdLife Australia's Woodland Birds program; Australian Research Council Linkage Grant(Australian Research Council); Victorian Department of Environment and Primary Industries; Museum of Victoria; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority	Funding was provided by BirdLife Australia's (http://birdlife.org.au) Woodland Birds program and the Australian Research Council (http://www.arc.gov.au) Linkage Grant (LP0776322), with contributing partner organizations Victorian Department of Environment and Primary Industries (http://www.dse.vic.gov.au), Museum of Victoria (http://museumvictoria.com.au), Parks Victoria (http://parkweb.vic.gov.au), North Central Catchment Management Authority (http://www.nccma.vic.gov.au), and Goulburn Broken Catchment Management Authority (http://www.gbcma.vic.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos JN, 2014, ECOLOGY, V95, P1556, DOI 10.1890/13-1328.1; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Barr KR, 2008, MOL ECOL, V17, P3628, DOI 10.1111/j.1365-294X.2008.03868.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cooke B, 2000, AUST J ZOOL, V48, P379, DOI 10.1071/ZO00005; Cooper CB, 2002, CONSERV BIOL, V16, P471, DOI 10.1046/j.1523-1739.2002.00346.x; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2010, CONSERV BIOL, V24, P1080, DOI 10.1111/j.1523-1739.2009.01438.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; DINERSTEIN E, 1990, CONSERV BIOL, V4, P417, DOI 10.1111/j.1523-1739.1990.tb00316.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; FORD H, 1993, EMU, V93, P277, DOI 10.1071/MU9930277; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Ford Hugh A., 2011, Pacific Conservation Biology, V17, P303; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; FRANKLIN DC, 1989, EMU, V89, P140, DOI 10.1071/MU9890140; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Geering D, 1998, EMU, V98, P104, DOI 10.1071/MU98011; Geering D, 2008, REGENTS ROAM NEWSLET; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Harrisson KA, 2014, EVOL APPL, V7, P1008, DOI 10.1111/eva.12149; Harrisson KA, 2014, J ANIM ECOL, V83, P616, DOI 10.1111/1365-2656.12172; Harrisson KA, 2013, J ANIM ECOL, V82, P322, DOI 10.1111/1365-2656.12007; Harrisson KA, 2012, LANDSCAPE ECOL, V27, P813, DOI 10.1007/s10980-012-9743-2; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hull JM, 2005, MOL ECOL, V14, P159, DOI 10.1111/j.1365-294X.2004.02366.x; Ingwersen Dean, 2014, Australian Birdlife, V3, P20; JORDE PE, 1995, GENETICS, V139, P1077; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; NEI M, 1981, GENETICS, V98, P625; Oliver D. L., 2010, Pacific Conservation Biology, V16, P27; Oliver DL, 1998, AUST J ZOOL, V46, P153, DOI 10.1071/ZO97028; Oliver DL, 1998, WILDLIFE RES, V25, P409, DOI 10.1071/WR97078; Oliver DL, 2000, EMU, V100, P12, DOI 10.1071/MU9837; Oliver DL, 1998, EMU, V98, P97, DOI 10.1071/MU98010; Oliver DL, 2001, AUSTR J ZOOLOGY, V49, P659; Oliver DL, 2001, PACIFIC CONSERVATION, V5, P224; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roderick M, 2013, SWIFT PARROTS REGENT; Roderick Michael, 2014, Australian Field Ornithology, V31, P113; de Cara MAR, 2013, MOL ECOL, V22, P6091, DOI 10.1111/mec.12560; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seabloom EW, 2002, P NATL ACAD SCI USA, V99, P11229, DOI 10.1073/pnas.162064899; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Sonsthagen S, 2015, CONSERV GENET, V16, P223, DOI 10.1007/s10592-014-0654-4; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALKER J, 1993, J APPL ECOL, V30, P265, DOI 10.2307/2404628; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300	80	16	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143746	10.1371/journal.pone.0143746	http://dx.doi.org/10.1371/journal.pone.0143746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649426	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903300026
J	Ohashi, A; Ohori, M; Iwai, K; Nambu, T; Miyamoto, M; Kawamoto, T; Okaniwa, M				Ohashi, Akihiro; Ohori, Momoko; Iwai, Kenichi; Nambu, Tadahiro; Miyamoto, Maki; Kawamoto, Tomohiro; Okaniwa, Masanori			A Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor Activity	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; SPINDLE-ASSEMBLY CHECKPOINT; MITOTIC KINESIN KSP; PROTEIN-E; PHASE-II; KINETOCHORE MOTOR; DNA-DAMAGE; CANCER; ISPINESIB; CELLS	Centromere-associated protein E (CENP-E) regulates both chromosome congression and the spindle assembly checkpoint (SAC) during mitosis. The loss of CENP-E function causes chromosome misalignment, leading to SAC activation and apoptosis during prolonged mitotic arrest. Here, we describe the biological and antiproliferative activities of a novel small-molecule inhibitor of CENP-E, Compound-A (Cmpd-A). Cmpd-A inhibits the ATPase activity of the CENP-E motor domain, acting as a time-dependent inhibitor with an ATP-competitive-like behavior. Cmpd-A causes chromosome misalignment on the metaphase plate, leading to prolonged mitotic arrest. Treatment with Cmpd-A induces antiproliferation in multiple cancer cell lines. Furthermore, Cmpd-A exhibits antitumor activity in a nude mouse xenograft model, and this antitumor activity is accompanied by the elevation of phosphohistone H3 levels in tumors. These findings demonstrate the potency of the CENP-E inhibitor Cmpd-A and its potential as an anticancer therapeutic agent.	[Ohashi, Akihiro; Ohori, Momoko; Iwai, Kenichi; Nambu, Tadahiro; Okaniwa, Masanori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Miyamoto, Maki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, DMPK Res Labs, Fujisawa, Kanagawa, Japan; [Kawamoto, Tomohiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Ohashi, A (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	akihiro.ohashi@takeda.com		Okaniwa, Masanori/0000-0002-6982-9947	Takeda Pharmaceutical Company, Ltd.	Takeda Pharmaceutical Company, Ltd.(Takeda Pharmaceutical Company Ltd)	This research was supported by Takeda Pharmaceutical Company, Ltd. The funder provided support in the form of salaries for authors (AO, MOh, KI, TN, MM, TK, MOk), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balamuth NJ, 2010, CANCER RES, V70, P2749, DOI 10.1158/0008-5472.CAN-09-3844; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Carter BZ, 2009, LEUKEMIA, V23, P1755, DOI 10.1038/leu.2009.101; Chung V, 2012, CANCER CHEMOTH PHARM, V69, P733, DOI 10.1007/s00280-011-1756-z; Hirayama T, 2015, J MED CHEM, V58, P8036, DOI 10.1021/acs.jmedchem.5b00836; Hirayama T, 2013, BIOORGAN MED CHEM, V21, P5488, DOI 10.1016/j.bmc.2013.05.067; Holen K, 2012, INVEST NEW DRUG, V30, P1088, DOI 10.1007/s10637-011-9653-1; Holen KD, 2011, CANCER CHEMOTH PHARM, V67, P447, DOI 10.1007/s00280-010-1346-5; Hollebecque A, 2013, INVEST NEW DRUG, V31, P1530, DOI 10.1007/s10637-013-0026-9; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kantarjian HM, 2012, INVEST NEW DRUG, V30, P1107, DOI 10.1007/s10637-011-9660-2; Knox JJ, 2008, INVEST NEW DRUG, V26, P265, DOI 10.1007/s10637-007-9103-2; Kung PP, 2014, MOL CANCER THER, V13, P2104, DOI 10.1158/1535-7163.MCT-14-0083-T; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lee CW, 2008, INVEST NEW DRUG, V26, P249, DOI 10.1007/s10637-007-9097-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lock RB, 2012, PEDIATR BLOOD CANCER, V58, P916, DOI 10.1002/pbc.23176; LoRusso PM, 2015, INVEST NEW DRUG, V33, P440, DOI 10.1007/s10637-015-0211-0; Luo L, 2007, NAT CHEM BIOL, V3, P722, DOI 10.1038/nchembio.2007.34; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Ohashi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8668; Qian XP, 2010, ACS MED CHEM LETT, V1, P30, DOI 10.1021/ml900018m; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Tang PA, 2008, INVEST NEW DRUG, V26, P257, DOI 10.1007/s10637-007-9098-8; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Tomillero A, 2010, Methods Find Exp Clin Pharmacol, V32, P517, DOI 10.1358/mf.2010.32.7.1549223; Wakui H, 2014, CANCER CHEMOTH PHARM, V74, P15, DOI 10.1007/s00280-014-2467-z; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	39	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144675	10.1371/journal.pone.0144675	http://dx.doi.org/10.1371/journal.pone.0144675			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649895	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300065
J	Woo, J; Bae, SH; Kim, B; Park, JS; Jung, S; Lee, M; Kim, YH; Choi, D				Woo, Jongsu; Bae, Seong-Ho; Kim, Bokyoung; Park, Jin Sil; Jung, Subin; Lee, Minhyung; Kim, Yong-Hee; Choi, Donghoon			Cardiac Usage of Reducible Poly(oligo-D-arginine) As a Gene Carrier for Vascular Endothelial Growth Factor Expression	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; VEGF PLASMID; THERAPY; ISCHEMIA; GENOME; OXYGEN	Developments of non-viral carriers have headed toward reducing cytotoxicity, which results from the use of conventional gene carriers, and enhancing gene delivery efficiency. Cys(D-R9)-Cys repeated reducible poly(oligo-D-arginine) (rPOA) is one of the most efficient non-viral carriers for gene therapy; however, while its efficiency has been verified in the lung and brain, it is necessary to confirm its activity in each organ or tissue since there are differences of gene carrier susceptibility to among tissue types. We therefore tested the compatibility of rPOA in cardiac tissue by in vitro or in vivo experiments and confirmed its high transfection efficiency and low cytotoxicity. Moreover, substantial regenerative effects were observed following transfection with rPOA/pVEGF expression vector complexes (79% decreased infarct size) compared to polyethyleneimine (PEI) (34% decreased infarct size) in a rat myocardial infarction (MI) model. These findings suggest that rPOA efficiently enables DNA transfection in cardiac tissue and can be used as a useful non-viral therapeutic gene carrier for gene therapy in ischemic heart disease.	[Woo, Jongsu; Kim, Bokyoung; Park, Jin Sil; Jung, Subin; Choi, Donghoon] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Bae, Seong-Ho] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Lee, Minhyung; Kim, Yong-Hee] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Choi, Donghoon] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University; Yonsei University Health System	Bae, SH (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	bshoooo@yuhs.ac; cdhlyj@yuhs.ac	Lee, Minhyung/W-1245-2018	Choi, Donghoon/0000-0002-2009-9760; Bae, Seong-ho/0000-0002-3624-6649	Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A085136, A102064]; Mid-career Researcher Program through NRF - MEST, Republic of Korea [2015R1A2A2A01002731]; Cardiovascular Research Center, Seoul, Korea	Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Mid-career Researcher Program through NRF - MEST, Republic of Korea; Cardiovascular Research Center, Seoul, Korea	This study was supported by a grant from the Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Nos. A085136 and A102064), the Mid-career Researcher Program through NRF grant funded by the MEST, Republic of Korea (No. 2015R1A2A2A01002731) and the Cardiovascular Research Center, Seoul, Korea.	Bull DA, 2003, J CONTROL RELEASE, V93, P175, DOI 10.1016/j.jconrel.2003.06.002; Frobert O, 2007, CATHETER CARDIO INTE, V70, P958, DOI 10.1002/ccd.21280; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; Gomez-Vargas A, 2004, SEMIN THROMB HEMOST, V30, P197, DOI 10.1055/s-2004-825633; Hyun H, 2010, BIOMATERIALS, V31, P9128, DOI 10.1016/j.biomaterials.2010.08.038; Kim HA, 2010, PHARM RES-DORDR, V27, P2075, DOI 10.1007/s11095-010-0206-7; Kim SH, 2011, MOL THER, V19, P741, DOI 10.1038/mt.2010.301; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Krijnen PAJ, 2002, J CLIN PATHOL, V55, P801, DOI 10.1136/jcp.55.11.801; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Moon HH, 2014, BIOMATERIALS, V35, P1744, DOI 10.1016/j.biomaterials.2013.11.019; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Wijesinghe M, 2009, HEART, V95, P198, DOI 10.1136/hrt.2008.148742; Willyard C, 2012, NAT MED, V18, P328, DOI 10.1038/nm0312-328; Wolfram JA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000119; Won YW, 2013, BIOMATERIALS, V34, P6229, DOI 10.1016/j.biomaterials.2013.04.061; Won YW, 2012, J CONTROL RELEASE, V160, P525, DOI 10.1016/j.jconrel.2012.03.010; Won YW, 2011, BIOMATERIALS, V32, P9766, DOI 10.1016/j.biomaterials.2011.08.089; Won YW, 2010, MOL THER, V18, P734, DOI 10.1038/mt.2009.297; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763	23	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144491	10.1371/journal.pone.0144491	http://dx.doi.org/10.1371/journal.pone.0144491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649571	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300051
J	Suarez, P; Nagamachi, CY; Lanzone, C; Malleret, MM; O'Brien, PCM; Ferguson-Smith, MA; Pieczarka, JC				Suarez, Pablo; Nagamachi, Cleusa Yoshiko; Lanzone, Cecilia; Maximiliano Malleret, Matias; O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew; Pieczarka, Julio Cesar			Clues on Syntenic Relationship among Some Species of Oryzomyini and Akodontini Tribes (Rodentia: Sigmodontinae)	PLOS ONE			English	Article							G-BANDING PATTERNS; CHROMOSOMAL EVOLUTION; WHOLE CHROMOSOME; ZOO-FISH; CRICETIDAE; CURSOR; DNA; DIVERSIFICATION; MUROIDEA; MOUSE	Sigmodontinae rodents represent one of the most diverse and complex components of the mammalian fauna of South America. Among them most species belongs to Oryzomyini and Akodontini tribes. The highly specific diversification observed in both tribes is characterized by diploid complements, which vary from 2n = 10 to 86. Given this diversity, a consistent hypothesis about the origin and evolution of chromosomes depends on the correct establishment of synteny analyzed in a suitable phylogenetic framework. The chromosome painting technique has been particularly useful for identifying chromosomal synteny. In order to extend our knowledge of the homeological relationships between Akodontini and Oryzomyini species, we analyzed the species Akodon montensis (2n = 24) and Thaptomys nigrita (2n = 52) both from the tribe Akodontini, with chromosome probes of Hylaeamys megacephalus (2n = 54) of the tribe Oryzomyini. The results indicate that at least 12 of the 26 autosomes of H. megacephalus show conserved synteny in A. montensis and 14 in T. nigrita. The karyotype of Akodon montensis, as well as some species of the Akodon cursor species group, results from many chromosomal fusions and therefore the syntenic associations observed probably represent synapomorphies. Our finding of a set of such associations revealed by H. megacephalus chromosome probes (6/21; 3/25; 11/16/17; and, 14/19) provides phylogenetic information for both tribes. An extension of these observations to other members of Akodontini and Oryzomyini tribes should improve our knowledge about chromosome evolution in both these groups.	[Suarez, Pablo; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] UFPa, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, Belem, Para, Brazil; [Lanzone, Cecilia; Maximiliano Malleret, Matias] CONICET UNaM, FCEQyN, IBS, Lab Genet Evolut, Posadas, Misiones, Argentina; [O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] CNPq Researchers, Brasilia, DF, Brazil	Universidade Federal do Para; University of Cambridge	Pieczarka, JC (corresponding author), UFPa, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, Belem, Para, Brazil.	juliopieczarka@gmail.com	Nagamachi, Cleusa/AAV-8985-2021; Pieczarka, Julio C/E-7585-2016	Pieczarka, Julio C/0000-0003-2951-8877; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734; Malleret, Matias Maximiliano/0000-0001-8409-6385	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) [552032/2010-7, ICAAF 007/2011]; Banco Nacional de Desenvolvimento Economico e Social-BNDES [2.318.697.0001]; FAPESPA [2010/110447]; Welcome Trust; CNPq [159537/2011-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Banco Nacional de Desenvolvimento Economico e Social-BNDES; FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Welcome Trust(Wellcome Trust); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) (Edital BIONORTE/CNPq Proc 552032/2010-7 and Edital BIONORTE/FAPESPA, ICAAF 007/2011) and the Banco Nacional de Desenvolvimento Economico e Social-BNDES (Operacao 2.318.697.0001) for financial support on a project coordinated by CY Nagamachi; the FAPESPA for financial support (Edital Vale-Proc 2010/110447) on a project coordinated by JC Pieczarka, and the Welcome Trust for a grant to MA Ferguson-Smith. CL thanks PICT 2010/1095 and CONICET PIP 198. PS thanks CNPq by postdoctoral fellowship (159537/2011-8).	BIANCHI NO, 1971, EVOLUTION, V25, P724, DOI 10.1111/j.1558-5646.1971.tb01929.x; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; Silva MJD, 2006, GENET MOL BIOL, V29, P469, DOI 10.1590/S1415-47572006000300012; Di-Nizo CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117579; Fagundes V, 1997, CYTOGENET CELL GENET, V78, P224, DOI 10.1159/000134662; Fagundes V, 1997, CHROMOSOME RES, V5, P228, DOI 10.1023/A:1018463401887; FORD CE, 1956, STAIN TECHNOL, V31, P247, DOI 10.3109/10520295609113814; Geise L, 1998, J HERED, V89, P158, DOI 10.1093/jhered/89.2.158; Geise L, 2001, J MAMMAL, V82, P92, DOI 10.1644/1545-1542(2001)082<0092:DITGAR>2.0.CO;2; Hass I, 2011, CYTOGENET GENOME RES, V135, P42, DOI 10.1159/000330259; Hass I, 2008, CHROMOSOME RES, V16, P75, DOI 10.1007/s10577-007-1211-5; Murphy WJ, 1999, GENOME RES, V9, P1223, DOI 10.1101/gr.9.12.1223; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Romanenko SA, 2012, HEREDITY, V108, P4, DOI 10.1038/hdy.2011.110; Romanenko SA, 2007, CHROMOSOME RES, V15, P283, DOI 10.1007/s10577-007-1124-3; Romanenko SA, 2006, MAMM GENOME, V17, P1183, DOI 10.1007/s00335-006-0081-z; Sbalqueiro IJ, 1996, BRAZ J GENET, V19, P565, DOI 10.1590/S0100-84551996000400005; SEABRIGH.M, 1971, LANCET, V2, P971; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; Stanyon R, 2004, CYTOGENET GENOME RES, V105, P406, DOI 10.1159/000078213; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swier VJ, 2009, CYTOGENET GENOME RES, V125, P54, DOI 10.1159/000218747; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Volobouev VT, 2000, CHROMOSOME RES, V8, P295, DOI 10.1023/A:1009223210737; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Yang Fengtang, 2009, P323, DOI 10.1007/978-3-540-70581-9_29	31	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143482	10.1371/journal.pone.0143482	http://dx.doi.org/10.1371/journal.pone.0143482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642204	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700018
J	Chen, LX; Wang, T; Wang, YM; Zhang, JX; Qi, YM; Weng, HB; Kang, QZ; Guo, XH; Baines, AJ; Mohandas, N; An, XL				Chen, Lixiang; Wang, Ting; Wang, Yaomei; Zhang, Jingxin; Qi, Yuanming; Weng, Haibo; Kang, Qiaozhen; Guo, Xinhua; Baines, Anthony J.; Mohandas, Narla; An, Xiuli			Protein 4.1G Regulates Cell Adhesion, Spreading, and Migration of Mouse Embryonic Fibroblasts through the beta 1 Integrin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL-DOMAIN; INTEGRIN ACTIVATION; SURFACE EXPRESSION; IN-VITRO; BINDING; MEMBRANE; COMPLEX; RECEPTOR; MOTILITY; KINASE	Protein 4.1G is a membrane skeletal protein that can serve as an adapter between transmembrane proteins and the underlying membrane skeleton. The function of 4.1G remains largely unexplored. Here, using 4.1G knockout mouse embryonic fibroblasts (MEFs) as a model system, we explored the function of 4.1G in motile cells. We show that the adhesion, spreading, and migration of 4.1G(-/-) MEF cells are impaired significantly. We further show that, although the total cellular expression of beta 1 integrin is unchanged, the surface expression of beta 1 integrin and its active form are decreased significantly in 4.1G(-/-) MEF cells. Moreover, the phosphorylation of focal adhesion kinase, a downstream component of the integrin-mediated signal transduction pathway, is suppressed in 4.1G(-/-) MEF cells. Co-immunoprecipitation experiments and in vitro binding assays showed that 4.1G binds directly to beta 1 integrin via its membrane-binding domain. These findings identified a novel role of 4.1G in cell adhesion, spreading, and migration in MEF cells by modulating the surface expression of beta 1 integrin and subsequent downstream signal transduction.	[Chen, Lixiang; Wang, Ting; Wang, Yaomei; Zhang, Jingxin; Qi, Yuanming; Weng, Haibo; Kang, Qiaozhen; An, Xiuli] Zhengzhou Univ, Coll Life Sci, Sci Rd 100, Zhengzhou 450001, Peoples R China; [Chen, Lixiang; Guo, Xinhua; Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10065 USA; [Weng, Haibo; An, Xiuli] New York Blood Ctr, Membrane Biol Lab, New York, NY 10065 USA; [Baines, Anthony J.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	Zhengzhou University; New York Blood Center; New York Blood Center; University of Kent	An, XL (corresponding author), Membrane Biol Lab, 310 E 67th St, New York, NY 10065 USA.	xan@nybloodcenter.org			Natural Science Foundation of China [81171905, 81272187]; National Institutes of Health [DK26263, DK100180]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants 81171905 and 81272187 from the Natural Science Foundation of China and by National Institutes of Health Grants DK26263 and DK100180. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen LX, 2011, J CELL SCI, V124, P2478, DOI 10.1242/jcs.078170; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Coleman SK, 2003, J NEUROSCI, V23, P798; FATH KR, 1989, J CELL SCI, V92, P67; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hemler M. E., 1999, INTEGRINS GUIDEBOOK, P196; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ILLC D, 1995, NATURE, V377, P539; Ivanovic A, 2012, J CELL BIOL, V196, P337, DOI 10.1083/jcb.201111127; Kang QZ, 2009, BLOOD, V113, P6128, DOI 10.1182/blood-2008-10-182329; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Krauss SW, 2003, P NATL ACAD SCI USA, V100, P10752, DOI 10.1073/pnas.1934680100; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lu DC, 2004, J NEUROSCI RES, V78, P49, DOI 10.1002/jnr.20230; Lu DC, 2004, BIOCHEM J, V377, P51, DOI 10.1042/BJ20030952; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; McCarty JH, 2005, P NATL ACAD SCI USA, V102, P13479, DOI 10.1073/pnas.0506068102; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sieg DJ, 1999, J CELL SCI, V112, P2677; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; vonBallestrem CG, 1996, HYBRIDOMA, V15, P125, DOI 10.1089/hyb.1996.15.125; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; Wang H, 2010, HISTOCHEM CELL BIOL, V134, P411, DOI 10.1007/s00418-010-0749-z; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Xu Z, 2013, BIOCHEM BIOPH RES CO, V434, P382, DOI 10.1016/j.bbrc.2013.03.086; Yang SM, 2011, MOL CELL BIOL, V31, P2276, DOI 10.1128/MCB.01105-10; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022	43	6	6	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2170	2180		10.1074/jbc.M115.658591	http://dx.doi.org/10.1074/jbc.M115.658591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644476	hybrid, Green Published			2022-12-26	WOS:000369610400011
J	Ballard, ME; Dean, AC; Mandelkern, MA; London, ED				Ballard, Michael E.; Dean, Andy C.; Mandelkern, Mark A.; London, Edythe D.			Striatal Dopamine D-2/D-3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; REFERENCE TISSUE MODEL; PREFRONTAL CORTEX; COGNITIVE PERFORMANCE; DISTRIBUTION VOLUME; D-2 RECEPTORS; COCAINE; DEFICITS; ADDICTION; BINDING	Background Dopamine D-2/D-3 receptor availability in the striatum has been linked with executive function in healthy individuals, and is below control levels among drug addicts, possibly contributing to diminished executive function in the latter group. This study tested for an association of striatal D-2/D-3 receptor availability with a measure of executive function among research participants who met DSM-IV criteria for methamphetamine dependence. Methods Methamphetamine users and non-user controls (n = 18 per group) completed the Wisconsin Card Sorting Test and positron emission tomography with [F-18]fallypride. Results The methamphetamine users displayed significantly lower striatal D-2/D-3 receptor availability on average than controls after controlling for age and education (p = 0.008), but they did not register greater proportions of either perseverative or non-perseverative errors when controlling for education (both ps >= 0.622). The proportion of non-perseverative, but not perseverative, errors was negatively correlated with striatal D2/D3 receptor availability among controls (r = -0.588, p = 0.010), but not methamphetamine users (r = 0.281, p = 0.258), and the group-wise interaction was significant (p = 0.030). Conclusions These results suggest that cognitive flexibility, as measured by perseverative errors on the Wisconsin Card Sorting Test, is not determined by signaling through striatal D-2/D-3 receptors in healthy controls, and that in stimulant abusers, who have lower D-2/D-3 receptor availability, compensation can effectively maintain other executive functions, which are associated with D-2/D-3 receptor signaling in controls.	[Ballard, Michael E.; Dean, Andy C.; London, Edythe D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Ballard, Michael E.; Mandelkern, Mark A.; London, Edythe D.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Dean, Andy C.; London, Edythe D.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Mandelkern, Mark A.] Univ Calif Irvine, Dept Phys, Irvine, CA 92717 USA; [London, Edythe D.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles	London, ED (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	elondon@mednet.ucla.edu	Ballard, Michael/F-9146-2013	Ballard, Michael/0000-0002-2651-6588	National Institutes of Health [R01 DA020726, P20 DA022539, K23 DA027734, M0I RR00865]; Marjorie M. Greene Trust; Thomas P. and Katherine K. Pike Chair in Addiction Studies;  [T32 DA024635]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA024635, K23DA027734, P20DA022539, R01DA020726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marjorie M. Greene Trust; Thomas P. and Katherine K. Pike Chair in Addiction Studies; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was supported by National Institutes of Health grants R01 DA020726 (EDL), P20 DA022539 (EDL), K23 DA027734 (ACD), M0I RR00865 (UCLA GCRC), by endowments from the Thomas P. and Katherine K. Pike Chair in Addiction Studies (EDL), and the Marjorie M. Greene Trust. MEB was supported by T32 DA024635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Backman L, 2000, AM J PSYCHIAT, V157, P635; Ballard ME, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu119; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bolla KI, 1999, J NEUROPSYCH CLIN N, V11, P361, DOI 10.1176/jnp.11.3.361; Brown AK, 2012, INT J NEUROPSYCHOPH, V15, P989, DOI 10.1017/S1461145711001957; Cervenka S, 2008, NEUROIMAGE, V40, P1287, DOI 10.1016/j.neuroimage.2007.12.063; Chen PS, 2005, PSYCHOL MED, V35, P197, DOI 10.1017/S0033291704003101; Chudasama Y, 2011, BEHAV NEUROSCI, V125, P327, DOI 10.1037/a0023766; Chung A, 2007, INT J NEUROPSYCHOPH, V10, P765, DOI 10.1017/Sl461145706007395; Cox SML, 2015, NEUROIMAGE, V109, P95, DOI 10.1016/j.neuroimage.2014.12.070; Cunha Paulo Jannuzzi, 2013, Front Psychiatry, V4, P126, DOI 10.3389/fpsyt.2013.00126; Dean AC, 2013, NEUROPSYCHOPHARMACOL, V38, P259, DOI 10.1038/npp.2012.179; Errico AL, 2002, ALCOHOL CLIN EXP RES, V26, P1198, DOI 10.1097/01.ALC.0000025885.23192.FF; Fereshteh A., 2012, ANN BIOL RES, V3, P415; First M. B, 1996, STRUCTURED CLINICAL; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Groman SM, 2012, J NEUROSCI, V32, P5843, DOI 10.1523/JNEUROSCI.0029-12.2012; Groman SM, 2011, J NEUROSCI, V31, P7291, DOI 10.1523/JNEUROSCI.0363-11.2011; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heaton RK, 1981, WISCONSIN CARD SORTI; Hoff AL, 1996, PSYCHIAT RES, V60, P167, DOI 10.1016/0165-1781(96)02758-8; Hosak L, 2012, PSYCHIAT DANUB, V24, P188; Ichise M, 2008, J CEREBR BLOOD F MET, V28, P420, DOI 10.1038/sj.jcbfm.9600530; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Izquierdo A, 2012, PSYCHOPHARMACOLOGY, V219, P607, DOI 10.1007/s00213-011-2579-7; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Johanson CE, 2006, PSYCHOPHARMACOLOGY, V185, P327, DOI 10.1007/s00213-006-0330-6; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kohno M, 2015, CEREB CORTEX, V25, P236, DOI 10.1093/cercor/bht218; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lawrence AD, 1998, BRAIN, V121, P1343, DOI 10.1093/brain/121.7.1343; Lee B, 2007, NEUROPSYCHOPHARMACOL, V32, P2125, DOI 10.1038/sj.npp.1301337; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; London ED, 2015, BRAIN RES, V1628, P174, DOI 10.1016/j.brainres.2014.10.044; Lumme V, 2007, PSYCHIAT RES-NEUROIM, V156, P69, DOI 10.1016/j.pscychresns.2006.12.012; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; McCann UD, 2008, SYNAPSE, V62, P91, DOI 10.1002/syn.20471; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Moeller SJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.110; MUKHERJEE J, 1995, NUCL MED BIOL, V22, P283, DOI 10.1016/0969-8051(94)00117-3; Nowakowska K, 2007, PSYCHIATR POL, V41, P693; Pau CWH, 2002, ARCH CLIN NEUROPSYCH, V17, P663, DOI 10.1016/S0887-6177(01)00169-X; Reeves SJ, 2005, NEUROIMAGE, V28, P216, DOI 10.1016/j.neuroimage.2005.05.034; Simon SL, 2010, J STUD ALCOHOL DRUGS, V71, P335, DOI 10.15288/jsad.2010.71.335; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; Takahashi H, 2008, J NEUROSCI, V28, P12032, DOI 10.1523/JNEUROSCI.3446-08.2008; Takahashi H, 2007, NEUROIMAGE, V34, P1643, DOI 10.1016/j.neuroimage.2006.11.008; Trifilieff P, 2014, NEUROPHARMACOLOGY, V76, P498, DOI 10.1016/j.neuropharm.2013.06.031; Vandehey NT, 2010, J CEREBR BLOOD F MET, V30, P994, DOI 10.1038/jcbfm.2009.270; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Woicik PA, 2011, NEUROPSYCHOLOGIA, V49, P1660, DOI 10.1016/j.neuropsychologia.2011.02.037; Woicik PA, 2009, NEUROPSYCHOPHARMACOL, V34, P1112, DOI 10.1038/npp.2008.60; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; Zorick T, 2012, MOL PSYCHIATR, V17, P569, DOI 10.1038/mp.2011.137	70	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143510	10.1371/journal.pone.0143510	http://dx.doi.org/10.1371/journal.pone.0143510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657223	Green Submitted, gold, Green Published			2022-12-26	WOS:000366715900012
J	Padmanabha, H; Correa, F; Rubio, C; Baeza, A; Osorio, S; Mendez, J; Jones, JH; Diuk-Wasser, MA				Padmanabha, Harish; Correa, Fabio; Rubio, Camilo; Baeza, Andres; Osorio, Salua; Mendez, Jairo; Jones, James Holland; Diuk-Wasser, Maria A.			Human Social Behavior and Demography Drive Patterns of Fine-Scale Dengue Transmission in Endemic Areas of Colombia	PLOS ONE			English	Article							RIO-DE-JANEIRO; AEDES-AEGYPTI; HUMAN MOVEMENT; VIRUS TRANSMISSION; POPULATIONS; VILLAGES; HETEROGENEITY; NICARAGUA; DISPERSAL; CULICIDAE	Dengue is known to transmit between humans and A. aegypti mosquitoes living in neighboring houses. Although transmission is thought to be highly heterogeneous in both space and time, little is known about the patterns and drivers of transmission in groups of houses in endemic settings. We carried out surveys of PCR positivity in children residing in 2-block patches of highly endemic cities of Colombia. We found high levels of heterogeneity in PCR positivity, varying from less than 30% in 8 of the 10 patches to 56 and 96%, with the latter patch containing 22 children simultaneously PCR positive (PCR22) for DEN2. We then used an agent-based model to assess the likely eco-epidemiological context of this observation. Our model, simulating daily dengue dynamics over a 20 year period in a single two block patch, suggests that the observed heterogeneity most likely derived from variation in the density of susceptible people. Two aspects of human adaptive behavior were critical to determining this density: external social relationships favoring viral introduction (by susceptible residents or infectious visitors) and immigration of households from non-endemic areas. External social relationships generating frequent viral introduction constituted a particularly strong constraint on susceptible densities, thereby limiting the potential for explosive outbreaks and dampening the impact of heightened vectorial capacity. Dengue transmission can be highly explosive locally, even in neighborhoods with significant immunity in the human population. Variation among neighborhoods in the density of local social networks and rural-to-urban migration is likely to produce significant fine-scale heterogeneity in dengue dynamics, constraining or amplifying the impacts of changes in mosquito populations and cross immunity between serotypes.	[Padmanabha, Harish] Univ Norte, Ctr Invest Desarrollo Humano CIDHUM, Puerto Colombia, Colombia; [Padmanabha, Harish; Baeza, Andres] Univ Maryland, Natl Socioenvironm Synth Ctr SESYNC, Annapolis, MD 21401 USA; [Correa, Fabio; Rubio, Camilo; Osorio, Salua; Mendez, Jairo] Inst Nacl Salud Colombia, Bogota, Dc, Colombia; [Jones, James Holland] Stanford Univ, Woods Inst Environm, Dept Anthropol, Stanford, CA 94305 USA; [Diuk-Wasser, Maria A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Diuk-Wasser, Maria A.] Yale Univ, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA	Universidad del Norte; Instituto Nacional de Salud (Colombia); Stanford University; Columbia University; Yale University	Padmanabha, H (corresponding author), Univ Norte, Ctr Invest Desarrollo Humano CIDHUM, Km 5 Via Puerto Colombia, Puerto Colombia, Colombia.	harishpadmanabha@gmail.com		Correa, Fabio/0000-0002-4562-7419; Jones, James/0000-0003-1680-6757	Global Environmental Facility/World Bank through the Integrated National Adaptation Pilot, a project executed in the Instituto Nacional de Salud de Colombia; National Virology Laboratory of the Instituto Nacional de Salud de Colombia; Yale Climate and Energy Institute; National Socio-Environmental Synthesis Center; Direct For Biological Sciences [1052875] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1639145] Funding Source: National Science Foundation	Global Environmental Facility/World Bank through the Integrated National Adaptation Pilot, a project executed in the Instituto Nacional de Salud de Colombia; National Virology Laboratory of the Instituto Nacional de Salud de Colombia; Yale Climate and Energy Institute; National Socio-Environmental Synthesis Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the Global Environmental Facility/World Bank through the Integrated National Adaptation Pilot, a project executed in the Instituto Nacional de Salud de Colombia. It also received funding from the National Virology Laboratory of the Instituto Nacional de Salud de Colombia, the Yale Climate and Energy Institute (grant awarded to MAD) and the National Socio-Environmental Synthesis Center (postdoctoral fellowships of HP, AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders KL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003528; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138; Boyd R, 1985, CULTURE EVOLUTIONARY, pviii; Breunlin R, 2006, AM ANTHROPOL, V108, P744, DOI 10.1525/aa.2006.108.4.744; Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876; Christophers R., 1960, AEDES AEGYPTI L YELL; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Domingo C., 2004, Dengue Bulletin, V28, P87; Dwiartama A, 2014, ECOL SOC, V19, DOI 10.5751/ES-06805-190328; Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; GWADZ RW, 1968, MOSQ NEWS, V28, P586; Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285; Li T, 2011, INT J TUBERC LUNG D, V15, P163; Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64; Mesch GS, 1998, ENVIRON BEHAV, V30, P504, DOI 10.1177/001391659803000405; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Nathan MB, 2006, ANN TROP MED PARASIT, V100, pS1, DOI 10.1179/136485906X105462; Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6; Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Pianka ER, 1988, EVOLUTIONARY ECOLOGY, pix; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003; Reyes M, 2010, AM J TROP MED HYG, V83, P683, DOI 10.4269/ajtmh.2010.10-0023; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Roy M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03710; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Sterelny K, 2007, PHILOS T R SOC B, V362, P719, DOI 10.1098/rstb.2006.2006; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; SUBRA R, 1983, ANN TROP MED PARASIT, V77, P195, DOI 10.1080/00034983.1983.11811697; Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	52	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144451	10.1371/journal.pone.0144451	http://dx.doi.org/10.1371/journal.pone.0144451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656072	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900050
J	Vagne, Q; Turner, MS; Sens, P				Vagne, Quentin; Turner, Matthew S.; Sens, Pierre			Sensing Size through Clustering in Non-Equilibrium Membranes and the Control of Membrane-Bound Enzymatic Reactions	PLOS ONE			English	Article							CELL-SURFACE; DOMAINS; ORGANIZATION; VESICLES; FLUID; ENDOCYTOSIS; MATURATION; MIXTURES; BEHAVIOR; RAFTS	The formation of dynamical clusters of proteins is ubiquitous in cellular membranes and is in part regulated by the recycling of membrane components. We show, using stochastic simulations and analytic modeling, that the out-of-equilibrium cluster size distribution of membrane components undergoing continuous recycling is strongly influenced by lateral confinement. This result has significant implications for the clustering of plasma membrane proteins whose mobility is hindered by cytoskeletal "corrals" and for protein clustering in cellular organelles of limited size that generically support material fluxes. We show how the confinement size can be sensed through its effect on the size distribution of clusters of membrane heterogeneities and propose that this could be regulated to control the efficiency of membrane-bound reactions. To illustrate this, we study a chain of enzymatic reactions sensitive to membrane protein clustering. The reaction efficiency is found to be a non-monotonic function of the system size, and can be optimal for sizes comparable to those of cellular organelles.	[Vagne, Quentin; Sens, Pierre] PSL Res Univ, CNRS, Inst Curie, UMR 168, F-75005 Paris, France; [Turner, Matthew S.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Turner, Matthew S.] Univ Warwick, Complex Ctr, Coventry CV4 7AL, W Midlands, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Warwick; University of Warwick	Sens, P (corresponding author), PSL Res Univ, CNRS, Inst Curie, UMR 168, 26 Rue Ulm, F-75005 Paris, France.	pierre.sens@curie.fr	sens, pierre/C-3537-2011; Turner, Matthew/D-1121-2011	sens, pierre/0000-0003-4523-3791; Turner, Matthew/0000-0002-3441-678X	Engineering and Physical Sciences Research Council	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council (MST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Buchner A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208104; Camacho J, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046112; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Cicuta P, 2007, J PHYS CHEM B, V111, P3328, DOI 10.1021/jp0702088; Connaughton C, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061114; Davies SC, 1999, J ENG MATH, V36, P57, DOI 10.1023/A:1004589822425; Dmitrieff S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062704; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Foret L, 2005, EUROPHYS LETT, V71, P508, DOI 10.1209/epl/i2005-10098-x; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GLOTZER SC, 1995, PHYS REV LETT, V74, P2034, DOI 10.1103/PhysRevLett.74.2034; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Johnson SA, 2010, BBA-BIOMEMBRANES, V1798, P1427, DOI 10.1016/j.bbamem.2010.03.009; Lavi Y, 2007, BIOPHYS J, V93, pL35, DOI 10.1529/biophysj.107.111567; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mugler A, 2013, P NATL ACAD SCI USA, V110, P5927, DOI 10.1073/pnas.1218301110; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nair PM, 2011, NAT PROTOC, V6, P523, DOI 10.1038/nprot.2011.302; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Pfeffer SR, 2010, P NATL ACAD SCI USA, V107, P19614, DOI 10.1073/pnas.1011016107; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Sengupta D, 2011, ANNU REV CELL DEV BI, V27, P57, DOI 10.1146/annurev-cellbio-100109-104003; Sens P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238101; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Sikder MKU, 2014, J CHEM PHYS, V141, DOI [10.1063/1.4890655, DOI 10.1063/1.4890655]; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smoluchowski MV., 1916, Z PHYS, V17, P557; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tang Q, 2001, BIOPHYS J, V81, P196, DOI 10.1016/S0006-3495(01)75691-3; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Turner MS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168301; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	44	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143470	10.1371/journal.pone.0143470	http://dx.doi.org/10.1371/journal.pone.0143470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656912	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900010
J	Ma, YJ; Sun, XH; Xu, XY; Zhao, Y; Pan, YJ; Hwang, CA; Wu, VCH				Ma, Yue-jiao; Sun, Xiao-hong; Xu, Xiao-yan; Zhao, Yong; Pan, Ying-jie; Hwang, Cheng-An; Wu, Vivian C. H.			Investigation of Reference Genes in Vibrio parahaemolyticus for Gene Expression Analysis Using Quantitative RT-PCR	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; REAL-TIME PCR; HOUSEKEEPING GENES; TEMPERATURE REGULATION; VIRULENCE; QUANTIFICATION; NORMALIZATION; SELECTION; CONTRIBUTES; INTEGRITY	Vibrio parahaemolyticus is a significant human pathogen capable of causing foodborne gastroenteritis associated with the consumption of contaminated raw or undercooked seafood. Quantitative RT-PCR (qRT-PCR) is a useful tool for studying gene expression in V. parahaemolyticus to characterize its virulence factors and understand the effect of environmental conditions on its pathogenicity. However, there is not a stable gene in V. parahaemolyticus that has been identified for use as a reference gene for qRT-PCR. This study evaluated the stability of 6 reference genes (16S rRNA, recA, rpoS, pvsA, pvuA, and gapdh) in 5 V. parahaemolyticus strains (O3:K6-clinical strain-tdh(+), ATCC33846-tdh(+), ATCC33847-tdh(+), ATCC17802-trh(+), and F13-environmental strain-tdh(+)) cultured at 4 different temperatures (15, 25, 37 and 42 degrees C). Stability values were calculated using GeNorm, NormFinder, BestKeeper, and Delta CT algorithms. The results indicated that recA was the most stably expressed gene in the V. parahaemolyticus strains cultured at different temperatures. This study examined multiple V. parahaemolyticus strains and growth temperatures, hence the finding provided stronger evidence that recA can be used as a reference gene for gene expression studies in V. parahaemolyticus.	[Ma, Yue-jiao; Sun, Xiao-hong; Zhao, Yong; Pan, Ying-jie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Ma, Yue-jiao; Sun, Xiao-hong; Zhao, Yong; Pan, Ying-jie] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai 201306, Peoples R China; [Xu, Xiao-yan] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Hwang, Cheng-An] ARS, Residue Chem & Predict Microbiol Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA; [Wu, Vivian C. H.] Univ Maine, Pathogen Microbiol Lab, Sch Food & Agr, Orono, ME 04469 USA; [Wu, Vivian C. H.] ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA	Shanghai Ocean University; Shanghai Ocean University; United States Department of Agriculture (USDA); University of Maine System; University of Maine Orono; United States Department of Agriculture (USDA)	Sun, XH (corresponding author), Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China.	xhsun@shou.edu.cn; Vivian.Wu@ARS.USDA.GOV		Wu, Vivian C.H./0000-0002-1525-1078	Shanghai Ocean University Doctoral Research Foundation; Key Project of Shanghai Agriculture Prosperity through Science and Technology [4-5]; Hatch Grant from the USDA National Institute of Food and Agriculture [ME08562-10]	Shanghai Ocean University Doctoral Research Foundation; Key Project of Shanghai Agriculture Prosperity through Science and Technology; Hatch Grant from the USDA National Institute of Food and Agriculture	This work was supported by grants from Shanghai Ocean University Doctoral Research Foundation, Key Project of Shanghai Agriculture Prosperity through Science and Technology (2015, 4-5). This work is based upon research supported in part by Hatch Grant number ME08562-10 from the USDA National Institute of Food and Agriculture.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boonyawantang A, 2012, FOOD CONTROL, V26, P479, DOI 10.1016/j.foodcont.2012.02.009; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Bustin SA, 2005, CLIN SCI, V109, P365, DOI 10.1042/CS20050086; Coutard F, 2007, APPL ENVIRON MICROB, V73, P5183, DOI 10.1128/AEM.02776-06; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Florindo C, 2012, J MICROBIOL METH, V90, P220, DOI 10.1016/j.mimet.2012.05.011; Hansen MC, 2001, J BACTERIOL, V183, P4747, DOI 10.1128/JB.183.16.4747-4751.2001; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Kallman O, 2009, MICROB DRUG RESIST, V15, P91, DOI 10.1089/mdr.2009.0883; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Li Qin, 2013, Weishengwu Xuebao, V53, P306; Mahoney JC, 2010, APPL ENVIRON MICROB, V76, P7459, DOI 10.1128/AEM.01450-10; Marco ML, 2008, J APPL MICROBIOL, V104, P587, DOI 10.1111/j.1365-2672.2007.03578.x; MAURELLI AT, 1989, MICROB PATHOGENESIS, V7, P1, DOI 10.1016/0882-4010(89)90106-X; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; McMillan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098162; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Sengupta P, 2013, CURR BIOL, V23, pR304, DOI 10.1016/j.cub.2013.03.009; Shivaji S, 2010, ARCH MICROBIOL, V192, P85, DOI 10.1007/s00203-009-0539-y; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Trevors JT, 2012, EXTREMOPHILES, V16, P167, DOI 10.1007/s00792-011-0423-y; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Whitaker WB, 2010, APPL ENVIRON MICROB, V76, P4720, DOI 10.1128/AEM.00474-10; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594	35	21	22	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144362	10.1371/journal.pone.0144362	http://dx.doi.org/10.1371/journal.pone.0144362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659406	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600038
J	Shitiz, K; Sharma, N; Pal, T; Sood, H; Chauhan, RS				Shitiz, Kirti; Sharma, Neha; Pal, Tarun; Sood, Hemant; Chauhan, Rajinder S.			NGS Transcriptomes and Enzyme Inhibitors Unravel Complexity of Picrosides Biosynthesis in Picrorhiza kurroa Royle ex. Benth	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; SUSPENSION-CULTURES; 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; UROPORPHYRINOGEN DECARBOXYLASE; ISOPRENOID BIOSYNTHESIS; GLYPHOSATE TOLERANCE; SHIKIMATE PATHWAY; MEDICINAL HERB; FERULIC ACID; EXPRESSION	Picrorhiza kurroa is an important medicinal herb valued for iridoid glycosides, Picroside-I (P-I) and Picroside-II (P-II), which have several pharmacological activities. Genetic interventions for developing a picroside production platform would require knowledge on biosynthetic pathway and key control points, which does not exist as of today. The current study reports that geranyl pyrophosphate (GPP) moiety is mainly contributed by the non-mevalonate (MEP) route, which is further modified to P-I and P-II through phenylpropanoid and iridoid pathways, in total consisting of 41 and 35 enzymatic steps, respectively. The role of the MEP pathway was ascertained through enzyme inhibitors fosmidomycin and mevinolin along with importance of other integrating pathways using glyphosate, aminooxy acetic acid (AOA) and actinomycin D, which overall resulted in 17%-92% inhibition of P-I accumulation. Retrieval of gene sequences for enzymatic steps from NGS transcriptomes and their expression analysis vis-a-vis picrosides content in different tissues/organs showed elevated transcripts for twenty genes, which were further shortlisted to seven key genes, ISPD, DXPS, ISPE, PMK, 2HFD, EPSPS and SK, on the basis of expression analysis between high versus low picrosides content strains of P. kurroa so as to eliminate tissue type/developmental variations in picrosides contents. The higher expression of the majority of the MEP pathway genes (ISPD, DXPS and ISPE), coupled with higher inhibition of DXPR enzyme by fosmidomycin, suggested that the MEP route contributed to the biosynthesis of P-I in P. kurroa. The outcome of the study is expected to be useful in designing a suitable genetic intervention strategy towards enhanced production of picrosides. Possible key genes contributing to picroside biosynthesis have been identified with potential implications in molecular breeding and metabolic engineering of P. kurroa.	[Shitiz, Kirti; Sharma, Neha; Pal, Tarun; Sood, Hemant; Chauhan, Rajinder S.] Jaypee Univ, Dept Biotechnol & Bioinformat, Solan 73234, Himachal Prades, India	Jaypee University of Information Technology	Chauhan, RS (corresponding author), Jaypee Univ, Dept Biotechnol & Bioinformat, Solan 73234, Himachal Prades, India.	rajinder.chauhan@juit.ac.in	Chauhan, Rajinder Singh/HGB-5642-2022; Pal, Tarun/V-4301-2019; Sood, Hemant/AAL-3516-2021	Pal, Tarun/0000-0002-4344-0351; 	Department of Biotechnology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Govt. of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The research work has been funded by Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Department of Biotechnology, Govt. of India for providing financial support to RSC in the form of a programme support on high value medicinal plants. The authors are also thankful to Dr. Jagdish Singh, Himalayan Forest Research Institute (HFRI), Shimla, India for providing Picrorhiza kurroa plant material.	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Ali MB, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-84; Bauer N, 2011, FOOD TECHNOL BIOTECH, V49, P24; Bhandari P, 2009, CHROMATOGRAPHIA, V69, P221, DOI 10.1365/s10337-008-0889-7; Bhat WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073804; BRECKE BJ, 1980, PLANT PHYSIOL, V66, P656, DOI 10.1104/pp.66.4.656; Cabe MC, 2014, SACNAS NAT C LOS ANG; Cao GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038718; Chakraborty D, 2008, J PLANT PHYSIOL, V165, P1033, DOI 10.1016/j.jplph.2007.09.002; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cui LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08227; DOTZLAF JE, 1987, J BACTERIOL, V169, P1611, DOI 10.1128/jb.169.4.1611-1618.1987; Dutt S., 2004, DIFFERENTIAL ACCUMUL; Eisenreich W, 1997, TETRAHEDRON LETT, V38, P3889, DOI 10.1016/S0040-4039(97)00761-2; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Flores-Sanchez IJ, 2002, PLANT CELL PHYSIOL, V43, P1502, DOI 10.1093/pcp/pcf181; FUNK C, 1992, PLANT PHYSIOL, V99, P256, DOI 10.1104/pp.99.1.256; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Garg Bharti, 2014, BMC Res Notes, V7, P58, DOI 10.1186/1756-0500-7-58; Guo YL, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-43; Gupta N, 2011, J PLANT PHYSIOL, V168, P2117, DOI 10.1016/j.jplph.2011.06.018; Hampel D, 2006, J AGR FOOD CHEM, V54, P1473, DOI 10.1021/jf0523972; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; HERRMANN KM, 1995, PLANT CELL, V7, P907; HOAGLAND RE, 1980, WEED SCI, V28, P393, DOI 10.1017/S0043174500055545; HOLLANDER H, 1980, PLANT PHYSIOL, V66, P823, DOI 10.1104/pp.66.5.823; Kamo T, 2000, BIOSCI BIOTECH BIOCH, V64, P2089, DOI 10.1271/bbb.64.2089; Kawoosa T, 2010, FUNCT INTEGR GENOMIC, V10, P393, DOI 10.1007/s10142-009-0152-9; KLEE HJ, 1987, MOL GEN GENET, V210, P437, DOI 10.1007/BF00327194; Kumar V, 2013, PHYTOCHEM ANALYSIS, V24, P598, DOI 10.1002/pca.2437; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Mahmoud SS, 2001, P NATL ACAD SCI USA, V98, P8915, DOI 10.1073/pnas.141237298; MEHROTRA R, 1990, INDIAN J MED RES-B, V92, P133; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Mock HP, 1998, PLANT PHYSIOL, V116, P107, DOI 10.1104/pp.116.1.107; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagatoshi M, 2011, J BIOL CHEM, V286, P32866, DOI 10.1074/jbc.M111.242586; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nakayama T, 2003, J MOL CATAL B-ENZYM, V23, P117, DOI 10.1016/S1381-1177(03)00078-X; Narbad A, 1998, MICROBIOL-SGM, V144, P1397, DOI 10.1099/00221287-144-5-1397; Olofsson L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-45; Palazon J, 2003, J BIOTECHNOL, V101, P157, DOI 10.1016/S0168-1656(02)00318-8; Pandit S, 2013, J PLANT BIOCHEM BIOT, V22, P335, DOI 10.1007/s13562-012-0136-z; Pandit S, 2013, MOL BIOL REP, V40, P1053, DOI 10.1007/s11033-012-2147-1; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Peiser G, 1998, POSTHARVEST BIOL TEC, V14, P171, DOI 10.1016/S0925-5214(98)00048-9; Rathee D, 2013, ARAB J CHEM, V6, P49, DOI 10.1016/j.arabjc.2011.01.011; Schwender J, 1999, FEBS LETT, V455, P140, DOI 10.1016/S0014-5793(99)00849-2; Shahzad A., 2013, RECENT TRENDS BIOTEC, P263, DOI [10.1007/978-94-007-6603-7_12, DOI 10.1007/978-94-007-6603-7_12]; Shen GA, 2006, BIOSCIENCE REP, V26, P19, DOI 10.1007/s10540-006-9007-y; Shimamura M, 2007, PLANT CELL PHYSIOL, V48, P1652, DOI 10.1093/pcp/pcm125; Simkin AJ, 2013, PHYTOCHEMISTRY, V85, P36, DOI 10.1016/j.phytochem.2012.09.014; Singh H, 2012, GENE, P320; Singh K, 2008, TREE PHYSIOL, V28; Singh RS, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-88; Sood H, 2010, PLANT CELL TISS ORG, V100, P113, DOI 10.1007/s11240-009-9618-7; Vashisht I, 2015, PLANTA, V241, P1255, DOI 10.1007/s00425-015-2255-y; Wang JF, 2010, BIOSCI BIOTECH BIOCH, V74, P1583, DOI 10.1271/bbb.100175; Wang L, 2015, EXP THER MED, V9, P817, DOI 10.3892/etm.2015.2192; Wu N, 2014, DRUG DES DEV THER, V8, P545, DOI 10.2147/DDDT.S62355; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x; Yendo ACA, 2010, MOL BIOTECHNOL, V46, P94, DOI 10.1007/s12033-010-9257-6; Zhang M, 2013, J NANOMATER, V2013, DOI 10.1155/2013/648346; Zhao L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-25	69	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144546	10.1371/journal.pone.0144546	http://dx.doi.org/10.1371/journal.pone.0144546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658062	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600055
J	Taha, MR; Mobasser, S				Taha, Mohd Raihan; Mobasser, Shariat			Adsorption of DDT and PCB by Nanomaterials from Residual Soil	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; MULTIWALLED CARBON NANOTUBES; GAS-CHROMATOGRAPHY; PACKED CARTRIDGE; WATER SAMPLES; ADSORBENT; SORPTION; REMOVAL; ALUMINA	This paper presents the findings of a study on adsorption of dichlorodiphenythreechloroethen (DDT) and polychlorinated biphenyls (PCBs) on three nanomaterials including Multi walled Carbon Nanotube (MWNT), nano-clay and nano-alumina. DDT and PCBs are of significant concern due their high toxicity and long environmental half-lives. Experiments were conducted using batch adsorption procedures at different DDT and PCBs concentrations, from 10 to 60 mg/L. The amounts of MWNT, nano-clay and Nano-alumina used were 0.25%, 0.50%, 0.75%, 1%, 2% and 10%. The adsorption of PCBs solution onto the MWNT, nano-clay and nano-alumina was characterized by an initial rapid adsorption which eventually became constant within 22, 20, and 17 hours, respectively. The adsorption of DDT solution onto the MWNT, nano-clay and nano-alumina was also characterized by an initial rapid adsorption which gradually became constant within 22, 22 and 16 hours, respectively. Results of this study indicated that MWNT was a better adsorbent material compared to nano-clay and nano-alumina for both contaminants in this study. While at 10% of MWNT 88.9% and 77% of DDT and PCB were removed by MWNT, respectively. The effect of pH and temperature were also investigated.	[Taha, Mohd Raihan; Mobasser, Shariat] Univ Kebangsaan Malaysia, Dept Civil & Struct Engn, Bangi 43600, Selangor, Malaysia; [Taha, Mohd Raihan] Univ Kebangsaan Malaysia, Inst Environm & Dev LESTARI, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Mobasser, S (corresponding author), Univ Kebangsaan Malaysia, Dept Civil & Struct Engn, Bangi 43600, Selangor, Malaysia.	shariat_m741@yahoo.com	Mobasser, Shariat/AFT-9643-2022	Taha, Mohd Raihan/0000-0001-6719-9147				Agnihotri S, 2005, CARBON, V43, P2379, DOI 10.1016/j.carbon.2005.04.020; Alyamani A., 2010, JORNAL ELECT TESTING, V3, P513; Anand D., 2010, THESIS SO ILLINOIS U; Anbia M, 2009, APPL SURF SCI, V255, P9487, DOI 10.1016/j.apsusc.2009.07.070; Bhatnagar A, 2010, CHEM ENG J, V163, P317, DOI 10.1016/j.cej.2010.08.008; Bhattacharya AK, 2008, CHEM ENG J, V137, P529, DOI 10.1016/j.cej.2007.05.021; Boehm F., 2006, NAN039A; Cai YQ, 2003, ANAL CHEM, V75, P2517, DOI 10.1021/ac0263566; Cai YQ, 2005, J CHROMATOGR A, V1081, P245, DOI 10.1016/j.chroma.2005.05.080; Cai YQ, 2003, ANAL CHIM ACTA, V494, P149, DOI 10.1016/j.aca.2003.08.006; Chen W, 2008, ENVIRON SCI TECHNOL, V42, P6862, DOI 10.1021/es8013612; Chen WQ, 2002, MAR POLLUT BULL, V45, P385, DOI 10.1016/S0025-326X(02)00092-9; Colborn T., 1996, OUR STOLEN FUTURE ED; Cornelissen G, 2006, ENVIRON POLLUT, V141, P526, DOI 10.1016/j.envpol.2005.08.053; Gotovac S, 2006, J PHYS CHEM B, V110, P16219, DOI 10.1021/jp0611830; HANCE RJ, 1967, WEED RES, V7, P29, DOI 10.1111/j.1365-3180.1967.tb01345.x; HIRAIDE M, 1995, ANAL SCI, V11, P611, DOI 10.2116/analsci.11.611; [胡建信 Hu Jiaxin], 2006, [环境污染与防治, Environmental Pollution & Control], V28, P222; Li YH, 2002, CHEM PHYS LETT, V357, P263, DOI 10.1016/S0009-2614(02)00502-X; Liao Q, 2008, COLLOID SURFACE A, V312, P160, DOI 10.1016/j.colsurfa.2007.06.045; Lu CY, 2007, SEP PURIF TECHNOL, V58, P113, DOI 10.1016/j.seppur.2007.07.036; Lu CS, 2005, WATER RES, V39, P1183, DOI 10.1016/j.watres.2004.12.033; NICHOLLS PH, 1991, PESTIC SCI, V33, P319, DOI 10.1002/ps.2780330306; Niu JJ, 2008, SOLID STATE SCI, V10, P1189, DOI 10.1016/j.solidstatesciences.2007.12.016; Nollet H, 2003, CHEMOSPHERE, V53, P655, DOI 10.1016/S0045-6535(03)00517-4; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P9005, DOI 10.1021/es801777n; Pan C. S., 2005, J AM SOC MASS SPECTR; Peng XJ, 2003, CHEM PHYS LETT, V376, P154, DOI 10.1016/S0009-2614(03)00960-6; Pyrzynska K, 2007, MICROCHIM ACTA, V159, P293, DOI 10.1007/s00604-007-0739-6; Salam M., 2008, APPL SURFECE SCI, P1975; Semple KT, 2003, EUR J SOIL SCI, V54, P809, DOI 10.1046/j.1351-0754.2003.0564.x; Shao D., 2010, J PHYS CHEM, P860; Sun XL, 2008, ENVIRON TOXICOL CHEM, V27, P2287, DOI 10.1897/08-020.1; Tchomgui-Kamga E, 2010, CARBON, V48, P333, DOI 10.1016/j.carbon.2009.09.034; Wang JX, 2006, J CHROMATOGR A, V1137, P8, DOI 10.1016/j.chroma.2006.10.003; Wang LP, 2006, J CHROMATOGR A, V1136, P99, DOI 10.1016/j.chroma.2006.09.088; Wang S. G., 2008, J CHEM TECHNOL BIOT, V82, P698; Wang XH, 2005, ENVIRON POLLUT, V136, P453, DOI 10.1016/j.envpol.2005.01.004; Wodarg D, 2004, MAR CHEM, V87, P23, DOI 10.1016/j.marchem.2003.12.002; Yang K, 2006, ENVIRON SCI TECHNOL, V40, P1855, DOI 10.1021/es052208w; Zhou QX, 2007, MICROCHIM ACTA, V157, P93, DOI 10.1007/s00604-006-0674-y	41	14	14	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144071	10.1371/journal.pone.0144071	http://dx.doi.org/10.1371/journal.pone.0144071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659225	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600020
J	Wang, SY; Jiang, BL; Zhou, X; Chen, JH; Li, WJ; Liu, J; Hu, W; Xiao, GQ; Dong, MY; Wang, YC				Wang, Shu-Yang; Jiang, Bo-Ling; Zhou, Xiang; Chen, Ji-Hong; Li, Wen-Jian; Liu, Jing; Hu, Wei; Xiao, Guo-Qing; Dong, Miao-Yin; Wang, Yu-Chen			Study of a High-Yield Cellulase System Created by Heavy-Ion Irradiation-Induced Mutagenesis of Aspergillus niger and Mixed Fermentation with Trichoderma reesei	PLOS ONE			English	Article							EXPLODED CORN STOVER; ENZYMATIC-HYDROLYSIS; NEUROSPORA-CRASSA; BETA-GLUCOSIDASE; BIO-ETHANOL; RUT-C30; OPTIMIZATION; ACID; SACCHARIFICATION; PRETREATMENT	The aim of this study was to evaluate and validate the efficiency of C-12(6+) irradiation of Aspergillus niger (A. niger) or mutagenesis via mixed Trichoderma viride (T. viride) culturing as well as a liquid cultivation method for cellulase production via mixed Trichoderma reesei (T. reesei) and A. niger culture fermentation. The first mutagenesis approach was employed to optimize yield from a cellulase-producing strain via heavy-ion mutagenesis and high-throughput screening, and the second was to effectively achieve enzymatic hydrolysis of cellulase from a mixed culture of mutant T. viride and A. niger. We found that C-12(6+)-ion irradiation induced changes in cellulase biosynthesis in A. niger but had no effect on the time course of the synthesis. It is notable that the exoglucanases (CBH) activities of A. niger strains H11-1 and H differed (6.71 U/mL vs. 6.01 U/mL) and were significantly higher than that of A. niger mutant H3-1. Compared with strain H, the filter paper assay (FPA), endoglucanase (EG) and beta-glucosidase (BGL) activities of mutant strain H11-1 were increased by 250.26%, 30.26% and 34.91%, respectively. A mixed culture system was successfully optimized, and the best ratio of T. reesei to A. niger was 5: 1 for 96 h with simultaneous inoculation. The BGL activity of the mixed culture increased after 72 h. At 96 h, the FPA and BGL activities of the mixed culture were 689.00 and 797.15 U/mL, respectively, significantly higher than those of monocultures, which were 408.70 and 646.98 U/mL for T. reesei and 447.29 and 658.89 U/mL for A. niger, respectively. The EG activity of the mixed culture was 2342.81 U/mL, a value that was significantly higher than that of monocultures at 2206.57 U/mL for T. reesei and 1727.62 U/mL for A. niger. In summary, cellulose production and hydrolysis yields were significantly enhanced by the proposed combination scheme.	[Wang, Shu-Yang; Jiang, Bo-Ling; Zhou, Xiang; Chen, Ji-Hong; Li, Wen-Jian; Liu, Jing; Hu, Wei; Xiao, Guo-Qing; Dong, Miao-Yin; Wang, Yu-Chen] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Gansu, Peoples R China; [Wang, Shu-Yang] Lanzhou Univ, Lanzhou 730000, Gansu, Peoples R China; [Jiang, Bo-Ling; Dong, Miao-Yin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Lanzhou University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, SY (corresponding author), Chinese Acad Sci, Inst Modern Phys, 509 Nanchang Rd, Lanzhou 730000, Gansu, Peoples R China.	wangsy@impcas.ac.cn			National Natural Science Foundation of China [11305225, 11105193]; Science and Technology Service Network Initiative [KFJ-EW-STS-086]; Western Action Plan of CCAS [kzcxz-xb3-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Service Network Initiative; Western Action Plan of CCAS	This work was supported by grants from the National Natural Science Foundation of China (11305225 and 11105193), the Science and Technology Service Network Initiative (KFJ-EW-STS-086) and the Western Action Plan of CCAS (kzcxz-xb3-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed A, 2008, BIOCHEM ENG J, V42, P41, DOI 10.1016/j.bej.2008.05.007; Ahamed A, 2008, BIOCHEM ENG J, V40, P399, DOI 10.1016/j.bej.2007.11.030; Avci A, 2013, BIORESOURCE TECHNOL, V130, P603, DOI 10.1016/j.biortech.2012.12.104; Chen M, 2008, CARBOHYD POLYM, V71, P411, DOI 10.1016/j.carbpol.2007.06.011; Fang H, 2010, BIORESOURCE TECHNOL, V101, P4111, DOI 10.1016/j.biortech.2010.01.078; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gutierrez-Correa M, 1999, BIORESOURCE TECHNOL, V68, P173, DOI 10.1016/S0960-8524(98)00139-4; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hu W, 2014, NUCL SCI TECH, V25; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Lei Y, 2013, OPT MATER, V35, P1179, DOI 10.1016/j.optmat.2013.01.010; Li ZZ, 2011, JOURNAL NAME; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Naveena B, 2012, BIORESOURCE TECHNOL, V111, P417, DOI 10.1016/j.biortech.2012.02.056; Ortega N, 2001, INT BIODETER BIODEGR, V47, P7, DOI 10.1016/S0964-8305(00)00101-3; Rana V, 2014, BIORESOURCE TECHNOL, V154, P282, DOI 10.1016/j.biortech.2013.12.059; Romero MD, 1999, ENZYME MICROB TECH, V25, P244, DOI 10.1016/S0141-0229(99)00035-6; Seyis I, 2003, MICROBIOLOGICA, V26, P75; Singh A, 2012, BIORESOURCE TECHNOL, V108, P94, DOI 10.1016/j.biortech.2011.12.084; STOCKTON BC, 1991, BIOTECHNOL LETT, V13, P57, DOI 10.1007/BF01033518; Sukumaran RK, 2009, RENEW ENERG, V34, P421, DOI 10.1016/j.renene.2008.05.008; Sun WC, 2008, PROCESS BIOCHEM, V43, P1083, DOI 10.1016/j.procbio.2008.05.015; Wang LY, 2010, J APPL MICROBIOL, V108, P851, DOI 10.1111/j.1365-2672.2009.04483.x; Wang SY, 2012, CHINESE PHYS C, V36, P1140, DOI 10.1088/1674-1137/36/11/019; Wooley R, 1999, BIOTECHNOL PROGR, V15, P794, DOI 10.1021/bp990107u; Wu WH, 2013, ARCH MICROBIOL, V195, P823, DOI 10.1007/s00203-013-0931-5; Wu WH, 2013, ENZYME MICROB TECH, V52, P184, DOI 10.1016/j.enzmictec.2012.12.010; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Yang B, 2008, BIOFUEL BIOPROD BIOR, V2, P26, DOI 10.1002/bbb.49; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhou X, 2014, BIORESOURCE TECHNOL, V161, P221, DOI 10.1016/j.biortech.2014.03.039	31	6	9	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144233	10.1371/journal.pone.0144233	http://dx.doi.org/10.1371/journal.pone.0144233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656155	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600031
J	Boersma, AT; Pyenson, ND				Boersma, Alexandra T.; Pyenson, Nicholas D.			Albicetus oxymycterus, a New Generic Name and Redescription of a Basal Physeteroid (Mammalia, Cetacea) from the Miocene of California, and the Evolution of Body Size in Sperm Whales	PLOS ONE			English	Article							CEPHALOPODS; FALL	Living sperm whales are represented by only three species (Physeter macrocephalus, Kogia breviceps and Kogia sima), but their fossil record provides evidence of an ecologically diverse array of different forms, including morphologies and body sizes without analog among living physeteroids. Here we provide a redescription of Ontocetus oxymycterus, a large but incomplete fossil sperm whale specimen from the middle Miocene Monterey Formation of California, described by Remington Kellogg in 1925. The type specimen consists of a partial rostrum, both mandibles, an isolated upper rostrum fragment, and incomplete tooth fragments. Although incomplete, these remains exhibit characteristics that, when combined, set it apart morphologically from all other known physeteroids (e.g., a closed mesorostral groove, and the retention of enameled tooth crowns). Kellogg originally placed this species in the genus Ontocetus, a enigmatic tooth taxon reported from the 19th century, based on similarities between the type specimen Ontocetus emmonsi and the conspicuously large lower dentition of Ontocetus oxymycterus. However, the type of the genus Ontocetus is now known to represent a walrus tusk (belonging to fossil Odobenidae) instead of a cetacean tooth. Thus, we assign this species to the new genus Albicetus, creating the new combination of Albicetus oxymycterus, gen. nov. We provide new morphological observations of the type specimen, including a 3D model. We also calculate a total length of approximately 6 m in life, using cranial proxies of body size for physeteroids. Lastly, a phylogenetic analysis of Albicetus oxymycterus with other fossil and living Physeteroidea resolves its position as a stem physeteroid, implying that large body size and robust dentition in physeteroids evolved multiple times and in distantly related lineages.	[Boersma, Alexandra T.] Vassar Coll, Dept Earth Sci & Geog, Poughkeepsie, NY 12604 USA; [Boersma, Alexandra T.; Pyenson, Nicholas D.] Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20013 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Mammal, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Paleontol, Seattle, WA 98195 USA	Vassar College; Smithsonian Institution; Smithsonian National Museum of Natural History	Boersma, AT (corresponding author), Vassar Coll, Dept Earth Sci & Geog, Poughkeepsie, NY 12604 USA.	boersma.alex@gmail.com		Pyenson, Nicholas/0000-0003-4678-5782	Vassar College; NMNH Remington Kellogg Fund; Basis Foundation	Vassar College; NMNH Remington Kellogg Fund; Basis Foundation	This work was supported by Vassar College (AB), and the NMNH Remington Kellogg Fund and Basis Foundation (NDP) (http://www.mnh.si.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameghino F., 1894, BOLET ACAD NAC CCIAS, V13, P259, DOI DOI 10.5962/BHL.TITLE.77348; [Anonymous], 1999, WALKERS MAMMALS WORL; BARNES LG, 1985, MAR MAMMAL SCI, V1, P15, DOI 10.1111/j.1748-7692.1985.tb00530.x; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Blainville H. M. de., 1838, ANN FRANCAISES ETRAN, V2, P335; Blake Z, 1972, THE SPERM WHALE; Boessenecker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054311; Brandt J.-F., 1873, MEMOIRES LACADEMIE I, V20, P1, DOI DOI 10.5962/BHL.TITLE.39524; Brisson AD., 1762, LUGDUM BATARORUM APU; Churchill M, 2015, EVOLUTION, V69, P201, DOI 10.1111/evo.12560; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Cope E. D., 1895, Proceedings of the American Philosophical Society, Vxxxiv, P135; Cope E. D., 1867, P ACAD NAT SCI PHILA, V19, P138; du Bus BAL., 1867, B ACAD ROYALE SCI LE, V24, P562; Emmons E, 1860, MANUAL GEOLOGY DESIG; Fitzgerald EMG, 2011, J VERTEBR PALEONTOL, V31, P929, DOI 10.1080/02724634.2011.579670; Flower W. H., 1867, T ZOOLOGICAL SOC LON, V6, P87, DOI DOI 10.1111/J.1096-3642.1867.TB00572.X; Flower WH., 1868, T ZOOLOGICAL SOC LON, V6, P309; Fordyce R.E., 2009, THERIAN SKULL LEXICO; FORDYCE RE, 2001, SECONDARY ADAPTATION; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Gibbs NJ, 2011, NEW ZEAL J MAR FRESH, V35, P325; Gondar D, 1974, AC PRIM C ARG PAL BI, V2, P349; Gray JE., 1868, SYNOPSIS SPECIES WHA; Hampe Oliver, 2006, Fossil Record, V9, P61, DOI 10.1002/mmng.200600002; Heyning JE, 1997, MAR MAMMAL SCI, V13, P596, DOI 10.1111/j.1748-7692.1997.tb00086.x; Hirota Kiyoharu, 1994, Island Arc, V3, P453, DOI 10.1111/j.1440-1738.1994.tb00125.x; Hope Ranch Home Owners Association, 2015, HISTORY; Kazar Emese, 2002, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V72, P151; Kelley NP, 2015, SCIENCE, V348, DOI 10.1126/science.aaa3716; Kellogg AR, 1925, CONTRIBUTIONS PALAEO, V348, P1; Kellogg R, 1927, ADDITIONS PALEONTOLO, V346, P3; Kellogg R, 1925, P US NATL MUSEUM, V66; Kellogg R, 1965, FOSSIL MARINE MAMMAL, P47; Kimura Toshiyuki, 2006, Bulletin of Gunma Museum of Natural History, V10, P1; Kleinpell RM, 1980, AM ASS PETROLEUM GEO, V11; KLEINPELL RM, 1938, MIOCENE STRATIGRAPHY; Kohno N, 2008, VIRGINIA MUSEUM NATU, V14, P39; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Lambert O, 2014, NATURWISSENSCHAFTEN, V101, P517, DOI 10.1007/s00114-014-1182-2; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Lambert O, 2008, BULL INST R SC N B-S, V78, P277; Leidy J, 1869, J ACAD NATURAL SCI P, P440; Leidy J, 1860, P ACAD NAT SCI PHILA, V11, P162; Lindberg DR, 2007, LETHAIA, V40, P335, DOI 10.1111/j.1502-3931.2007.00032.x; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Maddison WP., 2021, MESQUITE MODULAR SYS; MATSUMOTO HIKOSHIHIRO, 1926, SCI REPT TOHOKU IMP UNIV GEOL 2ND SER, V10, P17; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Mchedlidze G. A., 1970, NEKOTORYE OBSHCHIE C; Melnikov VV, 1997, J MORPHOL, V234, P37; Melville H, 1981, THE WHALE; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Muizon C, 1988, VERTEBRES FOSSILES F; Okazaki, 1976, B MIZUNAMI FOSSIL MU, V3, P25; Owen R., 1866, T ZOOLOGICAL SOC LON, V6, P17, DOI DOI 10.1111/J.1096-3642.1866.TB00570.X; Perez LM, 2011, ENV TAPHONOMY AMEGHI, P648; Pyenson ND, 2007, BIOLOGY LETT, V3, P709, DOI 10.1098/rsbl.2007.0342; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; RAY C E, 1975, Proceedings of the Biological Society of Washington, V88, P281; Rowlett R, 2005, LIGHTHOUSE DIRECTORY, P25; Santa Barbara County Genealogical Society, 2015, CEM REC; Shikama T, 1973, MEMOIRS GEOLOGICAL S, V8, P137; Smith CR, 2015, ANNU REV MAR SCI, V7, P571, DOI 10.1146/annurev-marine-010213-135144; SPAMER EE, 1995, ACAD NATURAL SCI PHI, V16, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tsai CH, 2016, J MAMM EVOL, V23, P33, DOI 10.1007/s10914-015-9292-y; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; United States Coast Guard, 2015, LIGHT LIST, VVI; Van Beneden PJ, 1877, B ACAD ROYAL SCI LET, V64, P851; Van Beneden PJ, 1869, MEMOIRES ACAD ROYALE, V28, P2; Velez-Juarbe J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123909; Velez-Juarbe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031294; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Whitehead H., 2003, SPERM WHALES SOCIAL; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133	81	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0135551	10.1371/journal.pone.0135551	http://dx.doi.org/10.1371/journal.pone.0135551			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26651027	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903300001
J	Matheson, AMM; Sakata, JT				Matheson, Andrew M. M.; Sakata, Jon T.			Relationship between the Sequencing and Timing of Vocal Motor Elements in Birdsong	PLOS ONE			English	Article							CONTEXT-DEPENDENT CHANGES; AUDITORY-FEEDBACK; BASAL GANGLIA; SONG MOTOR; TEMPORAL STRUCTURE; MUSIC PERFORMANCE; NEURAL MECHANISMS; FINCH SONG; BRAIN; GENERATION	Accurate coordination of the sequencing and timing of motor gestures is important for the performance of complex and evolutionarily relevant behaviors. However, the degree to which motor sequencing and timing are related remains largely unknown. Birdsong is a communicative behavior that consists of discrete vocal motor elements ('syllables') that are sequenced and timed in a precise manner. To reveal the relationship between syllable sequencing and timing, we analyzed how variation in the probability of syllable transitions at branch points, nodes in song with variable sequencing across renditions, correlated with variation in the duration of silent gaps between syllable transitions ('gap durations') for adult Bengalese finch song. We observed a significant negative relationship between transition probability and gap duration: more prevalent transitions were produced with shorter gap durations. We then assessed the degree to which long-term age-dependent changes and acute context-dependent changes to syllable sequencing and timing followed this inverse relationship. Age-but not context-dependent changes to syllable sequencing and timing were inversely related. On average, gap durations at branch points decreased with age, and the magnitude of this decrease was greater for transitions that increased in prevalence than for transitions that decreased in prevalence. In contrast, there was no systematic relationship between acute context-dependent changes to syllable sequencing and timing. Gap durations at branch points decreased when birds produced female-directed courtship song compared to when they produced undirected song, and the magnitude of this decrease was not related to the direction and magnitude of changes to transition probabilities. These analyses suggest that neural mechanisms that regulate syllable sequencing could similarly control syllable timing but also highlight mechanisms that can independently regulate syllable sequencing and timing.	[Matheson, Andrew M. M.; Sakata, Jon T.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Sakata, JT (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	jon.sakata@mcgill.ca		Matheson, Andrew/0000-0001-9062-2521	Natural Sciences and Engineering Research Council [402417-2011]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the Natural Sciences and Engineering Research Council (JTS; 402417-2011); http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROPHYSIOL, V99, P373, DOI 10.1152/jn.00830.2007; Bertram R, 2014, NEUROSCIENCE, V277, P806, DOI 10.1016/j.neuroscience.2014.07.061; Bohland JW, 2010, J COGNITIVE NEUROSCI, V22, P1504, DOI 10.1162/jocn.2009.21306; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chambers F., 1997, SYSTEM, V25, P535, DOI [10.1016/S0346-251X(97)00046-8, DOI 10.1016/S0346-251X(97)00046-8]; Clay Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018786; Clay Z, 2009, ANIM BEHAV, V77, P1387, DOI 10.1016/j.anbehav.2009.02.016; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Cooper BG, 2012, NEUROBIOL AGING, V33, P564, DOI 10.1016/j.neurobiolaging.2010.04.014; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Drake C, 2000, COGNITION, V74, P1, DOI 10.1016/S0010-0277(99)00061-X; Fee MS, 2010, ILAR J, V51, P362, DOI 10.1093/ilar.51.4.362; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fujimoto H, 2011, J NEUROSCI, V31, P10023, DOI 10.1523/JNEUROSCI.1606-11.2011; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2013, J NEUROPHYSIOL, V109, P1025, DOI 10.1152/jn.00578.2012; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamaguchi K, 2014, ELIFE, V3, DOI 10.7554/eLife.01833; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Heinig A, 2014, ANIM BEHAV, V97, P1, DOI 10.1016/j.anbehav.2014.08.016; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Housen A, 2009, APPL LINGUIST, V30, P461, DOI 10.1093/applin/amp048; Iwashita N, 2008, APPL LINGUIST, V29, P24, DOI 10.1093/applin/amm017; James LS, 2014, J NEUROPHYSIOL, V112, P2040, DOI 10.1152/jn.00217.2014; James LS, J NEUROPHYS IN PRESS; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jin DZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051902; Jungers M. K., 2002, COGN PROCESS, V1-2, P21; Kakishita Y, 2009, DATA MIN KNOWL DISC, V18, P446, DOI 10.1007/s10618-008-0122-1; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; Kershenbaum A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1370; Kormos J., 2004, SYSTEM, V32, P145, DOI [10.1016/j.system.2004.01.001, DOI 10.1016/J.SYSTEM.2004.01.001]; Kosche G, 2015, J NEUROSCI, V35, P1217, DOI 10.1523/JNEUROSCI.4346-14.2015; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Matheson LE, 2016, DEV NEUROBIOL, V76, P47, DOI 10.1002/dneu.22298; Matheson LE, 2015, EUR J NEUROSCI, V41, P1180, DOI 10.1111/ejn.12885; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; MORRIS D, 1954, BEHAVIOUR, V6, P271, DOI 10.1163/156853954X00130; Okanoya K, 1997, J NEUROBIOL, V33, P343; Palmer C, 1997, CAN J EXP PSYCHOL, V51, P369, DOI 10.1037/1196-1961.51.4.369; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Pfenning AR, 2014, SCIENCE, V346, P1333, DOI 10.1126/science.1256846; Sakata JT, 2008, J NEUROSCI, V28, P11378, DOI 10.1523/JNEUROSCI.3254-08.2008; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; SCHMIDT RA, 1998, MOTOR CONTROL LEARNI; Takahasi M, 2010, ETHOLOGY, V116, P481, DOI 10.1111/j.1439-0310.2010.01772.x; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; VU ET, 1994, J NEUROSCI, V14, P6924; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Warren TL, 2012, J NEUROSCI, V32, P15414, DOI 10.1523/JNEUROSCI.1254-12.2012; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	71	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143203	10.1371/journal.pone.0143203	http://dx.doi.org/10.1371/journal.pone.0143203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650933	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300013
J	Xia, XL; Shao, YF; Jiang, JF; Du, XP; Sheng, LP; Chen, FD; Fang, WM; Guan, ZY; Chen, SM				Xia, Xiaolong; Shao, Yafeng; Jiang, Jiafu; Du, Xinping; Sheng, Liping; Chen, Fadi; Fang, Weimin; Guan, Zhiyong; Chen, Sumei			MicroRNA Expression Profile during Aphid Feeding in Chrysanthemum (Chrysanthemum morifolium)	PLOS ONE			English	Article							GREEN PEACH APHID; NICOTIANA-ATTENUATA; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MIRNA; RNA; RESPONSES; TARGETS; IDENTIFICATION; TRANSCRIPTOME	MicroRNAs (miRNAs) are important regulators of gene expression, affecting many biological processes. As yet, their roles in the response of chrysanthemum to aphid feeding have not been explored. Here, the identity and abundance of miRNAs induced by aphid infestation have been obtained using high-throughput Illumina sequencing platform. Three leaf small RNA libraries were generated, one from plants infested with the aphid Macrosiphoniella sanbourni (library A), one from plants with mock puncture treatment (library M), and the third from untreated control plants (library CK). A total of 7,944,797, 7,605,251 and 9,244,002 clean unique reads, ranging from 18 to 30 nucleotides (nt) in length, were obtained from library CK, A and M, respectively. As a result, 303 conserved miRNAs belonging to 276 miRNAs families and 234 potential novel miRNAs were detected in chrysanthemum leaf, out of which 80, 100 and 79 significantly differentially expressed miRNAs were identified in the comparison of CK-VS-A, CK-VS-M and M-VS-A, respectively. Several of the differentially abundant miRNAs (in particular miR159a, miR160a, miR393a) may be associated with the plant's response to aphid infestation.	[Xia, Xiaolong; Shao, Yafeng; Jiang, Jiafu; Du, Xinping; Sheng, Liping; Chen, Fadi; Fang, Weimin; Guan, Zhiyong; Chen, Sumei] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, SM (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chensm@njau.edu.cn			National Nature Science Foundation of China (NSFC) [31471900, 31471913]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX(12)2020]; Program for Science and Technology Support, Jiangsu, China [BE2011325, BE2012350]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; Program for Science and Technology Support, Jiangsu, China	This work was supported by National Nature Science Foundation of China (NSFC, 31471900, 31471913), Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (CX(12)2020) and the Program for Science and Technology Support, Jiangsu, China (grant no. BE2011325, BE2012350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Barah P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058987; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bozorov TA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-209; Bozorov TA, 2012, J INTEGR PLANT BIOL, V54, P189, DOI 10.1111/j.1744-7909.2012.01104.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; da Silva JAT, 2013, CRIT REV PLANT SCI, V32, P21, DOI 10.1080/07352689.2012.696461; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Girousse C, 2005, PLANT PHYSIOL, V137, P1474, DOI 10.1104/pp.104.057430; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Kettles GJ, 2011, ANAL ARABIDOPSIS THA; Kettles GJ, 2013, NEW PHYTOL, V198, P1178, DOI 10.1111/nph.12218; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Pandey SP, 2008, P NATL ACAD SCI USA, V105, P4559, DOI 10.1073/pnas.0711363105; Pandey SP, 2007, PLANT J, V50, P40, DOI 10.1111/j.1365-313X.2007.03030.x; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Sattar S, 2012, MOL PLANT MICROBE IN, V25, P839, DOI 10.1094/MPMI-09-11-0252; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shinoyama H, 2012, PLANT BIOTECHNOL-NAR, V29, P323, DOI 10.5511/plantbiotechnology.12.0521a; Song AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057229; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Woodger FJ, 2003, J PLANT GROWTH REGUL, V22, P176, DOI 10.1007/s00344-003-0025-8; Xia XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1050; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200	46	15	17	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143720	10.1371/journal.pone.0143720	http://dx.doi.org/10.1371/journal.pone.0143720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650759	gold, Green Published			2022-12-26	WOS:000366903300023
J	Kinnunen, S; Valimaki, M; Tolli, M; Wohlfahrt, G; Darwich, R; Komati, H; Nemer, M; Ruskoaho, H				Kinnunen, Sini; Vaelimaeki, Mika; Toelli, Marja; Wohlfahrt, Gerd; Darwich, Rami; Komati, Hiba; Nemer, Mona; Ruskoaho, Heikki			Nuclear Receptor-Like Structure and Interaction of Congenital Heart Disease-Associated Factors GATA4 and NKX2-5	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; OF-FUNCTION MUTATION; DNA-BINDING TARGETS; CARDIAC TRANSCRIPTION; GENE-EXPRESSION; VENTRAL MORPHOGENESIS; MUTUAL COFACTORS; DEFINED FACTORS; TUBE FORMATION; ADULT HEART	Aims Transcription factor GATA4 is a dosage sensitive regulator of heart development and alterations in its level or activity lead to congenital heart disease (CHD). GATA4 has also been implicated in cardiac regeneration and repair. GATA4 action involves combinatorial interaction with other cofactors such as NKX2-5, another critical cardiac regulator whose mutations also cause CHD. Despite its critical importance to the heart and its evolutionary conservation across species, the structural basis of the GATA4-NKX2-5 interaction remains incompletely understood. Methods and Results A homology model was constructed and used to identify surface amino acids important for the interaction of GATA4 and NKX2-5. These residues were subjected to site-directed mutagenesis, and the mutant proteins were characterized for their ability to bind DNA and to physically and functionally interact with NKX2-5. The studies identify 5 highly conserved amino acids in the second zinc finger (N272, R283, Q274, K299) and its C-terminal extension (R319) that are critical for physical and functional interaction with the third alpha helix of NKX2-5 homeodomain. Integration of the experimental data with computational modeling suggests that the structural arrangement of the zinc finger-homeodomain resembles the architecture of the conserved DNA binding domain of nuclear receptors. Conclusions The results provide novel insight into the structural basis for protein-protein interactions between two important classes of transcription factors. The model proposed will help to elucidate the molecular basis for disease causing mutations in GATA4 and NKX2-5 and may be relevant to other members of the GATA and NK classes of transcription factors.	[Kinnunen, Sini; Vaelimaeki, Mika; Ruskoaho, Heikki] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Helsinki, Finland; [Kinnunen, Sini; Vaelimaeki, Mika; Toelli, Marja; Ruskoaho, Heikki] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Wohlfahrt, Gerd] Comp Aided Drug Design, Orion Pharma, Espoo, Finland; [Darwich, Rami; Komati, Hiba; Nemer, Mona] Univ Ottawa, Dept Biochem Immunol & Microbiol, Lab Cardiac Dev & Differentiat, Ottawa, ON, Canada	University of Helsinki; University of Oulu; Orion Corporation; University of Ottawa	Nemer, M (corresponding author), Univ Ottawa, Dept Biochem Immunol & Microbiol, Lab Cardiac Dev & Differentiat, Ottawa, ON, Canada.	mona.nemer@uottawa.ca; heikki.ruskoaho@helsinki.fi		Valimaki, Mika/0000-0002-9687-8197; Kinnunen, Sini/0000-0003-1592-8306; Wohlfahrt, Gerd/0000-0003-0530-2000	Academy of Finland [266661]; Tekes large strategic research opening [40395/13]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Canadian Institute for Health Research [MOP36382]; Orion Pharma	Academy of Finland(Academy of Finland); Tekes large strategic research opening; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Orion Pharma	This work was supported by grants from the Academy of Finland (266661) (HR), the Tekes large strategic research opening (project no. 40395/13) (HR), Sigrid Juselius Foundation (HR), the Finnish Foundation for Cardiovascular Research (HR) (the authors do not have specific grant numbers for these grants), and the Canadian Institute for Health Research (MN) (MOP36382). Funding for open access charge came from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Orion Pharma provided support in the form of salary for GW, but Orion Pharma or the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of GW is articulated in the 'author contributions' section.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; ARGENTIN S, 1994, MOL CELL BIOL, V14, P777, DOI 10.1128/MCB.14.1.777; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Dentice M, 2003, MOL ENDOCRINOL, V17, P1508, DOI 10.1210/me.2002-0348; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gallagher JM, 2012, MOL CELL BIOL, V32, P2214, DOI 10.1128/MCB.00218-12; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Gupta V, 2013, CURR BIOL, V23, P1221, DOI 10.1016/j.cub.2013.05.028; Hakkola J, 2003, J PHARMACOL EXP THER, V304, P1048, DOI 10.1124/jpet.102.041582; Hautala N, 2001, CIRCULATION, V103, P730; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Ho CKM, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-10; Hunter CC, 2014, EUKARYOT CELL, V13, P527, DOI 10.1128/EC.00040-14; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kasahara H, 2004, CARDIOVASC RES, V64, P40, DOI 10.1016/j.cardiores.2004.06.004; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kerkela R, 2002, J BIOL CHEM, V277, P13752, DOI 10.1074/jbc.M105736200; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kuo HC, 1999, DEVELOPMENT, V126, P4223; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Li RG, 2013, BIOCHEM BIOPH RES CO, V439, P591, DOI 10.1016/j.bbrc.2013.09.023; Lourenco D, 2011, P NATL ACAD SCI USA, V108, P1597, DOI 10.1073/pnas.1010257108; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Misra C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002690; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nemer Georges, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9410; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Philips AS, 2007, J BIOL CHEM, V282, P24915, DOI 10.1074/jbc.M701789200; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Ranganayakulu G, 1998, DEVELOPMENT, V125, P3037; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Rivkees SA, 1999, J BIOL CHEM, V274, P14204, DOI 10.1074/jbc.274.20.14204; Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Xiang R, 2014, GENE, V534, P320, DOI 10.1016/j.gene.2013.10.028; Yamak A, 2014, P NATL ACAD SCI USA, V111, P1415, DOI 10.1073/pnas.1312993111; Yang YQ, 2013, HUM MUTAT, V34, P1662, DOI 10.1002/humu.22434	67	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144145	10.1371/journal.pone.0144145	http://dx.doi.org/10.1371/journal.pone.0144145			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642209	gold, Green Published			2022-12-26	WOS:000366902700063
J	Rabadi, SM; Sanchez, BC; Varanat, M; Ma, Z; Catlett, SV; Melendez, JA; Malik, M; Bakshi, CS				Rabadi, Seham M.; Sanchez, Belkys C.; Varanat, Mrudula; Ma, Zhuo; Catlett, Sally V.; Melendez, Juan Andres; Malik, Meenakshi; Bakshi, Chandra Shekhar			Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; cytokine induction; immunosuppression; p38 MAPK; redox signaling	INNATE IMMUNE-RESPONSES; REACTIVE OXYGEN; INTRAMACROPHAGE SURVIVAL; OXIDATIVE STRESS; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR SURVIVAL; MEMBRANE-PROTEIN; IDENTIFICATION; ACTIVATION; TULAREMIA	Francisella tularensis, the causative agent of a fatal human disease known as tularemia, has been used in the bioweapon programs of several countries in the past, and now it is considered a potential bioterror agent. Extreme infectivity and virulence of F. tularensis is due to its ability to evade immune detection and to suppress the host's innate immune responses. However, Francisella-encoded factors and mechanisms responsible for causing immune suppression are not completely understood. Macrophages and neutrophils generate reactive oxygen species (ROS)/reactive nitrogen species as a defense mechanism for the clearance of phagocytosed microorganisms. ROS serve a dual role; at high concentrations they act as microbicidal effector molecules that destroy intracellular pathogens, and at low concentrations they serve as secondary signaling messengers that regulate the expression of various inflammatory mediators. We hypothesized that the antioxidant defenses of F. tularensis maintain redox homeostasis in infected macrophages to prevent activation of redox-sensitive signaling components that ultimately result in suppression of pro-inflammatory cytokine production and macrophage microbicidal activity. We demonstrate that antioxidant enzymes of F. tularensis prevent the activation of redox-sensitive MAPK signaling components, NF-B signaling, and the production of pro-inflammatory cytokines by inhibiting the accumulation of ROS in infected macrophages. We also report that F. tularensis inhibits ROS-dependent autophagy to promote its intramacrophage survival. Collectively, this study reveals novel pathogenic mechanisms adopted by F. tularensis to modulate macrophage innate immune functions to create an environment permissive for its intracellular survival and growth.	[Rabadi, Seham M.; Sanchez, Belkys C.; Varanat, Mrudula; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, BSB 340,15 Dana Rd, Valhalla, NY 10595 USA; [Ma, Zhuo; Catlett, Sally V.; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, Albany, NY 12208 USA; [Melendez, Juan Andres] SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Melendez, Juan Andres] SUNY Albany, Polytech Inst, Coll Engn, Albany, NY 12203 USA	New York Medical College; Albany College of Pharmacy & Health Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Bakshi, CS (corresponding author), New York Med Coll, Dept Microbiol & Immunol, BSB 340,15 Dana Rd, Valhalla, NY 10595 USA.; Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Basic & Social Sci, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu; Shekhar_Bakshi@nymc.edu	Malik, Meenakshi/F-1501-2015	Malik, Meenakshi/0000-0003-0051-4485; Sanchez, Belkys/0000-0002-7290-1460; Ma, Zhuo/0000-0002-9766-8239; Melendez, Juan/0000-0001-8021-3097	National Institutes of Health [P01AI056320, R56AI101109, R15AI107698]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107698, R56AI101109, P01AI056320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE023526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AI056320 and R56AI101109 (to C. S. B.) and R15AI107698 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen LAH, 2007, IMMUNOL REV, V219, P103, DOI 10.1111/j.1600-065X.2007.00544.x; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00009; Break TJ, 2012, J IMMUNOL, V188, P3342, DOI 10.4049/jimmunol.1102341; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Case ED, 2014, CELL MICROBIOL, V16, P862, DOI 10.1111/cmi.12246; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cremer TJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00013; DEBY C, 1990, BIOCHEM PHARMACOL, V39, P399, DOI 10.1016/0006-2952(90)90043-K; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Dieppedale J, 2011, INFECT IMMUN, V79, P1428, DOI 10.1128/IAI.01012-10; Elgort Marc G, 2010, Genes Cancer, V1, P893, DOI 10.1177/1947601910389604; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Franchini AM, 2013, J BIOL CHEM, V288, P25098, DOI 10.1074/jbc.M113.474106; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Geier H, 2011, INFECT IMMUN, V79, P2204, DOI 10.1128/IAI.01382-10; Gillette DD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00045; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Halliwell B, 1997, J NEUROCHEM, V69, P1330; Hayakawa T, 2011, GENETICS, V187, P785, DOI 10.1534/genetics.110.124883; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Ichijo Hidenori, 2007, Folia Pharmacologica Japonica, V129, P89, DOI 10.1254/fpj.129.89; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Ma Z, 2014, MOL MICROBIOL, V91, P976, DOI 10.1111/mmi.12509; Mahawar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061539; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Mendez-Samperio P, 2009, MICROB PATHOGENESIS, V47, P252, DOI 10.1016/j.micpath.2009.08.006; Miller JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000864; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Orekhov AN, 2015, EXP MOL PATHOL, V99, P151, DOI 10.1016/j.yexmp.2015.06.011; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Samuel LP, 2007, MICROBIOL-SGM, V153, P529, DOI 10.1099/mic.0.2006/002642-0; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Schwartz JT, 2012, J IMMUNOL, V189, P3064, DOI 10.4049/jimmunol.1200816; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; STEINBECK MJ, 1993, J BIOL CHEM, V268, P15649; Travanty E, 2015, J VIROL, V89, P11935, DOI 10.1128/JVI.01792-15; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Yang CS, 2008, CELL MICROBIOL, V10, P741, DOI 10.1111/j.1462-5822.2007.01081.x; Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Yuk JM, 2009, IMMUNOL CELL BIOL, V87, P100, DOI 10.1038/icb.2008.74; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	73	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5009	5021		10.1074/jbc.M115.681478	http://dx.doi.org/10.1074/jbc.M115.681478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26644475	Green Published, hybrid			2022-12-26	WOS:000371640600016
J	John, CM; Phillips, NJ; Din, R; Liu, MF; Rosenqvist, E; Hoiby, EA; Stein, DC; Jarvis, GA				John, Constance M.; Phillips, Nancy J.; Din, Richard; Liu, Mingfeng; Rosenqvist, Einar; Hoiby, E. Arne; Stein, Daniel C.; Jarvis, Gary A.			Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioinformatics; infection; lipid A; mass spectrometry (MS); phosphorylation; sialic acid; Neisseria meningitidis; acylation; lipooligosaccharide; phosphoethanolamine	LACTO-N-NEOTETRAOSE; GRAM-NEGATIVE BACTERIA; NORMAL HUMAN SERUM; FACTOR-H BINDING; INNER-CORE; SEROGROUP-B; MENINGOCOCCAL DISEASE; ALKALINE-PHOSPHATASE; ENDOTOXIN TOLERANCE; LIPID-A	The degree of phosphorylation and phosphoethanolaminylation of lipid A on neisserial lipooligosaccharide (LOS), a major cell-surface antigen, can be correlated with inflammatory potential and the ability to induce immune tolerance in vitro. On the oligosaccharide of the LOS, the presence of phosphoethanolamine and sialic acid substituents can be correlated with in vitro serum resistance. In this study, we analyzed the structure of the LOS from 40 invasive isolates and 25 isolates from carriers of Neisseria meningitidis without disease. Invasive strains were classified as groups 1-3 that caused meningitis, septicemia without meningitis, and septicemia with meningitis, respectively. Intact LOS was analyzed by high resolution matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Prominent peaks for lipid A fragment ions with three phosphates and one phosphoethanolamine were detected in all LOS analyzed. LOS from groups 2 and 3 had less abundant ions for highly phosphorylated lipid A forms and induced less TNF- in THP-1 monocytic cells compared with LOS from group 1. Lipid A from all invasive strains was hexaacylated, whereas lipid A of 6/25 carrier strains was pentaacylated. There were fewer O-acetyl groups and more phosphoethanolamine and sialic acid substitutions on the oligosaccharide from invasive compared with carrier isolates. Bioinformatic and genomic analysis of LOS biosynthetic genes indicated significant skewing to specific alleles, dependent on the disease outcome. Our results suggest that variable LOS structures have multifaceted effects on homeostatic innate immune responses that have critical impact on the pathophysiology of meningococcal infections.	[John, Constance M.; Din, Richard; Liu, Mingfeng; Jarvis, Gary A.] Vet Affairs Med Ctr, Ctr Immunochem, San Francisco, CA 94121 USA; [John, Constance M.; Phillips, Nancy J.; Liu, Mingfeng; Jarvis, Gary A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [John, Constance M.; Phillips, Nancy J.; Jarvis, Gary A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Rosenqvist, Einar; Hoiby, E. Arne] Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway; [Stein, Daniel C.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Norwegian Institute of Public Health (NIPH); University System of Maryland; University of Maryland College Park	Jarvis, GA (corresponding author), Vet Affairs Med Ctr, Dept 111W1,4150 Clement St, San Francisco, CA 94121 USA.	gary.jarvis@ucsf.edu		Stein, Daniel/0000-0003-3397-5720; Jarvis, Gary/0000-0002-7576-3702	Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health/NCI Cancer Center Support Grant [P30 CA082103]; Canary Foundation; National Institutes of Health/NCRR Shared Instrumentation Grant [S10 RR029446]; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029446] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000727] Funding Source: NIH RePORTER	Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health/NCI Cancer Center Support Grant; Canary Foundation; National Institutes of Health/NCRR Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs)	We gratefully acknowledge the University of California, San Francisco Sandler-Moore Mass Spectrometry Core Facility, which has received support from the Sandler Family Foundation, the Gordon and Betty Moore Foundation, National Institutes of Health/NCI Cancer Center Support Grant P30 CA082103, the Canary Foundation, and the National Institutes of Health/NCRR Shared Instrumentation Grant S10 RR029446 (to H. E. Witkowska). We thank the laboratory of Dominique Caugant for purification of DNA used in the genomic allele studies.	Balthazar JT, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00030; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Bevanger L, 1998, J MED MICROBIOL, V47, P993, DOI 10.1099/00222615-47-11-993; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Brandtzaeg P, 2012, METHODS MOL BIOL, V799, P21, DOI 10.1007/978-1-61779-346-2_2; Brouwer MC, 2011, J INFECTION, V62, P479, DOI 10.1016/j.jinf.2011.03.010; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Cheng H, 2011, J BIOL CHEM, V286, P43622, DOI 10.1074/jbc.M111.291583; Choudhury B, 2008, CARBOHYD RES, V343, P2971, DOI 10.1016/j.carres.2008.08.026; Conyn-van Spaendonck MAE, 1999, J INFECTION, V39, P42, DOI 10.1016/S0163-4453(99)90101-9; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; du Plessis M, 2014, J INFECTION, V68, P455, DOI 10.1016/j.jinf.2013.12.011; ERWIN AL, 1991, INFECT IMMUN, V59, P1881, DOI 10.1128/IAI.59.6.1881-1887.1991; ERWIN AL, 1990, J BIOL CHEM, V265, P16444; Estabrook MM, 2007, INFECT IMMUN, V75, P1025, DOI 10.1128/IAI.00882-06; ESTABROOK MM, 1992, J INFECT DIS, V166, P1079, DOI 10.1093/infdis/166.5.1079; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fransen F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000396; FROHOLM L O, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P139; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; GRIFFISS JM, 1991, J IMMUNOL, V147, P298; GU XX, 1992, J CLIN MICROBIOL, V30, P2047, DOI 10.1128/JCM.30.8.2047-2053.1992; Gulati S, 2005, INFECT IMMUN, V73, P7390, DOI 10.1128/IAI.73.11.7390-7397.2005; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hellerud BC, 2010, INFECT IMMUN, V78, P802, DOI 10.1128/IAI.01044-09; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; HOIBY E A, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P107; JARVIS GA, 1994, INFECT IMMUN, V62, P1755, DOI 10.1128/IAI.62.5.1755-1760.1994; John CM, 2012, INFECT IMMUN, V80, P4014, DOI 10.1128/IAI.00506-12; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; JOHNSON AP, 1983, J CLIN PATHOL, V36, P213, DOI 10.1136/jcp.36.2.213; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones JW, 2008, P NATL ACAD SCI USA, V105, P12742, DOI 10.1073/pnas.0800445105; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; Kahler CM, 1996, J BACTERIOL, V178, P1265, DOI 10.1128/jb.178.5.1265-1273.1996; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Lappann M, 2013, MOL MICROBIOL, V89, P433, DOI 10.1111/mmi.12288; Lewis LA, 2013, INFECT IMMUN, V81, P33, DOI 10.1128/IAI.00751-12; Lewis LA, 2012, J IMMUNOL, V188, P5063, DOI 10.4049/jimmunol.1103748; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Liu MF, 2014, J IMMUNOL, V192, P1768, DOI 10.4049/jimmunol.1301648; Liu MF, 2010, J IMMUNOL, V185, P6974, DOI 10.4049/jimmunol.1000953; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Lu MF, 2011, J IMMUNOL, V187, P3314, DOI 10.4049/jimmunol.1004087; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Persa OD, 2014, LANCET, V384, P1900, DOI 10.1016/S0140-6736(14)61645-7; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; Quinn EM, 2012, J LEUKOCYTE BIOL, V91, P721, DOI 10.1189/jlb.1111571; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Rodenburg GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049295; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; SODERSTROM C, 1987, J INFECT DIS, V156, P107, DOI 10.1093/infdis/156.1.107; Steinshamn S, 2000, APMIS, V108, P107, DOI 10.1034/j.1600-0463.2000.d01-33.x; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephenson HN, 2013, J BIOL CHEM, V288, P19661, DOI 10.1074/jbc.M113.468298; Su FH, 2006, CRIT CARE MED, V34, P2182, DOI 10.1097/01.CCM.0000229887.70579.29; Takahashi H, 2008, INFECT IMMUN, V76, P5777, DOI 10.1128/IAI.00676-08; Tsai CM, 2009, J BIOL CHEM, V284, P4616, DOI 10.1074/jbc.M808209200; Tsai CM, 2002, INFECT IMMUN, V70, P407, DOI 10.1128/IAI.70.1.407-411.2002; TSAI CM, 1987, INFECT IMMUN, V55, P1652, DOI 10.1128/IAI.55.7.1652-1656.1987; Tsai CM, 1998, GLYCOBIOLOGY, V8, P359, DOI 10.1093/glycob/8.4.359; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Vu DM, 2012, INFECT IMMUN, V80, P643, DOI 10.1128/IAI.05604-11; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wong HEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026130; YAMASAKI R, 1991, MOL IMMUNOL, V28, P1233, DOI 10.1016/0161-5890(91)90010-H; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	79	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3224	3238		10.1074/jbc.M115.666214	http://dx.doi.org/10.1074/jbc.M115.666214			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26655715	Green Published, hybrid			2022-12-26	WOS:000370854500010
J	Gai, ZB; Gui, T; Hiller, C; Kullak-Ublick, GA				Gai, Zhibo; Gui, Ting; Hiller, Christian; Kullak-Ublick, Gerd A.			Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL LIPID-METABOLISM; ENDOPLASMIC-RETICULUM STRESS; DIABETIC-NEPHROPATHY; MITOCHONDRIAL DYSFUNCTION; ACID; FIBROSIS; INFLAMMATION; PROGRESSION; ACTIVATION; GLOMERULOSCLEROSIS	Activation of the farnesoid X receptor (FXR) has indicated a therapeutic potential for this nuclear bile acid receptor in the prevention of diabetic nephropathy and obesity-induced renal damage. Here, we investigated the protective role of FXR against kidney damage induced by obesity in mice that had undergone uninephrectomy, a model resembling the clinical situation of kidney donation by obese individuals. Mice fed a high-fat diet developed the core features of metabolic syndrome, with subsequent renal lipid accumulation and renal injury, including glomerulosclerosis, interstitial fibrosis, and albuminuria. The effects were accentuated by uninephrectomy. In human renal biopsies, staining of 4-hydroxynonenal (4-HNE), glucose-regulated protein 78 (Grp78), and C/EBP-homologous protein, markers of endoplasmic reticulum stress, was more prominent in the proximal tubules of 15 obese patients compared with 16 non-obese patients. In mice treated with the FXR agonist obeticholic acid, renal injury, renal lipid accumulation, apoptosis, and changes in lipid peroxidation were attenuated. Moreover, disturbed mitochondrial function was ameliorated and the mitochondrial respiratory chain recovered following obeticholic acid treatment. Culturing renal proximal tubular cells with free fatty acid and FXR agonists showed that FXR activation protected cells from free fatty acid-induced oxidative stress and endoplasmic reticulum stress, as denoted by a reduction in the level of reactive oxygen species staining and Grp78 immunostaining, respectively. Several genes involved in glutathione metabolism were induced by FXR activation in the remnant kidney, which was consistent with a decreased glutathione disulfide/glutathione ratio. In summary, FXR activation maintains endogenous glutathione homeostasis and protects the kidney in uninephrectomized mice from obesity-induced injury.	[Gai, Zhibo; Hiller, Christian; Kullak-Ublick, Gerd A.] Univ Zurich, Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Ramistr 100, CH-8091 Zurich, Switzerland; [Gui, Ting] Inselspital Bern, Dept Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Kullak-Ublick, GA (corresponding author), Univ Zurich, Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Ramistr 100, CH-8091 Zurich, Switzerland.	gerd.kullak@usz.ch	GAI, ZHIBO/ABE-7650-2020	GAI, ZHIBO/0000-0003-1673-6541	Swiss National Science Foundation [320030-144193]; Swiss National Center for Competence in Research NCCR; International Fellowship Program on Integrative Kidney Physiology and Pathophysiology (IKPP) [246539]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center for Competence in Research NCCR(Swiss National Science Foundation (SNSF)); International Fellowship Program on Integrative Kidney Physiology and Pathophysiology (IKPP)	This study was supported by Grant 320030-144193 from the Swiss National Science Foundation (to G. K.-U.), a grant from the Swiss National Center for Competence in Research NCCR (Kidney.ch), and Grant 246539 from the International Fellowship Program on Integrative Kidney Physiology and Pathophysiology (IKPP). The authors declare that they have no conflicts of interest with the contents of this article.	Abrass CK, 2004, J AM SOC NEPHROL, V15, P2768, DOI 10.1097/01.ASN.0000141963.04540.3E; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Bonnet F, 2000, DIABETES METAB, V26, P254; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cao YP, 2014, INT J MOL MED, V33, P809, DOI 10.3892/ijmm.2014.1642; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Cho EJ, 2014, DIGEST DIS SCI, V59, P1461, DOI 10.1007/s10620-014-3217-0; Choi BH, 2014, MOLECULES, V19, P12727, DOI 10.3390/molecules190812727; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fujii H, 2010, AM J NEPHROL, V31, P342, DOI 10.1159/000297290; Gai ZB, 2014, BBA-MOL BASIS DIS, V1842, P1870, DOI 10.1016/j.bbadis.2014.07.001; Gai ZB, 2010, J AM SOC NEPHROL, V21, P1468, DOI 10.1681/ASN.2009121201; Gin H, 2000, DIABETES METAB, V26, P45; Gonzalez E, 2005, KIDNEY INT, V68, P263, DOI 10.1111/j.1523-1755.2005.00401.x; Habibi J, 2011, ENDOCRINOLOGY, V152, P659, DOI 10.1210/en.2010-1038; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Hu ZJ, 2012, KIDNEY BLOOD PRESS R, V36, P85, DOI 10.1159/000341485; Jaimes EA, 2010, AM J PHYSIOL-RENAL, V298, pF125, DOI 10.1152/ajprenal.00248.2009; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; Nelson D., 2005, LEHNINGER PRINCIPLES, P647; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Praga M, 2006, CURR OPIN NEPHROL HY, V15, P481, DOI 10.1097/01.mnh.0000242172.06459.7c; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Sieber J, 2010, AM J PHYSIOL-RENAL, V299, pF821, DOI 10.1152/ajprenal.00196.2010; Soumura M, 2010, BIOCHEM BIOPH RES CO, V402, P265, DOI 10.1016/j.bbrc.2010.10.012; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Tan SM, 2014, DIABETES, V63, P3091, DOI 10.2337/db13-1743; Tang JH, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/608397; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Zhan L., PLOS ONE, V9	52	52	56	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2397	2411		10.1074/jbc.M115.694323	http://dx.doi.org/10.1074/jbc.M115.694323			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26655953	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000369610400029
J	Hunter, RK; Nevitt, CD; Gaskins, JT; Keller, BB; Bohler, HCL; LeBlanc, AJ				Hunter, Robert K., II; Nevitt, Chris D.; Gaskins, Jeremy T.; Keller, Bradley B.; Bohler, Henry C. L., Jr.; LeBlanc, Amanda J.			Adipose-Derived Stromal Vascular Fraction Cell Effects on a Rodent Model of Thin Endometrium	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO FERTILIZATION; STEM-CELLS; LOCAL INJURY; EMBRYO IMPLANTATION; VAGINAL SILDENAFIL; THICKNESS; PERFUSION; CYCLES; VEGF	Endometrial dysfunction affects approximately 1% of infertile women, and there is currently no standard therapy for improving fertility treatment outcomes in these patients. In our study, we utilized a rodent model of thin endometrium to test whether intrauterine application of adipose-derived stromal vascular fraction cells (SVF) could improve morphological and physiological markers of endometrial receptivity. Using anhydrous ethanol, endometrial area and gland density were significantly reduced in our model of thin endometrium. Application of SVF was associated with a 29% reduction in endometrial vascular endothelial growth factor (VEGF) expression and significant increases in uterine artery systolic/diastolic velocity ratios and resistance index values, suggesting reduced diastolic microvascular tone. However, no significant improvements in endometrial area or gland density were observed following SVF treatment. 3D confocal imaging demonstrated poor engraftment of SVF cells into recipient tissue, which likely contributed to the negative results of this study. We suspect modified treatment protocols utilizing adjuvant estrogen and/or tail vein cell delivery may improve SVF retention and therapeutic response in subsequent studies. SVF is an easily-obtainable cell product with regenerative capability that may have a future role in the treatment of infertile women with endometrial dysfunction.	[Hunter, Robert K., II; Bohler, Henry C. L., Jr.] Univ Louisville, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod Endocrinol & Infertil, Louisville, KY 40292 USA; [Nevitt, Chris D.] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Gaskins, Jeremy T.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Keller, Bradley B.; LeBlanc, Amanda J.] Cardiovasc Innovat Inst, Louisville, KY 40202 USA; [LeBlanc, Amanda J.] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	LeBlanc, AJ (corresponding author), Cardiovasc Innovat Inst, Louisville, KY 40202 USA.	amanda.leblanc@louisville.edu		LeBlanc, Amanda/0000-0003-2507-1203	American Heart Association [12BGIA9310043]; Gheens Foundation; National Institutes of Health [P30 GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Gheens Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported by the American Heart Association (12BGIA9310043 to AJL), the Gheens Foundation (to AJL), and the National Institutes of Health (P30 GM103507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird AL, 2015, EXP GERONTOL, V63, P18, DOI 10.1016/j.exger.2015.01.044; Barash A, 2003, FERTIL STERIL, V79, P1317, DOI 10.1016/S0015-0282(03)00345-5; Bicknell R, 1996, ENDOTHELIAL CELL CUL; Binder NK, 2014, HUM REPROD, V29, P2278, DOI 10.1093/humrep/deu211; Bodombossou-Djobo MMA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-122; Casper RF, 2011, FERTIL STERIL, V96, P519, DOI 10.1016/j.fertnstert.2011.07.1096; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; Chen MJ, 2006, J ASSIST REPROD GEN, V23, P337, DOI 10.1007/s10815-006-9053-1; Cocuzza MA, 2011, FERTIL STERIL, V95, P2418, DOI 10.1016/j.fertnstert.2011.03.064; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Fanchin R, 2001, FERTIL STERIL, V76, P994, DOI 10.1016/S0015-0282(01)02841-2; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Gleicher N, 2013, HUM REPROD, V28, P172, DOI 10.1093/humrep/des370; Gleicher N, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.143; Gnainsky Y, 2010, FERTIL STERIL, V94, P2030, DOI 10.1016/j.fertnstert.2010.02.022; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Kellar RS, 2011, TISSUE ENG PT A, V17, P2177, DOI [10.1089/ten.tea.2010.0680, 10.1089/ten.TEA.2010.0680]; Kilic S, 2014, J ASSIST REPROD GEN, V31, P975, DOI 10.1007/s10815-014-0268-2; Koh YJ, 2011, ARTERIOSCL THROM VAS, V31, P1141, DOI 10.1161/ATVBAHA.110.218206; LeBlanc AJ, 2013, STEM CELL TRANSL MED, V2, P896, DOI 10.5966/sctm.2013-0046; LeBlanc AJ, 2012, AM J PHYSIOL-HEART C, V302, pH973, DOI 10.1152/ajpheart.00735.2011; Ledee-Bataille N, 2002, HUM REPROD, V17, P1249, DOI 10.1093/humrep/17.5.1249; Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Miwa I, 2009, FERTIL STERIL, V91, P998, DOI 10.1016/j.fertnstert.2008.01.029; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Morris ME, 2015, STEM CELL TRANSL MED, V4, P369, DOI 10.5966/sctm.2014-0252; Nagori Chaitanya B, 2011, J Hum Reprod Sci, V4, P43, DOI 10.4103/0974-1208.82360; NOYES N, 1995, HUM REPROD, V10, P919, DOI 10.1093/oxfordjournals.humrep.a136061; Nunes SS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02141; Qublan H, 2008, Hum Fertil (Camb), V11, P43, DOI 10.1080/14647270701704768; R Core Team. R, R LANG ENV STAT COMP; Revel A, 2012, FERTIL STERIL, V97, P1028, DOI 10.1016/j.fertnstert.2012.03.039; Richter KS, 2007, FERTIL STERIL, V87, P53, DOI 10.1016/j.fertnstert.2006.05.064; RUPNICK MA, 1989, J VASC SURG, V9, P788, DOI 10.1067/mva.1989.vs0090788; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Sher G, 2002, FERTIL STERIL, V78, P1073, DOI 10.1016/S0015-0282(02)03375-7; Shufaro Y, 2008, J ASSIST REPROD GEN, V25, P421, DOI 10.1007/s10815-008-9245-y; Singh Neeta, 2014, J Hum Reprod Sci, V7, P93, DOI 10.4103/0974-1208.138864; Singh Neeta, 2011, J Hum Reprod Sci, V4, P29, DOI 10.4103/0974-1208.82357; Tesarik Jan, 2003, Reprod Biomed Online, V7, P59; Weckstein LN, 1997, FERTIL STERIL, V68, P927, DOI 10.1016/S0015-0282(97)00330-0; Williams S K, 1989, Ann Vasc Surg, V3, P146, DOI 10.1016/S0890-5096(06)62008-6; Zhao J, 2012, J FERT IN VITRO, V2, P109, DOI [10.4172/2165-7491.1000109, DOI 10.4172/2165-7491.1000109]; Zhao J, 2015, REPROD SCI, V22, P181, DOI 10.1177/1933719114537715; Zhao J, 2014, FERTIL STERIL, V101, P587, DOI 10.1016/j.fertnstert.2013.10.053; Zhou L, 2008, FERTIL STERIL, V89, P1166, DOI 10.1016/j.fertnstert.2007.05.064; Zinger M, 2006, J WOMENS HEALTH, V15, P442, DOI 10.1089/jwh.2006.15.442	54	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144823	10.1371/journal.pone.0144823	http://dx.doi.org/10.1371/journal.pone.0144823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657744	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900112
J	Kumar, V; Sobhia, ME				Kumar, Vivek; Sobhia, M. Elizabeth			Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; WILD-TYPE; FORCE-FIELD; DIVERSE SET; PROTEIN; BINDING; SIMULATIONS; PREDICTION; REDUCTASE; PEPTIDE	Examination of InhA mutants I16T, I21V, I47T, S94A, and I95P showed that direct and water mediated H-bond interactions between NADH and binding site residues reduced drastically. It allowed conformational flexibility to NADH, particularly at the pyrophosphate region, leading to weakening of its binding at dinucleotide binding site. The highly scattered distribution of pyrophosphate dihedral angles and chi1 side chain dihedral angles of corresponding active site residues therein confirmed weak bonding between InhA and NADH. The average direct and water mediated bridged H-bond interactions between NADH and mutants were observed weaker as compared to wild type. Further, estimated NADH binding free energy in mutants supported the observed weakening of InhA-NADH interactions. Similarly, per residue contribution to NADH binding was also found little less as compared to corresponding residues in wild type. This investigation clearly depicted and supported the effect of mutations on NADH binding and can be accounted for isoniazid resistance as suggested by previous biochemical and mutagenic studies. Further, structural analysis of InhA provided the crucial points to enhance the NADH binding affinity towards InhA mutants in the presence of direct InhA inhibitors to combat isoniazid drug resistance. This combination could be a potential alternative for treatment of drug resistant tuberculosis.	[Kumar, Vivek; Sobhia, M. Elizabeth] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sect 67, Sas Nagar 160062, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Sobhia, ME (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sect 67, Sas Nagar 160062, Punjab, India.	mesophia@niper.ac.in			NIPER SAS Nagar; Ministry of chemicals and fertilizers, Govt. of India [PI/2010/VIII/278/P]	NIPER SAS Nagar; Ministry of chemicals and fertilizers, Govt. of India	This work is supported by the NIPER SAS Nagar and Ministry of chemicals and fertilizers, Govt. of India, Grant No. PI/2010/VIII/278/P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the NIPER SAS Nagar and Ministry of chemicals and fertilizers, Govt. of India, Grant No.: PI/2010/VIII/278/P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, 1010 SHERB ST W SUIT; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Basso LA, 1998, J INFECT DIS, V178, P769, DOI 10.1086/515362; Bello M, 2015, IMMUNOL RES, V62, P3, DOI 10.1007/s12026-015-8629-1; Bello M, 2014, BIOPOLYMERS, V101, P1010, DOI 10.1002/bip.22483; Bello M, 2014, BIOCHEM PHARMACOL, V90, P145, DOI 10.1016/j.bcp.2014.04.016; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Dias MVB, 2007, J STRUCT BIOL, V159, P369, DOI 10.1016/j.jsb.2007.04.009; Dobner P, 1997, INT J TUBERC LUNG D, V1, P365; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Ho YM, 2009, ANTIMICROB AGENTS CH, V53, P4010, DOI 10.1128/AAC.00433-09; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2012, J PROTEOME RES, V11, P2982, DOI 10.1021/pr3000688; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Oliveira JS, 2006, J MOL BIOL, V359, P646, DOI 10.1016/j.jmb.2006.03.055; Pavelites JJ, 1997, J COMPUT CHEM, V18, P221, DOI 10.1002/(SICI)1096-987X(19970130)18:2<221::AID-JCC7>3.0.CO;2-X; Reva BA, 1998, FOLD DES, V3, P141, DOI 10.1016/S1359-0278(98)00019-4; Robertson MJ, 2015, J CHEM THEORY COMPUT, V11, P3499, DOI 10.1021/acs.jctc.5b00356; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schroeder EK, 2005, BIOPHYS J, V89, P876, DOI 10.1529/biophysj.104.053512; Shafreen RMB, 2013, J MOL RECOGNIT, V26, P276, DOI 10.1002/jmr.2270; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Verkhivker GM, 1999, J MOL RECOGNIT, V12, P371, DOI 10.1002/(SICI)1099-1352(199911/12)12:6<371::AID-JMR479>3.0.CO;2-O; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Wang B, 2013, J CHEM INF MODEL, V53, P2659, DOI 10.1021/ci400312v; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Yang L, 2009, PROTEINS, V76, P164, DOI 10.1002/prot.22328; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144635	10.1371/journal.pone.0144635	http://dx.doi.org/10.1371/journal.pone.0144635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658674	gold, Green Published			2022-12-26	WOS:000366715900077
J	Moriwaki, Y; Terada, T; Tsumoto, K; Shimizu, K				Moriwaki, Yoshitaka; Terada, Tohru; Tsumoto, Kouhei; Shimizu, Kentaro			Rapid Heme Transfer Reactions between NEAr Transporter Domains of Staphylococcus aureus: A Theoretical Study Using QM/MM and MD Simulations	PLOS ONE			English	Article							REGULATED SURFACE DETERMINANT; ESCHERICHIA-COLI; NEAT DOMAIN; LISTERIA-MONOCYTOGENES; MOLECULAR-DYNAMICS; OUTER-MEMBRANE; ACQUISITION-SYSTEM; BINDING PROPERTIES; CELL-WALL; PROTEIN	In vertebrates, most iron is present as heme or is chelated by proteins. Thus, Gram-positive pathogens such as Staphylococcus aureus have evolved an iron-regulated surface determinant (Isd) system that transports heme across thick cell walls into the cytoplasm. Recent studies have demonstrated that heme is rapidly transferred between the NEAr Transporter (NEAT) domains of the Isd system, despite its high affinity toward each domain, suggesting the presence of an intermediate NEAT center dot heme center dot NEAT complex. In the present study, we performed short restrained molecular dynamics (MD) simulations to dock the acceptor NEAT domain to the donor NEAT center dot heme complex and obtained models where the two NEAT domains were arranged with two-fold pseudo symmetry around the heme molecule. After turning off the restraints, complex structures were stably maintained during subsequent unrestrained MD simulations, except for the hydrogen bond between the propionate group of the heme molecule and the donor NEAT domain, potentially facilitating the transition of heme from the donor to the acceptor. Subsequent structural optimization using the quantum mechanics/molecular mechanics (QM/MM) method showed that two tyrosine residues, one from each NEAT domain, were simultaneously coordinated to the ferric heme iron in the intermediate complex only if they were deprotonated. Based on these results, we propose a reaction scheme for heme transfer between NEAT domains.	[Moriwaki, Yoshitaka; Shimizu, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo, Japan; [Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan; [Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Moriwaki, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo, Japan.	virgospica93@bi.a.u-tokyo.ac.jp	Terada, Tohru/W-2956-2019	Terada, Tohru/0000-0002-7091-0646; Moriwaki, Yoshitaka/0000-0003-0448-9790	 [25-6526]		The work was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows 25-6526, https://www.jsps.go.jp/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2008, COMPUT PHYS COMMUN, V179, P26, DOI 10.1016/j.cpc.2008.01.006; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Case DA, 2012, AMBER 12; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; FISCHER E, 1989, J BACTERIOL, V171, P5127, DOI 10.1128/jb.171.9.5127-5134.1989; Frisch G. W., 2013, GAUSSIAN 09; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grubmueller H, 1996, SOLVATE V 1 0; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448975, 10.1063/1.448800, 10.1063/1.448799]; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanamori D, 2005, INORG CHIM ACTA, V358, P331, DOI 10.1016/j.ica.2004.09.014; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LETOFFE S, 1994, J BACTERIOL, V176, P5372; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Moriwaki Y, 2013, BIOCHEMISTRY-US, V52, P8866, DOI 10.1021/bi4008325; MURRAY RGE, 1965, CAN J MICROBIOL, V11, P547, DOI 10.1139/m65-072; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nee MW, 1999, J CHEM SOC DALTON, P3373, DOI 10.1039/a902636c; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Pluym M, 2007, J PORPHYR PHTHALOCYA, V11, P165, DOI 10.1142/S1088424607000217; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Tao P, 2009, BIOCHEMISTRY-US, V48, P9839, DOI 10.1021/bi901118r; Tiedemann MT, 2012, J AM CHEM SOC, V134, P16578, DOI 10.1021/ja305115y; Tiedemann MT, 2009, J PORPHYR PHTHALOCYA, V13, P1006, DOI 10.1142/S1088424609001352; Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473; UNO T, 1990, INORG CHEM, V29, P2803, DOI 10.1021/ic00340a018; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100744	57	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145125	10.1371/journal.pone.0145125	http://dx.doi.org/10.1371/journal.pone.0145125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658942	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900186
J	Takaoka, K; Yamamura, M; Nishioka, T; Abe, T; Tamaoka, J; Segawa, E; Shinohara, M; Ueda, H; Kishimoto, H; Urade, M				Takaoka, Kazuki; Yamamura, Michiyo; Nishioka, Toshihiro; Abe, Tetsuya; Tamaoka, Joji; Segawa, Emi; Shinohara, Masami; Ueda, Haruyasu; Kishimoto, Hiromitsu; Urade, Masahiro			Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats	PLOS ONE			English	Article							FRACTURE RISK; BONE; TYPE-1; CANCER; OSTEOMYELITIS; PREVENTION; MELLITUS; INSULIN	Background We evaluated the side effects of bisphosphonate (BP) on tooth extraction socket healing in spontaneously diabetic Torii (SDT) rats, an established model of non-obese type 2 diabetes mellitus, to develop an animal model of BP-related osteonecrosis of the jaws (BRONJ). Materials and Methods Male Sprague-Dawley (SD) rats and SDT rats were randomly assigned to the zoledronic acid (ZOL)-treated groups (SD/ZOL or SDT/ZOL) or to the control groups (SD/control or SDT/control). Rats in the SD/ZOL or SDT/ZOL groups received an intravenous bolus injection of ZOL (35 mu g/kg) every 2 weeks. Each group consisted of 6 rats each. Twenty-one weeks after ZOL treatment began, the left maxillary molars were extracted. The rats were euthanized at 2, 4, or 8 weeks after tooth extraction, and the total maxillae were harvested for histological and histochemical studies. Results In the oral cavity, bone exposure persisted at the tooth extraction site in all rats of the SDT/ZOL group until 8 weeks after tooth extraction. In contrast, there was no bone exposure in SD/control or SDT/control groups, and only 1 of 6 rats in the SD/ZOL group showed bone exposure. Histologically, necrotic bone areas with empty lacunae, microbial colonies, and less invasion by inflammatory cells were observed. The number of tartrate-resistant acid phosphatase-positive osteoclasts was lower in the SDT/ZOL group than in the SD/control group. The mineral apposition rate was significantly lower in the SDT/ZOL group compared with the SD/control group. Conclusions This study demonstrated the development of BRONJ-like lesions in rats and suggested that low bone turnover with less inflammatory cell infiltration plays an important role in the development of BRONJ.	[Takaoka, Kazuki; Yamamura, Michiyo; Nishioka, Toshihiro; Abe, Tetsuya; Tamaoka, Joji; Segawa, Emi; Kishimoto, Hiromitsu; Urade, Masahiro] Hyogo Coll Med, Dept Oral & Maxillofacial Surg, Nishinomiya, Hyogo 6638501, Japan; [Shinohara, Masami] CLEA Japan Inc, Planning & Dev Sect, Meguro Ku, Tokyo, Japan; [Ueda, Haruyasu] Hyogo Univ Hlth Sci, Immunobiol Lab, Sch Pharm, Kobe, Hyogo, Japan	Hyogo College of Medicine; Immuno-Biological Laboratories Co. Ltd.	Takaoka, K (corresponding author), Hyogo Coll Med, Dept Oral & Maxillofacial Surg, Nishinomiya, Hyogo 6638501, Japan.	ktaka@hyo-med.ac.jp			JSPS KAKENHI Grant [24593069, 15K11332]; Hyogo College of Medicine	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hyogo College of Medicine	This study was supported by JSPS KAKENHI Grant Number 24593069, 15K11332 (to K.T.) and by Grant-in-Aid for Researchers, Hyogo College of Medicine, 2013 (to M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAOMS, 2007, J ORAL MAXIL SURG, V65, P369, DOI 10.1016/j.joms.2006.11.003; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Bertoldo F, 2007, NAT CLIN PRACT ONCOL, V4, P711, DOI 10.1038/ncponc1000; Bonds DE, 2006, J CLIN ENDOCR METAB, V91, P3404, DOI 10.1210/jc.2006-0614; Boonyapakorn T, 2008, ORAL ONCOL, V44, P857, DOI 10.1016/j.oraloncology.2007.11.012; BURSELL SE, 1989, CURR EYE RES, V8, P821, DOI 10.3109/02713688909000872; Carnevale V, 2004, DIABETES-METAB RES, V20, P196, DOI 10.1002/dmrr.449; Cheng A, 2005, AUST DENT J, V50, pS4, DOI 10.1111/j.1834-7819.2005.tb00384.x; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fiore F, 2007, BLOOD, V110, P921, DOI 10.1182/blood-2006-09-044321; Fujii H, 2008, BONE, V42, P372, DOI 10.1016/j.bone.2007.10.007; Green JR, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.24154; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hill SL, 1999, AM J SURG, V177, P282, DOI 10.1016/S0002-9610(99)00050-1; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Jaiprakash A, 2012, INT J BIOL SCI, V8, P406, DOI 10.7150/ijbs.4221; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kobayashi Y, 2010, J BONE MINER METAB, V28, P165, DOI 10.1007/s00774-009-0128-9; Kumeda Yasuro, 2006, Clin Calcium, V16, P1277; Kyrgidis A, 2008, J CLIN ONCOL, V26, P4634, DOI 10.1200/JCO.2008.16.2768; Licata AA, 2005, ANN PHARMACOTHER, V39, P668, DOI 10.1345/aph.1E357; Maahs MP, 2011, HEAD NECK-J SCI SPEC, V33, P199, DOI 10.1002/hed.21422; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Michaelson MD, 2005, J CLIN ONCOL, V23, P8219, DOI 10.1200/JCO.2005.02.9579; Migliorati CA, 2005, J AM DENT ASSOC, V136, P1658, DOI 10.14219/jada.archive.2005.0108; Mortensen M, 2007, LARYNGOSCOPE, V117, P30, DOI 10.1097/01.mlg.0000240885.64568.9e; O'Ryan FS, 2009, J ORAL MAXIL SURG, V67, P1363, DOI 10.1016/j.joms.2009.03.005; Ohta T, 2015, J VET MED S IN PRESS; Purcell PM, 2005, MED J AUSTRALIA, V182, P417, DOI 10.5694/j.1326-5377.2005.tb06762.x; Ravosa MJ, 2011, ARCH ORAL BIOL, V56, P491, DOI 10.1016/j.archoralbio.2010.11.003; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Santini D, 2003, ANN ONCOL, V14, P1468, DOI 10.1093/annonc/mdg401; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; Sorensen VR, 2005, DIABETIC MED, V22, P871, DOI 10.1111/j.1464-5491.2005.01543.x; Stegeman Cynthia A, 2005, Home Healthc Nurse, V23, P233, DOI 10.1097/00004045-200504000-00009; Tao F, 2014, ANN BIOMED ENG, V42, P1238, DOI 10.1007/s10439-014-0998-4; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Urade M, 2011, J ORAL MAXIL SURG, V69, pE364, DOI 10.1016/j.joms.2011.03.051; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vestergaard P, 2005, DIABETOLOGIA, V48, P1292, DOI 10.1007/s00125-005-1786-3; Wang J, 2003, J ORAL MAXIL SURG, V61, P1104, DOI 10.1016/S0278-2391(03)00328-8; Wilkinson GS, 2007, JNCI-J NATL CANCER I, V99, P1016, DOI 10.1093/jnci/djm025; Wolf AM, 2006, HAEMATOLOGICA, V91, P1165; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yoshii Taishi, 2015, J Clin Med Res, V7, P762, DOI 10.14740/jocmr2278w	50	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144355	10.1371/journal.pone.0144355	http://dx.doi.org/10.1371/journal.pone.0144355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659123	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900041
J	Ahmad, Z; Rafeeq, M; Collombat, P; Mansouri, A				Ahmad, Zeeshan; Rafeeq, Maria; Collombat, Patrick; Mansouri, Ahmed			Pax6 Inactivation in the Adult Pancreas Reveals Ghrelin as Endocrine Cell Maturation Marker	PLOS ONE			English	Article							BETA-CELLS; INSULIN-SECRETION; MOUSE PANCREAS; ENZYMATIC-ACTIVITY; ALPHA-CELLS; DIFFERENTIATION; EXPRESSION; MICE; 7B2; IDENTITY	The transcription factor Pax6 is an important regulator of development and cell differentiation in various organs. Thus, Pax6 was shown to promote neural development in the cerebral cortex and spinal cord, and to control pancreatic endocrine cell genesis. However, the role of Pax6 in distinct endocrine cells of the adult pancreas has not been addressed. We report the conditional inactivation of Pax6 in insulin and glucagon producing cells of the adult mouse pancreas. In the absence of Pax6, beta- and alpha-cells lose their molecular maturation characteristics. Our findings provide strong evidence that Pax6 is responsible for the maturation of beta-, and alpha-cells, but not of delta-, and PP-cells. Moreover, lineage-tracing experiments demonstrate that Pax6-deficient beta- and alpha-cells are shunted towards ghrelin marked cells, sustaining the idea that ghrelin may represent a marker for endocrine cell maturation.	[Ahmad, Zeeshan; Rafeeq, Maria; Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Dev Biol, RG Mol Cell Differentiat, D-37077 Gottingen, Germany; [Collombat, Patrick] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Collombat, Patrick] Fac Med Nice, INSERM, U1091, IBV,Diabet Genet Team, F-06034 Nice, France; [Collombat, Patrick; Mansouri, Ahmed] JDRF, New York, NY USA; [Collombat, Patrick] Erciyes Univ, Genome & Stem Cell Ctr, GENKOK, Kayseri, Turkey; [Mansouri, Ahmed] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany	Max Planck Society; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Erciyes University; University of Gottingen	Ahmad, Z (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Dev Biol, RG Mol Cell Differentiat, D-37077 Gottingen, Germany.	zahmad@gwdg.de; amanou@gwdg.de	collombat, patrick/F-4495-2015; collombat, patrick/P-3741-2019	collombat, patrick/0000-0001-8232-1438; collombat, patrick/0000-0001-8232-1438	Max-Planck Society; Juvenile Diabetes Research foundation [17-2011-16, 2-2010-567, 26-2008-639, 17-2013-426]; INSERM AVENIR program; INSERM; European Research Council [StG-2011-281265]; FMR [DRC20091217179]; ANR/BMBF [GENO 105 01/01KU0906]; "Investments for the Future'' LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Club Isatis; Mr. and Mrs. Dorato; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Juvenile Diabetes Research foundation(Juvenile Diabetes Research Foundation); INSERM AVENIR program(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); FMR; ANR/BMBF(French National Research Agency (ANR)); "Investments for the Future'' LABEX SIGNALIFE; Club Isatis; Mr. and Mrs. Dorato; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche	This work was supported by the Max-Planck Society, the Juvenile Diabetes Research foundation (17-2011-16, 2-2010-567, 26-2008-639, 17-2013-426), the INSERM AVENIR program, the INSERM, the European Research Council (StG-2011-281265) the FMR (DRC20091217179), the ANR/BMBF (2009 GENO 105 01/01KU0906), the "Investments for the Future'' LABEX SIGNALIFE (ANR-11-LABX-0028-01), Club Isatis, Mr. and Mrs. Dorato, the Fondation Generale de Sante, and the Foundation Schlumberger pour l'Education et la Recherche.	Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Chandra V, 2014, CELL REP, V9, P2206, DOI 10.1016/j.celrep.2014.11.010; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Farber CR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-34; Fortenberry Y, 2002, J BIOL CHEM, V277, P5175, DOI 10.1074/jbc.M104531200; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Helwig M, 2013, J BIOL CHEM, V288, P1114, DOI 10.1074/jbc.M112.417071; Helwig M, 2011, J BIOL CHEM, V286, P42504, DOI 10.1074/jbc.M111.281980; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hoshino A, 2014, J NEUROCHEM, V128, P419, DOI 10.1111/jnc.12454; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Liu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046934; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pfeifer A, 2013, CELL CYCLE, V12, P3243, DOI 10.4161/cc.26357; Piccand J, 2014, CELL REP, V9, P2219, DOI 10.1016/j.celrep.2014.11.033; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Spijker HS, 2015, DIABETES, V64, P2928, DOI 10.2337/db14-1752; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; Wang JF, 2004, DEV BIOL, V266, P178, DOI 10.1016/j.ydbio.2003.10.018; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641	48	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144597	10.1371/journal.pone.0144597	http://dx.doi.org/10.1371/journal.pone.0144597			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658466	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600062
J	Cascao, R; Vidal, B; Lopes, IP; Paisana, E; Rino, J; Moita, LF; Fonseca, JE				Cascao, Rita; Vidal, Bruno; Lopes, Ines P.; Paisana, Eunice; Rino, Jose; Moita, Luis F.; Fonseca, Joao E.			Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; KAPPA-B-KINASE; INTERLEUKIN-1 RECEPTOR ANTAGONIST; EARLY RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; OSTEOCLAST DIFFERENTIATION; CLINICAL IMPROVEMENT; BONE DESTRUCTION; ALPHA BLOCKADE	Background Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease characterized by cellular infiltration into the joints, hyperproliferation of synovial cells and bone damage. Available treatments for RA only induce remission in around 30% of the patients, have important adverse effects and its use is limited by their high cost. Therefore, compounds that can control arthritis, with an acceptable safety profile and low production costs are still an unmet need. We have shown, in vitro, that celastrol inhibits both IL-1 beta and TNF, which play an important role in RA, and, in vivo, that celastrol has significant anti-inflammatory properties. Our main goal in this work was to test the effect of celastrol in the number of sublining CD68 macrophages (a biomarker of therapeutic response for novel RA treatments) and on the overall synovial tissue cellularity and joint structure in the adjuvant-induced rat model of arthritis (AIA). Methods Celastrol was administered to AIA rats both in the early (4 days after disease induction) and late (11 days after disease induction) phases of arthritis development. The inflammatory score, ankle perimeter and body weight were evaluated during treatment period. Rats were sacrificed after 22 days of disease progression and blood, internal organs and paw samples were collected for toxicological blood parameters and serum proinflammatory cytokine quantification, as well as histopathological and immunohistochemical evaluation, respectively. Results Here we report that celastrol significantly decreases the number of sublining CD68 macrophages and the overall synovial inflammatory cellularity, and halted joint destruction without side effects. Conclusions Our results validate celastrol as a promising compound for the treatment of arthritis.	[Cascao, Rita; Vidal, Bruno; Lopes, Ines P.; Paisana, Eunice; Rino, Jose; Fonseca, Joao E.] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Moita, Luis F.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Fonseca, Joao E.] Lisbon Acad Med Ctr, Hosp Santa Maria, Ctr Hosp Lisboa Norte, Dept Rheumatol,EPE, Lisbon, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Hospital Santa Maria	Cascao, R (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	ritacascao@medicina.ulisboa.pt	Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013; Rino, Jose/I-2990-2013; Cascao, Rita/N-6675-2013	Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X; Lopes, Ines/0000-0002-2109-6203; Rino, Jose/0000-0002-0637-4527; Paisana, Eunice/0000-0001-5915-8556; Cascao, Rita/0000-0001-5533-9413	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/92860/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	RC was supported with a fellowship from Fundacao para a Ciencia e a Tecnologia (FCT, SFRH/BPD/92860/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astry B, 2015, CLIN IMMUNOL, V157, P228, DOI 10.1016/j.clim.2015.01.011; Astry B, 2011, J INTERF CYTOK RES, V31, P927, DOI 10.1089/jir.2011.0094; Bendele AM, 2000, ARTHRITIS RHEUM-US, V43, P2648, DOI 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; BRAUER R, 1994, EXP TOXICOL PATHOL, V46, P383; Bresnihan B, 2009, J RHEUMATOL, V36, P1800, DOI 10.3899/jrheum.090348; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Chen SY, 2011, HUM GENE THER, V22, P145, DOI 10.1089/hum.2009.217; Cunnane G, 2001, RHEUMATOLOGY, V40, P62, DOI 10.1093/rheumatology/40.1.62; DaSilva JAP, 1996, CLIN EXP RHEUMATOL, V14, P43; Dolhain RJEM, 1998, BRIT J RHEUMATOL, V37, P502; Fonseca JE, 2002, ARTHRITIS RHEUM-US, V46, P1210, DOI 10.1002/art.10207; Fonseca JE, 2009, CLIN RHEUMATOL, V28, P1213, DOI 10.1007/s10067-009-1207-y; Gan K, 2015, INT IMMUNOPHARMACOL, V24, P239, DOI 10.1016/j.intimp.2014.12.012; Gerlag DM, 2004, ARTHRITIS RHEUM, V50, P3783, DOI 10.1002/art.20664; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hahn B, 2004, JCR-J CLIN RHEUMATOL, V10, pS3, DOI 10.1097/01.rhu.0000130683.61892.b2; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kim HY, 2012, LIFE SCI, V91, P250, DOI 10.1016/j.lfs.2012.07.003; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kraan MC, 2000, ARTHRITIS RHEUM, V43, P1820, DOI 10.1002/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D; Kusy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035733; LaBranche TP, 2012, ARTHRITIS RHEUM-US, V64, P3531, DOI 10.1002/art.34649; Le Goff B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2877; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li GQ, 2012, INT IMMUNOPHARMACOL, V14, P422, DOI 10.1016/j.intimp.2012.08.016; Li GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068905; Li H, 2008, J ETHNOPHARMACOL, V118, P479, DOI 10.1016/j.jep.2008.05.028; Ma YH, 2010, INT IMMUNOPHARMACOL, V10, P1456, DOI 10.1016/j.intimp.2010.08.022; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; NAWROTH PP, 1986, J EXP MED, V163, P1363, DOI 10.1084/jem.163.6.1363; Plasqui G, 2008, PHYSIOL BEHAV, V94, P270, DOI 10.1016/j.physbeh.2007.12.012; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Schett G, 2006, WIEN MED WOCHENSCHR, V156, P34, DOI 10.1007/s10354-005-0244-7; Sims NA, 2004, ARTHRITIS RHEUM-US, V50, P2338, DOI 10.1002/art.20382; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Smith MD, 2001, RHEUMATOLOGY, V40, P367, DOI 10.1093/rheumatology/40.4.367; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Stolina M, 2009, J CLIN IMMUNOL, V29, P158, DOI 10.1007/s10875-008-9238-8; Suzuki M, 2010, CYTOKINE, V51, P178, DOI 10.1016/j.cyto.2010.03.017; Tas SW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1958; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Tsubaki T, 2005, ARTHRITIS RES THER, V7, pR825, DOI 10.1186/ar1751; Venkatesha SH, 2012, BIOORGAN MED CHEM, V20, P5229, DOI 10.1016/j.bmc.2012.06.050; Venkatesha SH, 2011, J BIOL CHEM, V286, P15138, DOI 10.1074/jbc.M111.226365; Vidal B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117100; Vieira-Sousa Elsa, 2011, Open Rheumatol J, V5, P115, DOI 10.2174/1874312901105010115; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Vivar Nancy, 2014, F1000Prime Rep, V6, P31, DOI 10.12703/P6-31; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964; Xu SQ, 2012, RHEUMATOL INT, V32, P3397, DOI 10.1007/s00296-011-2175-5; YANNI G, 1994, ANN RHEUM DIS, V53, P315, DOI 10.1136/ard.53.5.315; Yu H, 2012, INT IMMUNOPHARMACOL, V13, P499, DOI 10.1016/j.intimp.2012.05.015; Zhang J, 2012, J ETHNOPHARMACOL, V144, P195, DOI 10.1016/j.jep.2012.09.005; Zhu XJ, 2014, J ETHNOPHARMACOL, V158, P283, DOI 10.1016/j.jep.2014.10.021	65	20	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142448	10.1371/journal.pone.0142448	http://dx.doi.org/10.1371/journal.pone.0142448			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658436	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600005
J	Tapsas, D; Hollen, E; Stenhammar, L; Falth-Magnusson, K				Tapsas, Dimitrios; Hollen, Elisabet; Stenhammar, Lars; Falth-Magnusson, Karin			Unusually High Incidence of Paediatric Coeliac Disease in Sweden during the Period 1973-2013	PLOS ONE			English	Article							ANTIGLIADIN ANTIBODIES; BIRTH COHORTS; DIAGNOSIS; CHILDREN; IGA; HISTOPATHOLOGY; SENSITIVITY; CRITERIA; GLUTEN; IMPACT	Objective The prevalence of coeliac disease in Sweden during the "epidemic period" (1984-1996) was one of the highest in the world. The aim of this study was to assess the coeliac disease incidence in our region over the 41-year period, and how diagnostic activity and diagnostic accuracy were affected by the introduction of antibody testing. We also looked into how patients with mild enteropathy were evaluated. Methods In the county of Ostergotland in Sweden, 2790 paediatric patients were investigated for suspected coeliac disease between 1973 and 2013. Notes were scrutinised for data on sex, age, histopathological reports and final diagnosis. For comparative purposes this period was divided into three sub-periods (1973-1983, 1984-1996 and 1997-2013) named pre-epidemic, epidemic and post-epidemic. Results Coeliac disease diagnosis was received by 1,030 patients. The peak incidence rate, 301 cases/100,000 in 1994 for the age group 0-1.9 years is the highest figure ever reported. The other age groups, 2-4.9, 5-14.9, and 15-17.9 years, also had high incidence rates. After the 1984-1996 "epidemic period" the incidence decreased for the youngest group but continued to increase for the other groups. The cumulative incidence at 18 years-of-age for children born during the epidemic reached 14 cases/1000 births, the highest figure hitherto reported. Diagnostic activity differed significantly between the three sub-periods (p<0.001) increasing gradually from 1984 and reaching a peak value of 0.87 in 2012. Cases of mild enteropathy were more frequently regarded as non-coeliac disease cases, decreasing significantly in the "post-epidemic" period (p<0.001). Conclusions The incidence rate and cumulative incidence of coeliac disease were possibly the highest ever reported. Changes in diagnostic activity and accuracy could not be attributed to the introduction of new antibody tests, possibly because of other changes e.g. variations in the symptoms at presentation and improved knowledge of the disease among parents and health professionals.	[Tapsas, Dimitrios; Stenhammar, Lars; Falth-Magnusson, Karin] Linkoping Univ, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden; [Hollen, Elisabet] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hollen, Elisabet] Linkoping Univ, Div Microbiol & Mol Med, Linkoping, Sweden; [Stenhammar, Lars] Linkoping Univ, Dept Paediat, Norrkoping, Sweden; [Stenhammar, Lars] Linkoping Univ, Dept Clin & Expt Med, Norrkoping, Sweden; [Falth-Magnusson, Karin] Linkoping Univ, Dept Paediat, Linkoping, Sweden; [Falth-Magnusson, Karin] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Tapsas, D (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden.	dimta624@student.liu.se	Tapsas, Dimitrios/H-7738-2019		Medical Research Council of Southeast Sweden; County Council of Ostergotland; Swedish Research Council	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of Ostergotland; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was received from the Medical Research Council of Southeast Sweden, the County Council of Ostergotland and the Swedish Research Council (KFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh D, 2015, PEDIATRICS, V135, P627, DOI 10.1542/peds.2014-3675; Arguelles-Grande C, 2012, J CLIN PATHOL, V65, P242, DOI 10.1136/jclinpath-2011-200372; CHORZELSKI TP, 1983, ANN NY ACAD SCI, V420, P325, DOI 10.1111/j.1749-6632.1983.tb22220.x; Cook Bramwell, 2004, N Z Med J, V117, pU772; Corrao G, 1996, J EPIDEMIOL COMMUN H, V50, P299, DOI 10.1136/jech.50.3.299; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Fortunato F, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-38; GRODZINSKY E, 1994, ALLERGY, V49, P593, DOI 10.1111/j.1398-9995.1994.tb00124.x; GRODZINSKY E, 1990, INT ARCH ALLER A IMM, V92, P119, DOI 10.1159/000235201; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kakar S, 2003, AM J GASTROENTEROL, V98, P2027, DOI 10.1016/S0002-9270(03)00542-2; Kelly CP, 2015, GASTROENTEROLOGY, V148, P1175, DOI 10.1053/j.gastro.2015.01.044; Ludvigsson JF, 2004, J PEDIATR GASTR NUTR, V38, P181, DOI 10.1097/00005176-200402000-00015; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; Cilleruelo ML, 2014, J PEDIATR GASTR NUTR, V59, P522, DOI 10.1097/MPG.0000000000000446; Mahadeva S, 2002, J CLIN PATHOL, V55, P424, DOI 10.1136/jcp.55.6.424; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; McGowan KE, 2009, PEDIATRICS, V124, P1572, DOI 10.1542/peds.2008-2373; Mubarak A, 2011, SCAND J GASTROENTERO, V46, P1065, DOI 10.3109/00365521.2011.589471; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Namatovu F, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-59; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Olsson C, 2008, PEDIATRICS, V122, P528, DOI 10.1542/peds.2007-2989; Ress K, 2012, EUR J PEDIATR, V171, P1823, DOI 10.1007/s00431-012-1835-0; Roma E, 2009, DIGESTION, V80, P185, DOI 10.1159/000227275; SAKULA J, 1957, LANCET, V2, P876; Savilahti E, 2010, ACTA PAEDIATR, V99, P1026, DOI 10.1111/j.1651-2227.2010.01740.x; Tanpowpong P, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.4; UNSWORTH DJ, 1981, CLIN EXP IMMUNOL, V46, P286; Volta U, 2011, CELL MOL IMMUNOL, V8, P96, DOI 10.1038/cmi.2010.64; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Weile B, 2000, APMIS, V108, P380, DOI 10.1034/j.1600-0463.2000.d01-72.x; White LE, 2013, ARCH DIS CHILD, V98, P52, DOI 10.1136/archdischild-2012-302056; Whyte LA, 2013, ARCH DIS CHILD, V98, P405, DOI 10.1136/archdischild-2012-303113; Zingone F, 2015, UNITED EUR GASTROENT, V3, P182, DOI 10.1177/2050640615571021	37	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144346	10.1371/journal.pone.0144346	http://dx.doi.org/10.1371/journal.pone.0144346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658809	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600037
J	Breit, C; Bange, T; Petrovic, A; Weir, JR; Muller, F; Vogt, D; Musacchio, A				Breit, Claudia; Bange, Tanja; Petrovic, Arsen; Weir, John R.; Mueller, Franziska; Vogt, Doro; Musacchio, Andrea			Role of Intrinsic and Extrinsic Factors in the Regulation of the Mitotic Checkpoint Kinase Bub1	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; SPINDLE CHECKPOINT; KINETOCHORE LOCALIZATION; CENP-E; CHROMOSOME SEGREGATION; PROTEIN; PHOSPHORYLATION; BINDING; CDC20; AUTOPHOSPHORYLATION	The spindle assembly checkpoint (SAC) monitors microtubule attachment to kinetochores to ensure accurate sister chromatid segregation during mitosis. The SAC members Bub1 and BubR1 are paralogs that underwent significant functional specializations during evolution. We report an in-depth characterization of the kinase domains of Bub1 and BubR1. BubR1 kinase domain binds nucleotides but is unable to deliver catalytic activity in vitro. Conversely, Bub1 is an active kinase regulated by intra-molecular phosphorylation at the P+1 loop. The crystal structure of the phosphorylated Bub1 kinase domain illustrates a hitherto unknown conformation of the P+1 loop docked into the active site of the Bub1 kinase. Both Bub1 and BubR1 bind Bub3 constitutively. A hydrodynamic characterization of Bub1: Bub3 and BubR1: Bub3 demonstrates both complexes to have 1: 1 stoichiometry, with no additional oligomerization. Conversely, Bub1: Bub3 and BubR1: Bub3 combine to form a heterotetramer. Neither BubR1: Bub3 nor Knl1, the kinetochore receptor of Bub1: Bub3, modulate the kinase activity of Bub1 in vitro, suggesting autonomous regulation of the Bub1 kinase domain. We complement our study with an analysis of the Bub1 substrates. Our results contribute to the mechanistic characterization of a crucial cell cycle checkpoint.	[Breit, Claudia; Bange, Tanja; Petrovic, Arsen; Weir, John R.; Mueller, Franziska; Vogt, Doro; Musacchio, Andrea] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, D-44227 Dortmund, Germany; [Musacchio, Andrea] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, D-45141 Essen, Germany	Max Planck Society; University of Duisburg Essen	Musacchio, A (corresponding author), Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	andrea.musacchio@mpi-dortmund.mpg.de	Weir, John R./AAF-5435-2020	Weir, John R./0000-0002-6904-0284; Muller, Franziska/0000-0002-4880-9269; Musacchio, Andrea/0000-0003-2362-8784; Petrovic, Arsen/0000-0003-4448-4230	European Research Council (ERC) Advanced Investigator Grant RECEPIANCE [669686]	European Research Council (ERC) Advanced Investigator Grant RECEPIANCE(European Research Council (ERC))	A.M. gratefully acknowledges funding by the European Research Council (ERC) Advanced Investigator Grant RECEPIANCE (proposal number no 669686).; We are grateful to Charlotte Smith and Marion Pesenti for providing the Borealin: Survivin complex as Bub1 substrate, Ivana Primorac for providing the MBP-Knl1 fragment, Stefano Maffini and the Dortmund Protein Facility for Mps1 kinase, Doro Vogt and Federica Basilico for the H3 and CENP-A nucleosome preparations, Sascha Gentz for help with peptide chemistry, and Alex Faesen for critical reading of the manuscript. We would like to thank Arthur Porfetye, David Bier, Andre Richters and Juliane John for collecting the crystallographic data as well as the SLS X10SA beam line staff for their outstanding support. A.M. gratefully acknowledges funding by the European Research Council (ERC) Advanced Investigator award RECEPIANCE (proposal number no 669686). The authors declare no competing financial interests.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asghar A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9364; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bolanos-Garcia VM, 2011, STRUCTURE, V19, P1691, DOI 10.1016/j.str.2011.09.017; Bourhis E, 2009, BIOCHEMISTRY-US, V48, P6783, DOI 10.1021/bi900530v; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Creixell P, 2015, CELL, V163, P187, DOI 10.1016/j.cell.2015.08.057; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernius J, 2007, PLOS GENET, V3, P2312, DOI 10.1371/journal.pgen.0030213; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Guo YG, 2012, J CELL BIOL, V198, P205, DOI 10.1083/jcb.201202152; Haase J, 2012, CURR BIOL, V22, P471, DOI 10.1016/j.cub.2012.02.006; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Harris L, 2005, EXP CELL RES, V308, P85, DOI 10.1016/j.yexcr.2005.03.036; Hashimoto Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-12; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kang JS, 2008, MOL CELL, V32, P394, DOI 10.1016/j.molcel.2008.09.017; KARASAKI Y, 1984, ARCH BIOCHEM BIOPHYS, V233, P796, DOI 10.1016/0003-9861(84)90508-3; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; KNIGHTON DR, 1993, ACTA CRYSTALLOGR D, V49, P357, DOI 10.1107/S0907444993000502; Krenn V, 2014, CURR BIOL, V24, P29, DOI 10.1016/j.cub.2013.11.046; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lin ZH, 2014, STRUCTURE, V22, P1616, DOI 10.1016/j.str.2014.08.020; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Murphy JM, 2014, BIOCHEM J, V457, P369, DOI 10.1042/BJ20131270; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Ni DQ, 2000, PROTEIN SCI, V9, P1818, DOI 10.1110/ps.9.9.1818; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Overlack K, 2015, ELIFE, V4, DOI 10.7554/eLife.05269; Perera D, 2010, J CELL SCI, V123, P653, DOI 10.1242/jcs.059501; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Qi W, 2007, J BIOL CHEM, V282, P3672, DOI 10.1074/jbc.M609376200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Seeley TW, 1999, BIOCHEM BIOPH RES CO, V257, P589, DOI 10.1006/bbrc.1999.0514; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2001, J CELL SCI, V114, P4385; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; van der Waal MS, 2012, EMBO REP, V13, P847, DOI 10.1038/embor.2012.93; Vleugel M, 2015, J CELL SCI, V128, P2975, DOI 10.1242/jcs.169821; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Zhang G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8162; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138	86	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144673	10.1371/journal.pone.0144673	http://dx.doi.org/10.1371/journal.pone.0144673			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658523	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500055
J	Gondos, AS; Al-Moyed, KA; Al-Robasi, ABA; Al-Shamahy, HA; Alyousefi, NA				Gondos, Adnan S.; Al-Moyed, Khaled A.; Al-Robasi, Abdul Baki A.; Al-Shamahy, Hassan A.; Alyousefi, Naelah A.			Urinary Tract Infection among Renal Transplant Recipients in Yemen	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIURIA; KIDNEY-TRANSPLANTATION; GRAFT FUNCTION; UNITED-STATES; COMPLICATIONS; PREVALENCE	Urinary tract infection (UTI) is the most common complication following kidney transplantation (KT), which could result in losing the graft. This study aims to identify the prevalence of bacterial UTI among KT recipients in Yemen and to determine the predisposing factors associated with post renal transplantation UTI. A cross sectional study included of 150 patients, who underwent KT was conducted between June 2010 and January 2011. A Morning mid-stream urine specimen was collected for culture and antibiotic susceptibility test from each recipient. Bacterial UTI was found in 50 patients (33.3%). The prevalence among females 40.3% was higher than males 29%. The UTI was higher in the age group between 41-50 years with a percentage of 28% and this result was statistically significant. Predisposing factors as diabetes mellitus, vesicoureteral reflux, neurogenic bladder and polycystic kidney showed significant association. High relative risks were found for polycystic kidney = 13.5 and neurogenic bladder = 13.5. The most prevalent bacteria to cause UTI was Escherichia coli represent 44%, followed by Staphylococcus saprophyticus 34%. Amikacin was the most effective antibiotic against gram-negative isolates while Ciprofloxacin was the most effective antibiotic against Staphylococcus saprophyticus. In conclusion, there is high prevalence of bacterial UTI among KT recipients in Yemen. Diabetes mellitus, vesicoureteral reflux, neurogenic bladder, polycystic kidney and calculi were the main predisposing factors.	[Gondos, Adnan S.; Al-Moyed, Khaled A.; Al-Robasi, Abdul Baki A.; Al-Shamahy, Hassan A.] Sanaa Univ, Fac Med & Hlth Sci, Dept Med Microbiol, Sanaa, Yemen; [Alyousefi, Naelah A.] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Alyousefi, NA (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia.	naelaalyousfi@gmail.com	Al-Shamahy, Hassan Abdulwahab/AAZ-5266-2021; Alyousefi, Naelah/D-2006-2010	Al-Shamahy, Hassan Abdulwahab/0000-0001-6958-7012; Alyousefi, Naelah/0000-0001-8871-1824	University of Malaya [GC002A-14HTM]	University of Malaya(Universiti Malaya)	This project was supported by University of Malaya grant number GC002A-14HTM but this financial support had no interference on the manuscript content.	Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Al-Awadi MAA, 2005, THESIS; Al-Rohani M, 2000, Saudi J Kidney Dis Transpl, V11, P82; Al-Rohani Muhamed, 2003, Saudi J Kidney Dis Transpl, V14, P80; Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Alkatheri AM, 2013, AGE, V30, P3; Alkhyat S. H., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P876; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Camargo L, 2014, TRANSPLANTATION P; Charfeddine K, 2005, TRANSPLANTATION P; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Elkehili I., 2010, AJNT, V3, P53; Ersoy A, 2015, NEPHROLOGY DIALYS S3, V30; Golebiewska J, 2011, TRANSPLANTATION P; Iqbal T, 2010, J PAK MED ASSOC, V60, P826; John U, 2006, NEPHROL DIAL TRANSPL, V21, P3269, DOI 10.1093/ndt/gfl464; Khanna P, 2010, SAUDI J KIDNEY DIS T, V21, P876; Khosroshahi H, 2006, TRANSPLANTATION P; Maraha B, 2001, CLIN MICROBIOL INFEC, V7, P619, DOI 10.1046/j.1198-743x.2001.00329.x; Munoz P, 2001, CLIN INFECT DIS, V33, pS53, DOI 10.1086/320905; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Nicolle LE, 2003, INFECT DIS CLIN N AM, V17, P367, DOI 10.1016/S0891-5520(03)00008-4; Oguz Y, 2002, Cent Eur J Public Health, V10, P153; Pelle G, 2007, AM J TRANSPLANT, V7, P899, DOI 10.1111/j.1600-6143.2006.01700.x; Procopio F, 2014, TRANSPLANTATION P; Rivera-Sanchez R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-245; Said R, 1998, Saudi J Kidney Dis Transpl, V9, P301; Samhan M, 2005, TRANSPLANTATION P; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Schmaldienst Sabine, 2002, Curr Opin Urol, V12, P125, DOI 10.1097/00042307-200203000-00007; Senger S., 2007, TRANSPLANTATION P; Shaheen F A, 1995, Saudi J Kidney Dis Transpl, V6, P41; Sheiban A, 1999, Saudi J Kidney Dis Transpl, V10, P183; Shirazi M, 2005, IRAN J PUBLIC HEALTH, V34, P62; Singh R, 2015, CURR OPIN INFECT DIS, V28, P112, DOI 10.1097/QCO.0000000000000120; Sorto R, 2010, TRANSPLANTATION P; Valera B., 2006, TRANSPLANTATION P; Veroux M, 2008, TRANSPLANTATION P	39	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144266	10.1371/journal.pone.0144266	http://dx.doi.org/10.1371/journal.pone.0144266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657128	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500018
J	Friedmann, MP; Torbeev, V; Zelenay, V; Sobol, A; Greenwald, J; Riek, R				Friedmann, Michael P.; Torbeev, Vladimir; Zelenay, Viviane; Sobol, Alexander; Greenwald, Jason; Riek, Roland			Towards Prebiotic Catalytic Amyloids Using High Throughput Screening	PLOS ONE			English	Article							AMINO-ACIDS; PEPTIDES; FIBRILS; LIFE; STABILITY; ORIGIN; PROTEINS; POLYPEPTIDES; CONFORMATION; HYDROLYSIS	Enzymes are capable of directing complex stereospecific transformations and of accelerating reaction rates many orders of magnitude. As even the simplest known enzymes comprise thousands of atoms, the question arises as to how such exquisite catalysts evolved. A logical predecessor would be shorter peptides, but they lack the defined structure and size that are apparently necessary for enzyme functions. However, some very short peptides are able to assemble into amyloids, thereby forming a well-defined tertiary structure called the cross-a-sheet, which bestows unique properties upon the peptides. We have hypothesized that amyloids could have been the catalytically active precursor to modern enzymes. To test this hypothesis, we designed an amyloid peptide library that could be screened for catalytic activity. Our approach, amenable to high-throughput methodologies, allowed us to find several peptides and peptide mixtures that form amyloids with esterase activity. These results indicate that amyloids, with their stability in a wide range of conditions and their potential as catalysts with low sequence specificity, would indeed be fitting precursors to modern enzymes. Furthermore, our approach can be efficiently expanded upon in library size, screening conditions, and target activity to yield novel amyloid catalysts with potential applications in aqueous-organic mixtures, at high temperature and in other extreme conditions that could be advantageous for industrial applications.	[Friedmann, Michael P.; Zelenay, Viviane; Sobol, Alexander; Greenwald, Jason; Riek, Roland] Swiss Fed Inst Technol, Dept Chem, Phys Chem Lab, Zurich, Switzerland; [Torbeev, Vladimir] Swiss Fed Inst Technol, Dept Chem, Organ Chem Lab, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Greenwald, J (corresponding author), Swiss Fed Inst Technol, Dept Chem, Phys Chem Lab, Zurich, Switzerland.	jason.greenwald@phys.chem.ethz.ch; roland.riek@phys.chem.ethz.ch	Torbeev, Vladimir/M-8813-2015	Torbeev, Vladimir/0000-0002-7865-1044				Altermann W, 2003, RES MICROBIOL, V154, P611, DOI 10.1016/j.resmic.2003.08.006; BARBIER B, 1992, J AM CHEM SOC, V114, P3511, DOI 10.1021/ja00035a053; Bourbo V, 2011, ORIGINS LIFE EVOL B, V41, P563, DOI 10.1007/s11084-011-9257-y; BRACK A, 1978, INT J PEPT PROT RES, V11, P128; BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0; Carny O, 2005, FASEB J, V19, P1051, DOI 10.1096/fj.04-3256hyp; Greenwald J, 2012, J MOL BIOL, V421, P417, DOI 10.1016/j.jmb.2012.04.015; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Higgs PG, 2015, NAT REV GENET, V16, P7, DOI 10.1038/nrg3841; Higgs PG, 2009, ASTROBIOLOGY, V9, P483, DOI 10.1089/ast.2008.0280; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Huber C, 2003, SCIENCE, V301, P938; Ikehara K, 2005, CHEM REC, V5, P107, DOI 10.1002/tcr.20037; KIRSCH JF, 1964, J AM CHEM SOC, V86, P833, DOI 10.1021/ja01059a018; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Leman L, 2004, SCIENCE, V306, P283, DOI 10.1126/science.1102722; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maury CPJ, 2009, ORIGINS LIFE EVOL B, V39, P141, DOI 10.1007/s11084-009-9165-6; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Mesquida P, 2007, J MATER SCI-MATER M, V18, P1325, DOI 10.1007/s10856-006-0075-0; PerezPaya E, 1996, J MOL RECOGNIT, V9, P488, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<488::AID-JMR289>3.0.CO;2-F; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rode BM, 1999, PEPTIDES, V20, P773, DOI 10.1016/S0196-9781(99)00062-5; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SCHWENDINGER MG, 1992, ORIGINS LIFE EVOL B, V22, P349, DOI 10.1007/BF01809371; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Stathopoulos P, 2006, J PEPT SCI, V12, P227, DOI 10.1002/psc.706; Takahashi Y, 2004, BIOORGAN MED CHEM, V12, P693, DOI 10.1016/j.bmc.2003.11.022; Takahashi Y, 2002, CHEMBIOCHEM, V3, P637, DOI 10.1002/1439-7633(20020703)3:7<637::AID-CBIC637>3.0.CO;2-9; Trifonov EN, 2000, GENE, V261, P139, DOI 10.1016/S0378-1119(00)00476-5; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211	35	47	46	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143948	10.1371/journal.pone.0143948	http://dx.doi.org/10.1371/journal.pone.0143948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650386	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903300032
J	Minor, RL; Koprowski, JL				Minor, Rebecca L.; Koprowski, John L.			Seed Removal Increased by Scramble Competition with an Invasive Species	PLOS ONE			English	Article							GRAHAM RED SQUIRREL; ABERTS SQUIRRELS; INTERSPECIFIC COMPETITION; BIOLOGICAL INVASIONS; POPULATION-DYNAMICS; GREY SQUIRRELS; MIXED-CONIFER; HOME RANGES; FOOD; SELECTION	Competition for seeds has a major influence on the evolution of granivores and the plants on which they rely. The complexity of interactions and coevolutionary relationships vary across forest types. The introduction of non-native granivores has considerable potential to alter seed dispersal dynamics. Non-native species are a major cause of endangerment for native species, but the mechanisms are often unclear. As biological invasions continue to rise, it is important to understand mechanisms to build up strategies to mitigate the threat. Our field experiment quantified the impact of introduced Abert's squirrels (Sciurus aberti) on rates of seed removal within the range of critically endangered Mount Graham red squirrels (Tamiasciurus hudsonicus grahamensis), which consumes similar foods. In the presence of invasive Abert's squirrels, the time cones were removed was faster than when the invasive was excluded, accounting for a median removal time of cones available to red and Abert's squirrels that is 32.8% less than that of cones available only to the rare native red squirrels. Moreover, in the presence of Abert's squirrels, removal rates are higher at great distance from a territorial red squirrel larderhoard and in more open portions of the forest, which suggests differential patterns of seed dispersal. The impact on food availability as a result of cone removal by Abert's squirrels suggests the potential of food competition as a mechanism of endangerment for the Mount Graham red squirrel. Furthermore, the magnitude and differential spatial patterns of seed removal suggest that non-native granivores may have impacts on forest regeneration and structure.	[Minor, Rebecca L.; Koprowski, John L.] Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA	University of Arizona	Minor, RL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA.	rlminor@email.arizona.edu		Koprowski, John/0000-0003-1406-9853	University of Arizona; Arizona Agricultural Experiment Station	University of Arizona; Arizona Agricultural Experiment Station	Funding was provided by the University of Arizona and the Arizona Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred WS, 2010, NATURAL HIST TASSEL; Atkinson IAE, 1996, WILDLIFE BIOL, V2, P135, DOI 10.2981/wlb.1996.011; Benkman CW, 2013, EVOLUTION, V67, P157, DOI 10.1111/j.1558-5646.2012.01736.x; Blount SJ, 2012, SOUTHWEST NAT, V57, P8, DOI 10.1894/0038-4909-57.1.8; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; BROWN DE, 1984, ARIZONAS TREE SQUIRR; Buck CL, 1999, J MAMMAL, V80, P430, DOI 10.2307/1383291; Choquenot D, 2000, J ANIM ECOL, V69, P1058, DOI 10.1046/j.1365-2656.2000.00462.x; Collar N.J., 1996, COLONIA WATERBIRDS, DOI [10.2307/1521829, DOI 10.2307/1521829]; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Connolly BM, 2014, ECOLOGY, V95, P1759, DOI 10.1890/13-1774.1; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; DAYAN T, 1994, AM NAT, V143, P462, DOI 10.1086/285613; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Eccard JA, 2002, OIKOS, V99, P580, DOI 10.1034/j.1600-0706.2002.11833.x; Edelman AJ, 2006, CAN J ZOOL, V84, P404, DOI 10.1139/z06-009; Edelman AJ, 2005, SOUTHWEST NAT, V50, P461, DOI 10.1894/0038-4909(2005)050[0461:DATUOA]2.0.CO;2; Edelman AJ, 2005, J MAMMAL, V86, P1220, DOI 10.1644/04-MAMM-A-029R1.1; Edelman Andrew J., 2005, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V36, P395; Edelman AJ, 2009, J MAMMAL, V90, P167, DOI 10.1644/07-MAMM-A-282.1; GURNELL J, 1984, ANIM BEHAV, V32, P1119, DOI 10.1016/S0003-3472(84)80228-6; GURNELL J, 1983, MAMMAL REV, V13, P133, DOI 10.1111/j.1365-2907.1983.tb00274.x; Gwinn RN, 2011, THESIS; Hatten JR, 2000, 160 AR GAM FISH DEP; Hayssen V, 2008, J MAMMAL, V89, P582, DOI 10.1644/07-MAMM-A-064R2.1; HERBOLD B, 1986, AM NAT, V128, P751, DOI 10.1086/284600; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Hutton KA, 2003, SOUTHWEST NAT, V48, P257, DOI 10.1894/0038-4909(2003)048&lt;0257:UOMASF&gt;2.0.CO;2; KEITH JO, 1965, ECOLOGY, V46, P150, DOI 10.2307/1935266; KLENNER W, 1991, J ANIM ECOL, V60, P961, DOI 10.2307/5425; Koprowski JL, 2005, J MAMMAL, V86, P309, DOI 10.1644/BWG-232.1; KOPROWSKI JL, 1991, J MAMMAL, V72, P367, DOI 10.2307/1382108; Koprowski John L., 2008, Endangered Species Research, V4, P227, DOI 10.3354/esr00026; Kuhn KM, 2009, WEST N AM NATURALIST, V69, P309, DOI 10.3398/064.069.0304; Kupferberg SJ, 1997, ECOLOGY, V78, P1736; LANGE KENNETH I, 1960, AMER MIDLAND NAT, V64, P436, DOI 10.2307/2422673; Larson MM, 2005, USDA FOREST SERVICE, VRM-58, P1; Leonard KM, 2009, AM MIDL NAT, V162, P125, DOI 10.1674/0003-0031-162.1.125; Lichti NI, 2014, ECOLOGY, V95, P1746, DOI 10.1890/13-1657.1; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Mendes CP, 2016, ECOGRAPHY, V39, P465, DOI 10.1111/ecog.01592; Posthumus EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123633; Prather JW, 2006, J WILDLIFE MANAGE, V70, P723, DOI 10.2193/0022-541X(2006)70[723:LMTPTI]2.0.CO;2; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Rushton SP, 2006, BIOL CONSERV, V131, P121, DOI 10.1016/j.biocon.2006.02.010; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanderson H.R., 2009, LAST REFUGE MT GRAHA; Sanguinetti J, 2010, BIOL INVASIONS, V12, P689, DOI 10.1007/s10530-009-9474-8; Schmitz DC, 1997, ISSUES SCI TECHNOL, V13, P33; Simberloff Daniel, 1995, Pacific Science, V49, P87; SMITH AA, 1994, J WILDLIFE MANAGE, V58, P437, DOI 10.2307/3809314; Steele MA, 2006, ANIM BEHAV, V71, P155, DOI 10.1016/j.anbehav.2005.05.005; Steele MA, 2008, CURR SCI INDIA, V95, P871; Sundaram M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130942; Talluto MV, 2013, ECOLOGY, V94, P1307, DOI 10.1890/12-2058.1; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Vander Wall SB, 2012, BOT REV, V78, P10, DOI 10.1007/s12229-011-9093-9; Wauters LA, 2002, BEHAV ECOL SOCIOBIOL, V52, P332, DOI 10.1007/s00265-002-0516-9; Wauters LA, 1995, P ROYAL SOC LOND B, V262, P227; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson DJ, 2007, ECOGRAPHY, V30, P105, DOI [10.1111/j.2006.0906-7590.04771.x, 10.1111/j.0906-7590.2007.04771.x]; WILSON E O, 1992; Wood DJA, 2007, J MAMMAL, V88, P1271, DOI 10.1644/06-MAMM-A-303.1; Young Paul J., 2009, P124; Zugmeyer CA, 2007, SOUTHWEST NAT, V52, P155, DOI 10.1894/0038-4909(2007)52[155:ANPBEM]2.0.CO;2; Zugmeyer CA, 2009, J MAMMAL, V90, P175, DOI 10.1644/07-MAMM-A-399.1	69	2	2	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143927	10.1371/journal.pone.0143927	http://dx.doi.org/10.1371/journal.pone.0143927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650073	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300030
J	Carpio, VH; Opata, MM; Montanez, ME; Banerjee, PP; Dent, AL; Stephens, R				Carpio, Victor H.; Opata, Michael M.; Montanez, Marelle E.; Banerjee, Pinaki P.; Dent, Alexander L.; Stephens, Robin			IFN-gamma and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection	PLOS ONE			English	Article							FOLLICULAR HELPER; PROTECTIVE IMMUNITY; MALARIA INFECTION; CUTTING EDGE; B-CELLS; TH1; EFFECTOR; INTERLEUKIN-21; BCL6; DIFFERENTIATION	CD4 T cells are required to fight malaria infection by promoting both phagocytic activity and B cell responses for parasite clearance. In Plasmodium chabaudi infection, one specific CD4 T cell subset generates anti-parasitic IFN-gamma and the antibody-promoting cytokine, IL-21. To determine the lineage of these multifunctional T cells, we followed IFN-gamma(+) effector T cells (Teff) into the memory phase using Ifng-reporter mice. While Ifng(+) Teff expanded, the level of the Th1 lineage-determining transcription factor T-bet only peaked briefly. Ifng(+) Teff also co-express ICOS, the B cell area homing molecule CXCR5, and other Tfh lineage-associated molecules including Bcl6, the transcription factor required for germinal center (GC) T follicular helper cells (Tfh) differentiation. Because Bcl6 and T-bet co-localize to the nucleus of Ifng(+) Teff, we hypothesized that Bcl6 controls the Tfh-like phenotype of Ifng(+) Teff cells in P. chabaudi infection. We first transferred Bcl6-deficient T cells into wildtype hosts. Bcl6-deficient T cells did not develop into GC Tfh, but they still generated CXCR5(+)IFN-gamma+IL-21(+)IL-10(+) Teff, suggesting that this predominant population is not of the Tfh-lineage. IL-10 deficient mice, which have increased IFN-gamma and T-bet expression, demonstrated expansion of both IFN-gamma+IL-21(+)CXCR5(+) cells and IFN-gamma(+) GC Tfh cells, suggesting a Th1 lineage for the former. In the memory phase, all Ifng(+) T cells produced IL-21, but only a small percentage of highly proliferative Ifng(+) T cells maintained a T-bethi phenotype. In chronic malaria infection, serum IFN-gamma correlates with increased protection, and our observation suggests Ifng(+) T cells are maintained by cellular division. In summary, we found that Ifng(+) T cells are not strictly Tfh derived during malaria infection. T cells provide the host with a survival advantage when facing this well-equipped pathogen, therefore, understanding the lineage of pivotal T cell players will aid in the rational design of an effective malaria vaccine.	[Carpio, Victor H.; Opata, Michael M.; Montanez, Marelle E.; Stephens, Robin] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA; [Carpio, Victor H.; Montanez, Marelle E.; Stephens, Robin] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Banerjee, Pinaki P.] Texas Childrens Hosp, Baylor Coll Med, Ctr Human Immunobiol, Houston, TX 77030 USA; [Dent, Alexander L.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis	Stephens, R (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA.	rostephe@utmb.edu	Opata, Michael/X-2751-2019		National Institute of Allergy and Infectious Diseases [R01AI08995304, R01AI08995304S1, T32AI7536-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089953, T32AI007536] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grant numbers R01AI08995304 (to RS and MMO), R01AI08995304S1 (to VHC), and T32AI7536-15 (to MMO).	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Bouneauld C, 2005, J EXP MED, V201, P579, DOI 10.1084/jem.20040876; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Chacon-Salinas R, 2011, J IMMUNOL, V186, P25, DOI 10.4049/jimmunol.1001657; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Curtis MM, 2010, CELL HOST MICROBE, V8, P163, DOI 10.1016/j.chom.2010.07.006; da Silva HB, 2013, J IMMUNOL, V191, P5160, DOI 10.4049/jimmunol.1300462; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hogan RJ, 2002, J IMMUNOL, V169, P4976, DOI 10.4049/jimmunol.169.9.4976; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Langhorne J, 1989, Int Immunol, V1, P416, DOI 10.1093/intimm/1.4.416; Langhorne J, 1998, P NATL ACAD SCI USA, V95, P1730, DOI 10.1073/pnas.95.4.1730; Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Mascle X, 2003, BIOCHEM BIOPH RES CO, V300, P391, DOI 10.1016/S0006-291X(02)02873-5; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; Mewono L, 2008, EUR CYTOKINE NETW, V19, P30, DOI 10.1684/ecn.2008.0114; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oakley MS, 2014, EUR J IMMUNOL, V44, P2680, DOI 10.1002/eji.201344437; Oakley MS, 2013, J IMMUNOL, V191, P4699, DOI 10.4049/jimmunol.1300396; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Perez-Mazliah D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004715; Portugal S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004079; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roetynck S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055195; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Shah S, 2015, ELIFE, V4, DOI 10.7554/eLife.09017; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Weinmann AS, 2014, IMMUNOL CELL BIOL, V92, P34, DOI 10.1038/icb.2013.49; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511	75	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144654	10.1371/journal.pone.0144654	http://dx.doi.org/10.1371/journal.pone.0144654			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646149	Green Published, gold			2022-12-26	WOS:000366903100031
J	Zhao, XJ; Xu, W; Ma, YJ; Hu, FY				Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu			Scenario-Based Multi-Objective Optimum Allocation Model for Earthquake Emergency Shelters Using a Modified Particle Swarm Optimization Algorithm: A Case Study in Chaoyang District, Beijing, China	PLOS ONE			English	Article							LOCATION; SELECTION; NETWORK	The correct location of earthquake emergency shelters and their allocation to residents can effectively reduce the number of casualties by providing safe havens and efficient evacuation routes during the chaotic period of the unfolding disaster. However, diverse and strict constraints and the discrete feasible domain of the required models make the problem of shelter location and allocation more difficult. A number of models have been developed to solve this problem, but there are still large differences between the models and the actual situation because the characteristics of the evacuees and the construction costs of the shelters have been excessively simplified. We report here the development of a multi-objective model for the allocation of residents to earthquake shelters by considering these factors using the Chaoyang district, Beijing, China as a case study. The two objectives of this model were to minimize the total weighted evacuation time from residential areas to a specified shelter and to minimize the total area of all the shelters. The two constraints were the shelter capacity and the service radius. Three scenarios were considered to estimate the number of people who would need to be evacuated. The particle swarm optimization algorithm was first modified by applying the von Neumann structure in former loops and global structure in later loops, and then used to solve this problem. The results show that increasing the shelter area can result in a large decrease in the total weighted evacuation time from scheme 1 to scheme 9 in scenario A, from scheme 1 to scheme 9 in scenario B, from scheme 1 to scheme 19 in scenario C. If the funding were not a limitation, then the final schemes of each scenario are the best solutions, otherwise the earlier schemes are more reasonable. The modified model proved to be useful for the optimization of shelter allocation, and the result can be used as a scientific reference for planning shelters in the Chaoyang district, Beijing.	[Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu] Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing 100875, Peoples R China; [Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu] Beijing Normal Univ, Minist Civil Affairs, Acad Disaster Reduct & Emergency Management, Beijing 100875, Peoples R China; [Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu] Beijing Normal Univ, Minist Educ, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University	Xu, W (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing 100875, Peoples R China.	xuwei@bnu.edu.cn		Zhao, Xiujuan/0000-0002-6650-5728; Ma, Yunjia/0000-0002-7856-9323	National Natural Science Foundation of China [41201547, 41321001]; State Administration of Foreign Experts Affairs P.R. China [B08008]; Ministry of Science and Technology of the People's Republic of China [2013BAK05B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Administration of Foreign Experts Affairs P.R. China; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	Support was provided by National Natural Science Foundation of China No. 41201547 [http://www.nsfc.gov.cn/] to WX; the National Natural Science Foundation of China No. 41321001 [http://www.nsfc.gov.cn/] to WX; the State Administration of Foreign Experts Affairs P.R. China No. B08008 [http://www.safea.gov.cn/] to WX; the Ministry of Science and Technology of the People's Republic of China No. 2013BAK05B02 [http://www.most.gov.cn/] to WX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshinmanesh F, 2005, EUROCON 2005: THE INTERNATIONAL CONFERENCE ON COMPUTER AS A TOOL, VOL 1 AND 2 , PROCEEDINGS, P217; Ai TJ, 2009, COMPUT OPER RES, V36, P1693, DOI 10.1016/j.cor.2008.04.003; Alcada-Almeida L, 2009, GEOGR ANAL, V41, P9, DOI 10.1111/j.1538-4632.2009.00745.x; Barzinpour F, 2014, INT J ADV MANUF TECH, V70, P1291, DOI 10.1007/s00170-013-5379-x; Beijing MPCO, 2010, EARTHQ EM SHELT PLAN; Cai Q, 2014, NEURAL NETWORKS, V58, P4, DOI 10.1016/j.neunet.2014.04.006; [陈志宗 Chen Zhizong], 2005, [自然灾害学报, Journal of Natural Disasters], V14, P131; Church R., 1974, PAP REG SCI ASS, V32, P101, DOI DOI 10.1007/BF01942293; Clerc M, 2004, STUD FUZZ SOFT COMP, V141, P219; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Dai S., 2010, J CATASTROPHOLOGY, V25, P50, DOI [10.3969/j.issn.1000-811X.2010.z1.011, DOI 10.3969/J.ISSN.1000-811X.2010.Z1.011]; Dalal J, 2007, DISASTER PREV MANAG, DOI [10.1108/09653560710739559, DOI 10.1108/09653560710739559]; Deb K., 2000, Parallel Problem Solving from Nature PPSN VI. 6th International Conference. Proceedings (Lecture Notes in Computer Science Vol.1917), P849; Doerner KF, 2009, OR SPECTRUM, V31, P651, DOI 10.1007/s00291-008-0126-7; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Gates TJ, 2006, P TRB 2006 ANN M; HAKIMI SL, 1965, OPER RES, V13, P462, DOI 10.1287/opre.13.3.462; HAKIMI SL, 1964, OPER RES, V12, P450, DOI 10.1287/opre.12.3.450; Hasan M., 1995, International Transactions in Operational Research, V2, P89, DOI 10.1111/j.1475-3995.1995.tb00007.x; He Q, 2007, APPL MATH COMPUT, V186, P1407, DOI 10.1016/j.amc.2006.07.134; Hu F, 2014, INT J GEOGR INF SYST, V28, P1; Hu FY, 2012, INT J GEOGR INF SCI, V26, P1643, DOI 10.1080/13658816.2011.643802; Jin YX, 2007, ELECTR POW SYST RES, V77, P227, DOI 10.1016/j.epsr.2006.02.016; Kennedy J, 1997, IEEE SYS MAN CYBERN, P4104, DOI 10.1109/ICSMC.1997.637339; Khan M. A. A., 2007, Proceedings. IEEE SoutheastCon 2007 (IEEE Cat. No.07CH37882); Li X, 2009, INT J GEOGR INF SCI, V23, P399, DOI 10.1080/13658810801918491; Pan QK, 2008, COMPUT OPER RES, V35, P2807, DOI 10.1016/j.cor.2006.12.030; Salman A, 2002, MICROPROCESS MICROSY, V26, P363, DOI 10.1016/S0141-9331(02)00053-4; Shen Q, 2007, TALANTA, V71, P1679, DOI 10.1016/j.talanta.2006.07.047; SHERALI HD, 1991, TRANSPORT RES B-METH, V25, P439, DOI 10.1016/0191-2615(91)90037-J; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Srinivas H, 2008, J ENVIRON MANAGE, V89, P4, DOI 10.1016/j.jenvman.2007.01.054; TOREGAS C, 1971, OPER RES, V19, P1363, DOI 10.1287/opre.19.6.1363; VANLAARHOVEN PJM, 1992, OPER RES, V40, P113, DOI 10.1287/opre.40.1.113; Widener MJ, 2011, J TRANSP GEOGR, V19, P821, DOI 10.1016/j.jtrangeo.2010.10.006; Widener MJ, 2009, MODELLING HURRICANE; Woods C, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.19821; Yaghini M, 2013, 4OR-Q J OPER RES, V11, P229, DOI 10.1007/s10288-012-0223-y; Yin PY, 2007, APPL MATH COMPUT, V184, P407, DOI 10.1016/j.amc.2006.06.071; Zhang Yang, 2009, Acta Seismologica Sinica, V31, P290	40	18	20	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144455	10.1371/journal.pone.0144455	http://dx.doi.org/10.1371/journal.pone.0144455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642322	Green Published, gold			2022-12-26	WOS:000366902700127
J	Friedline, RH; Ko, HJ; Jung, DY; Lee, Y; Bortell, R; Dagdeviren, S; Patel, PR; Hu, XD; Inashima, K; Kearns, C; Tsitsilianos, N; Shafiq, U; Shultz, LD; Lee, KW; Greiner, DL; Kim, JK				Friedline, Randall H.; Ko, Hwi Jin; Jung, Dae Young; Lee, Yongjin; Bortell, Rita; Dagdeviren, Sezin; Patel, Payal R.; Hu, Xiaodi; Inashima, Kunikazu; Kearns, Caitlyn; Tsitsilianos, Nicholas; Shafiq, Umber; Shultz, Leonard D.; Lee, Ki Won; Greiner, Dale L.; Kim, Jason K.			Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet-induced obesity and insulin resistance	FASEB JOURNAL			English	Article						glucose metabolism; energy balance; diabetes mouse models	SCID MOUSE; MODEL; INFLAMMATION; MACROPHAGES; SENSITIVITY; ENGRAFTMENT; DEFICIENT; IMMUNITY; TYPE-1	Obesity is characterized by a dysregulated immune system, which may causally associate with insulin resistance and type 2 diabetes. Despite widespread use of nonobese diabetic (NOD) mice, NOD with severe combined immunodeficiency (scid) mutation (SCID) mice, and SCID bearing a null mutation in the IL-2 common chain receptor (NSG) mice as animal models of human diseases including type 1 diabetes, the underlying metabolic effects of a genetically altered immune system are poorly understood. For this, we performed a comprehensive metabolic characterization of these mice fed chow or after 6 wk of a high-fat diet. We found that NOD mice had similar to 50% less fat mass and were 2-fold more insulin sensitive, as measured by hyperinsulinemic-euglycemic clamp, than C57BL/6 wild-type mice. SCID mice were also more insulin sensitive with increased muscle glucose metabolism and resistant to diet-induced obesity due to increased energy expenditure (similar to 10%) and physical activity (similar to 40%) as measured by metabolic cages. NSG mice were completely protected from diet-induced obesity and insulin resistance with significant increases in glucose metabolism in peripheral organs. Our findings demonstrate an important role of genetic background, lymphocytes, and cytokine signaling in diet-induced obesity and insulin resistance.	[Friedline, Randall H.; Ko, Hwi Jin; Jung, Dae Young; Lee, Yongjin; Bortell, Rita; Dagdeviren, Sezin; Patel, Payal R.; Hu, Xiaodi; Inashima, Kunikazu; Kearns, Caitlyn; Tsitsilianos, Nicholas; Shafiq, Umber; Greiner, Dale L.; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantation St,AS9-1041, Worcester, MA 01605 USA; [Bortell, Rita; Greiner, Dale L.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Lee, Ki Won] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; Seoul National University (SNU); Seoul National University (SNU)	Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantation St,AS9-1041, Worcester, MA 01605 USA.	jason.kim@umassmed.edu	Lee, Ki Won/M-4114-2018; Dagdeviren, Sezin/CAI-5833-2022; Dagdeviren, Sezin/I-9277-2019	Kim, Jason/0000-0002-7185-042X	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, R01-DK079999, R24-DK090963, U24-DK093000, U01-DK089572, UC4-DK1-4218]; American Diabetes Association Research Award [7-07-RA-80]; Helmsley Charitable Trust [2012PG-T1D018, 2015PG-T1D057]; National Leap Research Program through the National Research Foundation of Korea - Ministry of Science, International Cooperation and Future Planning of Korea [2010-0029233]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration (Seoul, Republic of Korea) [PJ008187]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK093000, U24DK093000, R24DK090963, R01DK079999, R01DK080756, U01DK089572] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association Research Award(American Diabetes Association); Helmsley Charitable Trust; National Leap Research Program through the National Research Foundation of Korea - Ministry of Science, International Cooperation and Future Planning of Korea; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration (Seoul, Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jung Yeon Kwon (University of Massachusetts Medical School) for editorial assistance in manuscript preparation. This study was supported by U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK080756, R01-DK079999, R24-DK090963, and U24-DK093000 (to J.K.K.), and U01-DK089572 and UC4-DK1-4218 (to L.D.S. and D.L.G.); American Diabetes Association Research Award 7-07-RA-80 (to J.K.K.); Helmsley Charitable Trust Grants 2012PG-T1D018 and 2015PG-T1D057 (to L.D.S. and D.L.G.); National Leap Research Program Grant 2010-0029233 (to K.W.L.) through the National Research Foundation of Korea funded by the Ministry of Science, International Cooperation and Future Planning of Korea, and Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008187), Rural Development Administration (Seoul, Republic of Korea). The authors declare no conflicts of interest.	Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Behan JW, 2013, OBESITY, V21, P1380, DOI 10.1002/oby.20159; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Gaber AO, 2004, TRANSPL P, V36, P1108, DOI 10.1016/j.transproceed.2004.04.055; Greiner DL, 2011, ANN NY ACAD SCI, V1245, P55, DOI 10.1111/j.1749-6632.2011.06318.x; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; LEITER EH, 1987, AM J PATHOL, V128, P380; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Parish Rebecca, 2005, Curr Diab Rep, V5, P177, DOI 10.1007/s11892-005-0006-3; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; van der Loo JCM, 1998, BLOOD, V92, P2556, DOI 10.1182/blood.V92.7.2556.2556_2556_2570; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	28	9	9	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1328	1338		10.1096/fj.15-280610	http://dx.doi.org/10.1096/fj.15-280610			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26644351	Green Published			2022-12-26	WOS:000370387800028
J	Kroczynska, B; Rafidi, RL; Majchrzak-Kita, B; Kosciuczuk, EM; Blyth, GT; Jemielity, J; Warminska, Z; Saleiro, D; Mehrotra, S; Arslan, AD; Fish, EN; Platanias, LC				Kroczynska, Barbara; Rafidi, Robert L.; Majchrzak-Kita, Beata; Kosciuczuk, Ewa M.; Blyth, Gavin T.; Jemielity, Jacek; Warminska, Zofia; Saleiro, Diana; Mehrotra, Swarna; Arslan, Ahmet Dirim; Fish, Eleanor N.; Platanias, Leonidas C.			Interferon gamma (IFN gamma) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; APLASTIC-ANEMIA; MAMMALIAN TARGET; KINASE; RICTOR; PATHWAY; PROTEIN; PHOSPHORYLATION; ACTIVATION; CANCER	We provide evidence for a unique pathway engaged by the type II IFN receptor, involving mTORC2/AKT-mediated downstream regulation of mTORC1 and effectors. These events are required for formation of the eukaryotic translation initiation factor 4F complex (eIF4F) and initiation of mRNA translation of type II interferon-stimulated genes. Our studies establish that Rictor is essential for the generation of type II IFN-dependent antiviral and antiproliferative responses and that it controls the generation of type II IFN-suppressive effects on normal and malignant hematopoiesis. Together, our findings establish a central role for mTORC2 in IFN gamma signaling and type II IFN responses.	[Kroczynska, Barbara; Rafidi, Robert L.; Kosciuczuk, Ewa M.; Blyth, Gavin T.; Saleiro, Diana; Mehrotra, Swarna; Arslan, Ahmet Dirim; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Kroczynska, Barbara; Rafidi, Robert L.; Kosciuczuk, Ewa M.; Blyth, Gavin T.; Saleiro, Diana; Mehrotra, Swarna; Arslan, Ahmet Dirim; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kroczynska, Barbara] Northwestern Univ, Dept Radiat Oncol, Chicago, IL 60611 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2MI, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2MI, Canada; [Kosciuczuk, Ewa M.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Jemielity, Jacek; Warminska, Zofia] Univ Warsaw, Ctr New Technol, PL-02097 Warsaw, Poland; [Warminska, Zofia] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, PL-02089 Warsaw, Poland	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Warsaw; University of Warsaw	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super Ave,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Jemielity, Jacek/E-2635-2013; Kosciuczuk, Ewa Maria/AAD-2815-2022	Jemielity, Jacek/0000-0001-7633-788X; 	National Institutes of Health [CA77816, CA155566, CA161796]; Department of Veterans Affairs [I01CX000916]; NCI/National Institutes of Health [T32 CA080621, T32 CA070085]; National Science Centre [UMO-2013/09/B/ST5/01341]; Canada Research Chair; NATIONAL CANCER INSTITUTE [R01CA161796, T32CA070085, P30CA060553, R01CA155566, T32CA080621, R01CA077816] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Centre(National Science Centre, Poland); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants CA77816, CA155566, and CA161796. This work was also supported by Grant I01CX000916 from the Department of Veterans Affairs, by NCI/National Institutes of Health Training Grants T32 CA080621 (to D. S.) and T32 CA070085 (to A. D. A), by National Science Centre Grant UMO-2013/09/B/ST5/01341, and by funds made available to E. N. F. as a Tier 1 Canada Research Chair. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aimbetov R, 2012, ONCOGENE, V31, P2115, DOI 10.1038/onc.2011.404; Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jemielity J, 2012, ORG BIOMOL CHEM, V10, P8570, DOI 10.1039/c2ob26060c; Joshi Sonali, 2015, BioMolecular Concepts, V6, P85, DOI 10.1515/bmc-2011-2000; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Killestein J, 2011, NAT REV NEUROL, V7, P221, DOI 10.1038/nrneurol.2011.22; Kroczynska B, 2014, P NATL ACAD SCI USA, V111, P11377, DOI 10.1073/pnas.1405250111; Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Larsen TS, 2013, LEUKEMIA RES, V37, P1041, DOI 10.1016/j.leukres.2013.06.012; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin FC, 2014, BLOOD, V124, P3699, DOI 10.1182/blood-2014-01-549527; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2013, J INTERF CYTOK RES, V33, P143, DOI 10.1089/jir.2013.0019; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2389	2396		10.1074/jbc.M115.664995	http://dx.doi.org/10.1074/jbc.M115.664995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645692	hybrid, Green Published			2022-12-26	WOS:000369610400028
J	Sekiguchi, T; Kuwasako, K; Ogasawara, M; Takahashi, H; Matsubara, S; Osugi, T; Muramatsu, I; Sasayama, Y; Suzuki, N; Satake, H				Sekiguchi, Toshio; Kuwasako, Kenji; Ogasawara, Michio; Takahashi, Hiroki; Matsubara, Shin; Osugi, Tomohiro; Muramatsu, Ikunobu; Sasayama, Yuichi; Suzuki, Nobuo; Satake, Honoo			Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; ACTIVITY-MODIFYING PROTEIN-1; CIONA-INTESTINALIS; AMPHIOXUS GENOME; RECEPTOR; ADRENOMEDULLIN; EXPRESSION; AMYLIN; CGRP; LOCALIZATION	The calcitonin (CT)/CT gene-related peptide (CGRP) family is conserved in vertebrates. The activities of this peptide family are regulated by a combination of two receptors, namely the calcitonin receptor (CTR) and the CTR-like receptor (CLR), and three receptor activity-modifying proteins (RAMPs). Furthermore, RAMPs act as escort proteins by translocating CLR to the cell membrane. Recently, CT/CGRP family peptides have been identified or inferred in several invertebrates. However, the molecular characteristics and relevant functions of the CTR/CLR and RAMPs in invertebrates remain unclear. In this study, we identified three CT/CGRP family peptides (Bf-CTFPs), one CTR/CLR-like receptor (Bf-CTFP-R), and three RAMP-like proteins (Bf-RAMP-LPs) in the basal chordate amphioxus (Branchiostoma floridae). The Bf-CTFPs were shown to possess an N-terminal circular region typical of the CT/CGRP family and a C-terminal Pro-NH2. The Bf-CTFP genes were expressed in the central nervous system and in endocrine cells of the midgut, indicating that Bf-CTFPs serve as brain and/or gut peptides. Cell surface expression of the Bf-CTFP-R was enhanced by co-expression with each Bf-RAMP-LP. Furthermore, Bf-CTFPs activated Bf-CTFP-R.Bf-RAMP-LP complexes, resulting in cAMP accumulation. These results confirmed that Bf-RAMP-LPs, like vertebrate RAMPs, are prerequisites for the function and translocation of the Bf-CTFP-R. The relative potencies of the three peptides at each receptor were similar. Bf-CTFP2 was a potent ligand at all receptors in cAMP assays. Bf-RAMP-LP effects on ligand potency order were distinct to vertebrate CGRP/adrenomedullin/amylin receptors. To the best of our knowledge, this is the first molecular and functional characterization of an authentic invertebrate CT/CGRP family receptor and RAMPs.	[Sekiguchi, Toshio; Sasayama, Yuichi; Suzuki, Nobuo] Kanazawa Univ, Noto Marine Lab, Div Marine Environm Studies, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9270553, Japan; [Kuwasako, Kenji] Miyazaki Univ, Frontier Sci Res Ctr, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan; [Ogasawara, Michio] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan; [Takahashi, Hiroki] Natl Inst Basic Biol, Lab Morphogenesis, 38 Nishigonaka Myodaiji, Okazaki, Aichi 4448585, Japan; [Osugi, Tomohiro; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, 8-1-1,Seikadai,Seika Cho, Kyoto 6190284, Japan; [Muramatsu, Ikunobu] Kanazawa Med Univ, Dept Pharmacol, Sch Med, Uchinada, Ishikawa 9200293, Japan	Kanazawa University; University of Miyazaki; Chiba University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Suntory Holdings Ltd; Kanazawa Medical University	Sekiguchi, T (corresponding author), Kanazawa Univ, Noto Marine Lab, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9270553, Japan.	t-sekiguchi@se.kanazawa-u.ac.jp	SUZUKI, Nobuo/J-8420-2015; Kuwasako, Kenji/H-8065-2016	SUZUKI, Nobuo/0000-0003-0283-9910; Takahashi, Hiroki/0000-0002-7658-0246; Matsubara, Shin/0000-0002-7794-534X; Osugi, Tomohiro/0000-0001-6987-9576	Japan Society for the Promotion of Science [23770069, 15K07126, 25440161]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Japan Society for the Promotion of Science (23770069 and 15K07126, to T. S. and 25440161, to H. S.). The authors declare that they have no conflict of interest with the contents of this article.	AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Bomberger JM, 2012, ADV EXP MED BIOL, V744, P25, DOI 10.1007/978-1-4614-2364-5_3; BRAIN SD, 1993, AGENTS ACTIONS, V38, pC19, DOI 10.1007/BF01991124; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Conner AC, 2004, BIOCHEM SOC T, V32, P843, DOI 10.1042/BST0320843; COOPER GJS, 1988, P NATL ACAD SCI USA, V85, P7763, DOI 10.1073/pnas.85.20.7763; COPP DH, 1970, CAN MED ASSOC J, V103, P821; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Flahaut M, 2003, BIOCHEMISTRY-US, V42, P10333, DOI 10.1021/bi0347508; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hiruta J, 2005, DEV DYNAM, V233, P1031, DOI 10.1002/dvdy.20401; Iga M, 2015, BIOSCI BIOTECH BIOCH, V79, P1305, DOI 10.1080/09168451.2015.1018128; Ittner LM, 2004, BIOCHEM BIOPH RES CO, V319, P1203, DOI 10.1016/j.bbrc.2004.05.103; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kitamura K, 2002, MICROSC RES TECHNIQ, V57, P3, DOI 10.1002/jemt.10052; Koller D, 2004, J BIOL CHEM, V279, P20387, DOI 10.1074/jbc.M313058200; Kuwasako K, 2004, PEPTIDES, V25, P2003, DOI 10.1016/j.peptides.2004.06.002; Kuwasako K, 2003, HYPERTENS RES, V26, pS25, DOI 10.1291/hypres.26.S25; Kuwasako K, 2003, J BIOL CHEM, V278, P22623, DOI 10.1074/jbc.M302571200; Kuwasako K, 2012, BRIT J PHARMACOL, V166, P137, DOI 10.1111/j.1476-5381.2011.01803.x; Kuwasako K, 2011, PEPTIDES, V32, P1540, DOI 10.1016/j.peptides.2011.05.022; Lafont AG, 2007, GEN COMP ENDOCR, V153, P155, DOI 10.1016/j.ygcen.2007.01.027; Louis A, 2012, BRIEF FUNCT GENOMICS, V11, P89, DOI 10.1093/bfgp/els003; Martins R, 2014, GEN COMP ENDOCR, V209, P61, DOI 10.1016/j.ygcen.2014.04.025; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MINAMITAKE Y, 1990, CHEM PHARM BULL, V38, P1920; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Mulder H, 1996, REGUL PEPTIDES, V62, P107, DOI 10.1016/0167-0115(96)00005-5; Okuda R, 1999, GEN COMP ENDOCR, V113, P267, DOI 10.1006/gcen.1998.7195; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qi T, 2010, BRIT J PHARMACOL, V159, P1059, DOI 10.1111/j.1476-5381.2009.00541.x; REICHWALD K, 1994, P NATL ACAD SCI USA, V91, P11894, DOI 10.1073/pnas.91.25.11894; ROBERTS AN, 1989, P NATL ACAD SCI USA, V86, P9662, DOI 10.1073/pnas.86.24.9662; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Rowe ML, 2014, GEN COMP ENDOCR, V197, P43, DOI 10.1016/j.ygcen.2013.12.002; Rowe ML, 2012, GEN COMP ENDOCR, V179, P331, DOI 10.1016/j.ygcen.2012.09.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai T, 2004, ENDOCRINOLOGY, V145, P5671, DOI 10.1210/en.2004-0722; Sakai T, 2012, ENDOCRINOLOGY, V153, P1841, DOI 10.1210/en.2011-1668; Sawada H, 2006, ENDOCRINOLOGY, V147, P2043, DOI 10.1210/en.2005-1226; Sekiguchi T, 2012, J ENDOCRINOL, V213, P99, DOI 10.1530/JOE-11-0410; Sekiguchi T, 2009, FEBS J, V276, P4437, DOI 10.1111/j.1742-4658.2009.07151.x; Sexton PM, 2009, DRUG DISCOV TODAY, V14, P413, DOI 10.1016/j.drudis.2008.12.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Zandawala M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082466; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P816, DOI 10.1016/j.ibmb.2012.06.006	52	20	22	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2345	2356		10.1074/jbc.M115.664003	http://dx.doi.org/10.1074/jbc.M115.664003			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644465	Green Published, hybrid			2022-12-26	WOS:000369610400024
J	Ostrow, KL; Donaldson, K; Blakeley, J; Belzberg, A; Hoke, A				Ostrow, Kimberly Laskie; Donaldson, Katelyn; Blakeley, Jaishri; Belzberg, Allan; Hoke, Ahmet			Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients	PLOS ONE			English	Article							FAMILIAL SCHWANNOMATOSIS; GENE; INI1/SMARCB1; EXPRESSION; HEREGULIN; FORSKOLIN	Schwannomatosis, a rare form of neurofibromatosis, is characterized predominantly by multiple, often painful, schwannomas throughout the peripheral nervous system. The current standard of care for schwannomatosis is surgical resection. A major obstacle to schwannomatosis research is the lack of robust tumor cell lines. There is a great need for mechanistic and drug discovery studies of schwannomatosis, yet appropriate tools are not currently available. Schwannomatosis tumors are difficult to grow in culture as they survive only a few passages before senescence. Our lab has extensive experience in establishing primary and immortalized human Schwann cell cultures from normal tissue that retain their phenotypes after immortalization. Therefore we took on the challenge of creating immortalized human Schwann cell lines derived from tumors from schwannomatosis patients. We have established and fully characterized 2 schwannomatosis cell lines from 2 separate patients using SV40 virus large T antigen. One patient reported pain and the other did not. The schwannomatosis cell lines were stained with S100B antibodies to confirm Schwann cell identity. The schwannomatosis cells also expressed the Schwann cell markers, p75NTR, S100B, and NGF after multiple passages. Cell morphology was retained following multiple passaging and freeze/thaw cycles. Gene expression microarray analysis was used to compare the cell lines with their respective parent tumors. No differences in key genes were detected, with the exception that several cell cycle regulators were upregulated in the schwannomatosis cell lines when compared to their parent tumors. This upregulation was apparently a product of cell culturing, as the schwannomatosis cells exhibited the same expression pattern of cell cycle regulatory genes as normal primary human Schwann cells. Cell growth was also similar between normal primary and immortalized tumor cells in culture. Accurate cell lines derived directly from human tumors will serve as invaluable tools for advancing schwannomatosis research, including drug screening.	[Ostrow, Kimberly Laskie; Donaldson, Katelyn; Blakeley, Jaishri; Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blakeley, Jaishri] Johns Hopkins Sch Med, Deparment Oncol, Baltimore, MD 21205 USA; [Blakeley, Jaishri; Belzberg, Allan] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Ostrow, KL (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	Kostrow3@jhmi.edu			Johns Hopkins Neurosurgery Pain Research Institute; Ohrstrom Foundation; Dr. Miriam and Sheldon Adelson Medical Foundation	Johns Hopkins Neurosurgery Pain Research Institute; Ohrstrom Foundation; Dr. Miriam and Sheldon Adelson Medical Foundation	Funded by The Johns Hopkins Neurosurgery Pain Research Institute (KLO AB), The Ohrstrom Foundation (KLO AB), and The Dr. Miriam and Sheldon Adelson Medical Foundation (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the by Dr. Miriam and Sheldon Adelson Medical Foundation, Ohrstrom Foundation and The Johns Hopkins Neurosurgery Pain Research Institute. Technical assistance was provided by Adrian Bumbut.	Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Jacoby LB, 1997, AM J HUM GENET, V61, P1293, DOI 10.1086/301633; Kaufman DL, 2003, ARCH NEUROL-CHICAGO, V60, P1317, DOI 10.1001/archneur.60.9.1317; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; MacCollin M, 2005, NEUROLOGY, V64, P1838, DOI 10.1212/01.WNL.0000163982.78900.AD; MacCollin M, 2003, NEUROLOGY, V60, P1968, DOI 10.1212/01.WNL.0000070184.08740.E0; May T, 2004, NUCLEIC ACIDS RES, V32, P5529, DOI 10.1093/nar/gkh887; Muir D, 2001, AM J PATHOL, V158, P501, DOI 10.1016/S0002-9440(10)63992-2; Patil S, 2008, BRAIN PATHOL, V18, P517, DOI 10.1111/j.1750-3639.2008.00155.x; Piotrowski A, 2014, NAT GENET, V46, P182, DOI 10.1038/ng.2855; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; Schularick NM, 2014, JOVE-J VIS EXP, DOI 10.3791/51093; Schworer CM, 2003, J NEUROSCI RES, V73, P456, DOI 10.1002/jnr.10679	13	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144620	10.1371/journal.pone.0144620	http://dx.doi.org/10.1371/journal.pone.0144620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657314	Green Submitted, gold, Green Published			2022-12-26	WOS:000366715900073
J	Polotsky, VY; Bevans-Fonti, S; Grigoryev, DN; Punjabi, NM				Polotsky, Vsevolod Y.; Bevans-Fonti, Shannon; Grigoryev, Dmitry N.; Punjabi, Naresh M.			Intermittent Hypoxia Alters Gene Expression in Peripheral Blood Mononuclear Cells of Healthy Volunteers	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; FACTOR-KAPPA-B; EARLY SIGNS; ATHEROSCLEROSIS; INTERLEUKIN-8; CHEMOKINES; RECEPTORS; MORTALITY; OBESITY	Obstructive sleep apnea is associated with high cardiovascular morbidity and mortality. Intermittent hypoxia of obstructive sleep apnea is implicated in the development and progression of insulin resistance and atherosclerosis, which have been attributed to systemic inflammation. Intermittent hypoxia leads to pro-inflammatory gene up-regulation in cell culture, but the effects of intermittent hypoxia on gene expression in humans have not been elucidated. A cross-over study was performed exposing eight healthy men to intermittent hypoxia or control conditions for five hours with peripheral blood mononuclear cell isolation before and after exposures. Total RNA was isolated followed by gene microarrays and confirmatory real time reverse transcriptase PCR. Intermittent hypoxia led to greater than two fold up-regulation of the pro-inflammatory gene toll receptor 2 (TLR2), which was not increased in the control exposure. We hypothesize that up-regulation of TLR2 by intermittent hypoxia may lead to systemic inflammation, insulin resistance and atherosclerosis in patients with obstructive sleep apnea.	[Polotsky, Vsevolod Y.; Bevans-Fonti, Shannon; Punjabi, Naresh M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Grigoryev, Dmitry N.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Punjabi, Naresh M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Polotsky, VY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	vpolots1@jhmi.edu	Punjabi, Naresh/EMH-1007-2022		National Institutes of Health [HL075078, HL080105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080105, R01HL075078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work has been supported by the National Institutes of Health grants HL075078 and HL080105.	[Anonymous], 1998, CLIN GUID ID EV TREA; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bijani FM, 2012, INT REV IMMUNOL, V31, P379, DOI 10.3109/08830185.2012.706761; Caricilli AM, 2008, J ENDOCRINOL, V199, P399, DOI 10.1677/JOE-08-0354; Davis JE, 2009, HORM METAB RES; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Drager LF, 2007, AM J RESP CRIT CARE, V176, P706, DOI 10.1164/rccm.200703-500OC; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erridge C, 2011, ATHEROSCLEROSIS, V216, P1, DOI 10.1016/j.atherosclerosis.2011.02.043; Fan CH, 2005, PHYSIOL GENOMICS, V22, P292, DOI 10.1152/physiolgenomics.00217.2004; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; GASTAUT H., 1966, BRAIN RES, V1, P167, DOI 10.1016/0006-8993(66)90117-X; Greenberg H, 2006, BIOCHEM BIOPH RES CO, V343, P591, DOI 10.1016/j.bbrc.2006.03.015; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Hoffmann MS, 2007, ANTIOXID REDOX SIGN, V9, P661, DOI 10.1089/ars.2007.1589; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Khalyfa A, 2009, SLEEP MED, V10, P75, DOI 10.1016/j.sleep.2007.11.006; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Li JG, 2005, J APPL PHYSIOL, V99, P1643, DOI 10.1152/japplphysiol.00522.2005; Louis M, 2009, J APPL PHYSIOL, V106, P1538, DOI 10.1152/japplphysiol.91523.2008; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Marshall NS, 2008, SLEEP, V31, P1079; Minoguchi K, 2005, AM J RESP CRIT CARE, V172, P625, DOI 10.1164/rccm.200412-1652OC; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Polotsky VY, 2010, PHYSIOL GENOMICS, V41, P306, DOI 10.1152/physiolgenomics.00091.2009; Poulain L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/620258; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Rahman SA, 2015, BRAIN BEHAV IMMUN, V47, P4, DOI 10.1016/j.bbi.2014.11.003; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan S, 2007, BIOCHEM BIOPH RES CO, V355, P728, DOI 10.1016/j.bbrc.2007.02.015; Ryan S, 2006, AM J RESP CRIT CARE, V174, P824, DOI 10.1164/rccm.200601-066OC; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Savransky V, 2007, AM J RESP CRIT CARE, V175, P1290, DOI 10.1164/rccm.200612-1771OC; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Young T, 2008, SLEEP, V31, P1071	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144725	10.1371/journal.pone.0144725	http://dx.doi.org/10.1371/journal.pone.0144725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657991	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900094
J	Wong, SB; Cheng, SJ; Hung, WC; Lee, WT; Min, MY				Wong, Shi-Bing; Cheng, Sin-Jhong; Hung, Wei-Chen; Lee, Wang-Tso; Min, Ming-Yuan			Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; EPILEPTIFORM ACTIVITY; NITRIC-OXIDE; BRAIN; EXPRESSION; CORTEX; MECHANISMS; BUMETANIDE; AGONIST	Peroxisomal proliferator-activated receptor gamma (PPAR.) is a nuclear hormone receptor whose agonist, rosiglitazone has a neuroprotective effect to hippocampal neurons in pilocarpine-induced seizures. Hippocampal slice preparations treated in Mg2+ free medium can induce ictal and interictal-like epileptiform discharges, which is regarded as an in vitro model of N-methyl-D-aspartate (NMDA) receptor-mediated temporal lobe epilepsy (TLE). We applied rosiglitazone in hippocampal slices treated in Mg2+ free medium. The effects of rosiglitazone on hippocampal CA1-Schaffer collateral synaptic transmission were tested. We also examined the neuroprotective effect of rosiglitazone toward NMDA excitotoxicity on cultured hippocampal slices. Application of 10 mu M rosiglitazone significantly suppressed amplitude and frequency of epileptiform discharges in CA1 neurons. Pretreatment with the PPAR. antagonist GW9662 did not block the effect of rosiglitazone on suppressing discharge frequency, but reverse the effect on suppressing discharge amplitude. Application of rosiglitazone suppressed synaptic transmission in the CA1-Schaffer collateral pathway. By miniature excitatory-potential synaptic current (mEPSC) analysis, rosiglitazone significantly suppressed presynaptic neurotransmitter release. This phenomenon can be reversed by pretreating PPAR. antagonist GW9662. Also, rosiglitazone protected cultured hippocampal slices from NMDA-induced excitotoxicity. The protective effect of 10 mu M rosiglitazone was partially antagonized by concomitant high dose GW9662 treatment, indicating that this effect is partially mediated by PPAR. receptors. In conclusion, rosiglitazone suppressed NMDA receptor-mediated epileptiform discharges by inhibition of presynaptic neurotransmitter release. Rosiglitazone protected hippocampal slice from NMDA excitotoxicity partially by PPAR. activation. We suggest that rosiglitazone could be a potential agent to treat patients with TLE.	[Wong, Shi-Bing; Hung, Wei-Chen] Taipei Tzu Chi Gen Hosp, Dept Pediat, Buddhist Tzu Chi Med Fdn, Taipei, Taiwan; [Wong, Shi-Bing; Min, Ming-Yuan] Natl Taiwan Univ, Inst Zool, Coll Life Sci, Taipei 10764, Taiwan; [Cheng, Sin-Jhong] Acad Sinica, Neurosci Program, Taipei 115, Taiwan; [Cheng, Sin-Jhong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Wang-Tso] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan	Buddhist Tzu Chi General Hospital; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Lee, WT (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	leeped@hotmail.com; mymin@ntu.edu.tw	Chang, Sin-Jhong/AAL-4118-2020	Lee, Wang-Tso/0000-0003-3231-9764	Taipei Tzu Chi General Hospital [TCRD-TPE-101-04, TCRD-TPE-102-23, TCRD-TPE-NSC-102-11]; National Science Council, Taiwan [NSC101-2314-B-303-101]	Taipei Tzu Chi General Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The paper is supported by Taipei Tzu Chi General Hospital (TCRD-TPE-101-04; TCRD-TPE-102-23; TCRD-TPE-NSC-102-11) and National Science Council, Taiwan (NSC101-2314-B-303-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DM, 2010, BRAIN RES, V1351, P246, DOI 10.1016/j.brainres.2010.06.034; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Berretta N, 2012, EPILEPSIA, V53, pe80, DOI 10.1111/j.1528-1167.2012.03420.x; Carta AR, 2013, CURR DRUG TARGETS, V14, P743, DOI 10.2174/1389450111314070004; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; de Moura JC, 2012, HIPPOCAMPUS, V22, P92, DOI 10.1002/hipo.20863; DURING MJ, 1993, LANCET, V341, P1607; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Eid T, 2013, EPILEPSIA, V54, P228, DOI 10.1111/epi.12008; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kilb W, 2007, NEUROPHARMACOLOGY, V53, P524, DOI 10.1016/j.neuropharm.2007.06.015; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Mohazab RA, 2012, EPILEPSY RES, V101, P28, DOI 10.1016/j.eplepsyres.2012.02.015; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Moser J, 2006, BRAIN RES, V1077, P170, DOI 10.1016/j.brainres.2006.01.024; Mrak RE, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-5; Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014; NEUMAN RS, 1989, NEUROSCIENCE, V28, P393, DOI 10.1016/0306-4522(89)90186-3; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ou ZS, 2006, BRAIN RES, V1096, P196, DOI 10.1016/j.brainres.2006.04.062; Pancani T, 2009, J NEUROCHEM, V109, P1800, DOI 10.1111/j.1471-4159.2009.06107.x; Park EJ, 2003, J BIOL CHEM, V278, P14747, DOI 10.1074/jbc.M210819200; Park EY, 2004, CANCER RES, V64, P3701, DOI 10.1158/0008-5472.CAN-03-3924; Petroff OAC, 1996, ANN NEUROL, V40, P908, DOI 10.1002/ana.410400613; Quilichini PP, 2002, EUR J NEUROSCI, V16, P850, DOI 10.1046/j.1460-9568.2002.02143.x; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun H, 2008, INT J DEV NEUROSCI, V26, P505, DOI 10.1016/j.ijdevneu.2008.01.009; Tellez-Zenteno Jose F, 2012, Epilepsy Res Treat, V2012, P630853, DOI 10.1155/2012/630853; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Upreti C, 2012, BRAIN, V135, P869, DOI 10.1093/brain/awr341; Yu X, 2008, BRAIN RES, V1200, P146, DOI 10.1016/j.brainres.2008.01.047; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009	43	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144806	10.1371/journal.pone.0144806	http://dx.doi.org/10.1371/journal.pone.0144806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659605	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900107
J	Abdel-Moneim, AM; Al-Kahtani, MA; El-Kersh, MA; Al-Omair, MA				Abdel-Moneim, Ashraf M.; Al-Kahtani, Mohammed A.; El-Kersh, Mohamed A.; Al-Omair, Mohammed A.			Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage	PLOS ONE			English	Article							TETRACHLORIDE-INDUCED HEPATOTOXICITY; INDUCED OXIDATIVE STRESS; INDUCED HEPATIC DAMAGE; CCL4-INDUCED HEPATOTOXICITY; SPECTROPHOTOMETRIC ASSAY; EXTRACT; ANTIOXIDANT; INJURY; FIBROSIS; ADIPONECTIN	The present study aims to investigate the hepatoprotective effect of taurine (TAU) alone or in combination with silymarin (SIL) on CCl4-induced liver damage. Twenty five male rats were randomized into 5 groups: normal control (vehicle treated), toxin control (CCl4 treated), CCl4+TAU, CCl4+SIL and CCl4+TAU+SIL. CCl4 provoked significant increases in the levels of hepatic TBARS, NO and NOS compared to control group, but the levels of endogenous antioxidants such as SOD, GPx, GR, GST and GSH were significantly decreased. Serum pro-inflammatory and fibrogenic cytokines including TNF-alpha, TGF-beta 1, IL-6, leptin and resistin were increased while the anti-inflammatory (adiponectin) cytokine was decreased in all treated rats. Our results also showed that CCl4 induced an increase in liver injury parameters like serum ALT, AST, ALP, GGT and bilirubin. In addition, a significant increase in liver tissue hydroxyproline (a major component of collagen) was detected in rats exposed to CCl4. Moreover, the concentrations of serum TG, TC, HDL-C, LDL-C, VLDL-C and FFA were significantly increased by CCl4. Both TAU and SIL (i.e., antioxidants) post-treatments were effectively able to relieve most of the above mentioned imbalances. However, the combination therapy was more effective than single applications in reducing TBARS levels, NO production, hydroxyproline content in fibrotic liver and the activity of serum GGT. Combined treatment (but not TAU-or SIL-alone) was also able to effectively prevent CCl4-induced decrease in adiponectin serum levels. Of note, the combined post-treatment with TAU+ SIL (but not monotherapy) normalized serum FFA in CCl4-treated rats. The biochemical results were confirmed by histological and ultrastructural changes as compared to CCl4-poisoned rats. Therefore, on the basis of our work, TAU may be used in combination with SIL as an additional adjunct therapy to cure liver diseases such as fibrosis, cirrhosis and viral hepatitis.	[Abdel-Moneim, Ashraf M.; Al-Kahtani, Mohammed A.] King Faisal Univ, Fac Sci, Dept Biol Sci, Al Hasa, Saudi Arabia; [Abdel-Moneim, Ashraf M.] Univ Alexandria, Fac Sci, Dept Zool, Alexandria, Egypt; [El-Kersh, Mohamed A.; Al-Omair, Mohammed A.] King Faisal Univ, Fac Sci, Dept Chem, Al Hasa, Saudi Arabia; [El-Kersh, Mohamed A.] Univ Alexandria, Fac Sci, Dept Biochem, Alexandria, Egypt	King Faisal University; Egyptian Knowledge Bank (EKB); Alexandria University; King Faisal University; Egyptian Knowledge Bank (EKB); Alexandria University	Abdel-Moneim, AM (corresponding author), King Faisal Univ, Fac Sci, Dept Biol Sci, Al Hasa, Saudi Arabia.	aabdelmoneim@kfu.edu.sa	Abdel-Moneim, Ashraf/A-4601-2009; Al-Omair, Mohammed/P-4396-2016; Abdel-Moneim, Ashraf/GQH-0206-2022	Abdel-Moneim, Ashraf/0000-0002-0270-703X; Al-Omair, Mohammed/0000-0003-4358-6665; 	Deanship of Scientific Research, King Faisal University [120041]	Deanship of Scientific Research, King Faisal University	This research work is financially supported by Deanship of Scientific Research, King Faisal University (project no. 120041).	Abdelaziz DHA, 2014, J ETHNOPHARMACOL, V155, P736, DOI 10.1016/j.jep.2014.06.026; Ahmed AF, 2011, ANN HEPATOL, V10, P207; Arulmozhi V, 2010, PHARMACOGN MAG, V6, P42, DOI 10.4103/0973-1296.59965; Bektur NE, 2016, TOXICOL IND HEALTH, V32, P589, DOI 10.1177/0748233713502841; Bertolani Cristiana, 2008, Pathophysiology, V15, P91, DOI 10.1016/j.pathophys.2008.05.001; Bhondave PD, 2014, J ETHNOPHARMACOL, V151, P183, DOI 10.1016/j.jep.2013.10.025; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Cao W, 2015, TOXICOL LETT, V232, P233, DOI 10.1016/j.toxlet.2014.11.009; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Das J, 2010, FREE RADICAL RES, V44, P340, DOI 10.3109/10715760903513017; Debnath S, 2013, FOOD CHEM TOXICOL, V59, P485, DOI 10.1016/j.fct.2013.06.036; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Devi SL, 2010, EUR J PHARMACOL, V647, P161, DOI 10.1016/j.ejphar.2010.08.011; Dincer S, 2002, AMINO ACIDS, V22, P417, DOI 10.1007/s007260200025; Domitrovic R, 2011, FOOD CHEM TOXICOL, V49, P848, DOI 10.1016/j.fct.2010.12.006; El Ashry FEZ, 2012, FOOD CHEM TOXICOL, V50, P1159, DOI 10.1016/j.fct.2011.12.020; El-Sayed WM, 2011, J HAZARD MATER, V192, P880, DOI 10.1016/j.jhazmat.2011.05.100; Essawy A. E., 2012, Journal of Applied Pharmaceutical Science, V2, P21; Flora SJS, 2008, OXID MED CELL LONGEV, V1, P39, DOI 10.4161/oxim.1.1.6481; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Ghigo D, 2006, NITRIC OXIDE-BIOL CH, V15, P148, DOI 10.1016/j.niox.2006.01.002; Girish C, 2012, J PHARMACOL PHARMACO, V3, P149, DOI 10.4103/0976-500X.95515; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hagar HH, 2004, TOXICOL LETT, V151, P335, DOI 10.1016/j.toxlet.2004.03.002; Hamdy N, 2012, TOXICOL APPL PHARM, V261, P292, DOI 10.1016/j.taap.2012.04.012; Haretskaya MV, 2014, BIOCHEM MOSC-SUPPL S, V8, P286, DOI 10.1134/S1990750814040039; Hsu YW, 2008, FOOD CHEM TOXICOL, V46, P3311, DOI 10.1016/j.fct.2008.07.027; Huo HZ, 2011, INT J MOL SCI, V12, P6529, DOI 10.3390/ijms12106529; JACOBSON B, 1988, CLIN CHEM, V34, P2164; Jelinek D, 2012, J NUTR, V142, P1935, DOI 10.3945/jn.112.162818; Kabil NN, 2014, PEPTIDES, V52, P90, DOI 10.1016/j.peptides.2013.11.022; Kamata K, 1996, EUR J PHARMACOL, V303, P47, DOI 10.1016/0014-2999(96)00094-5; Li Hong-Shan, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P546, DOI 10.3736/jcim20090610; Lindenmaier H, 2005, DRUG METAB DISPOS, V33, P1576, DOI 10.1124/dmd.105.005314; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mansour HH, 2006, J BIOCHEM MOL BIOL, V39, P656; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Militante JD, 2004, NUTR RES, V24, P787, DOI 10.1016/S0271-5317(04)00109-5; Miyazaki T, 2005, J HEPATOL, V43, P117, DOI 10.1016/j.jhep.2005.01.033; Moschen AR, 2012, CURR MED CHEM, V19, P5467; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parveen R, 2011, ARCH PHARM RES, V34, P767, DOI 10.1007/s12272-011-0510-8; Peng XD, 2009, BIOCHEM BIOPH RES CO, V388, P31, DOI 10.1016/j.bbrc.2009.07.099; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Raj S, 2014, FOOD CHEM TOXICOL, V67, P105, DOI 10.1016/j.fct.2014.02.028; Ramasamy P, 2014, INT J BIOL MACROMOL, V65, P559, DOI 10.1016/j.ijbiomac.2014.02.009; Ranawat L, 2010, J ETHNOPHARMACOL, V127, P777, DOI 10.1016/j.jep.2009.10.019; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360; Saller R, 2008, FORSCH KOMPLEMENTMED, V15, P9, DOI 10.1159/000113648; Shafik Amani N, 2011, Arab J Gastroenterol, V12, P143, DOI 10.1016/j.ajg.2011.07.001; Shaker ME, 2011, TOXICOL APPL PHARM, V252, P165, DOI 10.1016/j.taap.2011.02.004; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Tabassum H, 2006, CLIN CHIM ACTA, V370, P129, DOI 10.1016/j.cca.2006.02.006; Tasci I, 2008, WORLD J GASTROENTERO, V14, P4897, DOI 10.3748/wjg.14.4897; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Turgut O, 2011, J ATHEROSCLER THROMB, V18, P177, DOI 10.5551/jat.6189; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Vuda M, 2012, EXP TOXICOL PATHOL, V64, P855, DOI 10.1016/j.etp.2011.03.006; Wang BJ, 2004, FOOD CHEM TOXICOL, V42, P609, DOI 10.1016/j.fct.2003.11.011; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; Willianson FJ, 1996, SELECTION PREPARATIO; Wills PJ, 2012, ASIAN PAC J TROP MED, V5, P421, DOI 10.1016/S1995-7645(12)60072-8; Yadav NP, 2008, PHYTOMEDICINE, V15, P1053, DOI 10.1016/j.phymed.2008.08.002; Yang JY, 2010, J AGR FOOD CHEM, V58, P6525, DOI 10.1021/jf903070a	69	101	106	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144509	10.1371/journal.pone.0144509	http://dx.doi.org/10.1371/journal.pone.0144509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659465	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600049
J	Qiao, MN; Wu, D; Carey, M; Zhou, XB; Zhang, L				Qiao, Minna; Wu, Dan; Carey, Michelle; Zhou, Xiaobo; Zhang, Le			Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts	PLOS ONE			English	Article							BONE-MARROW; STEM-CELL; GLUCOCORTICOIDS; PATHOGENESIS; MECHANISMS; CYTOKINES; PROTEIN; RNA	Research Background Currently, multiple myeloma is the second most common hematological malignancy in the U.S., constituting 1% of all cancers. With conventional treatment, the median survival time is typically 3-4 years, although it can be extended to 5-7 years or longer with advanced treatments. Recent research indicated that an increase in osteoclast (OC) activity is often associated withmultiple myeloma (MM) and that a decrease inosteoblast (OB) activity contributesto the osteolytic lesions in MM. Normally, the populations of OCs and OBs are inequilibrium, and an imbalance in this statecontributes to the development of lesions. Research procedures A multi-scale agent-based multiple myeloma model was developed to simulate the proliferation, migration and death of OBs and OCs. Subsequently, this model was employed to investigate the efficacy of thethree most commonly used drugs for MM treatment under the following two premises: the reduction in the progression of MM and the re-establishment of the equilibrium between OCs and OBs. Research purposes The simulated results not only demonstrated the capacity of the model to choose optimal combinations of the drugs but also showed that the optimal use of the three drugs can restore the balance between OCs and OBs as well as kill MMs. Furthermore, the drug synergism analysis function of the model revealed that restoring the balance between OBs and OCs can significantly increase the efficacy of drugs against tumor cells.	[Qiao, Minna; Zhang, Le] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Wu, Dan; Zhou, Xiaobo] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA; [Carey, Michelle] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA	Southwest University - China; Wake Forest University; University of Rochester	Zhou, XB (corresponding author), Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA.	xizhou@wakehealth.edu; zhanglcq@swu.edu.cn	Zhang, Le/AAD-9104-2019	Zhang, Le/0000-0002-3708-1727; Carey, Michelle/0000-0002-5603-4264	 [U01 CA166886-01];  [P30AI078498];  [HHSN272201000055C];  [61372138]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by http://grants.nih.gov/grants/oer.htm: U01 CA166886-01, P30AI078498, HHSN272201000055C; and www.nsfc.gov.cn: No. 61372138.	ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; BATAILLE R, 1991, J CLIN INVEST, V88, P62, DOI 10.1172/JCI115305; Filella X, 1996, CANCER DETECT PREV, V20, P52; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Fulciniti M, 2009, BLOOD, V114, pS151; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; Guo J, 2004, CLIN CANCER RES, V10, P3333, DOI 10.1158/1078-0432.CCR-03-0366; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hiroshi T, 2003, NATURE, V423, P337; ISHIKAWA H, 1990, BLOOD, V75, P715; Jian-Ming Hou, 2012, Acta Pharmacologica Sinica, V33, P1277; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Maria-Victoria M, 2006, BLOOD, V108, P2165; Meletios D, 2007, NEW ENGL J MED, V357, P2123; MOALLI PA, 1993, CANCER RES, V53, P3877; MOALLI PA, 1992, BLOOD, V79, P213; Nicola G, 2006, BLOOD, V108, P3992; Oftedal S, 1921, J AMER MED ASSOC, V77, P1547; Politou MC, 2006, INT J CANCER, V119, P1728, DOI 10.1002/ijc.22033; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rongrong Z, 2013, BONE, V52, P145, DOI [10.1016/j.bone.2012.09.029, DOI 10.1016/J.BONE.2012.09.029]; Roodman GD, 2010, J BONE MINER METAB, V28, P244, DOI 10.1007/s00774-009-0154-7; Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124; Sun XQ, 2012, BIOMATERIALS, V33, P8265, DOI 10.1016/j.biomaterials.2012.07.041; Sundar J, 2005, BRIT J HAEMATOL, V129, P776; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yong-Zhan Z, 2009, ACTA PHARMACOL SIN, V7, P1025; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441; ZHANG XG, 1994, BLOOD, V83, P3654; Zhen YZ, 2009, INT J HEMATOL, V90, P44, DOI 10.1007/s12185-009-0340-3	32	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143206	10.1371/journal.pone.0143206	http://dx.doi.org/10.1371/journal.pone.0143206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659358	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903600009
J	Jarvinen, KM; Westfall, J; De Jesus, M; Mantis, NJ; Carroll, JA; Metzger, DW; Sampson, HA; Berin, MC				Jaervinen, Kirsi M.; Westfall, Jennifer; De Jesus, Magdia; Mantis, Nicholas J.; Carroll, Jessica A.; Metzger, Dennis W.; Sampson, Hugh A.; Berin, M. Cecilia			Role of Maternal Dietary Peanut Exposure in Development of Food Allergy and Oral Tolerance	PLOS ONE			English	Article							BREAST-MILK; INDUCED ANAPHYLAXIS; ATOPIC-DERMATITIS; MURINE MODEL; TREE NUTS; SENSITIZATION; CHILDREN; RISK; CONSUMPTION; INFANTS	Background The impact of maternal ingestion of peanut during pregnancy and lactation on an offspring's risk for peanut allergy is under debate. Objective To investigate the influence of maternal dietary peanut exposure and breast milk on an offspring's allergy risk. Methods Preconceptionally peanut-exposed C3H/HeJ females were either fed or not fed peanut during pregnancy and lactation. The offsprings' responses to peanut sensitization or oral tolerance induction by feeding antigen prior to immunization were assessed. We also assessed the impact of immune murine milk on tolerance induction pre- or post-weaning. For antigen uptake studies, mice were gavaged with fluorescent peanut in the presence or absence of immune murine milk; Peyer's patches were harvested for immunostaining. Results Preconceptional peanut exposure resulted in the production of varying levels of maternal antibodies in serum (and breast milk), which were transferred to the offspring. Despite this, maternal peanut exposure either preconceptionally or during pregnancy and lactation, when compared to no maternal exposure, had no impact on peanut allergy. When offspring were fed peanut directly, dose-dependent tolerance induction, unaltered by maternal feeding of peanut, was seen. Although peanut uptake into the gut-associated lymphoid tissues was enhanced by immune milk as compared to naive milk, tolerance induction was not affected by the co-administration of immune milk either pre- or post-weaning. Conclusion Maternal peanut exposure during pregnancy and lactation has no impact on the development of peanut allergy in the offspring. Tolerance to peanut can be induced early, even pre-weaning, by giving moderate amounts of peanut directly to the infant, and this is neither enhanced nor impaired by concurrent exposure to immune milk.	[Jaervinen, Kirsi M.; Westfall, Jennifer; Carroll, Jessica A.] Albany Med Coll, Div Allergy & Immunol, Albany, NY 12208 USA; [De Jesus, Magdia; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Mantis, Nicholas J.] SUNY Albany, Dept Biomed Sci, Albany, NY USA; [Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Div Pediat Allergy & Immunol, New York, NY 10029 USA; [Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10029 USA	Albany Medical College; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Jarvinen, KM (corresponding author), Univ Rochester, Sch Med & Dent, Div Pediat Allergy & Immunol, Rochester, NY 14627 USA.	kirsi_jarvinen-seppo@URMC.Rochester.edu	Metzger, Dennis W/I-2771-2019	Metzger, Dennis W/0000-0002-8000-9907; Mantis, Nicholas/0000-0002-5083-8640; berin, cecilia/0000-0002-9051-9249; Doering, Jennifer/0000-0001-8749-774X	NIH [AI44236, AI066738, AI093577, HD061916]; Life Sciences Research Foundation; Howard Hughes Medical Institute (HHMI);  [AI091655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093577, K08AI091655, U19AI066738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number AI091655 (K.M. Jarvinen), H.A. Sampson is supported in part by grants from the NIH, AI44236 and AI066738. M. Cecilia Berin is supported in part by NIH grant AI093577. N.J. Mantis was supported in part by NIH HD061916. M. De Jesus was supported by the Life Sciences Research Foundation, postdoctoral fellowship sponsored by the Howard Hughes Medical Institute (HHMI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.	Baker SS, 2000, PEDIATRICS, V106, P346; Ben-Shoshan M, 2010, J ALLERGY CLIN IMMUN, V125, P1327, DOI 10.1016/j.jaci.2010.03.015; Berin MC, 2013, MUCOSAL IMMUNOL, V6, P114, DOI 10.1038/mi.2012.55; Bernard H, 2014, ALLERGY, V69, P888, DOI 10.1111/all.12411; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Chan SMH, 2012, ALLERGY, V67, P336, DOI 10.1111/j.1398-9995.2011.02765.x; De Jesus M, 2013, JOVE-J VIS EXP, DOI 10.3791/50167; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Fleischer DM, 2015, ALLERGY, V70, P1193, DOI 10.1111/all.12687; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Frank L, 1999, PEDIATR ALLERGY IMMU, V10, P27, DOI 10.1034/j.1399-3038.1999.101010.x; Frazier AL, 2014, JAMA PEDIATR, V168, P156, DOI 10.1001/jamapediatrics.2013.4139; Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Jarvinen KM, 1999, J PEDIATR-US, V135, P506, DOI 10.1016/S0022-3476(99)70175-7; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Li XM, 2001, J ALLERGY CLIN IMMUN, V108, P639, DOI 10.1067/mai.2001.118787; Lopez-Exposito I, 2011, FOOD RES INT, V44, P1649, DOI 10.1016/j.foodres.2011.04.047; Lopez-Exposito I, 2009, J ALLERGY CLIN IMMUN, V124, P1039, DOI 10.1016/j.jaci.2009.08.024; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matson AP, 2007, J IMMUNOL, V179, P1282, DOI 10.4049/jimmunol.179.2.1282; Mosconi E, 2010, MUCOSAL IMMUNOL, V3, P461, DOI 10.1038/mi.2010.23; Mullins RJ, 2009, J ALLERGY CLIN IMMUN, V123, P689, DOI 10.1016/j.jaci.2008.12.1116; Palmer DJ, 2005, CLIN EXP ALLERGY, V35, P173, DOI 10.1111/j.1365-2222.2005.02170.x; Pumphrey RSH, 2007, J ALLERGY CLIN IMMUN, V119, P1018, DOI 10.1016/j.jaci.2007.01.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Vadas P, 2001, JAMA-J AM MED ASSOC, V285, P1746, DOI 10.1001/jama.285.13.1746; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9	39	18	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143855	10.1371/journal.pone.0143855	http://dx.doi.org/10.1371/journal.pone.0143855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656505	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500008
J	Mandrich, L; Cerreta, M; Manco, G				Mandrich, Luigi; Cerreta, Mariangela; Manco, Giuseppe			An Engineered Version of Human PON2 Opens the Way to Understand the Role of Its Post-Translational Modifications in Modulating Catalytic Activity	PLOS ONE			English	Article							SIGNAL N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; PSEUDOMONAS-AERUGINOSA; OXIDATIVE STRESS; SULFOLOBUS-SOLFATARICUS; ENDOPLASMIC-RETICULUM; PARAOXONASE 2; PHOSPHOTRIESTERASE; EXPRESSION; STABILITY; INFECTION	The human paraoxonase 2 (PON2) has been described as a highly specific lactonase hydrolysing the quorum sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone (3OC12-HSL) and having secondary esterase but not phosphotriesterase activity, in contrast with the related enzymes PON1 and PON3. It has been suggested that PON2 enzyme activity is dependent on glycosylation and its N-terminal region has been recently demonstrated to be a transmembrane domain mediating association to membranes. In the present study we describe a mutated form of PON2, lacking the above N-terminal region, which has been further stabilized by the insertion of six amino acidic substitutions. The engineered version, hence forth called rPON2, has been over-expressed in E.coli, refolded from inclusion bodies and purified, yielding an enzyme with the same characteristics as the full length enzyme. Therefore the first conclusion of this work was that the catalytic activity is independent from the N-terminus and protein glycosylation. The kinetic characterization confirmed the primary activity on 3OC12-HSL; accordingly, in vitro experiments of inhibition of the bio-film formed by Pseudomonas aeruginosa (PAO1) have demonstrated that rPON2 is more effective than PON1. In addition, we observed small but significant activity against organo-phosphorothiotes pesticides, m-parathion, coumaphos and malathion. The availability of fair amount of active protein allowed to pinpoint, by mass-spectrometry, ubiquitination of Lys 168 induced in rPON2 by HeLa extract and to correlate such post-translational modification to the modulation of catalytic activity. A mutational analysis of the modified residue confirmed the result.	[Mandrich, Luigi; Cerreta, Mariangela; Manco, Giuseppe] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Mandrich, L (corresponding author), CNR, Inst Prot Biochem, Via Pietro Castellino 111, I-80131 Naples, Italy.	l.mandrich@ibp.cnr.it	Manco, Giuseppe/AAL-3777-2020; MANDRICH, Luigi/L-7198-2019; Mandrich, Luigi/AAH-9328-2020	Manco, Giuseppe/0000-0001-6191-3952; MANDRICH, Luigi/0000-0002-0025-9544; Mandrich, Luigi/0000-0002-0025-9544	Italian Cystic Fibrosis Research Foundation [FFC10/2010]; Italian Ministry of Education, University and Research [PON01_01585]; CNR Flagship Project "Interomics"	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); CNR Flagship Project "Interomics"	This work was supported by The Italian Cystic Fibrosis Research Foundation (FFC10/2010); The "Programma Operativo Nazionale Ricerca e Competitivita 2007-2013" (PON), PON01_01585 from Italian Ministry of Education, University and Research; and The CNR Flagship Project "Interomics". The funders had no role in study design, data collection and analysis, decision to publish, or preparating of the manuscript.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Bar-Rogovsky H, 2013, J BIOL CHEM, V288, P23914, DOI 10.1074/jbc.M112.427922; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Bourquard N, 2008, PROTEINS CELL REGUL, V6, P103, DOI 10.1007/978-1-4020-6561-3_7; BROWN WC, 1993, GENE, V127, P99, DOI 10.1016/0378-1119(93)90622-A; Cleland JL, 2001, J PHARM SCI, V90, P310, DOI 10.1002/1520-6017(200103)90:3<310::AID-JPS6>3.3.CO;2-I; Costa LG, 2013, TOXICOLOGY, V307, P115, DOI 10.1016/j.tox.2012.07.011; DIEPGEN TL, 1986, ARCH TOXICOL, P154; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dorn J, 2014, J BIOL CHEM, V289, P7049, DOI 10.1074/jbc.M113.536094; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Gao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3656; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Jaouad L, 2006, ATHEROSCLEROSIS, V185, P191, DOI 10.1016/j.atherosclerosis.2005.06.012; Josse D, 1999, BIOCHEMISTRY-US, V38, P2816, DOI 10.1021/bi982281h; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; La Du BN, 1992, PHARMACOGENETICS DRU, P51; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Leviev I, 1997, ARTERIOSCL THROM VAS, V17, P2935, DOI 10.1161/01.ATV.17.11.2935; Li HG, 2013, TRENDS PHARMACOL SCI, V34, P313, DOI 10.1016/j.tips.2013.03.007; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Nagant C, 2011, J APPL MICROBIOL, V111, P763, DOI 10.1111/j.1365-2672.2011.05085.x; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Pezzullo M, 2013, PROTEIN ENG DES SEL, V26, P47, DOI 10.1093/protein/gzs066; Porzio E, 2007, BIOCHIMIE, V89, P625, DOI 10.1016/j.biochi.2007.01.007; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Sierksma A, 2002, ALCOHOL CLIN EXP RES, V26, P1430, DOI 10.1097/01.ALC.0000030639.57507.60; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Sorenson RC, 1995, GENOMICS, V30, P431, DOI 10.1006/geno.1995.1261; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Stoltz DA, 2009, J BIOL CHEM, V284, P35564, DOI 10.1074/jbc.M109.051706; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suzuki SM, 2010, ADV EXP MED BIOL, V660, P37, DOI 10.1007/978-1-60761-350-3_5; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9	45	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144579	10.1371/journal.pone.0144579	http://dx.doi.org/10.1371/journal.pone.0144579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656916	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500043
J	Markiewicz, I; Strupczewski, WG; Bogdanowicz, E; Kochanek, K				Markiewicz, Iwona; Strupczewski, Witold G.; Bogdanowicz, Ewa; Kochanek, Krzysztof			Generalized Exponential Distribution in Flood Frequency Analysis for Polish Rivers	PLOS ONE			English	Article							LOGISTIC PROBABILITY-DISTRIBUTIONS; HYDROLOGICAL ANALYSES; LOG-GUMBEL; APPLICABILITY; GAMMA; MODEL	Many distributions have been used in flood frequency analysis (FFA) for fitting the flood extremes data. However, as shown in the paper, the scatter of Polish data plotted on the moment ratio diagram shows that there is still room for a new model. In the paper, we study the usefulness of the generalized exponential (GE) distribution in flood frequency analysis for Polish Rivers. We investigate the fit of GE distribution to the Polish data of the maximum flows in comparison with the inverse Gaussian (IG) distribution, which in our previous studies showed the best fitting among several models commonly used in FFA. Since the use of a discrimination procedure without the knowledge of its performance for the considered probability density functions may lead to erroneous conclusions, we compare the probability of correct selection for the GE and IG distributions along with the analysis of the asymptotic model error in respect to the upper quantile values. As an application, both GE and IG distributions are alternatively assumed for describing the annual peak flows for several gauging stations of Polish Rivers. To find the best fitting model, four discrimination procedures are used. In turn, they are based on the maximized logarithm of the likelihood function (K procedure), on the density function of the scale transformation maximal invariant (QK procedure), on the Kolmogorov-Smirnov statistics (KS procedure) and the fourth procedure based on the differences between the ML estimate of 1% quantile and its value assessed by the method of moments and linear moments, in sequence (R procedure). Due to the uncertainty of choosing the best model, the method of aggregation is applied to estimate of the maximum flow quantiles.	[Markiewicz, Iwona; Strupczewski, Witold G.; Kochanek, Krzysztof] Polish Acad Sci, Inst Geophys, Dept Hydrol & Hydrodynam, Warsaw 42, Poland; [Bogdanowicz, Ewa] Polish Acad Sci, Inst Geophys, CHIHE Norway Grants, Warsaw 42, Poland	Polish Academy of Sciences; Institute of Geophysics of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Geophysics of the Polish Academy of Sciences	Markiewicz, I (corresponding author), Polish Acad Sci, Inst Geophys, Dept Hydrol & Hydrodynam, Warsaw 42, Poland.	iwonamar@igf.edu.pl	Bogdanowicz, Ewa/Q-6947-2018; Kochanek, Krzysztof/I-2824-2016		Polish National Science Centre titled "Modern statistical models for analysis of flood frequency and features of flood waves" [DEC-2012/05/B/ST10/00482]; Polish Ministry of Science and Higher Education under the Grant Iuventus Plus [IP 2010 024570]; Ministry of Science and Higher Education of Poland [3841/E-41/S/2015]	Polish National Science Centre titled "Modern statistical models for analysis of flood frequency and features of flood waves"; Polish Ministry of Science and Higher Education under the Grant Iuventus Plus; Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland)	This work was partly financed by the grant of the Polish National Science Centre titled "Modern statistical models for analysis of flood frequency and features of flood waves", decision nr DEC-2012/05/B/ST10/00482 and by the Polish Ministry of Science and Higher Education under the Grant Iuventus Plus IP 2010 024570 titled "Analysis of the efficiency of estimation methods in flood frequency modelling". This work was partially supported within statutory activities No 3841/E-41/S/2015 of the Ministry of Science and Higher Education of Poland.	Abramowitz M, 1972, HDB MATH FUNCTIONS; Adler RJ, 1998, PRACTICAL GUIDE TO HEAVY TAILS, P133; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2012, REV APPL EUR FLOOD F; [Anonymous], 1969, GUID DET ANN MAX FLO; [Anonymous], [No title captured]; Beard L.R., 1974, FLOOD FLOW FREQUENCY; BENSON MA, 1968, WATER RESOUR RES, V4, P891, DOI 10.1029/WR004i005p00891; BERNARDO JM, 1976, ROY STAT SOC C-APP, V25, P315, DOI 10.2307/2347257; Bogdanowicz E, 2010, MG KOM INZ SR PAN, P57; BOUGHTON WC, 1980, WATER RESOUR RES, V16, P347, DOI 10.1029/WR016i002p00347; Brzezinski J, 2010, MONOGRAPHS COMMITTEE, V68, P71; Chakravarty IM, 1967, HDB METHODS APPL STA, VI, P392; Cox D. R., 1965, THEORY STOCHASTIC PR; Cunnane C, 1989, 33 WORLD MET ORG; Dey AK, 2009, IEEE T RELIAB, V58, P416, DOI 10.1109/TR.2009.2019494; Dooge J. C. I., 1973, TECHNICAL B AGR RES, V1468; DYER AR, 1973, J AM STAT ASSOC, V68, P970, DOI 10.2307/2284533; El Adlouni S, 2008, J HYDROL, V355, P16, DOI 10.1016/j.jhydrol.2008.02.011; Foss S, 2013, SPRINGER SERIES OPER, DOI [10.1007/978-1-4614-7101-1, DOI 10.1007/978-1-4614-7101-1]; Griffis VW, 2007, J HYDROL ENG, V12, P283, DOI 10.1061/(ASCE)1084-0699(2007)12:3(283); Gumbel EJ, 1941, ANN MATH STAT, V12, P163, DOI 10.1214/aoms/1177731747; Gupta R, 2004, J STAT COMPUT SIM, V74, P107, DOI 10.1080/0094965031000114359; Gupta RD, 2007, J STAT PLAN INFER, V137, P3537, DOI 10.1016/j.jspi.2007.03.030; Gupta RD, 2003, COMPUT STAT DATA AN, V43, P179, DOI 10.1016/S0167-9473(02)00206-2; Gupta RD, 2003, COMMUN STAT-THEOR M, V32, P705, DOI 10.1081/STA-120018824; Gupta RD, 2001, J STAT COMPUT SIM, V69, P315, DOI 10.1080/00949650108812098; Gupta RD, 1999, AUST NZ J STAT, V41, P173, DOI 10.1111/1467-842X.00072; Hayami S., 1951, B DISASTER PREV RES, V1, P1; Hosking J.R.M., 1997, REGIONAL FREQUENCY A, DOI DOI 10.1017/CBO9780511529443; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Institute of Hydrology, 1999, FLOOD ESTIMATION HDB; Jenkinson AF, 1969, 233 WMO, P183; Kaczmarek Z., 1977, STAT METHODS HYDROLO; KAPPENMAN RF, 1988, STAT PROBABIL LETT, V7, P123, DOI 10.1016/0167-7152(88)90036-3; KAPPENMAN RF, 1982, COMMUN STAT A-THEOR, V11, P663, DOI 10.1080/03610928208828260; Katz RW, 2002, ADV WATER RESOUR, V25, P1287, DOI 10.1016/S0309-1708(02)00056-8; Kendall Atkinson E., 1989, INTRO NUMERICAL ANAL; Kendall M.G., 1973, ADV THEORY STAT, V2; Kendall M.G., 1969, ADV THEORY STAT, V1; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kundu D, 2005, J STAT PLAN INFER, V127, P213, DOI 10.1016/j.jspi.2003.08.017; Markiewicz I, 2010, HYDROL EARTH SYST SC, V14, P2167, DOI 10.5194/hess-14-2167-2010; Mitosek HT, 2006, J HYDROL, V323, P57, DOI 10.1016/j.jhydrol.2005.08.016; Moran PAP, 1957, T AM GEOPHYS UNION, V38, P519, DOI [10.1029/tr038i004p00519.4., DOI 10.1029/TR038I004P00519]; NERC (Natural Environment Research Council), 1975, FLOOD STUD REP, V1; QUESENBERRY CP, 1982, TECHNOMETRICS, V24, P59, DOI 10.2307/1267579; Rao AR., 2000, NEW D CIV E, V1, P376; Rowinski PM, 2002, HYDROLOG SCI J, V47, P107, DOI 10.1080/02626660209492911; Strupczewski W. G., 2002, Acta Geophysica Polonica, V50, P433; Strupczewski W. G., 2003, Acta Geophysica Polonica, V51, P85; Strupczewski W. G., 2006, STOCH ENV RES RISK A, V18, P1, DOI [10.1007/s00477-004-0210-8, DOI 10.1007/S00477-004-0210-8]; Strupczewski WG, 2002, J HYDROL, V258, P122, DOI 10.1016/S0022-1694(01)00563-7; Strupczewski WG, 2001, HYDROLOG SCI J, V46, P761, DOI 10.1080/02626660109492869; Strupczewski WG, 2011, HYDROL RES, V42, P171, DOI 10.2166/nh.2011.062; Weglarczyk S, 2002, HYDROLOG SCI J, V47, P123, DOI 10.1080/02626660209492912	57	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143965	10.1371/journal.pone.0143965	http://dx.doi.org/10.1371/journal.pone.0143965			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657239	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903500009
J	Wright, N; Hill, J; Pickles, A; Sharp, H				Wright, Nicola; Hill, Jonathan; Pickles, Andrew; Sharp, Helen			The Specific Role of Relationship Life Events in the Onset of Depression during Pregnancy and the Postpartum	PLOS ONE			English	Article							INTERPERSONAL PSYCHOTHERAPY; RISK-FACTORS; MAJOR DEPRESSION; WOMEN; ANXIETY; STRESS; METAANALYSIS; SYMPTOMS; DISORDER; PSYCHOPATHOLOGY	Background The precipitating role of life events in the onset of depression is well-established. The present study sought to examine whether life events hypothesised to be personally salient would be more strongly associated with depression than other life events. In a sample of women making the first transition to parenthood, we hypothesised that negative events related to the partner relationship would be particularly salient and thus more strongly predictive of depression than other events. Methods A community-based sample of 316 first-time mothers stratified by psychosocial risk completed interviews at 32 weeks gestation and 29 weeks postpartum to assess dated occurrence of life events and depression onsets from conception to 29 weeks postpartum. Complete data was available from 273 (86.4%). Cox proportional hazards regression was used to examine risk for onset of depression in the 6 months following a relationship event versus other events, after accounting for past history of depression and other potential confounders. Results 52 women (19.0%) experienced an onset of depression between conception and 6 months postpartum. Both relationship events (Hazard Ratio = 2.1, p =.001) and other life events (Hazard Ratio = 1.3, p =.020) were associated with increased risk for depression onset; however, relationship events showed a significantly greater risk for depression than did other life events (p =.044). Conclusions The results are consistent with the hypothesis that personally salient events are more predictive of depression onset than other events. Further, they indicate the clinical significance of events related to the partner relationship during pregnancy and the postpartum.	[Wright, Nicola; Sharp, Helen] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Hill, Jonathan] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Pickles, Andrew] Univ London, Kings Coll London, Biostat Dept, Inst Psychiat, London SW3 6LX, England	University of Liverpool; University of Reading; University of London; King's College London	Wright, N (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	nwright@liv.ac.uk	Sharp, Helen/G-5754-2016; Pickles, Andrew/A-9625-2011; Sharp, Helen/GOG-8045-2022	Pickles, Andrew/0000-0003-1283-0346; Sharp, Helen/0000-0002-0988-8718; wright, nicola/0000-0002-3285-2051	Medical Research Council [G0400577]; MRC [G0400577] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (grant number G0400577; http://www.mrc.ac.uk/).	American Psychiatric Association, 2017, DIAGN STAT MAN MENT, V5th; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Austin MP, 2014, BEST PRACT RES CL OB, V28, P179, DOI 10.1016/j.bpobgyn.2013.08.016; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Belli RF, 2001, PUBLIC OPIN QUART, V65, P45, DOI 10.1086/320037; Brown G., 1978, SOCIAL ORIGINS DEPRE; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; BROWN GW, 1987, BRIT J PSYCHIAT, V150, P30, DOI 10.1192/bjp.150.1.30; Brown GW, 1989, LIFE EVENTS ILLNESS; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cohn J F, 1986, New Dir Child Dev, P31; Connell AM, 2002, PSYCHOL BULL, V128, P746, DOI 10.1037//0033-2909.128.5.746; COX DR, 1972, J R STAT SOC B, V34, P187; Dayan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012942; FIELD T, 1985, DEV PSYCHOL, V21, P1152, DOI 10.1037/0012-1649.21.6.1152; FINLAYJONES R, 1981, PSYCHOL MED, V11, P803, DOI 10.1017/S0033291700041301; Freedman D, 1988, Sociol Methodol, V18, P37, DOI 10.2307/271044; GOTLIB IH, 1991, J ABNORM PSYCHOL, V100, P122, DOI 10.1037/0021-843X.100.2.122; Gotlib IH, 2002, HANDBOOK OF DEPRESSION, P1; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; HAMMEN C, 1990, ARCH GEN PSYCHIAT, V47, P1112; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; HARRINGTON R, 1988, PSYCHOL MED, V18, P487, DOI 10.1017/S0033291700008023; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; Hoffman S, 2000, HEALTH PSYCHOL, V19, P535, DOI 10.1037/0278-6133.19.6.535; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; LEWINSOHN PM, 1985, J CLIN PSYCHOL, V41, P483, DOI 10.1002/1097-4679(198507)41:4<483::AID-JCLP2270410407>3.0.CO;2-0; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Lloyd, 2004, ENGLISH INDICES DEPR; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Luoma I, 2001, J AM ACAD CHILD PSY, V40, P1367, DOI 10.1097/00004583-200112000-00006; Mazure CM, 1998, CLIN PSYCHOL-SCI PR, V5, P291, DOI 10.1111/j.1468-2850.1998.tb00151.x; Moffitt TE, 1997, PSYCHOL ASSESSMENT, V9, P47, DOI 10.1037/1040-3590.9.1.47; Monroe SM, 1999, J ABNORM PSYCHOL, V108, P606, DOI 10.1037/0021-843X.108.4.606; MURRAY D, 1995, BRIT J PSYCHIAT, V166, P595, DOI 10.1192/bjp.166.5.595; O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039; Paykel ES, 2003, ACTA PSYCHIAT SCAND, V108, P61, DOI 10.1034/j.1600-0447.108.s418.13.x; Pilkington PD, 2015, J AFFECT DISORDERS, V178, P165, DOI 10.1016/j.jad.2015.02.023; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Schmeelk KH, 1999, BEHAV MED, V25, P88, DOI 10.1080/08964289909595741; Sharp H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045446; Spinelli MG, 2013, J CLIN PSYCHIAT, V74, P393, DOI 10.4088/JCP.12m07909; Spinelli MG, 2003, AM J PSYCHIAT, V160, P555, DOI 10.1176/appi.ajp.160.3.555; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stuart S, 1995, J Psychother Pract Res, V4, P18; SURTEES PG, 1983, SOC PSYCHIATR, V18, P37, DOI 10.1007/BF00583386; Swendsen JD, 2000, CLIN PSYCHOL-SCI PR, V7, P17, DOI 10.1093/clipsy/7.1.17; ZIMMERMANNTANSELLA C, 1991, PSYCHOL MED, V21, P505, DOI 10.1017/S0033291700020614; ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1	59	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144131	10.1371/journal.pone.0144131	http://dx.doi.org/10.1371/journal.pone.0144131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YV	26645963	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100014
J	Whaley, C; Reed, M; Hsu, J; Fung, V				Whaley, Christopher; Reed, Mary; Hsu, John; Fung, Vicki			Functional Limitations, Medication Support, and Responses to Drug Costs among Medicare Beneficiaries	PLOS ONE			English	Article							HEALTH-INSURANCE; PART-D; CLINICAL EVENTS; SOCIAL SUPPORT; COVERAGE GAP; CARE; ADHERENCE; BENEFITS; ADULTS; NEEDS	Objective Standard Medicare Part D prescription drug benefits include substantial and complex cost-sharing. Many beneficiaries also have functional limitations that could affect self-care capabilities, including managing medications, but also have varying levels of social support to help with these activities. We examined the associations between drug cost responses, functional limitations, and social support. Data Sources and Study Setting We conducted telephone interviews in a stratified random sample of community-dwelling Medicare Advantage beneficiaries (N = 1,201, response rate = 70.0%). Participants reported their functional status (i.e., difficulty with activities of daily living) and social support (i.e., receiving help with medications). Drug cost responses included cost-reducing behaviors, cost-related non-adherence, and financial stress. Study Design We used multivariate logistic regression to assess associations among functional status, help with medications, and drug cost responses, adjusting for patient characteristics. Principal Findings Respondents with multiple limitations who did not receive help with their medications were more likely to report cost-related non-adherence (OR = 3.2, 95% CI: 1.2-8.5) and financial stress (OR = 2.4, 95% CI: 1.3-4.5) compared to subjects with fewer limitations and no help; however, those with multiple limitations and with medication help had similar odds of unfavorable cost responses as those with fewer limitations. Conclusion The majority of beneficiaries with functional limitations did not receive help with medications. Support with medication management for beneficiaries who have functional limitations could improve adherence and outcomes.	[Whaley, Christopher] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Whaley, Christopher; Reed, Mary] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Hsu, John; Fung, Vicki] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Hsu, John; Fung, Vicki] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hsu, John] Dept Hlth Care Policy, Boston, MA USA	University of California System; University of California Berkeley; Kaiser Permanente; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Whaley, C (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	cwhaley@berkeley.edu; mary.e.reed@kp.org			Kaiser Permanente Community Benefits; National Institute of Mental Health [R01MH090284]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090284] Funding Source: NIH RePORTER	Kaiser Permanente Community Benefits; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by Kaiser Permanente Community Benefits, recipient: John Hsu; National Institute of Mental Health, grant # R01MH090284, recipient: Vicki Fung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HLTH CAR SPEND MED P; Congressional Budget Office, 2013, RIS DEM LONG TERM SE; Desai MM, 2001, GERONTOLOGIST, V41, P82, DOI 10.1093/geront/41.1.82; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Donelan K, 2002, HEALTH AFFAIR, V21, P222, DOI 10.1377/hlthaff.21.4.222; Drainoni ML., 2006, J DIABIL POLICY STUD, V17, P101, DOI [10.1177/10442073060170020101, DOI 10.1177/10442073060170020101]; Foden-Vencil K, 2013, KAISER HLTH NEW 0710; Fung V, 2013, HLTH SERV RES; Fung V, 2013, MED CARE, V51, P614, DOI 10.1097/MLR.0b013e31829019c5; Fung V, 2010, HEALTH SERV RES, V45, P355, DOI 10.1111/j.1475-6773.2009.01071.x; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; Hudson TJ, 2013, J CLIN PSYCHIAT, V65, P211; Jaffe S, 2013, KAISER HLTH NEW 0625; Jaffe S, 2013, NY TIMES; Johnson R.W., 2006, PROFILE FRAIL OLDER; Kaye HS, 2013, HEALTH AFFAIR, V32, P127, DOI 10.1377/hlthaff.2012.0533; Klein D, 2004, GERONTOLOGIST, V44, P779, DOI 10.1093/geront/44.6.779; Kuye IO, 2013, JAMA INTERN MED, V173, P1100, DOI 10.1001/jamainternmed.2013.845; Kuzuya M, 2008, J AM GERIATR SOC, V56, P881, DOI 10.1111/j.1532-5415.2008.01676.x; Lew J, 2013, 2013 ANN REPORT BOAR; Long SK, 2002, HEALTH CARE FINANC R, V23, P159; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Newhouse JP, 1993, FREE ALL LESSONS RAN; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Sayers SL, 2008, ANN BEHAV MED, V35, P70, DOI 10.1007/s12160-007-9003-x; Schore J, 2011, 6555440 MATH POL RES; Soumerai SB, 2006, ARCH INTERN MED, V166, P1829, DOI 10.1001/archinte.166.17.1829; Talaga S, 2013, R42998 C RES OFF; Zhang YT, 2013, AM J MANAG CARE, V19, pE214; Zhang YT, 2012, ARCH GEN PSYCHIAT, V69, P672, DOI 10.1001/archgenpsychiatry.2011.1402	33	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144236	10.1371/journal.pone.0144236	http://dx.doi.org/10.1371/journal.pone.0144236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26642195	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700081
J	Cho, KS; Do Jung, H; Ham, WS; Chung, DY; Kang, YJ; Jang, WS; Kwon, JK; Choi, YD; Lee, JY				Cho, Kang Su; Do Jung, Hae; Ham, Won Sik; Chung, Doo Yong; Kang, Yong Jin; Jang, Won Sik; Kwon, Jong Kyou; Choi, Young Deuk; Lee, Joo Yong			Optimal Skin-to-Stone Distance Is a Positive Predictor for Successful Outcomes in Upper Ureter Calculi following Extracorporeal Shock Wave Lithotripsy: A Bayesian Model Averaging Approach	PLOS ONE			English	Article							NONCONTRAST COMPUTED-TOMOGRAPHY; FREE RATES; PARAMETERS; MANAGEMENT; SELECTION; DENSITY	Objectives To investigate whether skin-to-stone distance (SSD), which remains controversial in patients with ureter stones, can be a predicting factor for one session success following extracorporeal shock wave lithotripsy (ESWL) in patients with upper ureter stones. Patients and Methods We retrospectively reviewed the medical records of 1,519 patients who underwent their first ESWL between January 2005 and December 2013. Among these patients, 492 had upper ureter stones that measured 4-20 mm and were eligible for our analyses. Maximal stone length, mean stone density (HU), and SSD were determined on pretreatment non-contrast computed tomography (NCCT). For subgroup analyses, patients were divided into four groups. Group 1 consisted of patients with SSD<25th percentile, group 2 consisted of patients with SSD in the 25th to 50th percentile, group 3 patients had SSD in the 50th to 75th percentile, and group 4 patients had SSD >= 75th percentile. Results In analyses of group 2 patients versus others, there were no statistical differences in mean age, stone length and density. However, the one session success rate in group 2 was higher than other groups (77.9% vs. 67.0%; P = 0.032). The multivariate logistic regression model revealed that shorter stone length, lower stone density, and the group 2 SSD were positive predictors for successful outcomes in ESWL. Using the Bayesian model-averaging approach, longer stone length, lower stone density, and group 2 SSD can be also positive predictors for successful outcomes following ESWL. Conclusions Our data indicate that a group 2 SSD of approximately 10 cm is a positive predictor for success following ESWL.	[Cho, Kang Su] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Gangnam Severance Hosp, Seoul, South Korea; [Do Jung, Hae] Incheon Red Cross Hosp, Dept Urol, Incheon, South Korea; [Ham, Won Sik; Chung, Doo Yong; Kang, Yong Jin; Jang, Won Sik; Choi, Young Deuk; Lee, Joo Yong] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea; [Kwon, Jong Kyou] Yonsei Univ Hlth Syst, Dept Urol, Severance Check Up, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea.	joouro@yuhs.ac	Lee, Joo Yong/C-3851-2013	Lee, Joo Yong/0000-0002-3470-1767; Ham, Won Sik/0000-0003-2246-8838; Choi, Young Deuk/0000-0002-8545-5797; Jang, Won Sik/0000-0002-9082-0381; Cho, Kang Su/0000-0002-3500-8833	Yonsei University College of Medicine [6-2014-0156]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Yonsei University College of Medicine for 2014 (6-2014-0156).	Bandi G, 2009, BJU INT, V103, P524, DOI 10.1111/j.1464-410X.2008.08069.x; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Bhojani N, 2013, UROL CLIN N AM, V40, P59, DOI 10.1016/j.ucl.2012.09.001; Choi JW, 2012, KOREAN J UROL, V53, P424, DOI 10.4111/kju.2012.53.6.424; Cleveland RO, 1998, ULTRASOUND MED BIOL, V24, P293, DOI 10.1016/S0301-5629(97)00270-6; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; ERTURK E, 1993, J UROLOGY, V149, P1425, DOI 10.1016/S0022-5347(17)36405-4; Galvin DJ, 2006, BJU INT, V98, P1283, DOI 10.1111/j.1464-410X.2006.06514.x; Geng JH, 2015, KAOHSIUNG J MED SCI, V31, P34, DOI 10.1016/j.kjms.2014.10.001; Gonulalan U, 2014, UROL INT, V92, P444, DOI 10.1159/000356562; Jacobs BL, 2008, J ENDOUROL, V22, P1623, DOI 10.1089/end.2008.0169; Kacker R, 2008, J UROLOGY, V179, P1866, DOI 10.1016/j.juro.2008.01.038; Kim IK, 2014, KOREAN J UROL, V55, P574, DOI 10.4111/kju.2014.55.9.574; Kwon SY, 2013, J ENDOUROL, V27, P1209, DOI 10.1089/end.2013.0347; Lee AS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0834-y; Neisius A, 2015, WORLD J UROL, V33, P213, DOI 10.1007/s00345-014-1369-3; Ng CF, 2009, J UROLOGY, V181, P1151, DOI 10.1016/j.juro.2008.10.161; Pareek G, 2005, UROLOGY, V66, P941, DOI 10.1016/j.urology.2005.05.011; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; Pearle MS, 2012, NEW ENGL J MED, V367, P50, DOI 10.1056/NEJMct1103074; Perks AE, 2007, J UROLOGY, V178, P912, DOI 10.1016/j.juro.2007.05.043; Rush Elaine, 2004, N Z Med J, V117, pU1203; Seitz C, 2007, EUR UROL, V52, P1223, DOI 10.1016/j.eururo.2007.02.001; Tanaka M, 2013, KOREAN J UROL, V54, P454, DOI 10.4111/kju.2013.54.7.454; Tran TY, 2015, J ENDOUROL, V29, P226, DOI 10.1089/end.2014.0212; Wang DL, 2004, STAT MED, V23, P3451, DOI 10.1002/sim.1930; Weld KJ, 2007, UROLOGY, V70, P1043, DOI 10.1016/j.urology.2007.07.074; Wiesenthal JD, 2011, J UROLOGY, V186, P556, DOI 10.1016/j.juro.2011.03.109; Wiesenthal JD, 2010, UROL RES, V38, P307, DOI 10.1007/s00240-010-0295-0; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	30	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144912	10.1371/journal.pone.0144912	http://dx.doi.org/10.1371/journal.pone.0144912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659086	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900147
J	Huisman, M; Staruch, RM; Ladouceur-Wodzak, M; van den Bosch, MA; Burns, DK; Chhabra, A; Chopra, R				Huisman, Merel; Staruch, Robert M.; Ladouceur-Wodzak, Michelle; van den Bosch, Maurice A.; Burns, Dennis K.; Chhabra, Avneesh; Chopra, Rajiv			Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model	PLOS ONE			English	Article							CHRONIC PELVIC PAIN; PUDENDAL NEURALGIA; SCIATIC-NERVE; CANCER PAIN; FEASIBILITY; BLOCK; NEUROLYSIS; MANAGEMENT; DIAGNOSIS	Purpose Ultrasound (US)-guided high intensity focused ultrasound (HIFU) has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic resonance (MR)-imaging guidance may overcome these limitations and MR-guided HIFU (MR-HIFU) has been used successfully for other clinical indications. The primary purpose of this study was to evaluate the feasibility of utilizing 3D MR neurography to identify and guide ablation of peripheral nerves using a clinical MR-HIFU system. Methods Volumetric MR-HIFU was used to induce lesions in the peripheral nerves of the lower limbs in three pigs. Diffusion-prep MR neurography and T1-weighted images were utilized to identify the target, plan treatment and immediate post-treatment evaluation. For each treatment, one 8 or 12 mm diameter treatment cell was used (sonication duration 20 s and 36 s, power 160-300 W). Peripheral nerves were extracted <3 hours after treatment. Ablation dimensions were calculated from thermal maps, post-contrast MRI and macroscopy. Histological analysis included standard H&E staining, Masson's trichrome and toluidine blue staining. Results All targeted peripheral nerves were identifiable on MR neurography and T1-weighted images and could be accurately ablated with a single exposure of focused ultrasound, with peak temperatures of 60.3 to 85.7 degrees C. The lesion dimensions as measured on MR neurography were similar to the lesion dimensions as measured on CE-T1, thermal dose maps, and macroscopy. Histology indicated major hyperacute peripheral nerve damage, mostly confined to the location targeted for ablation. Conclusion Our preliminary results indicate that targeted peripheral nerve ablation is feasible with MR-HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired, and may also have potential for post-treatment verification of thermal lesions without contrast injection.	[Huisman, Merel; Staruch, Robert M.; Ladouceur-Wodzak, Michelle; Chhabra, Avneesh; Chopra, Rajiv] UT Southwestern Med Ctr, Dept Radiol, Dallas, TX 75390 USA; [Huisman, Merel; van den Bosch, Maurice A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Burns, Dennis K.] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX USA; [Staruch, Robert M.] Philips Res North Amer, Clin Sites Res Program, Briarcliff Manor, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Utrecht University; Utrecht University Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Philips; Philips Research	Chopra, R (corresponding author), UT Southwestern Med Ctr, Dept Radiol, Dallas, TX 75390 USA.	Rajiv.chopra@utsouthwestern.edu	Chopra, Rajiv/A-8367-2013	Chopra, Rajiv/0000-0003-3605-6076	Cancer Prevention and Research Institute of Texas [R1308]; MR and Evelyn Hudson Foundation; Philips; NATIONAL CANCER INSTITUTE [R01CA199937] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; MR and Evelyn Hudson Foundation; Philips; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was generously provided by the Cancer Prevention and Research Institute of Texas (R1308, http://www.cprit.state.tx.us/) and the MR and Evelyn Hudson Foundation. The MR-HIFU system used in this study is a product of Philips Healthcare. Philips also provided support in the form of salaries for authors [RS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chhabra A, 2011, AM J ROENTGENOL, V197, P583, DOI 10.2214/AJR.10.6012; Chopra R, 2012, RADIOLOGY, V265, P303, DOI 10.1148/radiol.12112263; Chopra R, 2009, MED PHYS, V36, P1867, DOI 10.1118/1.3115680; Colucci V, 2009, ULTRASOUND MED BIOL, V35, P1737, DOI 10.1016/j.ultrasmedbio.2009.05.002; Elias WJ, 2013, NEW ENGL J MED, V369, P640, DOI 10.1056/NEJMoa1300962; Ellens NPK, 2015, MED PHYS, V42, P430, DOI 10.1118/1.4903950; Fanucci E, 2009, RADIOL MED, V114, P425, DOI 10.1007/s11547-009-0371-0; Fite BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035509; Foley JL, 2008, MUSCLE NERVE, V37, P241, DOI 10.1002/mus.20932; Foley JL, 2007, ANN BIOMED ENG, V35, P109, DOI 10.1007/s10439-006-9162-0; Fritz J, 2014, NEUROIMAG CLIN N AM, V24, P211, DOI 10.1016/j.nic.2013.03.028; Fritz J, 2013, SKELETAL RADIOL, V42, P579, DOI 10.1007/s00256-012-1553-8; Gulati A, 2012, PAIN MANAG, V2, P569, DOI [10.2217/pmt.12.61, 10.2217/PMT.12.61]; Gulati A, 2014, REGION ANESTH PAIN M, V39, P26, DOI 10.1097/AAP.0000000000000028; Harnof S, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-9; Hurwitz MD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju082; HYNYNEN K, 1993, MED PHYS, V20, P107, DOI 10.1118/1.597093; Izumi M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-267; Kasper JM, 2015, EUR RADIOL, V25, P1672, DOI 10.1007/s00330-014-3552-8; Kasper JM, 2014, CLIN IMAG, V38, P540, DOI 10.1016/j.clinimag.2014.02.017; Kastler A, 2012, RADIOLOGY, V262, P701, DOI 10.1148/radiol.11110727; Kaye EA, 2015, CARDIOVASC INTER RAD, V38, P985, DOI 10.1007/s00270-015-1141-0; Kohler MO, 2009, MED PHYS, V36, P3521, DOI 10.1118/1.3152112; Lee YF, 2015, ULTRASOUND MED BIOL, V41, P132, DOI 10.1016/j.ultrasmedbio.2014.08.014; Mamlouk MD, 2014, AM J ROENTGENOL, V203, P196, DOI 10.2214/AJR.13.11346; McDannold N, 2006, RADIOLOGY, V240, P263, DOI 10.1148/radiol.2401050717; Monteith SJ, 2013, J NEUROSURG, V118, P319, DOI 10.3171/2012.10.JNS12186; Morrissey D, 2014, CURR OPIN UROL, V24, P336, DOI 10.1097/MOU.0000000000000062; Peng PWH, 2008, PAIN PHYSICIAN, V11, P215; Raslan AM, 2011, J NEUROSURG, V114, P155, DOI 10.3171/2010.6.JNS10119; Robert R, 2005, EUR UROL, V47, P403, DOI 10.1016/j.eururo.2004.09.003; Rofaeel A, 2008, REGION ANESTH PAIN M, V33, P139, DOI 10.1016/j.rapm.2007.10.004; Schroder JM, 2012, PATHOLOGY PERIPHERAL; ter Haar G, 2012, INTERVENTIONAL ONCOLOGY: A PRACTICAL GUIDE FOR THE INTERVENTIONAL RADIOLOGIST, P51, DOI 10.1007/978-1-4419-1469-9_5; Voogt MJ, 2011, EUR RADIOL; VUJASKOVIC Z, 1994, INT J HYPERTHER, V10, P845, DOI 10.3109/02656739409012377; Weeks EM, 2012, EUR RADIOL, V22, P2822, DOI 10.1007/s00330-012-2628-6; Yoneyama M, 2013, MAGN RESON MED SCI, V12, P111, DOI 10.2463/mrms.2012-0063	38	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144742	10.1371/journal.pone.0144742	http://dx.doi.org/10.1371/journal.pone.0144742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659073	gold, Green Published			2022-12-26	WOS:000366715900099
J	Zaychikova, MV; Zakharevich, NV; Sagaidak, MO; Bogolubova, NA; Smirnova, TG; Andreevskaya, SN; Larionova, EE; Alekseeva, MG; Chernousova, LN; Danilenko, VN				Zaychikova, Marina V.; Zakharevich, Natalia V.; Sagaidak, Maria O.; Bogolubova, Nadezhda A.; Smirnova, Tatiana G.; Andreevskaya, Sofya N.; Larionova, Elena E.; Alekseeva, Maria G.; Chernousova, Larisa N.; Danilenko, Valery N.			Mycobacterium tuberculosis Type II Toxin-Antitoxin Systems: Genetic Polymorphisms and Functional Properties and the Possibility of Their Use for Genotyping	PLOS ONE			English	Article							BEIJING GENOTYPE; STRAINS; VIRULENCE; BACTERIA; IDENTIFICATION; RIBONUCLEASES; RESISTANCE; TOLERANCE; CLEAVAGE; LINEAGE	Various genetic markers such as IS-elements, DR-elements, variable number tandem repeats (VNTR), single nucleotide polymorphisms (SNPs) in housekeeping genes and other groups of genes are being used for genotyping. We propose a different approach. We suggest the type II toxin-antitoxin (TA) systems, which play a significant role in the formation of pathogenicity, tolerance and persistence phenotypes, and thus in the survival of Mycobacterium tuberculosis in the host organism at various developmental stages (colonization, infection of macrophages, etc.), as the marker genes. Most genes of TA systems function together, forming a single network: an antitoxin from one pair may interact with toxins from other pairs and even from other families. In this work a bioinformatics analysis of genes of the type II TA systems from 173 sequenced genomes of M. tuberculosis was performed. A number of genes of type II TA systems were found to carry SNPs that correlate with specific genotypes. We propose a minimally sufficient set of genes of TA systems for separation of M. tuberculosis strains at nine basic genotype and for further division into subtypes. Using this set of genes, we genotyped a collection consisting of 62 clinical isolates of M. tuberculosis. The possibility of using our set of genes for genotyping using PCR is also demonstrated.	[Zaychikova, Marina V.; Zakharevich, Natalia V.; Sagaidak, Maria O.; Bogolubova, Nadezhda A.; Alekseeva, Maria G.; Danilenko, Valery N.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Smirnova, Tatiana G.; Andreevskaya, Sofya N.; Larionova, Elena E.; Chernousova, Larisa N.] Cent Res Inst TB, Moscow, Russia; [Zaychikova, Marina V.; Danilenko, Valery N.] Sci Res Ctr Biotechnol Antibiot BIOAN, Moscow, Russia; [Sagaidak, Maria O.] State Univ, Moscow Inst Phys & Technol, Moscow, Russia	Russian Academy of Sciences; Vavilov Institute of General Genetics; Moscow Institute of Physics & Technology	Danilenko, VN (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	valeridanilenko@yandex.ru	Smirnova, Tatiana G/H-4613-2014; Zakharevich, Natalia/L-3746-2016; Danilenko, Valery/K-2751-2015; Zaychikova, Marina V/F-3491-2017; Alekseeva, Maria/ABG-4819-2021	Zakharevich, Natalia/0000-0001-9336-2884; Alekseeva, Maria/0000-0002-0358-7017; Danilenko, Valery/0000-0001-5780-0621; Larionova, Elena/0000-0002-6032-175X				Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Averina O, 2015, ANAEROBE, V35, P59, DOI 10.1016/j.anaerobe.2015.07.007; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Chuang PC, 2010, J CLIN MICROBIOL, V48, P4245, DOI 10.1128/JCM.00970-10; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Demidenok OI, 2014, FEMS MICROBIOL LETT, V352, P69, DOI 10.1111/1574-6968.12380; Faksri K, 2014, ASIAN PAC J ALLERGY, V32, P124, DOI 10.12932/AP0361.32.2.2013; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jagielski T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/645802; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Klimina KM, 2013, ANAEROBE, V22, P82, DOI 10.1016/j.anaerobe.2013.05.007; Komi KK, 2015, MICROBES INFECT, V17, P34, DOI 10.1016/j.micinf.2014.10.010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Maslov DA, 2015, TUBERCULOSIS, V95, P608, DOI 10.1016/j.tube.2015.05.013; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Mokrousov I, 2012, J CLIN MICROBIOL, V50, P3757, DOI 10.1128/JCM.02001-12; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prozorov AA, 2014, RUSS J GENET+, V50, P775, DOI 10.1134/S1022795414080055; Prozorov AA, 2010, MICROBIOLOGY+, V79, P129, DOI 10.1134/S0026261710020013; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Rindi L, 2012, INFECT GENET EVOL, V12, P1551, DOI 10.1016/j.meegid.2012.06.008; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shur KV, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00403-15; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wang YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135696; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Xu YH, 2015, CRIT REV MICROBIOL, V41, P399, DOI 10.3109/1040841X.2013.860948; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yuan J, 2010, J BIOL CHEM, V285, P40397, DOI 10.1074/jbc.M110.138776; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	50	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143682	10.1371/journal.pone.0143682	http://dx.doi.org/10.1371/journal.pone.0143682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658274	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900016
J	Ahnaou, A; Lavreysen, H; Tresadern, G; Cid, JM; Drinkenburg, WH				Ahnaou, Abdallah; Lavreysen, Hilde; Tresadern, Gary; Cid, Jose M.; Drinkenburg, Wilhelmus H.			mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; GROUP-II; REM-SLEEP; SUPRACHIASMATIC NUCLEUS; PHARMACOLOGICAL CHARACTERIZATION; ACETYLCHOLINE-RELEASE; PREFRONTAL CORTEX; MOOD DISORDERS; AMYGDALA	G-protein-coupled receptor (GPCR) agonists are known to induce both cellular adaptations resulting in tolerance to therapeutic effects and withdrawal symptoms upon treatment discontinuation. Glutamate neurotransmission is an integral part of sleep-wake mechanisms, which processes have translational relevance for central activity and target engagement. Here, we investigated the efficacy and tolerance potential of the metabotropic glutamate receptors (mGluR2/3) agonist LY354740 versus mGluR2 positive allosteric modulator (PAM) JNJ-42153605 on sleep-wake organisation in rats. In vitro, the selectivity and potency of JNJ-42153605 were characterized. In vivo, effects on sleep measures were investigated in rats after once daily oral repeated treatment for 7 days, withdrawal and consecutive re-administration of LY354740 (1-10 mg/kg) and JNJ-42153605 (3-30 mg/kg). JNJ-42153605 showed high affinity, potency and selectivity at mGluR2. Binding site analyses and knowledge-based docking confirmed the specificity of JNJ-42153605 at the mGluR2 allosteric binding site. Acute LY354740 and JNJ-42153605 dose-dependently decreased rapid eye movement (REM) sleep time and prolonged its onset latency. Sub chronic effects of LY354740 on REM sleep measures disappeared from day 3 onwards, whereas those of JNJ-42153605 were maintained after repeated exposure. LY354740 attenuated REM sleep homeostatic recovery, while this was preserved after JNJ-42153605 administration. JNJ-42153605 enhanced sleep continuity and efficiency, suggesting its potential as an add-on medication for impaired sleep quality during early stages of treatment. Abrupt cessation of JNJ-42153605 did not induce withdrawal phenomena and sleep disturbances, while the initial drug effect was fully reinstated after re-administration. Collectively, long-term treatment with JNJ-42153605 did not induce tolerance phenomena to its primary functional effects on sleep measures, nor adverse effects at withdrawal, while it promoted homeostatic recovery sleep. From the translational perspective, the present rodent findings suggest that mGluR2 positive allosteric modulation has therapeutic potential based on its superior long term efficacy over agonists in psychiatric disorders, particularly of those commonly occurring with REM sleep overdrive.	[Ahnaou, Abdallah; Lavreysen, Hilde; Drinkenburg, Wilhelmus H.] Janssen Res & Dev, Dept Neurosci, B-2340 Beerse, Belgium; [Tresadern, Gary; Cid, Jose M.] Janssen Cilag SA, Janssen Res & Dev, Neurosci Med Chem, Toledo 45007, Spain	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Ahnaou, A (corresponding author), Janssen Res & Dev, Dept Neurosci, Turnhoutseweg 30, B-2340 Beerse, Belgium.	aahnaou@its.jnj.com		Drinkenburg, Wilhelmus/0000-0002-1095-7995; Tresadern, Gary/0000-0002-4801-1644	Janssen Research Development	Janssen Research Development	All authors are employed by Janssen Research & Development. Janssen Research & Development provided support in the form of salaries for authors [AA, HL, GT, CJ and WD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahnaou A, 2014, BEHAV BRAIN RES, V270, P56, DOI 10.1016/j.bbr.2014.05.003; Ahnaou A, 2009, EUR J PHARMACOL, V603, P62, DOI 10.1016/j.ejphar.2008.11.018; American Psychiatric Association, 2000, TASK FORC DSM 4 DIAG; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; Campbell IG, 1996, J NEUROPHYSIOL, V76, P3714, DOI 10.1152/jn.1996.76.6.3714; Cartmell J, 2000, N-S ARCH PHARMACOL, V361, P39, DOI 10.1007/s002109900151; Chaki S, 2011, CURR PHARM DESIGN, V17, P94, DOI 10.2174/138161211795049570; Cohrs S, 2008, CNS DRUGS, V22, P939, DOI 10.2165/00023210-200822110-00004; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; Cui LN, 2001, AM J PHYSIOL-REG I, V281, pR1283, DOI 10.1152/ajpregu.2001.281.4.R1283; Datta S, 2001, AM J PHYSIOL-REG I, V280, pR752, DOI 10.1152/ajpregu.2001.280.3.R752; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dong EH, 2012, BRAIN RES, V1452, P85, DOI 10.1016/j.brainres.2012.03.003; Doornbos MLJ, 2015, MOL MECH POSIT UNPUB; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Farinha A, 2015, BRIT J PHARMACOL, V172, P2383, DOI 10.1111/bph.13065; Feinberg I, 2005, J PHARMACOL EXP THER, V312, P826, DOI 10.1124/jpet.104.076547; Fell MJ, 2011, J PHARMACOL EXP THER, V336, P165, DOI 10.1124/jpet.110.172957; Fell MJ, 2010, NEUROPHARMACOLOGY, V58, P632, DOI 10.1016/j.neuropharm.2009.11.014; FEUILLADE P, 1992, J AFFECT DISORDERS, V24, P135, DOI 10.1016/0165-0327(92)90061-A; Fraley ME, 2009, EXPERT OPIN THER PAT, V19, P1259, DOI 10.1517/13543770903045009; Gewirtz JC, 2000, NEUROPSYCHOPHARMACOL, V23, P569, DOI 10.1016/S0893-133X(00)00136-6; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gu GB, 2008, BRAIN RES, V1197, P47, DOI 10.1016/j.brainres.2007.12.057; Guthrie CR, 2005, J PHARMACOL EXP THER, V313, P1003, DOI 10.1124/jpet.104.081919; Helton DR, 1998, J PHARMACOL EXP THER, V284, P651; Hemstapat K, 2007, J PHARMACOL EXP THER, V322, P254, DOI 10.1124/jpet.106.117093; Hermes MLHJ, 1996, J PHYSIOL-LONDON, V496, P749, DOI 10.1113/jphysiol.1996.sp021724; Hikichi H, 2013, J PHARMACOL SCI, V122, P10, DOI 10.1254/jphs.13036FP; Imre G, 2006, EUR J PHARMACOL, V544, P77, DOI 10.1016/j.ejphar.2006.06.037; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Ivarsson M, 2005, EUR J PHARMACOL, V522, P63, DOI 10.1016/j.ejphar.2005.08.050; Jha SK, 2005, PHYSIOL BEHAV, V86, P415, DOI 10.1016/j.physbeh.2005.06.033; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Jones CK, 2005, NEUROPHARMACOLOGY, V49, P206, DOI 10.1016/j.neuropharm.2005.05.008; Kahn M, 2013, INT J PSYCHOPHYSIOL, V89, P218, DOI 10.1016/j.ijpsycho.2013.05.010; Kalinchuk AV, 2008, NEUROSCIENCE, V157, P238, DOI 10.1016/j.neuroscience.2008.08.040; Kaur S, 2008, J NEUROSCI, V28, P491, DOI 10.1523/JNEUROSCI.1585-07.2008; Kerkhof GA, 2010, PROG BRAIN RES, V185, P49, DOI 10.1016/B978-0-444-53702-7.00004-X; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Kodama T, 1998, BRAIN RES, V780, P178, DOI 10.1016/S0006-8993(97)01308-5; Landolt HP, 2009, EUR J NEUROSCI, V29, P1795, DOI 10.1111/j.1460-9568.2009.06718.x; Landolt HP, 2001, ARCH GEN PSYCHIAT, V58, P268, DOI 10.1001/archpsyc.58.3.268; Lavreysen H, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.96; Lavreysen H, 2013, J PHARMACOL EXP THER, V346, P514, DOI 10.1124/jpet.113.204990; Leonard TO, 1997, J NEUROSCI, V17, P774; Linden A.M., 2006, DRUG DISCOV TODAY, V3, P507; Linden AM, 2006, NEUROPHARMACOLOGY, V51, P213, DOI 10.1016/j.neuropharm.2006.03.014; Lopez-Rodriguez F, 2007, ARCH MED RES, V38, P52, DOI 10.1016/j.arcmed.2006.07.004; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lundstrom L, 2011, BRIT J PHARMACOL, V164, P521, DOI 10.1111/j.1476-5381.2011.01409.x; Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76; Marek GJ, 2001, NEUROSCIENCE, V105, P379, DOI 10.1016/S0306-4522(01)00199-3; Cid JM, 2012, J MED CHEM, V55, P8770, DOI 10.1021/jm3010724; Marti M, 2003, J NEUROCHEM, V84, P792, DOI 10.1046/j.1471-4159.2003.01569.x; Mayers AG, 2005, HUM PSYCHOPHARM CLIN, V20, P533, DOI 10.1002/hup.726; Mela F, 2006, MOL CELL NEUROSCI, V31, P284, DOI 10.1016/j.mcn.2005.09.016; Naylor E, 2011, J ELECTROANAL CHEM, V656, P106, DOI 10.1016/j.jelechem.2010.12.031; Neckelmann D, 1996, BEHAV BRAIN RES, V79, P183, DOI 10.1016/0166-4328(96)00013-7; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; Parmentier-Batteur S, 2012, NEUROPHARMACOLOGY, V62, P1453, DOI 10.1016/j.neuropharm.2010.11.013; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; Peterson MJ, 2006, PSYCHIAT CLIN N AM, V29, P1009, DOI 10.1016/j.psc.2006.09.003; Pisani A, 2002, J NEUROSCI, V22, P6176; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riegel AC, 2003, NEUROPSYCHOPHARMACOL, V28, P1440, DOI 10.1038/sj.npp.1300193; Rowe BA, 2008, J PHARMACOL EXP THER, V326, P240, DOI 10.1124/jpet.108.138271; Saletu-Zyhlarz GM, 2002, METHOD FIND EXP CLIN, V24, P37; Sanford LD, 2002, BRAIN RES, V956, P276, DOI 10.1016/S0006-8993(02)03552-7; Schaffhauser H, 2003, MOL PHARMACOL, V64, P798, DOI 10.1124/mol.64.4.798; Schoepp Darryle D., 2002, Current Drug Targets - CNS and Neurological Disorders, V1, P215, DOI 10.2174/1568007024606177; Shea JL, 2008, BRAIN RES, V1213, P48, DOI 10.1016/j.brainres.2008.03.062; Silvestri R, 2001, J CLIN PSYCHIAT, V62, P642, DOI 10.4088/JCP.v62n0812; Smialowska M, 2002, FOLIA HISTOCHEM CYTO, V40, P153; Smolders I, 2004, J NEUROCHEM, V88, P1068, DOI 10.1046/j.1471-4159.2003.02251.x; Sodhi Monsheel, 2008, Expert Rev Neurother, V8, P1389, DOI 10.1586/14737175.8.9.1389; Steiger A, 2010, J PSYCHIATR RES, V44, P242, DOI 10.1016/j.jpsychires.2009.08.013; Sun X, 2001, EUR J NEUROSCI, V14, P1257, DOI 10.1046/j.0953-816x.2001.0001755.x; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tang XD, 2005, SLEEP, V28, P923, DOI 10.1093/sleep/28.8.923; Thase Michael E, 2006, Dialogues Clin Neurosci, V8, P217; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Turner JP, 2003, NEUROSCIENCE, V122, P459, DOI 10.1016/j.neuroscience.2003.08.014; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Wilson S, 2005, DRUGS, V65, P927, DOI 10.2165/00003495-200565070-00003; Witkin Jeffrey M., 2007, CNS & Neurological Disorders-Drug Targets, V6, P87, DOI 10.2174/187152707780363302; Wright RA, 2001, J PHARMACOL EXP THER, V298, P453; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	93	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144017	10.1371/journal.pone.0144017	http://dx.doi.org/10.1371/journal.pone.0144017			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658273	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600018
J	Henley, RY; Vazquez-Pagan, AG; Johnson, M; Kanavarioti, A; Wanunu, M				Henley, Robert Y.; Vazquez-Pagan, Ana G.; Johnson, Michael; Kanavarioti, Anastassia; Wanunu, Meni			Osmium-Based Pyrimidine Contrast Tags for Enhanced Nanopore-Based DNA Base Discrimination	PLOS ONE			English	Article							MEMBRANE CHANNEL; SEQUENCING DNA; RESOLUTION; TRANSPORT	Nanopores are a promising platform in next generation DNA sequencing. In this platform, an individual DNA strand is threaded into nanopore using an electric field, and enzyme-based ratcheting is used to move the strand through the detector. During this process the residual ion current through the pore is measured, which exhibits unique levels for different base combinations inside the pore. While this approach has shown great promise, accuracy is not optimal because the four bases are chemically comparable to one another, leading to small differences in current obstruction. Nucleobase-specific chemical tagging can be a viable approach to enhancing the contrast between different bases in the sequence. Herein we show that covalent modification of one or both of the pyrimidine bases by an osmium bipyridine complex leads to measureable differences in the blockade amplitudes of DNA molecules. We qualitatively determine the degree of osmylation of a DNA strand by passing it through a solid-state nanopore, and are thus able to gauge T and C base content. In addition, we show that osmium bipyridine reacts with dsDNA, leading to substantially different current blockade levels than exhibited for bare dsDNA. This work serves as a proof of principle for nanopore sequencing and mapping via base-specific DNA osmylation.	[Henley, Robert Y.; Wanunu, Meni] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Vazquez-Pagan, Ana G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Johnson, Michael; Wanunu, Meni] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Kanavarioti, Anastassia] Yenos Analyt LLC, El Dorado Hills, CA USA	Northeastern University; Northeastern University; Northeastern University	Wanunu, M (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.	wanunu@neu.edu		Vazquez-Pagan, Ana/0000-0001-9984-7129	National Institutes of Health [NHGRI HG006321]; Yenos Analytical LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yenos Analytical LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded by National Institutes of Health, NHGRI HG006321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Yenos Analytical LLC provided support in the form of salary for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Carson S, 2014, BIOPHYS J, V107, P2381, DOI 10.1016/j.bpj.2014.10.017; CHANG CH, 1977, BIOCHEMISTRY-US, V16, P33, DOI 10.1021/bi00620a006; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Connelly LS, 2014, ACS APPL MATER INTER, V6, P5290, DOI 10.1021/am500639q; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Feng J, 2015, NANO LETT, V15, P3431, DOI 10.1021/acs.nanolett.5b00768; Goodwin S., 2015, BIORXIV; Kanavarioti A, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/13/134003; Kanavarioti A, 2012, ELECTROPHORESIS, V33, P3529, DOI 10.1002/elps.201200214; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Larkin J, 2013, ACS NANO, V7, P10121, DOI 10.1021/nn404326f; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Thompson JF, 2012, ELECTROPHORESIS, V33, P3429, DOI 10.1002/elps.201200136; Venta K, 2013, ACS NANO, V7, P4629, DOI 10.1021/nn4014388; Waduge P, 2015, ACS NANO, V9, P7352, DOI 10.1021/acsnano.5b02369; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]	23	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142155	10.1371/journal.pone.0142155	http://dx.doi.org/10.1371/journal.pone.0142155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657869	Green Published, gold			2022-12-26	WOS:000366903600003
J	Khoury, EDT; Souza, GD; da Costa, CA; de Araujo, AAK; de Oliveira, CSB; Silveira, LCD; Pinheiro, MDN				Torres Khoury, Eliana Dirce; Souza, Givago da Silva; da Costa, Carlos Araujo; Kamogari de Araujo, Amelia Ayako; Baltazar de Oliveira, Claudia Simone; Silveira, Luiz Carlos de Lima; Pinheiro, Maria da Conceicao Nascimento			Somatosensory Psychophysical Losses in Inhabitants of Riverside Communities of the Tapajos River Basin, Amazon, Brazil: Exposure to Methylmercury Is Possibly Involved	PLOS ONE			English	Article							TACTILE SPATIAL-RESOLUTION; MINAMATA DISEASE; MERCURY POLLUTION; CONTRAST SENSITIVITY; FISH CONSUMPTION; COLOR-VISION; PARA STATE; POPULATIONS; HAIR; DISCRIMINATION	The purpose of this work was to evaluate the somatosensory system of methylmercury-exposed inhabitants living in the communities of the Tapajos river basin by using psychophysical tests and to compare with measurements performed in inhabitants of the Tocantins river basin. We studied 108 subjects from Barreiras and Sao Luiz do Tapajos, two communities of the Tapajos river basin, State of Para, Amazon, Brazil, aged 13-53 years old. Mercury analysis was performed in head hair samples weighting 0.1-0.2 g by using atomic absorption spectrometry. Three somatosensory psychophysical tests were performed: tactile sensation threshold, vibration sensation duration, and two-point discrimination. Semmes-Weinstein 20 monofilaments with different diameters were used to test the tactile sensation in the lower lip, right and left breasts, right and left index fingers, and right and left hallux. The threshold was the thinner monofilament perceived by the subject. Vibration sensation was investigated using a 128 Hz diapason applied to the sternum, right and left radial sides of the wrist, and right and left outer malleoli. Two trials were performed at each place. A stopwatch recorded the vibration sensation duration. The two-point discrimination test was performed using a two-point discriminator. Head hair mercury concentration was significantly higher in mercury-exposed inhabitants of Tapajos than in non-exposed inhabitants of Tocantins (p < 0.01). When all subjects were divided in two groups independently of age-mercury-exposed and non-exposed-the following results were found: tactile sensation thresholds in mercury-exposed subjects were higher than in non-exposed subjects at all body parts, except at the left chest; vibration sensation durations were shorter in mercury-exposed than in non-exposed subjects, at all locations except in the upper sternum; two-point discrimination thresholds were higher in mercury exposed than in non-exposed subjects at all body parts. There was a weak linear correlation between tactile sensation threshold and mercury concentration in the head hair samples. No correlation was found for the other two measurements. Mercury-exposed subjects had impaired somatosensory function compared with non-exposed control subjects. Long-term mercury exposure of riverside communities in the Tapajos river basin is a possible but not a definitely proven cause for psychophysical somatosensory losses observed in their population. Additionally, the relatively simple psychophysical measures used in this work should be followed by more rigorous measures of the same population.	[Torres Khoury, Eliana Dirce; Souza, Givago da Silva; da Costa, Carlos Araujo; Baltazar de Oliveira, Claudia Simone; Silveira, Luiz Carlos de Lima; Pinheiro, Maria da Conceicao Nascimento] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, PA, Brazil; [Souza, Givago da Silva; Silveira, Luiz Carlos de Lima] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, PA, Brazil; [Kamogari de Araujo, Amelia Ayako] Secretaria Saude, Itaituba, PA, Brazil; [Silveira, Luiz Carlos de Lima] Univ Ceuma, Sao Luis, MA, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Ceuma	Pinheiro, MDN (corresponding author), Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, PA, Brazil.	mconci@ufpa.br	Souza, Givago/W-6393-2019	Souza, Givago/0000-0002-4525-3971	CAPES Pro-Amazonia; CNPq [486545/2012-1, 479624/2012-7, 442191/2014-6]; FAPESPA [003/2012]; FINEP IBN Net [1723]	CAPES Pro-Amazonia(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); FINEP IBN Net(Financiadora de Inovacao e Pesquisa (Finep))	The work was supported by the following: CAPES Pro-Amazonia to MCNP; CNPq #486545/ 2012-1 to GSS, #479624/2012-7 to MCNP, #442191/2014-6 to LCLS; FAPESPA #003/2012 to MCNP; and FINEP IBN Net #1723 to LCLS. LCLS and MCNP are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 2000, J HEALTH SCI, V46, P323; Akagi H, 1995, MERCURY GLOBAL POLLU, P85; BAKIR F, 1980, POSTGRAD MED J, V56, P1, DOI 10.1136/pgmj.56.651.1; Barbieri FL, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-71; Barregard L, 2006, SCI TOTAL ENVIRON, V368, P326, DOI 10.1016/j.scitotenv.2005.08.048; Nevado JJB, 2010, ENVIRON INT, V36, P593, DOI 10.1016/j.envint.2010.03.011; Bidone ED, 1997, B ENVIRON CONTAM TOX, V59, P194, DOI 10.1007/s001289900464; Castilhos ZC, 1998, B ENVIRON CONTAM TOX, V61, P202, DOI 10.1007/s001289900749; Craig JC, 2000, CURR DIR PSYCHOL SCI, V9, P29, DOI 10.1111/1467-8721.00054; Dolbec J, 2000, INT ARCH OCC ENV HEA, V73, P195, DOI 10.1007/s004200050027; dos Santos LDN, 2000, SCI TOTAL ENVIRON, V261, P1, DOI 10.1016/S0048-9697(00)00590-8; Ekino S, 2007, J NEUROL SCI, V262, P131, DOI 10.1016/j.jns.2007.06.036; ETO K, 1978, ACTA PATHOL JAPON, V28, P565; ETO K, 1977, VIRCHOWS ARCH B, V23, P109; Eto K, 1997, TOXICOL PATHOL, V25, P614, DOI 10.1177/019262339702500612; Fillion M, 2011, ECOHEALTH, V8, P210, DOI 10.1007/s10393-011-0710-1; Fillion M, 2011, PUBLIC HEALTH NUTR, V14, P2236, DOI 10.1017/S1368980011001765; Freitas JD, 2015, INV OPHTHALMOL VIS S, V56; Grandjean P, 1999, ENVIRON HEALTH PERSP, V107, P587, DOI 10.2307/3434402; Harada M, 2005, B ENVIRON CONTAM TOX, V74, P689, DOI 10.1007/s00128-005-0638-7; Harada M, 2001, ENVIRON INT, V27, P285, DOI 10.1016/S0160-4120(01)00059-9; Harada M., 1997, MINERAL METAL NEUROT, P177; Harada Masazumi, 2004, MINAMATA DIS; Hunter D, 1940, Q J MED, V9, P193; HUNTER D, 1954, J NEUROL NEUROSUR PS, V17, P235, DOI 10.1136/jnnp.17.4.235; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Lebel J, 1996, NEUROTOXICOLOGY, V17, P157; Lebel J, 1998, ENVIRON RES, V79, P20, DOI 10.1006/enrs.1998.3846; Malm O, 1995, SCI TOTAL ENVIRON, V175, P141, DOI 10.1016/0048-9697(95)04910-X; MAURISSEN JPJ, 1988, TOXICOL LETT, V43, P321, DOI 10.1016/0378-4274(88)90036-7; Mergler D, 2000, ENVIRON TOXICOL PHAR, V12, P93; Ninomiya T, 2005, NEUROTOXICOL TERATOL, V27, P643, DOI 10.1016/j.ntt.2005.03.008; Nomura S, 1998, J OCCUP HEALTH, V40, P1, DOI 10.1539/joh.40.1; PassosD CJS, 2008, J EXPO SCI ENV EPID, V18, P76, DOI 10.1038/sj.jes.7500599; Pinheiro MCN, 2008, ENVIRON RES, V107, P53, DOI 10.1016/j.envres.2007.08.007; Pinheiro MCN, 2007, ENVIRON INT, V33, P56, DOI 10.1016/j.envint.2006.06.024; Pinheiro MCN, 2012, B ENVIRON CONTAM TOX, V89, P119, DOI 10.1007/s00128-012-0652-5; Pinheiro M d, 2000, Rev Soc Bras Med Trop, V33, P265; Pinheiro MCN, 2006, BRAZ J MED BIOL RES, V39, P411, DOI 10.1590/S0100-879X2006000300012; Pinheiro MCN, 2005, SCI TOTAL ENVIRON, V349, P284, DOI 10.1016/j.scitotenv.2005.06.026; Pinheiro MCN, 2003, ENVIRON SCI-TOKYO, V10, P99; Rodrigues AR, 2007, BRAZ J MED BIOL RES, V40, P415, DOI 10.1590/S0100-879X2007000300018; Santos ECD, 2000, ENVIRON RES, V84, P100, DOI 10.1006/enrs.2000.4088; Silveira LCL, 2003, NORMAL DEFECTIVE COL, P407; Soong TR, 1994, ENV SCI, V3, P41; Suzuki T., 2004, MERCURY ANAL MANUAL; Takaoka S, 2004, ENVIRON RES, V95, P126, DOI 10.1016/j.envres.2003.08.002; Takaoka S, 2008, ENVIRON RES, V107, P6, DOI 10.1016/j.envres.2007.05.012; Tavares Lydia Maria Bocayuva, 2005, Cad. Saúde Pública, V21, P1160, DOI 10.1590/S0102-311X2005000400018; Tong J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00579; Khoury EDT, 2013, CAD SAUDE PUBLICA, V29, P2307, DOI [10.1590/0102-311x00158012, 10.1590/0102-311X00158012]; Uchino M, 2001, TOHOKU J EXP MED, V195, P181, DOI 10.1620/tjem.195.181; UCHINO M, 1995, INTERNAL MED, V34, P744, DOI 10.2169/internalmedicine.34.744; VANBOVEN RW, 1994, BRAIN, V117, P149, DOI 10.1093/brain/117.1.149; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Ventura DF, 2005, ENVIRON TOXICOL PHAR, V19, P523, DOI 10.1016/j.etap.2004.12.016; Ventura DF, 2004, VISUAL NEUROSCI, V21, P421, DOI 10.1017/S0952523804213372; WHEATLEY B, 1994, ENV SCI, V3, P33; WHO-IPCS, 1990, ENV HLTH CRIT 101 ME; [No title captured]	60	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144625	10.1371/journal.pone.0144625	http://dx.doi.org/10.1371/journal.pone.0144625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658153	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600071
J	Oliva-Olivera, W; Coin-Araguez, L; Salas, J; Lhamyani, S; Gentile, AM; Garcia, ES; Hmadcha, A; Zayed, H; Vega-Rioja, A; Tinahones, FJ; El Bekay, R				Oliva-Olivera, Wilfredo; Coin-Aragueez, Leticia; Salas, Julian; Lhamyani, Said; Gentile, Adriana-Mariel; Garcia, Esteban Sarria; Hmadcha, Abdelkrim; Zayed, Hatem; Vega-Rioja, Antonio; Tinahones, Francisco J.; El Bekay, Rajaa			Myocardial Ischemic Subject's Thymus Fat: A Novel Source of Multipotent Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW; CORD BLOOD; DIFFERENTIATION; MECHANISMS; EXPRESSION; GENE; AGE	Objective Adipose Tissue Stromal Cells (ASCs) have important clinical applications in the regenerative medicine, cell replacement and gene therapies. Subcutaneous Adipose Tissue (SAT) is the most common source of these cells. The adult human thymus degenerates into adipose tissue (TAT). However, it has never been studied before as a source of stem cells. Material and Methods We performed a comparative characterization of TAT-ASCs and SAT-ASCs from myocardial ischemic subjects (n = 32) according to the age of the subjects. Results TAT-ASCs and SAT-ASCs showed similar features regarding their adherence, morphology and in their capacity to form CFU-F. Moreover, they have the capacity to differentiate into osteocyte and adipocyte lineages; and they present a surface marker profile corresponding with stem cells derived from AT; CD73(+)CD90(+)CD105(+)CD14(-)CD19(-)CD45(-)HLA-DR. Interestingly, and in opposition to SAT-ASCs, TAT-ASCs have CD14(+)CD34(+)CD133(+)CD45(-) cells. Moreover, TAT-ASCs from elderly subjects showed higher adipogenic and osteogenic capacities compared to middle aged subjects, indicating that, rather than impairing; aging seems to increase adipogenic and osteogenic capacities of TAT-ASCs. Conclusions This study describes the human TAT as a source of mesenchymal stem cells, which may have an enormous potential for regenerative medicine.	[Oliva-Olivera, Wilfredo; Coin-Aragueez, Leticia; Tinahones, Francisco J.; El Bekay, Rajaa] Carlos III Hlth Inst, CIBER Pathophysiol Obes & Nutr CB06 03, Malaga 29010, Spain; [Oliva-Olivera, Wilfredo; Coin-Aragueez, Leticia; Tinahones, Francisco J.; El Bekay, Rajaa] Virgen Victoria Clin Univ Hosp, Biomed Res Lab, Malaga 29010, Spain; [Salas, Julian; Garcia, Esteban Sarria] Univ Hosp Carlos Haya, Dept Cardiovasc Surg, Malaga, Spain; [Lhamyani, Said; Gentile, Adriana-Mariel] Univ Malaga, Sch Sci, Res Lab, E-29071 Malaga, Spain; [Hmadcha, Abdelkrim] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Stem Cells, Seville, Spain; [Hmadcha, Abdelkrim] Inst Salud Carlos III, CIBERDEM, Madrid, Spain; [Zayed, Hatem] Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, Program Biomed Sci, Doha, Qatar; [Vega-Rioja, Antonio] Hosp Univ Virgen Macarena, Serv Reg Inmunol & Alergia, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Carlos Haya; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Qatar University; Hospital Universitario Virgen Macarena	Vega-Rioja, A (corresponding author), Hosp Univ Virgen Macarena, Serv Reg Inmunol & Alergia, Seville, Spain.	macrofago@us.es; fjtinahones@hotmail.com; elbekay@gmail.com	LHAMYANI, said/AAQ-1973-2020; Hmadcha, Abdelkrim/T-1173-2019; Bekay, Rajaa El/AAZ-3959-2020; Zayed, Hatem/R-1800-2019; El Bekay, RAJAA/AGN-6069-2022; Tinahones, Francisco José/AAB-2882-2020; GENTILE, Adriana Mariel/AAB-3350-2020	LHAMYANI, said/0000-0002-9830-9772; Hmadcha, Abdelkrim/0000-0002-4105-3702; Zayed, Hatem/0000-0001-8838-6638; El Bekay, RAJAA/0000-0003-3332-3431; GENTILE, Adriana Mariel/0000-0002-2296-9117; Oliva Olivera, Wilfredo/0000-0003-3473-7898; Vega Rioja, Antonio/0000-0003-4698-9697; Tinahones, Francisco J/0000-0001-6871-4403	Instituto de Salud Carlos III/FEDER; EU [PI10/01947, PI13/02628]; Consejeria de Economia e Innovacion [CTS-7895]; Ciencia y Empleo; Junta de Andalucia/FEDER; ISCIII/FEDER, EU "Miguel Servet II" [CPII13/00041]; Ministerio de Economia y Competitividad [SAF2014-60649-JIN]; Fondo Europeo de Desarrollo Regional-FEDER	Instituto de Salud Carlos III/FEDER(Instituto de Salud Carlos IIIEuropean Commission); EU(European Commission); Consejeria de Economia e Innovacion; Ciencia y Empleo; Junta de Andalucia/FEDER(Junta de AndaluciaEuropean Commission); ISCIII/FEDER, EU "Miguel Servet II"; Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional-FEDER(European CommissionSpanish Government)	This work was supported in part by grants from the Instituto de Salud Carlos III/FEDER, EU (PI10/01947, PI13/02628), CTS-7895 from the Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia/FEDER, EU. R. El Bekay is supported by fellowships from the ISCIII/FEDER, EU "Miguel Servet II" (CPII13/00041). AV-R is under a contract Proyectos de I+D+i para jovenes investigadores from the Ministerio de Economia y Competitividad (SAF2014-60649-JIN) and co-funded by Fondo Europeo de Desarrollo Regional-FEDER.	Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Casteilla L, 2005, ARCH MAL COEUR VAISS, V98, P922; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FINA L, 1990, BLOOD, V75, P2417; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Habib HS, 2011, MED SCI MONITOR, V17, pRA233, DOI 10.12659/MSM.882036; Hale Laura P, 2004, Ann Diagn Pathol, V8, P50, DOI 10.1016/j.anndiagpath.2003.11.006; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; Huang SC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-18; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kawai M, 2012, J INTERN MED, V272, P317, DOI 10.1111/j.1365-2796.2012.02564.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Khan WS, 2012, CELL PROLIFERAT, V45, P111, DOI 10.1111/j.1365-2184.2011.00804.x; Khan WS, 2009, INJURY, V40, P150, DOI 10.1016/j.injury.2008.05.029; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Krenning G, 2009, J CELL MOL MED, V13, P2521, DOI 10.1111/j.1582-4934.2008.00479.x; Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017; Liu ZJ, 2009, J CELL BIOCHEM, V106, P984, DOI 10.1002/jcb.22091; Ma N, 2005, CARDIOVASC RES, V66, P45, DOI 10.1016/j.cardiores.2004.12.013; Madonna R, 2011, EUR J CLIN INVEST, V41, P126, DOI 10.1111/j.1365-2362.2010.02384.x; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mitterberger MC, 2014, J GERONTOL A-BIOL, V69, P13, DOI 10.1093/gerona/glt043; Mouiseddine M, 2008, STEM CELLS DEV, V17, P1165, DOI 10.1089/scd.2007.0252; Ogata K, 2005, STEM CELLS, V23, P619, DOI 10.1634/stemcells.2004-0280; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Perez LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123397; Popa ER, 2006, J MOL CELL CARDIOL, V41, P86, DOI 10.1016/j.yjmcc.2006.04.021; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Russo V, 2014, STEM CELL TRANSL MED, V3, P206, DOI 10.5966/sctm.2013-0125; Shi YY, 2005, PLAST RECONSTR SURG, V116, P1686, DOI 10.1097/01.prs.0000185606.03222.a9; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Tinahones F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008213; Toyoda M, 2009, CELL BIOCHEM FUNCT, V27, P440, DOI 10.1002/cbf.1591; Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026; Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165; Zhu XS, 2012, CLIN LAB, V58, P897, DOI 10.7754/Clin.Lab.2012.120312; Zimmerlin L, 2013, CYTOM PART A, V83A, P134, DOI 10.1002/cyto.a.22227; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	51	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144401	10.1371/journal.pone.0144401	http://dx.doi.org/10.1371/journal.pone.0144401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657132	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903500025
J	Loizides, C; Iacovides, D; Hadjiandreou, MM; Rizki, G; Achilleos, A; Strati, K; Mitsis, GD				Loizides, Charalambos; Iacovides, Demetris; Hadjiandreou, Marios M.; Rizki, Gizem; Achilleos, Achilleas; Strati, Katerina; Mitsis, Georgios D.			Model-Based Tumor Growth Dynamics and Therapy Response in a Mouse Model of De Novo Carcinogenesis	PLOS ONE			English	Article							SOLID TUMOR; CANCER; CHEMOTHERAPY; INFLAMMATION; GENE; E6	Tumorigenesis is a complex, multistep process that depends on numerous alterations within the cell and contribution from the surrounding stroma. The ability to model macroscopic tumor evolution with high fidelity may contribute to better predictive tools for designing tumor therapy in the clinic. However, attempts to model tumor growth have mainly been developed and validated using data from xenograft mouse models, which fail to capture important aspects of tumorigenesis including tumor-initiating events and interactions with the immune system. In the present study, we investigate tumor growth and therapy dynamics in a mouse model of de novo carcinogenesis that closely recapitulates tumor initiation, progression and maintenance in vivo. We show that the rate of tumor growth and the effects of therapy are highly variable and mouse specific using a Gompertz model to describe tumor growth and a two-compartment pharmacokinetic/pharmacodynamic model to describe the effects of therapy in mice treated with 5-FU. We show that inter-mouse growth variability is considerably larger than intra-mouse variability and that there is a correlation between tumor growth and drug kill rates. Our results show that in vivo tumor growth and regression in a double transgenic mouse model are highly variable both within and between subjects and that mathematical models can be used to capture the overall characteristics of this variability. In order for these models to become useful tools in the design of optimal therapy strategies and ultimately in clinical practice, a subject-specific modelling strategy is necessary, rather than approaches that are based on the average behavior of a given subject population which could provide erroneous results.	[Loizides, Charalambos; Hadjiandreou, Marios M.; Achilleos, Achilleas; Mitsis, Georgios D.] Univ Cyprus, Dept Elect & Elect Engn, CY-1678 Nicosia, Cyprus; [Loizides, Charalambos; Hadjiandreou, Marios M.; Achilleos, Achilleas; Mitsis, Georgios D.] Univ Cyprus, KIOS Res Ctr Intelligent Syst & Networks, CY-1678 Nicosia, Cyprus; [Iacovides, Demetris; Rizki, Gizem; Strati, Katerina] Univ Cyprus, Dept Biol Sci, CY-1678 Nicosia, Cyprus; [Rizki, Gizem] MIT, Dept Biol, Cambridge, MA USA; [Mitsis, Georgios D.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada	University of Cyprus; University of Cyprus; University of Cyprus; Massachusetts Institute of Technology (MIT); McGill University	Strati, K (corresponding author), Univ Cyprus, Dept Biol Sci, CY-1678 Nicosia, Cyprus.	strati.katerina@ucy.ac.cy; georgios.mitsis@mcgill.ca	Strati, Katerina/GSN-2131-2022; Mitsis, Georgios D/AGY-4548-2022	Strati, Katerina/0000-0002-2332-787X; Mitsis, Georgios/0000-0001-9975-5128	European Territorial Cooperation Programmes; national funds of Greece and Cyprus	European Territorial Cooperation Programmes; national funds of Greece and Cyprus	This work is co-funded by the European Territorial Cooperation Programmes (80%) and by national funds of Greece and Cyprus (20%). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilleos A, 2014, ANN BIOMED ENG, V42, P1095, DOI 10.1007/s10439-014-0975-y; Agliari E, 2014, SCI REP-UK, V4, DOI 10.1038/srep06639; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Barbolosi D, 2001, COMPUT BIOL MED, V31, P157, DOI 10.1016/S0010-4825(00)00032-9; Benzekry S, 2014, ARXIV14061446; Blesch KS, 2003, INVEST NEW DRUG, V21, P195, DOI 10.1023/A:1023525513696; Bresch D, 2010, SIAM J SCI COMPUT, V32, P2321, DOI 10.1137/070708895; CHEN HSG, 1979, CANCER CHEMOTH PHARM, V2, P85; Clairambault J, 2009, MATH MODEL NAT PHENO, V4, P12, DOI 10.1051/mmnp/20094302; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; d'Onofrio A, 2004, MATH BIOSCI, V191, P159, DOI 10.1016/j.mbs.2004.06.003; de Pillis LG, 2001, J THEO MED, V24, P79, DOI [10.1080/10273660108833067, DOI 10.1080/10273660108833067]; DeVita VT, 1997, CANC PRINCIPLES PRAC; Doyle F, 2007, J PROCESS CONTR, V17, P571, DOI 10.1016/j.jprocont.2007.01.012; Dua P, 2008, COMPUT CHEM ENG, V32, P99, DOI 10.1016/j.compchemeng.2007.07.001; Duff G, 1966, AM J PHYS, V34, P1205; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Glantz S., 1990, PRIMER APPL REGRESSI; Hadjiandreou MM, 2014, IEEE T BIO-MED ENG, V61, P415, DOI 10.1109/TBME.2013.2280189; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrold JM, 2009, COMPUT CHEM ENG, V33, P2042, DOI 10.1016/j.compchemeng.2009.06.005; Hattori Y, 2009, J CONTROL RELEASE, V136, P30, DOI 10.1016/j.jconrel.2009.01.013; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Malet-Martino M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P267; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Martin R. B., 1994, OPTIMAL CONTROL DRUG; MARTIN RB, 1992, AUTOMATICA, V28, P1113, DOI 10.1016/0005-1098(92)90054-J; Michael S, 2013, VIROLOGY, V443, P218, DOI 10.1016/j.virol.2013.04.008; MICHELSON S, 1987, CELL TISSUE KINET, V20, P343, DOI 10.1111/j.1365-2184.1987.tb01316.x; Moreira J, 2002, ADV COMPLEX SYST, V5, P247, DOI [10.1142/s0219525902000572, DOI 10.1142/S0219525902000572]; NORTON L, 1988, CANCER RES, V48, P7067; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Powathil G, 2014, SEMINARS CANC BIOL; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Sakkalis V, 2014, IEEE J BIOMED HEALTH, V18, P824, DOI 10.1109/JBHI.2013.2297167; Simeoni M, 2004, CANCER RES, V64, P1094, DOI 10.1158/0008-5472.CAN-03-2524; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; SKIPPER H E, 1964, Cancer Chemother Rep, V35, P1; Song S, 2000, VIROLOGY, V267, P141, DOI 10.1006/viro.1999.0106; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wang TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00358; Yu Sherry H, 2014, Adv Exp Med Biol, V810, P182; Zamboni WC, 2008, CANCER CHEMOTH PHARM, V62, P417, DOI 10.1007/s00280-007-0620-7	46	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143840	10.1371/journal.pone.0143840	http://dx.doi.org/10.1371/journal.pone.0143840			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649886	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300029
J	Mahmoodian, R; Yahya, R; Dabbagh, A; Hamdi, M; Hassan, MA				Mahmoodian, Reza; Yahya, Rosiyah; Dabbagh, Ali; Hamdi, Mohd; Hassan, Mohsen A.			Investigation of Embedded Si/C System Exposed to a Hybrid Reaction of Centrifugal-Assisted Thermite Method	PLOS ONE			English	Article							HIGH-TEMPERATURE SYNTHESIS; SILICON-CARBIDE; COMBUSTION SYNTHESIS; PHASE; NITRIDE; COMPOSITES; CERAMICS; SHS	A novel method is proposed to study the behavior and phase formation of a Si+C compacted pellet under centrifugal acceleration in a hybrid reaction. Si+C as elemental mixture in the form of a pellet is embedded in a centrifugal tube. The pellet assembly and tube are exposed to the sudden thermal energy of a thermite reaction resulted in a hybrid reaction. The hybrid reaction of thermite and Si+C produced unique phases. X-ray diffraction pattern (XRD) as well as microstructural and elemental analyses are then investigated. XRD pattern showed formation of materials with possible electronic and magnetic properties. The cooling rate and the molten particle viscosity mathematical model of the process are meant to assist in understanding the physical and chemical phenomena took place during and after reaction. The results analysis revealed that up to 85% of materials converted into secondary products as ceramics-matrix composite.	[Mahmoodian, Reza; Dabbagh, Ali; Hamdi, Mohd; Hassan, Mohsen A.] Univ Malaya, Fac Engn, Dept Mech Engn, Ctr Adv Mfg & Mat Proc AMMP, Kuala Lumpur, Malaysia; [Yahya, Rosiyah] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia; [Mahmoodian, Reza] Azarin Kar Ind Co, Dept Res & Dev, Kerman, Iran; [Hassan, Mohsen A.] Assiut Univ, Dept Mech Engn, Assiut, Egypt	Universiti Malaya; Universiti Malaya; Egyptian Knowledge Bank (EKB); Assiut University	Mahmoodian, R (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, Ctr Adv Mfg & Mat Proc AMMP, Kuala Lumpur, Malaysia.	mahmoodian@um.edu.my	Dabbagh, A/F-9075-2014; yahya, rosiyah/B-9604-2010; Abd Shukor, Mohd Hamdi/B-9093-2010; Hassan, Mohsen A./J-9534-2012; Mahmoodian, Reza/C-7875-2009	Dabbagh, A/0000-0002-5940-8882; Abd Shukor, Mohd Hamdi/0000-0003-2123-3041; Hassan, Mohsen A./0000-0001-8599-7732; Mahmoodian, Reza/0000-0001-5426-7665	Ministry of Higher Education, Malaysia [HIR-MOHE-16001-00-D000001, BK064-2014, RG048/09AET]; Azarin Kar Ind. Co.	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Azarin Kar Ind. Co.	The authors would like to acknowledge the University of Malaya for providing the necessary facilities and resources for this research. This research was fully funded by the Ministry of Higher Education, Malaysia with the high impact research (HIR) grant number of HIR-MOHE-16001-00-D000001, BKP grant (BK064-2014), UMRG (RG048/09AET). The funders have paid for professional services (characterizations, equipment and consumable materials) while had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author RM was employed by Azarin Kar Ind. Co. Author RM has not received any payment support from Azarin Kar Ind. Co. for this paper. The Azarin Kar Ind. Co. support was in form given space and using its equipment as courtesy. Azarin Kar Ind. Co. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Balout B, 2012, J MATER ENG PERFORM, V21, P450, DOI 10.1007/s11665-011-9873-8; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Burkes DE, 2006, J ENG MATER-T ASME, V128, P445, DOI 10.1115/1.2204950; Fan RH, 2006, THERMOCHIM ACTA, V440, P129, DOI 10.1016/j.tca.2005.10.020; Feng KQ, 2010, J ALLOY COMPD, V504, P277, DOI 10.1016/j.jallcom.2010.05.112; Feng PZ, 2012, ADV POWDER TECHNOL, V23, P133, DOI 10.1016/j.apt.2011.01.003; FERRO AC, 1995, ACTA METALL MATER, V43, P3061, DOI 10.1016/0956-7151(95)00014-M; Greco A, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.4000418; Greenwood N.N., 1997, CHEM ELEMENTS; Hassan MA, 2015, SURF COAT TECH, V277, P216, DOI 10.1016/j.surfcoat.2015.07.061; Hassan MA, 2014, SCI REP-UK, V4, DOI 10.1038/srep03724; HILL RJ, 1987, J APPL CRYSTALLOGR, V20, P467, DOI 10.1107/S0021889887086199; Ho YH, 1996, ISIJ INT, V36, P1030, DOI 10.2355/isijinternational.36.1030; Jin HB, 2009, POWDER TECHNOL, V196, P229, DOI 10.1016/j.powtec.2009.07.016; Kappe CO, 2012, MOL DIVERS, V16, P5, DOI 10.1007/s11030-011-9346-x; Kim YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5341; Kostic IG, 2011, HIGH TEMP MATER P-US, V15, P321; Ksandopulo GI, 2011, INT J SELF-PROPAG HI, V20, P220, DOI 10.3103/S1061386211040078; Kumar BVM, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/044303; Lee WC, 1997, J AM CERAM SOC, V80, P53, DOI 10.1111/j.1151-2916.1997.tb02790.x; Lin J, 2010, INT J REFRACT MET H, V28, P2, DOI 10.1016/j.ijrmhm.2009.07.012; Lu YJ, 2014, MAT SCI ENG A-STRUCT, V590, P368, DOI 10.1016/j.msea.2013.10.039; Mahmoodian R, 2013, JOM-US, V65, P80, DOI 10.1007/s11837-012-0498-7; Mahmoodian R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130836; Mahmoodian R, 2014, COMBUST SCI TECHNOL, V186, P737, DOI 10.1080/00102202.2013.878705; Mahmoodian R, 2014, COMPOS PART B-ENG, V59, P279, DOI 10.1016/j.compositesb.2013.12.016; Mahmoodian R, 2013, COMPOS PART B-ENG, V50, P187, DOI 10.1016/j.compositesb.2013.02.016; Mahmoodian R, 2012, HIGH TEMP MATER P-US, V16, P15, DOI 10.1615/HighTempMatProc.2012004708; Morsi K, 2012, J MATER SCI, V47, P68, DOI 10.1007/s10853-011-5926-5; Niu YR, 2011, CERAM INT, V37, P1675, DOI 10.1016/j.ceramint.2011.01.040; Odkhuu D, 2011, IEEE T MAGN, V47, P2920, DOI 10.1109/TMAG.2011.2154307; Park J, 2012, ELECTROCHEM SOLID ST, V15, pH148, DOI 10.1149/2.014205esl; Persson P, 2002, J MATER PROCESS TECH, V127, P131, DOI 10.1016/S0924-0136(02)00113-9; Rendtel A, 2008, HARDNESS HARDNESS DE; Rubtsov NM, 2010, THEOR FOUND CHEM EN+, V44, P458, DOI 10.1134/S0040579510040159; Ryu ZY, 2001, CARBON, V39, P1929, DOI 10.1016/S0008-6223(01)00153-1; Schubert U., 2005, SYNTHESIS INORGANIC; Schwetz KA, 2010, CERAMIC SCI TECHNOLO, V2, P131; Seo S-H, 2010, United States patent, Patent No. [US7767021 B2, 7767021]; Taylor JA, 2012, PROC MAT SCI, V1, P19, DOI 10.1016/j.mspro.2012.06.004; WASHBURN ME, 1988, AM CERAM SOC BULL, V67, P356; Woo MJ, 2006, J KOREAN PHYS SOC, V48, P1405; Yadhukulakrishnan GB, 2012, MAT SCI ENG A-STRUCT, V552, P125, DOI 10.1016/j.msea.2012.05.020; Yamamura K, 2011, CIRP ANN-MANUF TECHN, V60, P571, DOI 10.1016/j.cirp.2011.03.072; Yang H, 2012, CERAM INT, V38, P2213, DOI 10.1016/j.ceramint.2011.10.069; Yeh CL, 2011, J ALLOY COMPD, V509, P3257, DOI 10.1016/j.jallcom.2010.12.004; Young R.A, 1993, RIETVELD METHOD	47	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144632	10.1371/journal.pone.0144632	http://dx.doi.org/10.1371/journal.pone.0144632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641651	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700150
J	Mu, TH; Zhang, M; Raad, L; Sun, HN; Wang, C				Mu, Tai-Hua; Zhang, Miao; Raad, Leyla; Sun, Hong-Nan; Wang, Cheng			Effect of alpha-Amylase Degradation on Physicochemical Properties of Pre-High Hydrostatic Pressure-Treated Potato Starch	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; ULTRA-HIGH PRESSURE; RHEOLOGICAL PROPERTIES; NATIVE STARCHES; GELATINIZATION; ACID; NANOPARTICLES; HYDROLYSIS; L.; GRANULES	The effect of high hydrostatic pressure (HHP) on the susceptibility of potato starch (25%, w/v) suspended in water to degradation by exposure to bacterial alpha-amylase (0.02%, 0.04% and 0.06%, w/v) for 40 min at 25 degrees C was investigated. Significant differences (p < 0.05) in the structure, morphology and physicochemical properties were observed. HHP-treated potato starch (PS) exposed to alpha-amylase (0.06%, w/v) showed a significantly greater degree of hydrolysis and amount of reducing sugar released compared to alpha-amylase at a concentration of 0.04% (w/v) or 0.02% (w/v). Native PS (NPS) granules have a spherical and elliptical form with a smooth surface, whereas the hydrolyzed NPS (hNPS) and hydrolyzed HHP-treated PS granules showed irregular and ruptured forms with several cracks and holes on the surface. Hydrolysis of HHP-treated PS by alpha-amylase could decrease the average granule size significantly (p < 0.05) from 29.43 to 20.03 mu m. Swelling power decreased and solubility increased with increasing enzyme concentration and increasing pressure from 200-600 MPa, with the exception of the solubility of HHP-treated PS at 600 MPa (HHP600 PS). Fourier transform infrared spectroscopy (FTIR) showed extensive degradation of the starch in both the ordered and the amorphous structure, especially in hydrolyzed HHP600 PS. The B-type of hydrolyzed HHP600 PS with alpha-amylase at a concentration 0.06% (w/v) changed to a B+V type with an additional peak at 2 theta = 19.36 degrees. The HHP600 starch with 0.06% (w/v) alpha-amylase displayed the lowest value of To (onset temperature), T-c (conclusion temperature) and Delta H-gel (enthalpies of gelatinization). These results indicate the pre-HHP treatment of NPS leads to increased susceptibility of the granules to enzymatic degradation and eventually changes of both the amorphous and the crystalline structures.	[Mu, Tai-Hua; Zhang, Miao; Raad, Leyla; Sun, Hong-Nan] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing, Peoples R China; [Mu, Tai-Hua; Zhang, Miao; Raad, Leyla; Sun, Hong-Nan] Minist Agr, Key Lab Agroprod Proc, Beijing, Peoples R China; [Wang, Cheng] Xinjiang Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Xinjiang, Xinjiang Uygur, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Mu, TH (corresponding author), Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing, Peoples R China.	mutaihuacaas@126.com	ZHANG, MIAO/M-8080-2018	ZHANG, MIAO/0000-0003-3174-7994; Wang, Cheng/0000-0002-2497-3099; GUILBERT, Stephane/0000-0002-8964-670X	earmarked fund for China Agriculture Research System [CARS-11-B-19]	earmarked fund for China Agriculture Research System	This study was funded by the earmarked fund for China Agriculture Research System (CARS-11-B-19). The authors also thank the Fundamental Research budget incremental project of the Chinese Academy of Agricultural Sciences (2014ZL009).	Adzahan NM, 2002, THESIS, P222; [Anonymous], 1982, 3946 ISO EN; AOAC, 2000, OFF METH AN; Atichokudomchai N, 2002, STARCH-STARKE, V54, P343, DOI 10.1002/1521-379X(200208)54:8<343::AID-STAR343>3.0.CO;2-J; BILIADERIS CG, 1991, CAN J PHYSIOL PHARM, V69, P60, DOI 10.1139/y91-011; Biliaderis CG, 1998, POLYSACHARIDE ASS ST; Blaszczak W, 2005, CARBOHYD POLYM, V59, P377, DOI 10.1016/j.carbpol.2004.10.008; Chang YH, 2006, FOOD CHEM, V99, P794, DOI 10.1016/j.foodchem.2005.07.060; Cheftel J. C., 1992, HIGH PRESSURE BIOTEC; CROSBIE GB, 1991, J CEREAL SCI, V13, P145, DOI 10.1016/S0733-5210(09)80031-3; Dura A, 2014, CARBOHYD POLYM, V101, P837, DOI 10.1016/j.carbpol.2013.10.013; Fang JM, 2002, CARBOHYD POLYM, V47, P245, DOI 10.1016/S0144-8617(01)00187-4; FAO (Food and agriculture organization), 2012, FOOD AGR COMM PROD; FRANCO CML, 1992, STARCH-STARKE, V44, P422, DOI 10.1002/star.19920441106; FRENCH D, 1984, ORG STARCH GRANULES, P183; Fukami K., 2010, Journal of Applied Glycoscience, V57, P67, DOI 10.5458/jag.57.67; Gunaratne A, 2002, CARBOHYD POLYM, V49, P425, DOI 10.1016/S0144-8617(01)00354-X; Guo ZB, 2015, FOOD CHEM, V186, P223, DOI 10.1016/j.foodchem.2015.03.069; Hoover R., 2001, CURRENT PROTOCOLS FO, DOI DOI 10.1002/0471142913.FAE0203S00; Jiang QQ, 2011, FOOD HYDROCOLLOID, V25, P521, DOI 10.1016/j.foodhyd.2010.08.003; Kaur B, 2011, FOOD HYDROCOLLOIDS; Kaur L, 2002, FOOD CHEM, V79, P183, DOI 10.1016/S0308-8146(02)00130-9; Kaur M, 2004, FOOD CHEM, V85, P131, DOI 10.1016/j.foodchem.2003.06.013; Kawai K, 2007, CARBOHYD POLYM, V69, P590, DOI 10.1016/j.carbpol.2007.01.015; KRUEGER BR, 1987, J FOOD SCI, V52, P715, DOI 10.1111/j.1365-2621.1987.tb06709.x; Li WH, 2011, J FOOD ENG, V103, P388, DOI 10.1016/j.jfoodeng.2010.11.008; Liu YT, 2008, J FOOD ENG, V88, P126, DOI 10.1016/j.jfoodeng.2008.02.001; Madesn MH, 1996, STARCH, V48, P245; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Molina-Garcia A. D., 2007, MODERN RES ED TOPICS, P719; Oh HE, 2008, CARBOHYD POLYM, V73, P332, DOI 10.1016/j.carbpol.2007.11.038; Peshin A, 2001, J FOOD SCI TECH MYS, V38, P447; Reddy CK, 2014, FOOD CHEM, V155, P38, DOI 10.1016/j.foodchem.2014.01.023; Rubens P, 1999, CARBOHYD POLYM, V39, P231, DOI 10.1016/S0144-8617(99)00005-3; Sevenou O, 2002, INT J BIOL MACROMOL, V31, P79, DOI 10.1016/S0141-8130(02)00067-3; Shi AM, 2012, CARBOHYD POLYM, V88, P1334, DOI 10.1016/j.carbpol.2012.02.013; Srichuwong S, 2005, INT J BIOL MACROMOL, V37, P115, DOI 10.1016/j.ijbiomac.2005.09.006; Sun QJ, 2014, CARBOHYD POLYM, V111, P133, DOI 10.1016/j.carbpol.2014.03.094; Sun QJ, 2014, FOOD CHEM, V162, P223, DOI 10.1016/j.foodchem.2014.04.068; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Uthumporn U, 2012, APPL BIOCHEM BIOTECH, V166, P1167, DOI 10.1007/s12010-011-9502-x; Vallons KJR, 2009, EUR FOOD RES TECHNOL, V230, P343, DOI 10.1007/s00217-009-1172-3; Vasanthan T, 1999, FOOD RES INT, V32, P355, DOI 10.1016/S0963-9969(99)00096-4; Waigh TA, 2000, CARBOHYD RES, V328, P165, DOI 10.1016/S0008-6215(00)00098-7; Yaldagard M, 2008, AFR J BIOTECHNOL, V7, P2739; Yusuph M, 2003, FOOD CHEM, V82, P283, DOI 10.1016/S0308-8146(02)00549-6	46	21	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143620	10.1371/journal.pone.0143620	http://dx.doi.org/10.1371/journal.pone.0143620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642044	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700026
J	Hajek, A; Brettschneider, C; Lange, C; Posselt, T; Wiese, B; Steinmann, S; Weyerer, S; Werle, J; Pentzek, M; Fuchs, A; Stein, J; Luck, T; Bickel, H; Mosch, E; Wagner, M; Jessen, F; Maier, W; Scherer, M; Riedel-Heller, SG; Konig, HH				Hajek, Andre; Brettschneider, Christian; Lange, Carolin; Posselt, Tina; Wiese, Birgitt; Steinmann, Susanne; Weyerer, Siegfried; Werle, Jochen; Pentzek, Michael; Fuchs, Angela; Stein, Janine; Luck, Tobias; Bickel, Horst; Moesch, Edelgard; Wagner, Michael; Jessen, Frank; Maier, Wolfgang; Scherer, Martin; Riedel-Heller, Steffi G.; Koenig, Hans-Helmut		AgeCoDe Study Grp	Longitudinal Predictors of Institutionalization in Old Age	PLOS ONE			English	Article							NURSING-HOME PLACEMENT; RISK-FACTORS; DEMENTIA; IMPAIRMENT; ADMISSION; HEALTH; LONELINESS; COMMUNITY; DISEASES; FRAILTY	Objective To investigate time-dependent predictors of institutionalization in old age using a longitudinal approach. Methods In a representative survey of the German general population aged 75 years and older predictors of institutionalization were observed every 1.5 years over six waves. Conditional fixed-effects logistic regressions (with 201 individuals and 960 observations) were performed to estimate the effects of marital status, depression, dementia, and physical impairments (mobility, hearing and visual impairments) on the risk of admission to old-age home or nursing home. By exploiting the longitudinal data structure using panel econometric models, we were able to control for unobserved heterogeneity such as genetic predisposition and personality traits. Results The probability of institutionalization increased significantly with occurrence of widowhood, depression, dementia, as well as walking and hearing impairments. In particular, the occurrence of widowhood (OR = 78.3), dementia (OR = 154.1) and substantial mobility impairment (OR = 36.7) were strongly associated with institutionalization. Conclusion Findings underline the strong influence of loss of spouse as well as dementia on institutionalization. This is relevant as the number of old people (a) living alone and (b) suffering from dementia is expected to increase rapidly in the next decades. Consequently, it is supposed that the demand for institutionalization among the elderly will increase considerably. Practitioners as well as policy makers should be aware of these upcoming challenges.	[Hajek, Andre; Brettschneider, Christian; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany; [Lange, Carolin; Posselt, Tina; Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Ctr Psychosocial Med, Hamburg, Germany; [Wiese, Birgitt; Steinmann, Susanne] Hannover Med Sch, WG Med Stat & IT Infrastruct, Inst Gen Practice, Hannover, Germany; [Weyerer, Siegfried; Werle, Jochen] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Pentzek, Michael; Fuchs, Angela] Univ Dusseldorf, Inst Gen Practice, Fac Med, Dusseldorf, Germany; [Stein, Janine; Luck, Tobias; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Bickel, Horst; Moesch, Edelgard] Tech Univ Munich, Dept Psychiat, D-80290 Munich, Germany; [Wagner, Michael; Jessen, Frank; Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Wagner, Michael; Maier, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Jessen, Frank] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Leipzig University; Technical University of Munich; University of Munich; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany.	a.hajek@uke.de	Wagner, Michael/E-2325-2011; Jessen, Frank/AAK-6170-2020; König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021; Brettschneider, Christian/H-5920-2019	Wagner, Michael/0000-0003-2589-6440; König, Hans-Helmut/0000-0001-5711-6862; Brettschneider, Christian/0000-0002-5280-1075; Luck, Tobias/0000-0001-7551-4397; Pentzek, Michael/0000-0001-6538-0241; Hajek, Andre/0000-0002-6886-2745	German Federal Ministry of Education and Research [KND 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, 01GI0434, KNDD 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716, AgeQualiDe 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This publication is part of the German Research Network on Dementia (KND), the German Research Network on Degenerative Dementia (KNDD), and the Study on Needs, Health Service Use, Costs and Health-related Quality of Life in a large Sample of Oldest-old Primary Care Patients (85 +) (AgeQualiDe) and was funded by the German Federal Ministry of Education and Research (grants KND 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433 and 01GI0434; grants KNDD 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715 and 01GI0716; and grants AgeQualiDe 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; Andel R, 2007, J AGING HEALTH, V19, P213, DOI 10.1177/0898264307299359; Banaszak-Holl J, 2004, ALZ DIS ASSOC DIS, V18, P83, DOI 10.1097/01.wad.0000126619.80941.91; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Bickel H., 2012, DEMENZEN, V2, P18; Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Eaker ED, 2002, J CLIN EPIDEMIOL, V55, P462, DOI 10.1016/S0895-4356(01)00498-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fydrich T., 2009, Z MED PSYCHOL, V18, P43, DOI DOI 10.1026//0012-1924.45.4.212; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Grenade L, 2008, AUST HEALTH REV, V32, P468, DOI 10.1071/AH080468; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; Jee J, 2005, OPHTHAL EPIDEMIOL, V12, P199, DOI 10.1080/09286580590969707; Kinsella K, 2009, INT POPULATION REPOR; Lachs M, 2006, GERONTOLOGIST, V46, P583, DOI 10.1093/geront/46.5.583; Lachs MS, 2002, GERONTOLOGIST, V42, P734, DOI 10.1093/geront/42.6.734; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Luck T, 2010, ACTA PSYCHIAT SCAND, V121, P260, DOI 10.1111/j.1600-0447.2009.01481.x; Luck T, 2008, NEUROEPIDEMIOLOGY, V31, P100, DOI 10.1159/000146251; Ludwig V., 2015, SAGE HDB REGRESSION, P327, DOI DOI 10.4135/9781446288146.N15; Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027; Luppa M, 2012, SOC PSYCH PSYCH EPID, V47, P263, DOI 10.1007/s00127-010-0333-9; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Luppa M, 2009, INT PSYCHOGERIATR, V21, P1015, DOI 10.1017/S1041610209990238; MAHONEY F I, 1965, Md State Med J, V14, P61; Matthews Z, 2006, NOTES WORKFORCE IMPL; McCallum J, 2005, AUSTRALAS J AGEING, V24, P169, DOI 10.1111/j.1741-6612.2005.00116.x; Miller DK, 2008, J GERONTOL A-BIOL, V63, P487, DOI 10.1093/gerona/63.5.487; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Pollak C P, 1990, J Community Health, V15, P123, DOI 10.1007/BF01321316; Prieto-Flores ME, 2011, J AGING HEALTH, V23, P177, DOI 10.1177/0898264310382658; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Sarma S, 2009, SOC SCI MED, V68, P1106, DOI 10.1016/j.socscimed.2008.12.046; Shapiro E., 1985, CAN J AGING, V4, P11, DOI [10.1017/S0714980800015798, DOI 10.1017/S0714980800015798]; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; STATISTISCHES BUNDESAMT, 2009, BEV DTSCH 2060 12 KO; Tomiak M, 2000, J GERONTOL A-BIOL, V55, pM279, DOI 10.1093/gerona/55.5.M279; Tsai HJ, 2013, GERIATR GERONTOL INT, V13, P597, DOI 10.1111/j.1447-0594.2012.00944.x; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Victor, 2012, AGING HLTH, V8, P637, DOI [DOI 10.2217/AHE.12.65, 10.2217/ahe.12.65]; von Bonsdorff M, 2006, GERONTOLOGY, V52, P359, DOI 10.1159/000094985; Wang JJ, 2003, OPHTHALMIC EPIDEMIOL, V10, P3, DOI 10.1076/opep.10.1.3.13773; Wang SY, 2013, ARCH GERONTOL GERIAT, V57, P16, DOI 10.1016/j.archger.2013.03.007; WOLINSKY FD, 1993, J GERONTOL, V48, pS93	47	106	110	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144203	10.1371/journal.pone.0144203	http://dx.doi.org/10.1371/journal.pone.0144203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658776	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900031
J	Lu, J; Chang, C; Zhang, HP; Wang, SX; Sun, GL; Xiao, SH; Ma, CX				Lu, Jie; Chang, Cheng; Zhang, Hai-Ping; Wang, Sheng-Xing; Sun, Genlou; Xiao, Shi-He; Ma, Chuan-Xi			Identification of a Novel Allele of TaCKX6a02 Associated with Grain Size, Filling Rate and Weight of Common Wheat	PLOS ONE			English	Article							BACKCROSS QTL ANALYSIS; TRITICUM-AESTIVUM L.; CYTOKININ; GENE; YIELD; RICE; CROSS; ACCUMULATION; TRAITS; BARLEY	Cytokinin oxidase (CKX) plays a crucial role in plant growth and development by reversibly inactivating cytokinin (CTK). Twenty-four primer pairs, designed from ESTs of the TaCKX genes family of common wheat, were used to identify their allelic variations associated with grain size, weight, and filling rate in 169 recombinant inbred lines (RIL) derived from Jing 411 x Hongmangchun 21. TaCKX6a02, a member of TaCKX gene family, amplified by primer pair T31-32, showed a close association with grain traits in this RIL population. Statistical analysis indicated that allelic variation of TaCKX6a02 had significant correlation with grain size, weight, and filling rate (GFR; P < 0.001) under varied environments. The TaCKX6a02-D1a allele from Jing411 significantly increased grain size, weight and grain filling rate, compared with TaCKX6a02-D1b from Hongmangchun 21. TaCKX6a02 was located on chromosome 3DS in the interval of Xbarc1119 and Xbarc1162, with a genetic distance of 1.4 cM. The location was further confirmed using Chinese Spring nulli-tetrasomic lines. A major QTL (quantitative trait locus) tightly linked to TaCKX6a02 was detected in the RIL population, explaining 17.1 similar to 38.2% of phenotype variations for grain size, weight, GFRmax and GFRmean in different environments. In addition, significant effects of variations of TaCKX6a02 on grain weight and GFR were further validated by association analysis among 102 wheat varieties in two cropping seasons. 12.8 similar to 35.1% of phenotypic variations were estimated for these genotypes. A novel 29-bp InDel behind the stop codon was detected by DNA sequence analysis between the two alleles of TaCKX6a02-D1. The gene-specific marker, TKX3D, was designed according to the novel variation, and can be used in marker-assisted selection (MAS) for grain size, weight, and GFR in common wheat.	[Lu, Jie; Chang, Cheng; Zhang, Hai-Ping; Wang, Sheng-Xing; Sun, Genlou; Ma, Chuan-Xi] Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China; [Xiao, Shi-He] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Natl Wheat Improvement Ctr, Inst Crop Sci, Beijing 100081, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Saint Marys University - Canada	Sun, GL (corresponding author), Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China.	genlou.sun@smu.ca; machuanxi@ahau.edu.cn			National Natural Science Foundation of China [31000705]; China Agriculture Research System [CARS-03]; Scientific Research Special Program of Agricultural Commonwealth [201203033-04]; Anhui province natural science foundation of China [1508085MC57]; Agriculture Research System of Anhui Province [AHCYTX-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Scientific Research Special Program of Agricultural Commonwealth; Anhui province natural science foundation of China; Agriculture Research System of Anhui Province	This work was supported by grants from the National Natural Science Foundation of China (31000705), the China Agriculture Research System (CARS-03), the Scientific Research Special Program of Agricultural Commonwealth (201203033-04), Anhui province natural science foundation of China (1508085MC57), the Agriculture Research System of Anhui Province (AHCYTX-02) and the introduced leading talent research team for Universities in Anhui Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bednarek J, 2012, J EXP BOT, V63, P5945, DOI 10.1093/jxb/ers249; Chang C, 2010, MOL BREEDING, V25, P481, DOI 10.1007/s11032-009-9346-z; Chang C, 2011, EUPHYTICA, V179, P343, DOI 10.1007/s10681-011-0348-7; Criado MV, 2009, J PLANT PHYSIOL, V166, P1775, DOI 10.1016/j.jplph.2009.05.007; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Dong MingHui, 2008, Scientia Agricultura Sinica, V41, P370; [樊高琼 FAN Gaoqiong], 2007, [麦类作物学报, Journal of triticeae crops], V27, P327; Feng DS, 2008, PLANT MOL BIOL REP, V26, P143, DOI 10.1007/s11105-008-0033-8; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gupta NK, 2003, PLANT GROWTH REGUL, V40, P201, DOI 10.1023/A:1025023822806; [洪彦彬 Hong Yanbin], 2009, [分子植物育种, Molecular Plant Breeding], V7, P360; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Javid MG, 2011, PLANT GROWTH REGUL, V65, P305, DOI 10.1007/s10725-011-9602-1; Jeffrey CS, 1998, PHYSIOL PLANTARUM, V103, P59; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Kamo K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-79; Kang HW, 1998, PLANT MOL BIOL REP, V16, P90, DOI 10.1023/A:1007418606098; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Lazova G, 2010, INT J PLANT SCI, V171, P809, DOI 10.1086/655857; Lee Eung Gwan, 2002, Journal of Plant Biology, V45, P71; [李文阳 LI Wenyang], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P5; [李秀菊 Li Xiuju], 2005, [麦类作物学报, Journal of triticeae crops], V25, P42; Liang ZhenXing, 1998, Acta Agronomica Sinica, V24, P788; Ma X, 2011, PLANT MOL BIOL REP, V29, P98, DOI 10.1007/s11105-010-0209-x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; MCGAW BA, 1983, PHYTOCHEMISTRY, V22, P1103, DOI 10.1016/0031-9422(83)80200-3; Monde RA, 2000, PLANT MOL BIOL, V44, P529, DOI 10.1023/A:1026540310934; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Paradkar MR, 2001, J PLANT PHYSIOL, V158, P929, DOI 10.1078/0176-1617-00369; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Sivakumar T, 2001, J AGRON CROP SCI, V186, P43, DOI 10.1046/j.1439-037x.2001.00450.x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Subbaraj AK, 2010, J PLANT GROWTH REGUL, V29, P487, DOI 10.1007/s00344-010-9160-1; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Swartzberg D, 2008, EUR J PLANT PATHOL, V120, P289, DOI 10.1007/s10658-007-9217-6; Vignesh M, 2013, J PLANT BIOCHEM BIOT, V22, P401, DOI 10.1007/s13562-012-0168-4; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wang ZL, 2001, ACTA AGRONOMICA SINI, V27, P447; Wei YM, 2000, J TRITICEAE CROPS, V20, P35; [徐丽娜 Xu Lina], 2010, [作物学报, Acta Agronomica Sinica], V36, P1596; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2000, PLANT GROWTH REGUL, V30, P261, DOI 10.1023/A:1006356125418; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yue AQ, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0266-9; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang HaiPing, 2010, Acta Agronomica Sinica, V36, P1649, DOI 10.1016/S1875-2780(09)60077-8; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang JP, 2011, MOL BIOL REP, V38, P2337, DOI 10.1007/s11033-010-0367-9; Zhang Lei, 2007, Acta Agronomica Sinica, V33, P1419; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhang XY, 2013, EUPHYTICA, V192, P347, DOI 10.1007/s10681-012-0858-y; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7; Zhao BuHong, 2006, Scientia Agricultura Sinica, V39, P477; Zubo YO, 2008, PLANT PHYSIOL, V148, P1082, DOI 10.1104/pp.108.122275	62	24	29	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144765	10.1371/journal.pone.0144765	http://dx.doi.org/10.1371/journal.pone.0144765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657796	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900103
J	Lu, YJ; Chang, SH; Ye, JT; Ye, YS; Yu, YS				Lu, Ying-juan; Chang, Shao-hai; Ye, Jian-tao; Ye, Yu-shan; Yu, Yan-song			Finite Element Analysis of Bone Stress around Micro-Implants of Different Diameters and Lengths with Application of a Single or Composite Torque Force	PLOS ONE			English	Article							ROOT RESORPTION; MINI-IMPLANTS; CORTICAL BONE; STABILITY; ANCHORAGE; MAXILLARY; DESIGN	Background Stress on the bone surrounding dental micro-implants affects implant success. Purpose To compare the stress on the bone surrounding a micro-implant after application of a single force (SF) of 200 g or a composite force (CF) of 200 g and 6 N. mm torque. Materials and Methods Finite element models were developed for micro-implant diameters of 1.2, 1.6, and 2.0 mm, and lengths of 6, 8, 10, and 12 mm and either a SF or CF was applied. The maximum equivalent stress (Max EQS) of the bone surrounding the micro-implant was determined, and the relationships among type of force, diameter, and length were evaluated. Results The Max EQS of the CF exceeded that of the SF (P< 0.05). The effect of force on stress was related to implant diameter, but not to implant length. The larger CF led to greater instability of the micro-implant and the effect was most pronounced at an implant diameter of 1.2 mm. The use of implant diameters of 1.6 mm and 2.0 mm produced no significant difference in implant stability when either a CF or SF was applied. Conclusion When considering the use of an implant to perform three-dimensional control on the teeth, the implant diameter chosen should be > 1.2 mm.	[Lu, Ying-juan; Chang, Shao-hai; Ye, Jian-tao; Ye, Yu-shan; Yu, Yan-song] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Stomatol, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University	Chang, SH (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Stomatol, Guangzhou 510120, Guangdong, Peoples R China.	changshaoh@gmail.com			Guangdong Science and Technology Program Project [A002014004]	Guangdong Science and Technology Program Project	This work was supported by Guangdong Science and Technology Program Project (A002014004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Guangdong Science and Technology Program Project (A002014004).	Ao JH, 2010, COMPUT BIOL MED, V40, P681, DOI 10.1016/j.compbiomed.2009.10.007; Bahat O, 1993, Int J Oral Maxillofac Implants, V8, P151; Chan E, 2005, AM J ORTHOD DENTOFAC, V127, P186, DOI 10.1016/j.ajodo.2003.11.026; Chang JZC, 2012, AM J ORTHOD DENTOFAC, V141, P279, DOI 10.1016/j.ajodo.2011.09.008; Cheng SJ, 2004, INT J ORAL MAX IMPL, V19, P100; Coelho Goiato M, 2014, J CLIN DIAGN RES, V8, P86; De Clerck H, 2004, Ned Tijdschr Tandheelkd, V111, P10; Duaibis R, 2012, ANGLE ORTHOD, V82, P875, DOI 10.2319/111011-696.1; Eraslan O, 2010, CLIN ORAL INVEST, V14, P411, DOI 10.1007/s00784-009-0305-1; Garfinkle JS, 2008, AM J ORTHOD DENTOFAC, V133, P642, DOI 10.1016/j.ajodo.2006.04.053; Gracco A, 2009, EUR J ORTHODONT, V31, P12, DOI 10.1093/ejo/cjn066; Guo D., 2012, CHINESE J ORTHODONTI, V19, P86; Hohmann A, 2007, ANGLE ORTHOD, V77, P653, DOI 10.2319/060806-234; Holm L, 2012, ANGLE ORTHOD, V82, P1022, DOI 10.2319/011912-47.1; Jasmine MIF, 2012, AM J ORTHOD DENTOFAC, V141, P71, DOI 10.1016/j.ajodo.2011.06.031; Kang N, 2014, OR SURG OR MED OR PA, V118, P519, DOI 10.1016/j.oooo.2014.05.021; Lee JS, 2013, COMPUT METHOD BIOMEC, V16, P1143, DOI 10.1080/10255842.2012.654780; Lin CL, 2010, J BIOMECH, V43, P2174, DOI 10.1016/j.jbiomech.2010.03.043; Liu TC, 2012, AM J ORTHOD DENTOFAC, V141, P468, DOI 10.1016/j.ajodo.2011.11.012; Motoyoshi M, 2009, INT J ORAL MAX SURG, V38, P13, DOI 10.1016/j.ijom.2008.09.006; Singh S, 2012, AM J ORTHOD DENTOFAC, V141, P327, DOI 10.1016/j.ajodo.2011.07.022; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Verri FR, 2014, MAT SCI ENG C-MATER, V45, P234, DOI 10.1016/j.msec.2014.09.005; Woodall N, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2010.08.017	24	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144744	10.1371/journal.pone.0144744	http://dx.doi.org/10.1371/journal.pone.0144744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659581	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900101
J	Taioli, E; Wolf, AS; Camacho-Rivera, M; Kaufman, A; Lee, DS; Nicastri, D; Rosenzweig, K; Flores, RM				Taioli, Emanuela; Wolf, Andrea S.; Camacho-Rivera, Marlene; Kaufman, Andrew; Lee, Dong-Seok; Nicastri, Daniel; Rosenzweig, Kenneth; Flores, Raja M.			Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients	PLOS ONE			English	Article							SURGERY; PNEUMONECTOMY; FEASIBILITY; THERAPY	Introduction Left untreated, malignant pleural mesothelioma (MPM) is associated with uniformly poor prognosis. Better survival has been reported with surgery-based multimodality therapy, but to date, no trial has demonstrated survival benefit of surgery over other therapies. We evaluated whether cancer-directed surgery influenced survival independently from other predictors in a large population-based dataset. Methods The SEER database was explored from 1973 to 2009 to identify all cases of pathologically-Proven MPM. Age, sex, race, year of diagnosis, histology stage, cancer-directed surgery, radiation, and vital status were analyzed. The association between prognostic factors and survival was estimated using Cox regression and propensity matched analysis. Results There were 14,228 patients with pathologic diagnosis of MPM. On multivariable analysis, female gender, younger age, early stage, and treatment with surgery were independent predictors of longer survival. In comparison to no treatment, surgery alone was associated with significant improvement in survival [adjusted hazard ratio (adj HR) 0.64 (0.61-0.67)], but not radiation [adj HR 1.15 (1.08-1.23)]. Surgery and radiation combined had similar survival as surgery alone [adj HR 0.69 (0.64-0.76)]. Results were similar when cases diagnosed between 1973 and 1999 were compared to cases diagnosed between 2000 and 2009. Conclusions Despite developments in surgical and radiation techniques, the prognosis for MPM patients has not improved over the past 4 decades. Cancer-directed surgery is independently associated with better survival, suggesting that multimodal surgery-based therapy can benefit these patients. Further research in adjuvant treatment is necessary to improve prognosis in this challenging disease.	[Taioli, Emanuela; Wolf, Andrea S.; Kaufman, Andrew; Lee, Dong-Seok; Nicastri, Daniel; Flores, Raja M.] Mt Sinai Med Ctr, Dept Thorac Surg, New York, NY 10029 USA; [Taioli, Emanuela] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Taioli, Emanuela] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Camacho-Rivera, Marlene] CUNY City Coll, Dept Community Hlth & Social Med, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Rosenzweig, Kenneth] Mt Sinai Med Ctr, Dept Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; Icahn School of Medicine at Mount Sinai	Flores, RM (corresponding author), Mt Sinai Med Ctr, Dept Thorac Surg, One Gustave L Levy Pl,Box 1023, New York, NY 10029 USA.	raja.flores@mountsinai.org		Camacho-Rivera, Marlene/0000-0003-2343-2941				Baldini EH, 2015, J THORAC CARDIOV SUR, V149, P1374, DOI 10.1016/j.jtcvs.2014.10.128; Baumann F, 2015, CARCINOGENESIS, V36, P76, DOI 10.1093/carcin/bgu227; Blomberg C, 2015, ANTICANCER RES, V35, P2493; Bovolato P, 2014, J THORAC ONCOL, V9, P390, DOI 10.1097/JTO.0000000000000064; Cho BCJ, 2014, J THORAC ONCOL, V9, P397, DOI 10.1097/JTO.0000000000000078; Flores RM, 2010, J THORAC ONCOL, V5, P1649, DOI 10.1097/JTO.0b013e3181f1903e; Kapeles M, 2015, AM J CLIN ONCOL; Kotova S, 2015, CANCER MANAG RES, V7, P51, DOI 10.2147/CMAR.S72814; Price B, 2009, CRIT REV TOXICOL, V39, P576, DOI 10.1080/10408440903044928; Taioli E, 2015, ANN THORAC SURG, V99, P472, DOI 10.1016/j.athoracsur.2014.09.056; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8	11	67	71	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145039	10.1371/journal.pone.0145039	http://dx.doi.org/10.1371/journal.pone.0145039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660351	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900174
J	Giannakopoulos, T				Giannakopoulos, Theodoros			pyAudioAnalysis: An Open-Source Python Library for Audio Signal Analysis	PLOS ONE			English	Article								Audio information plays a rather important role in the increasing digital content that is available today, resulting in a need for methodologies that automatically analyze such content: audio event recognition for home automations and surveillance systems, speech recognition, music information retrieval, multimodal analysis (e.g. audio-visual analysis of online videos for content-based recommendation), etc. This paper presents pyAudioAnalysis, an open-source Python library that provides a wide range of audio analysis procedures including: feature extraction, classification of audio signals, supervised and unsupervised segmentation and content visualization. pyAudioAnalysis is licensed under the Apache License and is available at GitHub (https://github.com/tyiannak/pyAudioAnalysis/). Here we present the theoretical background behind the wide range of the implemented methodologies, along with evaluation metrics for some of the methods. pyAudioAnalysis has been already used in several audio analysis research applications: smart-home functionalities through audio event detection, speech emotion recognition, depression classification based on audiovisual features, music segmentation, multimodal content-based movie recommendation and health applications (e.g. monitoring eating habits). The feedback provided from all these particular audio applications has led to practical enhancement of the library.	[Giannakopoulos, Theodoros] NCSR Demokritos, Computat Intelligence Lab, Inst Informat & Telecommun, Athens 15310, Greece	National Centre of Scientific Research "Demokritos"	Giannakopoulos, T (corresponding author), NCSR Demokritos, Computat Intelligence Lab, Inst Informat & Telecommun, Patriarchou Grigoriou & Neapoleos St, Athens 15310, Greece.	tyiannak@gmail.com			European Union's Horizon research and innovation programme [643892]; RADIO EU Project (Robots in assisted living environments: Unobtrusive, efficient, reliable and modular solutions for independent ageing)	European Union's Horizon research and innovation programme; RADIO EU Project (Robots in assisted living environments: Unobtrusive, efficient, reliable and modular solutions for independent ageing)	This paper has been funded in the context of the RADIO EU Project (Robots in assisted living environments: Unobtrusive, efficient, reliable and modular solutions for independent ageing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 643892.	Miro XA, 2012, IEEE T AUDIO SPEECH, V20, P356, DOI 10.1109/TASL.2011.2125954; Bartsch MA, 2005, IEEE T MULTIMEDIA, V7, P96, DOI 10.1109/TMM.2004.840597; Giannakopoulos T, 2014, INT WORKSH ART INT A; Giannakopoulos T, 2015, AUTOMATIC SOUNDSCAPE; Giannakopoulos T, 2014, INTRO AUD ANAL MATLA; Giannakopoulos T, 2012, SYSTEMS MAN CYBERN A, V20, P1913, DOI [10.1109/TASL.2012.2191285, DOI 10.1109/TASL.2012.2191285]; Gouyon F, 2006, IEEE T AUDIO SPEECH, V14, P1832, DOI 10.1109/TSA.2005.858509; Hyoung-Gook K., 2005, MPEG 7 AUDIO AUDIO C; Lehinevych T, 2014, 2014 10 INT C SIGN I; Pikrakis A, 2004, P INT C MUS INF RETR; Pikrakis A, 2008, IEEE T MULTIMEDIA, V10, P846, DOI 10.1109/TMM.2008.922870; Plumpe M., 1998, P INT C SPOK LANG PR, P2751; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tranter SE, 2006, SYSTEMS MAN CYBERN A, V14, P1557, DOI [10.1109/TASL.2006.878256, DOI 10.1109/TASL.2006.878256]; Tsiakas K, 8 PERVASIVE TECHNOLO; Vendramin L., 2009, P 2009 SIAM INT C DA, P733, DOI 10.1137/1.9781611972795.63.; Vinciarelli A., 2009, P 3 INT C AFF COMP I, P1	17	201	202	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144610	10.1371/journal.pone.0144610	http://dx.doi.org/10.1371/journal.pone.0144610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656189	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600066
J	Moreira, AJ; Ordonez, R; Cerski, CT; Picada, JN; Garcia-Palomo, A; Marroni, NP; Mauriz, JL; Gonzalez-Gallego, J				Moreira, Andrea Janz; Ordonez, Raquel; Cerski, Carlos Thadeu; Picada, Jaqueline Nascimento; Garcia-Palomo, Andres; Marroni, Norma Possa; Mauriz, Jose L.; Gonzalez-Gallego, Javier			Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis	PLOS ONE			English	Article							INDUCED HEPATOCELLULAR-CARCINOMA; CELL-CYCLE ARREST; ER STRESS; SIGNALING PATHWAYS; HEPATOMA-CELLS; ANIMAL-MODEL; CANCER; LIVER; PREVENTION; INHIBITION	Hepatocellular carcinoma (HCC) is one of the most lethal human cancers worldwide because of its high incidence, its metastatic potential and the low efficacy of conventional treatment. Inactivation of apoptosis is implicated in tumour progression and chemotherapy resistance, and has been linked to the presence of endoplasmic reticulum stress. Melatonin, the main product of the pineal gland, exerts anti-proliferative, pro-apoptotic and anti-angiogenic effects in HCC cells, but these effects still need to be confirmed in animal models. Male Wistar rats in treatment groups received diethylnitrosamine (DEN) 50 mg/kg intraperitoneally twice/once a week for 18 weeks. Melatonin was given in drinking water at 1 mg/kg/d, beginning 5 or 12 weeks after the start of DEN administration. Melatonin improved survival rates and successfully attenuated liver injury, as shown by histopathology, decreased levels of serum transaminases and reduced expression of placental glutathione S-transferase. Furthermore, melatonin treatment resulted in a significant increase of caspase 3, 8 and 9 activities, polyadenosine diphosphate (ADP) ribose polymerase (PARP) cleavage, and Bcl-associated X protein (Bax)/Bcl-2 ratio. Cytochrome c, p53 and Fas-L protein concentration were also significantly enhanced by melatonin. Melatonin induced an increased expression of activating transcription factor 6 (ATF6), C/EBP-homologous protein (CHOP) and immunoglobulin heavy chain-binding protein (BiP), while cyclooxygenase (COX)-2 expression decreased. Data obtained suggest that induction of apoptosis and ER stress contribute to the beneficial effects of melatonin in rats with DEN-induced HCC.	[Moreira, Andrea Janz; Cerski, Carlos Thadeu; Marroni, Norma Possa] Hosp Clin Porto Alegre, Ctr Expt Res, Porto Alegre, RS, Brazil; [Moreira, Andrea Janz; Cerski, Carlos Thadeu; Marroni, Norma Possa] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Picada, Jaqueline Nascimento; Marroni, Norma Possa] Univ Luterana Brasil, Grad Program Cell & Mol Biol Appl Hlth, Canoas, Brazil; [Ordonez, Raquel; Mauriz, Jose L.; Gonzalez-Gallego, Javier] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain; [Ordonez, Raquel; Mauriz, Jose L.; Gonzalez-Gallego, Javier] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Leon, Spain; [Garcia-Palomo, Andres] Complejo Asistencial Univ Leon, Serv Oncol, Leon, Spain	Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil; Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Leon	Gonzalez-Gallego, J (corresponding author), Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain.	jgonga@unileon.es	Gonzalez-Gallego, Javier/D-8219-2012; Picada, Jaqueline Nascimento/B-2480-2014; Ordóñez, Raquel/H-6367-2015; Mauriz, Jose L/G-9970-2014	Gonzalez-Gallego, Javier/0000-0002-4386-9342; Picada, Jaqueline Nascimento/0000-0003-2360-1557; Mauriz, Jose L/0000-0003-3160-8599; Possa Marroni, Norma/0000-0001-7856-7953; Garcia Palomo, Andres/0000-0002-9159-9025	Instituto de la Salud Carlos III, Spain; program "Formacion del Profesorado Universitario" (Becas FPU) from the Ministry of Education (Spain) [FPU12/01433]; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES); Brazilian agency: Fundo de Incentivo a Pesquisa e Eventos (FIPE) of the Hospital de Clinicas of Porto Alegre (HCPA); Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Brazilian agency: Laboratorio Experimental de Hepatologia e Gastroenterologia (HCPA/UFRGS)	Instituto de la Salud Carlos III, Spain(Instituto de Salud Carlos III); program "Formacion del Profesorado Universitario" (Becas FPU) from the Ministry of Education (Spain); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency: Fundo de Incentivo a Pesquisa e Eventos (FIPE) of the Hospital de Clinicas of Porto Alegre (HCPA); Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Brazilian agency: Laboratorio Experimental de Hepatologia e Gastroenterologia (HCPA/UFRGS)	CIBERehd is granted by Instituto de la Salud Carlos III, Spain. Raquel Ordonez is supported by the program "Formacion del Profesorado Universitario" (Becas FPU, reference FPU12/01433) from the Ministry of Education (Spain). This study was supported by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES), Fundo de Incentivo a Pesquisa e Eventos (FIPE) of the Hospital de Clinicas of Porto Alegre (HCPA), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Laboratorio Experimental de Hepatologia e Gastroenterologia (HCPA/UFRGS).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Amin A, 2011, HEPATOLOGY, V54, P857, DOI 10.1002/hep.24433; Anisimov VN, 2006, BBA-BIOENERGETICS, V1757, P573, DOI 10.1016/j.bbabio.2006.03.012; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Balamurugan K, 2012, INDIAN J CLIN BIOCHE, V27, P157, DOI 10.1007/s12291-011-0166-7; Bejarano I, 2011, MOL CELL BIOCHEM, V353, P167, DOI 10.1007/s11010-011-0783-8; Blask DE, 2005, ENDOCRINE, V27, P179, DOI 10.1385/ENDO:27:2:179; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Carbajo-Pescador S, 2013, BRIT J CANCER, V108, P442, DOI 10.1038/bjc.2012.563; Carbajo-Pescador S, 2011, J PINEAL RES, V51, P463, DOI 10.1111/j.1600-079X.2011.00910.x; Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001; Cutando A, 2012, ANTICANCER RES, V32, P2747; Dakshayani KB, 2005, J PHARM PHARM SCI, V8, P316; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Fan LL, 2010, WORLD J GASTROENTERO, V16, P1473, DOI 10.3748/wjg.v16.i12.1473; Fan LL, 2013, J PINEAL RES, V55, P184, DOI 10.1111/jpi.12061; Fan LL, 2013, J PINEAL RES, V55, P174, DOI 10.1111/jpi.12060; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrin G, 2015, HEPATIC MED-EVID RES, V7, P1, DOI 10.2147/HMER.S50161; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fulda S, 2015, SEMIN CANCER BIOL, V31, P84, DOI 10.1016/j.semcancer.2014.05.002; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gao Y, 2012, MOL BIOL REP, V39, P1683, DOI 10.1007/s11033-011-0908-x; Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019; Ghosh D, 2012, CHEM-BIOL INTERACT, V195, P206, DOI 10.1016/j.cbi.2011.12.004; Hadem Khetbadei Lysinia Hynniewta, 2014, J Carcinog, V13, P7, DOI 10.4103/1477-3163.133520; Hickman ES, 2002, CURR OPIN GENET DEV, V12, P60, DOI 10.1016/S0959-437X(01)00265-9; Imamoto R, 2014, EXP THER MED, V7, P31, DOI 10.3892/etm.2013.1391; Jayakumar S, 2012, MOL CELL BIOCHEM, V360, P51, DOI 10.1007/s11010-011-1043-7; Kowsalya R, 2015, SOUTH ASIAN J CANCER, V4, P83, DOI 10.4103/2278-330X.155691; Liu R, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-1; Lu WL, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/192749; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Mauriz JL, 2008, MINI-REV MED CHEM, V8, P1485, DOI 10.2174/138955708786786499; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Moreira A RG, 2015, TOXICOLOGY REPORTS, V2, P8; Muchowicz A, 2015, BIOCHEM PHARMACOL, V93, P418, DOI 10.1016/j.bcp.2014.12.019; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ordonez R, 2014, J PINEAL RES, V56, P20, DOI 10.1111/jpi.12092; Perdomo J, 2013, J PINEAL RES, V55, P195, DOI 10.1111/jpi.12062; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rahman KW, 2003, NUTR CANCER, V47, P148, DOI 10.1207/s15327914nc4702_7; Rajasekaran D, 2011, MOL MED REP, V4, P1211, DOI 10.3892/mmr.2011.555; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Sakai M, 2007, BIOCHEM BIOPH RES CO, V357, P575, DOI 10.1016/j.bbrc.2007.03.174; San-Miguel B, 2006, APOPTOSIS, V11, P1945, DOI 10.1007/s10495-006-0090-0; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sivaramakrishnan V, 2010, CHEM-BIOL INTERACT, V183, P284, DOI 10.1016/j.cbi.2009.11.011; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Subramanian P, 2007, J PINEAL RES, V43, P305, DOI 10.1111/j.1600-079X.2007.00478.x; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Tomov B, 2013, ANTICANCER RES, V33, P4531; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Varghese L, 2005, CLIN CANCER RES, V11, P8441, DOI 10.1158/1078-0432.CCR-05-1646; Wang ZX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/732516; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yi X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093599; Yoon JS, 2013, PHYTOMEDICINE, V20, P1013, DOI 10.1016/j.phymed.2013.03.024; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zha LX, 2012, J PINEAL RES, V52, P322, DOI 10.1111/j.1600-079X.2011.00946.x	67	53	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144517	10.1371/journal.pone.0144517	http://dx.doi.org/10.1371/journal.pone.0144517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656265	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600051
J	Nanya, M; Sato, M; Tanimoto, K; Tozuka, M; Mizutani, S; Takagi, M				Nanya, Mai; Sato, Masaki; Tanimoto, Kousuke; Tozuka, Minoru; Mizutani, Shuki; Takagi, Masatoshi			Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells	PLOS ONE			English	Article							MLL GENE; INFANT-LEUKEMIA; ATAXIA-TELANGIECTASIA; IN-VITRO; ETOPOSIDE; ATM; THERAPY; EXPRESSION; MECHANISM; CLEAVAGE	Etoposide, a topoisomerase 2 (TOP2) inhibitor, is associated with the development of KMT2A (MLL)-rearranged infant leukemia. An epidemiological study suggested that in utero exposure to TOP2 inhibitors may be involved in generation of KMT2A (MLL) rearrangement. The present study examined the mechanism underlying the development of KMT2A (MLL)-rearranged infant leukemia in response to in utero exposure to etoposide in a mouse model. Fetal liver hematopoietic stem cells were more susceptible to etoposide than maternal bone marrow mononuclear cells. Etoposide-induced Kmt2a breakage was detected in fetal liver hematopoietic stem cells using a newly developed chromatin immuno-precipitation (ChIP) assay. Assessment of etoposide-induced chromosomal translocation by next-generation RNA sequencing (RNA-seq) identified several chimeric fusion messenger RNAs that were generated by etoposide treatment. However, Kmt2a (MII)-rearranged fusion mRNA was detected in Atm-knockout mice, which are defective in the DNA damage response, but not in wild-type mice. The present findings suggest that in utero exposure to TOP2 inhibitors induces Kmt2a rearrangement when the DNA damage response is defective.	[Nanya, Mai; Sato, Masaki; Mizutani, Shuki; Takagi, Masatoshi] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan; [Nanya, Mai; Tozuka, Minoru] Tokyo Med & Dent Univ, Analyt Chem Lab, Grad Sch Hlth Care Sci, Tokyo, Japan; [Tanimoto, Kousuke] Tokyo Med & Dent Univ, Dept Genom, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Mizutani, S (corresponding author), Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan.	skkmiz@gmail.com; m.takagi.ped@tmd.ac.jp	Sato, Masaki/L-2169-2017	Sato, Masaki/0000-0003-1277-7645	Ministry of education, culture, sport, science and technology, Japan [25461580]; Project for Development of innovative research on cancer therapeutics	Ministry of education, culture, sport, science and technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of innovative research on cancer therapeutics	This research was supported by grant aid from Project for Development of innovative research on cancer therapeutics, Grants-in-aid for Scientific Research 25461580, Ministry of education, culture, sport, science and technology, Japan.	Alexander FE, 2001, CANCER RES, V61, P2542; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; BLANCO JG, 2004, FASEB J, V18, P173, DOI 10.1096/fj.03-0638fje; Bueno C, 2011, LEUKEMIA, V25, P400, DOI 10.1038/leu.2010.284; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Cowell IG, 2012, INT J ENV RES PUB HE, V9, P2075, DOI 10.3390/ijerph9062075; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FELIX CA, 1995, BLOOD, V85, P3250, DOI 10.1182/blood.V85.11.3250.bloodjournal85113250; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii E, 2002, INT J HEMATOL, V76, P74, DOI 10.1007/BF02982722; Isoda T, 2012, BLOOD, V120, P789, DOI 10.1182/blood-2012-02-413195; Kobayashi M, 2014, STEM CELLS, V32, P1956, DOI 10.1002/stem.1672; Libura J, 2005, BLOOD, V105, P2124, DOI 10.1182/blood-2004-07-2683; Libura J, 2008, EUR J HAEMATOL, V81, P185, DOI 10.1111/j.1600-0609.2008.01103.x; Moneypenny CG, 2006, CARCINOGENESIS, V27, P874, DOI 10.1093/carcin/bgi322; Nakada S, 2006, J CLIN INVEST, V116, P80, DOI 10.1172/JCI25716; Nam C, 2013, EXP ANIM TOKYO, V62, P93, DOI 10.1538/expanim.62.93; Oguchi K, 2003, BLOOD, V101, P3622, DOI 10.1182/blood-2002-02-0570; ROSS JA, 1994, J NATL CANCER I, V86, P1678, DOI 10.1093/jnci/86.22.1678; Ross JA, 2000, P NATL ACAD SCI USA, V97, P4411, DOI 10.1073/pnas.97.9.4411; Sanjuan-Pla A, 2015, BLOOD, V126, P2676, DOI 10.1182/blood-2015-09-667378; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Takagi M, 2013, DNA REPAIR, V12, P500, DOI 10.1016/j.dnarep.2013.04.022; Tamaichi H, 2013, CANCER SCI, V104, P178, DOI 10.1111/cas.12067; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	32	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144540	10.1371/journal.pone.0144540	http://dx.doi.org/10.1371/journal.pone.0144540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657054	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600052
J	Rubio, M; Ballester, AR; Olivares, PM; de Moura, MC; Dicenta, F; Martinez-Gomez, P				Rubio, Manuel; Rosa Ballester, Ana; Manuel Olivares, Pedro; Castro de Moura, Manuel; Dicenta, Federico; Martinez-Gomez, Pedro			Gene Expression Analysis of Plum pox virus (Sharka) Susceptibility/Resistance in Apricot (Prunus armeniaca L.)	PLOS ONE			English	Article							RNA-SEQ; PEACH LEAVES; LINKAGE MAP; RESISTANCE; IDENTIFICATION; MARKERS; MODEL; PPV; INFECTION; ANALOGS	RNA-Seq has proven to be a very powerful tool in the analysis of the Plum pox virus (PPV, sharka disease)/Prunus interaction. This technique is an important complementary tool to other means of studying genomics. In this work an analysis of gene expression of resistance/ susceptibility to PPV in apricot is performed. RNA-Seq has been applied to analyse the gene expression changes induced by PPV infection in leaves from two full-sib apricot genotypes, "Rojo Pasion" and "Z506-7", resistant and susceptible to PPV, respectively. Transcriptomic analyses revealed the existence of more than 2,000 genes related to the pathogen response and resistance to PPV in apricot. These results showed that the response to infection by the virus in the susceptible genotype is associated with an induction of genes involved in pathogen resistance such as the allene oxide synthase, S-adenosylmethionine synthetase 2 and the major MLP-like protein 423. Over-expression of the Dicer protein 2a may indicate the suppression of a gene silencing mechanism of the plant by PPV HCPro and P1 PPV proteins. On the other hand, there were 164 genes involved in resistance mechanisms that have been identified in apricot, 49 of which are located in the PPVres region (scaffold 1 positions from 8,050,804 to 8,244,925), which is responsible for PPV resistance in apricot. Among these genes in apricot there are several MATH domain-containing genes, although other genes inside (Pleiotropic drug resistance 9 gene) or outside (CAP, Cysteine-rich secretory proteins, Antigen 5 and Pathogenesis-related 1 protein; and LEA, Late embryogenesis abundant protein) PPVres region could also be involved in the resistance.	[Rubio, Manuel; Manuel Olivares, Pedro; Dicenta, Federico; Martinez-Gomez, Pedro] Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Plant Breeding, E-30100 Espinardo, Murcia, Spain; [Rosa Ballester, Ana] Inst Agroquim & Tecnol Alimentos IATA CSIC, Dept Food Sci, Paterna 46980, Valencia, Spain; [Castro de Moura, Manuel] AScidea Computat Biol Solut, Barcelona 08193, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); Consejo Superior de Investigaciones Cientificas (CSIC)	Martinez-Gomez, P (corresponding author), Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Plant Breeding, POB 164, E-30100 Espinardo, Murcia, Spain.	pmartinez@cebas.csic.es	Castro, Manuel/AAF-5985-2019; Rubio, Manuel/E-8607-2010; Dicenta, Federico/L-1777-2017; Ballester, Ana-Rosa/D-9677-2011; Martinez-Gomez, Pedro/G-4217-2011; de Moura, Manuel Castro/L-4259-2017	Castro, Manuel/0000-0002-8488-5306; Rubio, Manuel/0000-0003-4605-8227; Ballester, Ana-Rosa/0000-0002-7688-7838; Martinez-Gomez, Pedro/0000-0003-1054-8814; de Moura, Manuel Castro/0000-0002-8488-5306; Dicenta, Federico/0000-0002-9593-7351	Spanish Ministry of Economy and Competitiveness [AGL2010-16335, AGL2013-43550-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by the projects "Gene expression analysis of the resistance to Plum pox virus, PPV (sharka) in apricot by transcriptome deep sequencing (RNA-Seq)" (AGL2010-16335) and "Regulation of gene expression in the resistance to Plum pox virus (Sharka) induced in peach by 'Garrigues' almond grafting" (AGL2013-43550-R) of the Spanish Ministry of Economy and Competitiveness. A.R. Ballester and M. Rubio are grateful to CSIC and the European Social Fund for their postdoctoral contracts. Author Manuel Castro de Moura is employed by aScidea Computational Biology Solutions, S.L. aScidea Computational Biology Solutions, S.L. provided support in the form of salary for author MCdM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Salazar JA, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0845-2; Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Clemente-Moreno MJ, 2015, J EXP BOT, V66, P25, DOI 10.1093/jxb/eru428; Cosson P, 2010, PLANT PHYSIOL, V154, P222, DOI 10.1104/pp.110.155754; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Decroocq S, 2014, TREE GENET GENOMES, V10, P1161, DOI 10.1007/s11295-014-0750-0; Decroocq V, 2006, MOL PLANT MICROBE IN, V19, P541, DOI 10.1094/MPMI-19-0541; Dondini L, 2004, J HORTIC SCI BIOTECH, V79, P729, DOI 10.1080/14620316.2004.11511834; Dondini L, 2011, MOL BREEDING, V27, P289, DOI 10.1007/s11032-010-9431-3; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Egea J, 2004, HORTSCIENCE, V39, P1490, DOI 10.21273/HORTSCI.39.6.1490; Gardiner DM, 2013, FEMS MICROBIOL LETT, V348, P36, DOI 10.1111/1574-6968.12240; Gonzalez-Ibeas D, 2012, MOL PLANT MICROBE IN, V25, P107, DOI 10.1094/MPMI-07-11-0193; Hurtado MA, 2002, THEOR APPL GENET, V105, P182, DOI 10.1007/s00122-002-0936-y; Jaouannet M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004918; Jung S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-76; Karayiannis I, 2008, TREE GENET GENOMES, V4, P143, DOI 10.1007/s11295-007-0095-z; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Lalli DA, 2008, TREE GENET GENOMES, V4, P481, DOI 10.1007/s11295-007-0125-x; Lalli DA, 2005, THEOR APPL GENET, V111, P1504, DOI 10.1007/s00122-005-0079-z; Lambert P, 2007, TREE GENET GENOMES, V3, P299, DOI 10.1007/s11295-006-0069-6; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindner R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052403; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Llacer G, 2008, ACTA HORTIC, P263, DOI 10.17660/ActaHortic.2008.781.39; Marandel G, 2009, MOL PLANT PATHOL, V10, P347, DOI [10.1111/j.1364-3703.2009.00535.x, 10.1111/J.1364-3703.2009.00535.X]; Mariette S, 2016, NEW PHYTOL, V209, P773, DOI 10.1111/nph.13627; Martinez-Gomez P, 2000, AGRONOMIE, V20, P407, DOI 10.1051/agro:2000137; Martinez-Gomez P, 2012, OMICS, V16, P268, DOI 10.1089/omi.2011.0133; Martinez-Gomez P, 2011, GENETICA, V139, P755, DOI 10.1007/s10709-011-9580-2; Soriano JM, 2012, MOL BREEDING, V30, P1017, DOI 10.1007/s11032-011-9685-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilarova P, 2010, TREE GENET GENOMES, V6, P467, DOI 10.1007/s11295-009-0264-3; Rasori A, 2002, J EXP BOT, V53, P2333, DOI [10.1093/jxb/\\, 10.1093/jxb/\\|[ast ]\\|, 10.1093/jxb/erf097]; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Rodamilans B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100477; Rubio M, 2007, SCI HORTIC-AMSTERDAM, V112, P361, DOI 10.1016/j.scienta.2006.12.049; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; Rubio M, 2014, TREE GENET GENOMES, V10, P513, DOI 10.1007/s11295-014-0700-x; Rubio M, 2010, TREE GENET GENOMES, V6, P291, DOI 10.1007/s11295-009-0249-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schurdi-Levraud Escalettes V, 2006, GENE, V374, P96, DOI 10.1016/j.gene.2006.01.021; Sicard O, 2008, MOL PLANT MICROBE IN, V21, P198, DOI 10.1094/MPMI-21-2-0198; Simon AS, 2014, ANNU REV MICROBIOL, V67, P21; Soriano JM, 2008, TREE GENET GENOMES, V4, P391, DOI 10.1007/s11295-007-0118-9; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; Ruiz EMV, 2011, MOL PLANT PATHOL, V12, P535, DOI [10.1111/J.1364-3703.2010.00691.X, 10.1111/j.1364-3703.2010.00691.x]; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vilanova S, 2003, THEOR APPL GENET, V107, P239, DOI 10.1007/s00122-003-1243-y; Wagner GP, 2013, THEOR BIOSCI, V132, P159, DOI 10.1007/s12064-013-0178-3; Wang A, 2005, CAN J PLANT PATHOL, V27, P410; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P403, DOI 10.1007/s11295-007-0119-8; Zhong WJ, 2013, PLANT MOL BIOL, V83, P247, DOI 10.1007/s11103-013-0086-4; Zuriaga E, 2013, MOL PLANT PATHOL, V14, P663, DOI 10.1111/mpp.12037	65	20	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144670	10.1371/journal.pone.0144670	http://dx.doi.org/10.1371/journal.pone.0144670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658051	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600074
J	Sun, L; Lu, JJ; Niu, ZH; Ding, KJ; Bi, DB; Liu, S; Li, JM; Wu, F; Zhang, H; Zhao, ZH; Ding, ST				Sun, Liang; Lu, Jiaju; Niu, Zhihong; Ding, Kejia; Bi, Dongbin; Liu, Shuai; Li, Jiamei; Wu, Fei; Zhang, Hui; Zhao, Zuohui; Ding, Sentai			A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer	PLOS ONE			English	Article							MITOTIC KINESIN EG5; TRITYL-L-CYSTEINE; RIBONUCLEOTIDE REDUCTASE M1; HUMAN PANCREATIC-CANCER; CELL LUNG-CANCER; OVARIAN-CANCER; SPINDLE PROTEIN; CARCINOMA; SUBUNIT; EXPRESSION	Development of resistance to gemcitabine is a major concern in bladder cancer therapy, and the mechanism remains unclear. Eg5 has been recently identified as an attractive target in cancer chemotherapy, so novel targeted chemotherapy with Eg5 inhibitor is expected to improve the anticancer effect in gemcitabine-resistant bladder cancer. In this research, RT112-Gr cells were 350-fold less sensitive to gemcitabine than the parental cell lines, while KU7-Gr cells were 15-fold less sensitive to gemcitabine than the parental cell lines. Human OneArray Microarray analysis was performed to obtain broad spectrum information about the genes differentially expressed in RT112 and RT112-Gr cells. The anti-proliferative activity of S(MeO) TLC, an Eg5 inhibitor, was analyzed in RT112-Gr cell lines using a cell viability assay. Furthermore, the inhibitory effect was evaluated in vivo using subcutaneous xenograft tumor model. According to the result of Human OneArray1GeneChip, RRM1 and RRM2 were up-regulated, while there was no significant change in Eg5. Trypan blue staining confirmed that in S(MeO) TLC and Gemcitabine combining S(MeO) TLC group cell viability were significantly decreased in RT112-Gr cells as compared with other groups. S (MeO) TLC and S(MeO) TLC+gemcitabine groups prominently suppressed tumor growth in comparison with other groups' in vivo. There were no significant differences in S(MeO) TLC and gemcitabine+S(MeO) TLC group in the effect of inhibition of bladder cancer in vivo and in vitro. Our data collectively demonstrated that S(MeO) TLC represents a novel strategy for the treatment of gemcitabine resistant bladder cancer.	[Sun, Liang; Lu, Jiaju; Niu, Zhihong; Ding, Kejia; Bi, Dongbin; Liu, Shuai; Wu, Fei; Zhang, Hui; Zhao, Zuohui; Ding, Sentai] Shandong Univ, Shandong Prov Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China; [Li, Jiamei] Shandong Univ, Shandong Prov Hosp, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Sun, Liang] Shandong Univ Tradit Chinese Med, Dept Cardiac Surg, Affiliated Hosp 2, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University of Traditional Chinese Medicine	Ding, ST (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China.	dingsentai@126.com	Wu, Fei/GWV-4224-2022	Wu, Fei/0000-0002-3601-9593	National Natural Science Foundation of China [81202017]; Natural Science Foundation of Shandong Province [ZR2011HQ027, ZR2014HQ041]; Science and Technology Research Foundation of Shandong Province [2012YD18049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science and Technology Research Foundation of Shandong Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 81202017) (http://www.nsfc.gov.cn), the Natural Science Foundation of Shandong Province (No. ZR2011HQ027 and No. ZR2014HQ041) (http://www.sdnsf.gov.cn), and the Science and Technology Research Foundation of Shandong Province (No. 2012YD18049) (http://www.sdnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abualhasan MN, 2012, EUR J MED CHEM, V54, P483, DOI 10.1016/j.ejmech.2012.05.034; Allory Y, 2014, EUR UROL, V65, P360, DOI 10.1016/j.eururo.2013.08.052; Amit D, 2012, INT J CLIN EXP MED, V5, P296; Angelova AL, 2009, CLIN CANCER RES, V15, P511, DOI 10.1158/1078-0432.CCR-08-1088; Barsanti PA, 2010, BIOORG MED CHEM LETT, V20, P157, DOI 10.1016/j.bmcl.2009.11.012; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bhutia YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053436; Chung WG, 2012, J CONTROL RELEASE, V157, P132, DOI 10.1016/j.jconrel.2011.08.004; Ding ST, 2010, J UROLOGY, V184, P1175, DOI 10.1016/j.juro.2010.04.073; Droller MJ, 2002, UROL CLIN N AM, V29, P229, DOI 10.1016/S0094-0143(02)00008-3; Gandaglia G, 2014, EUR UROL, V66, P561, DOI 10.1016/j.eururo.2014.01.014; Good JAD, 2013, J MED CHEM, V56, P1878, DOI 10.1021/jm3014597; Hodge LS, 2011, BIOCHEM PHARMACOL, V81, P950, DOI 10.1016/j.bcp.2011.01.016; Itoi T, 2007, J GASTROENTEROL, V42, P389, DOI 10.1007/s00535-007-2017-0; Kang HW, 2012, KOREAN J UROL, V53, P598, DOI 10.4111/kju.2012.53.9.598; Knight SD, 2008, CURR TOP MED CHEM, V8, P888, DOI 10.2174/156802608784911626; Leijen S, 2013, GYNECOL ONCOL, V130, P511, DOI 10.1016/j.ygyno.2013.05.001; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Matsui Y, 2010, BJU INT, V105, P558, DOI 10.1111/j.1464-410X.2009.08732.x; Motoyama T, 2012, CHEM BIOL, V19, P1611, DOI 10.1016/j.chembiol.2012.10.010; Muramaki M, 2009, BJU INT, V103, P384, DOI 10.1111/j.1464-410X.2008.08098.x; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Nakai R, 2009, CANCER RES, V69, P3901, DOI 10.1158/0008-5472.CAN-08-4373; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Ohtaka K, 2008, ONCOL REP, V20, P279, DOI 10.3892/or_00000004; Peters T, 2006, N-S ARCH PHARMACOL, V372, P291, DOI 10.1007/s00210-005-0022-5; Rosenberg JE, 2007, EXPERT REV ANTICANC, V7, P1729, DOI 10.1586/14737140.7.12.1729; Saijo T, 2006, LUNG CANCER, V54, P217, DOI 10.1016/j.lungcan.2006.06.018; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Sun DQ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0476-0; Tcherniuk S, 2010, BIOCHEM PHARMACOL, V79, P864, DOI 10.1016/j.bcp.2009.11.001; Wiltshire C, 2010, MOL CANCER THER, V9, P1730, DOI 10.1158/1535-7163.MCT-09-1103; Xie H, 2013, CANCER-AM CANCER SOC, V119, P173, DOI 10.1002/cncr.27715; Xing ND, 2011, ASIAN J ANDROL, V13, P236, DOI 10.1038/aja.2010.171; Yu HJ, 2013, HISTOPATHOLOGY, V62, P788, DOI 10.1111/his.12087; Zhang M, 2013, INT J GYNECOL CANCER, V23, P659, DOI 10.1097/IGC.0b013e318287e2b3	36	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144484	10.1371/journal.pone.0144484	http://dx.doi.org/10.1371/journal.pone.0144484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658059	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500030
J	Gao, Y; Zhang, XJ; Wei, JK; Sun, XQ; Yuan, JB; Li, FH; Xiang, JH				Gao, Yi; Zhang, Xiaojun; Wei, Jiankai; Sun, Xiaoqing; Yuan, Jianbo; Li, Fuhua; Xiang, Jianhai			Whole Transcriptome Analysis Provides Insights into Molecular Mechanisms for Molting in Litopenaeus vannamei	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; DE-NOVO TRANSCRIPTOME; INHIBITING HORMONE; ANTILIPOPOLYSACCHARIDE FACTOR; RNA-SEQ; PORTUNUS-TRITUBERCULATUS; CHERAX-QUADRICARINATUS; SWIMMING CRAB; WHITE SHRIMP; CYCLE	Molting is one of the most important biological processes in shrimp growth and development. All shrimp undergo cyclic molting periodically to shed and replace their exoskeletons. This process is essential for growth, metamorphosis, and reproduction in shrimp. However, the molecular mechanisms underlying shrimp molting remain poorly understood. In this study, we investigated global expression changes in the transcriptomes of the Pacific white shrimp, Litopenaeus vannamei, the most commonly cultured shrimp species worldwide. The transcriptome of whole L. vannamei was investigated by RNA-sequencing (RNA-seq) throughout the molting cycle, including the inter-molt (C), pre-molt (D0, D1, D2, D3, D4), and post-molt (P1 and P2) stages, and 93,756 unigenes were identified. Among these genes, we identified 5,117 genes differentially expressed (log(2)ratio >= 1 and FDR <= 0.001) in adjacent molt stages. The results were compared against the National Center for Biotechnology Information (NCBI) non-redundant protein/nucleotide sequence database, SwissProt, PFAM database, the Gene Ontology database, and the Kyoto Encyclopedia of Genes and Genomes database in order to annotate gene descriptions, associate them with gene ontology terms, and assign them to pathways. The expression patterns for genes involved in several molecular events critical for molting, such as hormone regulation, triggering events, implementation phases, skelemin, immune responses were characterized and considered as mechanisms underlying molting in L. vannamei. Comparisons with transcriptomic analyses in other arthropods were also performed. The characterization of major transcriptional changes in genes involved in the molting cycle provides candidates for future investigation of the molecular mechanisms. The data generated in this study will serve as an important transcriptomic resource for the shrimp research community to facilitate gene and genome annotation and to characterize key molecular processes underlying shrimp development.	[Gao, Yi; Zhang, Xiaojun; Wei, Jiankai; Sun, Xiaoqing; Yuan, Jianbo; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wei, Jiankai; Sun, Xiaoqing] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiang, JH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	jhxiang@qdio.ac.cn	zhang, jin/GXV-9154-2022		Major State Basic Research Development Program of China (973 program) [2012CB114403]; National Natural Science Foundation of China [31172396, 41376165]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major State Basic Research Development Program of China (973 program) (2012CB114403) and National Natural Science Foundation of China (31172396, 41376165).	Abehsera S, 2015, PLOS ONE, V10; Aiken D.E., 1980, P91; Bliss DE, 2012, INTEGUMENT PIGMENTS, V9, P44; BORST DW, 1987, INSECT BIOCHEM, V17, P1123, DOI 10.1016/0020-1790(87)90133-8; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Ceccaldi H.J., 1990, IFREMER Actes de Colloques, P243; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131503; Cheng WT, 2002, AQUACULTURE, V211, P325, DOI 10.1016/S0044-8486(01)00768-2; Christie AE, 2014, GEN COMP ENDOCR, V206, P96, DOI 10.1016/j.ygcen.2014.07.010; Chung JS, 2003, EUR J BIOCHEM, V270, P3280, DOI 10.1046/j.1432-1033.2003.03720.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corteel M, 2012, AQUACULT INT, V20, P13, DOI 10.1007/s10499-011-9437-9; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Devisetty UK, 2014, G3 GENES GENOMICS GE, V4; Diwan A. D., 2005, Indian Journal of Experimental Biology, V43, P209; Durica DS, 2014, GEN COMP ENDOCR, V206, P80, DOI 10.1016/j.ygcen.2014.05.034; Durica DS, 2002, MOL CELL ENDOCRINOL, V189, P59, DOI 10.1016/S0303-7207(01)00740-7; Feng CM, 2008, AQUAC RES, V39, P1639, DOI 10.1111/j.1365-2109.2008.02037.x; Fischbarg J, 1997, SCIENCE, V275, P1491; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Guo B, 2011, AQUACULTURE, V314, P210, DOI 10.1016/j.aquaculture.2011.02.023; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Hou CQ, 2011, AQUAC RES, V42, P1453, DOI 10.1111/j.1365-2109.2010.02737.x; Hudson NJ, 2002, J EXP BIOL, V205, P2297; Jiang HS, 2014, DEV COMP IMMUNOL, V48, P33; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kiran RBP, 2002, J FISH DIS, V25, P201, DOI 10.1046/j.1365-2761.2002.00357.x; Klein B, 1996, INT J BIOCHEM CELL B, V28, P551, DOI 10.1016/1357-2725(95)00169-7; Koenders A, 2002, J EXP ZOOL, V292, P618, DOI 10.1002/jez.10081; Kuballa AV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-147; Kuballa AV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-575; LACHAISE F, 1993, J CRUSTACEAN BIOL, V13, P198, DOI 10.2307/1548970; Lee KJ, 1998, BIOCHEM BIOPH RES CO, V249, P624, DOI 10.1006/bbrc.1998.9215; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Leslie T, 2014, G3 GENS GENOMICS GEN, V4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Li SH, 2014, DEV COMP IMMUNOL, V46, P349, DOI 10.1016/j.dci.2014.05.013; Li ZX, 2013, J WORLD AQUACULT SOC, V44, P826, DOI 10.1111/jwas.12083; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Liao IC, 2011, INVAD NAT SPRING SER, V6, P489, DOI 10.1007/978-94-007-0591-3_17; Liu CH, 2004, FISH SHELLFISH IMMUN, V16, P151, DOI 10.1016/S1050-4648(03)00058-5; Liu N, 2015, DEV COMP IMMUNOL, V49, P313, DOI 10.1016/j.dci.2014.11.021; Liu Y, 2013, FISH SHELLFISH IMMUN, V34, P463, DOI 10.1016/j.fsi.2012.11.050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margam VM, 2006, J INSECT PHYSIOL, V52, P558, DOI 10.1016/j.jinsphys.2006.02.003; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Soares MPM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-576; Mohd-Shamsudin MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060839; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhlia-Almazan A, 2003, DIGESTION PHYSL PROT, P77; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Nakatsuji T, 2000, ZOOL SCI, V17, P1129, DOI 10.2108/zsj.17.1129; NAYA Y, 1989, P NATL ACAD SCI USA, V86, P6826, DOI 10.1073/pnas.86.17.6826; Naylor E, 1957, BIOL CRUSTACEA; Ohira T, 1997, ZOOL SCI, V14, P785, DOI 10.2108/zsj.14.785; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Pamuru RR, 2012, GEN COMP ENDOCR, V178, P227, DOI 10.1016/j.ygcen.2012.05.007; Powell D, 2015, MAR GENOM, V22, P71, DOI 10.1016/j.margen.2015.04.006; Priya TAJ, 2010, COMP BIOCHEM PHYS B, V156, P149, DOI 10.1016/j.cbpb.2010.02.004; Priya TAJ, 2009, COMP BIOCHEM PHYS B, V153, P121, DOI 10.1016/j.cbpb.2009.02.009; Qian ZY, 2014, COMP BIOCHEM PHYS A, V172, P10, DOI 10.1016/j.cbpa.2014.02.011; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Reynolds SE, 1996, ADV INSECT PHYSIOL, V26, P157, DOI 10.1016/S0065-2806(08)60031-4; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sangsuriya P, 2014, FISH SHELLFISH IMMUN, V37, P46, DOI 10.1016/j.fsi.2014.01.007; Santos CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00298; Sathapondecha P, 2014, COMP BIOCHEM PHYS A, V175, P124, DOI 10.1016/j.cbpa.2014.06.001; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Seear PJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-582; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Shen WY, 2015, GENES GENOM, V37, P441, DOI 10.1007/s13258-015-0273-6; Skinner DM, 1985, MOLTING REGENERATION, P43; Uddowla MH, 2013, ANIM CELLS SYST, V17, P203, DOI 10.1080/19768354.2013.799100; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2003, J GENET GENOMICS, V30; Wang Z, 2001, OCEANOLOGIA LIMNOLOG, V33, P432; Wang Z, 2001, J FISHERIES CHINA, V26, P487; Wei JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106201; Wu WJ, 2008, EXP PARASITOL, V119, P313, DOI 10.1016/j.exppara.2008.03.001; Yang WJ, 1996, PEPTIDES, V17, P197, DOI 10.1016/0196-9781(95)02122-1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Zhang Peidong, 2006, Yingyong Shengtai Xuebao, V17, P340; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhang YJ, 2014, G3-GENES GENOM GENET, V4, P851, DOI 10.1534/g3.113.009779	93	56	61	7	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144350	10.1371/journal.pone.0144350	http://dx.doi.org/10.1371/journal.pone.0144350			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650402	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300044
J	Sereni, L; Einum, S				Sereni, Laura; Einum, Sigurd			No Evidence for Activity Adjustment in Response to Increased Density in Daphnia magna	PLOS ONE			English	Article							SWIMMING BEHAVIOR; DEPENDENT DISPERSAL; METABOLIC-RATES; FOOD; GROWTH; HERITABILITY; COMPETITION; LARVAE; SPEED; PREY	Increased population density may lead to a decrease in energy available for growth and reproduction via effects on the activity level of individuals. Whilst this may be of particular importance for organisms that compete for defendable resources and/or have a high frequency of social interactions, it is less obvious how individual activity should covary with population density when food resources are not defendable or direct interactions among individuals are negligible. Based on observations that there is a general negative relationship between population density and metabolism it has been suggested that organisms actively reduce activity under increased density to accommodate an expected decrease in food availability. However, in the absence of direct activity measurements the validity of this hypothesis is unclear. Here we test for such anticipatory adjustments of activity levels in the planktonic cladoceran Daphnia magna Straus, a filter feeder whose food resources are not defendable, meaning that density responses can be evaluated in the absence of direct interactions. We tested for changes in activity in response to two separate density cues, one being the direct physical and visual stimuli resulting from being in the vicinity of conspecifics ('direct density experiment'), and the other being the detection of olfactory cues in their environment ('olfactory cue experiment'). Ten genetically distinct clones were used to evaluate the potential for genetic variation in these responses. Our measures of activity were highly repeatable, and there was significant variation in activity among clones. Furthermore, this clonal variation was consistent in the 'direct density' and 'olfactory cue' experiments. The estimated evolvability of the trait (1.3-3.2%) was within the range typically observed in behavioural traits. However, there was no indication that the activity level of individuals respond to population density, either directly to actual density or to olfactory cues representing high density. In this case, the energetic influence of density on population dynamics is sufficiently described by effects on per capita resource availability.	[Sereni, Laura; Einum, Sigurd] Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, NTNU, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Einum, S (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, NTNU, NO-7491 Trondheim, Norway.	sigurd.einum@ntnu.no		Einum, Sigurd/0000-0002-3788-7800	Research Council of Norway [230482, SFF-III 223257/F50]; Norwegian University of Science and Technology (NTNU)	Research Council of Norway(Research Council of Norway); Norwegian University of Science and Technology (NTNU)	The study received funding from The Research Council of Norway (http://www.forskningsradet.no/), projects 230482 and SFF-III 223257/F50, and Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer SK, 2015, J ANIM ECOL, V84, P1405, DOI 10.1111/1365-2656.12384; Bates D., 2015, LME4 LINEAR MIXED EF; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; DeLong JP, 2014, J ANIM ECOL, V83, P51, DOI 10.1111/1365-2656.12065; DeLong JP, 2009, ISME J, V3, P1396, DOI 10.1038/ismej.2009.81; DINI ML, 1992, J PLANKTON RES, V14, P359, DOI 10.1093/plankt/14.3.359; Dodson SI, 1997, J PLANKTON RES, V19, P1537, DOI 10.1093/plankt/19.10.1537; Edelsparre AH, 2014, ECOL LETT, V17, P333, DOI 10.1111/ele.12234; Einum S, 2006, OIKOS, V113, P489, DOI 10.1111/j.2006.0030-1299.14806.x; Einum S, 2014, AM NAT, V183, P410, DOI 10.1086/674951; Fiksen O, 2011, MAR ECOL PROG SER, V432, P207, DOI 10.3354/meps09148; FORMANOWICZ DR, 1982, J ANIM ECOL, V51, P757, DOI 10.2307/4003; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gandon Sylvain, 2001, P155; GARLAND T, 1988, EVOLUTION, V42, P335, DOI 10.1111/j.1558-5646.1988.tb04137.x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Higginson AD, 2012, AM NAT, V180, P589, DOI 10.1086/667885; JOHANSSON F, 1991, HYDROBIOLOGIA, V209, P79, DOI 10.1007/BF00006721; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kuefler D, 2013, FUNCT ECOL, V27, P323, DOI 10.1111/1365-2435.12065; LAMPERT W, 1986, OECOLOGIA, V70, P495, DOI 10.1007/BF00379894; Lena JP, 1998, BEHAV ECOL, V9, P500, DOI 10.1093/beheco/9.5.500; Leonardsson K, 1997, J EVOLUTION BIOL, V10, P703; LI HW, 1977, J FISH BIOL, V11, P329, DOI 10.1111/j.1095-8649.1977.tb04126.x; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Mattila ALK, 2014, J EVOLUTION BIOL, V27, P1733, DOI 10.1111/jeb.12426; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; Nishikawa Jun, 1998, Plankton Biology and Ecology, V45, P55; O'Keefe TC, 1998, J PLANKTON RES, V20, P973; PORTER KG, 1982, LIMNOL OCEANOGR, V27, P935, DOI 10.4319/lo.1982.27.5.0935; R Development Core Team, 2014, R LANG ENV STAT COMP; Roozen F, 2001, J PLANKTON RES, V23, P797, DOI 10.1093/plankt/23.8.797; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; WALDE SJ, 1984, CAN J ZOOL, V62, P2221, DOI 10.1139/z84-323; Weber A, 2002, J PLANKTON RES, V24, P1335, DOI 10.1093/plankt/24.12.1335; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Zuur Alain F., 2009, P1	39	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144759	10.1371/journal.pone.0144759	http://dx.doi.org/10.1371/journal.pone.0144759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649427	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300074
J	Cohen, S; Benjamini, Y; Golani, I				Cohen, Shay; Benjamini, Yoav; Golani, Ilan			Coping with Space Neophobia in Drosophila melanogaster: The Asymmetric Dynamics of Crossing a Doorway to the Untrodden	PLOS ONE			English	Article							FREE EXPLORATION; CENTRAL COMPLEX; LOW RESPONDERS; MOVEMENT; BEHAVIOR; MEMORY; FLIGHT; DISCRIMINATION; RESPONSES; STRAIGHT	We discover and examine within a wide phylogenetic perspective spatial neophobia, avoidance of untrodden terrain, in fruit flies, in an experimental setup that reduces the gap between the field and the laboratory. In our setup, fruit flies use a natal fruit as their origin, freely exploring for days their surroundings, which consists of a mixture of trodden and untrodden terrain. The interface between trodden and untrodden is, however, reduced in our setup to a wide doorway, opened within a surrounding wall. Crossing this doorway, characterized by a sharp contrast interface between trodden and untrodden, generates a behavior whose dynamics betrays the flies' space neophobia. The moment-by-moment dynamics of crossing is remarkably similar to that reported in mouse models of anxiety. This means that neophobic behavior is either homologous across arthropods and vertebrates or, not less interesting, convergent, whereby the same behavior is mediated in the two phyla by two completely different schemata.	[Cohen, Shay; Golani, Ilan] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Benjamini, Yoav] Tel Aviv Univ, Dept Stat & OR, IL-69978 Tel Aviv, Israel; [Cohen, Shay; Benjamini, Yoav; Golani, Ilan] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Golani, I (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	ilan99@tau.ac.il			Israel Science Foundation (ISF) [1351]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by a grant from the Israel Science Foundation (ISF 1351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Israel Science Foundation (ISF 1351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Prof. Daniel Segal of the department of Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel, for supplying the experimental animals, and Prof. Segal and Prof. John Ringo of the University of Maine, Orono, ME USA for their advice along the way. Dr. Alex Gomez Marin of Champalimaud Neuroscience Lisbon and Dr. Eyal Gruntman of Janelia Farm HHMI provided useful comments on the manuscript. Ms Naomi Paz edited and proofread the manuscript. We thank Yair Wexler of Tel Aviv University for his help with the Figs.	Baerends GP, 1941, FORTPFLANZUNGSVERHAL; Barrows WM, 1907, J EXP ZOOL, V4, P513; Benjamini Y, 2011, P NATL ACAD SCI USA, V108, P15580, DOI 10.1073/pnas.1014837108; Brembs B, 2006, LEARN MEMORY, V13, P629, DOI 10.1101/lm.319406; Cartwright B, 1982, NATURE; CONNOLLY K, 1967, ANIM BEHAV, V15, P149, DOI 10.1016/S0003-3472(67)80026-5; COOLS AR, 1993, CAN J PHYSIOL PHARM, V71, P335, DOI 10.1139/y93-052; Cools AR, 1998, PHARMACOL BIOCHEM BE, V60, P151, DOI 10.1016/S0091-3057(97)00586-8; DACUNHA AB, 1951, EVOLUTION, V5, P97, DOI 10.1111/j.1558-5646.1951.tb02766.x; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Fonio E, 2009, P NATL ACAD SCI USA, V106, P21335, DOI 10.1073/pnas.0812513106; Forrest J, 2009, P ROY SOC B-BIOL SCI, V276, P935, DOI 10.1098/rspb.2008.1434; GOLANI I, 1992, BEHAV BRAIN SCI, V15, P249, DOI 10.1017/S0140525X00068539; Golani I, 2012, BEHAV BRAIN RES, V231, P309, DOI 10.1016/j.bbr.2012.01.039; Gordon G, 2014, J COMPUTATIONAL NEUR, P1; Hager T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00314; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; HOFFMANN AA, 1989, ANIM BEHAV, V38, P23, DOI 10.1016/S0003-3472(89)80062-4; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Markow TA, 2015, ELIFE, V4, DOI 10.7554/eLife.06793; Mittelstaedt H., 1957, P51; Mizunami M, 1998, J COMP NEUROL, V402, P520; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Olberg RM, 2012, CURR OPIN NEUROBIOL, V22, P267, DOI 10.1016/j.conb.2011.11.015; Pfeiffer K, 2007, CURR BIOL, V17, P960, DOI 10.1016/j.cub.2007.04.059; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Ritzmann RE, 2007, COLD SPRING HARB MON, V49, P229; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stamps J, 2005, ANIM BEHAV, V70, P609, DOI 10.1016/j.anbehav.2004.11.018; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; TINBERGEN N., 1948, LEVENDE NATUUR, V51, P65; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647	41	3	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0140207	10.1371/journal.pone.0140207	http://dx.doi.org/10.1371/journal.pone.0140207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646394	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903100001
J	Denisov, S; Bazykin, G; Favorov, A; Mironov, A; Gelfand, M				Denisov, Stepan; Bazykin, Georgii; Favorov, Alexander; Mironov, Andrey; Gelfand, Mikhail			Correlated Evolution of Nucleotide Positions within Splice Sites in Mammals	PLOS ONE			English	Article							PRE-MESSENGER-RNA; COMPENSATORY BASE CHANGE; U1 SNRNA; STATISTICAL-ANALYSIS; IN-VIVO; POLYPYRIMIDINE TRACT; U2 SNRNA; INTRON; EXONS; PROTEINS	Splice sites (SSs)-short nucleotide sequences flanking introns-are under selection for spliceosome binding, and adhere to consensus sequences. However, non-consensus nucleotides, many of which probably reduce SS performance, are frequent. Little is known about the mechanisms maintaining such apparently suboptimal SSs. Here, we study the correlations between strengths of nucleotides occupying different positions of the same SS. Such correlations may arise due to epistatic interactions between positions (i.e., a situation when the fitness effect of a nucleotide in one position depends on the nucleotide in another position), their evolutionary history, or to other reasons. Within both the intronic and the exonic parts of donor SSs, nucleotides that increase (decrease) SS strength tend to co-occur with other nucleotides increasing (respectively, decreasing) it, consistent with positive epistasis. Between the intronic and exonic parts of donor SSs, the correlations of nucleotide strengths tend to be negative, consistent with negative epistasis. In the course of evolution, substitutions at a donor SS tend to decrease the strength of its exonic part, and either increase or do not change the strength of its intronic part. In acceptor SSs, the situation is more complicated; the correlations between adjacent positions appear to be driven mainly by avoidance of the AG dinucleotide which may cause aberrant splicing. In summary, both the content and the evolution of SSs is shaped by a complex network of interdependences between adjacent nucleotides that respond to a range of sometimes conflicting selective constraints.	[Denisov, Stepan; Bazykin, Georgii; Mironov, Andrey; Gelfand, Mikhail] RAS, AA Kharkevich Inst Informat Transmiss Problems, Moscow 117901, Russia; [Bazykin, Georgii; Mironov, Andrey; Gelfand, Mikhail] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Favorov, Alexander] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Oncol Biostat, Baltimore, MD USA; [Favorov, Alexander] NI Vavilov Gen Genet Res Inst, Dept Computat Syst Biol, Lab Syst Biol & Computat Genet, Moscow 117809, Russia; [Favorov, Alexander] State Res Inst Genet & Select Ind Microorganism G, Lab Bioinformat, Moscow, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Johns Hopkins University; Johns Hopkins Medicine; Russian Academy of Sciences; Vavilov Institute of General Genetics; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms	Denisov, S (corresponding author), RAS, AA Kharkevich Inst Informat Transmiss Problems, Moscow 117901, Russia.	stepan@bioinf.fbb.msu.ru	Denisov, Stepan/AAX-4554-2021; Bazykin, Georgii/E-4601-2012; Favorov, Alexander V/K-2699-2018; Gelfand, Mikhail S/F-3425-2012	Denisov, Stepan/0000-0001-6465-3818; Bazykin, Georgii/0000-0003-2334-2751; Favorov, Alexander V/0000-0003-2595-1091; Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-50-00150, 16-24-00155]; National Institutes of Health [P30 CA006973]; Russian Foundation for Basic Research [14-04-01872 A, 14-04-00576 A]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Russian Science Foundation(Russian Science Foundation (RSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been performed in IITP RAS and supported by the Russian Science Foundation (grant 14-50-00150) http://rscf.ru/en/. The work was partially supported by Russian Science Foundation (grant 16-24-00155 to MG, SD) http://rscf.ru/en/; by National Institutes of Health (grant P30 CA006973 to AF) http://www.nih.gov/; Russian Foundation for Basic Research (14-04-01872 A to AF, 14-04-00576 A to AM, AF) http://www.rfbr.ru/rffi/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0141-5; Artamonova II, 2004, J MOL EVOL, V59, P620, DOI 10.1007/s00239-004-2654-3; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Barry D., 1987, STAT SCI, V2, P191, DOI DOI 10.1214/SS/1177013353; Bouck J, 1998, NUCLEIC ACIDS RES, V26, P4516, DOI 10.1093/nar/26.19.4516; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Denisov SV, 2014, GENOME BIOL EVOL, V6, P1437, DOI 10.1093/gbe/evu100; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; GELFAND MS, 1989, NUCLEIC ACIDS RES, V17, P6369, DOI 10.1093/nar/17.15.6369; GELFAND MS, 1992, J MOL EVOL, V35, P239; Gonzalez I, 2015, NAT STRUCT MOL BIOL, V22, P370, DOI 10.1038/nsmb.3005; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; Jenkins JL, 2013, NUCLEIC ACIDS RES, V41, P3859, DOI 10.1093/nar/gkt046; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kralovicova J, 2015, NUCLEIC ACIDS RES, V43, P3747, DOI 10.1093/nar/gkv194; KRETZNER L, 1987, CELL, V50, P593, DOI 10.1016/0092-8674(87)90032-8; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Mercer TR, 2015, GENOME RES, V25, P290, DOI 10.1101/gr.182899.114; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; NELSON KK, 1990, P NATL ACAD SCI USA, V87, P6253, DOI 10.1073/pnas.87.16.6253; Nurtdinov RN, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-249; Nurtdinov RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-142; Nurtdinov RN, 2006, BIOPHYSICS-USSR, V51, P523, DOI [10.1134/S0006350906040026, DOI 10.1134/S0006350906040026]; Ohno K, 1999, AM J HUM GENET, V65, P635, DOI 10.1086/302551; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Ram O, 2007, TRENDS GENET, V23, P5, DOI 10.1016/j.tig.2006.10.002; Roca X, 2005, RNA, V11, P683, DOI 10.1261/rna.2040605; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; SCARANO E, 1967, P NATL ACAD SCI USA, V57, P1394, DOI 10.1073/pnas.57.5.1394; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Segault V, 1999, MOL CELL BIOL, V19, P2782; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Shcherbakova I, 2013, CELL REP, V5, P151, DOI 10.1016/j.celrep.2013.08.026; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; Sverdlov AV, 2004, CURR BIOL, V14, P1505, DOI 10.1016/j.cub.2004.08.027; Sverdlov AV, 2003, CURR BIOL, V13, P2170, DOI 10.1016/j.cub.2003.12.003; Taggart AJ, 2012, NAT STRUCT MOL BIOL, V19, P719, DOI 10.1038/nsmb.2327; Thanaraj T A, 2000, Brief Bioinform, V1, P343, DOI 10.1093/bib/1.4.343; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Zheng CL, 2005, RNA, V11, P1777, DOI 10.1261/rna.2660805; Zheng ZM, 2000, J VIROL, V74, P5902, DOI 10.1128/JVI.74.13.5902-5910.2000; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	63	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144388	10.1371/journal.pone.0144388	http://dx.doi.org/10.1371/journal.pone.0144388			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642327	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700109
J	Eyring, KR; Pedersen, BS; Yang, IV; Schwartz, DA				Eyring, Kenneth R.; Pedersen, Brent S.; Yang, Ivana V.; Schwartz, David A.			In Utero Cigarette Smoke Affects Allergic Airway Disease But Does Not Alter the Lung Methylome	PLOS ONE			English	Article							MATERNAL SMOKING; IMMUNE-RESPONSES; TOBACCO-SMOKE; PREGNANCY; ASTHMA; METHYLATION; EXPOSURE; MICE; INFLAMMATION; EXPRESSION	Prenatal and postnatal cigarette smoke exposure enhances the risk of developing asthma. Despite this as well as other smoking related risks, 11% of women still smoke during pregnancy. We hypothesized that cigarette smoke exposure during prenatal development generates long lasting differential methylation altering transcriptional activity that correlates with disease. In a house dust mite (HDM) model of allergic airway disease, we measured airway hyperresponsiveness (AHR) and airway inflammation between mice exposed prenatally to cigarette smoke (CS) or filtered air (FA). DNA methylation and gene expression were then measured in lung tissue. We demonstrate that HDM-treated CS mice develop a more severe allergic airway disease compared to HDM-treated FA mice including increased AHR and airway inflammation. While DNA methylation changes between the two HDM-treated groups failed to reach genome-wide significance, 99 DMRs had an uncorrected p-value < 0.001. 6 of these 99 DMRs were selected for validation, based on the immune function of adjacent genes, and only 2 of the 6 DMRs confirmed the bisulfite sequencing data. Additionally, genes near these 6 DMRs (Lif, Il27ra, Tle4, Ptk7, Nfatc2, and Runx3) are differentially expressed between HDM-treated CS mice and HDM-treated FA mice. Our findings confirm that prenatal exposure to cigarette smoke is sufficient to modify allergic airway disease; however, it is unlikely that specific methylation changes account for the exposure-response relationship. These findings highlight the important role in utero cigarette smoke exposure plays in the development of allergic airway disease.	[Eyring, Kenneth R.; Pedersen, Brent S.; Yang, Ivana V.; Schwartz, David A.] Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA; [Schwartz, David A.] Univ Colorado, Dept Immunol, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Schwartz, DA (corresponding author), Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA.	david.schwartz@ucdenver.edu	Yang, Ivana V/P-3059-2018	Yang, Ivana V/0000-0002-1018-489X; Eyring, Kenneth/0000-0003-4163-5435	National Institute of Health, National Institute of Environmental Health Sciences [PO1-ES18181]; National Institute of Health, National Heart, Lung, and Blood Institute [RO1-HL101251]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants PO1-ES18181 (National Institute of Health, National Institute of Environmental Health Sciences, http://www.niehs.nih.gov/, to DA); and RO1-HL101251 (National Institute of Health, National Heart, Lung, and Blood Institute, http://www.nhlbi.nih.gov/, to DA and IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2002, J NEUROSCI, V22, P4153, DOI 10.1523/JNEUROSCI.22-10-04153.2002; Akinbami LJ, 2005, NATL HLTH STAT REP, V2011, P1; Blacquiere MJ, 2009, EUR RESPIR J, V33, P1133, DOI 10.1183/09031936.00129608; Bousquet J, 2004, ALLERGY, V59, P138, DOI 10.1046/j.1398-9995.2003.00359.x; Devereux G, 2002, CLIN EXP ALLERGY, V32, P43, DOI 10.1046/j.0022-0477.2001.01267.x; DeWan AT, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-95; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Hu FB, 1997, ANN ALLERG ASTHMA IM, V79, P80, DOI 10.1016/S1081-1206(10)63090-6; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P136, DOI 10.2105/AJPH.94.1.136; Kelada SNP, 2014, AM J RESP CELL MOL, V51, P436, DOI 10.1165/rcmb.2013-0501OC; Kim DH, 2001, CANCER RES, V61, P3419; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Launay JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007959; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Murin S, 2011, CLIN CHEST MED, V32, P75, DOI 10.1016/j.ccm.2010.11.004; Noakes PS, 2006, EUR RESPIR J, V28, P721, DOI 10.1183/09031936.06.00050206; Noakes PS, 2003, ALLERGY, V58, P1053, DOI 10.1034/j.1398-9995.2003.00290.x; Pedersen BS, 2014, ARXIV E PRINTS, P1401; Phillips JM, 2009, TOXICOLOGY, V260, P7, DOI 10.1016/j.tox.2009.03.001; Rosas SLB, 2001, CANCER RES, V61, P939; Rouse RL, 2007, ENVIRON HEALTH PERSP, V115, P1757, DOI 10.1289/ehp.10358; Singh SP, 2009, J IMMUNOL, V183, P2115, DOI 10.4049/jimmunol.0900826; Singh SP, 2003, AM J RESP CRIT CARE, V168, P342, DOI 10.1164/rccm.200211-1262OC; Sofer T, 2013, BIOINFORMATICS, V29, P2884, DOI 10.1093/bioinformatics/btt498; Tebow G, 2008, PEDIATRICS, V121, pE1563, DOI 10.1542/peds.2007-2795; Tong V. T., 2013, MMWR-MORBID MORTAL W, V62, P1; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wolff EM, 2008, CANCER RES, V68, P6208, DOI 10.1158/0008-5472.CAN-07-6616; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002	32	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144087	10.1371/journal.pone.0144087	http://dx.doi.org/10.1371/journal.pone.0144087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642056	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700053
J	Jin, Y; Liu, YL; Zhang, J; Huang, W; Jiang, HN; Hou, YY; Xu, C; Zhai, CW; Gao, X; Wang, SY; Wu, Y; Zhu, HG; Lu, SH				Jin, Yi; Liu, Yalan; Zhang, Jin; Huang, Wei; Jiang, Hongni; Hou, Yingyong; Xu, Chen; Zhai, Changwen; Gao, Xue; Wang, Shuyang; Wu, Ying; Zhu, Hongguang; Lu, Shaohua			The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; MICRORNA-375; ACTIVATION; TUMOR; HEAD; NECK; METASTASIS; PROFILES; MARKERS	Many studies demonstrated unique microRNA profiles in lung cancer. Nonetheless, the role and related signal pathways of miR-375 in lung cancer are largely unknown. Our study investigated relationships between carcinogenesis and miR-375 in adenocarcinoma, squamous cell carcinoma and small cell lung carcinoma to identify new molecular targets for treatment. We evaluated 723 microRNAs in microdissected cancerous cells and adjacent normal cells from 126 snap-frozen lung specimens using microarrays. We validated the expression profiles of miR-375 and its 22 putative target mRNAs in an independent cohort of 78 snap-frozen lung cancer tissues using quantitative reverse-transcriptase PCR. Moreover, we performed dual luciferase reporter assay and Western blot on 6 targeted genes (FZD8, ITGA10, ITPKB, LRP5, PIAS1 andRUNX1) in small cell lung carcinoma cell line NCI-H82. We also detected the effect of miR-375 on cell proliferation in NCI-H82. We found that miR-375 expression was significantly up-regulated in adenocarcinoma and small cell lung carcinoma but down-regulated in squamous cell carcinoma. Among the 22 putative target genes, 11 showed significantly different expression levels in at least 2 of 3 pair-wise comparisons (adenocarcinoma vs. normal, squamous cell carcinoma vs. normal or small cell lung carcinoma vs. normal). Six targeted genes had strong negative correlation with the expression level of miR-375 in small cell lung carcinoma. Further investigation revealed that miR-375 directly targeted the 3'UTR of ITPKB mRNA and over-expression of miR-375 led to significantly decreased ITPKB protein level and promoted cell growth. Thus, our study demonstrates the differential expression profiles of miR-375 in 3 subtypes of lung carcinomas and finds thatmiR-375 directly targets ITPKB and promoted cell growth in SCLC cell line.	[Jin, Yi; Wang, Shuyang; Wu, Ying; Zhu, Hongguang] Fudan Univ, Sch Basic Med Sci, Dept Pathol, Shanghai 200433, Peoples R China; [Jin, Yi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China; [Liu, Yalan; Hou, Yingyong; Xu, Chen; Zhai, Changwen; Lu, Shaohua] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Zhang, Jin] Fudan Univ, Shanghai Med Coll, Inst Med Sci,Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200433, Peoples R China; [Huang, Wei] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai 200092, Peoples R China; [Jiang, Hongni] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Gao, Xue; Zhu, Hongguang] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Wenzhou Medical University; Fudan University; Fudan University; Tongji University; Fudan University; Fudan University	Lu, SH (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China.	lushaohua2010@126.com			National Natural Science Foundation of China [81472174, 81401879]; Science and Technology Commission of Shanghai Municipality [14411965900, 14ZR1406100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China (No. 81472174 and 81401879), Science and Technology Commission of Shanghai Municipality (No. 14411965900 and 14ZR1406100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Chang CW, 2012, NEUROSCI LETT, V531, P204, DOI 10.1016/j.neulet.2012.10.021; Dai XN, 2012, MOL MED REP, V5, P1299, DOI 10.3892/mmr.2012.815; Feng QH, 2008, CANCER EPIDEM BIOMAR, V17, P645, DOI 10.1158/1055-9965.EPI-07-2518; Harris T, 2012, AM J PATHOL, V180, P917, DOI 10.1016/j.ajpath.2011.12.004; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Huang W, 2012, AM J RESP CRIT CARE, V186, P1160, DOI 10.1164/rccm.201203-0534OC; Hui ABY, 2011, CLIN CANCER RES, V17, P7539, DOI 10.1158/1078-0432.CCR-11-2102; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim S, 2009, COMPUT BIOL CHEM, V33, P94, DOI 10.1016/j.compbiolchem.2008.07.016; Kimura S, 2010, ONCOL REP, V23, P1625, DOI 10.3892/or_00000804; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Lee EHL, 2008, CLIN MED INSIGHTS-ON, V2, P169; Leidner RS, 2012, GENE CHROMOSOME CANC, V51, P473, DOI 10.1002/gcc.21934; Li JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053582; Li Y, 2012, J INT MED RES, V40, P1662, DOI 10.1177/030006051204000505; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Miller YE, 2005, AM J RESP CELL MOL, V33, P216, DOI 10.1165/rcmb.2005-0158OE; Nalaskowski MM, 2011, J BIOL CHEM, V286, P4500, DOI 10.1074/jbc.M110.173062; Nishikawa E, 2011, CANCER RES, V71, P6165, DOI 10.1158/0008-5472.CAN-11-1020; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Saitoh T, 2001, INT J ONCOL, V18, P991; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Tajouri L, 2005, BRAIN RES PROTOC, V15, P79, DOI 10.1016/j.brainresprot.2005.04.003; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang SY, 2013, GUT, V62, P280, DOI 10.1136/gutjnl-2011-301554; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Zhao HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P177, DOI 10.1093/abbs/gmr110	39	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144187	10.1371/journal.pone.0144187	http://dx.doi.org/10.1371/journal.pone.0144187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642205	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700072
J	Khorramian, K; Maleki, S; Shariati, M; Sulong, NHR				Khorramian, Koosha; Maleki, Shervin; Shariati, Mahdi; Sulong, N. H. Ramli			Behavior of Tilted Angle Shear Connectors	PLOS ONE			English	Article							CHANNEL; CONCRETE; STRENGTH	According to recent researches, angle shear connectors are appropriate to transfer longitudinal shear forces across the steel-concrete interface. Angle steel profile has been used in different positions as L-shaped or C-shaped shear connectors. The application of angle shear connectors in tilted positions is of interest in this study. This study investigates the behaviour of tilted-shaped angle shear connectors under monotonic loading using experimental push out tests. Eight push-out specimens are tested to investigate the effects of different angle parameters on the ultimate load capacity of connectors. Two different tilted angles of 112.5 and 135 degrees between the angle leg and steel beam are considered. In addition, angle sizes and lengths are varied. Two different failure modes were observed consisting of concrete crushing-splitting and connector fracture. By increasing the size of connector, the maximum load increased for most cases. In general, the 135 degrees tilted angle shear connectors have a higher strength and stiffness than the 112.5 degrees type.	[Khorramian, Koosha; Maleki, Shervin] Sharif Univ Technol, Dept Civil Engn, Tehran, Iran; [Shariati, Mahdi; Sulong, N. H. Ramli] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia	Sharif University of Technology; Universiti Malaya	Shariati, M (corresponding author), Sharif Univ Technol, Dept Civil Engn, Tehran, Iran.	shariati@um.edu.my	Shariati, Mahdi/C-9626-2019; SULONG, NOR HAFIZAH RAMLI/B-9311-2010	Shariati, Mahdi/0000-0002-0440-7612; SULONG, NOR HAFIZAH RAMLI/0000-0001-8209-313X; maleki, shervin/0000-0002-3574-2106	UM High Impact Research Grant from the Ministry of Higher Education Malaysia [UM.C/625/1/HIR/MOHE/ENG/57]	UM High Impact Research Grant from the Ministry of Higher Education Malaysia	This research was supported by the UM High Impact Research Grant UM.C/625/1/HIR/MOHE/ENG/57 from the Ministry of Higher Education Malaysia.	[Anonymous], 2004, C11 EN EUR COMM STAN; [Anonymous], 2010, MAN ABAQUS VERS 6 10; [Anonymous], 0595 STRUCT DIV SUB; Choi S M, 2011, THESIS; Choi SM, 2008, INT J STEEL STRUCT, V8, P199; Ciutina A L, CYCLIC PERFORMANCES; Fukazawa K., 2002, MITSUI ZOSEN TECHNIC, VI-456, P8; Khalilian M, 2013, THESIS; Maleki S, 2008, J CONSTR STEEL RES, V64, P1333, DOI 10.1016/j.jcsr.2008.01.010; Maleki S, 2008, J CONSTR STEEL RES, V64, P1341, DOI 10.1016/j.jcsr.2008.01.006; Maleki S, 2009, J CONSTR STEEL RES, V65, P1787, DOI 10.1016/j.jcsr.2009.04.008; Osamu K, 1986, STRENGTH PROPERTIES; Rao S N, 1970, J I ENG; Ros S., 2009, 8 S RES APPL HYBR CO, P1; Saidi T., 2008, J MAT CONCR STRUCT P, V64, P122; Shariati A, 2012, MATER DESIGN, V33, P325; Shariati M, 2014, ENG FAIL ANAL, V41, P124, DOI 10.1016/j.engfailanal.2014.02.017; Shariati M, 2013, CONSTR BUILD MATER, V38, P582, DOI 10.1016/j.conbuildmat.2012.07.050; Shariati M, 2012, MATER DESIGN, V41, P67, DOI 10.1016/j.matdes.2012.04.039	19	88	88	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144288	10.1371/journal.pone.0144288	http://dx.doi.org/10.1371/journal.pone.0144288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642193	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700090
J	Baeta, M; Nunez, C; Cardoso, S; Palencia-Madrid, L; Pineiro-Hermida, S; Arriba-Barredo, M; Villanueva-Millan, MJ; de Pancorbo, MM				Baeta, Miriam; Nunez, Carolina; Cardoso, Sergio; Palencia-Madrid, Leire; Pineiro-Hermida, Sergio; Arriba-Barredo, Miren; Jesus Villanueva-Millan, Maria; de Pancorbo, Marian M.			Different Evolutionary History for Basque Diaspora Populations in USA and Argentina Unveiled by Mitochondrial DNA Analysis	PLOS ONE			English	Article							CONTROL REGION; MTDNA; DIVERSITY; ADMIXTURE	The Basque Diaspora in Western USA and Argentina represents two populations which have maintained strong Basque cultural and social roots in a completely different geographic context. Hence, they provide an exceptional opportunity to study the maternal genetic legacy from the ancestral Basque population and assess the degree of genetic introgression from the host populations in two of the largest Basque communities outside the Basque Country. For this purpose, we analyzed the complete mitochondrial DNA control region of Basque descendants living in Western USA (n = 175) and in Argentina (n = 194). The Diaspora populations studied here displayed a genetic diversity in their European maternal input which was similar to that of the Basque source populations, indicating that not important founder effects would have occurred. Actually, the genetic legacy of the Basque population still prevailed in their present-day maternal pools, by means of a haplogroup distribution similar to the source population characterized by the presence of autochthonous Basque lineages, such as U5b1f1a and J1c5c1. However, introgression of non-Basque lineages, mostly Native American, has been observed in the Diaspora populations, particularly in Argentina, where the quick assimilation of the newcomers would have favored a wider admixture with host populations. In contrast, a longer isolation of the Diaspora groups in USA, because of language and cultural differences, would have limited the introgression of local lineages. This study reveals important differences in the maternal evolutionary histories of these Basque Diaspora populations, which have to be taken into consideration in forensic and medical genetic studies.	[Baeta, Miriam; Nunez, Carolina; Cardoso, Sergio; Palencia-Madrid, Leire; Pineiro-Hermida, Sergio; Arriba-Barredo, Miren; Jesus Villanueva-Millan, Maria; de Pancorbo, Marian M.] Univ Pais Vasco UPV EHU, BIOMICs Res Grp, Ctr Invest Lascaray Ikergunea, Vitoria, Spain	University of Basque Country	de Pancorbo, MM (corresponding author), Univ Pais Vasco UPV EHU, BIOMICs Res Grp, Ctr Invest Lascaray Ikergunea, Vitoria, Spain.	marian.mdepancorbo@ehu.es	Palencia-Madrid, Leire/AAW-8145-2020; Bafalluy, Miriam Baeta/L-6686-2014	Palencia-Madrid, Leire/0000-0002-4351-3450; Bafalluy, Miriam Baeta/0000-0002-6869-1413; Nunez, Carolina/0000-0001-5643-3970; Pineiro Hermida, Sergio/0000-0002-8915-5687; MARTINEZ DE PANCORBO, MARIA DE LOS ANGELES/0000-0002-7408-6068; M. de Pancorbo, Marian/0000-0002-8081-0702	Basque Government [IT833-13]; Basque Government (Dpto. de Educacion, Universidades e Investigacion)	Basque Government(Basque Government); Basque Government (Dpto. de Educacion, Universidades e Investigacion)(Basque Government)	Funds were provided by the Basque Government (Grupo Consolidado IT833-13). Leire Palencia-Madrid is a Ph.D. student granted by the Basque Government (Dpto. de Educacion, Universidades e Investigacion).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alfonso-Sanchez MA, 2008, AM J HUM BIOL, V20, P154, DOI 10.1002/ajhb.20706; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Cardoso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067835; Cardoso S, 2013, FORENSIC SCI INT-GEN, V7, pE52, DOI 10.1016/j.fsigen.2013.01.007; Cardoso S, 2012, FORENSIC SCI INT-GEN, V6, pE106, DOI 10.1016/j.fsigen.2011.12.007; Cardoso S, 2011, AM J PHYS ANTHROPOL, V145, P480, DOI 10.1002/ajpa.21532; Cardoso S, 2010, J FORENSIC SCI, V55, P1196, DOI 10.1111/j.1556-4029.2010.01440.x; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Chiang CWK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000866; Davis MC, 2011, AM J PHYS ANTHROPOL, V144, P516, DOI 10.1002/ajpa.21432; de Pancorbo MM, 2001, HUM GENET, V109, P224, DOI 10.1007/s004390100544; Diegoli TM, 2009, FORENSIC SCI INT-GEN, V4, pE45, DOI 10.1016/j.fsigen.2009.04.010; Douglass W., 2007, BASQUE CULTURE ANTHR; Douglass WA, 2013, BOGA BASQUE STUDIES, V1, DOI DOI 10.18122/B2D13T; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; Echeverria Jeromina, 1999, HOME AWAY HOME HIST; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gonzalez AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-124; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Illescas MJ, 2011, FORENS SCI INT-GEN S, V3, pE441, DOI 10.1016/j.fsigss.2011.09.082; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kaestle FA, 2006, AM CRIM LAW REV, V43, P53; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasagabaster D, 2008, J MULTILING MULTICUL, V29, P66, DOI 10.2167/jmmd567.0; Martinez-Cruz B, 2012, MOL BIOL EVOL, V29, P2211, DOI 10.1093/molbev/mss091; Nunez C, 2010, AM J PHYS ANTHROPOL, V143, P591, DOI 10.1002/ajpa.21355; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Perez-Miranda AM, 2005, J HUM GENET, V50, P403, DOI 10.1007/s10038-005-0268-2; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Rodas C, 2003, HUM BIOL, V75, P13, DOI 10.1353/hub.2003.0026; Sans M, 2011, HUM BIOL, V83, P55, DOI 10.3378/027.083.0104; Silva M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12526; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Totoricaguena G, 2005, BASQUE TEXTB SER, P1; Valverde L, 2012, INT J LEGAL MED, V126, P293, DOI 10.1007/s00414-011-0644-8; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yoldi P, 2011, EUSKARA, P24; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	44	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144919	10.1371/journal.pone.0144919	http://dx.doi.org/10.1371/journal.pone.0144919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659590	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900149
J	Curtis, LT; Wu, M; Lowengrub, J; Decuzzi, P; Frieboes, HB				Curtis, Louis T.; Wu, Min; Lowengrub, John; Decuzzi, Paolo; Frieboes, Hermann B.			Computational Modeling of Tumor Response to Drug Release from Vasculature-Bound Nanoparticles	PLOS ONE			English	Article							MACROMOLECULAR THERAPEUTICS; INTERSTITIAL PRESSURE; PLGA NANOPARTICLES; CANCER-THERAPY; SOLID TUMORS; DELIVERY; ADHESION; SYSTEMS; NANOMEDICINE; ANGIOGENESIS	Systemically injected nanoparticle (NPs) targeting tumor vasculature offer a venue for anti-angiogenic therapies as well as cancer detection and imaging. Clinical application has been limited, however, due to the challenge of elucidating the complex interplay of nanotechnology, drug, and tumor parameters. A critical factor representing the likelihood of endothelial adhesion is the NP vascular affinity, a function of vascular receptor expression and NP size and surface-bound ligand density. We propose a theoretical framework to simulate the tumor response to vasculature-bound drug-loaded NPs and examine the interplay between NP distribution and accumulation as a function of NP vascular affinity, size, and drug loading and release characteristics. The results show that uniform spatial distribution coupled with high vascular affinity is achievable for smaller NPs but not for larger sizes. Consequently, small (100 nm) NPs with high vascular affinity are predicted to be more effective than larger (1000 nm) NPs with similar affinity, even though small NPs have lower drug loading and local drug release compared to the larger NPs. Medium vascular affinity coupled with medium or larger sized NPs is also effective due to a more uniform distribution with higher drug loading and release. Low vascular affinity hampered treatment efficacy regardless of NP size, with larger NPs additionally impeded by heterogeneous distribution and drug release. The results further show that increased drug diffusivity mainly benefits heterogeneously distributed NPs, and would negatively affect efficacy otherwise due to increased wash-out. This model system enables evaluation of efficacy for vascular-targeted drug-loaded NPs as a function of critical NP, drug, and tumor parameters.	[Curtis, Louis T.; Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Wu, Min] Northwestern Univ, Dept Engn Sci & Appl Math, Chicago, IL 60611 USA; [Lowengrub, John] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Lowengrub, John] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Lowengrub, John] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA; [Decuzzi, Paolo] Houston Methodist Res Inst, Dept Translat Imaging, Houston, TX USA; [Decuzzi, Paolo] Houston Methodist Res Inst, Dept Nanomed, Houston, TX USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; Northwestern University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of Louisville	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.	hbfrie01@louisville.edu	Decuzzi, Paolo/F-1899-2016	Decuzzi, Paolo/0000-0001-6050-4188; Wu, Min/0000-0003-4728-6475	NIH/NCI [U54CA143907, U54CA143837]; NIH-ICBP [U54CA151668]; NIH [P50-GM76516, P30-CA062203]; National Science Foundation, Division of Mathematics; NATIONAL CANCER INSTITUTE [U54CA143837, P30CA062203, U54CA151668, U54CA143907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-ICBP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation, Division of Mathematics(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HF acknowledges funding by NIH/NCI U54CA143907. PD acknowledges funding by NIH/NCI U54CA143837 and NIH-ICBP U54CA151668. JL acknowledges NIH P50-GM76516 for a Center of Excellence in Systems Biology at the University of California, Irvine, and P30-CA062203 for the Chao Comprehensive Cancer Center at the University of California, Irvine. JL also acknowledges partial support from the National Science Foundation, Division of Mathematics.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; AUERBACH R, 1991, INT J RADIAT BIOL, V60, P1, DOI 10.1080/09553009114551401; Boso DP, 2011, INT J NANOMED, V6, P1517, DOI 10.2147/IJN.S20283; Caputo KE, 2005, BIOPHYS J, V89, P187, DOI 10.1529/biophysj.104.054171; Curtis LT, 2015, NANOMEDICINE UK IN P; Decuzzi P, 2006, BIOMATERIALS, V27, P5307, DOI 10.1016/j.biomaterials.2006.05.024; Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Drummond DC, 1999, PHARMACOL REV, V51, P691; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2006, BIOMEMS BIOMEDICAL N, P435, DOI DOI 10.1007/978-0-387-25842-3_15; Frieboes HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056876; Gao Y, 2013, AAPS J, V15, P816, DOI 10.1208/s12248-013-9478-2; Godin B, 2010, ADV GENET, V69, P31, DOI 10.1016/S0065-2660(10)69009-8; Haun JB, 2008, LANGMUIR, V24, P8821, DOI 10.1021/la8005844; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; JAIN RK, 1990, CANCER RES, V50, pS814; Kaddi CD, 2013, NANOMEDICINE-UK, V8, P1323, DOI [10.2217/NNM.13.117, 10.2217/nnm.13.117]; Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101; Li MG, 2013, DRUG DELIV TRANSL RE, V3, P551, DOI 10.1007/s13346-013-0162-y; Li MG, 2012, INT J NANOMED, V7, P1345, DOI 10.2147/IJN.S23758; Lu MG, 2010, ACS NANO, V4, P6303, DOI 10.1021/nn1018818; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Mingguang Li, 2011, International Journal of Nano and Biomaterials, V3, P222, DOI 10.1504/IJNBM.2011.042131; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Patil VRS, 2001, BIOPHYS J, V80, P1733, DOI 10.1016/S0006-3495(01)76144-9; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Tan JF, 2013, MICROFLUID NANOFLUID, V14, P77, DOI 10.1007/s10404-012-1024-5; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van de Ven AL, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/055004; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; Wu M, 2014, J THEOR BIOL, V355, P194, DOI 10.1016/j.jtbi.2014.04.012; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zern BJ, 2013, ACS NANO, V7, P2461, DOI 10.1021/nn305773f	40	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144888	10.1371/journal.pone.0144888	http://dx.doi.org/10.1371/journal.pone.0144888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660469	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900135
J	Kenmogne, LC; Ayan, D; Roy, J; Maltais, R; Poirier, D				Kenmogne, Lucie Carolle; Ayan, Diana; Roy, Jenny; Maltais, Rene; Poirier, Donald			The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers	PLOS ONE			English	Article							DRUG-DELIVERY; CHEMICAL-SYNTHESIS; GROWTH; CARBOPLATIN; PACLITAXEL; INHIBITOR; CELLS; DIHYDROARTEMISININ; APOPTOSIS; ANDROGEN	Ovarian and pancreatic cancers are two of the most aggressive and lethal cancers, whose management faces only limited therapeutic options. Typically, these tumors spread insidiously accompanied first with atypical symptoms, and usually shift to a drug resistance phenotype with the current pharmaceutical armamentarium. Thus, the development of new drugs acting via a different mechanism of action represents a clear priority. Herein, we are reporting for the first time that the aminosteroid derivative RM-133, developed in our laboratory, displays promising activity on two models of aggressive cancers, namely ovarian (OVCAR-3) and pancreatic (PANC-1) cancers. The IC50 value of RM-133 was 0.8 mu M and 0.3 mu M for OVCAR-3 and PANC-1 cell lines in culture, respectively. Based on pharmacokinetic studies on RM-133 using 11 different vehicles, we selected two main vehicles: aqueous 0.4% methylcellulose: ethanol (92: 8) and sunflower oil: ethanol (92: 8) for in vivo studies. Using subcutaneous injection of RM-133 with the methylcellulose-based vehicle, growth of PANC-1 tumors xenografted to nude mice was inhibited by 63%. Quite interestingly, RM-133 injected subcutaneously with the methylcellulose-based or sunflower-based vehicles reduced OVCAR-3 xenograft growth by 122% and 100%, respectively. After the end of RM-133 treatment using the methylcellulose-based vehicle, OVCAR-3 tumor growth inhibition was maintained for >= 1 week. RM-133 was also well tolerated in the whole animal, no apparent sign of toxicity having been detected in the xenograft studies.	[Kenmogne, Lucie Carolle; Ayan, Diana; Roy, Jenny; Maltais, Rene; Poirier, Donald] CHU Quebec, Res Ctr, Endocrinol & Nephrol Unit, Med Chem Lab, Quebec City, PQ, Canada; [Kenmogne, Lucie Carolle; Poirier, Donald] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Poirier, D (corresponding author), CHU Quebec, Res Ctr, Endocrinol & Nephrol Unit, Med Chem Lab, Quebec City, PQ, Canada.	donald.poirier@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR, POP-I); Quebec Breast Cancer Foundation (QBCF); Societe de valorisation de la recherche at Quebec City (SOVAR); Faculty of Medicine of Universite Laval; Centre de Recherche en Endocrinologie Moleculaire et Oncologique et Genomique Humaine (CREMOGH)	Canadian Institutes of Health Research (CIHR, POP-I)(Canadian Institutes of Health Research (CIHR)); Quebec Breast Cancer Foundation (QBCF); Societe de valorisation de la recherche at Quebec City (SOVAR); Faculty of Medicine of Universite Laval; Centre de Recherche en Endocrinologie Moleculaire et Oncologique et Genomique Humaine (CREMOGH)	This work was funded by Canadian Institutes of Health Research (CIHR, POP-I), Quebec Breast Cancer Foundation (QBCF), Societe de valorisation de la recherche at Quebec City (SOVAR), Faculty of Medicine of Universite Laval, and Centre de Recherche en Endocrinologie Moleculaire et Oncologique et Genomique Humaine (CREMOGH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayan D, 2014, BIOORGAN MED CHEM, V22, P5847, DOI 10.1016/j.bmc.2014.09.026; Banzato A, 2008, CLIN CANCER RES, V14, P3598, DOI 10.1158/1078-0432.CCR-07-2019; Bruell D, 2005, INT J MOL MED, V15, P305; CASTRO CA, 1995, PHARMACOL BIOCHEM BE, V50, P521, DOI 10.1016/0091-3057(94)00331-9; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chen Huaping, 2011, Frontiers in Genetics, V2, P67, DOI 10.3389/fgene.2011.00067; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Colombo PE, 2014, CRIT REV ONCOL HEMAT, V89, P207, DOI 10.1016/j.critrevonc.2013.08.017; Desai KGH, 2008, EUR J PHARM BIOPHARM, V70, P187, DOI 10.1016/j.ejpb.2008.03.007; Du JH, 2010, CANCER CHEMOTH PHARM, V65, P895, DOI 10.1007/s00280-009-1095-5; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; HAMILTON TC, 1983, CANCER RES, V43, P5379; Herzog TJ, 2014, GYNECOL ONCOL, V132, P8, DOI 10.1016/j.ygyno.2013.11.008; Huang YH, 2009, P NATL ACAD SCI USA, V106, P3426, DOI 10.1073/pnas.0813348106; Jegham H, 2012, INVEST NEW DRUG, V30, P176, DOI 10.1007/s10637-010-9548-6; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1045, DOI 10.1111/j.1745-7254.2007.00612.x; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Kwon Y., 2001, HDB ESSENTIAL PHARMA; Li J, 2009, MOL PHARMACOL, V76, P81, DOI 10.1124/mol.109.054551; MacDonald C, 2010, DRUG DELIV, V17, P434, DOI 10.3109/10717541003777548; Maltais R, 2014, STEROIDS, V82, P68, DOI 10.1016/j.steroids.2014.01.008; Masters GR, 2006, GYNECOL ONCOL, V102, P462, DOI 10.1016/j.ygyno.2005.12.004; Patrick-Iwuanyanwu KC, 2010, EXCLI J, V9, P187; Poveda A, 2014, CANCER TREAT REV, V40, P366, DOI 10.1016/j.ctrv.2013.08.001; Roy J, 2013, MOL CELL ENDOCRINOL, V376, P148, DOI 10.1016/j.mce.2013.06.022; Schmid BC, 2014, MATURITAS, V77, P128, DOI 10.1016/j.maturitas.2013.11.009; Schott, 1965, PHARMACOTOXIC EVALUA; Shaw AY, 2009, J PHARMACOL EXP THER, V331, P636, DOI 10.1124/jpet.109.156406; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Skarda J, 2001, PHYSIOL RES, V50, P275; Statistics CC, 2014, CAN CANC STAT 2014 E; van Zuylen L, 2001, INVEST NEW DRUG, V19, P125, DOI 10.1023/A:1010618632738; Wang Q, 2008, CANCER LETT, V272, P277, DOI 10.1016/j.canlet.2008.07.017; Weinberg BD, 2008, J PHARM SCI-US, V97, P1681, DOI 10.1002/jps.21038; Wistuba J, 2005, J MED PRIMATOL, V34, P178, DOI 10.1111/j.1600-0684.2005.00115.x; Xin B, 2007, CANCER, V110, P791, DOI 10.1002/cncr.22854; Yan C, 2009, MOL PHARMACOL, V76, P163, DOI 10.1124/mol.109.055855; Yu Jun, 2013, Curr Ther Res Clin Exp, V75, P8, DOI 10.1016/j.curtheres.2013.04.001; Zemskov V, 2002, LANGENBECK ARCH SURG, V387, P84, DOI 10.1007/s00423-002-0293-y	39	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144890	10.1371/journal.pone.0144890	http://dx.doi.org/10.1371/journal.pone.0144890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660672	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900136
J	Osiecki, MJ; Michl, TD; Babur, BK; Kabiri, M; Atkinson, K; Lott, WB; Griesser, HJ; Doran, MR				Osiecki, Michael J.; Michl, Thomas D.; Babur, Betul Kul; Kabiri, Mahboubeh; Atkinson, Kerry; Lott, William B.; Griesser, Hans J.; Doran, Michael R.			Packed Bed Bioreactor for the Isolation and Expansion of Placental-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; SHEAR-STRESS; PERFUSION BIOREACTOR; OXYGEN-TRANSPORT; CLINICAL-TRIALS; IN-VITRO; CULTURE; SYSTEM; DIFFERENTIATION	Large numbers of Mesenchymal stem/stromal cells (MSCs) are required for clinical relevant doses to treat a number of diseases. To economically manufacture these MSCs, an automated bioreactor system will be required. Herein we describe the development of a scalable closed-system, packed bed bioreactor suitable for large-scale MSCs expansion. The packed bed was formed from fused polystyrene pellets that were air plasma treated to endow them with a surface chemistry similar to traditional tissue culture plastic. The packed bed was encased within a gas permeable shell to decouple the medium nutrient supply and gas exchange. This enabled a significant reduction in medium flow rates, thus reducing shear and even facilitating single pass medium exchange. The system was optimised in a small-scale bioreactor format (160 cm(2)) with murine-derived green fluorescent protein-expressing MSCs, and then scaled-up to a 2800 cm(2) format. We demonstrated that placental derived MSCs could be isolated directly within the bioreactor and subsequently expanded. Our results demonstrate that the closed system large-scale packed bed bioreactor is an effective and scalable tool for large-scale isolation and expansion of MSCs.	[Osiecki, Michael J.; Babur, Betul Kul; Atkinson, Kerry; Lott, William B.; Doran, Michael R.] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Osiecki, Michael J.; Lott, William B.] Queensland Univ Technol, Fac Sci & Engn, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia; [Michl, Thomas D.] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5001, Australia; [Michl, Thomas D.; Griesser, Hans J.] Univ S Australia, Mawson Inst, Adelaide, SA 5001, Australia; [Kabiri, Mahboubeh] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Atkinson, Kerry] Univ Queensland, Univ Queensland Ctr Clin Res, Brisbane, Qld, Australia; [Doran, Michael R.] Univ Queensland, Mater Med Res Inst, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of South Australia; University of South Australia; University of Tehran; University of Queensland; Mater Research; University of Queensland	Osiecki, MJ (corresponding author), Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	m.osiecki@hdr.qut.edu.au	Doran, Michael R/F-6059-2014; Kabiri, Mahboubeh/ABE-1182-2021; Griesser, Hans J/E-5628-2011	Griesser, Hans J/0000-0003-1072-7863; Doran, Michael/0000-0001-5876-4757	Inner Wheel Australia; Wound Management Innovation CRC [1.06]	Inner Wheel Australia; Wound Management Innovation CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was funded by Inner Wheel Australia (http://www.innerwheelaustralia.org.au/) and Wound Management Innovation CRC (project 1.06, http://www.woundcrc.com/) awarded to MRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Josie Tarren and the Mater Hospital Pathology Unit for their assistance in performing the glucose and lactic acid quantification. We like to also thank Paul Reynolds of Styron, PA, USA for donating the polystyrene pellets. This research was supported by Wound Management Innovation CRC and Inner Wheel Australia.	Akhavan B, 2013, POWDER TECHNOL, V249, P403, DOI 10.1016/j.powtec.2013.09.018; Allen CB, 2001, LIMITATIONS OXYGEN D; Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; BALTZ JM, 1991, MOL REPROD DEV, V28, P351, DOI 10.1002/mrd.1080280407; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Bock A, 2009, BIOTECHNOL PROGR, V25, P1717, DOI 10.1002/btpr.262; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chen JP, 2006, J BIOSCI BIOENG, V102, P41, DOI 10.1263/jbb.102.41; Christensen ME, 2010, HAEMATOL-HEMATOL J, V95, P2102, DOI 10.3324/haematol.2010.028910; Cierpka K, 2013, CHEM-ING-TECH, V85, P67, DOI 10.1002/cite.201200151; Daculsi R, 2008, J BIOMECH, V41, P2781, DOI 10.1016/j.jbiomech.2008.06.003; De Napoli IE, 2011, J MEMBRANE SCI, V379, P341, DOI 10.1016/j.memsci.2011.06.001; dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255; Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974; Jager M, 2009, STEM CELL REV REP, V5, P266, DOI 10.1007/s12015-009-9083-z; Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874; Lanfrey PY, 2010, CHEM ENG SCI, V65, P1891, DOI 10.1016/j.ces.2009.11.011; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI [10.1089/ten.tea.2008.0540, 10.1089/ten.TEA.2008.0540]; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Mizukami A, 2013, BIOTECHNOL PROGR, V29, P568, DOI 10.1002/btpr.1707; Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Muscari C, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-63; Nold P, 2013, BIOCHEM BIOPH RES CO, V430, P325, DOI 10.1016/j.bbrc.2012.11.001; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Timmins NE, 2012, BIOTECHNOL BIOENG, V109, P1817, DOI 10.1002/bit.24425; van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; Wang J, 2011, EXPERT OPIN BIOL TH, V11, P893, DOI 10.1517/14712598.2011.574119; Weber C, 2010, ADV BIOCHEM ENG BIOT, V123, P143, DOI 10.1007/10_2009_25; Weber C, 2010, INT J ARTIF ORGANS, V33, P512, DOI 10.1177/039139881003300802; Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007; Zhao F, 2005, BIOTECHNOL PROGR, V21, P1269, DOI 10.1021/bp0500664; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184; Zhu XH, 2010, CHEM ENG SCI, V65, P2108, DOI 10.1016/j.ces.2009.12.006	38	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144941	10.1371/journal.pone.0144941	http://dx.doi.org/10.1371/journal.pone.0144941			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660475	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900153
J	van Bruggen, R; Gualtieri, C; Iliescu, A; Cheepsunthorn, CL; Mungkalasut, P; Trape, JF; Modiano, D; Sirima, BS; Singhasivanon, P; Lathrop, M; Sakuntabhai, A; Bureau, JF; Gros, P				van Bruggen, Rebekah; Gualtieri, Christian; Iliescu, Alexandra; Cheepsunthorn, Chalisa Louicharoen; Mungkalasut, Punchalee; Trape, Jean-Francois; Modiano, David; Sirima, Bienvenu Sodiomon; Singhasivanon, Pratap; Lathrop, Mark; Sakuntabhai, Anavaj; Bureau, Jean-Francois; Gros, Philippe			Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RED-BLOOD-CELL; HUMAN-ERYTHROCYTES; HOLOENDEMIC AREA; MOLECULAR-BASIS; DEFICIENCY; RESISTANCE; IDENTIFICATION; ENZYME; VIVAX	Pyruvate kinase (PKLR) is a critical erythrocyte enzyme that is required for glycolysis and production of ATP. We have shown that Pklr deficiency in mice reduces the severity (reduced parasitemia, increased survival) of blood stage malaria induced by infection with Plasmodium chabaudi AS. Likewise, studies in human erythrocytes infected ex vivo with P. falciparum show that presence of host PK-deficiency alleles reduces infection phenotypes. We have characterized the genetic diversity of the PKLR gene, including haplotype structure and presence of rare coding variants in two populations from malaria endemic areas of Thailand and Senegal. We investigated the effect of PKLR genotypes on rich longitudinal datasets including haematological and malaria-associated phenotypes. A coding and possibly damaging variant (R41Q) was identified in the Thai population with a minor allele frequency of similar to 4.7%. Arginine 41 (R41) is highly conserved in the pyruvate kinase family and its substitution to Glutamine (R41Q) affects protein stability. Heterozygosity for R41Q is shown to be associated with a significant reduction in the number of attacks with Plasmodium falciparum, while correlating with an increased number of Plasmodium vivax infections. These results strongly suggest that PKLR protein variants may affect the frequency, and the intensity of malaria episodes induced by different Plasmodium parasites in humans living in areas of endemic malaria.	[van Bruggen, Rebekah; Lathrop, Mark; Gros, Philippe] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Gualtieri, Christian; Iliescu, Alexandra; Gros, Philippe] McGill Univ, Dept Biochem, Fac Med, Montreal, PQ, Canada; [Cheepsunthorn, Chalisa Louicharoen; Mungkalasut, Punchalee] Chulalongkorn Univ, Dept Biochem, Fac Med, Bangkok 10330, Thailand; [Trape, Jean-Francois] Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal; [Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Inst Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sirima, Bienvenu Sodiomon] Minist Hlth, Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg Biomed & Hlth Informat, Bangkok, Thailand; [Sakuntabhai, Anavaj; Bureau, Jean-Francois] Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France; [Sakuntabhai, Anavaj; Bureau, Jean-Francois] Ctr Natl Rech Sci, URA3012, F-75015 Paris, France	McGill University; McGill University; Chulalongkorn University; Institut de Recherche pour le Developpement (IRD); Fondazione Cenci Bolognetti; Sapienza University Rome; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Gros, P (corresponding author), McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada.	philippe.gros@mcgill.ca		Singhasivanon, Pratap/0000-0002-9759-1702; Bureau, Jean-Francois/0000-0003-1945-1883	Canadian Institutes for Health Research [MOP-119342]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	This work was supported by research grants to PG from the Canadian Institutes for Health Research (MOP-119342) and funding to AS from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant No. ANR-10-LABX-62-IBEID).	Alves J, 2010, BLOOD CELL MOL DIS, V44, P62, DOI 10.1016/j.bcmd.2009.09.008; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berghout J, 2012, GENES IMMUN, V13, P98, DOI 10.1038/gene.2011.54; Beutler E, 1997, HUM MUTAT, V9, P282, DOI 10.1002/(SICI)1098-1004(1997)9:3<282::AID-HUMU13>3.0.CO;2-Z; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; CARDENAS JM, 1978, J CELL PHYSIOL, V96, P189, DOI 10.1002/jcp.1040960207; CARDENAS JM, 1978, J EXP ZOOL, V204, P361, DOI 10.1002/jez.1402040307; Durand PM, 2008, HAEMATOLOGICA, V93, P939, DOI 10.3324/haematol.12450; FANJUL AN, 1993, J BIOL CHEM, V268, P175; Fermo E, 2005, BRIT J HAEMATOL, V129, P839, DOI 10.1111/j.1365-2141.2005.05520.x; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; GUPTA RK, 1976, BIOCHEMISTRY-US, V15, P2881, DOI 10.1021/bi00658a028; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hedrick PW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-349; Hirono A, 2001, METABOLIC MOL BASES, V2, P4637; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; KAHN A, 1982, METHOD ENZYMOL, V90, P131; KANNO H, 1992, BIOCHEM BIOPH RES CO, V188, P516, DOI 10.1016/0006-291X(92)91086-6; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Machado P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047071; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; MARIE J, 1979, BIOCHEM BIOPH RES CO, V91, P123, DOI 10.1016/0006-291X(79)90592-8; MARIE J, 1980, EUR J BIOCHEM, V108, P251, DOI 10.1111/j.1432-1033.1980.tb04718.x; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Min-Oo G, 2004, GENES IMMUN, V5, P168, DOI 10.1038/sj.gene.6364069; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Modiano D, 2001, T ROY SOC TROP MED H, V95, P149, DOI 10.1016/S0035-9203(01)90141-5; Modiano D., 1995, Parassitologia (Rome), V37, P255; MORIMOTO M, 1995, BLOOD, V86, P4323, DOI 10.1182/blood.V86.11.4323.bloodjournal86114323; MUEGGLER PA, 1983, BIOCHEM GENET, V21, P691, DOI 10.1007/BF00498916; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olivieri NF, 2008, BRIT J HAEMATOL, V141, P388, DOI 10.1111/j.1365-2141.2008.07126.x; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Rowe JA, 2009, CURR OPIN HEMATOL, V16, P480, DOI 10.1097/MOH.0b013e3283313de0; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Smith T, 2001, AM J TROP MED HYG, V64, P262, DOI 10.4269/ajtmh.2001.64.262; STRANDHOLM JJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P125, DOI 10.1016/0003-9861(76)90242-3; Summerer M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-17; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; Tiono AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-163; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; VALENTINE W, 1961, T ASSOC AM PHYSICIAN, V74, P100; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; van Wijk R, 2009, HUM MUTAT, V30, P446, DOI 10.1002/humu.20915; Wang CQ, 2001, BLOOD, V98, P3113, DOI 10.1182/blood.V98.10.3113; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Zanella A, 2005, BRIT J HAEMATOL, V130, P11, DOI 10.1111/j.1365-2141.2005.05527.x; Zanella A, 2000, BEST PRACT RES CL HA, V13, P57, DOI 10.1053/beha.1999.0057; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973; Zurcher C, 1965, Folia Haematol Int Mag Klin Morphol Blutforsch, V83, P366	68	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144555	10.1371/journal.pone.0144555	http://dx.doi.org/10.1371/journal.pone.0144555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658699	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900062
J	Grangl, G; Zohrer, E; Kostenberger, M; Jud, A; Fauler, G; Scharnagl, H; Stojakovic, T; Marterer, R; Gamillscheg, A; Jahnel, J				Grangl, Gernot; Zoehrer, Evelyn; Koestenberger, Martin; Jud, Alexandra; Fauler, Goenter; Scharnagl, Hubert; Stojakovic, Tatjana; Marterer, Robert; Gamillscheg, Andreas; Jahnel, Joerg			Serum Bile Acids in Repaired Tetralogy of Fallot: A Marker for Liver and Heart?	PLOS ONE			English	Article							FUNCTION ABNORMALITIES; FAILURE; PERFORMANCE; REGURGITATION; DYSFUNCTION; PREVALENCE; PHYSIOLOGY; MOTION; ADULTS	Background and Aims Patients with repaired tetralogy of Fallot may develop chronic right ventricular dysfunction and hepatic congestion over time. We hypothesized that bile acid metabolism is altered in repaired tetralogy of Fallot patients and therefore sought to correlate right ventricular indices with serum bile acid levels. Methods Indexed right ventricular end diastolic volume, as assessed by cardiac magnetic-resonance imaging, was classified as <100ml/m(2) (Group 1, n = 5), 100-150ml/m(2) (Group 2, n = 18), and >150ml/m(2) (Group 3, n = 6) in 29 patients with repaired tetralogy of Fallot. Pulmonary regurgitation fraction and right ventricular ejection fraction were calculated. The serum bile acid profile, including 15 species, in these patients was determined by liquid chromatography coupled with mass spectrometry. Results Serum bile acid levels increased from Group 1 to Group 3 (2.5 +/- 0.7; 4.1 +/- 2.5; 6.0 +/- 2.8 mu mol/l, respectively) with significantly increased bile acid values in Group 3 compared to Group 1 (p <= 0.05). In Group 3, but not in Group 1 and 2, a significant increase in glycine-conjugated bile acids was observed. Pulmonary regurgitation fraction increased (12 +/- 1; 28 +/- 16; 43 +/- 3%, Groups 1-3, respectively) and right ventricular ejection fraction decreased (48.4 +/- 6.4; 48.5 +/- 6.5; 42.1 +/- 5.3%, Groups 1-3, respectively) with rising indexed right ventricular end diastolic volume. Conclusions These preliminary results suggest that serum bile acid levels are positively correlated with indexed right ventricular end-diastolic volume in patients with repaired tetralogy of Fallot; however, this needs to be confirmed in a larger patient cohort.	[Grangl, Gernot; Zoehrer, Evelyn; Koestenberger, Martin; Jud, Alexandra; Gamillscheg, Andreas; Jahnel, Joerg] Med Univ Graz, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Graz, Austria; [Scharnagl, Hubert; Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Marterer, Robert] Med Univ Graz, Div Pediat Radiol, Dept Radiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Jahnel, J (corresponding author), Med Univ Graz, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Graz, Austria.	joerg.jahnel@medunigraz.at	Marterer, Robert/Y-5278-2019	Marterer, Robert/0000-0001-6806-122X				Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Bouzas B, 2005, CARDIOL YOUNG, V15, P51, DOI 10.1017/S1047951105001034; Burchill Luke J, 2011, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V14, P92, DOI 10.1053/j.pcsu.2011.01.016; Davlouros PA, 2004, INT J CARDIOL, V97, P91, DOI 10.1016/j.ijcard.2004.08.013; Eindhoven JA, 2014, INT J CARDIOL, V174, P550, DOI 10.1016/j.ijcard.2014.04.137; Ford RM, 2015, TRANSPLANT REV-ORLAN, V29, P33, DOI 10.1016/j.trre.2014.11.003; GALATOLA G, 1991, GASTROENTEROLOGY, V100, P1100, DOI 10.1016/0016-5085(91)90288-V; GATZOULIS MA, 1995, CIRCULATION, V91, P1775, DOI 10.1161/01.CIR.91.6.1775; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Knauth AL, 2008, HEART, V94, P211, DOI 10.1136/hrt.2006.104745; Koestenberger M, 2012, CONGENIT HEART DIS, V7, P250, DOI 10.1111/j.1747-0803.2012.00655.x; Koestenberger M, 2011, J AM SOC ECHOCARDIOG, V24, P45, DOI 10.1016/j.echo.2010.10.001; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; Lotz J, 2009, ROFO-FORTSCHR RONTG, V181, P800, DOI 10.1055/s-0028-1109542; Marterer R, 2015, EUR RADIOL, V25, P3528, DOI 10.1007/s00330-015-3788-y; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Miller D, 2004, J AM SOC ECHOCARDIOG, V17, P443, DOI 10.1016/j.echo.2004.01.010; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Nikolaou M, 2013, EUR HEART J, V34, P742, DOI 10.1093/eurheartj/ehs332; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Poelzl G, 2012, EUR J CLIN INVEST, V42, P153, DOI 10.1111/j.1365-2362.2011.02573.x; Shinebourne EA, 2006, HEART, V92, P1353, DOI 10.1136/hrt.2005.061143; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Van Deursen VM, 2010, J CARD FAIL, V16, P84, DOI 10.1016/j.cardfail.2009.08.002; Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8	26	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144745	10.1371/journal.pone.0144745	http://dx.doi.org/10.1371/journal.pone.0144745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659834	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600082
J	Hassoun, N				Hassoun, Nicole			The Global Health Impact Index: Promoting Global Health	PLOS ONE			English	Article							FIXED-DOSE COMBINATION; TREATMENT-NAIVE; TENOFOVIR DF; EFAVIRENZ; SAFETY; LAMIVUDINE; EFFICACY; NEVIRAPINE; STAVUDINE; THERAPY	Millions of people cannot access essential medicines they need for deadly diseases like malaria, tuberculosis (TB) and HIV/AIDS. There is good information on the need for drugs for these diseases but until now, no global estimate of the impact drugs are having on this burden. This paper presents a model measuring companies' key malaria, TB and HIV/AIDS drugs' consequences for global health (global-health-impact.org). It aggregates drugs' impacts in several ways-by disease, country and originator-company. The methodology can be extended across diseases as well as drugs to provide a more extensive picture of the impact companies' drugs are having on the global burden of disease. The study suggests that key malaria, TB and HIV/AIDS drugs are, together, ameliorating about 37% of the global burden of these diseases and Sanofi, Novartis, and Pfizer's drugs are having the largest effect on this burden. Moreover, drug impacts vary widely across countries. This index provides important information for policy makers, pharmaceutical companies, countries, and other stake-holders that can help increase access to essential medicines.	[Hassoun, Nicole] SUNY Binghamton, Dept Philosophy, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Hassoun, N (corresponding author), SUNY Binghamton, Dept Philosophy, Binghamton, NY 13902 USA.	nhassoun@binghamton.edu			Binghamton University; Carnegie Mellon University; Academics Stand Against Poverty; Stanford University's Center for Ethics in Society; Justitia Amplificata, Germany; Center for Advanced Studies in Frankfurt, Germany; Binghamton University's Citizenship, Rights, and Belonging Transdisciplinary Area of Excellence; Swedish-Franco Program in Philosophy and Economics in Paris, France; Center for Poverty Research in Salzburg, Austria; World Institute for Development Economics Research in Helsinki, Finland; Berkman Foundation at Carnegie Mellon University; Falk Foundation at Carnegie Mellon University	Binghamton University; Carnegie Mellon University; Academics Stand Against Poverty; Stanford University's Center for Ethics in Society; Justitia Amplificata, Germany; Center for Advanced Studies in Frankfurt, Germany; Binghamton University's Citizenship, Rights, and Belonging Transdisciplinary Area of Excellence; Swedish-Franco Program in Philosophy and Economics in Paris, France; Center for Poverty Research in Salzburg, Austria; World Institute for Development Economics Research in Helsinki, Finland; Berkman Foundation at Carnegie Mellon University; Falk Foundation at Carnegie Mellon University	Binghamton University and Carnegie Mellon University seed grants were provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank Public Affairs Quarterly for allowing her to reprint some of the material from the HIV appendix in her article "Globalization, Global Justice, and Global Health Impact" in their July 2014 issue. The author would also like to thank all of the people and organizations that have contributed to the project-especially the Global Health Impact team. She is thankful for recent discussions about the project at the World Health Organization, The Global Fund; the Edmund J. Safra Center for Ethics at Harvard University; the University of Manchester; the American Philosophical Association; Yale University; Binghamton University; the University of Delaware; London School of Economics; William and Lee College; Goethe University; California University; University College London; Santa Clara University; the Universidad De Antioquia; Carnegie Mellon University; the American Society for Bioethics and Humanities; Stanford University; Dickinson College; Newcastle on the Tyne; and researchers at UNAIDS, the World Health Organization, and Medecins Sans Frontieres along with countless others. She is also especially grateful for support from Academics Stand Against Poverty; Stanford University's Center for Ethics in Society; Justitia Amplificata and the Center for Advanced Studies in Frankfurt, Germany; Binghamton University's Citizenship, Rights, and Belonging Transdisciplinary Area of Excellence collaborative grant program; the Swedish-Franco Program in Philosophy and Economics in Paris, France; the Center for Poverty Research in Salzburg, Austria; the World Institute for Development Economics Research in Helsinki, Finland; and the Berkman and Falk Foundations at Carnegie Mellon University.	Annan NT, 2009, JAIDS-J ACQ IMM DEF, V51, P140, DOI 10.1097/QAI.0b013e3181a56e81; [Anonymous], 2018, GLOBAL BURDEN DIS ST, DOI DOI 10.2147/DDDT.S164565; [Anonymous], WE CLASS COUNTRIES; [Anonymous], 2007 2008 XDR MDR TU; [Anonymous], 18 C RETR OPP INF BO; [Anonymous], AB THE FDN; [Anonymous], 2009, MAN MDR TB FIELD GUI; [Anonymous], 6 IAS C HIV PATH TRE; [Anonymous], 2010, GLOB REP ANT EFF DRU; [Anonymous], **NON-TRADITIONAL**; [Anonymous], J INT ASS PHYS AIDS; [Anonymous], J ACQUIR IMMUNE DEFI; [Anonymous], MONITORING FINANCIAL; [Anonymous], 2014, PUBLIC AFFAIRS Q; [Anonymous], HLTH INEQUALITIES GL; [Anonymous], GLOB HIV AIDS RESP; [Anonymous], JOINT UN PROGR HIV A; [Anonymous], N ENGL J MED; [Anonymous], J ACQUIR IMMUNE DEFI; [Anonymous], KEY FACTS GLOB HIV E; [Anonymous], ANT MED LOW MIDDL IN; [Anonymous], TB HIV FACTS 2011; [Anonymous], TUB TB DAT GLOB TUB; [Anonymous], 2013, ANT MED LOW MIDDL IN; [Anonymous], 2011 12 TUB GLOB FAC; [Anonymous], DAT HIV AIDS RESP AN; [Anonymous], CHILDR 5 FEV BEING T; [Anonymous], EST ANT THER COV CHI; [Anonymous], TUBERCULOSIS MULTIDR; Bao L, 2012, SEX TRANSM INFECT, V88, pI58, DOI 10.1136/sextrans-2012-050689; Bunupuradah T, 2012, ANTIVIR THER, V17, P1351, DOI 10.3851/IMP2443; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cohen CJ, 2012, JAIDS-J ACQ IMM DEF, V60, P33, DOI 10.1097/QAI.0b013e31824d006e; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2011, INT J CLIN PRACT, V65, P1240, DOI 10.1111/j.1742-1241.2011.02807.x; DeJesus E, 2012, HIV CLIN TRIALS, V13, P228, DOI 10.1310/hct1304-228; Echeverria P, 2010, ANTIVIR RES, V85, P403, DOI 10.1016/j.antiviral.2009.11.008; Frange P, 2011, PEDIATR INFECT DIS J, V30, P684, DOI 10.1097/INF.0b013e31821752d6; Galactionova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127818; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gay CL, 2011, AIDS, V25, P941, DOI 10.1097/QAD.0b013e3283463c07; Hassoun N, 2012, DEV WORLD BIOETH, V12, P121, DOI 10.1111/j.1471-8847.2011.00314.x; Kebba A, 2002, AIDS RES HUM RETROV, V18, P1181, DOI 10.1089/08892220260387922; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Lee BY, 2010, VACCINE, V28, P2806, DOI 10.1016/j.vaccine.2009.09.047; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Manosuthi W, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-136; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Munderi P, 2010, HIV MED, V11, P334, DOI 10.1111/j.1468-1293.2009.00786.x; Murphy RL, 2008, HIV CLIN TRIALS, V9, P1, DOI 10.1310/hct0901-1; Pensi T, 2007, INDIAN PEDIATR, V44, P519; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Puthanakit T, 2009, J ANTIMICROB CHEMOTH, V64, P1080, DOI 10.1093/jac/dkp322; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Saez-Llorens X, 2008, PEDIATRICS, V121, pE827, DOI 10.1542/peds.2006-3078; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sierra-Madero J, 2010, HIV CLIN TRIALS, V11, P127, DOI 10.1310/hct1103-125; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Soriano V, 2011, ANTIVIR THER, V16, P339, DOI 10.3851/IMP1745; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Vallecillo G, 2012, AIDS RES HUM RETROV, V28, P165, DOI 10.1089/aid.2011.0092; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2008, IMPL WHO STOP TB STR	70	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0141374	10.1371/journal.pone.0141374	http://dx.doi.org/10.1371/journal.pone.0141374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657064	Green Published, gold			2022-12-26	WOS:000366903600001
J	Herraiz, C; Olivares, C; Castejon-Grinan, M; Abrisqueta, M; Jimenez-Cervantes, C; Garcia-Borron, JC				Herraiz, Cecilia; Olivares, Conchi; Castejon-Grinan, Maria; Abrisqueta, Marta; Jimenez-Cervantes, Celia; Carlos Garcia-Borron, Jose			Functional Characterization of MC1R-TUBB3 Intergenic Splice Variants of the Human Melanocortin 1 Receptor	PLOS ONE			English	Article							RED HAIR; EXPRESSION; MELANOMA; PROTEIN; MC1R; GENE; PIGMENTATION; MELANOCYTES; DIMERIZATION; TRAFFICKING	The melanocortin 1 receptor gene (MC1R) expressed in melanocytes is a major determinant of skin pigmentation. It encodes a Gs protein-coupled receptor activated by alpha-melanocyte stimulating hormone (alpha MSH). Human MC1R has an inefficient poly(A) site allowing intergenic splicing with its downstream neighbour Tubulin-beta-III (TUBB3). Intergenic splicing produces two MC1R isoforms, designated Iso1 and Iso2, bearing the complete seven transmembrane helices from MC1R fused to TUBB3-derived C-terminal extensions, in-frame for Iso1 and out-of-frame for Iso2. It has been reported that exposure to ultraviolet radiation (UVR) might promote an isoform switch from canonical MC1R (MC1R-001) to the MC1R-TUBB3 chimeras, which might lead to novel phenotypes required for tanning. We expressed the Flag epitope-tagged intergenic isoforms in heterologous HEK293T cells and human melanoma cells, for functional characterization. Iso1 was expressed with the expected size. Iso2 yielded a doublet of Mr significantly lower than predicted, and impaired intracellular stability. Although Iso1- and Iso2 bound radiolabelled agonist with the same affinity as MC1R-001, their plasma membrane expression was strongly reduced. Decreased surface expression mostly resulted from aberrant forward trafficking, rather than high rates of endocytosis. Functional coupling of both isoforms to cAMP was lower than wild-type, but ERK activation upon binding of alpha MSH was unimpaired, suggesting imbalanced signaling from the splice variants. Heterodimerization of differentially labelled MC1R-001 with the splicing isoforms analyzed by co-immunoprecipitation was efficient and caused decreased surface expression of binding sites. Thus, UVR-induced MC1R isoforms might contribute to fine-tune the tanning response by modulating MC1R-001 availability and functional parameters.	[Herraiz, Cecilia] Univ Murcia, Sch Med, Dept Biochem Mol Biol & Immunol, Murcia, Spain; IMIB Arrixaca, Murcia, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Herraiz, C (corresponding author), Univ Murcia, Sch Med, Dept Biochem Mol Biol & Immunol, Campus Espinardo, Murcia, Spain.	ceciliahs@um.es	Jimenez-Cervantes, Celia/H-1953-2015; Garcia-Borron, Jose Carlos/H-2247-2015; Olivares, Conchi/H-2794-2015; Castejón Griñán, María/AAC-8557-2022; Serrano, Cecilia Herraiz/H-2550-2015; Abrisqueta Gonzalez, Marta/H-8998-2015	Jimenez-Cervantes, Celia/0000-0002-5821-9510; Garcia-Borron, Jose Carlos/0000-0002-9192-588X; Olivares, Conchi/0000-0001-7518-3858; Castejón Griñán, María/0000-0003-4494-3986; Serrano, Cecilia Herraiz/0000-0001-6912-0738; Abrisqueta Gonzalez, Marta/0000-0001-9464-3135	Comision Interministerial de Ciencia y Tecnologia, Spain [SAF2012-32134]; FEDER funds (European Community); University of Murcia	Comision Interministerial de Ciencia y Tecnologia, Spain(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); FEDER funds (European Community)(European Commission); University of Murcia	This work was supported by grant SAF2012-32134 (to JCGB) from the Comision Interministerial de Ciencia y Tecnologia, Spain, FEDER funds (European Community). CH holds a post-doctoral fellowship from the University of Murcia. MC is a fellow of the Fundacion Seneca (Agencia de Ciencia y Tecnologia de la Region de Murcia, Spain).	Abrisqueta M, 2013, J CELL SCI, V126, P3724, DOI 10.1242/jcs.128322; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Communi D, 2001, J BIOL CHEM, V276, P16561, DOI 10.1074/jbc.M009609200; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Corre S, 2006, J INVEST DERMATOL, V126, P916, DOI 10.1038/sj.jid.5700190; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Dalziel M, 2007, MOL CELL BIOL, V27, P1568, DOI 10.1128/MCB.01821-06; Dalziel M, 2011, NUCLEIC ACIDS RES, V39, P2378, DOI 10.1093/nar/gkq1125; Davies JR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12193; Funasaka Y, 1998, BRIT J DERMATOL, V139, P216; Garcia-Borron JC, 2014, PIGM CELL MELANOMA R, V27, P699, DOI 10.1111/pcmr.12257; Herraiz C, 2012, INT J BIOCHEM CELL B, V44, P2244, DOI 10.1016/j.biocel.2012.09.008; Herraiz C, 2011, MOL ENDOCRINOL, V25, P138, DOI 10.1210/me.2010-0217; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Jividen K, 2014, GENE CHROMOSOME CANC, V53, P963, DOI 10.1002/gcc.22207; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Maresca V, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12365; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; Minneman K P, 2001, Mol Interv, V1, P108; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com; Rouzaud F, 2003, FASEB J, V17, P2154, DOI 10.1096/fj.03-0206fje; Rouzaud F, 2006, FASEB J, V20, P1927, DOI 10.1096/fj.06-5922fje; Sanchez-Laorden BL, 2007, J BIOL CHEM, V282, P3241, DOI 10.1074/jbc.M606865200; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; Sanchez-Laorden L, 2006, CELL MOL BIOL, V52, P39, DOI 10.1170/T706; Sanchez-Mas A, 2005, PEPTIDES, V26, P1848, DOI 10.1016/j.peptides.2004.11.030; Sarangarajan R, 2006, MELANOMA RES, V16, P3, DOI 10.1097/01.cmr.0000195699.35143.df; Scott MC, 2002, PIGM CELL RES, V15, P433, DOI 10.1034/j.1600-0749.2002.02051.x; Smith AG, 2001, GENE, V281, P81, DOI 10.1016/S0378-1119(01)00791-0; Tan CP, 1999, FEBS LETT, V451, P137, DOI 10.1016/S0014-5793(99)00525-6; Taylor NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119920; Taylor NJ, 2015, INT J CANCER, V136, P2659, DOI 10.1002/ijc.29317; URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Zanna PT, 2008, BIOCHEM BIOPH RES CO, V368, P211, DOI 10.1016/j.bbrc.2008.01.060	41	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144757	10.1371/journal.pone.0144757	http://dx.doi.org/10.1371/journal.pone.0144757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657157	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600087
J	Phan, K; Mitchell, P; Liew, G; Plant, AJ; Wang, SB; Au, C; Chiha, J; Kovoor, P; Thiagalingam, A; Burlutsky, G; Gopinath, B				Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Au, Cheryl; Chiha, Joseph; Kovoor, Pramesh; Thiagalingam, Aravinda; Burlutsky, George; Gopinath, Bamini			Association between Retinal Arteriolar and Venule Calibre with Prevalent Heart Failure: A Cross-Sectional Study	PLOS ONE			English	Article							VASCULAR CALIBER; CARDIOVASCULAR-DISEASE; MICROVASCULAR ABNORMALITIES; ATHEROSCLEROSIS RISK; PROGNOSTIC IMPACT; RETINOPATHY; MORTALITY; COMMUNITIES; MESA	Background There is evidence to suggest that microvascular disease, particularly diabetic retinopathy, plays a role in the pathogenesis of HF. However, whether changes in retinal vessel calibre predicts HF is unclear. The purpose of this study was to examine the association of retinal microvascular structure with prevalent heart failure (HF). Methods The Australian Heart Eye Study (AHES) is a cross-sectional study that surveyed 1680 participants who presented to a tertiary referral hospital for the evaluation of potential coronary artery disease by coronary angiography. Retinal vessel calibre was graded using retinal photography and participants' self-reported echocardiography-confirmed HF was obtained via an extensive medical questionnaire. Results There were 107 participants (8.1%) with prevalent self-reported HF. Persons with wider retinal arteriolar calibre (comparing highest versus lowest tertile or reference) were more likely to have prevalent HF (OR 3.5; 95% CI, 1.7-7.2) when adjusted for age and sex. After further adjustment for body mass index, hypertension, diabetes, smoking status, triglycerides and estimated glomerular filtration rate, this association remained significant (OR 4.5; 95% CI, 2.0-9.8). After further stratification, this association remained significant among participants with diabetes (OR 10.3; 95% CI, 2.7-39.3) but not in those without diabetes (OR 2.7; 95% CI, 0.9-7.5). The strength of this association was not dependent on the length of history of diabetes, or retinopathy status. There was no significant association between retinal venular calibre and prevalence of HF. Conclusions Wider retinal arteriolar diameter was significantly and independently associated with prevalent HF in participants of a cross-sectional study. This association was significant stronger among participants with diabetes compared to without diabetes. No association was found between retinal venule calibre with prevalent HF.	[Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Au, Cheryl; Burlutsky, George; Gopinath, Bamini] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Au, Cheryl; Burlutsky, George; Gopinath, Bamini] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Chiha, Joseph; Kovoor, Pramesh; Thiagalingam, Aravinda] Univ Sydney, Westmead Millennium Inst, Ctr Heart Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research	Gopinath, B (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia.	bamini.gopinath@sydney.edu.au	Liew, Gerald/AAB-6870-2022; Mitchell, Paul/P-1498-2014; Gopinath, Bamini/K-4286-2019	Gopinath, Bamini/0000-0003-3573-359X; Thiagalingam, Aravinda/0000-0002-7763-7806; Phan, Kevin/0000-0002-5940-3555	National Health and Medical Research Council (NHMRC) [571012]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Project Grant 571012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibrahim E, 2006, OPHTHALMOLOGY, V113, P1499, DOI 10.1016/j.ophtha.2006.05.009; Brinchmann-Hansen O., 1986, ACTA OPHTHALMOL, V64, P20, DOI DOI 10.1111/J.1755-3768.1986.TB00699; Cheung N, 2008, J AM COLL CARDIOL, V51, P1573, DOI 10.1016/j.jacc.2007.11.076; Ciulla TA, 2002, ACTA OPHTHALMOL SCAN, V80, P468, DOI 10.1034/j.1600-0420.2002.800503.x; Dries DL, 2001, J AM COLL CARDIOL, V38, P421, DOI 10.1016/S0735-1097(01)01408-5; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ingelsson E, 2007, DIABETES, V56, P1718, DOI 10.2337/db07-0078; Kannel WB, 2011, CLIN CHEM, V57, P338, DOI 10.1373/clinchem.2010.149740; KEITH NM, 1974, AM J MED SCI, V268, P336, DOI 10.1097/00000441-197412000-00004; Kifley A, 2007, AM J OPHTHALMOL, V143, P1024, DOI 10.1016/j.ajo.2007.01.034; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; KULLER LH, 1995, CIRCULATION, V92, P720, DOI 10.1161/01.CIR.92.4.720; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Phan K, 2015, INT J CARDIOL, V182, P213, DOI 10.1016/j.ijcard.2014.12.146; Phan K, 2015, INT J CARDIOL, V178, P96, DOI 10.1016/j.ijcard.2014.10.102; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Tikellis G, 2007, DIABETOLOGIA, V50, P2263, DOI 10.1007/s00125-007-0822-x; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Yau JWY, 2012, DIABETES RES CLIN PR, V95, P265, DOI 10.1016/j.diabres.2011.10.027	29	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144850	10.1371/journal.pone.0144850	http://dx.doi.org/10.1371/journal.pone.0144850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659133	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600096
J	Cao, SJ; Yu, L; Mao, JY; Wang, Q; Ruan, JS				Cao, Shujuan; Yu, Liang; Mao, Jingyuan; Wang, Quan; Ruan, Jishou			Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ACE; TAU; ACTIVATION; HYPOTHESIS; INHIBITORS; AFFINITY; RECEPTOR; PROGRESS; BINDING	This study begins with constructing the mini metabolic networks (MMNs) of beta amyloid (A beta) and acetylcholine (ACh) which stimulate the Alzheimer's Disease (AD). Then we generate the AD network by incorporating MMNs of A beta and ACh, and other MMNs of stimuli of AD. The panel of proteins contains 49 enzymes/receptors on the AD network which have the 3D-structure in PDB. The panel of drugs is formed by 5 AD drugs and 5 AD nutraceutical drugs, and 20 non-AD drugs. All of these complexes formed by these 30 drugs and 49 proteins are transformed into dyadic arrays. Utilizing the prior knowledge learned from the drug panel, we propose a statistical classification (dry-lab). According to the wet-lab for the complex of amiloride and insulin degrading enzyme, and the complex of amiloride and neutral endopeptidase, we are confident that this dry-lab is reliable. As the consequences of the dry-lab, we discover many interesting implications. Especially, we show that possible causes of Tacrine, donepezil, galantamine and huperzine A cannot improve the level of ACh which is against to their original design purpose but they still prevent AD to be worse as A beta deposition appeared. On the other hand, we recommend Miglitol and Atenolol as the safe and potent drugs to improve the level of ACh before A beta deposition appearing. Moreover, some nutrients such as NADH and Vitamin E should be controlled because they may harm health if being used in wrong way and wrong time. Anyway, the insights shown in this study are valuable to be developed further.	[Cao, Shujuan; Yu, Liang; Ruan, Jishou] Nankai Univ, Coll Math Sci, Tianjin 300071, Peoples R China; [Cao, Shujuan; Yu, Liang; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Mao, Jingyuan] Tianjin Univ Tradit Chinese Med, Internal Med Heart, Tianjin, Peoples R China; [Wang, Quan] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100080, Peoples R China; [Wang, Quan] TEDA, Tianjin Int Joint Acad Biomed, High Throughput Mol Drug Discovery Ctr, Tianjin, Peoples R China; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem & Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Tianjin University of Traditional Chinese Medicine; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tianjin International Joint Academy of Biomedicine; Nankai University	Ruan, JS (corresponding author), Nankai Univ, Coll Math Sci, Tianjin 300071, Peoples R China.	jsruan@nankai.edu.cn			Natural Science Funding of China [10671100, 11101226, 31050110432, 31150110577]; International Development Research Center in Ottawa, Canada [104519010]	Natural Science Funding of China; International Development Research Center in Ottawa, Canada	J.R. and his research group are thankful for the financial support from the Natural Science Funding of China (grants 10671100, 11101226, 31050110432, and 31150110577). J.R. also expresses gratitude to the International Development Research Center in Ottawa, Canada (grant 104519010).	Amtul Z, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.014; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Cui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037790; Glenn ND, 1981, BRIT J CLIN PHARMACO, V11, P549; Gohlke P, 2001, J PHARMACOL EXP THER, V298, P62; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Grommes C, 2013, CANCER CHEMOTH PHARM, V71, P929, DOI 10.1007/s00280-013-2084-2; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hu G, 2012, STRUCTURE, V20, P1815, DOI 10.1016/j.str.2012.09.011; HUNG AY, 1993, J BIOL CHEM, V268, P22959; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; Jandeleit-Dahm KAM, 2006, J HUM HYPERTENS, V20, P478, DOI 10.1038/sj.jhh.1002018; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jouquey S, 1995, NEUROPHARMACOLOGY, V34, P1689, DOI 10.1016/0028-3908(95)00146-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kuhn W, 1996, J NEURAL TRANSM, V103, P1187, DOI 10.1007/BF01271203; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mellin V, 2005, J CARDIOVASC PHARM, V46, P390, DOI 10.1097/01.fjc.0000175457.48031.8b; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; Rossi GP, 2003, CARDIOVASC DRUG REV, V21, P51; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033709; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Yorulmaz H, 2011, NEUROPHYSIOLOGY+, V42, P349, DOI 10.1007/s11062-011-9168-6	42	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144387	10.1371/journal.pone.0144387	http://dx.doi.org/10.1371/journal.pone.0144387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650760	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300047
J	Gren, ST; Rasmussen, TB; Janciauskiene, S; Hakansson, K; Gerwien, JG; Grip, O				Gren, Susanne T.; Rasmussen, Thomas B.; Janciauskiene, Sabina; Hakansson, Katarina; Gerwien, Jens G.; Grip, Olof			A Single-Cell Gene-Expression Profile Reveals Inter-Cellular Heterogeneity within Human Monocyte Subsets	PLOS ONE			English	Article							BLOOD MONOCYTES; DENDRITIC CELLS; T-CELLS; CD16(+); MACROPHAGES; MIGRATION	Human monocytes are a heterogeneous cell population classified into three different subsets: Classical CD14(++)CD16(-), intermediate CD14(++)CD16(+), and non-classical CD14(+)CD16(++) monocytes. These subsets are distinguished by their differential expression of CD14 and CD16, and unique gene expression profile. So far, the variation in inter-cellular gene expression within the monocyte subsets is largely unknown. In this study, the cellular variation within each human monocyte subset from a single healthy donor was described by using a novel single- cell PCR gene-expression analysis tool. We investigated 86 different genes mainly encoding cell surface markers, and proteins involved in immune regulation. Within the three human monocyte subsets, our descriptive findings show multimodal expression of key immune response genes, such as CD40, NFkB1, RELA, TLR4, TLR8 and TLR9. Furthermore, we discovered one subgroup of cells within the classical monocytes, which showed alterations of 22 genes e.g. IRF8, CD40, CSF1R, NFkB1, RELA and TNF. Additionally one subgroup within the intermediate and non-classical monocytes also displayed distinct gene signatures by altered expression of 8 and 6 genes, respectively. Hence the three monocyte subsets can be further subdivided according to activation status and differentiation, independently of the traditional classification based on cell surface markers. Demonstrating the use and the ability to discover cell heterogeneity within defined populations of human monocytes is of great importance, and can be useful in unravelling inter-cellular variation in leukocyte populations, identifying subpopulations involved in disease pathogenesis and help tailor new therapies.	[Gren, Susanne T.; Hakansson, Katarina] Novo Nordisk AS, Cellular Pharmacol, Malov, Denmark; [Gren, Susanne T.; Grip, Olof] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Rasmussen, Thomas B.] Copenhagen Univ Hosp, Clin Immunol, Copenhagen, Denmark; [Janciauskiene, Sabina] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Gerwien, Jens G.] Novo Nordisk AS, Global Biobanking Management, Malov, Denmark	Novo Nordisk; Lund University; University of Copenhagen; Hannover Medical School; Novo Nordisk	Grip, O (corresponding author), Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden.	olof.grip@med.lu.se		Gren, Susanne Thiesen/0000-0003-4162-8083	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation	This work was supported by grants from Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation (http://en.fi.dk/funding/funding-opportunities/industrial-phdprogramme). The funder provided support in the form of salaries for authors [STG, TBR, KH, JGG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; FINGERLE G, 1993, BLOOD, V82, P3170; Grip O, 2007, INFLAMM BOWEL DIS, V13, P566, DOI 10.1002/ibd.20025; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Holmkvist P, 2015, MUCOSAL IMMUNOL, V8, P545, DOI 10.1038/mi.2014.87; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Kippner LE, 2014, PEERJ, V2, DOI 10.7717/peerj.452; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Thiesen S, 2014, J LEUKOCYTE BIOL, V95, P531, DOI 10.1189/jlb.0113021; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V291, P11, DOI 10.1016/j.cellimm.2014.06.008; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	29	70	71	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144351	10.1371/journal.pone.0144351	http://dx.doi.org/10.1371/journal.pone.0144351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650546	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300045
J	Luo, P; Dong, GT; Liu, L; Zhou, H				Luo, Pei; Dong, Gengting; Liu, Liang; Zhou, Hua			The Long-Term Consumption of Ginseng Extract Reduces the Susceptibility of Intermediate-Aged Hearts to Acute Ischemia Reperfusion Injury	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; PANAX-GINSENG; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; RATS; FAILURE; ANGIOGENESIS; DISEASE; YOUNG	Background A large number of experimental studies using young adult subjects have shown that ginseng (Panax ginseng C.A. Meyer) protects against ischemia heart disease. However, ginseng has not been explored for its anti-I/R effect and mechanism of action in the aged myocardium. The present study was designed to evaluate the effects of the long-term consumption of ginseng extract on myocardial I/R in an in vivo rat model and explore the potential underlying mechanism. Methods and Results Young (6-mo-old) and intermediate-aged (18-mo-old) rats were gavaged with either standardized ginseng extract (RSE) at 80 mg/kg or vehicle for 90 days. The rats were sacrificed after LAD coronary artery ligation was performed to induce 30 min of ischemia, followed by 90 min of reperfusion. The myocardial infarct size was measured. Left ventricular function was evaluated using pressure-volume loops. The levels of survival, apoptotic and longevity protein expression were assessed through Western blot analysis. Myocardial pathology was detected through H&E or Masson's trichrome staining. We observed higher infarct expansion with impairment in the LV functional parameters, such as LVSP and LVEDP, in aged rats compared with young rats. Enhanced Akt phosphorylation and eNOS expression in RSE-treated aged hearts were accompanied with reduced infarct size, improved cardiac performance, and inducted survival signals. In contrast, p-Erk and caspase 7 were significantly downregulated in aged rats, suggesting that cardiomyocyte apoptosis was suppressed after RSE treatment. RSE also inhibited caspase-3/7 activation and decreased Bax/Bcl-2 ratio. Consistent with the results of apoptosis, Sirt1 and Sirt3 were significantly increased in the RSE-treated aged heart compared with vehicle-treated I/R, suggesting that the anti-aging effect was correlated with the anti-apoptotic activity of RSE. Conclusion These findings suggest that the long-term consumption of ginseng extract reduced the susceptibility of intermediate-aged hearts to acute ischemia reperfusion injury in rats. These effects might be mediated through the activation of Akt/eNOS, suppression of Erk/caspase 7 and upregulation of Sirt1 and Sirt3 in intermediate-aged rats.	[Luo, Pei; Dong, Gengting; Liu, Liang; Zhou, Hua] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Luo, Pei; Liu, Liang; Zhou, Hua] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China	Macau University of Science & Technology; Hong Kong Baptist University	Liu, L (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Ave Wai Long, Taipa, Macau, Peoples R China.	lliu@must.edu.mo; hzhou@must.edu.mo			Macao Science and Technology Development Fund [071/2011/A3, 073/2011/A3, 052/2013/A2]; Faculty Research Grant of Hong Kong Baptist University [FRG 08-09 II-18]	Macao Science and Technology Development Fund; Faculty Research Grant of Hong Kong Baptist University	This research was supported by the Macao Science and Technology Development Fund (Grant numbers: 071/2011/A3, 073/2011/A3, www.fdct.gov.mo) and the Faculty Research Grant of Hong Kong Baptist University (Grant numbers: FRG 08-09 II-18; URL: www.hkbu.edu.hk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Macao Science and Technology Development Fund (Grant numbers: 071/2011/A3, 073/2011/A3, 052/2013/A2; URL: www.fdct.gov.mo) and the Faculty Research Grant of Hong Kong Baptist University (Grant numbers: FRG 08-09 II-18; URL: www.hkbu.edu.hk).	Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Choi KT, 2008, ACTA PHARMACOL SIN, V29, P1109, DOI 10.1111/j.1745-7254.2008.00869.x; Dai DF, 2012, ANTIOXID REDOX SIGN, V16, P1492, DOI 10.1089/ars.2011.4179; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Forman DE, 1997, J AM COLL CARDIOL, V30, P1872, DOI 10.1016/S0735-1097(97)00411-7; Fromm Annette, 2014, BMC Res Notes, V7, P176, DOI 10.1186/1756-0500-7-176; Fu Y, 2003, J NUTR, V133, P3603, DOI 10.1093/jn/133.11.3603; Gould KE, 2002, AM J PHYSIOL-HEART C, V282, pH615, DOI 10.1152/ajpheart.00206.2001; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; HOIT BD, 1986, CIRCULATION, V74, P712, DOI 10.1161/01.CIR.74.4.712; Im DS, 2013, ACTA PHARMACOL SIN, V34, P1367, DOI 10.1038/aps.2013.100; Joukar S, 2010, CARDIOVASC TOXICOL, V10, P66, DOI 10.1007/s12012-010-9063-1; Karmazyn M, 2011, DRUGS, V71, P1989, DOI 10.2165/11594300-000000000-00000; Kim JH, 2012, J GINSENG RES, V36, P16, DOI 10.5142/jgr.2012.36.1.16; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Lindsey ML, 2006, AM J PHYSIOL-HEART C, V290, pH232, DOI 10.1152/ajpheart.00457.2005; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Ramesh T, 2012, EXP GERONTOL, V47, P77, DOI 10.1016/j.exger.2011.10.007; Rich MW, 2006, AM J GERIATR CARDIOL, V15, P7, DOI 10.1111/j.1076-7460.2006.05273.x; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Weiss RG, 2005, P NATL ACAD SCI USA, V102, P808, DOI 10.1073/pnas.0408962102; Xiang YZ, 2008, PHYTOTHER RES, V22, P851, DOI 10.1002/ptr.2384; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yang YN, 2008, AM J PHYSIOL-HEART C, V294, pH1815, DOI 10.1152/ajpheart.00831.2007; Zhou H, 2011, J ETHNOPHARMACOL, V135, P287, DOI 10.1016/j.jep.2011.03.015	33	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144733	10.1371/journal.pone.0144733	http://dx.doi.org/10.1371/journal.pone.0144733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650753	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300071
J	O'Quin, KE; Doshi, P; Lyon, A; Hoenemeyer, E; Yoshizawa, M; Jeffery, WR				O'Quin, Kelly E.; Doshi, Pooja; Lyon, Anastasia; Hoenemeyer, Emma; Yoshizawa, Masato; Jeffery, William R.			Complex Evolutionary and Genetic Patterns Characterize the Loss of Scleral Ossification in the Blind Cavefish Astyanax mexicanus	PLOS ONE			English	Article							REGRESSIVE EVOLUTION; SKELETAL ELEMENTS; EYE-SIZE; OSSICLES; POPULATIONS; CHARACIDAE; TELEOSTEI; FISH; CONVERGENCE; ADAPTATIONS	The sclera is the tough outer covering of the eye that provides structural support and helps maintain intraocular pressure. In some fishes, reptiles, and birds, the sclera is reinforced with an additional ring of hyaline cartilage or bone that forms from scleral ossicles. Currently, the evolutionary and genetic basis of scleral ossification is poorly understood, especially in teleost fishes. We assessed scleral ossification among several groups of the Mexican tetra (Astyanax mexicanus), which exhibit both an eyed and eyeless morph. Although eyed Astyanax surface fish have bony sclera similar to other teleosts, the ossicles of blind Astyanax cavefish generally do not form. We first sampled cavefish from multiple independent populations and used ancestral character state reconstructions to determine how many times scleral ossification has been lost. We then confirmed these results by assessing complementation of scleral ossification among the F-1 hybrid progeny of two cavefish populations. Finally, we quantified the number of scleral ossicles present among the F-2 hybrid progeny of a cross between surface fish and cavefish, and used this information to identify quantitative trait loci (QTL) responsible for this trait. Our results indicate that the loss of scleral ossification is common-but not ubiquitous-among Astyanax cavefish, and that this trait has been convergently lost at least three times. The presence of wild-type, ossified sclera among the F1 hybrid progeny of a cross between different cavefish populations confirms the convergent evolution of this trait. However, a strongly skewed distribution of scleral ossicles found among surface fish x cavefish F-2 hybrids suggests that scleral ossification is a threshold trait with a complex genetic basis. Quantitative genetic mapping identified a single QTL for scleral ossification on Astyanax linkage group 1. We estimate that the threshold for this trait is likely determined by at least three genetic factors which may control the severity and onset of lens degeneration in cavefishes. We conclude that complex evolutionary and genetic patterns underlie the loss of scleral ossification in Astyanax cavefish.	[O'Quin, Kelly E.; Lyon, Anastasia; Hoenemeyer, Emma] Ctr Coll Danville, Biol Program, Danville, KY 40422 USA; [Doshi, Pooja; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Yoshizawa, Masato] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	University System of Maryland; University of Maryland College Park; University of Hawaii System; University of Hawaii Manoa	O'Quin, KE (corresponding author), Ctr Coll Danville, Biol Program, Danville, KY 40422 USA.	kelly.oquin@centre.edu	Yoshizawa, Masato/AAE-9415-2022; Yoshizawa, Masato/AFD-8467-2022	Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-8455-8252; Lyon, Anastasia/0000-0002-7365-4035	National Science Foundation [IBN-05384]; National Institutes of Health [R01-EY014619, R01-EY024941]; NATIONAL EYE INSTITUTE [R01EY024941] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Science Foundation (IBN-05384) and National Institutes of Health (R01-EY014619 and R01-EY024941) to WRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3769; Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Borowsky R, 2008, CURR BIOL, V18, pR23, DOI 10.1016/j.cub.2007.11.023; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Coghill LM, 2014, MOL PHYLOGENET EVOL, V79, P368, DOI 10.1016/j.ympev.2014.06.029; COULOMBRE J, 1975, DEV BIOL, V45, P291, DOI 10.1016/0012-1606(75)90067-6; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Duench K, 2012, DEV BIOL, V365, P251, DOI 10.1016/j.ydbio.2012.02.016; Dufton M, 2015, DEV DYNAM, V244, P1109, DOI 10.1002/dvdy.24278; Dufton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050308; EDINGER TILLY, 1929, ZOOL JAHRB ABT ANAT U ONTOGEN TIERE, V51, P163; Elipot Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4647; Espinasa L, 2001, ENVIRON BIOL FISH, V62, P339, DOI 10.1023/A:1011852603162; Franz-Odendaal TA, 2008, ANAT REC, V291, P161, DOI 10.1002/ar.20639; Franz-Odendaal TA, 2007, J EXP ZOOL PART B, V308B, P709, DOI 10.1002/jez.b.21185; Franz-Odendaal TA, 2006, J MORPHOL, V267, P1326, DOI 10.1002/jmor.10479; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hall B.K., 2015, BONES CARTILAGE DEV; Hanken J., 1981, Functional Photography, V16, P22; Jeffery WR, 2003, INTEGR COMP BIOL, V43, P531, DOI 10.1093/icb/43.4.531; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Koktekir BE, 2014, J CRANIOFAC SURG, V25, pE562, DOI 10.1097/SCS.0000000000001109; LANGECKER TG, 1993, COPEIA, P976; Lynch M., 1998, GENETICS ANAL QUANTI; Maddison W, 2014, MESQUITE MODUAL SYST, V2, P75; Manichaikul A, 2009, GENETICS, V181, P1077, DOI 10.1534/genetics.108.094565; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Mok HK, 2012, ZOOL STUD, V51, P1490; MULLANEY J, 1971, BRIT J OPHTHALMOL, V55, P243, DOI 10.1136/bjo.55.4.243; O'Quin KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057281; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PALMOSKI MJ, 1970, J EXP ZOOL, V174, P157, DOI 10.1002/jez.1401740205; Pecorella I, 2006, ORBIT, V25, P35, DOI 10.1080/01676830500505962; PINTO CB, 1991, J EXP ZOOL, V259, P92, DOI 10.1002/jez.1402590112; Poulson TL, 2001, ENVIRON BIOL FISH, V62, P345, DOI 10.1023/A:1011893916855; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Rasband WS, 2014, IMAGEJ; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schobert CS, 2013, VET OPHTHALMOL, V16, P359, DOI 10.1111/vop.12006; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Thompson H, 2010, DEV BIOL, V347, P40, DOI 10.1016/j.ydbio.2010.08.006; Wilkens H, 2003, BIOL J LINN SOC, V80, P545, DOI 10.1111/j.1095-8312.2003.00230.x; WILKENS H, 1971, EVOLUTION, V25, P530, DOI 10.1111/j.1558-5646.1971.tb01913.x; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Wright S, 1934, GENETICS, V19, P0537; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108	53	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142208	10.1371/journal.pone.0142208	http://dx.doi.org/10.1371/journal.pone.0142208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649887	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903300005
J	Oettler, J; Nachtigal, AL; Schrader, L				Oettler, Jan; Nachtigal, Anna-Lena; Schrader, Lukas			Expression of the Foraging Gene Is Associated with Age Polyethism, Not Task Preference, in the Ant Cardiocondyla obscurior	PLOS ONE			English	Article							DIVISION-OF-LABOR; HARVESTER ANT; PLASTICITY; SOCIETIES; BEHAVIORS; COLONIES	One of the fundamental principles of social organization, age polyethism, describes behavioral maturation of workers leading to switches in task preference. Here we present a system that allows for studying division of labor (DOL) by taking advantage of the relative short life of Cardiocondyla obscurior workers and thereby the pace of behavioral transitions. By challenging same-age young and older age cohorts to de novo establish DOL into nurse and foraging tasks and by forcing nurses to precociously become foragers and vice versa we studied expression patterns of one of the best known candidates for social insect worker behavior, the foraging gene. Contrary to our expectations we found that foraging gene expression correlates with age, but not with the task foraging per se. This suggests that this nutrition-related gene, and the pathways it is embedded in, correlates with physiological changes over time and potentially primes, but not determines task preference of individual workers.	[Oettler, Jan; Nachtigal, Anna-Lena; Schrader, Lukas] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany	University of Regensburg	Oettler, J (corresponding author), Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany.	joettler@gmail.com	Schrader, Lukas/AAU-6061-2021	Schrader, Lukas/0000-0001-9863-0526	Deutsche Forschungsgemeinschaft [He 1623/23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (www.dfg.de) grant: He 1623/23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bressan JMA, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00166; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Holbrook CT, 2014, ANIM BEHAV, V97, P177, DOI 10.1016/j.anbehav.2014.09.015; Ingram KK, 2005, MOL ECOL, V14, P813, DOI 10.1111/j.1365-294X.2005.02450.x; Ingram Krista K., 2011, BMC Ecology, V11, P19, DOI 10.1186/1472-6785-11-19; Julian GE, 2004, ANIM BEHAV, V68, P1, DOI 10.1016/j.anbehav.2003.06.023; Kaun KR, 2009, GENOME, V52, P1, DOI 10.1139/G08-090; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Lucas C, 2010, ARCH INSECT BIOCHEM, V74, P52, DOI 10.1002/arch.20363; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Modlmeier AP, 2012, P ROY SOC B-BIOL SCI, V279, P2142, DOI 10.1098/rspb.2011.2376; Oettler J, 2009, J INSECT BEHAV, V22, P217, DOI 10.1007/s10905-008-9167-7; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrader L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6495; Schwander T, 2011, TRENDS ECOL EVOL, V26, P143, DOI 10.1016/j.tree.2010.12.010; Uller T, 2011, TRENDS ECOL EVOL, V26, P435, DOI 10.1016/j.tree.2011.05.013; Waddington SJ, 2010, BEHAV ECOL, V21, P1165, DOI 10.1093/beheco/arq128; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wiernasz DC, 2008, MOL ECOL, V17, P1137, DOI 10.1111/j.1365-294X.2007.03646.x	28	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144699	10.1371/journal.pone.0144699	http://dx.doi.org/10.1371/journal.pone.0144699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650238	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300067
J	Plevock, KM; Galletta, BJ; Slep, KC; Rusan, NM				Plevock, Karen M.; Galletta, Brian J.; Slep, Kevin C.; Rusan, Nasser M.			Newly Characterized Region of CP190 Associates with Microtubules and Mediates Proper Spindle Morphology in Drosophila Stem Cells	PLOS ONE			English	Article							CENTROSOME-ASSOCIATED PROTEIN; ORDER CHROMATIN ORGANIZATION; INSULATOR PROTEINS; BINDING; TUBULIN; COMPLEX; LOCALIZATION; MELANOGASTER; DOMAIN	CP190 is a large, multi-domain protein, first identified as a centrosome protein with oscillatory localization over the course of the cell cycle. During interphase it has a well-established role within the nucleus as a chromatin insulator. Upon nuclear envelope breakdown, there is a striking redistribution of CP190 to centrosomes and the mitotic spindle, in addition to the population at chromosomes. Here, we investigate CP190 in detail by performing domain analysis in cultured Drosophila S2 cells combined with protein structure determination by X-ray crystallography, in vitro biochemical characterization, and in vivo fixed and live imaging of cp190 mutant flies. Our analysis of CP190 identifies a novel N-terminal centrosome and microtubule (MT) targeting region, sufficient for spindle localization. This region consists of a highly conserved BTB domain and a linker region that serves as the MT binding domain. We present the 2.5 resolution structure of the CP190 N-terminal 126 amino acids, which adopts a canonical BTB domain fold and exists as a stable dimer in solution. The ability of the linker region to robustly localize to MTs requires BTB domain-mediated dimerization. Deletion of the linker region using CRISPR significantly alters spindle morphology and leads to DNA segregation errors in the developing Drosophila brain neuroblasts. Collectively, we highlight a multivalent MT-binding architecture in CP190, which confers distinct subcellular cytoskeletal localization and function during mitosis.	[Plevock, Karen M.; Galletta, Brian J.; Rusan, Nasser M.] NIH, Cell Biol & Physiol Ctr, Natl Heart Lung & Blood Inst, Bethesda, MD 20892 USA; [Plevock, Karen M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu; nasser@nih.gov	Rusan, Nasser/U-2513-2017; Rusan, Nasser/P-3511-2016		National Institutes of Health [R01GM094415, T32GM008570]; Division of Intramural Research, National Heart Lung and Blood Institute [1ZIAHL006104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570, R01GM094415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant nos. R01GM094415, T32GM008570), and the Division of Intramural Research, National Heart Lung and Blood Institute (grant no. 1ZIAHL006104). Other than the grants listed above, the authors received no additional funding for this work.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahanger SH, 2013, NUCLEUS-AUSTIN, V4, P115, DOI 10.4161/nucl.23389; Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Butcher RDJ, 2004, J CELL SCI, V117, P1191, DOI 10.1242/jcs.00979; Campbell JN, 2011, METHODS MOL BIOL, V777, P87, DOI 10.1007/978-1-61779-252-6_6; Chodagam S, 2005, CURR BIOL, V15, P1308, DOI 10.1016/j.cub.2005.06.024; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Huang AM., 2009, COLD SPRING HARB PRO; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; KELLOGG DR, 1989, J CELL BIOL, V109, P2977, DOI 10.1083/jcb.109.6.2977; KELLOGG DR, 1992, MOL BIOL CELL, V3, P1, DOI 10.1091/mbc.3.1.1; Korenjak M, 2014, NUCLEIC ACIDS RES, V42, P8939, DOI 10.1093/nar/gku609; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Lerit DA, 2014, JOVE-J VIS EXP, DOI 10.3791/51756; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; OEGEMA K, 1995, J CELL BIOL, V131, P1261, DOI 10.1083/jcb.131.5.1261; Oegema K, 1997, J CELL SCI, V110, P1573; Oliver D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-101; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Vogelmann J, 2011, NUCLEUS-PHILA, V2, P358, DOI 10.4161/nucl.2.5.17860; Wallace HA, 2010, CHROMOSOMA, V119, P177, DOI 10.1007/s00412-009-0246-0; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; WHITFIELD WGF, 1995, J CELL SCI, V108, P3377	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144174	10.1371/journal.pone.0144174	http://dx.doi.org/10.1371/journal.pone.0144174			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649574	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300039
J	Kan, LJ; Smith, A; Chen, M; Ledford, BT; Fan, HM; Liu, ZM; He, JQ				Kan, Lijuan; Smith, Aubrie; Chen, Miao; Ledford, Benjamin T.; Fan, Huimin; Liu, Zhongmin; He, Jia-Qiang			Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells	PLOS ONE			English	Article							IN-VITRO; MIGRATION; CARDIOMYOPATHY; ACTIN; HEART; BCL-2; PROLIFERATION; INVOLVEMENT; EXPRESSION; PATHWAYS	Background Recent clinical trials using c-kit(+) human cardiac stem cells (CSCs) demonstrated promising results in increasing cardiac function and improving quality of life. However, CSC efficiency is low, likely due to limited cell survival and engraftment after transplantation. The Rho-associated protein kinase (ROCK) inhibitor, Y-27632, significantly increased cell survival rate, adhesion, and migration in numerous types of cells, including stem cells, suggesting a common feature of the ROCK-mediated apoptotic pathway that may also exist in human CSCs. In this study, we examine the hypothesis that pretreatment of human CSCs with Y-27632 protects cells from Doxorubicin (Dox) induced apoptosis. Methods and Results c-kit(+) CSCs were cultured in CSC medium for 3-5 days followed by 48hr treatment with 0 to 10 mu M Y-27632 alone, 0 to 1.0 mu M Dox alone, or Y-27632 followed by Dox (48hrs). Cell viability, toxicity, proliferation, morphology, migration, Caspase-3 activity, expression levels of apoptotic-related key proteins and c-kit(+) were examined. Results showed that 48hr treatment with Y-27632 alone did not result in great changes in c-kit(+) expression, proliferation, Caspase-3 activity, or apoptosis; however cell viability was significantly increased and cell migration was promoted. These effects likely involve the ROCK/Actin pathways. In contrast, 48hr treatment with Dox alone dramatically increased Caspase-3 activity, resulting in cell death. Although Y-27632 alone did not affect the expression levels of apoptotic-related key factors (p-Akt, Akt, Bcl-2, Bcl-xl, Bax, cleaved Caspase-3, and Caspase-3) under basal conditions, it significantly inhibited the Dox-induced increase in cleaved Caspase-3 and reduced cell death under Dox treatment. Conclusions We conclude that preconditioning human CSCs with Y-27632 significantly reduces Dox-induced cell death and possibly involves the cleaved Caspase-3 and ROCK/Actin pathways. The beneficial effects of Y-27632 may be applied to stem cell-based therapy to increase cell survival rates after transplantation or to act as a cardiac protective agent for Dox-treated cancer patients.	[Kan, Lijuan; Smith, Aubrie; Chen, Miao; Ledford, Benjamin T.; He, Jia-Qiang] Virginia Polytech Inst & State Univ, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Shanghai East Hosp, Res Inst Heart Failure, Shanghai 200092, Peoples R China	Virginia Polytechnic Institute & State University; Tongji University	He, JQ (corresponding author), Virginia Polytech Inst & State Univ, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	jiahe@vt.edu			PI's startup fund; Institute for Critical Technology and Applied Science (ICTAS) at Virginia Polytechnic Institute and State Universit [JFC2014_JIAHE958451025]	PI's startup fund; Institute for Critical Technology and Applied Science (ICTAS) at Virginia Polytechnic Institute and State Universit	This work was supported by the PI's startup fund and a grant from the Institute for Critical Technology and Applied Science (ICTAS) at Virginia Polytechnic Institute and State University (#JFC2014_JIAHE958451025). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Braam SR, 2010, ANN NY ACAD SCI, V1188, P52, DOI 10.1111/j.1749-6632.2009.05083.x; Bueno C, 2010, STEM CELL REV REP, V6, P215, DOI 10.1007/s12015-010-9118-5; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Don CW, 2013, J CELL MOL MED, V17, P1355, DOI 10.1111/jcmm.12147; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Grzanka D, 2013, ACTA HISTOCHEM, V115, P775, DOI 10.1016/j.acthis.2013.04.002; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Heng BC, 2009, TISSUE CELL, V41, P376, DOI 10.1016/j.tice.2009.01.004; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Huigsloot M, 2002, J BIOL CHEM, V277, P35869, DOI 10.1074/jbc.M200378200; Kajstura J, 2012, CIRC RES, V111, P894, DOI 10.1161/CIRCRESAHA.112.273649; Kaushal V, 2004, ENDOTHELIUM-J ENDOTH, V11, P253, DOI 10.1080/10623320490904124; Keith MCL, 2015, CIRC RES, V116, P1216, DOI 10.1161/CIRCRESAHA.116.305557; Kroening S, 2010, J CELL PHYSIOL, V223, P703, DOI 10.1002/jcp.22079; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Monti M, 2013, PHARMACOL RES, V76, P171, DOI 10.1016/j.phrs.2013.08.003; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4; Piltti J, 2015, PROTEOMICS, V15, P2953, DOI 10.1002/pmic.201400417; Pipparelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062095; Sano J, 2005, RES VET SCI, V79, P197, DOI 10.1016/j.rvsc.2005.03.001; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Surma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090758; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tu YP, 1996, BLOOD, V88, P1805, DOI 10.1182/blood.V88.5.1805.bloodjournal8851805; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vichalkovski A, 2005, CELL SIGNAL, V17, P447, DOI 10.1016/j.cellsig.2004.09.010; Wang N, 2011, FOOD CHEM TOXICOL, V49, P2975, DOI 10.1016/j.fct.2011.06.080; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Yu ZY, 2012, NEUROCHEM INT, V61, P1114, DOI 10.1016/j.neuint.2012.08.003; Zhang XJ, 2011, CELL MOL BIOL LETT, V16, P279, DOI 10.2478/s11658-011-0006-z	47	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144513	10.1371/journal.pone.0144513	http://dx.doi.org/10.1371/journal.pone.0144513			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645568	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100027
J	Sun, Y; Gu, XZ; Wang, ZJ; Huang, YM; Wei, YY; Zhang, MM; Tu, K; Pan, LQ				Sun, Ye; Gu, Xinzhe; Wang, Zhenjie; Huang, Yangmin; Wei, Yingying; Zhang, Miaomiao; Tu, Kang; Pan, Leiqing			Growth Simulation and Discrimination of Botrytis cinerea, Rhizopus stolonifer and Colletotrichum acutatum Using Hyperspectral Reflectance Imaging	PLOS ONE			English	Article							CARP CTENOPHARYNGODON-IDELLA; LISTERIA-MONOCYTOGENES; PREDICTIVE MICROBIOLOGY; SCATTERING; PATHOGENS	This research aimed to develop a rapid and nondestructive method to model the growth and discrimination of spoilage fungi, like Botrytis cinerea, Rhizopus stolonifer and Colletotrichum acutatum, based on hyperspectral imaging system (HIS). A hyperspectral imaging system was used to measure the spectral response of fungi inoculated on potato dextrose agar plates and stored at 28 degrees C and 85% RH. The fungi were analyzed every 12 h over two days during growth, and optimal simulation models were built based on HIS parameters. The results showed that the coefficients of determination (R-2) of simulation models for testing datasets were 0.7223 to 0.9914, and the sum square error (SSE) and root mean square error (RMSE) were in a range of 2.03-53.40x10(-4) and 0.011-0.756, respectively. The correlation coefficients between the HIS parameters and colony forming units of fungi were high from 0.887 to 0.957. In addition, fungi species was discriminated by partial least squares discrimination analysis (PLSDA), with the classification accuracy of 97.5% for the test dataset at 36 h. The application of this method in real food has been addressed through the analysis of Botrytis cinerea, Rhizopus stolonifer and Colletotrichum acutatum inoculated in peaches, demonstrating that the HIS technique was effective for simulation of fungal infection in real food. This paper supplied a new technique and useful information for further study into modeling the growth of fungi and detecting fruit spoilage caused by fungi based on HIS.	[Sun, Ye; Gu, Xinzhe; Wang, Zhenjie; Huang, Yangmin; Wei, Yingying; Zhang, Miaomiao; Tu, Kang; Pan, Leiqing] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Pan, LQ (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China.	pan_leiqing@njau.edu.cn	Tu, Kangsheng/N-1544-2019	Tu, Kangsheng/0000-0002-0032-1459; Wei, Yingying/0000-0003-2177-2301	Chinese National Foundation of Natural Science [31101282]; Special Fund for Agro-scientific Research in the Public Interest [201303088]; National Key Technology RD Program [2015BAD19B03]; Grain Industry Public Welfare Scientific Research Special Fund [201313002-01]	Chinese National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Technology RD Program(National Key Technology R&D Program); Grain Industry Public Welfare Scientific Research Special Fund	The research was financially supported by the Chinese National Foundation of Natural Science (31101282), Special Fund for Agro-scientific Research in the Public Interest (201303088), National Key Technology R&D Program (2015BAD19B03) and Grain Industry Public Welfare Scientific Research Special Fund (201313002-01). The authors acknowledge all of the support received.	[Anonymous], 2010, 20104789 GB; Bae E, 2007, APPL OPTICS, V46, P3639, DOI 10.1364/AO.46.003639; Bae E, 2011, J BIOPHOTONICS, V4, P236, DOI 10.1002/jbio.201000051; Banada PP, 2007, BIOSENS BIOELECTRON, V22, P1664, DOI 10.1016/j.bios.2006.07.028; Banada PP, 2009, BIOSENS BIOELECTRON, V24, P1685, DOI 10.1016/j.bios.2008.08.053; Baranyi J, 2014, INT J FOOD MICROBIOL, V170, P78, DOI 10.1016/j.ijfoodmicro.2013.10.018; Bautista-Banos S., 2014, POSTHARVEST DECAY, P1; Bhunia AK, 2014, FUTURE MICROBIOL, V9, P935, DOI [10.2217/FMB.14.61, 10.2217/fmb.14.61]; Cen HY, 2013, POSTHARVEST BIOL TEC, V85, P30, DOI 10.1016/j.postharvbio.2013.04.014; Cheng JH, 2015, LWT-FOOD SCI TECHNOL, V62, P1060, DOI 10.1016/j.lwt.2015.01.021; Cheng JH, 2014, INNOV FOOD SCI EMERG, V21, P179, DOI 10.1016/j.ifset.2013.10.013; Cheng JH, 2014, FOOD RES INT, V56, P190, DOI 10.1016/j.foodres.2013.12.009; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; Del Fiore A, 2010, INT J FOOD MICROBIOL, V144, P64, DOI 10.1016/j.ijfoodmicro.2010.08.001; Delwiche SR, 2000, PROC SPIE, V4203, P13, DOI 10.1117/12.411752; Dowell FE, 2002, CEREAL CHEM, V79, P222, DOI 10.1094/CCHEM.2002.79.2.222; El Ghaouth A, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 2, P219; Enos-Berlage JL, 2000, J BACTERIOL, V182, P5513, DOI 10.1128/JB.182.19.5513-5520.2000; Fernandez-Ibanez V, 2009, FOOD CHEM, V113, P629, DOI 10.1016/j.foodchem.2008.07.049; Gomez-Sanchis J, 2004, 2004 CIGR INT C BEIJ, P11; Gougouli M, 2010, INT J FOOD MICROBIOL, V140, P254, DOI 10.1016/j.ijfoodmicro.2010.03.021; Hahm BK, 2006, J APPL MICROBIOL, V100, P1017, DOI 10.1111/j.1365-2672.2006.02814.x; Haibo Yao, 2008, Sensing and Instrumentation for Food Quality and Safety, V2, P215, DOI 10.1007/s11694-008-9055-z; He HJ, 2013, INNOV FOOD SCI EMERG, V18, P237, DOI 10.1016/j.ifset.2013.02.009; Howard DL, 2006, J PHYS CHEM A, V110, P10245, DOI 10.1021/jp063631+; Iqbal A, 2013, J FOOD ENG, V117, P42, DOI 10.1016/j.jfoodeng.2013.02.001; Jackson R.S., 2014, BOTRYTIS ENCYCL FOOD, VSecond, P288, DOI [10.1016/B978-0-12-384730-0.00042-2, DOI 10.1016/B978-0-12-384730-0.00042-2]; Jasson V, 2010, FOOD MICROBIOL, V27, P710, DOI 10.1016/j.fm.2010.04.008; Jin P, 2009, STUDY REGULATION MEC, P5; KRISHNAN PS, 1954, APPL MICROBIOL, V2, P303, DOI 10.1128/AEM.2.6.303-308.1954; Lathrop AA, 2008, J APPL MICROBIOL, V104, P627, DOI 10.1111/j.1365-2672.2007.03574.x; Li JB, 2011, COMPUT ELECTRON AGR, V78, P38, DOI 10.1016/j.compag.2011.05.010; McDonald K, 1999, INT J FOOD MICROBIOL, V52, P1, DOI 10.1016/S0168-1605(99)00126-9; McMeekin TA, 2002, INT J FOOD MICROBIOL, V73, P395, DOI 10.1016/S0168-1605(01)00663-8; Mollazade K, 2012, FOOD BIOPROCESS TECH, V5, P1465, DOI 10.1007/s11947-012-0821-x; Monk IR, 2004, APPL ENVIRON MICROB, V70, P6686, DOI 10.1128/AEM.70.11.6686-6694.2004; Polder G, 2003, J NEAR INFRARED SPEC, V11, P193, DOI 10.1255/jnirs.366; Qin JW, 2013, J FOOD ENG, V118, P157, DOI 10.1016/j.jfoodeng.2013.04.001; Qing T.S.F., 2000, CHIN B BOT, V17, P211; Siripatrawan U, 2015, INT J FOOD MICROBIOL, V199, P93, DOI 10.1016/j.ijfoodmicro.2015.01.001; Teena MA, 2014, J STORED PROD RES, V59, P306, DOI 10.1016/j.jspr.2014.09.005; [韦莹莹 Wei Yingying], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P183; WHITING RC, 1994, FOOD TECHNOL-CHICAGO, V48, P113; WHITING RC, 1993, FOOD MICROBIOL, V10, P175; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088659; Zou XB, 2010, CHEMOMETR INTELL LAB, V104, P265, DOI 10.1016/j.chemolab.2010.08.019	46	19	19	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143400	10.1371/journal.pone.0143400	http://dx.doi.org/10.1371/journal.pone.0143400			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642054	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700017
J	Theobald, DM; Harrison-Atlas, D; Monahan, WB; Albano, CM				Theobald, David M.; Harrison-Atlas, Dylan; Monahan, William B.; Albano, Christine M.			Ecologically-Relevant Maps of Landforms and Physiographic Diversity for Climate Adaptation Planning	PLOS ONE			English	Article							TOPOGRAPHIC POSITION; SPECIES-DIVERSITY; LAND FACETS; CONSERVATION; BIODIVERSITY; LANDSCAPE; MANAGEMENT; DIVERSIFICATION; HETEROGENEITY; ASSESSMENTS	Key to understanding the implications of climate and land use change on biodiversity and natural resources is to incorporate the physiographic platform on which changes in ecological systems unfold. Here, we advance a detailed classification and high-resolution map of physiography, built by combining landforms and lithology (soil parent material) at multiple spatial scales. We used only relatively static abiotic variables (i.e., excluded climatic and biotic factors) to prevent confounding current ecological patterns and processes with enduring landscape features, and to make the physiographic classification more interpretable for climate adaptation planning. We generated novel spatial databases for 15 landform and 269 physiographic types across the conterminous United States of America. We examined their potential use by natural resource managers by placing them within a contemporary climate change adaptation framework, and found our physiographic databases could play key roles in four of seven general adaptation strategies. We also calculated correlations with common empirical measures of biodiversity to examine the degree to which the physiographic setting explains various aspects of current biodiversity patterns. Additionally, we evaluated the relationship between landform diversity and measures of climate change to explore how changes may unfold across a geophysical template. We found landform types are particularly sensitive to spatial scale, and so we recommend using high-resolution datasets when possible, as well as generating metrics using multiple neighborhood sizes to both minimize and characterize potential unknown biases. We illustrate how our work can inform current strategies for climate change adaptation. The analytical framework and classification of landforms and parent material are easily extendable to other geographies and may be used to promote climate change adaptation in other settings.	[Theobald, David M.; Albano, Christine M.] Conservat Sci Partners, Truckee, CA 96161 USA; [Theobald, David M.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Theobald, David M.; Harrison-Atlas, Dylan] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO USA; [Albano, Christine M.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA	Colorado State University; Colorado State University; United States Department of the Interior; University of California System; University of California Davis	Theobald, DM (corresponding author), Conservat Sci Partners, Truckee, CA 96161 USA.	davet@csp-inc.org			NASA Applied Sciences program [10-BIOCLIM10-0034]	NASA Applied Sciences program(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Applied Sciences program (http://www.nasa.gov/applied-sciences/) through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conservation Science Partners provided support in the form of salaries for authors (DMT, DH-A, CMA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Albano CM, 2015, LANDSCAPE ECOL, V30, P1023, DOI 10.1007/s10980-015-0167-7; Anderson MG, 2014, CONSERV BIOL, V28, P959, DOI 10.1111/cobi.12272; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; [Anonymous], 2011, SCANNING CONSERVATIO; Ashcroft MB, 2012, INT J CLIMATOL, V32, P2134, DOI 10.1002/joc.2428; Bates RL, 1995, GLOSSARY GEOLOGY; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Brierley G, 2006, AREA, V38, P165, DOI 10.1111/j.1475-4762.2006.00671.x; Clement JoelP., 2014, STRATEGY IMPROVING M; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; Davis EB, 2008, MOL ECOL, V17, P120, DOI 10.1111/j.1365-294X.2007.03469.x; Davis FW, 1990, LANDSC ECOL, V4; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; De Reu J, 2013, GEOMORPHOLOGY, V186, P39, DOI 10.1016/j.geomorph.2012.12.015; Deng YX, 2009, COMPUT GEOSCI-UK, V35, P327, DOI 10.1016/j.cageo.2008.08.005; Dickson BG, 2007, J ZOOL, V271, P270, DOI 10.1111/j.1469-7998.2006.00215.x; Dikau R., 1990, Proceedings of the 4th International Symposium on Spatial Data Handling, P230; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Dobrowski SZ, 2010, GLOB CHANG BIOL; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Geiger R., 2003, CLIMATE NEAR GROUND; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gray M., 2004, GEODIVERSITY; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Hammond EH, 1954, ANN ASSOC AM GEOGR, V44, P33; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hjort J, 2015, CONSERV BIOL, V29, P630, DOI 10.1111/cobi.12510; Holden ZA, 2011, FOREST ECOL MANAG, V262, P2133, DOI 10.1016/j.foreco.2011.08.002; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Huston M. A., 1994, BIOL DIVERSITY; Iverson LR, 1997, LANDSCAPE ECOL, V12, P331, DOI 10.1023/A:1007989813501; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Klausmeyer KR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00044.1; Klingseisen B, 2008, ENVIRON MODELL SOFTW, V23, P109, DOI 10.1016/j.envsoft.2007.05.007; Kruckeberg A. R., 2004, GEOLOGY PLANT LIFE E; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; Lawson CR, 2014, ECOGRAPHY, V37, P732, DOI 10.1111/ecog.00535; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; National Fish Wildlife and Plants Climate Adaptation Partnership (NFWPCAP). National Fish Wildlife and Plants Climate Adaptation Strategy, 2011, NAT FISH WILDL PLANT; PEET RK, 1981, VEGETATIO, V45, P3; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Phillips JD, 2006, HYDROL EARTH SYST SC, V3, P365, DOI DOI 10.5194/HESSD-3-365-2006; Pierce KB, 2005, LANDSCAPE ECOL, V20, P137, DOI 10.1007/s10980-004-1296-6; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Potts AJ, 2013, DIVERS DISTRIB, V19, P1418, DOI 10.1111/ddi.12113; Pressey RL, 2000, BIOL CONSERV, V96, P55, DOI 10.1016/S0006-3207(00)00050-1; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Core Team, 2014, R LANG ENV STAT COMP; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Ruhe R.V., 1968, P 9 C INT SOIL SCI S, V4, P551; Sayre R., 2014, NEW MAP GLOBAL ECOLO; Sayre R., 2009, 1768 USGS; Schloss CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028788; Schmitz OJ, 2015, NAT AREA J, V35, P190, DOI 10.3375/043.035.0120; Secretary of the Interior, 2009, 3289 SECR INT; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Soller D. R., 2009, US GEOLOGICAL SURVEY, V425; Stein B.A., 2014, CLIMATE SMART CONSER; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Theobald DM, 2013, LANDSCAPE ECOL, V28, P1859, DOI 10.1007/s10980-013-9941-6; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; Theobald DM, 2000, LANDSCAPE ECOL, V15, P35, DOI 10.1023/A:1008165311026; US Department of Agriculture Natural Resources Conservation Service (NRCS), 2015, NAT SOIL SURV HD 629; US Forest Service (USFS), 2010, FOR SERV GLOB CHANG; US Geological Survey Gap Analysis Program (USGS-GAP), 2010, NAT GAP LAND COV VER; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	82	83	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143619	10.1371/journal.pone.0143619	http://dx.doi.org/10.1371/journal.pone.0143619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641818	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700025
J	Dearborn, AD; Wall, JS; Cheng, NQ; Heymann, JB; Kajava, AV; Varkey, J; Langen, R; Steven, AC				Dearborn, Altaira D.; Wall, Joseph S.; Cheng, Naiqian; Heymann, J. Bernard; Kajava, Andrey V.; Varkey, Jobin; Langen, Ralf; Steven, Alasdair C.			alpha-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; ATOMIC-FORCE MICROSCOPY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LEWY BODIES; IN-VITRO; CORE STRUCTURE; MASS ANALYSIS; FILAMENTS; PROTEIN	Parkinson disease and other progressive neurodegenerative conditions are characterized by the intracerebral presence of Lewy bodies, containing amyloid fibrils of alpha-synuclein. We used cryo-electron microscopy and scanning transmission electron microscopy (STEM) to study in vitro-assembled fibrils. These fibrils are highly polymorphic. Focusing on twisting fibrils with an inter-crossover spacing of 77 nm, our reconstructions showed them to consist of paired protofibrils. STEM mass per length data gave one subunit per 0.47 nm axial rise per protofibril, consistent with a superpleated beta-structure. The STEM images show two thread-like densities running along each of these fibrils, which we interpret as ladders of metal ions. These threads confirmed the two-protofibril architecture of the 77-nm twisting fibrils and allowed us to identify this morphotype in STEM micrographs. Some other, but not all, fibril morphotypes also exhibit dense threads, implying that they also present a putative metal binding site. We propose a molecular model for the protofibril and suggest that polymorphic variant fibrils have different numbers of protofibrils that are associated differently.	[Dearborn, Altaira D.; Cheng, Naiqian; Heymann, J. Bernard; Steven, Alasdair C.] Natl Inst Hlth, Struct Biol Res Lab, Natl Inst Arthrit & Musculoskeletal & Skin Dis, Bethesda, MD 20892 USA; [Wall, Joseph S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Kajava, Andrey V.] Univ Montpellier, Ctr Rech Biochim Macromol, CNRS, F-34172 Montpellier, France; [Kajava, Andrey V.] Univ ITMO, Inst Bioengn, St Petersburg 197101, Russia; [Varkey, Jobin; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Varkey, Jobin] Karunya Univ, Coimbatore 641114, Tamil Nadu, India; Natl Inst Hlth, NIAMS, Struct Biol Res Lab, Bldg 50,Rm 1517,50 South Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Energy (DOE); Brookhaven National Laboratory; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; ITMO University; University of Southern California; Karunya Institute of Technology & Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steven, AC (corresponding author), Natl Inst Hlth, NIAMS, Struct Biol Res Lab, Bldg 50,Rm 1517,50 South Dr, Bethesda, MD 20892 USA.	stevena@mail.nih.gov	Kajava, Andrey V/E-1107-2014; Heymann, Bernard/H-8265-2019; Varkey, Jobin/I-5845-2019	Kajava, Andrey V/0000-0002-2342-6886; Heymann, Bernard/0000-0002-8872-5326; Dearborn, Altaira/0000-0003-0463-5233	NIAMS/National Institutes of Health; National Institutes of Health [1R01NS084345]; DBT-Ramalingaswami fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DBT-Ramalingaswami fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the intramural research program of NIAMS/National Institutes of Health (to A. C. S.) and National Institutes of Health Grant 1R01NS084345 (to R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a DBT-Ramalingaswami fellowship.	Adamcik J, 2010, NAT NANOTECHNOL, V5, P423, DOI [10.1038/nnano.2010.59, 10.1038/NNANO.2010.59]; Ahmed AB, 2015, ALZHEIMERS DEMENT, V11, P681, DOI 10.1016/j.jalz.2014.06.007; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Dudzik CG, 2011, BIOCHEMISTRY-US, V50, P1771, DOI 10.1021/bi101912q; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Goedert M, 1998, BIOCHEM SOC T, V26, P463, DOI 10.1042/bst0260463; Goldsbury C, 2011, J STRUCT BIOL, V173, P1, DOI 10.1016/j.jsb.2010.09.018; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; KSIEZAKREDING H, 1994, NEUROBIOL AGING, V15, P11, DOI 10.1016/0197-4580(94)90140-6; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Santner A, 2010, METALLOMICS, V2, P378, DOI 10.1039/b926659c; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THOMAS D, 1994, BIOL CELL, V80, P181, DOI 10.1016/0248-4900(94)90041-8; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wall JS, 2008, METHOD ENZYMOL, V436, P487, DOI 10.1016/S0076-6879(08)36027-3; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050	43	38	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2310	2318		10.1074/jbc.M115.698787	http://dx.doi.org/10.1074/jbc.M115.698787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644467	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000369610400021
J	Moeller, HB; Slengerik-Hansen, J; Aroankins, T; Assentoft, M; MacAulay, N; Moestrup, SK; Bhalla, V; Fenton, RA				Moeller, Hanne B.; Slengerik-Hansen, Joachim; Aroankins, Takwa; Assentoft, Mette; MacAulay, Nanna; Moestrup, Soeren K.; Bhalla, Vivek; Fenton, Robert A.			Regulation of the Water Channel Aquaporin-2 via 14-3-3 theta and-zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL MEMBRANE; PHOSPHORYLATION; PROTEINS; ENDOCYTOSIS; CELLS; IDENTIFICATION; EXPRESSION; SERUM; AQP2; 14-3-3-PROTEINS	The 14-3-3 family of proteins are multifunctional proteins that interact with many of their cellular targets in a phosphorylation-dependent manner. Here, we determined that 14-3-3 proteins interact with phosphorylated forms of the water channel aquaporin-2 (AQP2) and modulate its function. With the exception of sigma, all 14-3-3 isoforms were abundantly expressed in mouse kidney and mouse kidney collecting duct cells (mpkCCD(14)). Long-term treatment of mpkCCD(14) cells with the type 2 vasopressin receptor agonist dDAVP increased mRNA and protein levels of AQP2 alongside 14-3-3 beta and -zeta, whereas levels of 14-3-3 eta and -theta were decreased. Co-immunoprecipitation (co-IP) studies in mpkCCD(14) cells uncovered an AQP2/14-3-3 interaction that was modulated by acute dDAVP treatment. Additional co-IP studies in HEK293 cells determined that AQP2 interacts selectively with 14-3-3 zeta and -theta. Use of phosphatase inhibitors in mpkCCD(14) cells, co-IP with phosphorylation deficient forms of AQP2 expressed in HEK293 cells, or surface plasmon resonance studies determined that the AQP2/14-3-3 interaction was modulated by phosphorylation of AQP2 at various sites in its carboxyl terminus, with Ser-256 phosphorylation critical for the interactions. shRNA-mediated knockdown of 14-3-3 zeta in mpkCCD(14) cells resulted in increased AQP2 ubiquitylation, decreased AQP2 protein half-life, and reduced AQP2 levels. In contrast, knockdown of 14-3-3 theta resulted in increased AQP2 half-life and increased AQP2 levels. In conclusion, this study demonstrates phosphorylation-dependent interactions of AQP2 with 14-3-3 theta and -zeta. These interactions play divergent roles in modulating AQP2 trafficking, phosphorylation, ubiquitylation, and degradation.	[Moeller, Hanne B.; Slengerik-Hansen, Joachim; Aroankins, Takwa; Moestrup, Soeren K.; Fenton, Robert A.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Moeller, Hanne B.; Slengerik-Hansen, Joachim; Aroankins, Takwa; Moestrup, Soeren K.; Fenton, Robert A.] Aarhus Univ, Ctr Interact Proteins Epithelial Transport, DK-8000 Aarhus, Denmark; [Assentoft, Mette; MacAulay, Nanna] Univ Copenhagen, Dept Neurosci & Pharmacol, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Moestrup, Soeren K.] Univ Southern Denmark, Inst Mol Med, DK-5000 Odense, Denmark; [Bhalla, Vivek] Stanford Univ, Dept Med, Div Nephrol, Palo Alto, CA 94305 USA	Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark; Stanford University	Fenton, RA (corresponding author), Bldg 1233,Rm 213,Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark.	robert.a.fenton@biomed.au.dk	Fenton, Robert A/ABD-9824-2021; Moestrup, Søren Kragh/AAD-1735-2019; Fenton, Robert/AFR-6983-2022; MacAulay, Nanna/AER-7709-2022; Moestrup, Soren Kragh/A-1403-2014	Fenton, Robert/0000-0003-1623-199X; MacAulay, Nanna/0000-0002-7800-6600; Bhalla, Vivek/0000-0002-5420-9657; Moestrup, Soren Kragh/0000-0003-3862-2107	Danish Medical Research Council; Lundbeck Foundation; Novo Nordisk Foundation; Carlsberg Foundation; MEMBRANES; Aarhus University Research Foundation; Lundbeck Foundation [R54-2010-5398] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); MEMBRANES; Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation, the Carlsberg Foundation, MEMBRANES, and the Aarhus University Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Chandran S, 2011, J BIOL CHEM, V286, P37830, DOI 10.1074/jbc.M111.293233; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Feng XY, 2015, AM J PHYSIOL-RENAL, V309, pF71, DOI 10.1152/ajprenal.00546.2014; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; He YF, 2009, PROTEOMICS, V9, P5414, DOI 10.1002/pmic.200800864; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kortenoeven MLA, 2015, AM J PHYSIOL-RENAL, V309, pF280, DOI 10.1152/ajprenal.00093.2015; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Liang SF, 2009, ELECTROPHORESIS, V30, P4152, DOI 10.1002/elps.200900249; Liang SF, 2009, J CHROMATOGR B, V877, P627, DOI 10.1016/j.jchromb.2009.01.023; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Moeller HB, 2012, PFLUG ARCH EUR J PHY, V464, P133, DOI 10.1007/s00424-012-1129-4; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Panni S, 2011, PROTEOMICS, V11, P128, DOI 10.1002/pmic.201000030; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Pisitkun T, 2006, PHYSIOL GENOMICS, V25, P263, DOI 10.1152/physiolgenomics.00214.2005; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106	49	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2469	2484		10.1074/jbc.M115.691121	http://dx.doi.org/10.1074/jbc.M115.691121			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645691	hybrid, Green Published			2022-12-26	WOS:000369610400035
J	Alocci, D; Mariethoz, J; Horlacher, O; Bolleman, JT; Campbell, MP; Lisacek, F				Alocci, Davide; Mariethoz, Julien; Horlacher, Oliver; Bolleman, Jerven T.; Campbell, Matthew P.; Lisacek, Frederique			Property Graph vs RDF Triple Store: A Comparison on Glycan Substructure Search	PLOS ONE			English	Article							GLYCOMICS DATA; NOMENCLATURE; REPRESENTATION; PLATFORM	Resource description framework (RDF) and Property Graph databases are emerging technologies that are used for storing graph-structured data. We compare these technologies through a molecular biology use case: glycan substructure search. Glycans are branched tree-like molecules composed of building blocks linked together by chemical bonds. The molecular structure of a glycan can be encoded into a direct acyclic graph where each node represents a building block and each edge serves as a chemical linkage between two building blocks. In this context, Graph databases are possible software solutions for storing glycan structures and Graph query languages, such as SPARQL and Cypher, can be used to perform a substructure search. Glycan substructure searching is an important feature for querying structure and experimental glycan databases and retrieving biologically meaningful data. This applies for example to identifying a region of the glycan recognised by a glycan binding protein (GBP). In this study, 19,404 glycan structures were selected from Glycome-DB (www.glycome-db.org) and modelled for being stored into a RDF triple store and a Property Graph. We then performed two different sets of searches and compared the query response times and the results from both technologies to assess performance and accuracy. The two implementations produced the same results, but interestingly we noted a difference in the query response times. Qualitative measures such as portability were also used to define further criteria for choosing the technology adapted to solving glycan substructure search and other comparable issues.	[Alocci, Davide; Mariethoz, Julien; Horlacher, Oliver; Lisacek, Frederique] SIB Swiss Inst Bioinformat, Proteome Informat Grp, CH-1211 Geneva, Switzerland; [Alocci, Davide; Horlacher, Oliver; Lisacek, Frederique] Univ Geneva, Dept Comp Sci, CH-1227 Geneva, Switzerland; [Bolleman, Jerven T.] SIB Swiss Inst Bioinformat, Swiss Prot Grp, CH-1211 Geneva, Switzerland; [Campbell, Matthew P.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	Swiss Institute of Bioinformatics; University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; Macquarie University	Lisacek, F (corresponding author), SIB Swiss Inst Bioinformat, Proteome Informat Grp, CH-1211 Geneva, Switzerland.	Frederique.lisacek@isb-sib.ch	; Campbell, Matthew/D-8874-2015	Mariethoz, Julien/0000-0001-8974-4417; LISACEK, Frederique/0000-0002-0948-4537; Campbell, Matthew/0000-0002-9525-792X; Bolleman, Jerven/0000-0002-7449-1266	Seventh Framework Programme - Initial Training Network [316929]; Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; EU-ITN (FP7-PEOPLE-ITN) [316929]; Australian National eResearch Collaboration Tools and Resources project (NeCTAR)	Seventh Framework Programme - Initial Training Network; Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; EU-ITN (FP7-PEOPLE-ITN); Australian National eResearch Collaboration Tools and Resources project (NeCTAR)	This work is supported by the Seventh Framework Programme - Initial Training Network No 316929 (http://ec.europa.eu/research/fp7/index_en.cfm). The grant recipient is FL. This activity at SIB is supported by the Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI. DA is supported by EU-ITN (FP7-PEOPLE-2012-ITN # 316929). MPC acknowledges funding support from the Australian National eResearch Collaboration Tools and Resources project (NeCTAR).	Angles R, 2013, 1 INT WORKSH GRAPH D, DOI 10.1145/2484425.2484440; [Anonymous], RESOURCE DESCRIPTION; [Anonymous], BLAZ ULTR HIGH PERF; Aoki KF, 2004, NUCLEIC ACIDS RES, V32, pW267, DOI 10.1093/nar/gkh473; Aoki-Kinoshita KF, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-39; Aoki-Kinoshita Kiyoko F, 2008, Seikagaku, V80, P1038; Auer S, 2007, LECT NOTES COMPUT SC, V4825, P722, DOI 10.1007/978-3-540-76298-0_52; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Broekstra J., 2002, ISWC, V2002, P54, DOI DOI 10.1007/3-540-48005-6_; Campbell MP, 2014, NUCLEIC ACIDS RES, V42, pD215, DOI 10.1093/nar/gkt1128; Campbell MP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S9; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; DOUBET S, 1992, GLYCOBIOLOGY, V2, P505, DOI 10.1093/glycob/2.6.505; Erling O., 2009, NETWORKED KNOWLEDGE, P7; Herget S, 2008, CARBOHYD RES, V343, P2162, DOI 10.1016/j.carres.2008.03.011; Holzschuher F., 2013, P GRAPHQ EDBT ICDT 1, P195, DOI DOI 10.1145/2457317.2457351; Horlacher O, 2015, J PROTEOMICS, V129, P63, DOI 10.1016/j.jprot.2015.06.013; Kawasaki T., 2008, EXPT GLYCOSCIENCE, P429, DOI [10.1007/978-4-431-77922-3_104, DOI 10.1007/978-4-431-77922-3_104]; Kotera M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S2; McNaught AD, 1997, CARBOHYD RES, V297, P1, DOI 10.1016/S0008-6215(97)83449-0; Ranzinger R, 2015, BIOINFORMATICS, V31, P919, DOI 10.1093/bioinformatics/btu732; Ranzinger R, 2011, NUCLEIC ACIDS RES, V39, pD373, DOI 10.1093/nar/gkq1014; Sahoo SS, 2005, CARBOHYD RES, V340, P2802, DOI 10.1016/j.carres.2005.09.019; SHARON N, 1986, GLYCOCONJUGATE J, V3, P123, DOI 10.1007/BF01049370; Tanaka K, 2014, J CHEM INF MODEL, V54, P1558, DOI 10.1021/ci400571e; Toukach PV, 2016, NUCLEIC ACIDS RES, V44, pD1229, DOI 10.1093/nar/gkv840; Varki A., 1999, ESSENTIALS GLYCOBIOL; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; von der Lieth CW, 2011, GLYCOBIOLOGY, V21, P493, DOI 10.1093/glycob/cwq188; York William S., GLYDE 2 GLYCAN STRUC	30	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144578	10.1371/journal.pone.0144578	http://dx.doi.org/10.1371/journal.pone.0144578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656740	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900066
J	Mateescu, M; Baixe, S; Garnier, T; Jierry, L; Ball, V; Haikel, Y; Metz-Boutigue, MH; Nardin, M; Schaaf, P; Etienne, O; Lavalle, P				Mateescu, Mihaela; Baixe, Sebastien; Garnier, Tony; Jierry, Loic; Ball, Vincent; Haikel, Youssef; Metz-Boutigue, Marie Helene; Nardin, Michel; Schaaf, Pierre; Etienne, Olivier; Lavalle, Philippe			Antibacterial Peptide-Based Gel for Prevention of Medical Implanted-Device Infection	PLOS ONE			English	Article							RELEASE-INHIBITORY PEPTIDE; IN-VITRO; CHROMOGRANIN-A; DENTAL IMPLANTS; SOL-GEL; CATESTATIN; HYDROGELS; SURFACES; VIVO; ANTIBIOTICS	Implanted medical devices are prone to infection. Designing new strategies to reduce infection and implant rejection are an important challenge for modern medicine. To this end, in the last few years many hydrogels have been designed as matrices for antimicrobial molecules destined to fight frequent infection found in moist environments like the oral cavity. In this study, two types of original hydrogels containing the antimicrobial peptide Cateslytin have been designed. The first hydrogel is based on alginate modified with catechol moieties (AC gel). The choice of these catechol functional groups which derive from mussel's catechol originates from their strong adhesion properties on various surfaces. The second type of gel we tested is a mixture of alginate catechol and thiol-terminated Pluronic (AC/PlubisSH), a polymer derived from Pluronic, a well-known biocompatible polymer. This PlubisSH polymer has been chosen for its capacity to enhance the cohesion of the composition. These two gels offer new clinical uses, as they can be injected and jellify in a few minutes. Moreover, we show these gels strongly adhere to implant surfaces and gingiva. Once gelled, they demonstrate a high level of rheological properties and stability. In particular, the dissipative energy of the (AC/PlubisSH) gel detachment reaches a high value on gingiva (10 J.m(-2)) and on titanium alloys (4 J.m(-2)), conferring a strong mechanical barrier. Moreover, the Cateslytin peptide in hydrogels exhibited potent antimicrobial activities against P. gingivalis, where a strong inhibition of bacterial metabolic activity and viability was observed, indicating reduced virulence. Gel biocompatibility tests indicate no signs of toxicity. In conclusion, these new hydrogels could be ideal candidates in the prevention and/or management of periimplant diseases.	[Mateescu, Mihaela; Baixe, Sebastien; Ball, Vincent; Haikel, Youssef; Metz-Boutigue, Marie Helene; Schaaf, Pierre; Etienne, Olivier; Lavalle, Philippe] INSERM, UMR S 1121, Biomat & Bioingn, Strasbourg, France; [Mateescu, Mihaela; Baixe, Sebastien; Ball, Vincent; Haikel, Youssef; Metz-Boutigue, Marie Helene; Schaaf, Pierre; Etienne, Olivier; Lavalle, Philippe] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France; [Garnier, Tony; Jierry, Loic; Schaaf, Pierre] Univ Strasbourg, CNRS, Inst Charles Sadron, Strasbourg, France; [Nardin, Michel] CNRS, LRC 7228, Inst Sci Mat Mulhouse, Mulhouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA)	Etienne, O (corresponding author), INSERM, UMR S 1121, Biomat & Bioingn, Strasbourg, France.	olivier.etienne@unistra.fr	ETIENNE, olivier/D-1601-2013; SCHAAF, Pierre/J-2751-2016; etienne, olivier/D-9542-2011; Lavalle, Philippe/E-6328-2016; BALL, Vincent VB/E-8500-2016	ETIENNE, olivier/0000-0001-8870-4659; SCHAAF, Pierre/0000-0001-7423-5492; etienne, olivier/0000-0001-8870-4659; Lavalle, Philippe/0000-0001-8798-912X; JIERRY, Loic/0000-0002-7541-1360	Projet MICA Dopaglue	Projet MICA Dopaglue	This work was supported by Projet MICA Dopaglue (http://www.instituts-carnot.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Al N, 2011, MACROMOLECULAR BIOSC, V11, P1264, DOI [10.1002/mabi.201100083, DOI 10.1002/MABI.201100083]; Akaddar A, 2010, CELL MOL LIFE SCI, V67, P1005, DOI 10.1007/s00018-009-0235-8; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Ben-Nissan B, 2006, NANOMEDICINE-UK, V1, P311, DOI 10.2217/17435889.1.3.311; Besimo CE, 1999, INT J ORAL MAX IMPL, V14, P654; Brandl F, 2010, J CONTROL RELEASE, V142, P221, DOI 10.1016/j.jconrel.2009.10.030; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Cado G, 2012, LANGMUIR, V28, P8470, DOI 10.1021/la300563s; Chae JJ, 2014, MIL MED, V179, P686, DOI 10.7205/MILMED-D-13-00360; D'Ercole S, 2009, INT J IMMUNOPATH PH, V22, P1019, DOI 10.1177/039463200902200417; Ding FY, 2013, CARBOHYD POLYM, V98, P1547, DOI 10.1016/j.carbpol.2013.07.042; Etienne O, 2006, J DENT RES, V85, P44, DOI 10.1177/154405910608500107; Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011; Gupta H, 2015, J PHARM BIOALLIED SC, V7, P9, DOI 10.4103/0975-7406.149810; Johnson DW, 2009, PERITON DIALYSIS INT, V29, P303; Kastrup CJ, 2012, P NATL ACAD SCI USA, V109, P21444, DOI 10.1073/pnas.1217972110; Kennedy BP, 1998, PEPTIDES, V19, P1241, DOI 10.1016/S0196-9781(98)00086-2; Lee C, 2013, BIOMACROMOLECULES, V14, P2004, DOI 10.1021/bm400352d; Lee Y, 2010, SOFT MATTER, V6, P977, DOI 10.1039/b919944f; Lin HR, 2004, BIOMACROMOLECULES, V5, P2358, DOI 10.1021/bm0496965; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Matsuno H, 2006, J ORTHOP SCI, V11, P497, DOI 10.1007/s00776-006-1059-0; Nayak AG, 2014, J ORAL IMPLANTOL, V40, P11, DOI 10.1563/AAID-JOI-D-10-00167; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Paolantonio M, 2008, J PERIODONTOL, V79, P1419, DOI [10.1902/jop.2008.070660, 10.1902/jop.2008.070660 ]; Pingel LC, 2008, IMMUNOL CELL BIOL, V86, P643, DOI 10.1038/icb.2008.56; Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E; Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X; Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x; van Winkelhoff AJ, 2012, EUR J ORAL IMPLANTOL, V5, pS43; Wang GS, 2015, PHARMACEUTICALS-BASE, V8, P123, DOI 10.3390/ph8010123; Wang GS, 2014, PHARMACEUTICALS-BASE, V7, P545, DOI 10.3390/ph7050545; Xu JK, 2012, LANGMUIR, V28, P14010, DOI 10.1021/la3025414; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x	35	46	47	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145143	10.1371/journal.pone.0145143	http://dx.doi.org/10.1371/journal.pone.0145143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659616	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900187
J	Sharma, S; Kim, BN; Stansfeld, PJ; Sansom, MSP; Lindau, M				Sharma, Satyan; Kim, Brian N.; Stansfeld, Phillip J.; Sansom, Mark S. P.; Lindau, Manfred			A Coarse Grained Model for a Lipid Membrane with Physiological Composition and Leaflet Asymmetry	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; STRATUM-CORNEUM; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; CHOLESTEROL; BILAYERS; VESICLE; PERMEATION; EXTENSION; MOVEMENT	The resemblance of lipid membrane models to physiological membranes determines how well molecular dynamics (MD) simulations imitate the dynamic behavior of cell membranes and membrane proteins. Physiological lipid membranes are composed of multiple types of phospholipids, and the leaflet compositions are generally asymmetric. Here we describe an approach for self-assembly of a Coarse-Grained (CG) membrane model with physiological composition and leaflet asymmetry using the MARTINI force field. An initial set-up of two boxes with different types of lipids according to the leaflet asymmetry of mammalian cell membranes stacked with 0.5 nm overlap, reliably resulted in the self-assembly of bilayer membranes with leaflet asymmetry resembling that of physiological mammalian cell membranes. Self-assembly in the presence of a fragment of the plasma membrane protein syntaxin 1A led to spontaneous specific positioning of phosphatidylionositol(4,5)bisphosphate at a positively charged stretch of syntaxin consistent with experimental data. An analogous approach choosing an initial set-up with two concentric shells filled with different lipid types results in successful assembly of a spherical vesicle with asymmetric leaflet composition. Self-assembly of the vesicle in the presence of the synaptic vesicle protein synaptobrevin 2 revealed the correct position of the synaptobrevin transmembrane domain. This is the first CG MD method to form a membrane with physiological lipid composition as well as leaflet asymmetry by self-assembly and will enable unbiased studies of the incorporation and dynamics of membrane proteins in more realistic CG membrane models.	[Sharma, Satyan; Lindau, Manfred] Max Planck Inst Biophys Chem, Lab Nanoscale Cell Biol, D-37077 Gottingen, Germany; [Kim, Brian N.; Lindau, Manfred] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Stansfeld, Phillip J.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Max Planck Society; Cornell University; University of Oxford	Sharma, S (corresponding author), Max Planck Inst Biophys Chem, Lab Nanoscale Cell Biol, D-37077 Gottingen, Germany.	satyan.sharma@mpibpc.mpg.de	Stansfeld, Phillip James/AAA-9228-2020; Sansom, Mark S.P./C-5157-2009; Lindau, Manfred/ABD-3449-2021; Stansfeld, Phill/C-6213-2011	Stansfeld, Phillip James/0000-0001-8800-7669; Sansom, Mark S.P./0000-0001-6360-7959; Lindau, Manfred/0000-0002-5722-9557; Stansfeld, Phill/0000-0001-8800-7669; Kim, Brian/0000-0002-5523-6091	European Research Council [ADG 322699]; National Institutes of Health (NIH) [R01MH095046]; NIH Molecular Biophysics Training Grant at Cornell University [T32GM008267]; Biotechnology and Biological Sciences Research Council [BB/I019855/1] Funding Source: researchfish; BBSRC [BB/I019855/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095046] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Biophysics Training Grant at Cornell University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the European Research Council (Grant ADG 322699), National Institutes of Health (NIH) grant R01MH095046, and NIH Molecular Biophysics Training Grant T32GM008267 at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European Research Council (Grant ADG 322699), National Institutes of Health (NIH) grant R01MH095046, and NIH Molecular Biophysics Training Grant T32GM008267 at Cornell University.	Bennett WFD, 2009, J AM CHEM SOC, V131, P12714, DOI 10.1021/ja903529f; BRETSCHER MS, 1973, SCIENCE, V181, P622, DOI 10.1126/science.181.4100.622; Calderon RO, 1997, J NEUROSCI RES, V49, P372; Clarke S, 1981, J CHEM EDUC, V58, pA246, DOI DOI 10.1021/ED058PA246.1; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; Das C, 2009, BIOPHYS J, V97, P1941, DOI 10.1016/j.bpj.2009.06.054; de Vries AH, 2004, J AM CHEM SOC, V126, P4488, DOI 10.1021/ja0398417; Flinner N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133999; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Kasson PM, 2007, PLOS COMPUT BIOL, V3, P2228, DOI 10.1371/journal.pcbi.0030220; Khelashvili G, 2012, BIOCHEMISTRY-US, V51, P7685, DOI 10.1021/bi300833z; Knight CJ, 2015, BIOINFORMATICS; Koldso H, 2014, LIPID CLUSTERING COR; Kucerka N, 2009, LANGMUIR, V25, P13522, DOI 10.1021/la9020299; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindau M, 2012, BIOPHYS J, V103, P959, DOI 10.1016/j.bpj.2012.08.007; Marrink SJ, 2008, J AM CHEM SOC, V130, P10, DOI 10.1021/ja076641c; Marrink SJ, 2003, J AM CHEM SOC, V125, P15233, DOI 10.1021/ja0352092; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Morozova D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002067; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Paloncyova M, 2015, J PHYS CHEM B, V119, P9811, DOI 10.1021/acs.jpcb.5b05522; Perlmutter JD, 2011, J AM CHEM SOC, V133, P6563, DOI 10.1021/ja106626r; Polley A, 2012, J PHYS CHEM B, V116, P13403, DOI 10.1021/jp3032868; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rog T, 2003, ACTA BIOCHIM POL, V50, P789; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Schmidt MR, 2013, BIOCHEMISTRY-US, V52, P279, DOI 10.1021/bi301350s; SCHROEDER F, 1984, NEUROBIOL AGING, V5, P323, DOI 10.1016/0197-4580(84)90010-1; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Shinoda W, 1998, J CHEM PHYS, V109, P1517, DOI 10.1063/1.476702; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Stansfeld PJ, 2015, STRUCTURE; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vacha R, 2009, BIOPHYS J, V96, P4493, DOI 10.1016/j.bpj.2009.03.010; van Eerden FJ, 2015, BBA-BIOMEMBRANES, V1848, P1319, DOI 10.1016/j.bbamem.2015.02.025; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wan G, 2015, J MOL GRAPH MODEL, V60, P98, DOI 10.1016/j.jmgm.2015.06.005; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Wood WG, 2011, J NEUROCHEM, V116, P684, DOI 10.1111/j.1471-4159.2010.07017.x; Yesylevskyy SO, 2015, METHODS MOL BIOL, V1232, P291, DOI 10.1007/978-1-4939-1752-5_20; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0	57	34	34	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144814	10.1371/journal.pone.0144814	http://dx.doi.org/10.1371/journal.pone.0144814			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659855	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900108
J	Seo, JB; Jung, SR; Huang, WG; Zhang, QS; Koh, DS				Seo, Jong Bae; Jung, Seung-Ryoung; Huang, Weigang; Zhang, Qisheng; Koh, Duk-Su			Charge Shielding of PIP2 by Cations Regulates Enzyme Activity of Phospholipase C	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PIP2; MOLECULAR-DYNAMICS SIMULATIONS; ROSEUS TRANSFORMED ROOTS; ELECTROSTATIC INTERACTIONS; KINASE SUBSTRATE; BOVINE BRAIN; K+ CHANNELS; DELTA 1; MG2+; INHIBITION	Hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) of the plasma membrane by phospholipase C (PLC) generates two critical second messengers, inositol-1,4,5-trisphosphate and diacylglycerol. For the enzymatic reaction, PIP2 binds to positively charged amino acids in the pleckstrin homology domain of PLC. Here we tested the hypothesis that positively charged divalent and multivalent cations accumulate around the negatively charged PIP2, a process called electrostatic charge shielding, and therefore inhibit electrostatic PIP2-PLC interaction. This charge shielding of PIP2 was measured quantitatively with an in vitro enzyme assay using WH-15, a PIP2 analog, and various recombinant PLC proteins (beta 1,beta 1, and delta 1). Reduction of PLC activity by divalent cations, polyamines, and neomycin was well described by a theoretical model considering accumulation of cations around PIP2 via their electrostatic interaction and chemical binding. Finally, the charge shielding of PIP2 was also observed in live cells. Perfusion of the cations into cells via patch clamp pipette reduced PIP2 hydrolysis by PLC as triggered by M-1 muscarinic receptors with a potency order of Mg2+ < spermine(4+) < neomycin(6+). Accumulation of divalent cations into cells through divalent-permeable TRPM7 channel had the same effect. Altogether our results suggest that Mg2+ and polyamines modulate the activity of PLCs by controlling the amount of free PIP2 available for the enzymes and that highly charged biomolecules can be inactivated by counterions electrostatically.	[Seo, Jong Bae; Jung, Seung-Ryoung; Koh, Duk-Su] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Huang, Weigang; Zhang, Qisheng] Univ N Carolina, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Koh, DS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	koh@uw.edu		Zhang, Qisheng/0000-0001-9808-5038	National Institute of Diabetes and Digestive and Kidney Diseases [R01-080840]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01-080840 (http://www.niddk.nih.gov/about-niddk/Pages/default.aspx), National Institute of Diabetes and Digestive and Kidney Diseases to DSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester LY, 2007, CHANNELS, V1, P209, DOI 10.4161/chan.4770; Baumann MK, 2011, ANAL CHEM, V83, P6267, DOI 10.1021/ac2009178; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BRISTOL A, 1988, COLD SPRING HARB SYM, V53, P915, DOI 10.1101/SQB.1988.053.01.105; CARNEY DH, 1985, CELL, V42, P479, DOI 10.1016/0092-8674(85)90105-9; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Coburn RF, 2009, J CELL PHYSIOL, V221, P544, DOI 10.1002/jcp.21899; Echevarria-Machado I, 2002, J PLANT PHYSIOL, V159, P1179, DOI 10.1078/0176-1617-00893; EISENMAN G, 1962, Biophys J, V2, P259; Ellenbroek WG, 2011, BIOPHYS J, V101, P2178, DOI 10.1016/j.bpj.2011.09.039; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; HEINONEN E, 1986, NEUROSCI LETT, V72, P105, DOI 10.1016/0304-3940(86)90627-0; Helmholtz H. v., 1853, ANN PHYS-BERLIN, V165, P353, DOI 10.1002/andp.18531650702; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Huang WG, 2013, J BIOL CHEM, V288, P5840, DOI 10.1074/jbc.M112.422501; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kopka J, 1998, PLANT PHYSIOL, V116, P239, DOI 10.1104/pp.116.1.239; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Lo Vasco VR, 2013, J CELL COMMUN SIGNAL, V7, P141, DOI 10.1007/s12079-013-0194-6; Matecki A, 1997, INT J BIOCHEM CELL B, V29, P815, DOI 10.1016/S1357-2725(97)00014-9; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Neves-Petersen MT, 2003, BIOTECHNOL ANN REV, V9, P315, DOI 10.1016/S1387-2656(03)09010-0; Oldham KB, 2008, J ELECTROANAL CHEM, V613, P131, DOI 10.1016/j.jelechem.2007.10.017; Park Y, 2015, NAT STRUCT MOL BIOL, V22, P815, DOI 10.1038/nsmb.3097; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Pawelczyk T, 1997, EUR J BIOCHEM, V248, P459, DOI 10.1111/j.1432-1033.1997.00459.x; PICAL C, 1992, PLANT PHYSIOL, V100, P1296, DOI 10.1104/pp.100.3.1296; Pina-Chable ML, 1998, PROSTAG OTH LIPID M, V56, P19, DOI 10.1016/S0090-6980(98)00037-9; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; RYU SH, 1987, J BIOL CHEM, V262, P12511; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Slochower DR, 2013, J PHYS CHEM B, V117, P8322, DOI 10.1021/jp401414y; Subirana JA, 2003, ANNU REV BIOPH BIOM, V32, P27, DOI 10.1146/annurev.biophys.32.110601.141726; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Usachev YM, 1995, J PHYSIOL-LONDON, V489, P309, DOI 10.1113/jphysiol.1995.sp021052; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; WOJCIKIEWICZ RJH, 1988, BIOCHEM J, V255, P1015, DOI 10.1042/bj2551015; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003	55	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144432	10.1371/journal.pone.0144432	http://dx.doi.org/10.1371/journal.pone.0144432			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658739	gold, Green Published			2022-12-26	WOS:000366903600043
J	Watkins, D; Jiang, LW; Nahar, S; Maiti, S; Arya, DP				Watkins, Derrick; Jiang, Liuwei; Nahar, Smita; Maiti, Souvik; Arya, Dev P.			A pH Sensitive High-Throughput Assay for miRNA Binding of a Peptide-Aminoglycoside (PA) Library	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; DUAL RECOGNITION; MAJOR GROOVE; B-DNA; FLUORESCEIN; MICRORNAS; BIOGENESIS; SEQUENCES; HYBRID; PROBES	MicroRNAs (miRNA) are small RNAs that have a regulatory role in gene expression. Because of this regulatory role, miRNAs have become a new target for therapeutic compounds. Here, we outline an approach to target specific miRNAs using a high throughput capable assay and a 215 compound peptidic-aminosugar (PA) library. Aminosugars have been shown in a number of recent reports as important lead compounds that bind miRNA. In order to screen for compounds that bind miRNA, we have developed a high throughput displacement assay using a fluorescein-neomycin conjugated molecule (F-neo) as a probe for competitive miRNA binding compounds. We have applied the F-neo assay to four different miRNA constructs and the assay is applicable to most miRNAs, at various stages of processing. The results of the screen were validated by the determination of the IC50 for a select group of compounds from the library. For example, we identified eight compounds that bind to hsa-miR 504 with higher affinity than the parent neomycin. From the F-neo displacement assay we found that the number of binding sites differs for each miRNA, and the binding sites appear to differ both physically and chemically, with different affinity of the compounds resulting from the size of the molecule as well as the chemical structure. Additionally, the affinity of the compounds was dependent on the identity and position of the amino acid position of conjugation and the affinity of the compounds relative to other compounds in the library was miRNA dependent with the introduction of a second amino acid.	[Jiang, Liuwei; Arya, Dev P.] Clemson Univ, Dept Chem, Med Chem Lab, Clemson, SC 29634 USA; [Watkins, Derrick; Arya, Dev P.] NUBAD LLC, Greenville, SC USA; [Nahar, Smita; Maiti, Souvik] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Nahar, Smita; Maiti, Souvik] CSIR Inst Genom & Integrat Biol, Delhi, India	Clemson University; Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Arya, DP (corresponding author), Clemson Univ, Dept Chem, Med Chem Lab, Clemson, SC 29634 USA.	dparya@clemson.edu	Jiang, Liuwei/D-5406-2017	Jiang, Liuwei/0000-0001-6178-4505; Maiti, Souvik/0000-0001-9897-1419	NUBAD, LLC	NUBAD, LLC	NUBAD, LLC provided support in the form of salaries for author J.D.W., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of J.D.W. are articulated in the 'author contributions' section.	Alvarez-Pez JM, 2001, J PHYS CHEM A, V105, P6320, DOI 10.1021/jp010372+; Arya DP, 2011, ACCOUNTS CHEM RES, V44, P134, DOI 10.1021/ar100113q; Arya DP, 2003, J AM CHEM SOC, V125, P12398, DOI 10.1021/ja036742k; Arya DP, 2003, J AM CHEM SOC, V125, P3733, DOI 10.1021/ja027765m; Arya DP, 2001, J AM CHEM SOC, V123, P5385, DOI 10.1021/ja003052x; Arya DP, 2001, J AM CHEM SOC, V123, P11093, DOI 10.1021/ja016481j; Arya DP, 2003, J AM CHEM S IN PRESS; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; FRIEDRICH K, 1988, EUR J BIOCHEM, V173, P227, DOI 10.1111/j.1432-1033.1988.tb13988.x; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hamilton PL, 2012, NAT PROD REP, V29, P134, DOI 10.1039/c1np00054c; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jiang LW, 2015, ACS CHEM BIOL, V10, P1278, DOI 10.1021/cb5010367; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; King A, 2013, ANTIMICROB AGENTS CH; Knemeyer JP, 2000, ANAL CHEM, V72, P3717, DOI 10.1021/ac000024o; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar S, 2012, BIOCHEMISTRY-US, V51, P2331, DOI 10.1021/bi201657k; Kumar S, 2011, J AM CHEM SOC, V133, P7361, DOI 10.1021/ja108118v; Lavis LD, 2007, ANAL CHEM, V79, P6775, DOI 10.1021/ac070907g; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lynch SR, 2001, J MOL BIOL, V306, P1037, DOI 10.1006/jmbi.2000.4420; Maiti M, 2012, BIOORG MED CHEM LETT, V22, P1709, DOI 10.1016/j.bmcl.2011.12.103; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Ranasinghe RT, 2005, CHEM COMMUN, P5487, DOI 10.1039/b509522k; Ranjan N, 2013, MOLECULES, V18, P14228, DOI 10.3390/molecules181114228; Ranjan N, 2013, BIOORG MED CHEM LETT, V23, P5689, DOI 10.1016/j.bmcl.2013.08.014; Ranjan N, 2013, CHEM COMMUN, V49, P5796, DOI 10.1039/c3cc42721h; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526; Shaw NN, 2008, BIOORG MED CHEM LETT, V18, P4142, DOI 10.1016/j.bmcl.2008.05.090; Shaw NN, 2008, BIOCHIMIE, V90, P1026, DOI 10.1016/j.biochi.2008.04.011; Sjoback R, 1998, BIOPOLYMERS, V46, P445; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velagapudi SP, 2014, NAT CHEM BIOL, V10, P291, DOI [10.1038/NCHEMBIO.1452, 10.1038/nchembio.1452]; Velagapudi SP, 2011, J AM CHEM SOC, V133, P10111, DOI 10.1021/ja200212b; Watkins D, 2013, BIOORG MED CHEM LETT, V23, P6695, DOI 10.1016/j.bmcl.2013.10.030; Watkins D, 2013, ANAL BIOCHEM, V434, P300, DOI 10.1016/j.ab.2012.12.003; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Willis B, 2006, BIOCHEMISTRY-US, V45, P10217, DOI 10.1021/bi0609265; Willis B, 2006, ADV CARBOHYD CHEM BI, V60, P251, DOI 10.1016/S0065-2318(06)60006-1; Willis B, 2009, BIOORG MED CHEM LETT, V19, P4974, DOI 10.1016/j.bmcl.2009.07.079; Xi HJ, 2011, BIOCHEMISTRY-US, V50, P9088, DOI 10.1021/bi201077h; Xi HJ, 2010, BIOCHIMIE, V92, P514, DOI 10.1016/j.biochi.2010.02.004; Xue LA, 2011, BIOCHEMISTRY-US, V50, P2838, DOI 10.1021/bi1017304; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	60	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144251	10.1371/journal.pone.0144251	http://dx.doi.org/10.1371/journal.pone.0144251			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656788	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600032
J	Porcu, G; Serone, E; De Nardis, V; Di Giandomenico, D; Lucisano, G; Scardapane, M; Poma, A; Ragnini-Wilson, A				Porcu, Giampiero; Serone, Eliseo; De Nardis, Velia; Di Giandomenico, Daniele; Lucisano, Giuseppe; Scardapane, Marco; Poma, Anna; Ragnini-Wilson, Antonella			Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxR gamma Receptor Activation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EARLY POSTNATAL DEXAMETHASONE; SONIC-HEDGEHOG; OLIGODENDROCYTE DIFFERENTIATION; REGULATORY FACTOR; IN-VITRO; REMYELINATION; PROLIFERATION; CELLS; CNS	One of the causes of permanent disability in chronic multiple sclerosis patients is the inability of oligodendrocyte progenitor cells (OPCs) to terminate their maturation program at lesions. To identify key regulators of myelin gene expression acting at the last stages of OPC maturation we developed a drug repositioning strategy based on the mouse immortalized oligodendrocyte (OL) cell line Oli-neu brought to the premyelination stage by stably expressing a key factor regulating the last stages of OL maturation. The Prestwick Chemical Library1 of 1,200 FDA-approved compound(s) was repositioned at three dosages based on the induction of Myelin Basic Protein (MBP) expression. Drug hits were further validated using dosage-dependent reproducibility tests and biochemical assays. The glucocorticoid class of compounds was the most highly represented and we found that they can be divided in three groups according to their efficacy on MBP up-regulation. Since target identification is crucial before bringing compounds to the clinic, we searched for common targets of the primary screen hits based on their known chemical-target interactomes, and the pathways predicted by top ranking compounds were validated using specific inhibitors. Two of the top ranking compounds, Halcinonide and Clobetasol, act as Smoothened (Smo) agonists to up-regulate myelin gene expression in the Oli-neuM cell line. Further, RxR. activation is required for MBP expression upon Halcinonide and Clobetasol treatment. These data indicate Clobetasol and Halcinonide as potential promyelinating drugs and also provide a mechanistic understanding of their mode of action in the pathway leading to myelination in OPCs. Furthermore, our classification of glucocorticoids with respect to MBP expression provides important novel insights into their effects in the CNS and a rational criteria for their choice in combinatorial therapies in de-myelinating diseases.	[Porcu, Giampiero; Ragnini-Wilson, Antonella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Porcu, Giampiero; Serone, Eliseo; De Nardis, Velia; Di Giandomenico, Daniele; Lucisano, Giuseppe; Scardapane, Marco; Ragnini-Wilson, Antonella] Fdn Mario Negri Sud, Dept Translat Pharmacol, Santa Maria Imbaro, CH, Italy; [Serone, Eliseo; Poma, Anna] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Lucisano, Giuseppe; Scardapane, Marco] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy; [Lucisano, Giuseppe] Univ Bari Aldo Moro, Dipartimento Sci Med Base Neurosci & Organi Senso, Bari, Italy	University of Rome Tor Vergata; University of L'Aquila; Universita degli Studi di Bari Aldo Moro	Ragnini-Wilson, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	antonella.ragnini@uniroma2.it	Poma, Anna/AAH-5751-2019; Ragnini, Antonella/A-8089-2014	Ragnini, Antonella/0000-0001-7963-7554	Modello innovativo per l'identificazione di composti capaci di promuovere la rimielinazione in modelli cellulari di Sclerosi Multipla Fondazione Carichieti; Fondazione Mario Negri Sud	Modello innovativo per l'identificazione di composti capaci di promuovere la rimielinazione in modelli cellulari di Sclerosi Multipla Fondazione Carichieti; Fondazione Mario Negri Sud	This work was supported by Modello innovativo per l'identificazione di composti capaci di promuovere la rimielinazione in modelli cellulari di Sclerosi Multipla Fondazione Carichieti http://www.fondazionecarichieti.it/it/, and Fondazione Mario Negri Sud https://it-it.facebook.com/pages/Fondazione-Negri-Sud-ONLUS/221488934531828. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231; Baud O, 1999, ARCH DIS CHILD-FETAL, V80, pF159; Bergmann TK, 2012, CLIN PHARMACOKINET, V51, P711, DOI 10.1007/s40262-012-0007-8; Bhuta T, 1998, ARCH DIS CHILD-FETAL, V79, pF26, DOI 10.1136/fn.79.1.F26; Buckley CE, 2010, NEUROPHARMACOLOGY, V59, P149, DOI 10.1016/j.neuropharm.2010.04.014; Budni J, 2011, NEUROSCIENCE, V190, P346, DOI 10.1016/j.neuroscience.2011.05.053; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Clemente D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00268; Comabella M, 2011, CURR NEUROL NEUROSCI, V11, P484, DOI 10.1007/s11910-011-0211-1; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; De Vries GH, 2010, NEUROCHEM RES, V35, P1978, DOI 10.1007/s11064-010-0318-9; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Donia M, 2010, SCAND J IMMUNOL, V72, P396, DOI 10.1111/j.1365-3083.2010.02451.x; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Feldmann A, 2011, J NEUROSCI, V31, P5659, DOI 10.1523/JNEUROSCI.6638-10.2011; Ferent J, 2014, STEM CELL REP, V3, P312, DOI 10.1016/j.stemcr.2014.05.016; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Fulton DL, 2011, NUCLEIC ACIDS RES, V39, P7974, DOI 10.1093/nar/gkr326; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Goudarzvand M, 2010, CELL MOL NEUROBIOL, V30, P289, DOI 10.1007/s10571-009-9451-x; Gruenenfelder FI, 2011, J ANAT, V219, P33, DOI 10.1111/j.1469-7580.2011.01363.x; Hanafy KA, 2011, FEBS LETT, V585, P3821, DOI 10.1016/j.febslet.2011.03.048; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Inglese Melissa Dodd, 2009, J Pediatr Nurs, V24, P49, DOI 10.1016/j.pedn.2008.06.005; Jadasz JJ, 2012, CELL TISSUE RES, V349, P331, DOI 10.1007/s00441-012-1331-x; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Jenkins SI, 2014, ACS CHEM NEUROSCI, V5, P51, DOI 10.1021/cn400167n; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Keough MB, 2013, NEUROTHERAPEUTICS, V10, P44, DOI 10.1007/s13311-012-0152-7; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Lee JM, 2008, J NEUROSCI, V28, P3141, DOI 10.1523/JNEUROSCI.5547-07.2008; Lou KJ, 2010, SCIBX, V3; Loulier K, 2006, J NEUROCHEM, V98, P530, DOI 10.1111/j.1471-4159.2006.03896.x; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Munzel EJ, 2013, DRUGS, V73, P2017, DOI 10.1007/s40265-013-0146-8; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X; Porcu G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-88; Porcu G, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-197; Rezen T, 2010, BIOCHIM BIOPHYS ACTA, V1, P146; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roberg-Larsen H, 2014, BIOCHEM BIOPH RES CO, V446, P669, DOI 10.1016/j.bbrc.2014.01.087; Rosenberg SS, 2007, CELL MOL LIFE SCI, V64, P3059, DOI 10.1007/s00018-007-7265-x; Saher G, 2012, NAT MED, V18, P1130, DOI 10.1038/nm.2833; Shanks EJ, 2013, EUROPEAN PHARM REV, V18, P11; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; Wang JB, 2010, P NATL ACAD SCI USA, V107, P9323, DOI 10.1073/pnas.0910712107; White R, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00284; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Yeh TF, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.5.e7; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zuccaro E, 2013, NAT CELL BIOL, V15, P572, DOI 10.1038/ncb2750	75	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144550	10.1371/journal.pone.0144550	http://dx.doi.org/10.1371/journal.pone.0144550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658258	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903500039
J	Singam, A; Ytterberg, C; Tham, K; von Koch, L				Singam, Avvai; Ytterberg, Charlotte; Tham, Kerstin; von Koch, Lena			Participation in Complex and Social Everyday Activities Six Years after Stroke: Predictors for Return to Pre-Stroke Level	PLOS ONE			English	Article							FRENCHAY ACTIVITIES INDEX; FUNCTIONAL STATUS; REHABILITATION; DETERMINANTS; DISCHARGE; RECOVERY; IMPACT; LIFE	Background Long-term disability following stroke can lead to participation restrictions in complex and social everyday activities, yet information is lacking on to what extent stroke survivors return to their pre-stroke levels of participation. Objectives The objectives of this study were to investigate the level of participation in complex and social everyday activities 6 years after stroke, to compare this with pre-stroke participation and to identify predictors of returning to pre-stroke levels of participation. Method All patients admitted to Karolinska University Hospital's stroke units during a 1-year period were eligible to participate and 349 patients were recruited. Assessments were made at base-line, 3 months and 6 years using self-reported outcome measures. Participation was assessed using the Frenchay Activities Index (FAI). The 6-year score for each participant was compared to the pre-stroke score, both for the total score and for each domain (domestic chores, leisure/work and outdoor activities). Predictors of having the same or better level of participation at 6 years were identified using logistic regression. Results At 6 years, 121 participants were followed up, 166 were deceased, 44 declined to take part and 18 could not be traced. At 6 years 84% could be described as active (FAI >= 15). The same level of participation or better than pre-stroke was found in 35% of participants, in 65% the level was lower. Similar predictors were identified for achieving the same or better level of participation at 6 years for FAI total and the three domains; ability to walk without aids and a lower age at stroke onset, and perceived mobility, participation and recovery at 3 months. Conclusion Six years after stroke, 35% of participants had the same or better level of participation as pre-stroke. Rehabilitation after stroke to improve walking ability and participation might improve long-term participation in complex and social everyday activities.	[Singam, Avvai] Nykopings Hosp, Nykoping, Sweden; [Singam, Avvai; Ytterberg, Charlotte; Tham, Kerstin; von Koch, Lena] Karolinska Inst, Stockholm, Sweden; [Ytterberg, Charlotte; Tham, Kerstin; von Koch, Lena] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ytterberg, C (corresponding author), Karolinska Inst, Stockholm, Sweden.	charlotte.ytterberg@ki.se	von Koch, Lena/P-2310-2018; Tham, Kerstin/T-3964-2018	von Koch, Lena/0000-0002-8560-3016; Tham, Kerstin/0000-0001-7025-5226; Ytterberg, Charlotte/0000-0003-3704-8887	Swedish Research Council [2007-3087, 2013-2806]; Stockholms Lans Landsting [2006-0700]; Swedish Stroke Association	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholms Lans Landsting; Swedish Stroke Association	Swedish Research Council 2007-3087 and 2013-2806 http://www.vr.se/, Stockholms Lans Landsting 2006-0700 https://www.sll.se/, Swedish Stroke Association www.strokeforbundet.se/AS CY KT LvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ANN REPORT; ASPLUND K, 1985, STROKE, V16, P885; BOND MJ, 1995, DISABIL REHABIL, V17, P63, DOI 10.3109/09638289509166629; De Wit L, 2007, STROKE, V38, P2101, DOI 10.1161/STROKEAHA.107.482869; Desrosiers J, 2006, DISABIL REHABIL, V28, P221, DOI 10.1080/09638280500158372; Desrosiers Johanne, 2005, Can J Occup Ther, V72, P195; Dijkerman HC, 1996, J ROY COLL PHYS LOND, V30, P538; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Ellwardt L, 2014, EUR SOCIOL REV, V30, P413, DOI 10.1093/esr/jcu046; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Gadidi V, 2011, ARCH PHYS MED REHAB, V92, P1802, DOI 10.1016/j.apmr.2011.06.014; Gall SL, 2009, CEREBROVASC DIS, V27, P123, DOI 10.1159/000177919; Govan L, 2009, STROKE, V40, P3396, DOI 10.1161/STROKEAHA.109.557645; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jonsson AC, 2014, STROKE, V45, P1784, DOI 10.1161/STROKEAHA.114.005164; Kumlien S, 1999, DISABIL REHABIL, V21, P31, DOI 10.1080/096382899298070; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Liman TG, 2012, J NEUROL, V259, P1125, DOI 10.1007/s00415-011-6312-6; Lu WS, 2012, ARCH PHYS MED REHAB, V93, P1097, DOI 10.1016/j.apmr.2012.01.015; Norrving B., 2010, FOREKOMST BEFOLKNING; Patel MD, 2002, J AM GERIATR SOC, V50, P700, DOI 10.1046/j.1532-5415.2002.50165.x; Piercy W, 2000, CLIN REHABIL, V14, P433, DOI 10.1191/0269215500cr327oa; SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173; Spitzer J, 2011, OTJR THOROFARE N J, V31, P8; Tse T, 2013, ARCH PHYS MED REHAB, V94, P177, DOI 10.1016/j.apmr.2012.09.002; Turnbull JC, 2000, ARCH PHYS MED REHAB, V81, P1034, DOI 10.1053/apmr.2000.7162; von Koch L, 2000, CLIN REHABIL, V14, P574, DOI 10.1191/0269215500cr364oa; Wade D T, 1985, Int Rehabil Med, V7, P176; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; WHO, 2001, WHO INT CLASS FUNCT; Wilkinson PR, 1997, QUAL HEALTH CARE, V6, P125, DOI 10.1136/qshc.6.3.125; Wolfe C, 2011, PLOS MED, V8, P1; Young J, 2001, CEREBROVASC DIS, V12, P114, DOI 10.1159/000047690	34	58	59	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144344	10.1371/journal.pone.0144344	http://dx.doi.org/10.1371/journal.pone.0144344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658735	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500022
J	Mochizuki, H; Shapiro, SG; Breen, M				Mochizuki, Hiroyuki; Shapiro, Susan G.; Breen, Matthew			Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; DIGITAL PCR; KRAS MUTATIONS; RAPID RESPONSE; CANCER; VEMURAFENIB; BLADDER; DOGS; LEUKEMIA; DISEASE	Urothelial carcinoma (UC) of the lower urinary tract and prostatic carcinoma (PC) are aggressive genitourinary cancers in dogs, characterized by invasion to surrounding tissues and high metastatic potential. Current diagnosis of canine UC and PC requires histopathological examination of a biopsy. Such specimens require specialized medical equipment and are invasive procedures, limiting the availability of diagnosis by histopathology for many canine patients. Access to a non-invasive means to confirm diagnosis is currently an unmet need. Recently, the canine BRAF V595E mutation was detected in similar to 80% of canine UCs and PCs. In this study, we developed a droplet digital PCR (ddPCR) assay for detection of the canine BRAF V595E mutation in canine urogenital tumors. The assay was evaluated in DNA samples prepared from biopsy specimens of UC (n = 48) and PC (n = 27), as well and non-neoplastic bladder epithelium (n = 38). In addition the assay was assessed for use with DNA isolated from free catch urine samples derived from canine patients with UC (n = 23), PC (n = 3), as well as from dogs with cystitis and healthy controls (n = 37). In all cases the sensitivity to detect the mutant allele was compared with conventional Sanger sequencing. ddPCR had superior sensitivity for detection of the V595E mutation: 75% of UC, 85% of PC, and 0% of control samples were mutation positive, respectively, and the V595E mutation was detected at a level as low as just 1 in 10,000 alleles (similar to 0.01%). Furthermore, the ddPCR assay identified the mutation in free catch urine samples from 83% of canine UC and PC patients, demonstrating its utility as a non-invasive means of diagnosis. We have shown that ddPCR is a sensitive molecular technique with the potential to facilitate accurate and non-invasive means of canine UC and PC diagnosis.	[Mochizuki, Hiroyuki; Shapiro, Susan G.; Breen, Matthew] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Breen, Matthew] N Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Breen, Matthew] N Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Breen, Matthew] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Breen, M (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, 4700 Hillsborough St, Raleigh, NC 27695 USA.	Matthew_Breen@ncsu.edu	Mochizuki, Hiroyuki/L-9510-2015	Mochizuki, Hiroyuki/0000-0002-1520-0393; Breen, Matthew/0000-0002-8901-4155	NCSU Cancer Genomics Funds; NATIONAL CENTER FOR RESEARCH RESOURCES [T35RR025837] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011070] Funding Source: NIH RePORTER	NCSU Cancer Genomics Funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the NCSU Cancer Genomics Funds (MB).; The authors would like to thank Dr. T. Rosol for providing Leo cell line. We thank the NCSU Clinical Studies Core for assistance with case recruitment. This study was funded by the NCSU Cancer Genomics Fund (MB).	BELL FW, 1991, J AM VET MED ASSOC, V199, P1623; Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cornell KK, 2000, PROSTATE, V45, P173; Decker B, 2015, MOL CANC RES; Follows GA, 2013, BRIT J HAEMATOL, V161, P150, DOI 10.1111/bjh.12201; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Higuchi T, 2013, JAVMA-J AM VET MED A, V242, P499, DOI 10.2460/javma.242.4.499; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Knapp DW, 2014, ILAR J, V55, P100, DOI 10.1093/ilar/ilu018; Knapp DW, 2000, UROL ONCOL, V5, P47, DOI 10.1016/S1078-1439(99)00006-X; Lamy PJ, 2015, J MOL DIAGN; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Mochizuki H, PLOS ONE IN PRESS; Mochizuki H, 2015, PCR VET PATHOL, DOI [10.1177/0300985815614975, DOI 10.1177/0300985815614975]; Mochizuki Hiroyuki, 2015, Vet Sci, V2, P231, DOI 10.3390/vetsci2030231; Munoz J, 2013, J CLIN ONCOL, V31, pE351, DOI 10.1200/JCO.2012.45.7739; Nyland TG, 2002, VET RADIOL ULTRASOUN, V43, P50, DOI 10.1111/j.1740-8261.2002.tb00443.x; Powe JR, 2004, VET CLIN PATH, V33, P150, DOI 10.1111/j.1939-165X.2004.tb00365.x; Shapiro SG, 2015, CHROMOSOME RES, V23, P311, DOI 10.1007/s10577-015-9471-y; Smith J, 2008, THERIOGENOLOGY, V70, P375, DOI 10.1016/j.theriogenology.2008.04.039; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Thudi NK, 2011, PROSTATE, V71, P1251, DOI 10.1002/pros.21341; Toye B, 1998, J CLIN MICROBIOL, V36, P2356, DOI 10.1128/JCM.36.8.2356-2358.1998; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zinkl J, 2007, DIAGNOSTIC CYTOLOGY, P350	30	53	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144170	10.1371/journal.pone.0144170	http://dx.doi.org/10.1371/journal.pone.0144170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649430	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300038
J	da Silva, RCS; Milet-Pinheiro, P; da Silva, PCB; da Silva, AG; da Silva, MV; Navarro, DMDF; da Silva, NH				Santos da Silva, Rayane Cristine; Milet-Pinheiro, Paulo; Bezerra da Silva, Patricia Cristina; da Silva, Alexandre Gomes; da Silva, Marcia Vanusa; do Amaral Ferraz Navarro, Daniela Maria; da Silva, Nicacio Henrique			(E)-Caryophyllene and alpha-Humulene: Aedes aegypti Oviposition Deterrents Elucidated by Gas Chromatography-Electrophysiological Assay of Commiphora leptophloeos Leaf Oil	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; ACARICIDAL ACTIVITY; MEDICINAL-PLANTS; AROMATIC PLANTS; DENGUE VECTOR; OLEOGUM RESIN; MOSQUITO; CARYOPHYLLENE	Aedes aegypti is responsible for the transmission of dengue, a disease that infects millions of people each year. Although essential oils are well recognized as sources of compounds with repellent and larvicidal activities against the dengue mosquito, much less is known about their oviposition deterrent effects. Commiphora leptophloeos, a tree native to South America, has important pharmacological properties, but the chemical profile and applicability of its essential oil in controlling the spread of the dengue mosquito have not been investigated. The aim of this study was to determine the composition of C. leptophloeos leaf oil and to evaluate its larvicidal and oviposition deterrent effects against A. aegypti. Fifty-five components of the essential oil were detected by gas chromatography (GC)-mass spectrometry, with a-phellandrene (26.3%), (E)-caryophyllene (18.0%) and beta-phellandrene (12.9%) identified as the major constituents. Bioassays showed that the oil exhibited strong oviposition deterrent effects against A. aegypti at concentrations between 25 and 100 ppm, and possessed good larvicidal activity (LC50 = 99.4 ppm). Analysis of the oil by GC coupled with electroantennographic detection established that seven constituents could trigger antennal depolarization in A. aegypti gravid females. Two of these components, namely (E)-caryophyllene and a-humulene, were present in substantial proportions in the oil, and oviposition deterrence assays confirmed that both were significantly active at concentrations equivalent to those present in the oil. It is concluded that these sesquiterpenes are responsible, at least in part, for the deterrent effect of the oil. The oviposition deterrent activity of the leaf oil of C. leptophloeos is one of the most potent reported so far, suggesting that it could represent an interesting alternative to synthetic insecticides. The results of this study highlight the importance of integrating chemical and electrophysiological methods for screening natural compounds for their potential in combating vectors of insect-borne diseases.	[Santos da Silva, Rayane Cristine; Milet-Pinheiro, Paulo; Bezerra da Silva, Patricia Cristina; do Amaral Ferraz Navarro, Daniela Maria] Fed Univ Pernambuco UFPE, Dept Fundamental Chem, Lab Chem Ecol, Recife, PE, Brazil; [Santos da Silva, Rayane Cristine; da Silva, Alexandre Gomes; da Silva, Marcia Vanusa; da Silva, Nicacio Henrique] Fed Univ Pernambuco UFPE, Dept Biochem, Lab Nat Prod, Recife, PE, Brazil; [Milet-Pinheiro, Paulo] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Ulm University	Navarro, DMDF (corresponding author), Fed Univ Pernambuco UFPE, Dept Fundamental Chem, Lab Chem Ecol, Recife, PE, Brazil.	dmafn@ufpe.br	Navarro, Daniela Maria do Amaral Ferraz/C-4975-2013; Bezerra-Silva, Patricia C/E-8746-2016; Pinheiro, Paulo Milet/P-7035-2015; Navarro, Daniela Maria do Amaral Ferraz/GXM-4019-2022	Navarro, Daniela Maria do Amaral Ferraz/0000-0003-0158-7221; Bezerra-Silva, Patricia C/0000-0002-3774-8528; Pinheiro, Paulo Milet/0000-0002-4929-2177; Silva, Rayane Cristine Santos da/0000-0002-4765-7283	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)/Programa de Apoio a Nucleos de Excelencia (PRONEX); FACEPE/PRONEX [APQ-0981-1.06/08]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) CNPq/Universal [482866/2011-0]; CNPq/INCT-Dengue [15204]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)/Programa de Apoio a Nucleos de Excelencia (PRONEX); FACEPE/PRONEX(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) CNPq/Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq/INCT-Dengue	The study was supported financially by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)/Programa de Apoio a Nucleos de Excelencia (PRONEX) and the following funding sources were not involved in the study design, in the collection, analysis, and interpretation of data: FACEPE/PRONEX (APQ-0981-1.06/08); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) CNPq/Universal (Processo: 482866/2011-0); CNPq/INCT-Dengue (15204).	Abdel-Aziz S. E., 2000, Annals of Agricultural Science (Cairo), V45, P717; Adams R. P, 2009, IDENTIFICATION ESSEN; Agra MF, 2007, J ETHNOPHARMACOL, V111, P383, DOI 10.1016/j.jep.2006.12.007; Ali NAA, 2008, REC NAT PROD, V2, P70; Ali NAA, 2009, J ESSENT OIL BEAR PL, V12, P244, DOI 10.1080/0972060X.2009.10643717; Amiel E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/872394; ARN H, 1975, Z NATURFORSCH C, V30, P722; Arnason JT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511542664.002; Asres K, 1998, PLANTA MED, V64, P473, DOI 10.1055/s-2006-957489; Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055; Avlessi F, 2005, J ESSENT OIL RES, V17, P569, DOI 10.1080/10412905.2005.9698998; Ayedoun M. A., 1998, Journal of Essential Oil Research, V10, P105; Baser KHC, 2003, FLAVOUR FRAG J, V18, P153, DOI 10.1002/ffj.1166; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; BRIESKORN CH, 1982, PLANTA MED, V44, P87, DOI 10.1055/s-2007-971408; Burger H, 2012, OECOLOGIA, V168, P727, DOI 10.1007/s00442-011-2136-4; Campbell C, 2011, ENTOMOL EXP APPL, V138, P21, DOI 10.1111/j.1570-7458.2010.01072.x; CARROLL JF, 1989, ENTOMOL EXP APPL, V53, P111, DOI 10.1007/BF00187991; Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003; Chantraine JM, 1998, PHYTOTHER RES, V12, P350, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;350::AID-PTR311&gt;3.0.CO;2-7; Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038; Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693; DAVIS EE, 1976, J INSECT PHYSIOL, V22, P1371, DOI 10.1016/0022-1910(76)90160-8; De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017; Ferreira WS, 2011, J ETHNOPHARMACOL, V138, P238, DOI 10.1016/j.jep.2011.09.018; FLINT HM, 1979, ENVIRON ENTOMOL, V8, P1123, DOI 10.1093/ee/8.6.1123; Forattini OP, 2003, REV SAUDE PUBL, V37, P676, DOI 10.1590/S0034-89102003000500021; Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066; de Lima GPG, 2013, PARASITOL RES, V112, P1953, DOI 10.1007/s00436-013-3351-1; Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438; Habeeb S. M., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V5, P196; Hanus Lumir O., 2005, Biomedical Papers (Olomouc), V149, P3; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Jantan I., 1998, ARBEC, P1; Junor GAO, 2008, J ESSENT OIL RES, V20, P560, DOI 10.1080/10412905.2008.9700088; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Khandagle AJ, 2011, PARASITOL RES, V109, P339, DOI 10.1007/s00436-011-2261-3; Kim EH, 2003, APPL ENTOMOL ZOOL, V38, P261, DOI 10.1303/aez.2003.261; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu Yu-Qing, 2010, Acta Entomologica Sinica, V53, P396; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Meshram P. B., 2000, Indian Forester, V126, P961; Milet-Pinheiro P, 2013, J CHEM ECOL, V39, P1347, DOI 10.1007/s10886-013-0363-3; Mothana RA, 2010, MOLECULES, V15, P689, DOI 10.3390/molecules15020689; Navarro DMDF, 2013, NAT PROD J, V3, P268, DOI 10.2174/221031550304140328113732; Noge K, 2009, MOLECULES, V14, P5289, DOI 10.3390/molecules14125289; Phasomkusolsil S, 2011, SE ASIAN J TROP MED, V42, P1083; Pierson TC, 2014, ANNU REV VIROL, V1, P191; Pontes WJT, 2010, J ESSENT OIL RES, V22, P279, DOI 10.1080/10412905.2010.9700324; Pooter H. L. de, 1989, Journal of Essential Oil Research, V1, P9; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Ranaweera S. S., 1996, Journal of the National Science Council of Sri Lanka, V24, P63; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Rozendaal J.A., 1997, VECTOR CONTROL METHO; Sant'Ana J, 2001, P WORKSH CHEM COUPL, P47; Santos GKN, 2014, MOLECULES, V19, P16573, DOI 10.3390/molecules191016573; Santos GKN, 2012, IND CROP PROD, V40, P254, DOI 10.1016/j.indcrop.2012.03.020; Schiestl FP, 2002, MOLEC METH PLAN ANAL, V21, P173; Shen T, 2012, J ETHNOPHARMACOL, V142, P319, DOI 10.1016/j.jep.2012.05.025; Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064; Simoes C.M.O., 1999, FARMACOGN PLANTA AO, V1th, P467; Vera SS, 2014, PARASITOL RES, V113, P2647, DOI 10.1007/s00436-014-3917-6; SOUZA V. C., 2008, BOT SISTEMATICA GUIA; Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018; Pontes Wendel José Teles, 2007, Acta Amaz., V37, P103, DOI 10.1590/S0044-59672007000100012; Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675; Warikoo R, 2011, PARASITOL RES, V109, P1125, DOI 10.1007/s00436-011-2355-y; World Health Organization, 2019, DENG SEV DENG; World Health Organization, 2005, GUID LAB FIELD TEST, P7; Yang DP, 1999, MYCOPATHOLOGIA, V148, P79, DOI 10.1023/A:1007178924408	74	42	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144586	10.1371/journal.pone.0144586	http://dx.doi.org/10.1371/journal.pone.0144586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650757	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300059
J	Tang, WZ; Zhou, HF; Li, W				Tang, Weizhong; Zhou, Huafu; Li, Wei			Silver and Cyanine Staining of Oligonucleotides in Polyacrylamide Gel	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; ETHIDIUM-BROMIDE; DNA; PROTEINS; RNA	To explore why some oligonucleotides in denaturing polyacrylamide gel could not be silver-stained, 134 different oligonucleotides were analyzed using denaturing polyacrylamide gel electrophoresis stained with silver and asymmetric cyanine. As a result, we found that the sensitivity of oligos (dA), (dC), (dG) and (dT) to silver staining could be ranged as (dA) > (dG) > (dC) > (dT) from high to low. It was unexpected that oligo (dT) was hard to be silver-stained. Moreover, the silver staining of an oligonucleotide containing base T could be partially or completely inhibited by base T. The inhibition of silver staining by base T was a competitive inhibition which could be affected by the amounts of the argyrophil nucleobase and base T, the cis-distance between the argyrophil nucleobase and base T, and the gel concentration. The changes of the intensity of an oligonucleotide band caused by the changes of DNA base composition were diverse and interesting. The intensity of some oligonucleotide bands would significantly change when the changes of DNA base composition accumulated to a certain extent (usually >= 4 nt). The sensitivity of cyanine staining of <= 11-nt long oligonucleotides could be enhanced about 250-fold by fixing the gels with methanol fixing solution.	[Tang, Weizhong] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Nanning 530021, Guangxi, Peoples R China; [Zhou, Huafu] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning 530021, Guangxi, Peoples R China; [Li, Wei] Guangxi Med Univ, Med Sci Res Ctr, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, W (corresponding author), Guangxi Med Univ, Med Sci Res Ctr, 22 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China.	liwei60@yahoo.com			National Natural Science Foundation of China [31360218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is funded by National Natural Science Foundation of China, Grant No. 31360218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1993, APPL BIOCHEM BIOTECH, V42, P181, DOI 10.1007/BF02788051; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bassam BJ, 2007, NAT PROTOC, V2, P2649, DOI 10.1038/nprot.2007.330; BEIDLER JL, 1982, ANAL BIOCHEM, V126, P374, DOI 10.1016/0003-2697(82)90530-9; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOULIKAS T, 1981, J BIOCHEM BIOPH METH, V5, P219, DOI 10.1016/0165-022X(81)90046-4; FERRES MD, 1984, MUTAT RES, V126, P245, DOI 10.1016/0027-5107(84)90003-4; Gao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039251; GOLDMAN D, 1982, ELECTROPHORESIS, V3, P24, DOI 10.1002/elps.1150030105; GUILLEMETTE JG, 1983, ELECTROPHORESIS, V4, P92, DOI 10.1002/elps.1150040112; KOLODNY GM, 1984, ANAL BIOCHEM, V138, P66, DOI 10.1016/0003-2697(84)90769-3; Li W, 2006, CLIN BIOCHEM, V39, P833, DOI 10.1016/j.clinbiochem.2006.05.004; MARCOS R, 1981, EXPERIENTIA, V37, P559, DOI 10.1007/BF01990047; McKee DR, 2004, BIOTECHNIQUES, V37, P46, DOI 10.2144/04371BM04; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MERRIL CR, 1979, P NATL ACAD SCI USA, V76, P4335, DOI 10.1073/pnas.76.9.4335; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Shukla S, 2009, NANOSCALE, V1, P122, DOI 10.1039/b9nr00004f; Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7; SOMERVILLE LL, 1981, BIOCHEM BIOPH RES CO, V102, P53, DOI 10.1016/0006-291X(81)91487-X; Tuma RS, 1999, ANAL BIOCHEM, V268, P278, DOI 10.1006/abio.1998.3067	21	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144422	10.1371/journal.pone.0144422	http://dx.doi.org/10.1371/journal.pone.0144422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650843	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300048
J	Xing, GS; Wang, S; Sun, YM; Yuan, Z; Zhao, XM; Zhou, CW				Xing, Gu-sheng; Wang, Shuang; Sun, Yue-Min; Yuan, Zheng; Zhao, Xin-Ming; Zhou, Chun-wu			Small Bowel Stromal Tumors: Different Clinicopathologic and Computed Tomography Features in Various Anatomic Sites	PLOS ONE			English	Article							RECURRENCE; PATHOLOGY; LOCATION; RISK; GIST; CT	Gastrointestinal stromal tumors (GISTs) can present with different clinical and immunohistochemical characteristics according to different anatomic sites. The aim of this study was to compare clinicopathologic and computed tomography (CT) features of small bowel stromal tumors located in the duodenum, jejunum, and ileum. In total, 197 patients (109 male, 88 female) with small bowel GISTs were retrospectively reviewed. All tumors had definite anatomic sites in the small bowel tract with surgical confirmation. The clinicopathologic variables included age, sex, onset of symptoms, and tumor risk category. CT variables included tumor size, degree enhancement, enhancement pattern (region of necrosis), adjacent tissue involvement, lymphadenopathy, and distant metastasis. We assessed any possible differences according to different GIST site of origin. Based on tumor size and mitotic count, the risk categories in different anatomic sites did not differ significantly between duodenal and jejunal GISTs. However, high risk ileum GISTs accounted for 66.0% of ileal cases, which was higher than duodenum cases (36.8%, P = 0.002) and jejunum cases (43.9%, P = 0.004). The mean size of GISTs in the ileum was 9.77 cm, which was significantly larger than in the duodenum (7.41 cm, P = 0.043), and in the jejunum (8.14 cm, P = 0.027). On CT images, enhancement degree appeared to gradually increase from the duodenum to the ileum in the portal phase, and the enhancement pattern presented a tendency for heterogeneity. In Conclusions, the clinicopathologic and CT features of small bowel GISTs can differ according to different primary anatomic sites.	[Xing, Gu-sheng; Wang, Shuang; Zhao, Xin-Ming; Zhou, Chun-wu] Peking Union Med Coll, Canc Hosp & Inst, Dept Diagnost Imaging, Beijing 100021, Peoples R China; [Xing, Gu-sheng; Wang, Shuang; Sun, Yue-Min; Yuan, Zheng; Zhao, Xin-Ming; Zhou, Chun-wu] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Sun, Yue-Min] Peking Union Med Coll, Canc Hosp & Inst, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China; [Yuan, Zheng] Peking Union Med Coll, Canc Hosp & Inst, Dept Pathol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhou, CW (corresponding author), Peking Union Med Coll, Canc Hosp & Inst, Dept Diagnost Imaging, Beijing 100021, Peoples R China.	chunwuzhoucams@163.com						Burkill GJC, 2003, RADIOLOGY, V226, P527, DOI 10.1148/radiol.2262011880; Casali PG, 2014, ANN ONCOL, V25, P21, DOI 10.1093/annonc/mdu255; Caterino S, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-13; Crosby JA, 2001, ANN SURG ONCOL, V8, P50, DOI 10.1007/s10434-001-0050-4; De Vogelaere K, 2014, ACTA CHIR BELG, V114, P167, DOI 10.1080/00015458.2014.11681003; DeMatteo RP, 2008, CANCER-AM CANCER SOC, V112, P608, DOI 10.1002/cncr.23199; DeMatteo RP, 2002, ANN SURG ONCOL, V9, P831, DOI 10.1007/BF02557518; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Han IW, 2015, WORLD J SURG, V39, P1026, DOI 10.1007/s00268-014-2810-x; Hersh Marla R, 2005, Cancer Control, V12, P111; HONG X, 2006, GASTROINTESTINAL STR, V26, P481, DOI DOI 10.1148/RG.262055097; Horton KM, 2004, J COMPUT ASSIST TOMO, V28, P811, DOI 10.1097/00004728-200411000-00014; Horton KM, 2004, J COMPUT ASSIST TOMO, V28, P106, DOI 10.1097/00004728-200401000-00019; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Levy AD, 2003, RADIOGRAPHICS, V23, P283, DOI 10.1148/rg.232025146; Lupescu IG, 2007, J GASTROINTEST LIVER, V16, P147; Miettinen M, 2006, AM J SURG PATHOL, V30, P477, DOI 10.1097/00000478-200604000-00008; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Miettinen M, 2011, J SURG ONCOL, V104, P865, DOI 10.1002/jso.21945; Miki Y, 2010, J CLIN GASTROENTEROL, V44, P97, DOI 10.1097/MCG.0b013e3181b8e754; Pickhardt PJ, 2003, RADIOGRAPHICS, V23, P645, DOI 10.1148/rg.233025134; Sandrasegaran K, 2005, EUR RADIOL, V15, P1407, DOI 10.1007/s00330-005-2647-7; Ulusan S, 2008, BRIT J RADIOL, V81, P618, DOI 10.1259/bjr/90134736; Werewka-Maczuga A, 2011, POL J RADIOL, V76, P38; Wong RJ, 2013, DIGEST DIS SCI, V58, P3112, DOI 10.1007/s10620-013-2678-x; Xie Yi-bin, 2012, Zhonghua Yi Xue Za Zhi, V92, P1694; Yang WL, 2009, J SURG ONCOL, V100, P606, DOI 10.1002/jso.21378; Yu QX, 2014, WORLD J GASTROENTERO, V20, P11800, DOI 10.3748/wjg.v20.i33.11800	29	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144277	10.1371/journal.pone.0144277	http://dx.doi.org/10.1371/journal.pone.0144277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646242	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903100016
J	Gonzalez-Recio, O; Daetwyler, HD; MacLeod, IM; Pryce, JE; Bowman, PJ; Hayes, BJ; Goddard, ME				Gonzalez-Recio, Oscar; Daetwyler, Hans D.; MacLeod, Iona M.; Pryce, Jennie E.; Bowman, Phil J.; Hayes, Ben J.; Goddard, Michael E.			Rare Variants in Transcript and Potential Regulatory Regions Explain a Small Percentage of the Missing Heritability of Complex Traits in Cattle	PLOS ONE			English	Article							HOLSTEIN-FRIESIAN CATTLE; DAIRY-CATTLE; GENOMIC PREDICTIONS; SEQUENCE DATA; BREEDING VALUES; COMMON SNPS; ACCURACY; IMPUTATION; RELIABILITY; PERSISTENCE	The proportion of genetic variation in complex traits explained by rare variants is a key question for genomic prediction, and for identifying the basis of "missing heritability"-the proportion of additive genetic variation not captured by common variants on SNP arrays. Sequence variants in transcript and regulatory regions from 429 sequenced animals were used to impute high density SNP genotypes of 3311 Holstein sires to sequence. There were 675,062 common variants (MAF>0.05), 102,549 uncommon variants (0.01<MAF<0.05), and 83,856 rare variants (MAF<0.01). We describe a novel method for estimating the proportion of the rare variants that are sequencing errors using parent-progeny duos. We then used mixed model methodology to estimate the proportion of variance captured by these different classes of variants for fat, milk and protein yields, as well as for fertility. Common sequence variants captured 83%, 77%, 76% and 84% of the total genetic variance for fat, milk, and protein yields and fertility, respectively. This was between 2 and 5% more variance than that captured from 600k SNPs on a high density chip, although the difference was not significant. Rare variants captured 3%, 0%, 1% and 14% of the genetic variance for fat, milk and protein yields, and fertility respectively, whereas pedigree explained the remaining amount of genetic variance (none for fertility). The proportion of variation explained by rare variants is likely to be under-estimated due to reduced accuracies of imputation for this class of variants. Using common sequence variants slightly improved accuracy of genomic predictions for fat and milk yield, compared to high density SNP array genotypes. However, including rare variants from transcript regions did not increase the accuracy of genomic predictions. These results suggest that rare variants recover a small percentage of the missing heritability for complex traits, however very large reference sets will be required to exploit this to improve the accuracy of genomic predictions. Our results do suggest the contribution of rare variants to genetic variation may be greater for fitness traits.	[Gonzalez-Recio, Oscar; Daetwyler, Hans D.; MacLeod, Iona M.; Pryce, Jennie E.; Bowman, Phil J.; Hayes, Ben J.; Goddard, Michael E.] Biosci Res Div, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic 3083, Australia; [Gonzalez-Recio, Oscar; Daetwyler, Hans D.; MacLeod, Iona M.; Pryce, Jennie E.; Bowman, Phil J.; Hayes, Ben J.] Dairy Futures Cooperat Res Ctr, Bundoora, Vic 3083, Australia; [Daetwyler, Hans D.; Pryce, Jennie E.; Hayes, Ben J.] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic 3086, Australia; [MacLeod, Iona M.; Goddard, Michael E.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia	La Trobe University; University of Melbourne	Gonzalez-Recio, O (corresponding author), Biosci Res Div, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic 3083, Australia.	ogrecio@gmail.com	Daetwyler, Hans D/H-9775-2019; Hayes, Ben J/L-3308-2016; Pryce, Jennie E/AAC-2490-2019; Gonzalez-Recio, Oscar/C-8553-2016	Hayes, Ben J/0000-0002-5606-3970; Pryce, Jennie/0000-0002-1397-1282; Goddard, Michael/0000-0001-9917-7946; Gonzalez-Recio, Oscar/0000-0002-9106-4063; Daetwyler, Hans D/0000-0002-3018-3640	Biosciences Research Division, Department of Environment, Land, Water and Planning, Bundoora (Melbourne, Australia); Dairy Futures Cooperative Research Centre (Melbourne, Australia)	Biosciences Research Division, Department of Environment, Land, Water and Planning, Bundoora (Melbourne, Australia); Dairy Futures Cooperative Research Centre (Melbourne, Australia)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by Biosciences Research Division, Department of Environment, Land, Water and Planning, Bundoora (Melbourne, Australia) and Dairy Futures Cooperative Research Centre (Melbourne, Australia). The 1000 bull genomes project provided sequences used in this study. The funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	An SS, 2013, GENET EPIDEMIOL, V37, P13, DOI 10.1002/gepi.21685; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005048; Druet T, 2014, HEREDITY, V112, P39, DOI 10.1038/hdy.2013.13; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gilmour AR, 2009, ASREML USER GUIDE RE; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Jensen J, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-44; Koufariotis L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-436; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; de Maturana EL, 2014, HUM GENET, V133, P1235, DOI 10.1007/s00439-014-1461-1; Lund MS, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-43; MacLeod IM, 2014, GENETICS, V198, P1671, DOI 10.1534/genetics.114.168344; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roman-Ponce SI, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-36; Saunders EJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004129; Solberg TR, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-53; van Binsbergen R, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-41; VanRaden PM, 2013, J DAIRY SCI, V96, P668, DOI 10.3168/jds.2012-5702; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden PM, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-7; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-23; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2014, PNAS, V17, pE455; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	51	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143945	10.1371/journal.pone.0143945	http://dx.doi.org/10.1371/journal.pone.0143945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642058	gold, Green Published			2022-12-26	WOS:000366902700035
J	Schumacher, MA; Zeng, WJ; Huang, KH; Tchorzewski, L; Janakiraman, A				Schumacher, Maria A.; Zeng, Wenjie; Huang, Kuo-Hsiang; Tchorzewski, Lukasz; Janakiraman, Anuradha			Structural and Functional Analyses Reveal Insights into the Molecular Properties of the Escherichia coli Z Ring Stabilizing Protein, ZapC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEINS; BACTERIAL CYTOKINESIS; CYTOSKELETAL PROTEIN; CRYSTAL-STRUCTURE; FTSZ; PROMOTES; ZIPA; GTP; IDENTIFICATION; BINDING	In Escherichia coli cell division is driven by the tubulin-like GTPase, FtsZ, which forms the cytokinetic Z-ring. The Z-ring serves as a dynamic platform for the assembly of the multiprotein divisome, which catalyzes membrane cleavage to create equal daughter cells. Several proteins effect FtsZ assembly, thereby providing spatiotemporal control over cell division. One important class of FtsZ interacting/regulatory proteins is the Z-ring-associated proteins, Zaps, which typically modulate Z-ring formation by increasing lateral interactions between FtsZ protofilaments. Strikingly, these Zap proteins show no discernable sequence similarity, suggesting that they likely harbor distinct structures and mechanisms. The 19.8-kDa ZapC in particular shows no homology to any known protein. To gain insight into ZapC function, we determined its structure to 2.15 angstrom and performed genetic and biochemical studies. ZapC is a monomer composed of two domains, an N-terminal alpha/beta region and a C-terminal twisted beta barrel-like domain. The structure contains two pockets, one on each domain. The N-domain pocket is lined with residues previously implicated to be important for ZapC function as an FtsZ bundler. The adjacent C-domain pocket contains a hydrophobic center surrounded by conserved basic residues. Mutagenesis analyses indicate that this pocket is critical for FtsZ binding. An extensive FtsZ binding surface is consistent with the fact that, unlike many FtsZ regulators, ZapC binds the large FtsZ globular core rather than C-terminal tail, and the presence of two adjacent pockets suggests possible mechanisms for ZapC-mediated FtsZ bundling.	[Schumacher, Maria A.; Zeng, Wenjie] Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,Box 3711, Durham, NC 27710 USA; [Huang, Kuo-Hsiang; Tchorzewski, Lukasz; Janakiraman, Anuradha] CUNY City Coll, Dept Biol, MR 526, New York, NY 10031 USA; [Huang, Kuo-Hsiang; Janakiraman, Anuradha] CUNY, Grad Ctr, New York, NY 10016 USA	Duke University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, 243 Nanaline H Duke,Box 3711, Durham, NC 27710 USA.; Janakiraman, A (corresponding author), CUNY City Coll, Dept Biol, MR 526, New York, NY 10031 USA.	maria.schumacher@duke.edu; anuj@ccny.cuny.edu			National Institutes of Health [GM074815, 8G12MD007603-29]; National Science Foundation [MCB1158059]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants GM074815 (to M. A. S.) and 8G12MD007603-29 (NIMHD, for core facility support to CCNY). This work was also supported by National Science Foundation Grant MCB1158059 (to A. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhattacharya A, 2015, INT J BIOL MACROMOL, V81, P435, DOI 10.1016/j.ijbiomac.2015.08.030; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Buske PJ, 2013, MOL MICROBIOL, V89, P249, DOI 10.1111/mmi.12272; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Espeli O, 2012, EMBO J, V31, P3198, DOI 10.1038/emboj.2012.128; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Marteyn BS, 2014, MBIO, V5, DOI 10.1128/mBio.00022-14; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Ortiz C., 2015, FEMS MICROBIOL REV; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Roach EJ, 2014, J BIOL CHEM, V289, P23276, DOI 10.1074/jbc.M114.561928; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsang MJ, 2015, CURR OPIN MICROBIOL, V24, P60, DOI 10.1016/j.mib.2015.01.002; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003	49	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2485	2498		10.1074/jbc.M115.697037	http://dx.doi.org/10.1074/jbc.M115.697037			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26655719	Green Published, hybrid			2022-12-26	WOS:000369610400036
J	Woodfolk, JA; Glesner, J; Wright, PW; Kepley, CL; Li, M; Himly, M; Muehling, LM; Gustchina, A; Wlodawer, A; Chapman, MD; Pomes, A				Woodfolk, Judith A.; Glesner, Jill; Wright, Paul W.; Kepley, Christopher L.; Li, Mi; Himly, Martin; Muehling, Lyndsey M.; Gustchina, Alla; Wlodawer, Alexander; Chapman, Martin D.; Pomes, Anna			Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOUSE-DUST MITE; FLUORESCENT MULTIPLEX ARRAY; SITE-DIRECTED MUTAGENESIS; HUMAN IGE ANTIBODIES; AMINO-ACID-RESIDUES; B-CELL EPITOPES; RECOMBINANT ALLERGENS; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-E; GRASS-POLLEN	Bla g 2 is a major indoor cockroach allergen associated with the development of asthma. Antigenic determinants on Bla g 2 were analyzed by mutagenesis based on the structure of the allergen alone and in complex with monoclonal antibodies that interfere with IgE antibody binding. The structural analysis revealed mechanisms of allergen-antibody recognition through cation-pi interactions. Single and multiple Bla g 2 mutants were expressed in Pichia pastoris and purified. The triple mutant K132A/K251A/F162Y showed an similar to 100-fold reduced capacity to bind IgE, while preserving the native molecular fold, as proven by x-ray crystallography. This mutant was still able to induce mast cell release. T-cell responses were assessed by analyzing Th1/Th2 cytokine production and the CD4(+) T-cell phenotype in peripheral blood mononuclear cell cultures. Although T-cell activating capacity was similar for the KKF mutant and Bla g 2 based on CD25 expression, the KKF mutant was a weaker inducer of the Th2 cytokine IL-13. Furthermore, this mutant induced IL-10 from a non-T-cell source at higher levels that those induced by Bla g 2. Our findings demonstrate that a rational design of site-directed mutagenesis was effective in producing a mutant with only 3 amino acid substitutions that maintained the same fold as wild type Bla g 2. These residues, which were involved in IgE antibody binding, endowed Bla g 2 with a T-cell modulatory capacity. The antigenic analysis of Bla g 2 will be useful for the subsequent development of recombinant allergen vaccines.	[Woodfolk, Judith A.; Wright, Paul W.; Muehling, Lyndsey M.] Univ Virginia, Dept Med, Div Allergy, Charlottesville, VA 22903 USA; [Glesner, Jill; Chapman, Martin D.; Pomes, Anna] INDOOR Biotechnol Inc, 700 Harris St, Charlottesville, VA 22908 USA; [Kepley, Christopher L.] Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27401 USA; [Li, Mi; Gustchina, Alla; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Li, Mi] Leidos Biomed Res Inc, Frederick Natl Lab, Basic Sci Program, Frederick, MD 21702 USA; [Himly, Martin] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	University of Virginia; INDOOR Biotechnologies; University of North Carolina; University of North Carolina Greensboro; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Salzburg University	Pomes, A (corresponding author), INDOOR Biotechnol Inc, 700 Harris St, Charlottesville, VA 22908 USA.	apomes@inbio.com	Pomés, Anna/H-7010-2019; Himly, Martin/D-1568-2015	Pomés, Anna/0000-0002-8729-1829; Chapman, Martin/0000-0002-0845-3632; Muehling, Lyndsey/0000-0003-3203-3264; Himly, Martin/0000-0001-5416-085X	National Institutes of Health from NIAID [R01AI077653, R01AI77653-01A2S1]; Intramural Research Program of the National Institutes of Health, NCI Center for Cancer Research; National Institutes of Health from NCI [HHSN26120080001E]; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI077653] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the National Institutes of Health, NCI Center for Cancer Research; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI077653 and R01AI77653-01A2S1 from NIAID, in part by the Intramural Research Program of the National Institutes of Health, NCI Center for Cancer Research, and in part by National Institutes of Health Contract HHSN26120080001E from NCI. M. D. C is a co-owner and has a financial interest in Indoor Biotechnologies, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Health and Human Services.	Arruda LK, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0428-6; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; BERNTON HS, 1964, J ALLERGY, V35, P506, DOI 10.1016/0021-8707(64)90082-6; Cheng TT, 2008, BIOCHEM BIOPH RES CO, V375, P671, DOI 10.1016/j.bbrc.2008.08.097; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Cong YJ, 2013, J DAIRY SCI, V96, P6870, DOI 10.3168/jds.2013-6880; Davies JM, 2004, CLIN EXP ALLERGY, V34, P429, DOI 10.1111/j.1365-2222.2004.01900.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Flicker S, 2006, J ALLERGY CLIN IMMUN, V117, P1336, DOI 10.1016/j.jaci.2006.02.012; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Glesner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022223; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; GREENE WK, 1991, J IMMUNOL, V147, P3768; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Hulse KE, 2010, J ALLERGY CLIN IMMUN, V125, P247, DOI 10.1016/j.jaci.2009.10.027; Huss K, 2001, J ALLERGY CLIN IMMUN, V107, P48, DOI 10.1067/mai.2001.111146; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kepley CL, 2005, INT ARCH ALLERGY IMM, V138, P29, DOI 10.1159/000087355; Kepley CL, 2004, J BIOL CHEM, V279, P35139, DOI 10.1074/jbc.M404318200; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; Lee MF, 2012, ANN ALLERG ASTHMA IM, V108, P243, DOI 10.1016/j.anai.2012.01.014; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li M, 2011, J IMMUNOL, V186, P333, DOI 10.4049/jimmunol.1002318; Lin J, 2012, J ALLERGY CLIN IMMUN, V129, P1321, DOI 10.1016/j.jaci.2012.02.012; Linhart B, 2004, INT ARCH ALLERGY IMM, V134, P324, DOI 10.1159/000079535; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; Lustrek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078605; Mao Jian-hua, 2004, Zhejiang Da Xue Xue Bao Yi Xue Ban, V33, P155; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLLER BK, 1990, FEBS LETT, V276, P59, DOI 10.1016/0014-5793(90)80506-E; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oseroff C, 2012, J IMMUNOL, V189, P679, DOI 10.4049/jimmunol.1200694; Page K, 2008, J IMMUNOL, V180, P6317, DOI 10.4049/jimmunol.180.9.6317; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Roulias A, 2014, ALLERGY, V69, P208, DOI 10.1111/all.12306; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; Smith AM, 1998, J ALLERGY CLIN IMMUN, V101, P423, DOI 10.1016/S0091-6749(98)70259-3; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; Takai T, 1997, NAT BIOTECHNOL, V15, P754, DOI 10.1038/nbt0897-754; TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0; Toda M, 2011, J ALLERGY CLIN IMMUN, V128, P1022, DOI 10.1016/j.jaci.2011.04.020; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wood RA, 2014, J ALLERGY CLIN IMMUN, V133, P846, DOI 10.1016/j.jaci.2013.08.047; Wunschmann S, 2005, J ALLERGY CLIN IMMUN, V116, P140, DOI 10.1016/j.jaci.2005.04.024; Zhang GL, 2011, J IMMUNOL METHODS, V374, P53, DOI 10.1016/j.jim.2010.11.009	56	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2288	2301		10.1074/jbc.M115.702324	http://dx.doi.org/10.1074/jbc.M115.702324			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26644466	Green Published, hybrid			2022-12-26	WOS:000369610400019
J	Chang, EM; Lim, E; Yoon, S; Jeong, K; Bae, S; Lee, DR; Yoon, TK; Choi, Y; Lee, WS				Chang, Eun Mi; Lim, Eunjin; Yoon, Sookyoung; Jeong, Kyungah; Bae, Sijeong; Lee, Dong Ryul; Yoon, Tae Ki; Choi, Youngsok; Lee, Woo Sik			Cisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN/AKT/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in Mice	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; TUMOR-SUPPRESSOR GENE; SUBCELLULAR TARGETS; CANCER CELLS; PTEN; CHEMOTHERAPY; ACTIVATION; OOCYTES; MECHANISMS; RESISTANCE	Cisplatin is a first-line chemotherapeutic agent for ovarian cancer that acts by promoting DNA cross links and adduct. However drug resistance and considerable side effects including reproductive toxicity remain a significant challenge. PTEN is well known as a tumor suppressor function which plays a fundamental role in the regulation of the cell cycle, apoptosis and development of cancer. At the same time PTEN has been revealed to be critically important for the maintenance of the primordial follicle pool. In this study, we investigated the role of PTEN/Akt/FOXO3 pathway in cisplatin-induced primordial follicle depletion. Cisplatin induced ovarian failure mouse model was used to evaluate how this pathway involves. In vitro maturation was used for oocyte rescue after cisplatin damage. We found that cisplatin treatment decreased PTEN levels, leading to a subsequent increase in the phosphorylation of key molecules in the pathway. The activation of the PTEN/Akt/FOXO3 pathway cascade increased cytoplasmic translocation of FOXO3a in cisplatin-treated follicles, which in turn increased the pool size of growing follicles, and rapidly depleted the number of dormant follicles. Once activated, the follicles were more prone to apoptosis, and their cumulus cells showed a loss of luteinizing hormone (LH) receptor expression, which leads to failure during final maturation and ovulation. In vitro maturation to rescue oocytes in a cisplatin-treated mouse model resulted in successful maturation and fertilization. This study is the first to show the involvement of the PTEN/Akt/FOXO3 pathway in premature ovarian failure after cisplatin treatment and the possibility of rescue through in vitro maturation.	[Chang, Eun Mi; Yoon, Sookyoung; Lee, Dong Ryul; Yoon, Tae Ki; Lee, Woo Sik] CHA Univ, Dept Obstet & Gynecol, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea; [Lim, Eunjin; Yoon, Sookyoung; Bae, Sijeong; Lee, Dong Ryul; Choi, Youngsok] CHA Univ, Dept Biomed Sci, Songnam, South Korea; [Jeong, Kyungah] Ewha Womans Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Ewha Womans University	Choi, Y (corresponding author), CHA Univ, Dept Biomed Sci, Songnam, South Korea.	youngsokchoi@cha.ac.kr; wooslee@cha.ac.kr		Choi, Youngsok/0000-0002-3862-4105	Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A120080]; National Research foundation of Korea, Ministry of Science, ICT and Future planning [2014R1A1A1002702]	Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; National Research foundation of Korea, Ministry of Science, ICT and Future planning	This study was supported by a grant (A120080) from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea and a grant (2014R1A1A1002702) from the National Research foundation of Korea, Ministry of Science, ICT and Future planning.; This study was supported by a grant (A120080) from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea and a grant (2014R1A1A1002702) from the National Research foundation of Korea, Ministry of Science, ICT and Future planning.	Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Blumenfeld Z, 2012, BEST PRACT RES CL OB, V26, P379, DOI 10.1016/j.bpobgyn.2011.11.008; Boosani CS, 2013, EXPERT OPIN THER PAT, V23, P569, DOI 10.1517/13543776.2013.768985; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; FitzGerald MG, 1998, ONCOGENE, V17, P727, DOI 10.1038/sj.onc.1201984; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; LEIBBRANDT MEI, 1995, KIDNEY INT, V48, P761, DOI 10.1038/ki.1995.348; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Maccio A, 2013, EXPERT OPIN PHARMACO, V14, P1839, DOI 10.1517/14656566.2013.813934; Meirow D, 2007, HUM REPROD, V22, P1626, DOI 10.1093/humrep/dem027; Meirow D, 2000, MOL CELL ENDOCRINOL, V169, P123, DOI 10.1016/S0303-7207(00)00365-8; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042; Pelosi E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2861; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Sancho-Martinez SM, 2012, PHARMACOL THERAPEUT, V136, P35, DOI 10.1016/j.pharmthera.2012.07.003; Schondorf T, 2001, ANTI-CANCER DRUG, V12, P797, DOI 10.1097/00001813-200111000-00002; Singh M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-233; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Sobinoff AP, 2011, TOXICOL SCI, V123, P563, DOI 10.1093/toxsci/kfr195; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki H, 1998, CANCER RES, V58, P204; Tilly J L, 1996, Rev Reprod, V1, P162, DOI 10.1530/revreprod/1.3.162; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Winther JF, 2004, AM J HUM GENET, V74, P1282, DOI 10.1086/421473; Wu H, 2008, CANCER LETT, V271, P260, DOI 10.1016/j.canlet.2008.06.012; Wu HJ, 2014, BIOCHEM BIOPH RES CO, V444, P141, DOI 10.1016/j.bbrc.2014.01.014	39	72	76	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144245	10.1371/journal.pone.0144245	http://dx.doi.org/10.1371/journal.pone.0144245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656301	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900034
J	Gushchin, A; Tang, A				Gushchin, Andrey; Tang, Ao			Total Wiring Length Minimization of C-elegans Neural Network: A Constrained Optimization Approach	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; ORGANIZATION; ECONOMY; BRAIN	Using the most recent data on the connectivity of the C. elegans neural network, we find optimal two-dimensional positions of interneurons that minimize the total wiring length provided that the positions of motor and sensory neurons are fixed. The rationale behind fixing motor and sensory neurons is the following: while positions of motor and sensory neurons can be influenced by the locations of muscles and sensory organs they are attached to, the main function of interneurons is to connect other neurons, and their placement could try to minimize the wiring length. Solutions for l(1), l(2) and squared l(2)-norm were obtained. For the Euclidean norm l2, the relative and absolute difference between the real and optimal total wiring lengths is minimal among these functions of distance. Additional network constraints were discussed such as assignment of different weights to electrical or chemical connections, fixation of "tail" interneurons, minimal interneural distance limitation, and others. These constraints were compared by their influence on the optimal positions of interneurons.	[Gushchin, Andrey] Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA; [Tang, Ao] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA	Cornell University; Cornell University	Gushchin, A (corresponding author), Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA.	avg36@cornell.edu						Ahn YY, 2006, PHYSICA A, V367, P531, DOI 10.1016/j.physa.2005.12.013; [Anonymous], 1999, TEXTURE NERVOUS SYST; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Choe Y., 2004, SOC NEUR ABSTR, V30; HALL DH, 1991, J NEUROSCI, V11, P1; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kotter R, 2004, NEUROINFORMATICS, V2, P127; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Varshney LR, 2013, IEEE J SEL AREA COMM, V31, P1095, DOI 10.1109/JSAC.2013.130611; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	13	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145029	10.1371/journal.pone.0145029	http://dx.doi.org/10.1371/journal.pone.0145029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659722	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900171
J	Krug, AZ; Patzkowsky, ME				Krug, Andrew Z.; Patzkowsky, Mark E.			Phylogenetic Clustering of Origination and Extinction across the Late Ordovician Mass Extinction	PLOS ONE			English	Article							SELECTIVITY; RECOVERIES; GENERA; SIGNAL	Mass extinctions can have dramatic effects on the trajectory of life, but in some cases the effects can be relatively small even when extinction rates are high. For example, the Late Ordovician mass extinction is the second most severe in terms of the proportion of genera eliminated, yet is noted for the lack of ecological consequences and shifts in clade dominance. By comparison, the end-Cretaceous mass extinction was less severe but eliminated several major clades while some rare surviving clades diversified in the Paleogene. This disconnect may be better understood by incorporating the phylogenetic relatedness of taxa into studies of mass extinctions, as the factors driving extinction and recovery are thought to be phylogenetically conserved and should therefore promote both origination and extinction of closely related taxa. Here, we test whether there was phylogenetic selectivity in extinction and origination using brachiopod genera from the Middle Ordovician through the Devonian. Using an index of taxonomic clustering (RCL) as a proxy for phylogenetic clustering, we find that A) both extinctions and originations shift from taxonomically random or weakly clustered within families in the Ordovician to strongly clustered in the Silurian and Devonian, beginning with the recovery following the Late Ordovician mass extinction, and B) the Late Ordovician mass extinction was itself only weakly clustered. Both results stand in stark contrast to Cretaceous-Cenozoic bivalves, which showed significant levels of taxonomic clustering of extinctions in the Cretaceous, including strong clustering in the mass extinction, but taxonomically random extinctions in the Cenozoic. The contrasting patterns between the Late Ordovician and end-Cretaceous events suggest a complex relationship between the phylogenetic selectivity of mass extinctions and the long-term phylogenetic signal in origination and extinction patterns.	[Krug, Andrew Z.; Patzkowsky, Mark E.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Krug, AZ (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	azk102@psu.edu			NASA Astrobiology [11-EXO11-0070]	NASA Astrobiology	This work was funded by NASA Astrobiology grant number 11-EXO11-0070.; This work was funded by NASA Astrobiology grant number 11-EXO11-0070. We thank Judi Sclafani for producing S1 Fig, and Dr. Friedman, Dr. Renbin and 2 anonymous reviewers for their helpful suggestions.	Bapst DW, 2014, PALEOBIOLOGY, V40, P331, DOI 10.1666/13033; Bennett PM, 2005, CONSERV BIOL SER, V8, P317; Carlson SJ, 2008, EARTH ENV SCI T R SO, V98, P311, DOI 10.1017/S1755691007078437; Congreve CR, 2015, PALAEONTOLOGY, V58, P743, DOI 10.1111/pala.12177; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; de Weerd DRU, 2004, MOL PHYLOGENET EVOL, V33, P533, DOI 10.1016/j.ympev.2004.07.010; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Finnegan S, 2012, P NATL ACAD SCI USA, V109, P6829, DOI 10.1073/pnas.1117039109; Finnegan S, 2011, SCIENCE, V331, P903, DOI 10.1126/science.1200803; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Hardy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037977; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harnik PG, 2014, PALEOBIOLOGY, V40, P675, DOI 10.1666/14006; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1989, PHILOS T ROY SOC B, V325, P357, DOI 10.1098/rstb.1989.0093; Jablonski D, 2009, P NATL ACAD SCI USA, V106, P8262, DOI 10.1073/pnas.0902973106; Krug AZ, 2007, PALEOBIOLOGY, V33, P435, DOI 10.1666/06039.1; Krug AZ, 2004, P NATL ACAD SCI USA, V101, P17605, DOI 10.1073/pnas.0405199102; McGhee GR, 2013, PALAEOGEOGR PALAEOCL, V370, P260, DOI 10.1016/j.palaeo.2012.12.019; McGhee GR, 2004, PALAEOGEOGR PALAEOCL, V211, P289, DOI 10.1016/j.palaeo.2004.05.010; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Miller AI, 1996, PALEOBIOLOGY, V22, P304, DOI 10.1017/S0094837300016237; Mooers AO, 2005, CONSERV BIOL SER, V8, P120; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Schreiber HA, 2013, J PALEONTOL, V87, P550, DOI 10.1666/12-115; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; Soul LC, 2015, SYST BIOL, V64, P608, DOI 10.1093/sysbio/syv015; Stanley S.M., 1990, P103; Willams A, 2000, TREATISE INVERTEBR H, V3; Willams A, 2002, TREATISE INVERTEBR H, V4; Willams A, 2006, TREATISE INVERTEBR H, V5; Willams A, 2000, TREATISE INVERTEBR H, V2	42	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144354	10.1371/journal.pone.0144354	http://dx.doi.org/10.1371/journal.pone.0144354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658946	gold, Green Published			2022-12-26	WOS:000366715900040
J	Laboissiere, R; Letievant, JC; Ionescu, E; Barraud, PA; Mazzuca, M; Cian, C				Laboissiere, Rafael; Letievant, Jean-Charles; Ionescu, Eugen; Barraud, Pierre-Alain; Mazzuca, Michel; Cian, Corinne			Relationship between Spectral Characteristics of Spontaneous Postural Sway and Motion Sickness Susceptibility	PLOS ONE			English	Article							VERTICAL AXIS ROTATION; HEALTHY-SUBJECTS; VISUAL-FIELD; INSTABILITY; FREQUENCY; SIMULATOR; CUES; EQUILIBRIUM; OSCILLATION; ORIENTATION	Motion sickness (MS) usually occurs for a narrow band of frequencies of the imposed oscillation. It happens that this frequency band is close to that which are spontaneously produced by postural sway during natural stance. This study examined the relationship between reported susceptibility to motion sickness and postural control. The hypothesis is that the level of MS can be inferred from the shape of the Power Spectral Density (PSD) profile of spontaneous sway, as measured by the displacement of the center of mass during stationary, upright stance. In Experiment 1, postural fluctuations while standing quietly were related to MS history for inertial motion. In Experiment 2, postural stability measures registered before the onset of a visual roll movement were related to MS symptoms following the visual stimulation. Study of spectral characteristics in postural control showed differences in the distribution of energy along the power spectrum of the antero-posterior sway signal. Participants with MS history provoked by exposure to inertial motion showed a stronger contribution of the high frequency components of the sway signal. When MS was visually triggered, sick participants showed more postural sway in the low frequency range. The results suggest that subject-specific PSD details may be a predictor of the MS level. Furthermore, the analysis of the sway frequency spectrum provided insight into the intersubject differences in the use of postural control subsystems. The relationship observed between MS susceptibility and spontaneous posture is discussed in terms of postural sensory weighting and in relation to the nature of the provocative stimulus.	[Laboissiere, Rafael; Cian, Corinne] CNRS, LPNC, F-38000 Grenoble, France; [Laboissiere, Rafael; Cian, Corinne] Univ Grenoble Alpes, LPNC, F-38000 Grenoble, France; [Laboissiere, Rafael; Mazzuca, Michel] CNRS, CRNL, INSERM, F-69675 Bron, France; [Letievant, Jean-Charles; Ionescu, Eugen; Mazzuca, Michel] HCL, Serv Explorat Audiovestibulaires, F-69003 Lyon, France; [Barraud, Pierre-Alain] CNRS, TIMC IMAG, F-38000 Grenoble, France; [Cian, Corinne] Inst Rech Biomed Armees, F-91223 Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Laboissiere, R (corresponding author), CNRS, LPNC, F-38000 Grenoble, France.	rafael.laboissiere@upmf-grenoble.fr	Laboissière, Rafael/E-9814-2013	Laboissière, Rafael/0000-0002-2180-9250; Ionescu, Eugen Constant/0000-0003-3773-9848	Ministere de la Defense (France) [07co805]	Ministere de la Defense (France)	This work was supported by grant #07co805 from Ministere de la Defense (France), awarded to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD B, 1985, EXP BRAIN RES, V61, P21; Barbour AJ, 2014, COMPUT GEOSCI-UK, V63, P1, DOI 10.1016/j.cageo.2013.09.015; BENSEL CK, 1968, PERCEPT PSYCHOPHYS, V4, P285, DOI 10.3758/BF03210516; Bles W, 1998, BRAIN RES BULL, V47, P481, DOI 10.1016/S0361-9230(98)00115-4; Bonnet CT, 2006, HUM MOVEMENT SCI, V25, P800, DOI 10.1016/j.humov.2006.03.001; Bos JE, 1998, BRAIN RES BULL, V47, P537, DOI 10.1016/S0361-9230(98)00088-4; Bos JE, 2005, AVIAT SPACE ENVIR MD, V76, P1111; Bos JE, 2011, DISPLAYS, V32, P189, DOI 10.1016/j.displa.2010.09.005; Bos JE, 2010, APPL ERGON, V41, P516, DOI 10.1016/j.apergo.2009.11.007; Catanzariti JF, 2016, EUR SPINE J, V25, P438, DOI 10.1007/s00586-015-4060-5; Cobb SVG, 1999, APPL ERGON, V30, P47, DOI 10.1016/S0003-6870(98)00038-6; Diels C, 2013, HUM FACTORS, V55, P595, DOI 10.1177/0018720812469046; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Duh HBL, 2004, HUM FACTORS, V46, P142, DOI 10.1518/hfes.46.1.142.30384; Faugloire E, 2007, EXP BRAIN RES, V177, P520, DOI 10.1007/s00221-006-0700-7; FUKUDA T, 1975, ACTA OTO-LARYNGOL, P9; Golding JF, 2001, AVIAT SPACE ENVIR MD, V72, P188; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; Golding JF, 2009, AVIAT SPACE ENVIR MD, V80, P516, DOI 10.3357/ASEM.2433.2009; Golomer E, 2000, INT J NEUROSCI, V105, P15, DOI 10.3109/00207450009003262; GRAYBIEL A, 1970, AEROSPACE MED, V41, P650; Guignard JC, 1990, MOTION SPACE SICKNES, P123; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Horak F, 1996, HDB PHYSIOL 12, V12, P255; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 1998, HUM MOVEMENT SCI, V17, P367, DOI 10.1016/S0167-9457(98)00005-0; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kennedy RS, 1997, AVIAT SPACE ENVIR MD, V68, P13; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; Kennedy RS, 1996, INT J HUM-COMPUT INT, V8, P25, DOI 10.1080/10447319609526139; Kennedy RS, 1997, P DRIV SIM C DSC97 E, P115; Kennedy RS, 1990, MOTION SPACE SICKNES, P179; Koslucher FC, 2014, GAIT POSTURE, V39, P606, DOI 10.1016/j.gaitpost.2013.09.016; Lane N., 1988, 887 EOTR ESS CORP; LAWTHER A, 1986, ERGONOMICS, V29, P535, DOI 10.1080/00140138608968289; LAWTHER A, 1987, J ACOUST SOC AM, V82, P957, DOI 10.1121/1.395295; LAWTHER A, 1988, ERGONOMICS, V31, P1373, DOI 10.1080/00140138808966783; MONEY KE, 1970, PHYSIOL REV, V50, P1, DOI 10.1152/physrev.1970.50.1.1; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; Nashner L, 1970, REPORT NO MVT 70 3; Nishiike S, 2013, J MED INVESTIG, V60, P236; OHANLON JF, 1974, AEROSPACE MED, V45, P366; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Oman C M, 1982, Acta Otolaryngol Suppl, V392, P1; Oppenheim U, 1999, DIABETES CARE, V22, P328, DOI 10.2337/diacare.22.2.328; Owen N, 1998, BRAIN RES BULL, V47, P471, DOI 10.1016/S0361-9230(98)00101-4; Pavol MJ, 2005, J NEUROPHYSIOL, V93, P20, DOI 10.1152/jn.00864.2004; R Development Core Team, 2012, R A LANGUAGE AND ENV; REASON JT, 1969, INT J MAN MACH STUD, V1, P21, DOI 10.1016/S0020-7373(69)80009-X; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reason JT., 1975, MOTION SICKNESS; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Schubert P., 2012, J BIOMED SCI ENG, V5, P508, DOI [10.4236/jbise.2012.59063, DOI 10.4236/JBISE.2012.59063]; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; STOFFREGEN T A, 1991, Ecological Psychology, V3, P159, DOI 10.1207/s15326969eco0303_1; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Stoffregen TA, 1998, BRAIN RES BULL, V47, P437, DOI 10.1016/S0361-9230(98)00102-6; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Stoffregen TA, 2010, ECOL PSYCHOL, V22, P169, DOI 10.1080/10407413.2010.496645; TAKAHASHI M, 1992, AVIAT SPACE ENVIR MD, V63, P486; Tal D, 2010, NEUROSCI LETT, V479, P134, DOI 10.1016/j.neulet.2010.05.044; Venables WN., 2002, MODERN APPL STAT S 4; Villard SJ, 2008, HUM FACTORS, V50, P332, DOI 10.1518/001872008X250728; Wood SJ, 2002, NEUROSCI LETT, V323, P41, DOI 10.1016/S0304-3940(02)00118-0; Yokota Y, 2005, ACTA OTO-LARYNGOL, V125, P280, DOI 10.1080/00016480510003192	68	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144466	10.1371/journal.pone.0144466	http://dx.doi.org/10.1371/journal.pone.0144466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657203	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900054
J	Mastroianni, P; Monechi, B; Liberto, C; Valenti, G; Servedio, VDP; Loreto, V				Mastroianni, Pierpaolo; Monechi, Bernardo; Liberto, Carlo; Valenti, Gaetano; Servedio, Vito D. P.; Loreto, Vittorio			Local Optimization Strategies in Urban Vehicular Mobility	PLOS ONE			English	Article							SPATIAL STRUCTURE; SCALING LAWS	The comprehension of vehicular traffic in urban environments is crucial to achieve a good management of the complex processes arising from people collective motion. Even allowing for the great complexity of human beings, human behavior turns out to be subject to strong constraints-physical, environmental, social, economic-that induce the emergence of common patterns. The observation and understanding of those patterns is key to setup effective strategies to optimize the quality of life in cities while not frustrating the natural need for mobility. In this paper we focus on vehicular mobility with the aim to reveal the underlying patterns and uncover the human strategies determining them. To this end we analyze a large dataset of GPS vehicles tracks collected in the Rome (Italy) district during a month. We demonstrate the existence of a local optimization of travel times that vehicle drivers perform while choosing their journey. This finding is mirrored by two additional important facts, i.e., the observation that the average vehicle velocity increases by increasing the travel length and the emergence of a universal scaling law for the distribution of travel times at fixed traveled length. A simple modeling scheme confirms this scenario opening the way to further predictions.	[Mastroianni, Pierpaolo; Liberto, Carlo; Valenti, Gaetano] ENEA, Casaccia Res Ctr, I-00123 Rome, Italy; [Mastroianni, Pierpaolo; Monechi, Bernardo; Servedio, Vito D. P.; Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Servedio, Vito D. P.] Inst Complex Syst ISC CNR, I-00185 Rome, Italy; [Loreto, Vittorio] Inst Sci Interchange Fdn, I-10126 Turin, Italy; [Loreto, Vittorio] SONY CSL, F-75005 Paris, France	Italian National Agency New Technical Energy & Sustainable Economics Development; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Monechi, B (corresponding author), Univ Roma La Sapienza, Dept Phys, Ple Aldo Moro 2, I-00185 Rome, Italy.	mone.berna@gmail.com	Liberto, Carlo/AAC-6182-2022	Liberto, Carlo/0000-0003-2792-7722	EU [611272, 265432]; CNR PNR Project CRISIS Lab; KREYON project - Templeton Foundation [51663]; CNR PNR Project "CRISIS Lab"; Templeton Foundation [51663]	EU(European Commission); CNR PNR Project CRISIS Lab(Consiglio Nazionale delle Ricerche (CNR)); KREYON project - Templeton Foundation; CNR PNR Project "CRISIS Lab"(Consiglio Nazionale delle Ricerche (CNR)); Templeton Foundation	This work was supported by EU-STREP project EveryAware (Grant Agreement 265432), EU FP7 Grant 611272 (project GROWTHCOM), CNR PNR Project CRISIS Lab, KREYON project funded by the Templeton Foundation under contract n. 51663. SONY-CSL provided support in the form of research materials for author VL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.; The authors acknowledge support from the EU-STREP project EveryAware (Grant Agreement 265432), the EU FP7 Grant 611272 (project GROWTHCOM), the CNR PNR Project "CRISIS Lab" for financial support and the KREYON project funded by the Templeton Foundation under contract n. 51663. We acknowledge interesting discussions with P. Butta. We are grateful to A. Sirbu for providing us the OpenStreetMap and Google Directions data of the city of Rome and London. We thank M. Mancini for his valuable work on OctoTelematics data preprocessing. SONY-CSL provided support in the form of research material for author VL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author contribution statement.	[Anonymous], 2004, HDB STOCHASTIC METHO; Asgari F, 2013, ARXIV13070814; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M., 2013, NEW SCI CITIES; Belmonte A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05301; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brown B, 2011, MCKINSEY Q; Chowdhury D, 2000, PHYS REP, V329, P199, DOI 10.1016/S0370-1573(99)00117-9; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Eubank H, 2004, NATURE, V429; Gallotti R, 2013, STAT PHYS MODELLING; Garske T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016364; Gastner MT, 2006, EUR PHYS J B, V49, P247, DOI 10.1140/epjb/e2006-00046-8; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gonzalez-Bailon S, 2013, SOCIAL SCI RES NETWO; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Jenelius E, 2013, TRANSPORT RES B-METH, V53, P64, DOI 10.1016/j.trb.2013.03.008; Kolbl R, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/348; Lammer S, 2006, PHYSICA A, V363, P89, DOI 10.1016/j.physa.2006.01.051; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Mayer-Sch?nber V., 2013, BIG DATA REVOLUTION; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Rahmani M., 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P730, DOI 10.1109/ITSC.2010.5625177; Rambaldi S, 2007, P EUR C COMPL SYST D; Riccardo G, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500611; Rubinstein IS, 2013, 1256 NYU SCH LAW; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sirbu A, 2014, CCS14 P HUM COMP; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Tene O, 2012, NW J TECHNOLOGY INTE; United Nations Secretariat, 2014, WORLD URB PROSP 2014; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	35	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143799	10.1371/journal.pone.0143799	http://dx.doi.org/10.1371/journal.pone.0143799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656106	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900019
J	Vaughn, NR; Asner, GP; Smit, IPJ; Riddel, ES				Vaughn, Nicholas R.; Asner, Gregory P.; Smit, Izak P. J.; Riddel, Edward S.			Multiple Scales of Control on the Structure and Spatial Distribution of Woody Vegetation in African Savanna Watersheds	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; FIRE; RAINFALL; BIOMASS; TREES; LANDSCAPE; MECHANISMS; HERBIVORES; DYNAMICS; PATTERNS	Factors controlling savanna woody vegetation structure vary at multiple spatial and temporal scales, and as a consequence, unraveling their combined effects has proven to be a classic challenge in savanna ecology. We used airborne LiDAR (light detection and ranging) to map three-dimensional woody vegetation structure throughout four savanna watersheds, each contrasting in geologic substrate and climate, in Kruger National Park, South Africa. By comparison of the four watersheds, we found that geologic substrate had a stronger effect than climate in determining watershed-scale differences in vegetation structural properties, including cover, height and crown density. Generalized Linear Models were used to assess the spatial distribution of woody vegetation structural properties, including cover, height and crown density, in relation to mapped hydrologic, topographic and fire history traits. For each substrate and climate combination, models incorporating topography, hydrology and fire history explained up to 30% of the remaining variation in woody canopy structure, but inclusion of a spatial autocovariate term further improved model performance. Both crown density and the cover of shorter woody canopies were determined more by unknown factors likely to be changing on smaller spatial scales, such as soil texture, herbivore abundance or fire behavior, than by our mapped regional-scale changes in topography and hydrology. We also detected patterns in spatial covariance at distances up to 50-450 m, depending on watershed and structural metric. Our results suggest that large-scale environmental factors play a smaller role than is often attributed to them in determining woody vegetation structure in southern African savannas. This highlights the need for more spatially-explicit, wide-area analyses using high resolution remote sensing techniques.	[Vaughn, Nicholas R.; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Smit, Izak P. J.] South African Natl Pk, Sci Serv, Skukuza, South Africa; [Smit, Izak P. J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Riddel, Edward S.] South African Natl Pk, Conservat Management, Skukuza, South Africa; [Riddel, Edward S.] Univ KwaZulu Natal, Ctr Water Resources Res, Pietermaritzburg, South Africa	Carnegie Institution for Science; University of Witwatersrand; University of Kwazulu Natal	Vaughn, NR (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	nvaughn@carrnegiescience.edu	Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Vaughn, Nicholas/0000-0003-0428-2909	Andrew Mellon Foundation	Andrew Mellon Foundation	This work was supported by Andrew Mellon Foundation, mellon.org.; This study was funded by the Andrew Mellon Foundation. The Carnegie Airborne Observatory is made possible by the Avatar Alliance Foundation, John D. and Catherine T. MacArthur Foundation, Mary Anne Nyburg Baker and G. Leonard Baker, Jr., and William R. Hearst III.	Asner GP, 2016, ECOGRAPHY, V39, P240, DOI 10.1111/ecog.01640; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Ball MC, 2002, OECOLOGIA, V133, P120, DOI 10.1007/s00442-002-1044-z; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bivand R., 2017, SPDEP SPATIAL DEPEND; Bucini G., 2010, ECOSYSTEM FUNCTION S, P219, DOI DOI 10.1201/B10275; Bucini G, 2009, INT GEOSCI REMOTE SE, P2714, DOI 10.1109/IGARSS.2009.5417381; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Chadwick OA, 2013, GEOLOGY, V41, P1171, DOI 10.1130/G34721.1; Codron J, 2011, OECOLOGIA, V165, P89, DOI 10.1007/s00442-010-1835-6; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; COLE MM, 1982, ECOL STUD, V42, P145; COLE MM, 1987, PROG PHYS GEOG, V11, P334, DOI 10.1177/030913338701100302; Colgan MS, 2012, BIOGEOSCIENCES, V9, P1809, DOI 10.5194/bg-9-1809-2012; COUGHENOUR MB, 1993, J BIOGEOGR, V20, P383, DOI 10.2307/2845587; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Fisher J, 2009, INT GEOSCI REMOTE SE, P449, DOI 10.1109/IGARSS.2009.5418040; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Gillson L, 2009, VEG HIST ARCHAEOBOT, V18, P171, DOI 10.1007/s00334-008-0202-6; GOODRICH DC, 1995, J HYDROL, V173, P283, DOI 10.1016/0022-1694(95)02703-R; Govender N, 2012, AFR J RANGE FOR SCI, V29, P63, DOI 10.2989/10220119.2012.697918; Groen TA, 2008, J TROP ECOL, V24, P269, DOI 10.1017/S0266467408004872; Hanan N.P., 2011, ECOSYSTEM FUNCTION S, P39, DOI DOI 10.1201/B10275; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hoffmann WA, 2003, FOREST ECOL MANAG, V180, P273, DOI 10.1016/S0378-1127(02)00566-2; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Kaartinen H, 2012, REMOTE SENS-BASEL, V4, P950, DOI 10.3390/rs4040950; Khomo L, 2011, CATENA, V87, P119, DOI 10.1016/j.catena.2011.05.017; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Lambers H, 2008, PLANT PHYSL ECOLOGY, P154, DOI DOI 10.1007/978-0-387-78341-3; Levick SR, 2015, FUNCT ECOL, V29, P131, DOI 10.1111/1365-2435.12306; Levick SR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1066; Levick SR, 2009, BIOL CONSERV, V142, P1693, DOI 10.1016/j.biocon.2009.03.004; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Luoga EJ, 2004, FOREST ECOL MANAG, V189, P23, DOI 10.1016/j.foreco.2003.02.001; Meek CS, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1099; Milne G.G., 1935, SOIL RES, V4, P183; PASSIOURA JB, 1991, AUST J SOIL RES, V29, P717, DOI 10.1071/SR9910717; Pivello VR, 2010, PLANT SOIL, V337, P111, DOI 10.1007/s11104-010-0508-x; R Core Development Team, 2012, 2142 R COR DEV TEAM; Riddell ES, 2012, KOEDOE, V54, DOI 10.4102/koedoe.v54i1.1070; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes RJ, 2002, J VEG SCI, V13, P419, DOI 10.1111/j.1654-1103.2002.tb02066.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scholes RJ, 1993, AFRICAN SAVANNA SYNT, P2, DOI [10.1017/CBO9780511565472.002, DOI 10.1017/CBO9780511565472.002]; Scholes RJ, 2003, KRUGER EXPERIENCE EC, P243; Scholtz R, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00034.1; Schutte I. C., 1986, KOEDOE, V29, P13, DOI DOI 10.4102/K0ED0E.V29I1.517; Shackleton C. M., 2000, Koedoe, V43, P75; Shannon G, 2011, ECOSYSTEMS, V14, P1372, DOI 10.1007/s10021-011-9485-z; SKARPE C, 1991, J VEG SCI, V2, P565, DOI 10.2307/3236039; SKARPE C, 1992, J VEG SCI, V3, P293, DOI 10.2307/3235754; Smit IPJ, 2013, ECOGRAPHY, V36, P447, DOI 10.1111/j.1600-0587.2012.07555.x; Smit IPJ, 2010, ECOL APPL, V20, P1865, DOI 10.1890/09-0929.1; SMITH TM, 1986, BIOTROPICA, V18, P219, DOI 10.2307/2388488; Trollope W. S. W., 1998, Koedoe, V41, P103; Trollope W.S.W., 1986, J GRASSLAND SOC SO A, V3, P37, DOI [https://doi.org/10.1080/02566702.1986.9648030, DOI 10.1080/02566702.1986.9648030]; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; van Zijl G, 2014, WATER SA, V40, P331, DOI 10.4314/wsa.v40i2.15; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; Venter F. J., 1986, Koedoe, V29, P125; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; VETAAS OR, 1992, J VEG SCI, V3, P337, DOI 10.2307/3235758	69	16	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145192	10.1371/journal.pone.0145192	http://dx.doi.org/10.1371/journal.pone.0145192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660502	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900191
J	Zoega, H; Kieler, H; Norgaard, M; Furu, K; Valdimarsdottir, U; Brandt, L; Haglund, B				Zoega, Helga; Kieler, Helle; Norgaard, Mette; Furu, Kari; Valdimarsdottir, Unnur; Brandt, Lena; Haglund, Bengt			Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden	PLOS ONE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; NORDIC COUNTRIES; DRUG-USE; RISK; COHORT; DEPRESSION; PREVALENCE; PATTERNS; WOMEN	Background The purpose was to describe utilization of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), including trends in prevalence, characteristics of users, drug switching and changes in prescribed doses in a large group of pregnant women across four Nordic countries. Methods A drug utilization study based on linked individual-level data from the nationwide prescription- and medical birth registers in Denmark, Iceland, Norway and Sweden. The study population comprised all pregnancies in these countries, resulting in a live birth or stillbirth after gestational week 22 from January 1st 2008 to December 31st 2012 (N = 1 162 470). In addition to the main study drugs SSRIs and SNRIs, we included (concurrent) use of other antidepressants, antipsychotics, anxiolytics and hypnotics. Results A total of 38 219 (3.3%) pregnancies were exposed to SSRIs and 5 634 (0.5%) to SNRIs. Prevalence of SSRI and SNRI use varied by country (1.8% in Norway to 7.0% in Iceland). Use and prescribed dosages decreased with each passing trimester of pregnancy; prevalence was 2.7% at conception, and 2.1%, 1.7% and 1.3% respectively in 1st, 2nd and 3rd trimester. In 0.6% of pregnancies women filled a prescription before pregnancy and in every trimester. In one third of exposed pregnancies, women were also dispensed anxiolytics, hypnotics or sedatives. Conclusion Use of SSRI and SNRI use during pregnancy varied between the Nordic countries, but the overall prevalence remained low and relatively stable from 2008 to 2012. The low prevalence of use and high proportion of women who discontinue treatment in pregnancy raise questions about adequate treatment of depression in pregnant women.	[Zoega, Helga; Valdimarsdottir, Unnur] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Kieler, Helle; Brandt, Lena; Haglund, Bengt] Solna Karolinska Inst, Ctr Pharmacoepidemiol, Dept Med, Stockholm, Sweden; [Norgaard, Mette] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Furu, Kari] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Oslo, Norway; [Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Iceland; Karolinska Institutet; Aarhus University; Norwegian Institute of Public Health (NIPH); Harvard University; Harvard T.H. Chan School of Public Health	Zoega, H (corresponding author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.	helgaz@hi.is		Norgaard, Mette/0000-0001-6110-5891; Valdimarsdottir, Unnur/0000-0001-5382-946X; Zoega, Helga/0000-0003-0761-9028; Kieler, Helle/0000-0001-9338-7133	Icelandic Centre for Research, START-Reintegration Fellowship, FP7 Marie Curie Award [130814-051]; University of Iceland, Karolinska Institutet; Norwegian Institute of Public Health; Aarhus University Hospital	Icelandic Centre for Research, START-Reintegration Fellowship, FP7 Marie Curie Award; University of Iceland, Karolinska Institutet; Norwegian Institute of Public Health; Aarhus University Hospital	Helga Zoega received financial support from the Icelandic Centre for Research, START-Reintegration Fellowship, FP7 Marie Curie Award, (#130814-051), http://www.rannis.is/, http://ec.europa.eu/rea/index_en.htm. The study was otherwise funded by the authors' affiliations: the University of Iceland, Karolinska Institutet, the Norwegian Institute of Public Health and Aarhus University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Charlton RA, 2015, BJOG-INT J OBSTET GY, V122, P1010, DOI 10.1111/1471-0528.13143; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Deligiannidis KM, 2014, J CLIN PSYCHOPHARM, V34, P244, DOI 10.1097/JCP.0000000000000087; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gentile S, 2017, NEUROSCIENCE, V342, P154, DOI 10.1016/j.neuroscience.2015.09.001; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Jimenez-Solem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063034; Kieler H, 2015, BJOG-INT J OBSTET GY, V122, P1618, DOI 10.1111/1471-0528.13164; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Laugesen K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003024; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Lupattelli A, 2015, DEPRESS ANXIETY, V32, P426, DOI 10.1002/da.22352; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Organization for Economic Cooperation Development (OECD), 2013, HEALTH AT A GLANCE 2; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Ramos E, 2007, BJOG-INT J OBSTET GY, V114, P1055, DOI 10.1111/j.1471-0528.2007.01387.x; Reefhuis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3190; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; van Gelder MMHJ, 2014, HUM REPROD, V29, P161, DOI 10.1093/humrep/det369; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Warburton W, 2010, ACTA PSYCHIAT SCAND, V121, P471, DOI 10.1111/j.1600-0447.2009.01490.x; WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health, 2012, GUIDELINES FOR ATC C; Yamamoto A, 2015, J PERINATOL, V35, P246, DOI 10.1038/jp.2014.197; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; Zoega H, 2011, ACTA PSYCHIAT SCAND, V123, P360, DOI 10.1111/j.1600-0447.2010.01607.x; Zoega H, 2009, J CHILD ADOL PSYCHOP, V19, P757, DOI 10.1089/cap.2009.0003	42	67	67	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144474	10.1371/journal.pone.0144474	http://dx.doi.org/10.1371/journal.pone.0144474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657647	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900055
J	Ejsing, CS; Bilgin, M; Fabregat, A				Ejsing, Christer S.; Bilgin, Mesut; Fabregat, Andreu			Quantitative Profiling of Long-Chain Bases by Mass Tagging and Parallel Reaction Monitoring	PLOS ONE			English	Article							SHOTGUN LIPIDOMICS; SPHINGOLIPIDS; QUADRUPOLE; SPECTROMETER; QUANTIFICATION; METABOLISM	Long-chain bases (LCBs) are both intermediates in sphingolipid metabolism and potent signaling molecules that control cellular processes. To understand how regulation of sphingolipid metabolism and levels of individual LCB species impinge upon physiological and pathophysiological processes requires sensitive and specific assays for monitoring these molecules. Here we describe a shotgun lipidomics method for quantitative profiling of LCB molecules. The method employs a "mass-tag" strategy where LCBs are chemically derivatized with deuterated methyliodide (CD3I) to produce trimethylated derivatives having a positively charged quaternary amine group. This chemical derivatization minimizes unwanted in-source fragmentation of LCB analytes and prompts a characteristic trimethylaminium fragment ion that enables sensitive and quantitative profiling of LCB molecules by parallel reaction monitoring on a hybrid quadrupole time-of-flight mass spectrometer. Notably, the strategy provides, for the first time, a routine for monitoring endogenous 3-ketosphinganine molecules and distinguishing them from more abundant isomeric sphingosine molecules. To demonstrate the efficacy of the methodology we report an in-depth characterization of the LCB composition of yeast mutants with defective sphingolipid metabolism and the absolute levels of LCBs in mammalian cells. The strategy is generic, applicable to other types of mass spectrometers and can readily be applied as an additional routine in workflows for global lipidome quantification and for functional studies of sphingolipid metabolism.	[Ejsing, Christer S.; Bilgin, Mesut; Fabregat, Andreu] Univ Southern Denmark, Dept Biochem & Mol Biol, VILLUM Ctr Bioanalyt Sci, Odense, Denmark	University of Southern Denmark	Ejsing, CS (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, VILLUM Ctr Bioanalyt Sci, Odense, Denmark.	cse@bmb.sdu.dk	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276	VILLUM FONDEN [VKR023439]; Lundbeck Foundation [R44-A4342, R54-A5858]; Danish Council for Independent Research | Natural Sciences [09-072484, 09-076199]; Villum Fonden [00007363] Funding Source: researchfish	VILLUM FONDEN(Villum Fonden); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research | Natural Sciences(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	This work was supported by the VILLUM FONDEN (VKR023439; CSE; http://villumfonden.dk), Lundbeck Foundation (R44-A4342, R54-A5858; CSE; www.lundbeckfoundation.com) and the Danish Council for Independent Research | Natural Sciences (09-072484, 09-076199; CSE; www.ufm.dk).	Almeida R, 2015, J AM SOC MASS SPECTR, V26, P133, DOI 10.1007/s13361-014-1013-x; Bilgin M, 2011, BBA-MOL CELL BIOL L, V1811, P1081, DOI 10.1016/j.bbalip.2011.09.018; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chernushevich IV, 2001, J MASS SPECTROM, V36, P849, DOI 10.1002/jms.207; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Husen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079736; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; LESTER RL, 1993, ADV LIPID RES, V26, P253; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	24	10	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144817	10.1371/journal.pone.0144817	http://dx.doi.org/10.1371/journal.pone.0144817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26660097	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600093
J	Larstad, M; Almstrand, AC; Larsson, P; Bake, B; Larsson, S; Ljungstrom, E; Mirgorodskaya, E; Olin, AC				Larstad, Mona; Almstrand, Ann-Charlotte; Larsson, Per; Bake, Bjorn; Larsson, Sven; Ljungstrom, Evert; Mirgorodskaya, Ekaterina; Olin, Anna-Carin			Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE; AIRWAY-OBSTRUCTION; OXIDATIVE STRESS; HEALTHY SMOKERS; LUNG-DISEASE; BREATH; BIOMARKERS; ASTHMA; PROGRESSION; EXPRESSION	Background Exhaled, endogenous particles are formed from the epithelial lining fluid in small airways, where surfactant protein A (SP-A) plays an important role in pulmonary host defense. Based on the knowledge that chronic obstructive pulmonary disease (COPD) starts in the small airway epithelium, we hypothesized that chronic inflammation modulates peripheral exhaled particle SP-A and albumin levels. The main objective of this explorative study was to compare the SP-A and albumin contents in exhaled particles from patients with COPD and healthy subjects and to determine exhaled particle number concentrations. Methods Patients with stable COPD ranging from moderate to very severe (n = 13), and healthy nonsmoking subjects (n = 12) were studied. Subjects performed repeated breath maneuvers allowing for airway closure and re-opening, and exhaled particles were optically counted and collected on a membrane using the novel PExA1 instrument setup. Immunoassays were used to quantify SP-A and albumin. Results COPD patients exhibited significantly lower SP-A mass content of the exhaled particles (2.7 vs. 3.9 weight percent, p = 0.036) and lower particle number concentration (p<0.0001) than healthy subjects. Albumin mass contents were similar for both groups. Conclusions Decreased levels of SP-A may lead to impaired host defense functions of surfactant in the airways, contributing to increased susceptibility to COPD exacerbations. SP-A in exhaled particles from small airways may represent a promising non-invasive biomarker of disease in COPD patients.	[Larstad, Mona; Almstrand, Ann-Charlotte; Larsson, Per; Mirgorodskaya, Ekaterina; Olin, Anna-Carin] Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden; [Bake, Bjorn; Larsson, Sven] Univ Gothenburg, Dept Resp Med & Allergol, Sahlgrenska Acad, Gothenburg, Sweden; [Ljungstrom, Evert] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Larstad, M (corresponding author), Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden.	mona.larstad@amm.gu.se	Olin, Anna-Carin/ABH-2627-2021		Swedish Heart-Lung foundation [20130279]; LUA-ALF (lokalt utvecklingsavtal avtal om lakarutbildning och forskning), Sahlgrenska University Hospital	Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); LUA-ALF (lokalt utvecklingsavtal avtal om lakarutbildning och forskning), Sahlgrenska University Hospital	Grants from the Swedish Heart-Lung foundation (ACO; grant number 20130279) and from LUA-ALF (lokalt utvecklingsavtal avtal om lakarutbildning och forskning), Sahlgrenska University Hospital (ML), funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; Antczak A, 2012, ARCH MED SCI, V8, P277, DOI 10.5114/aoms.2012.28555; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Betsuyaku T, 2004, EUR RESPIR J, V24, P964, DOI 10.1183/09031936.04.00064004; Borrill ZL, 2008, EUR RESPIR J, V32, P472, DOI 10.1183/09031936.00116107; Burgel PR, 2011, EUR RESPIR REV, V20, P7, DOI 10.1183/09059180.10010610; Casaburi R, 2013, COPD, V10, P367, DOI 10.3109/15412555.2012.752807; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Effros RM, 2005, CURR OPIN PULM MED, V11, P135, DOI 10.1097/00063198-200503000-00006; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1080/15298668791385868; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; HENRIKSEN JH, 1984, SCAND J CLIN LAB INV, V44, P119, DOI 10.3109/00365518409161392; Hill AT, 1999, AM J RESP CRIT CARE, V160, P893, DOI 10.1164/ajrccm.160.3.9901091; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Holmgren H, 2011, J AEROSOL MED PULM D, V24, P253, DOI 10.1089/jamp.2011.0880; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; Ishikawa N, 2011, RESPIRATION, V82, P10, DOI 10.1159/000324539; Khor YH, 2009, CLIN EXP ALLERGY, V39, P1659, DOI 10.1111/j.1365-2222.2009.03349.x; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Koczulla AR, 2012, RESP MED, V106, P120, DOI 10.1016/j.rmed.2011.06.015; KOULOURIS NG, 1995, EUR RESPIR J, V8, P306, DOI 10.1183/09031936.95.08020306; Larsson P, 2012, RESP MED, V106, P197, DOI 10.1016/j.rmed.2011.10.008; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Mazur W, 2011, EUR RESPIR J, V38, P277, DOI 10.1183/09031936.00110510; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Minakata Y, 2005, THORAX, V60, P882, DOI 10.1136/thx.2005.045765; Montuschi P, 2005, CLIN CHIM ACTA, V356, P22, DOI 10.1016/j.cccn.2005.01.012; Nicola ML, 2014, CHEST, V145, P998, DOI 10.1378/chest.13-1355; Ohlmeler S, 2008, J PROTEOME RES, V7, P5125, DOI 10.1021/pr800423x; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Persson C, 2009, CLIN EXP ALLERGY, V39, P1626, DOI 10.1111/j.1365-2222.2009.03373.x; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ropcke S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046207; Schwarz K, 2015, J AEROSOL MED PULM D, V28, P52, DOI 10.1089/jamp.2013.1104; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Siddiqui S, 2012, NAT MED, V18, P1619, DOI 10.1038/nm.2981; Sundblad BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084110; van den Berge M, 2011, CHEST, V139, P412, DOI 10.1378/chest.10-1210; Vlachaki EM, 2010, CHEST, V137, P37, DOI 10.1378/chest.09-1029; Yigla M, 2007, ARCH ORAL BIOL, V52, P36, DOI 10.1016/j.archoralbio.2006.08.002	48	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144463	10.1371/journal.pone.0144463	http://dx.doi.org/10.1371/journal.pone.0144463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656890	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600048
J	Ohol, YM; Wang, ZT; Kemble, G; Duke, G				Ohol, Yamini M.; Wang, Zhaoti; Kemble, George; Duke, Gregory			Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses	PLOS ONE			English	Article							F-PROTEIN; LIPID RAFTS; INFECTED CELLS; IN-VIVO; FUSION; MEMBRANE; MICRODOMAINS; CAVEOLIN-1; CANCER; ASSAY	Fatty acid synthase (FASN) catalyzes the de novo synthesis of palmitate, a fatty acid utilized for synthesis of more complex fatty acids, plasma membrane structure, and post-translational palmitoylation of host and viral proteins. We have developed a potent inhibitor of FASN (TVB-3166) that reduces the production of respiratory syncytial virus (RSV) progeny in vitro from infected human lung epithelial cells (A549) and in vivo from mice challenged intranasally with RSV. Addition of TVB-3166 to the culture medium of RSV-infected A549 cells reduces viral spread without inducing cytopathic effects. The antiviral effect of the FASN inhibitor is a direct consequence of reducing de novo palmitate synthesis; similar doses are required for both antiviral activity and inhibition of palmitate production, and the addition of exogenous palmitate to TVB-3166-treated cells restores RSV production. TVB3166 has minimal effect on RSV entry but significantly reduces viral RNA replication, protein levels, viral particle formation and infectivity of released viral particles. TVB-3166 substantially impacts viral replication, reducing production of infectious progeny 250-fold. In vivo, oral administration of TVB-3166 to RSV-A (Long)-infected BALB/c mice on normal chow, starting either on the day of infection or one day post-infection, reduces RSV lung titers 21-fold and 9-fold respectively. Further, TVB-3166 also inhibits the production of RSV B, human parainfluenza 3 (PIV3), and human rhinovirus 16 (HRV16) progeny from A549, HEp2 and HeLa cells respectively. Thus, inhibition of FASN and palmitate synthesis by TVB-3166 significantly reduces RSV progeny both in vitro and in vivo and has broad-spectrum activity against other respiratory viruses. FASN inhibition may alter the composition of regions of the host cell membrane where RSV assembly or replication occurs, or change the membrane composition of RSV progeny particles, decreasing their infectivity.	[Ohol, Yamini M.; Wang, Zhaoti; Kemble, George; Duke, Gregory] 3V Biosci, Menlo Pk, CA 94025 USA		Duke, G (corresponding author), 3V Biosci, Menlo Pk, CA 94025 USA.	greg.duke@3vbio.com			3-V Biosciences, Inc.	3-V Biosciences, Inc.	The study was funded by 3-V Biosciences, Inc. Employees of the company were involved in study design, data collection and analysis, decision to publish, and writing the manuscript. Although the therapeutics characterized in this study are products of 3-V Biosciences, studies were designed, executed, and objectively interpreted with the goal of advancing basic research on RSV and other respiratory viruses.	Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; ARUMUGHAM RG, 1989, J BIOL CHEM, V264, P10339; Boukhvalova MS, 2007, J VIROL, V81, P9443, DOI 10.1128/JVI.00102-07; Branigan PJ, 2006, J GEN VIROL, V87, P395, DOI 10.1099/vir.0.81481-0; Brown G, 2002, J GEN VIROL, V83, P1841, DOI 10.1099/0022-1317-83-8-1841; Brown G, 2002, J GEN VIROL, V83, P611, DOI 10.1099/0022-1317-83-3-611; Centers for Disease Control and Prevention, 2013, RESP SYNC VIR INF RS; Chang TH, 2012, VIROLOGY, V422, P205, DOI 10.1016/j.virol.2011.10.029; Chapman J, 2007, ANTIMICROB AGENTS CH, V51, P3346, DOI 10.1128/AAC.00211-07; Cheng X, 2002, J VIROL METHODS, V105, P287, DOI 10.1016/S0166-0934(02)00122-2; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Coleman DT, 2009, MOL CANCER THER, V8, P214, DOI 10.1158/1535-7163.MCT-08-0722; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Daniels VW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106913; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; De Serres G, 2009, J CLIN VIROL, V46, P129, DOI 10.1016/j.jcv.2009.07.010; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Douglas JL, 2005, ANTIMICROB AGENTS CH, V49, P2460, DOI 10.1128/AAC.49.6.2460-2466.2005; Evanchik M, 2012, HEPATOLOGY, V56, p1066A; Fleming EH, 2006, J VIROL, V80, P12160, DOI 10.1128/JVI.00643-06; Geller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056762; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; HEMINWAY BR, 1994, VIROLOGY, V200, P801, DOI 10.1006/viro.1994.1245; Huang JT, 2013, J VIROL, V87, P4994, DOI 10.1128/JVI.02526-12; Jeffree CE, 2003, VIROLOGY, V306, P254, DOI 10.1016/S0042-6822(02)00016-8; Jensen-Urstad APL, 2013, J LIPID RES, V54, P1848, DOI 10.1194/jlr.M036103; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Matsumoto K, 2014, RESPIR INVESTIG, V52, P92, DOI 10.1016/j.resinv.2013.08.005; McCurdy LH, 2003, J VIROL, V77, P1747, DOI 10.1128/JVI.77.3.1747-1756.2003; McDonald TP, 2004, VIROLOGY, V330, P147, DOI 10.1016/j.virol.2004.09.034; Morton CJ, 2003, VIROLOGY, V311, P275, DOI 10.1016/S0042-6822(03)00115-6; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; NORRBY E, 1970, J VIROL, V6, P237, DOI 10.1128/JVI.6.2.237-242.1970; Oomens AGP, 2006, J VIROL, V80, P10465, DOI 10.1128/JVI.01439-06; Oslob JD, 2013, ACS MED CHEM LETT, V4, P113, DOI 10.1021/ml300335r; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15; Puig T, 2008, ANTICANCER RES, V28, P3671; Puig T, 2009, CLIN CANCER RES, V15, P7608, DOI 10.1158/1078-0432.CCR-09-0856; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; San-Juan-Vergara H, 2012, J VIROL, V86, P1832, DOI 10.1128/JVI.06274-11; Smans KA, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-801; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Tomek K, 2011, MOL CANCER RES, V9, P1767, DOI 10.1158/1541-7786.MCR-10-0467; Turner TL, 2014, CLINICOECONOMIC OUTC, V6, P217, DOI 10.2147/CEOR.S60710; Veit M, 2012, BIOL CELL, V104, P493, DOI 10.1111/boc.201200006; WALSH EE, 1985, J GEN VIROL, V66, P409, DOI 10.1099/0022-1317-66-3-409; Yeo DSY, 2009, VIROLOGY, V386, P168, DOI 10.1016/j.virol.2008.12.017; Zhang HM, 2013, J PROTEOME RES, V12, P2967, DOI 10.1021/pr400247f	51	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144648	10.1371/journal.pone.0144648	http://dx.doi.org/10.1371/journal.pone.0144648			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659560	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600072
J	Yang, JH; Chen, CD; Chen, SU; Yang, YS; Chen, MJ				Yang, Jehn-Hsiahn; Chen, Chin-Der; Chen, Shee-Uan; Yang, Yu-Shih; Chen, Mei-Jou			Factors Influencing the Recurrence Potential of Benign Endometrial Polyps after Hysteroscopic Polypectomy	PLOS ONE			English	Article							PREGNANCY RATES; RESECTION	Background An endometrial polyp is a frequently encountered gynecologic disease with abnormal uterine bleeding and infertility being the two common presenting problems, and hysteroscopic polypectomy is an effective method to remove them. The postoperative polyp recurrence might result in reappearance of abnormal uterine bleeding or infertility, whereas factors influencing the postoperative recurrence potential have limited data. Methods This case-series report included 168 premenopausal women who suffered from endometrial polyps and underwent hysteroscopic polypectomy. All of them were awaiting a future pregnancy. Office hysteroscopy was done before and after hysteroscopic polypectomy, in which preoperative hysteroscopy examined the number, type, and location of endometrial polyps, and postoperative hysteroscopy checked the polyp recurrence. Surgical indications, either infertility or the presentation of abnormal uterine bleeding, and follow-up duration were recorded. Results Seventy-three out of 168 (43%) women had polyp recurrence after hysteroscopic polypectomy. Multivariate logistic regression analysis revealed that more endometrial polyps (P = 0.015) and longer duration of follow-up (P = 0.004) were significantly associated with an increased risk of postoperative polyp recurrence. The type of endometrial polyps was not correlated with polyp recurrence potential, whereas pedunculated type endometrial polyps were closely related to the presentation of abnormal uterine bleeding (P = 0.001). Conclusions A higher number of endometrial polyps and longer follow-up duration are associated with a greater potential of polyp recurrence after hysteroscopic polypectomy.	[Chen, Mei-Jou] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, MJ (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	mjchen04@ntu.edu.tw	Chen, Mei-Jou/AAS-7698-2020	YANG, YU-SHIH/0000-0002-8633-0873; YANG, JEHN-HSIAHN/0000-0001-8648-0882; CHEN, CHIN-DER/0000-0002-6330-7742; CHEN, SHEE-UAN/0000-0001-7592-3238; CHEN, MEI-JOU/0000-0002-2305-1105				AAGL Advancing Minimally Invasive, 2012, J MINIM INVAS GYN, V19, P3, DOI 10.1016/j.jmig.2011.09.003; AlHilli MM, 2013, J MINIM INVAS GYN, V20, P215, DOI 10.1016/j.jmig.2012.10.013; Ayas S, 2011, SAJOG-S AFR J OBSTET, V17, P10; Brown SE, 2000, FERTIL STERIL, V74, P1029, DOI 10.1016/S0015-0282(00)01541-7; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Paradisi R, 2014, GYNECOL OBSTET INVES, V78, P26, DOI 10.1159/000362646; Perez-Medina T, 2005, HUM REPROD, V20, P1632, DOI 10.1093/humrep/deh822; PETERSON WF, 1956, OBSTET GYNECOL, V8, P40; Preutthipan S, 2005, FERTIL STERIL, V83, P705, DOI 10.1016/j.fertnstert.2004.08.031; Shokeir TA, 2004, J OBSTET GYNAECOL RE, V30, P84, DOI 10.1111/j.1447-0756.2003.00163.x; Stamatellos I, 2008, ARCH GYNECOL OBSTET, V277, P395, DOI 10.1007/s00404-007-0460-z; Tallini G, 2000, LAB INVEST, V80, P359, DOI 10.1038/labinvest.3780040; Varasteh NN, 1999, OBSTET GYNECOL, V94, P168, DOI 10.1016/S0029-7844(99)00278-1; Yang JH, 2008, FERTIL STERIL, V89, P1254, DOI 10.1016/j.fertnstert.2007.05.027; Yang JH, 2013, FERTIL STERIL, V99, P2092, DOI 10.1016/j.fertnstert.2013.01.137; Yang JH, 2011, FERTIL STERIL, V95, P1769, DOI 10.1016/j.fertnstert.2011.01.142; Yang JH, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2007.01.033; Yang JH, 2015, BJOG IN PRESS	18	28	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144857	10.1371/journal.pone.0144857	http://dx.doi.org/10.1371/journal.pone.0144857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26660149	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600098
J	Shiferaw, MB; Mengistu, AD				Shiferaw, Melashu Balew; Mengistu, Agmas Dessalegn			Helminthiasis: Hookworm Infection Remains a Public Health Problem in Dera District, South Gondar, Ethiopia	PLOS ONE			English	Article								Background Intestinal parasitic infections are significant cause of morbidity and mortality in endemic countries. In Ethiopia, helminthiasis was the third leading cause of outpatient visits. Despite the health extension program was launched to address this problem, there is limited information on the burden of intestinal parasites after implementation of the program in our setting. Therefore, the aim of this study was to assess the intestinal helminthic infections among clients attending at Anbesame health center, South Gondar, Ethiopia. Methods A cross sectional study was conducted at Anbesame health center from March to June 2015. A structured questionnaire was used to collect data from 464 study participants selected consecutively. Stool specimen collection, processing through formol-ether concentration technique and microscopic examination for presence of parasites were carried out. Data were entered, cleaned and analyzed using SPSS Version 20. Results Among the total 464 study participants with median (+/- IQR) age of 25.0 (+/- 21.75) years, 262 (56.5%) were females. Helminthic infection was found in 97 (20.9%) participants. Hookworm (68 [14.7%]) was the predominant parasite followed by S. mansoni (11 [2.4%]), E. vermicularis (9 [1.9%]) and S. stercoralis (5 [1.1%]). Patients with age group >= 15 years (AOR: 5.26; 95% CI: 2.05-13.46; P: 0.001) and walking barefoot (AOR: 2.20; 95% CI: 1.08-4.48; P: 0.031) were more vulnerable from the hookworm infections. Conclusions There was a high burden of hookworm infections in our setting. Hence, regular shoes wearing, considering all age groups in the albendazole deworming as mass treatment and environmental hygiene are important interventions to reduce the burden of such neglected tropical disease.	[Shiferaw, Melashu Balew] Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia; [Mengistu, Agmas Dessalegn] Felege Hiwot Referral Hosp, Bahir Dar, Ethiopia		Shiferaw, MB (corresponding author), Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia.	bmelashu@gmail.com	Shiferaw, Melashu/GPT-3320-2022	Shiferaw, Melashu Balew/0000-0002-5066-0758				Abate Abraraw, 2013, ISRN Parasitol, V2013, P757451, DOI 10.5402/2013/757451; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; [Anonymous], 2014, DER WOR OFF AGR ANN; [Anonymous], 2015, ANBESAME HLTH CTR SE; Ayalew A., 2011, J PARASITOL VECTOR B, V3, P75; Cheesbrough M, 2006, DISTRICT LAB PRACT 1, V18, P126; Debalke S, 2013, ETHIOP J HEALTH SCI, V23, P237, DOI 10.4314/ejhs.v23i3.6; Demissie F, 2008, ETHIOP J HLTH SCI, V18, P53; Girum Tadesse, 2005, Ethiopian Journal of Health Development, V19, P140; Guyatt H, 2000, PARASITOL TODAY, V16, P153, DOI 10.1016/S0169-4758(99)01634-8; Haque R, 2007, J HEALTH POPUL NUTR, V25, P387; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Lopiso Erosie, 2002, Ethiopian Journal of Health Development, V16, P113; Mathewos Biniam, 2014, BMC Res Notes, V7, P88, DOI 10.1186/1756-0500-7-88; Ministry of Health (MOH), 2011, HLTH HLTH REL IND; Sebhatu A., 2008, ADDIS ABABA; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Skolnik R., 2010, ENDING NEGLECT NEGLE, P1; USAID/ Pathfinder International, 2008, ETH HLTH EXT PROGR; Wegayehu T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-151; WHO, 1998, CONTR TROP DIS; World Health Organization, 2002, PREV CONTR SCHIST SO; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144588	10.1371/journal.pone.0144588	http://dx.doi.org/10.1371/journal.pone.0144588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657490	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500045
J	Stafford, RE; Coughlin, G; Lutton, NJ; Hodges, PW				Stafford, Ryan E.; Coughlin, Geoff; Lutton, Nicholas J.; Hodges, Paul W.			Validity of Estimation of Pelvic Floor Muscle Activity from Transperineal Ultrasound Imaging in Men	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; URINARY-INCONTINENCE; CONTRACTIONS; EXERCISES; SYMPTOMS; DYNAMICS; LENGTH	Purpose To investigate the relationship between displacement of pelvic floor landmarks observed with transperineal ultrasound imaging and electromyography of the muscles hypothesised to cause the displacements. Materials and Methods Three healthy men participated in this study, which included ultrasound imaging of the midurethra, urethra-vesical junction, ano-rectal junction and bulb of the penis. Fine-wire electromyography electrodes were inserted into the puborectalis and bulbocavernosus muscles and a transurethral catheter electrode recorded striated urethral sphincter electromyography. A nasogastric sensor recorded intra-abdominal pressure. Tasks included submaximal and maximal voluntary contractions, and Valsalva. The relationship between each of the parameters measured from ultrasound images and electromyography or intra-abdominal pressure amplitudes was described with nonlinear regression. Results Strong, non-linear relationships were calculated for each predicted landmark/muscle pair for submaximal contractions (R-2-0.87-0.95). The relationships between mid-urethral displacement and striated urethral sphincter electromyography, and bulb of the penis displacement and bulbocavernosus electromyography were strong during maximal contractions (R-2-0.74-0.88). Increased intra-abdominal pressure prevented shortening of puborectalis, which resulted in weak relationships between electromyography and anorectal and urethra-vesical junction displacement during all tasks. Conclusions Displacement of landmarks in transperineal ultrasound imaging provides meaningful measures of activation of individual pelvic floor muscles in men during voluntary contractions. This method may aid assessment of muscle function or feedback for training.	[Stafford, Ryan E.; Hodges, Paul W.] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Coughlin, Geoff] Royal Brisbane & Womens Hosp, Dept Urol, Brisbane, Qld, Australia; [Lutton, Nicholas J.] Princess Alexandra Hosp, Dept Colorectal Surg, Brisbane, Qld 4102, Australia	University of Queensland; Royal Brisbane & Women's Hospital	Hodges, PW (corresponding author), Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	p.hodges@uq.edu.au	Hodges, Paul W/B-6578-2008; Stafford, Ryan/F-3970-2010	Hodges, Paul W/0000-0002-1206-9107; Stafford, Ryan/0000-0002-5444-477X	Australian Research Council Linkage Project [LP100100400]; National Health and Medical Research Council (NHMRC) of Australia	Australian Research Council Linkage Project(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council Linkage Project grant LP100100400 - http://www.arc.gov.au/ to PH. Paul Hodges is funded by a Senior Principal Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell SE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001843.pub4; Davis SN, 2011, J SEX MED, V8, P3173, DOI 10.1111/j.1743-6109.2011.02452.x; Dietz HP, 2010, AM J OBSTET GYNECOL, V202, P321, DOI 10.1016/j.ajog.2009.08.018; Dietz HP, 2001, INT UROGYNECOL J PEL, V12, P166, DOI 10.1007/s001920170059; Dorey G, 2009, PHYSIOTHERAPY, V95, P199, DOI 10.1016/j.physio.2009.03.003; Floratos DL, 2002, BJU INT, V89, P714, DOI 10.1046/j.1464-410X.2002.02721.x; Geraerts I, 2013, BJU INT, V112, P936, DOI 10.1111/bju.12258; Glazener C, 2011, LANCET, V378, P328, DOI 10.1016/S0140-6736(11)60751-4; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1113/jphysiol.2001.012756; Hodges PW, 2003, MUSCLE NERVE, V27, P682, DOI 10.1002/mus.10375; Jones RCL, 2010, EUR UROL, V57, P1101, DOI 10.1016/j.eururo.2009.06.011; Junginger B, 2010, INT UROGYNECOL J, V21, P69, DOI 10.1007/s00192-009-0981-z; Koppenhaver SL, 2009, AUST J PHYSIOTHER, V55, P153, DOI 10.1016/S0004-9514(09)70076-5; Nahon I, 2011, NEUROUROL URODYNAM, V30, P1329, DOI 10.1002/nau.21069; Peng QY, 2007, ULTRASOUND MED BIOL, V33, P342, DOI 10.1016/j.ultrasmedbio.2006.08.020; Peschers UM, 2001, NEUROUROL URODYNAM, V20, P269, DOI 10.1002/nau.1004; Sladden MJ, 2000, AUST NZ J SURG, V70, P322, DOI 10.1046/j.1440-1622.2000.01738.x; Stafford RE, NEUROUROL URODYN; Stafford RE, 2014, J APPL PHYSIOL, V116, P953, DOI 10.1152/japplphysiol.01225.2013; Stafford RE, 2013, UROLOGY, V81, P685, DOI 10.1016/j.urology.2012.11.034; Stafford RE, 2012, J UROLOGY, V188, P1224, DOI 10.1016/j.juro.2012.06.028; Stafford RE, 2010, J UROLOGY, V183, P378, DOI 10.1016/j.juro.2009.08.105; WILKIE DR, 1949, J PHYSIOL-LONDON, V110, P249, DOI 10.1113/jphysiol.1949.sp004437	24	31	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144342	10.1371/journal.pone.0144342	http://dx.doi.org/10.1371/journal.pone.0144342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642347	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700100
J	Utne-Palm, AC; Eduard, K; Jensen, KH; Mayer, I; Jakobsen, PJ				Utne-Palm, A. C.; Eduard, K.; Jensen, K. H.; Mayer, I.; Jakobsen, P. J.			Size Dependent Male Reproductive Tactic in the Two-Spotted Goby (Gobiusculus flavescens)	PLOS ONE			English	Article							MALE MATING TACTICS; SEXUAL SELECTION; SPERM COMPETITION; FISH; INVESTMENT; TELEOSTEI; BEHAVIOR; GOBIES; RATIO; DIMORPHISM	Male investment in testes and sperm duct gland in the polygamous nest breeding two-spotted goby Gobiusculus flavescens (Fabricius) was investigated in relation to time in reproductive season and individual physical parameters. This small teleost fish is most likely the most abundant species found along the rocky shores of the North East Atlantic. The two-spotted goby has a single reproductive season, during which nest-caring males can raise several clutches of offspring. According to the literature the males are on average larger than the females. Here we report for the first time a population showing a reversal of this trend, with males on average being smaller than females, a difference likely caused by a large proportion of small males. Early in the breeding season these small males have typical sneaker characters, with relatively large testes and small seminal duct glands compared to the larger dominant territorial males. The presence of these two alternative male reproductive tactics is confirmed by histological studies, which shows the presence of sperm in the sperm duct glands (SDG) of smaller males, but not in the SDG of intermediate and larger males. To our knowledge, males with typical sneaker characters have not been reported in earlier studied populations of two-spotted goby. Interestingly we found that testes investment declined significantly over the course of the breeding season, and that this reduction was significantly more pronounced in small compared to the large males. Further, a significant increase in seminal duct gland (SDG) mass was observed for the smaller males over the breeding season. We propose that this indicates a possible shift in mating tactic by smaller males from a parasitic to a nest-holding tactic over the course of the breeding season. Thus, the observed size dependent plasticity in investment in SDG over time suggests that the reproductive tactic of G. flavescens is conditional, and possibly influenced by mate availability and male-male competition.	[Utne-Palm, A. C.] Inst Marine Res, N-5024 Bergen, Norway; [Eduard, K.; Jensen, K. H.; Jakobsen, P. J.] Univ Bergen, Dept Biol, Bergen, Norway; [Mayer, I.] Norwegian Univ Life Sci, Oslo, Norway; [Eduard, K.] Oslo Univ Hosp, N-0450 Oslo, Norway	Institute of Marine Research - Norway; University of Bergen; Norwegian University of Life Sciences; University of Oslo	Utne-Palm, AC (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	annecu@imr.no			University of Bergen	University of Bergen	This study was funded by the University of Bergen through the contributing work of a Master student.	Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Andersson Malte, 1994; CARROLL SP, 1995, BEHAV ECOL, V6, P46, DOI 10.1093/beheco/6.1.46; COSTELLO MJ, 1992, ENVIRON BIOL FISH, V33, P239, DOI 10.1007/BF00005868; CRESPI BJ, 1988, AM MIDL NAT, V119, P83, DOI 10.2307/2426056; Eggert C, 2003, CAN J ZOOL, V81, P46, DOI 10.1139/Z02-224; EMERSON LS, 1990, J FISH BIOL, V36, P721, DOI 10.1111/j.1095-8649.1990.tb04326.x; FISHELSON L, 1991, JPN J ICHTHYOL, V38, P17, DOI 10.1007/BF02910104; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forsgren E, 1996, EVOLUTION, V50, P646, DOI 10.1111/j.1558-5646.1996.tb03875.x; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; FOSSA JH, 1991, ICES MAR SC, V192, P147; Garcia CM, 1998, J FISH BIOL, V53, P104, DOI 10.1111/j.1095-8649.1998.tb01021.x; GORDON JCD, 1983, OPHELIA, V22, P173, DOI 10.1080/00785326.1983.10426593; GRIER HJ, 1981, AM ZOOL, V21, P345; Grier HJ, 1993, SERTOLI CELLS, P703; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Immler S, 2004, J EXP ZOOL PART A, V301A, P177, DOI 10.1002/jez.a.20019; KODRICBROWN A, 1988, ANIM BEHAV, V36, P1136, DOI 10.1016/S0003-3472(88)80073-3; Kokita T, 1998, J ETHOL, V16, P81, DOI 10.1007/BF02769286; Kvarnemo C, 2010, J FISH BIOL, V76, P1609, DOI 10.1111/j.1095-8649.2010.02587.x; Lengkeek W, 2008, CAN J ZOOL, V86, P1173, DOI 10.1139/Z08-103; Lindstrom K, 2001, AM NAT, V158, P64, DOI 10.1086/320867; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; MAGNHAGEN C, 1992, ANIM BEHAV, V44, P182, DOI 10.1016/S0003-3472(05)80772-9; MAGNHAGEN C, 1989, J FISH BIOL, V35, P755, DOI 10.1111/j.1095-8649.1989.tb03027.x; Magnhagen C, 1998, J FISH BIOL, V53, P130, DOI 10.1111/j.1095-8649.1998.tb00115.x; MARCONATO A, 1993, BEHAV ECOL SOCIOBIOL, V32, P229; Marconato A, 1996, ENVIRON BIOL FISH, V46, P321, DOI 10.1007/BF00005009; Mazzoldi C, 2000, MAR BIOL, V137, P1041, DOI 10.1007/s002270000417; Mills SC, 2003, BEHAV ECOL SOCIOBIOL, V54, P98, DOI 10.1007/s00265-003-0616-1; Mobley KB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-6; Myhre LC, 2012, AM NAT, V179, P741, DOI 10.1086/665651; Nakashima Y, 1996, ENVIRON BIOL FISH, V46, P281, DOI 10.1007/BF00005004; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P127, DOI 10.1098/rspb.1990.0115; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR, Vfourth; Pelabon C, 2005, MAR BIOL, V148, P189, DOI 10.1007/s00227-005-0056-8; Pelabon C, 2003, BEHAV ECOL, V14, P787, DOI 10.1093/beheco/arg074; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pujolar JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046711; RADWAN J, 1993, BEHAV ECOL SOCIOBIOL, V33, P201, DOI 10.1007/BF00216601; Rasotto MB, 2002, J FISH BIOL, V61, P173, DOI 10.1006/jfbi.2002.2029; Scaggiante M, 1999, J EXP ZOOL, V283, P81, DOI 10.1002/(SICI)1097-010X(19990101)283:1<81::AID-JEZ9>3.0.CO;2-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skolbekken R, 2001, J EXP MAR BIOL ECOL, V261, P137, DOI 10.1016/S0022-0981(01)00249-0; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; Taborsky M, 1997, BEHAV ECOL SOCIOBIOL, V41, P361, DOI 10.1007/s002650050396; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Wacker S, 2014, J EVOLUTION BIOL, V27, P466, DOI 10.1111/jeb.12314; Wacker S, 2014, MOL ECOL, V23, P3587, DOI 10.1111/mec.12826; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Young KA, 2005, P ROY SOC B-BIOL SCI, V272, P167, DOI 10.1098/rspb.2004.2931; Zuur AF, 2009, USE R, pVII	56	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143487	10.1371/journal.pone.0143487	http://dx.doi.org/10.1371/journal.pone.0143487			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642324	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700019
J	Khatun, I; Clark, RW; Vera, NB; Kou, K; Erion, DM; Coskran, T; Bobrowski, WF; Okerberg, C; Goodwin, B				Khatun, Irani; Clark, Ronald W.; Vera, Nicholas B.; Kou, Kou; Erion, Derek M.; Coskran, Timothy; Bobrowski, Walter F.; Okerberg, Carlin; Goodwin, Bryan			Characterization of a Novel Intestinal Glycerol-3-phosphate Acyltransferase Pathway and Its Role in Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-IV; PHARMACOLOGICAL INHIBITION; TRIGLYCERIDE SYNTHESIS; PROTECTS MICE; 1 DGAT1; ABSORPTION; IDENTIFICATION; BIOSYNTHESIS; ENZYME; ENTEROCYTES	Dietary triglycerides (TG) are absorbed by the enterocytes of the small intestine after luminal hydrolysis into monacylglycerol and fatty acids. Before secretion on chylomicrons, these lipids are reesterified into TG, primarily through the monoacylglycerol pathway. However, targeted deletion of the primary murine monoacylglycerol acyltransferase does not quantitatively affect lipid absorption, suggesting the existence of alternative pathways. Therefore, we investigated the role of the glycerol 3-phosphate pathway in dietary lipid absorption. The expression of glycerol-3-phosphate acyltransferase (GPAT3) was examined throughout the small intestine. To evaluate the role for GPAT3 in lipid absorption, mice harboring a disrupted GPAT3 gene (Gpat3(-/-)) were subjected to an oral lipid challenge and fed a Western-type diet to characterize the role in lipid and cholesterol homeostasis. Additional mechanistic studies were performed in primary enterocytes. GPAT3 was abundantly expressed in the apical surface of enterocytes in the small intestine. After an oral lipid bolus, Gpat3(-/-) mice exhibited attenuated plasma TG excursion and accumulated lipid in the enterocytes. Electron microscopy studies revealed a lack of lipids in the lamina propria and intercellular space in Gpat3(-/-) mice. Gpat3(-/-) enterocytes displayed a compensatory increase in the synthesis of phospholipid and cholesteryl ester. When fed a Western-type diet, hepatic TG and cholesteryl ester accumulation was significantly higher in Gpat3(-/-) mice compared with the wild-type mice accompanied by elevated levels of alanine aminotransferase, a marker of liver injury. Dysregulation of bile acid metabolism was also evident in Gpat3-null mice. These studies identify GPAT3 as a novel enzyme involved in intestinal lipid metabolism.	[Khatun, Irani; Clark, Ronald W.; Vera, Nicholas B.; Kou, Kou; Erion, Derek M.; Goodwin, Bryan] Pfizer Worldwide Res & Dev, Cardiovasc & Metab Dis Res Unit, 610 Main St, Cambridge, MA 02139 USA; [Coskran, Timothy; Bobrowski, Walter F.; Okerberg, Carlin] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Groton, CT 06340 USA	Pfizer; Pfizer	Goodwin, B (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc & Metab Dis Res Unit, 610 Main St, Cambridge, MA 02139 USA.	bryan.goodwin@pfizer.com						Anwar K, 2007, J LIPID RES, V48, P2028, DOI 10.1194/jlr.M700207-JLR200; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1176, DOI 10.1152/ajpendo.00666.2013; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cartwright IJ, 1999, J LIPID RES, V40, P1357; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; CLARK B, 1961, BIOCHIM BIOPHYS ACTA, V46, P479, DOI 10.1016/0006-3002(61)90579-0; CLARK B, 1960, NATURE, V185, P35, DOI 10.1038/185035b0; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Gao Y, 2013, J LIPID RES, V54, P1644, DOI 10.1194/jlr.M035493; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; JOHNSTON JM, 1967, BIOCHIM BIOPHYS ACTA, V137, P578, DOI 10.1016/0005-2760(67)90140-3; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KERN F, 1965, BIOCHIM BIOPHYS ACTA, V98, P520; Kieffer TJ, 2003, TRENDS PHARMACOL SCI, V24, P110, DOI 10.1016/S0165-6147(03)00031-2; Kohan AB, 2013, AM J PHYSIOL-GASTR L, V304, pG1128, DOI 10.1152/ajpgi.00409.2012; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Lewin TM, 2008, BBA-MOL CELL BIOL L, V1781, P352, DOI 10.1016/j.bbalip.2008.05.001; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Liu JQ, 2013, OBESITY, V21, P1406, DOI 10.1002/oby.20193; Ma SZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07633; Maciejewski BS, 2013, AM J PHYSIOL-GASTR L, V304, pG958, DOI 10.1152/ajpgi.00384.2012; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang H, 2007, J BIOL CHEM, V282, P33218, DOI 10.1074/jbc.M706841200; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Xu JH, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/272715; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	43	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2602	2615		10.1074/jbc.M115.683359	http://dx.doi.org/10.1074/jbc.M115.683359			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644473	Green Published, hybrid			2022-12-26	WOS:000369626900006
J	da Palma, JR; Cendron, L; Seidah, NG; Pasquato, A; Kunz, S				da Palma, Joel Ramos; Cendron, Laura; Seidah, Nabil Georges; Pasquato, Antonella; Kunz, Stefan			Mechanism of Folding and Activation of Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHORIOMENINGITIS VIRUS GLYCOPROTEIN; ARENAVIRUS ENVELOPE GLYCOPROTEINS; PROPROTEIN CONVERTASE SKI-1/S1P; ELEMENT-BINDING PROTEINS; INTRAMOLECULAR CHAPERONE; SUBTILASE SKI-1/S1P; SITE-1 PROTEASE; LDL RECEPTOR; CLEAVAGE; SEQUENCE	The proprotein convertase subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P) is implicated in lipid homeostasis, the unfolded protein response, and lysosome biogenesis. The protease is further hijacked by highly pathogenic emerging viruses for the processing of their envelope glycoproteins. Zymogen activation of SKI-1/S1P requires removal of an N-terminal prodomain, by a multistep process, generating the mature enzyme. Here, we uncover a modular structure of the human SKI-1/S1P prodomain and define its function in folding and activation. We provide evidence that the N-terminal AB fragment of the prodomain represents an autonomous structural and functional unit that is necessary and sufficient for folding and partial activation. In contrast, the C-terminal BC fragment lacks a defined structure but is crucial for autoprocessing and full catalytic activity. Phylogenetic analysis revealed that the sequence of the AB domain is highly conserved, whereas the BC fragment shows considerable variation and seems even absent in some species. Notably, SKI-1/S1P of arthropods, like the fruit fly Drosophila melanogaster, contains a shorter prodomain comprised of full-length AB and truncated BC regions. Swapping the prodomain fragments between fly and human resulted in a fully mature and active SKI-1/S1P chimera. Our study suggests that primordial SKI-1/S1P likely contained a simpler prodomain consisting of the highly conserved AB fragment that represents an independent folding unit. The BC region appears as a later evolutionary acquisition, possibly allowing more subtle fine-tuning of the maturation process.	[da Palma, Joel Ramos; Pasquato, Antonella; Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland; [da Palma, Joel Ramos; Pasquato, Antonella; Kunz, Stefan] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Cendron, Laura] Univ Padua, Dept Biol, I-35122 Padua, Italy; [Seidah, Nabil Georges] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Lausanne; University of Padua; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Pasquato, A; Kunz, S (corresponding author), Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland.; Pasquato, A; Kunz, S (corresponding author), Univ Lausanne, CH-1011 Lausanne, Switzerland.	Antonella.Pasquato@chuv.ch; Stefan.Kunz@chuv.ch	Seidah, Nabil/I-3596-2013; Kunz, Stefan/K-5840-2017	Seidah, Nabil/0000-0001-6503-9342; Cendron, Laura/0000-0002-0125-0461; Pasquato, Antonella/0000-0002-9428-0722; Kunz, Stefan/0000-0001-6030-9550	Swiss National Science Foundation [FN 31003A-135536, FN 310030_149746]; Novartis Stiftung fur Medizinisch-Biologische Forschung [14B086]; University of Lausanne; Canadian Institutes of Health Research [93792]; Canada Chair Grant [216684]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung fur Medizinisch-Biologische Forschung; University of Lausanne; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Chair Grant	This work was supported by Swiss National Science Foundation Grants FN 31003A-135536 and FN 310030_149746 (to S. K.), Grant 14B086 from the Novartis Stiftung fur Medizinisch-Biologische Forschung, and funds from the University of Lausanne (to S. K.), as well as by Canadian Institutes of Health Research Grant 93792 and Canada Chair Grant 216684 (to N. G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Blanchet M, 2015, ANTIVIR RES, V115, P94, DOI 10.1016/j.antiviral.2014.12.017; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burri DJ, 2013, J VIROL, V87, P6406, DOI 10.1128/JVI.00072-13; Burri DJ, 2012, J VIROL, V86, P4935, DOI 10.1128/JVI.00024-12; da Palma JR, 2014, J BIOL CHEM, V289, P35743, DOI 10.1074/jbc.M114.588525; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Lesage G, 2000, MOL BIOL CELL, V11, P1947, DOI 10.1091/mbc.11.6.1947; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Pasquato A, 2011, VIROLOGY, V417, P18, DOI 10.1016/j.virol.2011.04.021; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; WEBER EL, 1988, VIROLOGY, V164, P30, DOI 10.1016/0042-6822(88)90616-2; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	37	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2055	2066		10.1074/jbc.M115.677757	http://dx.doi.org/10.1074/jbc.M115.677757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26645686	Green Published, hybrid			2022-12-26	WOS:000369610400002
J	Aguirre, P; Mena, NP; Carrasco, CM; Munoz, Y; Perez-Henriquez, P; Morales, RA; Cassels, BK; Mendez-Galvez, C; Garcia-Beltran, O; Gonzalez-Billault, C; Nunez, MT				Aguirre, Pabla; Mena, Natalia P.; Carrasco, Carlos M.; Munoz, Yorka; Perez-Henriquez, Patricio; Morales, Rodrigo A.; Cassels, Bruce K.; Mendez-Galvez, Carolina; Garcia-Beltran, Olimpo; Gonzalez-Billault, Christian; Nunez, Marco T.			Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP plus /MPTP-Lesioned Dopaminergic Neurons	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; INDUCED APOPTOSIS; DENDRITIC TREE; NEURODEGENERATION; EXPRESSION; DEGENERATION; DISEASE; PROTEIN; MODELS; RESTORATION	Neuronal death in Parkinson's disease (PD) is often preceded by axodendritic tree retraction and loss of neuronal functionality. The presence of non-functional but live neurons opens therapeutic possibilities to recover functionality before clinical symptoms develop. Considering that iron accumulation and oxidative damage are conditions commonly found in PD, we tested the possible neuritogenic effects of iron chelators and antioxidant agents. We used three commercial chelators: DFO, deferiprone and 2.2'-dypyridyl, and three 8-hydroxyquinoline-based iron chelators: M30, 7MH and 7DH, and we evaluated their effects in vitro using a mesencephalic cell culture treated with the Parkinsonian toxin MPP+ and in vivo using the MPTP mouse model. All chelators tested promoted the emergence of new tyrosine hydroxylase (TH)-positive processes, increased axodendritic tree length and protected cells against lipoperoxidation. Chelator treatment resulted in the generation of processes containing the presynaptic marker synaptophysin. The antioxidants N-acetylcysteine and dymetylthiourea also enhanced axodendritic tree recovery in vitro, an indication that reducing oxidative tone fosters neuritogenesis in MPP+-damaged neurons. Oral administration to mice of the M30 chelator for 14 days after MPTP treatment resulted in increased TH- and GIRK2-positive nigra cells and nigrostriatal fibers. Our results support a role for oral iron chelators as good candidates for the early treatment of PD, at stages of the disease where there is axodendritic tree retraction without neuronal death.	[Aguirre, Pabla; Mena, Natalia P.; Carrasco, Carlos M.; Munoz, Yorka; Perez-Henriquez, Patricio; Morales, Rodrigo A.; Nunez, Marco T.] Univ Chile, Fac Sci, Dept Biol, Iron & Biol Aging Lab, Santiago, Chile; [Aguirre, Pabla; Carrasco, Carlos M.; Munoz, Yorka; Gonzalez-Billault, Christian; Nunez, Marco T.] Res Ring Oxidat Stress Nervous Syst, Santiago, Chile; [Cassels, Bruce K.; Mendez-Galvez, Carolina; Garcia-Beltran, Olimpo] Univ Chile, Fac Sci, Dept Chem, Chemobiodynam Lab, Santiago, Chile; [Garcia-Beltran, Olimpo] Univ Ibague, Fac Ciencias Nat & Matemat, Ibague, Colombia; [Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Dept Biol, Neuronal & Cellular Dynam Lab, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Nunez, MT (corresponding author), Univ Chile, Fac Sci, Dept Biol, Iron & Biol Aging Lab, Santiago, Chile.	mnunez@uchile.cl	García-Beltrán, Olimpo/O-1846-2017; Morales, Rodrigo A/H-2096-2017	García-Beltrán, Olimpo/0000-0003-3312-1776; Morales, Rodrigo A/0000-0003-4382-5777; Mendez-Galvez, Carolina/0000-0001-7977-9595	National Fund for Scientific and Technological Research of Chile, FONDECYT grant [1030068]; Program of Associative Research [ACT1114]	National Fund for Scientific and Technological Research of Chile, FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Program of Associative Research	This work was financed with funds from the National Fund for Scientific and Technological Research of Chile, FONDECYT grant 1030068 (http://www.conicyt.cl/fondecyt) and grant ACT1114 from the Program of Associative Research (http://www.conicyt.cl/pia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HH, 2014, CELL MOL LIFE SCI, V71, P1607, DOI 10.1007/s00018-013-1509-8; Baloyannis SJ, 2006, J NEUROL SCI, V248, P35, DOI 10.1016/j.jns.2006.05.006; Beurrier C, 2006, NEUROSCIENCE, V140, P77, DOI 10.1016/j.neuroscience.2006.02.029; Bowenkamp KE, 1996, EXP BRAIN RES, V111, P1; BROUARD A, 1992, J NEUROSCI, V12, P1409; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Capetillo-Zarate E, 2006, BRAIN, V129, P2992, DOI 10.1093/brain/awl176; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Cobb CA, 2015, NEUROBIOL DIS, V84, P4, DOI 10.1016/j.nbd.2015.04.020; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Fall CP, 1999, J NEUROSCI RES, V55, P620, DOI 10.1002/(SICI)1097-4547(19990301)55:5<620::AID-JNR9>3.0.CO;2-S; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Gal S, 2010, NEUROTOX RES, V17, P15, DOI 10.1007/s12640-009-9070-9; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Gomez FJ, 2011, J NEURAL TRANSM, V118, P421, DOI 10.1007/s00702-010-0489-1; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hung HC, 1996, MOL BRAIN RES, V41, P16, DOI 10.1016/0169-328X(96)00062-9; HURN PD, 1995, STROKE, V26, P688, DOI 10.1161/01.STR.26.4.688; Kruer MC, 2013, INT REV NEUROBIOL, V110, P165, DOI 10.1016/B978-0-12-410502-7.00009-0; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Kupershmidt L, 2011, NEUROSCIENCE, V189, P345, DOI 10.1016/j.neuroscience.2011.03.040; Kupershmidt L, 2009, FASEB J, V23, P3766, DOI 10.1096/fj.09-130047; Kurian MA, 2013, INT REV NEUROBIOL, V110, P49, DOI 10.1016/B978-0-12-410502-7.00003-X; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; OESTREICHER E, 1994, BRAIN RES, V660, P8, DOI 10.1016/0006-8993(94)90833-8; Oshiro S, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/378278; Polanski W, 2010, J NEUROCHEM, V113, P1659, DOI 10.1111/j.1471-4159.2010.06725.x; Reyes S, 2012, J COMP NEUROL, V520, P2591, DOI 10.1002/cne.23051; Rothblat DS, 2001, J NEUROSCI RES, V65, P254, DOI 10.1002/jnr.1149; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; SanMartin CD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00013; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Solis O, 2007, SYNAPSE, V61, P450, DOI 10.1002/syn.20381; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; TEMLETT JA, 1994, J NEUROCHEM, V62, P134; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Ward RJ, 2012, CURR MED CHEM, V19, P2760; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Xu Z, 2005, SYNAPSE, V55, P45, DOI 10.1002/syn.20089; Zaja-Milatovic S, 2006, NEUROLOGY, V66, P1591, DOI 10.1212/01.wnl.0000216137.09685.c1; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhang CY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0002.2001; Zhu W, 2007, FASEB J, V21, P3835, DOI 10.1096/fj.07-8386com	50	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144848	10.1371/journal.pone.0144848	http://dx.doi.org/10.1371/journal.pone.0144848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658949	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900118
J	Bennett, MR; Farnell, L; Gibson, WG; Lagopoulos, J				Bennett, Maxwell R.; Farnell, Les; Gibson, William G.; Lagopoulos, Jim			Cortical Network Models of Firing Rates in the Resting and Active States Predict BOLD Responses	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PROPOFOL-INDUCED LOSS; EYE-MOVEMENT SLEEP; FUNCTIONAL CONNECTIVITY; VISUAL-CORTEX; PYRAMIDAL NEURONS; BRAIN ACTIVITY; BALLOON MODEL; BLOOD-FLOW; FMRI	Measurements of blood oxygenation level dependent (BOLD) signals have produced some surprising observations. One is that their amplitude is proportional to the entire activity in a region of interest and not just the fluctuations in this activity. Another is that during sleep and anesthesia the average BOLD correlations between regions of interest decline as the activity declines. Mechanistic explanations of these phenomena are described here using a cortical network model consisting of modules with excitatory and inhibitory neurons, taken as regions of cortical interest, each receiving excitatory inputs from outside the network, taken as subcortical driving inputs in addition to extrinsic (intermodular) connections, such as provided by associational fibers. The model shows that the standard deviation of the firing rate is proportional to the mean frequency of the firing when the extrinsic connections are decreased, so that the mean BOLD signal is proportional to both as is observed experimentally. The model also shows that if these extrinsic connections are decreased or the frequency of firing reaching the network from the subcortical driving inputs is decreased, or both decline, there is a decrease in the mean firing rate in the modules accompanied by decreases in the mean BOLD correlations between the modules, consistent with the observed changes during NREM sleep and under anesthesia. Finally, the model explains why a transient increase in the BOLD signal in a cortical area, due to a transient subcortical input, gives rises to responses throughout the cortex as observed, with these responses mediated by the extrinsic (intermodular) connections.	[Bennett, Maxwell R.; Lagopoulos, Jim] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Bennett, Maxwell R.; Farnell, Les; Gibson, William G.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia; [Farnell, Les; Gibson, William G.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Bennett, MR (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	maxb@medsci.usyd.edu.au						Bennett MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060518; Bennett MR, 2015, P NATL ACAD SCI USA, V112, P4134, DOI 10.1073/pnas.1411513112; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bowman FD, 2012, NEUROIMAGE, V62, P1769, DOI 10.1016/j.neuroimage.2012.05.032; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Colonnese MT, 2008, NAT NEUROSCI, V11, P72, DOI 10.1038/nn2017; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Deco G, 2014, CEREB CORTEX, V24, P3180, DOI 10.1093/cercor/bht176; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Eldaief MC, 2011, P NATL ACAD SCI USA, V108, P21229, DOI 10.1073/pnas.1113103109; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Fiset P, 1999, J NEUROSCI, V19, P5506; FITZPATRICK D, 1987, J COMP NEUROL, V264, P73, DOI 10.1002/cne.902640107; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Hyder F, 2013, P NATL ACAD SCI USA, V110, P3549, DOI 10.1073/pnas.1214912110; Hyder F, 2012, NEUROIMAGE, V62, P985, DOI 10.1016/j.neuroimage.2012.04.027; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Maandag NJG, 2007, P NATL ACAD SCI USA, V104, P20546, DOI 10.1073/pnas.0709515104; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088254; Pan WJ, 2013, NEUROIMAGE, V74, P288, DOI 10.1016/j.neuroimage.2013.02.035; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schlunzen L, 2012, ACTA ANAESTH SCAND, V56, P248, DOI 10.1111/j.1399-6576.2011.02561.x; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Spoormaker Victor I, 2012, Front Neurol, V3, P80, DOI 10.3389/fneur.2012.00080; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Tao L, 2006, P NATL ACAD SCI USA, V103, P12911, DOI 10.1073/pnas.0605415103; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Wu CWW, 2012, BRAIN CONNECT, V2, P177, DOI 10.1089/brain.2012.0075; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144796	10.1371/journal.pone.0144796	http://dx.doi.org/10.1371/journal.pone.0144796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659399	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900106
J	Charreton, M; Decourtye, A; Henry, M; Rodet, G; Sandoz, JC; Charnet, P; Collet, C				Charreton, Mercedes; Decourtye, Axel; Henry, Mickael; Rodet, Guy; Sandoz, Jean-Christophe; Charnet, Pierre; Collet, Claude			A Locomotor Deficit Induced by Sublethal Doses of Pyrethroid and Neonicotinoid Insecticides in the Honeybee Apis mellifera	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; SKELETAL-MUSCLE FIBERS; ANTENNAL LOBE NEURONS; BEE; ACETYLCHOLINE; PESTICIDES; RECEPTOR; TOXICITY; FIPRONIL; BEHAVIOR	The toxicity of pesticides used in agriculture towards non-targeted organisms and especially pollinators has recently drawn the attention from a broad scientific community. Increased honeybee mortality observed worldwide certainly contributes to this interest. The potential role of several neurotoxic insecticides in triggering or potentiating honeybee mortality was considered, in particular phenylpyrazoles and neonicotinoids, given that they are widely used and highly toxic for insects. Along with their ability to kill insects at lethal doses, they can compromise survival at sublethal doses by producing subtle deleterious effects. In this study, we compared the bee's locomotor ability, which is crucial for many tasks within the hive (e.g. cleaning brood cells, feeding larvae...), before and after an acute sublethal exposure to one insecticide belonging to the two insecticide classes, fipronil and thiamethoxam. Additionally, we examined the locomotor ability after exposure to pyrethroids, an older chemical insecticide class still widely used and known to be highly toxic to bees as well. Our study focused on young bees (day 1 after emergence) since (i) few studies are available on locomotion at this stage and (ii) in recent years, pesticides have been reported to accumulate in different hive matrices, where young bees undergo their early development. At sublethal doses (SLD48h, i.e. causing nomortality at 48h), three pyrethroids, namely cypermethrin (2.5 ng/bee), tetramethrin (70 ng/bee), tau-fluvalinate (33 ng/bee) and the neonicotinoid thiamethoxam (3.8 ng/bee) caused a locomotor deficit in honeybees. While the SLD48h of fipronil (a phenylpyrazole, 0.5 ng/bee) had no measurable effect on locomotion, we observed high mortality several days after exposure, an effect that was not observed with the other insecticides. Although locomotor deficits observed in the sublethal range of pyrethroids and thiamethoxam would suggest deleterious effects in the field, the case of fipronil demonstrates that toxicity evaluation requires information on multiple endpoints (e.g. long term survival) to fully address pesticides risks for honeybees. Pyrethroid-induced locomotor deficits are discussed in light of recent advances regarding their mode of action on honeybee ion channels and current structure-function studies.	[Charreton, Mercedes; Henry, Mickael; Rodet, Guy; Collet, Claude] INRA, UR Abeilles & Environm 406, F-84914 Avignon, France; [Charreton, Mercedes; Decourtye, Axel; Henry, Mickael; Rodet, Guy; Collet, Claude] UMT, Protect Abeilles Environm, F-84914 Avignon, France; [Decourtye, Axel] ITSAP Inst Abeille, F-84914 Avignon, France; [Decourtye, Axel] ACTA, F-84914 Avignon, France; [Sandoz, Jean-Christophe] Univ Paris 11, CNRS, IRD, UMR Evolut Genomes Behav & Ecol 9191, F-91198 Gif Sur Yvette, France; [Charnet, Pierre] Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Collet, C (corresponding author), INRA, UR Abeilles & Environm 406, F-84914 Avignon, France.	claude.collet@avignon.inra.fr	SANDOZ, Jean-Christophe/A-6085-2012	SANDOZ, Jean-Christophe/0000-0002-5423-9645; Charnet, Pierre/0000-0003-4692-528X	Agence Nationale de la Recherche [ANR-13- BSV7-0010]; European Agricultural Guarantee Fund	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Agricultural Guarantee Fund	Financial support from the Agence Nationale de la Recherche (ANR Bee-channels ANR-13- BSV7-0010) was received by MC, JCS, PC, CC; and from the European Agricultural Guarantee Fund to MC, AD, CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara GS, 2005, J COMP PHYSIOL A, V191, P823, DOI 10.1007/s00359-005-0007-3; Barbara Guillaume Stephane, 2008, Invertebrate Neuroscience, V8, P19, DOI 10.1007/s10158-007-0062-2; Carlson F.D., 1974, MUSCLE PHYSL, VVolume 53; Cens T, 2015, INSECT BIOCHEM MOLEC, V58, P12, DOI 10.1016/j.ibmb.2015.01.005; Cens T, 2013, PFLUG ARCH EUR J PHY, V465, P985, DOI 10.1007/s00424-013-1223-2; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chauzat MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079018; Collet C, 2007, J EXP BIOL, V210, P454, DOI 10.1242/jeb.02667; Collet C, 2009, PFLUG ARCH EUR J PHY, V458, P601, DOI 10.1007/s00424-009-0642-6; Dahlgren L, 2012, J ECON ENTOMOL, V105, P1895, DOI 10.1603/EC12175; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; DELABIE J, 1985, PESTIC SCI, V16, P409, DOI 10.1002/ps.2780160417; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Eisenstein M, 2015, NATURE, V521, pS52, DOI 10.1038/521S52a; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Gosselin-Badaroudine P, 2015, SCIENTIFIC REPORTS I; GU GG, 1995, J NEUROBIOL, V28, P269, DOI 10.1002/neu.480280302; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Kadala A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112194; Kadala A, 2011, NEUROTOXICOLOGY, V32, P320, DOI 10.1016/j.neuro.2011.02.007; Kaneko H, 2011, J AGR FOOD CHEM, V59, P2786, DOI 10.1021/jf102567z; Khambay B.P., 2005, COMPREHENSIVE MOL IN, V6, P1, DOI [10.1016/B0-44-451924-6/00075-2, DOI 10.1016/B0-44-451924-6/00075-2]; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Maze IS, 2006, J INSECT PHYSIOL, V52, P1243, DOI 10.1016/j.jinsphys.2006.09.006; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; OECD, 1998, OECD GUID TEST CHEM, V1, P7; OEPP/EPPO, 2010, B OEPP EPPO B, V40, P323; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Papaefthimiou C, 2001, PESTIC BIOCHEM PHYS, V69, P77, DOI 10.1006/pest.2000.2519; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Poquet Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113728; R Development Core Team, 2014, R LANG ENV STAT COMP; Shafer TJ, 2004, TOXICOL APPL PHARM, V196, P303, DOI 10.1016/j.taap.2003.12.013; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Sokolowski MBC, 2012, J NEUROSCI METH, V207, P211, DOI 10.1016/j.jneumeth.2012.03.006; Teeters BS, 2012, ENVIRON TOXICOL CHEM, V31, P1349, DOI 10.1002/etc.1830; U.S. Environmental Protection Agency, 2015, ECOTOXICOLOGY DAT SY; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2014, ECOTOXICOLOGY, V23, P1409, DOI 10.1007/s10646-014-1283-x; Winston M.L., 1991, BIOL HONEY BEE; Zuur Alain F., 2009, P1	59	47	51	4	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144879	10.1371/journal.pone.0144879	http://dx.doi.org/10.1371/journal.pone.0144879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659095	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900130
J	Chen, RB; Liu, JH; Xiao, Y; Zhang, F; Chen, JF; Ji, Q; Tan, HX; Huang, X; Feng, H; Huang, BK; Chen, WS; Zhang, L				Chen, Rui-Bing; Liu, Jiang-Hua; Xiao, Ying; Zhang, Feng; Chen, Jun-feng; Ji, Qian; Tan, He-Xin; Huang, Xin; Feng, Hao; Huang, Bao-Kang; Chen, Wan-Sheng; Zhang, Lei			Deep Sequencing Reveals the Effect of MeJA on Scutellarin Biosynthesis in Erigeron breviscapus	PLOS ONE			English	Article							EXPRESSION; TRANSCRIPTOME; ACCUMULATION; GENE	Background Erigeron breviscapus, a well-known traditional Chinese medicinal herb, is broadly used in the treatment of cerebrovascular disease. Scutellarin, a kind of flavonoids, is considered as the material base of the pharmaceutical activities in E. breviscapus. The stable and high content of scutellarin is critical for the quality and efficiency of E. breviscapus in the clinical use. Therefore, understanding the molecular mechanism of scutellarin biosynthesis is crucial for metabolic engineering to increase the content of the active compound. However, there is virtually no study available yet concerning the genetic research of scutellarin biosynthesis in E. breviscapus. Results Using Illumina sequencing technology, we obtained over three billion bases of high-quality sequence data and conducted de novo assembly and annotation without prior genome information. A total of 182,527 unigenes (mean length = 738 bp) were found. 63,059 unigenes were functionally annotated with a cut-off E-value of 10(-5). Next, a total of 238 (200 up-regulated and 38 down-regulated genes) and 513 (375 up-regulated and 138 down-regulated genes) differentially expressed genes were identified at different time points after methyl jasmonate (MeJA) treatment, which fell into categories of 'metabolic process' and 'cellular process' using GO database, suggesting that MeJA-induced activities of signal pathway in plant mainly led to re-programming of metabolism and cell activity. In addition, 13 predicted genes that might participate in the metabolism of flavonoids were found by two co-expression analyses in E. breviscapus. Conclusions Our study is the first to provide a transcriptome sequence resource for E. breviscapus plants after MeJA treatment and it reveals transcriptome re-programming upon elicitation. As the result, several putative unknown genes involved in the metabolism of flavonoids were predicted. These data provide a valuable resource for the genetic and genomic studies of special flavonoids metabolism and further metabolic engineering in E. breviscapus.	[Chen, Rui-Bing; Ji, Qian; Tan, He-Xin; Huang, Xin; Zhang, Lei] Second Mil Med Univ, Sch Pharm, Dept Pharmaceut Bot, Shanghai 200433, Peoples R China; [Liu, Jiang-Hua] Southwest Forestry Univ, Sch Forestry, Kunming 650224, Yunnan, Peoples R China; [Xiao, Ying; Zhang, Feng; Chen, Jun-feng; Chen, Wan-Sheng] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Pharm, Shanghai 200003, Peoples R China; [Feng, Hao] Shanghai Pharmaceut Holding Co Ltd, Business Dev & Strateg Planning Cent Res Inst, Shanghai 200021, Peoples R China; [Huang, Bao-Kang] Second Mil Med Univ, Sch Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Naval Medical University; Southwest Forestry University - China; Naval Medical University; Naval Medical University	Zhang, L (corresponding author), Second Mil Med Univ, Sch Pharm, Dept Pharmaceut Bot, Shanghai 200433, Peoples R China.	zhanglei@smmu.edu.cn	Yu, Yaru/AAU-3372-2020	chen, wansheng/0000-0002-0025-1315	National Natural Science Foundation of China [31160059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31160059), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzellotti D, 2000, ARCH BIOCHEM BIOPHYS, V382, P161, DOI 10.1006/abbi.2000.2002; Baloglu MC, 2014, GENE, V550, P117, DOI 10.1016/j.gene.2014.08.025; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Guo H, 2011, CHINESE J PHYSIOL, V54, P399, DOI 10.4077/CJP.2011.AMM059; HELLER W, 1986, FLAVONOIDS ADV RES S, P499; Jiang NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100357; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li T, 2014, BIOCHEM BIOPH RES CO, V454, P78, DOI 10.1016/j.bbrc.2014.10.059; Ling Y, 2011, PLANT TRANSCRIPTION; Liu Chun-Xia, 2010, Wuhan Zhiwuxue Yanjiu, V28, P682, DOI 10.3724/SP.J.1142,2010.60682; Liu Tao, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2241; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; National Pharmacopoeia Committee, 2010, PHARM PEOPL REP CH 1, p[138, 379, 848]; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Torales SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-705; Mai VC, 2014, PLANT SCI, V221, P1, DOI 10.1016/j.plantsci.2014.01.011; Xiao Y, 2009, PHYSIOL PLANTARUM, V137, P1, DOI 10.1111/j.1399-3054.2009.01257.x; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Zhang Guang-Hui, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2231; [张盼盼 Zhang Panpan], 2014, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V31, P191	27	13	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143881	10.1371/journal.pone.0143881	http://dx.doi.org/10.1371/journal.pone.0143881			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656917	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900021
J	Desmet, CM; Lafosse, A; Veriter, S; Porporato, PE; Sonveaux, P; Dufrane, D; Leveque, P; Gallez, B				Desmet, Celine M.; Lafosse, Aurore; Veriter, Sophie; Porporato, Paolo E.; Sonveaux, Pierre; Dufrane, Denis; Leveque, Philippe; Gallez, Bernard			Application of Electron Paramagnetic Resonance (EPR) Oximetry to Monitor Oxygen in Wounds in Diabetic Models	PLOS ONE			English	Article							IN-VIVO EPR; RESPIRATORY GAS TENSIONS; LITHIUM PHTHALOCYANINE; TISSUE OXYGENATION; MURINE MODEL; BLOOD-FLOW; BENZYL NICOTINATE; SKIN OXYGENATION; NITRIC-OXIDE; RAT-BRAIN	A lack of oxygen is classically described as a major cause of impaired wound healing in diabetic patients. Even if the role of oxygen in the wound healing process is well recognized, measurement of oxygen levels in a wound remains challenging. The purpose of the present study was to assess the value of electron paramagnetic resonance (EPR) oximetry to monitor pO(2) in wounds during the healing process in diabetic mouse models. Kinetics of wound closure were carried out in streptozotocin (STZ)-treated and db/db mice. The pO(2) was followed repeatedly during the healing process by 1 GHz EPR spectroscopy with lithium phthalocyanine (LiPc) crystals used as oxygen sensor in two different wound models: a full-thickness excisional skin wound and a pedicled skin flap. Wound closure kinetics were dramatically slower in 12-week-old db/db compared to control (db/+) mice, whereas kinetics were not statistically different in STZ-treated compared to control mice. At the center of excisional wounds, measurements were highly influenced by atmospheric oxygen early in the healing process. In pedicled flaps, hypoxia was observed early after wounding. While reoxygenation occurred over time in db/+ mice, hypoxia was prolonged in the diabetic db/db model. This observation was consistent with impaired healing and microangiopathies observed using intravital microscopy. In conclusion, EPR oximetry using LiPc crystals as the oxygen sensor is an appropriate technique to follow wound oxygenation in acute and chronic wounds, in normal and diabetic animals. Nevertheless, the technique is limited for measurements in pedicled skin flaps and cannot be applied to excisional wounds in which diffusion of atmospheric oxygen significantly affects the measurements.	[Desmet, Celine M.; Leveque, Philippe; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium; [Lafosse, Aurore; Veriter, Sophie; Dufrane, Denis] Catholic Univ Louvain, Clin Univ St Luc, Endocrine Cell Therapy Unit, Ctr Tissue Cell Therapy,Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Lafosse, Aurore] Catholic Univ Louvain, Clin Univ St Luc, Plast & Reconstruct Surg Unit, B-1200 Brussels, Belgium; [Porporato, Paolo E.; Sonveaux, Pierre] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pharmacol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Gallez, B (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium.	bernard.gallez@uclouvain.be	Porporato, Paolo E./A-9932-2018	Porporato, Paolo E./0000-0001-8519-1552	European Research Council (ERC) [243188 TUMETABO]; Action de Recherche Concertee from the Communaute Francaise de Belgique [ARC14/19058]	European Research Council (ERC)(European Research Council (ERC)); Action de Recherche Concertee from the Communaute Francaise de Belgique	This work was supported by a Starting Grant from the European Research Council (ERC No. 243188 TUMETABO to Pierre Sonveaux) and an Action de Recherche Concertee from the Communaute Francaise de Belgique (ARC14/19058). P.S. is a Research Associate and P.E.P. a Postdoctoral Fellow of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovic Z, 2007, SKIN PHARMACOL PHYS, V20, P77, DOI 10.1159/000097654; Abramovic Z, 2008, INT J PHARMACEUT, V359, P220, DOI 10.1016/j.ijpharm.2008.03.014; Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; Baudelet C, 2004, MAGN RESON IMAGING, V22, P905, DOI 10.1016/j.mri.2004.02.005; BENSEBAA F, 1992, J PHYS CHEM-US, V96, P5739, DOI 10.1021/j100193a016; BENSEBAA F, 1992, SYNTHETIC MET, V52, P57, DOI 10.1016/0379-6779(92)90020-J; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Dunn JF, 2003, METHODS, V30, P159, DOI 10.1016/S1046-2023(03)00077-X; Dunn JF, 2002, J MAGN RESON IMAGING, V16, P511, DOI 10.1002/jmri.10192; Friedman BJ, 1996, MAGN RESON MED, V35, P214, DOI 10.1002/mrm.1910350213; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gallez B, 1999, MAGN RESON MED, V42, P627, DOI 10.1002/(SICI)1522-2594(199910)42:4<627::AID-MRM2>3.0.CO;2-M; Gallez B, 2004, NMR BIOMED, V17, P240, DOI 10.1002/nbm.900; Gallez B, 1998, MAGN RESON MED, V40, P152, DOI 10.1002/mrm.1910400120; Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3; Greenhalgh DG, 2003, METH MOLEC MED, V78, P181; Grinberg OY, 1997, ADV EXP MED BIOL, V428, P261; Grinberg OY, 2004, PHYSIOL MEAS, V25, P659, DOI 10.1088/0967-3334/25/3/006; Grinberg OY, 1997, ADV EXP MED BIOL, V411, P171; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hopf HW, 2003, WOUND REPAIR REGEN, V11, P424, DOI 10.1046/j.1524-475X.2003.11606.x; Hou HA, 2003, ANESTH ANALG, V96, P1467, DOI 10.1213/01.ANE.0000055648.41152.63; Hou HG, 2010, RADIAT RES, V173, P651, DOI 10.1667/RR1947.1; HUNT TK, 1967, AM J SURG, V114, P302, DOI 10.1016/0002-9610(67)90388-1; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; James PE, 2002, NITRIC OXIDE-BIOL CH, V6, P18, DOI 10.1006/niox.2001.0383; James PE, 1999, NITRIC OXIDE-BIOL CH, V3, P292, DOI 10.1006/niox.1999.0238; James PE, 1996, FREE RADICAL BIO MED, V21, P25, DOI 10.1016/0891-5849(95)02221-X; Jiang JJ, 1996, J APPL PHYSIOL, V80, P552, DOI 10.1152/jappl.1996.80.2.552; Khan M, 2010, LIFE SCI, V87, P269, DOI 10.1016/j.lfs.2010.06.013; Khan N, 2007, ANTIOXID REDOX SIGN, V9, P1169, DOI 10.1089/ars.2007.1635; Krzic M, 2001, J CONTROL RELEASE, V70, P203, DOI 10.1016/S0168-3659(00)00351-5; KUPPUSAMY P, 1994, P NATL ACAD SCI USA, V91, P3388, DOI 10.1073/pnas.91.8.3388; Lazarus Gerald S., 1994, Wound Repair and Regeneration, V2, P165, DOI 10.1046/j.1524-475X.1994.20305.x; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Li ZX, 2014, BIOMED OPT EXPRESS, V5, P3748, DOI 10.1364/BOE.5.003748; LIU KJ, 1993, P NATL ACAD SCI USA, V90, P5438, DOI 10.1073/pnas.90.12.5438; Liu SM, 2004, NMR BIOMED, V17, P327, DOI 10.1002/nbm.899; Lu CY, 2013, BONE, V52, P220, DOI 10.1016/j.bone.2012.09.037; Lu CY, 2011, J ORTHOP TRAUMA, V25, P494, DOI 10.1097/BOT.0b013e31822511e0; Lu Chuanyong, 2008, Iowa Orthop J, V28, P14; Madhani M, 2002, BBA-MOL BASIS DIS, V1588, P232, DOI 10.1016/S0925-4439(02)00170-9; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; NAKASHIMA T, 1995, MAGNET RESON MED, V34, P888, DOI 10.1002/mrm.1910340614; NIINIKOSKI J, 1972, ANN SURG, V175, P588, DOI 10.1097/00000658-197204000-00020; O'Hara JA, 2004, PHYSIOL MEAS, V25, P1413, DOI 10.1088/0967-3334/25/6/007; Parinandi NL, 2006, ANTIOXID REDOX SIGN, V8, P1385, DOI 10.1089/ars.2006.8.1385; Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; Rebalka IA, 2015, DIABETES; Rolett EL, 2000, AM J PHYSIOL-REG I, V279, pR9, DOI 10.1152/ajpregu.2000.279.1.R9; Ruzehaji N, 2014, DIABETOLOGIA, V57, P402, DOI 10.1007/s00125-013-3107-6; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Schreml S, 2014, THERANOSTICS, V4, P721, DOI 10.7150/thno.9052; Schreml S, 2011, EXP DERMATOL, V20, P550, DOI 10.1111/j.1600-0625.2011.01263.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Swartz HM, 2014, ACAD RADIOL, V21, P197, DOI 10.1016/j.acra.2013.10.011; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Towner RA, 2002, CHEM-BIOL INTERACT, V139, P231, DOI 10.1016/S0009-2797(02)00002-9; Trousdale RK, 2009, J SURG RES, V151, P100, DOI 10.1016/j.jss.2008.01.023; Van Eyck AS, 2009, FERTIL STERIL, V92, P374, DOI 10.1016/j.fertnstert.2008.05.012; Weaver J, 2014, J CEREBR BLOOD F MET, V34, P890, DOI 10.1038/jcbfm.2014.35; Weaver J, 2014, TOXICOL APPL PHARM, V275, P73, DOI 10.1016/j.taap.2013.12.023; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; ZWEIER JL, 1991, J BIOENERG BIOMEMBR, V23, P855, DOI 10.1007/BF00786005	72	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144914	10.1371/journal.pone.0144914	http://dx.doi.org/10.1371/journal.pone.0144914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659378	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900148
J	Horie, M; Warabi, E; Komine, S; Oh, S; Shoda, J				Horie, Masaki; Warabi, Eiji; Komine, Shoichi; Oh, Sechang; Shoda, Junichi			Cytoprotective Role of Nrf2 in Electrical Pulse Stimulated C2C12 Myotube	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATIVE STRESS; INDUCED APOPTOSIS; EXERCISE; ANTIOXIDANTS; ADAPTATION; MECHANISMS; MYOBLASTS; KEAP1	Regular physical exercise is central to a healthy lifestyle. However, exercise-related muscle contraction can induce reactive oxygen species and reactive nitrogen species (ROS/RNS) production in skeletal muscle. The nuclear factor-E2-related factor-2 (Nrf2) transcription factor is a cellular sensor for oxidative stress. Regulation of nuclear Nrf2 signaling regulates antioxidant responses and protects organ structure and function. However, the role of Nrf2 in exercise-or contraction-induced ROS/RNS production in skeletal muscle is not clear. In this study, using differentiated C2C12 cells and electrical pulse stimulation (EPS) of muscle contraction, we explored whether Nrf2 plays a role in the skeletal muscle response to muscle contraction-induced ROS/RNS. We found that EPS (40 V, 1 Hz, 2 ms) stimulated ROS/ RNS accumulation and Nrf2 activation. We also showed that expression of NQO1, HO-1 and GCLM increased after EPS-induced muscle contraction and was remarkably suppressed in cells with Nrf2 knockdown. We also found that the antioxidant N-acetylcysteine (NAC) significantly attenuated Nrf2 activation after EPS, whereas the nitric oxide synthetase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) did not. Furthermore, Nrf2 knockdown after EPS markedly decreased ROS/RNS redox potential and cell viability and increased expression of the apoptosis marker Annexin V in C2C12 myotubes. These results indicate that Nrf2 activation and expression of Nrf2 regulated-genes protected muscle against the increased ROS caused by EPS-induced muscle contraction. Thus, our findings suggest that Nrf2 may be a key factor for preservation of muscle function during muscle contraction.	[Horie, Masaki; Oh, Sechang; Shoda, Junichi] Univ Tsukuba, Fac Med, Div Med Sci, Tsukuba, Ibaraki, Japan; [Horie, Masaki; Oh, Sechang] Japan Soc Promot Sci, Tokyo, Japan; [Warabi, Eiji] Univ Tsukuba, Fac Med, Div Biomed Sci, Tsukuba, Ibaraki, Japan; [Komine, Shoichi] Univ Tsukuba, Grad Sch Comprehens Human Sci Majors Med Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; Japan Society for the Promotion of Science; University of Tsukuba; University of Tsukuba	Shoda, J (corresponding author), Univ Tsukuba, Fac Med, Div Med Sci, Tsukuba, Ibaraki, Japan.	shodaj@md.tsukuba.ac.jp			Japan Health Science Foundation; Ministry of Education, Science and culture, Japan [13J00516]; Grants-in-Aid for Scientific Research [26670109] Funding Source: KAKEN	Japan Health Science Foundation; Ministry of Education, Science and culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was, in part, supported by the Japan Health Science Foundation and a Grant-in-Aid for Scientific Research on Priority Areas, Ministry of Education, Science and culture, Japan (Research project number: 13J00516), MH.; This work was, in part, supported by the Japan Health Science Foundation and a Grant-in-Aid for Scientific Research on Priority Areas, Ministry of Education, Science and culture, Japan (Research project number: 13J00516).	Aldred S, 2007, ATHEROSCLEROSIS, V192, P1, DOI 10.1016/j.atherosclerosis.2007.02.001; Andrade FH, 2001, FASEB J, V15, P309; Aoi Wataru, 2011, Curr Aging Sci, V4, P101; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Crespo CJ, 2002, ANN EPIDEMIOL, V12, P543, DOI 10.1016/S1047-2797(01)00296-4; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jackson MJ, 2008, IUBMB LIFE, V60, P497, DOI 10.1002/iub.72; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Ji LL, 2007, EXP GERONTOL, V42, P582, DOI 10.1016/j.exger.2007.03.002; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Lee YH, 2013, BIOSCI BIOTECH BIOCH, V77, P375, DOI 10.1271/bbb.120465; McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Niess AM, 2007, FRONT BIOSCI-LANDMRK, V12, P4826, DOI 10.2741/2431; Pan HY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/145418; Patwell DM, 2004, FREE RADICAL BIO MED, V37, P1064, DOI 10.1016/j.freeradbiomed.2004.06.026; Peleli M, 2015, BIOORGAN MED CHEM, V23, P390, DOI 10.1016/j.bmc.2014.12.046; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Powers SK, 1999, CLIN SPORT MED, V18, P525, DOI 10.1016/S0278-5919(05)70166-6; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Vasilaki A, 2013, FREE RADICAL BIO MED, V65, P317, DOI 10.1016/j.freeradbiomed.2013.07.008	27	29	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144835	10.1371/journal.pone.0144835	http://dx.doi.org/10.1371/journal.pone.0144835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658309	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900115
J	Kibira, SPS; Makumbi, F; Daniel, M; Atuyambe, LM; Sandoy, IF				Kibira, Simon P. S.; Makumbi, Fredrick; Daniel, Marguerite; Atuyambe, Lynn Muhimbuura; Sandoy, Ingvild Fossgard			Sexual Risk Behaviours and Willingness to Be Circumcised among Uncircumcised Adult Men in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV PREVENTION; HUMAN-PAPILLOMAVIRUS; YOUNG MEN; WOMEN; COMPENSATION; PREVALENCE; INFECTION; KISUMU; TRIAL	Background There has been substantial demand for safe male circumcision (SMC) in Uganda in the early programme scale-up phase. Research indicates that early adopters of new interventions often differ from later adopters in relation to a range of behaviours. However, there is limited knowledge about the risk profile of men who were willing to be circumcised at the time of launching the SMC programme, i.e., potential early adopters, compared to those who were reluctant. The aim of this study was to address this gap to provide indications on whether it is likely that potential early adopters of male circumcision were more in need of this new prevention measure than others. Methods Data were from the 2011 Uganda AIDS Indictor Survey (UAIS), with a nationally representative sample of men 15 to 59 years. The analysis was based on generalized linear models, obtaining prevalence risk ratios (PRR) with 95% confidence intervals (CI) as measures of association between willingness to be circumcised and multiple sexual partners, transactional sex, non-marital sex and non-use of condoms at last non-marital sex. Results Of the 5,776 men in the survey, 44% expressed willingness to be circumcised. Willingness to be circumcised was higher among the younger, urban and educated men. In the unadjusted analyses, all the sexual risk behaviours were associated with willingness to be circumcised, while in the adjusted analysis, non-marital sex (Adj PRR 1.27; CI: 1.16-1.40) and non-use of condoms at last such sex (Adj PRR 1.18; CI: 1.07-1.29) were associated with higher willingness to be circumcised. Conclusion Willingness to be circumcised was relatively high at the launch of the SMC programme and was more common among uncircumcised men reporting sexual risk behaviours. This indicates that the early adopters of SMC were likely to be in particular need of such additional HIV protective measures.	[Kibira, Simon P. S.; Sandoy, Ingvild Fossgard] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Kibira, Simon P. S.; Atuyambe, Lynn Muhimbuura] Makerere Univ, Dept Community Hlth & Behav Sci, Sch Publ Hlth, Kampala, Uganda; [Makumbi, Fredrick] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Kampala, Uganda; [Daniel, Marguerite] Univ Bergen, Dept Hlth Promot & Dev, Bergen, Norway	University of Bergen; Makerere University; Makerere University; University of Bergen	Kibira, SPS (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway.	pskibira@gmail.com	Sandøy, Ingvild Fossgard/ABD-3557-2020	Kibira, Simon Peter Sebina/0000-0002-7385-423X; Sandoy, Ingvild/0000-0001-5567-4588	Norwegian State Education Loan Fund (Lanekassen); University of Bergen, Norway	Norwegian State Education Loan Fund (Lanekassen); University of Bergen, Norway	This work was supported by a scholarship to the first author from the Norwegian State Education Loan Fund (Lanekassen), and the University of Bergen, Norway. The funders had no role in conducting the study.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; AXELSON O, 1994, OCCUP ENVIRON MED, V51, P574, DOI 10.1136/oem.51.8.574; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brawley E. M., 2006, RELATIONSHIP GENDER; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Center for Communication Programs, 2012, HLTH COMM PARTN UG; Chikutsa A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0001-3; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Health Communication Partnerships, 2010, HCP 2010 SURV HIGHL; Keetile M, 2014, AFR POPUL STUD, V28, P1345, DOI DOI 10.11564/0-0-630; Kelly CA, 2014, STUD FAMILY PLANN, V45, P43, DOI 10.1111/j.1728-4465.2014.00375.x; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kitara DL, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.100.2338; Mnyika KS, 1997, INT J STD AIDS, V8, P176, DOI 10.1258/0956462971919840; MOH, 2010, SAF MAL CIRC HIV PRE; MOH and ICF International, 2012, UG AIDS IND SURV 201; Muhangi D., 2010, FACTORS INFLUENCE DE; MUSPH School of Public Health Makerere University College of Health Sciences, 2010, MUSPH ANN REP; Rogers EM, 1983, DIFFUSION INNOVATION; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Siegfried N., 2003, COCHRANE DATABASE SY; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Uganda AIDS Commission, 2014, HIV AIDS UG COUNTR P; Uganda Bureau of Statistics - UBOS ICF International, 2012, UG DEM HLTH SURV 201; UNAIDS, 2000, NAT AIDS PROGR GUID; UNAIDS, 2014, UND FAST TRACK ACC A; Wabwire-Mangen F., 2009, UGANDA HIV PREVENTIO; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Westercamp M, 2012, AIDS CARE, V24, P157, DOI 10.1080/09540121.2011.597944; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; WHO/UNAIDS, 2011, JOINT STRAT ACT FRAM; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; World Health Organization, 2007, NEW DAT MAL CIRC HIV	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144843	10.1371/journal.pone.0144843	http://dx.doi.org/10.1371/journal.pone.0144843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658740	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900117
J	Liu, BM; Li, M; Yin, BS; Zou, JY; Zhang, WG; Wang, SY				Liu, Bo-Ming; Li, Ming; Yin, Bao-Sheng; Zou, Ji-Yang; Zhang, Wei-Guo; Wang, Shou-Yu			Effects of Incorporating Carboxymethyl Chitosan into PMMA Bone Cement Containing Methotrexate	PLOS ONE			English	Article							ACRYLIC CEMENT; GROWTH; ENHANCEMENT	Treatment of bone metastases usually includes surgical resection with local filling of methotrexate (MTX) in polymethyl methacrylate (PMMA) cement. We investigated whether incorporating carboxymethyl chitosan (CMCS) in MTX-PMMA cement might overcome disadvantages associated with MTX. To determine the optimal CMCS+MTX concentration to suppress the viability of cancer cells, an integrated microfluidic chip culturing highly metastatic lung cancer cells (H460) was employed. The mechanical properties, microstructure, and MTX release of (CMCS+MTX)-PMMA cement were evaluated respectively by universal mechanical testing machine, scanning electron microscopy (SEM), and incubation in simulated body fluid with subsequent HPLC-MS. Implants of MTX-PMMA and (CMCS+MTX)PMMA cement were evaluated in vivo in guinea pig femurs over time using spiral computed tomography with three-dimensional image reconstruction, and SEM at 6 months. Viability of H460 cells was significantly lowest after treatment with 57 mu g/mL CMCS + 21 mu g/mL MTX, which was thus used in subsequent experiments. Incorporation of 1.6% (w/w) CMCS to MTX-PMMA significantly increased the bending modulus, bending strength, and compressive strength by 5, 2.8, and 5.2%, respectively, confirmed by improved microstructural homogeneity. Incorporation of CMCS delayed the time-to-plateau of MTX release by 2 days, but increased the fraction released at the plateau from 3.24% (MTX-PMMA) to 5.34%. Relative to the controls, the (CMCS+MTX)-PMMA implants integrated better with the host bone. SEM revealed pores in the cement of the (CMCS+MTX)-PMMA implants that were not obvious in the controls. In conclusion, incorporation of CMCS in MTX-PMMA appears a feasible and effective modification for improving the anti-tumor properties of MTX-PMMA cement.	[Liu, Bo-Ming; Li, Ming; Yin, Bao-Sheng; Zou, Ji-Yang; Zhang, Wei-Guo; Wang, Shou-Yu] Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian 116044, Liaoning, Peoples R China; [Liu, Bo-Ming; Li, Ming; Yin, Bao-Sheng; Zou, Ji-Yang; Zhang, Wei-Guo; Wang, Shou-Yu] Dalian Med Univ, Dalian 116044, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University	Zhang, WG (corresponding author), Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian 116044, Liaoning, Peoples R China.	weiguozhang2014@hotmail.com; shmily_lbm@hotmail.com		Yin, Baosheng/0000-0002-1696-9110	National Natural Science Foundation of China [81171464, 81270052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (No. 81171464 and No. 81270052). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amidi M, 2010, ADV DRUG DELIVER REV, V62, P59, DOI 10.1016/j.addr.2009.11.009; Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074; Chen C, 2013, MOLECULES, V18, P7239, DOI 10.3390/molecules18067239; Dadas B, 2007, EUR ARCH OTO-RHINO-L, V264, P539, DOI 10.1007/s00405-006-0227-3; Damien E, 2003, J BIOMED MATER RES A, V66A, P241, DOI 10.1002/jbm.a.10564; Decker S, 1999, J BONE JOINT SURG BR, V81B, P545, DOI 10.1302/0301-620X.81B3.9167; Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016; Guminska M., 1996, J PHARM, V48, P495; Handal JA, 2007, CLIN ORTHOP RELAT R, P105, DOI 10.1097/BLO.0b013e31804f5446; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; HERNIGOU P, 1989, J BONE JOINT SURG BR, V71, P804, DOI 10.1302/0301-620X.71B5.2584251; Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406; Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022; Kim TH, 2006, MOL CANCER THER, V5, P1723, DOI 10.1158/1535-7163.MCT-05-0540; KISSIN I, 1989, ANESTHESIOLOGY, V70, P689, DOI 10.1097/00000542-198904000-00025; Koev ST, 2010, LAB CHIP, V10, P3026, DOI [10.1039/c0lc00047g, 10.1039/c01c00047g]; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Li YC, 2010, TISSUE ENG PART C-ME, V16, P1267, DOI [10.1089/ten.tec.2009.0682, 10.1089/ten.TEC.2009.0682]; Lin LC, 2005, J MATER SCI-MATER M, V16, P567, DOI 10.1007/s10856-005-0533-0; Maccauro G, 2007, J MATER SCI-MATER M, V18, P839, DOI 10.1007/s10856-006-0036-7; Mun S, 2006, J COLLOID INTERF SCI, V296, P581, DOI 10.1016/j.jcis.2005.09.023; Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325; Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9; Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7; Prochazka E, 2010, INT ORTHOP, V34, P137, DOI 10.1007/s00264-008-0717-6; Seo SH, 2009, CLIN EXP METASTAS, V26, P179, DOI 10.1007/s10585-008-9228-5; Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8; Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0; Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0	31	10	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144407	10.1371/journal.pone.0144407	http://dx.doi.org/10.1371/journal.pone.0144407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657526	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900043
J	Olifiers, N; Jansen, AM; Herrera, HM; Bianchi, RD; D'Andrea, PS; Mourao, GD; Gompper, ME				Olifiers, Natalie; Jansen, Ana Maria; Herrera, Heitor Miraglia; Bianchi, Rita de Cassia; D'Andrea, Paulo Sergio; Mourao, Guilherme de Miranda; Gompper, Matthew Edzart			Co-Infection and Wild Animal Health: Effects of Trypanosomatids and Gastrointestinal Parasites on Coatis of the Brazilian Pantanal	PLOS ONE			English	Article							NASUA-NASUA; EXPERIMENTAL-INFECTION; BODY CONDITION; DIROFILARIA-IMMITIS; SEX-DIFFERENCES; CRUZI; EVANSI; HOST; POPULATIONS; EOSINOPHILS	Wild animals are infected by diverse parasites, but how they influence host health is poorly understood. We examined the relationship of trypanosomatids and gastrointestinal parasites with health of wild brown-nosed coatis (Nasua nasua) from the Brazilian Pantanal. We used coati body condition and hematological parameters as response variables in linear models that were compared using an information theoretic approach. Predictors were high/low parasitemias by Trypanosoma cruzi and T. evansi, and indices representing the abundance of distinct groups of gastrointestinal parasites. We also analyzed how host health changed with host sex and reproductive seasonality. Hemoparasites was best related to coati body condition and hematological indices, whereas abundance of gastrointestinal parasites was relatively less associated with coati health. Additionally, some associations were best predicted by models that incorporated reproductive seasonality and host sex. Overall, we observed a lower health condition during the breeding season, when coatis are under reproductive stress and may be less able to handle infection. In addition, females seem to handle infection better than males. Body condition was lower in coatis with high parasitemias of T. evansi, especially during the reproductive season. Total red blood cell counts, packed cell volume, platelets and eosinophils were also lower in animals with high T. evansi parasitemias. Total white blood cell counts and mature neutrophils were lower in animals with high parasitemias for both Trypanosoma species, with neutrophils decreasing mainly during the reproductive season. Overall, decreases in hematological parameters of females with T. evansi high parasitemias were less evident. For T. cruzi, monocytes decreased in individuals with high parasitemias. High abundances of microfilariae in the bloodstream, and cestode eggs and coccidian oocysts in feces were also associated with coati blood parameters. This study shows the potential value of examining hematological parameters as an approach to better understand the ecological relevance of parasite-host interactions.	[Olifiers, Natalie; D'Andrea, Paulo Sergio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Reservatorios, Rio De Janeiro, RJ, Brazil; [Jansen, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, RJ, Brazil; [Herrera, Heitor Miraglia] Univ Catolica Dom Bosco, Lab Parasitol Anim, Campo Grande, MS, Brazil; [Bianchi, Rita de Cassia] Univ Estadual Paulista, Dept Biol Aplicada Agr, Sao Paulo, Brazil; [Mourao, Guilherme de Miranda] Empresa Brasileira Pesquisa Agr, Lab Vida Selvagem, Ctr Pesquisa Agr Pantanal, Corumba, MS, Brazil; [Gompper, Matthew Edzart] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Catolica Dom Bosco (UCDB); Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Missouri System; University of Missouri Columbia	Olifiers, N (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Reservatorios, Rio De Janeiro, RJ, Brazil.	natolifiers@gmail.com	Mourão, Guilherme M/C-3319-2013; de Cassia Bianchi, Rita/E-5504-2012; Herrera, Heitor Miraglia/K-3759-2012; Olifiers, Natalie/N-5478-2019; D'Andrea, Paulo S./G-6820-2011	Mourão, Guilherme M/0000-0002-8300-4191; de Cassia Bianchi, Rita/0000-0001-8027-755X; Herrera, Heitor Miraglia/0000-0003-2404-8765; Olifiers, Natalie/0000-0002-3024-2049; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [484501/2006-2]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul [6654.235.476.06032007]; Empresa Brasileira de Estudos Agropecuarios (Macroprograma 3); Fundacao Oswaldo Cruz; University of Missouri; Earthwatch Institute; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Empresa Brasileira de Estudos Agropecuarios (Macroprograma 3); Fundacao Oswaldo Cruz; University of Missouri; Earthwatch Institute; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funds were provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (process number 484501/2006-2) to GMM, NO, AMJ, HMH, RCB, PSD; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (process number 6654.235.476.06032007) to GMM, NO, AMJ, HMH, RCB, PSD; Empresa Brasileira de Estudos Agropecuarios (Macroprograma 3) to GMM, NO, AMJ, HMH, RCB, PSD; Fundacao Oswaldo Cruz to AMJ e PSD; University of Missouri to MEG; and Earthwatch Institute to NO, AMJ, HMH and PSD. Doctoral grants were provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to RCB and by the University of Missouri to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Alves FM, 2011, VECTOR-BORNE ZOONOT, V11, P835, DOI 10.1089/vbz.2010.0096; ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; Aquino LPCT, 2002, ARQ BRAS MED VET ZOO, V54, P8, DOI 10.1590/S0102-09352002000100002; Arias JF, 1997, J WILDLIFE DIS, V33, P359, DOI 10.7589/0090-3558-33.2.359; ATWELL RB, 1983, RES VET SCI, V35, P364, DOI 10.1016/S0034-5288(18)32034-4; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; Beldomenico PM, 2008, P ROY SOC B-BIOL SCI, V275, P1753, DOI 10.1098/rspb.2008.0147; Bianchi R.C., 2009, THESIS; Booth-Binczik S. D., 2001, THESIS; Bordes F, 2009, OIKOS, V118, P801, DOI 10.1111/j.1600-0706.2008.17169.x; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Budischak Sarah A., 2012, International Journal for Parasitology Parasites and Wildlife, V1, P2, DOI 10.1016/j.ijppaw.2012.10.001; Burnham KP, 2001, MODEL SELECTION MULT; Cadioli FA, 2006, ARQ BRAS MED VET ZOO, V58, P749, DOI 10.1590/S0102-09352006000500008; Campos Z, 1987, CIENC INTERAM, V26, P30; Cizauskas CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120800; Cordoba-Aguilar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076246; Costa FJV, 2005, ANIM BEHAV, V70, P1401, DOI 10.1016/j.anbehav.2005.03.024; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Ebert D, 2000, AM NAT, V156, P459, DOI 10.1086/303404; Elias D, 2006, PARASITE IMMUNOL, V28, P507, DOI 10.1111/j.1365-3024.2006.00854.x; Foreyt W.J, 2001, VET PARASITOLOGY REF, V5th; Fowler M E, 2001, BIOL MED SURG S AM W, V54; Franciscato Carina, 2007, Cienc. Rural, V37, P288, DOI 10.1590/S0103-84782007000100049; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gompper Matthew E., 1998, Mammalian Species, V580, P1; Hakkarainen H, 2007, PARASITOLOGY, V134, P23, DOI 10.1017/S0031182006001120; Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002; Harvey J W, 1982, Vet Clin Pathol, V11, P5, DOI 10.1111/j.1939-165X.1982.tb00811.x; Herrera HM, 2008, T ROY SOC TROP MED H, V102, P1133, DOI 10.1016/j.trstmh.2008.04.041; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Herrera HM, 2004, VET PARASITOL, V125, P263, DOI 10.1016/j.vetpar.2004.07.013; Herrera HM, 2002, ACTA TROP, V81, P203, DOI 10.1016/S0001-706X(01)00204-2; Herrera HM, 2001, VET PARASITOL, V102, P209, DOI 10.1016/S0304-4017(01)00532-5; Hudson PJ, 1997, J PARASITOL, V83, P194, DOI 10.2307/3284438; Hughes VL, 2001, PARASITOLOGY, V123, P365, DOI 10.1017/S0031182001008599; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Jain NC, 1993, ESSENTIALS VET HEMAT; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Kassai T, 1999, VET HELMINTHOLOGY; Kipper M, 2011, RES VET SCI, V91, P240, DOI 10.1016/j.rvsc.2010.11.018; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; LAINSON R, 1989, ANN PARASIT HUM COMP, V64, P200, DOI 10.1051/parasite/1989643200; Lello J, 2005, INT J PARASITOL, V35, P1509, DOI 10.1016/j.ijpara.2005.06.002; Marcondes MCG, 2000, MICROBES INFECT, V2, P347, DOI 10.1016/S1286-4579(00)00333-6; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Meagher S, 2002, J PARASITOL, V88, P833, DOI 10.1645/0022-3395(2002)088[0833:EOTSOS]2.0.CO;2; Melo RCN, 2001, EXP PARASITOL, V97, P15, DOI 10.1006/expr.2000.4576; MILES MA, 1983, AM J TROP MED HYG, V32, P1251, DOI 10.4269/ajtmh.1983.32.1251; Monteiro RV, 2007, PARASITOL RES, V101, P1689, DOI 10.1007/s00436-007-0652-2; Newey S, 2004, WILDLIFE BIOL, V10, P171, DOI 10.2981/wlb.2004.023; Nunes V. L. B., 1993, Revista Brasileira de Parasitologia Veterinaria, V2, P41; OLIFIERS N, 2010, THESIS; Olifiers N, 2010, WILDLIFE BIOL, V16, P389, DOI 10.2981/09-104; Onah DN, 1996, PARASITOL RES, V82, P659, DOI 10.1007/s004360050181; ORIHEL TC, 1964, J PARASITOL, V50, P115, DOI 10.2307/3276043; OSHIRO E T, 1990, Memorias do Instituto Oswaldo Cruz, V85, P139; Ovington KS, 1997, MEM I OSWALDO CRUZ, V92, P93, DOI 10.1590/S0074-02761997000800013; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Pioz M, 2008, OECOLOGIA, V155, P691, DOI 10.1007/s00442-007-0942-5; POLACK B, 1991, NOUV REV FR HEMATOL, V33, P317; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Poulin R., 2004, PARASITE BIODIVERSIT; Prado Jose Clovis Do Jr., 1998, Parasitology Research, V84, P100; PUNG OJ, 1988, INT J PARASITOL, V18, P115, DOI 10.1016/0020-7519(88)90045-8; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; REPKA D, 1985, Revista Brasileira de Biologia, V45, P309; Rocha FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067463; da Paz RCR, 2012, THERIOGENOLOGY, V77, P1275, DOI 10.1016/j.theriogenology.2011.10.032; Rodriguez A, 1998, ACTA PARASITOL, V43, P128; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; ROSE ME, 1979, IMMUNOLOGY, V36, P71; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Santana VL, 2012, PESQUISA VET BRASIL, V32, P536, DOI 10.1590/S0100-736X2012000600011; Santos CD, 2007, VET PARASITOL, V143, P222, DOI 10.1016/j.vetpar.2006.08.038; Schalk G, 1997, OIKOS, V78, P67, DOI 10.2307/3545801; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Seidl AF, 2001, ECOL ECON, V36, P413, DOI 10.1016/S0921-8009(00)00238-X; Sevimli FK, 2007, PARASITOL RES, V101, P1487, DOI 10.1007/s00436-007-0665-x; Silva A. S. da, 2010, Comparative Clinical Pathology, V19, P207, DOI 10.1007/s00580-009-0855-2; Silva AS, 2010, SEMIN-CIENC AGRAR, P699; Silva R.A.M.S., 1999, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V52, P119; Silva R.A.M.S., 1995, REV ELEV MED VET PAY, V48, P315; Stien A, 2002, J ANIM ECOL, V71, P937, DOI 10.1046/j.1365-2656.2002.00659.x; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Vandegrift KJ, 2008, ECOLOGY, V89, P2251, DOI 10.1890/07-1935.1; Varela-Stokes AS, 2008, J PARASITOL, V94, P564, DOI 10.1645/GE-1346.1; Vezzani D, 2006, VET PARASITOL, V136, P259, DOI 10.1016/j.vetpar.2005.10.026; Vieira FM, 2008, ZOOTAXA, P1; Voigt G.L, 2000, HEMATOLOGY TECHNIQUE; Wimmer B, 2004, INT J PARASITOL, V34, P625, DOI 10.1016/j.ijpara.2003.11.022; Woo P. T. K., 1970, Acta trop., V27, P384; Worliczek HL, 2010, PARASITE IMMUNOL, V32, P232, DOI 10.1111/j.1365-3024.2009.01184.x; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	104	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143997	10.1371/journal.pone.0143997	http://dx.doi.org/10.1371/journal.pone.0143997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657699	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900022
J	Dashivets, T; Thomann, M; Rueger, P; Knaupp, A; Buchner, J; Schlothauer, T				Dashivets, Tetyana; Thomann, Marco; Rueger, Petra; Knaupp, Alexander; Buchner, Johannes; Schlothauer, Tilman			Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; ANTIINFLAMMATORY ACTIVITY; CONFORMATIONAL-CHANGES; GLYCOSYLATION PATTERN; ANTIBODY THERAPEUTICS; THERMAL-STABILITY; N-GLYCOSYLATION; SIALIC-ACID; BINDING; IMPACT	Therapeutic performance of recombinant antibodies relies on two independent mechanisms: antigen recognition and Fc-mediated antibody effector functions. Interaction of Fc-fragment with different FcR triggers antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity and determines longevity of the antibody in serum. In context of therapeutic antibodies Fc gamma Rs play the most important role. It has been demonstrated that the Fc-attached sugar moiety is essential for IgG effector functionality, dictates its affinity to individual Fc gamma Rs and determines binding to different receptor classes: activating or inhibitory. In this study, we systematically analyze effector functions of monoclonal IgG1 and its eight enzymatically engineered glycosylation variants. The analysis of interaction of glycovariants with FcRs was performed for single, as well as for antigen-bound antibodies and IgGs in a form of immune complex. In addition to functional properties we addressed impact of glycosylation on the structural properties of the tested glycovariants. We demonstrate a clear impact of glycosylation pattern on antibody stability and interaction with different Fc gamma Rs. Consistent with previous reports, deglycosylated antibodies failed to bind all Fc gamma-receptors, with the exception of high affinity Fc gamma RI. The Fc gamma RII and Fc gamma RIIIa binding activity of IgG1 was observed to depend on the galactosylation level, and hypergalactosylated antibodies demonstrated increased receptor interaction. Sialylation did not decrease the Fc gamma R binding of the tested IgGs; in contrast, sialylation of antibodies improved binding to Fc gamma RIIa and IIb. We demonstrate that glycosylation influences to some extent IgG1 interaction with FcRn. However, independent of glycosylation pattern the interaction of IgG1 with a soluble monomeric target surprisingly resulted in an impaired receptor binding. Here, we demonstrate, that immune complexes (IC), induced by multimeric ligand, compensated for the decreased affinity of target bound antibody towards FcRs, showing the importance of the IC-formation for the FcR-mediated effector functions.	[Dashivets, Tetyana; Rueger, Petra; Knaupp, Alexander; Schlothauer, Tilman] Roche Innovat Ctr, Biochem & Analyt Res, Large Mol Res, Roche Pharma Res & Early Dev PRED, Penzberg, Germany; [Thomann, Marco] Roche Diagnost GmbH, Pharma Biotech Dev Penzberg, Penzberg, Germany; [Dashivets, Tetyana; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85748 Garching, Germany	Roche Holding; Technical University of Munich	Schlothauer, T (corresponding author), Roche Innovat Ctr, Biochem & Analyt Res, Large Mol Res, Roche Pharma Res & Early Dev PRED, Penzberg, Germany.	tilman.schlothauer@roche.com	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737	Roche Pharma Research and Early Development (pRED) Roche Innovation Center Penzberg; Pharma Technical Development Penzberg, Roche Diagnostics GmbH	Roche Pharma Research and Early Development (pRED) Roche Innovation Center Penzberg; Pharma Technical Development Penzberg, Roche Diagnostics GmbH	The author(s) received no specific funding for this work. Roche Pharma Research and Early Development (pRED) Roche Innovation Center Penzberg and Pharma Technical Development Penzberg, Roche Diagnostics GmbH provided support in the form of salaries for authors TD, MT, PR, AK, and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anthony RM, 2011, CURR OPIN ORGAN TRAN, V16, P7, DOI 10.1097/MOT.0b013e328342538f; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Bohm S, 2012, SEMIN IMMUNOPATHOL, V34, P443, DOI 10.1007/s00281-012-0308-x; Boyd PN, 1995, MOL IMMUNOL, V32, P1311, DOI 10.1016/0161-5890(95)00118-2; Brorson K, 2014, CURR OPIN BIOTECH, V30, P140, DOI 10.1016/j.copbio.2014.06.012; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Buck PM, 2013, MABS-AUSTIN, V5, P904, DOI 10.4161/mabs.26453; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Hayes JM, 2014, J PROTEOME RES, V13, P5471, DOI 10.1021/pr500414q; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; HOGARTH PM, 1992, IMMUNOL RES, V11, P217, DOI 10.1007/BF02919128; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Hristodorov D, 2013, MOL BIOTECHNOL, V53, P326, DOI 10.1007/s12033-012-9531-x; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Ito K, 2014, J IMMUNOL, V192, P581, DOI 10.4049/jimmunol.1302488; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; JEFFERIS R, 1995, IMMUNOL LETT, V44, P111, DOI 10.1016/0165-2478(94)00201-2; JEFFERIS R, 1993, GLYCOCONJUGATE J, V10, P358; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jefferis Roy, 2009, V483, P223, DOI 10.1007/978-1-59745-407-0_13; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kapur R, 2014, IMMUNOL LETT; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kayser V, 2011, BIOTECHNOL J, V6, P38, DOI 10.1002/biot.201000091; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kumpel Belinda M., 1995, Human Antibodies and Hybridomas, V6, P82; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nimmerjahn Falk, 2008, V415, P151, DOI 10.1007/978-1-59745-570-1_9; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schlothauer T, 2013, MABS-AUSTIN, V5, P576, DOI 10.4161/mabs.24981; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Stracke J, 2014, MABS, V6; Thomann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134949; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Xue J, 2013, GLYCOCONJUGATE J, V30, P735, DOI 10.1007/s10719-013-9481-y; Yamada K, 2013, J AUTOIMMUN, V47, P104, DOI 10.1016/j.jaut.2013.09.001; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Zeck A, 2011, J PROTEOME RES, V10, P3031, DOI 10.1021/pr1012653; Zhang AM, 2014, ANAL CHEM, V86, P3468, DOI 10.1021/ac404130a; Zheng K, 2014, MABS-AUSTIN, V6, P649, DOI 10.4161/mabs.28588; Zheng K, 2011, MABS-AUSTIN, V3, P568, DOI 10.4161/mabs.3.6.17922	68	55	57	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143520	10.1371/journal.pone.0143520	http://dx.doi.org/10.1371/journal.pone.0143520			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657484	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600012
J	Fondo, EN; Chaloupka, M; Heymans, JJ; Skilleter, GA				Fondo, Esther N.; Chaloupka, Milani; Heymans, Johanna J.; Skilleter, Greg A.			Banning Fisheries Discards Abruptly Has a Negative Impact on the Population Dynamics of Charismatic Marine Megafauna	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PRAWN TRAWLERS; MORETON-BAY; BY-CATCH; SEABIRD COMMUNITIES; FOOD WEBS; ECOSYSTEM; AUSTRALIA; SUBSIDIES; ECOPATH	Food subsidies have the potential to modify ecosystems and affect the provision of goods and services. Predictable Anthropogenic Food Subsidies (PAFS) modify ecosystems by altering ecological processes and food webs. The global concern over the effects of PAFS in ecosystems has led to development of environmental policies aimed at curbing the production or ultimately banning of PAFS. However, the effects of reducing or banning PAFS are not known. We explore the consequences of PAFS removal in a marine ecosystem under two scenarios: 1) gradual reduction, or 2) an abrupt ban, using a mass balance model to test these hypotheses-The reduction or loss of PAFS will: i) modify trophic levels and food webs through effects on foraging by opportunistic species, ii) increase the resilience of opportunistic species to food shortages, and iii) modify predator-prey interactions through shifts in prey consumption. We found that PAFS lower the trophic levels of opportunistic scavengers and increase their food pathways. Scavengers are able to switch prey when PAFS are reduced gradually but they decline when PAFS are abruptly banned. PAFS reduction to a certain minimal level causes a drop in the ecosystem's stability. We recommend gradual reduction of PAFS to a minimal level that would maintain the ecosystem's stability and allow species exploiting PAFS to habituate to the food subsidy reduction.	[Fondo, Esther N.; Chaloupka, Milani; Skilleter, Greg A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Fondo, Esther N.] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Heymans, Johanna J.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland	University of Queensland; UHI Millennium Institute	Fondo, EN (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	sther.fondo@uqconnect.edu.au; g.skilleter@uq.edu.au	Heymans, Johanna J/H-4848-2012; Skilleter, Greg Alan/F-9250-2010; Fondo, Esther/A-9295-2016	Heymans, Johanna J/0000-0002-7290-8988; Skilleter, Greg Alan/0000-0002-4719-0409; Fondo, Esther/0000-0002-5529-1867	University of Queensland (UQ); Natural Environment Research Council [NE/L003058/1] Funding Source: researchfish; NERC [NE/L003058/1] Funding Source: UKRI	University of Queensland (UQ)(University of Queensland); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work forms part of a PhD dissertation of ENF at the University of Queensland. We wish to thank the following: The University of Queensland (UQ) for the PhD Scholarship, Queensland Department of Agriculture and Fisheries for the Queensland Fishing data, Scottish Association for Marine Science for the Ecopath with Ecosim (EwE) training undertaken by ENF, Kenya Marine and Fisheries Research Institute for approval to ENF to do the PhD, Moggill-Mt. Crosby Anglican Parish for travel support for ENF to attend the EwE training and the Ecopath Consortium for the EwE software. We also thank Russell Richard (UQ), Dylan Moffitt (UQ) and the Editor and reviewers from PLOS ONE for comments and improvements of earlier versions of this paper.	Alverson DLF M.H., 1994, FAO PUBLICATION; [Anonymous], 2005, DISCARDS WORLDS MARI; Bartels P, 2012, OECOLOGIA, V168, P807, DOI 10.1007/s00442-011-2141-7; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; Bozzano A, 2002, ICES J MAR SCI, V59, P15, DOI 10.1006/jmsc.2001.1142; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Cortes-Avizanda A, 2012, ECOLOGY, V93, P2570, DOI 10.1890/12-0221.1; COURTNEY AJ, 1995, ESTUAR COAST SHELF S, V41, P377, DOI 10.1016/0272-7714(95)90000-4; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Furness RW, 2007, MAR ECOL PROG SER, V350, P235, DOI 10.3354/meps07191; HILL BJ, 1990, AUST J MAR FRESH RES, V41, P53; Hill BJ, 2000, FISH RES, V48, P277, DOI 10.1016/S0165-7836(00)00185-5; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065857; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Mateo-Tomas P, 2015, DIVERS DISTRIB, P1; Matthew, 1994, BOOK MATTHEW, V13, P47; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; Morris DW, 2005, ECOLOGY, V86, P2568, DOI 10.1890/04-0909; Newsome TM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1, DOI 10.1111/geb.12236; Newsome TM, 2014, OECOLOGIA, V175, P139, DOI 10.1007/s00442-014-2889-7; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pitt K.A., 2009, JELLYFISH BLOOMS CAU, V206; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POLOVINA JJ, 1984, CORAL REEFS, V3, P1, DOI 10.1007/BF00306135; Ramsay K, 1996, MAR ECOL PROG SER, V144, P63, DOI 10.3354/meps144063; Robertson AI, 1994, HAMMOND LS SYNNOT RN, P297; Ruffino L, 2013, OECOLOGIA, V172, P737, DOI 10.1007/s00442-012-2545-z; Saila SB, 1983, FAO PUBLICATION, P1; Sarda F, 2015, FISH FISH, V16, P175, DOI 10.1111/faf.12060; Skilleter GA, 2007, MAR ECOL PROG SER, V351, P287, DOI 10.3354/meps07174; Svane I, 2008, FISH RES, V90, P158, DOI 10.1016/j.fishres.2007.10.008; Tamsett D, 1999, FISH RES, V42, P117, DOI 10.1016/S0165-7836(99)00030-2; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057376; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; WASSENBERG TJ, 1990, AUST J MAR FRESH RES, V41, P27, DOI 10.1071/MF9900027; WASSENBERG TJ, 1989, FISH RES, V7, P99, DOI 10.1016/0165-7836(89)90010-6; Zhou SJ, 2008, FISH FISH, V9, P308, DOI 10.1111/j.1467-2979.2008.00291.x	55	22	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144543	10.1371/journal.pone.0144543	http://dx.doi.org/10.1371/journal.pone.0144543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657412	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600054
J	Lind, TK; Wacklin, H; Schiller, J; Moulin, M; Haertlein, M; Pomorski, TG; Cardenas, M				Lind, Tania Kjellerup; Wacklin, Hanna; Schiller, Juergen; Moulin, Martine; Haertlein, Michael; Pomorski, Thomas Gunther; Cardenas, Marite			Formation and Characterization of Supported Lipid Bilayers Composed of Hydrogenated and Deuterated Escherichia coli Lipids	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; QUARTZ-CRYSTAL MICROBALANCE; QCM-D; VESICLE ADSORPTION; NEUTRON REFLECTION; PLANAR BILAYERS; MODEL MEMBRANES; SOLID-SURFACES; CELL; CARDIOLIPIN	Supported lipid bilayers are widely used for sensing and deciphering biomolecular interactions with model cell membranes. In this paper, we present a method to form supported lipid bilayers from total lipid extracts of Escherichia coli by vesicle fusion. We show the validity of this method for different types of extracts including those from deuterated biomass using a combination of complementary surface sensitive techniques; quartz crystal microbalance, neutron reflection and atomic force microscopy. We find that the head group composition of the deuterated and the hydrogenated lipid extracts is similar (approximately 75% phosphatidylethanolamine, 13% phosphatidylglycerol and 12% cardiolipin) and that both samples can be used to reconstitute high-coverage supported lipid bilayers with a total thickness of 41 +/- 3 angstrom, common for fluid membranes. The formation of supported lipid bilayers composed of natural extracts of Escherichia coli allow for following biomolecular interactions, thus advancing the field towards bacterial-specific membrane biomimics.	[Lind, Tania Kjellerup; Wacklin, Hanna; Cardenas, Marite] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Lind, Tania Kjellerup; Wacklin, Hanna; Cardenas, Marite] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Lind, Tania Kjellerup; Wacklin, Hanna] European Spallat Source ESS AB, Lund, Sweden; [Schiller, Juergen] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany; [Moulin, Martine; Haertlein, Michael] Inst Laue Langevin, Life Sci Grp, Grenoble, France; [Pomorski, Thomas Gunther] Univ Copenhagen, Ctr Membrane Pumps Cells & Disease PUMPKIN, Dept Plant & Environm Sci, Copenhagen, Denmark; [Cardenas, Marite] Malmoe Univ, Dept Biomed Sci Hlth & Soc, S-20500 Malmo, Sweden	University of Copenhagen; University of Copenhagen; European Spallation Source (ESS); Leipzig University; Institut Laue-Langevin (ILL); University of Copenhagen; Malmo University	Cardenas, M (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.	cardenas@nano.ku.dk	Pomorski, Thomas Günther/G-4804-2014; Cardenas, Marite/AAG-1793-2019; Lind, Tania/AAF-5003-2021; Cárdenas, Marité/O-4669-2014; Lind, Tania Kjellerup/A-1412-2012	Pomorski, Thomas Günther/0000-0002-4889-0829; Cardenas, Marite/0000-0003-0392-3540; Cárdenas, Marité/0000-0003-0392-3540; Lind, Tania Kjellerup/0000-0003-0800-5650	European Spallation Source ESS AB in Lund, Sweden; Danscatt Centre - Danish government; Research Centre 'bioSYNergy' at University of Copenhagen - UCPH Excellence Program for Interdisciplinary Research; Swedish Research Council; Engineering and Physical Sciences Research Council [GR/R99393/01, EP/C015452/1]; EU [RII3-CT-2003-505925, NMP4-CT-2006-033256]; European Spallation Source; EPSRC [GR/R99393/01, EP/C015452/1]	European Spallation Source ESS AB in Lund, Sweden; Danscatt Centre - Danish government; Research Centre 'bioSYNergy' at University of Copenhagen - UCPH Excellence Program for Interdisciplinary Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); European Spallation Source; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the following: European Spallation Source ESS AB in Lund, Sweden (TKL); Danscatt Centre funded by the Danish government (MC); The Research Centre 'bioSYNergy' at University of Copenhagen funded by the UCPH Excellence Program for Interdisciplinary Research (TGP and MC); The Swedish Research Council (MC); and The Engineering and Physical Sciences Research Council (grants GR/R99393/01 and EP/C015452/1), EU contracts RII3-CT-2003-505925 and NMP4-CT-2006-033256 (MH). The European Spallation Source provided support in the form of salaries for author Tania K. Lind, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.; The authors wish to thank the ILL for allocation of beam time and Robert Barker for local support. We thank Volker Wirth and Karen Martinez for providing the hydrogenated E. coli biomass and Vivien Jagalski for help with DLS measurements. We acknowledge funding from the European Spallation Source in the form of salaries for author Tania K. Lind. This work was supported by the Danscatt Centre funded by the Danish government, the Research Centre 'bioSYNergy' at University of Copenhagen funded by the UCPH Excellence Program for Interdisciplinary Research (to TGP and MC) and the Swedish Research Council (to MC). MH would like to acknowledge the EPSRC for support (grants GR/R99393/01 and EP/C015452/1) for the creation of the Deuteration Laboratory in ILL's Life Sciences Group and for EU contracts RII3-CT-2003-505925 and NMP4-CT-2006-033256 that have supported associated developments.	Akesson A, 2012, SOFT MATTER, V8, P5658, DOI 10.1039/c2sm00013j; Armen RS, 1998, BIOPHYS J, V75, P734, DOI 10.1016/S0006-3495(98)77563-0; Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022; Artero JB, 2005, ACTA CRYSTALLOGR D, V61, P1541, DOI 10.1107/S0907444905028532; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blodgett KB, 1935, J AM CHEM SOC, V57, P1007, DOI 10.1021/ja01309a011; Briand E, 2010, ANALYST, V135, P343, DOI 10.1039/b918288h; Campbell RA, 2011, EUR PHYS J PLUS, V126, DOI 10.1140/epjp/i2011-11107-8; Chan YHM, 2007, CURR OPIN CHEM BIOL, V11, P581, DOI 10.1016/j.cbpa.2007.09.020; Cho NJ, 2010, NAT PROTOC, V5, P1096, DOI 10.1038/nprot.2010.65; Clifton LA, 2015, ANGEW CHEM INT EDIT, V54, P11952, DOI 10.1002/anie.201504287; Clifton LA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0810; Cubitt R, 2002, APPL PHYS A-MATER, V74, pS329, DOI 10.1007/s003390201611; de Ghellinck A, 2015, BBA-BIOMEMBRANES, V1848, P2317, DOI 10.1016/j.bbamem.2015.06.006; Dodd CE, 2008, BIOINTERPHASES, V3, pFA59, DOI 10.1116/1.2896113; Domenech O, 2006, COLLOID SURFACE B, V47, P102, DOI 10.1016/j.colsurfb.2005.11.025; Fuchs B, 2009, ANAL BIOANAL CHEM, V395, P2479, DOI 10.1007/s00216-009-3032-1; Garcia-Manyes S, 2005, BIOPHYS J, V89, P1812, DOI 10.1529/biophysj.105.064030; Gidden J, 2009, INT J MASS SPECTROM, V283, P178, DOI 10.1016/j.ijms.2009.03.005; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; Hung WC, 2006, CHINESE J PHYS, V44, P137; ISHINAGA M, 1979, J BIOCHEM-TOKYO, V86, P161; Jing YJ, 2014, SOFT MATTER, V10, P187, DOI 10.1039/c3sm50947h; Kim YR, 2012, SENSORS-BASEL, V12, P9530, DOI 10.3390/s120709530; Lam KLH, 2012, BBA-BIOMEMBRANES, V1818, P194, DOI 10.1016/j.bbamem.2011.11.002; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lind TK, 2015, BBA-BIOMEMBRANES, V1848, P2075, DOI 10.1016/j.bbamem.2015.05.015; Lind TK, 2014, LANGMUIR, V30, P7259, DOI 10.1021/la500897x; Lopes S, 2010, ANAL BIOANAL CHEM, V398, P1357, DOI 10.1007/s00216-010-4028-6; Lopes SC, 2012, MOL MEMBR BIOL, V29, P207, DOI 10.3109/09687688.2012.700491; LUGTENBERG EJJ, 1976, BIOCHIM BIOPHYS ACTA, V441, P38, DOI 10.1016/0005-2760(76)90279-4; Mecke A, 2005, BIOPHYS J, V89, P4043, DOI 10.1529/biophysj.105.062596; Merino S, 2003, LANGMUIR, V19, P6922, DOI 10.1021/la034232y; Merz C, 2008, BIOINTERPHASES, V3, pFA41, DOI 10.1116/1.2896119; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; NOLLERT P, 1995, BIOPHYS J, V69, P1447, DOI 10.1016/S0006-3495(95)80014-7; Ollivon M, 2000, BBA-BIOMEMBRANES, V1508, P34, DOI 10.1016/S0304-4157(00)00006-X; Pandit KR, 2012, BBA-BIOMEMBRANES, V1818, P1205, DOI 10.1016/j.bbamem.2012.01.009; Peetla C, 2009, MOL PHARMACEUT, V6, P1264, DOI 10.1021/mp9000662; Piantavigna S, 2011, BBA-BIOMEMBRANES, V1808, P1811, DOI 10.1016/j.bbamem.2011.03.002; Pomorski TG, 2014, ADV COLLOID INTERFAC, V205, P207, DOI 10.1016/j.cis.2013.10.028; RAETZ CRH, 1978, MICROBIOL REV, V42, P614, DOI 10.1128/MMBR.42.3.614-659.1978; Rakowska PD, 2013, P NATL ACAD SCI USA, V110, P8918, DOI 10.1073/pnas.1222824110; Reimhult E, 2003, LANGMUIR, V19, P1681, DOI 10.1021/la0263920; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; RICE PA, 1988, REV INFECT DIS, V10, pS277; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; Richter RP, 2005, BIOPHYS J, V88, P3422, DOI 10.1529/biophysj.104.053728; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2004, BIOPHYS CHEM, V111, P1, DOI 10.1016/j.bpc.2004.03.006; Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015; Separovic F, 1996, BIOPHYS J, V71, P274, DOI 10.1016/S0006-3495(96)79223-8; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Suarez-Germa C, 2011, J PHYS CHEM B, V115, P12778, DOI 10.1021/jp206369k; Vacklin HP, 2005, LANGMUIR, V21, P2827, DOI 10.1021/la047389e; Vacklin HP, 2005, BBA-BIOMEMBRANES, V1668, P17, DOI 10.1016/j.bbamem.2004.11.001; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wacklin HP, 2010, CURR OPIN COLLOID IN, V15, P445, DOI 10.1016/j.cocis.2010.05.008; Wang KF, 2014, COLLOID SURFACE B, V116, P472, DOI 10.1016/j.colsurfb.2014.01.036; White Da Fau-Lennarz WJ, DISTRIBUTION LIPIDS; Yang LH, 2007, J AM CHEM SOC, V129, P12141, DOI 10.1021/ja072310o	64	34	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144671	10.1371/journal.pone.0144671	http://dx.doi.org/10.1371/journal.pone.0144671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658241	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600075
J	Zhang, ZQ; Han, YZ; Nian, Q; Chen, G; Cui, SQ; Wang, XY				Zhang, Zhi-Qiang; Han, Yu-Zhen; Nian, Qing; Chen, Gang; Cui, Shu-Qing; Wang, Xing-Yong			Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (<= 35 Years)	PLOS ONE			English	Article							VEGF-C; EXPRESSION; WOMEN; RECURRENCE; MMP-9; AGE; PATTERNS; FEATURES; SUBTYPES; VESSELS	The morbidity rate of breast cancer is on the rise, and the age of onset appears to be trending toward a young age. Breast cancer in young women (BCYW) has a number of distinctive features that differ from breast cancer in middle-aged or elderly women (BCMEW). Lymphatic metastasis plays an important role in the spread of BCYW; however, the mechanisms of lymph node metastasis (LNM) in BCYW are not clear. This study aimed to investigate the mechanism of lymphatic metastasis in BCYW and to evaluate the relationships between lymphangiogenesis, the expression of matrix metalloproteinase 9 (MMP-9) and vascular endothelial growth factor C (VEGF-C) expression, clinicopathological characteristics, and prognosis. Using immunohistochemistry, MMP-9, VEGF-C and the level of lymphatic microvessel density (LMVD) were analyzed in 106 cases of breast invasive ductal carcinoma and 20 cases of breast proliferative lesions. Compared with BCMEW, BCYW had higher MMP-9 expression, higher LNM, and more adverse prognoses. In BCYW, high MMP-9 expression was positively correlated with LNM and impaired survival time. However, in BCMEW, MMP-9 expression was not correlated with LNM or survival time. In addition, high VEGF-C expression was positively correlated with a high level of LMVD in both BCYW and BCMEW. Nevertheless, a high level of LMVD was not correlated with LNM or survival time in the two groups. More importantly, univariate and multivariate survival analysis showed that MMP-9 expression and LNM were independent prognostic factors in BCYW. Our present study indicates that lymphangiogenesis induced by VEGF-C is augmented in breast cancer; however, a higher level of lymphangiogenesis has no significant impact on LNM or survival time. We suggest that tumor invasiveness, rather than lymphangiogenesis, plays an important role in LNM among BCYW. Moreover, MMP-9 and LNM were independent prognostic factors for BCYW.	[Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China; [Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China; [Han, Yu-Zhen] Binzhou Med Univ, Affiliated Hosp, Dept Pathol, Binzhou, Peoples R China; [Chen, Gang] Binzhou Med Univ, Affiliated Hosp, Dept Vasc & Endovasc Surg, Binzhou, Peoples R China; [Cui, Shu-Qing] Community Hlth Serv Ctr North Binzhou, Dept Nursing Care & Intervent, Binzhou, Peoples R China	Chongqing Medical University; Binzhou Medical University; Binzhou Medical University	Zhang, ZQ (corresponding author), Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China.	ZhangZQ678@gmail.com; golden678@foxmail.com	Han, Yu/GZA-9220-2022					Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1643, DOI 10.1093/jnci/djn344; Colleoni M, 2002, ANN ONCOL, V13, P273, DOI 10.1093/annonc/mdf039; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Gnerlich JL, 2009, J AM COLL SURGEONS, V208, P341, DOI 10.1016/j.jamcollsurg.2008.12.001; Gou HF, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-14; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Han W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z; Hao L, 2007, CANCER LETT, V253, P34, DOI 10.1016/j.canlet.2007.01.005; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; HUTTER RVP, 1990, CANCER-AM CANCER SOC, V66, P1363, DOI 10.1002/1097-0142(19900915)66:14+<1363::AID-CNCR2820661411>3.0.CO;2-4; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Karpanen T, 2001, J EXP MED, V194, pF37, DOI 10.1084/jem.194.6.F37; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Livi L, 2010, EJSO-EUR J SURG ONC, V36, P639, DOI 10.1016/j.ejso.2010.05.016; Lowery AJ, 2012, BREAST CANCER RES TR, V133, P831, DOI 10.1007/s10549-011-1891-6; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Miles RC, 2012, ANN SURG ONCOL, V19, P1153, DOI 10.1245/s10434-011-2084-6; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Su JL, 2008, CANCER CELL, V13, P557, DOI 10.1016/j.ccr.2008.04.021; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; van der Schaft DWJ, 2007, CANCER LETT, V254, P128, DOI 10.1016/j.canlet.2007.03.001; Wei JT, 2014, SCI REP-UK, V4, DOI 10.1038/srep05360; Williams CSM, 2003, J PATHOL, V200, P195, DOI 10.1002/path.1343; Wu QW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097804; Wu QW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-47; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Yousef EM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-609; Zhang XH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-4; Zhuo W, 2012, CLIN CANCER RES, V18, P5387, DOI 10.1158/1078-0432.CCR-12-0708	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144376	10.1371/journal.pone.0144376	http://dx.doi.org/10.1371/journal.pone.0144376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656588	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600040
J	Almeida, F; Sardinha-Silva, A; da Silva, TA; Pessoni, AM; Pinzan, CF; Alegre-Maller, ACP; Ceclio, NT; Moretti, NS; Damsio, ARL; Pedersoli, WR; Mineo, JR; Silva, RN; Roque-Barreira, MC				Almeida, Fausto; Sardinha-Silva, Aline; da Silva, Thiago Aparecido; Pessoni, Andre Moreira; Pinzan, Camila Figueiredo; Paiva Alegre-Maller, Ana Claudia; Ceclio, Nerry Tatiana; Moretti, Nilmar Silvio; Lima Damsio, Andre Ricardo; Pedersoli, Wellington Ramos; Mineo, Jose Roberto; Silva, Roberto Nascimento; Roque-Barreira, Maria Cristina			Toxoplasma gondii Chitinase Induces Macrophage Activation	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; PARACOCCIDIOIDES-BRASILIENSIS; STRUCTURAL COMPONENT; STATISTICAL-MODEL; PURIFICATION; IDENTIFICATION; PROTEINS; TISSUE; TRANSMISSION; ENCEPHALITIS	Toxoplasma gondii is an obligate intracellular protozoan parasite found worldwide that is able to chronically infect almost all vertebrate species, especially birds and mammalians. Chitinases are essential to various biological processes, and some pathogens rely on chitinases for successful parasitization. Here, we purified and characterized a chitinase from T. gondii. The enzyme, provisionally named Tg_chitinase, has a molecular mass of 13.7 kDa and exhibits a Km of 0.34 mM and a Vmax of 2.64. The optimal environmental conditions for enzymatic function were at pH 4.0 and 50 degrees C. Tg_chitinase was immunolocalized in the cytoplasm of highly virulent T. gondii RH strain tachyzoites, mainly at the apical extremity. Tg_chitinase induced macrophage activation as manifested by the production of high levels of pro-inflammatory cytokines, a pathogenic hallmark of T. gondii infection. In conclusion, to our knowledge, we describe for the first time a chitinase of T. gondii tachyzoites and provide evidence that this enzyme might influence the pathogenesis of T. gondii infection.	[Almeida, Fausto; Sardinha-Silva, Aline; da Silva, Thiago Aparecido; Pessoni, Andre Moreira; Pinzan, Camila Figueiredo; Paiva Alegre-Maller, Ana Claudia; Ceclio, Nerry Tatiana; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, SP, Brazil; [Moretti, Nilmar Silvio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, SP, Brazil; [Lima Damsio, Andre Ricardo] Univ Estadual Campinas, Dept Bioquim & Biol Tecidual, Inst Biol, Campinas, SP, Brazil; [Pedersoli, Wellington Ramos; Silva, Roberto Nascimento] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, SP, Brazil; [Mineo, Jose Roberto] Univ Fed Uberlandia, Lab Imunoparasitol, Dept Imunol Microbiol & Parasitol, BR-38400902 Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Uberlandia	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	Silva, Roberto/F-3897-2012; da Silva, Thiago Aparecido/I-2315-2015; Moretti, Nilmar/G-1952-2015; Roque-Barreira, Maria-Cristina/A-4552-2008; Cecilio, Nerry/L-2378-2016; Almeida, Fausto/N-6540-2013; Mineo, Jose R/B-4151-2009; Cecilio, Nerry/L-9927-2017; Moretti, Nilmar Silvio/J-4459-2013; Damasio, André RL/H-1162-2016; Pessoni, André/A-3791-2014	Silva, Roberto/0000-0002-8992-7130; da Silva, Thiago Aparecido/0000-0001-5017-6539; Moretti, Nilmar/0000-0003-0455-2497; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Almeida, Fausto/0000-0002-3782-3698; Mineo, Jose R/0000-0002-9010-7228; Moretti, Nilmar Silvio/0000-0003-0455-2497; Damasio, André RL/0000-0001-9304-3998; Cecilio, Nerry Tatiana/0000-0001-5465-5238; Ramos Pedersoli, Wellington/0000-0002-3982-0626; Pessoni, Andre/0000-0003-4549-1387	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/10741-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant number 2013/10741-8). Additional financial help was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto.; This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant number 2013/10741-8). Additional financial help was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto. We are grateful to Dr Maria Aparecida Souza for fruitful discussions of our results. We also thank Patricia Vendruscolo and Sandra Thomaz for technical support.	Almeida F, 2015, EUKARYOT CELL, V14, P1173, DOI 10.1128/EC.00103-15; Arantes TEF, 2015, AM J OPHTHALMOL, V159, P1002, DOI 10.1016/j.ajo.2015.02.015; ARROYOBEGOVICH A, 1980, J PARASITOL, V66, P735, DOI 10.2307/3280662; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; CAMARGO ME, 1978, INFECT IMMUN, V21, P55, DOI 10.1128/IAI.21.1.55-58.1978; Castro LDS, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-41; Coppin A, 2003, BIOCHIMIE, V85, P353, DOI 10.1016/S0300-9084(03)00076-2; De Marco JL, 2004, APPL MICROBIOL BIOT, V64, P70, DOI 10.1007/s00253-003-1490-5; Almeida FBD, 2014, YEAST, V31, P1, DOI 10.1002/yea.2983; Almeida FBD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029216; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; ElMoudni B, 1996, EXP PARASITOL, V83, P167, DOI 10.1006/expr.1996.0063; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Jensen KDC, 2015, MBIO, V6, DOI 10.1128/mBio.02280-14; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koch BEV, 2015, GLYCOBIOLOGY, V25, P469, DOI 10.1093/glycob/cwv005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Li H, 2002, APPL MICROBIOL BIOT, V60, P420, DOI 10.1007/s00253-002-1129-y; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Marshall ES, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-80; Montoya JG, 2005, CLIN PERINATOL, V32, P705, DOI 10.1016/j.clp.2005.04.011; Nance JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002990; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Park JK, 2011, J APPL MICROBIOL, V110, P277, DOI 10.1111/j.1365-2672.2010.04879.x; Pinzan CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143087; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; ROSE NR, 1975, IMMUNOL COMMUN, V4, P1, DOI 10.3109/08820137509055757; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; SHAHABUDDIN M, 1993, P NATL ACAD SCI USA, V90, P4266, DOI 10.1073/pnas.90.9.4266; Shahabuddin M, 1999, EXS, V87, P223; Sobrinho IDJ, 2005, BIOTECHNOL LETT, V27, P1273, DOI 10.1007/s10529-005-0218-2; SUZUKI Y, 1989, J INFECT DIS, V159, P790, DOI 10.1093/infdis/159.4.790; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; WARD HD, 1985, INFECT IMMUN, V49, P629, DOI 10.1128/IAI.49.3.629-634.1985; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; YABUKI M, 1986, J GEN APPL MICROBIOL, V32, P25, DOI 10.2323/jgam.32.25; Zeng XM, 2000, J BACTERIOL, V182, P1916, DOI 10.1128/JB.182.7.1916-1922.2000	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144507	10.1371/journal.pone.0144507	http://dx.doi.org/10.1371/journal.pone.0144507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659253	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500034
J	Spencer, JD; Jackson, AR; Li, BR; Ching, CB; Vonau, M; Easterling, RS; Schwaderer, AL; McHugh, KM; Becknell, B				Spencer, John David; Jackson, Ashley R.; Li, Birong; Ching, Christina B.; Vonau, Martin; Easterling, Robert S.; Schwaderer, Andrew L.; McHugh, Kirk M.; Becknell, Brian			Expression and Significance of the HIP/PAP and RegIII gamma Antimicrobial Peptides during Mammalian Urinary Tract Infection	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; PANCREAS/PANCREATITIS-ASSOCIATED PROTEIN; HOST-DEFENSE; BACTERICIDAL LECTIN; MOUSE STRAINS; BLADDER; MICE; INTESTINE; CYSTITIS; CELLS	Recent evidence indicates that antimicrobial peptides (AMPs) serve key roles in defending the urinary tract against invading uropathogens. To date, the individual contribution of AMPs to urinary tract host defense is not well defined. In this study, we identified Regenerating islet-derived 3 gamma (RegIII gamma) as the most transcriptionally up-regulated AMP in murine bladder transcriptomes following uropathogenic Escherichia coli (UPEC) infection. We confirmed induction of RegIII gamma mRNA during cystitis and pyelonephritis by quantitative RT-PCR. Immunoblotting demonstrates increased bladder and urinary RegIII gamma protein levels following UPEC infection. Immunostaining localizes RegIII gamma protein to urothelial cells of infected bladders and kidneys. Human patients with UTI have increased urine concentrations of the orthologous Hepatocarcinoma-Intestine-Pancreas /Pancreatitis Associated Protein (HIP/PAP) compared to healthy controls. Recombinant RegIII gamma protein does not demonstrate bactericidal activity toward UPEC in vitro, but does kill Staphylococcus saprophyticus in a dose-dependent manner. Kidney and bladder tissue from RegIII gamma knockout mice and wild-type mice contain comparable bacterial burden following UPEC and Gram-positive UTI. Our results demonstrate that RegIII gamma and HIP/PAP expression is induced during human and murine UTI. However, their specific function in the urinary tract remains uncertain.	[Spencer, John David; Schwaderer, Andrew L.; Becknell, Brian] Ohio State Univ, Coll Med, Dept Pediat, Div Nephrol, Columbus, OH 43210 USA; [Spencer, John David; Li, Birong; Schwaderer, Andrew L.; Becknell, Brian] Res Inst Nationwide Childrens, Ctr Clin & Translat Res, Columbus, OH USA; [Jackson, Ashley R.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Ching, Christina B.] Ohio State Univ, Coll Med, Dept Surg, Div Urol, Columbus, OH 43210 USA; [Vonau, Martin] Ohio State Univ, Coll Med, Dept Pediat & Internal Med, Columbus, OH 43210 USA; [Easterling, Robert S.] Med Coll Ohio, Toledo, OH 43699 USA; [McHugh, Kirk M.] Ohio State Univ, Coll Med, Dept Anat, Columbus, OH 43210 USA; [McHugh, Kirk M.] Res Inst Nationwide Childrens, Ctr Mol & Human Genet, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Becknell, B (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Div Nephrol, Columbus, OH 43210 USA.	Brian.Becknell2@nationwidechildrens.org		Jackson, Ashley R./0000-0002-1571-3906	National Institute of Diabetes and Digestive and Kidney Diseases; NIDDK [K08-DK094970-02, RO1-DK106286-01];  [K08-DK102594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106286, K08DK102594, K08DK094970] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Three authors are supported by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov). JDS is supported by NIDDK K08-DK094970-02. ALS is supported by NIDDK RO1-DK106286-01. BB is supported by K08-DK102594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; [Anonymous], 2012, HEALTHCARE COST UTIL; Becknell B, 2015, NAT REV NEPHROL; Becknell B, 2015, KIDNEY INT, V87, P151, DOI 10.1038/ki.2014.268; Becknell B, 2015, EXPERT REV ANTI-INFE, V13, P81, DOI 10.1586/14787210.2015.986097; Becknell B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077714; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Choi SM, 2014, INFECT IMMUN, V82, P1402, DOI 10.1128/IAI.00974-13; Choi SM, 2013, J EXP MED, V210, P551, DOI 10.1084/jem.20120260; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dessing MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013394; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Gatermann S, 1988, FEMS Microbiol Immunol, V1, P179; Griebling TL, 2005, J UROLOGY, V173, P1281, DOI 10.1097/01.ju.0000155596.98780.82; Guha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088848; Gupta K, 2014, INFECT DIS CLIN N AM, V28, P49, DOI 10.1016/j.idc.2013.10.002; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Haversen LA, 2000, INFECT IMMUN, V68, P5816, DOI 10.1128/IAI.68.10.5816-5823.2000; Hopkins WJ, 1996, INFECT IMMUN, V64, P1369, DOI 10.1128/IAI.64.4.1369-1372.1996; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kline KA, 2010, INFECT IMMUN, V78, P1943, DOI 10.1128/IAI.01235-09; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Lee KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030786; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Makino T, 2010, UROLOGY, V75, P933, DOI 10.1016/j.urology.2009.05.044; Matsumoto S, 2012, J COMP NEUROL, V520, P479, DOI 10.1002/cne.22705; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Nienhouse V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114185; Nitta Y, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-24; Paragas N, 2014, J CLIN INVEST, V124, P2963, DOI 10.1172/JCI71630; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz DJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004599; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Spencer JD, 2014, PEDIATR NEPHROL, V29, P1139, DOI 10.1007/s00467-013-2513-9; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Stange J, 2012, J IMMUNOL, V188, P2410, DOI 10.4049/jimmunol.1102062; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; Stockinger S, 2014, J IMMUNOL, V193, P4223, DOI 10.4049/jimmunol.1302708; Takahara Y, 2008, J UROLOGY, V179, P1603, DOI 10.1016/j.juro.2007.11.034; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou G, 2001, J CELL SCI, V114, P4095	59	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144024	10.1371/journal.pone.0144024	http://dx.doi.org/10.1371/journal.pone.0144024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658437	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903500012
J	Spriewald, S; Glaser, J; Beutler, M; Koeppel, MB; Stecher, B				Spriewald, Stefanie; Glaser, Jana; Beutler, Markus; Koeppel, Martin B.; Stecher, Baerbel			Reporters for Single-Cell Analysis of Colicin Ib Expression in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; K ACTIVITY GENE; ESCHERICHIA-COLI; CHROMOSOMAL GENES; CONSTRUCTION; INDUCTION; K-12; CKA; INFLAMMATION; PROMOTER	Colicins are toxins that mediate interference competition in microbial ecosystems. They serve as a "common good" for the entire producer population but are synthesized by only few members which pay the costs of colicin production. We have previously shown that production of colicin Ib (cib), a group B colicin, confers a competitive advantage to Salmonella enterica serovar Typhimurium (S. Tm) over commensal E. coli strains. Here, we studied regulation of S. Tm cib expression at the single cell level. Comparative analysis of a single-and a multicopy gfp-reporter for the colicin Ib promoter (Pcib) revealed that the latter yielded optimal signal intensity for a diverse range of applications. We further validated this reporter and showed that gfp expression correlated well with colicin Ib (ColIb) protein levels in individual cells. Pcib is negatively controlled by two repressors, LexA and Fur. Only a small fraction of S. Tm expressed cib under non-inducing conditions. We studied Pcib activity in response to mitomycin C mediated DNA damage and iron limitation. Both conditions, if applied individually, lead to an increase in the fraction of GFP(+) S. Tm, albeit an overall low fluorescence intensity. When both conditions were applied simultaneously, the majority of S. Tm turned GFP(+) and displayed high fluorescence intensity. Thus, both repressors individually confine cib expression to a subset of the population. Taken together, we provide the first thorough characterization of a conventional gfp-reporter to study regulation of a group B colicin at the single cell level. This reporter will be useful to further investigate the costs and benefits of ColIb production in human pathogenic S. Tm and analyze cib expression under environmental conditions encountered in the mammalian gut.	[Spriewald, Stefanie; Glaser, Jana; Beutler, Markus; Koeppel, Martin B.; Stecher, Baerbel] Ludwig Maximilians Univ Munchen, Max Von Pettenkofer Inst, D-80336 Munich, Germany; [Glaser, Jana; Koeppel, Martin B.; Stecher, Baerbel] German Ctr Infect Res DZIF, Munich, Germany	University of Munich; German Center for Infection Research	Stecher, B (corresponding author), Ludwig Maximilians Univ Munchen, Max Von Pettenkofer Inst, Pettenkoferstr 9a, D-80336 Munich, Germany.	stecher@mvp.uni-muenchen.de	Stecher, Barbel/B-9940-2019; Stecher, Bärbel/A-2911-2015	Stecher, Bärbel/0000-0002-7445-5193	DFG [DFG STE 1971/2-1, DFG STE 1971/61]	DFG(German Research Foundation (DFG))	The work was supported by grants from the DFG (DFG STE 1971/2-1 and DFG STE 1971/61) to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Butala M, 2012, MOL MICROBIOL, V86, P129, DOI 10.1111/j.1365-2958.2012.08179.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIES JK, 1975, J BACTERIOL, V123, P96, DOI 10.1128/JB.123.1.96-101.1975; Ghazaryan L, 2014, ARCH MICROBIOL, V196, P753, DOI 10.1007/s00203-014-1017-8; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hol FJH, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0068-2; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Kamensek S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-283; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kuhar I, 1999, J BACTERIOL, V181, P7373, DOI 10.1128/JB.181.23.7373-7380.1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Majeed H, 2015, J ANTIBIOT, V68, P52, DOI 10.1038/ja.2014.84; Majeed H, 2011, ISME J, V5, P71, DOI 10.1038/ismej.2010.90; MANKOVICH JA, 1986, J BACTERIOL, V168, P228, DOI 10.1128/jb.168.1.228-236.1986; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; Mrak P, 2007, MOL GENET GENOMICS, V277, P391, DOI 10.1007/s00438-006-0185-x; Mulec J, 2003, J BACTERIOL, V185, P654, DOI 10.1128/JB.185.2.654-659.2003; Nanda AM, 2014, J BACTERIOL, V196, P180, DOI 10.1128/JB.01018-13; Nedialkova LP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003844; OZEKI H, 1959, NATURE, V184, P337, DOI 10.1038/184337a0; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2013, NAT REV MICROBIOL, V11, P277, DOI 10.1038/nrmicro2989; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WEAVER CA, 1981, BIOCHIM BIOPHYS ACTA, V645, P137, DOI 10.1016/0005-2736(81)90521-6; Yang TY, 2010, NUCLEIC ACIDS RES, V38, P3936, DOI 10.1093/nar/gkq177	40	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144647	10.1371/journal.pone.0144647	http://dx.doi.org/10.1371/journal.pone.0144647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659346	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903500052
J	Correa, ARV; Berbel, ACER; Papa, MP; de Morais, ATS; Pecanha, LMT; de Arruda, LB				Vargas Correa, Arturo Ramon; Egypto Rosa Berbel, Ana Carolina; Papa, Michelle Premazzi; de Morais, Ana Theresa Silveira; Torres Pecanha, Ligia Maria; de Arruda, Luciana Barros			Dengue Virus Directly Stimulates Polyclonal B Cell Activation	PLOS ONE			English	Article							CROSS-REACTIVE ANTIBODIES; ORIGINAL ANTIGENIC SIN; PRINCIPAL TARGET-CELLS; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; IMMUNE-RESPONSE; T-CELLS; INFECTION; PATHOGENESIS	Dengue infection is associated to vigorous inflammatory response, to a high frequency of activated B cells, and to increased levels of circulating cross-reactive antibodies. We investigated whether direct infection of B cells would promote activation by culturing primary human B lymphocytes from healthy donors with DENV in vitro. B cells were susceptible, but poorly permissive to infection. Even though, primary B cells cultured with DENV induced substantial IgM secretion, which is a hallmark of polyclonal B cell activation. Notably, DENV induced the activation of B cells obtained from either DENV immune or DENV naive donors, suggesting that it was not dependent on DENV-specific secondary/memory response. B cell stimulation was dependent on activation of MAPK and CD81. B cells cultured with DENV also secreted IL-6 and presented increased expression of CD86 and HLA-DR, which might contribute to B lymphocyte co-stimulatory function. Indeed, PBMCs, but not isolated B cells, secreted high amounts of IgG upon DENV culture, suggesting that interaction with other cell types in vivo might promote Ig isotype switching and IgG secretion from different B cell clones. These findings suggest that activation signaling pathways triggered by DENV interaction with non-specific receptors on B cells might contribute to the exacerbated response observed in dengue patients.	[Vargas Correa, Arturo Ramon; Egypto Rosa Berbel, Ana Carolina; Papa, Michelle Premazzi; de Morais, Ana Theresa Silveira; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil; [Torres Pecanha, Ligia Maria] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil.	arruda@micro.ufrj.br	Arruda, Luciana B/N-9086-2013	Vargas Correa, Arturo Ramon/0000-0002-9326-3074; Premazzi Papa, Michelle/0000-0003-1957-666X	Brazilian Ministry of Health; CAPES; CNPq; FAPERJ; program INCT-Dengue; program Pronex-Rede Dengue; CAPES fellowship; CNPq fellowship	Brazilian Ministry of Health; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); program INCT-Dengue; program Pronex-Rede Dengue; CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian Ministry of Health, CAPES, CNPq, FAPERJ, and by the programs INCT-Dengue and Pronex-Rede Dengue. A. C. E. R. Berbel was the recipient of a CAPES fellowship, A. R. V. Correa was the recipient of a FAPERJ and CAPES fellowship. A. T. S. Morais and M. P. Papa were the recipients of a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; BOONPUCKNAVIG S, 1976, AM J PATHOL, V85, P37; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; CHUNGUE E, 1994, J INFECT DIS, V170, P1304, DOI 10.1093/infdis/170.5.1304; Conceicao TM, 2010, J VIROL METHODS, V163, P1, DOI 10.1016/j.jviromet.2009.10.001; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; De Vita S, 2008, AUTOIMMUN REV, V8, P95, DOI 10.1016/j.autrev.2008.05.005; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DEUBEL V, 1988, VIROLOGY, V165, P234, DOI 10.1016/0042-6822(88)90677-0; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Efremov DG, 2007, AUTOIMMUN REV, V7, P102, DOI 10.1016/j.autrev.2007.02.021; Farquhar MJ, 2011, BIOCHEM SOC T, V39, P532, DOI 10.1042/BST0390532; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Friberg H, 2012, VIRAL IMMUNOL, V25, P348, DOI 10.1089/vim.2012.0010; Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Li XL, 2000, EUR J IMMUNOL, V30, P1576, DOI 10.1002/1521-4141(200006)30:6<1576::AID-IMMU1576>3.0.CO;2-0; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L; Lin YS, 2004, CURR PHARM DESIGN, V10, P213, DOI 10.2174/1381612043453469; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; Maddaly R, 2010, FEBS LETT, V584, P4883, DOI 10.1016/j.febslet.2010.08.022; MARKOFF LJ, 1991, J INFECT DIS, V164, P294, DOI 10.1093/infdis/164.2.294; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Rossbacher J, 2003, J EXP MED, V198, P591, DOI 10.1084/jem.20022042; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28; Thai KTD, 2011, CLIN MICROBIOL INFEC, V17, P1823, DOI 10.1111/j.1469-0691.2010.03434.x; THEOFILOPOULOS AN, 1976, J IMMUNOL, V117, P953; Woods A, 2007, J VIROL, V81, P12525, DOI 10.1128/JVI.00839-07; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11	58	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143391	10.1371/journal.pone.0143391	http://dx.doi.org/10.1371/journal.pone.0143391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656738	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903500003
J	Yabuno, K; Morise, J; Kizuka, Y; Hashii, N; Kawasaki, N; Takahashi, S; Miyata, S; Izumikawa, T; Kitagawa, H; Takematsu, H; Oka, S				Yabuno, Keiko; Morise, Jyoji; Kizuka, Yasuhiko; Hashii, Noritaka; Kawasaki, Nana; Takahashi, Satoru; Miyata, Shinji; Izumikawa, Tomomi; Kitagawa, Hiroshi; Takematsu, Hiromu; Oka, Shogo			A Sulfated Glycosaminoglycan Linkage Region Is a Novel Type of Human Natural Killer-1 (HNK-1) Epitope Expressed on Aggrecan in Perineuronal Nets	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CARBOHYDRATE EPITOPE; POSTNATAL-DEVELOPMENT; SYNAPTIC PLASTICITY; CORTICAL PLASTICITY; MOLECULAR-CLONING; GLUCURONIC-ACID; NERVOUS-SYSTEM; UP-REGULATION; TENASCIN-R	Human natural killer-1 (HNK-1) carbohydrate (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-R) is highly expressed in the brain and required for learning and neural plasticity. We previously demonstrated that expression of the HNK-1 epitope is mostly abolished in knockout mice for GlcAT-P (B3gat1), a major glucuronyltransferase required for HNK-1 biosynthesis, but remained in specific regions such as perineuronal nets (PNNs) in these mutant mice. Considering PNNs are mainly composed of chondroitin sulfate proteoglycans (CSPGs) and regulate neural plasticity, GlcAT-P-independent expression of HNK-1 in PNNs is suggested to play a role in neural plasticity. However, the function, structure, carrier glycoprotein and biosynthetic pathway for GlcAT-P-irrelevant HNK-1 epitope remain unclear. In this study, we identified a unique HNK-1 structure on aggrecan in PNNs. To determine the biosynthetic pathway for the novel HNK-1, we generated knockout mice for GlcAT-S (B3gat2), the other glucuronyltransferase required for HNK-1 biosynthesis. However, GlcAT-P and GlcAT-S double-knockout mice did not exhibit reduced HNK-1 expression compared with single GlcAT-P-knockout mice, indicating an unusual biosynthetic pathway for the HNK-1 epitope in PNNs. Aggrecan was purified from cultured cells in which GlcAT-P and -S are not expressed and we determined the structure of the novel HNK-1 epitope using liquid chromatography/mass spectrometry (LC/MS) as a sulfated linkage region of glycosaminoglycans (GAGs), HSO3-GlcA-Gal-Gal-Xyl-R. Taken together, we propose a hypothetical model where GlcAT-I, the sole glucuronyltransferase required for synthesis of the GAG linkage, is also responsible for biosynthesis of the novel HNK-1 on aggrecan. These results could lead to discovery of new roles of the HNK-1 epitope in neural plasticity.	[Yabuno, Keiko; Morise, Jyoji; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto 6068507, Japan; [Kizuka, Yasuhiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Miyata, Shinji; Izumikawa, Tomomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan	Kyoto University; Kyoto University; National Institute of Health Sciences - Japan; University of Tsukuba; Kobe Pharmaceutical University	Oka, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp	Miyata, Shinji/S-6000-2019; Kitagawa, Hiroshi/AAJ-1344-2020	Miyata, Shinji/0000-0001-6635-1645; Kitagawa, Hiroshi/0000-0002-9307-7079; Takematsu, Hiromu/0000-0003-1689-9500; Kizuka, Yasuhiko/0000-0002-3181-9743	MEXT of Japan [23110006]; Japan Society for the Promotion of Science [26291021, 24590078]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23110006 to S.O.) from MEXT of Japan, and Grantsin-Aid for Scientific Research (B) (No. 26291021 to S.O.) and Scientific Research (C) (No. 24590078 to H.T.) from the Japan Society for the Promotion of Science.	Alpar A, 2006, BRAIN RES, V1120, P13, DOI 10.1016/j.brainres.2006.08.069; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; Dwyer CA, 2015, J BIOL CHEM, V290, P10256, DOI 10.1074/jbc.M114.614099; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Frischknecht R, 2008, NEURON GLIA BIOL, V4, P249, DOI 10.1017/S1740925X09990226; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Hamada Y, 2015, NEUROSCI RES, V91, P63, DOI 10.1016/j.neures.2014.09.010; Hashiguchi T, 2011, J BIOL CHEM, V286, P33003, DOI 10.1074/jbc.M111.279174; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; Imiya K, 2002, GENE, V296, P29, DOI 10.1016/S0378-1119(02)00840-5; Izumikawa T, 2015, J BIOL CHEM, V290, P5438, DOI 10.1074/jbc.M114.603266; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KOSAKA T, 1989, BRAIN RES, V483, P158, DOI 10.1016/0006-8993(89)90048-6; Lander C, 1997, J NEUROSCI, V17, P1928; MAEDA N, 1992, DEV BIOL, V151, P564, DOI 10.1016/0012-1606(92)90194-L; Matsui F, 1998, BRAIN RES, V790, P45, DOI 10.1016/S0006-8993(98)00009-2; Matthews RT, 2002, J NEUROSCI, V22, P7536; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Miyata S, 2015, J BIOCHEM, V157, P13, DOI 10.1093/jb/mvu067; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Morris NP, 2000, EUR J NEUROSCI, V12, P828, DOI 10.1046/j.1460-9568.2000.00970.x; Myers AK, 2012, BRAIN RES, V1465, P34, DOI 10.1016/j.brainres.2012.05.024; Nakagawa N, 2013, GLYCOBIOLOGY, V23, P1066, DOI 10.1093/glycob/cwt043; Nakagawa N, 2011, BIOCHEM BIOPH RES CO, V415, P109, DOI 10.1016/j.bbrc.2011.10.023; Nakamura M, 2009, BRAIN RES, V1252, P117, DOI 10.1016/j.brainres.2008.11.022; Ohyama J, 1997, J COMP NEUROL, V389, P453; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Saitoh Y, 2008, J NEUROSCI RES, V86, P1316, DOI 10.1002/jnr.21582; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suzuki-Anekoji M, 2013, J BIOL CHEM, V288, P5007, DOI 10.1074/jbc.M112.433474; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Tone Y, 1999, FEBS LETT, V459, P415, DOI 10.1016/S0014-5793(99)01287-9; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Voshol H, 1996, J BIOL CHEM, V271, P22957, DOI 10.1074/jbc.271.38.22957; Wakabayashi H, 1999, J BIOL CHEM, V274, P5436, DOI 10.1074/jbc.274.9.5436; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wintergerst ES, 1996, INT J DEV NEUROSCI, V14, P249, DOI 10.1016/0736-5748(96)00011-1; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAMAMOTO M, 1988, NEUROSCI RES, V5, P273, DOI 10.1016/0168-0102(88)90031-4; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yuen CT, 1997, J BIOL CHEM, V272, P8924	63	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144560	10.1371/journal.pone.0144560	http://dx.doi.org/10.1371/journal.pone.0144560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659409	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903500041
J	Bai, L; Lan, RT; Zhang, XL; Cui, SH; Xu, J; Guo, YC; Li, FQ; Zhang, D				Bai, Li; Lan, Ruiting; Zhang, Xiuli; Cui, Shenghui; Xu, Jin; Guo, Yunchang; Li, Fengqin; Zhang, Ding			Prevalence of Salmonella Isolates from Chicken and Pig Slaughterhouses and Emergence of Ciprofloxacin and Cefotaxime Co-Resistant S. enterica Serovar Indiana in Henan, China	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; RETAIL CHICKEN; MULTIDRUG-RESISTANCE; NONTYPHOID SALMONELLA; QUINOLONE RESISTANCE; UNITED-STATES; SUSCEPTIBILITY; SEROTYPES	The prevalence of Salmonella from chicken and pig slaughterhouses in Henan, China and antimicrobial susceptibility of these isolates to antibiotics was determined. From 283 chicken samples and 240 pig samples collected, 128 and 70 Salmonella isolates were recovered with an isolation rate of 45.2 and 29.2% respectively. The predominant serovars in chicken samples were S. enterica serovar Enteritidis, S. enterica serovar Hadar and S. enterica serovar Indiana, while those in pig samples were S. enterica serovar Typhimurium, S. enterica serovar Derby and S. enterica serovar Enteritidis. Resistance to ciprofloxacin was 8.6 and 10.0% for isolates from chickens and pigs respectively, whereas resistance to cefotaxime was 5.5 and 8.6%, respectively. Multidrug resistance (resistance to three or more classes of antimicrobial agent) was markedly higher in pig isolates (57.1%) than in chicken isolates (39.8%). Of particular concern was the detection of ciprofloxacin and cefotaxime co-resistant S. enterica serovar Indiana isolates, which pose risk to public health. All 16 S. enterica serovar Indiana isolates detected were resistant to ciprofloxacin, among which 11 were co-resistant to cefotaxime. The S. enterica serovar Indiana isolates accumulated point mutations in quinolone resistance determination regions of gyrA (S83F/D87G or S83F/D87N) and parC (T57S/S80R). Two plasmid mediated quinolone resistant determinants were found with aac (6')-Ib-cr and oqxAB in 16 and 12 S. enterica serovar Indiana isolates respectively. Cefotaxime-resistance of S. enterica serovar Indiana was associated with the acquisition of a bla(CTX-M-65) gene. The potential risk of ciprofloxacin and cefotaxime co-resistant S. enterica serovar Indiana infection is a significant concern due to limited alternative treatment options. Reduction of Salmonella in chicken and pig slaughterhouses, in particular, ciprofloxacin and cefotaxime co-resistant S. enterica serovar Indiana will be an important measure to reduce the public health burden of Salmonella infections.	[Bai, Li; Xu, Jin; Guo, Yunchang; Li, Fengqin] China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Minist Hlth, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Zhang, Xiuli; Zhang, Ding] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Cui, Shenghui] Natl Inst Food & Drug Control, Dept Food Sci, Beijing, Peoples R China	University of New South Wales Sydney; National Institute of Food & Drug Control - China	Li, FQ (corresponding author), China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Minist Hlth, Beijing, Peoples R China.	lifengqin@cfsa.net.cn; zhangd222@hncdc.com.cn		Lan, Ruiting/0000-0001-9834-5258				Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen S, 2007, ANTIMICROB AGENTS CH, V51, P535, DOI 10.1128/AAC.00600-06; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLSI S; Cui SH, 2009, J ANTIMICROB CHEMOTH, V63, P87, DOI 10.1093/jac/dkn452; de Jong A, 2014, VET MICROBIOL, V171, P298, DOI 10.1016/j.vetmic.2014.01.030; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Hue O, 2011, FOOD CONTROL, V22, P1158, DOI 10.1016/j.foodcont.2011.01.009; Jacoby GA, 2003, ANTIMICROB AGENTS CH, V47, P559, DOI 10.1128/AAC.47.2.559-562.2003; Jiang HX, 2014, INT J ANTIMICROB AG, V43, P242, DOI 10.1016/j.ijantimicag.2013.12.005; Lai J, 2013, FOODBORNE PATHOG DIS, V10, P581, DOI 10.1089/fpd.2012.1455; Li JY, 2010, FOODBORNE PATHOG DIS, V7, P1387, DOI 10.1089/fpd.2010.0581; Li RC, 2013, INT J FOOD MICROBIOL, V163, P14, DOI 10.1016/j.ijfoodmicro.2013.01.020; Li YF, 2014, FOODBORNE PATHOG DIS, V11, P200, DOI 10.1089/fpd.2013.1629; Liang ZM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0784-4; Liu JH, 2008, ANTIMICROB AGENTS CH, V52, P2992, DOI 10.1128/AAC.01686-07; Lu Y, 2011, FOODBORNE PATHOG DIS, V8, P45, DOI 10.1089/fpd.2010.0605; Lunguya O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002103; M'ikanatha NM, 2010, FOODBORNE PATHOG DIS, V7, P929, DOI 10.1089/fpd.2009.0499; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Malorny B, 2003, INT J FOOD MICROBIOL, V89, P241, DOI 10.1016/S0168-1605(03)00154-5; Medalla F, 2013, FOODBORNE PATHOG DIS, V10, P302, DOI 10.1089/fpd.2012.1336; Munday CJ, 2004, INT J ANTIMICROB AG, V23, P175, DOI 10.1016/j.ijantimicag.2003.07.004; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sandt CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077836; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Su LH, 2004, CLIN INFECT DIS, V39, P546, DOI 10.1086/422726; Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933; Wang HH, 2013, FOOD CONTROL, V33, P378, DOI 10.1016/j.foodcont.2013.03.030; Wang YR, 2014, FOODBORNE PATHOG DIS, V11, P126, DOI 10.1089/fpd.2013.1586; White DG, 2001, NEW ENGL J MED, V345, P1147, DOI 10.1056/NEJMoa010315; Wong MHY, 2014, ANTIMICROB AGENTS CH, V58, P3752, DOI 10.1128/AAC.02770-13; Wu HY, 2013, J FOOD PROTECT, V76, P2040, DOI 10.4315/0362-028X.JFP-13-224; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0; Xu X, 2014, MICROB DRUG RESIST, V20, P73, DOI 10.1089/mdr.2012.0224; Yang BW, 2013, FOOD CONTROL, V32, P228, DOI 10.1016/j.foodcont.2012.11.022; Yang BW, 2011, J FOOD PROTECT, V74, P1724, DOI 10.4315/0362-028X.JFP-11-215; Yang BW, 2010, INT J FOOD MICROBIOL, V141, P63, DOI 10.1016/j.ijfoodmicro.2010.04.015	41	63	67	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144532	10.1371/journal.pone.0144532	http://dx.doi.org/10.1371/journal.pone.0144532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650239	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300055
J	Duong, M; Moles, RJ; Chaar, B; Chen, TF				Duong, Mai; Moles, Rebekah J.; Chaar, Betty; Chen, Timothy F.		World Hosp Pharm Res Consortium	Essential Medicines in a High Income Country: Essential to Whom?	PLOS ONE			English	Article								Objective To explore the perspectives of a diverse group of stakeholders engaged in medicines decision making around what constitutes an "essential" medicine, and how the Essential Medicines List (EML) concept functions in a high income country context. Methods In-depth qualitative semi-structured interviews were conducted with 32 Australian stakeholders, recognised as decision makers, leaders or advisors in the area of medicines reimbursement or supply chain management. Participants were recruited from government, pharmaceutical industry, pharmaceutical wholesale/distribution companies, medicines non-profit organisations, academic health disciplines, hospitals, and consumer groups. Perspectives on the definition and application of the EML concept in a high income country context were thematically analysed using grounded theory approach. Findings Stakeholders found it challenging to describe the EML concept in the Australian context because many perceived it was generally used in resource scarce settings. Stakeholders were unable to distinguish whether nationally reimbursed medicines were essential medicines in Australia. Despite frequent generic drug shortages and high prices paid by consumers, many struggled to describe how the EML concept applied to Australia. Instead, broad inclusion of consumer needs, such as rare and high cost medicines, and consumer involvement in the decision making process, has led to expansive lists of nationally subsidised medicines. Therefore, improved communication and coordination is needed around shared interests between stakeholders regarding how medicines are prioritised and guaranteed in the supply chain. Conclusions This study showed that decision-making in Australia around reimbursement of medicines has strayed from the fundamental utilitarian concept of essential medicines. Many stakeholders involved in medicine reimbursement decisions and management of the supply chain did not consider the EML concept in their approach. The wide range of views of what stakeholders considered were essential medicines, challenges whether the EML concept is out-dated or underutilised in high income countries.	[Duong, Mai; Moles, Rebekah J.; Chaar, Betty; Chen, Timothy F.; World Hosp Pharm Res Consortium] Univ Sydney, Discipline Pharm Practice, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney	Duong, M (corresponding author), Univ Sydney, Discipline Pharm Practice, Fac Pharm, Sydney, NSW 2006, Australia.	mai.duong@sydney.edu.au	Chen, Timothy/X-3684-2019	Chen, Timothy/0000-0003-4189-8403					0	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143654	10.1371/journal.pone.0143654	http://dx.doi.org/10.1371/journal.pone.0143654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650544	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300021
J	Wang, LG; Wu, XX; Liu, YF; Qiu, QS				Wang, Liguang; Wu, Xuexia; Liu, Yafen; Qiu, Quan-Sheng			AtNHX5 and AtNHX6 Control Cellular K+ and pH Homeostasis in Arabidopsis: Three Conserved Acidic Residues Are Essential for K+ Transport	PLOS ONE			English	Article							NA+/H+ EXCHANGER; SALT TOLERANCE; PLASMA-MEMBRANE; CATION/H+ ANTIPORTERS; PLANT-GROWTH; V-ATPASE; ROLES; YEAST; SOS1; OVEREXPRESSION	AtNHX5 and AtNHX6, the endosomal Na+, K+/H+ antiporters in Arabidopsis, play an important role in plant growth and development. However, their function in K+ and pH homeostasis remains unclear. In this report, we characterized the function of AtNHX5 and AtNHX6 in K+ and H+ homeostasis in Arabidopsis. Using a yeast expression system, we found that AtNHX5 and AtNHX6 recovered tolerance to high K+ or salt. We further found that AtNHX5 and AtNHX6 functioned at high K+ at acidic pH while AtCHXs at low K+ under alkaline conditions. In addition, we showed that the nhx5 nhx6 double mutant contained less K+ and was sensitive to low K+ treatment. Overexpression of AtNHX5 or AtNHX6 gene in nhx5 nhx6 recovered root growth to the wild-type level. Three conserved acidic residues, D164, E188, and D193 in AtNHX5 and D165, E189, and D194 in AtNHX6, were essential for K+ homeostasis and plant growth. nhx5 nhx6 had a reduced vacuolar and cellular pH as measured with the fluorescent pH indicator BCECF or semimicroelectrode. We further show that AtNHX5 and AtNHX6 are localized to Golgi and TGN. Taken together, AtNHX5 and AtNHX6 play an important role in K+ and pH homeostasis in Arabidopsis. Three conserved acidic residues are essential for K+ transport.	[Wang, Liguang; Wu, Xuexia; Liu, Yafen; Qiu, Quan-Sheng] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China	Lanzhou University	Qiu, QS (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China.	qiuqsh@lzu.edu.cn			National Basic Research Program of China (973 project) [2013CB429904]; National Natural Science Foundation of China (NSFC) [31070222, 31371438, 31571464]; Doctoral Fund of Ministry of Education of China (RFDP) [20130211110001]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k10]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China (RFDP); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program of China (973 project, 2013CB429904 to Quan-Sheng Qiu), National Natural Science Foundation of China (NSFC, 31070222 to Quan-Sheng Qiu), National Natural Science Foundation of China (NSFC, 31371438 to Quan-Sheng Qiu), National Natural Science Foundation of China (NSFC, 31571464 to Quan-Sheng Qiu), Doctoral Fund of Ministry of Education of China (RFDP, 20130211110001 to Quan-Sheng Qiu), Fundamental Research Funds for the Central Universities (lzujbky-2013-k10). All of the funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chanroj S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00025; Chanroj S, 2011, J BIOL CHEM, V286, P33931, DOI 10.1074/jbc.M111.252650; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dibrov P, 1998, BIOCHEMISTRY-US, V37, P8282, DOI 10.1021/bi9801457; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Guo Q, 2004, ENDOCRINOLOGY, V145, P1640, DOI 10.1210/en.2003-1270; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jiang XY, 2010, PLANT SIGNAL BEHAV, V5, P792, DOI 10.4161/psb.5.7.11767; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; Li MR, 2011, TREE PHYSIOL, V31, P349, DOI 10.1093/treephys/tpr003; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; MARRE E, 1988, BOT ACTA, V101, P24, DOI 10.1111/j.1438-8677.1988.tb00006.x; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Mei Y, 2012, CELL RES, V22, P581, DOI 10.1038/cr.2011.150; MENEGUS F, 1989, PLANT PHYSIOL, V90, P29, DOI 10.1104/pp.90.1.29; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Oh DH, 2010, J EXP BOT, V61, P1205, DOI 10.1093/jxb/erp391; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Qi Z, 2004, PLANT PHYSIOL, V136, P2548, DOI 10.1104/pp.104.049213; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Qiu QS, 2012, J GENET GENOMICS, V39, P167, DOI 10.1016/j.jgg.2012.02.001; Qiu QS, 2012, J INTEGR PLANT BIOL, V54, P66, DOI 10.1111/j.1744-7909.2012.01097.x; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Reguera M, 2014, MOL PLANT, V7, P261, DOI 10.1093/mp/sst091; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shi LY, 2008, FUNCT PLANT BIOL, V35, P185, DOI 10.1071/FP07269; Swanson SJ, 1996, PLANT CELL, V8, P2211, DOI 10.1105/tpc.8.12.2211; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; YOSHIDA S, 1994, PLANT PHYSIOL, V104, P1131, DOI 10.1104/pp.104.4.1131; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zheng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081463	52	20	26	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144716	10.1371/journal.pone.0144716	http://dx.doi.org/10.1371/journal.pone.0144716			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650539	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300069
J	Andrews, TD; Felzer, BS				Andrews, Travis D.; Felzer, Benjamin S.			Very-Heavy Precipitation in the Greater New York City Region and Widespread Drought Alleviation Tied to Western US Agriculture	PLOS ONE			English	Article							ATMOSPHERIC RESPONSE; GLOBAL IRRIGATION; CLIMATE; WATER; SIMULATIONS; IMPACTS; LAND	Observed intensification of precipitation extremes, responsible for extensive societal impacts, are widely attributed to anthropogenic sources, which may include indirect effects of agricultural irrigation. However quantifying the effects of irrigation on far-downstream climate remains a challenge. We use three paired Community Earth System Model simulations to assess mechanisms of irrigation-induced precipitation trends and extremes in the conterminous US and the effect on the terrestrial carbon sink. Results suggest precipitation enhancement in the central US reduced drought conditions and increased regional carbon uptake, while further downstream, the heaviest precipitation events were more frequent and intense. Specifically, moisture advection from irrigation in the western U.S. and recycling of enhanced local convective precipitation produced very-heavy storm events that were 11% more intense and occurred 23% more frequently in the densely populated greater New York City region.	[Andrews, Travis D.; Felzer, Benjamin S.] Lehigh Univ, Earth & Environm Sci, Bethlehem, PA 18015 USA	Lehigh University	Andrews, TD (corresponding author), Lehigh Univ, Earth & Environm Sci, Bethlehem, PA 18015 USA.	tda210@alum.lehigh.edu	Felzer, Benjamin S/AAB-3456-2021	Felzer, Benjamin S/0000-0002-3990-3739	NSF Macrosystems [1137306]; National Science Foundation (NSF); NSF Macrosystems Biology [1137306]	NSF Macrosystems; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Macrosystems Biology(National Science Foundation (NSF))	BSF supported by NSF Macrosystems 1137306.; We acknowledge the immense CESM development efforts provided by NCAR staff that made these analyses possible. All analysis R code and summarized datasets are publicly accessible via Github (github.com/wanderswest/IRRIG). Thanks to Zav Kothavala for assistance with experiments. We would like to acknowledge high-performance computing support from Yellowstone (ark:/85065/d7wd3xhc) provided by NCAR's Computational and Information Systems Laboratory, sponsored by the National Science Foundation (NSF). This material is based upon work supported by the NSF Macrosystems Biology under Grant Number 1137306 (program solicitation NSF 10-555).	Alter RE, 2015, J HYDROMETEOROLOGY; [Anonymous], 2009, ESTIMATED USE WATER; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Bacmeister JT, 2014, J CLIMATE, V27, P3073, DOI 10.1175/JCLI-D-13-00387.1; Boucher O, 2004, CLIM DYNAM, V22, P597, DOI 10.1007/s00382-004-0402-4; Change IPoC, 2014, CLIM CHANG 2013 PHYS; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; DeAngelis A, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013892; Frumhoff PC, 2007, CONFRONTING CLIMATE; Giorgi F, 2002, J CLIMATE, V15, P1141, DOI 10.1175/1520-0442(2002)015<1141:COAURA>2.0.CO;2; Harding KJ, 2012, J HYDROMETEOROL, V13, P1687, DOI 10.1175/JHM-D-11-099.1; Harding KJ, 2012, J HYDROMETEOROL, V13, P1667, DOI 10.1175/JHM-D-11-098.1; Houze RA, 1997, B AM METEOROL SOC, V78, P2179, DOI 10.1175/1520-0477(1997)078<2179:SPIROC>2.0.CO;2; Huber DB, 2014, CLIMATE, V2, P103, DOI 10.3390/cli2020103; Hurrell JW, 2013, 2011 COMMUNITY EARTH; Konzmann M, 2013, HYDROLOG SCI J, V58, P88, DOI 10.1080/02626667.2013.746495; Kooperman GJ, 2014, J ADV MODEL EARTH SY, V6, P859, DOI 10.1002/2014MS000306; Kopparla P, 2013, GEOPHYS RES LETT, V40, P5803, DOI 10.1002/2013GL057866; Kueppers LM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028679; Lawrence DM, 2012, J CLIMATE, V25, P2240, DOI 10.1175/JCLI-D-11-00103.1; Lee E., 2011, INT J GEOSCI, V2, P420, DOI [10.4236/ijg.2011.24046, DOI 10.4236/IJG.2011.24046]; Levis S, 2011, TECHNICAL DESCRIPTIO; Lo MH, 2013, GEOPHYS RES LETT, V40, P301, DOI 10.1002/grl.50108; McDonald RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065589; McGuire VL, 2009, CHANGES WATER LEVELS; Neale R. B., 2010, NCARTN486STR; Oleson K.W., 2010, TECHNICAL DESCRIPTIO; Perlman H, 2014, IRRIGATION WATER USE; Puma M, 2010, J GEOPHYS RES-ATMOS, P115; Qian Y, 2013, J HYDROMETEOROL, V14, P700, DOI 10.1175/JHM-D-12-0134.1; Sacks WJ, 2009, CLIM DYNAM, V33, P159, DOI 10.1007/s00382-008-0445-z; Schneiderman E, 2014, CURRENT FUTURE TREND; Segal M, 1998, J APPL METEOROL, V37, P325, DOI 10.1175/1520-0450-37.3.325; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Siebert S, 2015, HYDROL EARTH SYST SC, V19, P1521, DOI 10.5194/hess-19-1521-2015; Sorooshian S., 2011, J GEOPHYS RES ATMOSP, V116; Steward DR, 2013, P NATL ACAD SCI USA, V110, pE3477, DOI 10.1073/pnas.1220351110; Team RC, 2012, R LANG ENV STAT COMP; Wen LJ, 2012, HYDROL PROCESS, V26, P445, DOI 10.1002/hyp.8142	40	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144416	10.1371/journal.pone.0144416	http://dx.doi.org/10.1371/journal.pone.0144416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642049	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700116
J	Posluszny, A; Liguz-Lecznar, M; Turzynska, D; Zakrzewska, R; Bielecki, M; Kossut, M				Posluszny, Anna; Liguz-Lecznar, Monika; Turzynska, Danuta; Zakrzewska, Renata; Bielecki, Maksymilian; Kossut, Malgorzata			Learning-Dependent Plasticity of the Barrel Cortex Is Impaired by Restricting GABA-Ergic Transmission	PLOS ONE			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; OCULAR DOMINANCE PLASTICITY; LONG-TERM POTENTIATION; CORTICAL PLASTICITY; INDUCED ENHANCEMENT; ADULT MICE; 3-MERCAPTOPROPIONIC ACID; CEREBELLAR CORTEX; DENDRITIC SPINES; NMDA RECEPTORS	Experience-induced plastic changes in the cerebral cortex are accompanied by alterations in excitatory and inhibitory transmission. Increased excitatory drive, necessary for plasticity, precedes the occurrence of plastic change, while decreased inhibitory signaling often facilitates plasticity. However, an increase of inhibitory interactions was noted in some instances of experience-dependent changes. We previously reported an increase in the number of inhibitory markers in the barrel cortex of mice after fear conditioning engaging vibrissae, observed concurrently with enlargement of the cortical representational area of the row of vibrissae receiving conditioned stimulus (CS). We also observed that an increase of GABA level accompanied the conditioning. Here, to find whether unaltered GABAergic signaling is necessary for learning-dependent rewiring in the murine barrel cortex, we locally decreased GABA production in the barrel cortex or reduced transmission through GABAA receptors (GABAARs) at the time of the conditioning. Injections of 3-mercaptopropionic acid (3-MPA), an inhibitor of glutamic acid decarboxylase (GAD), into the barrel cortex prevented learning-induced enlargement of the conditioned vibrissae representation. A similar effect was observed after injection of gabazine, an antagonist of GABAARs. At the behavioral level, consistent conditioned response (cessation of head movements in response to CS) was impaired. These results show that appropriate functioning of the GABAergic system is required for both manifestation of functional cortical representation plasticity and for the development of a conditioned response.	[Posluszny, Anna; Liguz-Lecznar, Monika; Zakrzewska, Renata; Kossut, Malgorzata] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Bielecki, Maksymilian; Kossut, Malgorzata] SWPS Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Turzynska, Danuta] Inst Psychiat & Neurol, Dept Neurochem, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; SWPS University of Social Sciences & Humanities; Institute of Psychiatry & Neurology	Kossut, M (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	m.kossut@nencki.gov.pl	Bielecki, Maksymilian/AAI-6699-2020; Liguz-Lecznar, Monika/R-2834-2016; Liguz-Lecznar, Monika/K-6850-2019	Bielecki, Maksymilian/0000-0002-2881-4976; Liguz-Lecznar, Monika/0000-0002-2113-7407; Liguz-Lecznar, Monika/0000-0002-2113-7407; Turzynska, Danuta/0000-0001-5183-1435; Kossut, Malgorzata/0000-0001-7808-1101; Posluszny, Anna/0000-0003-1571-1393; Zakrzewska, Renata/0000-0002-7882-9463	Ministry of Science and Education [N N301 248639]	Ministry of Science and Education	The research was supported by grant no N N301 248639 of Ministry of Science and Education to MK.	Bekisz M, 2010, EUR J NEUROSCI, V32, P1715, DOI 10.1111/j.1460-9568.2010.07453.x; Bieszczad KM, 2010, NEUROBIOL LEARN MEM, V94, P127, DOI 10.1016/j.nlm.2010.04.009; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Cybulska-Klosowicz A, 2013, NEUROSCIENCE, V254, P18, DOI 10.1016/j.neuroscience.2013.09.020; Cybulska-Klosowicz A, 2009, BEHAV BRAIN RES, V204, P102, DOI 10.1016/j.bbr.2009.05.024; Duguid I, 2012, J NEUROSCI, V32, P11132, DOI 10.1523/JNEUROSCI.0460-12.2012; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Galvez R, 2006, J NEUROSCI, V26, P6062, DOI 10.1523/JNEUROSCI.5582-05.2006; Gandolfi D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00064; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gierdalski M, 2001, CEREB CORTEX, V11, P806, DOI 10.1093/cercor/11.9.806; Griffen TC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00091; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Holmgren CD, 2001, J NEUROSCI, V21, P8270; Jablonska B, 1999, CEREB CORTEX, V9, P222, DOI 10.1093/cercor/9.3.222; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jerome D, 2012, EUR J NEUROSCI, V36, P3134, DOI 10.1111/j.1460-9568.2012.08210.x; JULIANO SL, 1989, J NEUROSCI, V9, P1; KARLSSON A, 1974, BIOCHEM PHARMACOL, V23, P3053, DOI 10.1016/0006-2952(74)90281-0; Kilgard MP, 2007, HEARING RES, V229, P171, DOI 10.1016/j.heares.2007.01.005; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Komatsu Y, 2000, J NEUROSCI, V20, P7539; Kossut M, 1998, EXP BRAIN RES, V123, P110, DOI 10.1007/s002210050551; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Liguz-Lecznar M, 2015, BRAIN STRUCT FUNCT, V220, P1681, DOI 10.1007/s00429-014-0752-6; Liguz-Lecznar M, 2011, NEUROBIOL AGING, V32, P1896, DOI 10.1016/j.neurobiolaging.2009.11.009; LOSCHER W, 1985, J NEUROCHEM, V45, P879, DOI 10.1111/j.1471-4159.1985.tb04076.x; Lovett-Barron M, 2014, CURR OPIN NEUROBIOL, V26, P27, DOI 10.1016/j.conb.2013.11.002; Ma DS, 1999, ANAL BIOCHEM, V276, P124, DOI 10.1006/abio.1999.4352; McKay BM, 2013, J NEUROSCI, V33, P5499, DOI 10.1523/JNEUROSCI.4068-12.2013; Petrini EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4921; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Poorthuis RB, 2014, J PHYSIOL-LONDON, V592, P4155, DOI 10.1113/jphysiol.2014.273862; Saar D, 2012, J NEUROPHYSIOL, V107, P1222, DOI 10.1152/jn.00356.2011; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; SILLITO AM, 1986, NATURE, V320, P109, DOI 10.1038/320109a0; Siucinska E, 1996, CEREB CORTEX, V6, P506, DOI 10.1093/cercor/6.3.506; Siucinska E, 1999, BRAIN RES, V843, P62, DOI 10.1016/S0006-8993(99)01881-8; Siucinska E, 2006, BRAIN RES, V1106, P52, DOI 10.1016/j.brainres.2006.05.061; SPRINCE H, 1969, ANN NY ACAD SCI, V166, P323, DOI 10.1111/j.1749-6632.1969.tb46402.x; STROMINGER RN, 1987, J NEUROSCI METH, V22, P113, DOI 10.1016/0165-0270(87)90004-5; Thiele A, 2012, J NEUROSCI, V32, P16602, DOI 10.1523/JNEUROSCI.0554-12.2012; Tokarski K, 2007, EUR J NEUROSCI, V26, P134, DOI 10.1111/j.1460-9568.2007.05629.x; Urban-Ciecko J, 2010, J NEUROPHYSIOL, V104, P746, DOI 10.1152/jn.00988.2009; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WELKER E, 1989, EXP BRAIN RES, V78, P659, DOI 10.1007/BF00230256; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258	56	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144415	10.1371/journal.pone.0144415	http://dx.doi.org/10.1371/journal.pone.0144415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641862	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700115
J	Rudolph, A; Teske, M; Illner, S; Kiefel, V; Sternberg, K; Grabow, N; Wree, A; Hovakimyan, M				Rudolph, Andreas; Teske, Michael; Illner, Sabine; Kiefel, Volker; Sternberg, Katrin; Grabow, Niels; Wree, Andreas; Hovakimyan, Marina			Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity	PLOS ONE			English	Article							DRUG-ELUTING STENTS; CORONARY-ARTERY-DISEASE; BARE-METAL STENTS; POLY-(L-LACTIC ACID); ENDOTHELIALIZATION; HEMOCOMPATIBILITY; RESTENOSIS; THROMBOSIS; POLY(L-LACTIDE); IMMOBILIZATION	Purpose Drug-eluting stents (DES) based on permanent polymeric coating matrices have been introduced to overcome the in stent restenosis associated with bare metal stents (BMS). A further step was the development of DES with biodegradable polymeric coatings to address the risk of thrombosis associated with first-generation DES. In this study we evaluate the biocompatibility of biodegradable polymer materials for their potential use as coating matrices for DES or as materials for fully bioabsorbable vascular stents. Materials and Methods Five different polymers, poly(L-lactide) PLLA, poly(D, L-lactide) PDLLA, poly(L-lactide-co-glycolide) P(LLA-co-GA), poly(D, L-lactide-co-glycolide) P(DLLA-co-GA) and poly(L-lactideco-e-caprolactone), P(LLA-co-CL) were examined in vitro without and with surface modification. The surface modification of polymers was performed by means of wet-chemical (NaOH and ethylenediamine (EDA)) and plasma-chemical (O-2 and NH3) processes. The biocompatibility studies were performed on three different cell types: immortalized mouse fibroblasts (cell line L929), human coronary artery endothelial cells (HCAEC) and human umbilical vein endothelial cells (HUVEC). The biocompatibility was examined quantitatively using in vitro cytotoxicity assay. Cells were investigated immunocytochemically for expression of specific markers, and morphology was visualized using confocal laser scanning (CLSM) and scanning electron (SEM) microscopy. Additionally, polymer surfaces were examined for their thrombogenicity using an established hemocompatibility test. Results Both endothelial cell types exhibited poor viability and adhesion on all five unmodified polymer surfaces. The biocompatibility of the polymers could be influenced positively by surface modifications. In particular, a reproducible effect was observed for NH3-plasma treatment, which enhanced the cell viability, adhesion and morphology on all five polymeric surfaces. Conclusion Surface modification of polymers can provide a useful approach to enhance their biocompatibility. For clinical application, attempts should be made to stabilize the plasma modification and use it for coupling of biomolecules to accelerate the re-endothelialization of stent surfaces in vivo.	[Rudolph, Andreas; Teske, Michael; Illner, Sabine; Sternberg, Katrin; Grabow, Niels; Hovakimyan, Marina] Univ Rostock, Med Ctr, Inst Biomed Engn, D-18119 Rostock, Germany; [Kiefel, Volker] Univ Rostock, Med Ctr, Dept Transfus Med, D-18057 Rostock, Germany; [Wree, Andreas] Univ Rostock, Med Ctr, Inst Anat, D-18057 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Hovakimyan, M (corresponding author), Univ Rostock, Med Ctr, Inst Biomed Engn, Friedrich Barnewitz Str 4, D-18119 Rostock, Germany.	marina.hovakimyan@uni-rostock.de			BMBF; German Federal Ministry of Education and Research [FKZ: 03IS2081]	BMBF(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was financially supported by BMBF, the German Federal Ministry of Education and Research within the coordinated research project REMEDIS, "Hohere Lebensqualitat durch neuartige Mikroimplantate", (FKZ: 03IS2081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by BMBF, the German Federal Ministry of Education and Research within the coordinated research project REMEDIS, "Hohere Lebensqualitat durch neuartige Mikroimplantate", (FKZ: 03IS2081).	Bavry AA, 2007, CIRCULATION, V116, P696, DOI 10.1161/CIRCULATIONAHA.107.719484; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Bax DV, 2014, BIOMATERIALS, V35, P6797, DOI 10.1016/j.biomaterials.2014.04.082; Bedair T.M., 2014, BIOMATERIALS BIOMEDI, V1, P121, DOI 10.12989/bme.2014.1.3.121; Bonow R., 2012, BRAUNWALDS HEART DIS, DOI DOI 10.1093/eurheartj/ehw249; Byrne RA, 2009, JACC-CARDIOVASC INTE, V2, P291, DOI 10.1016/j.jcin.2008.11.015; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Chong DST, 2015, EUR J VASC ENDOVASC, V49, P335, DOI 10.1016/j.ejvs.2014.12.008; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Duraiswamy N, 2009, J BIOMATER APPL, V23, P367, DOI 10.1177/0885328208093854; Garcia-Garcia JM, 2012, J BIOMED MATER RES A, V100A, P7, DOI 10.1002/jbm.a.33215; Hirotsu T, 2002, POLYM ENG SCI, V42, P299, DOI 10.1002/pen.10949; Holmvang L, 2013, JACC-CARDIOVASC INTE, V6, P548, DOI 10.1016/j.jcin.2012.12.129; Hyuck Joon Kwon, 2014, Polymers, V6, P755, DOI 10.3390/polym6030755; Iijima R, 2013, INT J CARDIOL, V168, P2588, DOI 10.1016/j.ijcard.2013.03.046; Ino JM, 2013, J BIOMED MATER RES B, V101, P1549, DOI 10.1002/jbm.b.32977; Inoue M, 2013, J BIOMED MATER RES A, V101, P2049, DOI 10.1002/jbm.a.34488; Iqbal J, 2013, BRIT MED BULL, V106, P193, DOI 10.1093/bmb/ldt009; Jeewandara TM, 2014, MATERIALS, V7, P769, DOI 10.3390/ma7020769; Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Lemos PA, 2003, CIRCULATION, V107, P3003, DOI 10.1161/01.CIR.0000078025.19258.28; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P504, DOI 10.1016/j.jcin.2009.04.004; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Martin DM, 2011, MED ENG PHYS, V33, P148, DOI 10.1016/j.medengphy.2010.10.009; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Morent R, 2008, NUCL INSTRUM METH B, V266, P3081, DOI 10.1016/j.nimb.2008.03.166; Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Nguyen KT, 2003, BIOMATERIALS, V24, P5191, DOI 10.1016/S0142-9612(03)00451-4; Niemela KO, 2008, EUR HEART J, V29, P1930, DOI 10.1093/eurheartj/ehn304; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Petersen S, 2014, J BIOMED MATER RES B, V102, P345, DOI 10.1002/jbm.b.33012; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Scislowska-Czarnecka A, 2015, J BIOMED MATER RES A, V103, P3965, DOI 10.1002/jbm.a.35509; Sharma K, 2013, GLOB HEART, V8, P105, DOI 10.1016/j.gheart.2013.02.001; Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021; Smith SC, 2012, J AM COLL CARDIOL, V60, P2343, DOI 10.1016/j.jacc.2012.08.962; Solouk A, 2015, MAT SCI ENG C-MATER, V46, P400, DOI 10.1016/j.msec.2014.10.065; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Storm T, 2014, J MATER SCI-MATER M, V25, P2003, DOI 10.1007/s10856-014-5226-0; Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8; Wang LP, 2014, ARQ BRAS CARDIOL, V102, P529, DOI 10.5935/abc.20140070; Whyte EM, 2001, AM J PSYCHIAT, V158, P2074, DOI 10.1176/appi.ajp.158.12.2074; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; Xu H, 2011, TISSUE ENG PT A, V17, P865, DOI [10.1089/ten.tea.2010.0129, 10.1089/ten.TEA.2010.0129]; Yahagi K, 2015, ATHEROSCLEROSIS, V239, P260, DOI 10.1016/j.atherosclerosis.2015.01.017; Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272; Yoneda S, 2013, CORONARY ARTERY DIS, V24, P368, DOI 10.1097/MCA.0b013e32836222ec	52	25	30	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142075	10.1371/journal.pone.0142075	http://dx.doi.org/10.1371/journal.pone.0142075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641662	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700006
J	Dong, XL; Liu, TH; Wang, W; Pan, CX; Wu, YF; Du, GY; Chen, P; Lu, C; Pan, MH				Dong, Xiao-long; Liu, Tai-hang; Wang, Wei; Pan, Cai-xia; Wu, Yun-fei; Du, Guo-yu; Chen, Peng; Lu, Cheng; Pan, Min-hui			BmREEPa Is a Novel Gene that Facilitates BmNPV Entry into Silkworm Cells	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; BOMBYX-MORI; NUCLEOPOLYHEDROVIRUS GP64; EXPRESSION PROFILE; MAMMALIAN-CELLS; MEMBRANE-FUSION; BACULOVIRUS; RESISTANCE; PROTEINS; REEP2	We previously established two silkworm cell lines, BmN-SWU1 and BmN-SWU2, from Bombyx mori ovaries. BmN-SWU1 cells are susceptible while BmN-SWU2 cells are highly resistant to BmNPV infection. Interestingly, we found that the entry of BmNPV into BmN-SWU2 cells was largely inhibited. To explore the mechanism of this inhibition, in this study we used isobaric tags for relative and absolute quantitation (iTRAQ)-based quantitative protein expression profiling and identified 629 differentially expressed proteins between the two cell lines. Among them, we identified a new membrane protein termed BmREEPa. The gene encoding BmREEPa transcribes two splice variants; a 573 bp long BmREEPa-L encoding a protein with 190 amino acids and a 501 bp long BmREEPa-S encoding a protein with 166 amino acids. BmREEPa contains a conserved TB2/DP, HVA22 domain and three transmembrane domains. It is localized in the plasma membrane with a cytoplasmic C-terminus and an extracellular N-terminus. We found that limiting the expression of BmREEPa in BmN-SWU1 cells inhibited BmNPV entry, whereas over-expression of BmREEPa in BmN-SWU2 cells promoted BmNPV entry. Our results also indicated that BmREEPa can interact with GP64, which is the key envelope fusion protein for BmNPV entry. Taken together, the findings of our study revealed that BmREEPa is required for BmNPV to gain entry into silkworm cells, and may provide insights for the identification of BmNPV receptors.	[Dong, Xiao-long; Liu, Tai-hang; Wang, Wei; Pan, Cai-xia; Wu, Yun-fei; Du, Guo-yu; Chen, Peng; Lu, Cheng; Pan, Min-hui] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Dong, Xiao-long; Lu, Cheng; Pan, Min-hui] Southwest Univ, Minist Agr, Key Lab Sericulture Funct Genom & Biotechnol, Chongqing, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	lucheng@swu.edu.cn; pmh047@126.com			Hi-Tech Research and Development 863 Program of China [2013AA 102507]; National Natural Science Foundation of China [30972146, 31272505, 31472152]; Based and Advanced Research Projects of Chongqing, China [cstc2013jcyjA80019]; China Agriculture Research System [CARS-22]	Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Based and Advanced Research Projects of Chongqing, China; China Agriculture Research System	This work was supported by grants from the Hi-Tech Research and Development 863 Program of China (No. 2013AA 102507), the National Natural Science Foundation of China (Grant No. 30972146, 31272505 and 31472152), the Based and Advanced Research Projects of Chongqing, China (Grant No: cstc2013jcyjA80019) and China Agriculture Research System (CARS-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argasinska J, 2009, INT J DEV BIOL, V53, P37, DOI 10.1387/ijdb.072542ja; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Bjork S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076366; Castermans D, 2007, EUR J HUM GENET, V15, P422, DOI 10.1038/sj.ejhg.5201785; de Jong J, 2011, J VIROL, V85, P9696, DOI 10.1128/JVI.00833-11; Dong SC, 2012, J VIROL, V86, P9617, DOI 10.1128/JVI.00813-12; Du J, 2009, CHINESE MED J, P122; Esteves T, 2014, AM J HUM GENET, V94, P268, DOI 10.1016/j.ajhg.2013.12.005; Hurt CM, 2014, BRAIN RES, V1545, P12, DOI 10.1016/j.brainres.2013.12.008; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Kataoka C, 2012, J VIROL, V86, P2610, DOI 10.1128/JVI.06704-11; Li ZF, 2011, J VIROL, V85, P12492, DOI 10.1128/JVI.05153-11; Li ZF, 2010, J VIROL, V84, P8584, DOI 10.1128/JVI.00264-10; Lin YT, 2013, INT J MOL MED, V31, P459, DOI 10.3892/ijmm.2012.1225; Luz-Madrigal A, 2013, J VIROL, V87, P11894, DOI 10.1128/JVI.01356-13; Mainland J, 2012, ADV EXP MED BIOL, V744, P75, DOI 10.1007/978-1-4614-2364-5_7; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Qin LG, 2012, J PROTEOMICS, V75, P3630, DOI 10.1016/j.jprot.2012.04.015; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Selot R, 2010, ARCH INSECT BIOCHEM, V73, P163, DOI 10.1002/arch.20348; Shen HX, 2012, FEBS LETT, V586, P990, DOI 10.1016/j.febslet.2011.12.040; Tavares J, 2011, GENET MOL RES, V10, P471, DOI 10.4238/vol10-1gmr978; Wang WQ, 2014, ADV INTEL SYS RES, V59, P9; Yang ZX, 2012, GEN HOSP PSYCHIAT, V34, P571, DOI 10.1016/j.genhosppsych.2012.05.015; Yao HP, 2010, BIOSCIENCE REP, V30, P209, DOI 10.1042/BSR20090045; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105986; Zhang J, 2014, ANTIVIR RES, V104, P143, DOI 10.1016/j.antiviral.2014.01.017; Zhou Y, 2013, GENOMICS, V101, P256, DOI 10.1016/j.ygeno.2013.02.004	29	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144575	10.1371/journal.pone.0144575	http://dx.doi.org/10.1371/journal.pone.0144575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656276	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900065
J	Liang, J; Meng, F; Sun, S; Wu, CX; Wu, HY; Zhang, MR; Zhang, HF; Zheng, XB; Song, XY; Zhang, ZG				Liang, Jingang; Meng, Fang; Sun, Shi; Wu, Cunxiang; Wu, Haiying; Zhang, Mingrong; Zhang, Haifeng; Zheng, Xiaobo; Song, Xinyuan; Zhang, Zhengguang			Community Structure of Arbuscular Mycorrhizal Fungi in Rhizospheric Soil of a Transgenic High-Methionine Soybean and a Near Isogenic Variety	PLOS ONE			English	Article							MAIZE ZEA-MAYS; PHOSPHORUS CONCENTRATION; GENETIC MODIFICATIONS; RIBOSOMAL-RNA; BT-MAIZE; COLONIZATION; PLANTS; DYNAMICS; IMPACT; ROOTS	The use of transgenic plants in agriculture provides many economic benefits, but it also raises concerns over the potential impact of transgenic plants on the environment. We here examined the impact of transgenic high-methionine soybean ZD91 on the arbuscular mycorrhizal (AM) fungal community structure in rhizosphere soil. Our investigations based on clone libraries were conducted in field trials at four growth stages of the crops each year from 2012 to 2013. A total of 155 operational taxonomic units (OTUs) of AM fungi were identified based on the sequences of small subunit ribosomal RNA (SSU rRNA) genes. There were no significant differences found in AM fungal diversity in rhizosphere soil during the same growth stage between transgenic soybean ZD91 and its non-transgenic parental soybean ZD. In addition, plant growth stage and year had the strongest effect on the AM fungal community structure while the genetically modified (GM) trait studied was the least explanatory factor. In conclusion, we found no indication that transgenic soybean ZD91 cultivation poses a risk for AM fungal communities in agricultural soils.	[Liang, Jingang; Meng, Fang; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Liang, Jingang; Meng, Fang; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Liang, Jingang] Minist Agr, Dev Ctr Sci & Technol, Beijing, Peoples R China; [Sun, Shi; Wu, Cunxiang] Chinese Acad Agr Sci, Inst Crop Sci, MOA Key Lab Soybean Biol Beijing, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Wu, Haiying; Zhang, Mingrong] Nanchong Acad Agr Sci, Nanchong, Peoples R China; [Song, Xinyuan] Jilin Acad Agr Sci, Agrobiotechnol Res Inst, Changchun, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Jilin Academy of Agricultural Sciences	Song, XY (corresponding author), Jilin Acad Agr Sci, Agrobiotechnol Res Inst, Changchun, Peoples R China.	songxinyuan1980@163.com; zhgzhang@njau.edu.cn			Genetically Modified Organisms Breeding Major Projects of China [2016ZX08011-003, 2014ZX08011-003]; Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors	Genetically Modified Organisms Breeding Major Projects of China; Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors	This research was supported by Genetically Modified Organisms Breeding Major Projects of China (Grant No. 2016ZX08011-003 and 2014ZX08011-003) and Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2004, BIOSCIENCE, V54, P637, DOI 10.1641/0006-3568(2004)054[0637:SRAFNE]2.0.CO;2; Asghari HR, 2005, PLANT SOIL, V273, P245, DOI 10.1007/s11104-004-7942-6; de Azevedo LCB, 2014, BRAZ J MICROBIOL, V45, P995, DOI 10.1590/S1517-83822014000300032; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Burke DJ, 2008, AM J BOT, V95, P1416, DOI 10.3732/ajb.0800184; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castaldini M, 2005, APPL ENVIRON MICROB, V71, P6719, DOI 10.1128/AEM.71.11.6719-6729.2005; Cheeke TE, 2013, APPL ENVIRON MICROB, V79, P4078, DOI 10.1128/AEM.00702-13; Cheeke TE, 2012, AM J BOT, V99, P700, DOI 10.3732/ajb.1100529; Cheeke TE, 2011, FEMS MICROBIOL ECOL, V75, P304, DOI 10.1111/j.1574-6941.2010.01013.x; Clark NM, 2009, J ARID ENVIRON, V73, P834, DOI 10.1016/j.jaridenv.2009.03.004; Cotton TEA, 2015, NEW PHYTOL, V205, P1598, DOI 10.1111/nph.13224; de Vaufleury A, 2007, PEDOBIOLOGIA, V51, P185, DOI 10.1016/j.pedobi.2007.04.005; Alguacil MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034887; Duineveld BM, 2001, APPL ENVIRON MICROB, V67, P172, DOI 10.1128/AEM.67.1.172-178.2001; Filion M, 2008, MICROB BIOTECHNOL, V1, P463, DOI 10.1111/j.1751-7915.2008.00047.x; Fliessbach A, 2012, BIOL FERT SOILS, V48, P315, DOI 10.1007/s00374-011-0625-6; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Girlanda M, 2008, FEMS MICROBIOL LETT, V288, P9, DOI 10.1111/j.1574-6968.2008.01306.x; Gong CY, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00041; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; Hannula SE, 2014, BIOL FERT SOILS, V50, P433, DOI 10.1007/s00374-014-0895-x; Hannula SE, 2012, NEW PHYTOL, V194, P784, DOI 10.1111/j.1469-8137.2012.04089.x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hattori R., 2014, International Journal of Agricultural Policy and Research, V2, P41; Higo M, 2014, BIOL FERT SOILS, V50, P913, DOI 10.1007/s00374-014-0912-0; IBM-SPSS, 2008, SPSS STAT WIND VERS; Isobe K, 2011, ADV MICROBIOL, V1, P13, DOI DOI 10.4236/AIM.2011.11003; Jie WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072898; Kaldorf M, 2002, PLANTA, V214, P653, DOI 10.1007/s004250100658; Knox OGG, 2008, FIELD CROP RES, V109, P57, DOI 10.1016/j.fcr.2008.06.005; KORMANIK PP, 1980, CAN J MICROBIOL, V26, P536, DOI 10.1139/m80-090; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Liang JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103343; Liu WK, 2010, ECOTOXICOLOGY, V19, P229, DOI 10.1007/s10646-009-0423-1; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Martinelli L, 2013, CROAT MED J, V54, P91, DOI 10.3325/cmj.2013.54.91; Meyer JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053825; Naghashzadeh M., 2013, Advances in Environmental Biology, V7, P4623; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Powell JR, 2007, APPL ENVIRON MICROB, V73, P4365, DOI 10.1128/AEM.00594-07; [浦传亮 Pu Chuanliang], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P8; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Scheublin TR, 2006, NEW PHYTOL, V172, P732, DOI 10.1111/j.1469-8137.2006.01858.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Song SK, 2013, J EXP BOT, V64, P1917, DOI 10.1093/jxb/ert053; Tan FX, 2011, SOIL BIOL BIOCHEM, V43, P2473, DOI 10.1016/j.soilbio.2011.08.014; Turrini A, 2004, PLANT SOIL, V266, P69; Turrini A, 2015, RES MICROBIOL, V166, P121, DOI 10.1016/j.resmic.2015.02.006; Verbruggen E, 2012, APPL ENVIRON MICROB, V78, P7384, DOI 10.1128/AEM.01372-12; VIERHEILIG H, 1995, APPL ENVIRON MICROB, V61, P3031, DOI 10.1128/AEM.61.8.3031-3034.1995; Vilvert R. M., 2014, African Journal of Agricultural Research, V9, P2369; White CM, 2010, PLANT SOIL, V328, P507, DOI 10.1007/s11104-009-0131-x; Wrobel-Kwiatkowska M, 2012, MYCORRHIZA, V22, P493, DOI 10.1007/s00572-011-0427-6; Wu JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098394	60	32	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145001	10.1371/journal.pone.0145001	http://dx.doi.org/10.1371/journal.pone.0145001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658560	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900164
J	Paulsen, D; Weber, O; Ruebsamen-Schaeff, H; Tennant, BC; Menne, S				Paulsen, Daniela; Weber, Olaf; Ruebsamen-Schaeff, Helga; Tennant, Bud C.; Menne, Stephan			AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B	PLOS ONE			English	Article							VIRUS-REPLICATION; DENDRITIC CELLS; ANTIGEN; ALPHA-2B; THERAPY; HBV; COMBINATION; INHIBITION; TOLERANCE; INFECTION	AIC649 has been shown to directly address the antigen presenting cell arm of the host immune defense leading to a regulated cytokine release and activation of T cell responses. In the present study we analyzed the antiviral efficacy of AIC649 as well as its potential to induce functional cure in animal models for chronic hepatitis B. Hepatitis B virus transgenic mice and chronically woodchuck hepatitis virus (WHV) infected woodchucks were treated with AIC649, respectively. In the mouse system AIC649 decreased the hepatitis B virus titer as effective as the "gold standard", Tenofovir. Interestingly, AIC649-treated chronically WHV infected woodchucks displayed a bi-phasic pattern of response: The marker for functional cure-hepatitis surface antigen-first increased but subsequently decreased even after cessation of treatment to significantly reduced levels. We hypothesize that the observed bi-phasic response pattern to AIC649 treatment reflects a physiologically "concerted", reconstituted immune response against WHV and therefore may indicate a potential for inducing functional cure in HBV-infected patients.	[Paulsen, Daniela; Ruebsamen-Schaeff, Helga] AiCuris GmbH & Co KG, Wuppertal, Germany; [Weber, Olaf] Bayer Aktiengesell, Leverkusen, Germany; [Tennant, Bud C.; Menne, Stephan] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Bayer AG; Cornell University	Paulsen, D (corresponding author), AiCuris GmbH & Co KG, Wuppertal, Germany.	daniela.paulsen@aicuris.com			Bayer; AiCuris	Bayer(Bayer AG); AiCuris	The work was financially supported by Bayer. DP and HRS are employees of AiCuris. OW is an employee of Bayer. AiCuris provided support in the form of salaries for authors DP and HRS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bayer provided support in the form of salaries for authors OW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckebaum S, 2003, IMMUNOLOGY, V109, P487, DOI 10.1046/j.1365-2567.2003.01699.x; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Buchmann P, 2013, VACCINE, V31, P1197, DOI 10.1016/j.vaccine.2012.12.074; Cavanaugh VJ, 1998, J VIROL, V72, P2630, DOI 10.1128/JVI.72.4.2630-2637.1998; Cavanaugh VJ, 1997, J VIROL, V71, P3236, DOI 10.1128/JVI.71.4.3236-3243.1997; Cote Paul J., 1993, Viral Immunology, V6, P161, DOI 10.1089/vim.1993.6.161; Cote PJ, 2000, HEPATOLOGY, V31, P190, DOI 10.1002/hep.510310128; Fletcher SP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005103; Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954; Flink HJ, 2005, GUT, V54, P1604, DOI 10.1136/gut.2004.062208; Friebe A, 2011, J GEN VIROL, V92, P1571, DOI 10.1099/vir.0.028894-0; Gehring AJ, 2013, J CLIN INVEST, V123, P3766, DOI 10.1172/JCI66043; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Guidotti LG, 1996, P NATL ACAD SCI USA, V93, P4589, DOI 10.1073/pnas.93.10.4589; GUIDOTTI LG, 1994, J VIROL, V68, P1265, DOI 10.1128/JVI.68.3.1265-1270.1994; Hadziyannis SJ, 2012, GASTROENTEROLOGY, V143, P629, DOI 10.1053/j.gastro.2012.05.039; HORNBUCKLE WE, 1985, LAB ANIM SCI, V35, P376; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Kimura K, 2002, J VIROL, V76, P10702, DOI 10.1128/JVI.76.21.10702-10707.2002; Kruse N, 2001, J VIROL, V75, P4699, DOI 10.1128/JVI.75.10.4699-4704.2001; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lambotin M, 2010, NAT REV MICROBIOL, V8, P350, DOI 10.1038/nrmicro2332; Liu KH, 2011, J VIROL, V85, P4853, DOI 10.1128/JVI.02437-10; Menne S, 2002, INTERVIROLOGY, V45, P237, DOI 10.1159/000067914; Menne S, 2002, VET IMMUNOL IMMUNOP, V87, P97, DOI 10.1016/S0165-2427(02)00121-6; Menne S, 2008, ANTIMICROB AGENTS CH, V52, P3617, DOI 10.1128/AAC.00654-08; Menne S, 2007, HEPATOLOGY, V45, P614, DOI 10.1002/hep.21558; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; Nowatzky J, 2013, HEPATOL RES, V43, P535, DOI 10.1111/j.1872-034X.2012.01086.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Paulsen D, 2014, PLOS ONE, V8; Protzer U, 1999, P NATL ACAD SCI USA, V96, P10818, DOI 10.1073/pnas.96.19.10818; Shi M, 2007, CLIN EXP IMMUNOL, V147, P277, DOI 10.1111/j.1365-2249.2006.03281.x; Siegemund S, 2009, J VIROL; Sonneveld MJ, 2013, HEPATOLOGY, V58, P872, DOI 10.1002/hep.26436; Sonneveld MJ, 2010, HEPATOLOGY, V52, P1251, DOI 10.1002/hep.23844; ter Borg MJ, 2006, HEPATOLOGY, V44, P721, DOI 10.1002/hep.21302; von Buttlar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106188; Weber O, 2013, EUR J CLIN MICROBIOL, V32, P451, DOI 10.1007/s10096-012-1780-x; Weber O, 2003, J GEN VIROL, V84, P1843, DOI 10.1099/vir.0.19138-0; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Zheng BJ, 2004, J VIRAL HEPATITIS, V11, P217, DOI 10.1111/j.1365-2893.2004.00497.x	43	16	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144383	10.1371/journal.pone.0144383	http://dx.doi.org/10.1371/journal.pone.0144383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656974	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900042
J	Wu, XY; Ji, PL; Zhang, L; Bu, GW; Gu, H; Wang, XJ; Xiong, YZ; Zuo, B				Wu, Xinyu; Ji, Panlong; Zhang, Liang; Bu, Guowei; Gu, Hao; Wang, Xiaojing; Xiong, Yuanzhu; Zuo, Bo			The Expression of Porcine Prdx6 Gene Is Up-Regulated by C/EBP beta and CREB	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; PEROXIREDOXIN 6 GENE; GROWTH-FACTOR; 1-CYS PEROXIREDOXIN; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; ANTIOXIDANT DEFENSE; CELL-DEATH; ENZYME; DIFFERENTIATION	Peroxiredoxin6 (Prdx6) is one of the peroxiredoxin (Prdxs) family members that play an important role in maintaining cell homeostasis. Our previous studies demonstrated that Prdx6 was significantly associated with pig meat quality, especially meat tenderness. However, the transcriptional regulation of porcine Prdx6 remains unclear. In this study, we determined the transcription start site (TSS) of porcine Prdx6 gene by 50 rapid-amplification of cDNA ends (50 RACE). Several regulatory elements including CCAAT/enhancer-binding protein beta (C/EBP beta), Myogenic Differentiation (MyoD), cAMP response element binding protein (CREB), stimulating protein1 (Sp1) and heat shock factor (HSF) binding sites were found by computational analyses together with luciferase reporter system. Overexpression and RNA interference experiments showed that C/EBP beta or CREB could up-regulate the expression of porcine Prdx6 gene at both mRNA and protein level. Electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation assays (ChIP) confirmed that C/EBP beta and CREB could interact with Prdx6 promoter. Immuoprecipitation results also showed that C/EBP beta could interact with Prdx6 in vivo. Taken together, our findings identified C/EBP beta and CREB as the important regulators of porcine Prdx6 gene expression, and offered clues for further investigation of Prdx6 gene function.	[Wu, Xinyu; Ji, Panlong; Zhang, Liang; Bu, Guowei; Gu, Hao; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Coll Anim Sci & Vet Med, Wuhan 430070, Peoples R China; [Wu, Xinyu; Ji, Panlong; Zhang, Liang; Bu, Guowei; Gu, Hao; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Key Lab Agr Anim Genet & Breeding, Minist Educ, Coll Anim Sci & Vet Med, Wuhan 430070, Peoples R China; [Wang, Xiaojing] Huazhong Agr Univ, Dept Basic Vet Physiol, Wuhan 430070, Peoples R China; [Wang, Xiaojing] Huazhong Agr Univ, Biochem Lab, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Zuo, B (corresponding author), Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Coll Anim Sci & Vet Med, Wuhan 430070, Peoples R China.	zuobo@mail.hzau.edu.cn			Key National High Technology Development Project of China [2011AA100301]; National Key Technology Support Program of China [2014BAD20B01]; Agricultural Innovation Fund of Hubei Province [2007-620]; Fundamental Research Funds for the Central Universities [2014PY038]; Key Project of Science and Technology of Zhejiang Province [2014C02010]	Key National High Technology Development Project of China; National Key Technology Support Program of China(National Key Technology R&D Program); Agricultural Innovation Fund of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Project of Science and Technology of Zhejiang Province	This study was financially supported by the Key National High Technology Development Project of China (project no. 2011AA100301), the National Key Technology Support Program of China (grant no. 2014BAD20B01), the Agricultural Innovation Fund of Hubei Province (grant no. 2007-620), the Fundamental Research Funds for the Central Universities (grant no. 2014PY038) and the Key Project of Science and Technology of Zhejiang Province (grant no. 2014C02010).	Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Brinkmann C, 2013, J PHYSIOL SCI, V63, P1, DOI 10.1007/s12576-012-0237-4; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chhunchha B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.121; Chhunchha B, 2013, AM J PHYSIOL-CELL PH, V304, pC636, DOI 10.1152/ajpcell.00345.2012; Chowdhury I, 2014, ANTIOXID REDOX SIGN, V20, P391, DOI 10.1089/ars.2012.4634; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; El Eter E, 2014, CELL STRESS CHAPERON, V19, P173, DOI 10.1007/s12192-013-0442-y; Fatma N, 2009, J BIOL CHEM, V284, P22758, DOI 10.1074/jbc.M109.016071; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fuchs NV, 2011, J VIROL, V85, P3436, DOI 10.1128/JVI.02539-10; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Huang C, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/601508; Jia X, 2009, J ANIM SCI, V87, P2391, DOI 10.2527/jas.2009-1792; Jo M, 2013, FREE RADICAL BIO MED, V61, P453, DOI 10.1016/j.freeradbiomed.2013.04.032; JOHNSON PF, 1994, LIVER GENE EXPRESSIO, P231; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Kubo E, 2008, AM J PHYSIOL-CELL PH, V294, pC842, DOI 10.1152/ajpcell.00540.2007; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Liu FJ, 2014, ONCOL LETT, V7, P1851, DOI 10.3892/ol.2014.1978; Liu Yang, 2011, Yichuan, V33, P743, DOI 10.3724/SP.J.1005.2011.00743; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rolfs F, 2013, CANCER RES, V73, P3460, DOI 10.1158/0008-5472.CAN-12-4369; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Seibold P, 2013, BREAST, V22, P817, DOI 10.1016/j.breast.2013.02.008; Singh AK, 1998, J BIOL CHEM, V273, P26171, DOI 10.1074/jbc.273.40.26171; Stewart R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024714; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Won H, 2012, ANTIOXID REDOX SIGN, V16, P245, DOI 10.1089/ars.2011.3952; Xia XL, 2016, GENE, V575, P551, DOI 10.1016/j.gene.2015.09.042; Yun HM, 2014, MOL NEUROBIOL, P1; Zhang Y-X, 2016, CELLULAR SIGNALLING, V28, P60; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031; Zuloaga R, 2013, BIOCHEM BIOPH RES CO, V440, P258, DOI 10.1016/j.bbrc.2013.09.067	50	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144851	10.1371/journal.pone.0144851	http://dx.doi.org/10.1371/journal.pone.0144851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659441	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900119
J	Yeung, P; Sin, HS; Chan, S; Chan, GCF; Chan, BP				Yeung, Pan; Sin, Hoi Shun; Chan, Shing; Chan, Godfrey Chi Fung; Chan, Barbara Pui			Microencapsulation of Neuroblastoma Cells and Mesenchymal Stromal Cells in Collagen Microspheres: A 3D Model for Cancer Cell Niche Study	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; STEM-CELLS; BONE-MARROW; CROSS-TALK; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; TISSUE-CULTURE; E-CADHERIN; BREAST; ANGIOGENESIS	There is a growing trend for researchers to use in vitro 3D models in cancer studies, as they can better recapitulate the complex in vivo situation. And the fact that the progression and development of tumor are closely associated to its stromal microenvironment has been increasingly recognized. The establishment of such tumor supportive niche is vital in understanding tumor progress and metastasis. The mesenchymal origin of many cells residing in the cancer niche provides the rationale to include MSCs in mimicking the niche in neuroblastoma. Here we co-encapsulate and co-culture NBCs and MSCs in a 3D in vitro model and investigate the morphology, growth kinetics and matrix remodeling in the reconstituted stromal environment. Results showed that the incorporation of MSCs in the model lead to accelerated growth of cancer cells as well as recapitulation of at least partially the tumor microenvironment in vivo. The current study therefore demonstrates the feasibility for the collagen microsphere to act as a 3D in vitro cancer model for various topics in cancer studies.	[Yeung, Pan; Sin, Hoi Shun; Chan, Barbara Pui] Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China; [Chan, Shing; Chan, Godfrey Chi Fung] Univ Hong Kong, Dept Adolescence Med & Paediat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chan, BP (corresponding author), Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	bpchan@hku.hk	Chan, Barbara Pui/AAM-7767-2020; Chan, Godfrey Chi Fung/C-4205-2009	Yeung, Pan/0000-0003-2416-5179; Chan, Godfrey Chi Fung/0000-0001-5032-8985; Chan, BP/0000-0001-5419-2472				Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004; Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; American Cancer Society, 2015, CANCER FACTS FIGURES; Barcellos-de-Souza P, 2013, BBA-REV CANCER, V1836, P321, DOI 10.1016/j.bbcan.2013.10.004; Beierle EA, 2001, J SURG RES, V97, P34, DOI 10.1006/jsre.2001.6097; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blaheta RA, 2009, NEOPLASIA, V11, P1054, DOI 10.1593/neo.09762; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bray LJ, 2015, BIOMATERIALS, V53, P609, DOI 10.1016/j.biomaterials.2015.02.124; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041; Chan BP, 2010, TISSUE ENG PART C-ME, V16, P225, DOI 10.1089/ten.tec.2008.0709; Chen MK, 1998, J SURG RES, V78, P123, DOI 10.1006/jsre.1998.5363; Cheng HW, 2009, TISSUE ENG PART C-ME, V15, P697, DOI [10.1089/ten.tec.2008.0635, 10.1089/ten.TEC.2008.0635]; Chwalek K, 2014, ADV DRUG DELIVER REV, V79-80, P30, DOI 10.1016/j.addr.2014.05.006; Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414; Crigler L, 2007, FASEB J, V21, P2050, DOI 10.1096/fj.06-5880com; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; EAGLE H, 1958, CANCER RES, V18, P1017; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Fang ST, 2011, J MOL CELL CARDIOL, V50, P290, DOI 10.1016/j.yjmcc.2010.10.024; Fang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075187; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gill BJ, 2014, J BIOMECH, V47, P1969, DOI 10.1016/j.jbiomech.2013.09.029; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; Herrmann D, 2014, CARCINOGENESIS, V35, P1671, DOI 10.1093/carcin/bgu108; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; HIRSCHBERG E, 1958, CANCER RES, V18, P869; Huang SS, 2011, CELL REPROGRAM, V13, P465, DOI 10.1089/cell.2011.0045; Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001; Hutmacher DW, 2015, CURR OPIN BIOTECH, V35, P127, DOI 10.1016/j.copbio.2015.06.001; Jaganathan H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06468; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Lai W, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413508668; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Li YY, 2014, TISSUE ENG PT A, V20, P1379, DOI [10.1089/ten.tea.2013.0498, 10.1089/ten.TEA.2013.0498]; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Liu SQ, 2005, AM J PATHOL, V166, P891, DOI 10.1016/S0002-9440(10)62309-7; Loessner D, 2013, INTEGR BIOL-UK, V5, P597, DOI 10.1039/c3ib20252f; Loessner D, 2014, ADV DRUG DELIVER REV, V79-80, P193, DOI 10.1016/j.addr.2014.06.001; Loessner D, 2013, BIOMATERIALS, V34, P7389, DOI 10.1016/j.biomaterials.2013.06.009; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Ma M, 2011, CANCER LETT, V312, P1, DOI 10.1016/j.canlet.2011.06.028; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Merdad A, 2014, ANTICANCER RES, V34, P1355; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mueller L, 2007, AM J PATHOL, V171, P1608, DOI 10.2353/ajpath.2007.060661; NOEL A, 1993, BRIT J CANCER, V68, P909, DOI 10.1038/bjc.1993.453; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pajtler KW, 2014, ONCOTARGET, V5, P11180, DOI 10.18632/oncotarget.2611; Paunescu V, 2011, J CELL MOL MED, V15, P635, DOI 10.1111/j.1582-4934.2010.01044.x; Phinney DG, 2002, J CELL BIOCHEM, P7, DOI 10.1002/jcb.10084; Rothenberg AB, 2009, PEDIATR RADIOL, V39, P155, DOI 10.1007/s00247-008-1062-z; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Shankar V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120069; Sohara Yasuyoshi, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P1107; Song HHG, 2014, ADV DRUG DELIVER REV, V79-80, P19, DOI 10.1016/j.addr.2014.06.002; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sugiura Y, 1998, CANCER RES, V58, P2209; Szot CS, 2013, TISSUE ENG PART C-ME, V19, P864, DOI [10.1089/ten.tec.2012.0684, 10.1089/ten.TEC.2012.0684]; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Wong HL, 2007, BIOMATERIALS, V28, P5369, DOI 10.1016/j.biomaterials.2007.08.016; Yeung CW, 2009, TISSUE ENG PT A, V15, P3071, DOI [10.1089/ten.tea.2008.0661, 10.1089/ten.TEA.2008.0661]; Yuan MT, 2011, SPINE J, V11, P947, DOI 10.1016/j.spinee.2011.07.004; Zhang T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt221	82	16	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144139	10.1371/journal.pone.0144139	http://dx.doi.org/10.1371/journal.pone.0144139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657086	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900028
J	Zhang, JB; Li, BJ; Gao, JL; Shi, HQ; Wang, X; Jiang, YL; Ming, QS; Gao, YD; Ma, R; Yao, SQ				Zhang, Jibiao; Li, Baojuan; Gao, Junling; Shi, Huqing; Wang, Xiang; Jiang, Yali; Ming, Qingsen; Gao, Yidian; Ma, Ren; Yao, Shuqiao			Impaired Frontal-Basal Ganglia Connectivity in Male Adolescents with Conduct Disorder	PLOS ONE			English	Article							DISRUPTIVE BEHAVIOR DISORDERS; OPPOSITIONAL DEFIANT DISORDER; RESPONSE-INHIBITION; ANTISOCIAL-BEHAVIOR; BRAIN ABNORMALITIES; CHINESE VERSION; EXPECTED VALUE; MOTOR AREA; IMPULSIVITY; BOYS	Alack of inhibition control has been found in subjects with conduct disorder (CD), but the underlying neuropathophysiology remains poorly understood. The current study investigated the different mechanism of inhibition control in adolescent-onset CD males (n = 29) and well-matched healthy controls (HCs) (n = 40) when performing a GoStop task by functional magnetic resonance images. Effective connectivity (EC) within the inhibition control network was analyzed using a stochastic dynamic causality model. We found that EC within the inhibition control network was significantly different in the CD group when compared to the HCs. Exploratory relationship analysis revealed significant negative associations between EC between the IFG and striatum and behavioral scale scores in the CD group. These results suggest for the first time that the failure of inhibition control in subjects with CD might be associated with aberrant connectivity of the frontal-basal ganglia pathways, especially between the IFG and striatum.	[Zhang, Jibiao] Jianghan Univ, Sch Educ, Dept Psychol, Wuhan, Hubei, Peoples R China; [Zhang, Jibiao; Wang, Xiang; Jiang, Yali; Ming, Qingsen; Gao, Yidian; Ma, Ren; Yao, Shuqiao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Li, Baojuan] Fourth Mil Med Univ, Sch Biomed Engn, Xian 710032, Shaanxi, Peoples R China; [Gao, Junling] Univ Hong Kong, Ctr Buddhist Studies, Hong Kong, Hong Kong, Peoples R China; [Shi, Huqing] Shanghai Normal Univ, Dept Psychol, Shanghai, Peoples R China; [Yao, Shuqiao] Natl Technol Inst Psychiat, Changsha, Hunan, Peoples R China	Jianghan University; Central South University; Air Force Military Medical University; University of Hong Kong; Shanghai Normal University	Yao, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China.	shuqiaoyao@163.com	Gao, Yidian/GYU-8714-2022; GAO, Junling/U-9633-2018	Gao, Yidian/0000-0002-5979-2677; GAO, Junling/0000-0003-4024-4694	National Key Technologies R&D Program of China's 11th 5-year Plan [2009BAI77B02]; National Natural Science Foundation of China (NSFC) [81471384]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130162110043]	National Key Technologies R&D Program of China's 11th 5-year Plan; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by grants from the National Key Technologies R&D Program of China's 11th 5-year Plan grant 2009BAI77B02, National Natural Science Foundation of China (NSFC) grant 81471384, and Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) grant 20130162110043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aoki Y, 2014, SOC COGN AFFECT NEUR, V9, P1223, DOI 10.1093/scan/nst104; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Blair RJR, 2014, NEW ENGL J MED, V371, P2207, DOI 10.1056/NEJMra1315612; Castellanos-Ryan N, 2011, ALCOHOL CLIN EXP RES, V35, P140, DOI 10.1111/j.1530-0277.2010.01331.x; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Cohn MD, 2015, BIOL PSYCHIAT, V78, P615, DOI 10.1016/j.biopsych.2014.08.017; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dalwani MS, 2014, DRUG ALCOHOL DEPEN, V134, P242, DOI 10.1016/j.drugalcdep.2013.10.009; Daunizeau J, 2012, NEUROIMAGE, V62, P464, DOI 10.1016/j.neuroimage.2012.04.061; DeVito EE, 2013, NEUROPSYCHOPHARMACOL, V38, P1854, DOI 10.1038/npp.2013.92; Dougherty D.M., 2003, GOSTOP IMPULSIVITY P; Dougherty DM, 2003, J CHILD PSYCHOL PSYC, V44, P1145, DOI 10.1111/1469-7610.00197; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; First MB, 2002, STRUCTURED CLIN INTE; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Friston KJ, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/621670; Gong Y., 1993, WECHSLER INTELLIGENC; Herba CM, 2006, DEV NEUROPSYCHOL, V30, P659, DOI 10.1207/s15326942dn3002_2; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Hyde LW, 2013, DEV REV, V33, P168, DOI 10.1016/j.dr.2013.06.001; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Li BJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05027; Li BJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00206; Lockwood PL, 2013, CURR BIOL, V23, P901, DOI 10.1016/j.cub.2013.04.018; Ma LS, 2015, BRAIN CONNECT, V5, P177, DOI 10.1089/brain.2014.0275; Matthys W, 2013, DEV PSYCHOPATHOL, V25, P193, DOI 10.1017/S0954579412000272; O'Muircheartaigh J, 2011, NEUROIMAGE, V54, P2020, DOI 10.1016/j.neuroimage.2010.09.054; Olsson M, 2009, NORD J PSYCHIAT, V63, P102, DOI 10.1080/08039480802626939; Rubia K, 2008, AM J PSYCHIAT, V165, P889, DOI 10.1176/appi.ajp.2008.07071084; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sarkar S, 2015, EUR CHILD ADOLES PSY, V24, P909, DOI 10.1007/s00787-014-0639-3; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Stevens MC, 2012, J PSYCHIATR NEUROSCI, V37, P389, DOI 10.1503/jpn.110148; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Viding E, 2012, J ROY SOC MED, V105, P195, DOI 10.1258/jrsm.2011.110223; Vitacco MJ, 2003, ASSESSMENT, V10, P143, DOI 10.1177/1073191103010002005; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Wang MC, 2013, J CLIN PSYCHOL, V69, P966, DOI 10.1002/jclp.21978; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; White SF, 2014, J AM ACAD CHILD PSY, V53, P579, DOI 10.1016/j.jaac.2013.12.023; White SF, 2013, AM J PSYCHIAT, V170, P315, DOI 10.1176/appi.ajp.2012.12060840; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yao SQ, 2007, PERCEPT MOTOR SKILL, V104, P1169, DOI 10.2466/PMS.104.4.1169-1182; Yao SQ, 2007, CHILD PSYCHIAT HUM D, V38, P1, DOI 10.1007/s10578-006-0039-0; Yao SQ, 2009, J ADOLESCENT HEALTH, V45, P55, DOI 10.1016/j.jadohealth.2008.11.006; Zhang JB, 2014, J AM ACAD CHILD PSY, V53, P466, DOI 10.1016/j.jaac.2013.12.015; Zhong MT, 2011, BIOL PSYCHOL, V88, P233, DOI 10.1016/j.biopsycho.2011.08.007; Zhu Y, 2014, BRAIN IMAGING BEHAV, V8, P588, DOI 10.1007/s11682-013-9275-7	58	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145011	10.1371/journal.pone.0145011	http://dx.doi.org/10.1371/journal.pone.0145011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658732	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900166
J	Benavides, M; Moisander, PH; Berthelot, H; Dittmar, T; Grosso, O; Bonnet, S				Benavides, Mar; Moisander, Pia H.; Berthelot, Hugo; Dittmar, Thorsten; Grosso, Olivier; Bonnet, Sophie			Mesopelagic N-2 Fixation Related to Organic Matter Composition in the Solomon and Bismarck Seas (Southwest Pacific)	PLOS ONE			English	Article							NITROGEN; DIAZOTROPHS; DIVERSITY; WATERS; DISTRIBUTIONS; MICROORGANISMS; PHYLOTYPES; METABOLISM; EXPRESSION; ABUNDANCES	Dinitrogen (N-2) fixation was investigated together with organic matter composition in the mesopelagic zone of the Bismarck (Transect 1) and Solomon (Transect 2) Seas (Southwest Pacific). Transparent exopolymer particles (TEP) and the presence of compounds sharing molecular formulae with saturated fatty acids and sugars, as well as dissolved organic matter (DOM) compounds containing nitrogen (N) and phosphorus (P) were higher on Transect 1 than on Transect 2, while oxygen concentrations showed an opposite pattern. N-2 fixation rates (up to similar to 1 nmol N L-1 d(-1)) were higher in Transect 1 than in Transect 2, and correlated positively with TEP, suggesting a dependence of diazotroph activity on organic matter. The scores of the multivariate ordination of DOM molecular formulae and their relative abundance correlated negatively with bacterial abundances and positively with N-2 fixation rates, suggesting an active bacterial exploitation of DOM and its use to sustain diazotrophic activity. Sequences of the nifH gene clustered with Alpha-, Beta-, Gamma- and Deltaproteobacteria, and included representatives from Clusters I, III and IV. A third of the clone library included sequences close to the potentially anaerobic Cluster III, suggesting that N-2 fixation was partially supported by presumably particle-attached diazotrophs. Quantitative polymerase chain reaction (qPCR) primer-probe sets were designed for three phylotypes and showed low abundances, with a phylotype within Cluster III at up to 10(3) nifH gene copies L-1. These results provide new insights into the ecology of non-cyanobacterial diazotrophs and suggest that organic matter sustains their activity in the mesopelagic ocean.	[Benavides, Mar; Bonnet, Sophie] Univ Toulon & Var, IRD, Mediterranean Inst Oceanog MIO UM 110, Aix Marseille Univ,CNRS,INSU, Noumea 98848, New Caledonia; [Moisander, Pia H.] Univ Massachusetts, Dept Biol, N Dartmouth, MA 02747 USA; [Berthelot, Hugo; Grosso, Olivier] Univ Toulon & Var, Mediterranean Inst Oceanog MIO UM 110, Aix Marseille Univ, CNRS,INSU,IRD, F-13288 Marseille, France; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem, D-26129 Oldenburg, Germany	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Massachusetts System; University Massachusetts Dartmouth; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; Carl von Ossietzky Universitat Oldenburg	Benavides, M (corresponding author), Univ Toulon & Var, IRD, Mediterranean Inst Oceanog MIO UM 110, Aix Marseille Univ,CNRS,INSU, Noumea 98848, New Caledonia.	mar.benavides@ird.fr	Dittmar, Thorsten/L-7796-2013; Bonnet, Sophie/I-6274-2015; Hugo, BERTHELOT/Y-7435-2018; Benavides, Mar/K-5323-2015	Dittmar, Thorsten/0000-0002-3462-0107; Bonnet, Sophie/0000-0002-9886-8216; Hugo, BERTHELOT/0000-0003-1028-5938; Benavides, Mar/0000-0001-9502-108X; Moisander, Pia/0000-0002-3262-3662	Institut de Recherche pour le Developpement; People Programme (Marie Sklodowska-Curie Actions) of the European Union's Seventh Framework Programme (FP7) under Research Executive Agency (REA) grant [625185]; US National Science Foundation (NSF) Division of Ocean Sciences (OCE) [1130495]; French Ministry of Research and Education; NSF OCE grant [1029487]; French Agence National de Recherche [ANR-09-BLAN-0233-01]; Les Enveloppes Fluides et l'Environnement (INSU/LEFE) project Solwara	Institut de Recherche pour le Developpement; People Programme (Marie Sklodowska-Curie Actions) of the European Union's Seventh Framework Programme (FP7) under Research Executive Agency (REA) grant; US National Science Foundation (NSF) Division of Ocean Sciences (OCE)(National Science Foundation (NSF)); French Ministry of Research and Education; NSF OCE grant(National Science Foundation (NSF)); French Agence National de Recherche(French National Research Agency (ANR)); Les Enveloppes Fluides et l'Environnement (INSU/LEFE) project Solwara	This research was funded by Institut de Recherche pour le Developpement. MB was funded by the People Programme (Marie Sklodowska-Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under Research Executive Agency (REA) grant agreement number 625185. PM was supported by funding from the US National Science Foundation (NSF) Division of Ocean Sciences (OCE) grant number 1130495. HB was supported by a PhD scholarship from the French Ministry of Research and Education. SPICE is a contribution to the CLIVAR and GEOTRACES International programs. The MoorSPICE cruise has been co-funded by NSF OCE grant number 1029487, by French Agence National de Recherche project ANR-09-BLAN-0233-01 and by Les Enveloppes Fluides et l'Environnement (INSU/LEFE) project Solwara.	Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Baltar F, 2009, LIMNOL OCEANOGR, V54, P182, DOI 10.4319/lo.2009.54.1.0182; Benavides M, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00040; Bentzon-Tilia M, 2015, MBIO, V6, DOI 10.1128/mBio.00929-15; Bentzon-Tilia M, 2015, ISME J, V9, P273, DOI 10.1038/ismej.2014.119; Bonnet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081265; Bonnet S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003439; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Dabundo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110335; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; FARNELID H, 2008, NITROGEN FIXATION RE, P409; Farnelid H, 2013, ISME J, V7, P1413, DOI 10.1038/ismej.2013.26; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Ganachaud A, 2014, J GEOPHYS RES-OCEANS, V119, P7660, DOI 10.1002/2013JC009678; Grenier M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007477; Grossart HP, 2001, LIMNOL OCEANOGR, V46, P267, DOI 10.4319/lo.2001.46.2.0267; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Hamersley MR, 2011, AQUAT MICROB ECOL, V63, P193, DOI 10.3354/ame01494; Heller P, 2014, BIOINFORMATICS, V30, P2883, DOI 10.1093/bioinformatics/btu417; Hewson I, 2007, AQUAT MICROB ECOL, V46, P15, DOI 10.3354/ame046015; Jayakumar A, 2012, FEMS MICROBIOL ECOL, V82, P597, DOI 10.1111/j.1574-6941.2012.01430.x; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Knapp AN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00374; Koch BP, 2007, ANAL CHEM, V79, P1758, DOI 10.1021/ac061949s; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Loscher C. R., 2014, ISME J, V8, P2180, DOI DOI 10.1038/ismej.2014.71; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo YW, 2012, EARTH SYST SCI DATA, V4, P47, DOI 10.5194/essd-4-47-2012; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Moisander PH, 2014, ISME J, V8, P1962, DOI 10.1038/ismej.2014.49; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; PAERL HW, 1985, LIMNOL OCEANOGR, V30, P1246, DOI 10.4319/lo.1985.30.6.1246; PAERL HW, 1987, APPL ENVIRON MICROB, V53, P1078, DOI 10.1128/AEM.53.5.1078-1087.1987; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Rahav E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00227; Reinthaler T, 2013, GLOBAL BIOGEOCHEM CY, V27, P1151, DOI 10.1002/2013GB004634; Riedel T, 2014, ANAL CHEM, V86, P8376, DOI 10.1021/ac501946m; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Santl-Temkiv T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053550; Slemons LO, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003693; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Turk-Kubo KA, 2014, ENVIRON MICROBIOL, V16, P3095, DOI 10.1111/1462-2920.12346; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1	54	33	34	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143775	10.1371/journal.pone.0143775	http://dx.doi.org/10.1371/journal.pone.0143775			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659074	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600015
J	Sharafeldin, TA; Mor, SK; Sobhy, NM; Xing, Z; Reed, KM; Goyal, SM; Porter, RE				Sharafeldin, Tamer A.; Mor, Sunil K.; Sobhy, Nader M.; Xing, Zheng; Reed, Kent M.; Goyal, Sagar M.; Porter, Robert E.			A Newly Emergent Turkey Arthritis Reovirus Shows Dominant Enteric Tropism and Induces Significantly Elevated Innate Antiviral and T Helper-1 Cytokine Responses	PLOS ONE			English	Article							POULT ENTERITIS; AVIAN REOVIRUSES; VIRUS DISTRIBUTION; ORIGIN REOVIRUSES; YOUNG TURKEYS; CHICKENS; INFECTION; TENOSYNOVITIS; PATHOGENESIS; PATHOGENICITY	Newly emergent turkey arthritis reoviruses (TARV) were isolated from tendons of lame 15-week-old tom turkeys that occasionally had ruptured leg tendons. Experimentally, these TARVs induced remarkable tenosynovitis in gastrocnemius tendons of turkey poults. The current study aimed to characterize the location and the extent of virus replication as well as the cytokine response induced by TARV during the first two weeks of infection. One-week-old male turkeys were inoculated orally with TARV (O'Neil strain). Copy numbers of viral genes were estimated in intestines, internal organs and tendons at 1/2, 1, 2, 3, 4, 7, 14 days Post inoculation (dpi). Cytokine profile was measured in intestines, spleen and leg tendons at 0, 4, 7 and 14 dpi. Viral copy number peaked in jejunum, cecum and bursa of Fabricius at 4 dpi. Copy numbers increased dramatically in leg tendons at 7 and 14 dpi while minimal copies were detected in internal organs and blood during the same period. Virus was detected in cloacal swabs at 1-2 dpi, and peaked at 14 dpi indicating enterotropism of the virus and its early shedding in feces. Elevation of IFN-alpha and IFN-beta was observed in intestines at 7 dpi as well as a prominent T helper-1 response (IFN-gamma) at 7 and 14 dpi. IFN-gamma and IL-6 were elevated in gastrocnemius tendons at 14 dpi. Elevation of antiviral cytokines in intestines occurred at 7dpi when a significant decline of viral replication in intestines was observed. T helper-1 response in intestines and leg tendons was the dominant T-helper response. These results suggest the possible correlation between viral replication and cytokine response in early infection of TARV in turkeys. Our findings provide novel insights which help elucidate viral pathogenesis in turkey tendons infected with TARV.	[Sharafeldin, Tamer A.; Mor, Sunil K.; Sobhy, Nader M.; Goyal, Sagar M.; Porter, Robert E.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Sharafeldin, Tamer A.; Mor, Sunil K.; Sobhy, Nader M.; Goyal, Sagar M.; Porter, Robert E.] Univ Minnesota, Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA; [Xing, Zheng; Reed, Kent M.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Sharafeldin, Tamer A.] Zagazig Univ, Fac Vet Med, Dept Pathol, Zagazig 44519, Egypt; [Xing, Zheng] Nanjing Univ, Sch Med, Nanjing 210093, Jiangsu, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Egyptian Knowledge Bank (EKB); Zagazig University; Nanjing University	Sharafeldin, TA (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	shara022@umn.edu	Xing, Zheng/O-3137-2015; Sharafeldin, Tamer/E-6495-2016; Sobhy, Nader/AAA-2339-2021; Mor, Sunil Kumar/M-6325-2018	Xing, Zheng/0000-0002-7288-0268; Sharafeldin, Tamer/0000-0001-6422-4730; Mor, Sunil Kumar/0000-0002-1112-088X; Sobhy, Nader/0000-0002-9834-9627	Rapid Agriculture Response Fund, University Of Minnesota (RARF); Rapid Agricultural Response Fund	Rapid Agriculture Response Fund, University Of Minnesota (RARF); Rapid Agricultural Response Fund	This work was supported by Rapid Agriculture Response Fund, University Of Minnesota (RARF), https://www.maes.umn.edu/research/rapid-ag to SG.; This study was funded in part by the Rapid Agricultural Response Fund, established by the Minnesota legislature and administered by the University of Minnesota Agricultural Experiment Station. We thank Dr. Jack Rosenberger for providing TARV-O'Neil for the study.	Al Afaleq AA, 1980, AVIAN PATHOL, V18, P433; ALAFALEQ A, 1994, RES VET SCI, V57, P96, DOI 10.1016/0034-5288(94)90088-4; Calvert AJ, 2012, LIGHT TURKEY SYNDROM; Day JM, 2008, AVIAN DIS, V52, P387, DOI 10.1637/8190-120607-Reg; Forrest JC, 2003, J VIROL, V77, P9109, DOI 10.1128/JVI.77.17.9109-9115.2003; Haritova A. M., 2012, Bulgarian Journal of Veterinary Medicine, V15, P13; Heggen-Peay CL, 2002, AVIAN DIS, V46, P32, DOI 10.1637/0005-2086(2002)046[0032:IOARFP]2.0.CO;2; Islam MR, 1988, AVIAN PATHOL, V17, P421; Jindal N, 2010, POULTRY SCI, V89, P217, DOI 10.3382/ps.2009-00424; Jindal N, 2009, AVIAN DIS, V53, P268, DOI 10.1637/8513-110308-Reg.1; JONES RC, 1984, AVIAN PATHOL, V13, P13, DOI 10.1080/03079458408418504; JONES RC, 1989, AVIAN PATHOL, V18, P239, DOI 10.1080/03079458908418599; KIBENGE FSB, 1987, AVIAN DIS, V31, P39, DOI 10.2307/1590769; KIBENGE FSB, 1985, AVIAN PATHOL, V14, P87, DOI 10.1080/03079458508436210; Komatsu N, 2015, INT J BIOCHEM CELL B, V58, P92, DOI 10.1016/j.biocel.2014.11.008; Lai CM, 2013, MBIO, V4, DOI [10.1128/mBio.00049-13, 10.1128/mBio.00405-13]; LEVISOHN S, 1980, AVIAN PATHOL, V9, P1, DOI 10.1080/03079458008418380; Liu HJ, 2008, MOL CELLS, V26, P396; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lojkic I, 2010, ACTA VET BRNO, V79, P91, DOI 10.2754/avb201079010091; Mor SK, 2014, AVIAN DIS, V58, P404, DOI 10.1637/10779-012314-Reg.1; Mor SK, 2013, AVIAN PATHOL, V42, P497, DOI 10.1080/03079457.2013.832145; Mor SK, 2013, AVIAN DIS, V57, P97, DOI 10.1637/10353-090712-Reg.1; NERSESSIAN BN, 1985, AVIAN DIS, V29, P963, DOI 10.2307/1590449; PAGE RK, 1982, AVIAN DIS, V26, P924, DOI 10.2307/1589881; Pantin-Jackwood MJ, 2007, VET PATHOL, V44, P185, DOI 10.1354/vp.44-2-185; SAHU SP, 1975, AM J VET RES, V36, P847; Sharafeldin TA, 2015, VET RES, V46, DOI 10.1186/s13567-015-0144-9; Sharafeldin TA, 2014, AVIAN PATHOL, V43, P371, DOI 10.1080/03079457.2014.940496; Shen Pin-Chun, 2014, Taiwan Veterinary Journal, V40, P29, DOI 10.1142/S1682648514500048; Spackman E, 2005, AVIAN PATHOL, V34, P291, DOI 10.1080/03079450500178501; WALKER ER, 1972, J ULTRA MOL STRUCT R, V41, P67, DOI 10.1016/S0022-5320(72)90039-1; Woolcock PR, 2008, AVIAN DIS, V52, P209, DOI 10.1637/8106-090607-Reg.1	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144085	10.1371/journal.pone.0144085	http://dx.doi.org/10.1371/journal.pone.0144085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659460	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903600021
J	Yu, XT; Wang, PY; Shi, ZM; Dong, K; Feng, P; Wang, HX; Wang, XJ				Yu, XiaoTong; Wang, PengYan; Shi, ZhengMing; Dong, Kun; Feng, Ping; Wang, HongXia; Wang, XueJiang			Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; STEM-CELLS; GROWTH-FACTOR; LIVER-CANCER; RECEPTOR; EXPRESSION; RAT; RISE; BETA	Urotensin II (UII), a somatostatin-like cyclic peptide, is involved in tumor progression due to its mitogenic effect. Our previous study demonstrated that UII and its receptor UT were up-regulated in human hepatocellular carcinoma (HCC), and exogenous UII promoted proliferation of human hepatoma cell line BEL-7402. Hepatic progenitor cell (HPCs) are considered to be one of the origins of liver cancer cells, but their relationship with UII remains unclear. In this work, we aimed to investigate the effect of UII on ROS generation in HPCs and the mechanisms of UII-induced ROS in promoting cell proliferation. Human HCC samples were used to examine ROS level and expression of NADPH oxidase. Hepatic oval cell line WBF-344 was utilized to investigate the underlying mechanisms. ROS level was detected by dihydroethidium (DHE) or 2', 7'-dichlorofluorescein diacetate (DCF-DA) fluorescent probe. For HCC samples, ROS level and expression of NADPH oxidase were significantly up-regulated. In vitro, UII also increased ROS generation and expression of NADPH oxidase in WB-F344 cells. NADPH oxidase inhibitor apocynin pretreatment partially abolished UII-increased phosphorylation of PI3K/Akt and ERK, expression of cyclin E/cyclin-dependent kinase 2. Cell cycle was then analyzed by flow cytometry and UII-elevated S phase proportion was inhibited by apocynin pretreatment. Finally, bromodeoxyuridine (Brdu) incorporation assay showed that apocynin partially abolished UII induced cell proliferation. In conclusion, this study indicates that UII-increased ROS production via the NADPH oxidase pathway is partially associated with activation of the PI3K/Akt and ERK cascades, accelerates G1/S transition, and contributes to cell proliferation. These results showed that UII plays an important role in growth of HPCs, which provides novel evidence for the involvement of HPCs in the formation and pathogenesis of HCC.	[Yu, XiaoTong; Feng, Ping; Wang, HongXia; Wang, XueJiang] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Yu, XiaoTong; Feng, Ping; Wang, XueJiang] Capital Med Univ, Beijing Key Lab Canc Invas & Metastasis Res, Beijing, Peoples R China; [Wang, PengYan] Peking Union Med Hosp, Dept Pathol, Beijing, Peoples R China; [Shi, ZhengMing] Beijing Jishuitan Hosp, Dept Gen Surg, Beijing, Peoples R China; [Dong, Kun] Capital Med Univ, Beijing Youan Hosp, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University	Wang, XJ (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	xjwang@ccmu.edu.cn			National Natural Science Foundation of China [81272757]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality [IDHT20150502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality	This work was supported by grants from National Natural Science Foundation of China (Grant No. 81272757) and the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality (Grant No. IDHT20150502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2005, STEM CELL REV, V1, P253, DOI 10.1385/SCR:1:3:253; Baek SH, 2015, IMMUNOPHARM IMMUNOT, V37, P265, DOI 10.3109/08923973.2015.1027916; Barrette Pierre-Olivier, 2012, Front Endocrinol (Lausanne), V3, P165, DOI 10.3389/fendo.2012.00165; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Ghosh D, 2012, CHEM-BIOL INTERACT, V195, P206, DOI 10.1016/j.cbi.2011.12.004; He J, 2012, EMBO REP, V13, P1116, DOI 10.1038/embor.2012.162; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Monika H, 2015, MOL CARCINOG, DOI [10.1002/mc.22255, DOI 10.1002/MC.22255]; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Onan D, 2004, TRENDS ENDOCRIN MET, V15, P175, DOI 10.1016/j.tem.2004.03.007; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Qi L, 2013, BIOCHIM BIOPHYS ACTA, V1833, P3375, DOI [10.1016/j.bbamcr.2013.09.018 Epub 2013 Oct 8, DOI 10.1016/J.BBAMCR.2013.09.018]; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Takahashi K, 2003, PEPTIDES, V24, P301, DOI 10.1016/S0196-9781(03)00039-1; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Wang HX, 2013, FREE RADICAL BIO MED, V65, P897, DOI 10.1016/j.freeradbiomed.2013.08.179; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076796; Wang HX, 2011, PEPTIDES, V32, P382, DOI 10.1016/j.peptides.2010.10.032; Wong Robert, 2011, Gastroenterol Hepatol (N Y), V7, P16; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Xu Lei-Bo, 2014, World J Stem Cells, V6, P579, DOI 10.4252/wjsc.v6.i5.579; Xu RH, 2015, CLIN TRANSL ONCOL, V17, P230, DOI 10.1007/s12094-014-1218-2; Yoshimoto T, 2004, PEPTIDES, V25, P1775, DOI 10.1016/j.peptides.2004.03.028; Yu XT, 2014, MOLECULES, V19, P20768, DOI 10.3390/molecules191220768; Yun SP, 2014, BRIT J PHARMACOL, V171, P3283, DOI 10.1111/bph.12681; Zamule SM, 2011, CHEM-BIOL INTERACT, V190, P62, DOI 10.1016/j.cbi.2011.01.009; Zeng ZP, 2006, ANN NY ACAD SCI, V1073, P284, DOI 10.1196/annals.1353.032	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144433	10.1371/journal.pone.0144433	http://dx.doi.org/10.1371/journal.pone.0144433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658815	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903600044
J	Davis, CM; DeCicco-Skinner, KL; Hienz, RD				Davis, Catherine M.; DeCicco-Skinner, Kathleen L.; Hienz, Robert D.			Deficits in Sustained Attention and Changes in Dopaminergic Protein Levels following Exposure to Proton Radiation Are Related to Basal Dopaminergic Function	PLOS ONE			English	Article							HEAVY-PARTICLE IRRADIATION; WORKING-MEMORY; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; REACTIVE MICROGLIA; FE-56 PARTICLES; HZE PARTICLE; RATS; LEWIS; BEHAVIOR	The current report assessed the effects of low-level proton irradiation in inbred adult male Fischer 344 and Lewis rats performing an analog of the human Psychomotor Vigilance Test (PVT), commonly utilized as an object risk assessment tool to quantify fatigue and sustained attention in laboratory, clinical, and operational settings. These strains were used to determine if genetic differences in dopaminergic function would impact radiation-induced deficits in sustained attention. Exposure to head-only proton irradiation (25 or 100 cGy) disrupted rPVT performance in a strain-specific manner, with 25 cGy-exposed Fischer 344 rats displaying the most severe deficits in sustained attention (i.e., decreased accuracy and increased premature responding); Lewis rats did not display behavioral deficits following radiation. Fischer 344 rats displayed greater tyrosine hydroxylase and dopamine transporter levels in the frontal cortex compared to the Lewis rats, even though radiation exposure increased both of these proteins in the Lewis rats only. Tyrosine hydroxylase was decreased in the parietal cortex of both rat strains following radiation exposure, regardless of proton dose. Strain-specific cytokine changes were also found in the frontal cortex, with the Lewis rats displaying increased levels of putative neurotrophic cytokines (e.g., CNTF). These data support the hypothesis that basal dopaminergic function impacts the severity of radiation-induced deficits in sustained attention.	[Davis, Catherine M.; Hienz, Robert D.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA; [DeCicco-Skinner, Kathleen L.] Amer Univ, Dept Biol, Washington, DC 20016 USA	Johns Hopkins University; American University	Davis, CM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA.	cdavis91@jhmi.edu		Davis-Takacs, Catherine/0000-0002-2591-6352; DeCicco-Skinner, Kathleen/0000-0002-0256-5609	National Space Biomedical Research Institute (NSBRI) through NASA [NCC 9-58, NBPF01604, NBPF02802, NBPF04201, PF02602, EO00010]; NASA [NNX15AC71G]	National Space Biomedical Research Institute (NSBRI) through NASA; NASA(National Aeronautics & Space Administration (NASA))	Supported by the National Space Biomedical Research Institute (NSBRI) through NASA cooperative agreement NCC 9-58, grants NBPF01604 (RDH), NBPF02802 (RDH), NBPF04201 (RDH), PF02602 (CMD), EO00010 (CMD), and NASA NNX15AC71G (CMD).	Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Caspi RR, 1996, J IMMUNOL, V157, P2668; Chamberlain SR, 2006, CURR OPIN NEUROL, V19, P607, DOI 10.1097/01.wco.0000247613.28859.77; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Davis CM, 2014, RADIAT RES, V181, P258, DOI 10.1667/RR13359.1; Davis CM, 2010, ANN NY ACAD SCI, V1187, P247, DOI 10.1111/j.1749-6632.2009.05147.x; Elenkov IJ, 2008, J IMMUNOL, V181, P1737, DOI 10.4049/jimmunol.181.3.1737; Emerich DF, 2014, ADV DRUG DELIVER REV, V67-68, P131, DOI 10.1016/j.addr.2013.07.008; Flores G, 1998, BRAIN RES, V814, P34, DOI 10.1016/S0006-8993(98)01011-7; Gulley JM, 2007, BRAIN RES, V1151, P32, DOI 10.1016/j.brainres.2007.03.009; Haile CN, 2001, SYNAPSE, V41, P179, DOI 10.1002/syn.1073; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; JOSEPH JA, 1992, RADIAT RES, V130, P88, DOI 10.2307/3578484; Joseph JA, 1998, ADV SPACE RES, V22, P209, DOI 10.1016/S0273-1177(98)80012-4; JOSEPH JA, 1988, PHARMACOL BIOCHEM BE, V29, P335, DOI 10.1016/0091-3057(88)90166-9; Joseph JA, 2000, ADV SPACE RES, V25, P2057, DOI 10.1016/S0273-1177(99)01013-3; Koike Y, 2005, ACTA ASTRONAUT, V56, P367, DOI 10.1016/j.actaastro.2004.05.068; Kosten TA, 2002, PSYCHONEUROENDOCRINO, V27, P35, DOI 10.1016/S0306-4530(01)00035-X; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033767; Macmillan N. A., 1991, DETECTION THEORY USE; McGeer PL, 1998, ALZ DIS ASSOC DIS, V12, pS1; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mehta MA, 2006, CURR PHARM DESIGN, V12, P2487, DOI 10.2174/138161206777698891; Natelson BH, 2005, CLIN DIAGN LAB IMMUN, V12, P52, DOI 10.1128/CDLI.12.1.52-55.2005; Owen A M, 1999, Adv Neurol, V80, P49; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Rabin BM, 2005, RADIAT RES, V164, P552, DOI 10.1667/RR3349.1; Rabin BM, 2004, ADV SPACE RES, V33, P1330, DOI 10.1016/j.asr.2003.09.051; Rabin BM, 2002, J RADIAT RES, V43, pS225; Rabin BM, 2001, PHYS MEDICA, V17, P196; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Sakamoto S, 2001, MICROBIOL IMMUNOL, V45, P373, DOI 10.1111/j.1348-0421.2001.tb02633.x; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Savage CR, 1997, PSYCHIAT CLIN N AM, V20, P911, DOI 10.1016/S0193-953X(05)70352-X; Shtemberg AS, 2015, NEUROCHEM J+, V9, P66, DOI 10.1134/S1819712415010109; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Shukitt-Hale B, 2004, ADV SPACE RES-SERIES, V33, P1334, DOI 10.1016/j.asr.2003.10.038; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wersinger C, 2006, CURR MED CHEM, V13, P591, DOI 10.2174/092986706776055760; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028	45	32	33	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144556	10.1371/journal.pone.0144556	http://dx.doi.org/10.1371/journal.pone.0144556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658810	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903500040
J	Deng, XF; Chen, SJ; Bai, Y; Song, W; Chen, YC; Li, DX; Han, H; Liu, B				Deng, Xuefei; Chen, Shijun; Bai, Ya; Song, Wen; Chen, Yongchao; Li, Dongxue; Han, Hui; Liu, Bin			Vascular Complications of Intercavernous Sinuses during Transsphenoidal Surgery: An Anatomical Analysis Based on Autopsy and Magnetic Resonance Venography	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; GIANT PITUITARY-ADENOMAS; TRANSCRANIAL RESECTION; SELLAR REGION; VENOUS SYSTEM; MACROADENOMA; MANAGEMENT; DIAGNOSIS; SUPERIOR; TUMORS	Purpose Vascular complications induced by intercavernous sinus injury during dural opening in the transsphenoidal surgery may contribute to incomplete tumour resections. Preoperative neuro-imaging is of crucial importance in planning surgical approach. The aim of this study is to correlate the microanatomy of intercavernous sinuses with its contrast-enhanced magnetic resonance venography (CE-MRV). Methods Eighteen human adult cadavers and 24 patients were examined based on autopsy and CE-MRV. Through dissection of the cadavers and CE-MRV, the location, shape, number, diameter and type of intercavernous sinuses were measured and compared. Results Different intercavernous sinuses were identified by their location and shape in all the cadavers and CE-MRV. Compared to the cadavers, CE-MRV revealed 37% of the anterior intercavernous sinus, 48% of the inferior intercavernous sinus, 30% of the posterior intercavernous sinus, 30% of the dorsum sellae sinus and 100% of the basilar sinus. The smaller intercavernous sinuses were not seen in the neuro-images. According to the presence of the anterior and inferior intercavernous sinus, four types of the intercavernous sinuses were identified in cadavers and CE-MRV, and the corresponding operative space in the transsphenoidal surgical approach was implemented. Conclusion Themorphology and classification of the cavernous sinus can be identified by CE-MRV, especially for the larger vessels, which cause bleeding more easily. Therefore, CE-MRV provides a reliable measure for individualized preoperative planning during transsphenoidal surgery.	[Deng, Xuefei; Chen, Shijun; Han, Hui] Anhui Med Univ, Dept Anat, Hefei, Anhui, Peoples R China; [Bai, Ya; Song, Wen; Liu, Bin] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China; [Chen, Yongchao] PLA, Hosp 105, Ultrason Ctr, Hefei, Anhui, Peoples R China; [Li, Dongxue] Anhui Prov Hosp, Dept Neurosurg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, YC (corresponding author), PLA, Hosp 105, Ultrason Ctr, Hefei, Anhui, Peoples R China.	chenyongchaosnn@163.com; llwind@ahmu.edu.cn			National Natural Science Foundation of China [81200895]; Medical and Health Foundation of Nanjing Military Area [12z12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Foundation of Nanjing Military Area	The project was funded by the National Natural Science Foundation of China (Reference No: 81200895, XFD, URL: http://www.nsfc.gov.cn/) and the Medical and Health Foundation of Nanjing Military Area (Reference No: 12z12, YCC, URL: http://105yy.cn).	Agazzi S, 2010, SKULL BASE-INTERD AP, V20, P143, DOI 10.1055/s-0029-1246227; Alleyne CH, 2002, SURG NEUROL, V57, P380, DOI 10.1016/S0090-3019(02)00705-X; AQUINI MG, 1994, SKULL BASE SURG, V4, P145, DOI 10.1055/s-2008-1058966; Boxerman JL, 2010, AM J ROENTGENOL, V195, P720, DOI 10.2214/AJR.09.4128; Buchfelder M, 2008, PITUITARY, V11, P375, DOI 10.1007/s11102-008-0120-8; Burgers AMG, 2011, J CLIN ENDOCR METAB, V96, pE1163, DOI 10.1210/jc.2010-2673; Christian E, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14360; Di Somma A, 2014, RHINOLOGY, V52, P195, DOI [10.4193/Rhin13.165, 10.4193/Rhino13.165]; Gondim JA, 2015, J NEUROSURG, V123, P31, DOI 10.3171/2014.10.JNS14372; Guo FY, 2012, CLIN NEUROL NEUROSUR, V114, P885, DOI 10.1016/j.clineuro.2012.01.033; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Han H, 2010, NEUROSURGERY, V67, P9, DOI 10.1227/01.NEU.0000381683.27324.14; Han Hui, 2008, Neurosurgery, V62, pONS289, DOI 10.1227/01.neu.0000326009.46197.ab; Hazer DB, 2013, J NEUROSURG, V119, P1467, DOI 10.3171/2013.8.JNS13224; Hong YA, 2010, NEUROL INDIA, V58, P33, DOI 10.4103/0028-3886.73742; Jahangiri A, 2016, J NEUROSURG, V124, P589, DOI 10.3171/2015.1.JNS141543; KAPLAN HA, 1976, J NEUROSURG, V45, P166, DOI 10.3171/jns.1976.45.2.0166; Kilic T, 2005, EUR J RADIOL, V56, P212, DOI 10.1016/j.ejrad.2005.05.003; Kim EH, 2009, ACTA NEUROCHIR, V151, P803, DOI 10.1007/s00701-009-0356-8; Komotar RJ, 2012, PITUITARY, V15, P150, DOI 10.1007/s11102-011-0359-3; Lee JM, 2005, SURG NEUROL, V64, P128, DOI 10.1016/j.surneu.2004.10.029; Liauw L, 2000, RADIOLOGY, V214, P678, DOI 10.1148/radiology.214.3.r00mr41678; Little AS, 2015, J NEUROSURG, V123, P799, DOI 10.3171/2014.10.JNS14921; Mason RB, 1997, J NEUROSURG, V87, P343, DOI 10.3171/jns.1997.87.3.0343; MEROLA B, 1988, WORLD J SURG, V12, P445, DOI 10.1007/BF01655415; Mizutani K, 2015, CLIN NEUROL NEUROSUR, V131, P31, DOI 10.1016/j.clineuro.2015.01.021; Orozco LD, 2012, NEUROSURGERY, V71, pE204, DOI 10.1227/NEU.0b013e31825b1eac; Pratheesh R, 2013, PITUITARY, V16, P419, DOI 10.1007/s11102-012-0439-z; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; Svider PF, 2015, INT FORUM ALLERGY RH, V5, P659, DOI 10.1002/alr.21511; THERON J, 1979, NEURORADIOLOGY, V18, P23, DOI 10.1007/BF00346207; Tosaka M, 2015, NEUROL RES, V37, P951, DOI 10.1179/1743132815Y.0000000078; Tubbs RS, 2014, WORLD NEUROSURG, V82, pE475, DOI 10.1016/j.wneu.2012.11.052; Xiao DY, 2015, INT J CLIN EXP MED, V8, P5370; Zhou WG, 2009, CHINESE MED J-PEKING, V122, P1154, DOI 10.3760/cma.j.issn.0366-6999.2009.10.007	35	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144771	10.1371/journal.pone.0144771	http://dx.doi.org/10.1371/journal.pone.0144771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658152	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500060
J	Huber, R; Panterodt, T; Welz, B; Christmann, M; Friesenhagen, J; Westphal, A; Pietsch, D; Brand, K				Huber, Rene; Panterodt, Thomas; Welz, Bastian; Christmann, Martin; Friesenhagen, Judith; Westphal, Andreas; Pietsch, Daniel; Brand, Korbinian			C/EBP beta-LAP*/LAP Expression Is Mediated by RSK/eIF4B-Dependent Signalling and Boosted by Increased Protein Stability in Models of Monocytic Differentiation	PLOS ONE			English	Article							TRANSLATION INITIATION; GENE-EXPRESSION; TRANSCRIPTION FACTORS; S6 PHOSPHORYLATION; CALPAIN SYSTEM; MESSENGER-RNAS; CELLS; PROTEASOME; ALPHA; CANCER	The transcription factor C/EBP beta plays a key role in monocytic differentiation and inflammation. Its small isoform LIP is associated with proliferation at early premonocytic developmental stages and regulated via mTOR-dependent signalling. During later stages of (pre) monocytic differentiation there is a considerable increase in the large C/EBP beta isoforms LAP*/LAP which inhibit proliferation thus supporting terminal differentiation. Here, we showed in different models of monocytic differentiation that this dramatic increase in the LAP*/LAP protein and LAP/LIP ratio was accompanied by an only modest/retarded mRNA increase suggesting an important role for (post) translational mechanisms. We found that LAP*/LAP formation was induced via MEK/RSK-dependent cascades, whereas mTOR/S6K1 were not involved. Remarkably, LAP*/LAP expression was dependent on phosphorylated eIF4B, an acceleratory protein of RNA helicase eIF4A. PKR inhibition reduced the expression of eIF4B and C/EBP beta in an eIF2 alpha-independent manner. Furthermore, under our conditions a marked stabilisation of LAP*/LAP protein occurred, accompanied by reduced chymotrypsin-like proteasome/calpain activities and increased calpastatin levels. Our study elucidates new signalling pathways inducing LAP*/LAP expression and indicates new alternative PKR functions in monocytes. The switch from mTOR- to RSK-mediated signalling to orchestrate eIF4B-dependent LAP*/LAP translation, accompanied by increased protein stability but only small mRNA changes, may be a prototypical example for the regulation of protein expression during selected processes of differentiation/proliferation.	[Huber, Rene; Panterodt, Thomas; Welz, Bastian; Christmann, Martin; Friesenhagen, Judith; Westphal, Andreas; Pietsch, Daniel; Brand, Korbinian] Hannover Med Sch, Inst Clin Chem, D-30625 Hannover, Germany	Hannover Medical School	Brand, K (corresponding author), Hannover Med Sch, Inst Clin Chem, D-30625 Hannover, Germany.	brand.korbinian@mh-hannover.de	Christmann, Martin/AFT-2159-2022	Christmann, Martin/0000-0003-2646-5538; Huber, Rene/0000-0002-1041-9935	German Research Foundation [SFB 566/B17]; Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin (DGKL; Stiftung fur Pathobiochemie und Molekulare Diagnostik) [2012/14, 2014/15]	German Research Foundation(German Research Foundation (DFG)); Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin (DGKL; Stiftung fur Pathobiochemie und Molekulare Diagnostik)	This work was supported by the German Research Foundation (grant SFB 566/B17 to KB; www.dfg.de) and the Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin (DGKL; Stiftung fur Pathobiochemie und Molekulare Diagnostik; grant 2012/14 to KB and DP, grant 2014/15 to MC; www.dgkl.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Ali A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3667; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Atwood AA, 2010, ONCOGENE, V29, P6004, DOI 10.1038/onc.2010.336; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; BRAND K, 1993, J CLIN INVEST, V91, P2031, DOI 10.1172/JCI116425; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Galicia-Vazquez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087237; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Grolleau A, 2000, J CLIN INVEST, V106, P1561, DOI 10.1172/JCI9352; Gunther J, 2014, J IMMUNOL, V192, P3143, DOI 10.4049/jimmunol.1301610; Gutsch R, 2011, J BIOL CHEM, V286, P22716, DOI 10.1074/jbc.M110.152538; Haas SC, 2010, BRIT J HAEMATOL, V148, P777, DOI 10.1111/j.1365-2141.2009.08012.x; Hagner PR, 2011, ONCOGENE, V30, P1531, DOI 10.1038/onc.2010.533; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Kuang PP, 2005, AM J PHYSIOL-CELL PH, V289, pC766, DOI 10.1152/ajpcell.00525.2004; Kunjappu MJ, 2014, BBA-MOL CELL RES, V1843, P2, DOI 10.1016/j.bbamcr.2013.03.008; Lechner S, 2013, DIFFERENTIATION, V85, P20, DOI 10.1016/j.diff.2012.11.001; Li XR, 2009, J MOL BIOL, V391, P729, DOI 10.1016/j.jmb.2009.06.055; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pham TH, 2007, J BIOL CHEM, V282, P21924, DOI 10.1074/jbc.M611618200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; SEARS RC, 1994, MOL CELL BIOL, V14, P4855, DOI 10.1128/MCB.14.7.4855; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Um JW, 2010, J BIOL CHEM, V285, P36434, DOI 10.1074/jbc.M110.133777; Wang XN, 2006, J CELL PHYSIOL, V209, P253, DOI 10.1002/jcp.20731; Wei W, 2006, J CELL PHYSIOL, V208, P386, DOI 10.1002/jcp.20684; Welm AL, 1999, MOL CELL BIOL, V19, P1695; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Yajima Y, 2002, BIOL CHEM, V383, P757, DOI 10.1515/BC.2002.079; Yajima Y, 2006, ENDOCRINOLOGY, V147, P4811, DOI 10.1210/en.2005-1647; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V419, P550, DOI 10.1016/j.bbrc.2012.02.058; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144338	10.1371/journal.pone.0144338	http://dx.doi.org/10.1371/journal.pone.0144338			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646662	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903100019
J	Liu, YM; Li, Y; Bin Wei, W; Xu, XL; Jonas, JB				Liu, Yue Ming; Li, Yang; Bin Wei, Wen; Xu, Xiaolin; Jonas, Jost B.			Clinical Characteristics of 582 Patients with Uveal Melanoma in China	PLOS ONE			English	Article							YOUNG-PATIENTS; RISK-FACTORS; CELL-TYPE; SURVIVAL; PROGNOSIS; MELANOGENESIS; METASTASIS; RADIATION; EUROPE; SIZE	Objective To assess clinical characteristics, treatment and survival of patients with uveal melanoma in China. Methods The retrospective study included all patients with malignant uveal melanoma who were consecutively examined in the study period from January 2005 and June 2015 in the Beijing Tongren hospital. Results The mean age of the 582 patients (295(50.7%) women) was 44.6 +/- 12.6 years (range: 5-77 years). The tumors were located most often in the superior temporal region (in 117(21.5%) patients) and least common in the inferior region (in 31(5.7%) patients). In 548(94.2%) patients, the tumors were located in the choroid, in 33(5.7%) patients in the ciliary body, and in one (0.2%) patient in the iris. Treatment included episcleral brachytherapy (415(71.3%) patients), local tumor resection (48(8.2%) patients) and primary enucleation (119(20.4%) patients). In 53 individuals out of the 415 patients with primary brachytherapy, episcleral brachytherapy was followed by enucleation, due to an increasing tumor size or due to uncontrolled neovascular glaucoma. Median follow-up time was of 30 months (range: 1-124 months; mean: 34.8 +/- 24.4 months). Overall survival rate at 5 and 10 years was of 92.7% and 85.1%. Younger age (P = 0.017), tumor location in the nasal meridian(P = 0.004), smaller tumor size (P<0.001), hemispheric tumor shape (P = 0.025), histological tumor cell type (spindle-cell type versus epitheloid cell type;P = 0.014), and type of treatment (episcleral brachytherapy versus local tumor resection and versus primary enucleation; P<0.001) were significantly associated with the overall survival in univariate analysis, while in multivariate analysis only smaller tumor size was significantly (P<0.001; RR: 4.75; 95% confidence interval: 2.11,10.7) associated with better overall survival. Conclusions In this study on clinical characteristics of uveal melanoma of a larger group of patients from China, the onset age was considerably younger and survival rate better than in studies from Western countries. Tumor size was the most significant factor for survival.	[Liu, Yue Ming; Li, Yang; Bin Wei, Wen] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Xu, Xiaolin; Jonas, Jost B.] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Bin Wei, W (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	weiwenbintr@163.com			Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; National Natural Science Foundation of China [81272981]; Beijing Natural Science Foundation [7151003, 7112031]; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau [2014-2-003]	Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau	Supported by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, code: ZYLX201307; National Natural Science Foundation of China, NO. 81272981; Beijing Natural Science Foundation, NO. 7151003, 7112031; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM, 1998, AM J OPHTHALMOL, V125, P779; Apt L, 1962, INT OPHTHALMOL CLIN, V2, P403, DOI DOI 10.1097/00004397-196206000-00008; BARR CC, 1981, ARCH OPHTHALMOL-CHIC, V99, P2133; Bergman L, 2003, INVEST OPHTH VIS SCI, V44, P3282, DOI 10.1167/iovs.03-0081; Biswas Jyotirmay, 2004, Indian Journal of Ophthalmology, V52, P41; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Burr JM, 2007, OPHTHAL EPIDEMIOL, V14, P3, DOI 10.1080/09286580600977281; Callender G., 1931, T AM ACAD OPHTHALMOL, V36, P131; Collaborative Ocular Melanoma Grp, 2006, ARCH OPHTHALMOL-CHIC, V124, P1684; Collaborative Ocular Melanoma Study (COMS), 1995, GROUP COMS MAN PROC; Coupland SE, 2008, OPHTHALMOLOGY, V115, P1778, DOI 10.1016/j.ophtha.2008.04.025; Damato B, OPHTHALMOLOGY, V114, P1925; Ewens KG, 2014, INVEST OPHTH VIS SCI, V55, P5160, DOI 10.1167/iovs.14-14550; Frenkel S, 2009, ISR MED ASSOC J, V11, P280; Gill HS, 2012, CAN J OPHTHALMOL, V47, P246, DOI 10.1016/j.jcjo.2012.03.038; Graell X., 2007, Arch Soc Esp Oftalmol, V82, P343; Hawkins BS, 2004, AM J OPHTHALMOL, V138, P936, DOI DOI 10.1016/J.AJ0.2004.07.006; Kaliki S, 2013, EUR J OPHTHALMOL, V23, P208, DOI 10.5301/ejo.5000200; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; Lake SL, 2013, AM J PATHOL, V182, P678, DOI 10.1016/j.ajpath.2012.11.036; MCLEAN IW, 1982, HUM PATHOL, V13, P123; MCLEAN IW, 1983, AM J OPHTHALMOL, V96, P502, DOI 10.1016/S0002-9394(14)77914-0; Paul EV, 1962, INT OPHTHALMOL CLIN, V2, P387, DOI [10.1097/00004397-196206000-00007, DOI 10.1097/00004397-196206000-00007]; Pogrzebielski A, 2006, GRAEF ARCH CLIN EXP, V244, P1646, DOI 10.1007/s00417-006-0347-x; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Schoenfield L, 2014, ADV ANAT PATHOL, V21, P138, DOI 10.1097/PAP.0000000000000010; SEDDON JM, 1987, ARCH OPHTHALMOL-CHIC, V105, P801, DOI 10.1001/archopht.1987.01060060087039; Shields CL, 2015, EYE, V29, P1027, DOI 10.1038/eye.2015.51; Shields CL, 2012, RETINA-J RET VIT DIS, V32, P1363, DOI 10.1097/IAE.0b013e31824d09a8; Shields CL, 2011, OPHTHALMOLOGY, V118, P396, DOI 10.1016/j.ophtha.2010.05.023; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P989, DOI 10.1001/archophthalmol.2009.208; Singh AD, 2003, OPHTHALMOLOGY, V110, P962, DOI 10.1016/S0161-6420(03)00077-0; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Vicente N, 2013, Arch Soc Esp Oftalmol, V88, P433, DOI 10.1016/j.oftal.2013.06.003; Virgili G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1413, DOI 10.1001/archopht.126.10.1413; Virgili G, 2007, OPHTHALMOLOGY, V114, P2309, DOI 10.1016/j.ophtha.2007.01.032; Zloto O, 2013, INVEST OPHTH VIS SCI, V54, P652, DOI 10.1167/iovs.12-10365	39	14	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144562	10.1371/journal.pone.0144562	http://dx.doi.org/10.1371/journal.pone.0144562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645696	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100028
J	Rohani, M; Noohi, N; Talebi, M; Katouli, M; Pourshafie, MR				Rohani, Mahdi; Noohi, Nasrin; Talebi, Malihe; Katouli, Mohammad; Pourshafie, Mohammad R.			Highly Heterogeneous Probiotic Lactobacillus Species in Healthy Iranians with Low Functional Activities	PLOS ONE			English	Article							GUT MICROBIOTA; STRAINS; IDENTIFICATION; RESISTANCE; BACTERIA; COLITIS; DNA	Background Lactic acid bacteria (LAB) have been considered as potentially probiotic organisms due to their potential human health properties. This study aimed to evaluate both in vitro and in vivo, the potential probiotic properties of Lactobacillus species isolated from fecal samples of healthy humans in Iran. Methods and Results A total of 470 LAB were initially isolated from 53 healthy individual and characterized to species level. Of these, 88 (86%) were Lactobacillus species. Biochemical and genetic fingerprinting with Phene-Plate system (PhP-LB) and RAPD-PCR showed that the isolates were highly diverse consisted of 67(76.1%) and 75 (85.2%) single types (STs) and a diversity indices of 0.994 and 0.997, respectively. These strains were tested for production of adhesion to Caco-2 cells, antibacterial activity, production of B12, anti-proliferative effect and interleukin-8 induction on gut epithelial cell lines and antibiotic resistance against 9 commonly used antibiotics. Strains showing the characteristics consistent with probiotic strains, were further tested for their anti-inflammatory effect in mouse colitis model. Only one L. brevis; one L. rhamnosus and two L. plantarum were shown to have significant probiotic properties. These strains showed shortening the length of colon compared to dextran sulfate sodium and disease activity index (DAI) was also significantly reduced in mouse. Conclusion Low number of LAB with potential probiotic activity as well as high diversity of lactobacilli species was evident in Iranian population. It also suggest that specific strains of L. plantarum, L. brevis and L. rhamnosus with anti-inflammatory effect in mouse model of colitis could be used as a potential probiotic candidate in inflammatory bowel disease to decrease the disease activity index.	[Rohani, Mahdi; Noohi, Nasrin; Pourshafie, Mohammad R.] Pasteur Inst Iran, Dept Microbiol, Tehran, Iran; [Talebi, Malihe] Iran Univ Med Sci, Dept Microbiol, Sch Med, Tehran, Iran; [Katouli, Mohammad] Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Iran University of Medical Sciences; University of the Sunshine Coast	Pourshafie, MR (corresponding author), Pasteur Inst Iran, Dept Microbiol, Tehran, Iran.	pour@pasteur.ac.ir	Rohani, Mahdi/ABG-3890-2021; Rohani, Mahdi/K-9489-2017; Pourshafie, Mohammad R/GQH-4798-2022	Rohani, Mahdi/0000-0001-8956-5072; Rohani, Mahdi/0000-0001-8956-5072; 	research committee of the Pasteur Institute of Iran [B8802]; Iran National Science Foundation [90007454]	research committee of the Pasteur Institute of Iran; Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was supported by the research committee of the Pasteur Institute of Iran (PhD. Grant no.: B8802) and, in part, by a grant (No. 90007454) from Iran National Science Foundation.; Our special thanks go to the research committee of the Pasteur Institute of Iran (PhD. Grant no.: B8802) for the financial assistance and in part by a grant (No. 90007454) from Iran National Science Foundation.	Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; Benson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057998; Cano Roca CL, 2014, THESIS; Cary VA, 2010, J CLIN NURS, V19, P904, DOI 10.1111/j.1365-2702.2009.03123.x; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Davoodabadi A, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.22295; Davoodabadi A, 2015, ANAEROBE, V34, P53, DOI 10.1016/j.anaerobe.2015.04.014; Dixit G., 2013, EURASIA J BIOSCI, DOI [DOI 10.5053/ejobios.2013.7.0.1, 10.5053/ejobios.2013.7.0.1]; Fernandez MF, 2003, J APPL MICROBIOL, V94, P449, DOI 10.1046/j.1365-2672.2003.01850.x; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Grimoud J, 2010, INT J FOOD MICROBIOL, V144, P42, DOI 10.1016/j.ijfoodmicro.2010.09.007; Haghi F, 2014, J MED MICROBIOL, V63, P427, DOI 10.1099/jmm.0.064600-0; Hamamoto N, 1999, CLIN EXP IMMUNOL, V117, P462; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Klare I, 2007, J ANTIMICROB CHEMOTH, V59, P900, DOI 10.1093/jac/dkm035; Kwon HS, 2004, FEMS MICROBIOL LETT, V239, P267, DOI 10.1016/j.femsle.2004.08.049; Lee B, 2009, J MICROBIOL BIOTECHN, V19, P616, DOI 10.4014/jmb.0808.479; Lee DK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-310; Lee HS, 2009, INFLAMMATION, V32, P27, DOI 10.1007/s10753-008-9099-6; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Shahrokhi N, 2011, J INFECT DEV COUNTR, V5, P248; Shanahan F, 2004, INFLAMM BOWEL DIS, V10, pS16, DOI 10.1097/00054725-200402001-00004; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Tharmaraj N., 2009, International Food Research Journal, V16, P261; Tilsala-Timisjarvi A, 1998, APPL ENVIRON MICROB, V64, P4816; Tuomola E, 2001, AM J CLIN NUTR, V73, p393S, DOI 10.1093/ajcn/73.2.393s; Veerappan Ganesh R, 2012, Curr Gastroenterol Rep, V14, P324, DOI 10.1007/s11894-012-0265-5	34	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144467	10.1371/journal.pone.0144467	http://dx.doi.org/10.1371/journal.pone.0144467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645292	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903100025
J	Wobus, C; Prucha, R; Albert, D; Woll, C; Loinaz, M; Jones, R				Wobus, Cameron; Prucha, Robert; Albert, David; Woll, Christine; Loinaz, Maria; Jones, Russell			Hydrologic Alterations from Climate Change Inform Assessment of Ecological Risk to Pacific Salmon in Bristol Bay, Alaska	PLOS ONE			English	Article							SOCKEYE-SALMON; CHINOOK SALMON; CHUM SALMON; TEMPERATURE; COHO; COLUMBIA; IMPACTS; FLOW; MAGNITUDE; MIGRATION	We developed an integrated hydrologic model of the upper Nushagak and Kvichak watersheds in the Bristol Bay region of southwestern Alaska, a region under substantial development pressure from large-scale copper mining. We incorporated climate change scenarios into this model to evaluate how hydrologic regimes and stream temperatures might change in a future climate, and to summarize indicators of hydrologic alteration that are relevant to salmon habitat ecology and life history. Model simulations project substantial changes in mean winter flow, peak flow dates, and water temperature by 2100. In particular, we find that annual hydrographs will no longer be dominated by a single spring thaw event, but will instead be characterized by numerous high flow events throughout the winter. Stream temperatures increase in all future scenarios, although these temperature increases are moderated relative to air temperatures by cool baseflow inputs during the summer months. Projected changes to flow and stream temperature could influence salmon through alterations in the suitability of spawning gravels, changes in the duration of incubation, increased growth during juvenile stages, and increased exposure to chronic and acute temperature stress. These climate-modulated changes represent a shifting baseline in salmon habitat quality and quantity in the future, and an important consideration to adequately assess the types and magnitude of risks associated with proposed large-scale mining in the region.	[Wobus, Cameron; Jones, Russell] Abt Associates Inc, Boulder, CO 80302 USA; [Prucha, Robert] Integrated Hydro Syst, Golden, CO USA; [Albert, David; Woll, Christine] Nature Conservancy, Juneau, AK USA; [Loinaz, Maria] ADA Engn Inc, Tampa, FL USA	ABT Associates; Nature Conservancy	Wobus, C (corresponding author), Abt Associates Inc, Boulder, CO 80302 USA.	cwobus@stratusconsulting.com	Wöll, Christof/D-5563-2011	Wöll, Christof/0000-0003-1078-3304; Wobus, Cameron/0000-0002-9654-1738	Moore Foundation; Abt Associates; Integrated Hydro Systems; A.D.A. Engineering, Inc.	Moore Foundation(Gordon and Betty Moore Foundation); Abt Associates; Integrated Hydro Systems; A.D.A. Engineering, Inc.	This work was funded by a grant from the Moore Foundation to The Nature Conservancy, through an award to CW at Abt Associates. Abt Associates, Integrated Hydro Systems and A.D.A. Engineering, Inc., provided support in the form of salaries for authors CW, RJ, RP, and ML but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alaska Department of Fish and Game, 2014, AN WAT CAT; Alaska Department of Natural Resources, 2013, INT ACC STAET AL LAN; Armstrong JB, 2013, ECOSYSTEMS, V16, P1429, DOI 10.1007/s10021-013-9693-9; Beechie T, 2013, RIVER RES APPL, V29, P939, DOI 10.1002/rra.2590; Bukovsky MS, 2007, J HYDROMETEOROL, V8, P837, DOI 10.1175/JHM595.1; Chen YD, 1998, J ENVIRON ENG, V124, P304, DOI 10.1061/(ASCE)0733-9372(1998)124:4(304); Dittmer K, 2013, CLIMATIC CHANGE, V120, P627, DOI 10.1007/s10584-013-0745-0; Ghaffari H, 2011, 1056140100REPR000100; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Goode JR, 2013, HYDROL PROCESS, V27, P750, DOI 10.1002/hyp.9728; Graham DN, 2006, WATERSHED MODELS, P245; Hill M.C., 1998, METHODS GUIDELINES E, DOI DOI 10.1061/40517(2000)18; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Jeffries KM, 2014, EVOL APPL, V7, P286, DOI 10.1111/eva.12119; Keefer ML, 2008, T AM FISH SOC, V137, P1120, DOI 10.1577/T07-008.1; Knight Piesold & Co. and HDR Alaska, 2008, PREP ENV SOC DAT REP; Kurylyk BL, 2014, WATER RESOUR RES, V50, P3253, DOI 10.1002/2013WR014588; Leppi JC, 2014, GLOBAL CHANGE BIOL, V20, P1808, DOI 10.1111/gcb.12492; Loinaz MC, 2013, J HYDROL, V495, P238, DOI 10.1016/j.jhydrol.2013.04.039; Manciocco A, 2014, CHEMOSPHERE, V100, P1, DOI 10.1016/j.chemosphere.2013.12.072; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; Martins EG, 2012, REV FISH BIOL FISHER, V22, P887, DOI 10.1007/s11160-012-9271-9; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Montgomery DR, 1996, CAN J FISH AQUAT SCI, V53, P1061, DOI 10.1139/cjfas-53-5-1061; Moss Richard, 2008, NEW SCENARIOS ANAL E; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P163, DOI 10.1038/NCLIMATE2473; Natural Resources Conservation Service, 2011, DIG GEN SOIL MAP US; Nislow KH, 2012, FISHERIES MANAG ECOL, V19, P451, DOI 10.1111/j.1365-2400.2011.00810.x; Perschbacher PW, 2005, AQUACULTURE, V243, P225, DOI 10.1016/j.aquaculture.2004.10.006; Piper R.G., 1982, FISH HATCHERY MANAGE, V1st ed.; Quinn Thomas P., 2005, P1; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schlumberger Water Services, 2011, PEBBL PROJ ENV BAS D; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Shanley CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104799; U.S. EPA, 2014, ASS POT MIN IMP SALM; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Wobus C, 2012, REVIEW IN PRESS	42	13	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143905	10.1371/journal.pone.0143905	http://dx.doi.org/10.1371/journal.pone.0143905			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645380	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903100010
J	Ma, L; Zhu, FG; Li, ZW; Zhang, JF; Li, X; Dong, JL; Wang, T				Ma, Lei; Zhu, Fugui; Li, Zhenwei; Zhang, Jianfu; Li, Xin; Dong, Jiangli; Wang, Tao			TALEN-Based Mutagenesis of Lipoxygenase LOX3 Enhances the Storage Tolerance of Rice (Oryza sativa) Seeds	PLOS ONE			English	Article							GENE; LONGEVITY; SYSTEM; ARABIDOPSIS; GERMINATION; RESISTANCE; VIABILITY; QUALITY; ACID; NUCLEASES	The deterioration of rice grain reduces the quality of rice, resulting in serious economic losses for farmers. Lipoxygenases (LOXs) catalyze the dioxygenation of polyunsaturated fatty acids with at least one cis, cis-1,4-pentadiene to form hydroperoxide, which is a major factor influencing seed longevity and viability. Recently, genome editing, an essential tool employed in reverse genetics, has been used experimentally to investigate basic plant biology or to modify crop plants for the improvement of important agricultural traits. In this study, we performed targeted mutagenesis in rice using transcription activator-like effector nucleases (TALENs) to improve seed storability. A modified ligation-independent cloning method (LIC) was employed to allow for the quick and efficient directional insertion of TALEN monomer modules into destination vectors used in plants. We demonstrated the feasibility and flexibility of the technology by developing a set of modular vectors for genome editing. After construction and validation, the TALEN pairs were used to create stable transgenic rice lines via Agrobacterium-mediated transformation. One heterozygous mutant (4%) was recovered from 25 transgenic NPTII-resistant lines, and the mutation was transmitted to the next generation. Further molecular and protein level experiments verified LOX3 deficiency and demonstrated the improvement of seed storability. Our work provides a flexible genome editing tool for improving important agronomic traits, as well as direct evidence that Lox3 has only a limited impact on seed longevity.	[Ma, Lei; Zhu, Fugui; Li, Zhenwei; Li, Xin; Dong, Jiangli; Wang, Tao] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Ma, Lei] Inst Cotton Res CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China; [Zhang, Jianfu] Fujian Acad Agr Sci, Rice Res Inst, Fuzhou, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Fujian Academy of Agricultural Sciences	Wang, T (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	wangt@cau.edu.cn			National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China [2009ZX08001-01513, 2011ZX08009-002]; State Key Laboratory of Agrobiotechnology [2013SKLAB06-14]	National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China; State Key Laboratory of Agrobiotechnology	The National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China (2009ZX08001-01513, 2011ZX08009-002) received by T. Wand State Key Laboratory of Agrobiotechnology (2013SKLAB06-14) received by TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Addgene.org for providing plasmids and their initial constructors, we also thank Prof. Liying Zhang at Ministry of Agriculture Feed Industry Center for the supply of method of measuring the contents of linoleic acids. This work is supported by The National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China (2009ZX08001-01513, 2011ZX08009-002) and State Key Laboratory of Agrobiotechnology (2013SKLAB06-14).	Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carranco R, 2010, P NATL ACAD SCI USA, V107, P21908, DOI 10.1073/pnas.1014856107; Cermak T, 2011, NUCLEIC ACIDS RES, V39, P7879, DOI 10.1093/nar/gkr739; Chatelain E, 2013, P NATL ACAD SCI USA, V110, P3633, DOI 10.1073/pnas.1220589110; Chen HH, 2012, J EXP BOT, V63, P4107, DOI 10.1093/jxb/ers093; Chen KL, 2014, METHODS, V69, P2, DOI 10.1016/j.ymeth.2014.02.013; Devaiah SP, 2007, PLANT J, V50, P950, DOI 10.1111/j.1365-313X.2007.03103.x; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Gayen D, 2014, PLANT CELL TISS ORG, V118, P229, DOI 10.1007/s11240-014-0476-6; Halpin C, 2001, PLANT MOL BIOL, V47, P295, DOI 10.1023/A:1010604120234; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Huang JX, 2014, TRANSGENIC RES, V23, P643, DOI 10.1007/s11248-014-9803-2; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li T, 2014, METHODS, V69, P9, DOI 10.1016/j.ymeth.2014.03.019; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Long QZ, 2013, J PLANT BIOL, V56, P232, DOI 10.1007/s12374-013-0085-7; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Miller M, 2002, TRANSGENIC RES, V11, P381, DOI 10.1023/A:1016390621482; Miura K, 2002, THEOR APPL GENET, V104, P981, DOI 10.1007/s00122-002-0872-x; Mizuno K, 2003, PLANT CELL PHYSIOL, V44, P1168, DOI 10.1093/pcp/pcg142; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schmid-Burgk JL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks236; Seo YS, 2011, J EXP BOT, V62, P5683, DOI 10.1093/jxb/err250; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shirasawa K, 2008, BREEDING SCI, V58, P169, DOI 10.1270/jsbbs.58.169; Song M, 2007, NUCL INSTRUM METH B, V265, P495, DOI 10.1016/j.nimb.2007.09.035; Sun ZJ, 2013, J INTEGR PLANT BIOL, V55, P1092, DOI 10.1111/jipb.12091; Suzuki Y, 1999, J AGR FOOD CHEM, V47, P1119, DOI 10.1021/jf980967a; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; Wang R, 2008, PLANT MOL BIOL, V66, P401, DOI 10.1007/s11103-007-9278-0; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Xu H., 2014, PROC IEEE INT FUNCT, P1, DOI DOI 10.1111/PBI.12277; Yin JD, 2008, POULTRY SCI, V87, P284, DOI 10.3382/ps.2007-00220; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhou GX, 2014, PHYSIOL PLANTARUM, V152, P59, DOI 10.1111/ppl.12148	38	48	56	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143877	10.1371/journal.pone.0143877	http://dx.doi.org/10.1371/journal.pone.0143877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641666	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700033
J	Marin-Navarro, J; Roupain, N; Talens-Perales, D; Polaina, J				Marin-Navarro, Julia; Roupain, Nicole; Talens-Perales, David; Polaina, Julio			Identification and Structural Analysis of Amino Acid Substitutions that Increase the Stability and Activity of Aspergillus niger Glucose Oxidase	PLOS ONE			English	Article							DIRECTED EVOLUTION; BETA-GLUCOSIDASE; SACCHAROMYCES-CEREVISIAE; HISTIDINE-HISTIDINE; ANGSTROM RESOLUTION; SEQUENCE; PURIFICATION; RESISTANCE; POLYMYXA; GENE	Glucose oxidase is one of the most conspicuous commercial enzymes due to its many different applications in diverse industries such as food, chemical, energy and textile. Among these applications, the most remarkable is the manufacture of glucose biosensors and in particular sensor strips used to measure glucose levels in serum. The generation of ameliorated versions of glucose oxidase is therefore a significant biotechnological objective. We have used a strategy that combined random and rational approaches to isolate uncharacterized mutations of Aspergillus niger glucose oxidase with improved properties. As a result, we have identified two changes that increase significantly the enzyme's thermal stability. One (T554M) generates a sulfur-pi interaction and the other (Q90R/Y509E) introduces a new salt bridge near the interphase of the dimeric protein structure. An additional double substitution (Q124R/L569E) has no significant effect on stability but causes a twofold increase of the enzyme's specific activity. Our results disclose structural motifs of the protein which are critical for its stability. The combination of mutations in the Q90R/Y509E/T554M triple mutant yielded a version of A. niger glucose oxidase with higher stability than those previously described.	[Marin-Navarro, Julia; Roupain, Nicole; Talens-Perales, David; Polaina, Julio] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Polaina, J (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	jpolaina@iata.csic.es	, Marín-Navarro/F-7630-2016; Talens-Perales, David/E-8558-2017; Polaina, Julio/H-4498-2012; Talens-Perales, David/AAE-9116-2020	, Marín-Navarro/0000-0001-7893-3423; Talens-Perales, David/0000-0002-8693-4239; Polaina, Julio/0000-0001-9912-0640	Spain's "Secretaria de Estado de Investigacion, Desarrollo e Innovacion" [BIO2013-48779-C4-3-R]; European Union within the Project Leangreenfood; Ministerio de Economia y Competitividad; Spain's 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion' [BIO2013-48779-C4-3-R]	Spain's "Secretaria de Estado de Investigacion, Desarrollo e Innovacion"; European Union within the Project Leangreenfood; Ministerio de Economia y Competitividad(Spanish Government); Spain's 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion'	This work was funded by grant BIO2013-48779-C4-3-R from Spain's "Secretaria de Estado de Investigacion, Desarrollo e Innovacion". NR was supported by a Marie Curie ITN fellowship from the European Union within the Project Leangreenfood. DTP was supported by a FPU fellowship from "Ministerio de Economia y Competitividad".; This work was funded by grant BIO2013-48779-C4-3-R, from Spain's 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion'. N R was supported by a Marie Curie ITN fellowship from the European Union within the Project Leangreenfood. D T-P was supported by a FPU fellowship from 'Ministerio de Economia y Competitividad'.	ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; Gutierrez EA, 2013, BIOSENS BIOELECTRON, V50, P84, DOI 10.1016/j.bios.2013.06.029; Haghani K, 2012, INT J BIOL MACROMOL, V50, P1040, DOI 10.1016/j.ijbiomac.2011.12.009; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Heyda J, 2010, J PHYS CHEM B, V114, P8744, DOI 10.1021/jp101031v; Holland JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037924; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; KRIECHBAUM M, 1989, FEBS LETT, V255, P63, DOI 10.1016/0014-5793(89)81061-0; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P121, DOI 10.1007/s00253-010-2845-3; Mohammadi M, 2014, APPL BIOCHEM BIOTECH, V172, P157, DOI 10.1007/s12010-013-0404-y; Ostafe R, 2014, CHEM BIOL, V21, P414, DOI 10.1016/j.chembiol.2014.01.010; Sanz-Aparicio J, 1998, PROTEINS, V33, P567, DOI 10.1002/(SICI)1097-0134(19981201)33:4<567::AID-PROT9>3.0.CO;2-U; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SWOBODA BEP, 1965, J BIOL CHEM, V240, P2209; TSUGE H, 1975, J BIOCHEM, V78, P835, DOI 10.1093/oxfordjournals.jbchem.a130974; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Wohlfahrt G, 2004, MOL CELL BIOCHEM, V260, P69, DOI 10.1023/B:MCBI.0000026056.75937.98; Wong CM, 2008, APPL MICROBIOL BIOT, V78, P927, DOI 10.1007/s00253-008-1407-4; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhu Ziwei, 2007, Biotechnology Journal, V2, P241, DOI 10.1002/biot.200600185; Zhu ZW, 2006, BIOSENS BIOELECTRON, V21, P2046, DOI 10.1016/j.bios.2005.11.018; Zubillaga RA, 2006, PROTEIN PEPTIDE LETT, V13, P113, DOI 10.2174/092986606775101698	26	17	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144289	10.1371/journal.pone.0144289	http://dx.doi.org/10.1371/journal.pone.0144289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642312	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700091
J	Duckworth, C; Zhang, L; Carroll, SL; Ethier, SP; Cheung, HW				Duckworth, C.; Zhang, L.; Carroll, S. L.; Ethier, S. P.; Cheung, H. W.			Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression	ONCOGENE			English	Article							BREAST-CANCER; EPITHELIAL OVARIAN; TUMORIGENESIS; INHIBITION; PROLIFERATION; MALIGNANCIES; METASTASIS; ACTIVATION; RESISTANCE; BLOCKADE	We previously found that the scaffold adapter GRB2-associated binding protein 2 (GAB2) is amplified and overexpressed in a subset of primary high-grade serous ovarian cancers and cell lines. Ovarian cancer cells overexpressing GAB2 are dependent on GAB2 for activation of the phosphatidylinositol 3-kinase (PI3K) pathway and are sensitive to PI3K inhibition. In this study, we show an important role of GAB2 overexpression in promoting tumor angiogenesis by upregulating expression of multiple chemokines. Specifically, we found that suppression of GAB2 by inducible small hairpin RNA in ovarian cancer cells inhibited tumor cell proliferation, angiogenesis and peritoneal tumor growth in immunodeficient mice. Overexpression of GAB2 upregulated the secretion of several chemokines from ovarian cancer cells, including CXCL1, CXCL2 and CXCL8. The secreted chemokines not only signal through endothelial CXCR2 receptor in a paracrine manner to promote endothelial tube formation, but also act as autocrine growth factors for GAB2-induced transformation of fallopian tube secretory epithelial cells and clonogenic growth of ovarian cancer cells overexpressing GAB2. Pharmacological inhibition of inhibitor of nuclear factor kappa-B kinase subunit beta (IKK beta), but not PI3K, mechanistic target of rapamycin (mTOR) or mitogen-activated protein kinase (MEK), could effectively suppress GAB2-induced chemokine expression. Inhibition of IKK beta augmented the efficacy of PI3K/mTOR inhibition in suppressing clonogenic growth of ovarian cancer cells with GAB2 overexpression. Taken together, these findings suggest that overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating expression of CXCL1, CXCL2 and CXCL8 that is IKK beta-dependent. Co-targeting IKK beta and PI3K pathways downstream of GAB2 might be a promising therapeutic strategy for ovarian cancer that overexpresses GAB2.	[Duckworth, C.; Zhang, L.; Carroll, S. L.; Ethier, S. P.; Cheung, H. W.] Med Univ South Carolina, Dept Pathol & Lab Med, 68 President St,Room BE413,MSC 908, Charleston, SC 29425 USA; [Duckworth, C.; Zhang, L.; Carroll, S. L.; Ethier, S. P.; Cheung, H. W.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Duckworth, C.; Zhang, L.; Carroll, S. L.; Ethier, S. P.; Cheung, H. W.] Med Univ South Carolina, Ctr Genom Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Cheung, HW (corresponding author), Med Univ South Carolina, Dept Pathol & Lab Med, 68 President St,Room BE413,MSC 908, Charleston, SC 29425 USA.	cheungh@musc.edu	Duckworth, Carrie/AAC-8361-2020; Duckworth, Carrie A/K-7302-2014	Duckworth, Carrie/0000-0001-9992-7540; Duckworth, Carrie A/0000-0001-9992-7540	Ovarian Cancer Research Fund [292377]; V Foundation for Cancer Research; Marsha Rivkin Center for Ovarian Cancer Research; American Cancer Society Institutional Research Grant [IRG-97-219-14]; Colleen's Dream Foundation; Cancer Center Support Grant [P30 CA139313]; NATIONAL CANCER INSTITUTE [R03CA139313] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; V Foundation for Cancer Research; Marsha Rivkin Center for Ovarian Cancer Research; American Cancer Society Institutional Research Grant(American Cancer Society); Colleen's Dream Foundation; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the Ovarian Cancer Research Fund (292377) (HWC); the V Foundation for Cancer Research (HWC); the Marsha Rivkin Center for Ovarian Cancer Research (HWC); the American Cancer Society Institutional Research Grant #IRG-97-219-14 (HWC); Colleen's Dream Foundation (HWC); Department start-up fund (HWC). This research utilized the Cell & Molecular Imaging, and Genomics Shared Resources which were supported, in part, by Cancer Center Support Grant P30 CA139313 to the Hollings Cancer Center, Medical University of South Carolina. We thank Alfred Moore for assistance with bioluminescent imaging. We thank Dennis Watson, Patricia Watson, Bart Smits and Qi Wang for stimulating discussion.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Adams SJ, 2012, MOL CANCER RES, V10, P1265, DOI 10.1158/1541-7786.MCR-12-0352; Allegretti M, 2012, IMMUNOL LETT, V145, P68, DOI 10.1016/j.imlet.2012.04.003; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Behbakht K, 2011, GYNECOL ONCOL, V123, P19, DOI 10.1016/j.ygyno.2011.06.022; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Choi HJ, 2015, CANCER METAST REV, V34, P19, DOI 10.1007/s10555-014-9538-9; Davis SJ, 2015, MOL CANCER THER, V14, P1495, DOI 10.1158/1535-7163.MCT-15-0039; Dunn GP, 2014, P NATL ACAD SCI USA, V111, P1102, DOI 10.1073/pnas.1311909111; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Huang J, 2011, GENE CHROMOSOME CANC, V50, P606, DOI 10.1002/gcc.20883; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Schmitt J, 2012, CANCER TREAT REV, V38, P272, DOI 10.1016/j.ctrv.2011.06.004; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Wang Y, 2012, CYTOKINE, V59, P145, DOI 10.1016/j.cyto.2012.04.013; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yang Y, 2013, ONCOGENE, V32, P3627, DOI 10.1038/onc.2012.367; Yuan TL, 2008, P NATL ACAD SCI USA, V105, P9739, DOI 10.1073/pnas.0804123105	34	34	37	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4036	4047		10.1038/onc.2015.472	http://dx.doi.org/10.1038/onc.2015.472			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26657155	Green Published, hybrid			2022-12-26	WOS:000381020900002
J	Bian, C; Xu, TD; Zhu, H; Pan, DF; Liu, Y; Luo, YY; Wu, P; Li, DY				Bian, Chen; Xu, Tongda; Zhu, Hong; Pan, Defeng; Liu, Yang; Luo, Yuanyuan; Wu, Pei; Li, Dongye			Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE APOPTOSIS; ISCHEMIA-REPERFUSION; CONTRACTILE FUNCTION; INFARCTION; EXPRESSION; INFLAMMATION; MICRORNAS; MECHANISM; CELLS; ANTIOXIDANT	Background Luteolin (LUT), a kind of flavonoid which is extracted from a variety of diets, has been reported to convey protective effects of various diseases. Recent researches have suggested that LUT can carry out cardioprotective effects during ischemia/reperfusion (I/R). However, there have no reports on whether LUT can exert protective effects against myocardial I/R injury through the actions of specific microRNAs (miRs). The purpose of this study was to determine which miRs and target genes LUT exerted such function through. Methods Expression of various miRs in perfused rat hearts was detected using a gene chip. Target genes were predicted with TargetScan, MiRDB and MiRanda. Anoxia/reoxygenation was used to simulate I/R. Cells were transfected by miR-208b-3p mimic, inhibitor and small interfering RNA of Ets1 (avian erythroblastosis virus E26 (v ets) oncogene homolog 1). MiR208b-3p and Ets1 mRNA were quantified by real-time quantitative polymerase chain reaction. The percentage of apoptotic cells was detected by annexin V-fluorescein isothiocyanate/propidium iodide dyeing and flow cytometry. The protein expression levels of cleaved caspase-3, Bcl-2, Bax, and Ets1 were examined by western blot analysis. A luciferase reporter assay was used to verify the combination between miR-208b-3p and the 3'-untranslated region of Ets1. Results LUT pretreatment reduced miR-208b-3p expression in myocardial tissue, as compared to the I/R group. And LUT decreased miR-208b-3p expression and apoptosis caused by I/R. However, overexpression of miR-208b-3p further aggravated the changes caused by I/R and blocked all the effects of LUT. Knockdown of miR-208b-3p expression also attenuated apoptosis, while knockdown of Ets1 promoted apoptosis. Further, the luciferase reporter assay showed that miR-208b-3p could inhibit Ets1 expression. Conclusion LUT pretreatment conveys anti-apoptotic effects after myocardial I/R injury by decreasing miR-208b-3p and increasing Ets1 expression levels.	[Bian, Chen; Liu, Yang; Wu, Pei; Li, Dongye] Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China; [Xu, Tongda; Zhu, Hong; Pan, Defeng; Luo, Yuanyuan; Li, Dongye] Xuzhou Med Coll, Affiliated Hosp, Cardiol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China.	dongyeli@medmail.com.cn	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020	Xu, Tongda/0000-0002-5594-3992	National Natural Science Foundation of China [81570326]; China Postdoctoral Science Foundation [2014M551665]; Nature Science Foundation of Jiangsu Province [BK20141139]; Academic Degrees Committee; Department of Education of Jiangsu province [xyyc13-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Academic Degrees Committee; Department of Education of Jiangsu province	This study was supported by National Natural Science Foundation of China (81570326), China Postdoctoral Science Foundation funded project (2014M551665), The Nature Science Foundation of Jiangsu Province (BK20141139), Academic Degrees Committee and the Department of Education of Jiangsu province (xyyc13-32).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dong PX, 2013, NANOTOXICOLOGY, V7, P1028, DOI 10.3109/17435390.2012.694487; Fan F, 2013, CURR PHARM DESIGN, V19, P4865, DOI 10.2174/13816128113199990325; Fang F, 2011, PHARMACOLOGY, V88, P149, DOI 10.1159/000330068; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Han L, 2012, BIOMATERIALS, V33, P8517, DOI 10.1016/j.biomaterials.2012.07.034; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Jang SS, 2009, J PINEAL RES, V47, P147, DOI 10.1111/j.1600-079X.2009.00694.x; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kang DW, 2015, J EXP MED, V212, P1219, DOI 10.1084/jem.20141254; Kim DS, 2010, J PHARM PHARMACOL, V62, P197, DOI [10.1211/jpp.62.02.0007, 10.1211/jpp/62.02.0007]; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090096; Li MY, 2014, GENET MOL RES, V13, P6981, DOI 10.4238/2014.April.14.13; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Liu H, 2014, GENE, V545, P149, DOI 10.1016/j.gene.2014.04.043; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Meng XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094635; Minamino T, 2012, CIRC J, V76, P1074, DOI 10.1253/circj.CJ-12-0132; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Pan L, 2015, INT J MOL SCI, V16, P5420, DOI 10.3390/ijms16035420; Pan ZQ, 2014, J NEUROSCI, V34, P9476, DOI 10.1523/JNEUROSCI.5346-13.2014; Qi LL, 2011, EUR J PHARMACOL, V668, P201, DOI 10.1016/j.ejphar.2011.06.020; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Suh JH, 2012, BIOCHEM BIOPH RES CO, V423, P404, DOI 10.1016/j.bbrc.2012.05.138; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Takyar S, 2013, J EXP MED, V210, P1993, DOI 10.1084/jem.20121200; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075872; Wang WK, 2014, J CELL MOL MED, V18, P2311, DOI 10.1111/jcmm.12399; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Wu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082957; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Yang Q, 2015, INT J CLIN EXP PATHO, V8, P3735; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100298; Zhang XD, 2014, CELL PHYSIOL BIOCHEM, V34, P1050, DOI 10.1159/000366320	47	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144877	10.1371/journal.pone.0144877	http://dx.doi.org/10.1371/journal.pone.0144877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658785	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900129
J	Brodowska, AJ; Smigielski, K; Nowak, A; Czyzowska, A; Otlewska, A				Brodowska, Agnieszka Joanna; Smigielski, Krzysztof; Nowak, Agnieszka; Czyzowska, Agata; Otlewska, Anna			The Impact of Ozone Treatment in Dynamic Bed Parameters on Changes in Biologically Active Substances of Juniper Berries	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PHENOLIC COMPOSITION; MACROCARPA SIBTH.; ESCHERICHIA-COLI; BACILLUS-CEREUS; SPICES; ROOT; OXYCEDRUS	The development of the parameters of ozone decontamination method assuring the least possible losses of biologically active substances (essential oils and polyphenols) and their activity in common juniper (Juniperus communis (L.)) berries was studied. Ozone treatment in dynamic bed was conducted 9 times. The process was conducted under different ozone concentrations (100.0; 130.0; 160.0 g O-3/m(3)) and times (30, 60, 90 min). After each decontamination, the microbiological profile of the juniper berries was studied, and the contaminating microflora was identified. Next to the microbiological profile, the phenolic profile, as well as antioxidant activity of extracts and essential oils were determined. The total polyphenol content (TPC), composition of essential oils, free radical-scavenging capacity, total antioxidant capacity, ferric-reducing antioxidant power (FRAP), beta-carotene bleaching test (BCB) and LC-MS polyphenol analysis were carried out. The study reveals that during short ozone contact times, higher amounts of TPC, 15.47 and 12.91 mg CE/g of extract, for samples 100/30 and 130/30, respectively, were demonstrated. Whereas samples 100/60, 130/60, 100/90, and 160/90 exhibited the lowest amount of phenolics. The highest antioxidant activity was found in the methanol extract obtained from ozonated berries which exhibited the lowest IC50 in all the antioxidant assays, such as DPPH, FRAP, and BCB assays. Ozone treatment showed noteworthy potential and its usage in food manufacturing and as an alternative decontamination method should be considered.	[Brodowska, Agnieszka Joanna; Smigielski, Krzysztof] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Gen Food Chem, Lodz, Poland; [Nowak, Agnieszka; Czyzowska, Agata; Otlewska, Anna] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Fermentat Technol & Microbiol, Lodz, Poland	Lodz University of Technology; Lodz University of Technology	Brodowska, AJ (corresponding author), Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Gen Food Chem, Lodz, Poland.	aga.brodowska17@gmail.com	Otlewska, Anna/N-6143-2018; Czyzowska, Agata/N-1837-2018; Nowak, Agnieszka/M-7663-2018; Brodowska, Agnieszka/AAE-9234-2020; Smigielski, Krzysztof Benedykt/N-6705-2018	Otlewska, Anna/0000-0002-3536-3560; Czyzowska, Agata/0000-0002-1098-1602; Nowak, Agnieszka/0000-0002-6390-8425; Smigielski, Krzysztof Benedykt/0000-0002-4213-7852	 [28/DzS/9184];  [I28/DzS/9184]	; 	Financial support of this work by Statute Funds No. 28/DzS/9184. Science Young Leaders Fund.; Financial support of this work by Statute Funds No. I28/DzS/9184. Science Young Leaders Fund.	Adams RP, 1995, IDENTIFICATION OF ES; Akbas MY, 2008, FOOD MICROBIOL, V25, P386, DOI 10.1016/j.fm.2007.09.007; Akbas MY, 2006, INT J FOOD SCI TECH, V41, P513, DOI 10.1111/j.1365-2621.2005.01099.x; Banerjee M, 2003, FOOD RES INT, V36, P469, DOI 10.1016/S0963-9969(02)00194-1; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brodowska A, 2014, CHEMIK, V68, P100; Brodowska AJ, 2014, J FOOD SCI, V79, pC1649, DOI 10.1111/1750-3841.12591; Brodowska AJ, 2013, BIOTECHNOL FOOD SCI, V77, P37; Chaouche TM, 2015, IND CROP PROD, V64, P182, DOI 10.1016/j.indcrop.2014.10.051; Cheng WC, 2013, ENCY FORENSIC SCI, P280; Diao E., 2014, J FOOD NUTR RES, V2, P101, DOI [DOI 10.12691/JFNR-2-3-2, 10.12691/jfnr-2-3-2]; DYAS A, 1983, J CLIN PATHOL, V36, P1102, DOI 10.1136/jcp.36.10.1102; GARRIDO D, 1992, J FOOD PROTECT, V55, P451; Gonny M, 2006, FLAVOUR FRAG J, V21, P99, DOI 10.1002/ffj.1527; HATANO T, 1988, CHEM PHARM BULL, V36, P2090; International Commission on Microbiological Specification for Foods (ICMSF), 1974, MICR FOODS, V2; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Khadre MA, 2001, J FOOD SCI, V66, P1242, DOI 10.1111/j.1365-2621.2001.tb15196.x; KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kunicka - Styczyska A., 2011, PRZEMYSL SPOZYWCZY, V6, P50; Lesjak MM, 2014, J FUNCT FOODS, V7, P257, DOI 10.1016/j.jff.2014.02.003; Lesjak MM, 2013, LWT-FOOD SCI TECHNOL, V53, P530, DOI 10.1016/j.lwt.2013.03.010; Lesjak MM, 2011, FOOD CHEM, V124, P850, DOI 10.1016/j.foodchem.2010.07.006; MALLET JF, 1994, FOOD CHEM, V49, P61, DOI 10.1016/0308-8146(94)90233-X; MCKEE LH, 1995, FOOD SCI TECHNOL-LEB, V28, P1, DOI 10.1016/S0023-6438(95)80004-2; Miceli N, 2011, FOOD CHEM TOXICOL, V49, P2600, DOI 10.1016/j.fct.2011.07.004; Orhan N, 2011, FOOD CHEM TOXICOL, V49, P2305, DOI 10.1016/j.fct.2011.06.031; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pascual A, 2007, TRENDS FOOD SCI TECH, V18, pS29, DOI [10.1016/j.tifs.2006.10.006, 10.1016/j.tifs.2006.07.015]; Peterson SW, 2009, MYCOLOGIA, V101, P71, DOI 10.3852/08-036; Poljanowska M, 2007, ANN ACAD MED STETIN, V3, P114; Prasad N, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/154606; PRATT DE, 1980, AUTOXIDATION FOOD BI, P283; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Smigielski K, 2014, Patent application, Patent No. 409933; Smigielski K, 2009, J ESSENT OIL BEAR PL, V12, P338, DOI 10.1080/0972060X.2009.10643729; Taviano MF, 2013, FOOD CHEM TOXICOL, V58, P22, DOI 10.1016/j.fct.2013.03.049; Young SB, 2004, J APPL MICROBIOL, V96, P1133, DOI 10.1111/j.1365-2672.2004.02236.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	42	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144855	10.1371/journal.pone.0144855	http://dx.doi.org/10.1371/journal.pone.0144855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659905	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900120
J	Colson, P; Rolain, JM; Abat, C; Charrel, R; Fournier, PE; Raoult, D				Colson, Philippe; Rolain, Jean-Marc; Abat, Cedric; Charrel, Remi; Fournier, Pierre-Edouard; Raoult, Didier			EPIMIC: A Simple Homemade Computer Program for Real-Time EPIdemiological Surveillance and Alert Based on MICrobiological Data	PLOS ONE			English	Article							INFECTIOUS-DISEASES; FRANCE; MARSEILLES; HOSPITALS; ENGLAND; WALES; OUTBREAK; BURDEN; TRENDS	Background and Aims Infectious diseases (IDs) are major causes of morbidity and mortality and their surveillance is critical. In 2002, we implemented a simple and versatile homemade tool, named EPIMIC, for the real-time systematic automated surveillance of IDs at Marseille university hospitals, based on the data from our clinical microbiology laboratory, including clinical samples, tests and diagnoses. Methods This tool was specifically designed to detect abnormal events as IDs are rarely predicted and modeled. EPIMIC operates using Microsoft Excel software and requires no particular computer skills or resources. An abnormal event corresponds to an increase above, or a decrease below threshold values calculated based on the mean of historical data plus or minus 2 standard deviations, respectively. Results Between November 2002 and October 2013 (11 years), 293 items were surveyed weekly, including 38 clinical samples, 86 pathogens, 79 diagnosis tests, and 39 antibacterial resistance patterns. The mean duration of surveillance was 7.6 years (range, 1 month-10.9 years). A total of 108,427 Microsoft Excel file cells were filled with counts of clinical samples, and 110,017 cells were filled with counts of diagnoses. A total of 1,390,689 samples were analyzed. Among them, 172,180 were found to be positive for a pathogen. EPIMIC generated a mean number of 0.5 alert/week on abnormal events. Conclusions EPIMIC proved to be efficient for real-time automated laboratory-based surveillance and alerting at our university hospital clinical microbiology laboratory-scale. It is freely downloadable from the following URL: http://www.mediterranee-infection.com/article.php?larub=157&titre=bulletin-epidemiologique (last accessed: 20/11/2015).	[Colson, Philippe; Rolain, Jean-Marc; Charrel, Remi; Fournier, Pierre-Edouard; Raoult, Didier] CHU Timone, Assistance Publ Hop Marseille, Inst Hosp Univ IHU Mediterranee Infect, Pole Malad Infect & Trop Clin & Biol,Federat Bact, F-13385 Marseille 05, France; [Colson, Philippe; Rolain, Jean-Marc; Abat, Cedric; Fournier, Pierre-Edouard; Raoult, Didier] Aix Marseille Univ, URMITE, INSERM, UM 63,CNRS 7278,IRD,3R198,U1095, F-13385 Marseille 05, France; [Charrel, Remi] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR Emergence Pathol Virales D190, F-13385 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), CHU Timone, Assistance Publ Hop Marseille, Inst Hosp Univ IHU Mediterranee Infect, Pole Malad Infect & Trop Clin & Biol,Federat Bact, 264 Rue St Pierre, F-13385 Marseille 05, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Colson, Philippe/P-6355-2014; Rolain, Jean-Marc/Y-3788-2019; Fournier, Pierre-Edouard/AAC-6155-2021	RAOULT, Didier/0000-0002-0633-5974; Colson, Philippe/0000-0001-6285-0308; Rolain, Jean-Marc/0000-0002-2402-4467; Fournier, Pierre-Edouard/0000-0001-8463-8885				Abat C, 2015, INT J ANTIMICROB AG, V45, P144, DOI 10.1016/j.ijantimicag.2014.10.010; Aherfi S, 2014, CLIN MICROBIOL INFEC, V20, pO176, DOI 10.1111/1469-0691.12366; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; Centers for Disease Control, 1981, MMWR-MORBID MORTAL W, V30, P250; Colson P, 2013, Euro Surveill, V18, P4; Colson P, 2013, EUROSURVEILLANCE, V18, P18; Colson P, 2012, EMERG INFECT DIS, V18, P1361, DOI 10.3201/eid1808.111827; Dab W, 1998, REV EPIDEMIOL SANTE, V46, P249; Enki DG, 2013, EMERG INFECT DIS, V19, P35, DOI 10.3201/eid1901.120493; Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167; Hartfield M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003277; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Kempf M, 2013, APMIS, V121, P64, DOI 10.1111/j.1600-0463.2012.02935.x; Kman N. E., 2012, ADV PREV MED, V2012, DOI [10.1155/2012/301408, DOI 10.1155/2012/301408]; Lagier JC, 2013, INFECT CONT HOSP EP, V34, P1339, DOI 10.1086/673995; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Meynard JB, 2008, REV EPIDEMIOL SANTE, V56, P11, DOI 10.1016/j.respe.2007.11.003; Nougairede A, 2011, EUR J EPIDEMIOL, V26, P183, DOI 10.1007/s10654-010-9533-6; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Parola P, 2011, EUROSURVEILLANCE, V16, P25; Raoult D, 2003, RAPPORT DE MISSION; Raoult D, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00025; Raoult D, 2011, SCIENCE, V331, P144, DOI 10.1126/science.331.6014.144-c; Rolain JM, 2015, CLIN MICROBIOL INFEC; Scaber J, 2011, EUROSURVEILLANCE, V16, P2; Sharrar RG, 1976, MMWR-MORBID MORTAL W, V25, P244; Soler MS, 2011, LANCET, V378, P1833, DOI 10.1016/S0140-6736(11)60834-9; Texier G, 2010, REV EPIDEMIOL SANTE, V58, P425, DOI 10.1016/j.respe.2010.06.169; Thacker S B, 1989, J Public Health Policy, V10, P187, DOI 10.2307/3342679; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; World Health Organization, 2014, TOP 10 CAUS DEATH; World health organization, 2013, WORLD HLTH STAT 2013	32	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144178	10.1371/journal.pone.0144178	http://dx.doi.org/10.1371/journal.pone.0144178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658293	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900030
J	Sun, HF; Hu, PP; Shen, HC; Dong, W; Zhang, TH; Liu, Q; Du, JJ				Sun, Haifeng; Hu, Pingping; Shen, Hongchang; Dong, Wei; Zhang, Tiehong; Liu, Qi; Du, Jiajun			Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; C-REACTIVE PROTEIN; NUTRITIONAL-STATUS; SERUM-ALBUMIN; SURVIVAL; STATISTICS	Objectives It has been reported nutritional status and systemic inflammation were associated with the outcome of patients with malignancies. However, the prognostic value of combination of them was really scarce, especially in non-small cell lung cancer (NSCLC). In order to find a more simple and efficient predictor, we hypothesized that pretreatment albumin and neutrophil combined prognostic grade (ANPG) could offer an improved prognostic ability in NSCLC patients. Methods We collected pretreatment albumin and neutrophil, clinicopathological, treatment and follow-up data of 1033 consecutive NSCLC patients treated between 2006 and 2011 in this retrospective study. The ANPG was calculated according to pretreatment albumin and neutrophil levels dichotomized by the optimal cut-off values, the quartile values and the clinical reference values. Kaplan-Meier (K-M) curves and Cox proportional regression were used for survival analyses. All the data was analyzed by SPSS 20.0. Results According to optimal cut-off values and quartile values, significant differences were found in different pretreatment albumin, neutrophil levels and ANPG from the K-M curve (all p<0.05). Univariate analyses and multivariate analyses disclosed ANPG was a more sensitive independent predictor for both overall survival (OS) and progression free survival (PFS) than either albumin level or neutrophil level (HRs were higher for ANPG). As for clinical reference values, no significant difference of pretreatment albumin levels was found in K-M curve and univariate analyses. All three indexes lost their significance in multivariate analyses. Conclusion Higher ANPG predicts worse OS and PFS in NSCLC patients independently, and it is more sensitive than hypoalbuminaemia and neutrophilia. It might be used as a reliable, convenient and more sensitive predictor to assist the identification of patients with poor prognosis and be a hierarchical factor in the future NSCLC clinical trials.	[Sun, Haifeng; Hu, Pingping; Shen, Hongchang; Zhang, Tiehong; Liu, Qi; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250100, Shandong, Peoples R China; [Dong, Wei; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Thorac Surg, Jinan 250100, Shandong, Peoples R China; [Hu, Pingping] Shandong Univ, Qianfoshan Hosp, Dept Radiat Oncol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, Q (corresponding author), Shandong Univ, Shandong Prov Hosp, Inst Oncol, 324 Jingwu Rd, Jinan 250100, Shandong, Peoples R China.	liuqi66@sdu.edu.cn; dujiajun@sdu.edu.cn			National Natural Science Foundation of China [81301728]; Provincial Natural Science Foundation of Shandong [ZR2013HZ001, ZR2014HM100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	The work was supported by National Natural Science Foundation of China (81301728), Provincial Natural Science Foundation of Shandong (ZR2013HZ001), and Provincial Natural Science Foundation of Shandong (ZR2014HM100).	Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; Alifano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106914; Alifano M, 2011, J THORAC CARDIOV SUR, V142, P1161, DOI 10.1016/j.jtcvs.2011.07.021; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Boonpipattanapong T, 2006, J CLIN GASTROENTEROL, V40, P592, DOI 10.1097/00004836-200608000-00006; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Dumitru CA, 2013, SEMIN CANCER BIOL, V23, P141, DOI 10.1016/j.semcancer.2013.02.005; ESPINOSA E, 1995, LUNG CANCER, V12, P67, DOI 10.1016/0169-5002(95)00407-R; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garcia-Luna PP, 2006, NUTR HOSP, V21, P10; Kishida Y, 2009, BRIT J CANCER, V101, P1537, DOI 10.1038/sj.bjc.6605348; Koch A, 2009, J THORAC ONCOL, V4, P326, DOI 10.1097/JTO.0b013e31819578c8; Laky B, 2007, EUR J CLIN NUTR, V61, P642, DOI 10.1038/sj.ejcn.1602540; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McArdle PA, 2010, UROL INT, V84, P430, DOI 10.1159/000313364; Negrier S, 2002, PROG UROL, V12, P703; Onate-Ocana LF, 2007, ANN SURG ONCOL, V14, P381, DOI 10.1245/s10434-006-9093-x; Pastore CA, 2014, NUTR HOSP, V29, P629, DOI [10.3305/nh.2014.29.3.7195, 10.3305/NH.2014.29.3.7195]; Rami-Porta R, 2015, J THORAC ONCOL, V10, P990, DOI 10.1097/JTO.0000000000000559; Richards CH, 2010, BRIT J CANCER, V103, P1356, DOI 10.1038/sj.bjc.6605919; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; SHOENFELD Y, 1986, J CANCER RES CLIN, V111, P54, DOI 10.1007/BF00402777; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tomita M, 2014, ANTICANCER RES, V34, P3137; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X; Yildirim M, 2013, J BUON, V18, P728	30	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144663	10.1371/journal.pone.0144663	http://dx.doi.org/10.1371/journal.pone.0144663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656866	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900082
J	Taylor, SV; Burrack, HJ; Roe, RM; Bacheler, JS; Sorenson, CE				Taylor, Sally V.; Burrack, Hannah J.; Roe, R. Michael; Bacheler, Jack S.; Sorenson, Clyde E.			Systemic Imidacloprid Affects Intraguild Parasitoids Differently	PLOS ONE			English	Article							CAMPOLETIS-SONORENSIS HYMENOPTERA; HELIOTHIS-VIRESCENS LEPIDOPTERA; TOBACCO BUDWORM LEPIDOPTERA; CARDIOCHILES-NIGRICEPS; BIOLOGICAL-CONTROL; NATURAL ENEMIES; HOST; INSECTICIDES; NOCTUIDAE; GROWTH	Toxoneuron nigriceps (Viereck) (Hymenoptera, Braconidae) and Campoletis sonorensis (Cameron) (Hymenoptera, Ichneumonidae) are solitary endoparasitoids of the tobacco budworm, Heliothis virescens (Fabricius) (Lepidoptera, Noctuidae). They provide biological control of H. virescens populations in Southeastern US agricultural production systems. Field and greenhouse experiments conducted from 2011-2014 compared parasitism rates of parasitoids that developed inside H. virescens larvae fed on tobacco plants treated with and without imidacloprid. The parasitoids in our study did not have a similar response. Toxoneuron nigriceps had reduced parasitism rates, but parasitism rates of C. sonorensis were unaffected. Preliminary data indicate that adult female lifespans of T. nigriceps are also reduced. ELISA was used to measure concentrations of neonicotinoids, imidacloprid and imidacloprid metabolites in H. virescens larvae that fed on imidacloprid-treated plants and in the parasitoids that fed on these larvae. Concentrations were detectable in the whole bodies of parasitized H. virescens larvae, T. nigriceps larvae and T. nigriceps adults, but not in C. sonorensis larvae and adults. These findings suggest that there are effects of imidacloprid on multiple trophic levels, and that insecticide use may differentially affect natural enemies with similar feeding niches.	[Taylor, Sally V.; Burrack, Hannah J.; Roe, R. Michael; Bacheler, Jack S.; Sorenson, Clyde E.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Sorenson, CE (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	clyde_sorenson@ncsu.edu	Burrack, Hannah/CAJ-5730-2022	Burrack, Hannah/0000-0002-8460-8245; Roe, Richard/0000-0002-6386-0994	North Carolina Tobacco Research Commission	North Carolina Tobacco Research Commission	This work was funded by a grant from the North Carolina Tobacco Research Commission to CES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN IT, 1988, J CHEM ECOL, V14, P1113, DOI 10.1007/BF01019339; BARBOSA P, 1986, J CHEM ECOL, V12, P1319, DOI 10.1007/BF01012351; Barbosa P, 1982, P 5 INT S INS PLANT; Bethke JA, 1997, ANN APPL BIOL, V130, P397, DOI 10.1111/j.1744-7348.1997.tb07670.x; CALOW P, 1991, COMP BIOCHEM PHYS C, V100, P3, DOI 10.1016/0742-8413(91)90110-F; CAMPBELL BC, 1979, SCIENCE, V205, P700, DOI 10.1126/science.205.4407.700; Chamberlin FS, 1926, J AGRIC RES, V33, P0021; CROFT BA, 1975, ANNU REV ENTOMOL, V20, P285, DOI 10.1146/annurev.en.20.010175.001441; Croft BA, 1990, ARTHROPOD BIOL CONTR; DANKS HV, 1979, J GEORGIA ENTOMOL SO, V14, P36; De Moraes CM, 2005, ECOL ENTOMOL, V30, P564, DOI 10.1111/j.0307-6946.2005.00723.x; Dhammi A, 2010, THESIS; Douglas MR, 2015, J APPL ECOL, V52, P250, DOI 10.1111/1365-2664.12372; Fisher LR, 2007, FLUE CURED TABACCO G, P152; Grayson JM, 1944, J ECON ENTOMOL, V37, P712, DOI 10.1093/jee/37.5.712; GUILLOT FS, 1973, J INSECT PHYSIOL, V19, P2073, DOI 10.1016/0022-1910(73)90200-X; GUNASENA GH, 1989, ANN ENTOMOL SOC AM, V82, P187, DOI 10.1093/aesa/82.2.187; GUNASENA GH, 1990, J ECON ENTOMOL, V83, P1777, DOI 10.1093/jee/83.5.1777; Hu JS, 2000, ANN ENTOMOL SOC AM, V93, P220, DOI 10.1603/0013-8746(2000)093[0220:IBTLEC]2.0.CO;2; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; JOHNSON MT, 1992, ENVIRON ENTOMOL, V21, P586, DOI 10.1093/ee/21.3.586; KIRITANI K, 1973, BOTYU-KAGAKU, V38, P69; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; LAGADIC L, 1993, PESTIC SCI, V38, P323, DOI 10.1002/ps.2780380407; LEWIS WJ, 1968, J ECON ENTOMOL, V61, P673, DOI 10.1093/jee/61.3.673; Lewis WJ, 1970, ENVIRON ENTOMOL, V1, P468; LINGREN PD, 1970, J ECON ENTOMOL, V63, P518, DOI 10.1093/jee/63.2.518; METCALF RL, 1980, ANNU REV ENTOMOL, V25, P219, DOI 10.1146/annurev.en.25.010180.001251; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Paine TD, 2011, BIOL CONTROL, V56, P175, DOI 10.1016/j.biocontrol.2010.08.007; PENNACCHIO F, 1992, ARCH INSECT BIOCHEM, V19, P177, DOI 10.1002/arch.940190304; Price PW, 1992, INSECT ECOLOGY; Rabb RL, 1971, BIOL CONTROL, P294; Rogers ME, 2003, J ECON ENTOMOL, V96, P1412, DOI 10.1603/0022-0493-96.5.1412; SCHUSTER DJ, 1994, INT J PEST MANAGE, V40, P191, DOI 10.1080/09670879409371880; Stapel JO, 2000, BIOL CONTROL, V17, P243, DOI 10.1006/bcon.1999.0795; Stelinski LL, 2006, BIOL CONTROL, V36, P91, DOI 10.1016/j.biocontrol.2005.07.016; TAYLOR AD, 1988, J ANIM ECOL, V57, P163, DOI 10.2307/4770; Taylor David, 2015, THESIS; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tran DH, 2004, APPL ENTOMOL ZOOL, V39, P435, DOI 10.1303/aez.2004.435; VINSON SB, 1972, J INSECT PHYSIOL, V18, P1509, DOI 10.1016/0022-1910(72)90229-6; VINSON SB, 1979, J INVERTEBR PATHOL, V34, P133, DOI 10.1016/0022-2011(79)90092-2; VINSON SB, 1970, J INSECT PHYSIOL, V16, P1329, DOI 10.1016/0022-1910(70)90132-0; Watanabe E, 2007, FOOD CHEM, V102, P745, DOI 10.1016/j.foodchem.2006.06.031	46	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144598	10.1371/journal.pone.0144598	http://dx.doi.org/10.1371/journal.pone.0144598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658677	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900070
J	Baden, MY; Fukui, K; Hosokawa, Y; Iwahashi, H; Imagawa, A; Shimomura, I				Baden, Megu Yamaguchi; Fukui, Kenji; Hosokawa, Yoshiya; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro			Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PLURIPOTENT STEM-CELLS; TOLL-LIKE RECEPTOR-3; BETA-CELLS; ENTEROVIRUS INFECTION; IN-VITRO; INTERFERON; EXPRESSION; ACTIVATION; INDUCTION	Aims Viral infection is associated with pancreatic beta cell destruction in fulminant type 1 diabetes mellitus. The aim of this study was to investigate the acceleration and protective mechanisms of beta cell destruction by establishing a model of viral infection in pancreatic beta cells. Methods Polyinosinic: polycytidylic acid was transfected into MIN6 cells and insulin-producing cells differentiated from human induced pluripotent stem cells via small molecule applications. Gene expression was analyzed by real-time PCR, and apoptosis was evaluated by cas-pase-3 activity and TUNEL staining. The anti-apoptotic effect of Exendin-4 was also evaluated. Results Polyinosinic: polycytidylic acid transfection led to elevated expression of the genes encoding IFN alpha, IFN beta, CXCL10, Fas, viral receptors, and IFN-inducible antiviral effectors in MIN6 cells. Exendin-4 treatment suppressed the elevated gene expression levels and reduced polyinosinic: polycytidylic acid-induced apoptosis both in MIN6 cells and in insulin-producing cells from human induced pluripotent stem cells. Glucagon-like peptide-1 receptor, protein kinase A, and phosphatidylinositol-3 kinase inhibitors counteracted the anti-apoptotic effect of Exendin-4. Conclusions Polyinosinic: polycytidylic acid transfection can mimic viral infection, and Exendin-4 exerted an anti-apoptotic effect both in MIN6 and insulin-producing cells from human induced pluripotent stem cells.	[Baden, Megu Yamaguchi; Fukui, Kenji; Hosokawa, Yoshiya; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan	Osaka University	Imagawa, A (corresponding author), Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan.	aimagawa@endmet.med.osaka-u.ac.jp			JSPS KAKENHI [15K09429]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15K09429 received by AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2014, CYTOKINE GROWTH F R, V25, P57, DOI 10.1016/j.cytogfr.2014.01.006; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Blandino-Rosano M, 2008, J MOL ENDOCRINOL, V41, P35, DOI 10.1677/JME-07-0154; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Cho YM, 2007, DIABETOLOGIA, V50, P2276, DOI 10.1007/s00125-007-0812-z; Deng CL, 2006, WORLD J GASTROENTERO, V12, P1752, DOI 10.3748/wjg.v12.i11.1752; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P2102, DOI 10.1073/pnas.58.5.2102; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Hanafusa T, 2007, NAT CLIN PRACT ENDOC, V3, P36, DOI 10.1038/ncpendmet0351; Imagawa A, 2003, DIABETES CARE, V26, P2345, DOI 10.2337/diacare.26.8.2345; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mian MF, 2013, J LEUKOCYTE BIOL, V94, P1025, DOI 10.1189/jlb.0312125; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nair S, 2010, J MED VIROL, V82, P1950, DOI 10.1002/jmv.21900; Natalicchio A, 2010, ENDOCRINOLOGY, V151, P2019, DOI 10.1210/en.2009-1166; Nurminen Noora, 2012, Rev Diabet Stud, V9, P260, DOI 10.1900/RDS.2012.9.260; Olsson A, 2005, BIOCHEM BIOPH RES CO, V330, P571, DOI 10.1016/j.bbrc.2005.03.016; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pugazhenthi U, 2010, DIABETOLOGIA, V53, P2357, DOI 10.1007/s00125-010-1849-y; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schulte BM, 2012, DIABETES, V61, P2030, DOI 10.2337/db11-1547; Shibasaki S, 2010, ENDOCR J, V57, P211, DOI 10.1507/endocrj.K09E-291; Soga Y, 2009, TOHOKU J EXP MED, V217, P175, DOI 10.1620/tjem.217.175; Tanaka S, 2009, DIABETES, V58, P2285, DOI 10.2337/db09-0091; Tews D, 2009, HORM METAB RES, V41, P294, DOI 10.1055/s-0028-1105911; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wei Q, 2012, PEPTIDES, V37, P18, DOI 10.1016/j.peptides.2012.06.018; Yoshida I, 2013, MICROBIOL IMMUNOL, V57, P329, DOI 10.1111/1348-0421.12050; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	37	3	3	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144606	10.1371/journal.pone.0144606	http://dx.doi.org/10.1371/journal.pone.0144606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659307	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600065
J	Popova, AP; Cui, TX; Kaciroti, N; Goldsmith, AM; Linn, MJ; Pryhuber, GS; Hershenson, MB				Popova, Antonia P.; Cui, Tracy X.; Kaciroti, Niko; Goldsmith, Adam M.; Linn, Marisa J.; Pryhuber, Gloria S.; Hershenson, Marc B.			Tracheal Aspirate Levels of the Matricellular Protein SPARC Predict Development of Bronchopulmonary Dysplasia	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; INHALED NITRIC-OXIDE; CHRONIC LUNG-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; PREMATURE-INFANTS; NULL MICE; COLLAGEN FIBRILLOGENESIS; FACTOR-BETA; TGF-BETA; EXPRESSION	Background Isolation of tracheal aspirate mesenchymal stromal cells (MSCs) from premature infants has been associated with increased risk of bronchopulmonary dysplasia (BPD). MSCs show high levels of mRNAs encoding matricellular proteins, non-structural extracellular proteins that regulate cell-matrix interactions and participate in tissue remodeling. We hypothesized that lung matricellular protein expression predicts BPD development. Methods We collected tracheal aspirates and MSCs from mechanically-ventilated premature infants during the first week of life. Tracheal aspirate and MSC-conditioned media were analyzed for seven matricellular proteins including SPARC (for Secreted Protein, Acidic, Rich in Cysteine, also called osteonectin) and normalized to secretory component of IgA. A multiple logistic regression model was used to determine whether tracheal aspirate matricellular protein levels were independent predictors of BPD or death, controlling for gestational age (GA) and birth weight (BW). Results We collected aspirates from 89 babies (38 developed BPD, 16 died before 36 wks post-conceptual age). MSC-conditioned media showed no differences in matricellular protein abundance between cells from patients developing BPD and cells from patients who did not. However, SPARC levels were higher in tracheal aspirates from babies with an outcome of BPD or death (p<0.01). Further, our logistic model showed that tracheal aspirate SPARC (p<0.02) was an independent predictor of BPD/death. SPARC deposition was increased in the lungs of patients with BPD. Conclusions In mechanically-ventilated premature infants, tracheal aspirate SPARC levels predicted development of BPD or death. Further study is needed to determine the value of SPARC as a biomarker or therapeutic target in BPD.	[Popova, Antonia P.; Cui, Tracy X.; Goldsmith, Adam M.; Linn, Marisa J.; Hershenson, Marc B.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Hershenson, Marc B.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kaciroti, Niko] Univ Michigan, Sch Med, Ctr Computat Med & Bioinformat, Ann Arbor, MI USA; [Kaciroti, Niko] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Pryhuber, Gloria S.] Univ Rochester, Dept Pediat, Rochester, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Rochester	Hershenson, MB (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	mhershen@umich.edu	Kaciroti, Niko/AAG-3988-2021; Kaciroti, Niko/AAI-2613-2021	Kaciroti, Niko/0000-0001-8843-8231; 	National Institutes of Health [R01 HL79339, K23 HL109149]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079339, K23HL109149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health R01 HL79339 and National Institutes of Health K23 HL109149.	Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Bonniaud P, 2004, AM J RESP CELL MOL, V31, P510, DOI 10.1165/rcmb.2004-0158OC; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P163, DOI 10.1007/s12079-009-0069-z; Bozyk PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031336; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Brekken Rolf A., 2001, Matrix Biology, V19, P816; CHANDRASEKHAR S, 1994, BBA-MOL CELL RES, V1221, P7, DOI 10.1016/0167-4889(94)90209-7; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; Dargaville PA, 1999, AM J RESP CRIT CARE, V160, P778, DOI 10.1164/ajrccm.160.3.9811049; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hennrick KT, 2007, AM J RESP CRIT CARE, V175, P1158, DOI 10.1164/rccm.200607-941OC; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; Jonsson B, 2000, ACTA PAEDIATR, V89, P1375, DOI 10.1080/080352500300002606; Kirpalani H, 2013, NEW ENGL J MED, V369, P611, DOI 10.1056/NEJMoa1214533; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Popova AP, 2012, AM J PHYSIOL-LUNG C, V303, pL439, DOI 10.1152/ajplung.00408.2011; Popova AP, 2010, PEDIATRICS, V126, pE1127, DOI 10.1542/peds.2009-3445; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Shibata S, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-6; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Toti P, 1997, PEDIATR PULM, V24, P22, DOI 10.1002/(SICI)1099-0496(199707)24:1<22::AID-PPUL4>3.0.CO;2-L; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Wen W, 2010, J DENT RES, V89, P1439, DOI 10.1177/0022034510378684; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144122	10.1371/journal.pone.0144122	http://dx.doi.org/10.1371/journal.pone.0144122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656750	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600024
J	Prinz, J; Karacivi, A; Stormanns, ER; Recks, MS; Kuerten, S				Prinz, Johanna; Karacivi, Aylin; Stormanns, Eva R.; Recks, Mascha S.; Kuerten, Stefanie			Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; C57BL/6 MICE; ANIMAL-MODELS; SPINAL-CORD; CORTICAL PATHOLOGY; T-CELLS; DISEASE; DAMAGE	Background Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by inflammation, demyelination and axonal pathology. Myelin basic protein/proteolipid protein (MBP-PLP) fusion protein MP4 is capable of inducing chronic experimental autoimmune encephalomyelitis (EAE) in susceptible mouse strains mirroring diverse histopathological and immunological hallmarks of MS. Lack of human tissue underscores the importance of animal models to study the pathology of MS. Methods Twenty-two female C57BL/6 (B6) mice were immunized with MP4 and the clinical development of experimental autoimmune encephalomyelitis (EAE) was observed. Methylene blue-stained semi-thin and ultra-thin sections of the lumbar spinal cord were assessed at the peak of acute EAE, three months (chronic EAE) and six months after onset of EAE (long-term EAE). The extent of lesional area and inflammation were analyzed in semi-thin sections on a light microscopic level. The magnitude of demyelination and axonal damage were determined using electron microscopy. Emphasis was put on the ventrolateral tract (VLT) of the spinal cord. Results B6 mice demonstrated increasing demyelination and severe axonal pathology in the course of MP4-induced EAE. Additionally, mitochondrial swelling and a decrease in the nearest neighbor neurofilament distance (NNND) as early signs of axonal damage were evident with the onset of EAE. In semi-thin sections we observed the maximum of lesional area in the chronic state of EAE while inflammation was found to a similar extent in acute and chronic EAE. In contrast to the well-established myelin oligodendrocyte glycoprotein (MOG) model, disease stages of MP4-induced EAE could not be distinguished by assessing the extent of parenchymal edema or the grade of inflammation. Conclusions Our results complement our previous ultrastructural studies of B6 EAE models and suggest that B6 mice immunized with different antigens constitute useful instruments to study the diverse histopathological aspects of MS.	[Prinz, Johanna; Karacivi, Aylin; Stormanns, Eva R.] Univ Cologne, Dept Anat 1, D-50931 Cologne, Germany; [Recks, Mascha S.] Univ Cologne, Dept Anat 2, D-50931 Cologne, Germany; [Kuerten, Stefanie] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Cologne; University of Cologne; University of Wurzburg	Kuerten, S (corresponding author), Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany.	stefanie.kuerten@uni-wuerzburg.de						Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; BERNARD CCA, 1976, J IMMUNOGENET, V3, P263; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Calabrese M, 2010, NAT REV NEUROL, V6, P438, DOI 10.1038/nrneurol.2010.93; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; Dyer CA, 2002, NEUROCHEM RES, V27, P1279, DOI 10.1023/A:1021611430052; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goverman J, 1996, LAB ANIM SCI, V46, P482; Gruppe TL, 2012, HISTOL HISTOPATHOL, V27, P1163, DOI 10.14670/HH-27.1163; GUY J, 1991, BRAIN, V114, P281; Handel AE, 2011, EUR J CLIN INVEST, V41, P1254, DOI 10.1111/j.1365-2362.2011.02519.x; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Kuerten S, 2011, FORTSCHR NEUROL PSYC, V79, P83, DOI 10.1055/s-0029-1245937; Kuerten S, 2008, ANN ANAT, V190, P1, DOI 10.1016/j.aanat.2007.11.001; Kuerten S, 2008, CLIN IMMUNOL, V129, P256, DOI 10.1016/j.clim.2008.07.016; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Kuerten S, 2006, J NEUROIMMUNOL, V177, P99, DOI 10.1016/j.jneuroim.2006.03.021; Kuerten S, 2012, ACTA NEUROPATHOL, V124, P861, DOI 10.1007/s00401-012-1023-3; Kuerten S, 2011, APMIS, V119, P336, DOI 10.1111/j.1600-0463.2011.02744.x; Lassmann H, 1983, Schriftenr Neurol, V25, P1; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lunn MPT, 2002, BRAIN, V125, P904, DOI 10.1093/brain/awf072; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Merrill JE, 1999, NEUROPATH APPL NEURO, V25, P435; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Petzold A, 2008, EXP NEUROL, V213, P326, DOI 10.1016/j.expneurol.2008.06.008; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Recks MS, 2011, FORTSCHR NEUROL PSYC, V79, P161, DOI 10.1055/s-0029-1246014; Recks MS, 2013, CLIN IMMUNOL, V149, P32, DOI 10.1016/j.clim.2013.06.004; Recks MS, 2011, NEUROSCI LETT, V494, P227, DOI 10.1016/j.neulet.2011.03.021; Schmidt S, 1999, MULT SCLER J, V5, P147, DOI 10.1177/135245859900500303; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	45	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144847	10.1371/journal.pone.0144847	http://dx.doi.org/10.1371/journal.pone.0144847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658811	Green Submitted, gold, Green Published			2022-12-26	WOS:000366903600095
J	Jin, X; Ye, EM; Qi, JL; Wang, LB; Lei, Y; Chen, PH; Mi, GY; Zou, F; Shao, YC; Yang, Z				Jin, Xiao; Ye, Enmao; Qi, Jianlin; Wang, Lubin; Lei, Yu; Chen, Pinhong; Mi, Guiyun; Zou, Feng; Shao, Yongcong; Yang, Zheng			Recovery Sleep Reverses Impaired Response Inhibition due to Sleep Restriction: Evidence from a Visual Event Related Potentials Study	PLOS ONE			English	Article							ERP COMPONENTS; NEURAL BASIS; DEPRIVATION; TASKS; EEG	Objective To investigate response inhibition after total sleep deprivation (TSD) and the restorative effects of one night of recovery sleep (RS). Methods Fourteen healthy male participants performed a visual Go/NoGo task, and electroencephalogram recordings were conducted at five time points: (1) baseline, (2) after 12 h of TSD, (3) after 24 h of TSD, (4) after 36 h of TSD, and (5) following 8 h of RS. The dynamic changes in response inhibition during TSD and after 8 h of RS were investigated by examining the NoGo-N2 and NoGo-P3 event-related potential components. Results Compared with baseline, NoGo-P3 amplitudes were decreased, while the NoGo-N2 latency increased along with the awake time prolonged. NoGo anteriorization, which was minimized after 24 h of TSD, progressively decreased with increasing TSD. After 8 h of RS, recoveries of both the NoGo-P3 amplitude and NoGo-N2 latency in the prefrontal cortex were observed compared with the values after 36 h of TSD. Conclusion TSD induced a dose-dependent functional decline in the response inhibition of NoGo-N2 and NoGo-P3 on prefrontal cortex activation, and 8 h of RS resulted in recovery or maintenance of the response inhibition. However, it was not restored to baseline levels. Limitations Participants were chosen male college students only, thus the findings cannot be generalized to older people and women. Additionally, the sample size was small, and, thus, speculations on the meaning of the results of this study should be cautious. The EEG continuous recording should be employed to monitor the decline of alertness following TSD.	[Jin, Xiao; Ye, Enmao; Wang, Lubin; Lei, Yu; Chen, Pinhong; Mi, Guiyun; Shao, Yongcong; Yang, Zheng] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Jin, Xiao; Ye, Enmao; Wang, Lubin; Lei, Yu; Chen, Pinhong; Mi, Guiyun; Shao, Yongcong; Yang, Zheng] Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Qi, Jianlin] Air Force Gen Hosp, Dept Clin Psychol, Beijing, Peoples R China; [Zou, Feng] Chinese Peoples Liberat Army, Hosp 406, Clin 215, Dept Psychol, Dalian, Peoples R China	Academy of Military Medical Sciences - China; Air Force General Hospital PLA	Shao, YC (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	budeshao@aliyun.com; yangzhengchina@aliyun.com			National Military Science Foundation of China [BWS11J045, 06z066, AWS11Z005-2, AWS12J003, 12xlz329, 2013BAHD2806]	National Military Science Foundation of China	The research reported in this article was supported by grants from the National Military Science Foundation of China, Grant No. BWS11J045, No. 06z066, No. AWS11Z005-2, No. AWS12J003, No. 12xlz329, and No. 2013BAHD2806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; BONNET MH, 1991, SLEEP, V14, P307, DOI 10.1093/sleep/14.4.307; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 1999, Sleep Res Online, V2, P65; Carskadon M. A., 2017, PRINCIPLES PRACTICE, P15, DOI [10.1016/B0-72-160797-7%2F50009-4, DOI 10.1016/C2012-0-03543-0, 10.1016/C2012-0-03543-0, DOI 10.1016/B978-1-4160-6645-3.00002-5]; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Drummond SPA, 2004, SLEEP, V27, P445; Drummond SPA, 2005, SLEEP, V28, P1059; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goel M, 2013, CIRCADIAN RHYTHMS SL, V119, P155, DOI [10.1016/B978-0-12-396971-2.00007-5, DOI 10.1016/B978-0-12-396971-2.00007-5]; Gosselin A, 2005, CLIN NEUROPHYSIOL, V116, P211, DOI 10.1016/j.clinph.2004.07.033; Harrison Y, 1998, J SLEEP RES, V7, P95, DOI 10.1046/j.1365-2869.1998.00104.x; HASLAM DR, 1982, ERGONOMICS, V25, P163, DOI 10.1080/00140138208924935; Jennings JR, 2003, PSYCHOL SCI, V14, P473, DOI 10.1111/1467-9280.02456; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; KALES A, 1970, PSYCHOSOM MED, V32, P189, DOI 10.1097/00006842-197003000-00005; KENEMANS JL, 1991, PSYCHOPHYSIOLOGY, V28, P114, DOI 10.1111/j.1469-8986.1991.tb03397.x; Kleitman N., 1963, SLEEP WAKEFULNESS; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; Kreusch F, 2014, INT J PSYCHOPHYSIOL, V94, P92, DOI 10.1016/j.ijpsycho.2014.08.001; Lavie P, 2001, ANNU REV PSYCHOL, V52, P277, DOI 10.1146/annurev.psych.52.1.277; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; MORRIS AM, 1992, J OCCUP ENVIRON MED, V34, P1143; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nilsson JP, 2005, J SLEEP RES, V14, P1, DOI 10.1111/j.1365-2869.2005.00442.x; OPSTAD PK, 1987, PEPTIDES, V8, P175, DOI 10.1016/0196-9781(87)90183-5; Panjwani U, 2010, EUR J APPL PHYSIOL, V108, P549, DOI 10.1007/s00421-009-1222-3; Qi JL, 2010, SOC BEHAV PERSONAL, V38, P29, DOI 10.2224/sbp.2010.38.1.29; Raven JC, 1988, ADV PROGR MATRICES; Smith JL, 2007, CLIN NEUROPHYSIOL, V118, P343, DOI 10.1016/j.clinph.2006.09.027; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166; Zhang QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095653	43	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0142361	10.1371/journal.pone.0142361	http://dx.doi.org/10.1371/journal.pone.0142361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26658074	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903500002
J	Hai, X; Landeras, V; Dobre, MA; DeOreo, P; Meyer, TW; Hostetter, TH				Hai, Xin; Landeras, Veeda; Dobre, Mirela A.; DeOreo, Peter; Meyer, Timothy W.; Hostetter, Thomas H.			Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GUT MICROBIOTA; N-OXIDE; METABOLISM; UREMIA; BLOOD; UREA; PHOSPHATIDYLCHOLINE; CREATININE; SOLUTES	Large size, protein binding and intracellular sequestration are well known to limit dialytic removal of compounds. In studying the normal renal and dialytic handling of trimethylamine oxide (TMAO), a molecule associated with cardiovascular disease in the general population, we discovered two largely unrecognized additional limitations to sustained reduction of a solute by chronic hemodialysis. We measured solute levels and handling in subjects on chronic hemodialysis (ESRD, n = 7) and compared these with levels and clearance in normal controls (NLS, n = 6). The ESRD patients had much higher peak predialysis plasma levels of TMAO than NLS (77 +/- 26 vs 2 +/- 1 mu M, mean +/- SD, p<0.05). For comparison, predialysis BUN levels in ESRD subjects were 45 +/- 11 mg/dl and 15 +/- 3 mg/dl in NLS. Thus TMAO levels in ESRD average about 40 fold those in NLS while BUN is 3 fold NLS. However, the fractional reduction of TMAO concentration during dialysis, was in fact greater than that of urea (86 +/- 3 vs 74 +/- 6%, TMAO vs urea, p < 0.05) and its dialytic clearance while somewhat lower than that of urea was comparable to creatinine's. Also production rates were similar (533 +/- 272 vs 606 +/- 220 mu moles/day, ESRD vs NLS, p>0.05). However, TMAO has a volume of distribution about one half that of urea. Also in NLS the urinary clearance of TMAO was high (219 +/- 78 ml/min) compared to the urinary urea and creatinine clearances (55 +/- 14 and 119 +/- 21 ml/min, respectively). Thus, TMAO levels achieve multiples of normal much greater than those of urea due mainly to 1) TMAO's high clearance by the normal kidney relative to urea and 2) its smaller volume of distribution. Modelling suggests that only much more frequent dialysis would be required to lower levels Thus, additional strategies such as reducing production should be explored. Furthermore, using urea as the sole marker of dialysis adequacy may be misleading since a molecule, TMAO, that is dialyzed readily accumulates to much higher multiples of normal with urea based dialysis prescriptions.	[Hai, Xin; Landeras, Veeda; Dobre, Mirela A.; DeOreo, Peter; Hostetter, Thomas H.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Meyer, Timothy W.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Case Western Reserve University; Stanford University	Hostetter, TH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.	thomas.hostetter@uhhospitals.org	Dobre, Mirela/ABC-8901-2021	Dobre, Mirela/0000-0002-9059-9998	National Institutes of Health [RO1 DK 080123]; American Heart Association [FTF 15920005]; Rosenberg Foundation of the Centers for Dialysis Care; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Rosenberg Foundation of the Centers for Dialysis Care; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health RO1 DK 080123, THH and TWM; American Heart Association FTF 15920005, MAD; Rosenberg Foundation of the Centers for Dialysis Care, THH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; Chasis H, 1938, J CLIN INVEST, V17, P347, DOI 10.1172/JCI100959; DESCOMBES E, 1993, CLIN NEPHROL, V40, P286; Eloot S, 2009, NEPHROL DIAL TRANSPL, V24, P2225, DOI 10.1093/ndt/gfp059; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; LANGSDORF LJ, 1993, BLOOD, V81, P820; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Meyer TW, 2007, J AM SOC NEPHROL, V18, P868, DOI 10.1681/ASN.2006080863; Meyer TW, 2014, J AM SOC NEPHROL, V25, P2151, DOI 10.1681/ASN.2013121264; Schneditz D, 2009, HEMODIAL INT, V13, P215, DOI 10.1111/j.1542-4758.2009.00351.x; Sirich TL, 2014, J AM SOC NEPHROL, V25, P615, DOI 10.1681/ASN.2013060597; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Vanholder R, 2015, SEMIN DIALYSIS, V28, P114, DOI 10.1111/sdi.12331; Walther JL, 2006, KIDNEY INT, V69, P1056, DOI 10.1038/sj.ki.5000196; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	17	57	60	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143731	10.1371/journal.pone.0143731	http://dx.doi.org/10.1371/journal.pone.0143731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650937	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300025
J	Johansson, KA; Memirie, ST; Pecenka, C; Jamison, DT; Verguet, S				Johansson, Kjell Arne; Memirie, Solomon Tessema; Pecenka, Clint; Jamison, Dean T.; Verguet, Stephane			Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; CONJUGATE VACCINE; ROTAVIRUS VACCINATION; SEVERE MORBIDITY; NATIONAL CAUSES; PUBLIC-FINANCE; MORTALITY; DISEASE; CHILDREN; BENEFITS	Background Pneumonia and pneumococcal disease cause a large disease burden in resource-constrained settings. We pursue an extended cost-effectiveness analysis (ECEA) of two fully publicly financed interventions in Ethiopia: pneumococcal vaccination for newborns and pneumonia treatment for under-five children in Ethiopia. Methods We apply ECEA methods and estimate the program impact on: (1) government program costs; (2) pneumonia and pneumococcal deaths averted; (3) household expenses related to pneumonia/pneumococcal disease treatment averted; (4) prevention of household medical impoverishment measured by an imputed money-metric value of financial risk protection; and (5) distributional consequences across the wealth strata of the country population. Available epidemiological and cost data from Ethiopia are applied and the two interventions are assessed separately at various incremental coverage levels. Results Scaling-up pneumococcal vaccines at around 40% coverage would cost about $11.5 million and avert about 2090 child deaths annually, while a 10% increase of pneumonia treatment to all children under 5 years of age would cost about $13.9 million and avert 2610 deaths annually. Health benefits of the two interventions publicly financed would be concentrated among the bottom income quintile, where 30-40% of all deaths averted would be expected to occur in the poorest quintile. In sum, the two interventions would eliminate a total of $2.4 million of private household expenditures annually, where the richest quintile benefits from around 30% of the total private expenditures averted. The financial risk protection benefits would be largely concentrated among the bottom income quintile. The results are most sensitive to variations in vaccine price, population size, number of deaths due to pneumonia, efficacy of interventions and out-of-pocket copayment share. Conclusions Vaccine and treatment interventions for children, as shown with the illustrative examples of pneumococcal vaccine and pneumonia treatment, can bring large health and financial benefits to households in Ethiopia, most particularly among the poorest socio-economic groups.	[Johansson, Kjell Arne; Memirie, Solomon Tessema] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Pecenka, Clint] PATH, Seattle, WA USA; [Jamison, Dean T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Verguet, Stephane] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	University of Bergen; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health	Johansson, KA (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	kjell.johansson@igs.uib.no	Johansson, Kjell Arne/ABE-3628-2020; Memirie, Solomon T/AAH-3342-2020	Johansson, Kjell Arne/0000-0001-8912-8710; 	NORAD; Norwegian Research Council, through the Priority Setting in Global Health [218694]; Bill & Melinda Gates Foundation through the Disease Control Priorities Network (DCPN)	NORAD(CGIAR); Norwegian Research Council, through the Priority Setting in Global Health; Bill & Melinda Gates Foundation through the Disease Control Priorities Network (DCPN)	This work received funding from NORAD and the Norwegian Research Council, through the Priority Setting in Global Health - 2020 grant (grant number 218694) to the University of Bergen and the Bill & Melinda Gates Foundation through the Disease Control Priorities Network (DCPN) grant to the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisors DGD, 2013, ADV MARKET COMMITMEN; Ayieko P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067324; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brock Dan W, 2003, Cost Eff Resour Alloc, V1, P4, DOI 10.1186/1478-7547-1-4; Brock DW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P259; Central Statistical Agency [Ethiopia] and ORC Macro [USA], 2011, ETH DEM HLTH SURV; Chola Lumbwe, 2009, Cost Eff Resour Alloc, V7, P16, DOI 10.1186/1478-7547-7-16; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Daniels N, 2008, JUST HLTH; Griffiths UK, 2009, VACCINE, V27, P1426, DOI 10.1016/j.vaccine.2008.12.037; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Institute for Health Metrics and Evaluation, 2014, GLOB BURD DIS STUD 2; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jamison DT, 2013, GLOBAL HLTH 2035 WOR, P1; Johansson KA, 2011, AM J BIOETHICS, V11, P32, DOI 10.1080/15265161.2011.627287; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Johri M, 2012, INT J TECHNOL ASSESS, V28, P125, DOI 10.1017/S0266462312000050; Kim SY, 2008, PHARMACOECONOMICS, V26, P191, DOI 10.2165/00019053-200826030-00004; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McClellan M, 2006, J PUBLIC ECON, V90, P257, DOI 10.1016/j.jpubeco.2005.05.008; Ministry of Health [Ethiopia], 2010, HLTH SECT DEV PROGR; Mkandawire T, 2005, 23 SOC POL DEV PROGR; Norheim OF, 2010, GINI IMPACT ANAL MEA; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rheingans R, 2012, VACCINE, V30, pA15, DOI 10.1016/j.vaccine.2012.01.018; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; SALEM ABZ, 1974, ECONOMETRICA, V42, P1115, DOI 10.2307/1914221; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; The World Bank Group Africa Region Human Development Ministry of Health Ethiopia, 2005, COUNTR STAT REP HLTH, VII; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; UN Interagency Group for Child Mortality Estimates, 2013, LEV TRENDS CHILD MOR; UN-United Nations, 2012, WORLD POP PROSP 2012; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD FERT DAT 2012; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; Verguet Stephane, 2015, Lancet Glob Health, V3, pe288, DOI 10.1016/S2214-109X(14)70346-8; Verguet S, 2015, LANCET GLOB HEALTH, V3, pE206, DOI 10.1016/S2214-109X(15)70095-1; Verguet S, 2015, HEALTH ECON, V24, P318, DOI 10.1002/hec.3019; Verguet S, 2013, VACCINE, V31, P4902, DOI 10.1016/j.vaccine.2013.07.014; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wikler D., 2007, ETHICS PREVENTION PU, P78; World Bank, 2014, WORLD DEV IND 2014; World Health Organization, 2014, REV WHO CLASS TREATM; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH	52	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142691	10.1371/journal.pone.0142691	http://dx.doi.org/10.1371/journal.pone.0142691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650078	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903300006
J	Bahadori, L; Chakrabarti, MH; Manan, NSA; Hashim, MA; Mjalli, FS; AlNashef, IM; Brandon, N				Bahadori, Laleh; Chakrabarti, Mohammed Harun; Manan, Ninie Suhana Abdul; Hashim, Mohd Ali; Mjalli, Farouq Sabri; AlNashef, Inas Muen; Brandon, Nigel			The Effect of Temperature on Kinetics and Diffusion Coefficients of Metallocene Derivatives in Polyol-Based Deep Eutectic Solvents	PLOS ONE			English	Article							IONIC LIQUIDS; QUATERNARY AMMONIUM; CHOLINE-CHLORIDE; CYCLIC VOLTAMMETRY; PHYSICOCHEMICAL PROPERTIES; ELECTRICAL-CONDUCTIVITY; COBALTOCENIUM CATION; AQUEOUS MIXTURES; REDOX COUPLES; FERROCENE	The temperature dependence of the density, dynamic viscosity and ionic conductivity of several deep eutectic solvents (DESs) containing ammonium-based salts and hydrogen bond donvnors (polyol type) are investigated. The temperature-dependent electrolyte viscosity as a function of molar conductivity is correlated by means of Walden's rule. The oxidation of ferrocene (Fc/Fc(+)) and reduction of cobaltocenium (Cc(+)/Cc) at different temperatures are studied by cyclic voltammetry and potential-step chronoamperometry in DESs. For most DESs, chronoamperometric transients are demonstrated to fit an Arrhenius-type relation to give activation energies for the diffusion of redox couples at different temperatures. The temperature dependence of the measured conductivities of DES1 and DES2 are better correlated with the Vogel-Tamman-Fulcher equation. The kinetics of the Fc/Fc(+) and Cc(+)/Cc electrochemical systems have been investigated over a temperature range from 298 to 338 K. The heterogeneous electron transfer rate constant is then calculated at different temperatures by means of a logarithmic analysis. The glycerol-based DES (DES5) appears suitable for further testing in electrochemical energy storage devices.	[Bahadori, Laleh; Hashim, Mohd Ali] Univ Malaya, Dept Chem Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Chakrabarti, Mohammed Harun; Brandon, Nigel] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Manan, Ninie Suhana Abdul] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia; [Mjalli, Farouq Sabri] Sultan Qaboos Univ, Petr & Chem Engn Dept, Muscat 123, Oman; [AlNashef, Inas Muen] Masdar Inst Sci & Technol, Dept Chem & Environm Engn, Abu Dhabi, U Arab Emirates	Universiti Malaya; Imperial College London; Universiti Malaya; Sultan Qaboos University; Khalifa University of Science & Technology	Chakrabarti, MH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England.	mohammedharun77@yahoo.com	Nashef, Enas/AAA-1995-2022; Manan, Ninie Suhana Abdul/F-6067-2011; HASHIM, MOHD ALI/B-9065-2010	Manan, Ninie Suhana Abdul/0000-0001-9660-4383; HASHIM, MOHD ALI/0000-0002-0570-6788; Bahadori, Laleh/0000-0002-5677-5142; Mjalli, Farouq S./0000-0001-6584-8983; AlNashef, Inas/0000-0003-4654-2932; Chakrabarti, Barun/0000-0002-0172-986X; Brandon, Nicholas/0000-0002-3917-0096	University of Malaya; High Impact Research Grant in Malaysia (Ministry of Higher Education) [UM.C/HIR/MOHE/ENG/18]; Ministry of Higher Education [UM.C/HIR/MOHE/ENG/18]; EPSRC [EP/L014289/1, EP/K002252/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K002252/1, EP/L014289/1] Funding Source: researchfish	University of Malaya(Universiti Malaya); High Impact Research Grant in Malaysia (Ministry of Higher Education); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The University of Malaya and the Ministry of Higher Education funded this work by means of research grant UM.C/HIR/MOHE/ENG/18. The funder's website is http://hir.um.edu.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the financial support from the High Impact Research Grant (UM.C/HIR/MOHE/ENG/18) in Malaysia (Ministry of Higher Education).	Abbott AP, 2008, T I MET FINISH, V86, P234, DOI 10.1179/174591908X327581; Abbott AP, 2007, GREEN CHEM, V9, P868, DOI 10.1039/b702833d; Abbott AP, 2006, J CHEM ENG DATA, V51, P1280, DOI 10.1021/je060038c; Abbott AP, 2012, PHYS CHEM CHEM PHYS, V14, P2443, DOI 10.1039/c2cp23712a; Abbott AP, 2005, GREEN CHEM, V7, P705, DOI 10.1039/b511691k; Abbott AP, 2004, J AM CHEM SOC, V126, P9142, DOI 10.1021/ja048266j; Abbott AP, 2003, CHEM COMMUN, P70, DOI 10.1039/b210714g; Abbott AR, 2006, CHEMPHYSCHEM, V7, P803, DOI 10.1002/cphc.200500489; Bahadori L, 2013, ELECTROCHIM ACTA, V113, P205, DOI 10.1016/j.electacta.2013.09.102; Bahadori L, 2013, PHYS CHEM CHEM PHYS, V15, P1707, DOI 10.1039/c2cp43077k; Bandres I, 2011, J PHYS CHEM B, V115, P12499, DOI 10.1021/jp203433u; Barrosse-Antle LE, 2009, J PHYS CHEM B, V113, P2805, DOI 10.1021/jp810926u; Bockris J., 1998, MODERN ELECTROCHEMIS; Bonhote P, 1996, INORG CHEM, V35, P1168, DOI 10.1021/ic951325x; Carriazo D, 2012, CHEM SOC REV, V41, P4996, DOI 10.1039/c2cs15353j; Chakrabarti MH, 2015, CHEM ENG J, V274, P213, DOI 10.1016/j.cej.2015.03.083; Chakrabarti MH, 2013, INT J ELECTROCHEM SC, V8, P9652; Chakrabarti MH, 2013, J SOLUTION CHEM, V42, P2329, DOI 10.1007/s10953-013-0111-x; Ciocirlan O, 2010, REV CHIM-BUCHAREST, V61, P721; Serrano MC, 2012, CHEM COMMUN, V48, P579, DOI 10.1039/c1cc15284j; CROOKS RM, 1988, J ELECTROANAL CHEM, V243, P117, DOI 10.1016/0022-0728(88)85033-2; Dai YT, 2013, ANAL CHIM ACTA, V766, P61, DOI 10.1016/j.aca.2012.12.019; de Maria PD, 2011, CURR OPIN CHEM BIOL, V15, P220, DOI 10.1016/j.cbpa.2010.11.008; Gorke J, 2010, BIOTECHNOL BIOPROC E, V15, P40, DOI 10.1007/s12257-009-3079-z; Guo YL, 2010, J ELECTROANAL CHEM, V639, P109, DOI 10.1016/j.jelechem.2009.11.030; Hayamizu K, 2008, J PHYS CHEM B, V112, P1189, DOI 10.1021/jp077714h; Hayyan M, 2010, FUEL PROCESS TECHNOL, V91, P116, DOI 10.1016/j.fuproc.2009.09.002; Hu SQ, 2009, GREEN CHEM, V11, P873, DOI 10.1039/b822328a; Hultgren VM, 2002, ANAL CHEM, V74, P3151, DOI 10.1021/ac015729k; Ilgen F, 2009, GREEN CHEM, V11, P848, DOI 10.1039/b816551c; Kareem MA, 2010, J CHEM ENG DATA, V55, P4632, DOI 10.1021/je100104v; KEITA B, 1988, J ELECTROCHEM SOC, V135, P87, DOI 10.1149/1.2095596; Kim DY, 2013, ELECTROCHIM ACTA, V94, P49, DOI 10.1016/j.electacta.2013.01.140; Leron RB, 2012, FLUID PHASE EQUILIBR, V335, P32, DOI 10.1016/j.fluid.2012.08.016; Leron RB, 2012, J TAIWAN INST CHEM E, V43, P551, DOI 10.1016/j.jtice.2012.01.007; Lindberg D, 2010, J BIOTECHNOL, V147, P169, DOI 10.1016/j.jbiotec.2010.04.011; MacFarlane DR, 2009, PHYS CHEM CHEM PHYS, V11, P4962, DOI 10.1039/b900201d; Mamlouk M, 2014, J POWER SOURCES, V245, P915, DOI 10.1016/j.jpowsour.2013.07.050; Matsumiya M, 2006, ELECTROCHIM ACTA, V51, P1178, DOI 10.1016/j.electacta.2005.06.006; Maugeri Z, 2012, RSC ADV, V2, P421, DOI 10.1039/c1ra00630d; NICHOLSON RS, 1965, ANAL CHEM, V37, P1351, DOI 10.1021/ac60230a016; Ong SP, 2011, CHEM MATER, V23, P2979, DOI 10.1021/cm200679y; Pan Y, 2013, J ELECTROCHEMICAL SO, V159, pF125; Rogers EI, 2008, J PHYS CHEM C, V112, P2729, DOI 10.1021/jp710134e; Russ C, 2012, GREEN CHEM, V14, P2969, DOI 10.1039/c2gc36005e; Shahbaz K, 2012, THERMOCHIM ACTA, V527, P59, DOI 10.1016/j.tca.2011.10.010; Shahbaz K., 2010, Journal of Applied Sciences, V10, P3349, DOI 10.3923/jas.2010.3349.3354; Shiddiky MJA, 2009, J AM CHEM SOC, V131, P7976, DOI 10.1021/ja8092295; SHOUP D, 1982, J ELECTROANAL CHEM, V140, P237, DOI 10.1016/0022-0728(82)85171-1; Smith EL, 2014, CHEM REV, V114, P11060, DOI 10.1021/cr300162p; STOJANOVIC RS, 1993, ANAL CHEM, V65, P56, DOI 10.1021/ac00049a012; Sukardi SK, 2008, ELECTROCHEM COMMUN, V10, P250, DOI 10.1016/j.elecom.2007.11.022; Tang BK, 2013, MONATSH CHEM, V144, P1427, DOI 10.1007/s00706-013-1050-3; Taylor AW, 2011, PHYS CHEM CHEM PHYS, V13, P10147, DOI 10.1039/c1cp20373h; Torriero AAJ, 2012, ELECTROCHIM ACTA, V82, P60, DOI 10.1016/j.electacta.2012.01.115; Torriero AAJ, 2009, J PHYS CHEM B, V113, P11222, DOI 10.1021/jp9046769; Tsierkezos NG, 2007, J SOLUTION CHEM, V36, P289, DOI 10.1007/s10953-006-9119-9; Vila J, 2006, FLUID PHASE EQUILIBR, V242, P141, DOI 10.1016/j.fluid.2006.01.022; Vila J, 2007, PORT ELECTROCHIM ACT, V25, P163, DOI 10.4152/pea.200701163; Waligora L, 2009, ELECTROCHIM ACTA, V54, P1414, DOI 10.1016/j.electacta.2008.09.023; Wang YJ, 2010, J ELECTROANAL CHEM, V648, P15, DOI 10.1016/j.jelechem.2010.07.006; Weaver JEF, 2011, J PHYS CHEM C, V115, P19379, DOI 10.1021/jp206927w; Zhang J, 2003, ANAL CHEM, V75, P2694, DOI 10.1021/ac026329f; Zhang QH, 2012, CHEM SOC REV, V41, P7108, DOI 10.1039/c2cs35178a; Zhang ZH, 2012, GREEN CHEM, V14, P1502, DOI 10.1039/c2gc35258c; Zhao C, 2008, J PHYS CHEM B, V112, P6923, DOI 10.1021/jp711804j; Zhao H, 2013, J CHEM TECHNOL BIOT, V88, P3, DOI 10.1002/jctb.3935	67	25	25	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144235	10.1371/journal.pone.0144235	http://dx.doi.org/10.1371/journal.pone.0144235			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642045	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700080
J	Kumar, S; Jain, KK; Bhardwaj, KN; Chakraborty, S; Kuhad, RC				Kumar, Sandeep; Jain, Kavish Kumar; Bhardwaj, Kailash N.; Chakraborty, Subhojit; Kuhad, Ramesh Chander			Multiple Genes in a Single Host: Cost-Effective Production of Bacterial Laccase (cotA), Pectate Lyase (pel), and Endoxylanase (xyl) by Simultaneous Expression and Cloning in Single Vector in E. coli	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; PICHIA-PASTORIS; HYDROLYSIS; OVEREXPRESSION; FERMENTATION; SUBSTRATE; XYLANASE; ETHANOL; SYSTEM	This study attempted to reduce the enzyme production cost for exploiting lignocellulosic materials by expression of multiple genes in a single host. Genes for bacterial laccase (CotA), pectate lyase (Pel) and endoxylanase (Xyl), which hold significance in lignocellulose degradation, were cloned in pETDuet-1 vector containing two independent cloning sites (MCS). CotA and xyl genes were cloned in MCS1 and MCS 2, respectively. Pel gene was cloned by inserting complete cassette (T-7 promoter, ribosome binding site, pel gene, His tag and complete gene ORF) preceded by cotA open reading frame in the MCS1. IPTG induction of CPXpDuet-1 construct in E. coli BL21(DE3) resulted in expression of all three heterologous proteins of similar to 65 kDa (CotA), similar to 45 kDa (Pel) and similar to 25 kDa (Xyl), confirmed by SDS-PAGE and western blotting. Significant portions of the enzymes were also found in culture supernatant (similar to 16, similar to 720 and similar to 370 IU/ml activities of CotA, Pel and Xyl, respectively). Culture media optimization resulted in 2, 3 and 7 fold increased secretion of recombinant CotA, Pel and Xyl, respectively. Bioreactor level optimization of the recombinant cocktail expression resulted in production of 19 g/L dry cell biomass at OD600nm 74 from 1 L induced culture after 15 h of cultivation, from which 9, 627 and 1090 IU/ml secretory enzyme activities of CotA, Xyl and Pel were obtained, respectively. The cocktail was also found to increase the saccharification of orange peel in comparison to the xylanase alone. Thus, simultaneous expression as well as extra cellular secretion of these enzymes as cocktail can reduce the enzyme production cost which increases their applicability specially for exploiting lignocellulosic materials for their conversion to value added products like alcohol and animal feed.	[Kumar, Sandeep; Jain, Kavish Kumar; Chakraborty, Subhojit; Kuhad, Ramesh Chander] Univ Delhi South Campus, Dept Microbiol, Lignocellulose Biotechnol Lab, New Delhi 110021, India; [Bhardwaj, Kailash N.] Uttarakhand State Council Sci & Technol UCOST, Dehra Dun 248007, Uttarakhand, India; [Kuhad, Ramesh Chander] Cent Univ Haryana, Pali 123029, Haryana, India	University of Delhi; Central University of Haryana	Kuhad, RC (corresponding author), Univ Delhi South Campus, Dept Microbiol, Lignocellulose Biotechnol Lab, Benito Juarez Rd, New Delhi 110021, India.	kuhad85@gmail.com	Kuhad, Ramesh Chander/T-7753-2019	Kuhad, Ramesh Chander/0000-0002-4120-948X; Jain, Kavish Kumar/0000-0002-6609-1756	University of Delhi Research; PURSE Grant; Indian Medical Council of Research (ICMR); Council of Scientific and Industrial Research (CSIR); University of Delhi South Campus; DU/DST PURSE grant; Indian Council of Medical Research (ICMR), New Delhi	University of Delhi Research; PURSE Grant; Indian Medical Council of Research (ICMR); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University of Delhi South Campus; DU/DST PURSE grant; Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	The work has been sponsored by a University of Delhi Research and PURSE Grant to RCK (www.du.ac.in). SK received a research fellowship from the Indian Medical Council of Research (ICMR) (http://icmr.nic.in/). KKJ received a research fellowship from the Council of Scientific and Industrial Research (CSIR) (www.csirhrdg.res.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial assistance from University of Delhi South Campus and DU/DST PURSE grant is highly acknowledged. Also the fellowship grants from Indian Council of Medical Research (ICMR), New Delhi to SK and from Council of Scientific and industrial research (CSIR) to KKJ is gratefully acknowledged. We wish to thank Mayura Dutta, for her sincere effort in copy editing of the manuscript. The authors are grateful to Prof. J. P. Khurana, Department of Plant Molecular Biology, University of Delhi South Campus, New Delhi, for editing our manuscript. The authors also wish to thank Ms Urvashi Kuhad, Research Fellow, Department of Modern Indian Languages and Comparative Literature, University of Delhi, Delhi for language editing. We would also like to thank Dr. Rishi Gupta (DST Fast Track Young Scientist), Dr. Arvind and Dr. Rishikesh, Research Associates, Lignocellulose Biotechnology Laboratory, University of Delhi South Campus, New Delhi for their constructive suggestions during the preparation of the manuscript.	ALBERSHEIM P, 1962, ARCH BIOCHEM BIOPHYS, V97, P107, DOI 10.1016/0003-9861(62)90050-4; Broedel SE, 2007, ACES SIGNAL SEQUENCE; Busso D, 2011, J STRUCT BIOL, V175, P159, DOI 10.1016/j.jsb.2011.03.004; Carneiro S, 2013, J BIOTECHNOL, V164, P396, DOI 10.1016/j.jbiotec.2012.08.026; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Dzivenu OK, 2004, PROTEIN EXPRES PURIF, V38, P1, DOI 10.1016/j.pep.2004.07.016; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; Fonseca-Maldonado R, 2014, PROCESS BIOCHEM, V49, P1152, DOI 10.1016/j.procbio.2014.03.027; Gupta R, 2009, BIORESOURCE TECHNOL, V100, P1214, DOI 10.1016/j.biortech.2008.08.033; Jalal A, 2009, J BIOSCI BIOENG, V107, P360, DOI 10.1016/j.jbiosc.2008.12.005; Kapoor M, 2007, J APPL MICROBIOL, V103, P305, DOI 10.1111/j.1365-2672.2006.03251.x; Khamseh AAG, 2012, PROCESS BIOCHEM, V47, P1588, DOI 10.1016/j.procbio.2011.10.018; Khasa YP, 2011, YEAST, V28, P213, DOI 10.1002/yea.1832; Kuhad RC, 2011, RENEW SUST ENERG REV, V15, P4950, DOI 10.1016/j.rser.2011.07.058; Liu M, 2012, BIOCHEM ENG J, V68, P1, DOI 10.1016/j.bej.2012.07.003; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oberoi HS, 2010, J AGR FOOD CHEM, V58, P3422, DOI 10.1021/jf903163t; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; SAIER MH, 2006, MICROBE, V1, P414; Schlapschy M, 2006, PROTEIN ENG DES SEL, V19, P385, DOI 10.1093/protein/gzl018; Shokri A, 2002, APPL MICROBIOL BIOT, V58, P386, DOI 10.1007/s00253-001-0889-0; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Sweeney MD, 2012, CATALYSTS, V2, P244, DOI 10.3390/catal2020244; Tripathi, 2009, IND BIOTECHNOLOGY, V5, P179, DOI DOI 10.1089/IND.2009.3.179; Ukkonen K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-73; Ylitervo P, 2008, PRODUCTION ETHANOL B; Yu NY, 2010, BIOINFORMATICS, V13; Zhang CJ, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-26	31	9	10	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144379	10.1371/journal.pone.0144379	http://dx.doi.org/10.1371/journal.pone.0144379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642207	gold, Green Submitted, Green Published			2022-12-26	WOS:000366902700108
J	Manzur, JP; Fita, A; Prohens, J; Rodriguez-Burruezo, A				Pablo Manzur, Juan; Fita, Ana; Prohens, Jaime; Rodriguez-Burruezo, Adrian			Successful Wide Hybridization and Introgression Breeding in a Diverse Set of Common Peppers (Capsicum annuum) Using Different Cultivated Aji (C-baccatum) Accessions as Donor Parents	PLOS ONE			English	Article							LYCOPERSICON-ESCULENTUM; INTERSPECIFIC HYBRIDS; WILD RELATIVES; PERUVIANUM; RESISTANCE; GENETICS; CROSSES; GROWTH; L.	Capsicum baccatum, commonly known as aji, has been reported as a source of variation for many different traits to improve common pepper (C. annuum), one of the most important vegetables in the world. However, strong interspecific hybridization barriers exist between them. A comparative study of two wide hybridization approaches for introgressing C. baccatum genes into C. annuum was performed: i) genetic bridge (GB) using C. chinense and C. frutescens as bridge species; and, ii) direct cross between C. annuum and C. baccatum combined with in vitro embryo rescue (ER). A diverse and representative collection of 18 accessions from four cultivated species of Capsicum was used, including C. annuum (12), C. baccatum (3), C. chinense (2), and C. frutescens (1). More than 5000 crosses were made and over 1000 embryos were rescued in the present study. C. chinense performed as a good bridge species between C. annuum and C. baccatum, with the best results being obtained with the cross combination [C. baccatum (female) x C. chinense (male)] (female) x C. annuum (male), while C. frutescens gave poor results as bridge species due to strong prezygotic and postzygotic barriers. Virus-like-syndrome or dwarfism was observed in F-1 hybrids when both C. chinense and C. frutescens were used as female parents. Regarding the ER strategy, the best response was found in C. annuum (female) x C. baccatum (male) crosses. First backcrosses to C. annuum (BC(1)s) were obtained according to the crossing scheme [C. annuum (female) x C. baccatum (male)] (female) x C. annuum (male) using ER. Advantages and disadvantages of each strategy are discussed in relation to their application to breeding programmes. These results provide breeders with useful practical information for the regular utilization of the C. baccatum gene pool in C. annuum breeding.	[Pablo Manzur, Juan] Inst Invest Agr CRI La Platina, Santiago, Chile; [Fita, Ana; Prohens, Jaime; Rodriguez-Burruezo, Adrian] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, E-46022 Valencia, Spain	Universitat Politecnica de Valencia	Fita, A (corresponding author), Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Camino Vera S-N, E-46022 Valencia, Spain.	anfifer@upvnet.upv.es	Prohens, Jaime/H-2228-2015; Fita, ANA/K-4250-2017; Burruezo, Adrian Rodriguez/AAB-1498-2019; Prohens, Jaime/ABF-1229-2021	Prohens, Jaime/0000-0003-1181-9065; Prohens, Jaime/0000-0003-1181-9065; FITA, ANA/0000-0002-8637-5852; Rodriguez-Burruezo, Adrian/0000-0002-4530-8071	Universitat Politecnica de Valencia [2011-S2-4264]	Universitat Politecnica de Valencia	Juan P. Manzur thanks Universitat Politecnica de Valencia for a research predoctoral grant (2011-S2-4264, programa para la formacion de personal investigador). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Juan P. Manzur thanks Universitat Politecnica de Valencia for a research predoctoral grant (2011-S2-4264, programa para la formacion de personal investigador). Authors are grateful to Centro Inv. Agr. Mabegondo, S. Larregla from NEIKER, P.W. Bosland from NMSU and the Consejos Reguladores of IGP Pimiento Asado del Bierzo, DOP Pimenton de Murcia, and IGP Piquillo de Lodosa for providing us with seeds from Arnoia, Guindilla de Ibarra, Numex, Bierzo, Bola and Piquillo, respectively.	BARBANO PP, 1984, J AM SOC HORTIC SCI, V109, P95; Bento CS, 2013, GENET MOL RES, V12, P1074, DOI 10.4238/2013.April.10.3; Bosland P. W., 2012, Peppers: vegetable and spice capsicums, DOI 10.1079/9781845938253.0000; Chen LZ, 1996, PLANT BREEDING, V115, P251, DOI 10.1111/j.1439-0523.1996.tb00912.x; Monteiro CED, 2011, CROP BREED APPL BIOT, V11, P241, DOI 10.1590/S1984-70332011000300006; de Souza VL, 2003, PLANT PATHOL, V52, P613, DOI 10.1046/j.1365-3059.2003.00920.x; do Rego ER, 2009, EUPHYTICA, V168, P275, DOI 10.1007/s10681-009-9947-y; EGAWA Y, 1986, JPN J BREED, V36, P16; Eggink PM, 2014, THEOR APPL GENET, V127, P373, DOI 10.1007/s00122-013-2225-3; GONZALEZSALAN MM, 1991, EUPHYTICA, V59, P49; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Honnay O, 2012, FRONT ECOL ENVIRON, V10, P121, DOI 10.1890/12.WB.007; INAI S, 1993, THEOR APPL GENET, V87, P416, DOI 10.1007/BF00215086; Kamvorn W, 2014, SCI HORTIC-AMSTERDAM, V179, P9, DOI 10.1016/j.scienta.2014.09.003; Kim SangHoon, 2008, Journal of Crop Science and Biotechnology, V11, P13; Kollmannsberger H, 2011, J SCI FOOD AGR, V91, P1598, DOI 10.1002/jsfa.4354; Lafon-Placette C, 2015, CURR OPIN PLANT BIOL, V23, P39, DOI 10.1016/j.pbi.2014.10.006; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Mahasuk P, 2009, PHYTOPATHOLOGY, V99, P1100, DOI 10.1094/PHYTO-99-9-1100; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Manzur JP, 2013, SCI HORTIC-AMSTERDAM, V161, P181, DOI 10.1016/j.scienta.2013.06.036; Manzur JP, 2013, SCI AGR, V71, P488; Matsunaga H., 1995, Capsicum & Eggplant Newsletter, P60; Md. Amzad Hossain, 2003, Japanese Journal of Tropical Agriculture, V47, P9; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Mongkolporn O, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P43, DOI 10.1007/978-3-642-20450-0_4; MUHYI R, 1995, HORTSCIENCE, V30, P341, DOI 10.21273/HORTSCI.30.2.341; Nowack MK, 2010, BIOCHEM SOC T, V38, P604, DOI 10.1042/BST0380604; Nuez F, 2003, CULTIVO PIMIENTOS CH; Orr HA, 1996, GENETICS, V144, P1331; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; PICKERSGILL B, 1988, BIOL ZBL, V107, P381; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; RAO NB, 1992, EUPHYTICA, V59, P135, DOI 10.1007/BF00041265; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Shen XL, 2011, METHODS MOL BIOL, V710, P75, DOI 10.1007/978-1-61737-988-8_7; Shivanna KR, 2015, PLANT BIOL BIOTECHNO, V2, P347, DOI [10.1007/978-81-322-2283-5_17, DOI 10.1007/978-81-322-2283-5_17]; Soler S, 2015, ANN APPL BIOL, V167, P343, DOI 10.1111/aab.12229; Yang DC, 2001, THESIS; YAZAWA S, 1989, J JPN SOC HORTIC SCI, V58, P609, DOI 10.2503/jjshs.58.609; Yoon Jae Bok, 2005, Journal of the Korean Society for Horticultural Science, V46, P5; Yoon Jae Bok, 2004, Journal of the Korean Society for Horticultural Science, V45, P324; Yoon JB, 2006, BREEDING SCI, V56, P31, DOI 10.1270/jsbbs.56.31; ZIJLSTRA S, 1991, HORTSCIENCE, V26, P585, DOI 10.21273/HORTSCI.26.5.585	45	24	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144142	10.1371/journal.pone.0144142	http://dx.doi.org/10.1371/journal.pone.0144142			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642059	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700062
J	Uchida, K; Demirkhanyan, L; Asuthkar, S; Cohen, A; Tominaga, M; Zakharian, E				Uchida, Kunitoshi; Demirkhanyan, Lusine; Asuthkar, Swapna; Cohen, Alejandro; Tominaga, Makoto; Zakharian, Eleonora			Stimulation-dependent gating of TRPM3 channel in planar lipid bilayers	FASEB JOURNAL			English	Article						reconstituted system; pregnenolone sulfate; nifedipine; clotrimazole; PIP2	POTENTIAL MELASTATIN 3; VANILLOID 1 TRPV1; RECEPTOR; ACTIVATION; PHOSPHOINOSITIDES; EXPRESSION; AGONISTS; PROTEIN; CELLS; HEAT	The transient receptor potential melastatin (TRPM)-3 channel is critical for various physiologic processes. In somatosensory neurons, TRPM3 has been implicated in temperature perception and inflammatory hyperalgesia, whereas in pancreatic beta-cells the channel has been linked to glucose-induced insulin release. As a typical representative of the TRP family, TRPM3 is highly polymodal. In cells, it is activated by heat and chemical agonists, including pregnenolone sulfate (PS) and nifedipine (Nif). To define the nuances of TRPM3 channel activity and its modulators, we succeeded in incorporating the TRPM3 protein into planar lipid bilayers. We found that phosphatidylinositol-4,5-bisphosphate (PIP2) or clotrimazole is necessary for channel opening by PS. Unlike PS, the presence of Nif alone sufficed to induce TRPM3 activity and demonstrated distinct gating behavior. We also performed an extensive thermodynamic analysis of TRPM3 activation and found that TRPM3 exhibited slight temperature sensitivity in the bilayers. In the absence of other agonists TRPM3 channels remained closed upon heat-induced stimulation, but opened in the presence of PIP2, although with only a low open-probability profile. Together, our results elucidate the details peculiar to TRPM3 channel function in an isolated system. We confirmed its direct gating by PS and PIP2, but found a lack of the strong intrinsic temperature sensitivity common to other thermosensitive TRP channels.	[Uchida, Kunitoshi; Demirkhanyan, Lusine; Asuthkar, Swapna; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA; [Uchida, Kunitoshi; Tominaga, Makoto] Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi, Japan; [Uchida, Kunitoshi; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Hayama, Kanagawa, Japan; [Cohen, Alejandro] Dalhousie Univ, Life Sci Res Inst, Prote & Mass Spectrometry Core Facil, Halifax, NS, Canada	University of Illinois System; University of Illinois Peoria; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Dalhousie University	Uchida, K; Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.; Uchida, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	kuchida@nips.ac.jp; zakharel@uic.edu		Cohen, Alejandro/0000-0001-8646-8525	Young Researcher Overseas Visit Program Expenses from The Graduate University for Advanced Studies; U.S. National Institutes of Health/National Institute of General Medicine Sciences [R01GM098052];  [25871061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052] Funding Source: NIH RePORTER	Young Researcher Overseas Visit Program Expenses from The Graduate University for Advanced Studies; U.S. National Institutes of Health/National Institute of General Medicine Sciences; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank N. Fukuta and C. Saito (National Institute of Physiological Sciences) for technical assistance, the laboratory members for helpful discussions, and H. Sahakyan (Bradley University) for proofreading the manuscript. This work was supported by Young Researcher Overseas Visit Program Expenses from The Graduate University for Advanced Studies (to K.U.); Grant-in-Aid 25871061 for Young Scientists (B) (to K.U.); and U.S. National Institutes of Health/National Institute of General Medicine Sciences Grant R01GM098052 (to E. Z).	Asuthkar S, 2015, J BIOL CHEM, V290, P2670, DOI 10.1074/jbc.M114.610873; Asuthkar S, 2015, J BIOL CHEM, V290, P2659, DOI 10.1074/jbc.M114.610824; Badheka D, 2015, J GEN PHYSIOL, V146, P65, DOI 10.1085/jgp.201411336; Drews A, 2014, BRIT J PHARMACOL, V171, P1019, DOI 10.1111/bph.12521; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Held K, 2015, P NATL ACAD SCI USA, V112, pE1363, DOI 10.1073/pnas.1419845112; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Oberwinkler J, 2014, HANDB EXP PHARMACOL, V222, P427, DOI 10.1007/978-3-642-54215-2_17; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sun XH, 2015, J BIOL CHEM, V290, P4741, DOI 10.1074/jbc.M114.611459; Toth BI, 2015, J GEN PHYSIOL, V146, P51, DOI 10.1085/jgp.201411339; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vriens J, 2014, NAT CHEM BIOL, V10, P188, DOI [10.1038/nchembio.1428, 10.1038/NCHEMBIO.1428]; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	26	22	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1306	1316		10.1096/fj.15-281576	http://dx.doi.org/10.1096/fj.15-281576			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26655382	Green Published			2022-12-26	WOS:000370387800026
J	Gunawardane, RN; Fordstrom, P; Piper, DE; Masterman, S; Siu, S; Liu, DM; Brown, M; Lu, M; Tang, J; Zhang, R; Cheng, J; Gates, A; Meininger, D; Chan, J; Carlson, T; Walker, N; Schwarz, M; Delaney, J; Zhou, MY				Gunawardane, Ruwanthi N.; Fordstrom, Preston; Piper, Derek E.; Masterman, Stephanie; Siu, Sophia; Liu, Dongming; Brown, Mike; Lu, Mei; Tang, Jie; Zhang, Richard; Cheng, Janet; Gates, Andrew; Meininger, David; Chan, Joyce; Carlson, Tim; Walker, Nigel; Schwarz, Margrit; Delaney, John; Zhou, Mingyue			Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA LECITHIN; LECITHINCHOLESTEROL ACYLTRANSFERASE; MYOCARDIAL-INFARCTION; HDL CONCENTRATIONS; ATHEROSCLEROSIS; ATHEROPROTECTION; DEFICIENCY; DISEASE; RISK; LOCI	Drug discovery opportunities where loss-of-function alleles of a target gene link to a disease-relevant phenotype often require an agonism approach to up-regulate or re-establish the activity of the target gene. Antibody therapy is increasingly recognized as a favored drug modality due to multiple desirable pharmacological properties. However, agonistic antibodies that enhance the activities of the target enzymes are rarely developed because the discovery of agonistic antibodies remains elusive. Here we report an innovative scheme of discovery and characterization of human antibodies capable of binding to and agonizing a circulating enzyme lecithin cholesterol acyltransferase (LCAT). Utilizing a modified human LCAT protein with enhanced enzymatic activity as an immunogen, we generated fully human monoclonal antibodies using the XenoMouse (TM) platform. One of the resultant agonistic antibodies, 27C3, binds to and substantially enhances the activity of LCAT from humans and cynomolgus macaques. X-ray crystallographic analysis of the 2.45 angstrom LCAT-27C3 complex shows that 27C3 binding does not induce notable structural changes in LCAT. A single administration of 27C3 to cynomolgus monkeys led to a rapid increase of plasma LCAT enzymatic activity and a 35% increase of the high density lipoprotein cholesterol that was observed up to 32 days after 27C3 administration. Thus, this novel scheme of immunization in conjunction with high throughput screening may represent an effective strategy for discovering agonistic antibodies against other enzyme targets. 27C3 and other agonistic human anti-human LCAT monoclonal antibodies described herein hold potential for therapeutic development for the treaent of dyslipidemia and cardiovascular disease.	[Gunawardane, Ruwanthi N.; Siu, Sophia; Brown, Mike; Cheng, Janet; Gates, Andrew; Meininger, David] Amgen Inc, Therapeut Discovery, Seattle, WA 98119 USA; [Fordstrom, Preston; Liu, Dongming; Chan, Joyce; Schwarz, Margrit; Zhou, Mingyue] Amgen Inc, Cardiometab Disorders, San Francisco, CA 94080 USA; [Piper, Derek E.; Lu, Mei; Tang, Jie; Zhang, Richard; Walker, Nigel] Amgen Inc, Therapeut Discovery, San Francisco, CA 94080 USA; [Carlson, Tim] Amgen Inc, PKDM Dept, San Francisco, CA 94080 USA; [Masterman, Stephanie; Delaney, John] Amgen Inc, Therapeut Discovery, Burnaby, BC VSA 1V7, Canada	Amgen; Amgen; Amgen; Amgen	Zhou, MY (corresponding author), Amgen Inc, Cardio Metab Disorders, Therapeut Area, 1120 Vet Blvd, San Francisco, CA 94080 USA.	mzhou@amgen.com						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ayyobi AF, 2004, ATHEROSCLEROSIS, V177, P361, DOI 10.1016/j.atherosclerosis.2004.07.018; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Belmont W., 2012, International Patent Application, Patent No. [WO 98/24893, 9824893]; Berard AM, 1997, NAT MED, V3, P744, DOI 10.1038/nm0797-744; Boone T., 2015, U.S. Patent, Patent No. [US9006408 B2, 9006408]; Brousseau ME, 2000, ARTERIOSCL THROM VAS, V20, P450, DOI 10.1161/01.ATV.20.2.450; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calabresi L, 2005, ARTERIOSCL THROM VAS, V25, P1972, DOI 10.1161/01.ATV.0000175751.30616.13; Calabresi L, 2010, TRENDS CARDIOVAS MED, V20, P50, DOI 10.1016/j.tcm.2010.03.007; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; CARLSON LA, 1979, LANCET, V2, P921; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; CHEN CH, 1982, J LIPID RES, V23, P680; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Z, 2012, METABOLISM, V61, P470, DOI 10.1016/j.metabol.2011.08.006; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Dullaart RPF, 2008, J CLIN ENDOCR METAB, V93, P4860, DOI 10.1210/jc.2008-1213; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GLOMSET JA, 1966, J LIPID RES, V7, P638; GLOMSET JA, 1968, J LIPID RES, V9, P155; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Green L. L., 2000, International Patent Application, Patent No. [WO 00/76310, 0076310]; Hall CM, 2013, J IMMUNOL METHODS, V393, P70, DOI 10.1016/j.jim.2013.03.011; Hoeg JM, 1996, P NATL ACAD SCI USA, V93, P11448, DOI 10.1073/pnas.93.21.11448; Holleboom AG, 2010, J LIPID RES, V51, P416, DOI 10.1194/P900038-JLR200; Hovingh GK, 2005, CIRCULATION, V112, P879, DOI 10.1161/CIRCULATIONAHA.105.540427; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; JAUHIAINEN M, 1989, J BIOL CHEM, V264, P1963; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kuivenhoven JA, 1996, ARTERIOSCL THROM VAS, V16, P294, DOI 10.1161/01.ATV.16.2.294; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; NORUM KR, 1967, BIOCHIM BIOPHYS ACTA, V144, P698, DOI 10.1016/0005-2760(67)90064-1; Piper DE, 2015, J LIPID RES, V56, P1711, DOI 10.1194/jlr.M059873; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Rousset X, 2011, CURR ATHEROSCLER REP, V13, P249, DOI 10.1007/s11883-011-0171-6; Schreiber J. R., 2011, U.S. Patent Application, Patent No. [08/759,620, 08759620]; Sethi AA, 2010, CLIN CHEM, V56, P1128, DOI 10.1373/clinchem.2009.139931; SOLAJICBOZICEVIC N, 1991, ARTERY, V18, P326; Spahr C, 2013, PROTEIN SCI, V22, P1739, DOI 10.1002/pro.2373; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Van Craeyveld E, 2009, GENE THER, V16, P757, DOI 10.1038/gt.2009.8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang AH, 2004, FEBS LETT, V570, P25, DOI 10.1016/j.febslet.2004.06.017; Zhou M, 2008, THROMB VASC BIOL ANN, pe65; Zhou MY, 2009, CIRCULATION, V120, pS1175	50	19	27	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2799	2811		10.1074/jbc.M115.672790	http://dx.doi.org/10.1074/jbc.M115.672790			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644477	Green Published, hybrid			2022-12-26	WOS:000369626900020
J	Bernardo, BC; Sapra, G; Patterson, NL; Cemerlang, N; Kiriazis, H; Ueyama, T; Febbraio, MA; McMullen, JR				Bernardo, Bianca C.; Sapra, Geeta; Patterson, Natalie L.; Cemerlang, Nelly; Kiriazis, Helen; Ueyama, Tomomi; Febbraio, Mark A.; McMullen, Julie R.			Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SHOCK-PROTEIN; IN-VIVO; HEAT-SHOCK-PROTEIN-70; GENE; SIZE; CARDIOPROTECTION; HYPERTROPHY; ASSOCIATION; MYOCARDIUM	Previous animal studies had shown that increasing heat shock protein 70 (Hsp70) using a transgenic, gene therapy or pharmacological approach provided cardiac protection in models of acute cardiac stress. Furthermore, clinical studies had reported associations between Hsp70 levels and protection against atrial fibrillation (AF). AF is the most common cardiac arrhythmia presenting in cardiology clinics and is associated with increased rates of heart failure and stroke. Improved therapies for AF and heart failure are urgently required. Despite promising observations in animal studies which targeted Hsp70, we recently reported that increasing Hsp70 was unable to attenuate cardiac dysfunction and pathology in a mouse model which develops heart failure and intermittent AF. Given our somewhat unexpected finding and the extensive literature suggesting Hsp70 provides cardiac protection, it was considered important to assess whether Hsp70 could provide protection in another mouse model of heart failure and AF. The aim of the current study was to determine whether increasing Hsp70 could attenuate adverse cardiac remodeling, cardiac dysfunction and episodes of arrhythmia in a mouse model of heart failure and AF due to overexpression of Muscle-Restricted Coiled-Coil (MURC). Cardiac function and pathology were assessed in mice at approximately 12 months of age. We report here, that chronic overexpression of Hsp70 was unable to provide protection against cardiac dysfunction, conduction abnormalities, fibrosis or characteristic molecular markers of the failing heart. In summary, elevated Hsp70 may provide protection in acute cardiac stress settings, but appears insufficient to protect the heart under chronic cardiac disease conditions.	[Bernardo, Bianca C.; Sapra, Geeta; Patterson, Natalie L.; Cemerlang, Nelly; Kiriazis, Helen; Febbraio, Mark A.; McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Ueyama, Tomomi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan; [Febbraio, Mark A.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Baker Heart and Diabetes Institute; Kyoto Prefectural University of Medicine; Garvan Institute of Medical Research; St Vincents Hospital Sydney	McMullen, JR (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia.	julie.mcmullen@bakeridi.edu.au	Febbraio, Mark/AAE-9632-2019	Bernardo, Bianca Christine/0000-0002-4534-0549; Febbraio, Mark/0000-0002-9296-4418	National Health and Medical Research Council (NHMRC) [1008682]; Victorian Government's Operational Infrastructure Support Program; NHMRC Research Fellows [1021168-SPRF, 586604, 1078985-SRF]; Australia Research Council Future Fellowship [FT0001657]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NHMRC Research Fellows(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council Future Fellowship(Australian Research Council)	This study was funded by a National Health and Medical Research Council (NHMRC) Project Grant (1008682 to JRM) and supported in part by the Victorian Government's Operational Infrastructure Support Program. MAF and JRM are NHMRC Research Fellows (IDs 1021168-PRF and 586604 & 1078985-SRF). JRM was also supported by an Australia Research Council Future Fellowship (FT0001657).; This study was funded by a National Health and Medical Research Council (NHMRC) Project Grant (1008682 to JRM) and supported in part by the Victorian Government's Operational Infrastructure Support Program. M.A.F. and J.R.M. are NHMRC Research Fellows (IDs 1021168-SPRF and 586604 & 1078985-SRF). J.R.M. was also supported by an Australia Research Council Future Fellowship (FT0001657). We thank Yow Keat Tham (Baker IDI) for technical assistance.	Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; ANGELIDIS CE, 1996, TRANSGENICS, V2, P111; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Bernardo BC, 2012, DRUG DISCOV TODAY TH, V9, pe163, DOI [10.1016/j.ddstr.2013.10.001, DOI 10.1016/J.DDSTR.2013.10.001]; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033; Bristow MR, 2013, JACC-HEART FAIL, V1, P29, DOI 10.1016/j.jchf.2012.10.001; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2006, J MOL CELL CARDIOL, V41, P555, DOI 10.1016/j.yjmcc.2006.06.068; Chang YWE, 2006, CANCER RES, V66, P11700, DOI 10.1158/0008-5472.CAN-06-1818; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Hutter JJ, 1996, CIRCULATION, V94, P1408, DOI 10.1161/01.CIR.94.6.1408; Kumar S, 2012, PROG BIOPHYS MOL BIO, V110, P278, DOI 10.1016/j.pbiomolbio.2012.07.011; Lanters EAH, 2015, NETH HEART J, V23, P327, DOI 10.1007/s12471-015-0699-0; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athoracsur.2004.08.018; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Mirkes PE, 1999, DEV DYNAM, V214, P159, DOI 10.1002/(SICI)1097-0177(199902)214:2<159::AID-AJA6>3.0.CO;2-Y; Naka KK, 2014, CELL STRESS CHAPERON, V19, P853, DOI 10.1007/s12192-014-0509-4; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; NITTA Y, 1994, AM J PHYSIOL-HEART C, V267, pH1795, DOI 10.1152/ajpheart.1994.267.5.H1795; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Okubo S, 2001, CIRCULATION, V103, P877, DOI 10.1161/01.CIR.103.6.877; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Rienstra M, 2013, JACC-HEART FAIL, V1, P21, DOI 10.1016/j.jchf.2012.09.002; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Sakabe M, 2008, CARDIOVASC RES, V78, P63, DOI 10.1093/cvr/cvn019; Sapra G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6705; Schafler AE, 2002, BASIC RES CARDIOL, V97, P258, DOI 10.1007/s003950200019; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; St Rammos K, 2002, CARDIOVASC SURG, V10, P228; Suzuki K, 1997, J CLIN INVEST, V99, P1645, DOI 10.1172/JCI119327; Suzuki K, 2002, CIRCULATION, V106, pI270, DOI 10.1161/01.cir.0000032880.55215.92; Tham YK, 2015, ARCH TOXICOL, V89, P1401, DOI 10.1007/s00204-015-1477-x; Trost SU, 1998, J CLIN INVEST, V101, P855, DOI 10.1172/JCI265; Turner JG, 2007, J AM ASSOC LAB ANIM, V46, P10; Weeks KL, 2012, CIRC-HEART FAIL, V5, P523, DOI 10.1161/CIRCHEARTFAILURE.112.966622; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yang M, 2007, CELL STRESS CHAPERON, V12, P142, DOI 10.1379/CSC-253R.1	46	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145173	10.1371/journal.pone.0145173	http://dx.doi.org/10.1371/journal.pone.0145173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660322	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900190
J	Yokoyama, Y; Miyagi, T; Hikita, H; Yoshioka, T; Mukai, K; Nawa, T; Sakamori, R; Ohkawa, K; Hiramatsu, N; Takahashi, T; Suemizu, H; Ryo, A; Tatsumi, T; Takehara, T				Yokoyama, Yoshinobu; Miyagi, Takuya; Hikita, Hayato; Yoshioka, Teppei; Mukai, Kaori; Nawa, Takatoshi; Sakamori, Ryotaro; Ohkawa, Kazuyoshi; Hiramatsu, Naoki; Takahashi, Takeshi; Suemizu, Hiroshi; Ryo, Akihide; Tatsumi, Tomohide; Takehara, Tetsuo			The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; MOUSE MODEL; X PROTEIN; HBV INFECTION; 2 SUBGROUPS; CELL-DEATH; DNA; HEPATOCYTES; JAPAN; EXPRESSION	Background & Aims At least eight genotypes of Hepatitis B virus (HBV) have been identified. HBV genotype C is the most common genotype in Japan, although the incidence of HBV genotype A is increasing. The reason underlying the differences in viral multiplication of the HBV genotypes is unclear, especially in vivo. The purpose of this study was to elucidate the differences in HBV load and the persistence of viremia in vivo between genotypes A and C. Methods Immunodeficient NOG mice were transfected by hydrodynamic injection with the HBV expression plasmids pHBA1.2 or pHBC1.2, which contain overlength (1.2-mer) copies of the genomes of HBV genotype A or C, respectively. Results One day after transfection, the number of HBcAg-positive hepatocytes and serum HBV DNA levels were similar between mice transfected with pHBA1.2 and pHBC1.2. Serum levels of HBV DNA, HBsAg and HBeAg in mice transfected with pHBA1.2 were maintained over 5 months. In contrast, those in mice with pHBC1.2 gradually decreased over time and reached undetectable levels within 3 months after transfection. HBcAg-stained hepatocytes were detected in mice transfected with pHBA1.2, but not pHBC1.2, 5 months post-transfection. Double-staining immunohistochemistry revealed that the number of cleaved caspase3- stained, HBcAg-positive hepatocytes in the pHBC1.2-transfected mice was higher than in the pHBA1.2-transfected mice 3 days post-transfection. Moreover, the plasmid DNA and covalently closed circular DNA levels were decreased in the livers of pHBC1.2-transfected mice. These results suggested that hepatocytes expressing HBV genotype C were eliminated by apoptosis in the absence of immune cells more often than in hepatocytes expressing HBV genotype A. Conclusions Immunodeficient mice transfected with HBV genotype A develop persistent viremia, whereas those transfected with HBV genotype C exhibit transient viremia accompanied by apoptosis of HBV-expressing hepatocytes. This differences may affect the clinical courses of patients infected with HBV genotypes A and C.	[Yokoyama, Yoshinobu; Miyagi, Takuya; Hikita, Hayato; Yoshioka, Teppei; Mukai, Kaori; Nawa, Takatoshi; Sakamori, Ryotaro; Ohkawa, Kazuyoshi; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Takahashi, Takeshi; Suemizu, Hiroshi] Cent Inst Expt Anim, Lab Anim Res Dept, Kawasaki, Kanagawa, Japan; [Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa 232, Japan	Osaka University; Yokohama City University	Takehara, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan.	takehara@gh.med.osaka-u.ac.jp	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X; Suemizu, Hiroshi/0000-0002-3706-2454	Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and development	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-in-Aid for Research Program on Hepatitis from the Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, J CLIN MICROBIOL, V37, P2899, DOI 10.1128/JCM.37.9.2899-2903.1999; Busca A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-22; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Clippinger AJ, 2009, J VIROL, V83, P4718, DOI 10.1128/JVI.02590-08; Du J, 2009, CELL DEATH DIFFER, V16, P219, DOI 10.1038/cdd.2008.144; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5803, DOI 10.1073/pnas.1502400112; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; FUJIYAMA A, 1983, NUCLEIC ACIDS RES, V11, P4601, DOI 10.1093/nar/11.13.4601; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Han QJ, 2013, SEMIN IMMUNOPATHOL, V35, P23, DOI 10.1007/s00281-012-0331-y; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Ito K, 2016, J GASTROEN HEPATOL, V31, P180, DOI 10.1111/jgh.13030; Ito K, 2014, HEPATOLOGY, V59, P89, DOI 10.1002/hep.26635; Ito K, 2009, J VIROL, V83, P3507, DOI 10.1128/JVI.02348-08; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Liang XH, 2008, BIOCHEM BIOPH RES CO, V369, P456, DOI 10.1016/j.bbrc.2008.02.035; Liang XH, 2007, APOPTOSIS, V12, P1827, DOI 10.1007/s10495-007-0114-4; Lu YW, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-117; Lucifora J, 2010, HEPATOLOGY, V51, P63, DOI 10.1002/hep.23230; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Rawat S, 2012, VIRUSES-BASEL, V4, P2945, DOI 10.3390/v4112945; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Rojas MD, 2014, J MED VIROL, V86, P496, DOI 10.1002/jmv.23859; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V300, P784, DOI 10.1016/S0006-291X(02)02889-9; Takada S, 1999, ONCOGENE, V18, P6965, DOI 10.1038/sj.onc.1203188; Takehara T, 2006, J HEPATOL, V44, P267, DOI 10.1016/j.jhep.2005.07.030; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; Tanaka Y, 2005, HEPATOL RES, V33, P216, DOI 10.1016/j.hepres.2005.08.006; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144775	10.1371/journal.pone.0144775	http://dx.doi.org/10.1371/journal.pone.0144775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658490	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900104
J	Zhu, CH; Schwarz, P; Abakumova, I; Aguzzi, A				Zhu, Caihong; Schwarz, Petra; Abakumova, Irina; Aguzzi, Adriano			Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GROWTH-FACTOR EXPRESSION; PRP KNOCKOUT MICE; ALZHEIMERS-DISEASE; INTRANASAL INSULIN; AMYLOID-BETA; IMPROVES COGNITION; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; TRUNCATED PRP	Epidemiological, clinical, and experimental animal studies suggest a strong correlation between insulin resistance and Alzheimer's disease. In fact, type-2 diabetes is considered an important risk factor of developing Alzheimer's disease. In addition, impaired insulin signaling in the Alzheimer's disease brain may promote A beta production, impair A beta clearance and induce tau hyperphosphorylation, thereby leading to deterioration of the disease. The pathological prion protein, PrPSc, deposits in the form of extracellular aggregates and leads to dementia, raising the question as to whether prion pathogenesis may also be affected by insulin resistance. We therefore established high-fat diet-induced insulin resistance in tga20 mice, which overexpress the prion protein. We then inoculated the insulin-resistant mice with prions. We found that insulin resistance in tga20 mice did not affect prion disease progression, PrPSc deposition, astrogliosis or microglial activation, and had no effect on survival. Our study demonstrates that in a mouse model, insulin resistance does not significantly contribute to prion pathogenesis.	[Zhu, Caihong; Schwarz, Petra; Abakumova, Irina; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch		Aguzzi, Adriano/0000-0002-0344-6708	Advanced Grant of the European Research Council (ERC) [250356]; European Union (PRIORITY, NEURINOX); Swiss National Foundation (SNF, including a Sinergia grant); Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases"; Young Scientist Stipend of the Ernst-Jung foundation	Advanced Grant of the European Research Council (ERC)(European Research Council (ERC)); European Union (PRIORITY, NEURINOX); Swiss National Foundation (SNF, including a Sinergia grant)(Swiss National Science Foundation (SNSF)); Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases"; Young Scientist Stipend of the Ernst-Jung foundation	A. Aguzzi is the recipient of an Advanced Grant of the European Research Council (ERC, No. 250356) and is supported by grants from the European Union (PRIORITY, NEURINOX), the Swiss National Foundation (SNF, including a Sinergia grant), the Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX), the Novartis Institutes of Biomedical Research, and the Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases". C. Zhu is the recipient of a Young Scientist Stipend of the Ernst-Jung foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002651; Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Bedse G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00204; Bhat NR, 2013, J ALZHEIMERS DIS, V36, P781, DOI 10.3233/JAD-2012-121030; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; Goldstein B.J., 2002, AM J CARDIOL, V90, p3G, DOI DOI 10.1016/S0002-9149(02)02553-5; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Kuwahara C, 2000, BIOCHEM BIOPH RES CO, V268, P763, DOI 10.1006/bbrc.2000.2152; Ling X, 2002, J ALZHEIMERS DIS, V4, P369, DOI 10.3233/JAD-2002-4504; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mehla J, 2014, J ALZHEIMERS DIS, V39, P145, DOI 10.3233/JAD-131238; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Nielsen D, 2004, BIOCHEM J, V380, P571, DOI 10.1042/BJ20040010; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Okabayashi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117362; Ostlund P, 2001, MOL BRAIN RES, V97, P161, DOI 10.1016/S0169-328X(01)00316-3; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Petrov D, 2015, BBA-MOL BASIS DIS, V1852, P1687, DOI 10.1016/j.bbadis.2015.05.004; Pham N, 2014, BIOCHEM BIOPH RES CO, V448, P151, DOI 10.1016/j.bbrc.2014.04.071; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Satoh J, 2000, AM J PATHOL, V157, P59, DOI 10.1016/S0002-9440(10)64517-8; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Strom A, 2011, PANCREAS, V40, P229, DOI 10.1097/MPA.0b013e3181f7e547; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tan ZS, 2011, DIABETES CARE, V34, P1766, DOI 10.2337/dc11-0308; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Willette AA, 2015, JAMA NEUROL, V72, P1013, DOI 10.1001/jamaneurol.2015.0613; Willette AA, 2015, ALZHEIMERS DEMENT, V11, P504, DOI 10.1016/j.jalz.2014.03.011; Willette AA, 2013, DIABETES CARE, V36, P443, DOI 10.2337/dc12-0922; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yamamoto N, 2012, J NEUROCHEM, V121, P619, DOI 10.1111/j.1471-4159.2012.07668.x; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	65	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144983	10.1371/journal.pone.0144983	http://dx.doi.org/10.1371/journal.pone.0144983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658276	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900162
J	Ababneh, QO; Tindall, AJ; Herman, JK				Ababneh, Qutaiba O.; Tindall, Amanda J.; Herman, Jennifer K.			A Secreted Factor Coordinates Environmental Quality with Bacillus Development	PLOS ONE			English	Article							FACTOR SIGMA-H; SUBTILIS SPORULATION; STATIONARY-PHASE; TRANSCRIPTION FACTOR; CELL COMMUNICATION; MASTER REGULATOR; TRANSPORT-SYSTEM; GENE-EXPRESSION; SPO0A REGULON; COMPETENCE	Entry into sporulation is governed by the master regulator Spo0A. Spo0A accumulates in its active form, Spo0A-P, as cells enter stationary phase. Prior reports have shown that the acute induction of constitutively active Spo0A during exponential growth does not result in sporulation. However, a subsequent study also found that a gradual increase in Spo0A-P, mediated through artificial expression of the kinase, KinA, during exponential growth, is sufficient to trigger sporulation. We report here that sporulation via KinA induction depends on the presence of an extracellular factor or factors (FacX) that only accumulates to active levels during post-exponential growth. FacX is retained by dialysis with a cutoff smaller than 500 Dalton, can be concentrated, and is susceptible to proteinase K digestion, similar to described quorum-sensing peptides shown to be involved in promoting sporulation. However, unlike previously characterized peptides, FacX activity does not require the Opp or App oligopeptide transporter systems. In addition, FacX activity does not depend on SigH, Spo0A, or ComX. Importantly, we find that in the presence of FacX, B. subtilis can be induced to sporulate following the artificial induction of constitutively active Spo0A. These results indicate that there is no formal requirement for gradual Spo0A-P accumulation and instead support the idea that sporulation requires both sufficient levels of active Spo0A and at least one other signal or condition.	[Ababneh, Qutaiba O.; Tindall, Amanda J.; Herman, Jennifer K.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Herman, JK (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.	jkherman@tamu.edu	Ababneh, Qutaiba/GPW-9598-2022	Tindall, Amanda/0000-0003-0323-0795; Herman, Jennifer/0000-0003-4100-8167	Texas AM University; Center for Phage Technology at Texas AM University	Texas AM University; Center for Phage Technology at Texas AM University	This work was funded by start-up funding to JKH from Texas A&M University and the Center for Phage Technology at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Cutting SMHa CR, 1990, MOL BIOL METHODS BAC; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 2003, GENE DEV, V17, P1166, DOI 10.1101/gad.1078303; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GROSSMAN AD, 1988, P NATL ACAD SCI USA, V85, P4369, DOI 10.1073/pnas.85.12.4369; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; HOCH JA, 1993, ANNU REV MICROBIOL, V47, P441, DOI 10.1146/annurev.micro.47.1.441; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jiang M, 2000, J BACTERIOL, V182, P303, DOI 10.1128/JB.182.2.303-310.2000; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kleerebezem M, 2001, PEPTIDES, V22, P1579, DOI 10.1016/S0196-9781(01)00493-4; KOIDE A, 1994, MOL MICROBIOL, V13, P417, DOI 10.1111/j.1365-2958.1994.tb00436.x; KUNST F, 1994, REGULATION OF BACTERIAL DIFFERENTIATION, P1; Lazazzera BA, 1999, J BACTERIOL, V181, P5193, DOI 10.1128/JB.181.17.5193-5200.1999; Lazazzera BA, 1998, TRENDS MICROBIOL, V6, P288, DOI 10.1016/S0966-842X(98)01313-4; Lazazzera BA, 1997, CELL, V89, P917, DOI 10.1016/S0092-8674(00)80277-9; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; McQuade RS, 2001, J BACTERIOL, V183, P4905, DOI 10.1128/JB.183.16.4905-4909.2001; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Parsek MR, 1999, METHOD ENZYMOL, V310, P43; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Pottathil M, 2003, FRONT BIOSCI-LANDMRK, V8, pD32, DOI 10.2741/913; Rasband W., 2006, IMAGEJ; RUDNER DZ, 1991, J BACTERIOL, V173, P1388, DOI 10.1128/jb.173.4.1388-1398.1991; Rutherford ST, 2012, COLD SPRING HARB PER, V2; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Shank EA, 2011, CURR OPIN MICROBIOL, V14, P741, DOI 10.1016/j.mib.2011.09.016; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547; Solomon JM, 1996, TRENDS GENET, V12, P150, DOI 10.1016/0168-9525(96)10014-7; Thomson NR, 2000, MOL MICROBIOL, V36, P539, DOI 10.1046/j.1365-2958.2000.01872.x; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	45	2	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144168	10.1371/journal.pone.0144168	http://dx.doi.org/10.1371/journal.pone.0144168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657919	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903600026
J	Fryxell, RTT; Moore, JE; Collins, MD; Kwon, Y; Jean-Philippe, SR; Schaeffer, SM; Odoi, A; Kennedy, M; Houston, AE				Fryxell, R. T. Trout; Moore, J. E.; Collins, M. D.; Kwon, Y.; Jean-Philippe, S. R.; Schaeffer, S. M.; Odoi, A.; Kennedy, M.; Houston, A. E.			Habitat and Vegetation Variables Are Not Enough When Predicting Tick Populations in the Southeastern United States	PLOS ONE			English	Article							LONE STAR TICK; WHITE-TAILED DEER; IXODES-SCAPULARIS ACARI; DERMACENTOR-VARIABILIS ACARI; AMBLYOMMA-AMERICANUM ACARI; GULF-COAST TICK; BORRELIA-BURGDORFERI; DAMMINI ACARI; LYME-DISEASE; RICKETTSIA-PARKERI	Two tick-borne diseases with expanding case and vector distributions are ehrlichiosis (transmitted by Amblyomma americanum) and rickettiosis (transmitted by A. maculatum and Dermacentor variabilis). There is a critical need to identify the specific habitats where each of these species is likely to be encountered to classify and pinpoint risk areas. Consequently, an in-depth tick prevalence study was conducted on the dominant ticks in the southeast. Vegetation, soil, and remote sensing data were used to test the hypothesis that habitat and vegetation variables can predict tick abundances. No variables were significant predictors of A. americanum adult and nymph tick abundance, and no clustering was evident because this species was found throughout the study area. For A. maculatum adult tick abundance was predicted by NDVI and by the interaction between habitat type and plant diversity; two significant population clusters were identified in a heterogeneous area suitable for quail habitat. For D. variabilis no environmental variables were significant predictors of adult abundance; however, D. variabilis collections clustered in three significant areas best described as agriculture areas with defined edges. This study identified few landscape and vegetation variables associated with tick presence. While some variables were significantly associated with tick populations, the amount of explained variation was not useful for predicting reliably where ticks occur; consequently, additional research that includes multiple sampling seasons and locations throughout the southeast are warranted. This low amount of explained variation may also be due to the use of hosts for dispersal, and potentially to other abiotic and biotic variables. Host species play a large role in the establishment, maintenance, and dispersal of a tick species, as well as the maintenance of disease cycles, dispersal to new areas, and identification of risk areas.	[Fryxell, R. T. Trout] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Moore, J. E.] Christian Bros Univ, Dept Biol, Memphis, TN USA; [Collins, M. D.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Kwon, Y.] Univ Memphis, Dept Earth Sci, Memphis, TN 38152 USA; [Jean-Philippe, S. R.; Houston, A. E.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA; [Schaeffer, S. M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN USA; [Odoi, A.] Univ Tennessee, Dept Biomed & Diagnost Sci, Knoxville, TN USA; [Kennedy, M.] Univ Memphis, Dept Biol, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Memphis; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Memphis	Fryxell, RTT (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	RFryxell@utk.edu	Fiumefreddo, Andrea/T-2977-2019; Odoi, Agricola/I-9532-2019; Schaeffer, Sean M/G-5071-2012	Odoi, Agricola/0000-0001-5050-6737; Moore, James/0000-0003-0414-942X; Schaeffer, Sean/0000-0002-9684-2952; Trout Fryxell, Rebecca/0000-0003-2133-0220; Kwon, Youngsang/0000-0002-6955-8470	University of Tennessee; Department of Entomology and Plant Pathology; Ames Plantation Research and Education Center; Mellon Foundation; Rhodes College; AKC Canine Health Foundation [01864-A]; USDA Tennessee Hatch Project [TEN00433]	University of Tennessee; Department of Entomology and Plant Pathology; Ames Plantation Research and Education Center; Mellon Foundation; Rhodes College; AKC Canine Health Foundation; USDA Tennessee Hatch Project	This project was funded by the University of Tennessee and the Department of Entomology and Plant Pathology, Ames Plantation Research and Education Center, Mellon Foundation, Rhodes College, as well as AKC Canine Health Foundation (01864-A) and USDA Tennessee Hatch Project (TEN00433).	Adjemian JZ, 2009, AM J TROP MED HYG, V80, P72, DOI 10.4269/ajtmh.2009.80.72; [Anonymous], 2012, ARCGIS VERS 10 1; APPERSON CS, 1990, J WILDLIFE DIS, V26, P550, DOI 10.7589/0090-3558-26.4.550; Barre N, 2010, REV SCI TECH OIE, V29, P149; BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061; Bishopp FC, J EC ENTOMOL, V29, P1067; Bunnell JE, 2003, J MED ENTOMOL, V40, P570, DOI 10.1603/0022-2585-40.4.570; Burridge MJ, 2002, ANN NY ACAD SCI, V969, P269, DOI 10.1111/j.1749-6632.2002.tb04391.x; CALHOUN EL, 1954, AM J TROP MED HYG, V3, P360, DOI 10.4269/ajtmh.1954.3.360; CLYMER BC, 1970, J ECON ENTOMOL, V63, P504, DOI 10.1093/jee/63.2.504; Cohen SB, 2010, J MED ENTOMOL, V47, P415, DOI 10.1603/ME09065; Cortinas MR, 2006, J MED ENTOMOL, V43, P810, DOI 10.1603/0022-2585(2006)43[810:CSOWDI]2.0.CO;2; Cully JF, 1999, J RANGE MANAGE, V52, P139, DOI 10.2307/4003507; DUMLER JS, 1991, NEW ENGL J MED, V325, P1109, DOI 10.1056/NEJM199110103251517; Florin DA, 2014, SYST APPL ACAROL-UK, V19, P257, DOI 10.11158/saa.19.3.1; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Ginsberg HS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-394; Ginsberg HS, 2005, TICK-BORNE DISEASES OF HUMANS, P65; Gleim ER, 2013, J MED ENTOMOL, V50, P270, DOI 10.1603/ME12168; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Gooley R. A., 1944, Journal of Parasitology New York, V30, P77; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Hendricks B., 2013, THESIS; HOCH AL, 1971, J MED ENTOMOL, V8, P731, DOI 10.1093/jmedent/8.6.731; HOCH AL, 1972, J MED ENTOMOL, V9, P446, DOI 10.1093/jmedent/9.5.446; HOPLA C E, 1960, South Med J, V53, P92, DOI 10.1097/00007611-196001000-00020; Jean-Philippe SR, 2011, ENVIRON POLLUT, V159, P2733, DOI 10.1016/j.envpol.2011.05.017; Jordan BE, 2009, J MED ENTOMOL, V46, P131, DOI 10.1603/033.046.0117; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1998, J MED ENTOMOL, V35, P489, DOI 10.1093/jmedent/35.4.489; KOLLARS TM, 1993, J MED ENTOMOL, V30, P896, DOI 10.1093/jmedent/30.5.896; Kollars TM, 2001, J MED ENTOMOL, V38, P601, DOI 10.1603/0022-2585-38.4.601; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2014, SATSCAN SOFTWARE VER; MAEDA K, 1987, NEW ENGL J MED, V316, P853, DOI 10.1056/NEJM198704023161406; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; MCENROE W. D., 1971, Environmental Pollution, V2, P135, DOI 10.1016/0013-9327(71)90016-4; Moncayo AC, 2010, AM J TROP MED HYG, V83, P653, DOI 10.4269/ajtmh.2010.09-0197; Ogden NH, 2009, EPIDEMICS-NETH, V1, P196, DOI 10.1016/j.epidem.2009.06.002; Ostfeld RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107387; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Pagac BB, 2014, EMERG INFECT DIS, V20, P1750, DOI 10.3201/eid2010.140175; PATRICK CD, 1978, J PARASITOL, V64, P1100, DOI 10.2307/3279735; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; PRICE WH, 1953, AM J HYG, V58, P248, DOI 10.1093/oxfordjournals.aje.a119604; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; RICHARDSON ML, 1992, J WILDLIFE DIS, V28, P485, DOI 10.7589/0090-3558-28.3.485; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Scott JD, 2001, J MED ENTOMOL, V38, P493, DOI 10.1603/0022-2585-38.4.493; SEMTNER PJ, 1973, ANN ENTOMOL SOC AM, V66, P1264, DOI 10.1093/aesa/66.6.1264; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Sumner JW, 2007, EMERG INFECT DIS, V13, P751, DOI 10.3201/eid1305.061468; Teel PD, 2010, J MED ENTOMOL, V47, P707, DOI 10.1603/ME10029; Trout RT, 2010, J ENTOMOL SCI, V45, P140, DOI 10.18474/0749-8004-45.2.140; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Weiss E., 1988, P15; WILSON ML, 1985, ANN ENTOMOL SOC AM, V78, P172, DOI 10.1093/aesa/78.2.172; WILSON ML, 1986, J ECON ENTOMOL, V79, P693, DOI 10.1093/jee/79.3.693; WILSON ML, 1988, J MED ENTOMOL, V25, P224, DOI 10.1093/jmedent/25.4.224; Wylie BK, 2003, REMOTE SENS ENVIRON, V85, P243, DOI 10.1016/S0034-4257(03)00004-X; ZIMMERMAN RH, 1988, J MED ENTOMOL, V25, P461, DOI 10.1093/jmedent/25.6.461	66	27	27	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144092	10.1371/journal.pone.0144092	http://dx.doi.org/10.1371/journal.pone.0144092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656122	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903600022
J	Green, AW; Bailey, LL				Green, Adam W.; Bailey, Larissa L.			Using Bayesian Population Viability Analysis to Define Relevant Conservation Objectives	PLOS ONE			English	Article							FROG RANA-SYLVATICA; WOOD FROG; AMPHIBIAN DECLINES; DEMOGRAPHIC-MODELS; DECISION-ANALYSIS; SITE OCCUPANCY; HABITAT USE; METAPOPULATION; UNCERTAINTY; EXTINCTION	Adaptive management provides a useful framework for managing natural resources in the face of uncertainty. An important component of adaptive management is identifying clear, measurable conservation objectives that reflect the desired outcomes of stakeholders. A common objective is to have a sustainable population, or metapopulation, but it can be difficult to quantify a threshold above which such a population is likely to persist. We performed a Bayesian metapopulation viability analysis (BMPVA) using a dynamic occupancy model to quantify the characteristics of two wood frog (Lithobates sylvatica) metapopulations resulting in sustainable populations, and we demonstrate how the results could be used to define meaningful objectives that serve as the basis of adaptive management. We explored scenarios involving metapopulations with different numbers of patches (pools) using estimates of breeding occurrence and successful metamorphosis from two study areas to estimate the probability of quasi-extinction and calculate the proportion of vernal pools producing metamorphs. Our results suggest that >= 50 pools are required to ensure long-term persistence with approximately 16% of pools producing metamorphs in stable metapopulations. We demonstrate one way to incorporate the BMPVA results into a utility function that balances the trade-offs between ecological and financial objectives, which can be used in an adaptive management framework to make optimal, transparent decisions. Our approach provides a framework for using a standard method (i.e., PVA) and available information to inform a formal decision process to determine optimal and timely management policies.	[Green, Adam W.; Bailey, Larissa L.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Colorado State University	Green, AW (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	adamgreenw@gmail.com	Green, Adam/AAH-2892-2019; Bailey, Larissa/ABH-3513-2020; Bailey, Larissa/A-2565-2009		USGS Amphibian and Reptile Monitoring Initiative competitive grant program	USGS Amphibian and Reptile Monitoring Initiative competitive grant program	This work was funded by the 2008 USGS Amphibian and Reptile Monitoring Initiative competitive grant program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; [Anonymous], 2014, LANG ENV STAT COMP; Armstrong DP, 2005, CONSERV BIOL, V19, P1402, DOI 10.1111/j.1523-1739.2005.00117.x; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Bakker VJ, 2009, FRONT ECOL ENVIRON, V7, P158, DOI 10.1890/070220; Baldwin RF, 2006, CAN J ZOOL, V84, P1604, DOI 10.1139/Z06-146; Bauder ET, 2005, FRESHWATER BIOL, V50, P2129, DOI 10.1111/j.1365-2427.2005.01471.x; Beissinger SR, 2002, POPULATION VIABILITY ANALYSIS, P5; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bellman R., 1957, DYNAMIC PROGRAMMING; Ben-Haim Y., 2006, INFO GAP DECISION TH, V2; Berger J.O., 1993, STAT DECISION THEORY, V2nd ed.; BERVEN KA, 1995, AUST J ECOL, V20, P385, DOI 10.1111/j.1442-9993.1995.tb00554.x; BERVEN KA, 1982, EVOLUTION, V36, P962, DOI 10.1111/j.1558-5646.1982.tb05466.x; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Boyce M.S., 1990, New York State Museum Bulletin, P133; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brooks RT, 2004, WETLANDS, V24, P104, DOI 10.1672/0277-5212(2004)024[0104:WEOWVP]2.0.CO;2; Brooks RT, 2002, WETLANDS, V22, P247, DOI 10.1672/0277-5212(2002)022[0247:DAVAHR]2.0.CO;2; Calhoun AJK, 2003, WETLANDS, V23, P70, DOI 10.1672/0277-5212(2003)023[0070:EVPAAB]2.0.CO;2; Church DR, 2008, COPEIA, P115, DOI 10.1643/CE-05-258; Clark KE, 2006, WILDLIFE SOC B, V34, P419, DOI 10.2193/0091-7648(2006)34[419:AOMOSS]2.0.CO;2; Clemen R. T., 2013, MAKING HARD DECISION, V3; Conroy M. J., 2013, DECISION MAKING NATU; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Delbecq AL, 1975, J HUMAN SCI; EBERHARDT LL, 1977, J FISH RES BOARD CAN, V34, P183, DOI 10.1139/f77-028; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; FARQUHAR PH, 1984, MANAGE SCI, V30, P1283, DOI 10.1287/mnsc.30.11.1283; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Furman BLS, 2015, CONSERV GENET, V2015, P1; Green AW, 2015, POPUL ECOL, V57, P175, DOI 10.1007/s10144-014-0461-2; Green AW, 2013, J APPL ECOL, V50, P1116, DOI 10.1111/1365-2664.12121; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; GREEN DM, 2005, DECLINING AMPHIBIANS, P58; Groom Martha J., 1998, P4; Guitouni A, 1998, EUR J OPER RES, V109, P501, DOI 10.1016/S0377-2217(98)00073-3; Halpern BS, 2006, ECOL LETT, V9, P2, DOI 10.1111/j.1461-0248.2005.00827.x; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Heard GW, 2013, DIVERS DISTRIB, V19, P555, DOI 10.1111/ddi.12052; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; HOPEY ME, 1994, COPEIA, P1023; Johnson FA, 2014, J WILDLIFE MANAGE, V78, P531, DOI 10.1002/jwmg.682; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Keith DA, 2011, BIOL CONSERV, V144, P1175, DOI 10.1016/j.biocon.2010.11.022; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LANDE R, 1988, OECOLOGIA, V75, P601, DOI 10.1007/BF00776426; Levy JK, 2000, ECOL MODEL, V130, P79, DOI 10.1016/S0304-3800(00)00226-X; Lichko LE, 2003, ENVIRON MANAGE, V32, P141, DOI 10.1007/s00267-003-2967-9; Lubow BC, 1995, WILDLIFE SOC B, V23, P738; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; Martof B. S., 1959, AM MIDL NAT, V61, P350, DOI [10.2307/2422506, DOI 10.2307/2422506]; Mattfeldt SD, 2009, BIOL CONSERV, V142, P720, DOI 10.1016/j.biocon.2008.12.002; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; NICHOLS JD, 1995, ANNU REV ECOL SYST, V26, P177, DOI 10.1146/annurev.es.26.110195.001141; Nicholson E, 2007, ECOL APPL, V17, P251, DOI 10.1890/1051-0761(2007)017[0251:MCDUUF]2.0.CO;2; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Petranka JW, 2004, ECOL APPL, V14, P1065, DOI 10.1890/02-5394; Pilliod DS, 2010, DIVERS DISTRIB, V16, P959, DOI 10.1111/j.1472-4642.2010.00699.x; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Polsky C, 2000, CLIMATE RES, V14, P161; Possingham H. P., 1993, Pacific Conservation Biology, V1, P39; Possingham HP, 2002, POPULATION VIABILITY ANALYSIS, P470; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Ralls K, 2002, POPULATION VIABILITY ANALYSIS, P521; Ralls Katherine, 1997, P228; Reed JM, 1998, WILDLIFE SOC B, V26, P244; Regosin JV, 2003, J HERPETOL, V37, P390, DOI 10.1670/0022-1511(2003)037[0390:THUAWD]2.0.CO;2; Rittenhouse TAG, 2007, J HERPETOL, V41, P645, DOI 10.1670/07-015.1; ROHLF DJ, 1991, CONSERV BIOL, V5, P273, DOI 10.1111/j.1523-1739.1991.tb00139.x; RUGGIERO LF, 1994, CONSERV BIOL, V8, P364, DOI 10.1046/j.1523-1739.1994.08020364.x; Schwartz B, 2002, J PERS SOC PSYCHOL, V83, P1178, DOI 10.1037//0022-3514.83.5.1178; Servanty S, 2014, ECOL APPL, V24, P927, DOI 10.1890/13-0559.1; SHAFFER ML, 1990, CONSERV BIOL, V4, P39, DOI 10.1111/j.1523-1739.1990.tb00265.x; SHAFFER ML, 1985, AM NAT, V125, P144, DOI 10.1086/284332; Shaffer ML, 1983, INT C BEAR RES MANAG, V5, P133; Skinner D.., 2001, INTRO DECISION ANAL, V2nd; Smith MA, 2005, ECOGRAPHY, V28, P110; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SUCHY WJ, 1985, WILDLIFE SOC B, V13, P223; Van Meter R, 2008, WETLANDS, V28, P585, DOI 10.1672/07-237.1; Wade PR, 2002, POPULATION VIABILITY ANALYSIS, P213; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Walters C., 1986, ADAPTIVE MANAGEMENT; Wang JJ, 2009, RENEW SUST ENERG REV, V13, P2263, DOI 10.1016/j.rser.2009.06.021; Waples RS, 2013, BIOSCIENCE, V63, P723, DOI 10.1525/bio.2013.63.9.8; Weir LA, 2005, J HERPETOL, V39, P627; White GC, 2000, METH C CONS, P288; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams B.K., 2009, ADAPTIVE MANAGEMENT; Yang JB, 2001, EUR J OPER RES, V131, P31, DOI 10.1016/S0377-2217(99)00441-5	98	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144786	10.1371/journal.pone.0144786	http://dx.doi.org/10.1371/journal.pone.0144786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658734	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500062
J	Song, W; Cao, Y; Wang, DD; Hou, GJ; Shen, ZH; Zhang, SB				Song, Wei; Cao, Yang; Wang, Dandan; Hou, Guojun; Shen, Zaihua; Zhang, Shuangbao			An Investigation on Formaldehyde Emission Characteristics of Wood Building Materials in Chinese Standard Tests: Product Emission Levels, Measurement Uncertainties, and Data Correlations between Various Tests	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INITIAL EMITTABLE CONCENTRATION; MONTE-CARLO-SIMULATION; C-HISTORY METHOD; MOLE RATIO UF; SOLID WOOD; SEALING TREATMENT; DESICCATOR METHOD; COMPOSITE BOARDS; CHAMBER METHOD	As a large producer and consumer of wood building materials, China suffers product formaldehyde emissions (PFE) but lacks systematic investigations and basic data on Chinese standard emission tests (CST), so this paper presented a first effort on this issue. The PFE of fiberboards, particleboards, blockboards, floorings, and parquets manufactured in Beijing region were characterized by the perforator extraction method (PE), 9-11 L and 40 L desiccator methods (D9, D40), and environmental chamber method (EC) of the Chinese national standard GB 18580; based on statistics of PFE data, measurement uncertainties in CST were evaluated by the Monte Carlo method; moreover, PFE data correlations between tests were established. Results showed: (1) Different tests may give slightly different evaluations on product quality. In PE and D9 tests, blockboards and parquets reached E1 grade for PFE, which can be directly used in indoor environment; but in D40 and EC tests, floorings and parquets achieved E1. (2) In multiple tests, PFE data characterized by PE, D9, and D40 complied with Gaussian distributions, while those characterized by EC followed lognormal distributions. Uncertainties in CST were overall low, with uncertainties for 20 material- method combinations all below 7.5%, and the average uncertainty for each method under 3.5%, thus being acceptable in engineering application. A more complicated material structure and a larger test scale caused higher uncertainties. (3) Conventional linear models applied to correlating PFE values between PE, D9, and EC, with R-2 all over 0.840, while novel logarithmic (exponential) models can work better for correlations involving D40, with R-2 all beyond 0.901. This research preliminarily demonstrated the effectiveness of CST, where results for D40 presented greater similarities to EC-the currently most reliable test for PFE, thus highlighting the potential of Chinese D40 as a more practical approach in production control and risk assessment.	[Song, Wei; Cao, Yang; Wang, Dandan; Hou, Guojun; Zhang, Shuangbao] Beijing Forestry Univ, Beijing Key Lab Wood Sci & Engn, Beijing, Peoples R China; [Song, Wei; Zhang, Shuangbao] Beijing Forestry Univ, MOE Key Lab Wooden Mat Sci & Applicat, Beijing, Peoples R China; [Song, Wei; Zhang, Shuangbao] Beijing Forestry Univ, MOE Engn Res Ctr Forestry Biomass Mat & Bioenergy, Beijing, Peoples R China; [Shen, Zaihua] Zhejiang Chengzhu Adv Mat Technol Co Ltd, R&D Ctr Nat Fiber Composites & Environm Friendly, Shaoxing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Zhang, SB (corresponding author), Beijing Forestry Univ, Beijing Key Lab Wood Sci & Engn, Beijing, Peoples R China.	shuangbaozhangj5@163.com		Cao, Yang/0000-0002-3318-4921	Co-built Foundation; Beijing Natural Science Foundation, China [16F10217]; Forest Certification Foundation of State Forestry Administration, China; Fundamental Research Funds for the Central Universities, China; Zhejiang Chengzhu Advanced Material Technology Co., Ltd; Beijing Municipal Commission of Education, China; Zhejiang Province, China [CZXC201410]	Co-built Foundation; Beijing Natural Science Foundation, China(Beijing Natural Science Foundation); Forest Certification Foundation of State Forestry Administration, China; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Zhejiang Chengzhu Advanced Material Technology Co., Ltd; Beijing Municipal Commission of Education, China(Beijing Municipal Commission of Education); Zhejiang Province, China	This work was supported by Co-built Foundation with Beijing Municipal Commission of Education, China: SZ (www.bjedu.gov.cn), Co-built Foundation with Zhejiang Province, China (CZXC201410) "R & D on Natural Fiber Composites and Environmentally Friendly Adhesives": SZ (www.zjczxc.com), Beijing Natural Science Foundation, China (16F10217): SZ (www.bjnsf.org), Forest Certification Foundation of State Forestry Administration, China: SZ (www.forestry.gov.cn), and the Fundamental Research Funds for the Central Universities, China: WS (http://www.bjfu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zhejiang Chengzhu Advanced Material Technology Co., Ltd provided support in the form of salaries for authors [ZS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams RI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128022; Amegah AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069181; Bohm M, 2012, J HAZARD MATER, V221, P68, DOI 10.1016/j.jhazmat.2012.04.013; Brito-Santos F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115866; Chen LO, 2014, BIORESOURCES, V9, P2975; Chen W, 2015, IEEE T GEOSCI REMOTE, V53, P2925, DOI 10.1109/TGRS.2014.2366779; Cheng HT, 2015, HOLZFORSCHUNG, V69, P215, DOI 10.1515/hf-2014-0020; Cheng HT, 2014, WOOD FIBER SCI, V46, P247; Cui Y, 2015, BIORESOURCES, V10, P3865; Deng QH, 2015, BUILD ENVIRON, V93, P84, DOI 10.1016/j.buildenv.2015.01.019; Ding WB, 2013, BIORESOURCES, V8, P2568; Du ZJ, 2014, ENVIRON INT, V73, P33, DOI 10.1016/j.envint.2014.06.014; Fang LN, 2014, THESIS; Ho KF, 2015, ENVIRON POLLUT, V197, P316, DOI 10.1016/j.envpol.2014.11.014; Huang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079553; Huang SD, 2015, ENVIRON SCI TECHNOL, V49, P1537, DOI 10.1021/es5051875; Hwang GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126481; Ji WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124238; Jin ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102685; Jung CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095791; Kadimaliev D, 2015, BIORESOURCES, V10, P1644; Kaminski M, 2015, COMPOS STRUCT, V123, P374, DOI 10.1016/j.compstruct.2014.12.063; Kim EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119501; Kim J, 2015, J ADHES SCI TECHNOL, V29, P2090, DOI 10.1080/01694243.2015.1057394; Kim S, 2005, BIORESOURCE TECHNOL, V96, P1457, DOI 10.1016/j.biortech.2004.12.003; Kim S, 2007, INDOOR AIR, V17, P404, DOI 10.1111/j.1600-0668.2007.00488.x; Kim S, 2006, POLYM TEST, V25, P904, DOI 10.1016/j.polymertesting.2006.05.010; Kim S, 2010, BIORESOURCE TECHNOL, V101, P6562, DOI 10.1016/j.biortech.2010.03.059; Kumar RLV, 2015, COMPOS STRUCT, V121, P351, DOI 10.1016/j.compstruct.2014.11.029; Li LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128767; Li XN, 2015, BIORESOURCES, V10, P6624; Liang WH, 2015, ENVIRON SCI TECHNOL, V49, P10349, DOI 10.1021/acs.est.5b02217; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072445; Liu WW, 2013, CHINESE SCI BULL, V58, P3499, DOI 10.1007/s11434-013-5841-z; Liu WW, 2012, CHINESE SCI BULL, V57, P2533, DOI 10.1007/s11434-012-5208-x; Luo JL, 2015, BIORESOURCES, V10, P3265, DOI 10.15376/biores.10.2.3265-3276; Mao A, 2013, BIORESOURCES, V8, P4659; Mao A, 2013, BIORESOURCES, V8, P2470; Mao A, 2013, BIORESOURCES, V8, P2453; Nishimura Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132373; Park BD, 2011, EUR J WOOD WOOD PROD, V69, P311, DOI 10.1007/s00107-010-0446-6; Park CY, 2013, BIORESOURCES, V8, P5515; Park JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125251; Que ZL, 2013, COMPOS PART B-ENG, V49, P36, DOI 10.1016/j.compositesb.2013.01.008; Que ZL, 2013, COMPOS PART B-ENG, V47, P278, DOI 10.1016/j.compositesb.2012.11.019; Que ZL, 2013, J FORESTRY RES, V24, P137, DOI 10.1007/s11676-013-0333-1; Que Z, 2007, WOOD SCI TECHNOL, V41, P267, DOI 10.1007/s00226-006-0104-7; Ramos T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118207; Risholm-Sundman M, 1999, INDOOR AIR, V9, P268, DOI 10.1111/j.1600-0668.1999.00006.x; Risholm-Sundman M, 1999, HOLZ ROH WERKST, V57, P319, DOI 10.1007/s001070050351; Risholm-Sundman M, 2007, ATMOS ENVIRON, V41, P3193, DOI 10.1016/j.atmosenv.2006.10.079; Salem MZM, 2013, BIORESOURCES, V8, P4775; Salem MZM, 2013, BIORESOURCES, V8, P1199; Salem MZM, 2012, EUR J WOOD WOOD PROD, V70, P621, DOI 10.1007/s00107-011-0593-4; Salem MZM, 2012, BUILD ENVIRON, V49, P86, DOI 10.1016/j.buildenv.2011.09.011; Salem MZM, 2011, BUILD ENVIRON, V46, P1946, DOI 10.1016/j.buildenv.2011.04.004; Salthammer T, 2015, INT J HYG ENVIR HEAL, V218, P433, DOI 10.1016/j.ijheh.2015.02.005; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Shangguan WW, 2014, BIORESOURCES, V9, P7073; Shin SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126960; Song W, 2015, BIORESOURCES, V10, P5049; Tang XJ, 2009, ENVIRON INT, V35, P1210, DOI 10.1016/j.envint.2009.06.002; Tao HT, 2015, BUILD ENVIRON, V85, P85, DOI 10.1016/j.buildenv.2014.11.017; Tohmura S, 2015, FOREST PROD J, V65, P31, DOI 10.13073/FPJ-D-14-00043; Wei WB, 2014, BIORESOURCES, V9, P6087; Wei WJ, 2015, BUILD ENVIRON, V92, P10, DOI 10.1016/j.buildenv.2015.03.035; Wei WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080736; Xiao QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117311; Xing F, 2014, THESIS; Xiong J, 2010, INDOOR AIR, V20, P523, DOI 10.1111/j.1600-0668.2010.00675.x; Xiong JY, 2013, ENVIRON SCI TECHNOL, V47, P8540, DOI 10.1021/es401173d; Xiong JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049342; Xiong JY, 2011, ENVIRON SCI TECHNOL, V45, P3584, DOI 10.1021/es200277p; Xiong JY, 2011, INDOOR BUILT ENVIRON, V20, P217, DOI 10.1177/1420326X10387480; Yang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118141; Yao Y, 2011, THESIS; Yao Y, 2011, ATMOS ENVIRON, V45, P5602, DOI 10.1016/j.atmosenv.2011.04.033; Ye W, 2014, BUILD ENVIRON, V75, P58, DOI 10.1016/j.buildenv.2014.01.018; Zhang H, 2011, BIORESOURCES, V6, P4430; Zhang JZ, 2015, BIORESOURCES, V10, P782; Zhong Y, 2014, BIORESOURCES, V9, P7737	81	9	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144374	10.1371/journal.pone.0144374	http://dx.doi.org/10.1371/journal.pone.0144374			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656316	gold, Green Published, Green Submitted			2022-12-26	WOS:000366903500024
J	Verdes, A; Cho, WY; Hossain, M; Brennan, PLR; Hanley, D; Grim, T; Hauber, ME; Holford, M				Verdes, Aida; Cho, Wooyoung; Hossain, Marouf; Brennan, Patricia L. R.; Hanley, Daniel; Grim, Tomas; Hauber, Mark E.; Holford, Mande			Nature's Palette: Characterization of Shared Pigments in Colorful Avian and Mollusk Shells	PLOS ONE			English	Article							EGGSHELL PIGMENTS; ADAPTIVE SIGNIFICANCE; COLORATION; EVOLUTION; BIRDS; MECHANISMS; LOCATION; MATRIX	Pigment-based coloration is a common trait found in a variety of organisms across the tree of life. For example, calcareous avian eggs are natural structures that vary greatly in color, yet just a handful of tetrapyrrole pigment compounds are responsible for generating this myriad of colors. To fully understand the diversity and constraints shaping nature's palette, it is imperative to characterize the similarities and differences in the types of compounds involved in color production across diverse lineages. Pigment composition was investigated in eggshells of eleven paleognath bird taxa, covering several extinct and extant lineages, and shells of four extant species of mollusks. Birds and mollusks are two distantly related, calcareous shell-building groups, thus characterization of pigments in their calcareous structures would provide insights to whether similar compounds are found in different phyla (Chordata and Mollusca). An ethylenediaminetetraacetic acid (EDTA) extraction protocol was used to analyze the presence and concentration of biliverdin and protoporphyrin, two known and ubiquitous tetrapyrrole avian eggshell pigments, in all avian and molluscan samples. Biliverdin was solely detected in birds, including the colorful eggshells of four tinamou species. In contrast, protoporphyrin was detected in both the eggshells of several avian species and in the shells of all mollusks. These findings support previous hypotheses about the ubiquitous deposition of tetrapyrroles in the eggshells of various bird lineages and provide evidence for its presence also across distantly related animal taxa.	[Verdes, Aida; Hauber, Mark E.; Holford, Mande] CUNY, Grad Ctr, New York, NY 10021 USA; [Verdes, Aida; Holford, Mande] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Cho, Wooyoung; Hossain, Marouf; Holford, Mande] CUNY, Dept Chem, New York, NY 10021 USA; [Brennan, Patricia L. R.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Hanley, Daniel; Grim, Tomas] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Hanley, Daniel; Grim, Tomas] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic; [Hauber, Mark E.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA	City University of New York (CUNY) System; American Museum of Natural History (AMNH); City University of New York (CUNY) System; University of Massachusetts System; University of Massachusetts Amherst; Palacky University Olomouc; Palacky University Olomouc; City University of New York (CUNY) System; Hunter College (CUNY)	Verdes, A (corresponding author), CUNY, Grad Ctr, New York, NY 10021 USA.	averdes@gradcenter.cuny.edu; mholford@hunter.cuny.edu	Hanley, Daniel/C-9080-2016; Grim, Tomas/A-2852-2008	Hanley, Daniel/0000-0003-0523-4335; Verdes, Aida/0000-0002-9193-9253; Hossain, Marouf/0000-0002-9312-7435; Holford, Mande/0000-0001-9476-2687; Grim, Tomas/0000-0002-5775-6269; Brennan, Patricia/0000-0002-1905-3327	Weissman School of Arts and Sciences of Baruch College; Hunter College; Graduate Center of the City University of New York; CUNY Summer Undergraduate Research Program; National Science Foundation CAREER program [NSF-CHE 1247550, NSF-MRI 1228921]; Camille Dreyfus Teacher-Scholar Award; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0041]; Human Frontier Science Program Young Investigator Award	Weissman School of Arts and Sciences of Baruch College; Hunter College; Graduate Center of the City University of New York; CUNY Summer Undergraduate Research Program; National Science Foundation CAREER program(National Science Foundation (NSF)); Camille Dreyfus Teacher-Scholar Award; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Human Frontier Science Program Young Investigator Award(Human Frontier Science Program)	AV acknowledges funding from The Weissman School of Arts and Sciences of Baruch College, Hunter College and The Graduate Center of the City University of New York. Funding was also provided by CUNY Summer Undergraduate Research Program to WC. This project was supported by National Science Foundation CAREER program NSF-CHE 1247550, NSF-MRI 1228921, and Camille Dreyfus Teacher-Scholar Award to MH. The European Social Fund and the state budget of the Czech Republic (project no. CZ.1.07/2.3.00/30.0041) co-financed DH. Additional support came from a Human Frontier Science Program Young Investigator Award to MEH and TG.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Aidala Z, 2010, NAT ED KNOWL, V3, P53; BANNISTER WH, 1968, COMP BIOCHEM PHYSIOL, V27, P451, DOI 10.1016/0010-406X(68)90244-2; BERTRAM BCR, 1981, IBIS, V123, P207, DOI 10.1111/j.1474-919X.1981.tb00927.x; Boettiger A, 2009, P NATL ACAD SCI USA, V106, P6837, DOI 10.1073/pnas.0810311106; Brennan PLR, 2010, J AVIAN BIOL, V41, P419, DOI 10.1111/j.1600-048X.2010.04999.x; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Cassey P, 2012, METHODS ECOL EVOL, V3, P450, DOI 10.1111/j.2041-210X.2011.00152.x; Cassey P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012054; Cherry MI, 2010, BIOL J LINN SOC, V100, P753, DOI 10.1111/j.1095-8312.2010.01457.x; COMFORT A, 1949, BIOCHEM J, V44, P111, DOI 10.1042/bj0440111; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Davies SJJF., 2002, RATITES TINAMOUS TIN; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; ERMENTROUT B, 1986, VELIGER, V28, P369; Fargallo JA, 2014, EVOL ECOL, V28, P627, DOI 10.1007/s10682-014-9700-4; Gong ZQ, 2012, P NATL ACAD SCI USA, V109, pE234, DOI 10.1073/pnas.1119859109; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Hanley D, 2013, AVIAN BIOL RES, V6, P147, DOI 10.3184/175815513X13617279883973; Hanley D, 2013, EVOL ECOL, V27, P593, DOI 10.1007/s10682-012-9619-6; Harasewych G, 2010, BOOK SHELLS LIFE SIZ; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Igic B, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1210; Igic B, 2010, J FIELD ORNITHOL, V81, P402, DOI 10.1111/j.1557-9263.2010.00296.x; Igic B, 2010, CHEMOECOLOGY, V20, P43, DOI 10.1007/s00049-009-0038-2; JONES P, 1979, COMP BIOCHEM PHYS B, V63, P185, DOI 10.1016/0305-0491(79)90027-0; Keen A. M., 1971, SEA SHELLS TROPICAL, VSecond; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; LINDBERG DR, 1990, J EXP MAR BIOL ECOL, V140, P173, DOI 10.1016/0022-0981(90)90125-V; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Mathger LM, 2009, J R SOC INTERFACE, V6, pS149, DOI 10.1098/rsif.2008.0366.focus; Matsuno T, 2001, FISHERIES SCI, V67, P771, DOI 10.1046/j.1444-2906.2001.00323.x; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; Miksik I, 1996, COMP BIOCHEM PHYS B, V113, P607, DOI 10.1016/0305-0491(95)02073-X; Miksik I, 2007, CONNECT TISSUE RES, V48, P1, DOI 10.1080/03008200601003116; MONTEVECCHI WA, 1976, BEHAVIOUR, V58, P26, DOI 10.1163/156853976X00226; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; POPPE GT, 2008, PHILIPPINE MARINE 1, V1; Samiullah S, 2013, POULTRY SCI, V92, P2783, DOI 10.3382/ps.2013-03051; Shawkey MD, 2006, J R SOC INTERFACE, V3, P777, DOI 10.1098/rsif.2006.0131; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Sokolova IM, 2000, J EXP MAR BIOL ECOL, V245, P1, DOI 10.1016/S0022-0981(99)00132-X; Stemmer K, 2014, J MOLLUS STUD, V80, P365, DOI 10.1093/mollus/eyu033; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Storfer A, 1999, EVOLUTION, V53, P889, DOI 10.1111/j.1558-5646.1999.tb05383.x; Wallace AR, 1923, DARWINISM EXPOSITION; Wang XT, 2009, POULTRY SCI, V88, P1735, DOI 10.3382/ps.2008-00434; Winkler FM, 2001, J HERED, V92, P521, DOI 10.1093/jhered/92.6.521; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Zhang ZQ, 2013, ZOOTAXA, V3703, P5	58	22	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143545	10.1371/journal.pone.0143545	http://dx.doi.org/10.1371/journal.pone.0143545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650398	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300020
J	Newaz, K; Sriram, K; Bera, D				Newaz, Khalique; Sriram, K.; Bera, Debajyoti			Identification of Major Signaling Pathways in Prion Disease Progression Using Network Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROTEIN; MODELS; GENES; METABOLISM; BRAINS; CELLS; PRP	Prion diseases are transmissible neurodegenerative diseases that arise due to conformational change of normal, cellular prion protein (PrPC) to protease-resistant isofrom (rPrP(Sc)). Deposition of misfolded Prp(Sc) proteins leads to an alteration of many signaling pathways that includes immunological and apoptotic pathways. As a result, this culminates in the dysfunction and death of neuronal cells. Earlier works on transcriptomic studies have revealed some affected pathways, but it is not clear which is (are) the prime network pathway(s) that change during the disease progression and how these pathways are involved in crosstalks with each other from the time of incubation to clinical death. We perform network analysis on large-scale transcriptomic data of differentially expressed genes obtained from whole brain in six different mouse strain-prion strain combination models to determine the pathways involved in prion diseases, and to understand the role of crosstalks in disease propagation. We employ a notion of differential network centrality measures on protein interaction networks to identify the potential biological pathways involved. We also propose a crosstalk ranking method based on dynamic protein interaction networks to identify the core network elements involved in crosstalk with different pathways. We identify 148 DEGs (differentially expressed genes) potentially related to the prion disease progression. Functional association of the identified genes implicates a strong involvement of immunological pathways. We extract a bow-tie structure that is potentially dysregulated in prion disease. We also propose an ODE model for the bow-tie network. Predictions related to diseased condition suggests the downregulation of the core signaling elements (PI3Ks and AKTs) of the bow-tie network. In this work, we show using transcriptomic data that the neuronal dysfunction in prion disease is strongly related to the immunological pathways. We conclude that these immunological pathways occupy influential positions in the PFNs (protein functional networks) that are related to prion disease. Importantly, this functional network involvement is prevalent in all the five different mouse strain-prion strain combinations that we studied. We also conclude that the dysregulation of the core elements of the bow-tie structure, which belongs to PI3K-Akt signaling pathway, leads to dysregulation of the downstream components corresponding to other biological pathways.	[Newaz, Khalique; Bera, Debajyoti] IIIT Delhi, Dept Comp Sci, New Delhi, India; [Sriram, K.] IIIT Delhi, Ctr Computat Biol, New Delhi, India	Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi	Bera, D (corresponding author), IIIT Delhi, Dept Comp Sci, New Delhi, India.	dbera@iiitd.ac.in	Newaz, Khalique/AAT-6018-2020; Bera, Debajyoti/W-9963-2019	Newaz, Khalique/0000-0002-1192-8360; 				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Brown DR, 2001, MICROSC RES TECHNIQ, V54, P71, DOI 10.1002/jemt.1122; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burwinkel M, 2004, INT J DEV NEUROSCI, V22, P497, DOI 10.1016/j.ijdevneu.2004.07.017; Chaves M, 2004, J PHYS CHEM B, V108, P15311, DOI 10.1021/jp048935f; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Didonna A, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-29; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Faisal F. E., 2014, BIOINFORMATICS; Fernandez-Borges N., 2013, INT J CELL BIOL, V2013, DOI [10.1155/2013/583498, DOI 10.1155/2013/583498]; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Ghosh S, 2012, DRUG DISCOV TODAY, V17, P600, DOI 10.1016/j.drudis.2012.01.018; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Hegde SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000237; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kitano H, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100039; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Kovacs GG, 2008, AM J PATHOL, V172, P555, DOI 10.2353/ajpath.2008.070442; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Przytycka TM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-48; Rajarathinam Thanigaimani, 2006, Genomics Proteomics & Bioinformatics, V4, P80, DOI 10.1016/S1672-0229(06)60020-X; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Samelson LE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a011510; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Simon D, 2014, NEUROPATH APPL NEURO, V40, P311, DOI 10.1111/nan.12066; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Soto C, 2011, TRENDS MOL MED, V17, P14, DOI 10.1016/j.molmed.2010.09.001; Stein KC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004328; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Wang M, 2005, J NEUROCHEM, V95, P630, DOI 10.1111/j.1471-4159.2005.03408.x; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144389	10.1371/journal.pone.0144389	http://dx.doi.org/10.1371/journal.pone.0144389			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646948	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903100022
J	Poujol, F; Monneret, G; Pachot, A; Textoris, J; Venet, F				Poujol, Fanny; Monneret, Guillaume; Pachot, Alexandre; Textoris, Julien; Venet, Fabienne			Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo	PLOS ONE			English	Article							OKT3 MONOCLONAL-ANTIBODY; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; CELL-PROLIFERATION; SEPTIC SHOCK; COSTIMULATORY RECEPTOR; ENDOTOXIN TOLERANCE; ANTI-PD-1 ANTIBODY; IMPROVES SURVIVAL; IN-VIVO	Context Sepsis is characterized by the development of adaptive immune cell alterations, which intensity and duration are associated with increased risk of health-care associated infections and mortality. However, pathophysiological mechanisms leading to such lymphocyte dysfunctions are not completely understood, although both intrinsic lymphocyte alterations and antigen-presenting cells (APCs) dysfunctions are most likely involved. Study The aim of the current study was to evaluate whether lipopolysaccharide (LPS, mimicking initial Gram negative bacterial challenge) could directly impact lymphocyte function after sepsis. Therefore, we explored ex-vivo the effect of LPS priming on human T lymphocyte proliferation induced by different stimuli. Results We showed that LPS priming of PBMCs reduced T cell proliferative response and altered IFN gamma secretion after stimulation with OKT3 but not with phytohaemagglutinin or anti-CD2/CD3/CD28-coated beads stimulations. Interestingly only LPS priming of monocytes led to decreased T cell proliferative response as opposed to LPS priming of lymphocytes. Importantly, LPS priming was associated with reduced expression of HLA-DR, CD86 and CD64 on monocytes but not with the modification of CD3, CTLA4, PD-1 and CD28 expressions on lymphocytes. Finally, IFN gamma stimulation restored monocytes accessory functions and T cell proliferative response to OKT3. Conclusion We conclude that LPS priming does not directly impact lymphocyte functions but reduces APC's capacity to activate T cells. This recapitulates ex vivo indirect mechanisms participating in sepsis-induced lymphocyte alterations and suggests that monocyte-targeting immunoadjuvant therapies in sepsis may also help to improve adaptive immune dysfunctions. Direct mechanisms impacting lymphocytes being also at play during sepsis, the respective parts of direct versus indirect sepsis-induced lymphocyte alterations remain to be evaluated in clinic.	[Poujol, Fanny; Monneret, Guillaume; Pachot, Alexandre; Textoris, Julien; Venet, Fabienne] Hop Edouard Herriot, Hosp Civils Lyon BioMerieux, Joint Res Unit, BioMerieux, Lyon, France; [Monneret, Guillaume; Venet, Fabienne] Hop Edouard Herriot, Hosp Civils Lyon, Immunol Lab, Lyon, France; [Textoris, Julien] Hop Edouard Herriot, Hosp Civils Lyon, Anesthesiol & Intens Care Dept, Lyon, France	bioMerieux; CHU Lyon; CHU Lyon; CHU Lyon	Venet, F (corresponding author), Hop Edouard Herriot, Hosp Civils Lyon BioMerieux, Joint Res Unit, BioMerieux, Lyon, France.	fabienne.venet@chu-lyon.fr	Textoris, Julien/H-3317-2019	Textoris, Julien/0000-0002-3821-9337; Venet, Fabienne/0000-0003-0462-4235	bioMerieux; Hospices Civils de Lyon	bioMerieux; Hospices Civils de Lyon	This work was supported by funds from bioMerieux (FP, AP, JT) and the Hospices Civils de Lyon to GM and FV. FP, AP, and JT are bioMerieux employees. This commercial affiliation only provided support in the form of salaries for authors (FP, JT, AP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allantaz-Frager F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068218; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BISMUTH G, 1985, J IMMUNOL, V134, P1415; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; CHANG TW, 1982, J IMMUNOL, V128, P585; Chien EJ, 2000, J CELL BIOCHEM, V76, P404, DOI 10.1002/(SICI)1097-4644(20000301)76:3<404::AID-JCB8>3.0.CO;2-E; Cole MS, 1997, J IMMUNOL, V159, P3613; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dominguez-Villar M, 2015, NAT IMMUNOL, V16, P118, DOI 10.1038/ni.3036; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Fontaine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100909; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Inoue S, 2014, CRIT CARE, V18, DOI 10.1186/cc13941; KAWAKAMI K, 1989, J IMMUNOL, V142, P1818; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Lahn M, 1998, J IMMUNOL, V160, P5221; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; LOHRMANN HP, 1974, J EXP MED, V139, P1553, DOI 10.1084/jem.139.6.1553; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Manjuck J, 2000, J LAB CLIN MED, V135, P153, DOI 10.1067/mlc.2000.104306; MANZO C, 1990, CELL IMMUNOL, V125, P79, DOI 10.1016/0008-8749(90)90064-X; MATTERN T, 1994, J IMMUNOL, V153, P2996; Mattern T, 1998, J IMMUNOL, V160, P3412; Maxwell JR, 2002, J IMMUNOL, V168, P4372, DOI 10.4049/jimmunol.168.9.4372; McAleer JP, 2007, J IMMUNOL, V179, P6524, DOI 10.4049/jimmunol.179.10.6524; MILLER K, 1983, IMMUNOBIOLOGY, V165, P132, DOI 10.1016/S0171-2985(83)80055-2; Monneret G, 2011, MED MYCOL, V49, pS17, DOI 10.3109/13693786.2010.509744; Muszynski JA, 2014, CRIT CARE, V18, DOI 10.1186/cc13980; Nakagawa Y, 2003, J INFECT DIS, V188, P1284, DOI 10.1086/379036; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Poujol F, 2014, J IMMUNOL METHODS, V415, P71, DOI 10.1016/j.jim.2014.10.006; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Roger PM, 2009, EUR J CLIN MICROBIOL, V28, P575, DOI 10.1007/s10096-008-0673-5; SCHWAB R, 1985, J IMMUNOL, V135, P1714; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Turrel-Davin F, 2011, CRIT CARE, V15, DOI 10.1186/cc10513; Ulmer AJ, 2000, TOXICOLOGY, V152, P37, DOI 10.1016/S0300-483X(00)00290-0; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; VOGEL SN, 1983, J IMMUNOL, V130, P1774; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Yaqub S, 2003, MED SCI MONITOR, V9, pBR120; Zanin-Zhorov A, 2007, J IMMUNOL, V179, P41, DOI 10.4049/jimmunol.179.1.41	58	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144375	10.1371/journal.pone.0144375	http://dx.doi.org/10.1371/journal.pone.0144375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642057	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700107
J	Moxley, MA; Beard, DA; Bazil, JN				Moxley, Michael A.; Beard, Daniel A.; Bazil, Jason N.			Global Kinetic Analysis of Mammalian E3 Reveals pH-dependent NAD(+)/NADH Regulation, Physiological Kinetic Reversibility, and Catalytic Optimum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; HEART LIPOAMIDE DEHYDROGENASE; NICOTINAMIDE-ADENINE-DINUCLEOTIDE; STEADY-STATE KINETICS; ACETYL-COENZYME-A; ESCHERICHIA-COLI; DIHYDROLIPOAMIDE DEHYDROGENASE; CRYSTAL-STRUCTURE; RAT-HEART; REDOX STATE	Mammalian E3 is an essential mitochondrial enzyme responsible for catalyzing the terminal reaction in the oxidative catabolism of several metabolites. E3 is a key regulator of metabolic fuel selection as a component of the pyruvate dehydrogenase complex (PDHc). E3 regulates PDHc activity by altering the affinity of pyruvate dehydrogenase kinase, an inhibitor of the enzyme complex, through changes in reduction and acetylation state of lipoamide moieties set by the NAD(+)/NADH ratio. Thus, an accurate kinetic model of E3 is needed to predict overall mammalian PDHc activity. Here, we have combined numerous literature data sets and new equilibrium spectroscopic experiments with a multitude of independently collected forward and reverse steady-state kinetic assays using pig heart E3. The latter kinetic assays demonstrate a pH-dependent transition of NAD(+) activation to inhibition, shown here, to our knowledge, for the first time in a single consistent data set. Experimental data were analyzed to yield a thermodynamically constrained four-redoxstate model of E3 that simulates pH-dependent activation/inhibition and active site redox states for various conditions. The developed model was used to determine substrate/product conditions that give maximal E3 rates and show that, due to non-Michaelis-Menten behavior, the maximal flux is different compared with the classically defined k(cat).	[Moxley, Michael A.; Beard, Daniel A.; Bazil, Jason N.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48709 USA	University of Michigan System; University of Michigan	Beard, DA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48709 USA.	beardda@umich.edu			National Institutes of Health [R01-DK095210, R01-HL072011, T32-HL094273, K99-HL121160]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094273, R00HL121160, R01HL072011, K99HL121160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-DK095210, R01-HL072011, T32-HL094273, and K99-HL121160. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Argyrou A, 2003, BIOCHEMISTRY-US, V42, P2218, DOI 10.1021/bi020654f; Argyrou A, 2002, BIOCHEMISTRY-US, V41, P14580, DOI 10.1021/bi020376k; Bazil JN, 2013, BIOPHYS J, V105, P343, DOI 10.1016/j.bpj.2013.05.033; Beard DA, 2008, CAMB TEXT BIOMED ENG, P1, DOI 10.1017/CBO9780511803345; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Bryk R, 2013, BIOCHEMISTRY-US, V52, P9375, DOI 10.1021/bi401077f; CATE RL, 1978, J BIOL CHEM, V253, P496; Clark W. M., 1960, OXIDATION REDUCTION, P321; Constantin-Teodosiu D, 2013, DIABETES METAB J, V37, P301, DOI 10.4093/dmj.2013.37.5.301; Cook P. F., 2007, ENZYME KINETICS MECH, p[37, 128, 354]; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME, P33; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; DUGGLEBY RG, 1989, EXPERIENTIA, V45, P87, DOI 10.1007/BF01990457; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Frey P. A., 2007, ENZYMATIC REACTION M, P129; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; HANSFORD RG, 1976, J BIOL CHEM, V251, P5483; Hong YS, 1999, FREE RADICAL BIO MED, V26, P685, DOI 10.1016/S0891-5849(98)00243-3; IDE S, 1967, J BIOL CHEM, V242, P54; Johson K. A., 2013, FEBS LETT, V587, P2753; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; KERBEY AL, 1976, BIOCHEM J, V154, P327, DOI 10.1042/bj1540327; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; KOIKE M, 1963, J BIOL CHEM, V238, P30; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P55; LEICHUS BN, 1992, BIOCHEMISTRY-US, V31, P3065, DOI 10.1021/bi00127a006; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; LOFFELHARDT S, 1995, BIOCHEM PHARMACOL, V50, P637, DOI 10.1016/0006-2952(95)00175-Y; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Maeder M, 2007, PRACTICAL DATA ANAL; MASSEY V, 1961, BIOCHIM BIOPHYS ACTA, V48, P33, DOI 10.1016/0006-3002(61)90512-1; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V37, P314, DOI 10.1016/0006-3002(60)90239-0; MASSEY V, 1960, BIOCHEM J, V77, P341, DOI 10.1042/bj0770341; Massey V., 1966, METHOD ENZYMOL, V9, P272; MATTHEWS J, 1963, J BIOL CHEM, V238, P1869; MATTHEWS RG, 1976, J BIOL CHEM, V251, P3956; MATTHEWS RG, 1979, J BIOL CHEM, V254, P4974; MATTHEWS RG, 1977, J BIOL CHEM, V252, P3199; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Moxley MA, 2014, BIOPHYS J, V107, P2984, DOI 10.1016/j.bpj.2014.09.025; Neuhold Y.-M., 2007, PRACTICAL DATA ANAL, P33; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Raddatz G, 1997, J BIOTECHNOL, V58, P89, DOI 10.1016/S0168-1656(97)00135-1; Rahimi Y, 2014, P NATL ACAD SCI USA, V111, P16508, DOI 10.1073/pnas.1419104111; Ravindran S, 1996, J BIOL CHEM, V271, P653, DOI 10.1074/jbc.271.2.653; REED JK, 1973, J BIOL CHEM, V248, P4834; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; SAHLMAN L, 1989, J BIOL CHEM, V264, P8039; Schrodinger L, 2010, PYMOL MOL GRAPH SYST; Schulze A, 2011, MOL CELL, V44, P846, DOI 10.1016/j.molcel.2011.12.004; SCHWARTZ ER, 1970, BIOCHEMISTRY-US, V9, P1434, DOI 10.1021/bi00808a019; SCOTT DA, 1994, AM J PHYSIOL, V267, pH636, DOI 10.1152/ajpheart.1994.267.2.H636; Segel I. H., 1993, ENZYME KINETICS BEHA, p[657, 884]; Sidhu S, 2008, AM J PHYSIOL-HEART C, V295, pH946, DOI 10.1152/ajpheart.00363.2008; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; Teodoro JS, 2013, MOL CELL BIOCHEM, V376, P103, DOI 10.1007/s11010-012-1555-9; TSAI CS, 1992, INT J BIOCHEM, V24, P1801, DOI 10.1016/0020-711X(92)90131-J; TSAI CS, 1980, INT J BIOCHEM, V11, P407, DOI 10.1016/0020-711X(80)90311-0; Ussher JR, 2012, CIRC RES, V111, P628, DOI 10.1161/CIRCRESAHA.111.246371; v Muiswinkel-Voetberg H, 1973, Eur J Biochem, V33, P285; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; WILKINSON KD, 1981, J BIOL CHEM, V256, P2307; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	77	7	7	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2712	+		10.1074/jbc.M115.676619	http://dx.doi.org/10.1074/jbc.M115.676619			41	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26644471	Green Published, hybrid			2022-12-26	WOS:000369626900014
J	Chen, YH; Hsieh, TF; Lee, CC; Wu, MJ; Fu, YC				Chen, Yi-Hsin; Hsieh, Teng-Fu; Lee, Ching-Chih; Wu, Ming-Ju; Fu, Yun-Ching			Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan	PLOS ONE			English	Article							HORMONE-REPLACEMENT THERAPY; ENDOTHELIAL NITRIC-OXIDE; FACTOR-V-LEIDEN; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; ATRIAL-FIBRILLATION; GENDER-DIFFERENCES; RISK-FACTOR; SEX-DIFFERENCES; MEDROXYPROGESTERONE ACETATE	This study explores the possible association between the risk of ischemic stroke and conjugated equine estrogen (CEE) use in women who are over 55 years old and have diabetes. Data from the National Health Insurance system of Taiwan were used to identify 428 women over 55 years old with diabetes who used CEE (0.625 mg daily) from 2003 to 2009. For comparison, 21026 women with diabetes who were from the same cohort and did not use estrogen were used as a control group, excluding patients with previous ischemic stroke at the baseline. The propensity score method was used to identify a 1: 3 ratio for the matched cohort (n = 1284). Covariates used for propensity score-matching included age and comorbidities. Cox's proportional hazard model was applied to estimate the relationship between CEE use and ischemic stroke. The overall incidence of ischemic stroke was significantly lower in patients using CEE than in the control group (0.9% compared with 3.0%, p = 0.016). Further analyses using Cox's proportional hazard model revealed that after adjusting for age, comorbidities, socioeconomic status, urbanization, and other medications associated with ischemic stroke, a lower risk was present in patients with CEE use (hazard ratio: 0.34; 95% confidence interval: 0.12-0.97). Time of menopause could not be identified because of the nature of the database. CEE might decrease the risk of ischemic stroke in women with diabetes aged over 55 years, according to this population-based study.	[Chen, Yi-Hsin; Wu, Ming-Ju; Fu, Yun-Ching] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yi-Hsin] Taichung Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Nephrol, Taichung, Taiwan; [Hsieh, Teng-Fu] Taichung Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Urol, Taichung, Taiwan; [Chen, Yi-Hsin; Hsieh, Teng-Fu; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Wu, Ming-Ju] Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Wu, Ming-Ju] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Ju] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Fu, Yun-Ching] Taichung Vet Gen Hosp, Dept Pediat, Pediat Cardiol Sect, Taichung, Taiwan	National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Taichung Veterans General Hospital; Chung Shan Medical University; China Medical University Taiwan; Taichung Veterans General Hospital	Wu, MJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.	wmj530@gmail.com						Adams MR, 1997, ARTERIOSCL THROM VAS, V17, P217, DOI 10.1161/01.ATV.17.1.217; Baba Y, 2010, MENOPAUSE, V17, P506, DOI 10.1097/gme.0b013e3181c7dd41; Barros RPA, 2009, AM J PHYSIOL-ENDOC M, V297, pE124, DOI 10.1152/ajpendo.00189.2009; BRITTON M, 1985, STROKE, V16, P182, DOI 10.1161/01.STR.16.2.182; Chiang CH, 2012, J BONE MINER RES, V27, P1951, DOI 10.1002/jbmr.1645; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Chow SN, 1997, J FORMOS MED ASSOC, V96, P806; Ferrara A, 2003, CIRCULATION, V107, P43, DOI 10.1161/01.CIR.0000042701.17528.95; FINUCANE FF, 1993, ARCH INTERN MED, V153, P73, DOI 10.1001/archinte.153.1.73; FOLSOM AR, 1995, AM J PUBLIC HEALTH, V85, P1128, DOI 10.2105/AJPH.85.8_Pt_1.1128; Foryst-Ludwig A, 2010, J STEROID BIOCHEM, V122, P74, DOI 10.1016/j.jsbmb.2010.06.012; Franzini L, 2013, NUTR METAB CARDIOVAS, V23, P235, DOI 10.1016/j.numecd.2011.12.003; FRIEDMAN GD, 1968, CIRCULATION, V38, P533, DOI 10.1161/01.CIR.38.3.533; Fujishima M, 1996, DIABETES, V45, pS14, DOI 10.2337/diab.45.3.S14; Fung MM, 1999, J WOMENS HEALTH, V8, P359, DOI 10.1089/jwh.1999.8.359; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Gobl CS, 2010, GENDER MED, V7, P593, DOI 10.1016/j.genm.2010.11.003; GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157; Goto T, 2007, ANESTH ANALG, V104, P1016, DOI 10.1213/01.ane.0000263279.07361.1f; Grodstein F, 1999, EPIDEMIOLOGY, V10, P476, DOI 10.1097/00001648-199909000-00003; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; HAYASHI T, 1995, BIOCHEM BIOPH RES CO, V214, P847, DOI 10.1006/bbrc.1995.2364; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; Hira B, 2003, BJOG-INT J OBSTET GY, V110, P327, DOI 10.1016/S1470-0328(02)01590-2; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; HUNT K, 1990, BRIT J OBSTET GYNAEC, V97, P1080, DOI 10.1111/j.1471-0528.1990.tb02494.x; Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kobashi G, 1999, SEMIN THROMB HEMOST, V25, P487, DOI 10.1055/s-2007-994955; Kuo DJ, 2007, MATURITAS, V58, P259, DOI 10.1016/j.maturitas.2007.08.013; Labiche LA, 2002, ANN EMERG MED, V40, P453, DOI 10.1067/mem.2002.128682; LINDENSTROM E, 1993, STROKE, V24, P1468, DOI 10.1161/01.STR.24.10.1468; Lisabeth LD, 2009, STROKE, V40, P1044, DOI 10.1161/STROKEAHA.108.542993; Mascarenhas-Melo F, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-61; McCrohon JA, 1999, CIRCULATION, V100, P2319, DOI 10.1161/01.CIR.100.23.2319; Meendering JR, 2008, AM J PHYSIOL-HEART C, V294, pH1630, DOI 10.1152/ajpheart.01314.2007; Miyazaki-Akita A, 2007, J PHARMACOL EXP THER, V320, P591, DOI 10.1124/jpet.106.111641; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; Nilsson PM, 2004, SCAND J PRIM HEALTH, V22, P27, DOI 10.1080/02813430310003264; Ohmichi M, 2005, ENDOCR J, V52, P161, DOI 10.1507/endocrj.52.161; Pedersen AT, 1997, LANCET, V350, P1277, DOI 10.1016/S0140-6736(97)06005-4; Penno G, 2013, J INTERN MED, V274, P176, DOI 10.1111/joim.12073; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; PETERSEN P, 1986, STROKE, V17, P622, DOI 10.1161/01.STR.17.4.622; Petitti DB, 1998, STROKE, V29, P23, DOI 10.1161/01.STR.29.1.23; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; POSTHUMA WFM, 1994, BRIT MED J, V308, P1268; Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, CARDIOVASC RES, V53, P550, DOI 10.1016/S0008-6363(01)00478-3; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schairer C, 1997, EPIDEMIOLOGY, V8, P59, DOI 10.1097/00001648-199701000-00010; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STURGEON SR, 1995, EPIDEMIOLOGY, V6, P227, DOI 10.1097/00001648-199505000-00006; Su IH, 2012, MENOPAUSE, V19, P931, DOI 10.1097/gme.0b013e31824362ff; Tchernof A, 1998, CORONARY ARTERY DIS, V9, P503, DOI 10.1097/00019501-199809080-00006; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Vaccaro O, 2008, ATHEROSCLEROSIS, V198, P396, DOI 10.1016/j.atherosclerosis.2007.10.026; Vina J, 2006, FREE RADICAL RES, V40, P111, DOI 10.1080/10715760500405778; WALDEN CE, 1984, NEW ENGL J MED, V311, P953, DOI 10.1056/NEJM198410113111505; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Wassmann K, 2005, CIRC RES, V97, P1046, DOI 10.1161/01.RES.0000188212.57180.55; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	69	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144910	10.1371/journal.pone.0144910	http://dx.doi.org/10.1371/journal.pone.0144910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658781	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900145
J	Liu, XH; Tang, LM; Yang, LX; Zhang, XL; Wang, LQ; Yu, FX; Liu, Y; Chen, Q; Liu, DW				Liu, Xuehui; Tang, Longmei; Yang, Lixue; Zhang, Xiaolin; Wang, Liqin; Yu, Fengxue; Liu, Yi; Chen, Qing; Liu, Dianwu			Genotoxicity Evaluation of Irrigative Wastewater from Shijiazhuang City in China	PLOS ONE			English	Article							HUMAN HEALTH-RISK; HEAVY-METAL; COMET ASSAY; ORGANIC POLLUTION; MICRONUCLEUS TEST; DNA-DAMAGE; EFFLUENTS; SEWAGE; METABOLITES; TOXICITY	In the present study, the wastewater sample collected from the Dongming discharging river in Shijiazhuang city was analysed using both chemical analysis and biological assays including the Salmonella mutagenicity test, micronucleus test and single-cell gel electrophoresis. Chemical analysis of the sample was performed using gas chromatography mass spectrometry and inductively coupled plasma mass spectrometry. The Salmonella mutagenicity test was performed on Salmonella typhimurium TA97, TA98, TA100 and TA102 strains with and without S9 mixture. The mice received the wastewater in natura through drinking water at concentrations of 25%, 50%, and 100%. One group of mice was exposed for 2 consecutive days, and the other group of mice was exposed for 15 consecutive days. To establish the levels of primary DNA damage, single-cell gel electrophoresis was performed on treated mouse liver cell. The concentrations of chromium and lead in the sample exceeded the national standard (GB20922-2007) by 0.78 and 0.43-fold, respectively. More than 30 organic compounds were detected, and some of the detected compounds were mutagens, carcinogens and environmental endocrine disrupters. A positive response for Salmonella typhimurium TA98 strain was observed. Mouse exposure via drinking water containing 50% and 100% of wastewater for 15 consecutive days caused a significant increase of MN frequencies in a dose-response manner. Mouse exposure via drinking water containing 50% and 100% of wastewater for 15 consecutive days caused a significant increase of the Olive tail moments in a dose-response manner. All the results indicated that the sample from the Dongming discharging river in Shijiazhuang city exhibited genotoxicity and might pose harmful effects on the local residents.	[Liu, Xuehui] Hebei Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shijiazhuang 050017, Hebei, Peoples R China; [Tang, Longmei; Zhang, Xiaolin; Wang, Liqin; Liu, Dianwu] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Hyg Stat, Shijiazhuang 050017, Hebei, Peoples R China; [Yang, Lixue] Shijiazhuang Ctr Dis Control & Prevent, Dept Phys & Chem Inspect, Shijiazhuang 050011, Hebei, Peoples R China; [Yu, Fengxue] Hebei Med Univ, Div Gastroenterol, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China; [Liu, Yi] Hebei Med Univ, Sch Publ Hlth, Dept Toxicol, Shijiazhuang 050017, Hebei, Peoples R China; [Chen, Qing] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Reprod Med, Xian 710061, Shanxi, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Xi'an Jiaotong University	Liu, DW (corresponding author), Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Hyg Stat, Zhongshan East Rd 361, Shijiazhuang 050017, Hebei, Peoples R China.	Dwliu1956@hotmail.com			Health Department Science Research Foundation of Hebei Province [20090057]	Health Department Science Research Foundation of Hebei Province	This research was supported by the Health Department Science Research Foundation of Hebei Province (Project No. 20090057).	AGARWAL DK, 1985, J TOXICOL ENV HEALTH, V16, P61, DOI 10.1080/15287398509530719; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; [Anonymous], 2012, STANDARD METHODS EXA; Brendler-Schwaab S, 2005, MUTAGENESIS, V20, P245, DOI 10.1093/mutage/gei033; Celik A, 2005, MUTAGENESIS, V20, P411, DOI 10.1093/mutage/gei055; Chen Y, 2005, ENVIRON INT, V31, P778, DOI 10.1016/j.envint.2005.05.024; DEFLORA S, 1990, MUTAT RES, V238, P99, DOI 10.1016/0165-1110(90)90007-X; Dong YR, 2010, ECOTOX ENVIRON SAFE, V73, P944, DOI 10.1016/j.ecoenv.2009.12.026; Durgo K, 2009, J APPL TOXICOL, V29, P42, DOI 10.1002/jat.1381; Ferk F, 2009, MUTAT RES-GEN TOX EN, V672, P69, DOI 10.1016/j.mrgentox.2008.08.022; FRACASSO ME, 1992, MUTAT RES, V298, P91; Gambelunghe A, 2003, TOXICOLOGY, V188, P187, DOI 10.1016/S0300-483X(03)00088-X; GAUTHIER L, 1993, SCI TOTAL ENVIRON, V138, P249, DOI 10.1016/0048-9697(93)90419-7; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Ginsberg G, 2011, J TOXICOL ENV HEAL A, V74, P1175, DOI 10.1080/15287394.2011.586943; Hamilton AJ, 2007, VADOSE ZONE J, V6, P823, DOI 10.2136/vzj2007.0026; He PJ, 2001, WATER SCI TECHNOL, V43, P51; Huang C, 1984, ENV PROTECTION, V16, P34; Ingwersen J, 2006, J ENVIRON QUAL, V35, P1702, DOI 10.2134/jeq2005.0412; Jimenez B, 2008, SCI TECH REP SER, P1; JUNK GA, 1974, J CHROMATOGR, V99, P745, DOI 10.1016/S0021-9673(00)90900-2; Kabdasli I, 2010, WATER SCI TECHNOL, V61, P2617, DOI 10.2166/wst.2010.202; Khan MU, 2013, CHEMOSPHERE, V93, P2230, DOI 10.1016/j.chemosphere.2013.07.067; Kleinsasser NH, 2001, HNO, V49, P378, DOI 10.1007/s001060050766; Kobori H, 2009, ENVIRON MONIT ASSESS, V151, P243, DOI 10.1007/s10661-008-0265-y; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Krishnamurthi K, 2008, ARCH TOXICOL, V82, P965, DOI 10.1007/s00204-008-0380-0; LECURIEUX F, 1993, MUTAT RES, V319, P223, DOI 10.1016/0165-1218(93)90082-O; Lefebvre O, 2006, WATER RES, V40, P3671, DOI 10.1016/j.watres.2006.08.027; Liu JR, 2009, ENVIRON POLLUT, V157, P357, DOI 10.1016/j.envpol.2008.10.004; Llorente MT, 2012, WATER RES, V46, P6351, DOI 10.1016/j.watres.2012.08.039; Ma J., 2008, THESIS; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Moller P, 2006, BASIC CLIN PHARMACOL, V98, P336, DOI 10.1111/j.1742-7843.2006.pto_167.x; Oliveira-Martins CR, 2009, GENET MOL BIOL, V32, P853, DOI 10.1590/S1415-47572009005000094; PHILLIPS BJ, 1982, MUTAT RES, V102, P297, DOI 10.1016/0165-1218(82)90139-2; Piao FY, 2007, IND HEALTH, V45, P546, DOI 10.2486/indhealth.45.546; Radic S, 2010, SCI TOTAL ENVIRON, V408, P1228, DOI 10.1016/j.scitotenv.2009.11.055; Robbiano L, 1999, TOXICOL APPL PHARM, V161, P153, DOI 10.1006/taap.1999.8796; Santos DB, 2009, MUTAT RES-GEN TOX EN, V676, P21, DOI 10.1016/j.mrgentox.2009.03.006; Sasaki YF, 1997, MUTAT RES-GEN TOX EN, V391, P201, DOI 10.1016/S1383-5718(97)00072-7; SCHMID P, 1985, XENOBIOTICA, V15, P251, DOI 10.3109/00498258509045356; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Singh S, 2006, ENVIRON MONIT ASSESS, V120, P79, DOI 10.1007/s10661-005-9050-3; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; SUTOU S, 1990, MUTAT RES, V234, P205; Tapisso JT, 2009, MUTAT RES-GEN TOX EN, V678, P59, DOI 10.1016/j.mrgentox.2009.07.001; Thewes MR, 2011, GENET MOL BIOL, V34, P689, DOI 10.1590/S1415-47572011005000055; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tu JC, 2012, ENVIRON MONIT ASSESS, V184, P1645, DOI 10.1007/s10661-011-2067-x; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Wei N, 2006, WATER SAVING IRRIGAT, V1, P31; Xu JA, 2010, J HAZARD MATER, V183, P780, DOI 10.1016/j.jhazmat.2010.07.094	54	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144729	10.1371/journal.pone.0144729	http://dx.doi.org/10.1371/journal.pone.0144729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658348	Green Submitted, gold, Green Published			2022-12-26	WOS:000366715900096
J	Wei, HX; Zhao, X; Yuan, RH; Dai, XM; Li, YS; Liu, L				Wei, Hanxiao; Zhao, Xian; Yuan, Ruihong; Dai, Xiaoming; Li, Yisong; Liu, Liu			Effects of PB-EPCs on Homing Ability of Rabbit BMSCs via Endogenous SDF-1 and MCP-1	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; PERIPHERAL-BLOOD; BONE DEFECT; VASCULARIZATION; RECRUITMENT; MIGRATION; REPAIR; MOBILIZATION	Traumas, infections, tumors, and some congenital malformations can lead to bone defects or even bone loss. The goal of the present study was to investigate whether inclusion of endothelial progenitor cells derived from peripheral blood (PB-EPCs) in cell-seeded partially deproteinized bone (PDPB) implants would stimulate recruitment of systemically injected bone marrow stromal cells (BMSCs) to the implant. Methods: BMSCs were injected intravenously with lentiviral expression vector expressing enhanced green fluorescent protein (eGFP) for tracing. Recruitment of eGFP-positive BMSCs was tested for the following implant configurations: 1) seeded with both BMSC and PB-EPC, 2) BMSC alone, 3) PBEPC alone, and 4) unseeded PDPB. Protein and mRNA levels of endogenous stromal-derived factor-1 (SDF-1) and its receptor CXCR4, as well as monocyte chemotactic protein-1 (MCP-1) and its receptor CCR2, were evaluated on the 8th week. Immunohistochemical staining was performed to determine eGFP-positive areas at the defective sites. Masson's trichrome staining was conducted to observe the distribution of collagen deposition and evaluate the extent of osteogenesis. Results: The mRNA and protein levels of SDF-1 and CXCR4 in the co-culture group were higher than those in other groups (p < 0.05) 8 weeks after the surgery. MCP-1 mRNA level in the co-culture group was also higher than that in the other groups (p < 0.05). Immunohistochemical assays revealed that the area covered by eGFP-positive cells was larger in the co-culture group than in the other groups (p < 0.05) after 4 weeks. Masson's trichrome staining revealed better osteogenic potential of the co-culture group compared to the other groups (p < 0.05). Conclusion: These experiments demonstrate an association between PB-EPC and BMSC recruitment mediated by the SDF-1/CXCR4 axis that can enhance repair of bone defects.	[Wei, Hanxiao; Zhao, Xian; Yuan, Ruihong; Dai, Xiaoming; Li, Yisong; Liu, Liu] Kunming Med Univ, Dept Plast Surg, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China	Kunming Medical University	Liu, L (corresponding author), Kunming Med Univ, Dept Plast Surg, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China.	249121382@qq.com			Natural Science Foundation of China [81460298]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No: 81460298). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Amini AR, 2012, J ORTHOP RES, V30, P1507, DOI 10.1002/jor.22097; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Atesok K, 2010, J ORTHOP RES, V28, P1007, DOI 10.1002/jor.21083; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Benameur T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012392; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032; Cheng M, 2015, J MOL CELL CARDIOL, V81, P49, DOI 10.1016/j.yjmcc.2015.01.024; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; Duttenhoefer F, 2013, EUR CELLS MATER, V26, P49; Fu WL, 2015, TISSUE ENG PT A, V21, P948, DOI [10.1089/ten.TEA.2014.0267, 10.1089/ten.tea.2014.0267]; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Han YG, 2014, J VASC RES, V51, P369, DOI 10.1159/000368929; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Koga M, 2009, TISSUE ENG PT A, V15, P2727, DOI [10.1089/ten.tea.2008.0417, 10.1089/ten.TEA.2008.0417]; Kucia M, 2004, J MOL HISTOL, V35, P233; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Papadimitropoulos A, 2011, EUR CELLS MATER, V21, P445, DOI 10.22203/eCM.v021a33; Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x; Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rouwkema J, 2009, TISSUE ENG PT A, V15, P2015, DOI 10.1089/ten.tea.2008.0318; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI 10.1089/ten.TEA.2009.0715; Shi Y, 2014, EUR CELLS MATER, V27, P64, DOI 10.22203/eCM.v027a06; Sierra MD, 2004, BLOOD, V103, P2452; Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010; Sukegawa A, 2012, TISSUE ENG PT A, V18, P934, DOI [10.1089/ten.tea.2011.0380, 10.1089/ten.TEA.2011.0380]; Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142; Varda-Bloom N, 2014, ISR MED ASSOC J, V16, P774; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200	40	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145044	10.1371/journal.pone.0145044	http://dx.doi.org/10.1371/journal.pone.0145044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660527	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900175
J	Wondimu, A; Molla, F; Abrha, S; Mohammed, J; Demeke, B; Eticha, T; Assen, A; Melkam, W; Gebre-Samuel, N; Berhe, DF; Tadese, E; Endris, K				Wondimu, Abrham; Molla, Fantahun; Abrha, Solomon; Mohammed, Jemal; Demeke, Birhanu; Eticha, Tadele; Assen, Admassu; Melkam, Wondim; Gebre-Samuel, Naod; Berhe, Derbew Fikadu; Tadese, Ebisa; Endris, Kedir			Drug Use during Acute Illness in Tigray Region, Northern Ethiopia: A Household Study	PLOS ONE			English	Article							PATTERN	Background Drug use study in the community enables health authorities to understand pattern of drug utilization and its related aspects. This, in turn, can help to develop rational drug policies to be harmonized in accordance to the need of the community. Objective The aim of this study was to assess drug use during acute illness by the general population in Tigray region, Northern Ethiopia. Method A community based cross-sectional study was undertaken in April 2013 in Tigray Region, Ethiopia. A total of 1034 households were interviewed in the study. A multi-stage sampling technique was used to select households. Data were collected using a pre-tested structured questionnaire. Data were analyzed using descriptive statistics and bivariate and multivariate logistic regression model. Results Out of 1000 households, 210(21%) reported an episode of acute illness. The prevalence of acute illnesses in rural areas 126(25%) (AOR = 1.83, 95% CI: 1.21-2.76) was significantly higher than that of urban areas 84(17%). Cough, runny nose, sore throat, earache, fever and headache added up to 155(52%) of all reported symptoms of acute illnesses. The majority of the patients 162 (77%) took modern medications for the managements of their diseases. Half 105(50%) of the consumed medications were antibiotics. The large proportions 173(83%) of medicines for acute illness were taken orally. The greater proportions 150 (93%) of medications were prescribed by health professionals. Thirty-four households (21%) reported treatment discontinuation. Conclusion The prevalence of acute illnesses in this study was found to be 21%. Acute illnesses were more common in rural areas than urban areas. Antibiotics were the most frequently used drugs for acute illnesses.	[Wondimu, Abrham; Molla, Fantahun; Abrha, Solomon; Mohammed, Jemal; Demeke, Birhanu; Eticha, Tadele; Assen, Admassu; Melkam, Wondim; Gebre-Samuel, Naod; Berhe, Derbew Fikadu; Tadese, Ebisa] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia; [Endris, Kedir] Mekelle Univ, Coll Hlth Sci, Dept Nursing, Mekelle, Ethiopia	Mekelle University; Mekelle University	Wondimu, A (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia.	leabrham@gmail.com	Berhe, Derbew Fikadu/K-8802-2019	Berhe, Derbew Fikadu/0000-0002-0669-9241; Kassa, Fantahun Molla/0000-0002-4556-1245; Abrha, Solomon/0000-0002-8192-6985; Dagne, Abrham Wondimu/0000-0002-3922-287X	Mekelle University [CHS/RB/14/2012]	Mekelle University	This study is financially supported by Mekelle University (grant number is CHS/RB/14/2012). The author AW received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abula T., 2001, Ethiopian Journal of Health Development, V15, P25; Abula T., 2003, ETHIOP J HEALTH DEV, V3, P231; Amare G, 1997, E AFR MED J, V74, P362; Assen A., 2014, INT J PHARM SCI RES, V5, P777; Calva J, 1996, SOC SCI MED, V42, P1121, DOI 10.1016/0277-9536(95)00385-1; CSA, 2008, SUMM STAT REP 2007 P; Demeke B., 2015, IJPSR, V6, P343; Desalegn AA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-170; Desta Z, 1997, E AFR MED J, V74, P758; Eticha T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097464; Gottlieb H, 2000, MEDICATION NONADHERE; Gurbani N, 2011, PHARM TIMES, V43, P23; Kayode OM, 2012, J PHARM BIOMED SCI, V22, P1; Kloos H, CONTEXT MED DEV COUN, P81; KRISHNASWAMY K, 1985, EUR J CLIN PHARMACOL, V29, P363, DOI 10.1007/BF00544095; Le Grand A, 1999, HEALTH POLICY PLANN, V14, P89, DOI 10.1093/heapol/14.2.89; Ministry of Medical Services and Ministry of Public Health and Sanitation, 2009, ACC ESS MED KEN HOUS; Shankar P. R., 2003, SMJ Singapore Medical Journal, V44, P352; Thiruthopu Nimbagiri Swamy, 2014, Perspect Clin Res, V5, P178, DOI 10.4103/2229-3485.140558; WHO, 2009, PHIL PHARM SIT 2009; WHO, 2008, WHO LEV 2 HOUS SURV	21	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145007	10.1371/journal.pone.0145007	http://dx.doi.org/10.1371/journal.pone.0145007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658645	Green Published, gold			2022-12-26	WOS:000366715900165
J	Barsova, RM; Lvovs, D; Titov, BV; Matveeva, NA; Shakhnovich, RM; Sukhinina, TS; Kukava, NG; Ruda, MY; Karamova, IM; Nasibullin, TR; Mustafina, OE; Osmak, GJ; Tsareva, EY; Kulakova, OG; Favorov, AV; Favorova, OO				Barsova, Rosa M.; Lvovs, Dmitrijs; Titov, Boris V.; Matveeva, Natalia A.; Shakhnovich, Roman M.; Sukhinina, Tatiana S.; Kukava, Nino G.; Ruda, Mikhail Ya; Karamova, Irina M.; Nasibullin, Timur R.; Mustafina, Olga E.; Osmak, German J.; Tsareva, Ekaterina Yu; Kulakova, Olga G.; Favorov, Alexander V.; Favorova, Olga O.			Variants of the Coagulation and Inflammation Genes Are Replicably Associated with Myocardial Infarction and Epistatically Interact in Russians	PLOS ONE			English	Article							C-REACTIVE-PROTEIN; CORONARY-HEART-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; GENOME-WIDE ASSOCIATION; COMPLEMENT-FACTOR-H; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; POLYMORPHISMS; FIBRINOGEN; RISK	Background In spite of progress in cardiovascular genetics, data on genetic background of myocardial infarction are still limited and contradictory. This applies as well to the genes involved in inflammation and coagulation processes, which play a crucial role in the disease etiopathogenesis. Methods and Results In this study we found genetic variants of TGFB1, FGB and CRP genes associated with myocardial infarction in discovery and replication groups of Russian descent from the Moscow region and the Republic of Bashkortostan (325/185 and 220/197 samples, correspondingly). We also found and replicated biallelic combinations of TGFB1 with FGB, TGFB1 with CRP and IFNG with PTGS1 genetic variants associated with myocardial infarction providing a detectable cumulative effect. We proposed an original two-component procedure for the analysis of nonlinear (epistatic) interactions between the genes in biallelic combinations and confirmed the epistasis hypothesis for the set of alleles of IFNG with PTGS. The procedure is applicable to any pair of logical variables, e.g. carriage of two sets of alleles. The composite model that included three single gene variants and the epistatic pair has AUC of 0.66 both in discovery and replication groups. Conclusions The genetic impact of TGFB1, FGB, CRP, IFNG, and PTGS and/or their biallelic combinations on myocardial infarction was found and replicated in Russians. Evidence of epistatic interactions between IFNG with PTGS genes was obtained both in discovery and replication groups.	[Barsova, Rosa M.; Titov, Boris V.; Matveeva, Natalia A.; Tsareva, Ekaterina Yu; Kulakova, Olga G.; Favorova, Olga O.] Russian Cardiol Sci & Prod Ctr, Inst Expt Cardiol, Moscow, Russia; [Lvovs, Dmitrijs; Favorov, Alexander V.] Russian Acad Sci, Vavilov Inst Gen Genet, Dept Computat Biol, Moscow, Russia; [Titov, Boris V.; Matveeva, Natalia A.; Osmak, German J.; Tsareva, Ekaterina Yu; Kulakova, Olga G.; Favorova, Olga O.] Pirogov Russian Natl Res Med Univ, Dept Mol Biol & Med Biotechnol, Moscow, Russia; [Shakhnovich, Roman M.; Sukhinina, Tatiana S.; Kukava, Nino G.; Ruda, Mikhail Ya] Russian Cardiol Sci & Prod Ctr, Dept Emergency Cardiol, Moscow, Russia; [Karamova, Irina M.] Republican Cardiol Hlth Ctr, Div Cardiol, Ufa, The Republic Of, Russia; [Nasibullin, Timur R.; Mustafina, Olga E.] Russian Acad Sci, Dept Genom, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Favorov, Alexander V.] Johns Hopkins Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD USA	National Medical Research Center of Cardiology; Russian Academy of Sciences; Vavilov Institute of General Genetics; Pirogov Russian National Research Medical University; National Medical Research Center of Cardiology; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Johns Hopkins University; Johns Hopkins Medicine	Favorov, AV (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Dept Computat Biol, Moscow, Russia.	favorov@sensi.org	Nasibullin, Timur/C-2432-2017; Osmak, German/AAB-4101-2020; Favorova, Olga O/U-7912-2017; Titov, Boris V./N-3505-2016; Favorov, Alexander V/K-2699-2018; Kulakova, Olga/S-1426-2019; Tsareva, Ekaterina/AAO-6978-2020; Stefanadis, Christodoulos/ABH-2232-2020; Matveeva, Natalya A/AAH-6794-2020; Mustafina, Olga Evgenevna/A-4229-2016	Nasibullin, Timur/0000-0001-8823-8678; Titov, Boris V./0000-0002-2585-8471; Favorov, Alexander V/0000-0003-2595-1091; Tsareva, Ekaterina/0000-0003-2535-9450; Stefanadis, Christodoulos/0000-0001-5974-6454; Matveeva, Natalya A/0000-0002-4369-2882; Mustafina, Olga Evgenevna/0000-0002-5118-6533; Kulakova, Olga/0000-0002-5321-3101; Osmak, German/0000-0001-7839-9929; Favorova, Olga/0000-0002-5271-6698; Suhinina, Tat'ana/0000-0002-5509-6623	Russian Foundation for Basic Research [14-04-00984, 13-04-40279-H]; Russian Science Foundation [14-14-00605]; National Institutes of Health [P30 CA006973]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Russian Foundation for Basic Research (grants 14-04-00984 to RMB, BVT, RMS, OOF and 13-04-40279-H to AVF) [http://www.rfbr.ru/rffi/eng]; by the Russian Science Foundation (grant 14-14-00605 to NAM, EYuT, OGK) [http://rscf.ru/en/]; and by National Institutes of Health (P30 CA006973 to AVF) [http://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki A, 2011, J HUM GENET, V56, P47, DOI 10.1038/jhg.2010.141; Barsova RM, 2012, ACTA NATURAE, V4, P74, DOI 10.32607/20758251-2012-4-2-74-79; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Carty CL, 2008, THROMB HAEMOSTASIS, V99, P388, DOI 10.1160/TH07-08-0523; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; Crobu F, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-13; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Favorov AV, 2005, GENETICS, V171, P2113, DOI 10.1534/genetics.105.048090; Gigante B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011300; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hermann M, 2012, ATHEROSCLEROSIS, V220, P172, DOI 10.1016/j.atherosclerosis.2011.10.019; Hirokawa M, 2015, EUR J HUM GENET, V23, P374, DOI 10.1038/ejhg.2014.110; Jylhava J, 2009, CLIN EXP IMMUNOL, V155, P53, DOI 10.1111/j.1365-2249.2008.03752.x; Kardys I, 2007, AM J CARDIOL, V100, P646, DOI 10.1016/j.amjcard.2007.03.079; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koch W, 2006, ARTERIOSCL THROM VAS, V26, P1114, DOI 10.1161/01.ATV.0000217747.66517.11; Koch W, 2008, ARTERIOSCL THROM VAS, V28, P758, DOI 10.1161/ATVBAHA.107.157842; Lemaitre Rozenn N, 2009, Atherosclerosis, V204, pe58, DOI 10.1016/j.atherosclerosis.2008.10.011; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Licastro F, 2007, ANN NY ACAD SCI, V1119, P227, DOI 10.1196/annals.1404.004; Lu XF, 2008, CHINESE MED J-PEKING, V121, P1549, DOI 10.1097/00029330-200808020-00009; Lucas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041730; Lvovs D, 2012, ACTA NATURAE, V4, P59, DOI 10.32607/20758251-2012-4-3-59-71; Maksimov V N, 2012, Vestn Ross Akad Med Nauk, P24; Mannila MN, 2006, THROMB HAEMOSTASIS, V95, P420, DOI 10.1160/TH05-11-0777; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Sambrook J, 1989, MOL CLONING; Shakhnovitch RM, 2010, KARDIOLOGIYA, V50, P4; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Singh A, 2015, EUR J HUM GENET, V23, P854, DOI 10.1038/ejhg.2014.189; Singh P, 2014, MOL BIOL REP, V41, P5851, DOI 10.1007/s11033-014-3459-0; Tousoulis D, 2011, BLOOD REV, V25, P239, DOI 10.1016/j.blre.2011.05.001; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; White D.R., 1983, CROSS-CULT RES, V18, P103, DOI DOI 10.1177/106939718301800201.; Yamada Y, 2011, ATHEROSCLEROSIS, V215, P145, DOI 10.1016/j.atherosclerosis.2010.12.005; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	45	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144190	10.1371/journal.pone.0144190	http://dx.doi.org/10.1371/journal.pone.0144190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658659	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903500016
J	Galluzzi, G; Dufour, D; Thomas, E; van Zonneveld, M; Salamanca, AFE; Toro, AG; Rivera, A; Duque, HS; Baron, HS; Gallego, G; Scheldeman, X; Mejia, AG				Galluzzi, Gea; Dufour, Dominique; Thomas, Evert; van Zonneveld, Maarten; Escobar Salamanca, Andres Felipe; Giraldo Toro, Andres; Rivera, Andres; Salazar Duque, Hector; Suarez Baron, Harold; Gallego, Gerardo; Scheldeman, Xavier; Gonzalez Mejia, Alonso			An Integrated Hypothesis on the Domestication of Bactris gasipaes	PLOS ONE			English	Article							NUT BERTHOLLETIA-EXCELSA; CULTIVATED POPULATIONS; GENETIC-RESOURCES; NEW-WORLD; KUNTH; DIVERSITY; PATTERNS; PALMAE; AMAZON; WILD	Peach palm (Bactris gasipaes Kunth) has had a central place in the livelihoods of people in the Americas since pre-Columbian times, notably for its edible fruits and multi-purpose wood. The botanical taxon includes both domesticated and wild varieties. Domesticated var gasipaes is believed to derive from one or more of the three wild types of var. chichagui identified today, although the exact dynamics and location of the domestication are still uncertain. Drawing on a combination of molecular and phenotypic diversity data, modeling of past climate suitability and existing literature, we present an integrated hypothesis about peach palm's domestication. We support a single initial domestication event in south western Amazonia, giving rise to var. chichagui type 3, the putative incipient domesticate. We argue that subsequent dispersal by humans across western Amazonia, and possibly into Central America allowed for secondary domestication events through hybridization with resident wild populations, and differential human selection pressures, resulting in the diversity of present-day landraces. The high phenotypic diversity in the Ecuadorian and northern Peruvian Amazon suggest that human selection of different traits was particularly intense there. While acknowledging the need for further data collection, we believe that our results contribute new insights and tools to understand domestication and dispersal patterns of this important native staple, as well as to plan for its conservation.	[Galluzzi, Gea; Thomas, Evert; Scheldeman, Xavier] Biovers Int, Reg Off Amer, Cali, Valle Del Cauca, Colombia; [Dufour, Dominique] Ctr Cooperac Int invest Agron Desarrollo, CIRAD, Cali, Valle Del Cauca, Colombia; [van Zonneveld, Maarten] Biovers Int, Subreg Off Amer, Turrialba, Cartago, Costa Rica; [Escobar Salamanca, Andres Felipe; Giraldo Toro, Andres; Rivera, Andres; Gallego, Gerardo; Gonzalez Mejia, Alonso] Ctr Int Agr Trop, Cali, Valle Del Cauca, Colombia; [Salazar Duque, Hector] Univ Quindio, Programa Biol, Armenia, Colombia; [Suarez Baron, Harold] Univ Antioquia, Inst Biol, Medellin, Colombia	Alliance; Bioversity International; CIRAD; Alliance; Bioversity International; Alliance; International Center for Tropical Agriculture - CIAT; Universidad del Quindio; Universidad de Antioquia	Galluzzi, G (corresponding author), Biovers Int, Reg Off Amer, Cali, Valle Del Cauca, Colombia.	geagalluzzi@gmail.com	Toro, Andres Giraldo/AAF-2957-2019; Scheldeman, Xavier/AAF-7960-2021; Scheldeman, Xavier/ABE-9909-2021	Scheldeman, Xavier/0000-0001-7967-7361; Giraldo Toro, Andres/0000-0001-9208-4878	Amazon Initiative; MIDAS programme	Amazon Initiative; MIDAS programme	The authors are grateful to the Amazon Initiative and the MIDAS programme for the funding received for this study. The authors also wish to thank the CGIAR programme on Forest Trees and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin A, 2004, THEOR APPL GENET, V108, P1564, DOI 10.1007/s00122-003-1581-9; Hernandez-Ugalde JA, 2011, GENET RESOUR CROP EV, V58, P571, DOI 10.1007/s10722-010-9600-6; [Anonymous], 2014, ETHNOLOGUE LANGUAGES; Arroyo C, 1996, PEJIBAYE, V5, P18; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brush SB, 2000, GENES IN THE FIELD, P3; Casas A, 2006, BIODIVERS CONSERV, V15, P879, DOI 10.1007/s10531-004-2934-7; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clement C, 2009, MOBILITY MIGRATION I, P115; Clement C. R., 1988, Advances in Economic Botany, V6, P155; CLEMENT C R, 1989, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V5, P39; Clement C. R., 2010, Diversity, V2, P72; Clement CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004564; Clement CR, 2004, AGROFOREST SYST, V61-2, P195, DOI 10.1023/B:AGFO.0000028999.84655.17; Clement CR, 1997, ECON BOT, V51, P149, DOI 10.1007/BF02893108; Clement CR, 1999, ECON BOT, V53, P203, DOI 10.1007/BF02866499; Clement CR, 1995, EVOLUTION CROP PLANT, P383; Clement CR, COMMUNICATION; Clement CR, 2001, ANN 3 S REC GEN AM L, P517; Cole DM, 2007, GENET RESOUR CROP EV, V54, P189, DOI 10.1007/s10722-005-3134-3; Corrales-Ulloa F, 1990, B PEJIBAYE GUILIELMA, V2, P1; Couvreur TLP, 2006, GENET RESOUR CROP EV, V53, P1361, DOI 10.1007/s10722-005-5033-z; De Cristo-Araujo M, 2013, TIPITI, V11, P74; de Cristo-Araujo M, 2015, CROP BREED APPL BIOT, V15, P18, DOI 10.1590/1984-70332015v15n1a3; ESRI, 2011, ARCGIS DESKT REL 10; Ferreira E, 1999, MEM NEW YORK BOTAN G, V83, P225; Frankel OH, 1995, CONSERVATION PLANT B; Graefe S, 2013, BIODIVERS CONSERV, V22, P269, DOI 10.1007/s10531-012-0402-3; Henderson A, 2000, FLORA NEOTROP, V79, P1; Ugalde JAH, 2008, REV BIOL TROP, V56, P217; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Huber J, 1904, B MUSEU GOELDI HIST, V4, P375; Hughes CE, 2007, P NATL ACAD SCI USA, V104, P14389, DOI 10.1073/pnas.0702193104; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kindt R, 2005, TREE DIVERSITY ANAL, P197; Lahaye C, 2013, J ARCHAEOL SCI, V40, P2840, DOI 10.1016/j.jas.2013.02.019; Leeuwen J. van, 2005, Agrociencia (Montevideo), V9, P61; Martinez AK, 2002, MOL ECOL NOTES, V2, P408, DOI 10.1046/j.1471-8286.2002.00256.x; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Mora S, 2003, U PITTSBURG LATIN AM; Mora Urpi J, 1999, PALMITO PEJIBAYE BAC, P17; Mora-Urpi J., 1997, PEACH PALM BACTRIS G; Mora-Urpi J, 1984, ORIGEN BIOL FLORAL M, P18; Mora-Urpi J, 1993, 4 C INT BIOL AGR IND, P21; Morcote-Rios G, 2001, BOT REV, V67, P309, DOI 10.1007/BF02858098; Morueta-Holme N, 2013, ECOL LETT, V16, P1446, DOI 10.1111/ele.12184; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Neves EG, 2004, AMAZONIAN DARK EARTHS: EXPLORATIONS IN SPACE AND TIME, P125; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Patino VM, 1963, PLANTAS CULTIVADAS A; Perrault-Archambault M, 2008, ECON BOT, V62, P109, DOI 10.1007/s12231-008-9010-2; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; Prance GT, 1984, PRECOLUMBIAN PLANT M, P85; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez Villegas J., 2010, DOWNSCALING GLOBAL C; Ranere AJ, 2003, CANOPY ARCHAEOLOGY T, P219; RIVAL L, 1993, MAN, V28, P635, DOI 10.2307/2803990; Rodrigues DP, 2004, GENET RESOUR CROP EV, V51, P871, DOI 10.1007/s10722-005-0774-2; Roosevelt AC, 2013, ANTHROPOCENE, V4, P69, DOI 10.1016/j.ancene.2014.05.001; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Smith N, 2015, GEOBOT STUD, P1, DOI 10.1007/978-3-319-05509-1; Solorzano RGL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048438; Stone D, 1951, DEFINICION DISTINTAS, P353; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thomas E., 2014, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V9, P267; Thomas E, 2008, THESIS GHENT U; Thomas E, 2015, J BIOGEOGR, V42, P1367, DOI 10.1111/jbi.12540; Thomas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047676; Thomas E, 2010, AGROFOREST SYST, V80, P131, DOI 10.1007/s10457-010-9315-x; Valdez F, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P865, DOI 10.1007/978-0-387-74907-5_43; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845	75	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144644	10.1371/journal.pone.0144644	http://dx.doi.org/10.1371/journal.pone.0144644			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658881	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903500051
J	Trier, NH; Dam, CE; Olsen, DT; Hansen, PR; Houen, G				Trier, Nicole Hartwig; Dam, Catharina Essendrup; Olsen, Dorthe Tange; Hansen, Paul Robert; Houen, Gunnar			Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; COLLAGEN TYPE-II; PROTEIN/PEPTIDE ANTIBODIES; PROTEIN ANTIBODY; ALPHA-ENOLASE; AUTOANTIBODIES; DISEASE; EPITOPES; IDENTIFICATION; DETERMINANTS	Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, affecting approximately 1-2% of the world population. One of the characteristic features of RA is the presence of autoantibodies. Especially the highly specific anti-citrullinated peptide antibodies (ACPAs), which have been found in up to 70% of RA patients' sera, have received much attention. Several citrullinated proteins are associated with RA, suggesting that ACPAs may react with different sequence patterns, separating them from traditional antibodies, whose reactivity usually is specific towards a single target. As ACPAs have been suggested to be involved in the development of RA, knowledge about these antibodies may be crucial. In this study, we examined the influence of peptide backbone for ACPA reactivity in immunoassays. The antibodies were found to be reactive with a central Cit-Gly motif being essential for ACPA reactivity and to be cross-reactive between the selected citrullinated peptides. The remaining amino acids within the citrullinated peptides were found to be of less importance for antibody reactivity. Moreover, these findings indicated that the Cit-Gly motif in combination with peptide backbone is essential for antibody reactivity. Based on these findings it was speculated that any amino acid sequence, which brings the peptide into a properly folded structure for antibody recognition is sufficient for antibody reactivity. These findings are in accordance with the current hypothesis that structural homology rather than sequence homology are favored between citrullinated epitopes. These findings are important in relation to clarifying the etiology of RA and to determine the nature of ACPAs, e.g. why some Cit-Gly-containing sequences are not targeted by ACPAs.	[Trier, Nicole Hartwig; Dam, Catharina Essendrup; Olsen, Dorthe Tange; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen S, Denmark; [Hansen, Paul Robert] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen O, Denmark	Statens Serum Institut; University of Copenhagen	Trier, NH (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nhp@ssi.dk	Trier, Nicole/AAA-5164-2020	Hansen, Paul Robert/0000-0001-9357-8001; Trier, Nicole/0000-0003-1548-2009				Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Coenen D, 2007, CLIN CHEM, V53, P498, DOI 10.1373/clinchem.2006.078063; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Ioan-Facsinay A, 2008, ARTHRITIS RHEUM-US, V58, P3000, DOI 10.1002/art.23763; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pedersen JK, 2009, RHEUMATOL INT, V29, P411, DOI 10.1007/s00296-008-0713-6; Perez ML, 2007, J MED CHEM, V50, P3573, DOI 10.1021/jm0701932; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Sangha O, 2000, RHEUMATOLOGY, V39, P3, DOI 10.1093/rheumatology/39.suppl_2.3; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sebbag M, 2006, EUR J IMMUNOL, V36, P2250, DOI 10.1002/eji.200535790; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Trier NH, 2012, PROTEIN SCI, V21, P1929, DOI 10.1002/pro.2178; Trouw LA, 2009, ARTHRITIS RHEUM-US, V60, P1923, DOI 10.1002/art.24622; Union A, 2002, ARTHRITIS RHEUM, V46, P1185, DOI 10.1002/art.10229; Uysal H, 2010, IMMUNOL REV, V233, P9, DOI 10.1111/j.0105-2896.2009.00853.x; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; van Venrooij WJ, 2002, NETH J MED, V60, P383; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204; Willemze A, 2012, ANN RHEUM DIS, V71, P268, DOI 10.1136/annrheumdis-2011-200421	30	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144707	10.1371/journal.pone.0144707	http://dx.doi.org/10.1371/journal.pone.0144707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657009	gold, Green Submitted, Green Published			2022-12-26	WOS:000366903500057
J	Kim, JH; Kim, KH; Kim, HJ; Lee, J; Myung, SC				Kim, Jung Hoon; Kim, Kyeoung-Hwa; Kim, Hae Jong; Lee, Jaehyouk; Myung, Soon Chul			Expression of Beta-Defensin 131 Promotes an Innate Immune Response in Human Prostate Epithelial Cells	PLOS ONE			English	Article							LIPOTEICHOIC ACID; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; GENE-EXPRESSION; WALL COMPONENTS; RECEPTOR 2; IN-VITRO; KAPPA-B	Previously, using the Illumina HumanHT-12 microarray we found that beta-defensin 131 (DEFB131), an antimicrobial peptide, is upregulated in the human prostate epithelial cell line RWPE-1 upon stimulation with lipoteichoic acid (LTA; a gram-positive bacterial component), than that in the untreated RWPE-1 cells. In the current study, we aimed to investigate the role of DEFB131 in RWPE-1 cells during bacterial infection. We examined the intracellular signaling pathways and nuclear responses in RWPE-1 cells that contribute to DEFB131 gene induction upon stimulation with LTA. Chromatin immunoprecipitation was performed to determine whether NF-kappa B directly binds to the DEFB131 promoter after LTA stimulation in RWPE-1 cells. We found that DEFB131 expression was induced by LTA stimulation through TLR2 and p38MAPK/NF-kappa B activation, which was evident in the phosphorylation of both p38MAPK and I kappa B alpha. We also found that SB203580 and Bay11-7082, inhibitors of p38MAPK and NF-kappa B, respectively, suppressed LTA-induced DEFB131 expression. The chromatin immunoprecipitation assay showed that NF-kappa B directly binds to the DEFB131 promoter, suggesting that NF-kappa B is a direct regulator, and is necessary for LTA-induced DEFB131 expression in RWPE-1 cells. Interestingly, with DEFB131 overexpression in RWPE-1 cells, the accumulation of mRNA and protein secretion of cytokines (IL-1 alpha, IL-1 beta, IL-6, and IL-12 alpha) and chemokines (CCL20, CCL22, and CXCL8) were significantly enhanced. In addition, DEFB131-transfected RWPE-1 cells markedly induced chemotactic activity in THP-1 monocytes. We concluded that DEFB131 induces cytokine and chemokine upregulation through the TLR2/NF-kappa B signaling pathway in RWPE-1 cells during bacterial infection and promotes an innate immune response.	[Kim, Jung Hoon] KEPCO Med Ctr, Dept Urol, Seoul, South Korea; [Kim, Kyeoung-Hwa; Kim, Hae Jong; Lee, Jaehyouk] Chung Ang Univ, Coll Med, Res Inst Translat Syst Biom, Seoul 156756, South Korea; [Myung, Soon Chul] Chung Ang Univ, Coll Med, Dept Urol, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Myung, SC (corresponding author), Chung Ang Univ, Coll Med, Dept Urol, Seoul 156756, South Korea.	uromyung@cau.ac.kr	Kim, Jung Hoon/HHM-2687-2022	Kim, Jung Hoon/0000-0002-0947-876X	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2011824]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2013R1A1A2011824).	Baroni A, 2006, ARCH DERMATOL RES, V297, P280, DOI 10.1007/s00403-005-0594-4; Boniotto M, 2006, ANTIMICROB AGENTS CH, V50, P1433, DOI 10.1128/AAC.50.4.1433-1441.2006; Bunk S, 2010, J IMMUNOL, V185, P3708, DOI 10.4049/jimmunol.0901660; Charalambous C, 2005, CANCER RES, V65, P10347, DOI 10.1158/0008-5472.CAN-05-0949; COHENKAMINSKY S, 1991, CELL IMMUNOL, V138, P79, DOI 10.1016/0008-8749(91)90134-W; DEBLAKERHOHE DF, 1995, CELL IMMUNOL, V165, P33, DOI 10.1006/cimm.1995.1184; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jia HP, 2001, GENE, V263, P211; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kao CY, 2003, AM J RESP CELL MOL, V29, P71, DOI 10.1165/rcmb.2002-0205OC; Kim HJ, 2011, BJU INT, V107, P144, DOI 10.1111/j.1464-410X.2010.09469.x; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Menzies BE, 2006, INFECT IMMUN, V74, P6847, DOI 10.1128/IAI.00389-06; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Mukaida N, 2000, INT J HEMATOL, V72, P391; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Niyonsaba F, 2010, J IMMUNOL, V184, P3526, DOI 10.4049/jimmunol.0900712; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; POWRIE F, 1993, EUR J IMMUNOL, V23, P3043, DOI 10.1002/eji.1830231147; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; WHICHER JT, 1990, CLIN CHEM, V36, P1269; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yoshimura A, 1999, J IMMUNOL, V163, P1	40	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144776	10.1371/journal.pone.0144776	http://dx.doi.org/10.1371/journal.pone.0144776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649771	Green Published, Green Submitted, gold			2022-12-26	WOS:000366903300076
J	Pellecchia, U; Crestani, R; Decroo, T; Van den Bergh, R; Al-Kourdi, Y				Pellecchia, Umberto; Crestani, Rosa; Decroo, Tom; Van den Bergh, Rafael; Al-Kourdi, Yasmine			Social Consequences of Ebola Containment Measures in Liberia	PLOS ONE			English	Article							QUARANTINE	Introduction In the Ebola Virus Disease (EVD) outbreak in Liberia, two major emergency disease-control measures were cremation of bodies and enforcement of quarantine for asymptomatic individuals suspected of being in contact with a positive case. Enforced by State-related actors, these were promoted as the only method to curtail transmissions as soon as possible. However, as with other harsh measures witnessed by Liberian citizens, in many cases those measures elicited uncontrolled negative reactions within the communities (stigma; fear) that produced, in some cases, the opposite effect of that intended. Methodology The research has been conducted in two phases, for a total of 8 weeks. Ethnography of local practices was carried out in 7 neighbourhoods in Monrovia and 5 villages in Grand Cape Mount County in Liberia. 45 Focus Group Discussions (432 participants) and 30 semi-structured interviews sustained the observing participation. Randomly selected people from different social layers were targeted. The principal investigator worked with the help of two local assistants. Perceptions and practices were both analysed. Results Participants stressed how cremation perpetuated the social breakdown that started with the isolation for the sickness. Socio-economical divides were created by inequitable management of the dead: those who could bribe the burial teams obtained a burial in a private cemetery or the use of Funeral Homes. Conversely, those in economic disadvantage were forced to send their dead for cremation. State-enforced quarantine, with a mandatory prohibition of movement, raised condemnation, strengthened stigmatization and created serious socio-economic distress. Food was distributed intermittently and some houses shared latrines with non-quarantined neighbours. Escapes were also recorded. Study participants narrated how they adopted local measures of containment, through local task forces and socially-rooted control of outsiders. They also stressed how information that was not spread built up rumours and suspicion. Conclusions Populations experiencing an epidemic feel a high degree of social insecurity, in addition to the health hazards. Vertical and coercive measures increase mistrust and fear, producing a counter-productive effect in the containment of the epidemic. On the other hand, local communities show a will to be engaged and a high degree of flexibility in participating to the epidemic response. Efforts in the direction of awareness and community involvement could prove to be better strategy to control the epidemic and root the response on social participation.	[Pellecchia, Umberto] Med Sans Frontieres Operat Ctr Brussels, Liberia Mission, Monrovia, Liberia; [Crestani, Rosa] Med Sans Frontieres Operat Ctr Brussels, Operat Dept, Brussels, Belgium; [Decroo, Tom; Van den Bergh, Rafael; Al-Kourdi, Yasmine] Med Sans Frontieres Operat Ctr Brussels, Dept Med, Brussels, Belgium		Pellecchia, U (corresponding author), Med Sans Frontieres Operat Ctr Brussels, Liberia Mission, Monrovia, Liberia.	u.pellecchia@gmail.com	Decroo, Tom/AAV-7208-2020	Decroo, Tom/0000-0002-1205-1484; Van den Bergh, Rafael/0000-0001-6277-8713				Abramowitz S., 2014, 10 THINGS ANTHR CAN; ACAPS, 2015, EB OUTBR W AFR LESS; American Anthropological Association, 2012, THE ETHICS FORUM; American Anthropological Association, 2014, STRENGTH W AFR HLTH; [Anonymous], 2008, EBOLA CULTURE POLITI; [Anonymous], 2014, LANCET INFECT DIS, V14, P1163, DOI [10.1016/S1473-3099(14)71020-5, DOI 10.1016/S1473-3099(14)71020-5]; Campbell Dave, 2011, Mcgill J Med, V13, P76; Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; Flynn G, 2014, SMUGGLED BUSHMEAT IS; Gold McLean D., 2014, HIST TODAY, V64; Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229; Guerrier G, 2015, LANCET, V385, P603, DOI 10.1016/S0140-6736(15)60231-8; Haglage A, 2014, KISSING CORPSES EBOL; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Markovits D, 2005, J LAW MED ETHICS, V33, P323, DOI 10.1111/j.1748-720X.2005.tb00497.x; McGovern M., 2014, BUSHMEAT POLITICS DI; McNeil DG, 2014, USING TACTIC UNSEEN; Mullan Z, 2014, LANCET GLOB HEALTH, V2, pE550, DOI 10.1016/S2214-109X(14)70278-5; Press Union of Liberia, 2014, IM BATH DEAD BOD; Richards P., 2014, DO FUNERALS SPREAD E; Richards P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003567; Rothstein MA, 2015, INDIANA HLT IN PRESS, V12; Rothstein MA, 2015, HASTINGS CENT REP, V45, P5, DOI 10.1002/hast.411; Snyder RE, 2014, LANCET GLOB HEALTH, V2, pE685, DOI 10.1016/S2214-109X(14)70339-0; Upshur R, 2003, VIRTUAL MENTOR VM, V5; Wesley PJ, 2014, LIBERIAS EBOLA EPIDE; World Health Organization (WHO), 2015, EB SIT REP 3 JUN 201	28	128	130	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143036	10.1371/journal.pone.0143036	http://dx.doi.org/10.1371/journal.pone.0143036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650630	Green Published, gold, Green Submitted			2022-12-26	WOS:000366903300010
J	Tsou, YA; Lin, CD; Chen, HC; Hsu, HY; Wu, LT; Chiang-Ni, C; Chen, CJ; Wu, TF; Kao, MC; Chen, YA; Peng, MT; Tsai, MH; Chen, CM; Lai, CH				Tsou, Yung-An; Lin, Chia-Der; Chen, Hui-Chen; Hsu, Hui-Ying; Wu, Lii-Tzu; Chiang-Ni, Chuan; Chen, Chih-Jung; Wu, Tsu-Fang; Kao, Min-Chuan; Chen, Yu-An; Peng, Ming-Te; Tsai, Ming-Hsui; Chen, Chuan-Mu; Lai, Chih-Ho			Interleukin-13 Inhibits Lipopolysaccharide-Induced BPIFA1 Expression in Nasal Epithelial Cells	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; PSEUDOMONAS INFECTION; HOST-DEFENSE; SPLUNC1; AIRWAY; PROTEIN; PLUNC; NASOPHARYNX; CONTRIBUTES; SURFACTANT	Short palate, lung, and nasal epithelium clone 1 (SPLUNC1) protein is expressed in human nasopharyngeal and respiratory epithelium and has demonstrated antimicrobial activity. SPLUNC1 is now referred to as bactericidal/permeability-increasing fold containing family A, member 1 (BPIFA1). Reduced BPIFA1 expression is associated with bacterial colonization in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Interleukin 13 (IL-13), predominately secreted by T helper 2 (TH2) cells, has been found to contribute to airway allergies and suppress BPIFA1 expression in nasal epithelial cells. However, the molecular mechanism of IL-13 perturbation of bacterial infection and BPIFA1 expression in host airways remains unclear. In this study, we found that lipopolysaccharide (LPS)-induced BPIFA1 expression in nasal epithelial cells was mediated through the JNK/c-Jun signaling pathway and AP-1 activation. We further demonstrated that IL-13 downregulated the LPS-induced activation of phosphorylated JNK and c-Jun, followed by attenuation of BPIFA1 expression. Moreover, the immunohistochemical analysis showed that IL-13 prominently suppressed BPIFA1 expression in eosinophilic CRSwNP patients with bacterial infection. Taken together, these results suggest that IL-13 plays a critical role in attenuation of bacteria-induced BPIFA1 expression that may result in eosinophilic CRSwNP.	[Tsou, Yung-An; Lin, Chia-Der; Hsu, Hui-Ying; Tsai, Ming-Hsui] China Med Univ & Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan; [Tsou, Yung-An; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Chia-Der; Chen, Hui-Chen; Hsu, Hui-Ying; Wu, Lii-Tzu; Chen, Yu-An; Peng, Ming-Te; Lai, Chih-Ho] China Med Univ & Hosp, Sch Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chiang-Ni, Chuan; Chen, Chih-Jung; Kao, Min-Chuan; Lai, Chih-Ho] Chang Gung Univ, Grad Inst Biomed Sci, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Chen, Chih-Jung] Chang Gung Childrens Hosp, Dept Paediat, Div Paediat Infect Dis, Taoyuan, Taiwan; [Chen, Chih-Jung] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Wu, Tsu-Fang] Hung Kuang Univ, Dept Appl Cosmetol, Taichung, Taiwan; [Lai, Chih-Ho] Asia Univ, Dept Nursing, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Hungkuang University; Asia University Taiwan	Lin, CD (corresponding author), China Med Univ & Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan.	d6355@mail.cmuh.org.tw; chchen1@dragon.nchu.edu.tw; chlai@mail.cgu.edu.tw	Chen, Hui-Chen/L-8149-2013; Chiang-Ni, Chuan/ABD-9765-2021; Chen, Chuan-Mu/K-7049-2013	Chen, Hui-Chen/0000-0001-9751-5729; Chiang-Ni, Chuan/0000-0002-0753-035X; Chen, Chuan-Mu/0000-0003-2461-9150	Ministry of Science and Technology [103-2633-B-182-001, 104-2320-B-182-040, 104-2314-B-039-040]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University and Hospital [CMU102-ASIA-21, 103-S-15, 103-S-18, DMR103-025]; Chang Gung Memorial Hospital [CMRPD3E0511-3]; Tomorrow Medicine Foundation [TMF104-01]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University and Hospital(China Medical University); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Tomorrow Medicine Foundation	This work was supported by research grants from the Ministry of Science and Technology (103-2633-B-182-001, 104-2320-B-182-040, 104-2314-B-039-040); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University and Hospital (CMU102-ASIA-21, 103-S-15, 103-S-18, and DMR103-025); Chang Gung Memorial Hospital (CMRPD3E0511-3), and the Tomorrow Medicine Foundation (TMF104-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bartlett J, 2011, BIOCHEM SOC T, V39, P1012, DOI 10.1042/BST0391012; Bassiouni A, 2012, LARYNGOSCOPE, V122, P460, DOI 10.1002/lary.22461; Bingle CD, 2004, INT J BIOCHEM CELL B, V36, P2144, DOI 10.1016/j.biocel.2004.05.002; Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977; Chen HX, 2015, BIOMEDICINE-TAIWAN, V5, P39, DOI 10.7603/s40681-015-0006-9; Coticchia J, 2007, ARCH OTOLARYNGOL, V133, P110, DOI 10.1001/archotol.133.2.110; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; Di YP, 2007, BIOCHEM SOC T, V39, P1051; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fong YC, 2008, J BONE MINER RES, V23, P961, DOI 10.1359/JBMR.080206; Gakhar L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009098; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hsu J, 2011, AM J RHINOL ALLERGY, V25, P285, DOI 10.2500/ajra.2011.25.3680; Huang CC, 2012, J LARYNGOL OTOL, V126, P470, DOI 10.1017/S0022215112000497; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Hunsaker DH, 2008, CURR OPIN OTOLARYNGO, V16, P237, DOI 10.1097/MOO.0b013e3282fdc6d5; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; LeClair EE, 2003, BIOCHEM SOC T, V31, P801, DOI 10.1042/BST0310801; Lin CD, 2014, NANOMEDICINE-UK, V9, P1327, DOI [10.2217/NNM.14.48, 10.2217/nnm.14.48]; Lin CD, 2012, EUR ARCH OTO-RHINO-L, V269, P503, DOI 10.1007/s00405-011-1704-x; Lin CD, 2011, INFECT IMMUN, V79, P3563, DOI 10.1128/IAI.05175-11; Lin CD, 2011, LAB INVEST, V91, P1092, DOI 10.1038/labinvest.2011.69; Liu Y, 2013, AM J PATHOL, V182, P1519, DOI 10.1016/j.ajpath.2013.01.050; Liu YY, 2013, J IMMUNOL, V191, P4259, DOI 10.4049/jimmunol.1202340; Lu DY, 2012, INFECT IMMUN, V80, P1823, DOI 10.1128/IAI.05856-11; Lukinskiene L, 2011, J IMMUNOL, V187, P382, DOI 10.4049/jimmunol.1001769; McGillivary G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013224; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Park S, 1999, B KOR CHEM SOC, V20, P925; Sayeed S, 2013, INFECT IMMUN, V81, P285, DOI 10.1128/IAI.00500-12; Seshadri S, 2012, ALLERGY, V67, P920, DOI 10.1111/j.1398-9995.2012.02848.x; Singhal D, 2011, LARYNGOSCOPE, V121, P1578, DOI 10.1002/lary.21805; SMITH LF, 1993, OTOLARYNG HEAD NECK, V108, P688, DOI 10.1177/019459989310800610; Tsou YA, 2014, EUR ARCH OTO-RHINO-L, V271, P299, DOI 10.1007/s00405-013-2535-8; Tsou YA, 2013, LARYNGOSCOPE, V123, P845, DOI 10.1002/lary.23871; Wei Y, 2014, J ALLERGY CLIN IMMUN, V133, P420, DOI 10.1016/j.jaci.2013.09.052; Yeh TH, 2010, AMJ RHINOL ALLERGY, V24, P17, DOI 10.2500/ajra.2010.24.3381; You H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26845	40	6	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143484	10.1371/journal.pone.0143484	http://dx.doi.org/10.1371/journal.pone.0143484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646664	Green Submitted, Green Published, gold			2022-12-26	WOS:000366903100003
J	Booiman, T; Loukachov, VV; van Dort, KA; van 't Wout, AB; Kootstra, NA				Booiman, Thijs; Loukachov, Vladimir V.; van Dort, Karel A.; van 't Wout, Angelique B.; Kootstra, Neeltje A.			DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FUSION INHIBITOR T-20; CD4(+) T-CELLS; SODIUM-BUTYRATE; GENE-EXPRESSION; IN-VITRO; HISTONE DEACETYLATION; TYPE-1; ACTIVATION; INFECTION	Background Transcription of the HIV-1 provirus is regulated by both viral and host proteins and is very important in the context of viral latency. In latently infected cells, viral gene expression is inhibited as a result of the sequestration of host transcription factors and epigenetic modifications. Results In our present study we analyzed the effect of host factor dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) on HIV-1 replication. We show that DYRK1A controls HIV-1 replication by regulating provirus transcription. Downregulation or inhibition of DYRK1A increased LTR-driven transcription and viral replication in cell lines and primary PBMC. Furthermore, inhibition of DYRK1A resulted in reactivation of latent HIV-1 provirus to a similar extent as two commonly used broad-spectrum HDAC inhibitors. We observed that DYRK1A regulates HIV-1 transcription via the Nuclear Factor of Activated T-cells (NFAT) by promoting its translocation from the nucleus to the cytoplasm. Therefore, inhibition of DYRK1A results in increased nuclear levels of NFAT and increased NFAT binding to the viral LTR and thus increasing viral transcription. Conclusions Our data indicate that host factor DYRK1A plays a role in the regulation of viral transcription and latency. Therefore, DYRK1A might be an attractive candidate for therapeutic strategies targeting the viral reservoir.	[Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.a.kootstra@amc.uva.nl		van 't Wout, Angelique/0000-0003-3705-2392; Kootstra, Neeltje A./0000-0001-9429-7754	Landsteiner Foundation for Blood Transfusion Research [0526]	Landsteiner Foundation for Blood Transfusion Research	This study was funded by the Landsteiner Foundation for Blood Transfusion Research (0526).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bates DL, 2008, STRUCTURE, V16, P684, DOI 10.1016/j.str.2008.01.020; Borner K, 2010, BIOTECHNOL J, V5, P39, DOI 10.1002/biot.200900226; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GOLUB EI, 1991, AIDS, V5, P663, DOI 10.1097/00002030-199106000-00004; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kok KH, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-78; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; de Lagran MM, 2012, CEREB CORTEX, V22, P2867, DOI 10.1093/cercor/bhr362; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Novis CL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-119; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Rato S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009276; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; van de Klundert MA, 2015, J VIRAL HEPAT; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	74	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144229	10.1371/journal.pone.0144229	http://dx.doi.org/10.1371/journal.pone.0144229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641855	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700079
J	Shi, JD; Zhang, J; Li, SJ; Sun, J; Teng, YM; Wu, MN; Li, JF; Li, YH; Hu, NZ; Wang, HX; Hu, YZ				Shi, Jiandong; Zhang, Jing; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang			Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases	PLOS ONE			English	Article							EAST RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; T-CELL EPITOPES; MIDDLE-EAST; SYNDROME CORONAVIRUS; NUCLEOCAPSID PROTEIN; PEPTIDE BINDING; SPIKE PROTEIN; PREDICTION; IMMUNOGENICITY	Middle East respiratory syndrome coronavirus (MERS-CoV) with pandemic potential is a major worldwide threat to public health. However, vaccine development for this pathogen lags behind as immunity associated with protection is currently largely unknown. In this study, an immunoinformatics-driven genome-wide screening strategy of vaccine targets was performed to thoroughly screen the vital and effective dominant immunogens against MERS-CoV. Conservancy and population coverage analysis of the epitopes were done by the Immune Epitope Database. The results showed that the nucleocapsid (N) protein of MERS-CoV might be a better protective immunogen with high conservancy and potential eliciting both neutralizing antibodies and T-cell responses compared with spike (S) protein. Further, the B-cell, helper T-cell and cytotoxic T lymphocyte (CTL) epitopes were screened and mapped to the N protein. A total of 15 linear and 10 conformal B-cell epitopes that may induce protective neutralizing antibodies were obtained. Additionally, a total of 71 peptides with 9-mer core sequence were identified as helper T-cell epitopes, and 34 peptides were identified as CTL epitopes. Based on the maximum HLA binding alleles, top 10 helper T-cell epitopes and CTL epitopes that may elicit protective cellular immune responses against MERS-CoV were selected as MERS vaccine candidates. Population coverage analysis showed that the putative helper T-cell epitopes and CTL epitopes could cover the vast majority of the population in 15 geographic regions considered where vaccine would be employed. The B-and T-cell stimulation potentials of the screened epitopes is to be further validated for their efficient use as vaccines against MERS-CoV. Collectively, this study provides novel vaccine target candidates and may prompt further development of vaccines against MERS-CoV and other emerging infectious diseases.	[Shi, Jiandong; Zhang, Jing; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Shi, Jiandong; Zhang, Jing; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang] Peking Union Med Coll, Kunming, Peoples R China; [Shi, Jiandong; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Yunnan Prov Key Lab Arbo Infect Dis Control Res P, Kunming, Peoples R China; [Zhang, Jing] Shijiazhuang Obstet & Gynecol Hosp, Prenatal Diag Ctr, Shijiazhuang, Hebei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS	Hu, YZ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.	huyunzhangym@126.com			Applied and Fundamental Research program of Yunnan Province [2013FA025, 2013BC011]	Applied and Fundamental Research program of Yunnan Province	This research was supported by grant from the Applied and Fundamental Research program of Yunnan Province (Grant No. 2013FA025 and 2013BC011), which were received by Yunzhang Hu and Ningzhu Hu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Du LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081587; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Dutta NK, 2008, IMMUNOL LETT, V118, P65, DOI 10.1016/j.imlet.2008.03.003; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Firbas C, 2006, VACCINE, V24, P4343, DOI 10.1016/j.vaccine.2006.03.009; Gao X, 2015, J INFECTION, V71, P599, DOI 10.1016/j.jinf.2015.07.002; Guo XJ, 2015, IMMUNOLOGY, V145, P476, DOI 10.1111/imm.12462; Gupta V, 2006, VIROLOGY, V347, P127, DOI 10.1016/j.virol.2005.11.042; Han ZX, 2013, VIRUS RES, V171, P54, DOI 10.1016/j.virusres.2012.10.028; He LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12501; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hu H, 2009, BIOTECHNOL LETT, V31, P1685, DOI 10.1007/s10529-009-0061-y; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kim E, 2014, VACCINE, V32, P5975, DOI 10.1016/j.vaccine.2014.08.058; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Le TM, 2007, FEBS J, V274, P4211, DOI 10.1111/j.1742-4658.2007.05947.x; Liu DQ, 2012, APPL MICROBIOL BIOT, V93, P2437, DOI 10.1007/s00253-011-3734-0; Liu SJ, 2006, VACCINE, V24, P3100, DOI 10.1016/j.vaccine.2006.01.058; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Ma CL, 2006, CELL MOL IMMUNOL, V3, P459; Mackay IM, 2015, VIRUS RES, V202, P60, DOI 10.1016/j.virusres.2015.01.021; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13; Muh HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005861; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Sominskaya I, 2010, CLIN VACCINE IMMUNOL, V17, P1027, DOI 10.1128/CVI.00468-09; Song F, 2013, J VIROL, V87, P11950, DOI 10.1128/JVI.01672-13; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; Tang J, 2015, HUM VACC IMMUNOTHER, V11, P1244, DOI 10.1080/21645515.2015.1021527; Terry FE, 2015, EXPERT REV VACCINES, V14, P21, DOI 10.1586/14760584.2015.955478; VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207; Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang LM, 2012, BRIEF BIOINFORM, V13, P350, DOI 10.1093/bib/bbr060; Zhang NR, 2014, EXPERT REV VACCINES, V13, P761, DOI 10.1586/14760584.2014.912134; Zhao JC, 2007, J VIROL, V81, P6079, DOI 10.1128/JVI.02568-06; Zheng NY, 2009, VACCINE, V27, P5001, DOI 10.1016/j.vaccine.2009.05.073; Zhou MH, 2006, J IMMUNOL, V177, P2138, DOI 10.4049/jimmunol.177.4.2138; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	62	31	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144475	10.1371/journal.pone.0144475	http://dx.doi.org/10.1371/journal.pone.0144475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641892	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700133
J	Zhu, ZX; Cai, WH; Wang, T; Ye, HB; Zhu, YT; Chi, LS; Duan, YM; Sun, CC; Xuan, YH; Jin, LT				Zhu, Zhong Xin; Cai, Wan Hui; Wang, Tao; Ye, Hong Bo; Zhu, Yu Ting; Chi, Li Sha; Duan, Yuan Meng; Sun, Cong Cong; Xuan, Yuan Hu; Jin, Li Tai			bFGF-Regulating MAPKs Are Involved in High Glucose-Mediated ROS Production and Delay of Vascular Endothelial Cell Migration	PLOS ONE			English	Article							DIABETES-MELLITUS; GROWTH-FACTOR; SKIN REGENERATION; FIBROBLAST; ANGIOGENESIS; DYSFUNCTION; DEATH; RATS; JNK	High blood sugar is a symptom of diabetes mellitus (DM). Vascular endothelial cells (VECs) directly contact the blood and are damaged when blood sugar levels are high. However, the molecular mechanism underlying this process remains elusive. To analyze the effects of DM on migration, we simulated DM by applying high glucose (HG) to the human VEC. HG delayed cell migration and induced phosphorylation of MAPKs (JNK and ERK). By contrast, in presence of bFGF, cell migration was promoted and MAPK phosphorylation levels were reduced. Furthermore, treatment with JNK and ERK inhibitors rescued HG-mediated delay of cell migration. Molecular and cell biological studies demonstrated that HG increased ROS production, whereas treatment with bFGF or JNK/ERK inhibitors blocked HG-induced ROS accumulation. Addition of MnTMPyP, a ROS scavenger, reduced HG-induced ROS production and accelerated cell migration, suggesting that the influence of HG on bFGF-MAPK signaling causes accumulation of ROS, which in turn regulate cell migration. This is the first study to elucidate the molecular mechanism of HG-mediated VEC migration; these findings could facilitate the development of novel therapies for DM.	[Zhu, Zhong Xin; Cai, Wan Hui; Wang, Tao; Zhu, Yu Ting; Chi, Li Sha; Duan, Yuan Meng; Sun, Cong Cong; Xuan, Yuan Hu; Jin, Li Tai] Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol Pharmaceut Engn, Wenzhou 325000, Peoples R China; [Ye, Hong Bo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Wenzhou Medical University; Stanford University	Xuan, YH (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol Pharmaceut Engn, Wenzhou 325000, Peoples R China.	yhxuan@wzmc.edu.cn; jin_litai@126.com		, Yuanhu/0000-0002-4704-8090	National Nature Science Foundation of China [81371753, 81573069, 81201245]; Zhejiang Key Health Science and Technology [WKJ-ZJ-1415]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Key Health Science and Technology	This work was supported by grants from the National Nature Science Foundation of China (No. 81371753, No. 81573069, and No. 81201245), Zhejiang Key Health Science and Technology Project (WKJ-ZJ-1415).	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Brahmbhatt AA, 2003, J BIOL CHEM, V278, P13016, DOI 10.1074/jbc.M211873200; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Currie CJ, 1998, DIABETES CARE, V21, P42, DOI 10.2337/diacare.21.1.42; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hauck CR, 2001, CANCER RES, V61, P7079; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; LANGENSTROER P, 1992, AM J PHYSIOL, V263, pH257, DOI 10.1152/ajpheart.1992.263.1.H257; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; LORENZI M, 1985, DIABETES, V34, P621, DOI 10.2337/diabetes.34.7.621; LORENZI M, 1991, DIABETES, V40, P653, DOI 10.2337/diabetes.40.6.653; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; ONO H, 1988, THROMB HAEMOSTASIS, V60, P174; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; TESFAMARIAM B, 1992, AM J PHYSIOL, V263, pH321, DOI 10.1152/ajpheart.1992.263.2.H321; Uyen HD, 2002, J CELL SCI, V115, P3073; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Xuan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108182; Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042; Yu HY, 2014, INJURY, V45, P1054, DOI 10.1016/j.injury.2014.03.003	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144495	10.1371/journal.pone.0144495	http://dx.doi.org/10.1371/journal.pone.0144495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642060	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700134
